Citrus Sinensis ID: 002121
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 964 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LT96 | 946 | Probable leucine-rich rep | no | no | 0.921 | 0.938 | 0.527 | 0.0 | |
| C0LGD7 | 953 | Probable LRR receptor-lik | no | no | 0.856 | 0.866 | 0.375 | 1e-139 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.868 | 0.872 | 0.358 | 1e-138 | |
| Q9LFG1 | 937 | Putative leucine-rich rep | no | no | 0.848 | 0.872 | 0.362 | 1e-129 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.792 | 0.761 | 0.32 | 1e-91 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.832 | 0.642 | 0.287 | 8e-81 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.365 | 0.495 | 0.424 | 1e-74 | |
| Q3E8W4 | 858 | Receptor-like protein kin | no | no | 0.350 | 0.393 | 0.454 | 1e-74 | |
| Q9FN92 | 829 | Probable receptor-like pr | no | no | 0.364 | 0.423 | 0.441 | 5e-74 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.353 | 0.500 | 0.398 | 5e-74 |
| >sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 842 bits (2175), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 483/915 (52%), Positives = 613/915 (66%), Gaps = 27/915 (2%)
Query: 16 HIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNN-SRVTALGLST 73
I + + TD D ALQ+LK+ W +WK+SD PCG+ W G+TCNN +RV ++ L+
Sbjct: 19 QIYSVYAFTDGSDFTALQALKNEWDTLSKSWKSSD-PCGTEWVGITCNNDNRVVSISLTN 77
Query: 74 MGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEI 133
L GKL +I L+EL++LDL+ N L+G L IG+L+KL L L GC F G IPD I
Sbjct: 78 RNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAFNGPIPDSI 137
Query: 134 GNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS-PGLDQLKN 192
GNL +L+ L+LN N FSG IP S+G+LS+LYW D+ADNQL G +PVS S PGLD L
Sbjct: 138 GNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASLPGLDMLLQ 197
Query: 193 AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNAL 252
HFHF NKLSG I E+LFS +M L+HVLFDGNQ +G+IPESLG VQ L VLRLDRN L
Sbjct: 198 TGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTVLRLDRNRL 257
Query: 253 TGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLP 312
+G +P++LNNLTN+ EL+L+ N G P+L+ + SL +D+SNN + P W L
Sbjct: 258 SGDIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPVPSWIPFLN 317
Query: 313 SLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQI 372
SL+TL E L G VP LFS Q+Q V L++N N TLD+G L VDL++N I
Sbjct: 318 SLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLDFVDLRDNFI 377
Query: 373 SAITLGSGIKNYTLILVGNPVCTATLAN--TNYCQLQQPTTKAYSTSLANCG---GKSCP 427
+ ++L N VC AN + YC QP + +ST L CG GK
Sbjct: 378 TGYK-SPANNPVNVMLADNQVCQDP-ANQLSGYCNAVQPNS-TFST-LTKCGNHCGKGKE 433
Query: 428 PEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSL--WVKLGLTP-GSVFLQ 484
P Q C C YP G R PSF SN + F SL + K G P SV ++
Sbjct: 434 PNQ-----GCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNGKYPVDSVAMR 488
Query: 485 NPFFNIDDY-LQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPY-A 542
N N DY L I + +FPSG FN++E+ I + Q YKPP FGPY F+A Y
Sbjct: 489 NISENPTDYHLLINLLIFPSGRDRFNQTEMDSINSAFTIQDYKPPPRFGPYIFVADQYKT 548
Query: 543 FQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSG 602
F + ++S V G+ G VL+L L G+YA+RQKKRA+RA PFA W +G
Sbjct: 549 FSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFAKWD-AG 607
Query: 603 KDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQG 662
K+ APQL G + F+++EL KC+NNFS++N++G GGYG+VY+G L +GQV+AIKRAQQG
Sbjct: 608 KNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQG 667
Query: 663 SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHL 722
SMQG EFKTEIELLSRVHHKN+V L+GFCF+Q EQMLVYE++ NG+LR+ LSG++G+ L
Sbjct: 668 SMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSGKNGVKL 727
Query: 723 DWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782
DW RRL+IALGS +GLAYLHELA+PPIIHRDVKS NILLDE+LTAKVADFGLSKLV D
Sbjct: 728 DWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDPE 787
Query: 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842
K HV+TQVKGTMGYLDPEYYMT QLTEKSDVY FGVVMLEL+T K PI++G YVV+EV+
Sbjct: 788 KAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYVVKEVKK 847
Query: 843 AMNRDDEEHYGLTEMMDPTIRNTV--LLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900
M++ Y L E++D TI L GF +Y+++ALQCVE +RPTMSEVV+ +E+
Sbjct: 848 KMDK-SRNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEVVQELES 906
Query: 901 LLQNDGMNTNSTSAS 915
+L+ G+N N+ SA+
Sbjct: 907 ILRLVGLNPNADSAT 921
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGD7|Y1684_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g06840 OS=Arabidopsis thaliana GN=At1g06840 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 497 bits (1279), Expect = e-139, Method: Compositional matrix adjust.
Identities = 346/921 (37%), Positives = 494/921 (53%), Gaps = 95/921 (10%)
Query: 24 TDSRDAAALQSLKDAWQNTP----PTWKNSDDPCGS-WEGVTCNNSRVTALGLSTMGLTG 78
T+ + AL+ +K++ N P WK+ D PC S W GV C NS +
Sbjct: 33 TNPVEVRALRVIKESL-NDPVHRLRNWKHGD-PCNSNWTGVVCFNSTLD----------- 79
Query: 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAE 138
G + L L ++ L+G+LSP +G L +L IL TG+IP EIGN+
Sbjct: 80 ------DGYLHVSELQL-FSMNLSGNLSPELGRLSRLTILSFMWNKITGSIPKEIGNIKS 132
Query: 139 LSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHF 198
L L LN N +G +P LG L L + + +N+++G +P S L KHFH
Sbjct: 133 LELLLLNGNLLNGNLPEELGFLPNLDRIQIDENRISGPLPKS------FANLNKTKHFHM 186
Query: 199 NKNKLSGTISEQLFS-PDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK-V 256
N N +SG I +L S P +V H+L D N LSG +P L + L +L+LD N G +
Sbjct: 187 NNNSISGQIPPELGSLPSIV--HILLDNNNLSGYLPPELSNMPRLLILQLDNNHFDGTTI 244
Query: 257 PTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTT 316
P + N++ + +++L + L+GP PDLS + +L Y+DLS N + + S S+TT
Sbjct: 245 PQSYGNMSKLLKMSLRNCSLQGPVPDLSSIPNLGYLDLSQNQLNGSIPAGKLSD--SITT 302
Query: 317 LICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMG-------NAVGPLLQLVDLQN 369
+ SL G +P ++Q++ L NNA + ++ N+ ++ VDL+N
Sbjct: 303 IDLSNNSLTGTIPTNFSGLPRLQKLSLANNALSGSIPSRIWQERELNSTESII--VDLRN 360
Query: 370 NQISAITLGSGIK-NYTLILVGNPVCTATLANTNYCQLQQPTTKAY----STSLANCGGK 424
N S I+ S ++ N T+ L GNP+C+ + N +L P T+ ST+
Sbjct: 361 NGFSNISGRSDLRPNVTVWLQGNPLCS----DGNLLRLCGPITEEDINQGSTNSNTTICS 416
Query: 425 SCPPEQKLSPQ---SCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSV 481
CPP + SP+ C CA P + P F + V + E ++ GL+
Sbjct: 417 DCPPPYEFSPEPLRRCFCAAPLLVGYRLKSPGFSDF----VPYRSEFEQYITSGLSLNLY 472
Query: 482 FLQNPFFNIDD--YLQIQVALFP------SGEKSFNRSEVQKIGFELSNQTYKPPKEFGP 533
L+ F L++ + FP + FNRSEV++I + + FGP
Sbjct: 473 QLRLDSFQWQKGPRLRMYLKFFPVFGSNANNSFIFNRSEVRRIRGMFTGWNIRDEDLFGP 532
Query: 534 Y----YFIASPYAFQVPQGGNS-ISPGVAAGIACGGAVLVLGLVGL-GLYAIRQKKRAER 587
Y + + Y P S +S G AGI G + L + L +R++ R
Sbjct: 533 YELMNFTLLDVYRDVFPSASPSGLSNGAVAGIVLGSVAAAVTLTAIIALIIMRKRMRGYS 592
Query: 588 AIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM 647
A+ K + S + +++G + F+Y EL ++NF+ S +IG GGYGKVY+G
Sbjct: 593 AVARRK---------RSSKASLKIEGVKSFTYAELALATDNFNSSTQIGQGGYGKVYKGT 643
Query: 648 LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707
L G VVAIKRAQ+GS+QG EF TEIELLSR+HH+NLV L+GFC E+GEQMLVYE+M N
Sbjct: 644 LGSGTVVAIKRAQEGSLQGEKEFLTEIELLSRLHHRNLVSLLGFCDEEGEQMLVYEYMEN 703
Query: 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767
GTLR+++S + LD+ RLRIALGSA+G+ YLH ANPPI HRD+K++NILLD TA
Sbjct: 704 GTLRDNISVKLKEPLDFAMRLRIALGSAKGILYLHTEANPPIFHRDIKASNILLDSRFTA 763
Query: 768 KVADFGLSKL--VSDS---SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLE 822
KVADFGLS+L V D S HVST VKGT GYLDPEY++T QLT+KSDVYS GVV+LE
Sbjct: 764 KVADFGLSRLAPVPDMEGISPQHVSTVVKGTPGYLDPEYFLTHQLTDKSDVYSLGVVLLE 823
Query: 823 LITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVE 882
L T QPI GK +VRE+ A E + +D + + ++ LAL+C
Sbjct: 824 LFTGMQPITHGKNIVREINIAY-----ESGSILSTVDKRMSSVPDECLEKFATLALRCCR 878
Query: 883 ESATDRPTMSEVVKAIETLLQ 903
E RP+M+EVV+ +E + +
Sbjct: 879 EETDARPSMAEVVRELEIIWE 899
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 494 bits (1272), Expect = e-138, Method: Compositional matrix adjust.
Identities = 328/916 (35%), Positives = 496/916 (54%), Gaps = 79/916 (8%)
Query: 24 TDSRDAAALQ----SLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNSRVTALGLSTMGLTG 78
T D +ALQ LKD N WK +D PC S W GV C
Sbjct: 28 THPTDVSALQYVHRKLKDPL-NHLQDWKKTD-PCASNWTGVIC----------------- 68
Query: 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAE 138
+ G ++ L L N LTG L+P +G L L IL TG IP E+GNL
Sbjct: 69 -IPDPSDGFLHVKELRL-LNMNLTGQLAPELGLLSNLTILNFMWNDLTGQIPPELGNLTH 126
Query: 139 LSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHF 198
L FL L+ N +G +P LG LS L L + N+++G +P S L LK KHFH
Sbjct: 127 LIFLLLSGNQLTGSLPQELGSLSNLLILQIDYNEISGKLPTS------LANLKKLKHFHM 180
Query: 199 NKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG-KVP 257
N N ++G I + +S ++H L D N+L+GN+P L + +L +L+LD + G ++P
Sbjct: 181 NNNSITGQIPPE-YSTLTNVLHFLMDNNKLTGNLPPELAQMPSLRILQLDGSNFDGTEIP 239
Query: 258 TNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
++ ++ N+ +L+L + +L+GP PDLS+ L Y+D+S+N FS ++TT+
Sbjct: 240 SSYGSIPNLVKLSLRNCNLEGPIPDLSKSLVLYYLDISSNKLTGEIPKNKFSA--NITTI 297
Query: 318 ICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDM--GNAVGPLLQ--LVDLQNNQIS 373
L G +P ++Q+++++NN + + + N + + ++DL+NN S
Sbjct: 298 NLYNNLLSGSIPSNFSGLPRLQRLQVQNNNLSGEIPVIWENRILKAEEKLILDLRNNMFS 357
Query: 374 AIT--LGSGIKNYTLILVGNPVCT-------ATLANTNYCQLQQPTTKAYSTSLANCGGK 424
++ L + N T+ L GNPVC A L + +++ P T + + S +C +
Sbjct: 358 NVSSVLLNPPSNVTVKLYGNPVCANVNAGKLADLCGISTLEVESPATSSETISTGDCKRQ 417
Query: 425 SCPPEQKL-----SPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPG 479
SCP + SP +C CA P + R PSF + V + L+++ LG+ P
Sbjct: 418 SCPVSENYDYVIGSPVACFCAAPLGIDLRLRSPSFSDFRPYKVSYMLDVASPKNLGINPY 477
Query: 480 SVFLQNPFFNIDDYLQIQVALFPSGEK---SFNRSEVQKIGFELSNQTYKPPKEFGPYYF 536
+ + + L + + +FP + FN +EVQ+I + T GPY
Sbjct: 478 QISIDTFAWQSGPRLFMNMKIFPEYSELNSKFNSTEVQRIVDFFATFTLNTDDSLGPYEI 537
Query: 537 IA------SPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGL-YAIRQKKRAERAI 589
I+ P+ + +S GV+ GI G L L L L + I++ KR +
Sbjct: 538 ISINTGAYKDVTIIFPKK-SGMSIGVSVGIIIGAIAFFLVLSSLALVFFIKRSKRKRKTR 596
Query: 590 GLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS 649
+ P K +KG +++ EL +++FS+ ++IG GGYGKVY+G L
Sbjct: 597 EVD--MEQEHPLPKPPMNMESVKG---YNFTELDSATSSFSDLSQIGRGGYGKVYKGHLP 651
Query: 650 DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGT 709
G VVA+KRA+QGS+QG EF TEIELLSR+HH+NLV L+G+C ++GEQMLVYE+M NG+
Sbjct: 652 GGLVVAVKRAEQGSLQGQKEFFTEIELLSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGS 711
Query: 710 LRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769
L+++LS R L RLRIALGSARG+ YLH A+PPIIHRD+K +NILLD + KV
Sbjct: 712 LQDALSARFRQPLSLALRLRIALGSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKV 771
Query: 770 ADFGLSKLVSDSSKG----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
ADFG+SKL++ G HV+T VKGT GY+DPEYY++ +LTEKSDVYS G+V LE++T
Sbjct: 772 ADFGISKLIALDGGGVQRDHVTTIVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILT 831
Query: 826 AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESA 885
+PI G+ +VREV A + + ++D ++ +R++ELA++C +++
Sbjct: 832 GMRPISHGRNIVREVNEACDAG-----MMMSVIDRSMGQYSEECVKRFMELAIRCCQDNP 886
Query: 886 TDRPTMSEVVKAIETL 901
RP M E+V+ +E +
Sbjct: 887 EARPWMLEIVRELENI 902
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFG1|Y3359_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At3g53590 OS=Arabidopsis thaliana GN=At3g53590 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 463 bits (1191), Expect = e-129, Method: Compositional matrix adjust.
Identities = 326/900 (36%), Positives = 463/900 (51%), Gaps = 82/900 (9%)
Query: 33 QSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELR 91
+SL D +N W D PC S W G+ C G+ D G +R
Sbjct: 42 RSLIDPMRNLS-NWAKGD-PCNSNWTGIIC---------------FGRSHND--GHFHVR 82
Query: 92 SLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSG 151
L L L+G L+P +G L L IL + TG IP EIG ++ L L LN N F+G
Sbjct: 83 ELQL-MRLNLSGELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLNGNKFTG 141
Query: 152 RIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQL 211
+PP LG L L L + +N +TGS+P S L++ KH H N N +SG I +L
Sbjct: 142 SLPPELGNLQNLNRLQVDENNITGSVPFS------FGNLRSIKHLHLNNNTISGEIPVEL 195
Query: 212 FSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK-VPTNLNNLTNVNELN 270
S L+H++ D N L+G +P L + +L +L+LD N G +P + + + +L+
Sbjct: 196 -SKLPKLVHMILDNNNLTGTLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFSRLVKLS 254
Query: 271 LAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPD 330
L + L+G PDLS++ +LSY+DLS N T S ++TT+ + L G +P
Sbjct: 255 LRNCGLQGSIPDLSRIENLSYLDLSWNHLTGTIPESKLSD--NMTTIELSYNHLTGSIPQ 312
Query: 331 KLFSYSQIQQVKLRNNAFNNTLDM-----GNAVGPLLQLVDLQNNQISAITLGSGIKNYT 385
+ +Q + L NN+ + ++ + LQ+ DL NN A N T
Sbjct: 313 SFSDLNSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDLNNNFSDATGNLRTPDNVT 372
Query: 386 LILVGNPVCTAT---LANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQ-KLSPQSCECAY 441
L L GNP+C +T + + + + + S C SCP E K+SP C C
Sbjct: 373 LYLRGNPICKSTSIPMVTQFFEYICGEKKQTSTNSNTPCSNVSCPFENVKVSPGICLCTA 432
Query: 442 PYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYL------- 494
P + PSF F + + + +T S+ L+ ID +
Sbjct: 433 PLSIDYRLKSPSF-------FFFTPYIERQFREYIT-SSLQLETHQLAIDRLVDENRLRP 484
Query: 495 QIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPY----YFIASPYAFQVPQGGN 550
++ + L P G +FN+SEV +I + ++ FGPY + + PYA + Q +
Sbjct: 485 RMYLKLVPKGRITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLLAQT-S 543
Query: 551 SISPGVAAGIACGGAV--LVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGA 608
I V I G V VL + LY +KR E + L+K S
Sbjct: 544 GIRTIVWMMIVAGSVVAATVLSVTATLLYV---RKRRENSHTLTKKRVFRTISR------ 594
Query: 609 PQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL 668
++KG + FS+ EL +N F S IG G YGKVY+G+LS+ VAIKR ++ S+Q
Sbjct: 595 -EIKGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEK 653
Query: 669 EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL 728
EF EI+LLSR+HH+NLV L+G+ + GEQMLVYE+M NG +R+ LS + L + R
Sbjct: 654 EFLNEIDLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRS 713
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-----SDSSK 783
+ALGSA+G+ YLH ANPP+IHRD+K++NILLD L AKVADFGLS+L D
Sbjct: 714 HVALGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEP 773
Query: 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843
HVST V+GT GYLDPEY+MTQQLT +SDVYSFGVV+LEL+T P +G +++REVRTA
Sbjct: 774 AHVSTVVRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA 833
Query: 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
E + + D + ++ ELAL C E+ RP MS+VVK +E + Q
Sbjct: 834 -----NECGTVLSVADSRMGQCSPDKVKKLAELALWCCEDRPETRPPMSKVVKELEGICQ 888
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (867), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 280/875 (32%), Positives = 417/875 (47%), Gaps = 111/875 (12%)
Query: 43 PPTWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLT 102
PP++ GSW + L +S L GK+ +IG LT LR L + Y
Sbjct: 183 PPSY-------GSW-------PVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFE 228
Query: 103 GSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQ 162
L P IG+L +L A CG TG IP EIG L +L L L N FSG + LG LS
Sbjct: 229 DGLPPEIGNLSELVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSS 288
Query: 163 LYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL 222
L +DL++N TG IP S +LKN + +NKL G I E F D+ + VL
Sbjct: 289 LKSMDLSNNMFTGEIPAS------FAELKNLTLLNLFRNKLHGEIPE--FIGDLPELEVL 340
Query: 223 -FDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP 281
N +G+IP+ LG L ++ L N LTG +P N+ + + L N L G P
Sbjct: 341 QLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIP 400
Query: 282 D-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQ 340
D L + SL+ + + N L G +P LF ++ Q
Sbjct: 401 DSLGKCESLTRIRMGENF-------------------------LNGSIPKGLFGLPKLTQ 435
Query: 341 VKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYT----LILVGNPVCTA 396
V+L++N + L + V L + L NNQ+S L I N+T L+L GN
Sbjct: 436 VELQDNYLSGELPVAGGVSVNLGQISLSNNQLSG-PLPPAIGNFTGVQKLLLDGNKFQGP 494
Query: 397 TLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQKLSPQSCEC---AYPYEGTMYFRGPS 453
+ +LQQ + +S +L + +++P+ C + G
Sbjct: 495 IPSEVG--KLQQLSKIDFSHNLFS---------GRIAPEISRCKLLTFVDLSRNELSGEI 543
Query: 454 FRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYLQIQVALFP-SGEKS-FNRS 511
E++ + + + L +S +G PGS+ ++D L P +G+ S FN +
Sbjct: 544 PNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQFSYFNYT 603
Query: 512 EVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGN---SISPGVAAGIACGGAVLV 568
L N P GPY P V +GG+ S P A+ L+
Sbjct: 604 SF------LGN-----PDLCGPYL---GPCKDGVAKGGHQSHSKGPLSASMKLLLVLGLL 649
Query: 569 LGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNN 628
+ + + AI K R+ + S+ + A D F+ D++ ++
Sbjct: 650 VCSIAFAVVAI-IKARSLKKASESRAWRLTAFQRLD------------FTCDDVL---DS 693
Query: 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE--FKTEIELLSRVHHKNLV 686
E N IG GG G VY+G++ +G +VA+KR S + F EI+ L R+ H+++V
Sbjct: 694 LKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRHRHIV 753
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L+GFC +LVYE+M NG+L E L G+ G HL W R +IAL +A+GL YLH +
Sbjct: 754 RLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDTRYKIALEAAKGLCYLHHDCS 813
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
P I+HRDVKS NILLD N A VADFGL+K + DS + + G+ GY+ PEY T +
Sbjct: 814 PLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLK 873
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEK---GKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863
+ EKSDVYSFGVV+LEL+T ++P+ + G +V+ VR + + + + +++DP +
Sbjct: 874 VDEKSDVYSFGVVLLELVTGRKPVGEFGDGVDIVQWVRKMTDSNKDS---VLKVLDPRLS 930
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898
+ + +A+ CVEE A +RPTM EVV+ +
Sbjct: 931 SIPIHEVTHVFYVAMLCVEEQAVERPTMREVVQIL 965
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 8e-81, Method: Compositional matrix adjust.
Identities = 272/946 (28%), Positives = 431/946 (45%), Gaps = 143/946 (15%)
Query: 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLS-------------------- 96
+ + NN+ + L LS L+G++ ++ L+ LDLS
Sbjct: 329 KSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTD 388
Query: 97 ---YNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRI 153
+N L G+LSP I +L L L+L G +P EI L +L L L N FSG I
Sbjct: 389 LYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEI 448
Query: 154 PPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFS 213
P +G + L +D+ N G IP P + +LK H +N+L G + L +
Sbjct: 449 PQEIGNCTSLKMIDMFGNHFEGEIP------PSIGRLKELNLLHLRQNELVGGLPASLGN 502
Query: 214 PDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAH 273
+ I L D NQLSG+IP S G+++ LE L L N+L G +P +L +L N+ +NL+H
Sbjct: 503 CHQLNILDLAD-NQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSH 561
Query: 274 NDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF 333
N L G L +S D++NN F+ E PL +L L L G++P L
Sbjct: 562 NRLNGTIHPLCGSSSYLSFDVTNNGFE-DEIPLELGNSQNLDRLRLGKNQLTGKIPWTLG 620
Query: 334 SYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNN--------------QISAITLGS 379
++ + + +NA T+ + + L +DL NN Q+ + L S
Sbjct: 621 KIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSS 680
Query: 380 G---------IKNYTLILV----GN------PVCTATLANTNYCQLQQPTTKAYSTSLAN 420
+ N T +LV GN P L N L + +S SL
Sbjct: 681 NQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDK---NQFSGSLPQ 737
Query: 421 CGGK-SCPPEQKLSPQSCECAYPYE-GTMY------------FRGPSFRELSNVTVFHSL 466
GK S E +LS S P E G + F G + ++ +L
Sbjct: 738 AMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETL 797
Query: 467 EMSLWVKLGLTPGSVFLQNPFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYK 526
++S G PGSV YL + SFN +G +L Q +
Sbjct: 798 DLSHNQLTGEVPGSVGDMKSL----GYLNV----------SFN-----NLGGKLKKQFSR 838
Query: 527 PPKE--FGPYYFIASPYAFQVPQGGNSISPGVAA-GIACGGAVLVLGLVGLGLYAI---- 579
P + G SP + N+ G++A + A+ L +GL + I
Sbjct: 839 WPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFF 898
Query: 580 RQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGA------RWFSYDELKKCSNNFSESN 633
+Q+ + +G + + S + P + RW +++ + ++N SE
Sbjct: 899 KQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRW---EDIMEATHNLSEEF 955
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRA-QQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
IGSGG GKVY+ L +G+ VA+K+ + + F E++ L R+ H++LV L+G+C
Sbjct: 956 MIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYC 1015
Query: 693 FEQGE--QMLVYEFMANGTLRESLSGRSGIH------LDWKRRLRIALGSARGLAYLHEL 744
+ E +L+YE+M NG++ + L + LDW+ RLRIA+G A+G+ YLH
Sbjct: 1016 SSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHD 1075
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV--STQVKGTMGYLDPEYY 802
PPI+HRD+KS+N+LLD N+ A + DFGL+K+++++ + +T + GY+ PEY
Sbjct: 1076 CVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYA 1135
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT-----EM 857
+ + TEKSDVYS G+V++E++T K P + V M R E H + ++
Sbjct: 1136 YSLKATEKSDVYSMGIVLMEIVTGKMPTDS----VFGAEMDMVRWVETHLEVAGSARDKL 1191
Query: 858 MDPTIRNTVLLGFR-----RYLELALQCVEESATDRPTMSEVVKAI 898
+DP ++ LL F + LE+ALQC + S +RP+ + ++
Sbjct: 1192 IDPKLK--PLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 282 bits (721), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 152/358 (42%), Positives = 225/358 (62%), Gaps = 6/358 (1%)
Query: 570 GLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNF 629
G G G Y +Q+ + + G + + SG A G F+Y+EL + F
Sbjct: 294 GYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVMGSGQTHFTYEELTDITEGF 353
Query: 630 SESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLV 689
S+ N +G GG+G VY+G L+DG++VA+K+ + GS QG EFK E+E++SRVHH++LV LV
Sbjct: 354 SKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLV 413
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
G+C E++L+YE++ N TL L G+ L+W RR+RIA+GSA+GLAYLHE +P I
Sbjct: 414 GYCIADSERLLIYEYVPNQTLEHHLHGKGRPVLEWARRVRIAIGSAKGLAYLHEDCHPKI 473
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
IHRD+KS NILLD+ A+VADFGL+KL +DS++ HVST+V GT GYL PEY + +LT+
Sbjct: 474 IHRDIKSANILLDDEFEAQVADFGLAKL-NDSTQTHVSTRVMGTFGYLAPEYAQSGKLTD 532
Query: 810 KSDVYSFGVVMLELITAKQPIEK----GKYVVREVRTAMNRDDEEHYGLTEMMDPTI-RN 864
+SDV+SFGVV+LELIT ++P+++ G+ + E + E +E++D + ++
Sbjct: 533 RSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKH 592
Query: 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNSTSASSSATDFG 922
V R +E A CV S RP M +VV+A+++ ++ + SSA D G
Sbjct: 593 YVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGNKVGQSSAYDSG 650
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3E8W4|ANX2_ARATH Receptor-like protein kinase ANXUR2 OS=Arabidopsis thaliana GN=ANX2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (720), Expect = 1e-74, Method: Compositional matrix adjust.
Identities = 168/370 (45%), Positives = 225/370 (60%), Gaps = 32/370 (8%)
Query: 555 GVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAP-------------- 600
G A G+A AVL L + + Q+KR + G +SW P
Sbjct: 438 GSAGGVA---AVLFCALC----FTMYQRKR--KFSGSDSHTSSWLPIYGNSHTSATKSTI 488
Query: 601 SGKDSGGAPQLKGA----RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAI 656
SGK + G+ A R FS E+K ++NF ESN IG GG+GKVY+G++ G VAI
Sbjct: 489 SGKSNNGSHLSNLAAGLCRRFSLSEIKHGTHNFDESNVIGVGGFGKVYKGVIDGGTKVAI 548
Query: 657 KRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG 716
K++ S QG EF+TEIELLSR+ HK+LV L+G+C E GE L+Y++M+ GTLRE L
Sbjct: 549 KKSNPNSEQGLNEFETEIELLSRLRHKHLVSLIGYCDEGGEMCLIYDYMSLGTLREHLYN 608
Query: 717 RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776
L WKRRL IA+G+ARGL YLH A IIHRDVK+TNILLDEN AKV+DFGLSK
Sbjct: 609 TKRPQLTWKRRLEIAIGAARGLHYLHTGAKYTIIHRDVKTTNILLDENWVAKVSDFGLSK 668
Query: 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK--GK 834
+ + GHV+T VKG+ GYLDPEY+ QQLTEKSDVYSFGVV+ E++ A+ + K
Sbjct: 669 TGPNMNGGHVTTVVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVLFEVLCARPALNPSLSK 728
Query: 835 YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV-LLGFRRYLELALQCVEESATDRPTMSE 893
V AMN + L +++DP ++ + +++ + A +C+ +S DRPTM +
Sbjct: 729 EQVSLGDWAMNC--KRKGTLEDIIDPNLKGKINPECLKKFADTAEKCLSDSGLDRPTMGD 786
Query: 894 VVKAIETLLQ 903
V+ +E LQ
Sbjct: 787 VLWNLEFALQ 796
|
Receptor-like protein kinase that controls pollen tube behavior by directing rupture at proper timing to release the sperm cell. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN92|Y5597_ARATH Probable receptor-like protein kinase At5g59700 OS=Arabidopsis thaliana GN=At5g59700 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (716), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 165/374 (44%), Positives = 223/374 (59%), Gaps = 23/374 (6%)
Query: 545 VPQGGNSISP---GVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPS 601
+P G +S + G+ G+ G +L LV LG + + KKR G SK +W P
Sbjct: 392 LPSGSSSTTKKNVGMIIGLTIGS---LLALVVLGGFFVLYKKRGRDQDGNSK---TWIPL 445
Query: 602 GKDSGGAPQLKG-----ARWFSYD----ELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQ 652
+ + A SY +K+ +N+F E+ IG GG+GKVY+G L DG
Sbjct: 446 SSNGTTSSSNGTTLASIASNSSYRIPLVAVKEATNSFDENRAIGVGGFGKVYKGELHDGT 505
Query: 653 VVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRE 712
VA+KRA S QG EF+TEIE+LS+ H++LV L+G+C E E +LVYE+M NGTL+
Sbjct: 506 KVAVKRANPKSQQGLAEFRTEIEMLSQFRHRHLVSLIGYCDENNEMILVYEYMENGTLKS 565
Query: 713 SLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772
L G + L WK+RL I +GSARGL YLH P+IHRDVKS NILLDENL AKVADF
Sbjct: 566 HLYGSGLLSLSWKQRLEICIGSARGLHYLHTGDAKPVIHRDVKSANILLDENLMAKVADF 625
Query: 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK 832
GLSK + + HVST VKG+ GYLDPEY+ QQLTEKSDVYSFGVVM E++ A+ I+
Sbjct: 626 GLSKTGPEIDQTHVSTAVKGSFGYLDPEYFRRQQLTEKSDVYSFGVVMFEVLCARPVIDP 685
Query: 833 --GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL-GFRRYLELALQCVEESATDRP 889
+ +V AM + L ++DP++R + R++ E +C+ + DRP
Sbjct: 686 TLTREMVNLAEWAMKWQKKGQ--LEHIIDPSLRGKIRPDSLRKFGETGEKCLADYGVDRP 743
Query: 890 TMSEVVKAIETLLQ 903
+M +V+ +E LQ
Sbjct: 744 SMGDVLWNLEYALQ 757
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 280 bits (715), Expect = 5e-74, Method: Compositional matrix adjust.
Identities = 153/384 (39%), Positives = 233/384 (60%), Gaps = 43/384 (11%)
Query: 556 VAAGIACGGAVLVLGLVGLGLYAIRQKKRAERA--IGLSKPFASWA-PSGKD-------S 605
VA G+ G ++ L L +G++ R++KR + +G + P ++++ P G D S
Sbjct: 239 VAIGVIVG--LVFLSLFVMGVWFTRKRKRKDPGTFVGYTMPPSAYSSPQGSDVVLFNSRS 296
Query: 606 GGAPQLKG-------------------ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRG 646
P+++ WFSYDEL + ++ FSE N +G GG+G VY+G
Sbjct: 297 SAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSYDELSQVTSGFSEKNLLGEGGFGCVYKG 356
Query: 647 MLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706
+LSDG+ VA+K+ + G QG EFK E+E++SRVHH++LV LVG+C + ++LVY+++
Sbjct: 357 VLSDGREVAVKQLKIGGSQGEREFKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVP 416
Query: 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766
N TL L + W+ R+R+A G+ARG+AYLHE +P IIHRD+KS+NILLD +
Sbjct: 417 NNTLHYHLHAPGRPVMTWETRVRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFE 476
Query: 767 AKVADFGLSKLVSD-SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
A VADFGL+K+ + HVST+V GT GY+ PEY + +L+EK+DVYS+GV++LELIT
Sbjct: 477 ALVADFGLAKIAQELDLNTHVSTRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELIT 536
Query: 826 AKQPIEKGKYVVREVRTAMNR-------DDEEHYGLTEMMDPTIRNTVLLG-FRRYLELA 877
++P++ + + E R ++EE E++DP + + G R +E A
Sbjct: 537 GRKPVDTSQPLGDESLVEWARPLLGQAIENEE---FDELVDPRLGKNFIPGEMFRMVEAA 593
Query: 878 LQCVEESATDRPTMSEVVKAIETL 901
CV SA RP MS+VV+A++TL
Sbjct: 594 AACVRHSAAKRPKMSQVVRALDTL 617
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 964 | ||||||
| 356559110 | 967 | PREDICTED: probable leucine-rich repeat | 0.993 | 0.990 | 0.781 | 0.0 | |
| 359480969 | 1043 | PREDICTED: probable leucine-rich repeat | 0.988 | 0.913 | 0.777 | 0.0 | |
| 255557913 | 988 | receptor protein kinase, putative [Ricin | 0.979 | 0.955 | 0.776 | 0.0 | |
| 239056180 | 946 | ATP binding / kinase/ protein serine / t | 0.970 | 0.989 | 0.784 | 0.0 | |
| 356523826 | 969 | PREDICTED: probable leucine-rich repeat | 0.983 | 0.978 | 0.780 | 0.0 | |
| 224140667 | 946 | predicted protein [Populus trichocarpa] | 0.968 | 0.987 | 0.791 | 0.0 | |
| 296085805 | 950 | unnamed protein product [Vitis vinifera] | 0.964 | 0.978 | 0.786 | 0.0 | |
| 449439783 | 966 | PREDICTED: probable leucine-rich repeat | 0.996 | 0.994 | 0.750 | 0.0 | |
| 224069016 | 974 | predicted protein [Populus trichocarpa] | 0.990 | 0.980 | 0.766 | 0.0 | |
| 297842755 | 971 | hypothetical protein ARALYDRAFT_477135 [ | 0.989 | 0.982 | 0.725 | 0.0 |
| >gi|356559110|ref|XP_003547844.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1531 bits (3965), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 753/963 (78%), Positives = 843/963 (87%), Gaps = 5/963 (0%)
Query: 6 LLIFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNS 64
+L+F+ L I +ISS TD++D AL+SLKD WQNTPP+W +DDPCG+ WEGVTCN S
Sbjct: 6 VLLFLGLLWAEIHVISSFTDTQDVVALRSLKDVWQNTPPSWDKADDPCGAPWEGVTCNKS 65
Query: 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCG 124
RVT+LGLSTMGL GKL+GDIG LTELRSLDLS+N GLTG LSP++GDL LNILILAGC
Sbjct: 66 RVTSLGLSTMGLKGKLTGDIGQLTELRSLDLSFNRGLTGPLSPQLGDLSNLNILILAGCS 125
Query: 125 FTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS 184
F GNIPDE+GNL+ELSFLALNSNNF+G+IPPSLGKLS+LYWLDLADNQLTG IPVST T+
Sbjct: 126 FGGNIPDELGNLSELSFLALNSNNFTGKIPPSLGKLSKLYWLDLADNQLTGPIPVSTSTT 185
Query: 185 PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEV 244
PGLD L AKHFHFNKN+LSG+I +LFS +M+LIH+LFDGN LSG IP +L V+++EV
Sbjct: 186 PGLDLLLKAKHFHFNKNQLSGSIPPKLFSSEMILIHILFDGNNLSGTIPSTLVLVKSVEV 245
Query: 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304
LRLDRN LTG+VP++LNNLTN+NELNLAHN GP PDL+ M++L+YVDLSNNSFD ++A
Sbjct: 246 LRLDRNFLTGEVPSDLNNLTNINELNLAHNKFTGPLPDLTGMDTLNYVDLSNNSFDASDA 305
Query: 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQL 364
P WF+ LPSLTTLI EFGSLQG +P KLF QIQQVKLRNNA NNTLDMG+ + P LQL
Sbjct: 306 PTWFTILPSLTTLIMEFGSLQGTLPSKLFDIPQIQQVKLRNNALNNTLDMGDNICPQLQL 365
Query: 365 VDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGK 424
VDLQ+N+IS++TL S KN LIL+GNPVC L+NTN+CQLQQ + YSTSLA+CGGK
Sbjct: 366 VDLQDNEISSVTLRSQYKN-ILILIGNPVCGTALSNTNFCQLQQQAKQPYSTSLASCGGK 424
Query: 425 SCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQ 484
SCPP+QKLSPQSCECAYPYEGT+YFRGPSFRELS+V FHSLEMSLWVKLGLTPGSV LQ
Sbjct: 425 SCPPDQKLSPQSCECAYPYEGTLYFRGPSFRELSSVNTFHSLEMSLWVKLGLTPGSVSLQ 484
Query: 485 NPFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQ 544
NPFFN DDYLQ+Q+ALFP + FNRSEVQ+IGFELSNQTYKPPKEFGPYYFIA PY F
Sbjct: 485 NPFFNSDDYLQVQLALFPPMGQYFNRSEVQRIGFELSNQTYKPPKEFGPYYFIAFPYPFP 544
Query: 545 VPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKD 604
G S+S GV GI+ G +LVL L+GL +YAI QKKRAERAIGLS+PFASWAPSGKD
Sbjct: 545 GSHKGASLSKGVVIGISIGCIILVLSLIGLAIYAILQKKRAERAIGLSRPFASWAPSGKD 604
Query: 605 SGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM 664
SGGAPQLKGARWFSYDELKKCSNNFSESNEIG GGYGKVY+G+ DG++VAIKRAQQGSM
Sbjct: 605 SGGAPQLKGARWFSYDELKKCSNNFSESNEIGFGGYGKVYKGVFPDGKIVAIKRAQQGSM 664
Query: 665 QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDW 724
QGG+EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM NGTLRESLSGRS IHLDW
Sbjct: 665 QGGVEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMPNGTLRESLSGRSEIHLDW 724
Query: 725 KRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784
KRRLR+ALGS+RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS KG
Sbjct: 725 KRRLRVALGSSRGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSEKG 784
Query: 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM 844
HVSTQVKGT+GYLDPEYYMTQQLTEKSDVYSFGVVMLELIT++QPIEKGKY+VREVRT M
Sbjct: 785 HVSTQVKGTLGYLDPEYYMTQQLTEKSDVYSFGVVMLELITSRQPIEKGKYIVREVRTLM 844
Query: 845 NRDDEEHYGLTEMMDPTIRNTV-LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
N+ DEEHYGL E+MDP +RNT L+GF R+LELA+QCVEESATDRPTMSEVVKA+ET+LQ
Sbjct: 845 NKKDEEHYGLRELMDPVVRNTPNLIGFGRFLELAIQCVEESATDRPTMSEVVKALETILQ 904
Query: 904 NDGMNTNSTSASSSATDFGSSKGVVRQIYGDALPNNKKDIND--TNAFDYSGGYTLSAKV 961
NDGMNTNSTSASSSATDFG KG +R Y D K + ND ++AFDYSGGYTLS KV
Sbjct: 905 NDGMNTNSTSASSSATDFGVGKGGMRHPYIDCTFTKKDNANDSSSSAFDYSGGYTLSTKV 964
Query: 962 EPK 964
EPK
Sbjct: 965 EPK 967
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359480969|ref|XP_002264658.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1518 bits (3931), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 747/961 (77%), Positives = 843/961 (87%), Gaps = 8/961 (0%)
Query: 7 LIFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCG-SWEGVTCNNSR 65
L F+ +FS + I T+S DA LQSLK W+NTPP+W+ SD PCG WEG+TCNNSR
Sbjct: 88 LFFLLVFSGGMHGILCFTNSDDAGVLQSLKGQWENTPPSWEKSD-PCGVPWEGITCNNSR 146
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
V ALGLSTMGL GKL GDIGGLTELRSLDLS+N GLTGSL+P++G+L+ LNILILAGCGF
Sbjct: 147 VIALGLSTMGLKGKLEGDIGGLTELRSLDLSFNLGLTGSLTPKLGNLENLNILILAGCGF 206
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
TG IPDE+GNLA+L+FLALNSNN +G+IPPSLG+LS LYWLDLA+N+L+G P ST+TSP
Sbjct: 207 TGQIPDELGNLAQLTFLALNSNNLTGQIPPSLGRLSNLYWLDLAENKLSGPFPTSTLTSP 266
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
GLDQL AKHFHFNKN+LSG I +LFS DM LIHVLFDGNQLSG+IP++LG VQTLEVL
Sbjct: 267 GLDQLLKAKHFHFNKNQLSGPIPRKLFSSDMELIHVLFDGNQLSGSIPDTLGLVQTLEVL 326
Query: 246 RLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAP 305
RLDRN+L+G VP+NLNNLT VNELNLAHN L GP P+L+ M+ L+YVDLSNN+FDP+EAP
Sbjct: 327 RLDRNSLSGTVPSNLNNLTIVNELNLAHNQLIGPIPNLTGMDHLNYVDLSNNTFDPSEAP 386
Query: 306 LWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLV 365
WFSTLPSLTTLI E GSL G VP K+FS+ I+QVKL+NNAFN+T MG+++G LQLV
Sbjct: 387 AWFSTLPSLTTLILEHGSLYGSVPQKVFSFPGIEQVKLKNNAFNDTFSMGDSIGDQLQLV 446
Query: 366 DLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKS 425
DLQNNQI ++TL SG + LILVGNPVC TL NT YCQ+Q T K YST+LANCG +
Sbjct: 447 DLQNNQIPSVTLSSGYTD-ALILVGNPVCKVTLLNTAYCQIQDQTPKTYSTNLANCGSEL 505
Query: 426 CPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQN 485
C P+QKL+PQSCECAY YEGT+YFRGP+FR+LS++ FHSLE SLW KL LTPGSVFLQN
Sbjct: 506 CSPDQKLNPQSCECAYAYEGTLYFRGPTFRDLSDLNKFHSLESSLWTKLNLTPGSVFLQN 565
Query: 486 PFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQV 545
PFFNIDDYLQIQ+ALFP K FNRSEVQ+IGF LSNQTYKPP+EFGPYYFIASPY FQ
Sbjct: 566 PFFNIDDYLQIQLALFPPTGKYFNRSEVQRIGFSLSNQTYKPPEEFGPYYFIASPYHFQ- 624
Query: 546 PQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDS 605
GG S S GV GIA G +LV+GLV LG+YA+RQKKRAERAI LSKPFASWAPSGKDS
Sbjct: 625 GHGGTSFSLGVIIGIAIGCTILVVGLVALGIYAVRQKKRAERAIELSKPFASWAPSGKDS 684
Query: 606 GGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ 665
G APQLKGARWFSYDELKKC+NNFSESNEIGSGGYGKVYRGMLS GQ+VAIKRAQQGSMQ
Sbjct: 685 GAAPQLKGARWFSYDELKKCTNNFSESNEIGSGGYGKVYRGMLSGGQIVAIKRAQQGSMQ 744
Query: 666 GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWK 725
GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM NGTLRESLSGRSGIHLDWK
Sbjct: 745 GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMPNGTLRESLSGRSGIHLDWK 804
Query: 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785
RRLRIALGSARGLAYLHELANPPIIHRD+KSTNILLDENLTAKVADFGLSKLVSDS+KGH
Sbjct: 805 RRLRIALGSARGLAYLHELANPPIIHRDIKSTNILLDENLTAKVADFGLSKLVSDSAKGH 864
Query: 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN 845
VSTQVKGT+GYLDPEYYMTQQLTEKSDVYS+GVVMLEL++A+QPIEKGKY+VREVR AM+
Sbjct: 865 VSTQVKGTLGYLDPEYYMTQQLTEKSDVYSYGVVMLELVSARQPIEKGKYIVREVRMAMD 924
Query: 846 RDDEEHYGLTEMMDPTIRN-TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
++DEEHYGL E+MDP IRN T L+GFR++LELA+QCVEESA DRPTMS+VVK IET+LQN
Sbjct: 925 KNDEEHYGLREIMDPAIRNVTNLIGFRKFLELAMQCVEESAGDRPTMSDVVKTIETVLQN 984
Query: 905 DGM-NTNSTSASSSATDFGSSKGVVRQIYGDALPNNKKDINDTNAFDYSGGYTLSAKVEP 963
DGM ++TSASSSAT+FG+SKGV R Y D+LP +K++ND++AFDYSGGYTLS KVEP
Sbjct: 985 DGMNTNSTTSASSSATEFGASKGVPRHPYNDSLP--RKEVNDSDAFDYSGGYTLSTKVEP 1042
Query: 964 K 964
K
Sbjct: 1043 K 1043
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557913|ref|XP_002519985.1| receptor protein kinase, putative [Ricinus communis] gi|223540749|gb|EEF42309.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1508 bits (3905), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 752/968 (77%), Positives = 835/968 (86%), Gaps = 24/968 (2%)
Query: 16 HIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNSRVTALGLSTM 74
I I S TD RDAA LQSLKD+W NTPP+W S DPCG+ WEGVTC +SRVTALGLSTM
Sbjct: 26 RIHFIFSVTDPRDAATLQSLKDSWLNTPPSW-GSGDPCGTPWEGVTCKDSRVTALGLSTM 84
Query: 75 GLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIG 134
L GKL+GDIGGLTEL SLDLSYN LTGSL+PR+GDL+ LNILILAGCGFTG+IP+E+G
Sbjct: 85 SLAGKLTGDIGGLTELISLDLSYNPELTGSLTPRLGDLRNLNILILAGCGFTGSIPNELG 144
Query: 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK 194
NLAELSFLALNSNN +G IPPSLGKLS +YWLDLADN+LTG IP+ST +PGLDQLK AK
Sbjct: 145 NLAELSFLALNSNNLTGIIPPSLGKLSNVYWLDLADNELTGPIPISTPATPGLDQLKKAK 204
Query: 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG 254
HFHFNKN+LSG I QLFS DMVLIHVLFDGNQL+G IP ++G VQTLEVLRLDRNALTG
Sbjct: 205 HFHFNKNQLSGPIPSQLFSYDMVLIHVLFDGNQLNGTIPSTVGQVQTLEVLRLDRNALTG 264
Query: 255 KVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSL 314
+VPTNLNNLT++ ELNLAHN L GP P+L++MNSL+Y+DLSNNSF +EAP WFSTLPSL
Sbjct: 265 RVPTNLNNLTSLIELNLAHNQLTGPLPNLTEMNSLNYLDLSNNSFLTSEAPAWFSTLPSL 324
Query: 315 TTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374
TTL+ E GSLQG +P K+ S+ QIQQV L+NNAF+ LDMG ++GP LQLVDLQNN IS+
Sbjct: 325 TTLVLEHGSLQGPLPSKILSFQQIQQVLLKNNAFSGQLDMGESLGPQLQLVDLQNNNISS 384
Query: 375 ITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQKLSP 434
+TL + N TLILVGNPVC A L+NTNYCQLQQP+TK YSTSLANCG CP QKLSP
Sbjct: 385 VTLTADYTN-TLILVGNPVCNA-LSNTNYCQLQQPSTKPYSTSLANCGNTQCPVGQKLSP 442
Query: 435 QSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYL 494
QSCECAYPY+GTMYFR PSF++L+N +FHSLEM+LW KL LTPGSVF+QNPFFN+DDYL
Sbjct: 443 QSCECAYPYQGTMYFRAPSFKDLTNANIFHSLEMTLWTKLELTPGSVFIQNPFFNVDDYL 502
Query: 495 QIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNSISP 554
Q+++ALFP FNRSEV KIGF LSNQTYKPPK+FGPY FIASPY F G SIS
Sbjct: 503 QVELALFPPTGIYFNRSEVIKIGFYLSNQTYKPPKDFGPYLFIASPYPFPDGHKGKSISS 562
Query: 555 GVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGA 614
G AGI G A+LVL L G+G+YAIRQKKRAE+A+GLS+PFASWAPSGKDSGGAPQLKGA
Sbjct: 563 GAIAGIGVGCALLVLSLFGVGIYAIRQKKRAEKALGLSRPFASWAPSGKDSGGAPQLKGA 622
Query: 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEI 674
RWFSYDELKKC+NNFSESNEIGSGGYGKVYRG+L++G +VAIKRAQQGSMQGGLEFKTEI
Sbjct: 623 RWFSYDELKKCTNNFSESNEIGSGGYGKVYRGLLAEGHIVAIKRAQQGSMQGGLEFKTEI 682
Query: 675 ELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS 734
ELLSRVHHKNLVGLVGFCFEQGEQMLVYE+MANGTLRESLSGRSGIHLDWKRRLRIALGS
Sbjct: 683 ELLSRVHHKNLVGLVGFCFEQGEQMLVYEYMANGTLRESLSGRSGIHLDWKRRLRIALGS 742
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
ARGL YLHELA+PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS+KGHVSTQVKGT+
Sbjct: 743 ARGLTYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSTKGHVSTQVKGTL 802
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854
GYLDPEYYMTQQLTEKSDVYSFGVVMLEL+TAKQPIEKGKY+VREVR AM+R+DEEHYGL
Sbjct: 803 GYLDPEYYMTQQLTEKSDVYSFGVVMLELVTAKQPIEKGKYIVREVRMAMDRNDEEHYGL 862
Query: 855 TEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNSTS 913
E MDP IRN L+GF ++LELA+QCVEESA +RPTM EVVKAIET+LQNDGMNTNSTS
Sbjct: 863 KETMDPVIRNAGNLVGFEKFLELAMQCVEESAAERPTMGEVVKAIETILQNDGMNTNSTS 922
Query: 914 ASSSATDFGSSKGVVRQIY-----------------GDALPNNKKDINDTNAFDYSGGYT 956
ASSSATDFG+S+ R Y D LP KKD+ND NAFDYSGGY+
Sbjct: 923 ASSSATDFGASRNTSRHPYNNNNNNNNNNNNNNNNNNDHLP--KKDVNDFNAFDYSGGYS 980
Query: 957 LSAKVEPK 964
L AKVEPK
Sbjct: 981 LPAKVEPK 988
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|239056180|emb|CAQ58615.1| ATP binding / kinase/ protein serine / threonine kinase [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1508 bits (3903), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/944 (78%), Positives = 834/944 (88%), Gaps = 8/944 (0%)
Query: 24 TDSRDAAALQSLKDAWQNTPPTWKNSDDPCG-SWEGVTCNNSRVTALGLSTMGLTGKLSG 82
T+S DA LQSLK W+NTPP+W+ SD PCG WEG+TCNNSRV ALGLSTMGL GKL G
Sbjct: 8 TNSDDAGVLQSLKGQWENTPPSWEKSD-PCGVPWEGITCNNSRVIALGLSTMGLKGKLEG 66
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142
DIGGLTELRSLDLS+N GLTGSL+P++G+L+ LNILILAGCGFTG IPDE+GNLA+L+FL
Sbjct: 67 DIGGLTELRSLDLSFNLGLTGSLTPKLGNLENLNILILAGCGFTGQIPDELGNLAQLTFL 126
Query: 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
ALNSNN +G+IPPSLG+LS LYWLDLA+N+L+G P ST+TSPGLDQL AKH HFNKN+
Sbjct: 127 ALNSNNLTGQIPPSLGRLSNLYWLDLAENKLSGPFPTSTLTSPGLDQLLKAKHLHFNKNQ 186
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
LSG I +LFS DM LIHVLFDGNQLSG+IP++LG VQTLEVLRLDRN+L+G VP+NLNN
Sbjct: 187 LSGPIPRKLFSSDMELIHVLFDGNQLSGSIPDTLGLVQTLEVLRLDRNSLSGTVPSNLNN 246
Query: 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322
LT VNELNLAHN L GP P+L+ M+ L+YVDLSNN+FDP+EAP WFSTLPSLTTLI E G
Sbjct: 247 LTIVNELNLAHNQLIGPIPNLTGMDHLNYVDLSNNTFDPSEAPAWFSTLPSLTTLILEHG 306
Query: 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK 382
SL G VP K+FS+ I+QVKL+NNAFN+T MG+++G LQLVDLQNNQI ++TL SG
Sbjct: 307 SLYGSVPQKVFSFPGIEQVKLKNNAFNDTFSMGDSIGDQLQLVDLQNNQIPSVTLSSGYT 366
Query: 383 NYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQKLSPQSCECAYP 442
+ LILVGNPVC TL NT YCQ+Q T K YST+LANCG + C P+QKL+PQSCECAY
Sbjct: 367 D-ALILVGNPVCKVTLLNTAYCQIQDQTPKTYSTNLANCGSELCSPDQKLNPQSCECAYA 425
Query: 443 YEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYLQIQVALFP 502
YEGT+YFRGP+FR+LS++ FHSLE SLW KL LTPGSVFLQNPFFNIDDYLQIQ+ALFP
Sbjct: 426 YEGTLYFRGPTFRDLSDLNKFHSLESSLWTKLNLTPGSVFLQNPFFNIDDYLQIQLALFP 485
Query: 503 SGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNSISPGVAAGIAC 562
K FNRSEVQ+IGF LSNQTYKPP+EFGPYYFIASPY FQ GG S S GV GIA
Sbjct: 486 PTGKYFNRSEVQRIGFSLSNQTYKPPEEFGPYYFIASPYHFQ-GHGGTSFSLGVIIGIAI 544
Query: 563 GGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDEL 622
G +LV+GLV LG+YA+RQKKRAERAI LSKPFASWAPSGKDSG APQLKGARWFSYDEL
Sbjct: 545 GCTILVVGLVALGIYAVRQKKRAERAIELSKPFASWAPSGKDSGAAPQLKGARWFSYDEL 604
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH 682
KKC+NNFSESNEIGSGGYGKVYRGMLS GQ+VAIKRAQQGSMQGGLEFKTEIELLSRVHH
Sbjct: 605 KKCTNNFSESNEIGSGGYGKVYRGMLSGGQIVAIKRAQQGSMQGGLEFKTEIELLSRVHH 664
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
KNLVGLVGFCFEQGEQMLVYEFM NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH
Sbjct: 665 KNLVGLVGFCFEQGEQMLVYEFMPNGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 724
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
ELANPPIIHRD+KSTNILLDENLTAKVADFGLSKLVSDS+KGHVSTQVKGT+GYLDPEYY
Sbjct: 725 ELANPPIIHRDIKSTNILLDENLTAKVADFGLSKLVSDSAKGHVSTQVKGTLGYLDPEYY 784
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
MTQQLTEKSDVYS+GVVMLEL++A+QPIEKGKY+VREVR AM+++DEEHYGL E+MDP I
Sbjct: 785 MTQQLTEKSDVYSYGVVMLELVSARQPIEKGKYIVREVRMAMDKNDEEHYGLREIMDPAI 844
Query: 863 RN-TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM-NTNSTSASSSATD 920
RN T L+GFR++LELA+QCVEESA DRPTMS+VVK IET+LQNDGM ++TSASSSAT+
Sbjct: 845 RNVTNLIGFRKFLELAMQCVEESAGDRPTMSDVVKTIETVLQNDGMNTNSTTSASSSATE 904
Query: 921 FGSSKGVVRQIYGDALPNNKKDINDTNAFDYSGGYTLSAKVEPK 964
FG+SKGV R Y D+LP +K++ND++AFDYSGGYTLS KVEPK
Sbjct: 905 FGASKGVPRHPYNDSLP--RKEVNDSDAFDYSGGYTLSTKVEPK 946
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523826|ref|XP_003530535.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1506 bits (3900), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 745/955 (78%), Positives = 834/955 (87%), Gaps = 7/955 (0%)
Query: 16 HIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNSRVTALGLSTM 74
I +ISS TD+RD AL+SLKDAWQ+TPP+W SDDPCG+ WEGVTCN SRVT+LGLSTM
Sbjct: 16 EIHVISSFTDTRDVVALRSLKDAWQHTPPSWDKSDDPCGAPWEGVTCNKSRVTSLGLSTM 75
Query: 75 GLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIG 134
GL GKL+GDIG LTELRSLDLS+N LTG LSP++GDL LNILILAGC F+GNIPD++G
Sbjct: 76 GLKGKLTGDIGQLTELRSLDLSFNRDLTGPLSPQLGDLSNLNILILAGCSFSGNIPDDLG 135
Query: 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK 194
L+ELSFLALNSNNF+G+IPPSLG LS+LYWLDLADNQLTG IPVST +PGLD L AK
Sbjct: 136 KLSELSFLALNSNNFTGKIPPSLGNLSKLYWLDLADNQLTGPIPVSTSNTPGLDLLLKAK 195
Query: 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG 254
HFHFNKN LSG+I +LFS +M+LIH+LFDGN LSG IP +L V+++EVLRLDRN LTG
Sbjct: 196 HFHFNKNHLSGSIPPKLFSSEMILIHILFDGNNLSGTIPSTLVLVKSVEVLRLDRNFLTG 255
Query: 255 KVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSL 314
+VP+++NNLTN+NELNLAHN GP PDL+ M++L+YVDLSNNSFDP++AP WF+TLPSL
Sbjct: 256 EVPSDINNLTNINELNLAHNKFIGPLPDLTGMDTLNYVDLSNNSFDPSDAPTWFTTLPSL 315
Query: 315 TTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374
TTLI EFGSLQG +P KLF QIQQVKLRNNA NNT DMG+ + P LQLVDLQ N+IS+
Sbjct: 316 TTLIMEFGSLQGPLPSKLFDIPQIQQVKLRNNALNNTFDMGDNICPQLQLVDLQENEISS 375
Query: 375 ITLGSGIKNYTLILVGNPVCTAT-LANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQKLS 433
+T + KN TLIL+GNPVC+ + L+NTNYCQLQQ + YSTSLANCGGKSCPP+QKLS
Sbjct: 376 VTFRAQYKN-TLILIGNPVCSGSALSNTNYCQLQQQAKQPYSTSLANCGGKSCPPDQKLS 434
Query: 434 PQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDY 493
PQSCECAYPY GT+YFRGPSFRELS+V FHSLEMSLWVKLGLTPGSV LQNPFFN DDY
Sbjct: 435 PQSCECAYPYVGTLYFRGPSFRELSSVNTFHSLEMSLWVKLGLTPGSVSLQNPFFNSDDY 494
Query: 494 LQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNSIS 553
LQ+Q+ALFP + FNRSEVQ++GFELSNQTYKPPKEFGPYYFIA PY F Q G S++
Sbjct: 495 LQVQLALFPPIGQYFNRSEVQRLGFELSNQTYKPPKEFGPYYFIAFPYPFPGSQKGASLN 554
Query: 554 PGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKG 613
GV GI+ G VLVL L+GL +YAI QKKRAERAIGLS+PFASWAPSGKDSGGAPQLKG
Sbjct: 555 KGVVIGISIGCTVLVLSLIGLAIYAILQKKRAERAIGLSRPFASWAPSGKDSGGAPQLKG 614
Query: 614 ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTE 673
ARWFSYDELKKCSNNFSESNEIG GGYGKVY+G+ DG++VAIKRAQQGSMQGG+EFKTE
Sbjct: 615 ARWFSYDELKKCSNNFSESNEIGFGGYGKVYKGVFPDGKIVAIKRAQQGSMQGGVEFKTE 674
Query: 674 IELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALG 733
IELLSRVHHKNLVGLVGFCFEQGEQML+YEFM NGTLRESLSGRS IHLDWKRRLRIALG
Sbjct: 675 IELLSRVHHKNLVGLVGFCFEQGEQMLIYEFMPNGTLRESLSGRSEIHLDWKRRLRIALG 734
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS KGHVSTQVKGT
Sbjct: 735 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSEKGHVSTQVKGT 794
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN-RDDEEHY 852
+GYLDPEYYMTQQLTEKSDVYSFGVVMLELIT++QPIEKGKY+VREVR MN +DDEEH
Sbjct: 795 LGYLDPEYYMTQQLTEKSDVYSFGVVMLELITSRQPIEKGKYIVREVRMLMNKKDDEEHN 854
Query: 853 GLTEMMDPTIRNTV-LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNS 911
GL E+MDP +RNT L+GF R+LELA+QCV ESA DRPTMSEVVKA+ET+LQNDGMNTNS
Sbjct: 855 GLRELMDPVVRNTPNLVGFGRFLELAMQCVGESAADRPTMSEVVKALETILQNDGMNTNS 914
Query: 912 TSASSSATDFGSSKGVVRQIYGDALPNNKKDIND--TNAFDYSGGYTLSAKVEPK 964
TSASSSATDFG KG +R Y D K ++ND ++AFDYSGGYTLS KVEPK
Sbjct: 915 TSASSSATDFGVGKGGMRHPYIDGTFTKKDNVNDSSSSAFDYSGGYTLSTKVEPK 969
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140667|ref|XP_002323702.1| predicted protein [Populus trichocarpa] gi|222868332|gb|EEF05463.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1504 bits (3895), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 750/948 (79%), Positives = 836/948 (88%), Gaps = 14/948 (1%)
Query: 29 AAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNSRVTALGLSTMGLTGKLSGDIGGL 87
AAALQSLK WQNTPP+W S DPCG+ WEGVTC+NSR+TALGLSTM L GKLSGDIGGL
Sbjct: 1 AAALQSLKKQWQNTPPSWGQSHDPCGAPWEGVTCSNSRITALGLSTMNLKGKLSGDIGGL 60
Query: 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSN 147
TELRSLDLS+N LTGSL+PR GDL KLNILILAGCGF+G+IPDE+GNLAELSFLALNSN
Sbjct: 61 TELRSLDLSFNTNLTGSLTPRFGDLLKLNILILAGCGFSGSIPDELGNLAELSFLALNSN 120
Query: 148 NFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTI 207
NFSG IPPSLGKLS+LYWLDLADNQLTG IP+S T+PGLD L NAKHFHFNKN+LSG+I
Sbjct: 121 NFSGGIPPSLGKLSKLYWLDLADNQLTGPIPISKNTTPGLDLLLNAKHFHFNKNQLSGSI 180
Query: 208 SEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVN 267
+LFS DMVLIHVLFDGNQL GNIP +LG VQTLEVLRLDRNAL+GKVP NLNNL+++N
Sbjct: 181 PPELFSSDMVLIHVLFDGNQLEGNIPSTLGLVQTLEVLRLDRNALSGKVPKNLNNLSSLN 240
Query: 268 ELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGR 327
ELNLAHN L GP P+L++M++L+YVDLSNNSF +EAP WFSTLPSLTTL+ E GSL G
Sbjct: 241 ELNLAHNKLIGPLPNLTKMDALNYVDLSNNSFYSSEAPDWFSTLPSLTTLVIEHGSLHGT 300
Query: 328 VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLI 387
+P K+FS+ QIQQV LRNNA N + +MG+++ LQLVDLQNNQIS++TL + N TLI
Sbjct: 301 LPSKVFSFPQIQQVLLRNNALNGSFNMGDSISTQLQLVDLQNNQISSVTLTADYTN-TLI 359
Query: 388 LVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQKLSPQSCECAYPYEGTM 447
LVGNPVCTA L++TNYCQLQQ +TK YSTSLANCG K CPPEQKLSPQSCECAYPYEGT+
Sbjct: 360 LVGNPVCTA-LSDTNYCQLQQQSTKPYSTSLANCGSKMCPPEQKLSPQSCECAYPYEGTL 418
Query: 448 YFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYLQIQVALFPSGEKS 507
YFR PSFRELSNV +FHSLEMSLW KLGLTPGSVFLQNPFFN+DDYLQ+QVALFP +K
Sbjct: 419 YFRAPSFRELSNVNMFHSLEMSLWGKLGLTPGSVFLQNPFFNVDDYLQVQVALFPPTDKY 478
Query: 508 FNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVL 567
FNRSE+Q IGF+L+NQTYKPPK+FGPYYFIASPY F G+S+S GV GI G +L
Sbjct: 479 FNRSEIQSIGFDLTNQTYKPPKDFGPYYFIASPYPFPDASRGSSMSTGVVVGIGIGCGLL 538
Query: 568 VLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSN 627
V+ LVG+G+YAIRQKKRAE+AIGLSKPFASWAPSGKDSGG PQLKGARWFSY+ELK+C+
Sbjct: 539 VMSLVGVGIYAIRQKKRAEKAIGLSKPFASWAPSGKDSGGVPQLKGARWFSYEELKRCTY 598
Query: 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
NF+ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG
Sbjct: 599 NFTESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 658
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
LVGFCFEQGEQMLVYE+M NGTLRE LSG+SGI+LDW+RRLRIALGSARGLAYLHELANP
Sbjct: 659 LVGFCFEQGEQMLVYEYMPNGTLRECLSGKSGIYLDWRRRLRIALGSARGLAYLHELANP 718
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT+GYLDPEYYMTQQL
Sbjct: 719 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTLGYLDPEYYMTQQL 778
Query: 808 TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT-- 865
TEKSDVYSFGVVMLELI AKQPIEKGKY+VREVR AM+R+DEEHYGL E+MDP +RN
Sbjct: 779 TEKSDVYSFGVVMLELIAAKQPIEKGKYIVREVRMAMDRNDEEHYGLKEIMDPGLRNMGG 838
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM-NTNSTSASSSATDFGSS 924
L+GF R+LE+A+QCVEESAT+RPTMSEVVKAIE +LQNDG+ ++TSASSSATDFG+S
Sbjct: 839 NLVGFGRFLEVAMQCVEESATERPTMSEVVKAIEMILQNDGVNTNSTTSASSSATDFGAS 898
Query: 925 K--GVVRQIYGDALPNNKKD------INDTNAFDYSGGYTLSAKVEPK 964
+ G +R Y + K IN+ NAFDYSGGYTLSAKVEPK
Sbjct: 899 RGGGPLRHPYNHDVVAAKNKVDVVDNINNNNAFDYSGGYTLSAKVEPK 946
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296085805|emb|CBI31129.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1502 bits (3889), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 738/938 (78%), Positives = 830/938 (88%), Gaps = 8/938 (0%)
Query: 30 AALQSLKDAWQNTPPTWKNSDDPCG-SWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLT 88
LQSLK W+NTPP+W+ SD PCG WEG+TCNNSRV ALGLSTMGL GKL GDIGGLT
Sbjct: 18 GVLQSLKGQWENTPPSWEKSD-PCGVPWEGITCNNSRVIALGLSTMGLKGKLEGDIGGLT 76
Query: 89 ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNN 148
ELRSLDLS+N GLTGSL+P++G+L+ LNILILAGCGFTG IPDE+GNLA+L+FLALNSNN
Sbjct: 77 ELRSLDLSFNLGLTGSLTPKLGNLENLNILILAGCGFTGQIPDELGNLAQLTFLALNSNN 136
Query: 149 FSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTIS 208
+G+IPPSLG+LS LYWLDLA+N+L+G P ST+TSPGLDQL AKHFHFNKN+LSG I
Sbjct: 137 LTGQIPPSLGRLSNLYWLDLAENKLSGPFPTSTLTSPGLDQLLKAKHFHFNKNQLSGPIP 196
Query: 209 EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNE 268
+LFS DM LIHVLFDGNQLSG+IP++LG VQTLEVLRLDRN+L+G VP+NLNNLT VNE
Sbjct: 197 RKLFSSDMELIHVLFDGNQLSGSIPDTLGLVQTLEVLRLDRNSLSGTVPSNLNNLTIVNE 256
Query: 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRV 328
LNLAHN L GP P+L+ M+ L+YVDLSNN+FDP+EAP WFSTLPSLTTLI E GSL G V
Sbjct: 257 LNLAHNQLIGPIPNLTGMDHLNYVDLSNNTFDPSEAPAWFSTLPSLTTLILEHGSLYGSV 316
Query: 329 PDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLIL 388
P K+FS+ I+QVKL+NNAFN+T MG+++G LQLVDLQNNQI ++TL SG + LIL
Sbjct: 317 PQKVFSFPGIEQVKLKNNAFNDTFSMGDSIGDQLQLVDLQNNQIPSVTLSSGYTD-ALIL 375
Query: 389 VGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQKLSPQSCECAYPYEGTMY 448
VGNPVC TL NT YCQ+Q T K YST+LANCG + C P+QKL+PQSCECAY YEGT+Y
Sbjct: 376 VGNPVCKVTLLNTAYCQIQDQTPKTYSTNLANCGSELCSPDQKLNPQSCECAYAYEGTLY 435
Query: 449 FRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYLQIQVALFPSGEKSF 508
FRGP+FR+LS++ FHSLE SLW KL LTPGSVFLQNPFFNIDDYLQIQ+ALFP K F
Sbjct: 436 FRGPTFRDLSDLNKFHSLESSLWTKLNLTPGSVFLQNPFFNIDDYLQIQLALFPPTGKYF 495
Query: 509 NRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLV 568
NRSEVQ+IGF LSNQTYKPP+EFGPYYFIASPY FQ GG S S GV GIA G +LV
Sbjct: 496 NRSEVQRIGFSLSNQTYKPPEEFGPYYFIASPYHFQ-GHGGTSFSLGVIIGIAIGCTILV 554
Query: 569 LGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNN 628
+GLV LG+YA+RQKKRAERAI LSKPFASWAPSGKDSG APQLKGARWFSYDELKKC+NN
Sbjct: 555 VGLVALGIYAVRQKKRAERAIELSKPFASWAPSGKDSGAAPQLKGARWFSYDELKKCTNN 614
Query: 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
FSESNEIGSGGYGKVYRGMLS GQ+VAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGL
Sbjct: 615 FSESNEIGSGGYGKVYRGMLSGGQIVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 674
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
VGFCFEQGEQMLVYEFM NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP
Sbjct: 675 VGFCFEQGEQMLVYEFMPNGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 734
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
IIHRD+KSTNILLDENLTAKVADFGLSKLVSDS+KGHVSTQVKGT+GYLDPEYYMTQQLT
Sbjct: 735 IIHRDIKSTNILLDENLTAKVADFGLSKLVSDSAKGHVSTQVKGTLGYLDPEYYMTQQLT 794
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN-TVL 867
EKSDVYS+GVVMLEL++A+QPIEKGKY+VREVR AM+++DEEHYGL E+MDP IRN T L
Sbjct: 795 EKSDVYSYGVVMLELVSARQPIEKGKYIVREVRMAMDKNDEEHYGLREIMDPAIRNVTNL 854
Query: 868 LGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM-NTNSTSASSSATDFGSSKG 926
+GFR++LELA+QCVEESA DRPTMS+VVK IET+LQNDGM ++TSASSSAT+FG+SKG
Sbjct: 855 IGFRKFLELAMQCVEESAGDRPTMSDVVKTIETVLQNDGMNTNSTTSASSSATEFGASKG 914
Query: 927 VVRQIYGDALPNNKKDINDTNAFDYSGGYTLSAKVEPK 964
V R Y D+LP +K++ND++AFDYSGGYTLS KVEPK
Sbjct: 915 VPRHPYNDSLP--RKEVNDSDAFDYSGGYTLSTKVEPK 950
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439783|ref|XP_004137665.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Cucumis sativus] gi|449497159|ref|XP_004160329.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g49770-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1493 bits (3864), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 727/969 (75%), Positives = 829/969 (85%), Gaps = 8/969 (0%)
Query: 1 MDELRLLIFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGV 59
M + L+ A F I S TD RD+AAL+SL++ WQNTPP+W S DPCG+ WEGV
Sbjct: 1 MSPVETLLLFAFFYAGIDTAGSFTDPRDSAALESLRNEWQNTPPSWGASIDPCGTPWEGV 60
Query: 60 TCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILI 119
C NSRVTAL LSTMGL GKL GDIGGLTEL+SLDLS+N LTGS+SP +GDLQ L+ILI
Sbjct: 61 ACINSRVTALRLSTMGLKGKLGGDIGGLTELKSLDLSFNKDLTGSISPALGDLQNLSILI 120
Query: 120 LAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPV 179
LAGCGF+G+IP+++GNL+ LSFLALNSNNF+G IPPSLGKLS LYWLDLADNQLTGS+PV
Sbjct: 121 LAGCGFSGSIPEQLGNLSNLSFLALNSNNFTGTIPPSLGKLSNLYWLDLADNQLTGSLPV 180
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
ST +PGLD L AKHFHFNKN+LSG+IS +LF +MVLIH+LFDGN+ SGNIP +LG V
Sbjct: 181 STSETPGLDLLLKAKHFHFNKNQLSGSISPKLFRSEMVLIHILFDGNKFSGNIPPTLGLV 240
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSF 299
+TLEVLRLDRN+L G VP+NLNNLTN+NELNLA+N L GP P+L+QM+SL+YVDLSNNSF
Sbjct: 241 KTLEVLRLDRNSLAGTVPSNLNNLTNINELNLANNKLTGPLPNLTQMSSLNYVDLSNNSF 300
Query: 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359
D +EAP WFS L SLTTLI EFGS++G VP +FS QIQQVKL+ NAF++T DMG+ V
Sbjct: 301 DSSEAPEWFSNLQSLTTLIIEFGSMRGSVPQGVFSLPQIQQVKLKKNAFSDTFDMGDKVS 360
Query: 360 PLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVCT--ATLANTNYCQLQQPTTKAYSTS 417
LQLVDLQNN IS TLGS TL+L+GNPVC+ TL+NTNYCQ+Q K YSTS
Sbjct: 361 EQLQLVDLQNNNISHFTLGSRYTK-TLMLIGNPVCSTDVTLSNTNYCQVQDQPVKPYSTS 419
Query: 418 LANCGGKSCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLT 477
LA+C KSC P++KLSPQSCEC YP+EGT+YFR PSFR+LSNVT+FHSLE SLW KL LT
Sbjct: 420 LASCLSKSCSPDEKLSPQSCECTYPFEGTLYFRAPSFRDLSNVTLFHSLEFSLWKKLDLT 479
Query: 478 PGSVFLQNPFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFI 537
PGSV +QNPFFN+DDYLQ+Q+ALFPS K FNRSE+Q+IGF LSNQTYKPP EFGP+YFI
Sbjct: 480 PGSVSIQNPFFNVDDYLQMQLALFPSDGKYFNRSEIQRIGFYLSNQTYKPPHEFGPFYFI 539
Query: 538 ASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFAS 597
ASPY F G SISPGV G+A G A LVLGL+G+G+YAI QKKRAE+AIGLS+PFAS
Sbjct: 540 ASPYGFADTTKGTSISPGVIIGVAIGCAFLVLGLIGVGIYAIWQKKRAEKAIGLSRPFAS 599
Query: 598 WAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIK 657
WAPSG DSGGAPQLKGARWFSYDELKKC+NNFS SNE+GSGGYGKVYRGML DGQ VAIK
Sbjct: 600 WAPSGNDSGGAPQLKGARWFSYDELKKCTNNFSMSNEVGSGGYGKVYRGMLVDGQAVAIK 659
Query: 658 RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR 717
RAQQGSMQGGLEFKTEIELLSRVHHKNL+GLVGFCFEQGEQMLVYEFM NGTLR+SLSG+
Sbjct: 660 RAQQGSMQGGLEFKTEIELLSRVHHKNLLGLVGFCFEQGEQMLVYEFMPNGTLRDSLSGK 719
Query: 718 SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777
SGI+LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE+L AKVADFGLSKL
Sbjct: 720 SGINLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEHLNAKVADFGLSKL 779
Query: 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837
VSD+ KGHVSTQVKGT+GYLDPEYYMTQQLTEKSDVYSFGVVMLEL+T K PIEKGKYVV
Sbjct: 780 VSDNEKGHVSTQVKGTLGYLDPEYYMTQQLTEKSDVYSFGVVMLELLTGKLPIEKGKYVV 839
Query: 838 REVRTAMNRDDEEHYGLTEMMDPTIRN--TVLLGFRRYLELALQCVEESATDRPTMSEVV 895
REVR MN+ +EE+YGL ++MD TI N T ++G R+LELA++CVEESA DRPTMSE+V
Sbjct: 840 REVRMLMNKSEEEYYGLKQIMDVTILNNTTTIIGLGRFLELAMRCVEESAGDRPTMSEMV 899
Query: 896 KAIETLLQNDGMNTNSTSASSSATDFGSSKGVVRQIYGDALPNNKKDINDTNAFDYSGGY 955
KAIE++LQNDG+NTN+TSASSSATDFG+S+ R Y D +P KKD +D+N+FDYSGGY
Sbjct: 900 KAIESILQNDGINTNTTSASSSATDFGASRNAPRHPYNDPIP--KKDAHDSNSFDYSGGY 957
Query: 956 TLSAKVEPK 964
TLS KVEPK
Sbjct: 958 TLSTKVEPK 966
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224069016|ref|XP_002326254.1| predicted protein [Populus trichocarpa] gi|222833447|gb|EEE71924.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1442 bits (3734), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 741/967 (76%), Positives = 834/967 (86%), Gaps = 12/967 (1%)
Query: 5 RLLIFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNN 63
RLL F++ F+ I L+ S TD RDAAAL+SLK WQNTPP+W SDDPCG+ WEGVTC+N
Sbjct: 9 RLLFFLSFFTSGIHLLLSDTDPRDAAALKSLKSQWQNTPPSWDQSDDPCGAPWEGVTCSN 68
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123
SR+TALGLSTM L GKLSGDIGGL ELRSLDLS+N LTG LSPR+GDL LNILILAGC
Sbjct: 69 SRITALGLSTMSLVGKLSGDIGGLAELRSLDLSFNSNLTGPLSPRLGDLLNLNILILAGC 128
Query: 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTIT 183
GF+G+IPDE+GNLA+LSFLALNSN FSG IPPSLGKLS+LYWLDLADNQLTG+IP+S T
Sbjct: 129 GFSGSIPDELGNLAKLSFLALNSNKFSGGIPPSLGKLSKLYWLDLADNQLTGTIPISKGT 188
Query: 184 SPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLE 243
PGLD L NAKHFHFNKN+LSG++ +LF+ DM+LIHVLFDGNQL GNIP ++ VQ+LE
Sbjct: 189 IPGLDLLLNAKHFHFNKNQLSGSLPPELFNSDMMLIHVLFDGNQLEGNIPYTICQVQSLE 248
Query: 244 VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTE 303
VLRLDRN+L G+VP NLNNLTN+NELNLAHN L+GPFP+L++M++L+YVDLSNNSF+ +E
Sbjct: 249 VLRLDRNSLDGEVPDNLNNLTNLNELNLAHNKLRGPFPNLTRMDALNYVDLSNNSFESSE 308
Query: 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQ 363
AP WF TLPSLTTL+ E GSLQG P ++FS+ QIQQV LRNNAFN + +M ++ P LQ
Sbjct: 309 APDWFLTLPSLTTLVIEQGSLQGTFPSEVFSFPQIQQVLLRNNAFNGSFNMSVSISPQLQ 368
Query: 364 LVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGG 423
LVDLQNNQIS++TL + N LILVGNPVC A L+NT+YCQLQQ +TK YSTSLANCG
Sbjct: 369 LVDLQNNQISSVTLTADYTN-RLILVGNPVCIA-LSNTSYCQLQQQSTKPYSTSLANCGS 426
Query: 424 KSCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFL 483
K CP EQKLSPQSCECAYPYEGT+YFRGPSFRELSN FHSLEMSLW +LGLTPGSVFL
Sbjct: 427 KLCPIEQKLSPQSCECAYPYEGTLYFRGPSFRELSNDNTFHSLEMSLWDQLGLTPGSVFL 486
Query: 484 QNPFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPYAF 543
QNPFFN+DDYLQ+QVALFP FNRSE+Q+IGF LSNQTYKPPK FGPYYFIAS Y F
Sbjct: 487 QNPFFNVDDYLQVQVALFPPTGNFFNRSEIQRIGFALSNQTYKPPKYFGPYYFIASNYPF 546
Query: 544 QVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGK 603
GNS+S GV GI G +LV+ LVG+G+YAIRQKKRAE+AIGLSKPFASWAPSG
Sbjct: 547 PDGSRGNSLSTGVVVGIGIGCGLLVMSLVGVGIYAIRQKKRAEKAIGLSKPFASWAPSGN 606
Query: 604 DSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGS 663
DSGGAPQLKGARWFSYDELKKC+ NFS+SNEIGSGGYGKVYRGMLSDGQVVAIKRAQ+GS
Sbjct: 607 DSGGAPQLKGARWFSYDELKKCTCNFSQSNEIGSGGYGKVYRGMLSDGQVVAIKRAQKGS 666
Query: 664 MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD 723
MQGG EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE+M NGTLRESLSG+SGI+LD
Sbjct: 667 MQGGHEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEYMPNGTLRESLSGKSGIYLD 726
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783
WKRRLRIALGSARGL YLHELA+PPIIHRDVK+TNILLDENLTAKVADFGLSKLVSD SK
Sbjct: 727 WKRRLRIALGSARGLTYLHELADPPIIHRDVKTTNILLDENLTAKVADFGLSKLVSDISK 786
Query: 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843
GHVSTQVKGT+GYLDPEYYMTQQLTEKSDVYSFGVVMLELI AKQPIEKGKY+VREVR
Sbjct: 787 GHVSTQVKGTLGYLDPEYYMTQQLTEKSDVYSFGVVMLELIIAKQPIEKGKYIVREVRMT 846
Query: 844 MNRDDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
M+RDDEEH+GL E+MDP IRN L+GFRR+LELA+QCVEESA +RP MSEVVK IE +L
Sbjct: 847 MDRDDEEHHGLKEIMDPGIRNMGNLVGFRRFLELAMQCVEESAAERPPMSEVVKEIEMIL 906
Query: 903 QNDGM-NTNSTSASSSATDFGSSK-GVVRQIYGDALPNNKKDIN-----DTNAFDYSGGY 955
+NDGM ++TSASSSATDFG+S+ G +R Y D N KD+N + +AFD+SGG
Sbjct: 907 KNDGMNTNSTTSASSSATDFGASRVGPLRHPYNDVTAKN-KDVNSVDSVNHDAFDHSGGS 965
Query: 956 TLSAKVE 962
TLS K E
Sbjct: 966 TLSGKAE 972
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297842755|ref|XP_002889259.1| hypothetical protein ARALYDRAFT_477135 [Arabidopsis lyrata subsp. lyrata] gi|297335100|gb|EFH65518.1| hypothetical protein ARALYDRAFT_477135 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1421 bits (3679), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 701/966 (72%), Positives = 822/966 (85%), Gaps = 12/966 (1%)
Query: 5 RLLIFIALFSFHI-QLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCN 62
RLL+ +SF + +ISS TD RDAAAL+SL D W NTPP+W SDDPCG+ WEGV+CN
Sbjct: 12 RLLLIGFAYSFTVFSIISSVTDPRDAAALRSLMDQWDNTPPSWGGSDDPCGTPWEGVSCN 71
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAG 122
NSR+TALGLSTMGL G+LSGDIG L ELRSLDLS+N GLTGSL+ R+GDLQKLNILILAG
Sbjct: 72 NSRITALGLSTMGLKGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAG 131
Query: 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTI 182
CGFTG+IP+E+G L +LSFLALNSNNF+G+IP SLG L+++YWLDLADNQLTG IP+S+
Sbjct: 132 CGFTGSIPNELGYLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSG 191
Query: 183 TSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTL 242
+SPGLD L AKHFHFNKN+LSGTI +LFS +M+LIHVLFDGN+ +G+IP +LG +QTL
Sbjct: 192 SSPGLDLLLKAKHFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTL 251
Query: 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302
EVLRLDRN LTGKVP NL+NLTN+ ELNLAHN L G PDLS M S++YVDLSNNSFDP+
Sbjct: 252 EVLRLDRNTLTGKVPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPS 311
Query: 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLL 362
E+PLWFSTLPSLTTL+ E+G+L+G +P+K+F + Q+QQVKL+ NAFN TL +G+ VGP L
Sbjct: 312 ESPLWFSTLPSLTTLVMEYGALRGPLPNKIFGFPQLQQVKLKKNAFNGTLSLGDTVGPQL 371
Query: 363 QLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTK-AYSTSLANC 421
QLVDLQ+N IS++TL SG N TLILVGNPVCT L+NTNYCQ+QQ K YSTSLANC
Sbjct: 372 QLVDLQDNDISSVTLSSGYTN-TLILVGNPVCTTALSNTNYCQIQQQQVKRIYSTSLANC 430
Query: 422 GGKSCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSV 481
GGKSCP +QK+SPQSCECAYPYEGT+YFRGP FR+LSNV +HSLEMSLWVKLGLTPGSV
Sbjct: 431 GGKSCPLDQKISPQSCECAYPYEGTLYFRGPMFRDLSNVNTYHSLEMSLWVKLGLTPGSV 490
Query: 482 FLQNPFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPY 541
LQNPFFN DDYLQIQ+ALFP K FNR+EVQ+IGF+LSNQTYKPP FGPYYFIASPY
Sbjct: 491 SLQNPFFNNDDYLQIQLALFPPMGKYFNRTEVQRIGFDLSNQTYKPPPLFGPYYFIASPY 550
Query: 542 AFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSKPFASWAPS 601
F G+S+S + GI G + LVL LV LG+YAI QK+RAE+AIGLS+PF SWA S
Sbjct: 551 TFPAEGNGHSLSSRMVTGIITGCSALVLCLVALGIYAIWQKRRAEQAIGLSRPFVSWASS 610
Query: 602 GKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQ 661
GKDSGGAPQLKGARWFSY+ELKK +NNFS S+E+G GGYGKVY+GML DG +VAIKRAQQ
Sbjct: 611 GKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQ 670
Query: 662 GSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH 721
GS QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ+LVYE+M+NG+L++SL+GRSGI
Sbjct: 671 GSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGIT 730
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
LDWKRRLR+ALGSARGLAYLHELA+PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD
Sbjct: 731 LDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDC 790
Query: 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841
+KGHVSTQVKGT+GYLDPEYY TQ+LTEKSDVYSFGVVM+ELITAKQPIEKGKY+VRE++
Sbjct: 791 TKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIK 850
Query: 842 TAMNRDDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900
MN+ D+E YGL + MD ++R+ L RY+ELAL+CV+E+A++RPTMSEVVK IE
Sbjct: 851 LVMNKSDDEFYGLRDKMDRSLRDAGALPELGRYMELALKCVDETASERPTMSEVVKEIEI 910
Query: 901 LLQNDG-MNTNSTSASSSATDFGSSKGVVRQIYGDALPNNK-KDINDTNAFDYSGGYTLS 958
++QN G +++S SASSSATDFG + +YG +L + D + AFDYSGGY++
Sbjct: 911 IIQNSGTSSSSSASASSSATDFGE-----KLLYGGSLRKKEAGDGDGGGAFDYSGGYSVP 965
Query: 959 AKVEPK 964
K+EPK
Sbjct: 966 TKIEPK 971
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 964 | ||||||
| TAIR|locus:2019863 | 971 | AT1G79620 [Arabidopsis thalian | 0.989 | 0.982 | 0.686 | 0.0 | |
| TAIR|locus:2157042 | 953 | AT5G49760 [Arabidopsis thalian | 0.969 | 0.981 | 0.512 | 1.5e-241 | |
| TAIR|locus:2156992 | 946 | AT5G49770 [Arabidopsis thalian | 0.922 | 0.939 | 0.506 | 1.5e-223 | |
| TAIR|locus:2157002 | 857 | AT5G49780 [Arabidopsis thalian | 0.366 | 0.411 | 0.572 | 1.3e-191 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.903 | 0.915 | 0.350 | 3.3e-118 | |
| TAIR|locus:2084016 | 937 | AT3G53590 [Arabidopsis thalian | 0.823 | 0.847 | 0.348 | 8.4e-113 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.282 | 0.271 | 0.434 | 8.1e-86 | |
| TAIR|locus:2036636 | 632 | NIK3 "NSP-interacting kinase 3 | 0.296 | 0.452 | 0.412 | 4.6e-83 | |
| TAIR|locus:2171973 | 614 | AT5G45780 [Arabidopsis thalian | 0.296 | 0.465 | 0.446 | 4.9e-83 | |
| TAIR|locus:2118811 | 648 | SARK "SENESCENCE-ASSOCIATED RE | 0.309 | 0.459 | 0.422 | 7.2e-83 |
| TAIR|locus:2019863 AT1G79620 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3436 (1214.6 bits), Expect = 0., P = 0.
Identities = 663/966 (68%), Positives = 773/966 (80%)
Query: 5 RLLIFIALFSFHI-QLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCN 62
RLL+ +SF + +ISS TD RDAAAL+SL D W NTPP+W SDDPCG+ WEGV+CN
Sbjct: 12 RLLLICFAYSFTVFSMISSVTDPRDAAALRSLMDQWDNTPPSWGGSDDPCGTPWEGVSCN 71
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAG 122
NSR+TALGLSTMGL G+LSGDIG L ELRSLDLS+N GLTGSL+ R+GDLQKLNILILAG
Sbjct: 72 NSRITALGLSTMGLKGRLSGDIGELAELRSLDLSFNRGLTGSLTSRLGDLQKLNILILAG 131
Query: 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTI 182
CGFTG IP+E+G L +LSFLALNSNNF+G+IP SLG L+++YWLDLADNQLTG IP+S+
Sbjct: 132 CGFTGTIPNELGYLKDLSFLALNSNNFTGKIPASLGNLTKVYWLDLADNQLTGPIPISSG 191
Query: 183 TSPGLDQLXXXXXXXXXXXXLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTL 242
+SPGLD L LSGTI +LFS +M+LIHVLFDGN+ +G+IP +LG +QTL
Sbjct: 192 SSPGLDLLLKAKHFHFNKNQLSGTIPPKLFSSEMILIHVLFDGNRFTGSIPSTLGLIQTL 251
Query: 243 EVLRLDRNALTGKVPTXXXXXXXXXXXXXAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302
EVLRLDRN LTGKVP AHN L G PDLS M S++YVDLSNNSFDP+
Sbjct: 252 EVLRLDRNTLTGKVPENLSNLTNIIELNLAHNKLVGSLPDLSDMKSMNYVDLSNNSFDPS 311
Query: 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLL 362
E+PLWFSTLPSLTTL+ E+GSLQG +P+KLF + Q+QQV+L+ NAFN TL +G+ VGP L
Sbjct: 312 ESPLWFSTLPSLTTLVMEYGSLQGPLPNKLFGFPQLQQVRLKKNAFNGTLSLGDTVGPEL 371
Query: 363 QLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKA-YSTSLANC 421
QLVDLQ+N IS++TL SG N TLIL GNPVCT L+NTNYCQ+QQ K YSTSLANC
Sbjct: 372 QLVDLQDNDISSVTLSSGYTN-TLILEGNPVCTTALSNTNYCQIQQQQVKRIYSTSLANC 430
Query: 422 GGKSCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSV 481
GGKSCP +QK+SPQSCECAYPYEGT+YFRGP FR+LSNV +HSLEMSLWVKLGLTPGSV
Sbjct: 431 GGKSCPLDQKVSPQSCECAYPYEGTLYFRGPMFRDLSNVNTYHSLEMSLWVKLGLTPGSV 490
Query: 482 FLQNPFFNIDDYLQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPY 541
LQNPFFN DDYLQIQ+ALFP K FNR+EVQ+IGF+LSNQTYKPP FGPYYFIASPY
Sbjct: 491 SLQNPFFNNDDYLQIQLALFPPMGKYFNRTEVQRIGFDLSNQTYKPPPLFGPYYFIASPY 550
Query: 542 AFQVPQGGNSISPXXXXXXXXXXXXXXXXXXXXXXYAIRQKKRAERAIGLSKPFASWAPS 601
F G+S+S YA+ QK+RAE+AIGLS+PF SWA S
Sbjct: 551 TFPADGNGHSLSSRMVTGIITGCSALVLCLVALGIYAMWQKRRAEQAIGLSRPFVSWASS 610
Query: 602 GKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQ 661
GKDSGGAPQLKGARWFSY+ELKK +NNFS S+E+G GGYGKVY+GML DG +VAIKRAQQ
Sbjct: 611 GKDSGGAPQLKGARWFSYEELKKITNNFSVSSELGYGGYGKVYKGMLQDGHMVAIKRAQQ 670
Query: 662 GSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH 721
GS QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ+LVYE+M+NG+L++SL+GRSGI
Sbjct: 671 GSTQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQILVYEYMSNGSLKDSLTGRSGIT 730
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
LDWKRRLR+ALGSARGLAYLHELA+PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD
Sbjct: 731 LDWKRRLRVALGSARGLAYLHELADPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDC 790
Query: 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841
+KGHVSTQVKGT+GYLDPEYY TQ+LTEKSDVYSFGVVM+ELITAKQPIEKGKY+VRE++
Sbjct: 791 TKGHVSTQVKGTLGYLDPEYYTTQKLTEKSDVYSFGVVMMELITAKQPIEKGKYIVREIK 850
Query: 842 TAMNRDDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900
MN+ D++ YGL + MD ++R+ L RY+ELAL+CV+E+A +RPTMSEVVK IE
Sbjct: 851 LVMNKSDDDFYGLRDKMDRSLRDVGTLPELGRYMELALKCVDETADERPTMSEVVKEIEI 910
Query: 901 LLQNDGMXXXXXXXXXXXX-DFGSSKGVVRQIYGDALPNNK-KDINDTNAFDYSGGYTLS 958
++QN G DFG + +YG L + +D + AFDYSGGY++
Sbjct: 911 IIQNSGASSSSSASASSSATDFGE-----KLLYGGTLKKKEARDGDGGGAFDYSGGYSVP 965
Query: 959 AKVEPK 964
K+EPK
Sbjct: 966 TKIEPK 971
|
|
| TAIR|locus:2157042 AT5G49760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2328 (824.6 bits), Expect = 1.5e-241, P = 1.5e-241
Identities = 496/967 (51%), Positives = 629/967 (65%)
Query: 8 IFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNNSRV 66
+ + LF F I +S+ T+ DA+AL +LK W P W+ SD PCG+ W G+TC N RV
Sbjct: 9 LLLILFFFQICSVSALTNGLDASALNALKSEWTTPPDGWEGSD-PCGTNWVGITCQNDRV 67
Query: 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFT 126
++ L + L GKL DI L+ELR LDLSYN L+G L P IG+L KL LIL GC F+
Sbjct: 68 VSISLGNLDLEGKLPADISFLSELRILDLSYNPKLSGPLPPNIGNLGKLRNLILVGCSFS 127
Query: 127 GNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS-P 185
G IP+ IG L EL +L+LN N FSG IPPS+G LS+LYW D+ADNQ+ G +PVS TS P
Sbjct: 128 GQIPESIGTLKELIYLSLNLNKFSGTIPPSIGLLSKLYWFDIADNQIEGELPVSNGTSAP 187
Query: 186 GLDQLXXXXXXXXXXXXLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
GLD L LSG I ++LFS +M LIHVLFDGNQ +G IPE+L V+TL VL
Sbjct: 188 GLDMLLQTKHFHFGKNKLSGNIPKELFSSNMSLIHVLFDGNQFTGEIPETLSLVKTLTVL 247
Query: 246 RLDRNALTGKVPTXXXXXXXXXXXXXAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAP 305
RLDRN L G +P+ A+N G P+L+ + SL +D+SNN+ D + P
Sbjct: 248 RLDRNKLIGDIPSYLNNLTNLNELYLANNRFTGTLPNLTSLTSLYTLDVSNNTLDFSPIP 307
Query: 306 LWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLV 365
W S+LPSL+TL E L G +P FS Q+Q V L+ N+ +LD G V L+ V
Sbjct: 308 SWISSLPSLSTLRMEGIQLNGPIPISFFSPPQLQTVILKRNSIVESLDFGTDVSSQLEFV 367
Query: 366 DLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKS 425
DLQ N+I+ S K +IL NPVC +YC Q T ++ST NC
Sbjct: 368 DLQYNEITDYK-PSANKVLQVILANNPVCLEAGNGPSYCSAIQHNT-SFSTLPTNCS--P 423
Query: 426 CPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSL---WVKLGLTPGSVF 482
C P + SP +C CAYP+ GT+YFR PSF L N T F L+ ++ + K SV
Sbjct: 424 CEPGMEASP-TCRCAYPFMGTLYFRSPSFSGLFNSTNFSILQKAIADFFKKFNYPVDSVG 482
Query: 483 LQNPFFNIDDY-LQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFIASPY 541
++N N D+ L I + +FP G +SFN++ + +GF SNQTYKPP FGPY F A Y
Sbjct: 483 VRNIRENPTDHQLLIDLLVFPLGRESFNQTGMSLVGFAFSNQTYKPPPIFGPYIFKADLY 542
Query: 542 A-FQ-VPQGGNSISPXXXXXXXXXXXXXXXXXXXXXXYAIRQKKRAERAIGLSKPFASWA 599
F V S + YA+RQKKRAERA G + PFA W
Sbjct: 543 KQFSDVEVSSKSSNKSILIGAVVGVVVLLLLLTIAGIYALRQKKRAERATGQNNPFAKWD 602
Query: 600 PSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRA 659
S K S APQL GA+ F+++ELKKC++NFSE+N++G GGYGKVYRG+L +GQ++AIKRA
Sbjct: 603 TS-KSSIDAPQLMGAKAFTFEELKKCTDNFSEANDVGGGGYGKVYRGILPNGQLIAIKRA 661
Query: 660 QQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG 719
QQGS+QGGLEFKTEIELLSRVHHKN+V L+GFCF++ EQMLVYE+++NG+L++SLSG+SG
Sbjct: 662 QQGSLQGGLEFKTEIELLSRVHHKNVVRLLGFCFDRNEQMLVYEYISNGSLKDSLSGKSG 721
Query: 720 IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
I LDW RRL+IALGS +GLAYLHELA+PPIIHRD+KS NILLDENLTAKVADFGLSKLV
Sbjct: 722 IRLDWTRRLKIALGSGKGLAYLHELADPPIIHRDIKSNNILLDENLTAKVADFGLSKLVG 781
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839
D K HV+TQVKGTMGYLDPEYYMT QLTEKSDVY FGVV+LEL+T + PIE+GKYVVRE
Sbjct: 782 DPEKTHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVLLELLTGRSPIERGKYVVRE 841
Query: 840 VRTAMNRDDEEHYGLTEMMDPTI--RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897
V+T MN+ Y L E++D TI + L GF +Y++LAL+CVEE +RP+M EVVK
Sbjct: 842 VKTKMNKS-RSLYDLQELLDTTIIASSGNLKGFEKYVDLALRCVEEEGVNRPSMGEVVKE 900
Query: 898 IETLLQNDGMXXXXXXXXXXXXDFGSSKGVVRQIYGDALPNNKKDINDTNAFDYSGGYTL 957
IE ++Q G+ D +S + Y DA+ + D + +F YSG +
Sbjct: 901 IENIMQLAGLNPNS--------DSATSS----RTYEDAIKGSG-DPYGSESFQYSGNFPA 947
Query: 958 SAKVEPK 964
S K+EP+
Sbjct: 948 S-KLEPQ 953
|
|
| TAIR|locus:2156992 AT5G49770 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2158 (764.7 bits), Expect = 1.5e-223, P = 1.5e-223
Identities = 462/913 (50%), Positives = 588/913 (64%)
Query: 8 IFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS-WEGVTCNN-SR 65
+ I LF F I + + TD D ALQ+LK+ W +WK+SD PCG+ W G+TCNN +R
Sbjct: 12 LLILLF-FQIYSVYAFTDGSDFTALQALKNEWDTLSKSWKSSD-PCGTEWVGITCNNDNR 69
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
V ++ L+ L GKL +I L+EL++LDL+ N L+G L IG+L+KL L L GC F
Sbjct: 70 VVSISLTNRNLKGKLPTEISTLSELQTLDLTGNPELSGPLPANIGNLRKLTFLSLMGCAF 129
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS- 184
G IPD IGNL +L+ L+LN N FSG IP S+G+LS+LYW D+ADNQL G +PVS S
Sbjct: 130 NGPIPDSIGNLEQLTRLSLNLNKFSGTIPASMGRLSKLYWFDIADNQLEGKLPVSDGASL 189
Query: 185 PGLDQLXXXXXXXXXXXXLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEV 244
PGLD L LSG I E+LFS +M L+HVLFDGNQ +G+IPESLG VQ L V
Sbjct: 190 PGLDMLLQTGHFHFGNNKLSGEIPEKLFSSEMTLLHVLFDGNQFTGSIPESLGLVQNLTV 249
Query: 245 LRLDRNALTGKVPTXXXXXXXXXXXXXAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304
LRLDRN L+G +P+ + N G P+L+ + SL +D+SNN +
Sbjct: 250 LRLDRNRLSGDIPSSLNNLTNLQELHLSDNKFTGSLPNLTSLTSLYTLDVSNNPLALSPV 309
Query: 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQL 364
P W L SL+TL E L G VP LFS Q+Q V L++N N TLD+G L
Sbjct: 310 PSWIPFLNSLSTLRLEDIQLDGPVPTSLFSPLQLQTVSLKHNLINTTLDLGTNYSKQLDF 369
Query: 365 VDLQNNQISAITLGSGIKN-YTLILVGNPVCTATLAN--TNYCQLQQPTTKAYSTSLANC 421
VDL++N I+ S N ++L N VC AN + YC QP + +ST L C
Sbjct: 370 VDLRDNFITGYK--SPANNPVNVMLADNQVCQDP-ANQLSGYCNAVQPNS-TFST-LTKC 424
Query: 422 GGKSCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSL--WVKLGLTP- 478
G C + K Q C C YP G R PSF SN + F SL + K G P
Sbjct: 425 GNH-CG-KGKEPNQGCHCVYPLTGVFTLRSPSFSGFSNNSNFLKFGESLMTFFKNGKYPV 482
Query: 479 GSVFLQNPFFNIDDY-LQIQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPYYFI 537
SV ++N N DY L I + +FPSG FN++E+ I + Q YKPP FGPY F+
Sbjct: 483 DSVAMRNISENPTDYHLLINLLIFPSGRDRFNQTEMDSINSAFTIQDYKPPPRFGPYIFV 542
Query: 538 ASPY-AFQVPQGGNSISPXXXXXXXXXXXXXXXXXXXXXXYAIRQKKRAERAIGLSKPFA 596
A Y F + ++S YA+RQKKRA+RA PFA
Sbjct: 543 ADQYKTFSDLEDSKTVSMKVIIGVVVGVVVLLLLLALAGIYALRQKKRAQRATDQMNPFA 602
Query: 597 SWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAI 656
W +GK+ APQL G + F+++EL KC+NNFS++N++G GGYG+VY+G L +GQV+AI
Sbjct: 603 KW-DAGKNEMDAPQLMGTKAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAI 661
Query: 657 KRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG 716
KRAQQGSMQG EFKTEIELLSRVHHKN+V L+GFCF+Q EQMLVYE++ NG+LR+ LSG
Sbjct: 662 KRAQQGSMQGAFEFKTEIELLSRVHHKNVVKLLGFCFDQKEQMLVYEYIPNGSLRDGLSG 721
Query: 717 RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776
++G+ LDW RRL+IALGS +GLAYLHELA+PPIIHRDVKS NILLDE+LTAKVADFGLSK
Sbjct: 722 KNGVKLDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSK 781
Query: 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV 836
LV D K HV+TQVKGTMGYLDPEYYMT QLTEKSDVY FGVVMLEL+T K PI++G YV
Sbjct: 782 LVGDPEKAHVTTQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVVMLELLTGKSPIDRGSYV 841
Query: 837 VREVRTAMNRDDEEHYGLTEMMDPTI-RNTV-LLGFRRYLELALQCVEESATDRPTMSEV 894
V+EV+ M++ Y L E++D TI +N+ L GF +Y+++ALQCVE +RPTMSEV
Sbjct: 842 VKEVKKKMDKS-RNLYDLQELLDTTIIQNSGNLKGFEKYVDVALQCVEPEGVNRPTMSEV 900
Query: 895 VKAIETLLQNDGM 907
V+ +E++L+ G+
Sbjct: 901 VQELESILRLVGL 913
|
|
| TAIR|locus:2157002 AT5G49780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1078 (384.5 bits), Expect = 1.3e-191, Sum P(2) = 1.3e-191
Identities = 213/372 (57%), Positives = 280/372 (75%)
Query: 596 ASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVA 655
A W + ++S APQL G + F+++E++KC+NNFS +N++G GGYG+VY+G+L GQ++A
Sbjct: 502 AKW-DANQNSVDAPQLMGTKAFTFEEMRKCANNFSVANDVGGGGYGQVYKGILPSGQLIA 560
Query: 656 IKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLS 715
IKRAQ GS+QG LEFKTEIELLSRVHHKN+V L+GFCF++GEQMLVYE++ NG+LR+SLS
Sbjct: 561 IKRAQPGSLQGALEFKTEIELLSRVHHKNVVKLLGFCFDRGEQMLVYEYIPNGSLRDSLS 620
Query: 716 GRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775
G+SGI LDW RRLRIALGS +GLAYLHELA+PPIIHRDVKS+N+LLDE+LTAKVADFGLS
Sbjct: 621 GKSGIRLDWTRRLRIALGSGKGLAYLHELADPPIIHRDVKSSNVLLDESLTAKVADFGLS 680
Query: 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY 835
+LV D+ K +V+ QVKGTMGYLDPEYYMT QLTEKSDVY FGV+MLEL+T K PIE GKY
Sbjct: 681 QLVEDAEKANVTAQVKGTMGYLDPEYYMTNQLTEKSDVYGFGVMMLELLTGKIPIENGKY 740
Query: 836 VVREVRTAMNRDDEEHYGLTEMMDPTIR---NTVLLGFRRYLELALQCVEESATDRPTMS 892
VV+E++ MN+ + Y L + +D TI N L GF +Y+++AL+CV+ RP+M+
Sbjct: 741 VVKEMKMKMNKS-KNLYDLQDFLDTTISATSNRNLKGFEKYVDVALRCVDPEGVKRPSMN 799
Query: 893 EVVKAIETLLQNDGMXXXXXXXXXXXXDFGSSKGVVRQIYGDALPNNKKDINDTNAFDYS 952
EVVK IE ++Q G+ + SS+ Y +A D+ N+F+YS
Sbjct: 800 EVVKEIENIMQYAGLNPNVES-------YASSR-----TYDEA-SKESGDLYGNNSFEYS 846
Query: 953 GGYTLSAKVEPK 964
+ + +EP+
Sbjct: 847 ASFP-TTNLEPQ 857
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1164 (414.8 bits), Expect = 3.3e-118, P = 3.3e-118
Identities = 335/957 (35%), Positives = 480/957 (50%)
Query: 17 IQLISSA--TDSRDAAALQSLKDAWQNTPP---TWKNSDDPCGS-WEGVTCNNSRVTALG 70
+ L++ A T + AL+S+K + + W N DPC S W GV C N
Sbjct: 19 VLLLADAQRTHPSEVTALRSVKRSLLDPKDYLRNW-NRGDPCRSNWTGVICFNE------ 71
Query: 71 LSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIP 130
+G L +R L L N L+G+LSP + L L IL +G+IP
Sbjct: 72 ---IGTDDYL--------HVREL-LLMNMNLSGTLSPELQKLAHLEILDFMWNNISGSIP 119
Query: 131 DEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL 190
+EIG ++ L L LN N SG +P LG LS L + +N +TG IP S L
Sbjct: 120 NEIGQISSLVLLLLNGNKLSGTLPSELGYLSNLNRFQIDENNITGPIPKS------FSNL 173
Query: 191 XXXXXXXXXXXXLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250
L+G I +L + + HVL D N+LSGN+P L + L++L+LD N
Sbjct: 174 KKVKHLHFNNNSLTGQIPVELSNLTNIF-HVLLDNNKLSGNLPPQLSALPNLQILQLDNN 232
Query: 251 ALTGK-VPTXXXXXXXXXXXXXAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFS 309
+G +P + LKG PD S++ L Y+DLS N FS
Sbjct: 233 NFSGSDIPASYGNFSNILKLSLRNCSLKGALPDFSKIRHLKYLDLSWNELTGPIPSSNFS 292
Query: 310 TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMG---NAVGPLLQ--L 364
+TT+ L G +P +Q + L+NN + ++ N P L
Sbjct: 293 K--DVTTINLSNNILNGSIPQSFSDLPLLQMLLLKNNMLSGSVPDSLWKNISFPKKARLL 350
Query: 365 VDLQNNQISAITLG-SGIKNYTLILVGNPVCT-ATLANTN-YCQLQQP---TTKAYSTSL 418
+DL+NN +S + + +N TL L GN +CT +++N N +C+ + + ST+
Sbjct: 351 LDLRNNSLSRVQGDLTPPQNVTLRLDGNLICTNGSISNANLFCESKGKEWISLPNNSTNS 410
Query: 419 A-NCGGKSCP-PE-QKLSPQS---CECAYPYEGTMYFRGPSFRELSN-VTVFHSLEMSLW 471
A +C +CP P+ + SP S C CA P + PSF + F
Sbjct: 411 ALDCPPLACPTPDFYEYSPASPLRCFCAAPLRIGYRLKSPSFSYFPPYIDQFGEYVTDF- 469
Query: 472 VKLGLTPGSVFLQNPFFNIDDYLQIQVALFPS-GE---KSFNRSEVQKIGFELSNQTYKP 527
L + P +++ + + L++ + LFP E ++FN SEV +I ++ +
Sbjct: 470 --LQMEPYQLWIDSYQWEKGPRLRMYLKLFPKVNETYTRTFNESEVLRIRGIFASWRFPG 527
Query: 528 PKEFGPY----YFIASPYAF-QVPQGGNSIS-PXXXXXXXXXXXXXXXXXXXXXXYAIRQ 581
FGPY + + PY++ +S +R+
Sbjct: 528 SDLFGPYELLNFTLQGPYSYVNFNSERKGVSWRRLAAITAGAVVTAVAISAVVAALLLRR 587
Query: 582 KKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYG 641
+ ER I S+ +S S +SG ++G FS+ EL + +++FS S +G GGYG
Sbjct: 588 YSKHEREI--SRRRSSSKASLLNSG----IRG---FSFKELAEATDDFSSSTLVGRGGYG 638
Query: 642 KVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701
KVYRG+LSD V AIKRA +GS+QG EF EIELLSR+HH+NLV L+G+C E+ EQMLV
Sbjct: 639 KVYRGVLSDNTVAAIKRADEGSLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLV 698
Query: 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761
YEFM+NGTLR+ LS + L + R+R+ALG+A+G+ YLH ANPP+ HRD+K++NILL
Sbjct: 699 YEFMSNGTLRDWLSAKGKESLSFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILL 758
Query: 762 DENLTAKVADFGLSKLV-----SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSF 816
D N AKVADFGLS+L + HVST V+GT GYLDPEY++T +LT+KSDVYS
Sbjct: 759 DPNFNAKVADFGLSRLAPVLEDEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSI 818
Query: 817 GVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLEL 876
GVV LEL+T I GK +VREV+TA RD + + M+P +V ++ L
Sbjct: 819 GVVFLELLTGMHAISHGKNIVREVKTAEQRDMMVSL-IDKRMEPWSMESV----EKFAAL 873
Query: 877 ALQCVEESATDRPTMSEVVKAIETLLQNDGMXXXXXXXXXXXXDFG-SSKGVVRQIY 932
AL+C +S RP M+EVVK +E+LLQ SS V R +Y
Sbjct: 874 ALRCSHDSPEMRPGMAEVVKELESLLQASPDRETRVELASSSSVLSTSSSNVTRDLY 930
|
|
| TAIR|locus:2084016 AT3G53590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 8.4e-113, P = 8.4e-113
Identities = 292/838 (34%), Positives = 418/838 (49%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145
G +R L L L+G L+P +G L L IL + TG IP EIG ++ L L LN
Sbjct: 77 GHFHVRELQLM-RLNLSGELAPEVGQLLYLEILDVMWNNLTGRIPLEIGRISSLKLLLLN 135
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLXXXXXXXXXXXXLSG 205
N F+G +PP LG L L L + +N +TGS+P S L +SG
Sbjct: 136 GNKFTGSLPPELGNLQNLNRLQVDENNITGSVPFS------FGNLRSIKHLHLNNNTISG 189
Query: 206 TISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK-VPTXXXXXX 264
I +L S L+H++ D N L+G +P L + +L +L+LD N G +P
Sbjct: 190 EIPVEL-SKLPKLVHMILDNNNLTGTLPLELAQLPSLTILQLDNNNFEGSTIPEAYGHFS 248
Query: 265 XXXXXXXAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSL 324
+ L+G PDLS++ +LSY+DLS N T S ++TT+ + L
Sbjct: 249 RLVKLSLRNCGLQGSIPDLSRIENLSYLDLSWNHLTGTIPESKLSD--NMTTIELSYNHL 306
Query: 325 QGRVPDKLFSYSQIQQVKLRNNAFNNTLDMG-----NAVGPLLQLVDLQNNQISAITLGS 379
G +P + +Q + L NN+ + ++ + LQ+ DL NN A
Sbjct: 307 TGSIPQSFSDLNSLQLLSLENNSLSGSVPTEIWQDKSFENNKLQVYDLNNNFSDATGNLR 366
Query: 380 GIKNYTLILVGNPVCTATLAN--TNYCQLQQPTTKAYST-SLANCGGKSCPPEQ-KLSPQ 435
N TL L GNP+C +T T + + K ST S C SCP E K+SP
Sbjct: 367 TPDNVTLYLRGNPICKSTSIPMVTQFFEYICGEKKQTSTNSNTPCSNVSCPFENVKVSPG 426
Query: 436 SCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNPFFNIDDYLQ 495
C C P + PSF + + + L L + + +
Sbjct: 427 ICLCTAPLSIDYRLKSPSFFFFTPY-IERQFREYITSSLQLETHQLAIDRLVDENRLRPR 485
Query: 496 IQVALFPSGEKSFNRSEVQKIGFELSNQTYKPPKEFGPY----YFIASPYAFQVPQGGNS 551
+ + L P G +FN+SEV +I + ++ FGPY + + PYA + Q
Sbjct: 486 MYLKLVPKGRITFNKSEVIRIRDRFMSWSFNKTDFFGPYELLDFPLQGPYADLLAQTSGI 545
Query: 552 ISPXXXXXXXXXXXXXXXXXXXXXXYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQL 611
+ +R+++ + + F + + ++
Sbjct: 546 RTIVWMMIVAGSVVAATVLSVTATLLYVRKRRENSHTLTKKRVFRTISR---------EI 596
Query: 612 KGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFK 671
KG + FS+ EL +N F S IG G YGKVY+G+LS+ VAIKR ++ S+Q EF
Sbjct: 597 KGVKKFSFVELSDATNGFDSSTLIGRGSYGKVYKGILSNKTEVAIKRGEETSLQSEKEFL 656
Query: 672 TEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIA 731
EI+LLSR+HH+NLV L+G+ + GEQMLVYE+M NG +R+ LS + L + R +A
Sbjct: 657 NEIDLLSRLHHRNLVSLIGYSSDIGEQMLVYEYMPNGNVRDWLSANAADTLSFSMRSHVA 716
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-----SDSSKGHV 786
LGSA+G+ YLH ANPP+IHRD+K++NILLD L AKVADFGLS+L D HV
Sbjct: 717 LGSAKGILYLHTEANPPVIHRDIKTSNILLDCQLHAKVADFGLSRLAPAFGEGDGEPAHV 776
Query: 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR 846
ST V+GT GYLDPEY+MTQQLT +SDVYSFGVV+LEL+T P +G +++REVRTA
Sbjct: 777 STVVRGTPGYLDPEYFMTQQLTVRSDVYSFGVVLLELLTGMHPFFEGTHIIREVRTA--- 833
Query: 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
E + + D + ++ ELAL C E+ RP MS+VVK +E + Q+
Sbjct: 834 --NECGTVLSVADSRMGQCSPDKVKKLAELALWCCEDRPETRPPMSKVVKELEGICQS 889
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 565 (203.9 bits), Expect = 8.1e-86, Sum P(2) = 8.1e-86
Identities = 119/274 (43%), Positives = 166/274 (60%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE--FKTEIELLSRVHHKN 684
++ E N IG GG G VY+G + G +VA+KR S + F EI+ L R+ H++
Sbjct: 688 DSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRH 747
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V L+GFC +LVYE+M NG+L E L G+ G HL W R +IAL +A+GL YLH
Sbjct: 748 IVRLLGFCSNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHD 807
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
+P I+HRDVKS NILLD N A VADFGL+K + DS + + G+ GY+ PEY T
Sbjct: 808 CSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYT 867
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864
++ EKSDVYSFGVV+LELIT K+P+ + V V+ + D + +++D + +
Sbjct: 868 LKVDEKSDVYSFGVVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSS 927
Query: 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898
+ +AL CVEE A +RPTM EVV+ +
Sbjct: 928 VPVHEVTHVFYVALLCVEEQAVERPTMREVVQIL 961
|
|
| TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 588 (212.0 bits), Expect = 4.6e-83, Sum P(2) = 4.6e-83
Identities = 122/296 (41%), Positives = 193/296 (65%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGG-LEFKTEIE 675
+++ EL+ +N+F+ N +G GGYG VY+G L+DG +VA+KR + ++ GG ++F+TE+E
Sbjct: 289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348
Query: 676 LLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALG 733
+S H+NL+ L GFC E++LVY +M NG++ L R LDW RR +IA+G
Sbjct: 349 TISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVG 408
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
+ARGL YLHE +P IIHRDVK+ NILLDE+ A V DFGL+KL+ D HV+T V+GT
Sbjct: 409 TARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLL-DHRDSHVTTAVRGT 467
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE-VRTAMNRDDEEHY 852
+G++ PEY T Q +EK+DV+ FG+++LELIT ++ ++ G+ ++ V + +
Sbjct: 468 VGHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEG 527
Query: 853 GLTEMMDPTIRNTV-LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907
L +++D + + + +++AL C + + + RP MSEV+K +L+ DG+
Sbjct: 528 KLKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMK----MLEGDGL 579
|
|
| TAIR|locus:2171973 AT5G45780 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 4.9e-83, Sum P(2) = 4.9e-83
Identities = 130/291 (44%), Positives = 187/291 (64%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIEL 676
FS+ E++ ++NFS N +G GG+G VY+G L +G VVA+KR + G ++F+TE+E+
Sbjct: 288 FSFREIQTATSNFSPKNILGQGGFGMVYKGYLPNGTVVAVKRLKDPIYTGEVQFQTEVEM 347
Query: 677 LSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH--LDWKRRLRIALGS 734
+ H+NL+ L GFC E+MLVY +M NG++ + L G LDW RR+ IALG+
Sbjct: 348 IGLAVHRNLLRLFGFCMTPEERMLVYPYMPNGSVADRLRDNYGEKPSLDWNRRISIALGA 407
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
ARGL YLHE NP IIHRDVK+ NILLDE+ A V DFGL+KL+ D HV+T V+GT+
Sbjct: 408 ARGLVYLHEQCNPKIIHRDVKAANILLDESFEAIVGDFGLAKLL-DQRDSHVTTAVRGTI 466
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE-VRTAMNRDDEEHYG 853
G++ PEY T Q +EK+DV+ FGV++LELIT + I++G VR+ + + R +
Sbjct: 467 GHIAPEYLSTGQSSEKTDVFGFGVLILELITGHKMIDQGNGQVRKGMILSWVRTLKAEKR 526
Query: 854 LTEMMDPTIRNTVL-LGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
EM+D ++ L +ELAL C + RP MS+V+K +E L++
Sbjct: 527 FAEMVDRDLKGEFDDLVLEEVVELALLCTQPHPNLRPRMSQVLKVLEGLVE 577
|
|
| TAIR|locus:2118811 SARK "SENESCENCE-ASSOCIATED RECEPTOR-LIKE KINASE" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 599 (215.9 bits), Expect = 7.2e-83, Sum P(2) = 7.2e-83
Identities = 130/308 (42%), Positives = 188/308 (61%)
Query: 603 KDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQ- 661
K G L R F++ EL ++ FS N +G+GG+G VYRG L DG +VA+KR +
Sbjct: 277 KQEEGLQGLGNLRSFTFRELHVYTDGFSSKNILGAGGFGNVYRGKLGDGTMVAVKRLKDI 336
Query: 662 GSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH 721
G +F+ E+E++S HKNL+ L+G+C GE++LVY +M NG++ L +
Sbjct: 337 NGTSGDSQFRMELEMISLAVHKNLLRLIGYCATSGERLLVYPYMPNGSVASKLKSKPA-- 394
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
LDW R RIA+G+ARGL YLHE +P IIHRDVK+ NILLDE A V DFGL+KL++ +
Sbjct: 395 LDWNMRKRIAIGAARGLLYLHEQCDPKIIHRDVKAANILLDECFEAVVGDFGLAKLLNHA 454
Query: 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE-V 840
HV+T V+GT+G++ PEY T Q +EK+DV+ FG+++LELIT + +E GK V ++
Sbjct: 455 DS-HVTTAVRGTVGHIAPEYLSTGQSSEKTDVFGFGILLLELITGLRALEFGKTVSQKGA 513
Query: 841 RTAMNRDDEEHYGLTEMMDPTI-RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
R E + E++D + N + L++AL C + RP MSEVV
Sbjct: 514 MLEWVRKLHEEMKVEELLDRELGTNYDKIEVGEMLQVALLCTQYLPAHRPKMSEVV---- 569
Query: 900 TLLQNDGM 907
+L+ DG+
Sbjct: 570 LMLEGDGL 577
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | 26N20_130 | SubName- Full=Chromosome chr8 scaffold_68, whole genome shotgun sequence; (961 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 964 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-49 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-42 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-33 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-33 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-32 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 9e-31 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-30 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-28 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-27 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-27 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-27 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-27 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-25 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-25 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-25 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-24 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-24 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 5e-24 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 7e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-23 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-23 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-22 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-22 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-21 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-21 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 8e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-20 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-20 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-20 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-18 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-18 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-17 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-17 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 6e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-16 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-16 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 7e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-14 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 7e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-12 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-12 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 9e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 6e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 9e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 9e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-07 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 5e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.002 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.002 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.003 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 2e-54
Identities = 82/273 (30%), Positives = 126/273 (46%), Gaps = 28/273 (10%)
Query: 634 EIGSGGYGKVYRGMLSDG-----QVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVG 687
++G G +G+VY+G L VA+K ++ + + + EF E ++ ++ H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L+G C E+ M+V E+M G L + L L L AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK--- 122
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
IHRD+ + N L+ ENL K++DFGLS+ + D + K + ++ PE +
Sbjct: 123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YKVKGGKLPIRWMAPESLKEGKF 181
Query: 808 TEKSDVYSFGVVMLELIT--AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
T KSDV+SFGV++ E+ T + V E R + E+
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPELYK------ 235
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898
L LQC E DRPT SE+V+ +
Sbjct: 236 ----------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 188 bits (481), Expect = 3e-54
Identities = 83/281 (29%), Positives = 129/281 (45%), Gaps = 45/281 (16%)
Query: 634 EIGSGGYGKVYRGMLSD-----GQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVG 687
++G G +G+VY+G L VA+K ++ + + + EF E ++ ++ H N+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L+G C E+ +V E+M G L L L L AL ARG+ YL
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP-KLSLSDLLSFALQIARGMEYLESK--- 121
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
IHRD+ + N L+ ENL K++DFGLS+ + D + K + ++ PE +
Sbjct: 122 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWMAPESLKEGKF 180
Query: 808 TEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
T KSDV+SFGV++ E+ T +QP Y M + + +
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQP----------------------YP--GMSNEEVLEYL 216
Query: 867 LLGFRRYL---------ELALQCVEESATDRPTMSEVVKAI 898
G+R +L LQC E DRPT SE+V+ +
Sbjct: 217 KNGYRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (472), Expect = 7e-53
Identities = 83/294 (28%), Positives = 127/294 (43%), Gaps = 59/294 (20%)
Query: 633 NEIGSGGYGKVYRGMLSDGQ----VVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVG 687
++G G +G+VY+G L VA+K ++ + + +F E ++ ++ H N+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 688 LVGFCFEQGEQMLVYEFMANGTL-------RESLSGRSGIHLDWKRRLRIALGSARGLAY 740
L+G C E+ LV E+M G L R L K L A+ A+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
L +HRD+ + N L+ E+L K++DFGLS+ V D T K + ++ PE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 801 YYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
T KSDV+SFGV++ E+ T P Y
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATP-----Y------------------------ 208
Query: 860 PTIRNTVLL-----GFR---------RYLELALQCVEESATDRPTMSEVVKAIE 899
P + N +L G+R EL L C + DRPT SE+V+ +E
Sbjct: 209 PGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (450), Expect = 2e-50
Identities = 77/202 (38%), Positives = 107/202 (52%), Gaps = 10/202 (4%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGFC 692
+G GG+G VY G+ VAIK ++ LE EIE+L +++H N+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
++ LV E+ G+L++ L G L LRI L GL YLH IIHR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 753 DVKSTNILLDE-NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ-LTEK 810
D+K NILLD N K+ADFGLSKL++ + + GT Y+ PE + + +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEK 174
Query: 811 SDVYSFGVVMLELITAKQPIEK 832
SD++S GV++ EL K I K
Sbjct: 175 SDIWSLGVILYELPELKDLIRK 196
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-49
Identities = 87/286 (30%), Positives = 131/286 (45%), Gaps = 60/286 (20%)
Query: 634 EIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVG 687
++G G +G+VY+G L VA+K ++G+ + EF E ++ ++ H N+V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L+G C + +V E+M G L + L + G L K L++AL A+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLR-KHGEKLTLKDLLQMALQIAKGMEYLESK--- 121
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD-----PEYY 802
+HRD+ + N L+ ENL K++DFGLS+ + + K G L PE
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-----DYYRKRGGGKLPIKWMAPESL 176
Query: 803 MTQQLTEKSDVYSFGVVMLELIT-AKQP------------IEKGKYVVREVRTAMNRDDE 849
+ T KSDV+SFGV++ E+ T +QP +E G + R N DE
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRP----ENCPDE 232
Query: 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895
L E+M LQC DRPT SE+V
Sbjct: 233 ----LYELM-------------------LQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 3e-46
Identities = 111/307 (36%), Positives = 159/307 (51%), Gaps = 10/307 (3%)
Query: 68 ALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTG 127
L LS L+G++ DIG + L+ LDL N L G + + +L L L LA G
Sbjct: 144 TLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV-LVGKIPNSLTNLTSLEFLTLASNQLVG 202
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
IP E+G + L ++ L NN SG IP +G L+ L LDL N LTG IP S L
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS------L 256
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247
LKN ++ +NKLSG I +FS LI + N LSG IPE + +Q LE+L L
Sbjct: 257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQK-LISLDLSDNSLSGEIPELVIQLQNLEILHL 315
Query: 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPL 306
N TGK+P L +L + L L N G P +L + N+L+ +DLS N+ E P
Sbjct: 316 FSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT-GEIPE 374
Query: 307 WFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVD 366
+ +L LI SL+G +P L + +++V+L++N+F+ L PL+ +D
Sbjct: 375 GLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLD 434
Query: 367 LQNNQIS 373
+ NN +
Sbjct: 435 ISNNNLQ 441
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 66/199 (33%), Positives = 104/199 (52%), Gaps = 10/199 (5%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVG 690
++G G +GKVY G++VAIK ++ ++ E EI++L ++ H N+V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
++ + LV E+ G L + L R + D R L YLH I+
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF--YLRQILSALEYLHSK---GIV 119
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
HRD+K NILLDE+ K+ADFGL++ + K ++T V GT Y+ PE + + +
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEK--LTTFV-GTPEYMAPEVLLGKGYGKA 176
Query: 811 SDVYSFGVVMLELITAKQP 829
D++S GV++ EL+T K P
Sbjct: 177 VDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 62/201 (30%), Positives = 106/201 (52%), Gaps = 12/201 (5%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQ-QGSMQGGLE-FKTEIELLSRVHHKNLVGLVGF 691
+G G +G VY + D G+++A+K + G + LE + EI +LS + H N+V G
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 692 CFEQGEQML-VY-EFMANGTLRESLSGRSGIH-LDWKRRLRIALGSARGLAYLHELANPP 748
++ + L ++ E+++ G+L L + ++ R L GLAYLH
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL---EGLAYLHSNG--- 121
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
I+HRD+K NIL+D + K+ADFG +K + D G + V+GT ++ PE ++
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 809 EKSDVYSFGVVMLELITAKQP 829
+D++S G ++E+ T K P
Sbjct: 182 RAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 7e-42
Identities = 84/271 (30%), Positives = 128/271 (47%), Gaps = 30/271 (11%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF 691
+GSG +G VY+ G++VA+K + + + + EI +L R+ H N+V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
++ LV E+ G L + L G L +IAL RGL YLH IIH
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSNG---IIH 121
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL-TEK 810
RD+K NILLDEN K+ADFGL+K + SS ++T V GT Y+ PE + K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSS-SSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 811 SDVYSFGVVMLELITAKQP-----IEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
DV+S GV++ EL+T K P I ++R + + E +
Sbjct: 180 VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRI---LGPPLEFDEPKWSSGSEEAK-- 234
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+L +C+ + + RPT E+++
Sbjct: 235 ---------DLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT-------EIELLSRV 680
F +IG GG+G+VY+ G+ VAIK + LE K EI++L +
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK-------LESKEKKEKIINEIQILKKC 54
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGS 734
H N+V G ++ E +V EF + G+L++ L + L +
Sbjct: 55 KHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST-------NQTLTESQIAYVCKEL 107
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
+GL YLH IIHRD+K+ NILL + K+ DFGLS +SD+ + GT
Sbjct: 108 LKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV---GTP 161
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK 832
++ PE + K+D++S G+ +EL K P +
Sbjct: 162 YWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 2e-33
Identities = 98/298 (32%), Positives = 138/298 (46%), Gaps = 9/298 (3%)
Query: 76 LTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN 135
L+G + I L +L SLDLS N L+G + + LQ L IL L FTG IP + +
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNS-LSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330
Query: 136 LAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195
L L L L SN FSG IP +LGK + L LDL+ N LTG IP +S L +L
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI---- 386
Query: 196 FHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK 255
N L G I + L L V N SG +P + + L + N L G+
Sbjct: 387 --LFSNSLEGEIPKSL-GACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGR 443
Query: 256 VPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLT 315
+ + ++ ++ L+LA N G PD L +DLS N F P +L L
Sbjct: 444 INSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGA-VPRKLGSLSELM 502
Query: 316 TLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373
L L G +PD+L S ++ + L +N + + + P+L +DL NQ+S
Sbjct: 503 QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS 560
|
Length = 968 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 87/271 (32%), Positives = 130/271 (47%), Gaps = 40/271 (14%)
Query: 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF 691
EIGSG +G V+ G + + VAIK ++G+M +F E +++ ++ H LV L G
Sbjct: 9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGV 67
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
C E+ LV+EFM +G L + L + G + L + L G+AYL +IH
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN---VIH 123
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKS 811
RD+ + N L+ EN KV+DFG+++ V D ST K + + PE + + + KS
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKS 182
Query: 812 DVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870
DV+SFGV+M E+ + K P E NR + E + T+ GF
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYE-------------NRSNSE-----------VVETINAGF 218
Query: 871 RRY---------LELALQCVEESATDRPTMS 892
R Y EL C +E DRP+ S
Sbjct: 219 RLYKPRLASQSVYELMQHCWKERPEDRPSFS 249
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 83/288 (28%), Positives = 134/288 (46%), Gaps = 57/288 (19%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR-----AQQGSMQGGLEFKTEIELLSRVH 681
N+ + IG G +G VY+G+ L G VAIK+ ++ +++ EI+LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALK---SIMQEIDLLKNLK 57
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLR----------ESLSGRSGIHLDWKRRLRIA 731
H N+V +G ++ E+ NG+LR ESL +
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLV---------AVYVYQV 108
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
L +GLAYLHE +IHRD+K+ NIL ++ K+ADFG++ ++D SK V
Sbjct: 109 L---QGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVV 160
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DD 848
GT ++ PE + SD++S G ++EL+T P Y A+ R DD
Sbjct: 161 GTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP-----YYDLNPMAALFRIVQDD 215
Query: 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
H L E + P +++ +L +QC ++ RPT +++K
Sbjct: 216 --HPPLPEGISPELKD--------FL---MQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 66/193 (34%), Positives = 104/193 (53%), Gaps = 18/193 (9%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
IG G +G V G GQ VA+K + + Q F E +++ + H NLV L+G
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ---AFLAEASVMTTLRHPNLVQLLGVV 69
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
+ +V E+MA G+L + L R + ++L AL G+ YL E +HR
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHR 126
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ--VKGTMGYLDPEYYMTQQLTEK 810
D+ + N+L+ E+L AKV+DFGL+K ++S+G S + VK T PE ++ + K
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKLPVKWTA----PEALREKKFSTK 179
Query: 811 SDVYSFGVVMLEL 823
SDV+SFG+++ E+
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-32
Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 5/200 (2%)
Query: 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
F+ ++GSG +G+V+ G+ + VAIK + + +F+ E++ L R+ HK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
C ++ E M G+L L G L + +A A G+AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QN 124
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
IHRD+ + NIL+ E+L KVADFGL++L+ + ++S+ K + PE +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFS 182
Query: 809 EKSDVYSFGVVMLELITAKQ 828
KSDV+SFG+++ E+ T Q
Sbjct: 183 TKSDVWSFGILLYEMFTYGQ 202
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 82/272 (30%), Positives = 123/272 (45%), Gaps = 34/272 (12%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
E+GSG +G V+ G VAIK ++G+M +F E +++ ++ H NLV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
+Q +V E+MANG L L R G L + L + + YL IHRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSD----SSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
+ + N L+ E+ KV+DFGL++ V D SS+G K + + PE + + +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG-----TKFPVKWAPPEVFDYSRFSS 180
Query: 810 KSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
KSDV+SFGV+M E+ + K P E VV V R TE+
Sbjct: 181 KSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-RLYRPKLAPTEVYT------- 232
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAI 898
+ C E DRP +++ +
Sbjct: 233 ---------IMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 83/279 (29%), Positives = 139/279 (49%), Gaps = 31/279 (11%)
Query: 633 NEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSMQGG-LEFKTEIELLSRVHHKNLVG 687
IG G +G+V RG L VAIK + GS L+F TE ++ + H N++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L G + M++ E+M NG+L + L G + + + G A G+ YL E+
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN-- 126
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
+HRD+ + NIL++ NL KV+DFGLS+ + DS + + K + + PE ++
Sbjct: 127 -YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF 185
Query: 808 TEKSDVYSFGVVMLELIT-AKQPIEK--GKYVVREVRTAMNRDDEEHYGLTEMMD-PTIR 863
T SDV+SFG+VM E+++ ++P + V++ V E+ Y L MD P+
Sbjct: 186 TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV--------EDGYRLPPPMDCPSAL 237
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
+L L C ++ +RPT S++V ++ ++
Sbjct: 238 Y----------QLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 63/194 (32%), Positives = 109/194 (56%), Gaps = 11/194 (5%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694
+G+G +G+V+ G+ ++ VA+K + G+M +F E +++ ++ H L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDV 754
+ +V E M G+L E L G +G L + + +A A G+AYL E N IHRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN--YIHRDL 129
Query: 755 KSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQ--VKGTMGYLDPEYYMTQQLTEKS 811
+ N+L+ EN KVADFGL++++ D + + +K T PE + + + KS
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA----PEAALYNRFSIKS 185
Query: 812 DVYSFGVVMLELIT 825
DV+SFG+++ E++T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 79/277 (28%), Positives = 124/277 (44%), Gaps = 39/277 (14%)
Query: 632 SNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
N+IG G +GKVY + L G+++A+K R Q + E E+++L + H NLV
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64
Query: 689 VGFCFEQGEQMLVY-EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
G + E++ ++ E+ + GTL E L G LD L GLAYLH
Sbjct: 65 YGVEVHR-EKVYIFMEYCSGGTLEELL--EHGRILDEHVIRVYTLQLLEGLAYLHSHG-- 119
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG---YLDPEYYMT 804
I+HRD+K NI LD N K+ DFG + + +++ +V+ G Y+ PE
Sbjct: 120 -IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-EEVQSLAGTPAYMAPEVITG 177
Query: 805 QQLTEK---SDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH---YGLTEMM 858
+ +D++S G V+LE+ T K+P D E + +
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWS--------------ELDNEFQIMFHVGAGH 223
Query: 859 DPTI--RNTVLLGFRRYLELALQCVEESATDRPTMSE 893
P I + + +L+ +C+E RPT SE
Sbjct: 224 KPPIPDSLQLSPEGKDFLD---RCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 74/292 (25%), Positives = 133/292 (45%), Gaps = 37/292 (12%)
Query: 632 SNEIGSGGYGKVYRG---MLSDGQ--VVAIKRAQ-QGSMQGGLEFKTEIELLSRVHHKNL 685
++G G +GKV L D VA+K G Q +F+ EIE+L + H+N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 686 VGLVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
V G C + G + L+ E++ +G+LR+ L ++ KR L + +G+ YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGS 127
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT-MGYLDPEYY 802
IHRD+ + NIL++ K++DFGL+K++ + + + + + + PE
Sbjct: 128 QR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 803 MTQQLTEKSDVYSFGVVMLELIT----AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
T + + SDV+SFGV + EL T ++ P + ++ + M L E++
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQM-----IVTRLLELL 239
Query: 859 DPTIR--------NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
R + V +L C E DRP+ ++++ ++ L
Sbjct: 240 KEGERLPRPPSCPDEV-------YDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 64/194 (32%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694
+G+G +G+V+ G + VA+K + G+M F E +++ ++ H LV L C E
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCSE 72
Query: 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDV 754
+ +V E+M+ G+L + L G L + + +A A G+AYL IHRD+
Sbjct: 73 EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDL 129
Query: 755 KSTNILLDENLTAKVADFGLSKLVSDSS-KGHVSTQ--VKGTMGYLDPEYYMTQQLTEKS 811
+ NIL+ ENL K+ADFGL++L+ D + +K T PE + T KS
Sbjct: 130 AARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTA----PEAANYGRFTIKS 185
Query: 812 DVYSFGVVMLELIT 825
DV+SFG+++ E++T
Sbjct: 186 DVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 67/208 (32%), Positives = 103/208 (49%), Gaps = 22/208 (10%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG--LEFKTEIELLSRVHHKNLVGLV 689
+IG G +GKVY SDG++ +K +M + E+++L +++H N++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLS--GRSGIH------LDWKRRLRIALGSARGLAYL 741
E+G+ +V E+ G L + + + G LDW +++ L L YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW--FVQLCLA----LKYL 119
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H I+HRD+K NI L N K+ DFG+SK++S S+ T V GT YL PE
Sbjct: 120 HS-RK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVV-GTPYYLSPEL 174
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ KSD++S G V+ EL T K P
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-28
Identities = 70/224 (31%), Positives = 116/224 (51%), Gaps = 26/224 (11%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQ-GSMQGGLEFKTE 673
E+ + F E E+G G +GKVY+G L VAIK ++ + EF+ E
Sbjct: 1 EIPLSAVRFLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58
Query: 674 IELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH------------ 721
EL+S + H N+V L+G C ++ +++E++A+G L E L S
Sbjct: 59 AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118
Query: 722 --LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
LD L IA+ A G+ Y L++ +HRD+ + N L+ E LT K++DFGLS+ +
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEY---LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLEL 823
+ V ++ + ++ PE + + T +SD++SFGVV+ E+
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 4e-28
Identities = 74/276 (26%), Positives = 119/276 (43%), Gaps = 21/276 (7%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRV-HHKNLVGLV 689
++G G +G+VY D ++VA+K + E F EI++L+ + H N+V L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIH-LDWKRRLRIALGSARGLAYLHELANPP 748
F ++G LV E++ G+L + L L L I L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 749 IIHRDVKSTNILLDENLT-AKVADFGLSKLVSDSSKGHVSTQVK----GTMGYLDPEYYM 803
IIHRD+K NILLD + K+ DFGL+KL+ D + GT GY+ PE +
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 804 ---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
+ SD++S G+ + EL+T P E K +T + L + P
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241
Query: 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ + L+ + + + +R + S +
Sbjct: 242 SNPELISKAASDLLK---KLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 81/289 (28%), Positives = 134/289 (46%), Gaps = 40/289 (13%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHK 683
+ + +++G G YG+VY G+ VA+K ++ +M+ EF E ++ + H
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHP 62
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
NLV L+G C + ++ EFM G L + L + ++ L +A + + YL E
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL-E 121
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS-DSSKGHVSTQVKGTMGYLDPEYY 802
N IHRD+ + N L+ EN KVADFGLS+L++ D+ H K + + PE
Sbjct: 122 KKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA--KFPIKWTAPESL 177
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
+ + KSDV++FGV++ E+ T G D + Y L E
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------------DLSQVYELLEK----- 220
Query: 863 RNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLL 902
G+R + EL C + + +DRP+ +E+ +A ET+
Sbjct: 221 ------GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 69/220 (31%), Positives = 112/220 (50%), Gaps = 31/220 (14%)
Query: 634 EIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGG-LEFKTEIELLSRVHHKNLV 686
E+G G +GKV+ G D ++VA+K ++ + +F+ E ELL+ H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESL--SGRSGIHLDWKRR----------LRIALGS 734
G C E ++V+E+M +G L + L G L L+IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS----KGHVSTQV 790
A G+ Y LA+ +HRD+ + N L+ +L K+ DFG+S+ V + GH +
Sbjct: 132 ASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP 829
+ ++ PE M ++ T +SDV+SFGVV+ E+ T KQP
Sbjct: 189 R----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 81/276 (29%), Positives = 129/276 (46%), Gaps = 40/276 (14%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
E+G+G +G V G VAIK ++GSM EF E +++ ++ H+ LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGI-HLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
+Q +V E+M+NG L L R + L + G+AYL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYL--REHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSD----SSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
D+ + N L+D+ KV+DFGLS+ V D SS G K + + PE + + +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG-----SKFPVRWSPPEVLLYSKFS 179
Query: 809 EKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867
KSDV++FGV+M E+ + K P E+ + +E ++ + L
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYER-------------------FNNSETVEKVSQGLRL 220
Query: 868 ----LGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
L + + C E A +RPT +++ +IE
Sbjct: 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 88/279 (31%), Positives = 126/279 (45%), Gaps = 48/279 (17%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
E+GSG +G V+ G VAIK +G+M +F E +++ ++ H LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
+Q +V EFM NG L L R G L L + G+ YL E + IHRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYL-ERNS--FIHRD 125
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSD----SSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
+ + N L+ KV+DFG+++ V D SS G K + + PE + + +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG-----AKFPVKWSPPEVFNFSKYSS 180
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868
KSDV+SFGV+M E+ T K P E K EV ++R
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFE--KKSNYEVVEMISR---------------------- 216
Query: 869 GFRRY---------LELALQCVEESATDRPTMSEVVKAI 898
GFR Y E+ C E RPT +E+++AI
Sbjct: 217 GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-27
Identities = 91/287 (31%), Positives = 135/287 (47%), Gaps = 48/287 (16%)
Query: 635 IGSGGYGKVYRGML--SDGQVV--AIKRAQQ-GSMQGGLEFKTEIELLSRVHHKNLVGLV 689
IG G +G VY G L SDGQ + A+K + ++ +F E ++ H N++ L+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 690 GFCF-EQGEQMLVYEFMANGTLRESLSGRSGIH-LDWKRRLRIALGSARGLAYLHELANP 747
G C +G ++V +M +G LR + RS H K + L A+G+ YL A+
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---ASK 117
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--KGHVSTQVKGTMGYLDPEYYMTQ 805
+HRD+ + N +LDE+ T KVADFGL++ + D H T K + ++ E TQ
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177
Query: 806 QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
+ T KSDV+SFGV++ EL+T R A D + + +T
Sbjct: 178 KFTTKSDVWSFGVLLWELMT---------------RGAPPYPDVDSFDIT---------V 213
Query: 866 VLLGFRRYL----------ELALQCVEESATDRPTMSEVVKAIETLL 902
LL RR L E+ L C RPT SE+V IE +
Sbjct: 214 YLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 16/211 (7%)
Query: 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKN 684
+F N+IG G +G V++ + +D +V A+K+ M E E +L+++
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD----WKRRLRIALGSARGLAY 740
++ ++G+ +V E+ NG L + L + G L W+ ++I LG LA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
LH + I+HRD+KS N+ LD K+ D G++KL+SD++ + + + GT YL PE
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT--NFANTIVGTPYYLSPE 171
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
+ EKSDV++ GVV+ E T K P +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 79/258 (30%), Positives = 132/258 (51%), Gaps = 22/258 (8%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
++G G +G+V+ G + VAIK + G+M F E +++ ++ H+ LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
E+ +V E+M+ G+L + L G G +L + + +A A G+AY+ + +HRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRD 127
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTMGYLDPEYYMTQQLTEKSD 812
+++ NIL+ ENL KVADFGL++L+ D+ + + Q K + + PE + + T KSD
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 813 VYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRR 872
V+SFG+++ EL T K + V REV + R G P ++
Sbjct: 186 VWSFGILLTELTT-KGRVPYPGMVNREVLDQVER------GYRMPCPPECPESL------ 232
Query: 873 YLELALQCVEESATDRPT 890
+L QC + +RPT
Sbjct: 233 -HDLMCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 80/284 (28%), Positives = 145/284 (51%), Gaps = 28/284 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQG-SMQGGLEFKTEIELLSRVH 681
++ ++ IG+G +G+V+RG+L VAIK + G + + +F +E ++ +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
H N++ L G + M++ E+M NG L + L G + + + G A G+ YL
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYL 123
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG-HVSTQVKGTMGYLDPE 800
++ +HRD+ + NIL++ NL KV+DFGLS+++ D +G + ++ K + + PE
Sbjct: 124 SDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 801 YYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
++ T SDV+SFG+VM E+++ ++P EV A+N + + L MD
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--HEVMKAIN----DGFRLPAPMD 234
Query: 860 -PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
P+ +L LQC ++ RP ++V ++ LL
Sbjct: 235 CPSAVY----------QLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 86/302 (28%), Positives = 134/302 (44%), Gaps = 52/302 (17%)
Query: 627 NNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV 680
+N E+G G +GKV+ D +VA+K + S +F E ELL+ +
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESL-----------SGRSGIHLDWKRRLR 729
H+++V G C E ++V+E+M +G L + L G L + L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
IA A G+ YL A+ +HRD+ + N L+ ENL K+ DFG+S+ V + V
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH 181
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDD 848
+ ++ PE M ++ T +SDV+S GVV+ E+ T KQP
Sbjct: 182 TMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP------------------- 222
Query: 849 EEHYGLT--EMMDPTIRNTVLLGFR----RYLELALQCVEESATDRPTMSEVVKAIETLL 902
Y L+ E+++ + VL R +L L C + P M +K I +LL
Sbjct: 223 --WYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQR----EPHMRLNIKEIHSLL 276
Query: 903 QN 904
QN
Sbjct: 277 QN 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-26
Identities = 70/221 (31%), Positives = 110/221 (49%), Gaps = 9/221 (4%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
C++ + L L + L G++ +G LR + L N +G L L + L +
Sbjct: 377 CSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNS-FSGELPSEFTKLPLVYFLDI 435
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
+ G I ++ L L+L N F G +P S G +L LDL+ NQ +G++P
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRK 494
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ 240
+ L QLK ++NKLSG I ++L S L+ + NQLSG IP S +
Sbjct: 495 LGSLSELMQLK------LSENKLSGEIPDELSSCKK-LVSLDLSHNQLSGQIPASFSEMP 547
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP 281
L L L +N L+G++P NL N+ ++ ++N++HN L G P
Sbjct: 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588
|
Length = 968 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 80/293 (27%), Positives = 129/293 (44%), Gaps = 64/293 (21%)
Query: 634 EIGSGGYGKVYRGM---LSDGQV---VAIKRAQQ-GSMQGGLEFKTEIELLSRVHHKNLV 686
E+G G +G VY G+ + G+ VAIK + SM+ +EF E ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLR----------ESLSGRSGIHLDWKRRLRIALGSAR 736
L+G ++V E MA G L+ E+ G L + +++A A
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ--KFIQMAAEIAD 130
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV--SDSSKGHVSTQVKGTM 794
G+AYL +HRD+ + N ++ E+LT K+ DFG+++ + +D + KG
Sbjct: 131 GMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-------KGGK 180
Query: 795 GYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPI------EKGKYVVREVRT 842
G L PE T KSDV+SFGVV+ E+ T A+QP E K+V+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GG 238
Query: 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895
++ + L E+M C + + RPT E+V
Sbjct: 239 HLDLPENCPDKLLELM-------------------RMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 65/192 (33%), Positives = 106/192 (55%), Gaps = 6/192 (3%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
++G+G +G+V+ G + VAIK +QGSM F E L+ ++ H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
++ ++ E+M NG+L + L GI L + + +A A G+A++ E N IHRD
Sbjct: 72 QE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN--YIHRD 127
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDV 813
+++ NIL+ E L K+ADFGL++L+ D+ K + + PE T KSDV
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 814 YSFGVVMLELIT 825
+SFG+++ E++T
Sbjct: 187 WSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-25
Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 35/305 (11%)
Query: 49 SDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPR 108
S++ G + R+ L L + +G++ ++G L LDLS N LTG +
Sbjct: 317 SNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN-LTGEIPEG 375
Query: 109 IGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDL 168
+ L LIL G IP +G L + L N+FSG +P KL +Y+LD+
Sbjct: 376 LCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDI 435
Query: 169 ADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228
++N L G I P L L A+ N+
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLAR-------------------------------NKF 464
Query: 229 SGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMN 287
G +P+S G + LE L L RN +G VP L +L+ + +L L+ N L G PD LS
Sbjct: 465 FGGLPDSFGSKR-LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCK 523
Query: 288 SLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNA 347
L +DLS+N + P FS +P L+ L L G +P L + + QV + +N
Sbjct: 524 KLVSLDLSHNQLS-GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNH 582
Query: 348 FNNTL 352
+ +L
Sbjct: 583 LHGSL 587
|
Length = 968 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 69/248 (27%), Positives = 101/248 (40%), Gaps = 33/248 (13%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD-GQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHK 683
+F IG G +GKV D ++ A+K + + E +L ++H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 684 NLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKR-------RLRIA-LGS 734
LV L + F+ E M LV + + G LR HL K + I +
Sbjct: 61 FLVNLW-YSFQDEENMYLVVDLLLGGDLR--------YHLSQKVKFSEEQVKFWICEIVL 111
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
A L YLH IIHRD+K NILLDE + DF ++ V+ + +T GT
Sbjct: 112 A--LEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTP 163
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854
GY+ PE Q + D +S GV E + K+P +R+ A + Y
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPA 223
Query: 855 T---EMMD 859
T E +D
Sbjct: 224 TWSTEAID 231
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 58/211 (27%), Positives = 103/211 (48%), Gaps = 19/211 (9%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLV 689
+IG G YG+VY+ G++VA+K+ + + + G EI+LL ++ H N+V L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 690 GFCFE--QGEQMLVYEFMANGTLRESLSG---RSGIHLDWKRRLRIALGSARGLAYLHEL 744
+G +V+E+M + L+G + + GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-----DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM- 803
I+HRD+K +NIL++ + K+ADFGL++ + + + +V T+ Y PE +
Sbjct: 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLG 175
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ + D++S G ++ EL +PI +G
Sbjct: 176 ATRYGPEVDMWSVGCILAELFL-GKPIFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLVGF 691
IG G YG VY+ G++VAIK+ + G+ EI+LL ++H N++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
+G+ LV+EFM + L + + R L +GLA+ H I+H
Sbjct: 67 FRHKGDLYLVFEFM-DTDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS-HG--ILH 121
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEK 810
RD+K N+L++ K+ADFGL++ S T T Y PE + + +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179
Query: 811 SDVYSFGVVMLELITAKQPIEKGK 834
D++S G + EL++ ++P+ GK
Sbjct: 180 VDIWSVGCIFAELLS-RRPLFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-25
Identities = 80/268 (29%), Positives = 133/268 (49%), Gaps = 24/268 (8%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
++G G +G+V+ G + VAIK + G+M F E +++ ++ H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
E+ +V EFM G+L + L G +L + + +A A G+AY+ + IHRD
Sbjct: 72 EE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTMGYLDPEYYMTQQLTEKSD 812
+++ NIL+ +NL K+ADFGL++L+ D+ + + Q K + + PE + + T KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 813 VYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRR 872
V+SFG+++ EL+T K + V REV E ++ R G
Sbjct: 186 VWSFGILLTELVT-KGRVPYPGMVNREV--------------LEQVERGYRMPCPQGCPE 230
Query: 873 YL-ELALQCVEESATDRPTMSEVVKAIE 899
L EL C ++ +RPT + +E
Sbjct: 231 SLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 62/193 (32%), Positives = 108/193 (55%), Gaps = 8/193 (4%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
++G+G +G+V+ G + VA+K + G+M F E +++ ++ H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
E+ +V E+M+ G+L + L G L + +A A G+AY+ + IHRD
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTMGYLDPEYYMTQQLTEKSD 812
++S NIL+ + L K+ADFGL++L+ D+ + + Q K + + PE + + T KSD
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 813 VYSFGVVMLELIT 825
V+SFG+++ EL+T
Sbjct: 186 VWSFGILLTELVT 198
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 634 EIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
E+G G +GKV+ D +VA+K ++ S +F+ E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESL-------------SGRSGIHLDWKRRLRIALGS 734
G C E ++V+E+M +G L L + L + L IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
A G+ YL L +HRD+ + N L+ + L K+ DFG+S+ + + V + +
Sbjct: 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP 829
++ PE + ++ T +SD++SFGVV+ E+ T KQP
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 54/203 (26%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHH 682
+ +IG G G+VY+ + G+ VAIK R ++ + + EI ++ H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL---IINEILIMKDCKH 74
Query: 683 KNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
N+V + G+++ +V E+M G+L + ++ ++ + ++ + + +GL YL
Sbjct: 75 PNIVDYYD-SYLVGDELWVVMEYMDGGSLTDIIT-QNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H + +IHRD+KS NILL ++ + K+ADFG + ++ K ++ V GT ++ PE
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT-KEKSKRNSVV-GTPYWMAPEV 187
Query: 802 YMTQQLTEKSDVYSFGVVMLELI 824
+ K D++S G++ +E+
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 48/277 (17%)
Query: 649 SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--EQMLVYEFMA 706
+ G+VVA+K+ Q + + +F+ EIE+L + H N+V G C+ G LV E++
Sbjct: 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766
G+LR+ L + LD ++ L A +G+ YL +HRD+ + NIL++
Sbjct: 91 YGSLRDYLQ-KHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENR 146
Query: 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ-------------LTE---- 809
K+ DFGL+K++ D EYY ++ LTE
Sbjct: 147 VKIGDFGLTKVLP-----------------QDKEYYKVREPGESPIFWYAPESLTESKFS 189
Query: 810 -KSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH---YGLTEMMDPTIRNT 865
SDV+SFGVV+ EL T +K E M D + Y L E++ R
Sbjct: 190 VASDVWSFGVVLYELFTY---SDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246
Query: 866 VLLGF-RRYLELALQCVEESATDRPTMSEVVKAIETL 901
G + +C + RP+ SE+ +E +
Sbjct: 247 APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 44/285 (15%)
Query: 635 IGSGGYGKVYRGMLS----DGQVVAIKRAQQG-SMQGGLEFKTEIELLSRVHHKNLVGLV 689
IG+G +G+V RG L VAIK + G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSG----IHLDWKRRLRIALGSARGLAYLHELA 745
G + M++ EFM NG L L G I L R G A G+ YL E+
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLSEMN 126
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG---TMGYLDPEYY 802
+HRD+ + NIL++ NL KV+DFGLS+ + D + T G + + PE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD----DEEHYGLTEMM 858
++ T SDV+S+G+VM E+++ Y R N+D E+ Y L M
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS---------YGERPYWDMSNQDVINAIEQDYRLPPPM 234
Query: 859 D-PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
D PT + +L L C ++ RP ++V ++ ++
Sbjct: 235 DCPTALH----------QLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 72/214 (33%), Positives = 109/214 (50%), Gaps = 22/214 (10%)
Query: 628 NFSESNEIGSGGYGKVYR-GMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKN 684
+F ++G G YG VY+ LSD Q A+K GSM + + EI +L+ V+H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL-------RIALGSARG 737
++ + + +V E+ G L +++S R KR+L RI + RG
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKK-----KRKLIPEQEIWRIFIQLLRG 115
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L LHE I+HRD+KS NILL N K+ D G+SK++ K TQ+ GT Y+
Sbjct: 116 LQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYM 168
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
PE + + + KSD++S G ++ E+ T P E
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 31/207 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGLVGFC 692
+G G YG VY+ + GQVVAIK ++ L E EI +L + +V G
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIK---VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
F+ + +V E+ G++ + + L + I + +GL YLH + IHR
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLH---SNKKIHR 123
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG----------YLDPEYY 802
D+K+ NILL+E AK+ADFG VS Q+ TM ++ PE
Sbjct: 124 DIKAGNILLNEEGQAKLADFG------------VSGQLTDTMAKRNTVIGTPFWMAPEVI 171
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
K+D++S G+ +E+ K P
Sbjct: 172 QEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 64/207 (30%), Positives = 106/207 (51%), Gaps = 23/207 (11%)
Query: 633 NEIGSGGYGKVYRGML--SDGQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKNLVG 687
E+G+G G V + +L G+++A+K + + K E+++L + + +VG
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEA--IQKQILRELDILHKCNSPYIVG 63
Query: 688 LVGFCFEQGEQMLVYEFMANGTL---RESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
G + G+ + E+M G+L + + GR + K IA+ +GL YLHE
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK----IAVAVLKGLTYLHEK 119
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
IIHRDVK +NIL++ K+ DFG+S +LV+ +K V GT Y+ PE
Sbjct: 120 HK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQ 172
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPI 830
+ KSD++S G+ ++EL T + P
Sbjct: 173 GNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 15/209 (7%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF-KTEIELLSRVHHKNLVGLVG 690
IG G VY + L + + VAIKR Q ++ + E++ +S+ +H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSARGLAYLHELANP 747
E LV +++ G+L + + +S IA +GL YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS--SKGHVSTQVKGTMGYLDPEYYMTQ 805
IHRD+K+ NILL E+ + K+ADFG+S ++D V GT ++ PE M Q
Sbjct: 124 --IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE-VMEQ 180
Query: 806 Q--LTEKSDVYSFGVVMLELITAKQPIEK 832
K+D++SFG+ +EL T P K
Sbjct: 181 VHGYDFKADIWSFGITAIELATGAAPYSK 209
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 64/217 (29%), Positives = 109/217 (50%), Gaps = 24/217 (11%)
Query: 634 EIGSGGYGKVYRGM------LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
E+G G +GKV+ D +VA+K + ++ +F+ E ELL+ + H+++V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSG--------------RSGIHLDWKRRLRIALG 733
G C + ++V+E+M +G L + L ++ L + L IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
A G+ YL A+ +HRD+ + N L+ NL K+ DFG+S+ V + V
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 188
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP 829
+ ++ PE M ++ T +SDV+SFGV++ E+ T KQP
Sbjct: 189 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 634 EIGSGGYGKVYRGMLS-DGQVVAIKRAQ-QGSMQGGLEFKTEIELLSRVHHKNLVGLVGF 691
+G G G VY+ G++ A+K+ G + + E++ L +V G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL--RIALGSARGLAYLHELANPPI 749
+++GE +V E+M G+L L + G + IA +GL YLH + I
Sbjct: 68 FYKEGEISIVLEYMDGGSL-ADLLKKVGK---IPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
IHRD+K +N+L++ K+ADFG+SK++ ++ + GT+ Y+ PE + +
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV--GTVTYMSPERIQGESYSY 179
Query: 810 KSDVYSFGVVMLELITAKQPIEKGK 834
+D++S G+ +LE K P
Sbjct: 180 AADIWSLGLTLLECALGKFPFLPPG 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 77/274 (28%), Positives = 128/274 (46%), Gaps = 39/274 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKR---AQQGSMQGGL--EFKTEIELLSRVHHKNLVGL 688
+GSG +G VY G+ L DG A+K A G + + EI LLS++ H N+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL--RIALGSARGLAYLHELAN 746
+G E+ + E + G+L L + G + RL R L GL YLH +
Sbjct: 68 LGTEREEDNLYIFLELVPGGSL-AKLLKKYGSFPEPVIRLYTRQIL---LGLEYLH---D 120
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQ 805
+HRD+K NIL+D N K+ADFG++K V + S + KG+ ++ PE
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQG 177
Query: 806 QLTEKSDVYSFGVVMLELITAKQP---IEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
+D++S G +LE+ T K P +E V + R+ +E + + +
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS------KELPPIPDHLSDEA 231
Query: 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
++ + L+C++ + RPT +E+++
Sbjct: 232 KDFI-----------LKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 71/233 (30%), Positives = 113/233 (48%), Gaps = 35/233 (15%)
Query: 627 NNFSESNEIGSGGYGKVYR----GMLSDGQ--VVAIKRAQQG-SMQGGLEFKTEIELLSR 679
NN +IG G +G+V++ G+L +VA+K ++ S +F+ E L++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS------GIHLDWKRR------ 727
H N+V L+G C L++E+MA G L E L RS H R
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 728 --------LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV- 778
L IA A G+AYL E +HRD+ + N L+ EN+ K+ADFGLS+ +
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 779 -SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP 829
+D K + + + ++ PE + T +SDV+++GVV+ E+ + QP
Sbjct: 182 SADYYKASENDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 72/217 (33%), Positives = 118/217 (54%), Gaps = 23/217 (10%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIKRAQ-QGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
IG G +G V +G + GQ VA+K + + Q LE E +++++HHKNLV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQAFLE---ETAVMTKLHHKNLVRLLGVIL 69
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
G +V E M+ G L L R + + L+ +L A G+ YL + ++HRD
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRD 125
Query: 754 VKSTNILLDENLTAKVADFGLSKLVS---DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
+ + NIL+ E+ AKV+DFGL+++ S D+SK VK T PE ++ + K
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVGSMGVDNSK----LPVKWTA----PEALKHKKFSSK 177
Query: 811 SDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846
SDV+S+GV++ E+ + + P K ++EV+ + +
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYP--KMSLKEVKECVEK 212
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 4e-23
Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 34/279 (12%)
Query: 635 IGSGGYGKVYRGML---SDGQV-VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGLV 689
IG+G +G+V G L ++ VAIK + G + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
G + M+V E+M NG+L L G + + + G A G+ YL ++
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLSDMG---Y 127
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTMGYLDPEYYMTQQLT 808
+HRD+ + NIL++ NL KV+DFGLS+++ D + +T+ K + + PE ++ T
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD----DEEHYGLTEMMD-PTIR 863
SDV+S+G+VM E+++ Y R N+D EE Y L MD P
Sbjct: 188 SASDVWSYGIVMWEVMS---------YGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL 238
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
+ L L C ++ +RP ++V ++ L+
Sbjct: 239 HQ----------LMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 6e-23
Identities = 63/213 (29%), Positives = 108/213 (50%), Gaps = 24/213 (11%)
Query: 634 EIGSGGYGKVYRGML-----SDGQVVAIKRAQQ-GSMQGGLEFKTEIELLSRVHHKNLVG 687
E+G +GK+Y+G L Q+VAIK + + Q EF+ E L++ +HH N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRS---------------GIHLDWKRRLRIAL 732
L+G ++ +++E++ G L E L RS LD L IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
A G+ YL ++ +H+D+ + NIL+ E L K++D GLS+ + + V +
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 793 TMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
+ ++ PE M + + SD++SFGVV+ E+ +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 86/320 (26%), Positives = 143/320 (44%), Gaps = 69/320 (21%)
Query: 627 NNFSESNEIGSGGYGKVYRGML-SDG--QVVAIKRAQQ-GSMQGGLEFKTEIELLSRV-H 681
N+ + IG G +G+V + + DG AIKR ++ S +F E+E+L ++ H
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRE--------------SLSGRSGIHLDWKRR 727
H N++ L+G C +G L E+ +G L + +++ + L ++
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
L A ARG+ YL + IHRD+ + NIL+ EN AK+ADFGL S+G
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL-------SRGQ-E 175
Query: 788 TQVKGTMGYLDPEYYMTQQL-----TEKSDVYSFGVVMLELI----------TAKQPIEK 832
VK TMG L + + L T SDV+S+GV++ E++ T + EK
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMS 892
R + +N DDE + +L QC E +RP+ +
Sbjct: 236 LPQGYR-LEKPLNCDDEVY-----------------------DLMRQCWREKPYERPSFA 271
Query: 893 EVVKAIETLLQNDGMNTNST 912
+++ ++ +L+ N+T
Sbjct: 272 QILVSLNRMLEERKTYVNTT 291
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 67/214 (31%), Positives = 104/214 (48%), Gaps = 22/214 (10%)
Query: 635 IGSGGYGKVYRGMLSD-------GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLV 686
+GSG +G+VY G +D VA+K ++G+ Q EF E L+S +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSG-----RSGIHLDWKRRLRIALGSARGLAYL 741
L+G C Q ++ E M G L L L K L I L A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 742 HELANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
++ IHRD+ + N L+ E + K+ DFGL++ + S + + +
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 797 LDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP 829
+ PE + + T +SDV+SFGV+M E++T +QP
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-22
Identities = 99/357 (27%), Positives = 159/357 (44%), Gaps = 48/357 (13%)
Query: 560 IACG-GAVLVLGLVGLGLYAIRQK-----KRAERAIGLSKPFASWAPSGKDSGGAPQLKG 613
I C GA LVL LV G IR + KR E G +W DS K
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG------TWELQFFDS------KV 679
Query: 614 ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRG--MLSDGQVVAIKRAQQGSMQGGLEFK 671
++ + +++ E N I G G Y+G + + Q V + S+
Sbjct: 680 SKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----S 731
Query: 672 TEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIA 731
+EI + ++ H N+V L+G C + L++E++ L E L L W+RR +IA
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIA 786
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
+G A+ L +LH +P ++ ++ I++D + L L+ +K +S+
Sbjct: 787 IGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS--- 842
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP--IEKGKYVVREVRTAMNRDDE 849
Y+ PE T+ +TEKSD+Y FG++++EL+T K P E G V R
Sbjct: 843 ---AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHGSIVEWARYCY 896
Query: 850 EHYGLTEMMDPTIRNTVLLGFRRYLE---LALQCVEESATDRPTMSEVVKAIETLLQ 903
L +DP+IR V + +E LAL C T RP ++V+K +E+ +
Sbjct: 897 SDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953
|
Length = 968 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 3e-22
Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 35/288 (12%)
Query: 628 NFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGL-EFKTEIELLSRV 680
N E +G G +G+V+ +V +K Q+ + EF+ E+++ ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIH------LDWKRRLRIALG 733
HKN+V L+G C E ++ E+ G L++ L + +S L K+++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
A G+ + L+N +HRD+ + N L+ KV+ LSK V +S+ +
Sbjct: 126 IALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVY-NSEYYKLRNALIP 181
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHY 852
+ +L PE + KSDV+SFGV+M E+ T + P DEE
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG-------------LSDEEV- 227
Query: 853 GLTEMMDPTIRNTVLLGF-RRYLELALQCVEESATDRPTMSEVVKAIE 899
L + + V G R +L +C + DRP+ SE+V A+
Sbjct: 228 -LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 3e-22
Identities = 73/259 (28%), Positives = 129/259 (49%), Gaps = 23/259 (8%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGF 691
++G+G +G+V+ G ++ VA+K + G+M Q LE E L+ + H LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAV 69
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
++ ++ E+MA G+L + L G + + + + A G+AY+ E N IH
Sbjct: 70 VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYI-ERKN--YIH 126
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKS 811
RD+++ N+L+ E+L K+ADFGL++++ D+ K + + PE T KS
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKS 185
Query: 812 DVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFR 871
DV+SFG+++ E++T + G +V +A+ R Y + P + N
Sbjct: 186 DVWSFGILLYEIVTYGKIPYPGM-SNSDVMSALQRG----YRM-----PRMENCPD---- 231
Query: 872 RYLELALQCVEESATDRPT 890
++ C +E A +RPT
Sbjct: 232 ELYDIMKTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 62/196 (31%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGFCF 693
IG G +G VY+G+L VA+K + F E E+L + H N+V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
++ +V E + G+L L + L K+ L+++L +A G+ YL E N IHRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKN-RLTVKKLLQMSLDAAAGMEYL-ESKN--CIHRD 118
Query: 754 VKSTNILLDENLTAKVADFGLSK----LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
+ + N L+ EN K++DFG+S+ + S G +K T PE + T
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA----PEALNYGRYTS 174
Query: 810 KSDVYSFGVVMLELIT 825
+SDV+S+G+++ E +
Sbjct: 175 ESDVWSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 3e-22
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKR-------AQQGS--MQGGLE-FKTEIELLSRVHHK 683
IG G YG+VY + ++ G+++A+K+ A + + ++ ++EIE L + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 684 NLVGLVGFCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
N+V +GF E E+ L E++ G++ L R + GLAYL
Sbjct: 69 NIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV--LEGLAYL 124
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H + I+HRD+K+ N+L+D + K++DFG+SK D + ++G++ ++ PE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 802 YMTQQ--LTEKSDVYSFGVVMLELITAKQP 829
+ + K D++S G V+LE+ ++P
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (240), Expect = 6e-22
Identities = 67/208 (32%), Positives = 98/208 (47%), Gaps = 29/208 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRVHHKN 684
+G G +GKV G++ A+K R + TE +LSR++H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT------LTERNILSRINHPF 54
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRL--RIALGSARGLAYL 741
+V L + F+ E++ LV E+ G L LS + R I L L YL
Sbjct: 55 IVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA----LEYL 109
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H L II+RD+K NILLD + K+ DFGL+K SS+G + GT YL PE
Sbjct: 110 HSLG---IIYRDLKPENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEV 164
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ + + D +S GV++ E++T K P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (241), Expect = 6e-22
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 14/205 (6%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---EIELLSRVHHKNLVGLVG 690
+G G YG VY+ G++VA+K+ + + + G+ T EI LL + H N+V L+
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGI-PSTALREISLLKELKHPNIVKLLD 65
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
+ + LV+E+ L++ L R G L I RGLAY H I+
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCHSHR---IL 120
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
HRD+K NIL++ + K+ADFGL++ T T+ Y PE + +
Sbjct: 121 HRDLKPQNILINRDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILLGSKHYST 178
Query: 811 S-DVYSFGVVMLELITAKQPIEKGK 834
+ D++S G + E+IT +P+ G
Sbjct: 179 AVDIWSVGCIFAEMIT-GKPLFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 7e-22
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 628 NFSESNEIGSGGYGKVY--RGMLSDGQVVAIKR--AQQGSMQGGLEFKTEIELLSRVHHK 683
+ + +G G +G V+ R +D ++V IK+ +Q + L + E ++L + H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRR-KADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP 59
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
N++ E M+V E+ GTL E + R LD L + + L LH
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV---QILLALHH 116
Query: 744 LANPPIIHRDVKSTNILLDENLTA-KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+ I+HRD+K+ NILLD++ K+ DFG+SK++S SK + V GT Y+ PE
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPELC 173
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIE 831
+ +KSD+++ G V+ EL + K+ E
Sbjct: 174 EGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 9e-22
Identities = 73/302 (24%), Positives = 134/302 (44%), Gaps = 63/302 (20%)
Query: 635 IGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKNLV 686
+G G +G+V + VA+K + + + L + +E+E++ + HKN++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRI--------------AL 732
L+G C ++G +V E+ A+G LR+ L R A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD------SSKGHV 786
ARG+ +L A+ IHRD+ + N+L+ E+ K+ADFGL++ + ++ G +
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRL 196
Query: 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT------AKQPIEKGKYVVREV 840
VK ++ PE + T +SDV+SFGV++ E+ T P+E+ +++E
Sbjct: 197 P--VK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE- 249
Query: 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900
R ++ E+ Y L C E + RPT ++V+ ++
Sbjct: 250 ---GYRMEKPQNCTQEL---------------YH-LMRDCWHEVPSQRPTFKQLVEDLDR 290
Query: 901 LL 902
+L
Sbjct: 291 ML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 82/289 (28%), Positives = 127/289 (43%), Gaps = 43/289 (14%)
Query: 635 IGSGGYGKVYRGMLS--DG--QVVAIKRAQ-QGSMQGGLE-FKTEIELLSRVHHKNLVGL 688
+G G +G V G LS DG VA+K + +E F +E + H N++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 689 VGFCFEQGEQ------MLVYEFMANGTLRESL-SGRSG---IHLDWKRRLRIALGSARGL 738
+G CFE M++ FM +G L L R G L + L+ + A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS---KGHVSTQVKGTMG 795
YL +N IHRD+ + N +L E++T VADFGLSK + +G ++ K +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA---KMPVK 180
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEHYG 853
++ E + T KSDV++FGV M E+ T Q G + + + NR +
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDC 240
Query: 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
L E+ D L C DRPT +++ + +E +L
Sbjct: 241 LDELYD----------------LMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 2e-21
Identities = 66/192 (34%), Positives = 102/192 (53%), Gaps = 16/192 (8%)
Query: 635 IGSGGYGKVYRGMLSD--GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
IG G +G V ML D G VA+K + + F E +++++ H NLV L+G
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGVI 68
Query: 693 FEQ-GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
E+ G +V E+MA G+L + L R L L+ +L + YL AN +H
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--ANN-FVH 125
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKS 811
RD+ + N+L+ E+ AKV+DFGL+K S S++ VK T PE ++ + KS
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLPVKWTA----PEALREKKFSTKS 180
Query: 812 DVYSFGVVMLEL 823
DV+SFG+++ E+
Sbjct: 181 DVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 61/202 (30%), Positives = 109/202 (53%), Gaps = 15/202 (7%)
Query: 634 EIGSGGYGKVY------RGMLSDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLV 686
++G G +GKV G + G+ VA+K + S + + K EIE+L ++H+N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 687 GLVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
G C E G L+ EF+ +G+L+E L R+ ++ K++L+ A+ +G+ YL
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-RNKNKINLKQQLKYAVQICKGMDYL--- 125
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH-VSTQVKGTMGYLDPEYYM 803
+ +HRD+ + N+L++ K+ DFGL+K + + + V + + + PE +
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 804 TQQLTEKSDVYSFGVVMLELIT 825
+ SDV+SFGV + EL+T
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 44/288 (15%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT------EIELLSRV 680
+ + ++G+G + Y+ + G ++A+K+ + + EI L++R+
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG----RSGIHLDWKRRLRIALGSAR 736
+H +++ ++G E L E+MA G++ LS + + +++ +L R
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LR 114
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLS-KLVSD-SSKGHVSTQVKGT 793
GL+YLHE IIHRDVK N+L+D ++ADFG + +L + + G Q+ GT
Sbjct: 115 GLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGT 171
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853
+ ++ PE +Q DV+S G V++E+ TAK P H
Sbjct: 172 IAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN-------------AEKHSNHLA 218
Query: 854 L-----TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
L + P+I + G R ++ L+C+E DRP E++K
Sbjct: 219 LIFKIASATTAPSIPEHLSPGLR---DVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 3e-21
Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 36/230 (15%)
Query: 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRA------QQGSMQGGLEFKTEIELLSR 679
++F IG G + V + AIK ++ ++ K E E+L+R
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVK---YVKIEKEVLTR 57
Query: 680 V-HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
+ H ++ L + F+ E + V E+ NG L + + + R A
Sbjct: 58 LNGHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRF--YAAEILLA 114
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK------ 791
L YLH IIHRD+K NILLD+++ K+ DFG +K++ +S +
Sbjct: 115 LEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 792 ------------GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT Y+ PE + + SD+++ G ++ +++T K P
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 66/216 (30%), Positives = 111/216 (51%), Gaps = 25/216 (11%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNLVGLVGFCF 693
+G G +G+V++G L D VA+K ++ Q ++F +E +L + H N+V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
++ +V E + G L + L K+ ++ AL +A G+AYL E N IHRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYL-ESKN--CIHRD 118
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSD---SSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
+ + N L+ EN K++DFG+S+ D SS G +K T PE + + +
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTA----PEALNYGRYSSE 174
Query: 811 SDVYSFGVVMLELIT-------------AKQPIEKG 833
SDV+S+G+++ E + A++ +EKG
Sbjct: 175 SDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG 210
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 59/223 (26%), Positives = 96/223 (43%), Gaps = 33/223 (14%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT------------- 672
N + +G G YG V + G++VAIK +FK
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK-----------KFKESEDDEDVKKTALR 49
Query: 673 EIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL 732
E+++L ++ H+N+V L +G LV+E++ L + G+ D R L
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQL 109
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
+ +AY H IIHRD+K NIL+ E+ K+ DFG ++ + ++ V
Sbjct: 110 --LQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163
Query: 793 TMGYLDPEYYMTQQLTEKS-DVYSFGVVMLELITAKQPIEKGK 834
T Y PE + K DV++ G +M EL+ +P+ G
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 633 NEIGSGGYGKVYRG--MLSDGQV--VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVG 687
E+G G +G V +G ++ G+ VA+K +Q + G EF E +++++ H +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 688 LVGFCFEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L+G C +GE MLV E G L + L R I + +A A G+AYL E +
Sbjct: 61 LIGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPV--SDLKELAHQVAMGMAYL-ESKH 115
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYLDPE--YYM 803
+HRD+ + N+LL AK++DFG+S+ L + S +T + + + PE Y
Sbjct: 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQP 829
+ KSDV+S+GV + E +
Sbjct: 174 K--FSSKSDVWSYGVTLWEAFSYGAK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 6e-21
Identities = 81/289 (28%), Positives = 137/289 (47%), Gaps = 39/289 (13%)
Query: 634 EIGSGGYGKV--YRGMLSD---GQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVG 687
+G G +GKV Y ++ G++VA+K ++ Q +K EI +L ++H+N+V
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 688 LVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
G C EQG + L+ E++ G+LR+ L L+ + L A G+AYLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLH--- 124
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
+ IHRD+ + N+LLD + K+ DFGL+K V + GH +V+ G +Y +
Sbjct: 125 SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVRED-GDSPVFWYAVE 180
Query: 806 QLTE-----KSDVYSFGVVMLELIT----AKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856
L E SDV+SFGV + EL+T + P +K + ++ + M L E
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV-----VRLIE 235
Query: 857 MMDPTIR----NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901
+++ +R ++ C E A RPT ++ ++ +
Sbjct: 236 LLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 8e-21
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 635 IGSGGYGKVYR-GMLSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLVGF 691
IG G +G V++ G+ VA+K+ ++GG+ + EI+ L H +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 692 CFEQGEQM-LVYEFMANGTLRESL--SGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
F G LV E+M L E L R K +R+ L +G+AY+H
Sbjct: 68 -FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHANG--- 119
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE-YYMTQQL 807
I+HRD+K N+L+ + K+ADFGL++L S+ S QV T Y PE Y ++
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKY 178
Query: 808 TEKSDVYSFGVVMLELI 824
D+++ G + EL+
Sbjct: 179 DPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 65/201 (32%), Positives = 98/201 (48%), Gaps = 22/201 (10%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG---GLEFKT--EIELLSRVHHKNLVGL 688
+G G Y VY+ G++VAIK+ + G + G+ F EI+LL + H N++GL
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 689 VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHL---DWKRRLRIALGSARGLAYLHEL 744
+ F + LV+EFM T E + I L D K + + L RGL YLH
Sbjct: 68 LD-VFGHKSNINLVFEFME--TDLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLHSN 121
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM- 803
I+HRD+K N+L+ + K+ADFGL++ S ++ QV T Y PE
Sbjct: 122 W---ILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYRAPELLFG 176
Query: 804 TQQLTEKSDVYSFGVVMLELI 824
+ D++S G + EL+
Sbjct: 177 ARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 63/208 (30%), Positives = 105/208 (50%), Gaps = 9/208 (4%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKN 684
+ +IG G +GK+Y SD + IK M + K E+ LL+++ H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V E G +V E+ G L + ++ + G+ + L + + GL ++H+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 745 ANPPIIHRDVKSTNILLDEN-LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
I+HRD+KS NI L +N + AK+ DFG+++ ++DS + ++ GT YL PE
Sbjct: 121 K---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQ 175
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPIE 831
+ K+D++S G V+ EL T K P E
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 39/220 (17%)
Query: 634 EIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIELLSRV-----HHKNLVG 687
IG G YGKVY+ GQ+VAIK M + + EI+ + +H N+
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-----IMDIIEDEEEEIKEEYNILRKYSNHPNIAT 67
Query: 688 LVGFCF-------EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGS 734
G F + LV E G++ + + G +RL+ I +
Sbjct: 68 FYG-AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL----RKKGKRLKEEWIAYILRET 122
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
RGLAYLHE +IHRD+K NILL +N K+ DFG+S + DS+ G +T + GT
Sbjct: 123 LRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL-DSTLGRRNTFI-GTP 177
Query: 795 GYLDPE-----YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
++ PE +SDV+S G+ +EL K P
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 31/250 (12%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFK-----TEIELLSRVHHKNLV 686
IG G +G V + SDG+++ K G+M E + +E+ +L + H N+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT---EKEKQQLVSEVNILRELKHPNIV 62
Query: 687 GLVG-FCFEQGEQM-LVYEFMANGTLRESLS--GRSGIHLDWKRRLRIALGSARGLAYLH 742
+ + +V E+ G L + + + +++ + RI L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 743 --ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS---KGHVSTQVKGTMGYL 797
++HRD+K NI LD N K+ DFGL+K++ S K +V GT Y+
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYM 177
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYG-- 853
PE EKSD++S G ++ EL P + +++ R Y
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 854 ----LTEMMD 859
+ M++
Sbjct: 238 LNEVIKSMLN 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (228), Expect = 2e-20
Identities = 68/215 (31%), Positives = 105/215 (48%), Gaps = 35/215 (16%)
Query: 635 IGSGGYGKVYRGMLS-DG--QVVAIKRAQQ-GSMQGGLEFKTEIELLSRV-HHKNLVGLV 689
IG G +G+V + + DG AIKR ++ S +F E+E+L ++ HH N++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD--------------WKRRLRIALGSA 735
G C +G L E+ +G L + L + D ++ L A A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
RG+ YL + IHRD+ + NIL+ EN AK+ADFGLS+ VK TMG
Sbjct: 123 RGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKTMG 171
Query: 796 YLDPEYYMTQQL-----TEKSDVYSFGVVMLELIT 825
L + + L T SDV+S+GV++ E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-20
Identities = 67/188 (35%), Positives = 96/188 (51%), Gaps = 9/188 (4%)
Query: 71 LSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIP 130
L +G+L + L + LD+S N L G ++ R D+ L +L LA F G +P
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNN-LQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
Query: 131 DEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL 190
D G+ L L L+ N FSG +P LG LS+L L L++N+L+G IP L
Sbjct: 470 DSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE------LSSC 522
Query: 191 KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250
K + N+LSG I FS VL + NQLSG IP++LG V++L + + N
Sbjct: 523 KKLVSLDLSHNQLSGQIPAS-FSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHN 581
Query: 251 ALTGKVPT 258
L G +P+
Sbjct: 582 HLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 35/215 (16%)
Query: 635 IGSGGYGKVYRGMLS-DGQVV--AIKRAQQ-GSMQGGLEFKTEIELLSRV-HHKNLVGLV 689
IG G +G+V R M+ DG + AIK ++ S +F E+E+L ++ HH N++ L+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD--------------WKRRLRIALGSA 735
G C +G + E+ G L + L + D ++ L+ A A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
G+ YL E IHRD+ + N+L+ ENL +K+ADFGLS+ VK TMG
Sbjct: 130 TGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR--------GEEVYVKKTMG 178
Query: 796 YLDPEYYMTQQL-----TEKSDVYSFGVVMLELIT 825
L + + L T KSDV+SFGV++ E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 56/214 (26%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRA------QQGSMQGGLEFKTEIELLSRVHH 682
+++ +G G YG VY G+ + GQ++A+K+ + + + + E++LL + H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG--IHLDWKRRLRIALGSARGLAY 740
N+V +G C + + EF+ G++ L+ R G + + + L G+AY
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAY 117
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS----DSSKGHVSTQVKGTMGY 796
LH N ++HRD+K N++L N K+ DFG ++ ++ + ++ + GT +
Sbjct: 118 LH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174
Query: 797 LDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
+ PE KSD++S G + E+ T K P+
Sbjct: 175 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 31/269 (11%)
Query: 635 IGSGGYGK--VYRGMLSDGQVVAIKRAQ--QGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+G G +G+ +YR D +V K + S + + EI +LS + H N++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
+ ++ E+ GTL + + + G + + L ++Y+H+ I+
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---IL 123
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
HRD+K+ NI L + K+ DFG+SK++ S T V GT Y+ PE + K
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVV-GTPYYMSPELCQGVKYNFK 181
Query: 811 SDVYSFGVVMLELITAKQPIEKG---KYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867
SD+++ G V+ EL+T K+ + VV+ V N +E++
Sbjct: 182 SDIWALGCVLYELLTLKRTFDATNPLNLVVKIV--QGNYTPVVSVYSSELI--------- 230
Query: 868 LGFRRYLELALQCVEESATDRPTMSEVVK 896
L +++ RPT EV+
Sbjct: 231 -------SLVHSLLQQDPEKRPTADEVLD 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 25/212 (11%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKR-----------AQQGSMQGGLEFKTEIELLSRVHH 682
IGSG +G VY GM S G+++A+K+ ++ SM L EI LL + H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALA--REIALLKELQH 65
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR-LRIALGSARGLAYL 741
+N+V +G + + E++ G++ L+ R +R L +GL YL
Sbjct: 66 ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL---KGLNYL 122
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS----KGHVSTQVKGTMGYL 797
H N IIHRD+K NIL+D K++DFG+SK + +S ++G++ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
PE T K+D++S G +++E++T K P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 27/270 (10%)
Query: 634 EIGSGGYGKVYRG--MLSDGQV--VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGL 688
++G G +G V RG S G+V VA+K + + + +F E ++ + H+NL+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
G M+V E G+L + L + H A+ A G+ YL
Sbjct: 62 YGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KR 117
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST-QVKGTMGYLDPEYYMTQQL 807
IHRD+ + NILL + K+ DFGL + + + +V +K + PE T+
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 808 TEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD-PTIRNT 865
+ SDV+ FGV + E+ T ++P + + + D+E L P
Sbjct: 178 SHASDVWMFGVTLWEMFTYGEEP-----WAGLSGSQILKKIDKEGERLERPEACP----- 227
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVV 895
+ + LQC + DRPT + +
Sbjct: 228 -----QDIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 34/215 (15%)
Query: 635 IGSGGYGKVYRGM-LSDGQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGL 688
+GSG +G VY+G+ + +G+ VAIK ++ + + E E +++ V H ++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 689 VGFCFEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS----------ARG 737
+G C Q L+ + M G L LD+ R + +GS A+G
Sbjct: 75 LGICL--SSQVQLITQLMPLGCL-----------LDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
++YL E ++HRD+ + N+L+ K+ DFGL+KL+ K + + K + ++
Sbjct: 122 MSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIE 831
E + + T KSDV+S+GV + EL+T +P E
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 7e-20
Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLE-----FKTEIELLSRV 680
N+ +G G +G+VY D G+ +A+K+ + + EI+LL +
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 681 HHKNLVGLVGFCFEQGEQMLVY-EFMANGTLRESLSGRSGIHLDWKRRL-RIALGSARGL 738
H+ +V G C E + ++ E+M G++++ L + R+ R L G+
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL---EGV 117
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYL 797
YLH + I+HRD+K NIL D K+ DFG SK L + S G V GT ++
Sbjct: 118 EYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
PE + K+DV+S G ++E++T K P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 8e-20
Identities = 79/292 (27%), Positives = 132/292 (45%), Gaps = 41/292 (14%)
Query: 635 IGSGGYGKVYR----GMLSDGQ----VVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKN 684
+G G +G+V R G+ VA+K + + L + +E+EL+ + HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR--------------SGIHLDWKRRLRI 730
++ L+G C ++G ++ E+ A G LRE L R L +K +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
A ARG+ Y L + IHRD+ + N+L+ E+ K+ADFGL++ V D ++
Sbjct: 140 AYQVARGMEY---LESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850
+ + ++ PE + T +SDV+SFG++M E+ T + Y V E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT----LGGSPYPGIPVEELFKLLREG 252
Query: 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
H M P+ L R +C T RPT ++V+A++ +L
Sbjct: 253 H----RMDKPSNCTHELYMLMR------ECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 8e-20
Identities = 86/313 (27%), Positives = 142/313 (45%), Gaps = 43/313 (13%)
Query: 600 PSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR 658
PS +G + A F ++ +K F++ EIG G +G VY + +VVAIK+
Sbjct: 1 PSTSRAGSLKDPEIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKK 57
Query: 659 AQQGSMQGGLEFK---TEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLS 715
Q +++ E++ L R+ H N + G + LV E+ S S
Sbjct: 58 MSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-----SAS 112
Query: 716 GRSGIHLDWKRRLRIAL---GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772
+H + + IA G+ +GLAYLH + +IHRD+K+ NILL E K+ADF
Sbjct: 113 DLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 169
Query: 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVVMLELITAKQP 829
G + + S ++ GT ++ PE + Q K DV+S G+ +EL K P
Sbjct: 170 GSASIASPAN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223
Query: 830 IEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLG-FRRYLELALQCVEESATDR 888
+ AM+ Y + + PT+++ FR +++ C+++ DR
Sbjct: 224 LFN--------MNAMS----ALYHIAQNESPTLQSNEWSDYFRNFVD---SCLQKIPQDR 268
Query: 889 PTMSEVVKAIETL 901
PT E++K + L
Sbjct: 269 PTSEELLKHMFVL 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 73/307 (23%), Positives = 133/307 (43%), Gaps = 62/307 (20%)
Query: 635 IGSGGYGKVYRGM------LSDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVG 687
+G G +GKV + + VA+K ++ + L + +E LL +V+H +++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLS-----GRSGIHLDWKRR--------------- 727
L G C + G +L+ E+ G+LR L G S + D R
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 728 --LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785
+ A +RG+ YL E+ ++HRD+ + N+L+ E K++DFGLS+ V +
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT---AKQPIEKGKYVVREVRT 842
++ + + ++ E T +SDV+SFGV++ E++T P + + ++T
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT 244
Query: 843 A--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897
M R + EE Y L L C ++ RPT +++ K
Sbjct: 245 GYRMERPENCSEEMY----------------------NLMLTCWKQEPDKRPTFADISKE 282
Query: 898 IETLLQN 904
+E ++
Sbjct: 283 LEKMMVK 289
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 66/236 (27%), Positives = 116/236 (49%), Gaps = 35/236 (14%)
Query: 615 RW-FSYDELKKCSNNFSESNEIGSGGYGKVY--------RGMLSDGQVVAIKRAQQGSMQ 665
RW FS D+L + +G G +G+V + + VA+K + + +
Sbjct: 9 RWEFSRDKL-------TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATE 61
Query: 666 GGL-EFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD 723
L + +E+E++ + HKN++ L+G C + G ++ E+ + G LRE L R ++
Sbjct: 62 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 121
Query: 724 W--------------KRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769
+ K + ARG+ YL A+ IHRD+ + N+L+ EN K+
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKI 178
Query: 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
ADFGL++ V++ +T + + ++ PE + T +SDV+SFGV+M E+ T
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 12/202 (5%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
E+G G +GKVY+ G A K Q S + +F EI++LS H N+VGL
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
F + + ++ EF G L +S+ L + + L +LH + +IHR
Sbjct: 72 FYENKLWILIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHR 127
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE--- 809
D+K+ NILL + K+ADFG+S + + T + GT ++ PE + +
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR-DTFI-GTPYWMAPEVVACETFKDNPY 185
Query: 810 --KSDVYSFGVVMLELITAKQP 829
K+D++S G+ ++EL + P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 4e-19
Identities = 68/205 (33%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF-KTEIELLSRVHHKNLV 686
F+ IG G +G+VY+ + QVVAIK + +E + EI+ LS+ +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
G F +G ++ ++ E+ G+ + L + G LD I GL YLHE
Sbjct: 63 KYYG-SFLKGSKLWIIMEYCGGGSCLDLL--KPGK-LDETYIAFILREVLLGLEYLHEEG 118
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
IHRD+K+ NILL E K+ADFG+S +L S SK + T V GT ++ PE
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN--TFV-GTPFWMAPEVIKQ 172
Query: 805 QQLTEKSDVYSFGVVMLELITAKQP 829
EK+D++S G+ +EL + P
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-19
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 30/279 (10%)
Query: 628 NFSESNE---IGSGGYGKVYRGMLSDGQV-VAIKRAQQGSMQGGLEFKTEIELLSRVHHK 683
+ E+ E +G G YG VY QV +AIK + + EI L S + H+
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR 65
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSA--RGLAYL 741
N+V +G E G + E + G+L L + G L + I GL YL
Sbjct: 66 NIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYL 124
Query: 742 HELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
H+ I+HRD+K N+L++ + K++DFG SK ++ + + GT+ Y+ PE
Sbjct: 125 HDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPE 179
Query: 801 YYMTQQ--LTEKSDVYSFGVVMLELITAKQP-IEKGKYVVREVRTAMNRDDEEHYGLTEM 857
+D++S G ++E+ T K P IE G+ + M + H + E
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---HPEIPES 236
Query: 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ +N + L+C E R + ++++
Sbjct: 237 LSAEAKNFI-----------LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 86/294 (29%), Positives = 133/294 (45%), Gaps = 43/294 (14%)
Query: 614 ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFK- 671
A FS D+ +K F++ EIG G +G VY +VVAIK+ Q +++
Sbjct: 5 AELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 672 --TEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR 729
E+ L ++ H N + G + LV E+ S S +H + +
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-----SASDILEVHKKPLQEVE 116
Query: 730 IA---LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
IA G+ +GLAYLH IHRD+K+ NILL E T K+ADFG + LVS ++
Sbjct: 117 IAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---- 169
Query: 787 STQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843
GT ++ PE + Q K DV+S G+ +EL K P+ A
Sbjct: 170 --SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNA 219
Query: 844 MNRDDEEHYGLTEMMDPTIR-NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
M+ Y + + PT+ N FR +++ C+++ DRP+ E++K
Sbjct: 220 MS----ALYHIAQNDSPTLSSNDWSDYFRNFVDS---CLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 66/272 (24%), Positives = 126/272 (46%), Gaps = 32/272 (11%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
++G+G +G+V+ + VA+K + GSM F E ++ + H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
++ ++ EFMA G+L + L G + + + A G+A++ + IHRD
Sbjct: 72 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 127
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTMGYLDPEYYMTQQLTEKSD 812
+++ NIL+ +L K+ADFGL++++ D+ + + + K + + PE T KSD
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 813 VYSFGVVMLELITAKQ---PIEKGKYVVREVRTA--MNRDDEEHYGLTEMMDPTIRNTVL 867
V+SFG++++E++T + P V+R + M R + L +M
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM--------- 236
Query: 868 LGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
++C + +RPT + ++
Sbjct: 237 ----------MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 66/208 (31%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 635 IGSGGYGKVYRGMLS--DG----QVVAIK-RAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
+G G +G+VY G+ DG VA+K + S Q +F E ++S+ +H+N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIH----LDWKRRLRIALGSARGLAYLH 742
L+G FE+ + ++ E MA G L+ L R L K L A A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 743 ELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSDSS----KGHVSTQVKGTMG 795
E IHRD+ + N LL AK+ADFG+++ + +S G +K
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK---- 186
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVMLEL 823
++ PE ++ T K+DV+SFGV++ E+
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 73/284 (25%), Positives = 136/284 (47%), Gaps = 32/284 (11%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKR---AQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+G G YG V + + GQ+VAIK+ ++ M + + EI +L ++ H+NLV L+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLIE 67
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
+ LV+EF+ + L + +G LD R + RG+ + H + II
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCH---SHNII 122
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
HRD+K NIL+ ++ K+ DFG ++ + ++ G V T T Y PE + +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYTDYVATRWYRAPELLVGDTKYGR 180
Query: 811 S-DVYSFGVVMLELITAKQP-------IEKGKYVVREVRTAMNRDDEEHYG---LTEMMD 859
+ D+++ G ++ E++T +P I++ ++++ + + R E M
Sbjct: 181 AVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL 239
Query: 860 PTIRNTVLLGFRRY-------LELALQCVEESATDRPTMSEVVK 896
P ++ L +R+ L+LA QC+ DRP+ S+++
Sbjct: 240 PEVKEIEPLE-KRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 41/271 (15%)
Query: 643 VYRGMLSDGQVV--AIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM- 699
+Y+G+ ++ +V+ K+ +G + EI+ L R+ N++ + GF + + +
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 700 ---LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKS 756
L+ E+ G LRE L L +K +L +A+ +GL L++ N P ++++ S
Sbjct: 96 RLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTS 151
Query: 757 TNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVY 814
+ L+ EN K+ GL K++S +V+ M Y + + T K D+Y
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSPPFKNVNF-----MVYFSYKMLNDIFSEYTIKDDIY 206
Query: 815 SFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYL 874
S GVV+ E+ T K P E E+ D I L
Sbjct: 207 SLGVVLWEIFTGKIPFENLTT-------------------KEIYDLIINKNNSLKLPLDC 247
Query: 875 ELALQCVEESATD-----RPTMSEVVKAIET 900
L ++C+ E+ T RP + E++ +
Sbjct: 248 PLEIKCIVEACTSHDSIKRPNIKEILYNLSL 278
|
Length = 283 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 42/227 (18%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKN 684
F + N IG G YG VYR + G++VA+K+ + + + G+ + EI LL + H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 685 LVGL---------------VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR 729
+V L + +C EQ L+ + +
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVKC-------------- 112
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
+ L RGL YLHE IIHRD+K +N+LL + K+ADFGL++ +K
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKV 169
Query: 790 VKGTMGYLDPE--YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
V T+ Y PE T T D+++ G ++ EL+ K P+ GK
Sbjct: 170 V--TLWYRAPELLLGCTTY-TTAIDMWAVGCILAELLAHK-PLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 76/296 (25%), Positives = 128/296 (43%), Gaps = 46/296 (15%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGML--SDGQVVAIKRAQQGSMQGGLEFK--- 671
F+ ++LK EIG G +G V + ML G ++A+KR + S E K
Sbjct: 1 FTAEDLKDLG-------EIGRGAFGTVNK-MLHKPSGTIMAVKRIR--STVDEKEQKRLL 50
Query: 672 TEIELLSRVHH-KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL-- 728
+++++ R +V G F +G+ + E M + ++ K +
Sbjct: 51 MDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD--ISLDKFYKY--VYEVLKSVIPE 106
Query: 729 ----RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSK 783
+IA+ + + L YL E IIHRDVK +NILLD N K+ DFG+S +LV +K
Sbjct: 107 EILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK 164
Query: 784 GHVSTQVKGTMGYLDPEYYMTQQLTE---KSDVYSFGVVMLELITAKQPIEKGKYVVREV 840
T+ G Y+ PE +SDV+S G+ + E+ T K P K V ++
Sbjct: 165 ----TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220
Query: 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ G ++ + F ++ L C+ + + RP E+++
Sbjct: 221 TQVV-------KGDPPILSNSEEREFSPSFVNFINL---CLIKDESKRPKYKELLE 266
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-18
Identities = 54/188 (28%), Positives = 98/188 (52%), Gaps = 19/188 (10%)
Query: 654 VAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLR 711
VA+K + + + L + +E+E++ + HKN++ L+G C + G ++ E+ + G LR
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 712 ESLSGRSGIHLDW--------------KRRLRIALGSARGLAYLHELANPPIIHRDVKST 757
E L R +++ K + A ARG+ Y LA+ IHRD+ +
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY---LASKKCIHRDLAAR 169
Query: 758 NILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 817
N+L+ E+ K+ADFGL++ + +T + + ++ PE + T +SDV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229
Query: 818 VVMLELIT 825
V++ E+ T
Sbjct: 230 VLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 7e-18
Identities = 56/188 (29%), Positives = 98/188 (52%), Gaps = 19/188 (10%)
Query: 654 VAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLR 711
VA+K + + L + +E+E++ + HKN++ L+G C + G ++ E+ + G LR
Sbjct: 47 VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106
Query: 712 ESLSGRSGIHLDW--------------KRRLRIALGSARGLAYLHELANPPIIHRDVKST 757
E L R +D+ K + A ARG+ YL A+ IHRD+ +
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAAR 163
Query: 758 NILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 817
N+L+ E+ K+ADFGL++ V + +T + + ++ PE + T +SDV+SFG
Sbjct: 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 223
Query: 818 VVMLELIT 825
V++ E+ T
Sbjct: 224 VLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 8e-18
Identities = 70/288 (24%), Positives = 116/288 (40%), Gaps = 53/288 (18%)
Query: 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHH 682
E + +G G G V + L + G + A+K +Q + + E+E+
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI-LR-ELEINKSCKS 58
Query: 683 KNLVGLVGFCFEQGEQML--VYEFMANGTLR------ESLSGRSGIHLDWKRRLRIALGS 734
+V G ++ + E+ G+L + GR G + +IA
Sbjct: 59 PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV----LGKIAESV 114
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGT 793
+GL+YLH IIHRD+K +NILL K+ DFG+S +LV+ + GT
Sbjct: 115 LKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GT 166
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLEL-----------ITAKQPIEKGKYVVREVRT 842
Y+ PE + + SDV+S G+ +LE+ PIE Y+V
Sbjct: 167 SFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP 226
Query: 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT 890
+ + +E F+ +++ QC+E+ T RPT
Sbjct: 227 ELKDEPGNGIKWSE------------EFKDFIK---QCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 9e-18
Identities = 58/202 (28%), Positives = 106/202 (52%), Gaps = 21/202 (10%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRA-----QQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+GSG +G VY+G+ + +G+ V I A + + +EF E +++ + H +LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGR-----SGIHLDWKRRLRIALGSARGLAYLHE 743
+G C Q LV + M +G L + + S + L+W ++ A+G+ YL E
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLEE 127
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
++HRD+ + N+L+ K+ DFGL++L+ K + + K + ++ E
Sbjct: 128 RR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 804 TQQLTEKSDVYSFGVVMLELIT 825
++ T +SDV+S+GV + EL+T
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 9e-18
Identities = 67/223 (30%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EIELLSRVHHKN 684
IGSG YG V + G+ VAIK+ F EI+LL + H+N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKIS-------NVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 685 LVGLVG-FCFEQGEQM----LVYEFMANGT-LRESLSGRSGIHLDWKRRLRIALGSARGL 738
++GL+ E +V E M T L + + +S L RGL
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVI--KSPQPLTDDHIQYFLYQILRGL 116
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK------GHVSTQVKG 792
YLH AN +IHRD+K +NIL++ N K+ DFGL++ V +V T+
Sbjct: 117 KYLHS-AN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW-- 171
Query: 793 TMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
Y PE ++ + T+ D++S G + EL+T K P+ G+
Sbjct: 172 ---YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 70/279 (25%), Positives = 117/279 (41%), Gaps = 31/279 (11%)
Query: 635 IGSGGYGKVYRGMLSDGQ----VVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLV 689
IG G +G VY+G+ + VA+K + + E F E ++ + H ++V L+
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
G E +V E G LR L LD + + + LAYL
Sbjct: 74 GVITEN-PVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLESKR---F 128
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
+HRD+ + N+L+ K+ DFGLS+ + D S S K + ++ PE ++ T
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASK-GKLPIKWMAPESINFRRFTS 187
Query: 810 KSDVYSFGVVMLE-LITAKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
SDV+ FGV M E L+ +P + K V+ ++ E + PT+ +
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQGVKNNDVI------GRIENGERLPMPPNCPPTLYS-- 239
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
L +C + RP +E+ + +LQ +
Sbjct: 240 ---------LMTKCWAYDPSKRPRFTELKAQLSDILQEE 269
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 36/215 (16%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRV---HH 682
+ E EIG G YG VY+ L+ G+ VA+K+ + + G+ T EI LL ++ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 683 KNLVGLVGFCFEQGEQM-------LVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALG 733
N+V L+ C G + LV+E + + L LS + G+ + + L L
Sbjct: 61 PNIVRLLDVC--HGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQL- 116
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
RG+ +LH I+HRD+K NIL+ + K+ADFGL+++ S T V T
Sbjct: 117 -LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVT 169
Query: 794 MGYLDPE-----YYMTQQLTEKSDVYSFGVVMLEL 823
+ Y PE Y T D++S G + EL
Sbjct: 170 LWYRAPEVLLQSSYAT-----PVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-17
Identities = 54/158 (34%), Positives = 80/158 (50%), Gaps = 12/158 (7%)
Query: 11 ALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGS----WEGVTC---NN 63
A+ F I S T + +ALQ+LK + P + + DPC W G C +
Sbjct: 356 AIEVFEIITAESKTLLEEVSALQTLKSSLG-LPLRFGWNGDPCVPQQHPWSGADCQFDST 414
Query: 64 SR---VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+ LGL GL G + DI L L+S++LS N + G++ P +G + L +L L
Sbjct: 415 KGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS-IRGNIPPSLGSITSLEVLDL 473
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLG 158
+ F G+IP+ +G L L L LN N+ SGR+P +LG
Sbjct: 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 64/221 (28%), Positives = 103/221 (46%), Gaps = 42/221 (19%)
Query: 629 FSESNEIGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGGLEFKT---EIELLSRVHHKN 684
+ IGSG YG VY+ ++ G++VAIK ++ G +F+ EI +L H N
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIK---VIKLEPGDDFEIIQQEISMLKECRHPN 61
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSARGLAYL 741
+V G + + +V E+ G+L++ + L L+IA + +GLAYL
Sbjct: 62 IVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQ-VTRGPLS---ELQIAYVCRETLKGLAYL 117
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG----YL 797
HE IHRD+K NILL E+ K+ADFG VS Q+ T+ ++
Sbjct: 118 HETG---KIHRDIKGANILLTEDGDVKLADFG------------VSAQLTATIAKRKSFI 162
Query: 798 DPEYYMTQQL---------TEKSDVYSFGVVMLELITAKQP 829
Y+M ++ K D+++ G+ +EL + P
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 61/219 (27%), Positives = 111/219 (50%), Gaps = 20/219 (9%)
Query: 614 ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQV----VAIKRAQQGSMQGGL 668
AR EL+K +GSG +G V++G+ + +G VAIK Q S +
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 669 EFKTEIEL-LSRVHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKR 726
+ T+ L + + H +V L+G C G + LV + G+L + + LD +R
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQR 110
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
L + A+G+ YL E ++HR++ + NILL + ++ADFG++ L+ K +
Sbjct: 111 LLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167
Query: 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
++ K + ++ E + + T +SDV+S+GV + E+++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 69/238 (28%), Positives = 113/238 (47%), Gaps = 30/238 (12%)
Query: 633 NEIGSGGYGKV-----YRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
+EIG+G +GKV +RGM S +VV + + L F E++ ++H N++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGM-SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHLDWKRRL--RIALGSARGLAYLHEL 744
+G C E +LV EF G L+ L S R + ++ + R+A A GL +LH+
Sbjct: 60 CLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT--MGYLDPEYY 802
IH D+ N L +L+ K+ D+GL+ + + + T+ + +L PE
Sbjct: 120 D---FIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 803 -------MTQQLTEKSDVYSFGVVMLELIT-AKQP------IEKGKYVVREVRTAMNR 846
+ + T+KS+++S GV M EL T A QP + K VVRE + +
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 64/205 (31%), Positives = 94/205 (45%), Gaps = 23/205 (11%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF---KTEIELLSRVHHKNLVGLVG 690
I G YG+V+ S G + AIK ++ M + TE ++LS+ +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 691 FCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRL--RIALGSARGLAYLHELAN 746
+ F QG++ L V E++ G L L + D R I L L YLH
Sbjct: 60 YSF-QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLA----LEYLHSNG- 113
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSK--LVSDSSKGHVST----QVKGTMGYLDPE 800
IIHRD+K NIL+D N K+ DFGLSK LV + ++ GT Y+ PE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 801 YYMTQQLTEKSDVYSFGVVMLELIT 825
+ Q ++ D +S G ++ E +
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-17
Identities = 76/289 (26%), Positives = 134/289 (46%), Gaps = 44/289 (15%)
Query: 632 SNEIGSGGYGKVYRGMLSDGQV-------VAIKRAQQ-GSMQGGLEFKTEIELLSRVHHK 683
S E+G G +G VY G ++ G V VAIK + SM+ +EF E ++ +
Sbjct: 11 SRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 69
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANG-------TLRESLSGRSGIHL-DWKRRLRIALGSA 735
++V L+G + +++ E M G +LR + K+ +++A A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
G+AYL+ AN +HRD+ + N ++ E+ T K+ DFG+++ + ++ + +
Sbjct: 130 DGMAYLN--ANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHY 852
++ PE T SDV+SFGVV+ E+ T A+QP + + V+R V
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG--------- 237
Query: 853 GLTEMMD--PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
GL + D P + EL C + + RP+ E++ +I+
Sbjct: 238 GLLDKPDNCPDM----------LFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 59/196 (30%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 634 EIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLE--FKTEIELLSRVHHKNLVGLVG 690
IG G +G+V+ G L +D VA+K ++ ++ L+ F E +L + H N+V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
C ++ +V E + G L G L K +++ +A G+ YL + I
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLE---SKHCI 116
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSD----SSKGHVSTQVKGTMGYLDPEYYMTQQ 806
HRD+ + N L+ E K++DFG+S+ D S+ G VK T PE +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTA----PEALNYGR 172
Query: 807 LTEKSDVYSFGVVMLE 822
+ +SDV+SFG+++ E
Sbjct: 173 YSSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 71/279 (25%), Positives = 129/279 (46%), Gaps = 39/279 (13%)
Query: 629 FSESNEIGSGGYGK-VYRGMLSDGQVVAIKRAQQGSMQGG--LEFKTEIELLSRVHHKNL 685
+ + +IG G +GK + DG+ IK M E + E+ +LS + H N+
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH------LDWKRRLRIALGSARGLA 739
V E G +V ++ G L + ++ + G+ LDW ++ +AL
Sbjct: 62 VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------K 115
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
++H+ I+HRD+KS NI L ++ T K+ DFG++++++ + + ++ GT YL P
Sbjct: 116 HVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSP 170
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEHYGLTEM 857
E + KSD+++ G V+ E+ T K E G K +V ++ HY
Sbjct: 171 EICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHY----- 225
Query: 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+RN V F+R + DRP+++ +++
Sbjct: 226 -SYDLRNLVSQLFKR-----------NPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 5e-17
Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 36/224 (16%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKR------------AQQGSMQGGLEFKT--EIELL 677
+G G YGKV + G++VAIK+ +Q G+ F T E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 678 SRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
+ + H+N++GLV E LV + MA L++ + + I L + I L G
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNG 131
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL-------------SKLVSDSSKG 784
L LH +HRD+ NI ++ K+ADFGL SK + +
Sbjct: 132 LNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 785 HVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAK 827
++++V T+ Y PE M ++ D++S G + EL+T K
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-17
Identities = 60/262 (22%), Positives = 111/262 (42%), Gaps = 21/262 (8%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKR------AQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
+G GG+G+V + G++ A K+ ++ Q L E ++L +V + +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMAL---NEKKILEKVSSRFIVS 57
Query: 688 LVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L + FE + + LV M G L+ + R + A GL +LH+
Sbjct: 58 L-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR- 115
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
I++RD+K N+LLD++ +++D GL+ + K GT GY+ PE +
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEV 170
Query: 807 LTEKSDVYSFGVVMLELITAKQPI-EKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
D ++ G + E+I + P ++ + V +E + Y + P ++
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY--PDKFSPEAKDL 228
Query: 866 VLLGFRRYLELALQCVEESATD 887
++ E L C SA +
Sbjct: 229 CEALLQKDPEKRLGCRGGSADE 250
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 70/225 (31%), Positives = 116/225 (51%), Gaps = 27/225 (12%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT--EIELLSR 679
K+C + F +IG G YG+VY+ D G++VA+K+ + + + G EI++L +
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 680 VHHKNLVGL----------VGFCFEQGEQMLVYEFMAN---GTLRESLSGRSGIHLDWKR 726
++H+N+V L + F ++G LV+E+M + G L L S H+ K
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI--KS 120
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
++ L GL Y H +HRD+K +NILL+ K+ADFGL++L +
Sbjct: 121 FMKQLL---EGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY 174
Query: 787 STQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPI 830
+ +V T+ Y PE + ++ DV+S G ++ EL T K+PI
Sbjct: 175 TNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 71/229 (31%), Positives = 100/229 (43%), Gaps = 36/229 (15%)
Query: 634 EIGSGGYGKVYRGML--SDGQVVAIKR--AQQGSM-QGGLEFKTEIELLSRVHHKNLVGL 688
E+G G YG V + M G ++A+KR A S Q L +I + S V V
Sbjct: 8 ELGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRS-VDCPYTVTF 65
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL------RIALGSARGLAYLH 742
G F +G+ + E M SL D + +IA+ + L YLH
Sbjct: 66 YGALFREGDVWICMEVMDT-----SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEY 801
+IHRDVK +N+L++ N K+ DFG+S LV +K T G Y+ PE
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK----TIDAGCKPYMAPER 174
Query: 802 Y----MTQQLTEKSDVYSFGVVMLELITA-------KQPIEKGKYVVRE 839
+ KSDV+S G+ M+EL T K P ++ K VV E
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 634 EIGSGGYGKVYRG---MLSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGL 688
E+GSG +G V +G M + VA+K + + L E E ++ ++ + +V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+G C E MLV E G L + L H+ K + + G+ YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEE---TN 115
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
+HRD+ + N+LL AK++DFGLSK L +D + T K + + PE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 808 TEKSDVYSFGVVMLELITAKQPIEKG 833
+ KSDV+SFGV+M E + Q KG
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKG 201
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 61/207 (29%), Positives = 107/207 (51%), Gaps = 11/207 (5%)
Query: 634 EIGSGGYGKVYRGM--LSDGQV-VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGLV 689
E+GSG +G V +G+ + Q+ VAIK + + + E E E++ ++ + +V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
G C E MLV E + G L + LSG+ + + + + G+ YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKD-EITVSNVVELMHQVSMGMKYLEG---KNF 116
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
+HRD+ + N+LL AK++DFGLSK L +D S + K + + PE ++ +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 809 EKSDVYSFGVVMLELIT-AKQPIEKGK 834
+SDV+S+G+ M E + ++P +K K
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMK 203
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 58/210 (27%), Positives = 105/210 (50%), Gaps = 10/210 (4%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKN 684
++++ +IG G YG VY+G GQ+VA+K+ + S + G+ EI LL + H N
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V L ++ L++EF++ + S G ++D + +G+ + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM- 803
++HRD+K N+L+D K+ADFGL++ + V T T+ Y PE +
Sbjct: 121 R---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYRAPEVLLG 175
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPIEKG 833
+ + + D++S G + E+ T K+P+ G
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMAT-KKPLFHG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 8e-17
Identities = 64/209 (30%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC 692
+G+G YG+VY+G + GQ+ AIK + E K EI +L + HH+N+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 693 FEQG-----EQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
++ +Q+ LV EF G++ + + G L + I RGL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ--- 129
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+K N+LL EN K+ DFG+S + D + G +T + GT ++ PE +
Sbjct: 130 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFI-GTPYWMAPEVIACDE 187
Query: 807 LTE-----KSDVYSFGVVMLELITAKQPI 830
+ KSD++S G+ +E+ P+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 8e-17
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 19/216 (8%)
Query: 629 FSESNEIGSGGYGKVYRGML----SDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHH 682
F+ +G G +G V L Q VA+K +A S EF E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 683 KNLVGLVGFCFEQGEQ------MLVYEFMANGTLRE----SLSGRSGIHLDWKRRLRIAL 732
N++ L+G + M++ FM +G L S G L + +R +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
A G+ YL ++ IHRD+ + N +L+EN+T VADFGLSK + K
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 793 TMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQ 828
+ +L E T SDV++FGV M E++T Q
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 626 SNNFSESNEIGSGGYGKV--YRGMLSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVH 681
+N + + +G G +G V R L+ GQ VAIK+ + L +T E++LL +
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR 67
Query: 682 HKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
H+N++ L E + V E + R S L+ + RGL Y
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP----LEKQFIQYFLYQILRGLKY 123
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
+H ++HRD+K +NIL++EN K+ DFGL+++ G+VST+ Y PE
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPE 175
Query: 801 YYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+T Q+ + D++S G + E++ K P+ GK
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK-PLFPGK 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKN 684
FS+ EIG G +G VY + + +VVAIK+ Q +++ E+ L ++ H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSARGLAYL 741
+ G + LV E+ S S +H + + IA G+ +GLAYL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLG-----SASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H + +IHRDVK+ NILL E K+ DFG + +++ ++ GT ++ PE
Sbjct: 132 H---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------XFVGTPYWMAPEV 182
Query: 802 YMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
+ Q K DV+S G+ +EL K P+ AM+ Y + +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMS----ALYHIAQNE 230
Query: 859 DPTIR-NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
P ++ FR +++ LQ + + DRPT ++K
Sbjct: 231 SPALQSGHWSEYFRNFVDSCLQKIPQ---DRPTSEVLLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIE-------LLSRVHHKNLVG 687
+G G +G V G L+ Q +I + +M+ + ++E+E + H N++
Sbjct: 7 LGEGEFGSVMEGQLN--QDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 688 LVGFCFEQGEQ------MLVYEFMANGTLRE----SLSGRSGIHLDWKRRLRIALGSARG 737
L+G C + E +++ FM +G L S G +L + ++ A G
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+ YL ++ IHRD+ + N +L+EN+ VADFGLSK + + K + ++
Sbjct: 125 MEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQ 828
E + T KSDV+SFGV M E+ T Q
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQ 212
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-16
Identities = 70/206 (33%), Positives = 110/206 (53%), Gaps = 19/206 (9%)
Query: 635 IGSGGYGKVY---RGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIE--LLSRVHHKNLVGL 688
+G G +GKV+ + D GQ+ A+K ++ +++ +T++E +L+ V+H +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 689 VGFCFE-QGEQMLVYEFMANGTLRESLSGRSGI-HLDWKRRL-RIALGSARGLAYLHELA 745
+ F+ +G+ L+ +F+ G L LS D K L +AL L +LH L
Sbjct: 64 -HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA----LDHLHSLG 118
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
II+RD+K NILLDE K+ DFGLSK D K S GT+ Y+ PE +
Sbjct: 119 ---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVNRR 173
Query: 806 QLTEKSDVYSFGVVMLELITAKQPIE 831
T+ +D +SFGV+M E++T P +
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQ 199
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 61/211 (28%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGM---LSDGQV---VAIKRAQQGSMQGGLE-FKTEIELLSR 679
NN S +G+G +GKV LS VA+K + + E +E++++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 680 V-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
+ +H+N+V L+G C G +++ E+ G L L + L + L + A+G+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDS---SKGHVSTQVKGTM 794
A+L A+ IHRD+ + N+LL K+ DFGL++ +++DS KG+ VK
Sbjct: 155 AFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK--- 208
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
++ PE T +SDV+S+G+++ E+ +
Sbjct: 209 -WMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC 692
+G+G YG+VY+G + GQ+ AIK + E K EI +L + HH+N+ G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 693 FE-----QGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+ +Q+ LV EF G++ + + G L I RGLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA--- 139
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+K N+LL EN K+ DFG+S + D + G +T + GT ++ PE +
Sbjct: 140 HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVGRRNTFI-GTPYWMAPEVIACDE 197
Query: 807 LTE-----KSDVYSFGVVMLELITAKQPI 830
+ +SD++S G+ +E+ P+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 77/279 (27%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKN 684
F +EIG G +G VY S +VVA+K+ Q +++ E++ L ++ H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSARGLAYL 741
+ G ++ LV E+ S S +H + + IA G+ +GLAYL
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLG-----SASDLLEVHKKPLQEVEIAAITHGALQGLAYL 137
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H +IHRD+K+ NILL E K+ADFG + S ++ GT ++ PE
Sbjct: 138 HSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN------SFVGTPYWMAPEV 188
Query: 802 YMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
+ Q K DV+S G+ +EL K P+ AM+ Y + +
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN--------MNAMS----ALYHIAQND 236
Query: 859 DPTIR-NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
PT++ N FR +++ LQ + + +RP +E+++
Sbjct: 237 SPTLQSNEWTDSFRGFVDYCLQKIPQ---ERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 14/211 (6%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQ--QGSMQGGLE---FKTEIELLSRVH 681
N+ +G G +G+VY D G+ +A K+ Q S + E + EI+LL +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 682 HKNLVGLVGFCFEQGEQMLV--YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
H+ +V G ++ E+ L E+M G++++ L + R+ + G++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI--LEGMS 120
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYLD 798
YLH + I+HRD+K NIL D K+ DFG SK L + G V GT ++
Sbjct: 121 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
PE + K+DV+S G ++E++T K P
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 59/207 (28%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQ----VVAIKRAQQG-SMQGGLEFKTEIELLSRVHH 682
F + +GSG +G VY+G+ + +G+ VAIK ++ S + E E +++ V +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTL----RESLSGRSGIHLDWKRRLRIALGSARGL 738
++ L+G C Q L+ + M G L RE +L L + A+G+
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYL-----LNWCVQIAKGM 122
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
YL E ++HRD+ + N+L+ K+ DFGL+KL+ K + + K + ++
Sbjct: 123 NYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELIT 825
E + + T +SDV+S+GV + EL+T
Sbjct: 180 LESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 60/212 (28%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL--EFKTEIELLS 678
ELK ++F +E+G+G G V + ++ ++ ++ + + E+++L
Sbjct: 1 ELK--DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
+ +VG G + GE + E M G+L + L I + ++ IA+ RGL
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV--LRGL 116
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
AYL E I+HRDVK +NIL++ K+ DFG+S + DS ++ GT Y+
Sbjct: 117 AYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 170
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
PE + +SD++S G+ ++EL + PI
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 5e-16
Identities = 61/246 (24%), Positives = 110/246 (44%), Gaps = 27/246 (10%)
Query: 669 EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH------- 721
+F EI+++SR+ + N++ L+G C ++ E+M NG L + LS R I
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQRE-IESTFTHAN 121
Query: 722 ----LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777
+ L +A+ A G+ YL L +HRD+ + N L+ + T K+ADFG+S+
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRN 178
Query: 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQPIEK-GK 834
+ + + + ++ E + + T SDV++FGV + E+ T +QP
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238
Query: 835 YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEV 894
V E R+ L++ P + V +L ++C DRPT +++
Sbjct: 239 EQVIENTGEFFRNQGRQIYLSQT--PLCPSPV-------FKLMMRCWSRDIKDRPTFNKI 289
Query: 895 VKAIET 900
+
Sbjct: 290 HHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 7e-16
Identities = 51/206 (24%), Positives = 103/206 (50%), Gaps = 17/206 (8%)
Query: 638 GGYGKVYRGMLSDG-----QVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGF 691
G +G+++ G+L D + V +K + + + + E LL + H+N++ ++
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 692 CFEQGEQ-MLVYEFMANGTLRESL------SGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
C E GE ++Y +M G L+ L + L ++ + +A+ A G++YLH+
Sbjct: 77 CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR 136
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
+IH+D+ + N ++DE L K+ D LS+ + + + ++ E +
Sbjct: 137 G---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193
Query: 805 QQLTEKSDVYSFGVVMLELIT-AKQP 829
++ + SDV+SFGV++ EL+T + P
Sbjct: 194 KEYSSASDVWSFGVLLWELMTLGQTP 219
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-16
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKN 684
NF + +IG G YG VY+ G+VVA+K+ + + G+ EI LL ++H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESL--SGRSGIHLDWKRRLRIALGSARGLAYLH 742
+V L+ + + LV+EF+ + L++ + S SGI L + L +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCH 117
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE-- 800
+ ++HRD+K N+L++ K+ADFGL++ + + V T+ Y PE
Sbjct: 118 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEIL 172
Query: 801 ----YYMTQQLTEKSDVYSFGVVMLELITAK 827
YY T D++S G + E++T +
Sbjct: 173 LGCKYYST-----AVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 41/237 (17%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM------QGGLEFKTEIELLSR 679
NF +IG G + VY+ + L DG+VVA+K+ Q M Q L+ EI+LL +
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK---EIDLLKQ 58
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL-------RIAL 732
+ H N++ + E E +V E G L + H ++RL + +
Sbjct: 59 LDHPNVIKYLASFIENNELNIVLELADAGDLSRMIK-----HFKKQKRLIPERTIWKYFV 113
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
L ++H I+HRD+K N+ + K+ D GL + SSK + + G
Sbjct: 114 QLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVG 168
Query: 793 TMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP--------------IEKGKY 835
T Y+ PE KSD++S G ++ E+ + P IEK Y
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (195), Expect = 8e-16
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQG--SMQGGLEFKTEIELLSRV-HHKNLVGLV 689
++G G +G VY G++VAIK+ ++ S + + + E++ L ++ H N+V L
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKLK 64
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR-IALGSARGLAYLHELANPP 748
E E V+E+M G L + + R G + +R I +GLA++H+
Sbjct: 65 EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGLAHIHKHG--- 119
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH---VSTQVKGTMGYLDPE----- 800
HRD+K N+L+ K+ADFGL++ + S + VST+ Y PE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYVSTR-----WYRAPEILLRS 173
Query: 801 -YYMTQQLTEKSDVYSFGVVMLELITAK 827
Y + D+++ G +M EL T +
Sbjct: 174 TSY-----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 32/212 (15%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGFC 692
E+G G +GKVY+ + +A + + + LE + EIE+L+ +H +V L+G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGSARGLAYLHELAN 746
+ G+ ++ EF G + I L+ R L I L YLH +
Sbjct: 79 YWDGKLWIMIEFCPGGAV-------DAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK- 130
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK----GTMGYLDPEYY 802
IIHRD+K+ N+LL + K+ADFG+ S+K + Q + GT ++ PE
Sbjct: 131 --IIHRDLKAGNVLLTLDGDIKLADFGV------SAKNVKTLQRRDSFIGTPYWMAPEVV 182
Query: 803 MTQQLTE-----KSDVYSFGVVMLELITAKQP 829
M + + + K+D++S G+ ++E+ + P
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 73/253 (28%), Positives = 117/253 (46%), Gaps = 36/253 (14%)
Query: 594 PFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQ 652
P +S + S S + A S EL++ N IGSG G VY+ + G+
Sbjct: 49 PPSSSSSSSSSSSASGSAPSAA-KSLSELERV-------NRIGSGAGGTVYKVIHRPTGR 100
Query: 653 VVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710
+ A+K G+ + + + EIE+L V+H N+V GE ++ EFM G+L
Sbjct: 101 LYALK-VIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL 159
Query: 711 RESLSGRSGIHLDWKRRLR-IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769
G H+ ++ L +A G+AYLH I+HRD+K +N+L++ K+
Sbjct: 160 -------EGTHIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKI 209
Query: 770 ADFGLSKLVS---DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK-----SDVYSFGVVML 821
ADFG+S++++ D V GT+ Y+ PE T D++S GV +L
Sbjct: 210 ADFGVSRILAQTMDPCNSSV-----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 822 ELITAKQPIEKGK 834
E + P G+
Sbjct: 265 EFYLGRFPFGVGR 277
|
Length = 353 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 1e-15
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 61/300 (20%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--------RAQQGSMQGGLEFKTEIELLSRVHHKNL 685
+G G G VY+ L +++A+K Q+ M +E+E+L + +
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM-------SELEILYKCDSPYI 61
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL------RIALGSARGLA 739
+G G F + + EFM G+L D R++ RIA+ +GL
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSL------------DVYRKIPEHVLGRIAVAVVKGLT 109
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLD 798
YL L I+HRDVK +N+L++ K+ DFG+S +LV+ +K +V GT Y+
Sbjct: 110 YLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMA 161
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQP---IEK--GKYVVREVRTAMNRDDEEHYG 853
PE +Q SDV+S G+ +EL + P I+K G + ++ + +D
Sbjct: 162 PERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLP 221
Query: 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNSTS 913
+ + + ++ QC+ + +RP ++ + NDG N S
Sbjct: 222 VGQFSEK------------FVHFITQCMRKQPKERPAPENLMDHPFIVQYNDG-NAEVVS 268
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 1e-15
Identities = 62/220 (28%), Positives = 111/220 (50%), Gaps = 28/220 (12%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKN 684
+ + N I G YG VYR G++VA+K+ + + G + EI +L ++ H N
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN 65
Query: 685 LVGL----VGFCFEQGEQMLVYEFMANG--TLRESLSGR---SGIHLDWKRRLRIALGSA 735
+V + VG ++ +V E++ + +L E++ S + K + L
Sbjct: 66 IVTVKEVVVGSNLDK--IYMVMEYVEHDLKSLMETMKQPFLQSEV----KCLMLQLL--- 116
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
G+A+LH+ I+HRD+K++N+LL+ K+ DFGL++ K TQ+ T+
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK--PYTQLVVTLW 171
Query: 796 YLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
Y PE + ++ + D++S G + EL+T K+P+ GK
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPLFPGK 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 49/243 (20%)
Query: 625 CSN--NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSR 679
CS ++ ++G G +G+VY+ + G+VVA+K+ + + G EI++L +
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKK 63
Query: 680 VHHKNLVGLVGFCFEQGEQM--------LVYEFMANGTLRESLSG----------RSGIH 721
+ H N+V L+ E+ ++ +V +M + LSG S I
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-----DLSGLLENPSVKLTESQIK 118
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
+ L G+ YLHE I+HRD+K+ NIL+D K+ADFGL++
Sbjct: 119 CYMLQLLE-------GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 782 SK---------GHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIE 831
T + T Y PE + ++ T D++ G V E+ T + PI
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PIL 227
Query: 832 KGK 834
+GK
Sbjct: 228 QGK 230
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 17/217 (7%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLVGF 691
IGSG YG V + G+ VAIK+ L +T E+++L H N++ +
Sbjct: 13 IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72
Query: 692 CFEQGEQM----LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
G +V + M + L + + + R L RGL Y+H AN
Sbjct: 73 LRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQL--LRGLKYIHS-AN- 127
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH--VSTQVKGTMGYLDPEYYMT- 804
+IHRD+K +N+L++E+ ++ DFG+++ +S S H T+ T Y PE ++
Sbjct: 128 -VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841
+ T D++S G + E++ +Q + GK V +++
Sbjct: 187 PEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLK 222
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 35/275 (12%)
Query: 629 FSESNEIGSGGYGKVYRGMLSDGQ-VVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLV 686
F++ IG G +G+V++G+ + Q VVAIK + +E + EI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
G + + ++ E++ G+ + L L+ L +GL YLH
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK-----GTMGYLDPEY 801
IHRD+K+ N+LL E K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861
K+D++S G+ +EL + P + +R + + + + PT
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP-NSDMHPMRVL-----------FLIPKNNPPT 220
Query: 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ F+ +++ C+ + + RPT E++K
Sbjct: 221 LTGEFSKPFKEFID---ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-15
Identities = 70/277 (25%), Positives = 130/277 (46%), Gaps = 46/277 (16%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHH---KNLVGLV 689
IG G YG VYRG + G+VVA+K + + + + E+ LLS++ N+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWK----RRLRIALGSARGLAYLHEL 744
G + +G ++ ++ E+ G++R +L I + R + +AL Y+H++
Sbjct: 69 G-SYLKGPRLWIIMEYAEGGSVR-TLMKAGPIAEKYISVIIREVLVAL------KYIHKV 120
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
+IHRD+K+ NIL+ K+ DFG++ L +SSK ST V GT ++ PE
Sbjct: 121 ---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR--STFV-GTPYWMAPEVIT 174
Query: 804 T-QQLTEKSDVYSFGVVMLELITAKQP---IEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
+ K+D++S G+ + E+ T P ++ + ++ ++ R ++ Y
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY------S 228
Query: 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+R V C++E +R + E++K
Sbjct: 229 KLLREFVAA-----------CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-15
Identities = 59/194 (30%), Positives = 94/194 (48%), Gaps = 19/194 (9%)
Query: 651 GQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLV--GFCFEQGEQMLVYEFM 705
G VAIK + + + + F+ E L +R++H N+V L+ G G V+E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61
Query: 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---D 762
TLRE L+ L R+ L LA H N I+HRD+K NI++
Sbjct: 62 PGRTLREVLAADGA--LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTG 116
Query: 763 ENLTAKVADFGLSKLVSDSSKGHV-----STQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 817
AKV DFG+ L+ V +T+V GT Y PE + +T SD+Y++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176
Query: 818 VVMLELITAKQPIE 831
++ LE +T ++ ++
Sbjct: 177 LIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/212 (28%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRA--QQGSMQGGLE---FKTEIELLSRVH 681
N+ +G G +G+VY +D G+ +A+K+ S + E + EI+LL +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 682 HKNLVGLVGFCFEQGEQ---MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
H +V G C E+ + E+M G++++ L + + RR + +G+
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI--LQGV 119
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD-SSKGHVSTQVKGTMGYL 797
+YLH + I+HRD+K NIL D K+ DFG SK + G V GT ++
Sbjct: 120 SYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
PE + K+DV+S ++E++T K P
Sbjct: 177 SPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQ--QGSMQGGLE---FKTEIELLSRVHHKNLVGL 688
+G G +G+VY +D G+ +A+K+ Q S + E + EI+LL + H+ +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 689 VGFCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
G + E+ L E M G++++ L + + R+ + G++YLH +
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI--LEGVSYLH---S 124
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
I+HRD+K NIL D K+ DFG SK L + G V GT ++ PE +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 806 QLTEKSDVYSFGVVMLELITAKQP 829
K+D++S G ++E++T K P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 31/207 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRA-----QQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+GSG +G VY+G+ + DG+ V I A + S + E E +++ V + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS----------ARGL 738
+G C Q LV + M G L LD+ R + +GS A+G+
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCL-----------LDYVRENKDRIGSQDLLNWCVQIAKGM 122
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
+YL E+ ++HRD+ + N+L+ K+ DFGL++L+ + + K + ++
Sbjct: 123 SYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELIT 825
E + ++ T +SDV+S+GV + EL+T
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 3e-15
Identities = 61/223 (27%), Positives = 102/223 (45%), Gaps = 21/223 (9%)
Query: 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EI 674
Y++L+K IG G YG V++ ++VA+KR + G+ EI
Sbjct: 1 KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50
Query: 675 ELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS 734
LL + HKN+V L + LV+E+ + S I + + L
Sbjct: 51 CLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL-- 108
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
+GLA+ H ++HRD+K N+L+++N K+ADFGL++ + + + V T+
Sbjct: 109 LKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV--TL 163
Query: 795 GYLDPEYYMTQQLTEKS-DVYSFGVVMLELITAKQPIEKGKYV 836
Y P+ +L S D++S G + EL A +P+ G V
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 54/205 (26%), Positives = 86/205 (41%), Gaps = 16/205 (7%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG---LEFKTEIELLSRVHHKNLVGLV 689
I G +G VY S G AIK ++ M K E ++ V +
Sbjct: 3 PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+ F+ + + LV E++ G + G+ DW ++ + G+ LH+
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEV--VLGVEDLHQRG--- 117
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
IIHRD+K N+L+D+ K+ DFGLS+ G + + GT YL PE +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN------GLENKKFVGTPDYLAPETILGVGDD 171
Query: 809 EKSDVYSFGVVMLELITAKQPIEKG 833
+ SD +S G V+ E + P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPPFHAE 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVH---HKNLVG 687
EIG G YG VY+ G VA+K + + + GL T E+ LL R+ H N+V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 688 LVGFCF-----EQGEQMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAY 740
L+ C + + LV+E + + LR L G+ + + L RGL +
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQF--LRGLDF 123
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS-TQVKGTMGYLDP 799
LH AN I+HRD+K NIL+ K+ADFGL+++ S ++ T V T+ Y P
Sbjct: 124 LH--ANC-IVHRDLKPENILVTSGGQVKLADFGLARIYS----CQMALTPVVVTLWYRAP 176
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAK 827
E + D++S G + E+ K
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 5e-15
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 38/231 (16%)
Query: 629 FSESNEIGSGGYGKVYRGML---SDGQVVAIKRAQQGSMQG-GLEFKT--EIELLSRVHH 682
+ IG G YG+VY+ DG+ AIK+ + Q G+ EI LL + H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 683 KNLVGLVGFCFEQGEQM--LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR---- 736
+N+V LV E ++ L++++ A L + I + R+ +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQI------IK--FHRQAKRVSIPPSMVKS 112
Query: 737 -------GLAYLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGH 785
G+ YLH +N ++HRD+K NIL+ E K+ D GL++L + K
Sbjct: 113 LLWQILNGVHYLH--SNW-VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 786 VS-TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
V T+ Y PE + + T+ D+++ G + EL+T + PI KG+
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PIFKGR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 5e-15
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHK 683
NF +IG G + +VYR L DG VA+K+ Q + + + EI+LL +++H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL---------RIALGS 734
N++ E E +V E G L + H ++RL + L S
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIK-----HFKKQKRLIPEKTVWKYFVQLCS 117
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
A L ++H + ++HRD+K N+ + K+ D GL + S SK + + GT
Sbjct: 118 A--LEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS--SKTTAAHSLVGTP 170
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
Y+ PE KSD++S G ++ E+ + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 23/210 (10%)
Query: 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQ----QGSMQGGLEFKTEIELLSRVHHKNLVG 687
+E+G G YG VY+ + G +A+K + + + E+++L + +V
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQII---MELDILHKAVSPYIVD 63
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH-LDWKRRLRIALGSARGLAYLHELAN 746
G F +G + E+M G+L + +G + RI +GL +L E N
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYY--- 802
IIHRDVK TN+L++ N K+ DFG+S LV+ +K ++ Q Y+ PE
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ-----SYMAPERIKSG 176
Query: 803 -MTQQLTE--KSDVYSFGVVMLELITAKQP 829
Q T +SDV+S G+ +LE+ + P
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 61/221 (27%), Positives = 108/221 (48%), Gaps = 33/221 (14%)
Query: 634 EIGSGGYGKVYRGMLSD---GQV---VAIKRAQQ-GSMQGGLEFKTEIELLSRVHHKNLV 686
E+G G +G VY G D G+ VA+K + S++ +EF E ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLR----------ESLSGRSGIHLDWKRRLRIALGSAR 736
L+G + ++V E MA+G L+ E+ GR L + +++A A
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL--QEMIQMAAEIAD 130
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG- 795
G+AYL+ +HRD+ + N ++ + T K+ DFG+++ + ++ KG G
Sbjct: 131 GMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----KGGKGL 182
Query: 796 ----YLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIE 831
++ PE T SD++SFGVV+ E+ + A+QP +
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQ 223
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-15
Identities = 56/173 (32%), Positives = 85/173 (49%), Gaps = 20/173 (11%)
Query: 668 LEFKTEI------ELLSRVHHK----NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR 717
LE K I EL +V H+ +VG G + GE + E M G+L + L
Sbjct: 36 LEIKPAIRNQIIREL--KVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 93
Query: 718 SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777
I + ++ IA+ RGL YL E I+HRDVK +NIL++ K+ DFG+S
Sbjct: 94 GRIPENILGKISIAV--LRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 149
Query: 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
+ DS ++ GT Y+ PE T +SD++S G+ ++E+ + PI
Sbjct: 150 LIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 7e-15
Identities = 76/283 (26%), Positives = 120/283 (42%), Gaps = 67/283 (23%)
Query: 654 VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRE 712
VA+K + + +F E+++LSR+ N+ L+G C ++ E+M NG L +
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 713 SLSGR----SGIHLDWKR-----RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE 763
L SG+ + K L +A A G+ YL L +HRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165
Query: 764 NLTAKVADFGLSK--LVSDSSKGHVSTQVKGT-------MGYLDPEYYMTQQLTEKSDVY 814
N T K+ADFG+S+ SD + V+G M + E + + T KSDV+
Sbjct: 166 NYTIKIADFGMSRNLYSSDYYR------VQGRAPLPIRWMAW---ESVLLGKFTTKSDVW 216
Query: 815 SFGVVMLELIT--AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRR 872
+FGV + E++T +QP E D+ ++++ G +
Sbjct: 217 AFGVTLWEILTLCREQPYEH-------------LTDQ------QVIENAGHFFRDDGRQI 257
Query: 873 YL-----------ELALQCVEESATDRPTMSEVVKAIETLLQN 904
YL EL L+C DRPT E I LQ
Sbjct: 258 YLPRPPNCPKDIYELMLECWRRDEEDRPTFRE----IHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-15
Identities = 56/214 (26%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLVGF 691
IG G YG VY+ G++VA+K+ + + G+ EI LL ++H N+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL----RIALGSA----------RG 737
+ + LV+EF+ LD K+ + L +G
Sbjct: 67 VHSENKLYLVFEFL---------------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+AY H + ++HRD+K N+L+D K+ADFGL++ + + V T+ Y
Sbjct: 112 IAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYR 166
Query: 798 DPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPI 830
PE + ++Q + D++S G + E++ ++P+
Sbjct: 167 APEILLGSRQYSTPVDIWSIGCIFAEMVN-RRPL 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 7e-15
Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 12/212 (5%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL--EFKTEIELLS 678
ELK ++F + +E+G+G G V++ ++ ++ ++ + + E+++L
Sbjct: 1 ELK--DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH 58
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
+ +VG G + GE + E M G+L + L I ++ IA+ +GL
Sbjct: 59 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV--IKGL 116
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
YL E I+HRDVK +NIL++ K+ DFG+S + DS ++ GT Y+
Sbjct: 117 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 170
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
PE + +SD++S G+ ++E+ + PI
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 8e-15
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 20/208 (9%)
Query: 629 FSESNEIGSGGYGKVYRGMLSDGQ-VVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLV 686
F++ +IG G +G+V++G+ + Q VVAIK + +E + EI +LS+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
G + + ++ E++ G+ + L LD + I +GL YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK-----GTMGYLDPEY 801
IHRD+K+ N+LL E+ K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQP 829
K+D++S G+ +EL + P
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 32/212 (15%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGFC 692
E+G G +GKVY+ + V+A + + LE + EI++L+ H N+V L+
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGSARGLAYLHELAN 746
+ + ++ EF A G + + L+ +R L + + L YLHE
Sbjct: 72 YYENNLWILIEFCAGGAV-------DAVMLELERPLTEPQIRVVCKQTLEALNYLHE--- 121
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK----GTMGYLDPEYY 802
IIHRD+K+ NIL + K+ADFG+ S+K + Q + GT ++ PE
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGV------SAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 803 MTQQLTE-----KSDVYSFGVVMLELITAKQP 829
M + + K+DV+S G+ ++E+ + P
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 64/210 (30%), Positives = 101/210 (48%), Gaps = 36/210 (17%)
Query: 635 IGSGGYGKVYRGMLSDGQV-VAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+GSG YG+V + VAIK R Q ++ ++ E+ LL + H+N++GL+
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLD 81
Query: 691 -FC----FEQGEQM-LVYEFMA---NGTLR-ESLSGRSGIHLDWKRRLRIALGSARGLAY 740
F E + + LV M N ++ + LS H+ + + RGL Y
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDD---HIQF-----LVYQILRGLKY 133
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
+H A IIHRD+K +NI ++E+ K+ DFGL++ D G+V T Y PE
Sbjct: 134 IHS-AG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYV-----ATRWYRAPE 185
Query: 801 ---YYMTQQLTEKSDVYSFGVVMLELITAK 827
+M + D++S G +M EL+T K
Sbjct: 186 IMLNWM--HYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 72/229 (31%), Positives = 105/229 (45%), Gaps = 28/229 (12%)
Query: 620 DELKKCSNNFSESNEIGSGGYGKVYR-GMLSDGQVVAIKRAQQGSMQGGLEFKTEIE--- 675
+ L ++ + IG G YGKVY+ DG + A+K S + EIE
Sbjct: 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-----DVDEEIEAEY 69
Query: 676 --LLSRVHHKNLVGLVGFCFEQ-----GEQMLVYEFMANGTLRESLSG--RSGIHLDWKR 726
L S +H N+V G ++ G+ LV E G++ E + G G LD
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
I G+ GL +LH N IIHRDVK NILL K+ DFG+S ++ S++
Sbjct: 130 ISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLRR 185
Query: 787 STQVKGTMGYLDPEYYMTQQLTEKS-----DVYSFGVVMLELITAKQPI 830
+T V GT ++ PE +Q + S DV+S G+ +EL P+
Sbjct: 186 NTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 47/233 (20%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQ----QGSMQGGLEFKTEIELLSRV 680
+ + IG G YG V G VAIK+ Q Q L EI++L R
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR---EIKILRRF 60
Query: 681 HHKNLVGLVGF-CFEQGEQM----LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS- 734
H+N++G++ E +V E M E+ D + ++ S
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELM------ET---------DLYKLIKTQHLSN 105
Query: 735 ----------ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784
RGL Y+H AN ++HRD+K +N+LL+ N K+ DFGL++ ++D
Sbjct: 106 DHIQYFLYQILRGLKYIHS-AN--VLHRDLKPSNLLLNTNCDLKICDFGLAR-IADPEHD 161
Query: 785 HVS--TQVKGTMGYLDPEYYMTQQLTEKS-DVYSFGVVMLELITAKQPIEKGK 834
H T+ T Y PE + + K+ D++S G ++ E+++ + P+ GK
Sbjct: 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 25/215 (11%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHK 683
NF +IG G + +VYR L D + VA+K+ Q M + + EI+LL +++H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL---------RIALGS 734
N++ + E E +V E G L + + + ++RL + L S
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIK-----YFKKQKRLIPERTVWKYFVQLCS 117
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
A + ++H + ++HRD+K N+ + K+ D GL + SSK + + GT
Sbjct: 118 A--VEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTP 170
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
Y+ PE KSD++S G ++ E+ + P
Sbjct: 171 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 50/180 (27%), Positives = 89/180 (49%), Gaps = 22/180 (12%)
Query: 669 EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR----------- 717
+F E+++LSR+ N++ L+G C ++ ++ E+M NG L + LS
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 718 ------SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771
+ + L +AL A G+ YL L +HRD+ + N L+ ENLT K+AD
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIAD 181
Query: 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQP 829
FG+S+ + + + + ++ E + + T SDV++FGV + E++ +QP
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 71/273 (26%), Positives = 123/273 (45%), Gaps = 22/273 (8%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQ--GGLEFKT-EIELLSRVHHKNLVGLVG 690
+G GG+G+V + + G++ A K+ + ++ G + E E+L +V+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
+ FE + LV M G L+ + L+ +R + + G+ +LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---I 116
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
++RD+K N+LLD+ +++D GL+ + D G TQ GT GY+ PE + +
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMAPEILKEEPYSY 173
Query: 810 KSDVYSFGVVMLELITAKQPIE--KGKYVVREV--RTAMNRDDEEHYGLTEMMDPTIRNT 865
D ++ G + E++ + P + K K E+ RT + EH TE R
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR-- 231
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898
L + E L E++ D P E K I
Sbjct: 232 --LFLAKKPEDRLGSREKN--DDPRKHEFFKTI 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-14
Identities = 43/132 (32%), Positives = 73/132 (55%), Gaps = 1/132 (0%)
Query: 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNI 759
LV ++ G LR+ + R+ + + R L + L +H + + +IHRD+KS NI
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTF-REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANI 174
Query: 760 LLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVV 819
LL N K+ DFG SK+ + + V GT Y+ PE + + ++K+D++S GV+
Sbjct: 175 LLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVL 234
Query: 820 MLELITAKQPIE 831
+ EL+T K+P +
Sbjct: 235 LYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 5e-14
Identities = 60/232 (25%), Positives = 115/232 (49%), Gaps = 17/232 (7%)
Query: 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKN 684
F + +G GG+G+V + + G++ A K+ ++ ++ G E ++L +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
+V L + +E + + LV M G L+ + + R + A GL LH+
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--KGHVSTQVKGTMGYLDPEY 801
I++RD+K NILLD++ +++D GL+ V + KG V GT+GY+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV-----GTVGYMAPEV 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPI-EKGKYVVREVRTAMNRDDEEHY 852
++ T D ++ G ++ E+I + P ++ K + RE + ++ +E Y
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 62/229 (27%), Positives = 113/229 (49%), Gaps = 36/229 (15%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHK 683
+ + + +IG G +G+V++ Q+VA+K+ + + G EI++L + H+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 684 NLVGLVGFCFEQGEQ--------MLVYEF--------MANGTLRESLSGRSGIHLDWKRR 727
N+V L+ C + LV+EF ++N ++ +LS + K+
Sbjct: 72 NVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS-------EIKKV 124
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS--SKGH 785
+++ L GL Y+H I+HRD+K+ NIL+ ++ K+ADFGL++ S S SK +
Sbjct: 125 MKMLLN---GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPN 178
Query: 786 VSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKG 833
T T+ Y PE + + D++ G +M E+ T + PI +G
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQG 226
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 66/215 (30%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEI----ELLSRVH 681
N+ EIGSG G+VY+ G V+A+K Q G E I +++ + H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVK---QMRRTGNKEENKRILMDLDVVLKSH 71
Query: 682 H-KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGL 738
+V G+ + + E M+ T + L R I D ++ +A+ A L
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKA--L 127
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
YL E +IHRDVK +NILLD + K+ DFG+S + D SK T+ G Y+
Sbjct: 128 HYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVD-SKAK--TRSAGCAAYMA 182
Query: 799 PEYYMTQQLTEK----SDVYSFGVVMLELITAKQP 829
PE K +DV+S G+ ++EL T + P
Sbjct: 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 9/204 (4%)
Query: 635 IGSGGYGK--VYRGMLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGF 691
+G G +G+ + + + SD Q A+K + +E + E LL+++ H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
G +V E+ G L + + + G L+ + G+ ++HE ++H
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLH 123
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKS 811
RD+KS NI L +N K+ DFG ++L++ S + T V GT Y+ PE + KS
Sbjct: 124 RDIKSKNIFLTQNGKVKLGDFGSARLLT-SPGAYACTYV-GTPYYVPPEIWENMPYNNKS 181
Query: 812 DVYSFGVVMLELITAKQPIEKGKY 835
D++S G ++ EL T K P + +
Sbjct: 182 DIWSLGCILYELCTLKHPFQANSW 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 9e-14
Identities = 57/215 (26%), Positives = 103/215 (47%), Gaps = 28/215 (13%)
Query: 634 EIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNL 685
E+G +GKVY+G L Q VAIK + +G L EFK E + SR+ H N+
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKD-KAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR---------------LRI 730
V L+G ++ +++ + ++ L E L RS H D + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSP-HSDVGSTDDDKTVKSTLEPADFVHI 129
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
A G+ + L++ ++H+D+ + N+L+ + L K++D GL + V + +
Sbjct: 130 VTQIAAGMEF---LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
+ ++ PE M + + SD++S+GVV+ E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 45/157 (28%), Positives = 76/157 (48%), Gaps = 8/157 (5%)
Query: 673 EIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL 732
E++++ +V G + + EFM G+L I ++ + IA+
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAV 110
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
GL YL+ + I+HRD+K +NIL++ K+ DFG+S + +S ++ G
Sbjct: 111 AVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVG 164
Query: 793 TMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
T Y+ PE + T KSDV+S G+ ++EL K P
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 70/275 (25%), Positives = 123/275 (44%), Gaps = 35/275 (12%)
Query: 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLV 686
F++ IG G +G+VY+G+ + +VVAIK + +E + EI +LS+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
G + + ++ E++ G+ + L LR L +GL YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHSERK 122
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK-----GTMGYLDPEY 801
IHRD+K+ N+LL E K+ADFG++ ++D TQ+K GT ++ PE
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------TQIKRNTFVGTPFWMAPEV 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861
K+D++S G+ +EL + P + +R + + + PT
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSD----LHPMRVL--------FLIPKNSPPT 220
Query: 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ F+ ++E C+ + RPT E++K
Sbjct: 221 LEGQYSKPFKEFVE---ACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 635 IGSGGYGKV----YRGMLSDGQVVAIKRA--QQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G G YG+V +R +DG+ IK+ + S + + E +LLS++ H N+V
Sbjct: 8 VGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 689 V-GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ E G +V F G L L + G L + + + A L YLHE
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---K 121
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
I+HRD+K+ N+ L KV D G+++++ ++ +++ + GT Y+ PE + +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 808 TEKSDVYSFGVVMLELITAKQ 828
KSDV++ G + E+ T K
Sbjct: 180 NYKSDVWALGCCVYEMATLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 56/210 (26%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF---KTEIELLSRVHHK 683
+F IGSG YG VY+ ++ G++ AIK + ++ G +F + EI ++ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
N+V G + + + EF G+L++ + +IA S L L+
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPL-----SESQIAYVSRETLQGLYY 121
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
L + +HRD+K NILL +N K+ADFG+S ++ + S GT ++ PE
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEVAA 179
Query: 804 TQQ---LTEKSDVYSFGVVMLELITAKQPI 830
++ + D+++ G+ +EL + P+
Sbjct: 180 VERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-13
Identities = 43/133 (32%), Positives = 75/133 (56%), Gaps = 1/133 (0%)
Query: 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758
+L+ E+ + G L + + R HL ++ + L + + L E+ + ++HRD+KS N
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEY-EVGLLFYQIVLALDEVHSRKMMHRDLKSAN 199
Query: 759 ILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 818
I L K+ DFG SK SDS V++ GT YL PE + ++ ++K+D++S GV
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259
Query: 819 VMLELITAKQPIE 831
++ EL+T +P +
Sbjct: 260 ILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 3e-13
Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 27/209 (12%)
Query: 635 IGSGGYGKVYRGMLSDG----QVVAIKRAQQGSM----QGGLEFKTEIELLSRVHHKNLV 686
+G GGYGKV++ G ++ A+K ++ ++ + K E +L V H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLD-----WKRRLRIALGSARGLAY 740
L+ + F+ G ++ L+ E+++ G L L R GI ++ + + +AL +
Sbjct: 64 DLI-YAFQTGGKLYLILEYLSGGELFMHLE-REGIFMEDTACFYLSEISLALE------H 115
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
LH+ II+RD+K NILLD K+ DFGL K +G V+ GT+ Y+ PE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPE 170
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
M + D +S G +M +++T P
Sbjct: 171 ILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 635 IGSGGYGKVYRGMLS----DGQVVAIKRAQQG-SMQGGLEFKTEIELLSRVHHKNLVGLV 689
+G+G +G++ RG L VAI + G S + F E L + H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
G M+V E+M+NG L L G L + + + G A G+ YL E+
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEG-QLVAGQLMGMLPGLASGMKYLSEMG---Y 128
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV-KGTMGYLDPEYYMTQQLT 808
+H+ + + +L++ +L K++ F +L D S+ +T K + + PE +
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186
Query: 809 EKSDVYSFGVVMLELIT 825
SDV+SFG+VM E+++
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 63/232 (27%), Positives = 109/232 (46%), Gaps = 17/232 (7%)
Query: 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKN 684
F + +G GG+G+V + + G++ A KR ++ ++ G E ++L +V+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
+V L + +E + + LV M G L+ + + +R L A GL LH
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR 120
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV--SDSSKGHVSTQVKGTMGYLDPEY 801
++RD+K NILLD+ +++D GL+ + +S +G V GT+GY+ PE
Sbjct: 121 ---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV-----GTVGYMAPEV 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK-YVVREVRTAMNRDDEEHY 852
Q+ T D + G ++ E+I + P K V RE + EE Y
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 57/203 (28%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++ +IG G G VY + ++ GQ VAIK+ EI ++ H N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ E +V E++A G+L + ++ +D + + + L +LH +N
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH--SNQ 135
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGL-SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+KS NILL + + K+ DFG +++ + SK ST V GT ++ PE +
Sbjct: 136 -VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTPYWMAPEVVTRKA 191
Query: 807 LTEKSDVYSFGVVMLELITAKQP 829
K D++S G++ +E++ + P
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 5e-13
Identities = 57/239 (23%), Positives = 106/239 (44%), Gaps = 26/239 (10%)
Query: 669 EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR---------SG 719
+F EI+++SR+ N++ L+ C ++ E+M NG L + LS
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 720 IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
+ + + + +A A G+ YL L +HRD+ + N L+ +N T K+ADFG+S+ +
Sbjct: 125 VTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839
+ + + ++ E + + T SDV++FGV + E++T + +E
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT----------LCKE 231
Query: 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVL----LGFRRYLELALQCVEESATDRPTMSEV 894
+ D++ E R L L +L L C +A +RP+ E+
Sbjct: 232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 23/222 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHK 683
+ + + +IG G YGKVY+ + G++VA+K+ + + G+ EI LL +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 684 N-LVGLVGFCFEQGEQ-------MLVYEFMANGTLRESLSGRSGIH--LDWKRRLRIALG 733
+V L+ E E+ LV+E++ + + S G L K
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
+G+A+ H+ ++HRD+K N+L+D + K+AD GL + S K + V
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-- 173
Query: 793 TMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKG 833
T+ Y PE + + + D++S G + E+ KQP+ G
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFPG 214
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 53/203 (26%), Positives = 99/203 (48%), Gaps = 11/203 (5%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++ +IG G G VY M ++ GQ VAI++ EI ++ + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ E +V E++A G+L + ++ +D + + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH---SN 135
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGL-SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+KS NILL + + K+ DFG +++ + SK + + GT ++ PE +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKA 192
Query: 807 LTEKSDVYSFGVVMLELITAKQP 829
K D++S G++ +E+I + P
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 58/212 (27%), Positives = 107/212 (50%), Gaps = 26/212 (12%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR----AQQGSMQGGLEFKTEIELLSRVHH 682
NF + ++G G Y VY+G + G++VA+K A++G+ + EI L+ + H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR---EISLMKELKH 57
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLR--ESLSGRSGIHLDWKRRLRIALGSARGLAY 740
+N+V L + + MLV+E+M + ++ R + + + L +G+A+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAF 115
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL----VSDSSKGHVSTQVKGTMGY 796
HE ++HRD+K N+L+++ K+ADFGL++ V+ S V T+ Y
Sbjct: 116 CHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV------TLWY 166
Query: 797 LDPEYYMTQQLTEKS-DVYSFGVVMLELITAK 827
P+ + + S D++S G +M E+IT +
Sbjct: 167 RAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 8e-13
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+GSG YG V + G+ VAIK R Q + ++ E+ LL + H+N++GL+
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLD 81
Query: 691 FCFEQGEQMLVYEF-MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
+F + ++ L G L + + GL Y+H I
Sbjct: 82 VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---I 138
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLT 808
IHRD+K N+ ++E+ K+ DFGL++ G+V T+ Y PE +
Sbjct: 139 IHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILNWMHYN 193
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGK 834
+ D++S G +M E++T K + KGK
Sbjct: 194 QTVDIWSVGCIMAEMLTGKT-LFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-12
Identities = 65/217 (29%), Positives = 101/217 (46%), Gaps = 27/217 (12%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---EIELLSRVHHKN 684
+ + ++GSG YG V + G VAIK+ + Q L K E+ LL + H+N
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMKHEN 75
Query: 685 LVGLVGFCFEQGEQM-------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
++GL+ F + LV FM GT L + D R + +G
Sbjct: 76 VIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSED--RIQFLVYQMLKG 130
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L Y+H IIHRD+K N+ ++E+ K+ DFGL++ G+V T+ Y
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYR 182
Query: 798 DPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKG 833
PE + T+ D++S G +M E++T K P+ KG
Sbjct: 183 APEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 69/227 (30%), Positives = 102/227 (44%), Gaps = 24/227 (10%)
Query: 634 EIGSGGYGKVYRGMLSDG----QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLV 689
EIG+G +GKV G ++ G QVV + S+Q ++F E + + H NL+ +
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 690 GFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHL--DWKRRLRIALGSARGLAYLHELAN 746
G C E +LV EF G L+ L S R + D R+A A GL +LH+
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK--- 118
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY----- 801
IH D+ N LL +LT K+ D+GLS Q+ + ++ PE
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 802 --YMTQQLTEKSDVYSFGVVMLELIT-AKQPI------EKGKYVVRE 839
+ T++S+V+S GV + EL QP + Y VRE
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 61/232 (26%), Positives = 109/232 (46%), Gaps = 18/232 (7%)
Query: 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKN 684
F +G GG+G+V + + G++ A K+ ++ ++ G E +L +V+ +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
+V L + +E + + LV M G L+ + D +R + A GL L
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR 120
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--KGHVSTQVKGTMGYLDPEY 801
I++RD+K NILLD+ +++D GL+ + + +G V GT+GY+ PE
Sbjct: 121 ---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-----GTVGYMAPEV 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR--EVRTAMNRDDEEH 851
++ T D + G ++ E+I + P K K V+ EV + D EE+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 63/258 (24%), Positives = 112/258 (43%), Gaps = 31/258 (12%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGLEFKTEIELLSRVHH 682
+IG G G V S G+ VA+K R QQ + L F E+ ++ H
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLF-NEVVIMRDYQH 75
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
N+V + E +V EF+ G L + ++ ++ ++ + L + L++LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH 132
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+IHRD+KS +ILL + K++DFG VS S + GT ++ PE
Sbjct: 133 ---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVI 187
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
+ D++S G++++E++ + P Y AM R + + + P +
Sbjct: 188 SRLPYGTEVDIWSLGIMVIEMVDGEPP-----YFNEPPLQAMKR-------IRDNLPPKL 235
Query: 863 RNTVLLG--FRRYLELAL 878
+N + R +L+ L
Sbjct: 236 KNLHKVSPRLRSFLDRML 253
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (168), Expect = 2e-12
Identities = 68/270 (25%), Positives = 124/270 (45%), Gaps = 24/270 (8%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++ +IG G G VY + ++ GQ VAIK+ EI ++ + N+V
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ E +V E++A G+L + ++ +D + + + L +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLH---SN 134
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGL-SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+KS NILL + + K+ DFG +++ + SK ST V GT ++ PE +
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTPYWMAPEVVTRKA 191
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
K D++S G++ +E++ + P + A N G E+ +P + V
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-------GTPELQNPERLSAV 244
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVK 896
FR +L +C+E R + E+++
Sbjct: 245 ---FRDFLN---RCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 63/209 (30%), Positives = 93/209 (44%), Gaps = 29/209 (13%)
Query: 635 IGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQGGLEF------KTEIELLSRVHHKN 684
+G G +GKV +L++ G++ AIK ++G + E K E + H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR---GLAY 740
LV L CF+ + + V E+ A G L IH D R +A GL Y
Sbjct: 64 LVNLFA-CFQTEDHVCFVMEYAAGGDLMMH------IHTDVFSEPRAVFYAACVVLGLQY 116
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
LHE I++RD+K N+LLD K+ADFGL K G ++ GT +L PE
Sbjct: 117 LHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK--EGMGFGDRTSTFCGTPEFLAPE 171
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
T D + GV++ E++ + P
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 634 EIGSGGYGKVY--RGMLSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVH---HKNLV 686
EIG G YGKV+ R + + G+ VA+KR + + + G+ T E+ +L + H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 687 GLVGFCF-----EQGEQMLVYEFMANG-TLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
L C + + LV+E + T G+ + + + L RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLDF 125
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
LH + ++HRD+K NIL+ + K+ADFGL+++ S T V T+ Y PE
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE 179
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG 833
+ D++S G + E+ ++P+ +G
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 61/226 (26%), Positives = 110/226 (48%), Gaps = 17/226 (7%)
Query: 635 IGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVG 690
+G GG+G+V + + G++ A K+ ++ ++ G E ++L +V+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL-A 66
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
+ +E + + LV M G L+ + D +R + A GL LH I
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERI 123
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--KGHVSTQVKGTMGYLDPEYYMTQQL 807
++RD+K NILLD+ +++D GL+ + + +G V GT+GY+ PE ++
Sbjct: 124 VYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV-----GTVGYMAPEVVKNERY 178
Query: 808 TEKSDVYSFGVVMLELITAKQPIEKGK-YVVREVRTAMNRDDEEHY 852
T D + G ++ E+I K P + K V RE ++D+E Y
Sbjct: 179 TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY 224
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 19/214 (8%)
Query: 628 NFSESNEIGSGGYGKVY----RGMLSDGQVVAIKRAQQGSM---QGGLEF-KTEIELLSR 679
NF +G+G YGKV+ G G++ A+K ++ ++ E +TE ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 680 VHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS-ARG 737
V + + + F+ ++ L+ +++ G L L R +R+ +
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLA 117
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L +LH+L II+RD+K NILLD + DFGLSK + + GT+ Y+
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFC-GTIEYM 173
Query: 798 DPEYYMTQQLTEKS--DVYSFGVVMLELITAKQP 829
PE D +S GV+ EL+T P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 79/343 (23%), Positives = 128/343 (37%), Gaps = 90/343 (26%)
Query: 635 IGSGGYGKVYRG------MLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRV-HHKNLV 686
+G G +G+V + + VA+K ++G+ +E+++L + HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 687 GLVGFCFEQG-EQMLVYEFMANGTL---------------------RESLSGRSGIHLDW 724
L+G C + G M++ EF G L R+ SG I D
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL 134
Query: 725 KRRLRIALGS--------------------------------------------ARGLAY 740
KRRL S A+G+ +
Sbjct: 135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF 194
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
L A+ IHRD+ + NILL EN K+ DFGL++ + + + ++ PE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
+ T +SDV+SFGV++ E+ + G + E + T M P
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-------TRMRAP 304
Query: 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ + L C + RPT SE+V+ + LLQ
Sbjct: 305 DYTTPEM------YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 8/179 (4%)
Query: 651 GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710
G+ VA+K+ Q E+ ++ HH+N+V + E +V EF+ G L
Sbjct: 47 GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106
Query: 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770
+ ++ ++ ++ + L R L+YLH N +IHRD+KS +ILL + K++
Sbjct: 107 TDIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLS 160
Query: 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
DFG VS S + GT ++ PE + D++S G++++E+I + P
Sbjct: 161 DFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 4e-12
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 52/229 (22%)
Query: 635 IGSGGYGKVY--RGMLSDGQVVAIKRAQQGSM----QGGLEFKTEIELLSRVHHKNLVGL 688
IG G +G+V+ R GQV A+K ++ M Q + E ++L+ +V L
Sbjct: 9 IGRGAFGEVWLVR-DKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADADSPWIVKL 66
Query: 689 VGFCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKR----RLRIALGSARGLAYLH 742
+ Q E+ L V E+M G L L + + R L +AL S L +
Sbjct: 67 --YYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF-- 122
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSK----------------LVSDSSKGHV 786
IHRD+K NIL+D + K+ADFGL K + V
Sbjct: 123 -------IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 787 STQVK-----------GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELI 824
+ GT Y+ PE + D +S GV++ E++
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 5e-12
Identities = 67/270 (24%), Positives = 126/270 (46%), Gaps = 24/270 (8%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++ +IG G G V+ + ++ GQ VAIK+ EI ++ + + N+V
Sbjct: 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ E +V E++A G+L + ++ +D + + + L +LH AN
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLH--ANQ 135
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGL-SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+KS N+LL + + K+ DFG +++ + SK ST V GT ++ PE +
Sbjct: 136 -VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMV-GTPYWMAPEVVTRKA 191
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
K D++S G++ +E++ + P + A N G E+ +P + +
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-------GTPELQNPEKLSPI 244
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVK 896
FR +L +C+E R + E+++
Sbjct: 245 ---FRDFLN---RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 66/207 (31%), Positives = 93/207 (44%), Gaps = 26/207 (12%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIE----LLSRVHHKNLVGLV 689
IG G +GKV +DG+ A+K Q+ ++ E K + LL V H LVGL
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKR-----RLRI-ALGSARGLAYLH 742
+ F+ +++ V +++ G L HL +R R R A A L YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELF--------FHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
L II+RD+K NILLD + DFGL K + SK ++ GT YL PE
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVL 168
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
Q D + G V+ E++ P
Sbjct: 169 RKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 6e-12
Identities = 59/200 (29%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 635 IGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLE--FKTEIELLSRVHHKNLVGLV- 689
+G GG+G+V + S + A+K ++ + + G + +E E+L +H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
F ++ ML+ E+ G L L R G+ ++ R IA YLH I
Sbjct: 61 TFKDKKYIYMLM-EYCLGGELWTILRDR-GLFDEYTARFYIA-CVVLAFEYLHNRG---I 114
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
I+RD+K N+LLD N K+ DFG +K + K T GT Y+ PE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGYDF 171
Query: 810 KSDVYSFGVVMLELITAKQP 829
D +S G+++ EL+T + P
Sbjct: 172 SVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 635 IGSGGYGKVYR-GMLSDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVG 690
+G GG+G+V M + G++ A K+ + + +G E +L++VH + +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 691 FCFE-QGEQMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ F+ + + LV M G LR + R GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---R 116
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSD---SSKGHVSTQVKGTMGYLDPEYYMT 804
II+RD+K N+LLD + +++D GL+ + D +KG+ GT G++ PE
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELLQG 171
Query: 805 QQLTEKSDVYSFGVVMLELITAKQP 829
++ D ++ GV + E+I A+ P
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 6e-12
Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 29/209 (13%)
Query: 635 IGSGGYGKVYRGMLSD---GQVVAIKR---AQQGSMQGGLEFKTEIELLSRV-HHKNLVG 687
+G G YG V++ + D +VVA+K+ A + + F+ EI L + H N+V
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 688 LVGFCFEQGEQ--MLVYEFMANGTLRES-LSG--RSGIHLDWKRRLRIALGSARGLAYLH 742
L+ + ++ LV+E+M E+ L R+ I D +R I + L Y+H
Sbjct: 72 LLNVIKAENDKDIYLVFEYM------ETDLHAVIRANILEDVHKRY-IMYQLLKALKYIH 124
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS---DSSKGHVSTQVKGTMGYLDP 799
N +IHRD+K +NILL+ + K+ADFGL++ +S ++ + V T T Y P
Sbjct: 125 S-GN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181
Query: 800 EYYM-TQQLTEKSDVYSFGVVMLELITAK 827
E + + + T+ D++S G ++ E++ K
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 9e-12
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 16/208 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHH 682
+F ++G GGYG+V+ D G++VA+KR ++ + E + TE ++L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 683 KNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+ LV L+ + F+ E + L E++ G R L+ + D R + A + L
Sbjct: 61 EWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEA--VDAL 117
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
HEL IHRD+K N L+D + K+ DFGLSK + + V G+ Y+ PE
Sbjct: 118 HELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEV 169
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ D +S G ++ E + P
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 9e-12
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQ--GSMQGGLEFKTEIELLSRV-HHKNLVGL 688
+IG G + +V + G+ AIK ++ S++ + EI+ L R+ H N++ L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLR-EIQALRRLSPHPNILRL 63
Query: 689 VGFCFEQ--GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+ F++ G LV+E M + L E + GR L KR + L ++H
Sbjct: 64 IEVLFDRKTGRLALVFELM-DMNLYELIKGRKR-PLPEKRVKSYMYQLLKSLDHMHRNG- 120
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG----HVSTQVKGTMGYLDPE-- 800
I HRD+K NIL+ ++ K+ADFG + + SK ++ST+ Y PE
Sbjct: 121 --IFHRDIKPENILIKDD-ILKLADFGSCRGI--YSKPPYTEYISTR-----WYRAPECL 170
Query: 801 ----YYMTQQLTEKSDVYSFGVVMLELIT 825
YY K D+++ G V E+++
Sbjct: 171 LTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 16/206 (7%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT---EIELLSRVHHKNLVGLVG 690
IG G YG V++ + GQ+VAIK+ + S + K EI +L ++ H NLV L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVE-SEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
F + ++ LV+E+ + L E G + +I + + + + H+
Sbjct: 68 -VFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKIIWQTLQAVNFCHKHN---C 121
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLT 808
IHRDVK NIL+ + K+ DFG ++++ + G T T Y PE + Q
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARIL--TGPGDDYTDYVATRWYRAPELLVGDTQYG 179
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGK 834
DV++ G V EL+T QP+ GK
Sbjct: 180 PPVDVWAIGCVFAELLTG-QPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 635 IGSGGYGKVY--RGMLSDGQVVAIKRAQQGSMQGGLEFK----------TEIELL-SRVH 681
+GSG +G VY R + ++A+K + G + + +E+ ++ ++
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLA 739
H N+V E +V + + L E + +R I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
YLH+ I+HRD+ NI+L E+ + DFGL+K SK T V GT+ Y P
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSCP 182
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
E + EK+DV++FG ++ ++ T + P
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF---KTEIELLSRVHH 682
+++ +GSG YG VY+ L G++ A+K + ++ G +F + EI ++ H
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKH 65
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSARGLA 739
N+V G + + + E+ G+L++ + L+IA + +GLA
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPL-----SELQIAYVCRETLQGLA 120
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
YLH +HRD+K NILL +N K+ADFG++ ++ + S GT ++ P
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAP 175
Query: 800 EYYMTQQ---LTEKSDVYSFGVVMLELITAKQPI 830
E ++ + D+++ G+ +EL + P+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 1e-11
Identities = 54/205 (26%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIK--RAQQGSMQGGLEFKT--EIELLSRV 680
++++ + ++G G Y VY+G +G++VA+K R Q+ + G F E LL +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGL 60
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
H N+V L + LV+E++ + G+H + + L RGL+Y
Sbjct: 61 KHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL--LRGLSY 118
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
+H+ I+HRD+K N+L+ + K+ADFGL++ + S H + T+ Y P+
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTYSNEVVTLWYRPPD 173
Query: 801 YYM-TQQLTEKSDVYSFGVVMLELI 824
+ + + + D++ G + +E+I
Sbjct: 174 VLLGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-11
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 35/219 (15%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSR------VHHKNLVG 687
EIG+G +GKV + VA R ++ K + E L + + H N++
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVA--RVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR-------LRIALGSARGLAY 740
+G C E +LV+E+ G L+ LS W RR R+A A G+ +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMACEIAAGVTH 114
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK--GTMGYLD 798
+H+ +H D+ N L +LT KV D+G+ S + ++ T+ + +L
Sbjct: 115 MHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLA 169
Query: 799 PEY-------YMTQQLTEKSDVYSFGVVMLELI-TAKQP 829
PE +T + T+ S+V++ GV + EL A QP
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 50/197 (25%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 634 EIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
+IG G G V + S G++VA+K+ Q E+ ++ H+N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
E +V EF+ G L + ++ ++ ++ + L + L+ LH +IHR
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQG---VIHR 140
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSD 812
D+KS +ILL + K++DFG VS S + GT ++ PE + D
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVD 198
Query: 813 VYSFGVVMLELITAKQP 829
++S G++++E++ + P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 635 IGSGGYGKV---YRGMLSDGQVVAIKRAQ---QGSMQGGLEFKTEIELLSRVHHKNLVGL 688
IGSG G V Y + GQ VAIK+ Q ++ E+ L+ V+HKN++GL
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGL 80
Query: 689 VGFCF-------EQGEQMLVYEFM-ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
+ F E + LV E M AN L + LD +R + G+ +
Sbjct: 81 LN-VFTPQKSLEEFQDVYLVMELMDAN------LCQVIQMDLDHERMSYLLYQMLCGIKH 133
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
LH + IIHRD+K +NI++ + T K+ DFGL++ S + T T Y PE
Sbjct: 134 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 187
Query: 801 YYMTQQLTEKSDVYSFGVVMLELI 824
+ E D++S G +M E+I
Sbjct: 188 VILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (164), Expect = 3e-11
Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 62/307 (20%)
Query: 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFK------- 671
YD+ + N + +IG+G +G+V+ +V KR Q+ + ++
Sbjct: 5 YDDGESRLNEYEVIKKIGNGRFGEVF--------LVKHKRTQEFFCWKAISYRGLKEREK 56
Query: 672 ----TEIELLSRVHHKNLVGLVGFCFEQGEQML--VYEFMANGTLRESLS------GRSG 719
E+ ++ + HKN+V + + Q L + EF G L ++ G+
Sbjct: 57 SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIE 116
Query: 720 IH--LDWKRRLRIALGSARGLAYLHELANPP----IIHRDVKSTNILLDENL-------- 765
H +D R+L AL AY H L + P ++HRD+K NI L +
Sbjct: 117 EHAIVDITRQLLHAL------AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 766 ---------TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM--TQQLTEKSDVY 814
AK+ DFGLSK + S H GT Y PE + T+ +KSD++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIESMAHSCV---GTPYYWSPELLLHETKSYDDKSDMW 227
Query: 815 SFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYL 874
+ G ++ EL + K P K + + D G ++ ++ I+N + L +
Sbjct: 228 ALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP 287
Query: 875 ELALQCV 881
ALQC+
Sbjct: 288 S-ALQCL 293
|
Length = 1021 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 635 IGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKNLVGLVG 690
+G G +GKV + G++ A+K ++ + + + TE +LS + + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 691 FCFEQGEQML-VYEFMANGTLRESLSGRSGIHLDWKRRL---RIALGSARGLAYLHELAN 746
CF+ +++ V EF+ G L H+ RR R +A + L L +
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLM--------FHIQKSRRFDEARARFYAAEITSALMFLHD 114
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
II+RD+K N+LLD K+ADFG+ K G ++ GT Y+ PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEML 172
Query: 807 LTEKSDVYSFGVVMLELITAKQPIE 831
D ++ GV++ E++ P E
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 4e-11
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 635 IGSGGYGKVYRGMLSD----GQVVAIKR------AQQGSMQGGLEFKTEIELLSRVHHKN 684
+G G +GKV +L++ ++ A+K Q ++ + K + L + H
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPF 57
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESL--SGRSGIHLDWKRRLRIALGSARGLAYL 741
L L CF+ +++ V E++ G L + SGR D R A GL +L
Sbjct: 58 LTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFL 112
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
HE II+RD+K N+LLD K+ADFG+ K G ++ GT Y+ PE
Sbjct: 113 HERG---IIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEI 167
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
Q D ++ GV++ E++ + P E
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 634 EIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLVG 690
++G G Y VY+G+ +GQ+VA+K + +G + F E LL + H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
+ V+E+M + + G+H R L RGLAY+H I+
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL--LRGLAYIH---GQHIL 125
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQQLTE 809
HRD+K N+L+ K+ADFGL++ S S+ + S V T+ Y P+ + +
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATDYSS 183
Query: 810 KSDVYSFGVVMLELITAKQPIEKG 833
D++ G + +E++ QP G
Sbjct: 184 ALDIWGAGCIFIEMLQG-QPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 5e-11
Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 28/225 (12%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT-------EIELLSRVHHKNLV 686
IG G YG V S+ + VAIK+ + + + EI+LL + H+N++
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKK-----IANAFDNRIDAKRTLREIKLLRHLDHENVI 67
Query: 687 GLVGF----CFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+ E + +VYE M + L + + + D + L RGL Y+
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQL--LRGLKYI 124
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H AN ++HRD+K +N+LL+ N K+ DFGL++ + S KG T+ T Y PE
Sbjct: 125 HS-AN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPEL 179
Query: 802 YMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN 845
+ + T DV+S G + EL+ K P+ GK V +++
Sbjct: 180 LLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITE 223
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 5e-11
Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 48/211 (22%)
Query: 635 IGSGGYGKV----YRG--------MLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH 682
+G+G +G+V ++G +LS ++V +K+ + E +L + H
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH--------VLNEKRILQSIRH 60
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL-RIALGSAR----- 736
LV L G + LV E++ G L R+ R AR
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL-----------FSHLRKSGRFPEPVARFYAAQ 109
Query: 737 ---GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
L YLH L I++RD+K N+LLD + K+ DFG +K V KG T + GT
Sbjct: 110 VVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRV----KGRTYT-LCGT 161
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELI 824
YL PE +++ + D ++ G+++ E++
Sbjct: 162 PEYLAPEIILSKGYGKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 7e-11
Identities = 68/234 (29%), Positives = 103/234 (44%), Gaps = 31/234 (13%)
Query: 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFK-TEIELLSRV-HHKNLVGLV 689
+G G +GKV+ L Q AIK ++ M +E E +LS H L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL- 61
Query: 690 GFC-FEQGEQML-VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+C F+ E + V E++ G L + +S D R A GL +LH
Sbjct: 62 -YCTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFYAAEIICGLQFLHSKG-- 116
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV-KGTMGYLDPEYYMTQQ 806
I++RD+K NILLD + K+ADFG+ K ++ G T GT Y+ PE + Q+
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
D +SFGV++ E++ + P D+EE + M +P
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFH-------------GHDEEELFQSIRMDNP 213
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 29/254 (11%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIK--RAQQGSMQGG--LEFKTEIELLSRVHHKNLVGLV 689
IG GG+G+VY +D G++ A+K ++ M+ G L I +LS V + +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI-MLSLVSTGDCPFIV 60
Query: 690 --GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+ F +++ + + M G L LS + G+ + + R A GL ++H N
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEAEMRF-YAAEIILGLEHMH---N 115
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+++RD+K NILLDE+ +++D GL+ S K H S GT GY+ PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKGV 171
Query: 807 LTEKS-DVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
+ S D +S G ++ +L+ P + K +D E +T M + ++
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHK----------TKDKHEIDRMTLTMAVELPDS 221
Query: 866 VLLGFRRYLELALQ 879
R LE LQ
Sbjct: 222 FSPELRSLLEGLLQ 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 18/199 (9%)
Query: 635 IGSGGYGKVYRGMLSDGQVVA------IKRAQQGSMQGG--LEFKTEIELLSRVHHKNLV 686
+G G +G VY ++ D + VA +K G + ++ E +LLS++ H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLS--GRSGIHLDWKRRLRIALGSARGLAYLHEL 744
E+ ++ E+ L L +G L + + G+ Y+H+
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR 125
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
I+HRD+K+ NI L NL K+ DFG+S+L+ S ++T GT Y+ PE
Sbjct: 126 R---ILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKH 179
Query: 805 QQLTEKSDVYSFGVVMLEL 823
Q KSD++S G ++ E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 7e-11
Identities = 85/343 (24%), Positives = 136/343 (39%), Gaps = 96/343 (27%)
Query: 635 IGSGGYGKVYR------GMLSDGQVVAIKRAQQGSMQGGLEFK---TEIELLSRV-HHKN 684
+G G +GKV + + + VA+K ++G+ E+K TE+++L + HH N
Sbjct: 15 LGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATAS--EYKALMTELKILIHIGHHLN 72
Query: 685 LVGLVGFCFEQ-GEQMLVYEFMANG-------TLRESLSG-------------------- 716
+V L+G C + G M++ E+ G + RE S
Sbjct: 73 VVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQR 132
Query: 717 -----------RSGIHLD---------------WKRRLRI------ALGSARGLAYLHEL 744
SG D +K L + + ARG+ +L
Sbjct: 133 LDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL--- 189
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSS---KGHVSTQVKGTMGYLDPE 800
A+ IHRD+ + NILL EN K+ DFGL++ + D KG +K ++ PE
Sbjct: 190 ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPE 245
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
+ T +SDV+SFGV++ E+ + G + E + T M P
Sbjct: 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG-------TRMRAP 298
Query: 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ + L C + DRPT SE+V+ + LLQ
Sbjct: 299 EYATPEI------YSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 59/214 (27%), Positives = 107/214 (50%), Gaps = 17/214 (7%)
Query: 633 NEIGSGGYGKVYRG--MLSDGQVVAIKRAQQGSMQGG-LEFKTEIELLSRVHHKNLVGLV 689
+++G G Y VY+G L+D +VA+K + +G E+ LL + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLS--GRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ LV+E++ + L++ L G S I++ + L RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYL-DKDLKQYLDDCGNS-INMHNVKLFLFQL--LRGLNYCHR---R 123
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQQ 806
++HRD+K N+L++E K+ADFGL++ S +K + + V T+ Y P+ + +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREV 840
+ + D++ G + E+ T + P+ G V ++
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 1e-10
Identities = 76/283 (26%), Positives = 122/283 (43%), Gaps = 37/283 (13%)
Query: 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAE 138
L + L L L S L GS + +L L L L NI E+ L
Sbjct: 61 LLPSSLSRLLSLDLLSPSGISSLDGSENL--LNLLPLPSLDLNLNRLRSNI-SELLELTN 117
Query: 139 LSFLALNSNNFSGRIPPSLGKL-SQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFH 197
L+ L L++NN + IPP +G L S L LDL+DN++ ++ SP L L N K+
Sbjct: 118 LTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKI------ESLPSP-LRNLPNLKNLD 169
Query: 198 FNKNKLS-----GTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNAL 252
+ N LS + L + D+ GN++S ++P + + LE L L N++
Sbjct: 170 LSFNDLSDLPKLLSNLSNLNNLDL-------SGNKIS-DLPPEIELLSALEELDLSNNSI 221
Query: 253 TGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN---SFDPTEAPLWFS 309
++ ++L+NL N++ L L++N L+ + +++L +DLSNN S
Sbjct: 222 I-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQISSISS------LG 274
Query: 310 TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTL 352
+L +L L SL +P + L N
Sbjct: 275 SLTNLRELDLSGNSLSNALPLIA--LLLLLLELLLNLLLTLKA 315
|
Length = 394 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-10
Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+GSG YG V G VA+K R Q + ++ E+ LL + H+N++GL+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 691 F-----CFEQGEQMLVYEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHE 743
E+ + + + L + + + H+ + + RGL Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-----LIYQILRGLKYIH- 137
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
+ IIHRD+K +N+ ++E+ K+ DFGL++ D G+V+T+ Y PE +
Sbjct: 138 --SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIML 190
Query: 804 T-QQLTEKSDVYSFGVVMLELITAK 827
+ D++S G +M EL+T +
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIE----LLSRVHHKNLVGLV 689
IG G +GKV DG+ A+K Q+ + E K + LL V H LVGL
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKR-----RLRIALGS-ARGLAYLH 742
+ F+ E++ V +F+ G L HL +R R R A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELF--------FHLQRERSFPEPRARFYAAEIASALGYLH 113
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+ I++RD+K NILLD + DFGL K ++ +T GT YL PE
Sbjct: 114 SIN---IVYRDLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
Q D + G V+ E++ P
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 51/224 (22%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKR---AQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+G G G V+ + SD + VA+K+ S++ L EI+++ R+ H N+V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALR---EIKIIRRLDHDNIVK--- 66
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHL------------DWKRRLRIALGSA--- 735
VYE + + S L D L S
Sbjct: 67 ----------VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHA 116
Query: 736 --------RGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSD--SSKG 784
RGL Y+H AN ++HRD+K N+ ++ E+L K+ DFGL+++V S KG
Sbjct: 117 RLFMYQLLRGLKYIHS-AN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173
Query: 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAK 827
++S + T Y P ++ T+ D+++ G + E++T K
Sbjct: 174 YLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 60/215 (27%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 628 NFSESNEIGSGGYGKVY--RGML--SDGQVVAIKRAQQGSM----QGGLEFKTEIELLSR 679
NF +G+G YGKV+ R + G++ A+K ++ ++ + +TE ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 680 VHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS-ARG 737
+ + + + F+ ++ L+ +++ G L LS R ++ ++I G
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK---EQEVQIYSGEIVLA 117
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGY 796
L +LH+L II+RD+K NILLD N + DFGLSK D + S GT+ Y
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS--FCGTIEY 172
Query: 797 LDPEYYMTQQLTEKS--DVYSFGVVMLELITAKQP 829
+ P+ D +S GV+M EL+T P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 36/104 (34%), Positives = 57/104 (54%), Gaps = 11/104 (10%)
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
RGL YLH A I+HRD+K N+L++ N K+ DFGL+++ H++ +V T
Sbjct: 114 RGLKYLHS-AG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169
Query: 796 YLDPEYYM-TQQLTEKSDVYSFGVVMLELIT------AKQPIEK 832
Y PE M ++ T D++S G + EL+ A+ PI++
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 635 IGSGGYGKVYRGMLSDGQVV----AIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
IG G +GKV + D Q + I++A S E +L++V+ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIA-LGSARGLAYLHELANPP 748
F F+ E++ LV F+ G L L R G + R A L A L LH+
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTAELLCA--LENLHKFN--- 113
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
+I+RD+K NILLD + DFGL KL + + GT YL PE + T
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYT 171
Query: 809 EKSDVYSFGVVMLELITAKQP 829
+ D ++ GV++ E++T P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 63/230 (27%), Positives = 102/230 (44%), Gaps = 28/230 (12%)
Query: 619 YDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIE-- 675
+D S+ + IG G YGKV++ + +G A+K + + EIE
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-----ILDPIHDIDEEIEAE 64
Query: 676 ---LLSRVHHKNLVGLVGFCFEQ----GEQM-LVYEFMANGTLRESLSG--RSGIHLDWK 725
L + H N+V G +++ G+Q+ LV E G++ + + G + G ++
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERME-- 122
Query: 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785
IA L L L IHRDVK NILL K+ DFG+S ++ S++
Sbjct: 123 -EPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT-STRLR 180
Query: 786 VSTQVKGTMGYLDPEYYMTQQ-----LTEKSDVYSFGVVMLELITAKQPI 830
+T V GT ++ PE +Q + DV+S G+ +EL P+
Sbjct: 181 RNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 50/173 (28%), Positives = 79/173 (45%), Gaps = 24/173 (13%)
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS----SKGHVSTQV 790
ARG+ +L A+ IHRD+ + NILL EN K+ DFGL++ + KG +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850
K ++ PE + T +SDV+SFGV++ E+ + G + E + +D
Sbjct: 241 K----WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRL-KDG-- 293
Query: 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
T M P + + L C + +RPT S +V+ + LLQ
Sbjct: 294 ----TRMRAPENATPEIYR------IMLACWQGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 60/207 (28%), Positives = 86/207 (41%), Gaps = 26/207 (12%)
Query: 635 IGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIE----LLSRVHHKNLVGLV 689
IG G +GKV SDG A+K Q+ ++ E + LL + H LVGL
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL- 61
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGSARGLAYLH 742
+ F+ E++ V +++ G L HL +R A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELF--------FHLQRERCFLEPRARFYAAEVASAIGYLH 113
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
L II+RD+K NILLD + DFGL K ++ GT YL PE
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVL 168
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
+ D + G V+ E++ P
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 5e-10
Identities = 53/203 (26%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKNLVGLVG 690
+IG G YG VY+ + +A+K+ + G+ EI LL + H N+V L
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIA----LGSARGLAYLHELAN 746
+ LV+E++ + L++ + D+ + R+ RG+AY H +
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSP----DFAKNPRLIKTYLYQILRGIAYCH---S 120
Query: 747 PPIIHRDVKSTNILLDENLTA-KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-T 804
++HRD+K N+L+D A K+ADFGL++ + V T+ Y PE + +
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLGS 178
Query: 805 QQLTEKSDVYSFGVVMLELITAK 827
+ + D++S G + E++ K
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 21/220 (9%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVY--RGMLSDGQVVAIKRAQQGSMQGGLE---FKTEIE 675
+L+ + +F IG G +G+V R S QV A+K + M + F E +
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSK-QVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 676 LLSRVHHKNLVGLVGFCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLRIALG 733
+++ + + +V L Q ++ L V E+M G L +L I W R +
Sbjct: 96 IMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDL-VNLMSNYDIPEKWARFYTAEVV 152
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
A L +H + IHRDVK N+LLD++ K+ADFG + + T V GT
Sbjct: 153 LA--LDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 794 MGYLDPEYYMTQ----QLTEKSDVYSFGVVMLELITAKQP 829
Y+ PE +Q + D +S GV + E++ P
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 8e-10
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+GSG YG V Q VA+K R Q + ++ E+ LL + H+N++GL+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 691 FCF------EQGEQMLVYEFMA---NGTLR-ESLSGRSGIHLDWKRRLRIALGSARGLAY 740
E LV M N ++ + LS H+ + + RGL Y
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE---HVQF-----LIYQLLRGLKY 133
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
+H IIHRD+K +N+ ++E+ ++ DFGL++ D G+V+T+ Y PE
Sbjct: 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPE 185
Query: 801 YYMT-QQLTEKSDVYSFGVVMLELITAK 827
+ + D++S G +M EL+ K
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 9e-10
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIK--RAQQGSMQGGLEFKT-- 672
+Y +L K +G G Y VY+G GQ+VA+K R + + G F
Sbjct: 6 TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEH---EEGAPFTAIR 52
Query: 673 EIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR-SGIHLDWKRRLRIA 731
E LL + H N+V L + LV+E++ + L++ + G+ + R
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
L RGLAY H+ ++HRD+K N+L+ E K+ADFGL++ S SK + + V
Sbjct: 112 L--LRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV- 165
Query: 792 GTMGYLDPEYYMTQQLTEKS---DVYSFGVVMLELIT 825
T+ Y P+ + TE S D++ G + E+ T
Sbjct: 166 -TLWYRPPDVLLGS--TEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 628 NFSESNEIGSGGYGKVYR----GMLSDGQVVAIKRAQQGSM----QGGLEFKTEIELLSR 679
NF +G+G YGKV+ G++ A+K Q+ ++ + +TE +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 680 VHHKNLVGLVGFCFE-QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSA-RG 737
V + + + F+ + + L+ ++++ G + L R D +R G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSGEIILA 117
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L +LH+L I++RD+K NILLD + DFGLSK K + GT+ Y+
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIEYM 173
Query: 798 DPEYYMTQQLTEKS-DVYSFGVVMLELITAKQP 829
PE + K+ D +S G+++ EL+T P
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-09
Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIE----LLSRVHHKNLVGLV 689
IG G +GKV ++ + A+K Q+ ++ E K + LL V H LVGL
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL- 61
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
F F+ +++ V +++ G L L R L+ + R A A L YLH L
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEPRARF-YAAEIASALGYLHSLN--- 116
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
I++RD+K NILLD + DFGL K + ++ GT YL PE Q
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD 174
Query: 809 EKSDVYSFGVVMLELITAKQP 829
D + G V+ E++ P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 17/208 (8%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKN--LVGL 688
IG GG+G+VY +D G++ A+K + + QG E +LS V + +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 689 VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ + F +++ + + M G L LS + G+ + + R A GL ++H N
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLS-QHGVFSEKEMRF-YATEIILGLEHMH---NR 116
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
+++RD+K NILLDE+ +++D GL+ S K H S GT GY+ PE
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPHASV---GTHGYMAPEVLQKGTA 172
Query: 808 TEKS-DVYSFGVVMLELITAKQPIEKGK 834
+ S D +S G ++ +L+ P + K
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHK 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 60/265 (22%), Positives = 107/265 (40%), Gaps = 40/265 (15%)
Query: 649 SDGQVVAIKRAQQGS---MQGGLEFKTEIE--LLSRVHHKNLVGLVGFCFEQGEQMLVYE 703
S+G+V + Q ++ G + T IE LL V+H +++ + +V
Sbjct: 78 SEGRVFVATKPGQPDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137
Query: 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE 763
+ L L+ RS L + L I GL YLH IIHRDVK+ NI +++
Sbjct: 138 HY-SSDLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFIND 192
Query: 764 NLTAKVADFGLSK--LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVML 821
+ D G ++ +V+ + G + GT+ PE + K+D++S G+V+
Sbjct: 193 VDQVCIGDLGAAQFPVVAPAFLG-----LAGTVETNAPEVLARDKYNSKADIWSAGIVLF 247
Query: 822 ELI------------TAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLG 869
E++ T ++ ++ + ++ + + EE DP R
Sbjct: 248 EMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPR-----DPGSRLV---- 298
Query: 870 FRRYLELALQCVEESATDRPTMSEV 894
R ++E A + T P V
Sbjct: 299 -RGFIEYA-SLERQPYTRYPCFQRV 321
|
Length = 357 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/212 (26%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGG-LEFKTEIELLSRVHHKNLVGLVG 690
+++G G Y V++G +VA+K + +G E+ LL + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSA-RGLAYLHELANPPI 749
+ LV+E++ + L++ L +L ++I + RGL+Y H+ I
Sbjct: 71 IIHTERCLTLVFEYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---I 124
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQQLT 808
+HRD+K N+L++E K+ADFGL++ S +K + + V T+ Y P+ + + + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGKYVVREV 840
D++ G ++ E+ T + P+ G V E+
Sbjct: 183 TPIDMWGVGCILYEMATGR-PMFPGSTVKEEL 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 56/203 (27%), Positives = 86/203 (42%), Gaps = 20/203 (9%)
Query: 672 TEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRI 730
TE +L H L L + F+ +++ V E+ G L LS R + + + R
Sbjct: 44 TESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLS-RERVFSEDRARFYG 101
Query: 731 A-LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
A + SA L YLH +++RD+K N++LD++ K+ DFGL K S G
Sbjct: 102 AEIVSA--LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKT 154
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY-------VVREVRT 842
GT YL PE D + GVVM E++ + P + ++ E+R
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRF 214
Query: 843 AMNRDDEEHYGLTEMM--DPTIR 863
E L ++ DP R
Sbjct: 215 PRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 48/141 (34%), Positives = 74/141 (52%), Gaps = 9/141 (6%)
Query: 691 FCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
FC Q ++ L V E++ G L + +S D R A GL +LH+
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHI--QSSGRFDEARARFYAAEIICGLQFLHKKG--- 116
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
II+RD+K N+LLD++ K+ADFG+ K + + +G ST GT Y+ PE Q+
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKAST-FCGTPDYIAPEILKGQKYN 174
Query: 809 EKSDVYSFGVVMLELITAKQP 829
E D +SFGV++ E++ + P
Sbjct: 175 ESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 39/250 (15%)
Query: 635 IGSGGYGKV---YRGMLSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
IGSG G V Y +L + VAIK R Q ++ E+ L+ V+HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 689 VGFCFEQG------EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
+ Q + LV E M + L + + + LD +R + G+ +LH
Sbjct: 82 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH 136
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
IIHRD+K +NI++ + T K+ DFGL++ S + T T Y PE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVI 190
Query: 803 MTQQLTEKSDVYSFGVVMLELITAK------QPIEKGKYVVREVRTAMNRDDEEHYGLTE 856
+ E D++S G +M E++ K I++ V+ ++ T +
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE-------FMK 243
Query: 857 MMDPTIRNTV 866
+ PT+RN V
Sbjct: 244 KLQPTVRNYV 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 633 NEIGSGGYGKVYRG--MLSDGQVVAIKRAQQGSMQGG-LEFKTEIELLSRVHHKNLVGLV 689
++G G Y V++G L++ +VA+K + +G E+ LL + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSA-RGLAYLHELANPP 748
LV+E++ + L++ + I ++I L RGLAY H
Sbjct: 71 DIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRRK--- 124
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQQL 807
++HRD+K N+L++E K+ADFGL++ S +K + + V T+ Y P+ + + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEY 182
Query: 808 TEKSDVYSFGVVMLELITAKQPIEKGKYVVREV 840
+ + D++ G + E+ + +P+ G V E+
Sbjct: 183 STQIDMWGVGCIFFEM-ASGRPLFPGSTVEDEL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 635 IGSGGYGKV---YRGMLSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
IGSG G V Y +L + VAIK R Q ++ E+ L+ V+HKN++GL
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 689 VGF-----CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
+ E+ + + + + + L + + + LD +R + G+ +LH
Sbjct: 89 LNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHS 144
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
IIHRD+K +NI++ + T K+ DFGL++ S + T T Y PE +
Sbjct: 145 AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVIL 198
Query: 804 TQQLTEKSDVYSFGVVMLELITAK 827
E D++S G +M E+I
Sbjct: 199 GMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 60/207 (28%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 629 FSESNEIGSGGYGKVYRGMLSD-GQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKN 684
+ + IGSG G V + G VA+K R Q ++ E+ LL V+HKN
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKN 81
Query: 685 LVGLVGFCFEQG------EQMLVYEFM-ANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
++ L+ Q + LV E M AN L + LD +R + G
Sbjct: 82 IISLLNVFTPQKSLEEFQDVYLVMELMDAN------LCQVIHMELDHERMSYLLYQMLCG 135
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+ +LH IIHRD+K +NI++ + T K+ DFGL++ + + T T Y
Sbjct: 136 IKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYYR 189
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELI 824
PE + E D++S G +M EL+
Sbjct: 190 APEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 9e-09
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKNLVGLVG 690
IG G +G+VY+ D ++ A+K + + E E +L R +VG
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 691 --FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
F F+ + LV ++M+ G L L + G + + + IA L +LH+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHLHKY--- 115
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ- 806
I++RD+K NILLD + DFGLSK ++ + + GT YL PE + ++
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKG 173
Query: 807 LTEKSDVYSFGVVMLELITAKQP 829
T+ D +S GV++ E+ P
Sbjct: 174 YTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 20/214 (9%)
Query: 651 GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710
G+ VA+K Q E+ ++ H+N+V + E ++ EF+ G L
Sbjct: 46 GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105
Query: 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770
+ +S L+ ++ + + L YLH +IHRD+KS +ILL + K++
Sbjct: 106 TDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159
Query: 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
DFG +S S + GT ++ PE + D++S G++++E++ + P
Sbjct: 160 DFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP- 216
Query: 831 EKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864
Y AM R L + P ++N
Sbjct: 217 ----YFSDSPVQAMKR-------LRDSPPPKLKN 239
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 56/221 (25%), Positives = 102/221 (46%), Gaps = 14/221 (6%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT----EIELLSRVH 681
N F +G G YG V + + ++VAIK+ + + E K E+++L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLK 58
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+N+V L +G+ LV+E++ L +G+ + R L A +
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKA-----I 113
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H I+HRD+K N+L+ N K+ DFG ++ +S+ S + T+ T Y PE
Sbjct: 114 HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPEL 172
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842
+ + D++S G ++ EL + QP+ G+ + ++ T
Sbjct: 173 LLGAPYGKAVDMWSVGCILGEL-SDGQPLFPGESEIDQLFT 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 53/191 (27%), Positives = 91/191 (47%), Gaps = 36/191 (18%)
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSD 780
LD LR + A+G+ +L A+ IHRDV + N+LL + AK+ DFGL++ +++D
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265
Query: 781 SS---KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP-----IE 831
S+ KG+ VK ++ PE T +SDV+S+G+++ E+ + K P +
Sbjct: 266 SNYVVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN 321
Query: 832 KGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTM 891
Y + + M+R D + E+ +I C T+RPT
Sbjct: 322 SKFYKMVKRGYQMSRPD---FAPPEIY--SIMKM--------------CWNLEPTERPTF 362
Query: 892 SEVVKAIETLL 902
S++ + I+ L
Sbjct: 363 SQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 9/95 (9%)
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK--LVSDSSKGHVSTQVKGTM 794
GL +LH + II+RD+K N++LD + K+ADFG+ K + D+ ++ GT
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR----ASTFCGTP 160
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
Y+ PE + T D +SFGV++ E++ + P
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-08
Identities = 59/238 (24%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD---GQVVA---IKRAQQGSMQGGLEFKTEIELLSRV 680
+F + +G G +G+V ++ + G + A +K++ + + F+ E ++LS
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLD------WKRRLRIALG 733
+ + L + F+ + + LV E+ G L SL R D + L +A+
Sbjct: 59 NSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLL-SLLNRYEDQFDEDMAQFYLAELVLAIH 116
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
S +H++ +HRD+K N+L+D K+ADFG S ++K S GT
Sbjct: 117 S------VHQMG---YVHRDIKPENVLIDRTGHIKLADFG-SAARLTANKMVNSKLPVGT 166
Query: 794 MGYLDPEYYMTQQLTEKS------DVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN 845
Y+ PE T K D +S GV+ E+I + P +G + MN
Sbjct: 167 PDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMN 223
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 32/94 (34%), Positives = 47/94 (50%), Gaps = 5/94 (5%)
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L +LH +I+RD+K NILLD K+ADFG+ K G +T GT Y+
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYI 163
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
PE + D ++ GV+M E++ + P E
Sbjct: 164 APEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 57/213 (26%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 635 IGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEF---KTEIELLSRV-HHKNLVGLV 689
IG G Y KV L ++ A+K ++ + + +TE + +H LVGL
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRL----------RIALGSARGL 738
CF+ ++ V EF++ G L H+ +R+L I+L L
Sbjct: 63 S-CFQTESRLFFVIEFVSGGDLM--------FHMQRQRKLPEEHARFYSAEISLA----L 109
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
+LHE II+RD+K N+LLD K+ D+G+ K G ++ GT Y+
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIA 164
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
PE + D ++ GV+M E++ + P +
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 39/106 (36%), Positives = 62/106 (58%), Gaps = 10/106 (9%)
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK---GHVSTQVKG 792
GL Y+H AN ++HRD+K N+L++ + K+ DFGL++ S++ G ++ V
Sbjct: 116 CGLKYIHS-AN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171
Query: 793 TMGYLDPEYYMTQQLTEKS-DVYSFGVVMLELITAKQPIEKGK-YV 836
T Y PE ++ Q K+ DV+S G ++ EL+ K P+ KGK YV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYV 216
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEF---KTEIELLSRVHHKN-LVGLV 689
IG G Y KV L + Q+ A+K ++ + + +TE + + LVGL
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGSARGLAYLH 742
CF+ ++ LV E++ G L H+ +R+L A L +LH
Sbjct: 63 S-CFQTTSRLFLVIEYVNGGDLM--------FHMQRQRKLPEEHARFYAAEICIALNFLH 113
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
E II+RD+K N+LLD + K+ D+G+ K G ++ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIE 831
++ D ++ GV+M E++ + P +
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEF---KTEIELLSRV-HHKNLVGLV 689
IG G Y KV L ++ A+K ++ + + +TE + + +H LVGL
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 690 GFCFEQGEQML-VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
CF+ ++ V E++ G L + + + + R + A L YLHE
Sbjct: 63 S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA--LNYLHERG--- 116
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
II+RD+K N+LLD K+ D+G+ K G ++ GT Y+ PE +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYG 174
Query: 809 EKSDVYSFGVVMLELITAKQPIE 831
D ++ GV+M E++ + P +
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 7e-08
Identities = 51/220 (23%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 628 NFSESNEIGSGGYGKVYRG------------MLSDGQVVAIKRAQQGSMQGGLEFKTEIE 675
+ +G+G +G+V+ +++ +V+ +K+ Q E
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQH--------VHNEKR 53
Query: 676 LLSRVHHKNLVGLVGFCFEQGEQML--VYEFMANGT----LRESLSGRSGIHLDWKRRLR 729
+L V H ++ L F E ++ L + E++ G LR S + L + +
Sbjct: 54 VLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV 111
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
AL YLH I++RD+K NILLD+ K+ DFG +K + D +
Sbjct: 112 CAL------EYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWT 157
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ GT YL PE ++ + D ++ G+++ E++ P
Sbjct: 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 8e-08
Identities = 66/287 (22%), Positives = 109/287 (37%), Gaps = 44/287 (15%)
Query: 127 GNIPDEIGNL--AELSFLALNSNNFSGRI-----PPSLGKLSQLYWLDLADNQLTGSIPV 179
N+ L + LS L I +L L L LDL N+L +I
Sbjct: 52 LNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS- 110
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
L +L N + N ++ I + L + N++ ++P L +
Sbjct: 111 ------ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNL 162
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSF 299
L+ L L N L+ +P L+NL+N+N L+L+ N + P++ +++L +DLSNNS
Sbjct: 163 PNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNS- 220
Query: 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359
E S L +L+ L L NN + +
Sbjct: 221 -IIELLSSLSNLKNLSGLE------------------------LSNNKLEDLPE-SIGNL 254
Query: 360 PLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQL 406
L+ +DL NNQIS+I+ + N + + + L L
Sbjct: 255 SNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLL 301
|
Length = 394 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 8e-08
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 24/188 (12%)
Query: 719 GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778
+ LD + L + A+G+++L A+ IHRD+ + NILL K+ DFGL++ +
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264
Query: 779 SDSS----KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ S KG+ VK ++ PE T +SDV+S+G+++ E+ + +
Sbjct: 265 RNDSNYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS----LGSSP 316
Query: 835 YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEV 894
Y V + + +E Y M+ P + + + C + RPT ++
Sbjct: 317 YPGMPVDSKFYKMIKEGY---RMLSPECAPSEMYDIMK------SCWDADPLKRPTFKQI 367
Query: 895 VKAIETLL 902
V+ IE L
Sbjct: 368 VQLIEQQL 375
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 5/97 (5%)
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
A GL +LH II+RD+K N++LD K+ADFG+ K + G + GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTP 165
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
Y+ PE Q + D ++FGV++ E++ + P E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 32/97 (32%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
A GL +LH + II+RD+K N++LD K+ADFG+ K + G + GT
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTP 165
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
Y+ PE Q + D ++FGV++ E++ + P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-07
Identities = 13/42 (30%), Positives = 18/42 (42%), Gaps = 4/42 (9%)
Query: 25 DSRDAAALQSLKDAWQNTPP----TWKNSDDPCGSWEGVTCN 62
+ D AL + K + P +W S SW GVTC+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 14/169 (8%)
Query: 666 GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ----MLVYEFMANGTLRESLSGRSGIH 721
GG EI++L + H+ ++ L+ + M Y+ L + +
Sbjct: 129 GGKTPGREIDILKTISHRAIINLI-HAYRWKSTVCMVMPKYKC----DLFTYVDRSGPLP 183
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
L ++ + I LAYLH IIHRDVK+ NI LDE A + DFG + +
Sbjct: 184 L--EQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238
Query: 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
GT+ PE K+D++S G+V+ E+ +
Sbjct: 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 31/119 (26%)
Query: 142 LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKN 201
L L++ G IP + KL L ++L+ N + G+IP S + L+ L
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLD---------- 472
Query: 202 KLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL 260
L + N +G+IPESLG + +L +L L+ N+L+G+VP L
Sbjct: 473 ----------------LSY-----NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 13/145 (8%)
Query: 691 FCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
FC Q ++ L V E+M G L +S + W + +A + L + +
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAK-----FYTAEVVLALDAIHSMG 162
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ--- 805
+IHRDVK N+LLD++ K+ADFG + ++ T V GT Y+ PE +Q
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 806 -QLTEKSDVYSFGVVMLELITAKQP 829
+ D +S GV + E++ P
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 42/169 (24%), Positives = 68/169 (40%), Gaps = 19/169 (11%)
Query: 672 TEIELLSRVH-----HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKR 726
IE + VH + N + L +L+ +++ +G L + L + L
Sbjct: 55 NAIEPM--VHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAE 110
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT-AKVADFGLSKLVSDSSKGH 785
+I L LH IIH D+K N+L D + D+GL K++ G
Sbjct: 111 VKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GT 162
Query: 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
S GT+ Y PE D ++ GV+ EL+T K P ++ +
Sbjct: 163 PSCY-DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210
|
Length = 267 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 53/189 (28%), Positives = 78/189 (41%), Gaps = 21/189 (11%)
Query: 672 TEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRI 730
TE +L H L L + F+ +++ V E+ G L LS D R
Sbjct: 44 TENRVLQNSRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
+ SA L YLH N +++RD+K N++LD++ K+ DFGL K G
Sbjct: 103 EIVSA--LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTF 156
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850
GT YL PE D + GVVM E++ + P N+D E+
Sbjct: 157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-------------YNQDHEK 203
Query: 851 HYGLTEMMD 859
+ L M +
Sbjct: 204 LFELILMEE 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 30/232 (12%)
Query: 635 IGSGGYGKV--YRGMLSDGQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKNLVGLV 689
+G G +GKV R S G+ A+K ++ + E TE +L H L L
Sbjct: 3 LGKGTFGKVILVREKAS-GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+ F+ +++ V E++ G L LS D R + SA L YLH +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSA--LDYLH---SGK 115
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKL-VSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
I++RD+K N++LD++ K+ DFGL K ++D++ GT YL PE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---TMKTFCGTPEYLAPEVLEDNDY 172
Query: 808 TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
D + GVVM E++ + P N+D E+ + L M D
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPF-------------YNQDHEKLFELILMED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 11/110 (10%)
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL-VSDSSKGHVSTQVKGTM 794
R L Y+H AN + HRD+K NIL + + K+ DFGL+++ +D+ T T
Sbjct: 114 RALKYIHT-AN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 795 GYLDPE----YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREV 840
Y PE ++ + T D++S G + E++T K P+ GK VV ++
Sbjct: 171 WYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQL 217
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 5/97 (5%)
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
+ GL +LH II+RD+K N++LD K+ADFG+ K G + GT
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTP 165
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
Y+ PE Q + D +++GV++ E++ + P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 55/235 (23%), Positives = 105/235 (44%), Gaps = 28/235 (11%)
Query: 603 KDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQV--VAIKRAQ 660
KDS + K Y++ NF + +G+G +G+V + VAIKR +
Sbjct: 13 KDSDSTKEPKRKNKMKYEDF-----NFIRT--LGTGSFGRVILATYKNEDFPPVAIKRFE 65
Query: 661 QGSMQGGLEFK---TEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGR 717
+ + + +E ++L+ ++H V L G ++ LV EF+ + G
Sbjct: 66 KSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFV--------IGGE 117
Query: 718 SGIHLDWKRRLRIALG---SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774
L +R +G +A+ + L + I++RD+K N+LLD++ K+ DFG
Sbjct: 118 FFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+K+V + + GT Y+ PE + + +D ++ G+ + E++ P
Sbjct: 178 AKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-07
Identities = 27/57 (47%), Positives = 35/57 (61%)
Query: 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP 281
GN + GNIP SLG + +LEVL L N+ G +P +L LT++ LNL N L G P
Sbjct: 451 GNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 47/159 (29%), Positives = 70/159 (44%), Gaps = 9/159 (5%)
Query: 672 TEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRI 730
TE +L H L L + F+ +++ V E+ G L LS + R
Sbjct: 44 TESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 102
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
+ SA L YLH + +++RD+K N++LD++ K+ DFGL K S G
Sbjct: 103 EIVSA--LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 155
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT YL PE D + GVVM E++ + P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 631 ESNEIGSGGYGKVYRGMLSDG---QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
E ++G G YG VY+ DG + A+K+ + + + EI LL + H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62
Query: 688 LVGFCFEQGEQM--LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY----- 740
L ++ L++++ A L + + K+ +++ G + L Y
Sbjct: 63 LQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDG 120
Query: 741 LHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTMG 795
+H L ++HRD+K NIL+ E K+AD G ++L + K V T
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW 180
Query: 796 YLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPI 830
Y PE + + T+ D+++ G + EL+T+ +PI
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 6e-07
Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 8/90 (8%)
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
YLH II+RD+K N+LLD KV DFG +K V D + + GT YL P
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
E ++ + D ++ GV++ E I P
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 23/217 (10%)
Query: 631 ESNEIGSGGYGKVYRGMLSDG---QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
E ++G G YG VY+ DG + A+K+ + + + EI LL + H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62
Query: 688 LVGFCFEQGEQM--LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLA 739
L ++ L++++ + R S + + + L + G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 740 YLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQ-VKGTM 794
YLH AN ++HRD+K NIL+ E K+AD G ++L + K V T
Sbjct: 123 YLH--AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 795 GYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPI 830
Y PE + + T+ D+++ G + EL+T+ +PI
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 9e-07
Identities = 44/181 (24%), Positives = 78/181 (43%), Gaps = 42/181 (23%)
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDS---SKGHVSTQV 790
ARG+ +L A+ +HRD+ + N+LL + K+ DFGL++ ++ DS SKG V
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV 303
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850
K ++ PE T SDV+S+G+++ E+ + G
Sbjct: 304 K----WMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM---------------- 343
Query: 851 HYGLTEMMDPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETL 901
++D T N + G+R ++ ++C RP+ + +E+L
Sbjct: 344 ------IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397
Query: 902 L 902
L
Sbjct: 398 L 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 9e-07
Identities = 51/201 (25%), Positives = 77/201 (38%), Gaps = 38/201 (18%)
Query: 651 GQVVAIKRA--QQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMAN 707
+VA+K+ S + + EI ++ H N++ V F ++ +V MA
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TSFIVDSELYVVSPLMAY 83
Query: 708 GTLRESL-----SGRSGIHLDWKRRLRIAL---GSARGLAYLHELANPPIIHRDVKSTNI 759
G+ + L G L IA L Y+H IHR VK+++I
Sbjct: 84 GSCEDLLKTHFPEGLP--------ELAIAFILKDVLNALDYIHSKG---FIHRSVKASHI 132
Query: 760 LLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG-------TMGYLDPEYYMTQQ----LT 808
LL + ++ GL VS G V + +L PE + QQ
Sbjct: 133 LLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE--VLQQNLQGYN 188
Query: 809 EKSDVYSFGVVMLELITAKQP 829
EKSD+YS G+ EL P
Sbjct: 189 EKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 16/105 (15%)
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-----LVSDSSKGHVST---- 788
L YLH N I+HRD+K N+L+ K+ DFGLSK L ++ +GH+
Sbjct: 114 LEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 789 ----QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
QV GT Y+ PE + Q + D ++ G+++ E + P
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 33/209 (15%)
Query: 635 IGSGGYGKVYRG----MLSDGQV----VAIK---RAQQGSMQGGLEFKTEIELLSRVHHK 683
+G G + K+++G + G++ V +K ++ + + E + ++S++ HK
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAAS---MMSQLSHK 59
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLS-GRSGIHLDWKRRLRIALGSARGLAY-L 741
+LV G C E ++V E++ G+L L ++ I++ WK L A+ LA+ L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWAL 113
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD--- 798
H L + + H +V + N+LL K + KL SD +S V L+
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL-SDPG---ISITVLPKEILLERIP 169
Query: 799 ---PEYYM-TQQLTEKSDVYSFGVVMLEL 823
PE Q L+ +D +SFG + E+
Sbjct: 170 WVPPECIENPQNLSLAADKWSFGTTLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 59/241 (24%), Positives = 93/241 (38%), Gaps = 53/241 (21%)
Query: 634 EIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFK---TEIELLSRVHHKNLVGLV 689
+G G G+V+ L G++ A+K + M + K TE E+L+ + H L L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--------GLAY 740
F+ + LV ++ G L L + G + L AR L Y
Sbjct: 68 A-SFQTETYLCLVMDYCPGGELFRLLQRQPG------KCLSEE--VARFYAAEVLLALEY 118
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD------------SSKGHVST 788
LH L I++RD+K NILL E+ ++DF LSK S + V++
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 789 QVK---------------GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG 833
GT Y+ PE D ++ G+++ E++ P KG
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF-KG 234
Query: 834 K 834
Sbjct: 235 S 235
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 32/209 (15%)
Query: 635 IGSGGYGKVYRGML---------SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKN 684
+G G + +Y+G+L GQ V++ GS L F L+S++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHLDWKRRLRIALGSARGLAYLHE 743
LV L G C M V E++ G L L ++ + L WK L +A A L YL +
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED 119
Query: 744 LANPPIIHRDVKSTNILLDEN-------LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
++H +V NIL+ K++D G+ V +V+ + +
Sbjct: 120 KK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-----LSREERVE-RIPW 170
Query: 797 LDPEYYMTQQ--LTEKSDVYSFGVVMLEL 823
+ PE Q LT +D +SFG +LE+
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-06
Identities = 55/236 (23%), Positives = 96/236 (40%), Gaps = 44/236 (18%)
Query: 635 IGSGGYGKVYRGMLSD---GQVVAIKRAQQGSMQGGL---EFKTEIELLSRVHHKNLVGL 688
IG GG G+VY D + VA+K+ ++ + L F E ++ + + H +V +
Sbjct: 10 IGKGGMGEVYLAY--DPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 689 VGFCFEQGEQMLVY---EFMANGTLR---------ESLSGRSGIHLDWKRRLRIALGSAR 736
C G+ VY ++ TL+ ESLS L I
Sbjct: 68 YSIC-SDGD--PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICA 124
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV----------------SD 780
+ Y+H ++HRD+K NILL + D+G +
Sbjct: 125 TIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPI--EKGK 834
S + ++ GT Y+ PE + +E +D+Y+ GV++ +++T P +KG+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237
|
Length = 932 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 3e-06
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 30/212 (14%)
Query: 635 IGSGGYGKVYRGMLSDG-QVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLVG 690
IG G +G+V L + +V A+K + M E F+ E ++L ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL-H 67
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSG-RSGIHLDWKR----RLRIALGSARGLAYLHEL 744
+ F+ + LV ++ G L LS + D R + IA+ S L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY---- 123
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVK-GTMGYLDPEYY 802
+HRD+K NIL+D N ++ADFG KL+ D G V + V GT Y+ PE
Sbjct: 124 -----VHRDIKPDNILMDMNGHIRLADFGSCLKLMED---GTVQSSVAVGTPDYISPEIL 175
Query: 803 MTQQ-----LTEKSDVYSFGVVMLELITAKQP 829
+ + D +S GV M E++ + P
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-06
Identities = 32/95 (33%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK-LVSDS---SKGHVSTQV 790
A G+ +L A+ +HRD+ + N+L+ E K+ DFGL++ ++ DS SKG +
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
K ++ PE T SDV+SFG+++ E+ T
Sbjct: 306 K----WMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 64/234 (27%), Positives = 112/234 (47%), Gaps = 37/234 (15%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT-EIELLSRVHHK 683
+ ++ N IG+G +G VY + D + VAIK+ Q ++K E+ ++ ++H
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHI 119
Query: 684 NLVGLVGF----CFEQGEQML----VYEFMANGTLRESLS--GRSGIHLDWKRRLRIALG 733
N++ L + CF++ E+ + V EF+ T+ + + R+ L + L
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL---FLVKLY 175
Query: 734 S---ARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSK--LVSDSSKGHVS 787
S R LAY+H + I HRD+K N+L+D N T K+ DFG +K L S ++
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232
Query: 788 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREV 840
++ Y PE + T D++S G ++ E+I PI G+ V ++
Sbjct: 233 SRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPIFSGQSSVDQL 280
|
Length = 440 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 55/235 (23%)
Query: 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLE------FKTEIELLSRVHHKNLVG 687
IG G +G+V D G + A+K+ ++ M LE + E ++L+ + +V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM---LEKEQVAHVRAERDILAEADNPWVVK 65
Query: 688 LVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
L + Q E L+ E++ G + +L + + + R IA + + +H+L
Sbjct: 66 L--YYSFQDENYLYLIMEYLPGGDMM-TLLMKKDTFTEEETRFYIA-ETILAIDSIHKLG 121
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSK-------------LVSDSSKGHVSTQVK- 791
IHRD+K N+LLD K++DFGL L + K
Sbjct: 122 ---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKP 178
Query: 792 ----------------------GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELI 824
GT Y+ PE ++ ++ D +S GV+M E++
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 58/241 (24%), Positives = 101/241 (41%), Gaps = 46/241 (19%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSM----QGGLEFKTEIELLSRVHH 682
+F IG G +G+V D G V A+K ++ M Q G + E ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG-HIRAERDILVEADS 60
Query: 683 KNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+V + + F+ + L+ EF+ G + L + + + + + IA + + +
Sbjct: 61 LWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTL-TEEETQFYIA-ETVLAIDSI 117
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLS-----------------KLVSDSSKG 784
H+L IHRD+K N+LLD K++DFGL L SD +
Sbjct: 118 HQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 785 HVSTQVK----------------GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQ 828
+++++ K GT Y+ PE +M + D +S GV+M E++
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 829 P 829
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 63/285 (22%), Positives = 111/285 (38%), Gaps = 61/285 (21%)
Query: 577 YAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIG 636
A AE + F AP D+ G L A+ DE +F +++
Sbjct: 104 SAGDGPSGAEDSDASHLDFDE-APP--DAAGPVPLAQAKLKHDDEFLA---HFRVIDDLP 157
Query: 637 SGGYGKVY--------------RGMLSDGQVVA------IKRAQQGSMQGGLEFKTEIEL 676
+G +GK++ RG+ S Q KR + GS + ++ + EI
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGS-RAAIQLENEILA 216
Query: 677 LSRVHHKNLVGL--------VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWK--- 725
L R++H+N++ + + Q +Y FM + DWK
Sbjct: 217 LGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF------------DWKDRP 264
Query: 726 -----RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780
R + L A + Y+H + +IHRD+K NI L+ + + DFG +
Sbjct: 265 LLKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEK 319
Query: 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
+ V GT+ PE E +D++S G+++L++++
Sbjct: 320 EREAFDYGWV-GTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 635 IGSGGYGKV-YRGMLSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLVG 690
IG G +G+V M + GQV A+K + M E F+ E ++L + + L
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL-H 67
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHL--DWKR----RLRIALGSARGLAYLHE 743
+ F+ + LV ++ G L LS + L D R + +A+ S L Y
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLS-KFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVK-GTMGYLDPEY 801
+HRD+K N+LLD+N ++ADFG +L++D G V + V GT Y+ PE
Sbjct: 124 ------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD---GTVQSNVAVGTPDYISPE- 173
Query: 802 YMTQQLTE-------KSDVYSFGVVMLELITAKQP 829
+ Q + + + D +S GV M E++ + P
Sbjct: 174 -ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 2/89 (2%)
Query: 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTE 303
L LD L G +P +++ L ++ +NL+ N ++G P L + SL +DLS NSF+ +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS- 481
Query: 304 APLWFSTLPSLTTLICEFGSLQGRVPDKL 332
P L SL L SL GRVP L
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 12/144 (8%)
Query: 691 FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
+ F+ + +V E+M G L +S + W R +A + L + +
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWAR-----FYTAEVVLALDAIHSMGF 163
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ---- 805
IHRDVK N+LLD++ K+ADFG ++ T V GT Y+ PE +Q
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222
Query: 806 QLTEKSDVYSFGVVMLELITAKQP 829
+ D +S GV + E++ P
Sbjct: 223 YYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 28/94 (29%), Positives = 44/94 (46%), Gaps = 6/94 (6%)
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
+H + +HRD+K N+LLD N ++ADFG ++ S V GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173
Query: 801 YYMTQQ-----LTEKSDVYSFGVVMLELITAKQP 829
+ + D +S GV M E++ + P
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 24/76 (31%), Positives = 45/76 (59%), Gaps = 1/76 (1%)
Query: 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD- 282
D L G IP + ++ L+ + L N++ G +P +L ++T++ L+L++N G P+
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 283 LSQMNSLSYVDLSNNS 298
L Q+ SL ++L+ NS
Sbjct: 486 LGQLTSLRILNLNGNS 501
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 5e-05
Identities = 20/59 (33%), Positives = 29/59 (49%), Gaps = 1/59 (1%)
Query: 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSF 299
L+ L L N LT L N+ L+L+ N+L P+ S + SL +DLS N+
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 55/241 (22%), Positives = 100/241 (41%), Gaps = 44/241 (18%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHH 682
++F IG G +G+V D G + A+K ++ M + + E ++L
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 683 KNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+V + + F+ + L+ EF+ G + L + + + + IA + + +
Sbjct: 61 AWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS-EEATQFYIA-ETVLAIDAI 117
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-----------------SDSSKG 784
H+L IHRD+K N+LLD K++DFGL + SD S
Sbjct: 118 HQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 785 HVSTQVK----------------GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQ 828
+++++ K GT Y+ PE +M + D +S GV+M E++
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 829 P 829
P
Sbjct: 235 P 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 51/190 (26%), Positives = 88/190 (46%), Gaps = 27/190 (14%)
Query: 668 LEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG-IHLDWKR 726
L F L+S+V H +L + G C E ++V EF+ +G L L G + + WK
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI 120
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNIL-----LDENLTA--KVADFGLSKLVS 779
+ L SA L+YL + ++H +V + NIL L E + K++D G+S +
Sbjct: 121 TVAQQLASA--LSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTA 174
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLEL-------ITAKQPIE 831
S + V + ++ PE L+ +D +SFG +LE+ + + P E
Sbjct: 175 LSREERVE-----RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229
Query: 832 KGKYVVREVR 841
K ++ ++ R
Sbjct: 230 KERFYEKKHR 239
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 43/173 (24%), Positives = 74/173 (42%), Gaps = 15/173 (8%)
Query: 654 VAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG-FCFEQGEQMLVYEFMANGTLRE 712
V IK Q+G TE +L ++H +++ L G F + + +++ + + L
Sbjct: 120 VVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD--LYC 171
Query: 713 SLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772
L+ + I + L I R + YLH IIHRD+K+ NI ++ + DF
Sbjct: 172 YLAAKRNIAI--CDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF 226
Query: 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
G + D + GT+ PE D++S G+V+ E+ T
Sbjct: 227 GAACFPVDINANKYYGWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 47/195 (24%), Positives = 80/195 (41%), Gaps = 22/195 (11%)
Query: 651 GQVVAIKRAQQGSMQGGLE--FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708
G+ V ++R + + + E+ + +H N+V E +V FMA G
Sbjct: 25 GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYG 84
Query: 709 TLRESLSGRSGIHLDWKRRLRIA---LGSARGLAYLHELANPPIIHRDVKSTNILLDENL 765
+ ++ + +D L IA G + L Y+H + +HR VK+++IL+ ++
Sbjct: 85 SAKDLICTH---FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILI--SV 136
Query: 766 TAKVADFGLSKLVSDSSKGHVSTQVKG-------TMGYLDPEYYMT--QQLTEKSDVYSF 816
KV GL +S + G V + +L PE Q KSD+YS
Sbjct: 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 817 GVVMLELITAKQPIE 831
G+ EL P +
Sbjct: 197 GITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 3e-04
Identities = 31/111 (27%), Positives = 50/111 (45%), Gaps = 10/111 (9%)
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
IIHRD+K+ N+L++ + DFG + S + GT+ PE T
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340
Query: 809 EKSDVYSFGVVMLE-------LITAKQPIEKGKY---VVREVRTAMNRDDE 849
D++S G+V+ E L +A + E+ Y ++R +R A DE
Sbjct: 341 PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391
|
Length = 461 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 51/194 (26%), Positives = 79/194 (40%), Gaps = 22/194 (11%)
Query: 646 GMLSDGQVVAIKRAQQGSMQGGLEFKTEI--ELLSRVHH--KNLVGLVGFCFEQGEQMLV 701
G++ +V R QQ + GL +E E L+ + H N+V L + + LV
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLV 63
Query: 702 YEFMANGTLRESLSGRSGIHLD----WKRRLRIALGSARGLAYLHELANPPIIHRDVKST 757
+ G L +S I + W + +AL + LH I+ RD+
Sbjct: 64 LQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA------LHREG---IVCRDLNPN 114
Query: 758 NILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 817
NILLD+ ++ F V DS G + Y PE + TE D +S G
Sbjct: 115 NILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEETEACDWWSLG 169
Query: 818 VVMLELITAKQPIE 831
++ EL+T K +E
Sbjct: 170 AILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-04
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 16/112 (14%)
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
I G+ RGL YLH+ IHR++K+++IL+ + V+ GLS L S G +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGD--GLVSLSGLSHLYSLVRNGQKAKV 160
Query: 790 V-------KGTMGYLDPEYYMTQQL---TEKSDVYSFGVVMLELITAKQPIE 831
V + +L PE + Q L KSD+YS G+ EL T + P +
Sbjct: 161 VYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 6e-04
Identities = 22/82 (26%), Positives = 40/82 (48%), Gaps = 2/82 (2%)
Query: 266 VNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSL 324
++ L L + L+G P D+S++ L ++LS NS P ++ SL L + S
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR-GNIPPSLGSITSLEVLDLSYNSF 478
Query: 325 QGRVPDKLFSYSQIQQVKLRNN 346
G +P+ L + ++ + L N
Sbjct: 479 NGSIPESLGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 60/253 (23%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 627 NNFSESNEIGSGGYGKV-YRGMLSDGQVVAIKRAQQGSMQGGLEF---KTEIELLSRVHH 682
+F IG G +G+V G++ A+K + M + K E ++L+
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 683 KNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+V L + F+ + + L+ EF+ G L L D R +A + +
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR-FYMA-ECVLAIEAV 117
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLS-------------------------- 775
H+L IHRD+K NIL+D K++DFGLS
Sbjct: 118 HKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174
Query: 776 ---KLVSD------SSKGHVSTQVK----------GTMGYLDPEYYMTQQLTEKSDVYSF 816
+ D SSK ++T K GT Y+ PE ++ Q ++ D +S
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234
Query: 817 GVVMLELITAKQP 829
G +M E + P
Sbjct: 235 GAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 27/93 (29%), Positives = 50/93 (53%), Gaps = 1/93 (1%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123
S + L LS L+G++ ++ +L SLDLS+N L+G + ++ L+ L L+
Sbjct: 499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ-LSGQIPASFSEMPVLSQLDLSQN 557
Query: 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS 156
+G IP +GN+ L + ++ N+ G +P +
Sbjct: 558 QLSGEIPKNLGNVESLVQVNISHNHLHGSLPST 590
|
Length = 968 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.002
Identities = 38/137 (27%), Positives = 58/137 (42%), Gaps = 31/137 (22%)
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDW------------------KRRLRIALGS 734
F +G Q LV++F ++ TL ++L G+ G KR + + G
Sbjct: 255 FTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGV 314
Query: 735 AR----GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
R GL LH + I+HRD+K N+L+ + K+ DFG + D G
Sbjct: 315 MRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAA---VDMCTG---INF 365
Query: 791 KGTMGYLDPEYYMTQQL 807
G LDP Y ++L
Sbjct: 366 NPLYGMLDPRYSPPEEL 382
|
Length = 507 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.003
Identities = 56/262 (21%), Positives = 93/262 (35%), Gaps = 44/262 (16%)
Query: 198 FNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN----IPESLGYVQTLEVL-------- 245
L + +L + L + +GN L + +L +L+ L
Sbjct: 5 LKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETG 64
Query: 246 RLDRNALTGKVPTNLNNLTNVNELNLAHN----DLKGPFPDLSQMNSLSYVDLSNNSFDP 301
R+ R + L + EL+L+ N D G L + +SL + L+NN
Sbjct: 65 RIPRG--LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGD 122
Query: 302 TEAPLWFSTL----PSLTTLICEFGSLQGR----VPDKLFSYSQIQQVKLRNNAFNN--- 350
L L P+L L+ L+G + L + ++++ L NN +
Sbjct: 123 RGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGI 182
Query: 351 -TLDMGNAVGPLLQLVDLQNNQIS-------AITLGSGIKNYTLILVGNPV---CTATLA 399
L G L+++DL NN ++ A TL S L L N + A LA
Sbjct: 183 RALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALA 242
Query: 400 NTNYCQLQQPTTKAYSTSLANC 421
+ L P + SL+
Sbjct: 243 S----ALLSPNISLLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 964 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.98 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.73 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.71 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.7 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.69 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.45 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.36 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.33 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.32 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.3 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.29 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.18 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.99 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.93 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.89 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.83 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.79 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.78 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.69 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.59 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.58 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.56 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.49 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.38 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.37 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-81 Score=797.18 Aligned_cols=834 Identities=26% Similarity=0.399 Sum_probs=494.0
Q ss_pred hccCCCHHHHHHHHHHHHHcCCC---CCCCCCCCCCCCCCccEEecC-CCeeEEEcCCCCccccccCCcCCCCcccEEec
Q 002121 20 ISSATDSRDAAALQSLKDAWQNT---PPTWKNSDDPCGSWEGVTCNN-SRVTALGLSTMGLTGKLSGDIGGLTELRSLDL 95 (964)
Q Consensus 20 ~~~~~~~~~~~aL~~~k~~~~~~---~~~W~~~~~~C~~w~gv~C~~-~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L 95 (964)
..+..++.|+.||++||+++.+. ..+|...+++| .|.||.|++ ++|+.|+|++++++|.++..+..+++|+.|+|
T Consensus 22 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 22 NFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100 (968)
T ss_pred HccCCCHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence 34455779999999999999643 26897666665 999999974 79999999999999999999999999999999
Q ss_pred ccCCCCCCCCCCCCC-CcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccc
Q 002121 96 SYNGGLTGSLSPRIG-DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174 (964)
Q Consensus 96 ~~N~~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 174 (964)
++| .+.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.
T Consensus 101 s~n-~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~ 177 (968)
T PLN00113 101 SNN-QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177 (968)
T ss_pred CCC-ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCccc
Confidence 999 78888888765 888888888888888877775 45677777777777777777777777777777777777777
Q ss_pred cccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCcc
Q 002121 175 GSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG 254 (964)
Q Consensus 175 g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 254 (964)
+.+| ..+..+++|++|+|++|.+.+.+|.. +..+.+|++|++++|++++.+|..++++++|+.|+|++|.+++
T Consensus 178 ~~~p------~~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 250 (968)
T PLN00113 178 GKIP------NSLTNLTSLEFLTLASNQLVGQIPRE-LGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG 250 (968)
T ss_pred ccCC------hhhhhCcCCCeeeccCCCCcCcCChH-HcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc
Confidence 6666 34566677777777777776666543 3455667777777777776667666777777777777777766
Q ss_pred ccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhcc
Q 002121 255 KVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF 333 (964)
Q Consensus 255 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 333 (964)
.+|..|.++++|++|+|++|.+++..| .+..+++|++|+|++|.+. ...|..+..+++|+.|+|++|.+.+.+|..+.
T Consensus 251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~-~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~ 329 (968)
T PLN00113 251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLS-GEIPELVIQLQNLEILHLFSNNFTGKIPVALT 329 (968)
T ss_pred ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeec-cCCChhHcCCCCCcEEECCCCccCCcCChhHh
Confidence 666667667777777777776666544 3566666666666666665 44555666666666666666666666666666
Q ss_pred CCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC---CCcccceeEeecCCcccccc------cccC--
Q 002121 334 SYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG---SGIKNYTLILVGNPVCTATL------ANTN-- 402 (964)
Q Consensus 334 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~---~~~~l~~l~l~~Np~c~~~l------~~~~-- 402 (964)
.+++|+.|+|++|++.+.+|..+..+++|+.|+|++|+++...+. ....+..|++.+|++....- ..+.
T Consensus 330 ~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L 409 (968)
T PLN00113 330 SLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRV 409 (968)
T ss_pred cCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEE
Confidence 666666666666666666666666666666666666665532211 11122333333333211000 0000
Q ss_pred ---ccccCCCCC----------cccccccccCCCCC-------CCCCCCCCCCceeEe--------eeeeeeEEEeCCCC
Q 002121 403 ---YCQLQQPTT----------KAYSTSLANCGGKS-------CPPEQKLSPQSCECA--------YPYEGTMYFRGPSF 454 (964)
Q Consensus 403 ---~~~~~~~~~----------~~~~~~~~~c~~~~-------~~~~~~~~~~~~~c~--------~~~~~~~~~~~~~~ 454 (964)
.|......+ ..........+..+ .......+ .|.-. .+.-..+.+.+..+
T Consensus 410 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~--~n~~~~~~p~~~~~~~L~~L~ls~n~l 487 (968)
T PLN00113 410 RLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA--RNKFFGGLPDSFGSKRLENLDLSRNQF 487 (968)
T ss_pred ECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECc--CceeeeecCcccccccceEEECcCCcc
Confidence 000000000 00000000000000 00000000 00000 00001111111111
Q ss_pred C-----CCCCchhHhhHHHHHHHHhCcccc---------eEEeecccccC--------Ccc---eeEEEeec----CCCc
Q 002121 455 R-----ELSNVTVFHSLEMSLWVKLGLTPG---------SVFLQNPFFNI--------DDY---LQIQVALF----PSGE 505 (964)
Q Consensus 455 ~-----~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~--------~~~---~~~~~~~~----~~~~ 505 (964)
. .+.+++....++.+-....+..|. ...+.++.... -.+ +.+.-+.+ |..-
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 0 000000000000000000000000 11222211110 000 00000000 1100
Q ss_pred ceeeccceeeeeeEeecceeCCCcccCCcc-------------cccCCcccccCC-CC--CCCCcceeehhHHHHHHHHH
Q 002121 506 KSFNRSEVQKIGFELSNQTYKPPKEFGPYY-------------FIASPYAFQVPQ-GG--NSISPGVAAGIACGGAVLVL 569 (964)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~-~~--~~~~~~~i~~~~~~~~~~~~ 569 (964)
.. .+.. ..+.++++....+.+....+ .+..+.....++ .. ....+.++++++++++ +++
T Consensus 568 ~~--l~~L--~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~-~~~ 642 (968)
T PLN00113 568 GN--VESL--VQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAF-LVL 642 (968)
T ss_pred hc--Cccc--CEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHH-HHH
Confidence 00 0000 01122222222111111000 000000000110 11 1112233333333332 233
Q ss_pred HHHHHHHHHhhhhhhhhhhcCCCCCCCcCCCCCCCCCCCCCCCCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEe-
Q 002121 570 GLVGLGLYAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGML- 648 (964)
Q Consensus 570 ~l~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~- 648 (964)
++++++++++|+|++.+. .........|... .........++++++. ..|...+.||+|+||.||+|+.
T Consensus 643 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~ 712 (968)
T PLN00113 643 ALVAFGFVFIRGRNNLEL-KRVENEDGTWELQ------FFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSI 712 (968)
T ss_pred HHHHHHHHHHHhhhcccc-ccccccccccccc------ccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEEC
Confidence 333333333333322111 1111000111100 0000112234555544 4577888999999999999996
Q ss_pred cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHH
Q 002121 649 SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL 728 (964)
Q Consensus 649 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~ 728 (964)
.+|..||||+++..... ..+|++++++++|||||+++|+|.+.+..++|||||++|+|.++++ .++|.++.
T Consensus 713 ~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~ 783 (968)
T PLN00113 713 KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-----NLSWERRR 783 (968)
T ss_pred CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHH
Confidence 57899999998754322 2356899999999999999999999999999999999999999996 38999999
Q ss_pred HHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCC
Q 002121 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808 (964)
Q Consensus 729 ~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 808 (964)
+++.|+|+||+|||..+.++|+||||||+||+++.++.+++. ||.+...... ....||+.|+|||++.+..++
T Consensus 784 ~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~ 856 (968)
T PLN00113 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDIT 856 (968)
T ss_pred HHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCC
Confidence 999999999999997766779999999999999999998886 6665433211 123588999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCC----CchhHHHHHHHhccCcccccccccccCccchhh---hHHHHHHHHHHHHHhh
Q 002121 809 EKSDVYSFGVVMLELITAKQPIEK----GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT---VLLGFRRYLELALQCV 881 (964)
Q Consensus 809 ~~sDv~S~Gvvl~elltg~~p~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~---~~~~~~~l~~li~~cl 881 (964)
.++|||||||++|||+||+.||+. .....+|.+....... ....+|+.+... ...+..++.+++.+||
T Consensus 857 ~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl 931 (968)
T PLN00113 857 EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH-----LDMWIDPSIRGDVSVNQNEIVEVMNLALHCT 931 (968)
T ss_pred cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc-----hhheeCccccCCCCccHHHHHHHHHHHHhhC
Confidence 999999999999999999999853 2334555544332221 333445444221 3345567889999999
Q ss_pred hcCCCCCCCHHHHHHHHHHHHH
Q 002121 882 EESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 882 ~~dP~~RPs~~evl~~L~~~~~ 903 (964)
+.||++||+|+||++.|+++.+
T Consensus 932 ~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 932 ATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred cCCchhCcCHHHHHHHHHHhhc
Confidence 9999999999999999998764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=483.21 Aligned_cols=284 Identities=54% Similarity=0.913 Sum_probs=249.6
Q ss_pred CcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEE
Q 002121 613 GARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692 (964)
Q Consensus 613 ~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 692 (964)
..+.|+++|++.||++|+..+.||+|+||.||+|.+++|+.||||++.........+|.+|++++++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 46779999999999999999999999999999999999999999988765543145699999999999999999999999
Q ss_pred EeeC-ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 693 FEQG-EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 693 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
.+.+ +.+||||||++|+|.++|+.....+++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999987643889999999999999999999999989999999999999999999999999
Q ss_pred cccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC-----CchhHHHHHHHhcc
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK-----GKYVVREVRTAMNR 846 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~-----~~~~~~~~~~~~~~ 846 (964)
||+|+..+.... ...+...||.+|+||||+..+..+.|+|||||||+++||+||++|.+. ...+.+|....+..
T Consensus 221 FGLa~~~~~~~~-~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 221 FGLAKLGPEGDT-SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred ccCcccCCcccc-ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 999976543111 111111799999999999999999999999999999999999998873 23478888777766
Q ss_pred CcccccccccccCccch-hhhH--HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 847 DDEEHYGLTEMMDPTIR-NTVL--LGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~-~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.. +.+++|+.+. .... .++.++.+++.+|++.+|++||+|.||+++|+.+.
T Consensus 300 ~~-----~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 300 GK-----LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cc-----hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 64 8899999986 4433 67888999999999999999999999999996654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=422.60 Aligned_cols=405 Identities=28% Similarity=0.396 Sum_probs=284.7
Q ss_pred CCCCCCC-chhHhhHHHHHHHHhCcccc-eEEeecccccCC------cceeEEEeec-----------------CCCcce
Q 002121 453 SFRELSN-VTVFHSLEMSLWVKLGLTPG-SVFLQNPFFNID------DYLQIQVALF-----------------PSGEKS 507 (964)
Q Consensus 453 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~~~-----------------~~~~~~ 507 (964)
+|.+++- +.+.+..+++||.++.+... .+||++||+.+. .+++.+.|+| +.|+|.
T Consensus 29 sf~~Gd~~~~~~~~~~~~Ww~ar~~~~~~~g~ip~N~v~~~~~~~~~~~l~~~~Wf~~~isR~~ae~~ll~p~~~~G~fl 108 (468)
T KOG0197|consen 29 SFRKGDVVLILLETTNGDWWRARSLQLGQEGYIPSNYVARNRGSPAFIKLSDEPWFFGKISREEAERQLLAPENKEGAFL 108 (468)
T ss_pred ccccCceEEEeeccCChhHHHHHHhhcCCCCcCcCceeeccccCCCccccccCCchhccccHHHHHHhhcCCCCCcccee
Confidence 3555555 66677888999998888544 689999999998 9999999999 559999
Q ss_pred eeccceeeeeeEeecceeCCCc--ccCCcccccCCcccccCCCCCCCCcceeehhHHHHHHHHHHHHHHHHHHhhhhhhh
Q 002121 508 FNRSEVQKIGFELSNQTYKPPK--EFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRA 585 (964)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~r~ 585 (964)
++.|+..+..+.++.++..... .....|-+- .- ...+..+. +... ..+-.+--+.-+. +..+.
T Consensus 109 vR~se~~~g~yslsv~~~~~~~~~~~v~hyri~-----~~--~~~~~~~~----~~~~--~~F~~l~~lv~~~--~~~~~ 173 (468)
T KOG0197|consen 109 VRESESDKGDYSLSVREGDSGGLGAKVKHYRIR-----QL--DGGGLYPY----IDER--ELFSSLQQLVNYY--SKNAD 173 (468)
T ss_pred eecccCCcCCeeEEEEeccccCCccceeeeeee-----Ec--CCCCeecC----CCHH--HhhhhHHHHHhhh--hccCc
Confidence 9999999999998877754221 000111000 00 00000000 0000 0000000001111 01111
Q ss_pred hhhcCCCCCCCcCCCCCCCCCCCCCC----CCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecC
Q 002121 586 ERAIGLSKPFASWAPSGKDSGGAPQL----KGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQ 661 (964)
Q Consensus 586 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~ 661 (964)
.-......|.....+ ..|+. .+.-.+..+++. ..+.||+|.||.||.|.++....||+|.++.
T Consensus 174 gl~~~l~~p~~~~~~------~~p~~~~~~~d~wei~r~~l~-------l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~ 240 (468)
T KOG0197|consen 174 GLCTRLRDPCSKQGH------TKPQTPDLARDPWEIPREELK-------LIRELGSGQFGEVWLGKWNGSTKVAVKTIKE 240 (468)
T ss_pred chhhcccCchhccCC------CCCCCCccccCCeeecHHHHH-------HHHHhcCCccceEEEEEEcCCCcccceEEec
Confidence 000011111111000 11111 122234444444 4578999999999999998777999999987
Q ss_pred CCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHH
Q 002121 662 GSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741 (964)
Q Consensus 662 ~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL 741 (964)
.... .+.|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|.++|....+..+...+.+.++.|||+||+||
T Consensus 241 ~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YL 319 (468)
T KOG0197|consen 241 GSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYL 319 (468)
T ss_pred cccC-hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHH
Confidence 6444 357889999999999999999999999988999999999999999999986677899999999999999999999
Q ss_pred hhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHH
Q 002121 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVML 821 (964)
Q Consensus 742 H~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ 821 (964)
++++ +|||||.++||||+++..+||+||||||...++ .........-...|.|||.+..+.++.|||||||||+||
T Consensus 320 es~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~ 395 (468)
T KOG0197|consen 320 ESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLW 395 (468)
T ss_pred HhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHH
Confidence 9988 999999999999999999999999999955433 333444445577899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 822 ELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 822 ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
||+| |+.|+.. ....+ +...+.++.. + + .+..+...+.+++..||+.+|++|||++.+...+++
T Consensus 396 E~fT~G~~py~~-msn~e-v~~~le~GyR----l--------p-~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 396 ELFTYGRVPYPG-MSNEE-VLELLERGYR----L--------P-RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred HHhccCCCCCCC-CCHHH-HHHHHhccCc----C--------C-CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 9999 7777643 22222 2233333221 1 0 012234567799999999999999999999999888
Q ss_pred HHHhC
Q 002121 901 LLQND 905 (964)
Q Consensus 901 ~~~~~ 905 (964)
+....
T Consensus 461 ~~~~~ 465 (468)
T KOG0197|consen 461 FFTST 465 (468)
T ss_pred hhhcc
Confidence 76543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=414.71 Aligned_cols=257 Identities=37% Similarity=0.535 Sum_probs=212.4
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEeeC-ceEEEEEeccCC
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQG-EQMLVYEFMANG 708 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~~g 708 (964)
.+.||+|+||+||+|.++....||||++....... .++|.+|+.+|++++|||||+++|+|.+.. ..++|||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 35599999999999999754459999998654433 458999999999999999999999999887 799999999999
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeecCCCCCcee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~ 787 (964)
+|.++++......+++..+++||.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccc
Confidence 99999988545689999999999999999999999763 99999999999999998 99999999998765432 233
Q ss_pred ecccccCcccCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 788 TQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
+...||+.|||||++. ...|+.|+|||||||++|||+||+.||..-.. .+.......... .+.+...
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~----------Rp~~p~~ 270 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGL----------RPPIPKE 270 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCC----------CCCCCcc
Confidence 4468999999999999 56999999999999999999999999986554 332222221111 1111111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
....+..++.+||+.||++||++.|++..|+.+.....
T Consensus 271 ---~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 271 ---CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred ---CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 23556789999999999999999999999999887554
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=378.72 Aligned_cols=251 Identities=26% Similarity=0.449 Sum_probs=209.5
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
++.+|++. .+.||+|..|+|||++++ +++.+|+|++.... ....+++.+|++++++.+||+||+++|.|..
T Consensus 76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 56667765 478999999999999965 78999999995443 3345689999999999999999999999999
Q ss_pred eC-ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 695 QG-EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 695 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
++ ...++||||++|||++.+...+ .+++...-+|+.+|++||.|||+ ++ ||||||||+|||++..|++|||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccc
Confidence 98 4999999999999999998653 58999999999999999999996 55 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC----chhHHHHHHHhccCc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG----KYVVREVRTAMNRDD 848 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~----~~~~~~~~~~~~~~~ 848 (964)
|.++.+.+. .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+... ....+.+..++...+
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 999887654 334567999999999999999999999999999999999999999653 233333333333222
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
|+++.. ....++..++..|+++||.+||+++|+++
T Consensus 300 -----------P~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 -----------PRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred -----------CCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222221 23356778999999999999999999976
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=398.87 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=210.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..|...+.||+|||++||+++. ..|+.||+|++.+.. ...++.+.+||++.++|+|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4688899999999999999996 889999999987632 334567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|+|++|+|.++++.+ .++++.++..+..||+.||.|||+++ |||||||-.|++|++++++||+|||||..+..++
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 999999999999854 48999999999999999999999988 9999999999999999999999999999886543
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
. .....+|||.|+|||++....++..+||||+|||+|-||.|++||+.. .+.+-+..+...+ |..+..+.
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-~vkety~~Ik~~~----Y~~P~~ls--- 242 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-TVKETYNKIKLNE----YSMPSHLS--- 242 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-hHHHHHHHHHhcC----cccccccC---
Confidence 2 234578999999999999999999999999999999999999999643 3333333333222 22222211
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..-.+||.++|+++|.+|||+.+|+.
T Consensus 243 --------~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 243 --------AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred --------HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22348999999999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=377.78 Aligned_cols=199 Identities=31% Similarity=0.497 Sum_probs=179.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..+|...+.||+|+||+||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||.+++++..++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 357778888999999999999964 6899999998765 3445566889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC------CcEEEeecccce
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN------LTAKVADFGLSK 776 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~------~~~kl~DFGla~ 776 (964)
|||.+|+|.+|++.++ .+++.....++.|+|.||++||+.+ ||||||||.||||+.. -.+||+|||+||
T Consensus 89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999999999875 6899999999999999999999988 9999999999999764 468999999999
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
.+.+. ......+|++.|||||+++.++|+.|+|+||+|+++|||++|+.||+.
T Consensus 164 ~L~~~---~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQPG---SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCCch---hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 98754 334568999999999999999999999999999999999999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=379.64 Aligned_cols=253 Identities=24% Similarity=0.377 Sum_probs=202.4
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcch-------hHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG-------GLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
.+.|-..+.||+|+||.|-+|. .++|+.||||+++...... ....++|+++|++++|||||++++++...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 4567778999999999999998 5689999999987543221 1235799999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC---CcEEEeeccc
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN---LTAKVADFGL 774 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGl 774 (964)
.|+|||||+||+|.+.+..++ .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|||+
T Consensus 251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999998765 5777778899999999999999999 9999999999999655 8899999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCC---CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL---TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
|+..... ..+...+||+.|.|||++.++.+ ..++|+||+||+||-+++|.+||...........++.....
T Consensus 326 AK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y--- 399 (475)
T KOG0615|consen 326 AKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRY--- 399 (475)
T ss_pred hhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcc---
Confidence 9987633 45677899999999999986543 34889999999999999999999743322212222221111
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
. +.|..+.. -..+..++|.+||..||++||++.|+++.
T Consensus 400 -~----f~p~~w~~---Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 400 -A----FGPLQWDR---ISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred -c----ccChhhhh---hhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 1 11111211 22445689999999999999999999863
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=361.00 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=205.8
Q ss_pred CCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeE-EEEeeC-ceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVG-FCFEQG-EQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~-~~~lV~ 702 (964)
+|.+.++||+|.||+|||++ ..+|..||.|.++-... +.+.....|+.+|++++|||||++++ -+.++. ..+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46667899999999999999 57899999999874333 34456889999999999999999998 444444 489999
Q ss_pred EeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcC-CCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 703 EFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELA-NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|||..|+|.++++.- ++..+++..++++..|+++||.++|..- ...|+||||||.||+|+.+|.+||+||||++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999998642 3557999999999999999999999832 1238999999999999999999999999999886
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... ......+|||.||+||.+....|+.||||||+||++|||+.-++||... ++.+.-+.+.+.+.
T Consensus 180 s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-n~~~L~~KI~qgd~----------- 245 (375)
T KOG0591|consen 180 SKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-NLLSLCKKIEQGDY----------- 245 (375)
T ss_pred chh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-cHHHHHHHHHcCCC-----------
Confidence 543 3445678999999999999999999999999999999999999999654 44433333222211
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
+.+++ .-+...+.++|..|+..||+.||+...++..++.
T Consensus 246 ~~~p~--~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPD--EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcH--HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11221 2233567789999999999999996555555444
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=405.75 Aligned_cols=262 Identities=31% Similarity=0.495 Sum_probs=219.7
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
+.+....+.||+|+||+||+|+.. +.+.||||.++..... .+.+|++|++++..++|||||+|+|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344555688999999999999853 3467999999987665 678999999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCC--------CC----ccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc
Q 002121 699 MLVYEFMANGTLRESLSGRS--------GI----HLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~--------~~----~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
++|+|||..|||.++|..++ +. +++..+.+.||.|||.||+||-++. +|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 99999999999999997543 22 3889999999999999999999988 999999999999999999
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhc
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 845 (964)
|||+||||+|.+-..++++......-.++|||||.+..++++.+||||||||||||++| |+.||..-.+ +++...+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--~EVIe~i~ 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--QEVIECIR 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--HHHHHHHH
Confidence 99999999998877776665555667889999999999999999999999999999999 8999863221 22222222
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
... +......+..++.+|+..||+..|++||+++||-..|+.+.+..
T Consensus 720 ~g~-------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 720 AGQ-------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred cCC-------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 221 22223344567889999999999999999999999999886543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=384.57 Aligned_cols=269 Identities=28% Similarity=0.446 Sum_probs=221.0
Q ss_pred cHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEee
Q 002121 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 695 (964)
Q Consensus 618 ~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 695 (964)
+.+++....+++.+...||+|.||+||+|.|. -.||||+++..... ..+.|++|+.++++-+|.||+-|.|||..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 33566666677777899999999999999985 36999999865443 346799999999999999999999999987
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
.. .+|+.+|+|-+|+.++|..+ ..++..+.+.||.|||+|+.|||.++ |||||||+.||+|++++.|||+|||++
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLa 535 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLA 535 (678)
T ss_pred ce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccce
Confidence 77 99999999999999999765 57999999999999999999999998 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 852 (964)
................|...|||||+++.+ +|++.+||||||+|+|||+||..||. ....+++.-++.++.
T Consensus 536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys--i~~~dqIifmVGrG~---- 609 (678)
T KOG0193|consen 536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS--IQNRDQIIFMVGRGY---- 609 (678)
T ss_pred eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC--CCChhheEEEecccc----
Confidence 876554333444556788999999999753 68999999999999999999999996 222233222222221
Q ss_pred ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
+.++.......+.+.+.+|+..||..++++||.+.+++..|+.++..
T Consensus 610 -----l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 -----LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred -----cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 12233333444556778999999999999999999999999988763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=362.87 Aligned_cols=242 Identities=24% Similarity=0.353 Sum_probs=202.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|+..+.||+|+||+||.++. ++++.+|+|++++.... +.+...+|..+|.+++||.||+++..|.+.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 35788999999999999999995 56899999999865432 345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
+||+.||.|..+|.+.+ .+++..+..++..|+.||.|||+.+ ||||||||+|||||++|+++|+||||++..-..
T Consensus 104 ld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999998764 6899999999999999999999999 999999999999999999999999999864332
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
+ ..+...+||+.|||||++.+..|+..+|.||+||++|||++|.+||.. .+...++..+....... ....++
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~-~~~~~~~~~I~~~k~~~---~p~~ls-- 250 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA-EDVKKMYDKILKGKLPL---PPGYLS-- 250 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC-ccHHHHHHHHhcCcCCC---CCccCC--
Confidence 2 234457999999999999999999999999999999999999999964 34444444444333110 111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRP 889 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RP 889 (964)
....+++.+.+..||++|-
T Consensus 251 ---------~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 251 ---------EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---------HHHHHHHHHHhccCHHHhc
Confidence 3345899999999999995
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=368.26 Aligned_cols=263 Identities=23% Similarity=0.337 Sum_probs=213.1
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcch-hHHHHHHHHHHHhcC-CCCccceeEEEEeeC-ceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVH-HKNLVGLVGFCFEQG-EQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lV 701 (964)
.++|...++||.|+||.||+|+ ..+|..||||+++.....- +..=.+|+..|+++. |||||++.+++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4578888999999999999999 5679999999998654332 223468999999998 999999999999988 89999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||||+. +|+++++.+ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||.+...
T Consensus 89 fE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccC
Confidence 999975 999999987 678999999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCceeecccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC-------cccccc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD-------DEEHYG 853 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~ 853 (964)
. ..+..+.|.+|.|||++. .+-|+.+.|+||+|||++|+.+-++-| .|.+..+++..+..-- +.+.+.
T Consensus 164 p---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF-PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 164 P---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF-PGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred C---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC-CCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 3 346678899999999975 678999999999999999999987555 5666666665554311 111111
Q ss_pred cccccCcc--------chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMDPT--------IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d~~--------l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+...+.-. +.........+.++++.+|++.||.+||||.|+++.
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 22222222 222223344667899999999999999999999864
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=363.27 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=207.9
Q ss_pred cCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 701 (964)
+.|+.+++||+|.||.||+|+ ..+|+.||+|++..... .......+||.+|++++||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 456667889999999999999 57899999999876543 3334578999999999999999999999887 689999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
+|||+. +|.-++... +..++..++..++.|++.||+|||..+ |+|||||.+|||||.+|.+||+|||||+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999998 888888754 467999999999999999999999999 999999999999999999999999999988655
Q ss_pred CCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcccccccccc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHYGLTEM 857 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 857 (964)
.. ...+..+-|.+|.|||.+.+ ..|+.++|+||.||||.||++|++.|. +...++++..++. ...+..+....+
T Consensus 272 ~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~-G~tEveQl~kIfklcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 272 GS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ-GRTEVEQLHKIFKLCGSPTEDYWPVSKL 349 (560)
T ss_pred CC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC-CccHHHHHHHHHHHhCCCChhccccccC
Confidence 43 33566778999999999986 579999999999999999999997774 4555555554433 222222111111
Q ss_pred -----cCcc------chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 -----MDPT------IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 -----~d~~------l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+. +.+.........++|+..+|..||.+|.|+.++++
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111 11111111134578999999999999999999875
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=370.37 Aligned_cols=249 Identities=25% Similarity=0.397 Sum_probs=213.0
Q ss_pred cCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
..|....+||+|+.|.||.|. ..+++.||||++.......++-+.+|+.+|+..+|+|||++++.|..+++.|.|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 356667889999999999998 5678999999998877777777899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+.+... .+++.++..|+.++++||+|||..+ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 999999998764 4999999999999999999999998 99999999999999999999999999998866543
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....+||+.|||||++....|++|+||||||++++||+-|.+||..+..+......+....++ ....+.+
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~--lk~~~kl------- 495 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK--LKNPEKL------- 495 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC--cCCcccc-------
Confidence 3455789999999999999999999999999999999999999998765555444433322221 0111111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+||+.|+++||++.|+++
T Consensus 496 ----S~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 496 ----SPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ----CHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 245668999999999999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=341.53 Aligned_cols=262 Identities=23% Similarity=0.326 Sum_probs=203.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
+.|+...++|+|+||+|||++.+ +|+.||||++...... -.+-..+|+++|++++|+|+|.++++|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 35677789999999999999965 6999999999764432 23446799999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||+.--|.++-+.. ..++...+.+++.|+++|+.|+|+++ +|||||||+|||++.+|.+||||||+|+.+....
T Consensus 82 ~~dhTvL~eLe~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg- 155 (396)
T KOG0593|consen 82 YCDHTVLHELERYP--NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG- 155 (396)
T ss_pred ecchHHHHHHHhcc--CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc-
Confidence 99985554443332 35788899999999999999999988 9999999999999999999999999999887432
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh--------------ccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM--------------NRDD 848 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~--------------~~~~ 848 (964)
...+..+.|.+|.|||.+.+ .+|...+||||+||++.||++|.+-|. +.+.++++..+. ...+
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P-G~SDiDQLy~I~ktLG~L~prhq~iF~~N~ 233 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP-GRSDIDQLYLIRKTLGNLIPRHQSIFSSNP 233 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC-CcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence 34566789999999999886 789999999999999999999997764 344333332221 1111
Q ss_pred cc-ccccccccCcc-chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EE-HYGLTEMMDPT-IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~-~~~~~~~~d~~-l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. ...+++.-+++ +....+....-+++++..|++.||++|++-+|++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 10 01122222222 11122333345789999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=359.14 Aligned_cols=254 Identities=28% Similarity=0.454 Sum_probs=201.8
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC--ceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--EQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~E~ 704 (964)
++...+.||+|+||+||++... +|+..|||..........+.+.+|+.+|++++|||||+.+|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4566789999999999999964 59999999887654333456899999999999999999999855544 58999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccceeecC-CC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSD-SS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~-~~ 782 (964)
+++|+|.+++...++ .+++..+..++.||++||+|||+++ ||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred cCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 999999999998776 7999999999999999999999988 999999999999999 79999999999987653 11
Q ss_pred CCceeecccccCcccCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.........||+.|||||++..+. ...++||||+||++.||+||++||........++........ -|.
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~----------~P~ 243 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS----------LPE 243 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC----------CCC
Confidence 112234567999999999999643 335999999999999999999999753222222222221211 112
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
++.... ....+++.+|+..+|++||||.|+++..
T Consensus 244 ip~~ls---~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 244 IPDSLS---DEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CCcccC---HHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 222211 2344889999999999999999998753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=372.65 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=205.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEee-C
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ-G 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 696 (964)
.++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+.+|++++.++ +||||++++++|... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999974 2356899999875432 2345688999999999 899999999998764 4
Q ss_pred ceEEEEEeccCCChhhhhcCCC----------------------------------------------------------
Q 002121 697 EQMLVYEFMANGTLRESLSGRS---------------------------------------------------------- 718 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 718 (964)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999986532
Q ss_pred --CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcc
Q 002121 719 --GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796 (964)
Q Consensus 719 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 796 (964)
..++++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 124788899999999999999999988 999999999999999999999999999865433222222334567889
Q ss_pred cCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHH
Q 002121 797 LDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLE 875 (964)
Q Consensus 797 ~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 875 (964)
+|||++.+..++.++|||||||++|||++ |..||........ +...+..... ..... .....+.+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~~~----------~~~~~---~~~~~l~~ 308 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLKDGTR----------MRAPE---NATPEIYR 308 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHhcCCC----------CCCCC---CCCHHHHH
Confidence 99999999999999999999999999997 9999864332211 1121111110 00000 11235678
Q ss_pred HHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 876 LALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 876 li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
++.+||+.||++||++.|+++.|+.++++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=365.53 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=211.2
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC----Cc-chhHHHHHHHHHHHhcC-CCCccceeEEEEeeCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG----SM-QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 697 (964)
..+.|...+.||+|+||+||.|.. .+|+.||+|++... .. ...+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456888999999999999999984 57899999977653 11 22346778999999999 9999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeecccce
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLSK 776 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~ 776 (964)
.++||||+.+|+|.+++... .++.+.+..+++.|++.|++|||+.+ |+||||||+|||+|.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999874 36888999999999999999999998 9999999999999999 999999999999
Q ss_pred eecCCCCCceeecccccCcccCccccccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ-LT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+. .......+.+... .+.+
T Consensus 170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d-~~~~~l~~ki~~~----~~~~ 242 (370)
T KOG0583|consen 170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD-SNVPNLYRKIRKG----EFKI 242 (370)
T ss_pred ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC-ccHHHHHHHHhcC----CccC
Confidence 774 1223445678999999999999877 86 899999999999999999999986 3333333332222 1223
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
.+.++ ...+..++.+|+..+|.+|+++.|++ ...+++.
T Consensus 243 p~~~~----------S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 243 PSYLL----------SPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred CCCcC----------CHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 33331 24456899999999999999999998 4566655
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=376.25 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=215.4
Q ss_pred CCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
...+.++||.|.||.||+|+++- ...||||.++.... +.+.+|..|+.||.+..||||++|.|+.......++|+
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 34556899999999999999752 35799999997654 44568999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||+||+|+.+|+.+.+ ++++.+..-+.++||.||.||-+++ +|||||.++|||++.+..+|++|||++|.+.++.
T Consensus 710 EyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999998765 5999999999999999999999998 9999999999999999999999999999886554
Q ss_pred CC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 783 KG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 783 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. +.+..-.-..+|.|||.+..++++.+|||||||||+||.++ |.+||-+-. -+.+...++.+. .++.-+
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIkaIe~gy----RLPpPm-- 857 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKAIEQGY----RLPPPM-- 857 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHHHHhcc----CCCCCC--
Confidence 22 22222233578999999999999999999999999999887 999985321 122333332222 233222
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
++...+.+|++.||++|-.+||++.+++..|.+++++..
T Consensus 858 -------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 858 -------DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred -------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 344567899999999999999999999999999987653
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=360.81 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=208.3
Q ss_pred HHhhcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCc
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 697 (964)
++..++|...+.||+|+|++||+|+ ...++.+|||++.+.-. ...+-+..|-++|.+| .||.|++|+..|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4445788899999999999999999 45799999999865322 2223567899999999 89999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+|+||+++|+|.++|+..+ .+++.....+|.+|+.||+|||++| ||||||||+|||||+||++||+|||.|+.
T Consensus 149 LYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999998765 6899999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCC---------ce--eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc
Q 002121 778 VSDSSKG---------HV--STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 778 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 846 (964)
+.+.... .. ....+||..|++||++..+..++.+|+|+|||++|+|+.|.+||..... .-.++.++..
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-yliFqkI~~l 302 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-YLIFQKIQAL 302 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-HHHHHHHHHh
Confidence 7643221 11 1347899999999999999999999999999999999999999975432 2222222222
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. |.+.+.++ ....+|+.+.|..||.+|++.+++.+
T Consensus 303 ~----y~fp~~fp-----------~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 303 D----YEFPEGFP-----------EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred c----ccCCCCCC-----------HHHHHHHHHHHccCccccccHHHHhh
Confidence 2 12333222 33458999999999999999988865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=350.05 Aligned_cols=262 Identities=29% Similarity=0.435 Sum_probs=206.7
Q ss_pred CCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHh--cCCCCccceeEEEEeeC----ceEEEE
Q 002121 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSR--VHHKNLVGLVGFCFEQG----EQMLVY 702 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lV~ 702 (964)
....+.||+|.||.||||.+. ++.||||++... ..+.|++|-+|.+- ++|+||++++++-...+ +++||+
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 344577999999999999995 599999998643 34578888888775 48999999999877655 889999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc------CCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL------ANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
||.+.|+|.+||..+ .++|....+||..+++||+|||+. .+|+|+|||||++||||.+|+++.|+|||+|.
T Consensus 288 ~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl 364 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL 364 (534)
T ss_pred eeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence 999999999999876 499999999999999999999973 36889999999999999999999999999999
Q ss_pred eecCCCCCceeecccccCcccCccccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCC---------------ch
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVVMLELITAKQPIEKG---------------KY 835 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~elltg~~p~~~~---------------~~ 835 (964)
.+..+.........+||.+|||||++.+. ..-.+.||||+|.|||||++....++.+ ..
T Consensus 365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP 444 (534)
T KOG3653|consen 365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP 444 (534)
T ss_pred EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence 88765444444557899999999998653 1224789999999999999976544210 01
Q ss_pred hHHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 836 VVREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
-.+.++..+ +.+...|.+++. ....+..+.+.+..||++||+.|.|+.=|.+++.++..-..
T Consensus 445 t~e~mq~~V---------V~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 445 TLEEMQELV---------VRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred CHHHHHHHH---------HhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 112222222 222333444433 22556778899999999999999999999999888775443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-40 Score=346.86 Aligned_cols=262 Identities=27% Similarity=0.374 Sum_probs=209.8
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcch-hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.+.|....+||.|..++||+|+ .+.++.||||++....... .+.+++|+..|+.++||||++.+..|..+...|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3578889999999999999999 5678999999998655443 4789999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||.+||+.+.++..-...+++..+..|.+++++||.|||.+| .||||||+.||||+++|.+||+|||.+..+.+.+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999998765556999999999999999999999999 99999999999999999999999998876554332
Q ss_pred C-cee-ecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 784 G-HVS-TQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 784 ~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
. ... ....||+.|||||+++. ..|+.|+||||||++..||.+|..||..-... +.+...++..+... .....+
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-kvLl~tLqn~pp~~--~t~~~~ 258 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-KVLLLTLQNDPPTL--LTSGLD 258 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-HHHHHHhcCCCCCc--ccccCC
Confidence 1 112 45689999999999654 46899999999999999999999999643221 22222222222100 111111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. +........+.+++..|++.||++|||++++++
T Consensus 259 ~---d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 259 K---DEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred h---HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1 112223346789999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=327.62 Aligned_cols=269 Identities=25% Similarity=0.393 Sum_probs=213.2
Q ss_pred cCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.+|...+.+|+|.||.||+|+ ..+|+.||||+++.....+ .....+|++.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 356777899999999999999 5689999999998764443 2457899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||+- +|+..++.+. ..++-.++..++.++.+|++|||++. |+||||||.|+|++++|.+||+|||+|+.......
T Consensus 82 fm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9986 9999998764 57899999999999999999999988 99999999999999999999999999999876543
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc---Cc----ccccccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DD----EEHYGLT 855 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~----~~~~~~~ 855 (964)
. .+.-+-|.+|.|||.+.+ +.|+..+||||.||++.||+-|. |+..|++..+++..++.. .. .+-..+.
T Consensus 157 ~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 157 I--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred c--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 2 233367999999999876 57999999999999999999866 666777777666555432 11 1111111
Q ss_pred cccCcc------chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 856 EMMDPT------IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 856 ~~~d~~------l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+...-. .............+++..++..||.+|+++.|++++ ...+..
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~--~yf~~~ 287 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH--PYFKSL 287 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc--hhhhcC
Confidence 111111 111122333456899999999999999999999864 444433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.21 Aligned_cols=263 Identities=25% Similarity=0.408 Sum_probs=217.7
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcch-hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.....+.++||+|-||.|..++...+..||||+++...... +.+|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 44566678999999999999999888999999999876554 47899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
|++|+|.+++..+....+.-.....|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+|||++|-+-.++..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 99999999998775444566777889999999999999988 999999999999999999999999999987777777
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCC--chhHHHHHHHhccCcccccccccccCc
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQPIEKG--KYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt--g~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
+.....+-.++|||+|.+.-++++.++|||+|||++||+++ ...||..- +..++.....+......
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~---------- 763 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ---------- 763 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc----------
Confidence 77777778899999999999999999999999999999877 56787532 22222222222222110
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.....+..+...+.+++.+||..|-++||+++++...|++.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111223345677999999999999999999998887753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=357.01 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=209.8
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|.+.+.||+|+||+||||+.+ +++.||+|.+.+... ++.+.+++|++++++++|||||.++++|+...+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 689999999876443 334568999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+.+ +|..+|...+ .++++.+..|+.++..||.|||+.+ |+|||+||.|||++..|.+|+||||+|+.... .
T Consensus 82 ~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--N 153 (808)
T ss_pred hhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc--C
Confidence 9987 9999998754 6999999999999999999999988 99999999999999999999999999998754 3
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
..+.+.+.|||-|||||.+.++.|+..+|.||+||++||+++|++||.. ..+.+.++.+..+...
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-~si~~Lv~~I~~d~v~-------------- 218 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-RSITQLVKSILKDPVK-------------- 218 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-HHHHHHHHHHhcCCCC--------------
Confidence 4566788999999999999999999999999999999999999999953 3334444444333221
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.......+..++...+.+||.+|.+..+++.
T Consensus 219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 01123356778999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=328.26 Aligned_cols=236 Identities=25% Similarity=0.357 Sum_probs=200.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||.|+||+|..++.+ +|..+|+|+++....- ..+...+|..+|+.+.||+++++.+.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35667789999999999999954 6889999999765432 2345678999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||++||.|..+++..+ ++++.....+|.||+.||+|||+.+ |++||+||+|||+|.+|.+||+|||.|+.+...
T Consensus 124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999998765 6999999999999999999999988 999999999999999999999999999987532
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
+...+|||.|+|||++....|..++|.|||||++|||+.|.+||..... ...+..++...-. .+..+.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~~~v~----fP~~fs--- 265 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILEGKVK----FPSYFS--- 265 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHhCccc----CCcccC---
Confidence 4568999999999999999999999999999999999999999975443 4444444433321 222333
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCC
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDR 888 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~R 888 (964)
..+.+|+...++.|-.+|
T Consensus 266 --------~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 --------SDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------HHHHHHHHHHHhhhhHhh
Confidence 234478888888888888
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=364.37 Aligned_cols=265 Identities=29% Similarity=0.438 Sum_probs=210.9
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEecC--C---cEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEE
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLSD--G---QVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFC 692 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--g---~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 692 (964)
.++...++....+.||+|+||.||+|.+.. + ..||||..+... .....+|.+|+++|++++|||||+++|++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 344445566666999999999999999643 2 238999988532 34567899999999999999999999999
Q ss_pred EeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 693 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
......++|||+|.||+|.++|...++ .++..+++.++.++|+||+|||+.+ +|||||.++|+|++.++.+||+||
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999999987653 6999999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHh-ccCccc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAM-NRDDEE 850 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~-~~~~~~ 850 (964)
|+++.... .........-...|+|||.+..+.+++++|||||||++||+++ |..||..-... .++..+ ....
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~~~~~-- 380 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIVKNGY-- 380 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHHhcCc--
Confidence 99875431 1111112245689999999999999999999999999999999 78888643322 222222 1111
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
...... .....+..++.+||..+|+.||+|.++.+.++.+.....
T Consensus 381 ----r~~~~~-------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 ----RMPIPS-------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred ----cCCCCC-------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 001111 112445578889999999999999999999999887654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=347.44 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=205.2
Q ss_pred ccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcch---hHHHHHHHHHHHhcCCCCccceeEE
Q 002121 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG---GLEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 615 ~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
+.++.+|+.. .....||+|++|.||+|.+ +|+.||||+++...... .+.+.+|+++|++++|||||+++|+
T Consensus 13 ~~i~~~~i~~-----~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~ 86 (283)
T PHA02988 13 KCIESDDIDK-----YTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86 (283)
T ss_pred eecCHHHcCC-----CCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence 4455666632 2236799999999999998 68999999987654333 3567899999999999999999999
Q ss_pred EEe----eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCc
Q 002121 692 CFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 692 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
+.+ ....++||||+++|+|.+++.... .++|.....++.|++.||+|||+. + ++||||||+|||+++++.
T Consensus 87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~ 161 (283)
T PHA02988 87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYK 161 (283)
T ss_pred EEecccCCCceEEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCc
Confidence 977 346789999999999999997653 689999999999999999999974 5 789999999999999999
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 844 (964)
+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||.... ..+......
T Consensus 162 ~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~-~~~~~~~i~ 235 (283)
T PHA02988 162 LKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT-TKEIYDLII 235 (283)
T ss_pred EEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC-HHHHHHHHH
Confidence 9999999998654322 22458899999999976 689999999999999999999999997543 222222222
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
...... .++. .....+.+++.+||+.||++|||++|+++.|+.+.
T Consensus 236 ~~~~~~------~~~~-------~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 236 NKNNSL------KLPL-------DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred hcCCCC------CCCC-------cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 221110 0110 11245678999999999999999999999998764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=354.69 Aligned_cols=239 Identities=29% Similarity=0.468 Sum_probs=195.8
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
.++-||+|+.|.||+|+++ ++.||||+++.- -..+|+-|++|+||||+.|.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4577999999999999995 689999987642 23578889999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
++.|+..+ .+.-.....|..+||.||.|||.+. |||||||+-||||..+..+||+|||.++...+. .....+
T Consensus 200 ~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 200 YEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred HHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99998754 6888888999999999999999988 999999999999999999999999999876543 223457
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
+||..|||||+++..++++|+|||||||||||||||..||.+-+.. ..++.-. ...+.-.++ ..+.
T Consensus 272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVG-------sNsL~LpvP---stcP 337 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVG-------SNSLHLPVP---STCP 337 (904)
T ss_pred hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----eeEEecc-------CCcccccCc---ccCc
Confidence 8999999999999999999999999999999999999999642210 0000000 001111111 1222
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.-+.-|+++||+..|..||++.+++..|.
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 34557899999999999999999987764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=350.92 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=201.4
Q ss_pred cCCCccceeecCCcEEEEEEEecC-----------------CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccce
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD-----------------GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGL 688 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l 688 (964)
++|...++||+|+||.||+|.+++ +..||+|++...... ...+|.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999998532 347999998764332 34578999999999999999999
Q ss_pred eEEEEeeCceEEEEEeccCCChhhhhcCCC-----------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeec
Q 002121 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRS-----------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751 (964)
Q Consensus 689 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 751 (964)
++++.+.+..++||||+++|+|.+++.... ...++|.++.+++.|++.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885432 134788999999999999999999988 999
Q ss_pred cCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh--CCCC
Q 002121 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQP 829 (964)
Q Consensus 752 ~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt--g~~p 829 (964)
|||||+|||+++++.+||+|||+++...............++..|+|||++..+.++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999987654333222334456889999999988899999999999999999997 4566
Q ss_pred CCCCc--hhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 830 IEKGK--YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 830 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
|.... .....+.......... ...... ......+.+++.+||+.||++||++.||.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQ---VYLFRP-------PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhcccc---ccccCC-------CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 65322 1122222111111000 000000 111245779999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=362.25 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=203.7
Q ss_pred hcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 697 (964)
.++|+..+.||+|+||+||+|++ .++..||||+++.... ...+.+.+|+++++.+ +|||||+++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34677889999999999999973 2356899999875432 3345688999999999 89999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 002121 698 QMLVYEFMANGTLRESLSGRS----------------------------------------------------------- 718 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 718 (964)
.++|||||++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886432
Q ss_pred --------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 719 --------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 719 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
...++|..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 124789999999999999999999987 999999999999999999999999999876543322
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.......... ..+..... . ..+.
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~-~~~~~~~~----~---~~~~-- 340 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFY-KMIKEGYR----M---LSPE-- 340 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHH-HHHHhCcc----C---CCCC--
Confidence 22223345678999999999999999999999999999998 888886432221111 11211110 0 0001
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
....++.+++.+||+.||++||++.||++.|++.
T Consensus 341 ----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 ----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0124567999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.35 Aligned_cols=249 Identities=23% Similarity=0.347 Sum_probs=200.3
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|+..+.||+|+||+||+|.. .+|+.||+|++..... .....+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 367789999999999999995 5789999998864322 223457889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999998886554456899999999999999999999988 9999999999999999999999999998754322
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCcccccccccccCcc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......||..|+|||++.+..++.++|||||||++|||++|+.||...... .+.+........ ......
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 227 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ-------EEYSEK 227 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc-------ccCCcc
Confidence 223456999999999999999999999999999999999999999753321 111211111111 000111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
....+.+++.+||+.||++||+ ++|+++
T Consensus 228 -------~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 228 -------FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1245668999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=361.48 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=204.5
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 697 (964)
.++|+..+.||+|+||.||+|+.. ++..||||+++..... ....+.+|+++++++ +|+|||+++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 347888899999999999998842 2457999999754332 345688999999999 89999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 002121 698 QMLVYEFMANGTLRESLSGRS----------------------------------------------------------- 718 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 718 (964)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ---------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeec
Q 002121 719 ---------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789 (964)
Q Consensus 719 ---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~ 789 (964)
..++++.++++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 124788999999999999999999988 99999999999999999999999999987644322222223
Q ss_pred ccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHH
Q 002121 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868 (964)
Q Consensus 790 ~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (964)
..++..|+|||++.+..++.++|||||||++|||++ |+.||........ .......... ......
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-~~~~~~~~~~--~~~~~~----------- 339 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-FYKMVKRGYQ--MSRPDF----------- 339 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-HHHHHHcccC--ccCCCC-----------
Confidence 345678999999998899999999999999999997 9999864322111 1111111110 000001
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 869 GFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 869 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
....+.+++.+||+.||++||++.||++.|++++
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1145678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=381.49 Aligned_cols=260 Identities=29% Similarity=0.494 Sum_probs=211.7
Q ss_pred cCCCccceeecCCcEEEEEEEecC--Cc----EEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD--GQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~--g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
.+.+..+.||+|+||.||+|...+ |. .||||.++... .+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 345566899999999999999643 43 49999887654 455678999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC-----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 700 LVYEFMANGTLRESLSGRS-----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
+++|||++|+|..+|+..+ ...++..+.+.++.|||+|+.||++++ +|||||.++|+||++...+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999998763 346899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
||.+-+.+.........-...|||||.+..+.++.|+|||||||++||++| |..||....+. +.+...+....
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~ggR----- 922 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLEGGR----- 922 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHhCCc-----
Confidence 996655544333333234578999999999999999999999999999999 78888643321 11111111111
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
++ .+..+...+.+++.+||+.+|++||++..+++++..+.+.
T Consensus 923 ----L~-----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 923 ----LD-----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ----cC-----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11 1222335677999999999999999999999999888764
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=315.92 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=208.3
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|+..+.||+|.||.||.|+. +++-.||+|++.+... ....++++|+++-+.|+||||+++++|+.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35678889999999999999995 4678999999875432 2345799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
+||.++|++...|.......+++.....++.|+|.||.|+|..+ ||||||||+|+|++.++..||+|||.+...+.
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~- 176 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 176 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC-
Confidence 99999999999999776678999999999999999999999887 99999999999999999999999999876542
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......+||.-|.|||+..+..++..+|+|++||+.||++.|.+||.... ..+-++.+.... ..+|
T Consensus 177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~---------~~~p- 242 (281)
T KOG0580|consen 177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVD---------LKFP- 242 (281)
T ss_pred ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHcc---------ccCC-
Confidence 23345789999999999999999999999999999999999999997533 222233222111 1112
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.... ....++|.+|+..+|.+|.+..|+++.
T Consensus 243 --~~is---~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 --STIS---GGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred --cccC---hhHHHHHHHHhccCccccccHHHHhhh
Confidence 1111 234589999999999999999999764
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=353.93 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=206.8
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+-|...+.||+|+-|.|-.|+. .+|+.+|||++..... .....+.+|+-+|+-+.||||++++++++++.++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 3466678899999999999994 6899999999876532 12345889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|.|.+++..++ ++.+.+..+++.||..|+.|+|..+ |+|||+||+|+|||..+++||+|||+|..-..+
T Consensus 92 Eyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred EecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999998765 6899999999999999999999998 999999999999999999999999999875433
Q ss_pred CCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
..-...+|++.|.|||++++.+|+ .++||||+|||||.||||+.||++ +++...+.+.. ...+.++..+.
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-dNir~LLlKV~----~G~f~MPs~Is-- 236 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-DNIRVLLLKVQ----RGVFEMPSNIS-- 236 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-ccHHHHHHHHH----cCcccCCCcCC--
Confidence 334456899999999999999987 899999999999999999999984 33333333222 12222333333
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.+..+|+.+|+..||++|.|++||++.
T Consensus 237 ---------~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 237 ---------SEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ---------HHHHHHHHHHhccCccccccHHHHhhC
Confidence 334589999999999999999999864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=353.18 Aligned_cols=265 Identities=29% Similarity=0.457 Sum_probs=218.6
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
|+++-...+....++||-|.||.||.|.|+. .-.||||.++...+. .++|..|+.+|+.++|||+|+++|+|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 5555555667778999999999999999864 568999999876554 46899999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
|||+|||.+|+|.+||+.+....++-...+.+|.||+.||+||...+ +|||||.++|.|+.++..+||+||||++++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999887777888888999999999999999988 999999999999999999999999999987
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..+ .+.......-.+.|.|||-+....++.|+|||+|||+|||+.| |-.||. +..+ .++...++.+..
T Consensus 416 tgD-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-Gidl-SqVY~LLEkgyR-------- 484 (1157)
T KOG4278|consen 416 TGD-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-GIDL-SQVYGLLEKGYR-------- 484 (1157)
T ss_pred cCC-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-CccH-HHHHHHHhcccc--------
Confidence 643 3233333445788999999999999999999999999999999 666664 3322 233333333221
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
|+ ....+...+.+|++.||+.+|.+||+++|+-+.++.++..
T Consensus 485 M~-----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 485 MD-----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred cc-----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 11 1233446778999999999999999999999999887654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.44 Aligned_cols=250 Identities=33% Similarity=0.534 Sum_probs=195.2
Q ss_pred ccceeecCCcEEEEEEEec-----CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 631 ESNEIGSGGYGKVYRGMLS-----DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
..+.||+|+||.||+|.+. .+..|+||.++..... ..+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3578999999999999976 2568999999764333 357899999999999999999999999988889999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.++++......+++.++..|+.|||+||+|||+.+ |+||||+++||++++++.+||+|||+++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 99999999999875567999999999999999999999987 999999999999999999999999999876332222
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.......+...|+|||.+....++.++||||||+++|||++ |+.|+... ...+..... ..... .. ...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~~~-~~~~~-----~~-~~~--- 228 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIEKL-KQGQR-----LP-IPD--- 228 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHHHH-HTTEE-----TT-SBT---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccc-ccccc-----ce-ecc---
Confidence 22333457789999999999889999999999999999999 67888654 222222222 11110 00 000
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.....+.+++.+||+.+|++||++.++++.|
T Consensus 229 ----~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 ----NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ----TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ----chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1124566899999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.55 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=207.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
..|+..+.||+|+||.||||.. ..++.||+|++...... ..+++++|+.+|.+++|+||.+.|+.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 3566678999999999999995 57899999999865544 346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
|.+|++.+.++... .+++..+..|.+++..||.|||.++ .+|||||+.|||+..+|.+||+|||.+..+......
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999998654 4588888899999999999999988 999999999999999999999999999887654432
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
....+||+.|||||++....|+.|+||||+|++.+||.+|.+|+..-.. ...-+.+.+-..|.+.+
T Consensus 168 --r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP------------mrvlflIpk~~PP~L~~ 233 (467)
T KOG0201|consen 168 --RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP------------MRVLFLIPKSAPPRLDG 233 (467)
T ss_pred --cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc------------ceEEEeccCCCCCcccc
Confidence 2567899999999999988999999999999999999999999864221 01111233333444443
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+.+++..|+..+|+.||+|.++++
T Consensus 234 ---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 ---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 22244678999999999999999999865
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.94 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=203.9
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchh--HHHHHHHHHHHhcCCCCccceeEEEEe--eCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGG--LEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 702 (964)
+|...+.|++|+||.||+|+. ++++.||+|+++....... ..-.+||.+|.+.+|||||.+-.+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 456678899999999999995 5789999999986543322 246799999999999999999998875 36799999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||+. +|..+++..+ .++...++.-+..|+++|++|||... |+|||||++|+|+++.|.+||+|||+||.+....
T Consensus 157 e~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL 231 (419)
T ss_pred HHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence 99998 9999998765 57999999999999999999999988 9999999999999999999999999999887653
Q ss_pred CCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc---Ccccc---cccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DDEEH---YGLT 855 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~---~~~~ 855 (964)
...+..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++-| .|....+++..++.. ..+.. +...
T Consensus 232 --k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf-~G~sE~dQl~~If~llGtPte~iwpg~~~l 308 (419)
T KOG0663|consen 232 --KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLF-PGKSEIDQLDKIFKLLGTPSEAIWPGYSEL 308 (419)
T ss_pred --ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCC-CCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence 34566778999999999886 57999999999999999999998665 455555555544332 11111 0000
Q ss_pred cccC-ccch--------hhhHHH--HHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMD-PTIR--------NTVLLG--FRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d-~~l~--------~~~~~~--~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+. ..+. ...... ...-.+++...+..||.+|.|+.|.++
T Consensus 309 p~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 309 PAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred chhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 0011 001111 123468899999999999999999876
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=334.22 Aligned_cols=257 Identities=26% Similarity=0.361 Sum_probs=201.8
Q ss_pred HHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--------------hhHHHHHHHHHHHhcCCCCcc
Q 002121 622 LKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--------------GGLEFKTEIELLSRVHHKNLV 686 (964)
Q Consensus 622 l~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~H~nIv 686 (964)
-.+..++|.+.+.||+|.||.|-+|+. .+++.||||++.+.... ..+..++|+.+|++++|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345578999999999999999999994 57899999998643211 124688999999999999999
Q ss_pred ceeEEEEee--CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC
Q 002121 687 GLVGFCFEQ--GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN 764 (964)
Q Consensus 687 ~l~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 764 (964)
+|+++..+. +..|||+|||..|.+...-... ..++..+.++++.++..||+|||.++ ||||||||+|+||+++
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 999999764 6789999999988876543222 23899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecccceeecCCC---CCceeecccccCcccCccccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCchhH
Q 002121 765 LTAKVADFGLSKLVSDSS---KGHVSTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837 (964)
Q Consensus 765 ~~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~ 837 (964)
|++||+|||.+.....+. ........+|||.|+|||....+. .+.+.||||+||+||.|+.|+.||.. ....
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-~~~~ 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-DFEL 325 (576)
T ss_pred CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-chHH
Confidence 999999999987663221 112223468999999999987633 34789999999999999999999954 3344
Q ss_pred HHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+....++...-.. |. ..+....+.+|+.++|++||++|.+..+|...
T Consensus 326 ~l~~KIvn~pL~f---------P~----~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 326 ELFDKIVNDPLEF---------PE----NPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHHHHhcCcccC---------CC----cccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 4444443332210 01 11223556799999999999999999999754
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.37 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=201.3
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch---hHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG---GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
...++|+.+..||+|+||.||.|+- .+|..+|+|++++..... .+.++.|-++|....+|+||+++..|.+.+..|
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LY 217 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLY 217 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeE
Confidence 3467899999999999999999995 579999999998765543 345788999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|||||++||++..+|.... .|++.....++.+++-|++-+|+.| +|||||||+|+|||..|++||+||||+.-+.
T Consensus 218 LiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 9999999999999998765 6888888999999999999999999 9999999999999999999999999985322
Q ss_pred CC----------------------CCC----cee-------------------ecccccCcccCccccccCCCCCchhHH
Q 002121 780 DS----------------------SKG----HVS-------------------TQVKGTMGYLDPEYYMTQQLTEKSDVY 814 (964)
Q Consensus 780 ~~----------------------~~~----~~~-------------------~~~~gt~~y~aPE~~~~~~~~~~sDv~ 814 (964)
.. +.. ... -..+|||-|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 000 000 023599999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC---H
Q 002121 815 SFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT---M 891 (964)
Q Consensus 815 S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs---~ 891 (964)
|+|||+||||.|.+||..... .+-.+.++..... ...++-. .+ ..+..++|.+|+. ||++|-- +
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp-~~T~rkI~nwr~~--l~fP~~~--~~-------s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETP-QETYRKIVNWRET--LKFPEEV--DL-------SDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhhh--ccCCCcC--cc-------cHHHHHHHHHHhc-CHHHhcCcccH
Confidence 999999999999999965433 2222332222110 0000000 01 1445689999999 9999965 5
Q ss_pred HHHH
Q 002121 892 SEVV 895 (964)
Q Consensus 892 ~evl 895 (964)
+||.
T Consensus 440 ~EIK 443 (550)
T KOG0605|consen 440 EEIK 443 (550)
T ss_pred HHHh
Confidence 5554
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=350.82 Aligned_cols=241 Identities=22% Similarity=0.272 Sum_probs=195.2
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+.||+|+||.||+|.. .+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999987532 222346788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 788 (964)
+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~ 153 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence 9999987643 6899999999999999999999988 9999999999999999999999999997542221 2223
Q ss_pred cccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHH
Q 002121 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (964)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ........... ..... +
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~----~~p~~----~------ 218 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLFELILMEEI----RFPRT----L------ 218 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHHHHHHcCCC----CCCCC----C------
Confidence 456999999999999999999999999999999999999999654321 11111111111 01111 1
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 869 GFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 869 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 -SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 13456899999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=345.38 Aligned_cols=244 Identities=21% Similarity=0.284 Sum_probs=199.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888899999999999999964 689999999864321 23446889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999997653 5889999999999999999999988 999999999999999999999999999865432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ....+
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~----~~~~~---- 221 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-FGIYEKILAGKLE----FPRHL---- 221 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCcC----CCccC----
Confidence 1234689999999999988899999999999999999999999965332 2222222211110 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
...+.+++.+||+.||.+||+ ++|+++
T Consensus 222 -------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 222 -------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 134568999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=351.06 Aligned_cols=244 Identities=24% Similarity=0.346 Sum_probs=199.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999964 68999999987532 223356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT 172 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence 9999999999997643 5788889999999999999999988 9999999999999999999999999998764322
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .....++
T Consensus 173 -----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~----~~p~~~~--- 239 (329)
T PTZ00263 173 -----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-FRIYEKILAGRL----KFPNWFD--- 239 (329)
T ss_pred -----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCc----CCCCCCC---
Confidence 234699999999999998899999999999999999999999965432 222222221111 0111111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
..+.+++.+||+.||++||+ ++|++.
T Consensus 240 --------~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 240 --------GRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --------HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 34568999999999999997 577653
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=355.06 Aligned_cols=260 Identities=22% Similarity=0.361 Sum_probs=204.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcC-CCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 697 (964)
.++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+++++++. |||||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567888899999999999999852 134799999975433 23457899999999996 9999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC-----------------------------------------------------------
Q 002121 698 QMLVYEFMANGTLRESLSGRS----------------------------------------------------------- 718 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------- 718 (964)
.++|||||++|+|.++++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 999999999999999886421
Q ss_pred -----------------------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC
Q 002121 719 -----------------------------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE 763 (964)
Q Consensus 719 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~ 763 (964)
...+++.++..++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788899999999999999999988 999999999999999
Q ss_pred CCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHH
Q 002121 764 NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRT 842 (964)
Q Consensus 764 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~ 842 (964)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||....... .+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-~~~~ 351 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-TFYN 351 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-HHHH
Confidence 99999999999987643322222233457788999999998899999999999999999997 888986432111 1111
Q ss_pred HhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.+..... . ... ......+.+++.+||+.+|++||++.+|.+.|+++.
T Consensus 352 ~~~~~~~----~------~~~---~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 KIKSGYR----M------AKP---DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHhcCCC----C------CCC---ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111100 0 000 111245678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=333.47 Aligned_cols=251 Identities=31% Similarity=0.481 Sum_probs=202.7
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|+..+.||+|+||.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 35777889999999999999998888999998864432 34578899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.++++... ..++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce-ec
Confidence 999999997643 25899999999999999999999988 99999999999999999999999999986543221 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||++....++.++||||||+++|||++ |+.||..... .+.+........ ...+..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~i~~~~~--------~~~~~~--- 225 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEMISRGFR--------LYRPKL--- 225 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHHCCCC--------CCCCCC---
Confidence 122345678999999988889999999999999999999 8889864332 222222211111 001111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
....+.+++.+||+.+|++||+++|+++.|
T Consensus 226 ---~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 113567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=335.10 Aligned_cols=254 Identities=27% Similarity=0.477 Sum_probs=206.1
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|+..++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 46788899999999999999988888999998765332 34678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.++++...+..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 160 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-TA 160 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce-ec
Confidence 999999997665567899999999999999999999987 99999999999999999999999999987643221 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||++..+.++.++|||||||++|||+| |+.||..... .. ....+..... . +.. .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~-~~~~~~~~~~----~-----~~~-~- 227 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN-SD-VMSALQRGYR----M-----PRM-E- 227 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH-HH-HHHHHHcCCC----C-----CCC-C-
Confidence 223346778999999988889999999999999999998 8999854321 11 1111111110 0 000 0
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.....+.+++.+|+..+|++||+++++.+.|++
T Consensus 228 --~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 --NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111346789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=338.03 Aligned_cols=255 Identities=23% Similarity=0.366 Sum_probs=202.4
Q ss_pred cCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|+..+.||+|+||.||+|.+. .+..||+|+++.... .....+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999853 356899999886533 2345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... ..++|.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999997643 36899999999999999999999988 999999999999999999999999987654222
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. .......++..|+|||++.++.++.++|||||||++||+++ |+.||..... .+.+. .+..... .
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~-~~~~~~~----~------ 227 (266)
T cd05064 161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIK-AVEDGFR----L------ 227 (266)
T ss_pred ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHH-HHHCCCC----C------
Confidence 11 11112335678999999999999999999999999999875 9999864322 11122 1111110 0
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
... ......+.+++.+||+.+|++||++.|+.+.|+++
T Consensus 228 ~~~---~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PAP---RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC---CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 000 11124567899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=342.43 Aligned_cols=259 Identities=24% Similarity=0.462 Sum_probs=205.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.+|+..+.||+|+||.||+|++. +|+ .||+|+++.... ....++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999853 344 489999875432 3456789999999999999999999999764 5789
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|+||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998653 35889999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||..... . .+......... .. .
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-~-~~~~~~~~~~~----~~---~ 232 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-S-EISSILEKGER----LP---Q 232 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-H-HHHHHHhCCCC----CC---C
Confidence 333222223345678999999999999999999999999999998 9999864321 1 12222221110 00 0
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+. .....+.+++.+||..+|++||++.+++..+..+.+..
T Consensus 233 ~~------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 233 PP------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00 11234678999999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.77 Aligned_cols=243 Identities=25% Similarity=0.347 Sum_probs=200.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 699 (964)
..++|...++||+|+||+|+++..+ +++.+|||++++...- +.+..+.|.+|+... +||.++.++++|...++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3468889999999999999999965 6889999999876543 344577888888877 5999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+.||++..+.+.. .+++.+...+|..|+.||.|||+++ |||||||-+|||||.+|.+||+|||+++...
T Consensus 446 fvmey~~Ggdm~~~~~~~---~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHIHTD---VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEecCCCcEEEEEecc---cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccC
Confidence 999999999966665543 5999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
- .+..+...+||+.|||||++..+.|+.++|.|||||+|||||.|..||.. ++..+....++..+. .-
T Consensus 520 ~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g-ddEee~FdsI~~d~~---------~y 587 (694)
T KOG0694|consen 520 G--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG-DDEEEVFDSIVNDEV---------RY 587 (694)
T ss_pred C--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC---------CC
Confidence 2 22355678999999999999999999999999999999999999999963 222333333332222 11
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
|... ..+.+.++.+++..+|++|--+
T Consensus 588 P~~l------s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 588 PRFL------SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCcc------cHHHHHHHHHHhccCcccccCC
Confidence 2111 1455689999999999999866
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.18 Aligned_cols=256 Identities=30% Similarity=0.489 Sum_probs=204.9
Q ss_pred cCCCccceeecCCcEEEEEEEecC------CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
++|+..+.||+|+||.||+|.... ...||+|.++.... ....++.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 367778999999999999998532 25799999875433 23456899999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCCC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC
Q 002121 700 LVYEFMANGTLRESLSGRSG--------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL 765 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~ 765 (964)
++|||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999875421 45889999999999999999999988 99999999999999999
Q ss_pred cEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002121 766 TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 766 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 844 (964)
.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||..... .+... .+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-~~~~~-~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-QEVIE-MI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH-HH
Confidence 999999999986644333233344557889999999998899999999999999999998 9999864321 11111 11
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.... ... . .......+.+++.+||+.+|.+||++.||++.|+.
T Consensus 240 ~~~~-----~~~-----~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 RSRQ-----LLP-----C---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HcCC-----cCC-----C---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111 000 0 11122567799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.85 Aligned_cols=241 Identities=23% Similarity=0.277 Sum_probs=194.5
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+.||+|+||.||+++. .+|+.||+|+++... ......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999995 468999999987532 223345778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 788 (964)
+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 9999887543 6899999999999999999999988 9999999999999999999999999987532221 1223
Q ss_pred cccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHH
Q 002121 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (964)
...||+.|+|||++.++.++.++|||||||++|||++|+.||...... ........... .....+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-~~~~~~~~~~~----~~p~~~---------- 218 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RLFELILMEEI----RFPRTL---------- 218 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCC----CCCCCC----------
Confidence 456999999999999999999999999999999999999999654322 11111111111 011111
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 869 GFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 869 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||++|| ++.++++
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 -SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 13456899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.18 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=208.7
Q ss_pred cCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|.+.+.||+|+||+||++... ++..+|+|.+..........+.+|++++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999842 345699999876655555679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC-----------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 701 VYEFMANGTLRESLSGRS-----------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 234899999999999999999999988 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
+|||+++...............++..|+|||++....++.++|||||||++|||++ |..||..... .+..........
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~~~~~i~~~~~ 240 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEVIECITQGRV 240 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCc
Confidence 99999986543322222233446788999999998889999999999999999999 8888864322 111222111110
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
. .... .....+.+++.+||+.+|.+||++.|+.+.|+.+.+..
T Consensus 241 ~---~~~~-----------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 241 L---QRPR-----------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred C---CCCC-----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 0 0000 11134679999999999999999999999999987553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.30 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=202.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||.||+|+.. +|+.||||+++... ......+.+|++++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36888999999999999999965 58999999987532 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997543 5889999999999999999999988 99999999999999999999999999986543
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+............ ......++.
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~--~~~~~~~~~- 226 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP-NETWENLKYWKETL--QRPVYDDPR- 226 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH-HHHHHHHHhccccc--cCCCCCccc-
Confidence 12345699999999999988999999999999999999999999964332 12111111111000 000000000
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
......+.+++.+|+..+|++||++.|+++.
T Consensus 227 ----~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 ----FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ----cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1122456789999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.55 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=211.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
...+|+..+.||+|+||.||+|...++..+|+|++..........+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 45578888999999999999999888999999999876655566799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++....+..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 99999999998766667899999999999999999999988 99999999999999999999999999987643221
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......++..|+|||++..+.++.++||||||+++|+|++ |+.||.... ..+.+........ . ...
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~-----~------~~~ 226 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYR-----M------PCP 226 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-HHHHHHHHHhCCc-----C------CCC
Confidence 1223346778999999988889999999999999999998 888885432 2222222221110 0 000
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
......+.+++.+|++.+|++|||++++++.|+.
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 ---AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred ---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1112456799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=361.48 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=210.4
Q ss_pred hcCCCccceeecCCcEEEEEEEecCC-cEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEE-EEe------eC
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDG-QVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGF-CFE------QG 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~-~~~------~~ 696 (964)
..++++.+.|.+|||+.||.|+...+ ..||+|++-.....+...+++|+++|++|+ |+|||.+++. ... .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 44667789999999999999997655 999999988777777778999999999997 9999999993 221 13
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
+++|.||||++|.|-+++..+-...|++.++++|+.|+++|+++||.. .+||||||||-+||||+.++..||||||-|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 678999999999999999876656699999999999999999999986 4899999999999999999999999999986
Q ss_pred eecCCCCCc-e------eecccccCcccCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc
Q 002121 777 LVSDSSKGH-V------STQVKGTMGYLDPEYY---MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 777 ~~~~~~~~~-~------~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 846 (964)
......... . ......|+.|+|||++ .+...++|+||||+||+||-|+....||+....+
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---------- 264 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---------- 264 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----------
Confidence 433222100 0 0123479999999987 4668899999999999999999999999864211
Q ss_pred CcccccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 847 DDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.+++....-. ...+..++.+||..||+.+|++||++.+|+..+..+....
T Consensus 265 ---------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 265 ---------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 1111111111 2345577889999999999999999999999998887543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.41 Aligned_cols=255 Identities=27% Similarity=0.495 Sum_probs=206.7
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|+..+.||+|+||.||+|...+++.||+|.++.... ...++.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999987788999999875443 3457899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++....+..++|.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~ 159 (261)
T cd05068 84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E 159 (261)
T ss_pred cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence 9999999997665557899999999999999999999988 99999999999999999999999999987653221 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.......+..|+|||++....++.++||||||+++|||+| |+.||..... ..... .+..... .. ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~-~~~~~~~----~~--~~~---- 227 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-AEVLQ-QVDQGYR----MP--CPP---- 227 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHH-HHHcCCC----CC--CCC----
Confidence 1122223468999999998899999999999999999999 8988864321 11111 1111110 00 000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 228 ---~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 228 ---GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 112456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=361.99 Aligned_cols=251 Identities=21% Similarity=0.275 Sum_probs=202.7
Q ss_pred CCCccceeecCCcEEEEEEEec-C-CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-D-GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.|...+.||+|+||.||+|... + ++.||+|.+..........+++|++++++++|||||++++++..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3778899999999999999853 3 6788999876554444556889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 706 ANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 706 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
++|+|.++++.. ...++++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988642 2346889999999999999999999988 99999999999999999999999999987654332
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+.......... .. ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-~~~~~~~~~~~~~~~---~~----~~-- 294 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-QREIMQQVLYGKYDP---FP----CP-- 294 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCC---CC----cc--
Confidence 223345679999999999999999999999999999999999999996432 222222222111100 00 01
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.+++.+||+.+|++||++.+++.
T Consensus 295 -----~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 295 -----VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -----CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1134678999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=346.58 Aligned_cols=238 Identities=25% Similarity=0.336 Sum_probs=192.6
Q ss_pred eecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||+||+|... +++.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999964 68899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~ 153 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTF 153 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccccc
Confidence 99997643 5899999999999999999999988 9999999999999999999999999998543221 223345
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... ....++
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~-~~~~~~~~~~~~~~----~~~~~~----------- 217 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN-VNEMYRKILQEPLR----FPDGFD----------- 217 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCCC----CCCcCC-----------
Confidence 79999999999999999999999999999999999999996433 22233332222110 111111
Q ss_pred HHHHHHHHHhhhcCCCCCCCH---HHHH
Q 002121 871 RRYLELALQCVEESATDRPTM---SEVV 895 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~---~evl 895 (964)
..+.+++.+||+.||++||++ .|++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 345689999999999999864 5554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.64 Aligned_cols=260 Identities=27% Similarity=0.464 Sum_probs=208.7
Q ss_pred cCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|...+.||+|+||.||+|... ++..+++|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677789999999999999842 345799999876665556679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc
Q 002121 701 VYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
||||+++++|.+++.... ...++|..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986532 234899999999999999999999988 999999999999999999
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhc
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 845 (964)
+||+|||+++...............++..|+|||++....++.++|||||||++|||+| |+.||...... +.... +.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~-~~ 239 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIEC-IT 239 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH-Hh
Confidence 99999999986544322222233456889999999998899999999999999999999 99998643321 11111 11
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
... ..+. .......+.+++.+||+.+|++||++.+|++.|+++...
T Consensus 240 ~~~-----~~~~--------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 240 QGR-----VLER--------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred CCC-----CCCC--------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 111 0000 011124567999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=347.57 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=204.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccceeEEEEee-C
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ-G 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 696 (964)
.++|++.+.||+|+||.||+|... +++.||+|+++..... ....+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 346888899999999999999732 3578999998754322 234678899999999 899999999988754 5
Q ss_pred ceEEEEEeccCCChhhhhcCCC----------------------------------------------------------
Q 002121 697 EQMLVYEFMANGTLRESLSGRS---------------------------------------------------------- 718 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 718 (964)
..++||||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999885432
Q ss_pred -CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCccc
Q 002121 719 -GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797 (964)
Q Consensus 719 -~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 797 (964)
..+++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 126899999999999999999999988 9999999999999999999999999998764432222223345678899
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHH
Q 002121 798 DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLEL 876 (964)
Q Consensus 798 aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 876 (964)
|||++.+..++.++|||||||++|||++ |..||...... +.....+.... ....+ ......+.++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-~~~~~~~~~~~------~~~~~-------~~~~~~~~~l 308 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-EEFCRRLKEGT------RMRAP-------EYATPEIYSI 308 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-HHHHHHHhccC------CCCCC-------ccCCHHHHHH
Confidence 9999999999999999999999999998 99998642211 11111111111 00000 0112456799
Q ss_pred HHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 877 ALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 877 i~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
+.+||+.+|++||++.|+++.|+++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=336.59 Aligned_cols=255 Identities=27% Similarity=0.458 Sum_probs=204.7
Q ss_pred cCCCccceeecCCcEEEEEEEecC------CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ....+.+|++++++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778999999999999998633 478999998765444 4568999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 700 LVYEFMANGTLRESLSGRS------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
+||||+++|+|.+++...+ ...+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997542 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||..... .+.+.... .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~-~~~~~~~~-~ 239 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN-EEVIECIT-Q 239 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHH-c
Confidence 9999999986543322122233446788999999999999999999999999999999 9999864322 12222111 1
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.. .. ... ......+.+++.+||+.+|++||++.||++.|+
T Consensus 240 ~~-----~~-~~~-------~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 240 GR-----LL-QRP-------RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred CC-----cC-CCC-------CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11 00 000 011245679999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=346.83 Aligned_cols=251 Identities=23% Similarity=0.384 Sum_probs=211.1
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCc-eEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE-QMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lV~ 702 (964)
++|...+.+|+|+||.++..+.+ ++..+|+|++...... .+....+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 56788899999999999998854 6789999998765443 34467899999999999999999999999988 99999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
+||+||++.+.+...++..++++++.+++.|++.|+.|||+.. |+|||||+.||+++.+..+||+|||+|+.+....
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999998887788999999999999999999999877 9999999999999999999999999999886553
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....+.||+.||.||++.+.+|..|+||||+||++|||++-+++|..... ..-+..++... ++ .+
T Consensus 161 --~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-~~Li~ki~~~~----------~~-Pl 226 (426)
T KOG0589|consen 161 --SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-SELILKINRGL----------YS-PL 226 (426)
T ss_pred --hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-HHHHHHHhhcc----------CC-CC
Confidence 133457899999999999999999999999999999999999999965432 22222222111 11 11
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...+...+..++..|++.+|+.||++.+++.+
T Consensus 227 ---p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 ---PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 12233556789999999999999999999875
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=339.05 Aligned_cols=264 Identities=20% Similarity=0.283 Sum_probs=200.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|++.+.||+|+||+||+|+.+ +++.||||+++.... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999975 688999999875432 223567899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|++++.+..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 99998776654432 35889999999999999999999988 99999999999999999999999999987643322
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH--HHHHhccCcccc-------ccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE--VRTAMNRDDEEH-------YGL 854 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~-------~~~ 854 (964)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.......+... ...
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1223456899999999999888999999999999999999999999743322111 111110000000 000
Q ss_pred ccccCccchh------h-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRN------T-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~------~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.... . .......+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0 0012245789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=331.75 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=205.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.+|...+.||+|+||.||+|... .++.||+|++.... ....++.+|++++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999964 58899999987543 33457899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.......+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....... .
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 9999999997655557899999999999999999999988 99999999999999999999999999987643321 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......++..|+|||++.+..++.++|||||||++|||++ |..||.... ..+...... .... +....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-~~~~~~~~~-~~~~----------~~~~~ 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLE-KGYR----------MERPE 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHH-CCCC----------CCCCC
Confidence 1112234678999999998899999999999999999998 888886432 222222221 1110 00000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.....+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 229 ---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 ---GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1124567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=348.08 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred hcCCCccceeecCCcEEEEEEEecC--CcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD--GQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|...+.||+|+||.||+|.... +..||+|++.... ......+.+|+++++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3468888999999999999998543 3689999986432 2233468899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 109 v~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997653 5889999999999999999999988 99999999999999999999999999987543
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .. +
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~~~~~~----~p----~ 249 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-LIYQKILEGIIY----FP----K 249 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-HHHHHHhcCCCC----CC----C
Confidence 2 12356999999999999888999999999999999999999999754322 112222211110 11 1
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
.+. ..+.+++.+|++.||++|+ +++|+++
T Consensus 250 ~~~-------~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 250 FLD-------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCC-------HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 111 3356899999999999995 7888765
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=326.37 Aligned_cols=266 Identities=23% Similarity=0.346 Sum_probs=205.6
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEe-----e
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE-----Q 695 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~ 695 (964)
.....|...+.||+|+||.|++|.. .+|+.||||++... .....++-.+|+++|+.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3445666678999999999999995 57999999998743 33344677899999999999999999998865 3
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
+..|+|+|+|+ -+|...++... .++......++.|+++||.|+|+.+ |+|||+||+|+|++.+...||+|||+|
T Consensus 99 ~DvYiV~elMe-tDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLA 172 (359)
T KOG0660|consen 99 NDVYLVFELME-TDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLA 172 (359)
T ss_pred ceeEEehhHHh-hHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccce
Confidence 56899999995 59999998653 5999999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
|..........++..+.|.+|.|||++. ...|+.+.||||.||++.||++|++-|. |.....++..++.--+......
T Consensus 173 R~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp-G~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 173 RYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP-GKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC-CCchHHHHHHHHHhcCCCCHHH
Confidence 9886543334557788999999999976 4689999999999999999999997774 4444444443332211110000
Q ss_pred ccccC----------------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMD----------------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d----------------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+. ..+....+......++++.+||..||.+|+|++|+++
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 0011111122234578999999999999999999986
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=343.05 Aligned_cols=200 Identities=29% Similarity=0.459 Sum_probs=175.3
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||.||+++.. +|..||+|.+..... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367889999999999999999965 688999999875432 234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ .|+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 999999999997643 5889999999999999999999742 39999999999999999999999999997654321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG 833 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~ 833 (964)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 23356899999999999889999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=345.77 Aligned_cols=241 Identities=23% Similarity=0.274 Sum_probs=195.1
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+.||+|+||.||++.. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 468999999987532 223356788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 788 (964)
+|..++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9999887543 6899999999999999999999988 9999999999999999999999999987542221 1223
Q ss_pred cccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHH
Q 002121 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (964)
...||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .+.. .+
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-~~~~~~~~~~~~----~~p~----~~------ 218 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEDI----KFPR----TL------ 218 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-HHHHHHhccCCc----cCCC----CC------
Confidence 45799999999999988999999999999999999999999965332 122222111111 0111 11
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 869 GFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 869 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||++|| ++.|+++
T Consensus 219 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 219 -SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred -CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 13456899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.34 Aligned_cols=262 Identities=25% Similarity=0.371 Sum_probs=196.8
Q ss_pred cCCCccceeecCCcEEEEEEEe-c-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhc---CCCCccceeEEEEe-----
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-S-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRV---HHKNLVGLVGFCFE----- 694 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~----- 694 (964)
++|+..+.||+|+||+||+|+. . +|+.||+|+++..... ....+.+|+++++++ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688899999999999999986 3 4688999988754322 233566788777766 69999999999863
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
....++||||++ ++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999997 59999997655556899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc---Ccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DDEEH 851 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~ 851 (964)
++..... .......||+.|+|||++....++.++|||||||++|||++|++||...... +.+...... .....
T Consensus 157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence 9876433 2223456899999999998889999999999999999999999999754322 222222111 00000
Q ss_pred cc----c-ccccCcc----chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 YG----L-TEMMDPT----IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ~~----~-~~~~d~~----l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. . ...+.+. +..........+.+++.+|++.||++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00 0 0000000 00001112244678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=335.73 Aligned_cols=256 Identities=28% Similarity=0.453 Sum_probs=202.2
Q ss_pred cCCCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.+|+..+.||+|+||+||+|.. .++..||+|.+...... ...++.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567779999999999999984 24678999998754332 33578899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC---------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC
Q 002121 701 VYEFMANGTLRESLSGRS---------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL 765 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~ 765 (964)
||||+++|+|.+++.... ...+++.+.+.++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 134789999999999999999999988 99999999999999999
Q ss_pred cEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002121 766 TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 766 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 844 (964)
.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||..... .... ...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~~-~~~ 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVI-EMV 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHH-HHH
Confidence 999999999987644332222333446778999999988889999999999999999999 8888854321 1111 111
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
..... ....+. ....+.+++.+|++.+|++||++.++.+.|..
T Consensus 240 ~~~~~--~~~~~~-----------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 RKRQL--LPCSED-----------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HcCCc--CCCCCC-----------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 11110 001111 12456789999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=340.39 Aligned_cols=241 Identities=25% Similarity=0.370 Sum_probs=194.1
Q ss_pred ceeecCCcEEEEEEEe----cCCcEEEEEEecCCC----cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 633 NEIGSGGYGKVYRGML----SDGQVVAIKRAQQGS----MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+.||+|+||.||+++. .+++.||||+++... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 357899999987532 12234578899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.... .+.+..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-- 154 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--
Confidence 99999999997643 5788888999999999999999988 9999999999999999999999999997543222
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+........ .+...+
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-~~~~~~~~~~~~----~~~~~~------ 223 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-KKTIDKILKGKL----NLPPYL------ 223 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCC----CCCCCC------
Confidence 122345699999999999988899999999999999999999999975432 222222221111 011111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+|++.+|++|| ++.++++
T Consensus 224 -----~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 224 -----TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 13456899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=337.06 Aligned_cols=262 Identities=22% Similarity=0.351 Sum_probs=199.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|...+.||+|+||+||+|... +++.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888999999999999999964 689999999875432 2334678999999999999999999999998899999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++ +|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~- 158 (288)
T cd07871 85 LDS-DLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK- 158 (288)
T ss_pred CCc-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence 985 9999886543 35789999999999999999999988 99999999999999999999999999986543221
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCccccc-c------
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDEEHY-G------ 853 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~-~------ 853 (964)
......|++.|+|||++.+ ..++.++||||+||++|||+||+.||.... ..+.+... ......... .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST-VKEELHLIFRLLGTPTEETWPGITSNEE 236 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHHhCCCChHHhhccccchh
Confidence 1233468999999999865 568999999999999999999999996432 22222211 111110000 0
Q ss_pred cccccCccc-----hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 LTEMMDPTI-----RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.. ............+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000110 0000111245679999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=329.83 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=205.6
Q ss_pred cCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|+..+.||+|+||+||+|.+.. ...||||+++..... ...+|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999999742 358999998754332 345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999997654 36899999999999999999999988 999999999999999999999999999877522
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
..........++..|+|||++.+..++.++||||||+++|||++ |..||...... .+...+..... ..
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~----~~----- 228 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGYR----LP----- 228 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCCC----CC-----
Confidence 22222223345678999999998899999999999999999998 99998543211 11121111110 00
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
. .......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 229 ~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 P----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 011124567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=335.86 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=202.6
Q ss_pred hhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
.+++|+..+.||+|+||.||+|... .+..||+|++..... ....++.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4678999999999999999999753 256799999865332 334568899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 698 QMLVYEFMANGTLRESLSGRS--------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
.++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999986532 124688999999999999999999987 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||.... ..+..........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~ 239 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-NEQVLRFVMEGGL 239 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCc
Confidence 99999976543322222222345788999999998899999999999999999999 678885432 2222222111111
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.. ... .....+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ------~~-----~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 240 ------LD-----KPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred ------CC-----CCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 00 000 11245678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=348.47 Aligned_cols=258 Identities=21% Similarity=0.268 Sum_probs=197.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|+..+.||+|+||.||+|.. .+++.||+|+... ..+.+|++++++++|||||++++++..+...++|||+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 35799999999999999999995 4689999997532 3567899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+. ++|.+++.... .+++.+++.++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 95 68988886543 5889999999999999999999988 99999999999999999999999999975432211
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch------hHHHHHHHhc---cCccccc-c-
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY------VVREVRTAMN---RDDEEHY-G- 853 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~------~~~~~~~~~~---~~~~~~~-~- 853 (964)
.......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ....+...+. ..+.+.. .
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 122345799999999999988999999999999999999999988753211 1111111111 1000000 0
Q ss_pred ---cccc---------cCcc---chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 ---LTEM---------MDPT---IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ---~~~~---------~d~~---l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+. ..+. ...........+.+++.+||+.||++|||++|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 0000 00011122345778999999999999999999985
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=336.86 Aligned_cols=264 Identities=22% Similarity=0.360 Sum_probs=200.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...+.||+|+||+||+|... +|+.||||++..... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467899999999999999999965 689999999875432 223467889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|++ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~- 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS- 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence 996 68888776543 35888999999999999999999988 9999999999999999999999999997643322
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh---ccCccccc----ccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM---NRDDEEHY----GLT 855 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~----~~~ 855 (964)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.......+.+.... ........ ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP 236 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence 12233568999999999865 4578999999999999999999999975444333332221 11110000 000
Q ss_pred cc----c----Cccchhhh--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EM----M----DPTIRNTV--LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~----~----d~~l~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. + ...+.... ......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 0 00000000 001234678999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=331.21 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=202.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|+..+.||+|+||+||+|.+. +|+ .|++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35667789999999999999963 454 477887754332 22346788888999999999999999885 456789
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|+||+++|+|.+++.... ..++|..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997643 36899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........++..|+|||++.++.++.++|||||||++|||++ |+.||..... ..+...+..... . ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~----~---~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGER----L---AQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc----C---CC
Confidence 332223334567789999999998899999999999999999998 9999864321 111222221110 0 01
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+.. ....+.+++.+||..+|++||++.|+++.|..+.++.
T Consensus 233 ~~~------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 233 PQI------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CCC------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 111 1134567899999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=328.65 Aligned_cols=258 Identities=22% Similarity=0.364 Sum_probs=206.2
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||.||+|+. .+++.||||.++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999995 478999999876432 223346889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 703 EFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 703 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999888532 2245788999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.........+...+.... .+
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~----------~~ 226 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD----------YP 226 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC----------CC
Confidence 221 122346889999999998888999999999999999999999998644322212222211111 01
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
... .......+.+++.+||+.+|++||++.||++.++++
T Consensus 227 ~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 227 PLP--TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCC--hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 110 111224567999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=312.77 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=202.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+++|++.++||+|.|+.||++.. .+|+.+|+|.+... ...+.+++.+|++|-+.++|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 45677778999999999999984 57999999977532 2235567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecccceeec
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~ 779 (964)
|+|.||+|..-+..+ ...++...-..+.||+++|+|+|..+ |||||+||+|+++- ..--+||+|||+|..+.
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999998877654 35788888899999999999999988 99999999999994 34468999999999887
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.+ ......+|||+|||||+++..+|+..+|||+.||+||-|+.|++||... ...+.+..++..... ++
T Consensus 165 ~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~-~~~rlye~I~~g~yd--------~~ 232 (355)
T KOG0033|consen 165 DG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-DQHRLYEQIKAGAYD--------YP 232 (355)
T ss_pred Cc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhccccC--------CC
Confidence 32 3455678999999999999999999999999999999999999999642 223333333333221 22
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+..++...++ -.+++.+|+..||.+|.|+.|.++
T Consensus 233 ~~~w~~is~~---Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPE---AKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHH---HHHHHHHHhccChhhhccHHHHhC
Confidence 2222222222 347999999999999999988764
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.46 Aligned_cols=252 Identities=31% Similarity=0.469 Sum_probs=202.5
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|...+.||+|+||+||+|...++..+|+|.+..... ...++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35677889999999999999987777899998875433 34578999999999999999999999999889999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++..... .++|.+++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++....... ..
T Consensus 83 ~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred CCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 9999999976433 6899999999999999999999988 99999999999999999999999999986543321 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||+.....++.++|||||||++|||++ |+.||...... +............ ...
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~~---~~~--------- 224 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-ETVEKVSQGLRLY---RPH--------- 224 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HHHHHHhcCCCCC---CCC---------
Confidence 222345678999999988889999999999999999999 99998643321 1111111111100 000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.....+.+++.+||+.+|++||++.++++.|+
T Consensus 225 --~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 --LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01245679999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=310.88 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=208.2
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee-----CceE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GEQM 699 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~ 699 (964)
.++|.+.+.+|+|||+-||.++ ..++..+|+|++.-...++.+...+|++..++++|||++++++++..+ .+.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678899999999999999999 678899999999877777778899999999999999999999987543 3589
Q ss_pred EEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 700 LVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
|++.|...|+|.+.+.... +..+++.++++|+.++++||.+||+.. ++++||||||.|||+.+.+.++|.|||.++.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 9999999999999987653 457999999999999999999999975 7899999999999999999999999999875
Q ss_pred ecCCCCCc-------eeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 778 VSDSSKGH-------VSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 778 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
.+-.-... .......|..|.|||.+. +...++++|||||||++|+|+.|..||+.. ...+
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~----------~~~G 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI----------YQQG 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH----------hhcC
Confidence 43211100 011234789999999884 456789999999999999999999999631 1111
Q ss_pred cccccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 848 DEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.... .....+.+.-+ .......+.+++..|++.||.+||++.+++..++.+.
T Consensus 249 gSla---LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 GSLA---LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred CeEE---EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1100 01111111100 1124466789999999999999999999998887653
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.76 Aligned_cols=246 Identities=25% Similarity=0.401 Sum_probs=207.1
Q ss_pred cCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchh---HHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG---LEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.+|.+.+.||+|.||+|-+|. ...|+.||||.+++....++ ..+++|++||+.++||||+.++.+|+..+...+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 466777889999999999998 47899999999887655443 35789999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||..+|.|++|+..++ .+++.+...++.||..|+.|+|.++ ++|||||.+|||||.++++||+|||++..+.+.
T Consensus 133 EYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~- 206 (668)
T KOG0611|consen 133 EYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK- 206 (668)
T ss_pred EecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc-
Confidence 9999999999998765 6999999999999999999999988 999999999999999999999999999877543
Q ss_pred CCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
...+.++|++-|.+||++.+.+|. +.+|-||+||+||-|+.|..||+..+ ....++++-.... ..|.
T Consensus 207 --kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-hk~lvrQIs~GaY---------rEP~ 274 (668)
T KOG0611|consen 207 --KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-HKRLVRQISRGAY---------REPE 274 (668)
T ss_pred --cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-HHHHHHHhhcccc---------cCCC
Confidence 344668999999999999998886 89999999999999999999997433 3333333322221 1121
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
-+ ....-||.+|+..+|++|.|+.+|...
T Consensus 275 ~P-------SdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 275 TP-------SDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CC-------chHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11 122368999999999999999999754
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=327.37 Aligned_cols=255 Identities=28% Similarity=0.442 Sum_probs=204.5
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|.+.++||+|+||.||+|...+...||+|+++.... ..+++.+|++++++++|+||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 46888999999999999999987777899999875333 3457899999999999999999999875 456899999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++....+..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~ 159 (262)
T cd05071 84 KGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TA 159 (262)
T ss_pred CCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc-cc
Confidence 999999998654456899999999999999999999988 99999999999999999999999999987654322 12
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||+..++.++.++||||||+++|||+| |+.||...... +.......... . ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~-----~--~~~------ 225 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EVLDQVERGYR-----M--PCP------ 225 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HHHHHHhcCCC-----C--CCc------
Confidence 223446778999999988899999999999999999999 78788643221 11111111100 0 001
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
......+.+++.+|++.+|++||++.++++.|+...
T Consensus 226 -~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 226 -PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 112245679999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=357.88 Aligned_cols=256 Identities=24% Similarity=0.360 Sum_probs=204.4
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeC---
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--- 696 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 696 (964)
+...++|.+.+.||+|+||+||+|.. .+|+.||||++..... .....+.+|+.++..++|+||+++++.+...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34457899999999999999999984 5799999999875432 33456889999999999999999988775432
Q ss_pred -----ceEEEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 697 -----EQMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 697 -----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
..++||||+++|+|.++++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEE
Confidence 3679999999999999986532 346899999999999999999999987 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.+........
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-~~~~~~~~~~~~~- 262 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-MEEVMHKTLAGRY- 262 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHhcCCC-
Confidence 99999987654322223344679999999999999999999999999999999999999996432 2233332222111
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+.+ ...+.+++.+||+.||++||++.++++
T Consensus 263 ------~~~~~~~-------~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 263 ------DPLPPSI-------SPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred ------CCCCCCC-------CHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 0011111 245678999999999999999999875
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.27 Aligned_cols=258 Identities=24% Similarity=0.403 Sum_probs=205.1
Q ss_pred cCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 698 (964)
++|...+.||+|+||.||+|.. ..+..||||+++.... ...+.+.+|+++++++ +||||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 4688889999999999999974 1345899999875433 2345689999999999 799999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.++++......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+++..
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~ 191 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDI 191 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccc
Confidence 99999999999999997655445899999999999999999999988 999999999999999999999999999866
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
.............++..|+|||++..+.++.++|||||||++|||++ |..||........ .......... .....
T Consensus 192 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~~~~~~~--~~~~~- 267 (302)
T cd05055 192 MNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKLIKEGYR--MAQPE- 267 (302)
T ss_pred cCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHHHHcCCc--CCCCC-
Confidence 43322122223346788999999998889999999999999999998 9999864332111 1111111110 00000
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.....+.+++.+|+..+|++||++.|+++.|++.
T Consensus 268 ----------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 268 ----------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ----------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0124567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=344.02 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=195.7
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC-----ceE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG-----EQM 699 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 699 (964)
+|+..+.||+|+||.||+|+. .+|+.||||+++... .....++.+|++++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 477889999999999999995 468999999987432 223346889999999999999999999886432 479
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+|||||+ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999996 68999887543 5899999999999999999999988 9999999999999999999999999998653
Q ss_pred CCCC-CceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccc--
Q 002121 780 DSSK-GHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHY-- 852 (964)
Q Consensus 780 ~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~-- 852 (964)
.... ........||+.|+|||++.+ ..++.++|||||||++|||+||+.||....... ..+............
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2221 112234579999999999865 678999999999999999999999996433211 111111111000000
Q ss_pred -----------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -----------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+..................+.+++.+||+.||++||+++|+++
T Consensus 235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000000000000111234678999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=345.14 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=203.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||+||+|+.. +|+.||||+++... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999965 68999999987532 133456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999765 36899999999999999999999988 9999999999999999999999999998654332
Q ss_pred ---------------------------CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch
Q 002121 783 ---------------------------KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY 835 (964)
Q Consensus 783 ---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~ 835 (964)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112345699999999999999999999999999999999999999975442
Q ss_pred hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 002121 836 VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT-MSEVVKA 897 (964)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 897 (964)
. ............. ...... . ....+.+++.+|+. ||++||+ +.|+++.
T Consensus 236 ~-~~~~~i~~~~~~~--~~p~~~--~-------~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 Q-ETYNKIINWKESL--RFPPDP--P-------VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred H-HHHHHHhccCCcc--cCCCCC--C-------CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2 2222222211100 010000 0 12456689999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=335.40 Aligned_cols=261 Identities=25% Similarity=0.447 Sum_probs=206.6
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEee
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ 695 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 695 (964)
...++|+..+.||+|+||.||+|... ....+|+|++..... ....++.+|++++.++ +|+||+++++++.++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34457888899999999999999863 236899999875432 2335688999999999 899999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCC--------------CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 696 GEQMLVYEFMANGTLRESLSGR--------------SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+..++||||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998642 2346899999999999999999999987 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..... .+ +
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~-~ 243 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-EE-L 243 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH-HH-H
Confidence 9999999999999987654332222223345678999999988899999999999999999998 8888864321 11 1
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
...+..... . . ........+.+++.+|++.+|++|||+.|+++.|+.++
T Consensus 244 ~~~~~~~~~----~------~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGYR----M------E---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCCc----C------C---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 121111110 0 0 00111245679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=343.94 Aligned_cols=241 Identities=22% Similarity=0.267 Sum_probs=193.9
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+.||+|+||.||++.. .+|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999985 478999999987532 223346778999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
+|..++.... .+++.++..++.|++.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATM 153 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--ccc
Confidence 9999887543 68999999999999999999997 56 9999999999999999999999999987543221 122
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............ .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-~~~~~~i~~~~~----~~p~~~--------- 219 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEI----RFPRTL--------- 219 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-HHHHHHHhcCCC----CCCCCC---------
Confidence 345699999999999999999999999999999999999999965432 111121111111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||++|+ ++.++++
T Consensus 220 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 --SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred --CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 13456899999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.04 Aligned_cols=255 Identities=25% Similarity=0.440 Sum_probs=203.0
Q ss_pred cCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.+|...++||+|+||.||++... ++..+|+|.+..........+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35667889999999999999742 356899999876665556689999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCC-------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 701 VYEFMANGTLRESLSGRSG-------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875431 34899999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||..... .+.+......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~ 240 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIECITQG 240 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHHHHHcC
Confidence 9999999986543222112223345788999999998899999999999999999998 8989854322 1112111111
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
... .... .....+.+++.+||+.||++||++.||++.|+
T Consensus 241 ~~~---~~~~-----------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 241 REL---ERPR-----------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ccC---CCCC-----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 110 0000 11234669999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=326.68 Aligned_cols=253 Identities=28% Similarity=0.457 Sum_probs=203.3
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46778899999999999999988888999999876443 3457899999999999999999999885 456899999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+++|.++++......+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........ ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc-cc
Confidence 999999998655556899999999999999999999988 99999999999999999999999999987643321 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||+.....++.++||||||+++|||++ |+.||.... ..+.......... . ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-~~~~~~~~~~~~~-----~------~~~-- 225 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN-NREVLEQVERGYR-----M------PCP-- 225 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCC-----C------CCC--
Confidence 122345678999999988889999999999999999999 888885432 2222222211110 0 000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
......+.+++.+|+..+|++|||+.++.+.|+.
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 -QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112456799999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=348.36 Aligned_cols=252 Identities=21% Similarity=0.338 Sum_probs=198.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999964 68999999987532 222345788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997643 5899999999999999999999988 9999999999999999999999999987653211
Q ss_pred CCc------------------------------------eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhC
Q 002121 783 KGH------------------------------------VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITA 826 (964)
Q Consensus 783 ~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg 826 (964)
... ......||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 01124699999999999999999999999999999999999
Q ss_pred CCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 002121 827 KQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT---MSEVVK 896 (964)
Q Consensus 827 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 896 (964)
+.||..... .+........... ..... +.. ....+.+++.+|+. +|.+|++ +.|+++
T Consensus 236 ~~Pf~~~~~-~~~~~~i~~~~~~--~~~~~--~~~-------~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNP-QETYRKIINWKET--LQFPD--EVP-------LSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCH-HHHHHHHHcCCCc--cCCCC--CCC-------CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999975432 2222222221110 00000 000 11345578888886 9999997 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=347.88 Aligned_cols=252 Identities=19% Similarity=0.295 Sum_probs=195.0
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|...+.||+|+||+||+|+. .+++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999985 5689999999875322 233568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997643 5888899999999999999999988 99999999999999999999999999764311000
Q ss_pred ---------------------------------------------CceeecccccCcccCccccccCCCCCchhHHHHHH
Q 002121 784 ---------------------------------------------GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 818 (964)
Q Consensus 784 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gv 818 (964)
........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00012346999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHH--hhhcCCCCCCCHHHHHH
Q 002121 819 VMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQ--CVEESATDRPTMSEVVK 896 (964)
Q Consensus 819 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 896 (964)
++|||++|+.||.......... ........ ..... . . .....+.+++.+ |+..+|..||++.|+++
T Consensus 237 il~elltG~~Pf~~~~~~~~~~-~i~~~~~~--~~~~~----~-~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL-KVINWENT--LHIPP----Q-V----KLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH-HHHccccc--cCCCC----C-C----CCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999997544322211 11111100 00000 0 0 011334567766 55667777999999976
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.71 Aligned_cols=267 Identities=27% Similarity=0.403 Sum_probs=201.1
Q ss_pred CCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEE
Q 002121 629 FSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQML 700 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 700 (964)
|...+.||+|+||+||++.. .+++.||+|.++.... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37789999999999988653 3578999999876433 2345788999999999999999999998764 35789
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 99999999999999754 4899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
..... ......++..|+|||++....++.++||||||+++|||+||+.|+................ ........+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG-QMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccc-ccchhhhhhhhh
Confidence 32211 1122345677999999988889999999999999999999999986432211111100000 000000111111
Q ss_pred ccch-hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 860 PTIR-NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 860 ~~l~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.... .........+.+++.+||+.+|++||+++++++.|+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000 001112356789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.80 Aligned_cols=262 Identities=26% Similarity=0.440 Sum_probs=202.8
Q ss_pred hcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccceeEEEEee-C
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ-G 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~-~ 696 (964)
.++|+..+.||+|+||+||+|.. .+++.||||+++..... ....+.+|++++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788889999999999999973 34789999998754332 334688999999999 689999999988654 4
Q ss_pred ceEEEEEeccCCChhhhhcCCC----------------------------------------------------------
Q 002121 697 EQMLVYEFMANGTLRESLSGRS---------------------------------------------------------- 718 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 718 (964)
..++||||+++|+|.++++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986432
Q ss_pred -------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeeccc
Q 002121 719 -------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791 (964)
Q Consensus 719 -------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 791 (964)
...++|.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++...............
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 123688899999999999999999988 9999999999999999999999999998654322212222334
Q ss_pred ccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 792 gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
++..|+|||++....++.++||||||+++|||++ |..||........ ....+..... ....... .
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~~--~~~~~~~-----------~ 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKEGTR--MRAPDYT-----------T 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhccCC--CCCCCCC-----------C
Confidence 6678999999988899999999999999999997 8889864322111 1111111110 0011111 1
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
..+.+++.+||+.+|++||++.|+++.|+.+++.
T Consensus 309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=335.52 Aligned_cols=241 Identities=21% Similarity=0.276 Sum_probs=193.2
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCC-CccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHK-NLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~ 702 (964)
+|+..+.||+|+||.||+|+.. +++.||||++.... ......+..|++++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999964 57899999987532 22345678899999999765 5888999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999987543 5889999999999999999999988 9999999999999999999999999987532221
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......||+.|+|||++.+..++.++||||+||++|||+||+.||..... .+.+........ .....+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~~----~~~~~~---- 224 (324)
T cd05587 156 --KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNV----SYPKSL---- 224 (324)
T ss_pred --CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC----CCCCCC----
Confidence 123345699999999999999999999999999999999999999964432 222222221111 011111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
...+.+++.+|++.||.+|++.
T Consensus 225 -------~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 225 -------SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -------CHHHHHHHHHHhhcCHHHcCCC
Confidence 1345689999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=344.95 Aligned_cols=243 Identities=26% Similarity=0.413 Sum_probs=189.5
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999964 689999999865432 234578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+.. ..++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 156 ~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 224 (353)
T PLN00034 156 GGSLEGTH------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DP 224 (353)
T ss_pred CCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--cc
Confidence 99986542 3466778899999999999999988 9999999999999999999999999998764322 11
Q ss_pred eecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccccccccC
Q 002121 787 STQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.....||..|+|||++.. ...+.++|||||||++|||++|+.||..... .............
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----------- 293 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP----------- 293 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC-----------
Confidence 234569999999998743 2345689999999999999999999963221 1111111100000
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+... ......+.+++.+||+.||++||++.|+++
T Consensus 294 ~~~~---~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 PEAP---ATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCC---CccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 111245679999999999999999999986
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=344.53 Aligned_cols=202 Identities=24% Similarity=0.394 Sum_probs=174.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+|... +++.||+|++..... .....+++|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888999999999999999854 689999999875322 22346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997643 6899999999999999999999988 9999999999999999999999999987543211
Q ss_pred CC---------------------------------ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCC
Q 002121 783 KG---------------------------------HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829 (964)
Q Consensus 783 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p 829 (964)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 011235799999999999999999999999999999999999999
Q ss_pred CCCC
Q 002121 830 IEKG 833 (964)
Q Consensus 830 ~~~~ 833 (964)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.71 Aligned_cols=250 Identities=30% Similarity=0.445 Sum_probs=200.5
Q ss_pred CCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+|+..+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4677789999999999999987778899999865433 334688999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
++|.+++.... ..++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...+... ...
T Consensus 84 ~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~ 158 (256)
T cd05059 84 GCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS 158 (256)
T ss_pred CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence 99999997654 36899999999999999999999988 99999999999999999999999999986543221 111
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
....++..|+|||++....++.++||||||+++|||++ |+.||...... +...... ... .....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~-~~~----------~~~~~--- 223 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVVESVS-AGY----------RLYRP--- 223 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHHHHHH-cCC----------cCCCC---
Confidence 12234567999999998899999999999999999999 78888643321 1111111 110 00000
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
......+.+++.+||..+|++||++.|+++.|
T Consensus 224 ~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 01224577999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=330.51 Aligned_cols=242 Identities=23% Similarity=0.344 Sum_probs=193.6
Q ss_pred eecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||.||++.. .+|+.||+|++..... .....+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999996 4689999999864322 1233456799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 99887655556899999999999999999999988 9999999999999999999999999998764322 22345
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH---HHHHHHhccCcccccccccccCccchhhhH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV---REVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
.|+..|+|||++.+..++.++||||+||++|||++|+.||....... +......... +... ..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~----~~ 220 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE----------VKFE----HQ 220 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc----------cccc----cc
Confidence 68999999999998889999999999999999999999996432211 1111111110 0000 00
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+||+.||++||+++|+++
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 11244679999999999999999987763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=337.64 Aligned_cols=200 Identities=27% Similarity=0.464 Sum_probs=174.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||.||+|... +|..+|+|.++.... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 368889999999999999999965 688999998875432 234568999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ +|+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 999999999997643 5888999999999999999999742 29999999999999999999999999987653321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG 833 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~ 833 (964)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 22346899999999999888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=339.12 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=192.6
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHH---HhcCCCCccceeEEEEeeCceEEE
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELL---SRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999964 68999999987532 22234566676655 566899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|..+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999988653 5899999999999999999999988 999999999999999999999999998753222
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........... ... .
T Consensus 155 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~~~----~p~----~ 223 (324)
T cd05589 155 G--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-EEVFDSIVNDEVR----YPR----F 223 (324)
T ss_pred C--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC----CCC----C
Confidence 1 222346799999999999998999999999999999999999999964332 2222222211110 111 1
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
+ ...+.+++.+||+.||.+||+ +.++++
T Consensus 224 ~-------~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 224 L-------SREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred C-------CHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1 134568999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=329.54 Aligned_cols=255 Identities=27% Similarity=0.401 Sum_probs=200.6
Q ss_pred CCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc-----
Q 002121 629 FSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE----- 697 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 697 (964)
|.+.+.||+|+||.||+|.... +..||+|+++.... .....+.+|+++++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998642 36799999875432 233578999999999999999999999876554
Q ss_pred -eEEEEEeccCCChhhhhcCCC----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 698 -QMLVYEFMANGTLRESLSGRS----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 698 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
.++||||+++|+|..++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999885432 236899999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
|+++...............++..|+|||++....++.++|||||||++|||++ |..||..... .+...........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~-- 234 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLRHGNRL-- 234 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC--
Confidence 99987654332222222345678999999988889999999999999999999 8888854332 2222221111110
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
... ......+.+++.+||+.||++||++.|+++.|+++
T Consensus 235 -~~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 -KQP-----------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -CCC-----------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 011 11224577999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.44 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=199.7
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
+|+..+.||+|+||+||++.. .+++.||||++...... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477789999999999999995 46899999998653322 23457789999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 999999999887554456899999999999999999999988 99999999999999999999999999987543221
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCcccccccccccCcc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.....|++.|+|||++.+..++.++||||+||++|||++|+.||...... .+.+...+.... .....
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-------~~~~~- 226 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ-------EEYSE- 226 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc-------cccCc-
Confidence 22346899999999999888999999999999999999999999743321 112221111111 00011
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
.....+.+++.+||+.||++|| +++++++
T Consensus 227 ------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 ------KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ------ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1124466899999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=345.53 Aligned_cols=261 Identities=24% Similarity=0.385 Sum_probs=204.2
Q ss_pred hhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcch-hHHHHHHHHHHHhcC-CCCccceeEEEEeeC
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVH-HKNLVGLVGFCFEQG 696 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 696 (964)
..++|...+.||+|+||.||+|++. .++.||||+++...... ...+.+|+++|.++. |||||+++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3446777899999999999999863 24689999997643332 346889999999997 999999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCC----------------------------------------------------------
Q 002121 697 EQMLVYEFMANGTLRESLSGRS---------------------------------------------------------- 718 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------- 718 (964)
..++||||+++|+|.++++..+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986532
Q ss_pred --------------------------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 002121 719 --------------------------------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNIL 760 (964)
Q Consensus 719 --------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 760 (964)
...++|.+++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 123678889999999999999999877 999999999999
Q ss_pred ECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHH
Q 002121 761 LDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVRE 839 (964)
Q Consensus 761 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 839 (964)
+++++.+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||..... .+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~-~~~ 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM-NEQ 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-hHH
Confidence 99999999999999986543222112223457889999999998889999999999999999998 8888864321 111
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
....+..... +.... .....+.+++.+||..+|++||+++|+++.|+.++
T Consensus 351 ~~~~~~~~~~----------~~~p~---~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKRGYR----------MAKPA---HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcCCC----------CCCCC---CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1111111110 00000 01245678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=341.14 Aligned_cols=249 Identities=25% Similarity=0.329 Sum_probs=195.5
Q ss_pred CCCccceeecCCcEEEEEEEe----cCCcEEEEEEecCCC----cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCce
Q 002121 628 NFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGS----MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 698 (964)
+|++.+.||+|+||+||+++. .+|+.||+|++.... ....+.+.+|++++.++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999885 357899999986432 12234578899999999 599999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++..+. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999987543 5889999999999999999999988 999999999999999999999999999865
Q ss_pred cCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC--chhHHHHHHHhccCcccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~ 855 (964)
..... .......||+.|+|||++.+. .++.++|||||||++|||+||+.||... ......+...+...
T Consensus 156 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-------- 226 (332)
T cd05614 156 LSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC-------- 226 (332)
T ss_pred cccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--------
Confidence 43222 122345799999999998764 4789999999999999999999999632 11222222211111
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
++.+... ....+.+++.+||+.||++|| +++++++
T Consensus 227 ---~~~~~~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 227 ---DPPFPSF---IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCCC---CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1111111 113456899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=323.72 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=195.2
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC-----ceEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG-----EQMLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV 701 (964)
.|...+.+|.|+||.||+|... +++.||||+.-.... .-.+|+++|++++|||||++.-+|.... ...||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 4666789999999999999964 578999998754332 2247999999999999999999887543 23589
Q ss_pred EEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeecccceee
Q 002121 702 YEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLSKLV 778 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~~~ 778 (964)
|||||. +|.+.++.. .+..++...+.-+..|+++||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999997 999988742 2346888889999999999999999988 9999999999999976 99999999999988
Q ss_pred cCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCccccc--
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDEEHY-- 852 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~-- 852 (964)
..+... .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|. |++..+++..+ +.....+.-
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp-G~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP-GDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC-CCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 655432 33457889999999876 579999999999999999999997764 34444443332 222221110
Q ss_pred ---ccccccCccchhh------hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 ---GLTEMMDPTIRNT------VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ---~~~~~~d~~l~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+...+.+... ......+.++++.+++..+|.+|.++.|++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 0011111222111 1122356789999999999999999999974
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=323.62 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=195.7
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
+.||+|+||.||+|+. .+|+.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999996 4789999998765432 3345789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++.... ..++|.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99997543 35899999999999999999999988 999999999999999999999999998765432111111111
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLG 869 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (964)
.++..|+|||++..+.++.++|||||||++|||++ |..||...... .......... ..... ...
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--~~~~~~~~~~----------~~~~~---~~~ 221 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--QTREAIEQGV----------RLPCP---ELC 221 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--HHHHHHHcCC----------CCCCc---ccC
Confidence 23467999999998889999999999999999998 88888543221 1111111110 00000 011
Q ss_pred HHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 870 FRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 870 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
...+.+++.+|++.+|++||++.|+.++|+
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 245678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=324.16 Aligned_cols=258 Identities=23% Similarity=0.396 Sum_probs=207.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||.||+|... +|+.||+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999975 78999999886432 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 703 EFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 703 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||+++|+|.+++... ....+++.++..++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999988642 2346899999999999999999999988 99999999999999999999999999886543
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
... ......+++.|+|||++.+..++.++|||||||++|||++|+.||.........+........ .+
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~ 226 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD----------YP 226 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCC----------CC
Confidence 221 122345889999999998888999999999999999999999998643321111111111110 00
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
... .......+.+++.+||..+|++||++.+|+++++.+
T Consensus 227 ~~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 227 PLP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CCC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 011 011224567899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=326.67 Aligned_cols=258 Identities=22% Similarity=0.365 Sum_probs=206.3
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||.||+|+. .+|+.+|||.+..... ....++.+|+++++.++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4677889999999999999995 5789999998765332 23357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 703 EFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 703 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988632 2346899999999999999999999988 99999999999999999999999999886643
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
... ......|+..|+|||++.+..++.++||||||+++|||++|..||................. ..+
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~ 226 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------DYP 226 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC----------CCC
Confidence 321 12234688999999999888899999999999999999999999864332111111111110 011
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
... .......+.+++.+||+.+|++||||.+|++.++++
T Consensus 227 ~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 227 PLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 111 011224567899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.15 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=203.8
Q ss_pred CCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
+|+..+.||+|+||+||+|... ....+|+|.+..... ....++.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4677889999999999999853 235789998875443 234568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC----------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 002121 701 VYEFMANGTLRESLSGRS----------------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 758 (964)
||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999876421 135889999999999999999999988 9999999999
Q ss_pred EEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhH
Q 002121 759 ILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVV 837 (964)
Q Consensus 759 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~ 837 (964)
||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.... .
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-P- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-H-
Confidence 9999999999999999986543322112223346778999999988889999999999999999999 998885432 1
Q ss_pred HHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
..+......... .... ......+.+++.+|++.+|++||+++|+++.|++++.
T Consensus 236 ~~~~~~~~~~~~----------~~~~---~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ERLFNLLKTGYR----------MERP---ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHHhCCCC----------CCCC---CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 122222211110 0000 1112456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.80 Aligned_cols=268 Identities=26% Similarity=0.439 Sum_probs=201.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-----CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-----DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 699 (964)
++|+..+.||+|+||.||+|..+ +++.||+|+++.........+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999742 578999999886655556688999999999999999999998754 34688
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+++|+|.+++.... ..++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 9999999999999997543 35899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCce-eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc---cccc
Q 002121 780 DSSKGHV-STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH---YGLT 855 (964)
Q Consensus 780 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~ 855 (964)
....... .....++..|+|||++.+..++.++|||||||++|||++|..++..... .+. ..+....... ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EFM-RMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hhh-hhcccccccccchHHHH
Confidence 4322111 1112244569999999888899999999999999999998877542211 111 1111100000 0000
Q ss_pred cccCccc-hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 856 EMMDPTI-RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 856 ~~~d~~l-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
+.+.... ..........+.+++.+||+.+|++||||.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0000000 000011124577999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=346.73 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=200.3
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
..++|+..+.||+|+||+||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567889999999999999999964 68899999986422 2223457889999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998754 4778888899999999999999988 99999999999999999999999999987643
Q ss_pred CCCCceeecccccCcccCccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... ...+.......... ...+
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~~--~~~~ 270 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMDHKNSL--TFPD 270 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-HHHHHHHHcCCCcC--CCCC
Confidence 221 122345699999999998643 478999999999999999999999975432 22233332211100 0010
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVKA 897 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 897 (964)
. ......+.+++.+|++.+|++ ||++.|+++.
T Consensus 271 -----~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 -----D----IEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----c----CCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 011245568999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.48 Aligned_cols=264 Identities=27% Similarity=0.412 Sum_probs=206.8
Q ss_pred HhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc--CCCCccceeEEEEee----Cc
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV--HHKNLVGLVGFCFEQ----GE 697 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~----~~ 697 (964)
....+....+.||+|.||.||+|.|+ |+.||||++.... +..+.+|.++++.+ +|+||+.|++.-..+ ..
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 34567778899999999999999996 8999999997543 44788999998865 999999999876543 35
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-----cCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-----LANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
.|||++|.++|||+++|... .++....++++..+|.||+|||. +|+|.|.|||||+.|||+..++.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 79999999999999999874 58999999999999999999995 67899999999999999999999999999
Q ss_pred ccceeecCCCC--CceeecccccCcccCccccccCC----C--CCchhHHHHHHHHHHHHhC----------CCCCC---
Q 002121 773 GLSKLVSDSSK--GHVSTQVKGTMGYLDPEYYMTQQ----L--TEKSDVYSFGVVMLELITA----------KQPIE--- 831 (964)
Q Consensus 773 Gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~sDv~S~Gvvl~elltg----------~~p~~--- 831 (964)
|||........ .......+||.+|||||++...- + -..+||||||.|+||+.-. +.||.
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 99987654321 11234567999999999985431 2 2468999999999998863 24553
Q ss_pred CCchhHHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 832 KGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
..+...+.++..+-. +.+.|.++.. ....+..+.+++..||..+|..|-|+-.+-+.|.++.+
T Consensus 441 p~DPs~eeMrkVVCv---------~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 441 PSDPSFEEMRKVVCV---------QKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCHHHHhcceee---------cccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 122223333333222 2223333322 45567788899999999999999999999999888764
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=337.08 Aligned_cols=240 Identities=24% Similarity=0.334 Sum_probs=189.7
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|... +++.||+|+++... ....+.+..|.+++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 58899999987532 12233456677777654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999987643 5889999999999999999999988 9999999999999999999999999998653322 223
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-~~~~~~i~~~~~----~~~~~~--------- 219 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-DELFDSILNDRP----HFPRWI--------- 219 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC----CCCCCC---------
Confidence 345799999999999988999999999999999999999999964332 222222211111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMS-EVV 895 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~-evl 895 (964)
...+.+++.+||+.+|++||++. ++.
T Consensus 220 --~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 220 --SKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred --CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 13456899999999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.70 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=201.4
Q ss_pred CCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCC-ccceeEEEEeeC------c
Q 002121 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKN-LVGLVGFCFEQG------E 697 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~ 697 (964)
.|...++||+|+||+||+|+ ..+|+.||+|++...... ......+|+.+|++++|+| ||++++++...+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45555779999999999999 457999999998765442 2235689999999999999 999999998877 7
Q ss_pred eEEEEEeccCCChhhhhcCCCC--CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 698 QMLVYEFMANGTLRESLSGRSG--IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
.++||||++. +|..++..... ..++...+..++.|+++||+|||+++ |+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 8899999976 99999987653 35677889999999999999999998 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCc---
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDD--- 848 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~--- 848 (964)
+...-+. ...+..++|.+|.|||++.+. .|+...||||+||+++||++++.-|. +.+..++...++. ...
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp-G~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP-GDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC-CCcHHHHHHHHHHHcCCCCccC
Confidence 9665332 224556789999999999875 79999999999999999999776664 4444444443332 111
Q ss_pred -ccccccccccCccchhh-----h----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 849 -EEHYGLTEMMDPTIRNT-----V----LLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 849 -~~~~~~~~~~d~~l~~~-----~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.....+.+. +...... . ........+++.+|++.+|.+|.|++.+++.
T Consensus 245 Wp~v~~~~~~-k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDY-KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccc-cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 111111111 1111111 1 1111356799999999999999999998864
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=325.28 Aligned_cols=254 Identities=26% Similarity=0.390 Sum_probs=196.4
Q ss_pred CccceeecCCcEEEEEEEecC-Cc--EEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee------Cce
Q 002121 630 SESNEIGSGGYGKVYRGMLSD-GQ--VVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------GEQ 698 (964)
Q Consensus 630 ~~~~~lG~G~fg~Vy~~~~~~-g~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 698 (964)
.+.+.||+|+||.||+|...+ ++ .||+|.++... ......+.+|++++++++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999999754 33 68999887542 23345788999999999999999999988542 246
Q ss_pred EEEEEeccCCChhhhhcCC----CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 699 MLVYEFMANGTLRESLSGR----SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
++||||+++|+|.+++... ....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887422 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
++...............+++.|+|||+.....++.++|||||||++|||++ |+.||..... .+.... +.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~-~~~~~~---- 232 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SEIYDY-LRQGNR---- 232 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH-HHcCCC----
Confidence 987644322111223346778999999998899999999999999999999 7888854322 222221 211110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.. ..+ .....+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 233 ~~--~~~-------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 233 LK--QPP-------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC--CCC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 011 1123467999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=323.35 Aligned_cols=249 Identities=28% Similarity=0.445 Sum_probs=204.2
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||+|... +|+.|++|.+... ......++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677899999999999999964 6899999998643 233456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++++|.++++......+++.+++.++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 99999999998764567999999999999999999999987 99999999999999999999999999987654321
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......|++.|+|||+..++.++.++|||||||++|||++|+.||..... ............ +.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~-----------~~~~~ 223 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GALILKIIRGVF-----------PPVSQ 223 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCC-----------CCCcc
Confidence 22334688999999999998999999999999999999999999965432 222222211110 00110
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+||+.+|++||++.++++
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 ---MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred ---ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 12245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.29 Aligned_cols=236 Identities=24% Similarity=0.309 Sum_probs=190.5
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|+.. +++.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 68899999987532 22334577888888877 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT 153 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence 99999887643 5899999999999999999999988 9999999999999999999999999987543221 223
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~~~~~~----~~~~~--------- 219 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEVV----YPTWL--------- 219 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCCC----CCCCC---------
Confidence 34579999999999998899999999999999999999999996433 22222222221110 11111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 868 LGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
...+.+++.+|++.||++||++
T Consensus 220 --~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 220 --SQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred --CHHHHHHHHHHcccCHHHCCCC
Confidence 1345689999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=332.90 Aligned_cols=261 Identities=26% Similarity=0.449 Sum_probs=206.3
Q ss_pred hcCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEee
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ 695 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 695 (964)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... .....++.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456778899999999999999741 24579999887543 23345789999999999 899999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+..++||||+++|+|.+++.... ...++|.++..++.||++||+|||+.+ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999997542 135789999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
++++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||... ...+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-~~~~~~ 249 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI-PVEELF 249 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-CHHHHH
Confidence 9999999999999987654332222223346778999999988889999999999999999998 77777532 222222
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
.. +..... . + .. ......+.+++.+||+.+|++||++.|+++.|+++..-
T Consensus 250 ~~-~~~~~~----~----~--~~---~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 250 KL-LKEGHR----M----D--KP---ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HH-HHcCCc----C----C--CC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 22 211110 0 0 00 11224567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.18 Aligned_cols=254 Identities=21% Similarity=0.354 Sum_probs=201.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|+..+.||+|+||.||+|+. .+|+.||+|++..........+++|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 34788899999999999999995 57899999998765444455688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.++++... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 99999999987543 6899999999999999999999987 99999999999999999999999999987643221
Q ss_pred ceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 785 HVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......|+..|+|||.+. ...++.++|||||||++|||++|+.||.......... .. ... ....+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~-~~~--------~~~~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LM-SKS--------NFQPPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-ee-ecC--------CCCCCC
Confidence 122346889999999874 3457889999999999999999999986432111110 00 000 000111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
... .......+.+++.+||+.+|++||+++++++.
T Consensus 231 ~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Ccc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 110 01112456789999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=338.70 Aligned_cols=241 Identities=23% Similarity=0.298 Sum_probs=193.5
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|+.. +|+.||+|+++... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999964 57899999987532 22334577889998876 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTT 153 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccc
Confidence 99999887543 5889999999999999999999988 9999999999999999999999999997643222 223
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-~~~~~~i~~~~~~----~p~~~--------- 219 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESILHDDVL----YPVWL--------- 219 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC----CCCCC---------
Confidence 345699999999999988999999999999999999999999974332 2222222221110 11111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-------CHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRP-------TMSEVVK 896 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RP-------s~~evl~ 896 (964)
...+.+++.+||+.||++|| ++.++++
T Consensus 220 --~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 --SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred --CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 13466899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=332.47 Aligned_cols=255 Identities=25% Similarity=0.367 Sum_probs=201.5
Q ss_pred CCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
+|...+.||+|+||+||+|... .++.||+|+++..... ....+.+|+.++++++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3556688999999999999853 2578999998754432 23568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc
Q 002121 701 VYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
++||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 234889999999999999999999988 999999999999999999
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhc
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 845 (964)
+||+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||.... ..+.......
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-~~~~~~~i~~ 241 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVIEMIRN 241 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHc
Confidence 99999999986644332222233456789999999988889999999999999999998 777875432 2233322222
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.... . +. ......+.+++.+||+.+|++||+++||+..|+.
T Consensus 242 ~~~~------~-~~-------~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 242 RQVL------P-CP-------DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred CCcC------C-CC-------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1110 0 00 1122446789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=347.39 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=196.1
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+|.. .+|+.||||++.... ......+++|++++++++|||||++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999985 478999999986432 223356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997543 5888899999999999999999988 9999999999999999999999999996432110
Q ss_pred CC---------------------------------------------ceeecccccCcccCccccccCCCCCchhHHHHH
Q 002121 783 KG---------------------------------------------HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFG 817 (964)
Q Consensus 783 ~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~G 817 (964)
.. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000124699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCC---CCHHHH
Q 002121 818 VVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDR---PTMSEV 894 (964)
Q Consensus 818 vvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ev 894 (964)
|++|||++|+.||..... .+.+......... ....+. ......+.+++.+|+. +|.+| +++.|+
T Consensus 236 vil~elltG~~Pf~~~~~-~~~~~~i~~~~~~--~~~p~~---------~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENS-HETYRKIINWRET--LYFPDD---------IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCH-HHHHHHHHccCCc--cCCCCC---------CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999965332 2222222211110 001000 0011345688999997 66665 599998
Q ss_pred HHH
Q 002121 895 VKA 897 (964)
Q Consensus 895 l~~ 897 (964)
++.
T Consensus 303 l~h 305 (377)
T cd05629 303 KSH 305 (377)
T ss_pred hcC
Confidence 763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=324.97 Aligned_cols=254 Identities=29% Similarity=0.480 Sum_probs=205.6
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|+..++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 457888899999999999999988899999999875443 3457899999999999999999999874 56789999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++....+..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~ 158 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T 158 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence 9999999997665567899999999999999999999988 99999999999999999999999999987653221 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......++..|+|||++....++.++|||||||++|||++ |+.||..... .+.... +..... . ....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~~-~~~~~~----~------~~~~ 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQN-LERGYR----M------PRPD 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHHH-HHcCCC----C------CCCC
Confidence 2223446788999999988889999999999999999999 9999864321 222221 111110 0 0000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.....+.+++.+|++.+|++||+++++...|+.
T Consensus 227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112457799999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.38 Aligned_cols=238 Identities=27% Similarity=0.394 Sum_probs=192.9
Q ss_pred ceeecCCcEEEEEEEe----cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 633 NEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 3588999999875332 233457789999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~ 154 (318)
T cd05582 82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KK 154 (318)
T ss_pred CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cc
Confidence 99999999654 36899999999999999999999988 9999999999999999999999999998654321 12
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
.....||+.|+|||++....++.++|||||||++|||++|+.||..... .+.......... .+...++
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-~~~~~~i~~~~~----~~p~~~~------- 222 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-KETMTMILKAKL----GMPQFLS------- 222 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-HHHHHHHHcCCC----CCCCCCC-------
Confidence 2345799999999999988899999999999999999999999964332 222222221111 1111111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSE 893 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~e 893 (964)
..+.+++.+||+.||++||++.+
T Consensus 223 ----~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 ----PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ----HHHHHHHHHHhhcCHhHcCCCCC
Confidence 34568999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=335.03 Aligned_cols=240 Identities=24% Similarity=0.324 Sum_probs=190.6
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|+.. +++.||||+++... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999965 57899999987532 12234566788888765 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKT 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cce
Confidence 99999997543 5889999999999999999999988 9999999999999999999999999987543221 122
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.......... .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-~~~~~~i~~~~~----~~~~~~--------- 219 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-EELFQSIRMDNP----CYPRWL--------- 219 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----CCCccC---------
Confidence 345699999999999988999999999999999999999999964332 121211111111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMS-EVV 895 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~-evl 895 (964)
...+.+++.+||+.||++||++. ++.
T Consensus 220 --~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 --TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred --CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 13456899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=329.50 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=192.3
Q ss_pred eecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||+||++... +|+.||+|++...... ..+.+..|++++++++|+||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999854 7899999998653322 224577899999999999999999999999999999999999999
Q ss_pred hhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceee
Q 002121 711 RESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788 (964)
Q Consensus 711 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 788 (964)
..++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9887532 2346899999999999999999999988 99999999999999999999999999987644322 123
Q ss_pred cccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCcccccccccccCccchhhh
Q 002121 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ . ...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~---~--------~~~--- 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS---V--------TYP--- 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC---C--------CCc---
Confidence 456899999999999999999999999999999999999999643221 111111110000 0 000
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
......+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11124566899999999999999 6666664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=342.33 Aligned_cols=252 Identities=22% Similarity=0.302 Sum_probs=201.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||+||+|... +|+.||+|+++.... .....+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999954 789999999875432 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999997652 36899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCceeecccccCcccCccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYM------TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||...... ..+...+....... ...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~~~i~~~~~~~~--~~~ 232 (330)
T cd05601 157 M-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-KTYNNIMNFQRFLK--FPE 232 (330)
T ss_pred c-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-HHHHHHHcCCCccC--CCC
Confidence 2 2233456999999999986 456789999999999999999999999754432 22222222111000 000
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
++. ....+.+++.+|++ +|++||++.++++
T Consensus 233 --~~~-------~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 233 --DPK-------VSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CCC-------CCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 011 12446688899997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=328.63 Aligned_cols=260 Identities=22% Similarity=0.374 Sum_probs=206.9
Q ss_pred hcCCCccceeecCCcEEEEEEEecC-----CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEe-eCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD-----GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFE-QGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 698 (964)
.++|...+.||+|+||.||+|...+ +..||+|++..... .....+.+|+.++++++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578888999999999999999765 68899998875432 334568899999999999999999999876 4678
Q ss_pred EEEEEeccCCChhhhhcCCCC------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 699 MLVYEFMANGTLRESLSGRSG------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
++++||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999865431 46899999999999999999999987 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
|+++.+.............++..|+|||++....++.++|||||||++||+++ |+.||.... ..+.. ........
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~~~-~~~~~~~~-- 237 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFEMA-AYLKDGYR-- 237 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHHHH-HHHHcCCC--
Confidence 99986543322222223446778999999988889999999999999999999 999986432 22222 11111110
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
... . ......+.+++.+||..+|++||++.|+++.|+.+.+
T Consensus 238 --~~~--~-------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 --LAQ--P-------INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --CCC--C-------CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 0 0112456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=334.19 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=209.6
Q ss_pred cCCCccceeecCCcEEEEEEEecC---Cc--EEEEEEecCC-CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD---GQ--VVAIKRAQQG-SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
+.....++||+|-||.||+|++.+ |+ .||||.-+.. .....+.|.+|+.+|++++|||||+++|+|.+ ...|+
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi 467 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI 467 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence 344556789999999999999532 33 6899988763 44556679999999999999999999999976 57899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|||.++-|.|.++|+.++ ..++......++.||+.||+|||+.. .|||||.++|||+.+.--+||+|||++|.+.+
T Consensus 468 vmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999998765 46899999999999999999999987 99999999999999999999999999999887
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
......+ ...-.+.|||||.+.-++++.++|||.|||++||+++ |..||+.-++- + ....+.
T Consensus 544 ~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-----------D-----VI~~iE 606 (974)
T KOG4257|consen 544 DAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-----------D-----VIGHIE 606 (974)
T ss_pred cchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-----------c-----eEEEec
Confidence 7654443 4456789999999999999999999999999999887 89999742210 0 000000
Q ss_pred cc-chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 860 PT-IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 860 ~~-l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.. -...++.+...+..++.+||+.||.+||.+.|+...|..+++.+
T Consensus 607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qee 653 (974)
T KOG4257|consen 607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEE 653 (974)
T ss_pred CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHh
Confidence 00 00112334456678999999999999999999999999888743
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=344.12 Aligned_cols=253 Identities=26% Similarity=0.444 Sum_probs=208.7
Q ss_pred cceeecCCcEEEEEEEe-cCCc----EEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 632 SNEIGSGGYGKVYRGML-SDGQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++||+|+||+||||.| ++|+ +||+|++.... .+...++.+|+-+|.+++|||+++++|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 47899999999999995 4554 78999876543 345678999999999999999999999998765 88999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+.|+|.++++.++ ..+--...+.|..|||+||.|||++. +|||||.++|||+.+-..+||.|||+|+.+..+....
T Consensus 780 P~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey 855 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY 855 (1177)
T ss_pred ccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence 9999999998765 46788889999999999999999887 9999999999999999999999999999887665555
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......-.+.|||-|.+....|+.++|||||||.+||++| |..|++.- ..+.+...++... ++ .
T Consensus 856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi--~~~eI~dlle~ge------------RL-s 920 (1177)
T KOG1025|consen 856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGI--PAEEIPDLLEKGE------------RL-S 920 (1177)
T ss_pred cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCC--CHHHhhHHHhccc------------cC-C
Confidence 4445556788999999999999999999999999999999 88898642 2333333333222 11 1
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
+.+.....+..++.+||..|+..||+++++...+.+..+.
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 1223335577899999999999999999999998877654
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.84 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=202.3
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|...+.||+|+||.||+|....+..||+|++..... ..+.+.+|++++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 45777889999999999999987777899998765432 3457889999999999999999999875 456889999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.++++......++|..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++....... ..
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA 159 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence 999999998655556899999999999999999999988 99999999999999999999999999987643221 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||+..+..++.++|||||||++|||+| |+.||...... +...... .... . ...
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~~-~~~~----~------~~~-- 225 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLEQVE-RGYR----M------PCP-- 225 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHH-cCCC----C------CCC--
Confidence 222346778999999988899999999999999999999 88888643321 1122111 1110 0 000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
......+.+++.+||+.+|++||+++++++.|+.
T Consensus 226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 -QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0112456789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=333.01 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=205.4
Q ss_pred cCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeC
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG 696 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 696 (964)
++|.+.+.||+|+||.||+|... ++..+|+|.++... .....++.+|+++++++ +||||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 46888899999999999999852 23579999987543 23345688899999999 7999999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC
Q 002121 697 EQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD 762 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~ 762 (964)
..++||||+++|+|.+++.... ...++|.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999997542 124899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002121 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVR 841 (964)
Q Consensus 763 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 841 (964)
.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||... ... .+.
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~-~~~-~~~ 252 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV-PVE-ELF 252 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC-CHH-HHH
Confidence 999999999999976543221111122234578999999998889999999999999999998 78887532 222 222
Q ss_pred HHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 842 TAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
..+..... .+ .. ......+.+++.+|+..+|++||++.||++.|+++++..
T Consensus 253 ~~~~~~~~-----~~-----~~---~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 253 KLLKEGHR-----MD-----KP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHHcCCC-----CC-----CC---CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 22211110 00 00 111245668999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=344.17 Aligned_cols=256 Identities=21% Similarity=0.282 Sum_probs=199.1
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
....++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999965 68899999986422 22334578999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 9999999999999999754 4788889999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
..... .......||+.|+|||++... .++.++||||+||++|||++|+.||..... ...+.......... ..
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~--~~ 268 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-VGTYSKIMDHKNSL--NF 268 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCccc--CC
Confidence 43221 122345799999999998653 378899999999999999999999975432 22333332211100 01
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVKA 897 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 897 (964)
.+. ......+.+++.+|+..++.+ ||++.|+++.
T Consensus 269 p~~---------~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 PED---------VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCc---------ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 100 001133457888888755543 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=327.51 Aligned_cols=256 Identities=26% Similarity=0.425 Sum_probs=201.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|...+.||+|+||.||+|.+. .+..||+|.+..... .....+.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467888999999999999999975 356899998865432 2345689999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCC-----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cEEEe
Q 002121 699 MLVYEFMANGTLRESLSGRS-----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TAKVA 770 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 770 (964)
++||||+++|+|.++++... ...++|.+++.++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999987643 125899999999999999999999988 99999999999998654 69999
Q ss_pred ecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-~~~~~~-~~~~~~ 239 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-QEVMEF-VTGGGR 239 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH-HHcCCc
Confidence 9999987633221111112234568999999998899999999999999999997 9999864332 111211 111110
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
. + .... ....+.+++.+|++.+|++||++.+|++.|+
T Consensus 240 ~-----~-~~~~-------~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 240 L-----D-PPKG-------CPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred C-----C-CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0 0111 1245678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=360.47 Aligned_cols=263 Identities=20% Similarity=0.291 Sum_probs=205.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|.+.++||+|+||.||+|... +|+.||+|++..... ...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999964 689999999875322 22457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCC---------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 703 EFMANGTLRESLSGRS---------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
||+++|+|.+++.... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 234678889999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCC----------------CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH
Q 002121 774 LSKLVSDSSK----------------GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837 (964)
Q Consensus 774 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~ 837 (964)
+++....... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987621110 001123469999999999999999999999999999999999999996432111
Q ss_pred HHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHhC
Q 002121 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP-TMSEVVKAIETLLQND 905 (964)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 905 (964)
........ ++.-..........+.+++.+|++.||++|| +++++.+.|+.+++..
T Consensus 239 i~~~~~i~-------------~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 ISYRDVIL-------------SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhhhhcc-------------ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11111000 0000000011124466899999999999995 6777888888887643
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=331.87 Aligned_cols=261 Identities=27% Similarity=0.423 Sum_probs=204.0
Q ss_pred hcCCCccceeecCCcEEEEEEEecC-----------------CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD-----------------GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVG 687 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~-----------------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~ 687 (964)
.++|+..+.||+|+||.||+|.... +..||+|++..... ....++.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578888999999999999988542 24689999875543 34567899999999999999999
Q ss_pred eeEEEEeeCceEEEEEeccCCChhhhhcCCC---------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 002121 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRS---------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758 (964)
Q Consensus 688 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 758 (964)
+++++..++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999987543 126899999999999999999999988 9999999999
Q ss_pred EEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCch-
Q 002121 759 ILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQPIEKGKY- 835 (964)
Q Consensus 759 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt--g~~p~~~~~~- 835 (964)
|+++.++.++|+|||+++...............+++.|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986644332233334556789999999988889999999999999999998 6677754321
Q ss_pred -hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 836 -VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 836 -~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.............. ....+ .......++.+++.+|++.||++||++.|+++.|+
T Consensus 241 ~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGR-----QIYLP-----RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccc-----cccCC-----CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111111110 00000 00111246789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=335.46 Aligned_cols=240 Identities=23% Similarity=0.307 Sum_probs=191.0
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|+.. +|+.||+|+++... ......+..|.+++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999965 68899999987532 12334567788888765 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99999987643 5889999999999999999999988 9999999999999999999999999987532221 223
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............ .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-~~~~~~~~~~~~----~~~~~~--------- 219 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRVDTP----HYPRWI--------- 219 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCC----CCCCCC---------
Confidence 446799999999999999999999999999999999999999964332 222222111111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMS-EVV 895 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~-evl 895 (964)
...+.+++.+||+.||++||++. ++.
T Consensus 220 --~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 --TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 13456899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=331.97 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=199.9
Q ss_pred cCCCccceeecCCcEEEEEEEecC---------------CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD---------------GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVG 690 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~---------------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~ 690 (964)
++|.+.+.||+|+||.||+++... ...||+|+++.... .....+.+|++++++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578888999999999999987532 23589999875432 23456899999999999999999999
Q ss_pred EEEeeCceEEEEEeccCCChhhhhcCCC----------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 002121 691 FCFEQGEQMLVYEFMANGTLRESLSGRS----------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNIL 760 (964)
Q Consensus 691 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 760 (964)
++...+..++||||+++++|.+++.... ...++|..++.++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986432 124789999999999999999999988 999999999999
Q ss_pred ECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCc--hh
Q 002121 761 LDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQPIEKGK--YV 836 (964)
Q Consensus 761 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt--g~~p~~~~~--~~ 836 (964)
+++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||.... ..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986543322222233445778999999998899999999999999999998 556765322 11
Q ss_pred HHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 837 VREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
............... .. ...+ .....+.+++.+|++.+|++||++.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~--~~-~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 IENTGEFFRNQGRQI--YL-SQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHhhhhccccc--cC-CCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000 00 0000 11245779999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.96 Aligned_cols=252 Identities=24% Similarity=0.366 Sum_probs=201.5
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc-----hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ-----GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|...+.||+|++|.||+|.. .+++.||+|.+...... ....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999985 46899999988643221 22468899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999987643 5888999999999999999999988 99999999999999999999999999986543
Q ss_pred CCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
..... ......|+..|+|||++.+..++.++||||+|+++|||++|+.||........... ...... .....+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~-~~~~~~--~~~~~~~-- 231 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK-IATQPT--NPQLPSH-- 231 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHH-HhccCC--CCCCCcc--
Confidence 21111 11234578899999999988899999999999999999999999965433222211 111110 0001111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....+.+++.+||..+|++||++.|+++.
T Consensus 232 ---------~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 232 ---------VSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---------CCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 12346689999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=328.67 Aligned_cols=259 Identities=27% Similarity=0.412 Sum_probs=202.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc--EEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ--VVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|++.+.||+|+||.||+|... ++. .+++|.++... ......+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46888899999999999999864 343 57888887432 23345788999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 702 YEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
|||+++|+|.++++... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 124889999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||++...... ........+..|+|||++....++.++|||||||++|||++ |..||..... .+........
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-~~~~~~~~~~ 234 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-AELYEKLPQG 234 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHHHHHHhcC
Confidence 99999998643211 11111223567999999988889999999999999999998 9999864322 2222211111
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
. .+.... .....+.+++.+|++.+|.+||++.++++.|+.+.+...
T Consensus 235 ~-----------~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 235 Y-----------RMEKPR---NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred C-----------CCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 0 000000 111446789999999999999999999999999886654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=318.56 Aligned_cols=252 Identities=25% Similarity=0.300 Sum_probs=203.4
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchh---HHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGG---LEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|+..+.||+|.-|+||+++.+ ++..+|+|++.+.....+ .+.+.|-+||+.++||.++.||+.++.++..+||||
T Consensus 78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me 157 (459)
T KOG0610|consen 78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME 157 (459)
T ss_pred HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence 3445688999999999999976 458999999987654433 457789999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC--
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS-- 781 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~-- 781 (964)
||+||+|..+++.+.+..+++..+..+|.++.-||+|||..| ||+|||||+||||.++|++.|+||.|+......
T Consensus 158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt 234 (459)
T KOG0610|consen 158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT 234 (459)
T ss_pred cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence 999999999999988889999999999999999999999999 999999999999999999999999987543210
Q ss_pred ------------------------------C-C---------------------CceeecccccCcccCccccccCCCCC
Q 002121 782 ------------------------------S-K---------------------GHVSTQVKGTMGYLDPEYYMTQQLTE 809 (964)
Q Consensus 782 ------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 809 (964)
. . ...+...+||-.|+|||++.+...+.
T Consensus 235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs 314 (459)
T KOG0610|consen 235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS 314 (459)
T ss_pred eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence 0 0 00112346999999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC
Q 002121 810 KSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP 889 (964)
Q Consensus 810 ~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP 889 (964)
++|.|+|||++|||+.|..||..... .+-+..++..... +.+. ........+||.+.|.+||++|.
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~-~~Tl~NIv~~~l~------------Fp~~-~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNN-KETLRNIVGQPLK------------FPEE-PEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCc-hhhHHHHhcCCCc------------CCCC-CcchhHHHHHHHHHhccChhhhh
Confidence 99999999999999999999964332 2223333322221 1111 12224556999999999999998
Q ss_pred C----HHHHHH
Q 002121 890 T----MSEVVK 896 (964)
Q Consensus 890 s----~~evl~ 896 (964)
- ++||-+
T Consensus 381 g~~rGA~eIK~ 391 (459)
T KOG0610|consen 381 GSKRGAAEIKR 391 (459)
T ss_pred ccccchHHhhc
Confidence 7 777753
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=342.57 Aligned_cols=259 Identities=19% Similarity=0.220 Sum_probs=196.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.+|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||++
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 36889999999999999999965 578999996432 24678999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
. ++|.+++.... ..++|.+++.|+.|+++||+|||+.+ ||||||||+|||++.++.+||+|||+++.........
T Consensus 243 ~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 243 R-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred C-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 5 68998886543 36999999999999999999999988 9999999999999999999999999998764332222
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc------hhHHHHHHHhccCcccccccccccC
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK------YVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
......||+.|+|||++.+..++.++|||||||++|||++|..|+.... .....+...+...............
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2334579999999999999999999999999999999999887654211 1111122111111100000000000
Q ss_pred ccc--------------------hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTI--------------------RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l--------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+ +.........+.+++.+||+.||.+|||+.|+++
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 000 0000011124678999999999999999999986
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=337.19 Aligned_cols=242 Identities=21% Similarity=0.303 Sum_probs=192.0
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|... +++.||+|+++.... .....+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 688999999875322 2234578899999998 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccc
Confidence 99999886543 6899999999999999999999988 9999999999999999999999999987532211 222
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------chhHHHHHHHhccCcccccccccccCc
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG-------KYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||+.. ....++....+..... .+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~p~---- 226 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI---RIPR---- 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC---CCCC----
Confidence 3457999999999999999999999999999999999999999621 1111222222211110 0111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCC------HHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPT------MSEVV 895 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~evl 895 (964)
.+ ...+.+++.+|++.||.+||+ +.+++
T Consensus 227 ~~-------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 227 SL-------SVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred CC-------CHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 11 134568999999999999998 55664
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=337.03 Aligned_cols=238 Identities=21% Similarity=0.293 Sum_probs=188.8
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|+.. +++.||+|+++.... .....+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 688999999875422 2334577899988877 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Ccc
Confidence 99999886543 6899999999999999999999988 9999999999999999999999999997532221 122
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-------chhHHHHHHHhccCcccccccccccCc
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG-------KYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... .....++...+..... .+. .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---~~p----~ 226 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---RIP----R 226 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC---CCC----C
Confidence 3457999999999999999999999999999999999999999521 1111222221111110 011 1
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
. ....+.+++.+||+.||++||++
T Consensus 227 ~-------~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 227 S-------LSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C-------CCHHHHHHHHHHhcCCHHHcCCC
Confidence 1 11345689999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=336.03 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=193.4
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+|...+.||+|+||+||+|+.. +++.||+|++..... .....+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999965 578999999875322 2233566788888877 5899999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999987543 5889999999999999999999988 9999999999999999999999999997543221
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ............. ... .+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-~~~~~~i~~~~~~----~p~----~~ 224 (323)
T cd05616 156 --VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DELFQSIMEHNVA----YPK----SM 224 (323)
T ss_pred --CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC----CCC----cC
Confidence 122345799999999999999999999999999999999999999975332 2222222221110 111 11
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
...+.+++.+|++.+|++|++.
T Consensus 225 -------s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 225 -------SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -------CHHHHHHHHHHcccCHHhcCCC
Confidence 1345689999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.60 Aligned_cols=249 Identities=28% Similarity=0.478 Sum_probs=204.9
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|+..+.||+|+||.||+|... |+.||+|.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999975 78999999986544 45678999999999999999999999999899999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+++|.+++.......++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999998665456999999999999999999999988 9999999999999999999999999998663221
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
....++..|+|||++..+.++.++||||||+++|||++ |+.||.... ...+......... .....
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~~--~~~~~--------- 222 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHVEKGYR--MEAPE--------- 222 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhcCCC--CCCcc---------
Confidence 12335678999999998889999999999999999997 999986432 1222222211110 00000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.....+.+++.+|+..+|++||++.|++++|+.
T Consensus 223 --~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 --GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112456789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=322.61 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=207.4
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|.+.+.||+|+||.||+|..++++.||||.+..... ...++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888999999999999999988888999999875443 3467899999999999999999999999889999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++....+..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... .
T Consensus 84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (261)
T cd05034 84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY-T 159 (261)
T ss_pred CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-h
Confidence 9999999998765567999999999999999999999988 99999999999999999999999999987643211 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......++..|+|||.+.+..++.++||||+||++|||++ |+.||..... ............ . .....
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~~~~~~~-----~--~~~~~--- 228 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERGYR-----M--PRPPN--- 228 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCC-----C--CCCCC---
Confidence 1122335678999999998889999999999999999999 9999864322 222222211100 0 00000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 229 ----~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 229 ----CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 12456789999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.43 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=200.6
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEee------
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ------ 695 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------ 695 (964)
.+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888899999999999999964 68899999987543 3345788999999998 799999999998753
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
...++||||+++|+|.+++.......++|..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 35789999999999999998755557899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 850 (964)
+...... .......|++.|+|||++. ...++.++|||||||++|||++|+.||............ . ...
T Consensus 159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~-~-~~~-- 232 (272)
T cd06637 159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI-P-RNP-- 232 (272)
T ss_pred eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-h-cCC--
Confidence 8654321 1223456899999999986 345788999999999999999999999643322222111 1 111
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.. ....+.+++.+||..+|.+||++.|+++
T Consensus 233 ---~~~~~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 ---APRLKSKK-------WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---CCCCCCCC-------cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00111111 1135678999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=328.52 Aligned_cols=260 Identities=24% Similarity=0.373 Sum_probs=203.8
Q ss_pred hhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
..++|++.+.||+|+||.||+|..+ .+..||+|.+..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568889999999999999999753 245899998764432 233468899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 698 QMLVYEFMANGTLRESLSGRS--------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
.++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996432 234577888999999999999999988 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.... ..+..........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~ 239 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-NEQVLKFVMDGGY 239 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCC
Confidence 99999986543322222222345778999999998899999999999999999999 677885322 1222222211111
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
. ... ......+.+++.+|++.+|++||++.|+++.++..+
T Consensus 240 ~-----------~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 240 L-----------DQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred C-----------CCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 0 000 011245779999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=345.62 Aligned_cols=356 Identities=21% Similarity=0.228 Sum_probs=318.5
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
++++.|+|.+|-|+..-..++..++.|+.||||.| .|+....++|..-.++++|+|++|+|+..--+.|..+.+|.+|.
T Consensus 125 ghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN-~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 125 GHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN-LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred cceeEEeeeccccccccHHHHHhHhhhhhhhhhhc-hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 57888999999998888888999999999999999 78887778888888999999999999987888899999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|+++...+..|.+|++|+.|+|..|+|. +...-.|.+|++|+.|.|..|++. .+.+++|..+.++++|+|
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~ir------ive~ltFqgL~Sl~nlklqrN~I~-kL~DG~Fy~l~kme~l~L 276 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIR------IVEGLTFQGLPSLQNLKLQRNDIS-KLDDGAFYGLEKMEHLNL 276 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhcccccee------eehhhhhcCchhhhhhhhhhcCcc-cccCcceeeecccceeec
Confidence 9999999777788999999999999999998 444567899999999999999999 899999999999999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~ 302 (964)
..|+++..-..++-+++.|+.|+||+|.|....++.+.-+++|++|+|++|+|+...+. |..+..|+.|.|++|.++ .
T Consensus 277 ~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~-~ 355 (873)
T KOG4194|consen 277 ETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSID-H 355 (873)
T ss_pred ccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchH-H
Confidence 99999988888999999999999999999988899999999999999999999998885 999999999999999997 6
Q ss_pred CCCcccCCCCCCcEEECCCCccccccCh---hccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC
Q 002121 303 EAPLWFSTLPSLTTLICEFGSLQGRVPD---KLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379 (964)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 379 (964)
+....|..+++|+.|||++|.|...+.+ .|.+|+.|+.|.|.+|+|..+.-.+|..++.|+.|||.+|.|.+|.+.+
T Consensus 356 l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nA 435 (873)
T KOG4194|consen 356 LAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNA 435 (873)
T ss_pred HHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccc
Confidence 6677899999999999999999987664 6889999999999999999999999999999999999999999999887
Q ss_pred Ccc--cceeEeecCC-cccccccccCccccCCCCCcccccccccCCCCCCCCCCC
Q 002121 380 GIK--NYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQK 431 (964)
Q Consensus 380 ~~~--l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~ 431 (964)
+.. +..|.+.--. +|||.+.++..|....... ......|+.|+.+.++.
T Consensus 436 Fe~m~Lk~Lv~nSssflCDCql~Wl~qWl~~~~lq---~sv~a~CayPe~Lad~~ 487 (873)
T KOG4194|consen 436 FEPMELKELVMNSSSFLCDCQLKWLAQWLYRRKLQ---SSVIAKCAYPEPLADQS 487 (873)
T ss_pred cccchhhhhhhcccceEEeccHHHHHHHHHhcccc---cceeeeccCCcccccce
Confidence 766 5667766656 9999999999997655442 44567899998888873
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=344.72 Aligned_cols=251 Identities=19% Similarity=0.295 Sum_probs=192.6
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|...+.||+|+||+||+|+. .+++.||+|++..... .....+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578889999999999999995 4688999999875322 223468899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||++|+|.+++...+ .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997643 5788889999999999999999988 99999999999999999999999999753210000
Q ss_pred ---------------------------------------------CceeecccccCcccCccccccCCCCCchhHHHHHH
Q 002121 784 ---------------------------------------------GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGV 818 (964)
Q Consensus 784 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gv 818 (964)
........||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 002121 819 VMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT---MSEVV 895 (964)
Q Consensus 819 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl 895 (964)
++|||++|+.||...... +............ .. +.. ... .....+++.+++ .+|++|++ +.|++
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~--~~-----p~~-~~~---s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPL-ETQMKVINWQTSL--HI-----PPQ-AKL---SPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHH-HHHHHHHccCCCc--CC-----CCc-ccC---CHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999999754322 2222222111100 00 000 001 123446666654 59999987 77765
Q ss_pred H
Q 002121 896 K 896 (964)
Q Consensus 896 ~ 896 (964)
+
T Consensus 304 ~ 304 (382)
T cd05625 304 A 304 (382)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=323.47 Aligned_cols=258 Identities=24% Similarity=0.456 Sum_probs=202.3
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCc----EEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQ----VVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|+..+.||+|+||+||+|.+ .+|+ .||+|+++.... ....++.+|+.+++.++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 4677889999999999999985 3454 489999875433 334578899999999999999999999975 45789
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
+|||+++|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 86 ~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999997643 35899999999999999999999988 99999999999999999999999999987653
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........+++.|+|||...+..++.++|||||||++|||++ |..||..... ..+...+..... .. ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~----~~--~~ 233 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--REIPDLLEKGER----LP--QP 233 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCCc----CC--CC
Confidence 322111222345678999999998899999999999999999998 8889864321 111111111110 00 00
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
+ .....+.+++.+||+.||++||++.|+++.++.+.+.
T Consensus 234 ~-------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 234 P-------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred c-------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 0 1124567899999999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=334.21 Aligned_cols=241 Identities=22% Similarity=0.302 Sum_probs=193.6
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|... +++.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999965 57899999987532 22334577899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTT 153 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Ccc
Confidence 99999887543 6899999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ... .+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-~~~~~~i~~~~~~----~~~----~~----- 219 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-DELFQSILEDEVR----YPR----WL----- 219 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-HHHHHHHHcCCCC----CCC----cC-----
Confidence 335689999999999999999999999999999999999999964332 2222222211110 111 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTM-----SEVVK 896 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 896 (964)
...+.+++.+||+.||++||++ .++++
T Consensus 220 --~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 --SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred --CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1346689999999999999999 77654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=345.29 Aligned_cols=251 Identities=21% Similarity=0.314 Sum_probs=194.2
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
+|++.+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688899999999999999995 4689999999864321 223468899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC-
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS- 782 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~- 782 (964)
|+++|+|.+++...+ .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|.......
T Consensus 82 ~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999997653 5788888999999999999999988 9999999999999999999999999975321000
Q ss_pred ----------------------------------------CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHH
Q 002121 783 ----------------------------------------KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLE 822 (964)
Q Consensus 783 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~e 822 (964)
.........||+.|+|||++.+..++.++|||||||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 0001123469999999999999999999999999999999
Q ss_pred HHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC---CHHHHHH
Q 002121 823 LITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP---TMSEVVK 896 (964)
Q Consensus 823 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~ 896 (964)
|++|+.||...... +........... ... +. .. .....+.+++.+|+ .+|++|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~-~~~~~i~~~~~~--~~~-----~~-~~---~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPA-ETQLKVINWETT--LHI-----PS-QA---KLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHH-HHHHHHhccCcc--ccC-----CC-CC---CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999754322 111111111100 000 00 00 01133456777765 5999999 8888875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=330.52 Aligned_cols=258 Identities=25% Similarity=0.423 Sum_probs=201.2
Q ss_pred cCCCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEee--Cce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 698 (964)
..|+..+.||+|+||.||++.. .++..||+|.++... ......+.+|++++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467789999999999999974 357899999987543 23345789999999999999999999999875 568
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++++|.+++.... ..++|.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 159 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence 99999999999999986543 35899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH-------------HHHHHHh
Q 002121 779 SDSSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV-------------REVRTAM 844 (964)
Q Consensus 779 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~-------------~~~~~~~ 844 (964)
...... .......++..|+|||++.+..++.++|||||||++|||+|++.|........ .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05079 160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239 (284)
T ss_pred ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence 433221 11223456778999999988889999999999999999999887653211100 0000000
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.... .... .......+.+++.+|++.+|++||++.++++.++.+
T Consensus 240 ~~~~----------~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGK----------RLPR---PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCc----------cCCC---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000 0000 111235678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.82 Aligned_cols=248 Identities=24% Similarity=0.361 Sum_probs=198.0
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
|+..+.||+|+||+||+|.. .+|+.||+|.+...... ....+.+|++++++++|+||+++.+++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66678999999999999986 46899999998654322 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.......+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 99999999887655456999999999999999999999988 9999999999999999999999999997654321
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCcccccccccccCccc
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||....... ..+........ ....+.+
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 228 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE-------EVYSAKF 228 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc-------cccCccC
Confidence 1233468999999999998899999999999999999999999997543221 11111111110 0011111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
...+.+++.+|++.||++||+ +.++++
T Consensus 229 -------~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 229 -------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred -------CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 134568999999999999999 555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=325.92 Aligned_cols=256 Identities=28% Similarity=0.437 Sum_probs=203.4
Q ss_pred hcCCCccceeecCCcEEEEEEEecC------CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|.+.+.||+|+||.||+|.... +..||+|.+..... .....+.+|+.++++++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998642 36899999875432 3345788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCC--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEe
Q 002121 699 MLVYEFMANGTLRESLSGRS--------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999986532 124789999999999999999999987 9999999999999999999999
Q ss_pred ecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
|||+++...............++..|+|||.+..+.++.++|||||||++||++| |+.||.... ..+... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~-~~~~~~- 238 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEVLK-FVIDGG- 238 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHHHH-HHhcCC-
Confidence 9999986544332222233456889999999988889999999999999999998 888885322 111111 111111
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
...... .....+.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 -~~~~~~-----------~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 239 -HLDLPE-----------NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -CCCCCC-----------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000111 01245679999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.04 Aligned_cols=253 Identities=27% Similarity=0.360 Sum_probs=191.6
Q ss_pred ceeecCCcEEEEEEEecC---CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 633 NEIGSGGYGKVYRGMLSD---GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+.||+|+||.||+|.+.+ +..+|+|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999998643 45799998875443 33457889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 709 TLRESLSGRS---GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 709 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+|.+++.... ....++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997532 234678888899999999999999988 9999999999999999999999999997544332212
Q ss_pred eeecccccCcccCccccccC-------CCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 786 VSTQVKGTMGYLDPEYYMTQ-------QLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
......|+..|+|||++... .++.++|||||||++|||++ |+.||............ ..... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~------~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-VREQQ------LKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-hhccc------CCC
Confidence 22334578899999998642 35789999999999999996 99999653322211111 11100 111
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.++.+... ....+.+++.+|+ .+|++||+++||++.|+
T Consensus 231 ~~~~~~~~---~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKLP---LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCCC---CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111 1134567889998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=336.22 Aligned_cols=237 Identities=28% Similarity=0.354 Sum_probs=188.6
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHH-HHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIE-LLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|+.. +|+.||+|++..... ....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999964 789999999864321 22234445544 56789999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 99999987543 6889999999999999999999988 9999999999999999999999999987543221 223
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......... .+.+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~--------~~~~~~----- 219 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-TAEMYDNILNKPL--------RLKPNI----- 219 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC-HHHHHHHHHcCCC--------CCCCCC-----
Confidence 34569999999999999999999999999999999999999996432 2222222222111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMS 892 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~ 892 (964)
...+.+++.+|++.||++||++.
T Consensus 220 --~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 220 --SVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred --CHHHHHHHHHHhhcCHHhCCCCC
Confidence 24466899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=327.97 Aligned_cols=249 Identities=22% Similarity=0.365 Sum_probs=202.9
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.+|+..+.||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4788889999999999999985 468999999987665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~ 171 (296)
T cd06654 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (296)
T ss_pred CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc--c
Confidence 999999998653 4789999999999999999999988 9999999999999999999999999987653321 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........... ...... ...-.
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~-~~~~~~------~~~~~------ 238 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL-IATNGT------PELQN------ 238 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH-HhcCCC------CCCCC------
Confidence 12234688999999999888889999999999999999999999975443222221 111110 00000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||..+|++||++.|+++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0111244668999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.51 Aligned_cols=247 Identities=26% Similarity=0.396 Sum_probs=194.8
Q ss_pred eeecCCcEEEEEEEe---cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 634 EIGSGGYGKVYRGML---SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+||+|+||.||+|.+ .++..+|+|+++..... ..+++.+|+.++++++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 35789999998754332 3457899999999999999999999885 45778999999999
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc-ee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH-VS 787 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~ 787 (964)
+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997543 5899999999999999999999988 9999999999999999999999999998764332211 11
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
....++..|+|||.+....++.++|||||||++|||++ |+.||..... ...... +..... ......
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~-i~~~~~--~~~~~~--------- 222 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVTQM-IESGER--MECPQR--------- 222 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HHCCCC--CCCCCC---------
Confidence 12234678999999988889999999999999999998 9999864321 222222 221110 001111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
....+.+++.+||+.||++||++.+|++.|+..
T Consensus 223 --~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 223 --CPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 124566899999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.73 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=202.8
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+|+..+.||+|+||.||++... +++.+|+|.++... ....+.+.+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4777899999999999999954 68999999986432 333457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++....+..+++.....++.|++.||.|||+.+ |+|+||||+||++++++.++++|||+++...... .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~ 155 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG--A 155 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc--c
Confidence 9999999987655556899999999999999999999988 9999999999999999999999999998664322 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ............ ..+...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-~~~~~~~~~~~~-------~~~~~~---- 223 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-KNLILKVCQGSY-------KPLPSH---- 223 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-HHHHHHHhcCCC-------CCCCcc----
Confidence 22335689999999999888899999999999999999999999975432 222222111111 001111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....+.+++.+||+.||++||++.|++..
T Consensus 224 ---~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 ---YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11346689999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=340.33 Aligned_cols=260 Identities=22% Similarity=0.273 Sum_probs=201.6
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
..++....++|+..+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3455556789999999999999999999965 68899999986422 2223457889999999999999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
++..++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 99999999999999999998754 4788888999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccC----CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ----QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 850 (964)
++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||..... .......+......
T Consensus 189 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~~ 266 (371)
T cd05622 189 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-VGTYSKIMNHKNSL 266 (371)
T ss_pred eeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCcc
Confidence 987643321 122345799999999998653 378999999999999999999999975432 22333333221100
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVKA 897 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 897 (964)
. .. +. ......+.+++.+|+..++.+ ||++.|+++.
T Consensus 267 ~--~~---~~------~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 267 T--FP---DD------NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred c--CC---Cc------CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0 00 00 011234568889999844433 7789888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=329.80 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=202.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc--EEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ--VVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|+..+.||+|+||.||+|..+ +|. .+|+|.++... .....++.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46778899999999999999964 454 46888776433 23345788999999999 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 702 YEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
|||+++|+|.++++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999997532 235789999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||+++..... .......++..|+|||++....++.++|||||||++|||+| |..||..... .+.... ...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~-~~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEK-LPQ 238 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHHH-Hhc
Confidence 99999998643211 11111234678999999988889999999999999999998 9999853221 122211 111
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
... . .... .....+.+++.+||+.+|++||++.++++.++.++....
T Consensus 239 ~~~----~------~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 239 GYR----L------EKPL---NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred CCc----C------CCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 100 0 0000 112346789999999999999999999999999886664
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.42 Aligned_cols=257 Identities=28% Similarity=0.503 Sum_probs=203.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CC---cEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DG---QVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|+..+.||+|+||.||+|... ++ ..+|+|.++... .....++.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346778899999999999999964 33 379999887543 2334578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++++|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 84 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 84 ITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999997543 36899999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCcee-ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 781 SSKGHVS-TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 781 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
....... .....+..|+|||++..+.++.++|||||||++|||++ |+.||..... .+.......... ...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-~~~~~~i~~~~~-----~~~-- 231 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAINDGFR-----LPA-- 231 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-HHHHHHHhcCCC-----CCC--
Confidence 3221111 11223567999999988889999999999999999998 9999864322 222222211110 000
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 232 -------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 -------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 001124567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=327.76 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=200.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-----------------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccce
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-----------------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGL 688 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-----------------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l 688 (964)
++|+..+.||+|+||.||++... ++..||+|++..... ....++.+|++++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998532 234799999875433 334578999999999999999999
Q ss_pred eEEEEeeCceEEEEEeccCCChhhhhcCCC---------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 002121 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRS---------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNI 759 (964)
Q Consensus 689 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 759 (964)
++++...+..++||||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 999999999999999999999999987543 124778899999999999999999988 99999999999
Q ss_pred EECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh--CCCCCCCCchhH
Q 002121 760 LLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT--AKQPIEKGKYVV 837 (964)
Q Consensus 760 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt--g~~p~~~~~~~~ 837 (964)
|+++++.++|+|||+++.+.............+++.|+|||+...+.++.++|||||||++|||++ |..||..... .
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-E 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-H
Confidence 999999999999999986543322122223345678999999888889999999999999999998 6678753221 1
Q ss_pred HHHHH---HhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 838 REVRT---AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 838 ~~~~~---~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
+.+.. ....... ....+. .......+.+++.+||+.||++||++.||++.|+
T Consensus 241 ~~~~~~~~~~~~~~~------~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGR------QVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccc------cccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11111 1111000 000000 0111245779999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=329.02 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=202.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|+..+.||+|+||.||+|... ++..||+|++..... ....++.+|+.++++++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888999999999999999853 467899999875433 3345789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCC--------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 002121 699 MLVYEFMANGTLRESLSGRS--------------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 758 (964)
++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986432 134788999999999999999999988 9999999999
Q ss_pred EEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhH
Q 002121 759 ILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVV 837 (964)
Q Consensus 759 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~ 837 (964)
|++++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... ..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-~~ 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-HE 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HH
Confidence 9999999999999999886543322122222345678999999988899999999999999999998 888885322 22
Q ss_pred HHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
+.......... .. .. ......+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ~~~~~~~~~~~------~~-~~-------~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYVRDGNV------LS-CP-------DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHhcCCC------CC-CC-------CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 22222211110 00 00 011245778999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.54 Aligned_cols=247 Identities=26% Similarity=0.440 Sum_probs=197.6
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChh
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLR 711 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 711 (964)
+.||+|+||.||+|...+++.||+|+++..... ....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 368999999999999888999999998765432 2346889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeeccc
Q 002121 712 ESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791 (964)
Q Consensus 712 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 791 (964)
+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++....... .......
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 155 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQ 155 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCC
Confidence 9987543 35899999999999999999999988 99999999999999999999999999976433211 1111223
Q ss_pred ccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 792 gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
++..|+|||++..+.++.++|||||||++||+++ |..||..... .. .......... . . .... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-~~-~~~~~~~~~~----~-~-~~~~-------~~ 220 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-QQ-AREQVEKGYR----M-S-CPQK-------CP 220 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-HH-HHHHHHcCCC----C-C-CCCC-------CC
Confidence 4678999999998899999999999999999999 8989864321 11 1111111110 0 0 0011 12
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
..+.+++.+|++.+|++||++.|+++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 45678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.10 Aligned_cols=248 Identities=27% Similarity=0.445 Sum_probs=199.6
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEE-eeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF-EQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~E~~ 705 (964)
.+|...+.||+|+||.||+|..+ |..||+|.++... ..+.+.+|+.++++++|+|++++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36778899999999999999875 7889999986533 2457899999999999999999999765 456789999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999998765556899999999999999999999988 9999999999999999999999999988653321
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
....++..|+|||++....++.++|||||||++|||++ |+.||.... ..+.... +..... ....+
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~~~-~~~~~~--~~~~~-------- 222 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPR-VEKGYK--MDAPD-------- 222 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH-HhcCCC--CCCCC--------
Confidence 12335678999999988889999999999999999998 898886432 2222221 111110 00111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
.....+.+++.+|++.+|++||++.++++.|+.
T Consensus 223 ---~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 ---GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 112456689999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=320.29 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=193.5
Q ss_pred ceeecCCcEEEEEEEec----CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEe-eCceEEEEEecc
Q 002121 633 NEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE-QGEQMLVYEFMA 706 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E~~~ 706 (964)
+.||+|+||.||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.. ++..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 23579999886433 2334578899999999999999999998764 556899999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc-
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH- 785 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~- 785 (964)
+|+|.+++.... ...++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997643 34678888999999999999999987 9999999999999999999999999997654321111
Q ss_pred -eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCC-CCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 786 -VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQ-PIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 786 -~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......++..|+|||++....++.++|||||||++|||++|.. ||.. ....+........... ...+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~-~~~~~~~~~~~~~~~~---~~~~------- 225 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VDSFDITVYLLQGRRL---LQPE------- 225 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHHhcCCCC---CCCC-------
Confidence 1123346778999999988899999999999999999999654 5543 2222222222111110 0000
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.....+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 226 ----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 ----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 01235678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.67 Aligned_cols=248 Identities=24% Similarity=0.349 Sum_probs=198.5
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
|+..+.||+|+||.||++... +++.||||.+...... ....+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999964 6899999988653322 224577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 99999999986554456899999999999999999999987 99999999999999999999999999976543221
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCcccccccccccCccc
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.......... . ..
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------~----~~ 224 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------E----EY 224 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh-------h----hc
Confidence 123468999999999999899999999999999999999999997532211 11111111000 0 00
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
.. .....+.+++.+||+.||++||+ ++|+++
T Consensus 225 ~~---~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SE---KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred Cc---cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 00 11234568999999999999999 778875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=318.98 Aligned_cols=254 Identities=24% Similarity=0.441 Sum_probs=204.5
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|+..+.||+|+||.||+|...++..+|+|.++... .....+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 45788899999999999999998778889999887543 234578899999999999999999999887 7889999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++....+..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 158 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-T 158 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc-c
Confidence 9999999998755567899999999999999999999987 99999999999999999999999999986543221 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......++..|+|||++..+.++.++|||||||++||++| |+.||..... .+... ....... . . ..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-~~~~~-~~~~~~~----~-~-----~~- 225 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVIR-ALERGYR----M-P-----RP- 225 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-HHHHH-HHhCCCC----C-C-----Cc-
Confidence 2223346678999999998889999999999999999999 8888864322 11111 1111110 0 0 00
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 --~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 --ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred --ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0112456789999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=329.77 Aligned_cols=239 Identities=22% Similarity=0.292 Sum_probs=190.2
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|.. .+++.||+|+++.... .....+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999996 4678999999975432 2234578899999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++...+ .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT 153 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence 99999886543 5899999999999999999999988 9999999999999999999999999997532221 223
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----chhHHHHHHHhccCcccccccccccCccc
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG-----KYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+.+......... .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~p~~~---- 226 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI---RIPRFL---- 226 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC---CCCCCC----
Confidence 3467999999999999999999999999999999999999999521 1112222222211110 011111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMS 892 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 892 (964)
...+.+++.+||+.||++|+++.
T Consensus 227 -------~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 227 -------SVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -------CHHHHHHHHHHhccCHHHcCCCC
Confidence 13456899999999999999854
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=329.34 Aligned_cols=261 Identities=28% Similarity=0.458 Sum_probs=204.0
Q ss_pred cCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEeeC
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG 696 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 696 (964)
++|.+.+.||+|+||.||+|+.. ....||+|.++.... ....++.+|+++++++ +||||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 245799998875432 3345688999999999 6999999999999989
Q ss_pred ceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC
Q 002121 697 EQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD 762 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~ 762 (964)
..++||||+++|+|.+++.... ...++|.++..++.|++.||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996532 235899999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002121 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVR 841 (964)
Q Consensus 763 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 841 (964)
+++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |+.||.... ..+ +.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-~~~-~~ 246 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP-VEE-LF 246 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC-HHH-HH
Confidence 999999999999986543222111122234568999999998889999999999999999999 888885322 112 11
Q ss_pred HHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 842 TAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
....... ..+. . ......+.+++.+|+..+|++||++.|+++.|+++....
T Consensus 247 ~~~~~~~-----~~~~-~-------~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 247 KLLREGH-----RMDK-P-------SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHcCC-----CCCC-C-------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 1111111 0000 0 111235668999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.58 Aligned_cols=256 Identities=25% Similarity=0.357 Sum_probs=201.9
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
|++.+++++.....||+|+||.||+|.. ++++.||+|.+..........+.+|++++++++|+||+++++++.+++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3455677777788999999999999995 467899999987666556668999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCcc--chHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccce
Q 002121 700 LVYEFMANGTLRESLSGRSGIHL--DWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSK 776 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~ 776 (964)
+||||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~ 157 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSK 157 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence 9999999999999997542 234 88889999999999999999987 999999999999976 6799999999997
Q ss_pred eecCCCCCceeecccccCcccCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH-hccCcccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA-MNRDDEEHYG 853 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~ 853 (964)
....... ......|++.|+|||++... .++.++|||||||++|||++|+.||............. ...
T Consensus 158 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 228 (268)
T cd06624 158 RLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------- 228 (268)
T ss_pred ecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc-------
Confidence 6543221 12234588999999998654 37899999999999999999999986432211111100 000
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+.. .....+.+++.+||+.+|++||++.|+++
T Consensus 229 ----~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 ----IHPEIPE---SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----cCCCCCc---ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0011111 11244668999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.48 Aligned_cols=263 Identities=21% Similarity=0.338 Sum_probs=198.1
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|...+.||+|+||.||+|+.. +++.||+|+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999964 678999999875432 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence 985 8888886543 35889999999999999999999988 99999999999999999999999999976533221
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCccccc---------
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHY--------- 852 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~--------- 852 (964)
......+|+.|+|||++.+ ..++.++|||||||++|||+||+.||...... ...+...+........
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999999865 56889999999999999999999999643321 1111111111110000
Q ss_pred ---ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 ---GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ---~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.........+..........+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000000111234678999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.94 Aligned_cols=257 Identities=25% Similarity=0.396 Sum_probs=203.5
Q ss_pred cCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778999999999999998643 2479999887654 3345679999999999999999999998875 567899
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 35899999999999999999999988 999999999999999999999999999876443
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. .......++..|+|||++....++.++|||||||++|||++ |..||...... +.......... .
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~~~~~~~~-----~------ 227 (270)
T cd05056 161 SY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIGRIENGER-----L------ 227 (270)
T ss_pred cc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHcCCc-----C------
Confidence 21 12222335578999999988889999999999999999996 99999654322 11111111110 0
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
... ......+.+++.+|+..+|++||++.++++.|+.+...
T Consensus 228 ~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 PMP---PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000 01124567899999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.17 Aligned_cols=249 Identities=26% Similarity=0.414 Sum_probs=199.6
Q ss_pred ceeecCCcEEEEEEEecC--C--cEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLSD--G--QVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999999643 3 3699999987665 455689999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc-e
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH-V 786 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~ 786 (964)
|+|.+++.......++|..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654346899999999999999999999988 9999999999999999999999999998765432211 1
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... .+........... .. .+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~----~~---~~----- 223 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG-SQILKKIDKEGER----LE---RP----- 223 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCc----CC---CC-----
Confidence 223457889999999998899999999999999999999 9999864322 1222221111110 00 00
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
......+.+++.+|++.+|++||++.|+++.|.
T Consensus 224 -~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 -EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011245678999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=301.04 Aligned_cols=262 Identities=25% Similarity=0.356 Sum_probs=209.1
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc----h----hHHHHHHHHHHHhc-CCCCccceeEEE
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ----G----GLEFKTEIELLSRV-HHKNLVGLVGFC 692 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----~----~~~~~~E~~~l~~l-~H~nIv~l~~~~ 692 (964)
+..-+.|...+.||.|..++|-++.. .+|..+|+|++...... . .++-.+|+.+|+++ .||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34456788889999999999998885 46889999988653221 1 12356799999999 599999999999
Q ss_pred EeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 693 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
+.+...++|+|.|+.|.|.++|... ..+++.+..+|+.|+.+|+.|||... ||||||||+|||+|++.++||+||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDF 167 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDF 167 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecc
Confidence 9999999999999999999999865 47999999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCcccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 846 (964)
|+|..+.++. .-...+|||+|+|||.+.- ..|+..+|+||+||++|-|+.|.+||...+.. -.++.++..
T Consensus 168 GFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-lMLR~ImeG 243 (411)
T KOG0599|consen 168 GFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-LMLRMIMEG 243 (411)
T ss_pred ceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-HHHHHHHhc
Confidence 9999886653 3456899999999999852 35788999999999999999999999654322 223444433
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHHHh
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK--AIETLLQN 904 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~~~ 904 (964)
... .-.|++. .......++|.+|++.||++|.|++|+++ .+.++..+
T Consensus 244 kyq-------F~speWa----dis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~ 292 (411)
T KOG0599|consen 244 KYQ-------FRSPEWA----DISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQ 292 (411)
T ss_pred ccc-------cCCcchh----hccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHh
Confidence 321 1122221 12234568999999999999999999986 34444433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.04 Aligned_cols=251 Identities=23% Similarity=0.374 Sum_probs=207.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch---hHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG---GLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 700 (964)
...|...+.||+|.||.||+++.+ +|+.+|+|.+.+..... ...+.+|+.+|+++. |||||.+++++++.+..++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 457888899999999999999965 49999999998765533 357899999999998 9999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC----CcEEEeecccce
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN----LTAKVADFGLSK 776 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~ 776 (964)
|||+|.||.|.+.+... .+++.....++.|++.+++|||+.+ |+||||||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999766 3899999999999999999999988 9999999999999533 579999999999
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
.... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.......... ....... +
T Consensus 188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~i~~~~~-------~ 256 (382)
T KOG0032|consen 188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-AILRGDF-------D 256 (382)
T ss_pred EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-HHHcCCC-------C
Confidence 8765 244567889999999999999999999999999999999999999997544322222 2222211 1
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
++...+... .....+++..++..||.+|+|+.++++.
T Consensus 257 -f~~~~w~~i---s~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 257 -FTSEPWDDI---SESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCcccc---CHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 111112112 2344589999999999999999999873
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=317.68 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=194.4
Q ss_pred eeecCCcEEEEEEEec---CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCC
Q 002121 634 EIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
.||+|+||.||+|.+. .+..||+|++...... ..+++.+|+.++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 3557999998765332 3456899999999999999999999885 457899999999999
Q ss_pred hhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc-eee
Q 002121 710 LRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH-VST 788 (964)
Q Consensus 710 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-~~~ 788 (964)
|.+++.... ..+++.++.+++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......... ...
T Consensus 81 L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 81 LNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred HHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence 999997543 36899999999999999999999988 9999999999999999999999999998654332211 111
Q ss_pred cccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
...++..|+|||++..+.++.++|||||||++||+++ |..||..... .+... .+..... ...++
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~-~~~~~~~------~~~~~------- 221 (257)
T cd05115 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-PEVMS-FIEQGKR------LDCPA------- 221 (257)
T ss_pred CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-HHHHH-HHHCCCC------CCCCC-------
Confidence 2234578999999988889999999999999999996 9999864322 11111 1111110 00111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.....+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1124566899999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=338.70 Aligned_cols=262 Identities=22% Similarity=0.307 Sum_probs=197.0
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC-----ceE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG-----EQM 699 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 699 (964)
+|+..+.||+|+||.||+|.. .+|+.||||++.... .....++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999995 478999999986532 223457889999999999999999999998776 789
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+. ++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999997 5888887654 36899999999999999999999988 9999999999999999999999999998654
Q ss_pred CCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCccccc---
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDEEHY--- 852 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~--- 852 (964)
.... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...... +.+... .........
T Consensus 155 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI-QQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCHHHHHHh
Confidence 3222 222344689999999998764 5789999999999999999999999643321 111111 111000000
Q ss_pred -------ccccccCc-cch---hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 853 -------GLTEMMDP-TIR---NTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 853 -------~~~~~~d~-~l~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.......+ ... .........+.+++.+|++.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000000 000 0000112456789999999999999999999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=331.39 Aligned_cols=242 Identities=20% Similarity=0.273 Sum_probs=193.1
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+|+..+.||+|+||+||+|... +|+.||+|++.... ......+..|.+++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677899999999999999954 68999999987532 223345778899998885 577888999999989999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999987543 5899999999999999999999988 9999999999999999999999999987543221
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+......... ....+
T Consensus 156 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~i~~~~~~----~p~~~---- 224 (323)
T cd05615 156 --VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSIMEHNVS----YPKSL---- 224 (323)
T ss_pred --ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC----CCccC----
Confidence 122345699999999999988999999999999999999999999965332 2222222221110 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMS 892 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 892 (964)
...+.+++.+|++.+|.+|++..
T Consensus 225 -------~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 225 -------SKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -------CHHHHHHHHHHcccCHhhCCCCC
Confidence 13456899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=324.31 Aligned_cols=262 Identities=26% Similarity=0.362 Sum_probs=195.1
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhc---CCCCccceeEEEEee-----C
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRV---HHKNLVGLVGFCFEQ-----G 696 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~-----~ 696 (964)
+|...+.||+|+||+||+|+.. +|+.||+|.++..... ....+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999964 6899999988753322 223566787777766 699999999998652 3
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+++ +|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999985 8999887655456899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccc--
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHY-- 852 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~-- 852 (964)
...... ......||..|+|||++.+..++.++||||+||++|||++|++||....... ..+............
T Consensus 157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 764322 1233568999999999998889999999999999999999999986433211 111111111100000
Q ss_pred --cc-ccccCc----cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 --GL-TEMMDP----TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 --~~-~~~~d~----~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .....+ .+..........+.+++.+|++.||++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000 011111112245679999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=320.81 Aligned_cols=255 Identities=29% Similarity=0.487 Sum_probs=200.8
Q ss_pred CCCccceeecCCcEEEEEEEec-CC---cEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DG---QVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.|+..+.||+|+||.||+|... +| ..||||.++... .....+|..|+.++++++||||+++++++.+++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999964 33 369999987542 233457999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997653 36899999999999999999999988 9999999999999999999999999987654332
Q ss_pred CCceeec-cc--ccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 783 KGHVSTQ-VK--GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 783 ~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
....... .. .+..|+|||++..+.++.++|||||||++|||++ |..||...... + +...+..... ...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~-~~~~i~~~~~----~~~-- 232 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-D-VINAIEQDYR----LPP-- 232 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-H-HHHHHHcCCc----CCC--
Confidence 2111111 11 2457999999998999999999999999999887 99998643321 1 1111111110 000
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
. ......+.+++.+||+.+|++||++.+++..|+.+
T Consensus 233 ~-------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 P-------MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c-------ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 01123466899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=319.72 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=187.9
Q ss_pred eeecCCcEEEEEEEecC---CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCC
Q 002121 634 EIGSGGYGKVYRGMLSD---GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
+||+|+||.||+|.... ...+|+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997543 35788888764432 233568899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCC---CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 710 LRESLSGRSG---IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 710 L~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
|.+++..... ...++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999976432 23567888999999999999999988 99999999999999999999999999875433222111
Q ss_pred eecccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 787 STQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.....+++.|+|||+... ..++.++|||||||++|||++ |..||...... +.......... ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~------~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE-QVLKQVVREQD------IKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH-HHHHHHhhccC------ccCC
Confidence 233446778999998743 356789999999999999999 77787643322 11222221111 0111
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.+.+.. .....+.+++..|+ .||++||+++||++.|
T Consensus 232 ~~~~~~---~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 KPQLDL---KYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCcccc---cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 111111 11234557788888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=334.54 Aligned_cols=240 Identities=26% Similarity=0.326 Sum_probs=188.7
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHH-HHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEI-ELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 678899999874321 2223344444 457788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+.+.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~ 153 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GTT 153 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CCc
Confidence 99999997643 5778888899999999999999988 9999999999999999999999999997543221 123
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+.+........ .+.+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~--------~~~~~~----- 219 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-AEMYDNILNKPL--------QLKPNI----- 219 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-HHHHHHHHhCCc--------CCCCCC-----
Confidence 345799999999999999999999999999999999999999964332 222222221111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
...+.+++.+|++.+|.+||++.+.+
T Consensus 220 --~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 220 --TNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred --CHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 13456899999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=335.63 Aligned_cols=239 Identities=27% Similarity=0.328 Sum_probs=189.5
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHH-HHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIE-LLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|.. .+|+.||+|++.... .....++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 478999999986532 122334555554 56778999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTT 153 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCc
Confidence 99999887543 6899999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+.......... .+.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-~~~~~~~~~~~~~--------~~~~~~----- 219 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEMYDNILHKPL--------VLRPGA----- 219 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-HHHHHHHHHcCCc--------cCCCCC-----
Confidence 34579999999999999999999999999999999999999997543 2222222221111 011111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEV 894 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~ev 894 (964)
...+.+++.+|++.+|++||++.+.
T Consensus 220 --~~~~~~ll~~ll~~~p~~R~~~~~~ 244 (325)
T cd05604 220 --SLTAWSILEELLEKDRQRRLGAKED 244 (325)
T ss_pred --CHHHHHHHHHHhccCHHhcCCCCCC
Confidence 1345689999999999999988643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=331.10 Aligned_cols=244 Identities=30% Similarity=0.452 Sum_probs=198.3
Q ss_pred CCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcch---hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG---GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
-|+.++.||.|+||.||-|+ .++.+.||||++.-...+. ..++..|+..|++++|||+|.+.|+|..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 35556889999999999999 4678999999997654443 3467899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||- |+-.+++.-.. +++.+.++..|..+.+.||+|||+++ .||||||+.||||++.|.|||+|||.|....+.
T Consensus 107 YCl-GSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred HHh-ccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 995 47777775543 57999999999999999999999998 999999999999999999999999999876543
Q ss_pred CceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
..++|||.|||||++. .|.|+-|+||||+|++..||...++|+.+-......+..+-+.. |
T Consensus 180 ----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes------------P 243 (948)
T KOG0577|consen 180 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES------------P 243 (948)
T ss_pred ----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC------------C
Confidence 2367999999999985 58899999999999999999999999875332222222222221 2
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+.. ......|..++..|++.-|.+|||.+++++
T Consensus 244 tLqs--~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 244 TLQS--NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCCC--chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2221 111244668889999999999999988754
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=319.33 Aligned_cols=256 Identities=27% Similarity=0.464 Sum_probs=202.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-C---CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-D---GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~---g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|+..+.||+|+||.||+|... + +..+|+|.++.... .....+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999853 2 34799998875432 2345789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.++|+|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997653 35899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCce-eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 782 SKGHV-STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 782 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
..... .....++..|+|||++.++.++.++||||||+++||+++ |..||..... .+.... +..... ..
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~~~-~~~~~~----~~---- 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKA-IEEGYR----LP---- 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHHHH-HhCCCc----CC----
Confidence 22111 111223568999999998889999999999999999887 9999864322 111111 111110 00
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.. ......+.+++.+|++.+|++||+|.++++.|+++
T Consensus 230 --~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 --AP---MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred --CC---CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 01124567899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.48 Aligned_cols=252 Identities=23% Similarity=0.374 Sum_probs=199.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|...+.||+|+||.||+|.. .+++.||+|.++.........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4677778899999999999985 468999999987655444456889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++...+ .+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~--~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI--A 161 (267)
T ss_pred CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--c
Confidence 9999999987553 6899999999999999999999988 9999999999999999999999999987654321 1
Q ss_pred eeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 786 VSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......|+..|+|||++. .+.++.++|||||||++|||++|+.||........ +........ ..+..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~---------~~~~~ 231 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNF---------QPPKL 231 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCC---------CCCcc
Confidence 223456899999999974 45688999999999999999999999864322111 111111110 00000
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .......+.+++.+|++.+|++||+++++++
T Consensus 232 ~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00 0011134668999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=317.26 Aligned_cols=249 Identities=31% Similarity=0.500 Sum_probs=202.0
Q ss_pred ceeecCCcEEEEEEEecC----CcEEEEEEecCCCcch-hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|.... +..||+|.++...... ...+.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999999653 7899999988655443 56789999999999999999999999999999999999999
Q ss_pred CChhhhhcCCC-------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 708 GTLRESLSGRS-------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 708 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998652 256899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........++..|+|||.+....++.++||||+|+++|||++ |..||..... .+.... ...... .....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~-~~~~~~--~~~~~--- 230 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVLEY-LRKGYR--LPKPE--- 230 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHHHH-HHcCCC--CCCCc---
Confidence 332222334567889999999988889999999999999999999 5889865421 111111 111110 00111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.....+.+++.+|++.+|++||++.|+++.|+
T Consensus 231 --------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 231 --------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11245778999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=335.17 Aligned_cols=262 Identities=23% Similarity=0.301 Sum_probs=197.1
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC-----
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG----- 696 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 696 (964)
..++|+..+.||+|+||.||+|.. .+|+.||||++.... .....++.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 357899999999999999999986 468999999986532 233456789999999999999999999986543
Q ss_pred -ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 697 -EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 697 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
..++||||+++ +|.+.++. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCc
Confidence 46999999975 67666643 3788899999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH--H----------
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT--A---------- 843 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~--~---------- 843 (964)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........+... .
T Consensus 171 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (359)
T cd07876 171 RTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN 247 (359)
T ss_pred cccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence 764322 1223456899999999999999999999999999999999999999754332221110 0
Q ss_pred ---------hccCccc-ccccccccCc----cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 844 ---------MNRDDEE-HYGLTEMMDP----TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 844 ---------~~~~~~~-~~~~~~~~d~----~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....... .....+.... ............+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000000000 0000001112456799999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=330.03 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=205.8
Q ss_pred cCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEeeC
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG 696 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 696 (964)
.+|.+.+.||+|+||.||+|+.. .+..||+|.++.... ....++.+|+++++++ +||||++++++|.+.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999742 123689998875432 2345789999999999 7999999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC
Q 002121 697 EQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD 762 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~ 762 (964)
..++||||+++|+|.+++.... ...++|.+++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999987532 235889999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHH
Q 002121 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVR 841 (964)
Q Consensus 763 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~ 841 (964)
+++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||... ...+...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-~~~~~~~ 247 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-PVEELFK 247 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHH
Confidence 999999999999987644322222222334578999999999899999999999999999999 78888543 2222222
Q ss_pred HHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 842 TAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
....... .+ .. ......+.+++.+|++.+|++||++.|+++.|+.+....
T Consensus 248 ~~~~~~~------~~-----~~---~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 248 LLKEGHR------MD-----KP---ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHcCCC------CC-----CC---CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 2211111 00 00 011245678999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=344.23 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=191.9
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee--------
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-------- 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------- 695 (964)
..++|...+.||+|+||+||+|.. .+++.||||++.... ....+|+.++++++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999996 468999999885432 2345799999999999999999987532
Q ss_pred CceEEEEEeccCCChhhhhcC--CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeec
Q 002121 696 GEQMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADF 772 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DF 772 (964)
...++||||+++ +|.+++.. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999985 77776642 12346899999999999999999999988 99999999999999665 7999999
Q ss_pred ccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDD 848 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~ 848 (964)
|+|+....... .....||+.|+|||++.+ ..++.++|||||||++|||++|.+||...... +.+...+. ...
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~-~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV-DQLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCC
Confidence 99987643221 223568999999999865 46899999999999999999999999644322 22222111 111
Q ss_pred ccc----------cccccccCccchhhh-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EEH----------YGLTEMMDPTIRNTV-LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~~----------~~~~~~~d~~l~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+. ..........+.... ......+.+++.+||+.||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 000 000000001111100 011245779999999999999999999985
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=331.16 Aligned_cols=255 Identities=22% Similarity=0.290 Sum_probs=195.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+++.. +++.||+|++.... ......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888999999999999999964 68999999986421 223345889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999997532 35889999999999999999999988 9999999999999999999999999997654332
Q ss_pred CCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
. .......||+.|+|||++.. +.++.++|||||||++|||++|+.||..... .+........... ..
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~-~~~~~~i~~~~~~-----~~- 228 (331)
T cd05597 157 T-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHKEH-----FQ- 228 (331)
T ss_pred C-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH-HHHHHHHHcCCCc-----cc-
Confidence 2 12233469999999999863 4578899999999999999999999965332 2222222221110 00
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCC--CCCCCHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESA--TDRPTMSEVVKA 897 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP--~~RPs~~evl~~ 897 (964)
+.+... .....+.+++.+|+..++ ..||++.++++.
T Consensus 229 ~~~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 FPPDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011100 011344577777765433 347899888754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=338.45 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=198.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec---CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..+|.+.+.||+|+||.||++... .++.||+|.+... ....+|++++++++|||||++++++...+..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999753 3578999987643 24568999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|++. ++|.+++... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9996 6888888433 46899999999999999999999988 9999999999999999999999999998765443
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHH---hccCcccccc----
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTA---MNRDDEEHYG---- 853 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~---~~~~~~~~~~---- 853 (964)
.........||+.|+|||++....++.++|||||||++|||++|+.||..... ....++.. +.....+...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 319 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccch
Confidence 32333456799999999999988999999999999999999999999963321 11222211 1111100000
Q ss_pred --------cccccCccc--hhhh--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 --------LTEMMDPTI--RNTV--LLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 --------~~~~~d~~l--~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
......+.. .... ......+.+++.+|+..||++||++.|++..
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 320 NLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 0000 0011346688999999999999999999864
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.39 Aligned_cols=244 Identities=25% Similarity=0.421 Sum_probs=195.5
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+|+..+.||+|+||.||+|+. .+++.||+|++.... .....++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 577789999999999999985 578999999986542 233457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~--- 149 (279)
T cd06619 82 DGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--- 149 (279)
T ss_pred CCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence 999997653 3678889999999999999999988 9999999999999999999999999998654321
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh------HHHHHHHhccCcccccccccccC
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV------VREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.....||..|+|||++.+..++.++|||||||++|||++|+.||...... ........... .
T Consensus 150 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------~ 217 (279)
T cd06619 150 -AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----------P 217 (279)
T ss_pred -ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----------C
Confidence 23356899999999999888999999999999999999999998632110 01111111010 0
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+.+.. ......+.+++.+|++.+|++||+++|+++.
T Consensus 218 ~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 218 PVLPV--GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCC--CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 11100 0112356789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=323.80 Aligned_cols=249 Identities=21% Similarity=0.369 Sum_probs=203.2
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.+|+..+.||.|+||.||+|.. .+|+.||+|.+..........+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 3688889999999999999985 578999999987655555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 170 (296)
T cd06655 99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-- 170 (296)
T ss_pred CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc--
Confidence 999999998653 4899999999999999999999988 99999999999999999999999999876543221
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ......... . . ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-~~~~~~~~~-~--~---~~------ 237 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP-E--L---QN------ 237 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCc-c--c---CC------
Confidence 122346889999999999888999999999999999999999999754432222 111111100 0 0 00
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||..||++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 0011134668999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.60 Aligned_cols=262 Identities=23% Similarity=0.307 Sum_probs=197.5
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee------
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 695 (964)
..++|+..+.||+|+||.||+|.. ..++.||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 457899999999999999999985 4688999999875432 2335678899999999999999999988643
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
...++||||+++ +|.+.+.. .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCccc
Confidence 346999999975 67776643 4788999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH--h---------
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA--M--------- 844 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~--~--------- 844 (964)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+.... +
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (355)
T cd07874 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_pred ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 865432 12234568999999999998899999999999999999999999997544322211110 0
Q ss_pred ----------ccCcccc-cccccccCccch----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 845 ----------NRDDEEH-YGLTEMMDPTIR----NTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 845 ----------~~~~~~~-~~~~~~~d~~l~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....... ............ .........+.+++.+|++.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 000000000000 0011122456799999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=316.88 Aligned_cols=249 Identities=27% Similarity=0.419 Sum_probs=202.8
Q ss_pred cCCCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|+..+.||+|+||.||+|...+ ++.||+|.+..... ..++.+|++++++++|+||+++++++.+....++||||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999764 78999999875432 568999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++.... ..++|..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 81 GAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 9999999986543 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ... ... .+.+. .
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-~~~-~~~----------~~~~~-~ 221 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIP-NKP----------PPTLS-D 221 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-hhc-cCC----------CCCCC-c
Confidence 2233458899999999988889999999999999999999999986433221111 100 000 00000 0
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+|++.+|++||++.|+++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 1112245678999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=330.32 Aligned_cols=254 Identities=21% Similarity=0.269 Sum_probs=196.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||+||+++.. +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47888999999999999999964 67899999986422 122345788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999997642 35889999999999999999999988 9999999999999999999999999998764332
Q ss_pred CCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
. .......||+.|+|||++.+ +.++.++|||||||++|||++|+.||..... .+........... ...
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-~~~~~~i~~~~~~--~~~--- 229 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-VETYGKIMNHEER--FQF--- 229 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-HHHHHHHHcCCCc--ccC---
Confidence 2 12233569999999999865 5678999999999999999999999965432 2222222221110 001
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 896 (964)
...+ ......+.+++.+|+..++++ |++++++++
T Consensus 230 -p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 230 -PSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -CCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 1111 111244567888888865544 467888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=325.22 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=200.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|+..+.||+|+||.||+|... +|..+|+|.++.... ....++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888999999999999999954 688999998875432 2334688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
+++|+|.++++.. ..+++..+..++.|+++||+|||+ .+ ++||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999999765 358899999999999999999997 35 9999999999999999999999999987653321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc---------
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL--------- 854 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 854 (964)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||..... ......+..........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCcccccCC
Confidence 2335689999999999888899999999999999999999999864331 11111111110000000
Q ss_pred ----------ccc-------cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 855 ----------TEM-------MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 855 ----------~~~-------~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.+. ..+.+.. ......+.+++.+||..+|++||++.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 0000000 0112357799999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=316.37 Aligned_cols=251 Identities=23% Similarity=0.439 Sum_probs=200.1
Q ss_pred CCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc------chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM------QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
+|...+.||+|+||+||+|...+|+.+|+|.++.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999988899999998864321 1124588999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997643 5789999999999999999999988 999999999999999999999999998764321
Q ss_pred CC----CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 782 SK----GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 782 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
.. ........|+..|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL--------- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC---------
Confidence 11 11122356899999999999888999999999999999999999999754332221111100000
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+.+.. .....+.+++.+||+.+|++||++.|+++
T Consensus 227 -~~~~~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 -MPRLPD---SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -CCCCCC---CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011111 11244678999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=319.56 Aligned_cols=250 Identities=30% Similarity=0.485 Sum_probs=200.2
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhH--HHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
|+..+.||+|+||+||++... +++.||+|++......... ...+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999965 5678999999876544332 3456999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..... ...
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNE 153 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTS
T ss_pred cccccccccccc--cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--ccc
Confidence 999999999832 36899999999999999999999988 99999999999999999999999999986421 223
Q ss_pred eeecccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcccccccccccCccc
Q 002121 786 VSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......++..|+|||++. ...++.++||||+|+++|+|++|..||.... .............. ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~ 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL----------PSSS 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH----------HHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc----------cccc
Confidence 344567899999999998 7889999999999999999999999997641 11121211111100 0000
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ........+.+++.+||+.||++||++.++++
T Consensus 224 ~-~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 Q-QSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp T-SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred c-ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001266789999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=318.29 Aligned_cols=249 Identities=29% Similarity=0.462 Sum_probs=194.6
Q ss_pred ceeecCCcEEEEEEEec-CCc--EEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQ--VVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|... +|. .+|+|.++... ......+.+|+++++++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999974 343 57888887533 23345788999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 708 GTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 708 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
|+|.+++.... ...+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 124789999999999999999999987 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 852 (964)
+++..... ........+..|+|||++....++.++|||||||++|||++ |..||.... ..+..... .....
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-~~~~~~~~-~~~~~--- 229 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-CAELYEKL-PQGYR--- 229 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-HHHHHHHH-hCCCC---
Confidence 98632211 11111234567999999988889999999999999999997 999985432 11222211 11100
Q ss_pred ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
. + .. ......+.+++.+|++.+|.+||++.|+++.|++++
T Consensus 230 -~----~--~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 -L----E--KP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -C----C--CC---CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 0 00 011235679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=325.91 Aligned_cols=262 Identities=22% Similarity=0.342 Sum_probs=198.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999864 688999999875432 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
++ ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 97 59999887543 35889999999999999999999988 99999999999999999999999999976433221
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH---HhccCcccc---------
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT---AMNRDDEEH--------- 851 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~~--------- 851 (964)
......+++.|+|||++.+ ..++.++|||||||++|||+||+.||..... .+.+.. .+.......
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGILSNEE 237 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHcCCCChhhchhhhcccc
Confidence 1223457899999999865 4578899999999999999999999964432 222211 111111000
Q ss_pred ---cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 ---YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ---~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..........+..........+.+++.+|++.||.+|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000001111235678999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.25 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=197.7
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999964 689999999865332 2235688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
++ ++|.+++.... +..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 68988886543 356899999999999999999999988 9999999999999999999999999997653321
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH--hccCccccc--------
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA--MNRDDEEHY-------- 852 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~--~~~~~~~~~-------- 852 (964)
.......+++.|+|||++.+ ..++.++|||||||++|||+||+.||............. .........
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 11223457899999998865 457899999999999999999999997543322111110 000000000
Q ss_pred ---ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 ---GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ---~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.........+.........++.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000001112245678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=313.79 Aligned_cols=248 Identities=27% Similarity=0.441 Sum_probs=197.6
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChh
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLR 711 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 711 (964)
++||+|+||.||+|...+++.||+|++...... ....+.+|++++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 468999999999999877999999998765443 4567899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeeccc
Q 002121 712 ESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791 (964)
Q Consensus 712 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 791 (964)
+++.... ..+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...............
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9997543 35889999999999999999999988 9999999999999999999999999998654221111111223
Q ss_pred ccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 792 gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
++..|+|||++.++.++.++|||||||++|||+| |..||..... .... ........ . ... ....
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~~-~~~~~~~~----~------~~~---~~~~ 221 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQTR-ERIESGYR----M------PAP---QLCP 221 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHHH-HHHhcCCC----C------CCC---ccCC
Confidence 4667999999988899999999999999999999 7888854321 1111 11111110 0 000 0112
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
..+.+++.+|+..+|++||++.|+++.|+
T Consensus 222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 45778999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=331.65 Aligned_cols=237 Identities=25% Similarity=0.314 Sum_probs=186.9
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHH-HHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEI-ELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|+.. +|+.||+|++..... .....+.+|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999964 689999999864321 2223455554 467889999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++... ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 9999888654 35788889999999999999999988 9999999999999999999999999987532221 123
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............. .+.+.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-~~~~~~~i~~~~~--------~~~~~------ 218 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-VSQMYDNILHKPL--------QLPGG------ 218 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC-HHHHHHHHhcCCC--------CCCCC------
Confidence 34569999999999998899999999999999999999999996543 2222222221111 01111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMS 892 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~ 892 (964)
....+.+++.+|++.||.+||++.
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 -KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCHHHHHHHHHHccCCHhhcCCCC
Confidence 113466899999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=334.27 Aligned_cols=249 Identities=27% Similarity=0.467 Sum_probs=204.2
Q ss_pred ceeecCCcEEEEEEEec-CCcEEEEEEecC----CCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCc--eEEEEEec
Q 002121 633 NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQ----GSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE--QMLVYEFM 705 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lV~E~~ 705 (964)
.+||+|+|-+||||... +|..||--.++. ......++|..|+.+|+.|+|||||+++.++.+... ..+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 46999999999999964 577777543321 122334689999999999999999999999987654 78999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccceeecCCCCC
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~ 784 (964)
..|+|..|++..+ .++...+..|++||++||.|||++. |||||||||.+||+|+. .|.|||+|.|||........
T Consensus 126 TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a- 201 (632)
T KOG0584|consen 126 TSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA- 201 (632)
T ss_pred cCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcccc-
Confidence 9999999998765 5788899999999999999999974 89999999999999974 68999999999998754322
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
..+.|||.|||||+.. ..|++.+||||||++++||+|+..||..-.+..+.+++........ .+..+-||.
T Consensus 202 ---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~--sl~kV~dPe--- 272 (632)
T KOG0584|consen 202 ---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPA--ALSKVKDPE--- 272 (632)
T ss_pred ---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHH--HhhccCCHH---
Confidence 2378999999999987 7899999999999999999999999988777788887776554422 233333444
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+.++|.+|+.. .++|||+.|+++- .++..+
T Consensus 273 --------vr~fIekCl~~-~~~R~sa~eLL~d--~Ff~~d 302 (632)
T KOG0584|consen 273 --------VREFIEKCLAT-KSERLSAKELLKD--PFFDED 302 (632)
T ss_pred --------HHHHHHHHhcC-chhccCHHHHhhC--hhhccc
Confidence 44899999999 9999999999852 444444
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=317.90 Aligned_cols=239 Identities=23% Similarity=0.405 Sum_probs=188.2
Q ss_pred ceeecCCcEEEEEEEecC-------------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 633 NEIGSGGYGKVYRGMLSD-------------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
+.||+|+||.||+|.+.. ...||+|.+..........+.+|+.++++++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358999877654444557889999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc-------EEEeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT-------AKVADF 772 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-------~kl~DF 772 (964)
+||||+++|+|..+++... ..+++..++.++.||++||+|||+.+ |+||||||+|||++.++. +|++||
T Consensus 81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 9999999999999887543 35899999999999999999999988 999999999999987664 899999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccc-cCCCCCchhHHHHHHHHHHHH-hCCCCCCCCchhHHHHHHHhccCccc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELI-TAKQPIEKGKYVVREVRTAMNRDDEE 850 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 850 (964)
|++...... ....++..|+|||++. ...++.++|||||||++|||+ +|+.|+.... ..+. ........
T Consensus 157 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~-~~~~~~~~-- 226 (262)
T cd05077 157 GIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT-LAEK-ERFYEGQC-- 226 (262)
T ss_pred CCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc-hhHH-HHHHhcCc--
Confidence 998754321 2245788999999886 467889999999999999998 5777775322 1111 11111100
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
....+ ....+.+++.+||+.||++||++.++++.+
T Consensus 227 -----~~~~~--------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 227 -----MLVTP--------SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----cCCCC--------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00010 124567899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=314.33 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=196.3
Q ss_pred ceeecCCcEEEEEEEec--C--CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS--D--GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~--~--g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
++||+|+||.||+|.+. + +..||+|.+...... ..+++.+|+++++++.|+|||++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999853 2 268999998865542 4457899999999999999999999876 4568999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce-
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV- 786 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~- 786 (964)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999997654 6899999999999999999999988 99999999999999999999999999987654332111
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++..|+|||.+....++.++|||||||++|||++ |..||..... .+... ....... . . ..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~-~~~~~~~----~-~-----~~-- 220 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIA-MLESGER----L-P-----RP-- 220 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHH-HHHcCCc----C-C-----CC--
Confidence 111224568999999998899999999999999999998 9999864332 11111 1111110 0 0 00
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
......+.+++.+|+..+|++||++.++++.|+.+
T Consensus 221 -~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 -EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01124567999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=318.25 Aligned_cols=258 Identities=26% Similarity=0.456 Sum_probs=204.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.+|+..+.||+|+||+||+|... +|+ .||+|....... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677899999999999999964 343 689998876543 234578899999999999999999999987 78899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999997654 35899999999999999999999987 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........++..|+|||.+....++.++||||||+++||+++ |+.||.... ..+ +...+..... ....
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~-~~~~~~~~~~--~~~~---- 233 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP-AVE-IPDLLEKGER--LPQP---- 233 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC-HHH-HHHHHhCCCC--CCCC----
Confidence 332222222234678999999988889999999999999999999 999986432 112 2222211110 0000
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
.. ....+.+++.+||..+|.+||++.++++.|+.+.+.
T Consensus 234 -~~------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 234 -PI------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred -CC------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 00 113466899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.84 Aligned_cols=239 Identities=21% Similarity=0.376 Sum_probs=188.4
Q ss_pred ceeecCCcEEEEEEEecC--------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 633 NEIGSGGYGKVYRGMLSD--------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+.||+|+||.||+|.... ...||+|.+........+++.+|+.++++++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 358999999999998632 234888887655444456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc--------EEEeecccce
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT--------AKVADFGLSK 776 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl~DFGla~ 776 (964)
+++|+|.++++..+ ..+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++.
T Consensus 81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999997654 36899999999999999999999988 999999999999987765 5999999886
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHhccCccccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAK-QPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
..... ....++..|+|||++.+ ..++.++|||||||++|||++|. .|+..... ..... ......
T Consensus 157 ~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~-~~~~~-~~~~~~------ 222 (258)
T cd05078 157 TVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS-QKKLQ-FYEDRH------ 222 (258)
T ss_pred ccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH-HHHHH-HHHccc------
Confidence 54321 23457889999999976 45789999999999999999995 45433221 11111 111110
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.+... ....+.+++.+||+.+|++||+++++++.|
T Consensus 223 --~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 --QLPAP-------KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --cCCCC-------CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01111 113467999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=337.73 Aligned_cols=252 Identities=22% Similarity=0.370 Sum_probs=194.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+|+.. +|+.||+|+++... ......+++|++++.+++|+||+++++++.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999964 68999999987432 223346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999997643 5889999999999999999999988 9999999999999999999999999987543211
Q ss_pred CC---------------------------------ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCC
Q 002121 783 KG---------------------------------HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829 (964)
Q Consensus 783 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p 829 (964)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 00 001234699999999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 002121 830 IEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT---MSEVVK 896 (964)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 896 (964)
|..... ............. . .+.+... ......+++.+++ .+|++|++ +.|+++
T Consensus 236 f~~~~~-~~~~~~i~~~~~~----~--~~p~~~~-----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 236 FCSETP-QETYRKVMNWKET----L--VFPPEVP-----ISEKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCCH-HHHHHHHHcCCCc----e--ecCCCCC-----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 964332 2222222211110 0 0111100 1133456777765 49999985 556543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=327.62 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=196.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+++.+ +++.||+|++.... ......+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999965 57889999986422 122335888999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999997632 35899999999999999999999988 9999999999999999999999999997654322
Q ss_pred CCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
. .......||+.|+|||++. .+.++.++|||||||++|||++|+.||.... ..+.+.......... ..
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~-~~~~~~~i~~~~~~~--~~--- 229 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHKERF--QF--- 229 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC-HHHHHHHHhCCCccc--cC---
Confidence 2 2223456999999999986 3468899999999999999999999996543 233333332221100 00
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVKA 897 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 897 (964)
. .........+.+++.+|+..++.+ |+++.|+++.
T Consensus 230 -p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 230 -P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 000111234557888877654444 6899998754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=316.18 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=199.0
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch---------hHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG---------GLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
+|...+.||+|+||.||+|.. .+++.||+|.+....... .+.+.+|++++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 366778999999999999986 468899999886543221 1457899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997643 5889999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCC----CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 778 VSDSSK----GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 778 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~------- 227 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFKIGEN------- 227 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHHHhcc-------
Confidence 642211 011123458899999999998889999999999999999999999997543322 12111110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+.. .....+.+++.+||+.||++||++.|+++
T Consensus 228 ----~~~~~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ----ASPEIPS---NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ----CCCcCCc---ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111111 11245668999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=324.84 Aligned_cols=249 Identities=22% Similarity=0.364 Sum_probs=202.5
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.+|+..+.||+|+||.||+|.. .+|+.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 5788899999999999999995 578999999987655555567889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-- 170 (297)
T cd06656 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (297)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence 999999998653 4789999999999999999999988 99999999999999999999999999986543321
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........... ... .. ......
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~-~~-----~~~~~~------ 237 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT-NG-----TPELQN------ 237 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ecc-CC-----CCCCCC------
Confidence 12334688999999999988899999999999999999999999964332111110 000 00 000000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||+.+|++||++.++++
T Consensus 238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111234568999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=377.25 Aligned_cols=328 Identities=30% Similarity=0.446 Sum_probs=204.8
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|++++.+|..++++++|++|+|++| .+.+.+|..++++++|++|+|++|.+++.+|..+.++++|++|+
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 290 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN-NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLD 290 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCc-eeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEE
Confidence 35666666666666666666666666666666666 56666666666666666666666666666666666666666666
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCC------------------CCccccccCCCeeEccCCcccc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTIT------------------SPGLDQLKNAKHFHFNKNKLSG 205 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~------------------~~~l~~l~~L~~L~L~~N~l~g 205 (964)
|++|.+++.+|..+.++++|++|++++|.+++.+|..... ...+..+++|+.|++++|++++
T Consensus 291 Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~ 370 (968)
T PLN00113 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTG 370 (968)
T ss_pred CcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEe
Confidence 6666665555555555555555555555555444421100 0224445556666666666655
Q ss_pred ccccccc-----------------------CCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccC
Q 002121 206 TISEQLF-----------------------SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262 (964)
Q Consensus 206 ~l~~~~f-----------------------~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 262 (964)
.+|..+. ..+++|+.|++++|++++.+|..+..+++|+.|++++|.+++.+|..+..
T Consensus 371 ~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 450 (968)
T PLN00113 371 EIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWD 450 (968)
T ss_pred eCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhcc
Confidence 5554322 22334444444444444444444555555555555555555555555555
Q ss_pred CCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEE
Q 002121 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (964)
+++|+.|+|++|++.+..|....+++|+.|++++|+++ ...|..+.++++|+.|+|++|++.+.+|..+..+++|+.|+
T Consensus 451 l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 529 (968)
T PLN00113 451 MPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFS-GAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLD 529 (968)
T ss_pred CCCCcEEECcCceeeeecCcccccccceEEECcCCccC-CccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEE
Confidence 55555555555555555555445566777777777776 55666777888888888888888888888888888888888
Q ss_pred cCCcccccccCCCCccCCCCcEEeccCCcceee-cc--CCCcccceeEeecCCc
Q 002121 343 LRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAI-TL--GSGIKNYTLILVGNPV 393 (964)
Q Consensus 343 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i-~~--~~~~~l~~l~l~~Np~ 393 (964)
|++|.+++.+|..+..+++|+.|+|++|+++.. |. .....+..|++.+|++
T Consensus 530 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l 583 (968)
T PLN00113 530 LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583 (968)
T ss_pred CCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc
Confidence 888888888888888888888888888888753 32 2334467788888874
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.10 Aligned_cols=250 Identities=23% Similarity=0.375 Sum_probs=204.5
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||.++. .+++.+++|++.... .....++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478889999999999999984 468899999876543 33445788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 99999999998764556899999999999999999999988 99999999999999999999999999987644321
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ..+.......... .. ..
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~~~~------~~-~~----- 222 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-PLNLVVKIVQGNY------TP-VV----- 222 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCC------CC-Cc-----
Confidence 2234568999999999988888999999999999999999999986432 2233322222111 00 00
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
......+.+++.+||+.+|++||++.|+++.
T Consensus 223 --~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 --SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred --cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1112456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=313.97 Aligned_cols=251 Identities=32% Similarity=0.539 Sum_probs=202.0
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+..... ...++.+|++++++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677899999999999999987788999998875433 23578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++....... ..
T Consensus 83 ~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 83 HGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred CCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 999999997643 35889999999999999999999988 99999999999999999999999999986543211 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....++.+|+|||++.++.++.++||||||+++|||++ |+.||..... ............ ...+..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~--------~~~~~~--- 225 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVETINAGFR--------LYKPRL--- 225 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHHhCCCC--------CCCCCC---
Confidence 122335678999999998889999999999999999998 8999864321 222222111100 011111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
....+.+++.+||+.+|++||++.|+++.|
T Consensus 226 ---~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ---CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.11 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=204.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|...+.||+|+||.||+|... +++.+|+|.+..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 357888899999999999999964 5789999998866555567899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++++|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 99999999987642 36889999999999999999999988 9999999999999999999999999987654321
Q ss_pred ceeecccccCcccCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.......++..|+|||.+... .++.++|||||||++|||+||+.||.......... ....... ..+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~---------~~~~ 225 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNF---------PPPK 225 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccC---------CCcc
Confidence 112335688899999998766 88999999999999999999999996533221111 1111100 0001
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+. ........+.+++.+||..+|.+||++.+++.
T Consensus 226 ~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 LK-DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc-chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 11122345779999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=319.86 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=198.0
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
|++.+.||+|+||.||+|... ++..+|+|.+..........+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455688999999999999965 5788999998765555556788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|..++.... .++++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~ 160 (282)
T cd06643 87 GAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR 160 (282)
T ss_pred CcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence 99999886533 36899999999999999999999988 9999999999999999999999999987653321 122
Q ss_pred ecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 788 TQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
....++..|+|||++. ...++.++|||||||++|||++|+.||..... .+.+......... ....+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-~~~~~~~~~~~~~------~~~~~~- 232 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEPP------TLAQPS- 232 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH-HHHHHHHhhcCCC------CCCCcc-
Confidence 3346899999999974 34577899999999999999999999864332 2222222111110 000000
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+||+.+|++||++.++++
T Consensus 233 -----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 233 -----RWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -----ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11145678999999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=317.42 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=188.5
Q ss_pred eeecCCcEEEEEEEecCC---cEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCC
Q 002121 634 EIGSGGYGKVYRGMLSDG---QVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
+||+|+||+||+|...++ ..+++|.+.... ......+.+|+.+++.++||||++++++|.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999985433 356677665433 2345679999999999999999999999999999999999999999
Q ss_pred hhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 710 LRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 710 L~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|.++++... ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 999997543 234677788899999999999999987 999999999999999999999999998643222111122
Q ss_pred ecccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHhC-CCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 788 TQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVVMLELITA-KQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
....++..|+|||++.. ..++.++|||||||++|||+++ ..||.... ..+.+........ ....+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-~~~~~~~~~~~~~------~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS-DREVLNHVIKDQQ------VKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhhcc------cccCC
Confidence 34568899999998753 2457899999999999999974 66775432 2222332222211 11222
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
+.+... ....+.+++..|| .+|++||+++||++.|.
T Consensus 232 ~~~~~~---~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP---YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC---CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222211 1244567888999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.35 Aligned_cols=249 Identities=30% Similarity=0.479 Sum_probs=196.2
Q ss_pred ceeecCCcEEEEEEEecC-------CcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 633 NEIGSGGYGKVYRGMLSD-------GQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+.||+|+||.||+|...+ ++.+|+|.+.... .....++.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998642 2579999876543 23455788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC-----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-----cEEEeeccc
Q 002121 705 MANGTLRESLSGRS-----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-----TAKVADFGL 774 (964)
Q Consensus 705 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-----~~kl~DFGl 774 (964)
+++|+|.+++.... ...++|.+++.++.|++.||+|||+.+ ++|+||||+||+++.++ .+|++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 234889999999999999999999987 99999999999999887 899999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
++...............++..|+|||++.++.++.++|||||||++|||+| |+.||...... +.... +.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~~~-~~~~~~---- 231 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVLQH-VTAGGR---- 231 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHHHH-HhcCCc----
Confidence 986543322222223346788999999999999999999999999999998 99998643321 11111 111100
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
. ... ......+.+++.+||..+|++||++.++++.|+
T Consensus 232 ~------~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 232 L------QKP---ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred c------CCc---ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0 000 111245678999999999999999999998876
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=355.24 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=200.5
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee--Cc
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GE 697 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~ 697 (964)
....++|.+.+.||+|+||+||+|... .++.||+|++..... .....+..|+.++++++|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999964 578899998875432 2345688999999999999999999988653 46
Q ss_pred eEEEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCC----CCeeccCCCCCcEEECC--------
Q 002121 698 QMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELAN----PPIIHRDVKSTNILLDE-------- 763 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~Dlk~~NILl~~-------- 763 (964)
.|+||||+++|+|.++|.... ...+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999987532 2468999999999999999999998542 34999999999999964
Q ss_pred ---------CCcEEEeecccceeecCCCCCceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 764 ---------NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 764 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
.+.+||+|||+++...... ......||+.|+|||++.. ..++.++|||||||++|||+||+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 3458999999998664322 2234569999999999854 4588999999999999999999999976
Q ss_pred CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+... ...+. + .+. .....+.+++.+||+.+|.+||++.|++.
T Consensus 246 ~~~~~qli~~l-k~~p~----l------pi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 246 ANNFSQLISEL-KRGPD----L------PIK----GKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcHHHHHHHH-hcCCC----C------CcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 54433333222 11110 0 000 01245678999999999999999999985
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.03 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=203.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-----CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEe--eCce
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-----DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 698 (964)
+.|+..+.||+|+||.||+|.+. ++..||||+++..... ....+.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3679999998865443 45679999999999999999999999987 5578
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++++|.+++.... ..++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997653 35899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCce-eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh-------------HHHHHHHh
Q 002121 779 SDSSKGHV-STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-------------VREVRTAM 844 (964)
Q Consensus 779 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-------------~~~~~~~~ 844 (964)
........ .....++..|+|||+.....++.++||||||+++|||+||+.|+...... .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL 239 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence 53322111 11233566799999998889999999999999999999999997532211 11111111
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.... ... ........+.+++.+|++.+|++||+|.||+++|+.+
T Consensus 240 ~~~~------------~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGE------------RLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCC------------cCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1100 000 0011124577999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=322.97 Aligned_cols=259 Identities=25% Similarity=0.478 Sum_probs=202.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|+..+.||+|+||.||+|.+. +|+ .||+|.+..... ....++.+|+.++++++||||++++++|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46677789999999999999853 454 578888765433 2234688999999999999999999998754 5679
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999987643 35889999999999999999999988 99999999999999999999999999987643
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........++..|+|||++.+..++.++|||||||++|||++ |+.||.... .+........... .. .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~----~~---~ 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKGER----LP---Q 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCCC----CC---C
Confidence 322222223446778999999988889999999999999999998 888985422 1222222222110 00 0
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+. .....+.+++.+||..+|++||+++|+++.++.+.+..
T Consensus 233 ~~------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 233 PP------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred CC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 00 01134678999999999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=333.85 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=197.3
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee------
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 695 (964)
..++|...+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 356899999999999999999995 468899999987532 22345678999999999999999999987543
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
...++||||+++ +|.+++.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 357999999975 77777743 4788999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc------
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE------ 849 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 849 (964)
+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........+ ...+.....
T Consensus 174 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~ 249 (364)
T cd07875 174 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW-NKVIEQLGTPCPEFM 249 (364)
T ss_pred cccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcCCCCHHHH
Confidence 865432 1223456899999999999999999999999999999999999999754332221 111110000
Q ss_pred -----------------cccccccccCccc----hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 850 -----------------EHYGLTEMMDPTI----RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 850 -----------------~~~~~~~~~d~~l----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+...+...... ..........+.+++.+|++.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000000000 00001112456799999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=326.97 Aligned_cols=199 Identities=21% Similarity=0.289 Sum_probs=166.2
Q ss_pred ccceeecC--CcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 631 ESNEIGSG--GYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 631 ~~~~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
..++||+| +|++||++.. .+|+.||+|++..... .....+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35789999 7899999985 5789999999875432 22346788999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC-
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG- 784 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 784 (964)
++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.++++|||.+.........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999997654446899999999999999999999988 999999999999999999999999875443221110
Q ss_pred ----ceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 785 ----HVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 785 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 01122346778999999875 4688999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=330.75 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=197.9
Q ss_pred eeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhh
Q 002121 634 EIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRE 712 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 712 (964)
+||+|.||+||.|+.. +...+|||.+..........+.+|+.+.++++|+|||+.+|.|.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 7999999999999965 456799999877666656678999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCcc--chHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEEEeecccceeecCCCCCceeec
Q 002121 713 SLSGRSGIHL--DWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQ 789 (964)
Q Consensus 713 ~l~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~ 789 (964)
+|+..= .++ ++.+.-.+..||++||.|||+.. |||||||-+|||++ -.|.+||+|||.++.+.. -...+..
T Consensus 662 LLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET 735 (1226)
T KOG4279|consen 662 LLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET 735 (1226)
T ss_pred HHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence 998653 245 77888899999999999999988 99999999999995 578999999999987642 2244556
Q ss_pred ccccCcccCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHhccCcccccccccccCccchhhh
Q 002121 790 VKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVVMLELITAKQPIEKGKYV-VREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 790 ~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
..||..|||||++..+ .|..++|||||||++.||.||++||-+-... ...++-- .-.+.|.++...
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-----------myKvHP~iPeel 804 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-----------MYKVHPPIPEEL 804 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-----------ceecCCCCcHHH
Confidence 7799999999999865 5889999999999999999999999642222 1111110 111233444332
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .+...+|.+|+.+||.+||+++++++
T Consensus 805 s---aeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 805 S---AEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred H---HHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2 34557999999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.17 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=200.2
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee-CceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-GEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~E 703 (964)
+|+..+.||+|++|.||++... +++.||+|++..... ...+.+.+|++++++++|+|++++++.+... ...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788899999999999999954 578999999865332 3345688999999999999999999987644 45789999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.+++.......+++.++..++.+++.|++|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 999999999998655556899999999999999999999988 9999999999999999999999999998764322
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ............ . ...
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~------~-----~~~ 223 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-NSLVYRIIEGKL------P-----PMP 223 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHhcCC------C-----CCc
Confidence 122345689999999999999999999999999999999999999864332 222222211110 0 001
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+|++.+|++||++.|+++
T Consensus 224 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 ---KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred ---cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=321.39 Aligned_cols=262 Identities=24% Similarity=0.386 Sum_probs=204.5
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE 694 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 694 (964)
+.++++..+.++|+..+.||+|+||.||+|.. .+++.+|+|++.... ....++.+|+.+++++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 55677888899999999999999999999986 468899999876432 2235688999999999 69999999998853
Q ss_pred -----eCceEEEEEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 695 -----QGEQMLVYEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 695 -----~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
++..++||||+++|+|.++++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 35689999999999999987532 2346889999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 842 (964)
||+|||+++...... .......|++.|+|||++.. ..++.++||||+||++|||++|+.||.......... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-~ 240 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-K 240 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-h
Confidence 999999998764322 11233468999999999753 457889999999999999999999987543222111 1
Q ss_pred HhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.. ... .....++.. ....+.+++.+||+.+|++||++.|+++.
T Consensus 241 ~~-~~~-----~~~~~~~~~------~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 IP-RNP-----PPTLHQPEL------WSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cc-ccC-----CCcccCCCC------cCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 10 000 001111111 11356789999999999999999999863
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=323.98 Aligned_cols=194 Identities=25% Similarity=0.422 Sum_probs=160.2
Q ss_pred cceeecCCcEEEEEEEec---CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceEEEEEecc
Q 002121 632 SNEIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQMLVYEFMA 706 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~ 706 (964)
.++||+|+||+||+|+.. +++.||+|++..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999864 467899999875432 2457889999999999999999999865 346789999986
Q ss_pred CCChhhhhcCCC-------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----CCCCcEEEeecccc
Q 002121 707 NGTLRESLSGRS-------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLS 775 (964)
Q Consensus 707 ~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla 775 (964)
+ +|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 8888765321 235889999999999999999999988 9999999999999 56689999999999
Q ss_pred eeecCCCCC-ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 776 KLVSDSSKG-HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 776 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
+........ .......||+.|+|||++.+ ..++.++||||+||++|||++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 876433211 12234578999999999876 458899999999999999999999996
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=317.11 Aligned_cols=248 Identities=26% Similarity=0.411 Sum_probs=201.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|+..+.||.|+||.||+|... +++.||+|.+.... ......+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778899999999999999964 68999999987543 33345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++++|.+++... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 152 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-- 152 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc--
Confidence 9999999999764 6899999999999999999999988 9999999999999999999999999998775432
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.......+++.|+|||++.+..++.++|||||||++|||+||+.||..... ........... .+.+..
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~-----------~~~~~~ 220 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP-MRVLFLIPKNN-----------PPSLEG 220 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch-HHHHHHhhhcC-----------CCCCcc
Confidence 122334688899999999988899999999999999999999999964331 11111111110 011110
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .....+.+++.+||..+|++||+++++++
T Consensus 221 ~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 N--KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 01234668999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=314.27 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=203.1
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||++.. .+|+.||+|++.... .....++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 477889999999999999985 468999999986432 23345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++++|.+++.......+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 99999999997655456899999999999999999999988 99999999999999999999999999986543221
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......|++.|+|||+..++.++.++|||||||+++||++|+.||..... .+.+......... ...
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-~~~~~~~~~~~~~-----------~~~- 222 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-KNLVLKIIRGSYP-----------PVS- 222 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-HHHHHHHhcCCCC-----------CCc-
Confidence 12234588999999999888899999999999999999999999975432 2222222211110 000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+||+.+|++||++.||++
T Consensus 223 --~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 --SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 111245678999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=316.37 Aligned_cols=254 Identities=24% Similarity=0.439 Sum_probs=198.3
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc----------hhHHHHHHHHHHHhcCCCCccceeEEEEeeC
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ----------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQG 696 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 696 (964)
+|...+.||+|+||.||+|.. .+|+.||+|.++..... ..+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 366678999999999999985 46899999987632111 1235788999999999999999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997653 6899999999999999999999987 9999999999999999999999999997
Q ss_pred eecCCCCCceeecccccCcccCccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
...............|+..|+|||++.... ++.++||||||+++||+++|..||........... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~------ 229 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-LGNKRS------ 229 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHH-hhcccc------
Confidence 654322112223456889999999987654 78999999999999999999999965443322211 111100
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...++.... ......+.+++.+|+..+|++||++.||++
T Consensus 230 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 230 APPIPPDVS---MNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CCcCCcccc---ccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 000111110 112245678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=318.68 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=200.1
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+.|++.+.||+|+||.||+|... +++.||+|.+..........+.+|++++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46778899999999999999964 58999999988665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|..++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~ 165 (292)
T cd06644 92 PGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--Q 165 (292)
T ss_pred CCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--c
Confidence 9999998876543 35899999999999999999999987 9999999999999999999999999987543221 1
Q ss_pred eeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 786 VSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
......++..|+|||++. ...++.++|||||||++|||++|+.||..... ...+........ .....+
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~------~~~~~~ 238 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLLKIAKSEP------PTLSQP 238 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH-HHHHHHHhcCCC------ccCCCC
Confidence 123346889999999984 34568899999999999999999999864332 222222211111 000000
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+||..+|++||++.|+++
T Consensus 239 ------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 239 ------SKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ------cccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 011234678999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=314.12 Aligned_cols=237 Identities=24% Similarity=0.406 Sum_probs=188.5
Q ss_pred ceeecCCcEEEEEEEecC-C----------cEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 633 NEIGSGGYGKVYRGMLSD-G----------QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~-g----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999754 3 25788877654333 5688999999999999999999999988 788999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-------cEEEeeccc
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-------TAKVADFGL 774 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-------~~kl~DFGl 774 (964)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 999999999999976542 6899999999999999999999987 99999999999999888 799999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccC--CCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
++.... .....++..|+|||++... .++.++|||||||++|||++ |..|+.... ......... ...
T Consensus 155 a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-~~~~~~~~~-~~~--- 223 (259)
T cd05037 155 PITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-SSEKERFYQ-DQH--- 223 (259)
T ss_pred cccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-chhHHHHHh-cCC---
Confidence 986543 1223467889999998876 78999999999999999999 466765432 111111111 000
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.. ... ....+.+++.+||..+|++||++.|+++.|
T Consensus 224 -----~~----~~~---~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 224 -----RL----PMP---DCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -----CC----CCC---CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 00 000 015677999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=328.73 Aligned_cols=193 Identities=25% Similarity=0.358 Sum_probs=166.5
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
...+|.+.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++.+.+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3468999999999999999999965 5788999975432 23569999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+. |+|.+++.... ..++|..+..|+.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred ccC-CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 995 68888886543 46899999999999999999999988 999999999999999999999999999754322
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 12234569999999999999999999999999999999999766653
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=311.76 Aligned_cols=247 Identities=28% Similarity=0.435 Sum_probs=199.4
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-----chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-----QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999975 789999998865331 2345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997543 5889999999999999999999988 999999999999999999999999998875433
Q ss_pred CCCceeecccccCcccCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. ......|+..|+|||.+.... ++.++|+|||||++|||++|+.||...... ........... .. .+.+
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~-----~~-~~~~ 225 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIGRSKE-----LP-PIPD 225 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHHHHhccc-----CC-CcCC
Confidence 2 223456899999999987766 899999999999999999999999754421 22211111000 00 0111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ....+.+++.+||+.+|++||++.+++.
T Consensus 226 ~-------~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 226 H-------LSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred C-------cCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1 1144568999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-35 Score=317.12 Aligned_cols=238 Identities=24% Similarity=0.377 Sum_probs=186.0
Q ss_pred eeecCCcEEEEEEEecC-------------------------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccce
Q 002121 634 EIGSGGYGKVYRGMLSD-------------------------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 688 (964)
.||+|+||.||+|.+.. ...||+|++.........++.+|++++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 58999999999997421 13588998875544445578899999999999999999
Q ss_pred eEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---
Q 002121 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL--- 765 (964)
Q Consensus 689 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--- 765 (964)
+++|.+....++||||+++|+|..++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCccc
Confidence 999999999999999999999999986543 36889999999999999999999987 99999999999997654
Q ss_pred ----cEEEeecccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHH-hCCCCCCCCchhHHH
Q 002121 766 ----TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELI-TAKQPIEKGKYVVRE 839 (964)
Q Consensus 766 ----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~ell-tg~~p~~~~~~~~~~ 839 (964)
.+|++|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 158 ~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred CccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3799999998644221 12347888999998865 56889999999999999985 6888886432111
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.......... ..+ . ....+.+++.+||+.+|++||++.++++.|
T Consensus 230 ~~~~~~~~~~----~~~----~-------~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFYEKKHR----LPE----P-------SCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHHHhccC----CCC----C-------CChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1111111100 110 0 113467899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=314.36 Aligned_cols=250 Identities=25% Similarity=0.422 Sum_probs=194.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-----chhHHHHHHHHHHHhcCCCCccceeEEEEee--Cce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-----QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 698 (964)
.+|...+.||+|+||.||+|.. .+|..||+|++..... .....+.+|+.++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999986 4689999998864321 2234688999999999999999999998763 567
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 89999999999999997643 5889999999999999999999887 999999999999999999999999999765
Q ss_pred cCCCC-CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 779 SDSSK-GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 779 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||....... .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~-~~~~~~~~~---------- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA-AIFKIATQP---------- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH-HHHHHhcCC----------
Confidence 32111 111123458899999999998889999999999999999999999997543222 222211111
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+.... ...+.+++ +||..+|++||+++||++
T Consensus 226 ~~~~~~~~~---~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 226 TNPQLPSHI---SEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCCchhc---CHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 011111111 12334555 788899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=319.58 Aligned_cols=261 Identities=27% Similarity=0.418 Sum_probs=204.8
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE 694 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 694 (964)
++.+++..++++|...+.||+|+||.||+|.. .+++.+|+|++..... ...++.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 55677778899999999999999999999996 4688999999865322 235678899999999 79999999999876
Q ss_pred e-----CceEEEEEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 695 Q-----GEQMLVYEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 695 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
. +..++||||+++|+|.++++.. .+..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 3579999999999999988642 2346899999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-----QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 842 (964)
||+|||+++....... ......|+..|+|||++... .++.++|||||||++|||++|+.||........ +..
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-~~~ 244 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-LFK 244 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-HHH
Confidence 9999999886543221 12234688999999997643 368899999999999999999999965432221 111
Q ss_pred HhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ....++ ......+.+++.+||+.+|++||++.|+++
T Consensus 245 ~~~~~~------~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 245 IPRNPP------PTLLHP------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HhcCCC------CCCCcc------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 001111 111235778999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=342.80 Aligned_cols=265 Identities=18% Similarity=0.285 Sum_probs=194.9
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCC------CccceeEEE
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHK------NLVGLVGFC 692 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~ 692 (964)
+++...+++|.+.+.||+|+||+||+|.. ..++.||||+++... ....++..|++++++++|. +++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44555678999999999999999999986 467899999986432 2234567788888877654 588899988
Q ss_pred Eee-CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCC-----
Q 002121 693 FEQ-GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENL----- 765 (964)
Q Consensus 693 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~----- 765 (964)
... +..++|||++ +++|.+++...+ .+++..+..|+.||+.||+|||+ .+ ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 764 5688999988 678998887543 68999999999999999999997 46 99999999999998765
Q ss_pred -----------cEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Q 002121 766 -----------TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834 (964)
Q Consensus 766 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~ 834 (964)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998864321 2234679999999999999999999999999999999999999997443
Q ss_pred hhH--HHHHHHhccCcccc------------cc----cccccCccch-h-------hhHHHHHHHHHHHHHhhhcCCCCC
Q 002121 835 YVV--REVRTAMNRDDEEH------------YG----LTEMMDPTIR-N-------TVLLGFRRYLELALQCVEESATDR 888 (964)
Q Consensus 835 ~~~--~~~~~~~~~~~~~~------------~~----~~~~~d~~l~-~-------~~~~~~~~l~~li~~cl~~dP~~R 888 (964)
... ..+...+...+... +. +....++... . ........+.+++.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 221 11111111100000 00 0000111000 0 000112456799999999999999
Q ss_pred CCHHHHHH
Q 002121 889 PTMSEVVK 896 (964)
Q Consensus 889 Ps~~evl~ 896 (964)
||++|+++
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.64 Aligned_cols=255 Identities=26% Similarity=0.385 Sum_probs=201.3
Q ss_pred cCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
++|+..+.||+|+||.||+|+.+ +.+.||+|.+...... ...++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999964 2467999988754433 3457999999999999999999999999989999
Q ss_pred EEEEeccCCChhhhhcCCCC-------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 700 LVYEFMANGTLRESLSGRSG-------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999975441 25899999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
|+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..... ...+........
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~~~~~~~~~--- 236 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVLNRLQAGKL--- 236 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHHHHHHcCCc---
Confidence 99875432211 12233456788999999988888999999999999999999 7778853221 111211111110
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
...... .....+.+++.+||+.+|++||++.|+++.|+
T Consensus 237 ---~~~~~~-------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 237 ---ELPVPE-------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ---CCCCCC-------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 000000 11245678999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=327.83 Aligned_cols=261 Identities=23% Similarity=0.353 Sum_probs=196.4
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee-----
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ----- 695 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 695 (964)
...++|...+.||+|+||+||+|.. .+++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999985 5688999999875322 2334677899999999999999999988543
Q ss_pred -CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 696 -GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 696 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
...+++||++ +++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 67998888643 5899999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+.............
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI-DQLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence 9875432 223468999999999876 56889999999999999999999999643322 2221111100000000
Q ss_pred cccccC----------------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMD----------------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d----------------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....+. ..+..........+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00000000111346789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.95 Aligned_cols=248 Identities=28% Similarity=0.422 Sum_probs=201.3
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||+|.. .+++.+|+|++..... .....+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 477889999999999999985 4688999999875432 2345788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~~~~~~~~ 783 (964)
+++++|.+++....+..+++..+..++.+++.||+|||+.+ |+||||||+||+++++ +.+||+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999998765556899999999999999999999988 9999999999999855 4689999999987654321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+......... ...+
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~------- 223 (256)
T cd08220 158 ---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-PALVLKIMSGTFA---PISD------- 223 (256)
T ss_pred ---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-HHHHHHHHhcCCC---CCCC-------
Confidence 2234688999999999988899999999999999999999999865432 2222222211110 0111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+||+.+|++||++.|+++
T Consensus 224 ----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 ----RYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred ----CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11245678999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.06 Aligned_cols=246 Identities=29% Similarity=0.483 Sum_probs=198.1
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|...+.||+|+||.||+|.. +++.||+|+.+... ....+.+|+.++++++||||+++++++..+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999985 67889999986532 235789999999999999999999998654 5799999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999998765556899999999999999999999987 9999999999999999999999999997643221
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....+..|+|||++.++.++.++|||||||++|||++ |+.||..... .+ .......... .++ .
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~-~~~~~~~~~~--------~~~--~-- 219 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-KE-VKECVEKGYR--------MEP--P-- 219 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-HH-HHHHHhCCCC--------CCC--C--
Confidence 12234678999999988899999999999999999998 8988864332 12 1222221110 000 0
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
......+.+++.+||+.+|++||+++++++.|+
T Consensus 220 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 220 -EGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred -CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 011245678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.42 Aligned_cols=263 Identities=23% Similarity=0.336 Sum_probs=198.2
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999864 689999998864332 2234688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+. ++|.+++.......+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 96 68999987655567899999999999999999999988 99999999999999999999999999876543211
Q ss_pred ceeecccccCcccCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH--HhccCcccc----------
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT--AMNRDDEEH---------- 851 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~---------- 851 (964)
......++..|+|||++.+.. ++.++|||||||++|||+||+.||..........+. .........
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY 234 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence 122334788999999887644 688999999999999999999999654332211111 111000000
Q ss_pred -cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 -YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 -~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..........+..........+.+++.+|++.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000010000111234568999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.65 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=199.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888899999999999999975 689999998864322 223467899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|++++.|..++.... .++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999998888775432 5899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHH--HHHHHhccCcccc---cc----
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR--EVRTAMNRDDEEH---YG---- 853 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~---~~---- 853 (964)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ............. ..
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1223457889999999875 5678999999999999999999999964432211 1111111000000 00
Q ss_pred cccccCcc------chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 LTEMMDPT------IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~------l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+. +..........+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000 00001111245779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=318.48 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=198.1
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 555678999999999999854 678999998875432 334578999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+++|.+++... .+++..+..++.|+++|++|||+.+ ++|+||+|+||++++++.++|+|||+++...... ..
T Consensus 86 ~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06642 86 GGSALDLLKPG---PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK 157 (277)
T ss_pred CCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence 99999998643 5899999999999999999999987 9999999999999999999999999998654322 11
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
.....|+..|+|||++.+..++.++|||||||++|||++|+.|+...... .... ..... ..+.+.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~-~~~~~----------~~~~~~--- 222 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-RVLF-LIPKN----------SPPTLE--- 222 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-hHHh-hhhcC----------CCCCCC---
Confidence 22345889999999999888999999999999999999999998632211 1111 11100 011111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
......+.+++.+||+.+|++||++.|+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1122456789999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=308.45 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=204.5
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
-|.+..+||+|+||.||+|.++ .|+.||+|++... .+..++..|+.+|++.+.|++|++||.+......|+|||||.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3566788999999999999964 6999999987643 345688999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
-|+..+.++.++ .++++.++..+....+.||+|||... -||||||+.|||++.+|.+||+|||.|..+.+.. ..
T Consensus 112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK 185 (502)
T KOG0574|consen 112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK 185 (502)
T ss_pred CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence 999999998654 68999999999999999999999877 7999999999999999999999999998775432 23
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
...+.||+.|||||++..-.|+.++||||+|++..||..|++||..-.. ++.++.- +- -.|......
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----MRAIFMI--------PT-~PPPTF~KP 252 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----MRAIFMI--------PT-KPPPTFKKP 252 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----cceeEec--------cC-CCCCCCCCh
Confidence 3457899999999999998999999999999999999999999864211 1111111 11 111112223
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..-...+-+++++|+-..|++|-|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 334466789999999999999999988754
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=317.18 Aligned_cols=251 Identities=26% Similarity=0.396 Sum_probs=201.1
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|.+.+.||+|+||.||+|... +++.||+|+++.........+.+|++++++++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 46778889999999999999964 68999999987665555567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~ 158 (280)
T cd06611 85 DGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q 158 (280)
T ss_pred CCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence 9999999987543 36899999999999999999999988 9999999999999999999999999987653322 1
Q ss_pred eeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 786 VSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
......|++.|+|||++. ...++.++||||||+++|||++|+.||...... +.+........ . .++.
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~------~-~~~~ 230 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-RVLLKILKSEP------P-TLDQ 230 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-HHHHHHhcCCC------C-CcCC
Confidence 223356899999999974 345678999999999999999999999643322 22222111110 0 0000
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||+.+|++||++.++++
T Consensus 231 -----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 231 -----PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred -----cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 0011235668999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=312.72 Aligned_cols=257 Identities=27% Similarity=0.392 Sum_probs=204.3
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|+..+.||+|+||+||+|.. .++..+|+|++..... .....+.+|+++++.++|+||+++++.+...+..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688899999999999999995 4688999999875432 2446789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSG-IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
+++++|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976432 46899999999999999999999988 99999999999999999999999999876654322
Q ss_pred Cc--eeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GH--VSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. ......|+..|+|||++... .++.++|||||||++|||++|+.||....... .+.......... ......
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~---~~~~~~- 232 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDPPS---LETGAD- 232 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCCCC---cCCccc-
Confidence 21 22334689999999998876 78899999999999999999999996543221 122222111100 000000
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+|++.||++||++.|+++
T Consensus 233 -----~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 233 -----YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred -----cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0122255679999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.60 Aligned_cols=248 Identities=26% Similarity=0.437 Sum_probs=197.4
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+|+..+.||+|+||.||+|... +|+.||+|.++.... .....+.+|++++++++|+||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5778899999999999999975 789999998875422 23457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 706 ANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 706 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
++++|.+++.... ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999887542 23689999999999999999999963 5 9999999999999999999999999987653221
Q ss_pred CceeecccccCcccCccccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~ 855 (964)
.....+++.|+|||++.+. .++.++|||||||++|||++|+.||..... ....+........
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------- 227 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------- 227 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC-------
Confidence 2234588899999998543 357899999999999999999999964322 1111111111110
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+. ......+.+++.+|++.+|++||++.++++
T Consensus 228 ----~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----PTLP---SGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCC---cccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111 112245668999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.27 Aligned_cols=271 Identities=25% Similarity=0.396 Sum_probs=203.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-----hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-----GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
+|+..+.||+|+||.||+|... +|+.||||++...... ....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677889999999999999964 6899999998765432 234567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+ +|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997653 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc---Cccccc----c
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DDEEHY----G 853 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~----~ 853 (964)
.. ......+++.|+|||++.+ ..++.++|||||||++|||++|.+||...... +........ ...... .
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI-DQLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH-HHHHHHHHHcCCCchhhhhhccc
Confidence 21 1222346788999998864 46789999999999999999997777543322 111111110 000000 0
Q ss_pred ccccc------CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCC
Q 002121 854 LTEMM------DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMN 908 (964)
Q Consensus 854 ~~~~~------d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 908 (964)
..... ..............+.+++.+||+.+|++||++.|+++ ..++++...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~~~~~~~~~ 291 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HPYFSNDPAP 291 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--CccccCCCCC
Confidence 00000 00000111122356789999999999999999999987 3455444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=317.81 Aligned_cols=262 Identities=25% Similarity=0.377 Sum_probs=199.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|+||.||+|..+ +++.||+|++...... ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999975 5899999987653322 24568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.++..... .++|.++..++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988876543 4899999999999999999999987 9999999999999999999999999998754332
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc---ccc-
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY---GLT- 855 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~---~~~- 855 (964)
.......++..|+|||++.+ ..++.++|||||||++|||++|++||........ ...... ....... ...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-LYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHHHhCCCchhhHHHhccch
Confidence 22233458899999999875 4578899999999999999999998865443221 111111 0000000 000
Q ss_pred ---cccCccch------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 ---EMMDPTIR------NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ---~~~d~~l~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+... .........+.+++.+||+.+|++||++.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00000000 001112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=327.31 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=204.7
Q ss_pred ccceeecCCcEEEEEEEec--CCc--EEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 631 ESNEIGSGGYGKVYRGMLS--DGQ--VVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
..++||+|.||.|++|.|. +|+ .||||.++..... ....|.+|+.+|-+|+|||+++|||+..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 3578999999999999985 344 6899999876554 45689999999999999999999999988 6778999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+.|+|.+.|+......+-......++.|||.||.||.+++ .|||||.++|+||-..-.+||+||||.|-+...+..+
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 9999999999855567888999999999999999999988 9999999999999999999999999999887665544
Q ss_pred eee-cccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCc-cc
Q 002121 786 VST-QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP-TI 862 (964)
Q Consensus 786 ~~~-~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~l 862 (964)
++. ...-.+.|.|||.++.++++.++|||+|||++|||+| |..||-. -.-.+.++ .+|. +.
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G-~~g~qIL~---------------~iD~~er 333 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG-CRGIQILK---------------NIDAGER 333 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC-CCHHHHHH---------------hcccccc
Confidence 433 3456778999999999999999999999999999999 6778743 22222221 1111 11
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
......+.+++.+++++||.++|++||++..+.+.+
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 122344557788999999999999999999997543
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.21 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=198.0
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|...+.||+|+||.||+|+.. +|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4777899999999999999964 689999999865322 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
++ ++|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 97 58888876543 35899999999999999999999988 99999999999999999999999999986543211
Q ss_pred ceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc---Cccccc-ccccccC
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DDEEHY-GLTEMMD 859 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~d 859 (964)
......++..|+|||++.+. .++.++|||||||++|||+||+.|+..+......+...... .....+ ...+..+
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD 233 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence 12234578999999998764 46899999999999999999999976554433333322111 000000 0000000
Q ss_pred --------ccc--hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 --------PTI--RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 --------~~l--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ..........+.+++.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000 0001112245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.32 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=200.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|+..+.||+|+||+||+|... +|+.||+|++.... ......+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677789999999999999954 68899999876543 23346789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
+++|+|.+++...+ .+++..+..++.+++.||.|||+ .+ ++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 99999999987643 58999999999999999999997 35 9999999999999999999999999987543221
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh----------HHHHHHHhccCcccccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV----------VREVRTAMNRDDEEHYG 853 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~----------~~~~~~~~~~~~~~~~~ 853 (964)
.....|+..|+|||++.++.++.++|||||||++|||++|+.||...... ...+........
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 230 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP----- 230 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-----
Confidence 12346899999999998888999999999999999999999999642211 112222111110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+.+.. ......+.+++.+|++.||++||++.|+++.
T Consensus 231 ------~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 231 ------PRLPS--SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ------CCCCc--hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01100 1122456789999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.47 Aligned_cols=195 Identities=25% Similarity=0.417 Sum_probs=160.2
Q ss_pred cceeecCCcEEEEEEEec---CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceEEEEEecc
Q 002121 632 SNEIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQMLVYEFMA 706 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~E~~~ 706 (964)
..+||+|+||+||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 367999999999999964 357899999875432 2467899999999999999999999854 456799999987
Q ss_pred CCChhhhhcCC-------CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----CCCCcEEEeecccc
Q 002121 707 NGTLRESLSGR-------SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLS 775 (964)
Q Consensus 707 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla 775 (964)
+ +|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 777776422 1235889999999999999999999988 9999999999999 56789999999999
Q ss_pred eeecCCCCC-ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 776 KLVSDSSKG-HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 776 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876433211 12234568999999999876 4588999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=328.31 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=203.0
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-C-----CCccceeEEEEeeCceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-H-----KNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~l 700 (964)
+|.+.+.||+|+||.|-||.. .+++.||||+++....- ..+...|+.+|..++ | -|+|++++|+...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f-~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRF-LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHH-HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 788999999999999999994 57999999999864322 345678999999997 4 389999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC--CcEEEeecccceee
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN--LTAKVADFGLSKLV 778 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGla~~~ 778 (964)
|+|.+.. +|+++++.++-..++...+..|+.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.|...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999865 9999999988778999999999999999999999988 9999999999999643 47999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc----------
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD---------- 848 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 848 (964)
..... ...-+..|.|||++.+.+|+.+.||||||||++||++|. |...|++..+++..+++--.
T Consensus 342 ~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~ 415 (586)
T KOG0667|consen 342 SQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGE-PLFPGDNEYDQLARIIEVLGLPPPKMLDTA 415 (586)
T ss_pred CCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCc-cccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 54322 455788999999999999999999999999999999995 55455555555443322100
Q ss_pred ------------ccccc-c--------------------ccccCc-cchhh---hH-HHHHHHHHHHHHhhhcCCCCCCC
Q 002121 849 ------------EEHYG-L--------------------TEMMDP-TIRNT---VL-LGFRRYLELALQCVEESATDRPT 890 (964)
Q Consensus 849 ------------~~~~~-~--------------------~~~~d~-~l~~~---~~-~~~~~l~~li~~cl~~dP~~RPs 890 (964)
..... . .+..-| ..... .. ..-..+++++++|+..||.+|+|
T Consensus 416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t 495 (586)
T KOG0667|consen 416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT 495 (586)
T ss_pred cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence 00000 0 000001 00000 11 23356899999999999999999
Q ss_pred HHHHHH
Q 002121 891 MSEVVK 896 (964)
Q Consensus 891 ~~evl~ 896 (964)
..|+++
T Consensus 496 p~qal~ 501 (586)
T KOG0667|consen 496 PAQALN 501 (586)
T ss_pred HHHHhc
Confidence 999876
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=320.78 Aligned_cols=245 Identities=23% Similarity=0.374 Sum_probs=197.2
Q ss_pred cceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 632 SNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
...||+|+||.||++.. .++..||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 46799999999999986 46889999998765555556789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........ .....
T Consensus 107 ~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~ 178 (292)
T cd06658 107 TDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSL 178 (292)
T ss_pred HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCcee
Confidence 9988643 4889999999999999999999988 99999999999999999999999999876533221 12234
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
.|+..|+|||+..+..++.++|||||||++|||++|+.||...... ..+...... +.+.+... ....
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-~~~~~~~~~-----------~~~~~~~~-~~~~ 245 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-QAMRRIRDN-----------LPPRVKDS-HKVS 245 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhc-----------CCCccccc-cccC
Confidence 6899999999998888999999999999999999999999654322 111111110 01111100 0112
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+.+++.+|+..||.+|||++|+++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 345688999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.76 Aligned_cols=251 Identities=31% Similarity=0.479 Sum_probs=200.8
Q ss_pred CCccceeecCCcEEEEEEEecC-----CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 629 FSESNEIGSGGYGKVYRGMLSD-----GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
|++.+.||+|+||.||++...+ +..||+|+++..... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3456889999999999999653 488999999765543 4568999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++++|.+++.......+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999997654333899999999999999999999988 9999999999999999999999999998765442
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
... .....+++.|+|||.+....++.++||||+|+++|||++ |+.||... .............. ..
T Consensus 158 ~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~~~~~~~~------~~----- 224 (258)
T smart00219 158 YYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLEYLKKGYR------LP----- 224 (258)
T ss_pred ccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHHHhcCCC------CC-----
Confidence 211 112337789999999988889999999999999999999 77777532 22222222111111 00
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.. ......+.+++.+|+..+|++|||+.|+++.|
T Consensus 225 ~~---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KP---ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC---CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 00 01224577899999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=318.37 Aligned_cols=252 Identities=23% Similarity=0.405 Sum_probs=203.7
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecC--CCcchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQ--GSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E 703 (964)
..|++++.||+||.++||++...+.+.+|+|++.. .+.+....|.+|+..|.+++ |.+||++++|-..++..|+|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 46888899999999999999988888999987654 33344567999999999995 9999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|= ..+|..+|........+| .+..+..||+.++.++|.++ |||.||||.|+|+-. |.+||+|||.|..+..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 64 569999999877666667 78889999999999999999 999999999999864 6999999999998877666
Q ss_pred CceeecccccCcccCccccccC-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQ-----------QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 852 (964)
.-....-+||+.||+||.+... +++.++||||+||+||+|+.|+.||..-.+...-+..+.....+..
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie- 593 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE- 593 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc-
Confidence 5666667899999999988432 3668999999999999999999999754444443333332221111
Q ss_pred ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
-|.+... .+++++++.||+.||.+||++.|+++
T Consensus 594 ------fp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 594 ------FPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ------ccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1111111 22789999999999999999999985
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=318.23 Aligned_cols=245 Identities=21% Similarity=0.315 Sum_probs=197.7
Q ss_pred cceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 632 SNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
...||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 356999999999999864 6899999998765555556788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 106 ~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~ 177 (297)
T cd06659 106 TDIVSQT---RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSL 177 (297)
T ss_pred HHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--ccccce
Confidence 9988643 4899999999999999999999988 9999999999999999999999999987554322 112335
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+........ . ... .. ....
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~-~---~~~-~~-------~~~~ 244 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-QAMKRLRDSPP-P---KLK-NA-------HKIS 244 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhccCC-C---Ccc-cc-------CCCC
Confidence 6899999999999888999999999999999999999999743322 22222111110 0 000 00 0112
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+.+++.+|++.+|++||++.|+++.
T Consensus 245 ~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 245 PVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 346689999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=312.07 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=197.1
Q ss_pred CCccceeecCCcEEEEEEEec----CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC------
Q 002121 629 FSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------ 696 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 696 (964)
|.+.+.||+|+||.||+|.+. .++.||||++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456788999999999999853 36899999987543 223456889999999999999999999886532
Q ss_pred ceEEEEEeccCCChhhhhcCCC----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 697 EQMLVYEFMANGTLRESLSGRS----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
..++++||+++|+|.+++.... ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478999999999998875321 235788999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
|+++...............+++.|++||.+..+.++.++|||||||++|||++ |+.||..... .+..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~--- 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYNYLIKGNR--- 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHHHHHcCCc---
Confidence 99986643322222223345678999999988889999999999999999999 8888754322 111111111111
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.. ..+ .....+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 234 --~~--~~~-------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 --LK--QPP-------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --CC--CCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 001 1124677999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=316.50 Aligned_cols=244 Identities=22% Similarity=0.349 Sum_probs=199.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||.||++... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999964 689999999865322 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997653 6899999999999999999999988 999999999999999999999999999876433
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....|++.|+|||.+.+...+.++||||||+++|||++|+.||...... ........... .+...+
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~----~~~~~~---- 221 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-QIYEKILEGKV----RFPSFF---- 221 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhcCCc----cCCccC----
Confidence 23346899999999998888899999999999999999999999754421 11112111111 011111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.+|.+|| +++|+++
T Consensus 222 -------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 -------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -------CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 24566899999999999998 6666653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.66 Aligned_cols=263 Identities=24% Similarity=0.371 Sum_probs=198.1
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|+..+.||+|+||.||+|..+ +++.||+|.+...... ....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999965 6899999998654322 234577899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++ +|.+++.... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 985 9999887543 36899999999999999999999988 99999999999999999999999999875432211
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh---ccCccccc--------
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM---NRDDEEHY-------- 852 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~-------- 852 (964)
......++..|+|||++.+ ..++.++||||+||++|||++|+.||.......+.+.... ........
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE 237 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence 1122346889999999875 4578999999999999999999999965442222222111 11100000
Q ss_pred ----ccccccCccchhhhH--HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 ----GLTEMMDPTIRNTVL--LGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ----~~~~~~d~~l~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.........+..... .....+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000100000 11145678999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=312.71 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=200.1
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999964 58899999987543 233457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++... ++++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++....... .
T Consensus 85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 156 (277)
T cd06640 85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--I 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--c
Confidence 999999998753 5889999999999999999999987 9999999999999999999999999998764322 1
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......++..|+|||++.+..++.++|||||||++|||++|..||...... .... ..... ..+.+
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~-~~~~~----------~~~~~--- 221 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-RVLF-LIPKN----------NPPTL--- 221 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-hHhh-hhhcC----------CCCCC---
Confidence 123346888999999998888999999999999999999999998643211 1111 11000 01111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11233557799999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=328.89 Aligned_cols=240 Identities=23% Similarity=0.284 Sum_probs=185.2
Q ss_pred eecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc---CCCCccceeEEEEeeCceEEEEEeccC
Q 002121 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV---HHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
||+|+||+||+|+.. +|+.||||++..... .....+..|..++.+. +||||+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 689999999864322 1222355677777665 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~ 153 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTT 153 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCc
Confidence 99999987543 5899999999999999999999988 9999999999999999999999999987543221 122
Q ss_pred ecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 788 TQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .+........... .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-~~~~~~i~~~~~~----~~---~~~----- 220 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-QQMYRNIAFGKVR----FP---KNV----- 220 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-HHHHHHHHcCCCC----CC---Ccc-----
Confidence 345699999999998754 478999999999999999999999965332 2222222111110 10 000
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPT----MSEVVK 896 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 896 (964)
....+.+++.+||+.||++||+ +.|+++
T Consensus 221 --~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 --LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred --CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1134568999999999999985 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=311.17 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=199.0
Q ss_pred CCCccceeecCCcEEEEEEEecC--CcEEEEEEecCCC----------cchhHHHHHHHHHHHh-cCCCCccceeEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSD--GQVVAIKRAQQGS----------MQGGLEFKTEIELLSR-VHHKNLVGLVGFCFE 694 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 694 (964)
+|+..+.||+|+||.||+|.... ++.+|+|.+.... .....++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47778899999999999999754 6889999875321 1122356778888875 799999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 695 QGEQMLVYEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
++..++||||+++++|.+++... ....+++..++.++.|++.||.|||+ .+ ++||||||+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999987532 23468999999999999999999996 45 99999999999999999999999
Q ss_pred cccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
||++....... ......|+..|+|||++.++.++.++||||||+++|||++|+.||..... ............
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-~~~~~~~~~~~~--- 230 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-LSLATKIVEAVY--- 230 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-HHHHHHHhhccC---
Confidence 99998765432 23445689999999999988899999999999999999999999864432 222222111111
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
..... ......+.+++.+||+.||++||++.|+.++++
T Consensus 231 ---~~~~~-------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 231 ---EPLPE-------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---CcCCc-------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 00000 011245678999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=308.82 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=201.5
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||+|... +++.||+|.++..... ....+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999964 6899999998765443 456789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++++|.+++.... .+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999997643 5789999999999999999999988 999999999999999999999999999876543221
Q ss_pred ce--eecccccCcccCccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 785 HV--STQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 785 ~~--~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.. .....++..|+|||++.... ++.++||||||+++|||++|+.||............... .. .
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~----------~ 224 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GH----------K 224 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CC----------C
Confidence 11 12356789999999998765 889999999999999999999999754322222211111 10 0
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+... ......+.+++.+|++.+|++||++.|++.
T Consensus 225 ~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111110 011244568999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=312.63 Aligned_cols=251 Identities=27% Similarity=0.456 Sum_probs=198.8
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc------chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM------QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
+|+..+.||+|+||.||+|.. .+++.||+|++..... .....+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477789999999999999985 5789999999874331 123568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeec
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVS 779 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~ 779 (964)
||||+++++|.+++.... ++++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997543 6889999999999999999999988 99999999999998776 59999999987664
Q ss_pred CCCC--CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCcccccccc
Q 002121 780 DSSK--GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 780 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~ 855 (964)
.... ........|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 228 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT------- 228 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC-------
Confidence 3211 11122346889999999998888999999999999999999999998643221 111111110000
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+... ......+.+++.+|+..+|++||++.|+++
T Consensus 229 ---~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 229 ---APSIP---EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ---CCCCc---hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 01111 112245678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=317.34 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=199.6
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||.||++... .++.||+|.+..... .....+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999964 578999998875432 22346789999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997653 5899999999999999999999987 9999999999999999999999999987421110
Q ss_pred C-------------CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc
Q 002121 783 K-------------GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 783 ~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
. ........|+..|+|||++....++.++|||||||++|||++|..||.... ..+..........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-~~~~~~~~~~~~~- 233 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDI- 233 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccc-
Confidence 0 001112457889999999988889999999999999999999999996432 2222222111110
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
..+... ......+.+++.+||+.+|++||++.++.+.++.
T Consensus 234 --------~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 --------EWPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred --------CCCCcc---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000 0112446799999999999999997666655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=309.75 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=194.7
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-----chhHHHHHHHHHHHhcCCCCccceeEEEEee--Cce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-----QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 698 (964)
++|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999996 4689999998753221 1234688899999999999999999998764 457
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... .+++....+++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987543 4788889999999999999999988 999999999999999999999999999765
Q ss_pred cCCCC-CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 779 SDSSK-GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 779 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||......... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~-~--------- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-FKIATQ-P--------- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-HHHhcC-C---------
Confidence 32111 01122345889999999998888999999999999999999999999654322221 111111 1
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+... ......+.+++.+|+. +|++||+++|+++
T Consensus 226 ~~~~~~---~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 TNPVLP---PHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCCc---hhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 011111 1122445678888884 8999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=314.80 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=198.2
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++++|...+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|++++++++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457899999999999999999985 46899999998654332 2346788999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||++ ++|.+++.... ..+.+.++..++.|++.||+|||+.+ |+||||||+||+++.++++||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 67777765432 35788889999999999999999988 9999999999999999999999999997643321
Q ss_pred CCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc---ccc-------
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD---EEH------- 851 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~------- 851 (964)
. ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||+......+.+........ ...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 1223457899999999875 35788999999999999999999999754433333222211000 000
Q ss_pred -ccccccc----Cccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 -YGLTEMM----DPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 -~~~~~~~----d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.. .+.+... .......+.+++.+|++.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000 0000000 0011245678999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=317.97 Aligned_cols=253 Identities=23% Similarity=0.281 Sum_probs=201.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+|++++++++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999965 5899999998764433 3346889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+.+++|.+++....+..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999999998655567999999999999999999999988 9999999999999999999999999987543221
Q ss_pred CC---------------------------ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch
Q 002121 783 KG---------------------------HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY 835 (964)
Q Consensus 783 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~ 835 (964)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 001123588999999999988899999999999999999999999964433
Q ss_pred hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHH
Q 002121 836 VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT----MSEVVK 896 (964)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 896 (964)
... .......... .... ......+.+++.+|++.+|++||+ ++|+++
T Consensus 238 ~~~-~~~~~~~~~~----~~~~---------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DET-FSNILKKEVT----FPGS---------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHH-HHHHhcCCcc----CCCc---------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 222 2222211110 1000 002245679999999999999999 666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.60 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=202.5
Q ss_pred cHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe-
Q 002121 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE- 694 (964)
Q Consensus 618 ~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 694 (964)
+..++..+.+.|+..+.||+|+||.||+|.. .+++.||+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4556666778899999999999999999996 468899999886543 2335688899999998 69999999999853
Q ss_pred -----eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 695 -----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 695 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEE
Confidence 356799999999999999997655556888899999999999999999988 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 844 (964)
+|||+++....... ......|+..|+|||.+. ...++.++|||||||++|||++|+.||........ +....
T Consensus 163 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~~~~ 239 (282)
T cd06636 163 VDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-LFLIP 239 (282)
T ss_pred eeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-hhhHh
Confidence 99999876532211 122356899999999875 34678899999999999999999999964322111 11111
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... .+.+. .......+.+++.+||+.||.+||++.|+++
T Consensus 240 ~~~-----------~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 RNP-----------PPKLK--SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred hCC-----------CCCCc--ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 000 00000 0011245779999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=312.94 Aligned_cols=262 Identities=23% Similarity=0.331 Sum_probs=200.5
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999964 689999999876542 2345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+ +++|.+++.... ..+++.++..++.|+++||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP- 154 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-
Confidence 9 999999987543 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred ceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcccc-ccccc---
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEH-YGLTE--- 856 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~-~~~~~--- 856 (964)
.......|+..|+|||++.+. .++.++||||+|+++|||++|.+||..... ......... ...... ....+
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPD 233 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcch
Confidence 112334689999999998654 468999999999999999999877754332 222211111 100000 00000
Q ss_pred ---ccCc-----cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 ---MMDP-----TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ---~~d~-----~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+ .+..........+.+++.+|++.+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000 011111122356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=313.48 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=194.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHH-HHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIEL-LSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|++.+.||+|+||.||+|+.. +|+.||+|+++.... ....++..|+.+ ++..+||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999964 699999999875432 233455566665 566789999999999999999999999
Q ss_pred eccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 704 FMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|++ |+|.+++... ....+++..++.++.|++.||+|||+. + ++||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6888877542 234689999999999999999999986 5 99999999999999999999999999986543
Q ss_pred CCCCceeecccccCcccCcccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
.. ......|+..|+|||++.. ..++.++|+|||||++|||++|+.||.......+.+........
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------- 225 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS-------- 225 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCC--------
Confidence 21 1233468899999998854 45688999999999999999999999754333333333222111
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+.. ......+.+++.+||..+|++||++.++++
T Consensus 226 ---~~~~~--~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ---PQLPA--EKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCCCc--cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11100 011245678999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=311.60 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=203.8
Q ss_pred cCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.-|...+.||+|.|+.|-.|+ .-+|++||||++.+..... ...+.+|++.|+-++|||||++|++...+...|||.|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 456777889999999999998 4589999999998765443 3468899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE-CCCCcEEEeecccceeecCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL-DENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DFGla~~~~~~~ 782 (964)
.=++|+|++|+-.+. ..+.+.-..+++.||..|+.|+|+.+ +|||||||+||.+ ..-|-+||.|||++..+.++.
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999997654 35888999999999999999999998 9999999999766 667899999999998765543
Q ss_pred CCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
..+..+|+..|-|||++.+..|+ +++||||+||+||.|++|+.||+...+ .+- +..++|-.
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND-SET--------------LTmImDCK 235 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND-SET--------------LTMIMDCK 235 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc-hhh--------------hhhhhccc
Confidence 34557899999999999998888 789999999999999999999975332 122 22223322
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..- +.....++.+||.+|+..||++|.+.+||+.
T Consensus 236 Ytv-PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 236 YTV-PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccC-chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 110 1122255679999999999999999999875
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.69 Aligned_cols=248 Identities=25% Similarity=0.438 Sum_probs=202.2
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+|+..+.||+|+||.||+|... +++.||+|++..... ....++.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999975 689999999876533 34457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
++++|.+++.... ..+++..+..++.|++.||+|||+ .+ ++||||||+||++++++.+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 82 DGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred CCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 9999999997653 468899999999999999999999 77 99999999999999999999999999876533211
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC----chhHHHHHHHhccCcccccccccccCc
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG----KYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
....++..|+|||++.+..++.++||||||+++|+|++|+.||... ....+.+........ +
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~ 222 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-----------P 222 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-----------C
Confidence 1156889999999998889999999999999999999999999654 222333332222111 0
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+... .....+.+++.+||..+|++||++.|++.
T Consensus 223 ~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSG--KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChh--hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11100 02245678999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=312.23 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=201.2
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.+.|+.-++||+|+||.||-++. .+|+.+|.|++.+... .++....+|-.+|++++.+.||.+-..|+.++..+||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45788889999999999999985 4799999998764322 2334567899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
+..|.||+|.-+|...+...+++.+.+.+|.+|+.||++||... ||+||+||+|||||+.|+++|+|.|||..+...
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999998888778999999999999999999999988 999999999999999999999999999988765
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHH--HHHHHhccCcccccccccccC
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR--EVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d 859 (964)
.. ....+||.+|||||++..+.|+...|.||+||++|||+.|+.||.....-+. .+........++ ..+.+.
T Consensus 341 ~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~e---y~~kFS 414 (591)
T KOG0986|consen 341 KP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEE---YSDKFS 414 (591)
T ss_pred Cc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhh---cccccC
Confidence 32 3445899999999999999999999999999999999999999975433222 222222222111 111111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
.+...+-...|+.||++|.-.
T Consensus 415 -----------~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 415 -----------EEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred -----------HHHHHHHHHHHccCHHHhccC
Confidence 233466777889999998643
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=311.72 Aligned_cols=254 Identities=29% Similarity=0.445 Sum_probs=200.7
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeC-----
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG----- 696 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~----- 696 (964)
.++++|+..+.||+|+||.||+|... +++.+|+|++..... ...++.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999974 678999999875443 345789999999999 6999999999997654
Q ss_pred -ceEEEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 697 -EQMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 697 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
..++||||+++++|.+++.... +..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999886533 456899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
++....... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ...........
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~ 235 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRNPP 235 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhccCC
Confidence 998654322 12233568999999998753 34678999999999999999999999643222 11211111110
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+.. .......+.+++.+||..||++|||+.|+++
T Consensus 236 -----------~~~~~-~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 236 -----------PTLKS-PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----------CCCCc-hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 01110 1112345779999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=312.39 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=197.9
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
|+..+.||+|++|.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999964 799999999875432 22346889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+ ++|.+++.......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence 5 69999987655456899999999999999999999987 99999999999999999999999999976532211
Q ss_pred eeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc---Cccccc---------
Q 002121 786 VSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR---DDEEHY--------- 852 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~--------- 852 (964)
......++..|+|||++.+. .++.++||||||+++|||++|+.||.......... ..+.. ......
T Consensus 155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCCChHHhhhhhhchhh
Confidence 11223568899999988654 57899999999999999999999997544322211 11110 000000
Q ss_pred --ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 --GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 --~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....................+.+++.+|++.+|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000111111111245779999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=306.92 Aligned_cols=251 Identities=23% Similarity=0.393 Sum_probs=205.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|+..+.||+|++|.||+|+.. +|+.||||++..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999975 589999999876544 3456799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
+++++|.+++... ..+++..+..++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999764 368999999999999999999999 88 99999999999999999999999999987654322
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcccccccccccCcc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. .....++..|+|||.+....++.++||||||+++|||++|+.||.... ...+.......... . ..+..
T Consensus 156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~------~-~~~~~ 226 (264)
T cd06623 156 Q--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP------P-SLPAE 226 (264)
T ss_pred c--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC------C-CCCcc
Confidence 1 123458899999999998899999999999999999999999996543 22222222221111 0 01111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.....+.+++.+|+..+|++||++.|+++.
T Consensus 227 ------~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 227 ------EFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ------cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 022457789999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.91 Aligned_cols=249 Identities=29% Similarity=0.466 Sum_probs=201.7
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||+|... +|..||+|.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777899999999999999964 588999999865322 2345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 783 (964)
+++++|.+++....+..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM- 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc-
Confidence 99999999997655556899999999999999999999988 99999999999999885 46999999998664322
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.......|++.|+|||+..+..++.++|||||||++|||++|+.||.... ..+.+........ . ...+..
T Consensus 157 -~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~------~-~~~~~~- 226 (257)
T cd08225 157 -ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLVLKICQGYF------A-PISPNF- 226 (257)
T ss_pred -ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhcccC------C-CCCCCC-
Confidence 12223458999999999988889999999999999999999999986432 2333332222111 0 011111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+|+..+|++||++.|+++
T Consensus 227 ------~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 227 ------SRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ------CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 145678999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=308.90 Aligned_cols=247 Identities=25% Similarity=0.410 Sum_probs=199.2
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
-|+..+.||+|+||.||+|.. .+++.||+|....... .....+.+|++++++++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 366678999999999999986 4688999998865432 23456889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||+++.......
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 999999998753 5899999999999999999999988 99999999999999999999999999876643221
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......++..|+|||++.+..++.++|||||||++|||++|..||..... ....... .... ...++..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~~-~~~~------~~~~~~~---- 224 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP-MKVLFLI-PKNN------PPTLEGN---- 224 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch-HHHHHHH-hcCC------CCCCCcc----
Confidence 12234688899999999888889999999999999999999999864321 1111111 1111 0001111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....+.+++.+|++.+|++||++.++++.
T Consensus 225 ---~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 ---YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ---cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 12446689999999999999999999873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=314.83 Aligned_cols=250 Identities=22% Similarity=0.381 Sum_probs=202.1
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|...+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788889999999999999985 468899999987555555567899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++++|.+++... .+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-- 170 (293)
T cd06647 99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 170 (293)
T ss_pred CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--
Confidence 999999999754 4789999999999999999999988 99999999999999999999999999876543322
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......|++.|+|||++..+.++.++|||||||++||+++|+.||....... .+........ +... .
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~~~~~-----------~~~~-~ 237 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGT-----------PELQ-N 237 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeehhcCCC-----------CCCC-C
Confidence 2233468899999999988889999999999999999999999996533221 1111100000 0000 0
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.......+.+++.+||+.+|++||++.+++..
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11112346689999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=307.61 Aligned_cols=252 Identities=23% Similarity=0.380 Sum_probs=199.2
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV~ 702 (964)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... ...+++.+|++++++++|+||+++++++.. +...++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 477789999999999999985 4688999999875432 334568899999999999999999998864 34578999
Q ss_pred EeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 703 EFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELA--NPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
||+++++|.+++.... ...+++..++.++.|++.||+|||..+ ..+|+||||||+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986531 346899999999999999999999332 334999999999999999999999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
..... ......|++.|+|||++....++.++||||||+++|+|++|+.||.... ...... ...... .
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~-~~~~~~-----~---- 227 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQLAS-KIKEGK-----F---- 227 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHHHHH-HHhcCC-----C----
Confidence 54321 1233468999999999998889999999999999999999999997543 222221 111111 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+. ......+.+++.+|++.+|++||++.+|++
T Consensus 228 -~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 -RRIP---YRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -CCCc---cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 0111 112245679999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=310.04 Aligned_cols=247 Identities=25% Similarity=0.426 Sum_probs=198.6
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcC---CCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVH---HKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.|+..+.||+|+||.||+|.. .+|+.||+|.+.... .....++.+|++++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 467778999999999999995 578999999987543 233457889999999997 999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++++|.+++... .+++.....++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998653 5899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. ......|+..|+|||++..+ .++.++|||||||++|||++|+.||..... ....... ... ..+.
T Consensus 156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~-~~~----------~~~~ 221 (277)
T cd06917 156 S--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA-FRAMMLI-PKS----------KPPR 221 (277)
T ss_pred c--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh-hhhhhcc-ccC----------CCCC
Confidence 1 12334689999999998754 468999999999999999999999964322 1111110 000 0111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+... .....+.+++.+||+.||++||++.|+++
T Consensus 222 ~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 222 LEDN--GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCcc--cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1110 02245678999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.20 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=199.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 702 (964)
++|...+.||.|++|.||+|... +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999974 688999999875433 3345789999999999999999999998654 4689999
Q ss_pred EeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 703 EFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 703 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887532 2345889999999999999999999988 99999999999999999999999999876543
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc----hhHHHHHHHhccCccccccccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK----YVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
.. .....++..|+|||.+.+..++.++||||+||++|||++|+.||.... ...+........... ....
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 230 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP---ELKD 230 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch---hhcc
Confidence 21 123457889999999998899999999999999999999999997542 112222211111100 0000
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ........+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPG-----NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCC-----CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000 00112345779999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.48 Aligned_cols=247 Identities=22% Similarity=0.366 Sum_probs=199.9
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
|...+.||+|++|.||+|.. .+++.||+|++........+.+.+|+.++++++|+||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999995 47899999998765545556788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||.+........ ..
T Consensus 101 ~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~ 172 (285)
T cd06648 101 GALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR 172 (285)
T ss_pred CCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence 9999998763 5899999999999999999999988 99999999999999999999999998875543211 12
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...+........ +.... ..
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-~~~~~~~~~~~~-----------~~~~~-~~ 239 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-LQAMKRIRDNLP-----------PKLKN-LH 239 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHHhcCC-----------CCCcc-cc
Confidence 234589999999999888899999999999999999999999865432 222222211111 00000 00
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 11245679999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=313.60 Aligned_cols=246 Identities=30% Similarity=0.436 Sum_probs=196.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+.|+..+.||+|+||+||+|... +|+.||+|++..... ....++.+|++++++++||||++++++|.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778899999999999999964 689999998864332 22346889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||++ |++.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9997 57777775433 35899999999999999999999988 999999999999999999999999998765432
Q ss_pred CCceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 783 KGHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
....+++.|+|||++. .+.++.++||||||+++|||+||+.||.......... .......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~-~~~~~~~----------- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNDS----------- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH-HHhcCCC-----------
Confidence 2245788999999874 4568899999999999999999999986543322211 1111110
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+.+. .......+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~~--~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 PTLS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCC--chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 01122457799999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=301.69 Aligned_cols=249 Identities=28% Similarity=0.463 Sum_probs=204.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
+|+..+.||+|++|.||++... +++.+++|++..........+.+|++++++++|+||+++++++...+..++|+||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677899999999999999975 689999999987655556689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc---
Confidence 999999987653 46899999999999999999999987 99999999999999999999999999987654321
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
.....++..|+|||++....++.++||||||+++|+|++|+.||........... ..... ........
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~------~~~~~~~~----- 221 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK-IATNG------PPGLRNPE----- 221 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH-HHhcC------CCCcCccc-----
Confidence 2345688999999999888899999999999999999999999975432221111 11110 01111110
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+|++.||++||++.|+++
T Consensus 222 -~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 -KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred -ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01245678999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=311.19 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=200.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999965 58899999886532 2234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|++++.+..+.... ..+++.++..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99987777665543 35899999999999999999999988 99999999999999999999999999987654332
Q ss_pred CceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCcc---------c
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDE---------E 850 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~---------~ 850 (964)
.......++..|+|||++... .++.++||||||+++|||++|+.||...... +.+... ...... .
T Consensus 156 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-DQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred -ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHhhhcccCc
Confidence 122345688999999999887 8899999999999999999999998643221 111111 100000 0
Q ss_pred cc---ccccccCccch-hhhH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HY---GLTEMMDPTIR-NTVL-LGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~---~~~~~~d~~l~-~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+ ...+..++... .... .....+.+++.+||..+|++||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 00011111000 0001 11356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.03 Aligned_cols=268 Identities=27% Similarity=0.383 Sum_probs=203.4
Q ss_pred ccceeecCCcEEEEEEE-ecCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC------ceEEEE
Q 002121 631 ESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------EQMLVY 702 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lV~ 702 (964)
..+.||+|+||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|+|||++++.-++.. ...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 34679999999999999 5689999999998744 344567889999999999999999999876544 568999
Q ss_pred EeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE--CCCC--cEEEeeccccee
Q 002121 703 EFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL--DENL--TAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~kl~DFGla~~ 777 (964)
|||.+|||+..+..-. ...+++.+.+.+..+++.||.|||+++ ||||||||.||++ .++| ..||+|||.||.
T Consensus 97 EyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred eecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999997644 456999999999999999999999988 9999999999998 3434 469999999998
Q ss_pred ecCCCCCceeecccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh---HHHHHHHhccCcccc-c
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV---VREVRTAMNRDDEEH-Y 852 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~-~ 852 (964)
+++.. ..+.++||..|++||... .+.|+..+|.|||||++||+.||..||...... .+.......+.+... .
T Consensus 174 l~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i 250 (732)
T KOG4250|consen 174 LDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAI 250 (732)
T ss_pred CCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeE
Confidence 87653 566788999999999998 488999999999999999999999999633222 122222222222110 0
Q ss_pred ccccccC-c-----cchh---hhHHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHh
Q 002121 853 GLTEMMD-P-----TIRN---TVLLGFRRYLELALQCVEESATDRP--TMSEVVKAIETLLQN 904 (964)
Q Consensus 853 ~~~~~~d-~-----~l~~---~~~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~~~~~ 904 (964)
...+... | .++. .......++...+..++..+|++|- ...+....+..++..
T Consensus 251 ~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 251 GAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 0111100 0 1111 1233345666777888888999998 666666666666553
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.80 Aligned_cols=251 Identities=25% Similarity=0.418 Sum_probs=205.1
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 702 (964)
+|+..+.||+|++|.||+|... +++.|++|++..... ...+.+.+|++++++++|+||+++++.+.+. +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999975 789999999876543 3456789999999999999999999999988 8899999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++++|.+++.... .+++..+..++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999997654 7899999999999999999999987 9999999999999999999999999998765443
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.........++..|+|||.......+.++||||||+++|+|++|+.||.................. . +.+
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~-----~~~ 225 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE-----P-----PEI 225 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCC-----C-----cCC
Confidence 211133456889999999998888999999999999999999999999765433322222111000 0 001
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .....+.+++.+|++.+|++||++.|+++
T Consensus 226 ~~---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PE---HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred Cc---ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11 11255678999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.26 Aligned_cols=259 Identities=24% Similarity=0.345 Sum_probs=194.5
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcC-CCCccceeEEEEee--CceEEEEE
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQ--GEQMLVYE 703 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~E 703 (964)
|+..+.||+|+||.||+|.. .+++.||+|+++.... .......+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56678999999999999995 4689999999875422 22234557899999985 99999999999987 88999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|++ |+|.+.+.... ..++|.++..++.|++.||+|||+.+ |+||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 997 58888876543 36899999999999999999999988 999999999999999 9999999999986643321
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcc-----------
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDE----------- 849 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~----------- 849 (964)
.....++..|+|||++.. +.++.++|||||||++|||++|..||..... ..............
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 155 ---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred ---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 123457899999997654 5678999999999999999999999964332 11222211111110
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
............+..........+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00001111111111112223466889999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=312.86 Aligned_cols=253 Identities=26% Similarity=0.401 Sum_probs=194.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|...+.||+|+||.||++... +|+.||+|++..... .....+.+|+.++.++. |+||+++++++..++..++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445678999999999999954 689999999875432 33457889999999996 99999999999999999999999
Q ss_pred ccCCChhhh---hcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 705 MANGTLRES---LSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 705 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
++. ++.++ +.......+++..+..++.+++.||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 55443 3322334689999999999999999999974 5 99999999999999999999999999976543
Q ss_pred CCCCceeecccccCcccCccccccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
... .....|+..|+|||++... .++.++|||||||++|||++|+.||.........+......... .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------~ 230 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPP-------I 230 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCC-------c
Confidence 221 1233588999999998765 68899999999999999999999997544333333322211110 0
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+.... .......+.+++.+||+.+|++||++.||++.
T Consensus 231 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 231 LSNSE---EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcC---CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 01122457799999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=311.37 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=195.6
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcC-CCCccceeEEEEeeCc-----
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGE----- 697 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 697 (964)
++|+..+.||+|+||.||+|... +|+.||+|+++..... ....+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999964 6899999987654322 2346888999999995 6999999999987665
Q ss_pred eEEEEEeccCCChhhhhcCCC---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecc
Q 002121 698 QMLVYEFMANGTLRESLSGRS---GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFG 773 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFG 773 (964)
.++||||+++ +|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 8988876432 246899999999999999999999988 999999999999998 8999999999
Q ss_pred cceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDE 849 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~ 849 (964)
+++....... ......+++.|+|||++.+ ..++.++|||||||++|||++|..||........ ...... ....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 9986533211 1122356889999998865 4578999999999999999999999864433222 221111 0000
Q ss_pred ccc----cc------ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 EHY----GL------TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 ~~~----~~------~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... .. .......+..........+.+++.+||..+|.+||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00 000000000001112345778999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=310.59 Aligned_cols=263 Identities=22% Similarity=0.342 Sum_probs=197.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|++|+||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888999999999999999964 689999998865432 223568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccceeecCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~ 782 (964)
|++ ++|.+++.......+++.....++.||+.||+|||+.+ |+||||||+||++++ ++.+||+|||+++......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 58888886555445788889999999999999999987 999999999999985 5679999999997653321
Q ss_pred CCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc----cc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY----GL 854 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~----~~ 854 (964)
.......+++.|+|||++.+ ..++.++||||+||++|||+||+.||...... +.+...+. ....... .+
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-DELFKIFRILGTPNEETWPGVTSL 234 (294)
T ss_pred --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChhhccccccc
Confidence 11223457889999998865 45789999999999999999999999654322 22222111 1000000 00
Q ss_pred cc-------ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TE-------MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~-------~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+ ................+.+++.+|++.+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0000111111112245678999999999999999999986
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.03 Aligned_cols=252 Identities=23% Similarity=0.390 Sum_probs=204.8
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++.|+..+.||+|+||.||+|..+ +++.||+|++..... ....+.+|++++++++|+||+++++++...+..++|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999876544 45678899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 96 YMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred ccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999998653 36999999999999999999999987 99999999999999999999999999876543221
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......++..|+|||++.+..++.++|||||||++|||++|+.||......... ........ ....++
T Consensus 172 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~-~~~~~~~~------~~~~~~--- 239 (286)
T cd06614 172 --KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL-FLITTKGI------PPLKNP--- 239 (286)
T ss_pred --hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCC------CCCcch---
Confidence 122345788999999998888999999999999999999999998654332221 11111110 000011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+|++.+|.+||++.++++
T Consensus 240 ---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 ---EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ---hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 001245678999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=319.17 Aligned_cols=249 Identities=23% Similarity=0.396 Sum_probs=199.7
Q ss_pred CCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 629 FSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
|.++..||.|+||.||+|..++ +-..|.|++...+....+.|.-|++||...+||+||++++.|...+..|++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3445679999999999999764 445567888766666667899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|.....+-.-+ ..+.+.++.-++.|++.||.|||+.. |||||||+.|||++-+|.++|+|||.+..... .....
T Consensus 114 GAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkR 187 (1187)
T KOG0579|consen 114 GAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKR 187 (1187)
T ss_pred chHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HHhhh
Confidence 99998776543 47999999999999999999999988 99999999999999999999999998754322 11233
Q ss_pred ecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 788 TQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
..+.|||.|||||+.. ..+|++++||||||++|.||.-+.+|-.. -+.++.+..+-...+ +-.+.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe-lnpMRVllKiaKSeP------PTLlqP-- 258 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE-LNPMRVLLKIAKSEP------PTLLQP-- 258 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc-cchHHHHHHHhhcCC------CcccCc--
Confidence 4578999999999874 57899999999999999999999988643 233333333322222 111222
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+|+..+|..||+++++++
T Consensus 259 ----S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 259 ----SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ----chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 222356778999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=318.79 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=197.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeC-----ce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG-----EQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~ 698 (964)
.++|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.++++++|+||+++++++...+ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999985 4789999999864322 23356788999999999999999999876543 57
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++ +|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELMET-DLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhccc-CHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeec
Confidence 999999975 888887643 5899999999999999999999988 999999999999999999999999999875
Q ss_pred cCCCCC-ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccccc
Q 002121 779 SDSSKG-HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHYGL 854 (964)
Q Consensus 779 ~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 854 (964)
...... .......||..|+|||++.+ ..++.++||||+||++|||++|+.||....... ..+.........+. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED--L 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH--H
Confidence 432211 11233568999999998754 568899999999999999999999996443221 11111111111000 0
Q ss_pred ccccCc-------------c--chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 855 TEMMDP-------------T--IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 855 ~~~~d~-------------~--l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....+. . +..........+.+++.+||+.+|++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0 000011123457799999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=310.27 Aligned_cols=262 Identities=23% Similarity=0.332 Sum_probs=197.6
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEee--CceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV 701 (964)
++|+..+.||+|+||.||+|..+ +++.+|+|.++...... ...+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999975 68899999987543322 23567899999999999999999999887 889999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++ +|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 85 ~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 999974 9999887643 36899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcccc------
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEH------ 851 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~------ 851 (964)
.. ......+++.|+|||++.+. .++.++|+||+|+++|||++|+.||...... +....... ......
T Consensus 160 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 160 LK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI-DQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred cc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCchHHHHHhhc
Confidence 21 12234578899999998754 4689999999999999999999998643321 11111111 000000
Q ss_pred ------cccccccCccchhhhHH--HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 ------YGLTEMMDPTIRNTVLL--GFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ------~~~~~~~d~~l~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..........+...... ....+.+++.+||+.+|++||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000011111111 1345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=299.52 Aligned_cols=247 Identities=30% Similarity=0.470 Sum_probs=202.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|++|.||+|... +++.||+|.+..... .....+.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999864 678999999876554 3445789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999765 36899999999999999999999988 999999999999999999999999999876543221
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.....++..|+|||+.....++.++||||+|+++|+|++|+.||............ .... ....... .
T Consensus 156 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~---~~~~~~~----~-- 223 (254)
T cd06627 156 --DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI-VQDD---HPPLPEG----I-- 223 (254)
T ss_pred --ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH-hccC---CCCCCCC----C--
Confidence 23346889999999998877899999999999999999999999754432222111 1110 0001111 1
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+|+..+|++||++.|++.
T Consensus 224 -----~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 224 -----SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -----CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 245568999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=310.95 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=195.8
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|...+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|++++++++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366678999999999999995 4689999999864322 223468889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|++ |+|.+.+.... .+++|.++..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 997 58888775433 46899999999999999999999988 999999999999999999999999998754322
Q ss_pred CceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||........ ......... .
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~------~----- 242 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNES------P----- 242 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhccC------C-----
Confidence 2345889999999974 45788999999999999999999999865332221 111111110 0
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
... .......+.+++.+|++.+|.+||++.++++....
T Consensus 243 ~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 TLQ--SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCC--CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 000 01112346789999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.92 Aligned_cols=262 Identities=21% Similarity=0.357 Sum_probs=198.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+|+..+.||+|++|.||+|+.. +|+.||||+++..... ....+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788899999999999999975 6899999998754332 2356778999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 706 ANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 706 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
++ +|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888876543 346899999999999999999999988 99999999999999999999999999976543211
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc--------
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY-------- 852 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~-------- 852 (964)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||...... +....... .......
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-DQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCChhhHHHHhcCch
Confidence 1123457889999998865 45688999999999999999999998644321 11111111 0000000
Q ss_pred ---ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 ---GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ---~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.............+.+++.+|++.||.+||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000010011122345779999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=306.11 Aligned_cols=242 Identities=22% Similarity=0.323 Sum_probs=191.5
Q ss_pred eecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||+||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999985 4689999999865322 2234567899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++.......+++.++..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||.+...... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR 154 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence 99997655456899999999999999999999988 999999999999999999999999998765432 112234
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccccccccCccchhhhHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (964)
.++..|+|||++.++.++.++|||||||++|||++|+.||..... ....+........ ......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~----------- 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA---VEYPDK----------- 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccc---ccCCcc-----------
Confidence 578899999999888899999999999999999999999964332 1111111110000 001111
Q ss_pred HHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 869 GFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 869 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
....+.+++.+||+.+|++|| ++.+++.
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 124466899999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=346.70 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=199.1
Q ss_pred hhcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.+-+++....||.|.||.||-|. ..+|+..|+|.++... ......+.+|+.++..++|||+|+.+|+-...+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 45577778899999999999999 6689999999776433 33345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||||++|+|.+.+...+ -.++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|..+...
T Consensus 1313 MEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred HHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCc
Confidence 99999999999997543 4667777778899999999999999 999999999999999999999999999877543
Q ss_pred CC--CceeecccccCcccCccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH-HhccCcccccccc
Q 002121 782 SK--GHVSTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT-AMNRDDEEHYGLT 855 (964)
Q Consensus 782 ~~--~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 855 (964)
.. ........||+.|||||++.+.. ..-+.||||+|||+.||+||++||.+-++....+.. .+...
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~-------- 1459 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHK-------- 1459 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCC--------
Confidence 21 11223567999999999997543 456899999999999999999999754432222221 11111
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
|.+++... .+=.+++.+|++.||++|.++.|+++
T Consensus 1460 ----Pq~P~~ls---~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 ----PQIPERLS---SEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred ----CCCchhhh---HhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 22222211 22347888999999999998887764
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=306.44 Aligned_cols=251 Identities=23% Similarity=0.378 Sum_probs=199.8
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChh
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLR 711 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~ 711 (964)
..||+|+||.||+|.. .+|+.||||++..........+.+|+.++++++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478999999987555455567899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeeccc
Q 002121 712 ESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791 (964)
Q Consensus 712 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 791 (964)
+++... .+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........ ......
T Consensus 106 ~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 177 (292)
T cd06657 106 DIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLV 177 (292)
T ss_pred HHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccc
Confidence 988643 4899999999999999999999988 99999999999999999999999999876543221 123356
Q ss_pred ccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHH
Q 002121 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFR 871 (964)
Q Consensus 792 gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 871 (964)
|++.|+|||++.+..++.++|||||||++|||++|..||..... .+.+.......+ +.+.. ......
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~-~~~~~~~~~~~~-----------~~~~~-~~~~~~ 244 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-LKAMKMIRDNLP-----------PKLKN-LHKVSP 244 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhhCC-----------cccCC-cccCCH
Confidence 88999999999888889999999999999999999999864322 121211111111 00000 001123
Q ss_pred HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 872 RYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 872 ~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
.+.+++.+||+.+|.+||++.|+++ ..++....
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~ 277 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG 277 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccC
Confidence 4568899999999999999999986 34444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=305.59 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=200.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
+|+..+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999965 689999999875432 234578999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 36899999999999999999999988 9999999999999999999999999988654332
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHhccCcccccccccccCccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-VREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||...... ..++........ ....+.+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~ 225 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD-------VLYPATW 225 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcccc-------ccCcccC
Confidence 223456888999999998888999999999999999999999999754321 222222111100 0011111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTM--SEVV 895 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 895 (964)
...+.+++.+||+.||.+||++ +|++
T Consensus 226 -------~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 226 -------STEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------cHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1556789999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=315.58 Aligned_cols=262 Identities=24% Similarity=0.326 Sum_probs=198.1
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee------
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 695 (964)
..++|+..+.||+|+||.||+|.. .+|+.||+|++.... .....++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 457899999999999999999995 478999999986432 22334677899999999999999999988643
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
...++||||+. ++|.+.+... +++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999996 4888887642 888999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH--HhccCc-----
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT--AMNRDD----- 848 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~--~~~~~~----- 848 (964)
+...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||........+... .+....
T Consensus 166 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (353)
T cd07850 166 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242 (353)
T ss_pred eeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 8764322 122345789999999999999999999999999999999999999754332211111 000000
Q ss_pred ---------------ccccccccccCccch----hh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 849 ---------------EEHYGLTEMMDPTIR----NT-VLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 849 ---------------~~~~~~~~~~d~~l~----~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.......+.+..... .. .......+.+++.+||+.||++||++.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000001111110000 00 11123456799999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=290.28 Aligned_cols=262 Identities=21% Similarity=0.347 Sum_probs=202.0
Q ss_pred cHHHHHHhhcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEee
Q 002121 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQ 695 (964)
Q Consensus 618 ~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 695 (964)
+++|+-+.|. +.||+|+|+.|--++ ..+|..+|||++.+.....+.++.+|++++.+.+ |+||++++++|+++
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3677777775 789999999999887 6789999999998887777888999999999995 99999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cEEEeec
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TAKVADF 772 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DF 772 (964)
+..|||||.|.||.|..+++.+. .+++.+..++..+||.||+|||.++ |.|||+||+|||-.+.. -+|||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~--~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK--HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh--hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 99999999999999999998764 6999999999999999999999999 99999999999986554 4799999
Q ss_pred ccceeecCCC-----CCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCC----------
Q 002121 773 GLSKLVSDSS-----KGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEK---------- 832 (964)
Q Consensus 773 Gla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~---------- 832 (964)
.+..-+.... ....-...+|+..|||||+.. ...|+.++|.||+|||+|-|++|.+||..
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 9875432111 111223467899999999863 34688999999999999999999999851
Q ss_pred CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
|+.=..--...+....+..|. .-|.++. .... +-.+++...+..|+.+|-++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkYe---FPdkdWa-hIS~---eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKYE---FPDKDWA-HISS---EAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCCc---CChhhhH-HhhH---HHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111111122222222222 2222221 1222 2346777888899999999999876
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=298.76 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=204.4
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||++... +++.||+|++..... ....++.+|++++++++|+|++++++.+...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999964 689999999876543 3456788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
+++++|.+++.... +..+++.++..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 357999999999999999999999987 9999999999999999999999999998764432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......|++.|+|||......++.++||||+|+++|+|++|+.||.... ..+.......... . .+
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~~------~-----~~ 223 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILKGQY------P-----PI 223 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhcCCC------C-----CC
Confidence 22334568899999999988889999999999999999999999996543 2222222221111 0 01
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .....+.+++.+||..+|++||++.|+++
T Consensus 224 ~~---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 PS---QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 10 11245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=308.74 Aligned_cols=263 Identities=26% Similarity=0.368 Sum_probs=196.7
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEee--CceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 700 (964)
.++|+..+.||+|+||.||+|... +|+.||+|+++...... ...+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888999999999999999964 68999999987543222 23567899999999999999999998765 46899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++ +|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~-~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 9999975 8888887543 46899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc----
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY---- 852 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~---- 852 (964)
... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.+..... .......
T Consensus 161 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07845 161 PAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-IEQLDLIIQLLGTPNESIWPGFS 237 (309)
T ss_pred ccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHhcCCCChhhchhhh
Confidence 321 1222346788999999865 5578999999999999999999999964332 222222111 1100000
Q ss_pred --------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 --------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 --------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.........+..........+.+++.+|++.||++||++.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000000000000111345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=303.15 Aligned_cols=260 Identities=26% Similarity=0.359 Sum_probs=196.9
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhc---CCCCccceeEEEEeeCc-----
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRV---HHKNLVGLVGFCFEQGE----- 697 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 697 (964)
|++.+.||+|+||.||+|+.+ +++.||+|+++..... ....+.+|+.+++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999976 4899999998753322 223566788877766 59999999999998776
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+++ +|.+++.......+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999974 8999887654446899999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC---cccccc-
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD---DEEHYG- 853 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~- 853 (964)
...... .....++..|+|||++.+..++.++|||||||++|||++|++||.... ..+.....+... ......
T Consensus 157 ~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 157 YSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred ccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC-hHHHHHHHHHHcCCCChHhcCC
Confidence 643321 123347889999999998889999999999999999999998886432 222222222110 000000
Q ss_pred --------cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 --------LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 --------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...................+.+++.+||+.||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000011111111222355678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=301.46 Aligned_cols=247 Identities=20% Similarity=0.275 Sum_probs=191.5
Q ss_pred HHHHHHhhcCCCcccee--ecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe
Q 002121 619 YDELKKCSNNFSESNEI--GSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE 694 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~l--G~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 694 (964)
..+.....++|.+.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34555556777777776 9999999999995 468899999986533221 122222222 69999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecc
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFG 773 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFG 773 (964)
.+..++||||+++|+|.+++.... .++|.++..++.|+++||+|||+.+ ++||||||+||+++.++ .++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg 155 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG 155 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCc
Confidence 999999999999999999997653 7899999999999999999999988 99999999999999998 99999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH---HHHHHHhccCccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV---REVRTAMNRDDEE 850 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~ 850 (964)
+++...... ...|+..|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 156 ~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 227 (267)
T PHA03390 156 LCKIIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL-- 227 (267)
T ss_pred cceecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccC--
Confidence 988654321 2358999999999998889999999999999999999999996332111 11111110000
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT-MSEVVK 896 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 896 (964)
.... .....+.+++.+||+.+|.+||+ ++|+++
T Consensus 228 --~~~~-----------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 228 --PFIK-----------NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --Cccc-----------ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0111 12245678999999999999996 588763
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=306.06 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=195.6
Q ss_pred cCCCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCc-chhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|+||.||+|..++ |+.||||+++.... ....++..|+.++.+.. |+||+++++++.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 567788999999999999999764 89999999875433 23345677887777775 9999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|+++ ++.+++.... ..+++..+..++.|++.||+|||+ .+ |+||||+|+||++++++.+||+|||++.......
T Consensus 95 ~~~~-~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMST-CLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccCc-CHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 9864 7777665433 368999999999999999999997 35 9999999999999999999999999997654322
Q ss_pred CCceeecccccCcccCccccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
. .....++..|+|||++.... ++.++||||||+++|||++|+.||.......+.+.......... ...
T Consensus 170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~-- 241 (296)
T cd06618 170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPS---LPP-- 241 (296)
T ss_pred c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCC---CCC--
Confidence 1 22345788999999987543 78899999999999999999999975433333333333221100 000
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
. ......+.+++.+||+.||++||++.++++.
T Consensus 242 -~------~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 -N------EGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -C------CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0122456789999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=313.63 Aligned_cols=265 Identities=22% Similarity=0.344 Sum_probs=197.4
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCC--CcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeC--ce
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQG--SMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG--EQ 698 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~--~~ 698 (964)
..++|+..+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++++ +||||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3567888899999999999999965 6889999988542 223334677899999999 9999999999986543 57
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||++ ++|.+++... .++|..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999997 5999988754 5889999999999999999999987 999999999999999999999999999866
Q ss_pred cCCCCC---ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccc--
Q 002121 779 SDSSKG---HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY-- 852 (964)
Q Consensus 779 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 852 (964)
...... .......||..|+|||++.+ ..++.++||||||+++|||++|+.||...... +..............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-NQLEKIIEVIGPPSAED 236 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHH
Confidence 443221 12234568999999998764 56789999999999999999999998643221 111111111000000
Q ss_pred ----------ccccccC----ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 853 ----------GLTEMMD----PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 853 ----------~~~~~~d----~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...+.+. .............+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000 00000011123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=304.22 Aligned_cols=261 Identities=23% Similarity=0.381 Sum_probs=198.9
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEEEEE
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQMLVYE 703 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~E 703 (964)
|+..+.||+|+||.||+|... +|+.+|+|++.... ......+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 566789999999999999965 58899999998653 22335688999999999999999999999988 88999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred cccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 9985 8998887653 46899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc-cccc--
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY-GLTE-- 856 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~-~~~~-- 856 (964)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...+..... ....... ...+
T Consensus 156 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07840 156 -ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE-LEQLEKIFELCGSPTDENWPGVSKLP 233 (287)
T ss_pred -ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHHhCCCchhhccccccch
Confidence 12233457889999998764 4578999999999999999999999964332 222222111 1110000 0000
Q ss_pred ---------ccCccchhhhHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 ---------MMDPTIRNTVLL-GFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ---------~~d~~l~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+.... ....+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000001111111 1456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=309.14 Aligned_cols=200 Identities=26% Similarity=0.404 Sum_probs=167.1
Q ss_pred CCCccceeecCCcEEEEEEEec---CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEee--CceE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS---DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQM 699 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 699 (964)
.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4777889999999999999964 47899999988633 23335678899999999999999999999988 7899
Q ss_pred EEEEeccCCChhhhhcCCC---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC----CCcEEEeec
Q 002121 700 LVYEFMANGTLRESLSGRS---GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE----NLTAKVADF 772 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DF 772 (964)
+||||+++ +|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 6776664322 236889999999999999999999988 999999999999999 999999999
Q ss_pred ccceeecCCCC-CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 773 GLSKLVSDSSK-GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 773 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
|+++....... ........++..|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 217 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 99986543322 112234567899999998866 457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=303.81 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=200.0
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
|+..+.||+|++|.||+|... +|+.+|+|++...... ....+.+|++++++++|+||+++++++..++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999964 7899999998754333 3457889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++ +|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--R 153 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--c
Confidence 75 8888887643 46899999999999999999999988 9999999999999999999999999998765432 1
Q ss_pred eeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcccc-ccc------
Q 002121 786 VSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEH-YGL------ 854 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~-~~~------ 854 (964)
......++..|+|||.+.+. .++.++||||+|+++|+|+||+.||...... +.+..... ...... ...
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI-DQLFKIFRTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCchHhcccchhhhhh
Confidence 12234578899999998776 7899999999999999999999998654432 22211111 100000 000
Q ss_pred -----ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 -----TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 -----~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.............+.+++.+||+.||.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000001111111223356789999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=305.12 Aligned_cols=260 Identities=22% Similarity=0.366 Sum_probs=197.7
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEec
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
|+..+.||+|+||+||+|... +++.||||++..... .......+|+..+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 566789999999999999975 578999999875433 22334567999999999 999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+|+|.+++....+..+++..+..++.|++.+|.|||+.+ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889999987765457899999999999999999999988 99999999999999999999999999986643322
Q ss_pred eeecccccCcccCccccc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh---ccCcc------------
Q 002121 786 VSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM---NRDDE------------ 849 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~~~------------ 849 (964)
.....++..|+|||++. ...++.++|+||||++++||++|+.||..... .+.+.... .....
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE-IDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh-HHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 22345888999999875 45678999999999999999999998853321 11111111 11000
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
............+..........+.+++.+||+.+|++||+++|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00001111111111111112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=307.85 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=198.8
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeC----
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG---- 696 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 696 (964)
.+.++|+..+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34678899999999999999999975 689999999875432 22346788999999999999999999987654
Q ss_pred ------ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEe
Q 002121 697 ------EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 697 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
..++||||+++ ++...+... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeC
Confidence 78999999986 777777654 236899999999999999999999988 9999999999999999999999
Q ss_pred ecccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccC
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRD 847 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~ 847 (964)
|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|++||....... ..+.......
T Consensus 159 dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 237 (302)
T cd07864 159 DFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSP 237 (302)
T ss_pred cccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 9999987644321 11222346788999998764 457899999999999999999999997543221 1112211111
Q ss_pred ccccc-ccccc-----cC------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 848 DEEHY-GLTEM-----MD------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 848 ~~~~~-~~~~~-----~d------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+ .+.+. .+ ..+..........+.+++.+||+.+|.+||++.+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 238 CPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred ChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 10000 00000 00 0000011112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=299.92 Aligned_cols=241 Identities=22% Similarity=0.336 Sum_probs=194.5
Q ss_pred eecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999964 589999999875432 2345789999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99997653 5899999999999999999999988 9999999999999999999999999998765432 12234
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHhccCcccccccccccCccchhhhHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY-VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLG 869 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 869 (964)
.|+..|+|||.+....++.++|+||+|+++|||++|..||..... ..+........... .......
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~----------- 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK--LEFPNYI----------- 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC--CCCCccc-----------
Confidence 688999999999888899999999999999999999999975431 22222222211110 0011111
Q ss_pred HHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 870 FRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 870 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
...+.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 245679999999999999999 666654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=303.66 Aligned_cols=240 Identities=23% Similarity=0.308 Sum_probs=184.6
Q ss_pred eeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHh---cCCCCccceeEEEEeeCceEEEEEecc
Q 002121 634 EIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSR---VHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~---l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
.||+|+||.||++.. .+|+.+|+|.+...... ....+.+|..+++. .+||||+++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999996 46899999988653321 12234455444443 479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999987543 5899999999999999999999988 9999999999999999999999999987654321
Q ss_pred eecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHhccCcccccccccccCccchh
Q 002121 787 STQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY-VVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.....||..|+|||.+.. ..++.++|||||||++|||++|+.||..... ........... .+..+..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----------~~~~~~~ 220 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------VNVELPD 220 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc-----------CCcCCcc
Confidence 123468999999999864 5688999999999999999999999963221 11111111100 0111111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
.....+.+++.+|+..||++|| +++|+++
T Consensus 221 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 221 ---SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ---ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1124566899999999999999 5888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=313.71 Aligned_cols=270 Identities=22% Similarity=0.353 Sum_probs=199.5
Q ss_pred cHHHHHHh----hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeE
Q 002121 618 SYDELKKC----SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVG 690 (964)
Q Consensus 618 ~~~el~~~----~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~ 690 (964)
+.+|+..+ .++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++
T Consensus 2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~ 81 (342)
T cd07879 2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81 (342)
T ss_pred chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhh
Confidence 34455544 37899999999999999999995 4689999999875322 22346789999999999999999999
Q ss_pred EEEeeC------ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC
Q 002121 691 FCFEQG------EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN 764 (964)
Q Consensus 691 ~~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 764 (964)
++.... ..++||||+.. +|..+.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.+
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~ 153 (342)
T cd07879 82 VFTSAVSGDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNED 153 (342)
T ss_pred eecccccCCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCC
Confidence 987543 46899999974 7777653 25889999999999999999999988 9999999999999999
Q ss_pred CcEEEeecccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002121 765 LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843 (964)
Q Consensus 765 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 843 (964)
+.+||+|||+++..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ..+...
T Consensus 154 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-~~~~~~ 227 (342)
T cd07879 154 CELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQI 227 (342)
T ss_pred CCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence 99999999998764322 123457889999999876 46889999999999999999999999754322 222221
Q ss_pred hccCccccccc----------------ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--HHHH
Q 002121 844 MNRDDEEHYGL----------------TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA--IETL 901 (964)
Q Consensus 844 ~~~~~~~~~~~----------------~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~~ 901 (964)
+.......... .......+..........+.+++.+||+.||++||+++|++.. ++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 11100000000 0000000100011123457799999999999999999999853 5544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=307.86 Aligned_cols=260 Identities=19% Similarity=0.219 Sum_probs=191.9
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
+.+|.|+++.||++.. +|+.||||++... .......+.+|++++++++|+||+++++++.+.+..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3445555555555555 6899999998754 233446799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC-----c
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG-----H 785 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-----~ 785 (964)
.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+......... .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99998655456889999999999999999999988 999999999999999999999999998765322110 1
Q ss_pred eeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc---------ccccc
Q 002121 786 VSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE---------EHYGL 854 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~ 854 (964)
......++..|+|||++.. ..++.++|||||||++|||++|+.||................... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1223457788999999865 358899999999999999999999997544332222211100000 00000
Q ss_pred cc----ccCccchhh-----hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TE----MMDPTIRNT-----VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~----~~d~~l~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. ..++..... .......+.+++.+||+.||++||++.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00 000100000 1112245778999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=302.08 Aligned_cols=246 Identities=25% Similarity=0.329 Sum_probs=195.6
Q ss_pred eecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||.||+++.. +|+.+|+|++..... .....+.+|++++++++||||+++++.+.+++..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999875443 3345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC------C
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK------G 784 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~------~ 784 (964)
.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99997644 6899999999999999999999988 99999999999999999999999999876433211 0
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.......++..|+|||+.....++.++||||||+++|||++|+.||..... ............. .....
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~~----~~~~~------ 224 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-EEIFQNILNGKIE----WPEDV------ 224 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHhcCCcC----CCccc------
Confidence 122345678899999999888899999999999999999999999964432 1222221111100 00000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
.....+.+++.+|++.+|++||++.++.+.|+
T Consensus 225 ---~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 ---EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ---cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01245679999999999999999966554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=298.49 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=195.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC-----cchhHHHHHHHHHHHhcCCCCccceeEEEEee--Cce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS-----MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 698 (964)
.+|+..+.||+|+||.||+|.. .+|+.||+|++.... ......+++|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999995 468999999875321 22334688999999999999999999998764 457
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++++|.+++.... .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987543 4788999999999999999999988 999999999999999999999999999865
Q ss_pred cCCCC-CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 779 SDSSK-GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 779 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..... ........|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+........ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~------~~~ 229 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIATQPT------KPM 229 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHHcCCC------CCC
Confidence 32111 111223568999999999988889999999999999999999999996543222 2222211111 011
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+... ....+.+++.+|+. +|..||++.+++.
T Consensus 230 ~p~~-------~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 230 LPDG-------VSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCcc-------cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 1111 11446689999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=306.89 Aligned_cols=265 Identities=22% Similarity=0.343 Sum_probs=194.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeC-------
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------- 696 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------- 696 (964)
++|+..+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 47888999999999999999964 6899999988643322 2235678999999999999999999987654
Q ss_pred -ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 697 -EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 697 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
..++||||+.+ +|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||++
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCc
Confidence 34999999975 8888876543 35899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCC--ceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCccc
Q 002121 776 KLVSDSSKG--HVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEE 850 (964)
Q Consensus 776 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~ 850 (964)
......... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...... ...+.......+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (310)
T cd07865 167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE 246 (310)
T ss_pred ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence 866432211 112234578899999988654 4788999999999999999999998643321 11122211111100
Q ss_pred ccc------------cccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HYG------------LTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~~------------~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ............ .......+.+++.+||..||++||+++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 000 000000000000 0001234568999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=305.95 Aligned_cols=258 Identities=17% Similarity=0.205 Sum_probs=182.3
Q ss_pred cCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCcch--h---------HHHHHHHHHHHhcCCCCccceeEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQG--G---------LEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~~--~---------~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
++|.+.+.||+|+||+||+|...+ +..+|+|+........ + .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578889999999999999999654 3456666543222111 0 012233445566789999999998
Q ss_pred EEeeC----ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 692 CFEQG----EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 692 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 76544 34678887643 6666665432 3578888999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecCCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002121 768 KVADFGLSKLVSDSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 842 (964)
+|+|||+|+........ .......||+.|+|||+..+..++.++|||||||++|||++|+.||.........+..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999876432211 1112346999999999999999999999999999999999999999743221111111
Q ss_pred HhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
..... .......... .......+.+++..|+..+|++||++.++++.+
T Consensus 246 ~~~~~------~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 246 AKCDF------IKRLHEGKIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred hHHHH------HHHhhhhhhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00000 0000000000 011125577999999999999999999998765
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=290.74 Aligned_cols=247 Identities=25% Similarity=0.285 Sum_probs=199.7
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHH---HHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|..+++||+|.||+|-.++ ..+|+.+|+|++++...-...+ -..|-++|+..+||.+..+...+...++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678889999999999999998 4579999999998766544433 35688999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+.||.|.-+|...+ .+++.+...+-..|..||.|||+.+ ||+||||.+|.|+|.||++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~- 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK- 320 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc-
Confidence 99999999999987654 6888999999999999999999988 99999999999999999999999999985332
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.+..+...+|||.|+|||++....|..++|.|.+|||+|||++|+.||...+...-.-...+.. -+
T Consensus 321 -~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed-------------~k 386 (516)
T KOG0690|consen 321 -YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED-------------LK 386 (516)
T ss_pred -ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh-------------cc
Confidence 2345667899999999999999999999999999999999999999997544322111111111 11
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVV 895 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl 895 (964)
++.... .+...++...+..||.+|. .+.||.
T Consensus 387 FPr~ls---~eAktLLsGLL~kdP~kRLGgGpdDakEi~ 422 (516)
T KOG0690|consen 387 FPRTLS---PEAKTLLSGLLKKDPKKRLGGGPDDAKEIM 422 (516)
T ss_pred CCccCC---HHHHHHHHHHhhcChHhhcCCCchhHHHHH
Confidence 111111 2233677889999999995 355554
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=326.74 Aligned_cols=267 Identities=16% Similarity=0.243 Sum_probs=187.6
Q ss_pred hhcCCCccceeecCCcEEEEEEEecC--CcEEEEEEec-----------------CCCcchhHHHHHHHHHHHhcCCCCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSD--GQVVAIKRAQ-----------------QGSMQGGLEFKTEIELLSRVHHKNL 685 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~--g~~vavK~~~-----------------~~~~~~~~~~~~E~~~l~~l~H~nI 685 (964)
..++|++.+.||+|+||+||++..+. +..+++|.+. .........+.+|+++|++++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 45789999999999999999987532 2222222110 0111223468899999999999999
Q ss_pred cceeEEEEeeCceEEEEEeccCCChhhhhcCCC---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC
Q 002121 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS---GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD 762 (964)
Q Consensus 686 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~ 762 (964)
|++++++.+.+..++|+|++. ++|.+++.... .......+...++.|++.||+|||+.+ ||||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 999999999999999999985 57777765432 112335567789999999999999988 99999999999999
Q ss_pred CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCC-CCCC-chhHHHH
Q 002121 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP-IEKG-KYVVREV 840 (964)
Q Consensus 763 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p-~~~~-~~~~~~~ 840 (964)
.++.+||+|||+++.+..... .......||..|+|||++.+..++.++|||||||++|||++|..+ +... ......+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999987654322 222345799999999999999999999999999999999998754 4321 1222222
Q ss_pred HHHhccCcccccccc-------cccC--------ccchhhh--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 841 RTAMNRDDEEHYGLT-------EMMD--------PTIRNTV--LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~-------~~~d--------~~l~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+........... +.++ ..+.... ......+.+++.+|++.||++||++.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 222211110000000 0000 0000000 001124567899999999999999999986
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=313.07 Aligned_cols=266 Identities=22% Similarity=0.348 Sum_probs=198.2
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEe----eCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFE----QGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~ 698 (964)
.++|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36788899999999999999995 4689999999875422 234567789999999999999999998763 3467
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+. |+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999996 68999987543 5899999999999999999999988 999999999999999999999999999865
Q ss_pred cCCCCC--ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccc-
Q 002121 779 SDSSKG--HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHY- 852 (964)
Q Consensus 779 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~- 852 (964)
...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||....... ..+.......+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~ 237 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence 432211 11234468999999999865 568899999999999999999999996433221 111111111000000
Q ss_pred -----ccc---cccC----ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 853 -----GLT---EMMD----PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 853 -----~~~---~~~d----~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
... +... ..+..........+.+++.+|++.+|++||++.+++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 0000 00000011123567899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=298.77 Aligned_cols=243 Identities=22% Similarity=0.276 Sum_probs=187.6
Q ss_pred ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch---hHHHHHHHHHH-HhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG---GLEFKTEIELL-SRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||.||+|.. .+|+.||+|++....... ...+..|..++ ...+|+||+++++++.+.+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999986 468999999987543221 22344555444 445899999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997643 5888999999999999999999988 99999999999999999999999999876432 1
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
....|+..|+|||.+.+..++.++||||||+++|||++|..||..... ............. ... ... .
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~----~~~----~~~---~ 218 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-DAVFDNILSRRIN----WPE----EVK---E 218 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcccC----CCC----ccc---c
Confidence 234588999999999888889999999999999999999999964432 2222211111110 000 000 0
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.....+.+++.+||+.+|++||++.++.+.+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1124567999999999999999876554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=308.31 Aligned_cols=260 Identities=20% Similarity=0.272 Sum_probs=192.4
Q ss_pred ceeecC--CcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSG--GYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G--~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
..||+| +||+||+|.. .+|+.||+|++..... ...+.+++|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999996 4799999999875432 2335788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc--
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH-- 785 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~-- 785 (964)
|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99999988654456899999999999999999999988 9999999999999999999999998654322111100
Q ss_pred ---eeecccccCcccCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc-------
Q 002121 786 ---VSTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG------- 853 (964)
Q Consensus 786 ---~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 853 (964)
......++..|+|||++.+. .++.++|||||||++|||++|+.||........... .+.........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQ-KLKGPPYSPLDITTFPCE 239 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHH-HhcCCCCCCccccccchh
Confidence 01112356679999998763 478999999999999999999999965432222111 11111000000
Q ss_pred --------------cc----------cccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 --------------LT----------EMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 --------------~~----------~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. ...+..+... .......+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 0000011111 1123356789999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=312.42 Aligned_cols=264 Identities=24% Similarity=0.359 Sum_probs=198.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee-----Cc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 697 (964)
.++|...+.||+|+||+||+|.. .+|+.||||+++... ......+.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45788899999999999999995 468999999987532 22344677899999999999999999988654 34
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 799999996 68998887543 6899999999999999999999988 99999999999999999999999999986
Q ss_pred ecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCcccccc-
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHYG- 853 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~- 853 (964)
..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||....... ................
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 158 TSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred cCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 64332 12233457899999998865 468899999999999999999999996433211 1111111111000000
Q ss_pred ------------cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 ------------LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ------------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.....++............+.+++.+||+.+|++||+++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00000111111111223557899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=302.16 Aligned_cols=248 Identities=25% Similarity=0.325 Sum_probs=193.5
Q ss_pred CCCccceeecCCcEEEEEEEe----cCCcEEEEEEecCCCc----chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCce
Q 002121 628 NFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM----QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 698 (964)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467789999999999999985 3689999999875322 2235678999999999 599999999999988899
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++++|.+++.... .+++.++..++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999997643 5888999999999999999999988 999999999999999999999999999865
Q ss_pred cCCCCCceeecccccCcccCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCc---hhHHHHHHHhccCcccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVVMLELITAKQPIEKGK---YVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~ 853 (964)
..... .......|+..|+|||++... .++.++||||||+++|||++|+.||.... ...............
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---- 230 (290)
T cd05613 156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---- 230 (290)
T ss_pred ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC----
Confidence 43221 122235689999999998753 46789999999999999999999986321 111222211111110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
.... ....+.+++.+|++.+|++|| ++.+++.
T Consensus 231 ~~~~-----------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YPQE-----------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCcc-----------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111 113456899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=298.36 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=200.6
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|+..+.||+|+||.||++.. .+|+.+|+|++..... ....++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 477889999999999999985 4788999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
+++++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999986522 346899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......+++.|+|||+..+..++.++|+||+|+++|||++|+.||...... + ......... .. .+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~-~~~~~~~~~-----~~-----~~ 221 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-D-LRYKVQRGK-----YP-----PI 221 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-H-HHHHHhcCC-----CC-----CC
Confidence 122345889999999999888999999999999999999999999654321 1 111111111 00 01
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+|++.+|++||++.|+++
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 ---PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ---chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122355779999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.94 Aligned_cols=245 Identities=28% Similarity=0.431 Sum_probs=192.7
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|+..+.||+|+||.||+|+.. +++.||+|.+..... ....++.+|+++++.++|+|++++++++.+.+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666688999999999999964 678999998864322 223467889999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+. |++.+++.... ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 997 68888775433 35899999999999999999999987 999999999999999999999999998765432
Q ss_pred CceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...... ......... . . +
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~-~-----~-----~ 232 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQN-E-----S-----P 232 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-HHHHHHhhc-C-----C-----C
Confidence 2345889999999974 356788999999999999999999998643221 111111110 0 0 0
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
... .......+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 233 ALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CcC--cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000 01122446789999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.55 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=197.0
Q ss_pred CCCccceeecCCcEEEEEEEe----cCCcEEEEEEecCCCc----chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCce
Q 002121 628 NFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM----QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 698 (964)
+|+..+.||+|+||.||++.. .+++.||||+++.... .....+.+|++++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 467789999999999999984 3578899999874322 2234678999999999 599999999999988999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987543 5889999999999999999999987 999999999999999999999999998865
Q ss_pred cCCCCCceeecccccCcccCccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHH-HHHhccCcccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREV-RTAMNRDDEEHYG 853 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~-~~~~~~~~~~~~~ 853 (964)
..... .......|+..|+|||...+.. .+.++||||||+++|||++|..||..... ....+ .........
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 230 (288)
T cd05583 156 LAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP---- 230 (288)
T ss_pred ccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCC----
Confidence 43322 1122346899999999987654 78899999999999999999999853221 11111 111111110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
....+ ...+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 231 ~~~~~-----------~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 231 FPKTM-----------SAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCccc-----------CHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11111 1345689999999999999999988776553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=332.01 Aligned_cols=255 Identities=26% Similarity=0.379 Sum_probs=189.1
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEe-------
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE------- 694 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------- 694 (964)
+-..+|.+.+.||+||||.|||++.+ ||+.+|||++.... ......+.+|+.++++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567888899999999999999965 89999999987653 2223457899999999999999998754420
Q ss_pred ------------------------------------------------e-------------------------------
Q 002121 695 ------------------------------------------------Q------------------------------- 695 (964)
Q Consensus 695 ------------------------------------------------~------------------------------- 695 (964)
.
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence 0
Q ss_pred ---------------------------------CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHh
Q 002121 696 ---------------------------------GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742 (964)
Q Consensus 696 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH 742 (964)
-..|+-||||+...|.++++.+.... .-...++++.+|++||+|+|
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence 11478899999978887777653111 45678899999999999999
Q ss_pred hcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec----------------CCCCCceeecccccCcccCccccccC-
Q 002121 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS----------------DSSKGHVSTQVKGTMGYLDPEYYMTQ- 805 (964)
Q Consensus 743 ~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~- 805 (964)
+.+ ||||||||.||++|+++.+||+|||+|.... .+......+..+||.-|+|||.+.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 998 9999999999999999999999999998721 01111234567899999999998754
Q ss_pred --CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhc
Q 002121 806 --QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEE 883 (964)
Q Consensus 806 --~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~ 883 (964)
.|+.|+|+||+|||++||+. ||.....-...+. .+.... ++.- +.+ ....+..=..+|.+++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~-~LR~g~-----iP~~--~~f---~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT-NLRKGS-----IPEP--ADF---FDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH-hcccCC-----CCCC--ccc---ccccchHHHHHHHHHhcC
Confidence 59999999999999999986 6654332222222 222221 1111 111 111222335789999999
Q ss_pred CCCCCCCHHHHHH
Q 002121 884 SATDRPTMSEVVK 896 (964)
Q Consensus 884 dP~~RPs~~evl~ 896 (964)
||.+||||.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=309.35 Aligned_cols=267 Identities=22% Similarity=0.336 Sum_probs=200.2
Q ss_pred cHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 618 ~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
...++..++++|...+.||+|+||.||+|.. .+|+.||+|+++.... ...+.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 3456777889999999999999999999985 5789999999875322 224567889999999999999999998864
Q ss_pred e------CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEE
Q 002121 695 Q------GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAK 768 (964)
Q Consensus 695 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 768 (964)
. ...++|+|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3 3467888877 77999888653 4899999999999999999999988 99999999999999999999
Q ss_pred EeecccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 769 VADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 769 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ..........
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~ 234 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLV 234 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHh
Confidence 9999998764322 223468899999998865 56889999999999999999999998643221 1111111100
Q ss_pred cccccccccccCc----------------cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 848 DEEHYGLTEMMDP----------------TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 848 ~~~~~~~~~~~d~----------------~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..........+.. ............+.+++.+|++.||++||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000 0000000112456799999999999999999999864
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=305.66 Aligned_cols=265 Identities=25% Similarity=0.366 Sum_probs=195.7
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeC------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------ 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 696 (964)
.++|+..+.||+|+||.||+|... +++.||+|++...... ....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999964 6899999988654322 2245788999999999999999999876543
Q ss_pred --ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 697 --EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 697 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
..++||||+.+ +|...+.... ..+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS-VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence 46999999975 6777776532 46999999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCC---------ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002121 775 SKLVSDSSKG---------HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 775 a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 844 (964)
++........ ...+...|++.|+|||++.+ ..++.++|||||||++|||++|++||..... ........
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-~~~~~~~~ 240 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-IDQLHLIF 240 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Confidence 9865432211 11123457889999998765 4578999999999999999999999864322 22222211
Q ss_pred c---cCccccc----ccc--------cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 845 N---RDDEEHY----GLT--------EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 845 ~---~~~~~~~----~~~--------~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ....... .+. ....+.+..........+.+++.+|++.+|++|||+.|++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1 0000000 000 00111111111112245789999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=286.75 Aligned_cols=267 Identities=22% Similarity=0.304 Sum_probs=216.7
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEecC------CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEE
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
..|+.....+++....+-+|.||+||+|.|++ .+.|-||.++....+ ....+..|.-.+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666667778888899999999999998754 345778877654433 33468899999999999999999999
Q ss_pred EEee-CceEEEEEeccCCChhhhhcCCC------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC
Q 002121 692 CFEQ-GEQMLVYEFMANGTLRESLSGRS------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN 764 (964)
Q Consensus 692 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~ 764 (964)
+.+. +..+.+|.++.-|+|..+|..++ .+.++-.+...+|.|++.|++|||.++ |||.||.++|.++|+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9775 56788999999999999997332 345778889999999999999999998 9999999999999999
Q ss_pred CcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHH
Q 002121 765 LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTA 843 (964)
Q Consensus 765 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~ 843 (964)
.++||+|=.++|.+.+.+.............||+||.+....|+.++|||||||++|||+| |+.|+.+-+ ..++...
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm~~y 510 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEMEHY 510 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHHHHH
Confidence 9999999999999988887776666778889999999999999999999999999999999 888875422 1122222
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
+..+. + ..++..+..++..++.-||+..|++||++++++..|.++-.
T Consensus 511 lkdGy------------R-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 511 LKDGY------------R-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred Hhccc------------e-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 22221 1 11223345678899999999999999999999998887653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=301.95 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=200.6
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV 701 (964)
++|...+.||+|+||.||+|... +|+.||+|++.... ......+.+|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999964 78999999987532 223456889999999998 99999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999997653 6999999999999999999999988 999999999999999999999999998865432
Q ss_pred CCC------------------ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002121 782 SKG------------------HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843 (964)
Q Consensus 782 ~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 843 (964)
... .......++..|+|||+.....++.++||||||++++|+++|+.||...... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHH
Confidence 210 1122345789999999998888999999999999999999999999754421 112222
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH----HHHH
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTM----SEVV 895 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl 895 (964)
..... .... .+ ...+.+++.+||+.+|++||++ .+++
T Consensus 235 ~~~~~----~~~~----~~-------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 235 LKLEY----SFPP----NF-------PPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HhcCC----CCCC----cc-------CHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 11111 0111 11 2456799999999999999999 6665
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=285.59 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=197.9
Q ss_pred cCCCccceeecCCcEEEEEEEec---C--CcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEe-eCce
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS---D--GQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFE-QGEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~---~--g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 698 (964)
..|+....||+|.||.||+|.-. + ...+|+|+++...... .....+|+.+++.++||||+.+..++.+ +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46788899999999999999633 2 2379999998764332 2357899999999999999999999987 7788
Q ss_pred EEEEEeccCCChhhhhcCCC---CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC----CcEEEee
Q 002121 699 MLVYEFMANGTLRESLSGRS---GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN----LTAKVAD 771 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~D 771 (964)
++++||.+. +|.+.++.++ ...++-..+..|+.||+.|+.|||+.- |+||||||.|||+..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999998 8988886543 346888899999999999999999987 9999999999999877 9999999
Q ss_pred cccceeecCCCCCc-eeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCc--------hhHHHHH
Q 002121 772 FGLSKLVSDSSKGH-VSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK--------YVVREVR 841 (964)
Q Consensus 772 FGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--------~~~~~~~ 841 (964)
||++|.+.+.-... ....++-|.+|.|||.+.+ ..|+.+.||||+||++.||+|-.+-|...+ ...+++.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999876543222 3345678999999999886 579999999999999999999887664211 1223333
Q ss_pred HHh---ccCcccccccccccCccchhh---------h----HHHH-------HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 842 TAM---NRDDEEHYGLTEMMDPTIRNT---------V----LLGF-------RRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 842 ~~~---~~~~~~~~~~~~~~d~~l~~~---------~----~~~~-------~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.++ ...........+.+ |+.... . ...+ ..-.+++.+++..||.+|.|+++.++-
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~-Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKM-PEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhC-cchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 222 22111111000000 011000 0 0000 114689999999999999999998763
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=298.21 Aligned_cols=240 Identities=23% Similarity=0.299 Sum_probs=185.3
Q ss_pred eeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHH---HHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 634 EIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIE---LLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
.||+|+||.||+|.. .+|+.||+|.+...... ....+..|.. .++...||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 46899999988654322 1223444444 3444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 99999988654 36899999999999999999999988 9999999999999999999999999987553321
Q ss_pred eecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHhccCcccccccccccCccchh
Q 002121 787 STQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYV-VREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.....|+..|+|||++.++ .++.++||||+||++|||++|+.||...... .......... .++.+..
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~~~~ 220 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----------MAVELPD 220 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-----------cCCCCCC
Confidence 1234689999999998754 6899999999999999999999999653211 1111111100 0111111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
. ....+.+++.+|+..+|.+|| ++.|+++
T Consensus 221 ~---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 221 S---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred c---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 124567899999999999999 8888874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=301.23 Aligned_cols=243 Identities=27% Similarity=0.430 Sum_probs=192.1
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
|...+.||+|+||+||+|+. .+|+.||+|++..... .....+.+|++++++++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999995 4688999999865332 2234678899999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+. |++.+++.... .++++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 96 57888776543 46899999999999999999999988 99999999999999999999999999864322
Q ss_pred ceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 785 HVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.....|+..|+|||++. .+.++.++|||||||++|||++|..||........ +........ .......
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~------~~~~~~~ 244 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDS------PTLQSNE 244 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCC------CCCCccc
Confidence 12346889999999984 45688999999999999999999999865432222 211111111 0111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+ ...+.+++.+||+.+|++||++.+++.
T Consensus 245 ~-------~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 245 W-------TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred c-------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 134668999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.24 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=195.2
Q ss_pred cCCCc-cceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch--------------hHHHHHHHHHHHhcCCCCccceeE
Q 002121 627 NNFSE-SNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG--------------GLEFKTEIELLSRVHHKNLVGLVG 690 (964)
Q Consensus 627 ~~~~~-~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~ 690 (964)
++|.. .+.||+|+||+||+|... +|+.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 34543 467999999999999954 68999999886533221 124778999999999999999999
Q ss_pred EEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEe
Q 002121 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 691 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
++...+..++||||++ |+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEEC
Confidence 9999999999999997 69999986543 5889999999999999999999988 9999999999999999999999
Q ss_pred ecccceeecCCCC------------CceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhH
Q 002121 771 DFGLSKLVSDSSK------------GHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837 (964)
Q Consensus 771 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~ 837 (964)
|||+++....... ........++..|+|||++.+. .++.++||||+||++|||++|+.||.......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~ 241 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID 241 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999986541110 0111223468899999998764 46899999999999999999999996443321
Q ss_pred --HHHHHHhccCcccccc----------cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 838 --REVRTAMNRDDEEHYG----------LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 838 --~~~~~~~~~~~~~~~~----------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+...........+. ......+............+.+++.+|++.+|++||+++|++.
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111111100000 0000011111111112345779999999999999999999985
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=307.81 Aligned_cols=263 Identities=25% Similarity=0.357 Sum_probs=201.0
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC-----ceE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG-----EQM 699 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 699 (964)
+|...+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999965 58999999987643 233457889999999999999999999998765 789
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999998 48999887643 7999999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCC-ceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc-c--
Q 002121 780 DSSKG-HVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG-L-- 854 (964)
Q Consensus 780 ~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-- 854 (964)
..... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..... .+.....+......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-IDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHhcCCCChhHhhh
Confidence 43210 112334578899999999877 789999999999999999999999964332 22222221111000000 0
Q ss_pred ------ccccC-------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 855 ------TEMMD-------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 855 ------~~~~d-------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.+.+. ..+..........+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00000 00000011123457799999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=307.41 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=197.3
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeC---
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--- 696 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--- 696 (964)
....++|+..+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 33567899999999999999999984 4789999999864322 22346889999999999999999999987543
Q ss_pred ---ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 697 ---EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 697 ---~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
..++||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 67999888643 5899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 852 (964)
+++..... .....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ......+........
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~ 237 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL-DQLMEIMKVTGTPSK 237 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCH
Confidence 99865332 123457889999999875 45889999999999999999999999754332 222221111110000
Q ss_pred cc----------------ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 GL----------------TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ~~----------------~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+ .......+..........+.+++.+|++.||++||++.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 000000011111112245779999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=279.28 Aligned_cols=246 Identities=22% Similarity=0.408 Sum_probs=195.6
Q ss_pred cceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEeccCC
Q 002121 632 SNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
...||.|+.|.|++++.+ .|..+|||.+...... +.+++...++++.+-+ .|.||+-+|||..+...++.||.|.-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 466999999999999965 5899999999765443 3456677777777665 89999999999999999999998853
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~ 788 (964)
.++.++..- ..++++.-.-++...+..||.||.+++ .|+|||+||+|||+|+.|++|+||||.+..+.+. ...+
T Consensus 176 C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAht 249 (391)
T KOG0983|consen 176 CAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAHT 249 (391)
T ss_pred HHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---cccc
Confidence 455555543 346888888889999999999998743 4999999999999999999999999999877654 3345
Q ss_pred cccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 789 QVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.-.|-+.|||||-+.- ..|+-++||||||+.++||.||+.||..-+...+.+....+..+. .++...
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP-------~L~~~~--- 319 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPP-------LLPGHM--- 319 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCC-------CCCccc---
Confidence 5679999999999853 478899999999999999999999998766666666665553321 111111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++..|+.+|+.+||...++++
T Consensus 320 --gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 320 --GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred --CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 12356778999999999999999988765
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=307.21 Aligned_cols=247 Identities=23% Similarity=0.369 Sum_probs=202.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
...|.+...||+|.|++|..|+. .+|..||+|.+++.... ....+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 46788899999999999999995 47999999999875443 2345889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+.+|.+++++...+ .+.......+..|+.+|++|||+++ |||||||++||||+.++++||+|||++..+...
T Consensus 135 eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~- 208 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG- 208 (596)
T ss_pred EeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc-
Confidence 9999999999998775 4555888889999999999999998 999999999999999999999999999987633
Q ss_pred CCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......+|++.|.|||++.+.+|. +++|+||+||++|-|+.|..||+... +...-...+ ...+.+...+
T Consensus 209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk~Lr~rvl----~gk~rIp~~m--- 278 (596)
T KOG0586|consen 209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LKELRPRVL----RGKYRIPFYM--- 278 (596)
T ss_pred --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-cccccchhe----eeeeccccee---
Confidence 344567899999999999987765 89999999999999999999997432 111000000 0001111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+++-.+|.+|++++++.+
T Consensus 279 --------s~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 279 --------SCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred --------echhHHHHHHhhccCccccCCHHHhhh
Confidence 123458899999999999999999865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=285.87 Aligned_cols=262 Identities=25% Similarity=0.367 Sum_probs=206.2
Q ss_pred cccccHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeE
Q 002121 614 ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVG 690 (964)
Q Consensus 614 ~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~ 690 (964)
...|+.++++.. ..||.|+||+|+|-.+ +.|+..|||++..... .+.+++..|.+...+- +.||||+++|
T Consensus 58 ~~~F~~~~Lqdl-------g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-------GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHH-------HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 344666666654 6799999999999985 4799999999986554 4556788888875555 7999999999
Q ss_pred EEEeeCceEEEEEeccCCChhhh---hcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 691 FCFEQGEQMLVYEFMANGTLRES---LSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 691 ~~~~~~~~~lV~E~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
.+..++..|+.||.|.- ||..+ ........+++.-.-.|+.-+.+||.||.+.. .|||||+||+|||+|..|.+
T Consensus 131 a~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 99999999999999964 65543 33333456888888889999999999998743 39999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 845 (964)
||||||.+..+.+. ...+.-.|-..|||||-+.. ..|+-+|||||+|++|||+.||+.|+..-.++.+++.+...
T Consensus 208 KLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 208 KLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred eeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 99999998766432 23344568889999999864 34889999999999999999999999988888888888776
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.++..- .... ........+..++.-|+.+|-..||...++.+.
T Consensus 285 gdpp~l-------~~~~--~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPIL-------LFDK--ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCee-------cCcc--cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 654221 1100 011223457789999999999999999998753
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=295.21 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=194.1
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-----cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-----MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
+|.+.+.||+|+||.||++... .+..+++|.++... .....++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4777899999999999999864 34556666655322 12234577899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 702 YEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|||+++++|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988642 2346899999999999999999999988 999999999999975 569999999998764
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... .......|++.|+|||+.....++.++|+||||+++|+|++|..||..... ............
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~----------- 222 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-LSVVLRIVEGPT----------- 222 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHcCCC-----------
Confidence 332 122345688999999999888889999999999999999999999964332 222222221111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+... ......+.+++.+|++.+|++||++.|+++
T Consensus 223 ~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 PSLP---ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCc---chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1111 112245678999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=304.25 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=197.6
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEe-eC
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE-QG 696 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 696 (964)
++..++++|+..+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|++++++++||||+++++++.. .+
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999854 78999999876432 2234568899999999999999999999876 45
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+ +++|.+++... .+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 789999998 46899888643 4788888999999999999999988 9999999999999999999999999987
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccc-
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHY- 852 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~- 852 (964)
..... .....++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+............
T Consensus 157 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 157 IQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred ccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 54321 123457889999998765 568999999999999999999999986433211 111111111000000
Q ss_pred -----ccccc---c----CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -----GLTEM---M----DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -----~~~~~---~----d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+. . ..............+.+++.+|++.+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 0 00000001112256779999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=325.89 Aligned_cols=264 Identities=27% Similarity=0.437 Sum_probs=207.0
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEec----C----CcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccceeEEE
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLS----D----GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGLVGFC 692 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 692 (964)
+...++..+.+.+|+|.||.|++|... . ...||||.++..... +.+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 334445555669999999999999843 1 357999999865443 456799999999999 699999999999
Q ss_pred EeeCceEEEEEeccCCChhhhhcCCC--------C------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCc
Q 002121 693 FEQGEQMLVYEFMANGTLRESLSGRS--------G------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758 (964)
Q Consensus 693 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~N 758 (964)
.+.+..++|+||+..|+|.++++.++ + ..++..+.+.++.|||.|++||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999998664 0 23888999999999999999999987 9999999999
Q ss_pred EEECCCCcEEEeecccceeecCCCCCceeecccc--cCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCch
Q 002121 759 ILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG--TMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKY 835 (964)
Q Consensus 759 ILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~ 835 (964)
||++++..+||+|||+|+.......... ....| ...|||||.+....|+.|+|||||||+|||++| |..||..-..
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999997655443221 22222 456999999999999999999999999999999 7778754111
Q ss_pred hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 836 VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
..+. ...+..+.. + ..+..+..++.+++..||+.+|++||++.|+++.++..++.
T Consensus 528 ~~~l-~~~l~~G~r--------~-----~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 TEEL-LEFLKEGNR--------M-----EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHH-HHHHhcCCC--------C-----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1111 112222110 0 01111235567999999999999999999999999987653
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=307.85 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=194.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee----------
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ---------- 695 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------- 695 (964)
.+|...+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 5788899999999999999995 46899999998766555556788999999999999999999876543
Q ss_pred ----CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEEEe
Q 002121 696 ----GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVA 770 (964)
Q Consensus 696 ----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~ 770 (964)
...++||||++ ++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++ +++.+||+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEEC
Confidence 35789999997 5898888643 4889999999999999999999988 99999999999997 45678999
Q ss_pred ecccceeecCCCCC-ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc
Q 002121 771 DFGLSKLVSDSSKG-HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 771 DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
|||+++........ .......++..|+|||++.. ..++.++|||||||++|||++|+.||....... .........+
T Consensus 158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~ 236 (342)
T cd07854 158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE-QMQLILESVP 236 (342)
T ss_pred CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 99999865332111 11123357889999998754 567889999999999999999999996443222 1211111110
Q ss_pred cccc--------ccccccC-------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EEHY--------GLTEMMD-------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~~~--------~~~~~~d-------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.... .....+. .............+.+++.+||+.||++||++.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000 0000000 0000001112245678999999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=297.54 Aligned_cols=260 Identities=25% Similarity=0.356 Sum_probs=198.5
Q ss_pred CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
|+..+.||+|+||.||+|+.. +++.||+|++.... ......+..|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 456688999999999999965 58999999987653 222356788999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+ ++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-- 153 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-- 153 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--
Confidence 8 59999998653 36899999999999999999999988 99999999999999999999999999986643321
Q ss_pred eeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccc-----------
Q 002121 786 VSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEE----------- 850 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~----------- 850 (964)
......++..|+|||++.+. .++.++|||||||++|||++|+.||..... ...+..... .....
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-IDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12233467889999998766 789999999999999999999999864332 222211111 00000
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......................+.+++.+||+.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000010111112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=304.34 Aligned_cols=261 Identities=25% Similarity=0.336 Sum_probs=192.3
Q ss_pred CCCccceeecCCcEEEEEEEec-C--CcEEEEEEecCCCc--chhHHHHHHHHHHHhc-CCCCccceeEEEEee----Cc
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-D--GQVVAIKRAQQGSM--QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ----GE 697 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~--g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 697 (964)
+|+..+.||+|+||.||++... . +..||+|++..... .....+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999964 4 78999998864322 2234678899999999 599999999976533 45
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++++||+. ++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999886 68999886543 6899999999999999999999988 99999999999999999999999999986
Q ss_pred ecCCCCC--ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCccccc
Q 002121 778 VSDSSKG--HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHY 852 (964)
Q Consensus 778 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~ 852 (964)
....... .......||..|+|||++.+ ..++.++||||+||++|+|++|+.||...... ...+...+.......
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 233 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET- 233 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH-
Confidence 6432211 11233568999999998765 46889999999999999999999998654321 111111111100000
Q ss_pred ccccccC---------------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 GLTEMMD---------------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ~~~~~~d---------------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ..+..........+.+++.+|++.+|++||++.|++.
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 -LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred -HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 0000001111245779999999999999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=280.59 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=199.8
Q ss_pred hhcCCCcc-ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe----eCc
Q 002121 625 CSNNFSES-NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE----QGE 697 (964)
Q Consensus 625 ~~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~ 697 (964)
.+++|++. ++||-|-.|.|-.+.. .+|+.+|+|++... ...++|++..-.. .|||||.++++|+. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 46777775 4789999999999885 47999999998753 2457888887766 59999999999864 345
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeeccc
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGL 774 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGl 774 (964)
.++|||.|+||.|...+..++...+++.+.-.|+.||+.|+.|||+.+ |.||||||+|+|... +..+||+|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 689999999999999999988889999999999999999999999998 999999999999964 55789999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC--CchhHHHHHHHhccCccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK--GKYVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~--~~~~~~~~~~~~~~~~~~~~ 852 (964)
|+..... ......+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||.. +..+...++..+....
T Consensus 211 AK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gq---- 283 (400)
T KOG0604|consen 211 AKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQ---- 283 (400)
T ss_pred ccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccC----
Confidence 9875432 233456789999999999999999999999999999999999999963 2222222332222221
Q ss_pred ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.++-++++ ....+...++|+.+|..+|++|.|+.|+++.
T Consensus 284 --y~FP~pEW----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 --YEFPEPEW----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --ccCCChhH----hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11112222 2222344589999999999999999999763
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=307.19 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=197.2
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCc----
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE---- 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 697 (964)
..++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|+.++++++|+||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4568899999999999999999964 68899999886532 2233467789999999999999999998876554
Q ss_pred --eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 698 --QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 698 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
.++|+||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 56999998753 5899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+..............
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH-IDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHHHHhcCCCCHHH
Confidence 865432 223457889999999865 3678999999999999999999999964432 222222211110000000
Q ss_pred cccc----------------CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMM----------------DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~----------------d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+ .+............+.+++.+|++.+|++|||+.||++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000 00011111112356789999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-34 Score=310.89 Aligned_cols=300 Identities=21% Similarity=0.201 Sum_probs=173.3
Q ss_pred CeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEc
Q 002121 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLAL 144 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 144 (964)
.+..|||++|.+..+.+..|.++++|+.++|.+|. ...+|...+...+|+.|+|.+|.|+..-..++..++.|+.|||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~--Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNE--LTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccch--hhhcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 45668888888887777778888888888887772 4456655555556667777766666555556666666666666
Q ss_pred ccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEcc
Q 002121 145 NSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFD 224 (964)
Q Consensus 145 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~ 224 (964)
|.|.|+...-..|..-.++++|+|++|+|+ .+....|..+.+|..|.|++|+++ .+|...|+.++.|+.|+|.
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It------~l~~~~F~~lnsL~tlkLsrNrit-tLp~r~Fk~L~~L~~LdLn 229 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRIT------TLETGHFDSLNSLLTLKLSRNRIT-TLPQRSFKRLPKLESLDLN 229 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeecccccc------ccccccccccchheeeecccCccc-ccCHHHhhhcchhhhhhcc
Confidence 666666443445555556666666666666 333455666666666666666666 6666666666666666666
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCC
Q 002121 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
.|+|.-.---.|.++++|+.|.|..|.++..-...|..|.++++|+|+.|+++.+-.. +.++++|+.|+||+|.|. .+
T Consensus 230 rN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~-ri 308 (873)
T KOG4194|consen 230 RNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQ-RI 308 (873)
T ss_pred ccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhh-ee
Confidence 6666533344455555555555555555544445555555555555555555544332 445555555555555554 33
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
.++.....++|++|+|++|+|+...+.+|..|..|+.|+|++|++..+....|..+.+|++|||++|.|+.
T Consensus 309 h~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~ 379 (873)
T KOG4194|consen 309 HIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSW 379 (873)
T ss_pred ecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEE
Confidence 44444444555555555555554444444444444444444444444444444444444444444444443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=285.25 Aligned_cols=240 Identities=22% Similarity=0.279 Sum_probs=191.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch---hHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG---GLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
.+|..+.+||+|+||+|-+|..+ +.+.+|||++++...-. .+--..|-++|.-. +-|.+++++.++...+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47889999999999999999864 46789999988654322 12234566777666 578999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+.||+|--++++-+ .+.++....+|..||-||-+||+.+ ||+||||.+|||||.+|++||+|||+++.---+
T Consensus 429 MEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 99999999998887654 5778889999999999999999999 999999999999999999999999999854322
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
+ ..+...+||+.|+|||++..++|+..+|.|||||+||||+.|++||+.. ...+..+.+++.... .+ ..
T Consensus 504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe-DE~elF~aI~ehnvs----yP----Ks 572 (683)
T KOG0696|consen 504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE-DEDELFQAIMEHNVS----YP----KS 572 (683)
T ss_pred C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHccCc----Cc----cc
Confidence 2 3445689999999999999999999999999999999999999999643 233333333322211 11 11
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRP 889 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RP 889 (964)
+. .+.+.+....+...|.+|.
T Consensus 573 lS-------kEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 573 LS-------KEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred cc-------HHHHHHHHHHhhcCCcccc
Confidence 11 3445777888899999984
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-33 Score=297.36 Aligned_cols=243 Identities=22% Similarity=0.363 Sum_probs=198.9
Q ss_pred cceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCC
Q 002121 632 SNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
.+.||+|.||+||-|+. ++|+.||||++.+... ..+.++++|+.||++++||.||.+..-|+..+..+.|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999995 5899999999976543 3456799999999999999999999999999999999999965
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccceeecCCCCCc
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+..+++-......+++..-..++.||+.||.|||..+ |||+||||+|||+.+ .-++||||||.||++++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 5555544444457888888899999999999999988 999999999999953 4589999999999987653
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
....++||+.|+|||+++++.|...-|+||+||++|.-++|.-||.+++...++++.+-- +..+..+..
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF-----------MyPp~PW~e 790 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF-----------MYPPNPWSE 790 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc-----------ccCCCchhh
Confidence 345578999999999999999999999999999999999999999988877777654211 112222222
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
.. ...+++|...++..-.+|-+....+
T Consensus 791 is---~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 791 IS---PEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cC---HHHHHHHHHHHHHHHHHhcchHhhc
Confidence 22 3345788888888888898877654
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.2e-32 Score=255.46 Aligned_cols=262 Identities=24% Similarity=0.331 Sum_probs=202.5
Q ss_pred CCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|...++||+|.||+||+|+ +.+++.||+|+.+..... ......+|+.+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45667889999999999999 557899999988754332 234678999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
|.. +|..+..... ..++.+....++.|+.+||.|+|+++ +.|||+||.|.|++.+|+.|++|||+++...-+.
T Consensus 83 cdq-dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred hhH-HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence 975 8888887664 35899999999999999999999988 9999999999999999999999999998765432
Q ss_pred ceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC---ccc-ccccccccC
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD---DEE-HYGLTEMMD 859 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~---~~~-~~~~~~~~d 859 (964)
.-....+-|.+|.+|+++.+. -|+...|+||-||++.|+.....|...+..+.+++..++..- .+. -..+...-|
T Consensus 156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 122345679999999999874 588999999999999999997788777777777766554321 111 111122111
Q ss_pred ccc----h------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTI----R------NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l----~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
-.. . +..+.....=.+++...+.-+|.+|.++++.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 110 0 001111122356777888889999999988764
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=287.24 Aligned_cols=236 Identities=28% Similarity=0.354 Sum_probs=192.9
Q ss_pred eecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 635 IGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
||+|+||.||++... +++.+|+|++...... ....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 5899999998764432 345788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99997653 5899999999999999999999987 9999999999999999999999999998764321 122345
Q ss_pred cccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
.++..|+|||...+...+.++|+||||+++|||++|+.||..... ............ .....+ .
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~~~~~~~~----~~~~~~-----------~ 217 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYEKILKDPL----RFPEFL-----------S 217 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHhcCCC----CCCCCC-----------C
Confidence 688999999999888889999999999999999999999965432 222222211111 111111 2
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSE 893 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~e 893 (964)
..+.+++.+||..||++||++++
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 45568999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-33 Score=292.69 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=198.4
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCc-ch------hHHHHHHHHHHHhcCCCCccceeEEEEe-eC
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM-QG------GLEFKTEIELLSRVHHKNLVGLVGFCFE-QG 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~-~~------~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~ 696 (964)
.++|-.++.||+|||+.||+|. +...+.||||+-..... .+ .+...+|.+|.+.+.||.||++|+|+.- .+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 3456667899999999999998 55678999998654321 11 1246789999999999999999999974 56
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecc
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFG 773 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFG 773 (964)
..+-|.|||+|-+|.-||+.++ .+++.+...|+.||..||.||.+.. +||||-||||.||||- ..|.+||.|||
T Consensus 542 sFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred cceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 7899999999999999998764 6899999999999999999999874 8999999999999994 56899999999
Q ss_pred cceeecCCCCC-----ceeecccccCcccCcccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH-
Q 002121 774 LSKLVSDSSKG-----HVSTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA- 843 (964)
Q Consensus 774 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~- 843 (964)
+++++.++... ..+....||++|++||.+.- .+.+.|+||||+||++|.++.|+.||.......+.+...
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNT 698 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENT 698 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhc
Confidence 99998765543 23456789999999998753 357889999999999999999999997655443333221
Q ss_pred -hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 844 -MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 844 -~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
+.... -.+.+. +....+...+|.+|++.--++|....++.
T Consensus 699 IlkAtE-------VqFP~K-----PvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 699 ILKATE-------VQFPPK-----PVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhccee-------ccCCCC-----CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 11110 001110 00112334789999999999998887765
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=325.07 Aligned_cols=145 Identities=28% Similarity=0.392 Sum_probs=130.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|.+.+.||+|+||+||+|... +++.||||+++..... ....+.+|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999965 6899999998754322 2356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
||+++|+|.+++.... .+++..++.++.||+.||+|||..+ ||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 5788999999999999999999987 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-32 Score=317.74 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=207.7
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
..+++--.++|.+.++||+|+||.|..++.+ +++.+|+|++.+..+ ....-|..|-++|..-+.+-||+++..|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 4566666789999999999999999999964 689999999887433 233469999999999999999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
+.+.|+|||||+||+|-.++.... ++++.....++..|.-||+-+|+.| +|||||||+|||||..|++||+|||.
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 999999999999999999998765 5777778899999999999999999 99999999999999999999999998
Q ss_pred ceeecCCCCCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
+-.+...+. ......+|||-|++||++.. +.|+..+|.||+||++|||+.|..||. .+.+++-+..++.-...
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY-adslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY-ADSLVETYGKIMNHKES 299 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch-HHHHHHHHHHHhchhhh
Confidence 876654332 44566789999999999852 678999999999999999999999995 45666666666544221
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT---MSEVVK 896 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 896 (964)
...++..+ .. ....++|.+.+. +|+.|-. +.++-.
T Consensus 300 --l~FP~~~~------VS---eeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 300 --LSFPDETD------VS---EEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred --cCCCcccc------cC---HHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 11111111 22 233456665554 6777776 777743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=298.45 Aligned_cols=240 Identities=23% Similarity=0.306 Sum_probs=193.9
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++.|.....+|.|+|+.|-.+.. .+++..+||++..... +-.+|+.++... +||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 366788888899999999998884 5788999999986522 335677776666 6999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE-CCCCcEEEeecccceeecCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL-DENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~~~~~~kl~DFGla~~~~~~ 781 (964)
|++.+|-+.+.+.... ... ..+..|+.+|+.|+.|||++| ||||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998888776543 233 677789999999999999988 9999999999999 69999999999999876543
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
....+-|..|.|||++....|++++|+|||||+||+||+|+.||..+... ..+...+.... ..+.
T Consensus 470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~-----~s~~---- 534 (612)
T KOG0603|consen 470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPK-----FSEC---- 534 (612)
T ss_pred -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCc-----cccc----
Confidence 22345688999999999999999999999999999999999999755443 23333332222 1111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. ....+|+.+||+.||.+||+|.++..
T Consensus 535 ----vS---~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 535 ----VS---DEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----cC---HHHHHHHHHhccCChhhCcChhhhcc
Confidence 12 23348999999999999999999875
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=301.68 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=209.4
Q ss_pred cHHHHHHhhcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe-
Q 002121 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE- 694 (964)
Q Consensus 618 ~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 694 (964)
.++.+...++-|.+.+.||.|.+|.||+++ .++|+.+|+|+..... ...++...|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344555556778889999999999999999 5689999999887543 3345788899999988 69999999999974
Q ss_pred ----eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEe
Q 002121 695 ----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 695 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
++..|||||||.+||..++++.-.+..+.|+.+.-|+..+++|+.|||... ++|||||-.|||++.++.+|++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 468999999999999999998776788999999999999999999999887 9999999999999999999999
Q ss_pred ecccceeecCCCCCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 845 (964)
|||++..++... .......||+.|||||++.- ..|+.++|+||+|++..||--|.+|+.+-.. ++.++.
T Consensus 166 DFGvSaQldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP----mraLF~ 239 (953)
T KOG0587|consen 166 DFGVSAQLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP----MRALFL 239 (953)
T ss_pred eeeeeeeeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch----hhhhcc
Confidence 999998876432 23345679999999999853 3477899999999999999999999854221 222222
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.... -.|.+. ....-.+++.++|..|+..|-++||++.++++
T Consensus 240 IpRN--------PPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 IPRN--------PPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCC--------CCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 2111 111221 13334567889999999999999999998764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=280.78 Aligned_cols=222 Identities=24% Similarity=0.205 Sum_probs=176.6
Q ss_pred CCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcC
Q 002121 638 GGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG 716 (964)
Q Consensus 638 G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 716 (964)
|.||+||+++. .+|+.||+|++.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 478999999987543 234555666666799999999999999999999999999999999875
Q ss_pred CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcc
Q 002121 717 RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796 (964)
Q Consensus 717 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 796 (964)
.. .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++++|||.+...... .....++..|
T Consensus 79 ~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y 148 (237)
T cd05576 79 FL--NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMY 148 (237)
T ss_pred hc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccc
Confidence 43 5899999999999999999999988 999999999999999999999999988655332 1223467789
Q ss_pred cCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHH
Q 002121 797 LDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLEL 876 (964)
Q Consensus 797 ~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 876 (964)
+|||+...+.++.++||||+|+++|||++|+.|+...... ... .....+... ....+.++
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~~~----------~~~~~~~~~---~~~~~~~l 208 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------INT----------HTTLNIPEW---VSEEARSL 208 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------ccc----------ccccCCccc---CCHHHHHH
Confidence 9999998888999999999999999999999886432110 000 000001111 12446689
Q ss_pred HHHhhhcCCCCCCCHHHH
Q 002121 877 ALQCVEESATDRPTMSEV 894 (964)
Q Consensus 877 i~~cl~~dP~~RPs~~ev 894 (964)
+.+|++.||++||++.+.
T Consensus 209 i~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 209 LQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHccCCHHHhcCCCcc
Confidence 999999999999997443
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=299.59 Aligned_cols=265 Identities=20% Similarity=0.303 Sum_probs=180.8
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-----------------cCCcEEEEEEecCCCcchhH--------------HHHHH
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-----------------SDGQVVAIKRAQQGSMQGGL--------------EFKTE 673 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~--------------~~~~E 673 (964)
..++|++.++||+|+||+||+|.. ..++.||||+++.......+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 23568999998754322222 23457
Q ss_pred HHHHHhcCCCCc-----cceeEEEEe--------eCceEEEEEeccCCChhhhhcCCC----------------------
Q 002121 674 IELLSRVHHKNL-----VGLVGFCFE--------QGEQMLVYEFMANGTLRESLSGRS---------------------- 718 (964)
Q Consensus 674 ~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------- 718 (964)
+.++.+++|.++ ++++++|.. ++..+|||||+++|+|.++++...
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 778888877654 678888764 356899999999999999987532
Q ss_pred CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccC
Q 002121 719 GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798 (964)
Q Consensus 719 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a 798 (964)
...++|..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 113467889999999999999999987 99999999999999999999999999976543221 11122335889999
Q ss_pred ccccccCC--------------------C--CCchhHHHHHHHHHHHHhCCC-CCCCCchhHHHHHHHhccCcccccccc
Q 002121 799 PEYYMTQQ--------------------L--TEKSDVYSFGVVMLELITAKQ-PIEKGKYVVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 799 PE~~~~~~--------------------~--~~~sDv~S~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (964)
||.+.... + ..+.||||+||++|||++|.. |+.............-...........
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99875432 1 135799999999999999875 654221111111100000000000000
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESA---TDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 896 (964)
...+....+ .......+++.+++..+| .+|+|++|+++
T Consensus 459 ~~~~~~~~d---~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFSLLD---RNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCccccc---ccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 001111111 112345688999998766 68999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-32 Score=269.17 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=196.2
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEee--------Cc
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--------GE 697 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--------~~ 697 (964)
|....+||+|.||.||+|+. ++|+.||+|+.--. ...-.....+|+++|..++|+|++.+++.|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 44457899999999999995 46888999865432 222234567899999999999999999988642 34
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+||.+|+. +|..+|.... ..++..++.+++.++..||.|+|... |+|||+||.|+|++.+|.+||+|||+++.
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccc
Confidence 7999999987 8888887653 56899999999999999999999987 99999999999999999999999999987
Q ss_pred ecCCCC--CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCccccc
Q 002121 778 VSDSSK--GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHY 852 (964)
Q Consensus 778 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~ 852 (964)
+..... ....+..+-|.+|.+||.+.+ ..|+++.|||.-||++.||+||.+-++.... ....+.........+.+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW 253 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW 253 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence 653322 222345567999999999875 6799999999999999999999877764332 22333443333322211
Q ss_pred ------ccccccCcc-chhh----hHHHHH------HHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 853 ------GLTEMMDPT-IRNT----VLLGFR------RYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 853 ------~~~~~~d~~-l~~~----~~~~~~------~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.+.+.+.-+ +... .....+ .-.+++.+++..||.+|+++.+++..
T Consensus 254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 011111000 1110 111112 45689999999999999999998753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=272.64 Aligned_cols=238 Identities=28% Similarity=0.403 Sum_probs=194.2
Q ss_pred CcEEEEEEEec-CCcEEEEEEecCCCcch-hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcC
Q 002121 639 GYGKVYRGMLS-DGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSG 716 (964)
Q Consensus 639 ~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 716 (964)
+||.||+|... +|+.+|+|++....... ...+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 58999999998665544 57899999999999999999999999999999999999999999999976
Q ss_pred CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcc
Q 002121 717 RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796 (964)
Q Consensus 717 ~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 796 (964)
.. .+++..+..++.+++++++|||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~ 152 (244)
T smart00220 81 RG--RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEY 152 (244)
T ss_pred cc--CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCC
Confidence 54 3899999999999999999999987 9999999999999999999999999998765432 22345688999
Q ss_pred cCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHH
Q 002121 797 LDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLEL 876 (964)
Q Consensus 797 ~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 876 (964)
++||......++.++||||||+++++|++|..||................... .. . . .......+.++
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~---~-~----~~~~~~~~~~~ 220 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----FP---P-P----EWKISPEAKDL 220 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----Cc---c-c----cccCCHHHHHH
Confidence 99999988888999999999999999999999996533222222221111110 00 0 0 00022457789
Q ss_pred HHHhhhcCCCCCCCHHHHHH
Q 002121 877 ALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 877 i~~cl~~dP~~RPs~~evl~ 896 (964)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=307.40 Aligned_cols=261 Identities=20% Similarity=0.281 Sum_probs=170.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-C----CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEE------EE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-D----GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF------CF 693 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 693 (964)
..++|...+.||+|+||.||+|+.. + +..||||++...... +.+..| .+.+..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999964 4 689999987643221 111111 1222223333333222 23
Q ss_pred eeCceEEEEEeccCCChhhhhcCCCC------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 002121 694 EQGEQMLVYEFMANGTLRESLSGRSG------------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVK 755 (964)
Q Consensus 694 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 755 (964)
+....++||||+++++|.++++.... ....+..+..++.|++.||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 45688999999999999999875421 01123345679999999999999987 9999999
Q ss_pred CCcEEECC-CCcEEEeecccceeecCCCCCceeecccccCcccCccccccC----------------------CCCCchh
Q 002121 756 STNILLDE-NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ----------------------QLTEKSD 812 (964)
Q Consensus 756 ~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sD 812 (964)
|+|||+++ ++.+||+|||+|+....... .......+|+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 58999999999986543322 233456789999999965321 2345679
Q ss_pred HHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh-------hHHHHHHHHHHHHHhhhcCC
Q 002121 813 VYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT-------VLLGFRRYLELALQCVEESA 885 (964)
Q Consensus 813 v~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-------~~~~~~~l~~li~~cl~~dP 885 (964)
||||||++|||+++..+.+. ........ +.........+.....+..... .........+++.+|++.||
T Consensus 362 VwSlGviL~el~~~~~~~~~--~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS--NLIQFNRQ-LKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch--HHHHHHHH-HHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999999997766432 12111111 1111100000111111110000 00011234589999999999
Q ss_pred CCCCCHHHHHH
Q 002121 886 TDRPTMSEVVK 896 (964)
Q Consensus 886 ~~RPs~~evl~ 896 (964)
++|||++|+++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999986
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=250.40 Aligned_cols=217 Identities=26% Similarity=0.424 Sum_probs=176.2
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.+.......||+|++|.|-+.++ .+|+..|||++..... +..++..+|+++..+- .+|.+|.++|.+......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 33444457799999999988885 5799999999876433 3445677888876665 7999999999999999999999
Q ss_pred EeccCCChhhhhcC--CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 703 EFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 703 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|.|.- ||..+-.. ..+..+++.-.-+||..+.+||.|||++- .|||||+||+|||++.+|++|+||||.+..+.+
T Consensus 125 E~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99964 77654432 12456888889999999999999999854 499999999999999999999999999987754
Q ss_pred CCCCceeecccccCcccCcccccc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
.- ..+.-.|-..|||||.+.. ..|+-|+||||+|+.+.||.+++.||+......+++++.+....
T Consensus 202 Si---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 202 SI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred hh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 32 2233457888999998853 47899999999999999999999999988888888877765543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=281.34 Aligned_cols=241 Identities=21% Similarity=0.300 Sum_probs=196.1
Q ss_pred CCCccceeecCCcEEEEEEEecCCc-EEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDGQ-VVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g~-~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++.....||-|+||+|=.+..+... .+|+|.+++.. ....+.+..|-.+|...+.|.||++|..|.+....|+.||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4444567999999999998875433 48888776543 3344568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
-|-||.|...+..++ .++..+...++.-+.+|++|||+++ ||+|||||+|.+||.+|-+||.|||+|+.+..+.
T Consensus 501 aClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 501 ACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 999999999998765 6888899999999999999999999 9999999999999999999999999999887553
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.+...+||+.|+|||++.+...+.++|.||+|+++|||++|.+||...+. +.-+..++..... .+ +...+
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid~-----i~-~Pr~I- 644 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGIDK-----IE-FPRRI- 644 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhhh-----hh-ccccc-
Confidence 35668999999999999999999999999999999999999999975432 2223333222210 00 01111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPT 890 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs 890 (964)
.+.-.+++++....+|.+|.-
T Consensus 645 ------~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 645 ------TKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------chhHHHHHHHHHhcCcHhhhc
Confidence 133458899999999999975
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=270.78 Aligned_cols=270 Identities=20% Similarity=0.294 Sum_probs=205.0
Q ss_pred ccccHHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-C-C----Cccc
Q 002121 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-H-K----NLVG 687 (964)
Q Consensus 615 ~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~----nIv~ 687 (964)
..+...|.. +++|.+...+|+|.||.|-++..+ .+..||||+++... ..++..+-|+++|+++. + | -+|.
T Consensus 79 ~v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 79 YVYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 344444443 788999999999999999998854 47899999987533 33456678999999994 2 2 3788
Q ss_pred eeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-----
Q 002121 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD----- 762 (964)
Q Consensus 688 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~----- 762 (964)
+.+|+.-.++.++|+|.+ |-|+.+++..++-.+++..++..++.|++++++|||+.+ ++|-||||+|||+-
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceE
Confidence 889999999999999987 459999999888788999999999999999999999988 99999999999992
Q ss_pred ---------------CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCC
Q 002121 763 ---------------ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAK 827 (964)
Q Consensus 763 ---------------~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~ 827 (964)
....+||+|||-|+...... ..++.|..|.|||++.+-.++.++||||+||||+|+.||.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 13468999999998754332 4466899999999999999999999999999999999999
Q ss_pred CCCCCCchhH--HHHHHHhccCccc--------ccccccccC---------------c-c-ch---hhhHHHHHHHHHHH
Q 002121 828 QPIEKGKYVV--REVRTAMNRDDEE--------HYGLTEMMD---------------P-T-IR---NTVLLGFRRYLELA 877 (964)
Q Consensus 828 ~p~~~~~~~~--~~~~~~~~~~~~~--------~~~~~~~~d---------------~-~-l~---~~~~~~~~~l~~li 877 (964)
.-|+..++.. ..+..++...+.. .+-....+| + . +. .....+..++.+|+
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 9887443211 1222221111100 000000111 0 0 10 11334456789999
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 002121 878 LQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 878 ~~cl~~dP~~RPs~~evl~ 896 (964)
.+++..||.+|+|+.|++.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHccCccccccHHHHhc
Confidence 9999999999999999875
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=260.88 Aligned_cols=199 Identities=26% Similarity=0.380 Sum_probs=173.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch---hHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG---GLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|...++||+|+|++|..+++ ++.+.+|+|++++.-..+ ..=.+.|-.+..+. +||.+|-+..++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46788999999999999999995 467899999988643322 22356777777766 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|.||+++|+|--++.+.+ .++++....+...|+-||.|||+.| ||+||||..|||+|..|.+||.|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999987776543 6899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
+ +..+...+|||.|+|||++++..|...+|.|++||+++||+.|+.||+
T Consensus 404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 2 234567899999999999999999999999999999999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=292.86 Aligned_cols=246 Identities=26% Similarity=0.390 Sum_probs=185.9
Q ss_pred CCCccceeecCCcE-EEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYG-KVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
-|...+.+|.|+-| .||+|.. +|+.||||++-.... .-.++|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 34555678999987 6799999 589999998864332 2567999999988 5999999998888888999999999
Q ss_pred cCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-----CCcEEEeecccceee
Q 002121 706 ANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSKLV 778 (964)
Q Consensus 706 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGla~~~ 778 (964)
.. +|.+++... ......-...+.+..|++.||+|||+.+ ||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 65 999999874 1111111445788999999999999988 999999999999965 357899999999987
Q ss_pred cCCCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 779 SDSSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITA-KQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 779 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
..+... .......||-+|+|||++....-+.++||||+|||+|+.++| .+||.. ...++... +... +.+..
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd--~~~R~~NI-l~~~----~~L~~ 734 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD--SLERQANI-LTGN----YTLVH 734 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc--hHHhhhhh-hcCc----cceee
Confidence 644322 223457799999999999988888899999999999999986 899953 22222111 1111 11111
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+ ...... +-.+||.+|++++|..||++.+|+.
T Consensus 735 L-----~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 L-----EPLPDC---EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred e-----ccCchH---HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 1 100111 3458999999999999999999953
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=276.51 Aligned_cols=201 Identities=23% Similarity=0.371 Sum_probs=170.3
Q ss_pred cCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.-|..++.||-|+||+|.+++ .++...+|.|.+++.+.- .....+.|.+||.....+-||+|+..|.+++..|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 356778899999999999998 455678999988765432 2345789999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec---
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS--- 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~--- 779 (964)
||++||++-.+|.+.+ -+.+.-...++.+++.|+++.|..| +|||||||+|||||.+|++||.||||+.-+.
T Consensus 709 dYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 9999999999987664 5777888888999999999999999 9999999999999999999999999985321
Q ss_pred CCC-----CCc--------------------------------eeecccccCcccCccccccCCCCCchhHHHHHHHHHH
Q 002121 780 DSS-----KGH--------------------------------VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLE 822 (964)
Q Consensus 780 ~~~-----~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~e 822 (964)
+.. ... .....+||+.|+|||++....|+..+|.||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 100 000 0012459999999999999999999999999999999
Q ss_pred HHhCCCCCCC
Q 002121 823 LITAKQPIEK 832 (964)
Q Consensus 823 lltg~~p~~~ 832 (964)
|+.|+.||..
T Consensus 864 m~~g~~pf~~ 873 (1034)
T KOG0608|consen 864 MLVGQPPFLA 873 (1034)
T ss_pred HhhCCCCccC
Confidence 9999999964
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-31 Score=291.59 Aligned_cols=313 Identities=25% Similarity=0.318 Sum_probs=242.1
Q ss_pred CeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEc
Q 002121 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLAL 144 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 144 (964)
++..|.+++|++. .+-++++.|+.|+.+++..|+.-..-+|+.+.+|..|+.||||+|++. +.|..+...+++-.|+|
T Consensus 56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 3445555566655 444556666666666666663334456777777777777777777777 77777777777777777
Q ss_pred ccCcccCcCCC-cCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 145 NSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 145 s~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|+|+|. .||. -|.+|+.|-+||||+|++. .+| +....|..|+.|.|++|.+. ...-.-.-.+.+|..|.+
T Consensus 134 S~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LP------PQ~RRL~~LqtL~Ls~NPL~-hfQLrQLPsmtsL~vLhm 204 (1255)
T KOG0444|consen 134 SYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLP------PQIRRLSMLQTLKLSNNPLN-HFQLRQLPSMTSLSVLHM 204 (1255)
T ss_pred ccCccc-cCCchHHHhhHhHhhhccccchhh-hcC------HHHHHHhhhhhhhcCCChhh-HHHHhcCccchhhhhhhc
Confidence 777777 4444 4567777777777777777 566 55677777888888888764 111111223556777777
Q ss_pred cCCcCc-ccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCC
Q 002121 224 DGNQLS-GNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 224 ~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
++.+=+ ..+|.++..+.+|..+|||.|.+. .+|+.+.++++|+.|+||+|+|+..........+|++|+||.|++ +
T Consensus 205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQL--t 281 (1255)
T KOG0444|consen 205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQL--T 281 (1255)
T ss_pred ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchh--c
Confidence 776543 467888899999999999999999 899999999999999999999998887777888999999999999 6
Q ss_pred CCCcccCCCCCCcEEECCCCccccc-cChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC--C
Q 002121 303 EAPLWFSTLPSLTTLICEFGSLQGR-VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG--S 379 (964)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~--~ 379 (964)
..|+.+..|++|+.|++.+|+++-. +|..+++|.+|+.+..++|.+. ..|..++.+..|+.|.|+.|+|-.+|.+ .
T Consensus 282 ~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLPeaIHl 360 (1255)
T KOG0444|consen 282 VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLPEAIHL 360 (1255)
T ss_pred cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeechhhhhh
Confidence 7899999999999999999998743 8899999999999999999886 7788999999999999999999998854 5
Q ss_pred CcccceeEeecCC
Q 002121 380 GIKNYTLILVGNP 392 (964)
Q Consensus 380 ~~~l~~l~l~~Np 392 (964)
...+..|+|..||
T Consensus 361 L~~l~vLDlreNp 373 (1255)
T KOG0444|consen 361 LPDLKVLDLRENP 373 (1255)
T ss_pred cCCcceeeccCCc
Confidence 5557889999998
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=243.30 Aligned_cols=257 Identities=19% Similarity=0.355 Sum_probs=197.0
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEee--CceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQ--GEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV 701 (964)
+++|++.+++|+|.|+.||.|. ..+.+.++||+++.-. .+.+++|+.+|+.++ ||||+++++...+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678888999999999999999 5678999999998643 346899999999997 99999999999875 456899
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeecccceeecC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLSKLVSD 780 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~~~~~ 780 (964)
+||+.+.+...+.. .++-..+...+.+++.||.|+|+.| |+|||+||.||++|.. -..+|+|+|+|.+..+
T Consensus 114 FE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99999988777654 3667788899999999999999999 9999999999999864 5789999999998866
Q ss_pred CCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc-cCcccccc----c
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN-RDDEEHYG----L 854 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~----~ 854 (964)
+.... ..+.+..|--||.+.. +.|+..-|+|||||++..|+..+.||..|.+-.+++..+.. -+.++-+. .
T Consensus 186 ~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Cceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 54432 2346778899999864 67889999999999999999999999876654443322111 01000000 0
Q ss_pred ccccCccchhh------------h-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNT------------V-----LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~------------~-----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.-.+||++.+. . .....+.++++.+.+..|-++|+|++|...
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00123322221 0 011245678999999999999999999864
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-30 Score=253.71 Aligned_cols=196 Identities=27% Similarity=0.398 Sum_probs=164.7
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee-----CceEE
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GEQML 700 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~l 700 (964)
.+..+.||-|+||.||.++. ++|+.||+|++.... ....+++.+|+++|.-.+|.|++..++...-. .+.|.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468899999999999985 589999999886432 23446788999999999999999988876543 35688
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|+|.|.. +|...+..- ..++-..+.-+..||++||.|||+.+ |.||||||.|.|++++...||||||+||....
T Consensus 135 ~TELmQS-DLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHh-hhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 9998864 888887654 46888889999999999999999988 99999999999999999999999999997654
Q ss_pred CCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
++. ..++..+-|..|.|||++++ +.|+.+.||||+||++.||+-.+--|+
T Consensus 209 d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 209 RDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred hhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 433 44566778999999999986 579999999999999999998776665
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=243.04 Aligned_cols=210 Identities=36% Similarity=0.580 Sum_probs=182.8
Q ss_pred eecCCcEEEEEEEecC-CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhh
Q 002121 635 IGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRE 712 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~ 712 (964)
||+|++|.||++...+ |+.+++|++...... ....+.+|++.+++++|++|+++++++......++||||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 899999998865443 34578999999999999999999999999899999999999999999
Q ss_pred hhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccceeecCCCCCceeeccc
Q 002121 713 SLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSDSSKGHVSTQVK 791 (964)
Q Consensus 713 ~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~ 791 (964)
++.... ..+++..+..++.+++++++|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~ 154 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIV 154 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhccc
Confidence 997652 35899999999999999999999987 999999999999999 89999999999987654321 123345
Q ss_pred ccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHH
Q 002121 792 GTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870 (964)
Q Consensus 792 gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 870 (964)
+...|++||..... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 788999999999999999
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 871 RRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 871 ~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 234589999999999999999998863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=273.20 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=202.8
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|.....+|.|.||.||||+ .+.++..|||+++........-.++|+-+++..+|||||.++|.+...+..|++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 4578888999999999999999 457999999999987777667788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
|.+|+|.+.-+.-+ ++++.++..+.+...+||+|||+.+ =+|||||-.|||+++.|.+|++|||.+..+...-
T Consensus 94 cgggslQdiy~~Tg--plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-- 166 (829)
T ss_pred cCCCcccceeeecc--cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--
Confidence 99999999887654 7999999999999999999999988 7999999999999999999999999987654321
Q ss_pred ceeecccccCcccCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 785 HVSTQVKGTMGYLDPEYY---MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.......||+.|||||+. +.+.|..++|||+.|+...|+-.-++|...- ...+....+...... -...-|+.
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdl-hpmr~l~LmTkS~~q----pp~lkDk~ 241 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDL-HPMRALFLMTKSGFQ----PPTLKDKT 241 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccccc-chHHHHHHhhccCCC----CCcccCCc
Confidence 223456799999999986 4678999999999999999998878775432 122222221111111 11111222
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
.-...+-++++.|+..+|++||+++.++
T Consensus 242 ------kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 242 ------KWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ------cchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 1224466899999999999999998764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=242.88 Aligned_cols=199 Identities=32% Similarity=0.512 Sum_probs=173.5
Q ss_pred CCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 629 FSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ....+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567889999999999999764 899999999865544 56688999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+++|.+++..... .+++..+..++.+++.+++|||+.+ ++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-AL 155 (225)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cc
Confidence 9999999976542 2889999999999999999999987 99999999999999999999999999987754321 12
Q ss_pred eecccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 787 STQVKGTMGYLDPEYY-MTQQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
.....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334578899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-27 Score=244.30 Aligned_cols=258 Identities=24% Similarity=0.298 Sum_probs=193.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEee------Cc
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------GE 697 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~ 697 (964)
.+|...+.+|.|.- .|..|.. -.++.||+|+.... .....++..+|..++..+.|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666678888887 5555542 35889999987543 223445778999999999999999999998643 46
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+|||||.. +|.+.++- .++-.+...|..|++.|+.|||+.+ |+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m~~-nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVILM----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhhhh-HHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcc
Confidence 7999999965 99988873 4788899999999999999999998 99999999999999999999999999986
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc---------
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD--------- 848 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 848 (964)
.... ...+..+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.....+.+|.+..-..+.
T Consensus 168 e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL 244 (369)
T KOG0665|consen 168 EDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL 244 (369)
T ss_pred cCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence 4332 4556778899999999999888999999999999999999999887655444444332110000
Q ss_pred -------------ccccccccccCccc-hhh---hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 -------------EEHYGLTEMMDPTI-RNT---VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 -------------~~~~~~~~~~d~~l-~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+...+ +.. .........+++.+||-.+|++|.+++++++
T Consensus 245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 00011111111111 100 1112234568999999999999999999985
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-29 Score=276.35 Aligned_cols=305 Identities=24% Similarity=0.310 Sum_probs=267.2
Q ss_pred ecCCCeeEEEcCCCCccc-cccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcc-cCCCCC
Q 002121 61 CNNSRVTALGLSTMGLTG-KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDE-IGNLAE 138 (964)
Q Consensus 61 C~~~~v~~L~L~~~~l~g-~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~ 138 (964)
.+.+++.++++..|++.. -+|+.|..|..|+.||||+|. ....|..+..-+++-.|+||+|+|. .||.. |.+|+.
T Consensus 75 s~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNq--L~EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtD 151 (1255)
T KOG0444|consen 75 SDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQ--LREVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTD 151 (1255)
T ss_pred ccchhhHHHhhhccccccCCCCchhcccccceeeecchhh--hhhcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHh
Confidence 344568888899999864 589999999999999999994 4578999999999999999999999 67765 668999
Q ss_pred ccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccc-ccccccccCCCcc
Q 002121 139 LSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS-GTISEQLFSPDMV 217 (964)
Q Consensus 139 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~-g~l~~~~f~~~~~ 217 (964)
|-.||||+|++. .+|+.+..|.+|++|+|++|.+. .+....+-.+++|+.|++++.+=+ ..+|.. ...+.+
T Consensus 152 LLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~------hfQLrQLPsmtsL~vLhms~TqRTl~N~Pts-ld~l~N 223 (1255)
T KOG0444|consen 152 LLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLN------HFQLRQLPSMTSLSVLHMSNTQRTLDNIPTS-LDDLHN 223 (1255)
T ss_pred Hhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhh------HHHHhcCccchhhhhhhcccccchhhcCCCc-hhhhhh
Confidence 999999999999 78889999999999999999886 333345556778888999877643 244443 456789
Q ss_pred eeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCC
Q 002121 218 LIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297 (964)
Q Consensus 218 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 297 (964)
|..++|+.|.+. .+|+.+-.+.+|+.|+||+|+|+ .+......+.+|+.|+||.|+|+..+..+.++++|+.|.+.+|
T Consensus 224 L~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~N 301 (1255)
T KOG0444|consen 224 LRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNN 301 (1255)
T ss_pred hhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccC
Confidence 999999999999 89999999999999999999999 6777788899999999999999999999999999999999999
Q ss_pred CCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeecc
Q 002121 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITL 377 (964)
Q Consensus 298 ~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 377 (964)
+++-..+|..++.|.+|+++..++|.+. .+|+.+..+..|+.|.|+.|++. +.|.++..++.|+.|||.+|+=-..|+
T Consensus 302 kL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 302 KLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred cccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 9998899999999999999999999998 89999999999999999999997 568899999999999999997666555
Q ss_pred CCC
Q 002121 378 GSG 380 (964)
Q Consensus 378 ~~~ 380 (964)
.+.
T Consensus 380 KP~ 382 (1255)
T KOG0444|consen 380 KPN 382 (1255)
T ss_pred Ccc
Confidence 433
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-27 Score=258.40 Aligned_cols=196 Identities=22% Similarity=0.383 Sum_probs=168.6
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc------hh--HHHHHHHHHHHhcC---CCCccceeEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ------GG--LEFKTEIELLSRVH---HKNLVGLVGFCFE 694 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~--~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 694 (964)
.+|...+.+|+|+||.|+.|+++ +...|+||.+.+...- ++ -.+-.|+.||..++ |+||+|++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 36888999999999999999975 4567899988754321 00 12557999999997 9999999999999
Q ss_pred eCceEEEEEec-cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 695 QGEQMLVYEFM-ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 695 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
++.+||+||-. ++-+|.+++..+. .+++.+...|..||+.|+++||+.+ |||||||-+||.++.+|-+||+|||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 99999999976 4568999998764 6999999999999999999999999 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCC
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
.|.....+. ....+||..|.|||++.+.+|- ..-|||++|++||-++....||.
T Consensus 716 saa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred chhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998765543 3456799999999999988775 67899999999999998888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=234.13 Aligned_cols=252 Identities=19% Similarity=0.306 Sum_probs=185.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEE-EEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGF-CFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lV~ 702 (964)
.+.|.+.+.+|+|.||.+-+++++ +.+.+|+|.+..... ..++|.+|..-=-.| .|.||+.-+++ |...+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 457888899999999999999976 467889998775433 346788887665555 59999987765 55677888999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE-C-CCCcEEEeecccceeecC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL-D-ENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-~-~~~~~kl~DFGla~~~~~ 780 (964)
||+|.|+|.+-+... .+.+....+++.|+++|+.|||+.+ +||||||.+|||+ + +..++||||||+.+..+.
T Consensus 102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 999999999988764 3778888999999999999999988 9999999999999 3 445899999999875432
Q ss_pred CCCCceeecccccCcccCcccccc---C--CCCCchhHHHHHHHHHHHHhCCCCCCCCc----hhHHHHHHHhccCcccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT---Q--QLTEKSDVYSFGVVMLELITAKQPIEKGK----YVVREVRTAMNRDDEEH 851 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~sDv~S~Gvvl~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~ 851 (964)
......-+..|.|||.... + ...+.+|||.||+++|.++||+.||+... ...+|....
T Consensus 176 -----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~-------- 242 (378)
T KOG1345|consen 176 -----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL-------- 242 (378)
T ss_pred -----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh--------
Confidence 2223345667999997643 2 35688999999999999999999997322 222332211
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
....+.++........+..++.++-+.++|++|-...++.++....
T Consensus 243 ----~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 243 ----KRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred ----cccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 1111222222222224456777888999999997776766554433
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-28 Score=257.97 Aligned_cols=85 Identities=31% Similarity=0.318 Sum_probs=65.1
Q ss_pred cCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccc-----------------------cccCCCCccCCCCcE
Q 002121 308 FSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN-----------------------NTLDMGNAVGPLLQL 364 (964)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-----------------------~~~~~~~~~l~~L~~ 364 (964)
++.+++|..|+|++|-+. .+|..++.+..|+.|+|+.|++. .+.+..+.++.+|.+
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~t 509 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTT 509 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcce
Confidence 445667777777777665 56677777777777777766654 344455778899999
Q ss_pred EeccCCcceeecc--CCCcccceeEeecCCc
Q 002121 365 VDLQNNQISAITL--GSGIKNYTLILVGNPV 393 (964)
Q Consensus 365 L~L~~N~l~~i~~--~~~~~l~~l~l~~Np~ 393 (964)
|||.+|.|..||+ +...+++.|.|.|||+
T Consensus 510 LDL~nNdlq~IPp~LgnmtnL~hLeL~gNpf 540 (565)
T KOG0472|consen 510 LDLQNNDLQQIPPILGNMTNLRHLELDGNPF 540 (565)
T ss_pred eccCCCchhhCChhhccccceeEEEecCCcc
Confidence 9999999999985 5677789999999995
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=243.52 Aligned_cols=203 Identities=27% Similarity=0.428 Sum_probs=168.5
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEee
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQ 695 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 695 (964)
++....+.|...++||+|.|++||+|... ..+.||+|.+...+.. .++.+|+++|..+. |.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34456678899999999999999999853 4678999998765544 36889999999995 99999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeeccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGL 774 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGl 774 (964)
+...+|+||++...-.++... ++..++..+...+..||+|+|..| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 999999999999988888763 667889999999999999999998 999999999999974 57789999999
Q ss_pred ceeecCC-------C-----------C--------------C----------ceeecccccCcccCcccccc-CCCCCch
Q 002121 775 SKLVSDS-------S-----------K--------------G----------HVSTQVKGTMGYLDPEYYMT-QQLTEKS 811 (964)
Q Consensus 775 a~~~~~~-------~-----------~--------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~~~s 811 (964)
|...... . . + .......||+||.|||++.. +..+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 8721100 0 0 0 00112459999999999864 5678999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCC
Q 002121 812 DVYSFGVVMLELITAKQPIEKG 833 (964)
Q Consensus 812 Dv~S~Gvvl~elltg~~p~~~~ 833 (964)
||||.||+++-+++++.||...
T Consensus 260 Diws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeeccceeehhhccccccccC
Confidence 9999999999999999999743
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=248.88 Aligned_cols=200 Identities=25% Similarity=0.293 Sum_probs=168.7
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcC------CCCccceeEEEEee
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH------HKNLVGLVGFCFEQ 695 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~~~~~~~ 695 (964)
+..-..|.+....|+|-|++|.+|... -|+.||||++.....-. +.=..|+++|++|. ..|+++++..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 344578988999999999999999953 58899999998643221 23467999999995 35899999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFG 773 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFG 773 (964)
++.|||+|-+. .+|.+.|+.-+ ...|....+..++.|+.-||..|...+ |+|.||||.|||+++.- .+||||||
T Consensus 507 nHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 507 NHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred ceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCc
Confidence 99999999774 59999997654 456888999999999999999999988 99999999999998764 56999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
.|....+.. .+.+..+..|.|||++.+-.|+...|+||+||+||||.||+.-|.
T Consensus 583 SA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 583 SASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred ccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 998765432 233445678999999999999999999999999999999998775
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-25 Score=234.89 Aligned_cols=131 Identities=24% Similarity=0.308 Sum_probs=111.9
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-----C---CCccceeEEEEe---
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-----H---KNLVGLVGFCFE--- 694 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H---~nIv~l~~~~~~--- 694 (964)
++|.+.++||=|.|++||++.. .+.+.||+|+.+.... -.+....||++|++++ | ..||+|+++|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 6888999999999999999985 4678999999885432 2345678999999984 3 369999999975
Q ss_pred -eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 695 -QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 695 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+.+.++|+|+. |.+|..+|.......++...+.+|+.||+.||.|||..+ +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 45789999988 569999998777667999999999999999999999876 49999999999999
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.4e-27 Score=248.46 Aligned_cols=290 Identities=25% Similarity=0.344 Sum_probs=215.8
Q ss_pred eeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccC-CCCCccEEEc
Q 002121 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIG-NLAELSFLAL 144 (964)
Q Consensus 66 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~L 144 (964)
+..||..+|-+ +++|++++.+.+|..|+|..| .+. .+| +|..++.|++|++..|+|. .+|.+.. ++.+|.+|||
T Consensus 185 L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~N-ki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDL 259 (565)
T KOG0472|consen 185 LKHLDCNSNLL-ETLPPELGGLESLELLYLRRN-KIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDL 259 (565)
T ss_pred HHhcccchhhh-hcCChhhcchhhhHHHHhhhc-ccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeec
Confidence 33444444444 356666666666666666666 232 333 5666666666666666665 5555544 7788888888
Q ss_pred ccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccc--------------------
Q 002121 145 NSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS-------------------- 204 (964)
Q Consensus 145 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~-------------------- 204 (964)
.+|+++ ..|+.++-+.+|.+||+|+|.++ .+| ..++++ .|+.|-+.+|.+.
T Consensus 260 RdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp------~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs 330 (565)
T KOG0472|consen 260 RDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLP------YSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS 330 (565)
T ss_pred cccccc-cCchHHHHhhhhhhhcccCCccc-cCC------cccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH
Confidence 888888 78888888888888888888888 555 335555 5555555555543
Q ss_pred --------------------------------------------ccccccccCCCc--ceeEEEccCCcCcccCCcccCC
Q 002121 205 --------------------------------------------GTISEQLFSPDM--VLIHVLFDGNQLSGNIPESLGY 238 (964)
Q Consensus 205 --------------------------------------------g~l~~~~f~~~~--~L~~L~l~~N~l~~~~p~~~~~ 238 (964)
..+|+.+|.... -...++++.|++. .+|..+..
T Consensus 331 ~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~ 409 (565)
T KOG0472|consen 331 KIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVE 409 (565)
T ss_pred hhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHH
Confidence 044444444322 2666778888887 67766666
Q ss_pred CCCCc-EEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEE
Q 002121 239 VQTLE-VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317 (964)
Q Consensus 239 l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L 317 (964)
++.+. .+.+++|.+. .+|..++.+++|..|+|++|.+...|.+++.+..|+.||+++|.| ...|..+-.+..|+.+
T Consensus 410 lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrF--r~lP~~~y~lq~lEtl 486 (565)
T KOG0472|consen 410 LKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRF--RMLPECLYELQTLETL 486 (565)
T ss_pred HHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhhhcchhhhhhhhhheeccccccc--ccchHHHhhHHHHHHH
Confidence 65553 4556666666 899999999999999999999999999999999999999999998 6778877777778888
Q ss_pred ECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 318 ICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 318 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
-.++|++..+.|..+.++.+|..|||.+|.+. .+|..++++.+|++|+|.+|+++.
T Consensus 487 las~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 487 LASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred HhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 88889999888888999999999999999997 566789999999999999999994
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.4e-25 Score=276.07 Aligned_cols=196 Identities=20% Similarity=0.264 Sum_probs=140.1
Q ss_pred hcCC-CCccceeEEE-------EeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCee
Q 002121 679 RVHH-KNLVGLVGFC-------FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750 (964)
Q Consensus 679 ~l~H-~nIv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 750 (964)
.++| +||++++++| .+.+..+++|||+ +++|.+++... ...+++.+++.++.||++||+|||+.+ ||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG---IV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence 4456 6888888887 2334567889987 55999999754 246999999999999999999999988 99
Q ss_pred ccCCCCCcEEECC-------------------CCcEEEeecccceeecCCCC--------------CceeecccccCccc
Q 002121 751 HRDVKSTNILLDE-------------------NLTAKVADFGLSKLVSDSSK--------------GHVSTQVKGTMGYL 797 (964)
Q Consensus 751 H~Dlk~~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~ 797 (964)
||||||+||||+. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999955 44556666666653211000 00011235889999
Q ss_pred CccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHH
Q 002121 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELA 877 (964)
Q Consensus 798 aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li 877 (964)
|||++.+..++.++|||||||+||||++|..|+.........+... .+++.. .........++
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~-------------~~~~~~----~~~~~~~~~~~ 245 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR-------------VLPPQI----LLNWPKEASFC 245 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh-------------hcChhh----hhcCHHHHHHH
Confidence 9999999999999999999999999999988875322221111110 011111 01122345778
Q ss_pred HHhhhcCCCCCCCHHHHHH
Q 002121 878 LQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 878 ~~cl~~dP~~RPs~~evl~ 896 (964)
.+||+.+|.+||+|.|+++
T Consensus 246 ~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHhCCCChhhCcChHHHhh
Confidence 8999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=217.14 Aligned_cols=171 Identities=21% Similarity=0.266 Sum_probs=129.2
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|+|.++++..+ ..++|.+++.|+.|++.||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc-----
Confidence 78999997543 46999999999999999999999864 999999999999999 99998764321
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
..||+.|||||++.+..++.++|||||||++|||+||+.||.........+.......... ...+..... ..
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~ 135 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD-----DPRDRSNLE-SV 135 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC-----CccccccHH-HH
Confidence 2589999999999999999999999999999999999999965433333333222111100 000000000 01
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
.....+.+++.+||+.+|++||++.|+++.+.....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 111257899999999999999999999998876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-26 Score=239.76 Aligned_cols=340 Identities=19% Similarity=0.178 Sum_probs=217.6
Q ss_pred cEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCC
Q 002121 58 GVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLA 137 (964)
Q Consensus 58 gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 137 (964)
+.+|++..-..++-++-+++ .+|..+- ..-+.++|..| .|+...+..|+.+++|+.|||++|+|+-+-|++|.+++
T Consensus 40 pC~Cs~~~g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN-~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVEGGIVDCRGKGLT-EVPANLP--PETVEIRLDQN-QISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCCCceEEccCCCcc-cCcccCC--CcceEEEeccC-CcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 34455433344455555555 3333221 12355666667 56666666777777777777777777766677777776
Q ss_pred CccEEEccc-CcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCc
Q 002121 138 ELSFLALNS-NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDM 216 (964)
Q Consensus 138 ~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~ 216 (964)
+|..|-+.+ |+|+...-..|++|..|+.|.+.-|++. .++ ...|..|++|..|.+..|.+. .++...|..+.
T Consensus 116 ~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~-Cir-----~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~ 188 (498)
T KOG4237|consen 116 SLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHIN-CIR-----QDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLA 188 (498)
T ss_pred hhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhc-chh-----HHHHHHhhhcchhcccchhhh-hhccccccchh
Confidence 665554444 6676444456666777777777666666 333 235666666666666666666 55555555555
Q ss_pred ceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-C-CCCCCCCE-EE
Q 002121 217 VLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-L-SQMNSLSY-VD 293 (964)
Q Consensus 217 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l-~~l~~L~~-L~ 293 (964)
.++.+.+..|.+.. ..+++.|.. +....|-.+++..-..-..|.++++..+.+. + ..+..+.. +.
T Consensus 189 ~i~tlhlA~np~ic-----dCnL~wla~-------~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~ 256 (498)
T KOG4237|consen 189 AIKTLHLAQNPFIC-----DCNLPWLAD-------DLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLS 256 (498)
T ss_pred ccchHhhhcCcccc-----ccccchhhh-------HHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhc
Confidence 55555555554220 111111111 1123344455555555555666666555443 1 11222222 22
Q ss_pred ccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcce
Q 002121 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 294 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
...+.. ...+...|..|++|+.|+|++|+|+.+-+.+|.++..|++|.|..|+|..+....|.++..|++|+|++|+|+
T Consensus 257 ~~d~~d-~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it 335 (498)
T KOG4237|consen 257 SEDFPD-SICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQIT 335 (498)
T ss_pred cccCcC-CcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeE
Confidence 223333 2445567889999999999999999999999999999999999999999998899999999999999999999
Q ss_pred eeccCCCcc---cceeEeecCC-cccccccccCccccCCCCCcccccccccCCCCCC
Q 002121 374 AITLGSGIK---NYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGKSC 426 (964)
Q Consensus 374 ~i~~~~~~~---l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~~ 426 (964)
.+..+.+.. +.+|.|.+|| .|+|.+.++..|..... ++..+.|.+|..
T Consensus 336 ~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~-----~~~~~~Cq~p~~ 387 (498)
T KOG4237|consen 336 TVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS-----VVGNPRCQSPGF 387 (498)
T ss_pred EEecccccccceeeeeehccCcccCccchHHHHHHHhhCC-----CCCCCCCCCCch
Confidence 998776655 5678899999 89999999999954433 456677777753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=232.46 Aligned_cols=166 Identities=20% Similarity=0.195 Sum_probs=130.5
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec--CCcEEEEEEecCCC-----cchhHHHHHHHHHHHhcCCCCccceeEEEEeeC
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS--DGQVVAIKRAQQGS-----MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG 696 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 696 (964)
...++|...+.||+|+||+||+|+.. +++.||||++.... ......+.+|+++|++++|+|+++.+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34568999999999999999999864 57888999875331 1234568999999999999999963322 25
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCC-CCCcEEECCCCcEEEeecccc
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDV-KSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DFGla 775 (964)
..++||||+++++|... .... ...++.++++||+|||+.+ |+|||| ||+|||++.++.+||+|||+|
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~~~--------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RPHG--------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cccc--------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 68999999999999732 1111 1467889999999999988 999999 999999999999999999999
Q ss_pred eeecCCCCCce------eecccccCcccCcccccc
Q 002121 776 KLVSDSSKGHV------STQVKGTMGYLDPEYYMT 804 (964)
Q Consensus 776 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 804 (964)
+.......... .+...+++.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 97765432111 135678899999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=213.27 Aligned_cols=246 Identities=23% Similarity=0.406 Sum_probs=187.5
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
.+|.+...|..|+|+|. |..+++|++...... ..+.|.+|.-.|+-..||||++++|.|.......++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 45888999999999995 667778877654333 235799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecc
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 790 (964)
+..+|...+...+-.+..++|.+||+|++|||+.. +-|----+.+..|++|++.+++|+= +-+++. ......
T Consensus 275 ynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarism-ad~kfs------fqe~gr 346 (448)
T KOG0195|consen 275 YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISM-ADTKFS------FQEVGR 346 (448)
T ss_pred HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheec-ccceee------eecccc
Confidence 99999988888899999999999999999999964 3333446899999999999988751 111111 111122
Q ss_pred cccCcccCccccccCCCC---CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhH
Q 002121 791 KGTMGYLDPEYYMTQQLT---EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867 (964)
Q Consensus 791 ~gt~~y~aPE~~~~~~~~---~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 867 (964)
.-.+.||+||.+...+-+ .++|+|||++++|||.|...||.+-....--++.+++. +.-.+.|.+
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeg-------lrv~ippgi----- 414 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEG-------LRVHIPPGI----- 414 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcc-------ccccCCCCc-----
Confidence 346889999999876544 57999999999999999999996432211111111111 111222222
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 868 LGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 868 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
...+.+++.-|+..||.+||.+..|+-.|+++
T Consensus 415 --s~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 415 --SRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --cHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 24566899999999999999999999888765
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=241.47 Aligned_cols=267 Identities=24% Similarity=0.270 Sum_probs=204.7
Q ss_pred EecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCc
Q 002121 60 TCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAEL 139 (964)
Q Consensus 60 ~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L 139 (964)
.|-...-..|+|+.++|+ .+|+.+. ++|+.|+|++| .++. +|.. +++|++|+|++|+|+ .+|.. .++|
T Consensus 197 ~Cl~~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N-~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL 264 (788)
T PRK15387 197 ACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDN-NLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGL 264 (788)
T ss_pred HHhcCCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCC-cCCC-CCCC---CCCCcEEEecCCccC-cccCc---cccc
Confidence 455556678999999998 7888776 48999999999 5664 5542 578999999999999 56753 4689
Q ss_pred cEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCccee
Q 002121 140 SFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLI 219 (964)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~ 219 (964)
+.|+|++|.|+ .+|..+ .+|+.|+|++|+++ .+|. .+++|+.|+|++|+++ .+|. ....|.
T Consensus 265 ~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~---------~p~~L~~LdLS~N~L~-~Lp~----lp~~L~ 325 (788)
T PRK15387 265 LELSIFSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPV---------LPPGLQELSVSDNQLA-SLPA----LPSELC 325 (788)
T ss_pred ceeeccCCchh-hhhhch---hhcCEEECcCCccc-cccc---------cccccceeECCCCccc-cCCC----Cccccc
Confidence 99999999998 555533 56888999999998 5662 2478999999999998 4654 234688
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSF 299 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 299 (964)
.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|.. ..+|+.|++++|+|+.++.. ..+|+.|+|++|+|
T Consensus 326 ~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~LP~l---~~~L~~LdLs~N~L 394 (788)
T PRK15387 326 KLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRL 394 (788)
T ss_pred ccccccCcccc-cccc---ccccceEecCCCccC-CCCCC---CcccceehhhccccccCccc---ccccceEEecCCcc
Confidence 89999999985 5542 257999999999999 45653 35788889999999875542 35789999999999
Q ss_pred CCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC
Q 002121 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG 378 (964)
Q Consensus 300 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 378 (964)
+ .+|.. .++|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+...+.
T Consensus 395 t--~LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 395 T--SLPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred c--CCCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 6 34432 3678899999999885 5543 346788999999987 4577788888999999999998865433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-21 Score=215.24 Aligned_cols=262 Identities=19% Similarity=0.285 Sum_probs=197.5
Q ss_pred CCCccceeecCCcEEEEEEEecCC--cEEEEEEecCCCcchhHHHHHHHHHHHhcCC----CCccceeEEE-EeeCceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDG--QVVAIKRAQQGSMQGGLEFKTEIELLSRVHH----KNLVGLVGFC-FEQGEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 700 (964)
+|.+.+.||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999996543 4788888766544333378899999999873 5888999888 47778899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-----CcEEEeecccc
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-----LTAKVADFGLS 775 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-----~~~kl~DFGla 775 (964)
||+.+ |.+|.++........++..+...|+.|++.+|.++|+.| ++||||||.|+++... ..++|.|||+|
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99977 669999886555567999999999999999999999999 9999999999999755 46999999999
Q ss_pred e--eecCCCCC----c-e-eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhc
Q 002121 776 K--LVSDSSKG----H-V-STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMN 845 (964)
Q Consensus 776 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~ 845 (964)
+ ........ . . .....||..|.+++...+...+.+.|+||++.++.|++.|..||...... ...+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8 33222111 0 1 22356999999999999999999999999999999999999999643321 222221111
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
... ... .....+ ..+.++...+-..+..++|....+...++......+
T Consensus 255 ~~~---------~~~-~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 255 KLL---------TDR-FGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred hhc---------ccc-ccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 111 000 111111 233445555555899999999999999988876653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-24 Score=225.10 Aligned_cols=324 Identities=21% Similarity=0.221 Sum_probs=253.9
Q ss_pred CCCC-CCC---ccEEecC-----------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCccc
Q 002121 50 DDPC-GSW---EGVTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQK 114 (964)
Q Consensus 50 ~~~C-~~w---~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~ 114 (964)
+.+| |+= .-|.|+. ...+.|+|..|+|+.+-+.+|+.+++|+.|||++| .|..+-|.+|..|.+
T Consensus 38 P~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N-~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 38 PAPCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKN-NISFIAPDAFKGLAS 116 (498)
T ss_pred CCCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceeccccc-chhhcChHhhhhhHh
Confidence 4556 443 3489974 36788999999999777789999999999999999 899999999999999
Q ss_pred chhhcccc-ccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCC
Q 002121 115 LNILILAG-CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA 193 (964)
Q Consensus 115 L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L 193 (964)
|..|-+.+ |+|+..--+.|++|..|+.|.+.-|++.-...+.|..|++|..|.+.+|.+. .++ ...+..+..+
T Consensus 117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~-----~~tf~~l~~i 190 (498)
T KOG4237|consen 117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SIC-----KGTFQGLAAI 190 (498)
T ss_pred hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhc-----cccccchhcc
Confidence 99987776 9999555568999999999999999999888889999999999999999998 454 3478899999
Q ss_pred CeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCC-CCCCeeecc
Q 002121 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL-TNVNELNLA 272 (964)
Q Consensus 194 ~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls 272 (964)
+.+++..|.+-. .-+|..+- .+.-..|..++.+.......|.++++...-+..|... ..+..=..+
T Consensus 191 ~tlhlA~np~ic---------dCnL~wla----~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~ 257 (498)
T KOG4237|consen 191 KTLHLAQNPFIC---------DCNLPWLA----DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSS 257 (498)
T ss_pred chHhhhcCcccc---------ccccchhh----hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhcc
Confidence 999999998531 11222210 0111233445666666667777777775555555432 222222223
Q ss_pred CccCccCCCC--CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccc
Q 002121 273 HNDLKGPFPD--LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 273 ~N~l~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
.....++-|. |.++++|++|+|++|+|+ .+.+.+|.++..|++|.|..|+|..+....|.++..|+.|+|.+|+|+.
T Consensus 258 ~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~-~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~ 336 (498)
T KOG4237|consen 258 EDFPDSICPAKCFKKLPNLRKLNLSNNKIT-RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITT 336 (498)
T ss_pred ccCcCCcChHHHHhhcccceEeccCCCccc-hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEE
Confidence 3334445553 899999999999999998 7888999999999999999999999999999999999999999999999
Q ss_pred ccCCCCccCCCCcEEeccCCcceee----ccCCCcccceeEeecCCcccc
Q 002121 351 TLDMGNAVGPLLQLVDLQNNQISAI----TLGSGIKNYTLILVGNPVCTA 396 (964)
Q Consensus 351 ~~~~~~~~l~~L~~L~L~~N~l~~i----~~~~~~~l~~l~l~~Np~c~~ 396 (964)
..|..|..+..|.+|+|-.|++.+= ..+.|..... ..|||-|-.
T Consensus 337 ~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~--~~~~~~Cq~ 384 (498)
T KOG4237|consen 337 VAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS--VVGNPRCQS 384 (498)
T ss_pred EecccccccceeeeeehccCcccCccchHHHHHHHhhCC--CCCCCCCCC
Confidence 9999999999999999999999863 2344444444 678887753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-21 Score=198.09 Aligned_cols=261 Identities=18% Similarity=0.273 Sum_probs=198.7
Q ss_pred CCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEec
Q 002121 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+|.+.++||+|.||.++.|. +-+++.||||.-...+ ..-+++.|.+.++.|. .+.|...+.+..++.+-.||||..
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 78889999999999999998 5579999999754322 2246888999999884 789999998888888899999988
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-----CCcEEEeecccceeecC
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSKLVSD 780 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGla~~~~~ 780 (964)
|-||++++.-++ ..++..++..||.|+..-++|+|++. +|+|||||+|+||.. ...+.++|||+|+.+.+
T Consensus 107 -GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD 181 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD 181 (449)
T ss_pred -CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence 569999887664 57999999999999999999999988 999999999999964 34689999999998876
Q ss_pred CCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--chhHHHHHHHhccCcccccc
Q 002121 781 SSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 781 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~ 853 (964)
.... .......||.+||+-....+.+.+.+-|.-|+|-|+.+.|-|..||+.- ....+.+..+-+.... ..
T Consensus 182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~--T~ 259 (449)
T KOG1165|consen 182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS--TP 259 (449)
T ss_pred ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc--CC
Confidence 5432 2234567999999999999999999999999999999999999999842 2333333332211110 00
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+. .+-...+.++..+++.+ -..+-++-|..+-+...+..++...
T Consensus 260 i~-----~Lc~g~P~efa~Yl~yv---R~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 260 IE-----VLCEGFPEEFATYLRYV---RRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred HH-----HHHhcCHHHHHHHHHHH---HhcCcccCCCHHHHHHHHHHHHHhc
Confidence 11 11112333444444444 3456778899988888777777643
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-24 Score=245.23 Aligned_cols=332 Identities=26% Similarity=0.331 Sum_probs=212.5
Q ss_pred CeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEc
Q 002121 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLAL 144 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 144 (964)
++..||+++|.+. ..|..+..+.+|+.|+++.| ....+|.+.+++.+|++|.|.+|.+. .+|.++..+++|++||+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n--~i~~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~Ldl 121 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRN--YIRSVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDL 121 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchh--hHhhCchhhhhhhcchhheeccchhh-cCchhHHhhhccccccc
Confidence 3788999998886 78888999999999999998 35577889999999999999999988 89999999999999999
Q ss_pred ccCcccCcCCCcCCCcccccccccccc-------------------ccccccCcccCC-------------CCccccccC
Q 002121 145 NSNNFSGRIPPSLGKLSQLYWLDLADN-------------------QLTGSIPVSTIT-------------SPGLDQLKN 192 (964)
Q Consensus 145 s~N~l~~~~p~~~~~l~~L~~L~Ls~N-------------------~l~g~iP~~~~~-------------~~~l~~l~~ 192 (964)
|.|++. .+|.-+..++.++.+..++| .+.+.++..... ...+..+.+
T Consensus 122 S~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~~ldLr~N~~~~~dls~~~~ 200 (1081)
T KOG0618|consen 122 SFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTHQLDLRYNEMEVLDLSNLAN 200 (1081)
T ss_pred chhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhheeeecccchhhhhhhhhccc
Confidence 999998 67766666655555555555 222222211000 011223333
Q ss_pred CCeeEccCCcccccc-----------------cccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccc
Q 002121 193 AKHFHFNKNKLSGTI-----------------SEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK 255 (964)
Q Consensus 193 L~~L~L~~N~l~g~l-----------------~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 255 (964)
|+.|+...|++..-. .........+|+++++++|++++ +|++++.+.+|+.|+..+|.|+ .
T Consensus 201 l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~ 278 (1081)
T KOG0618|consen 201 LEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-A 278 (1081)
T ss_pred hhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-h
Confidence 333333333332000 00011223467888888888884 5588888888888888888775 5
Q ss_pred cCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCC-----------------------------------
Q 002121 256 VPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD----------------------------------- 300 (964)
Q Consensus 256 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~----------------------------------- 300 (964)
+|..+...++|+.|.+..|.+..+++.+.+++.|++|||..|+|.
T Consensus 279 lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~ 358 (1081)
T KOG0618|consen 279 LPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNH 358 (1081)
T ss_pred hHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhh
Confidence 555554444444444444444444444444444444444444442
Q ss_pred --------------CCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccC-------------
Q 002121 301 --------------PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD------------- 353 (964)
Q Consensus 301 --------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~------------- 353 (964)
....| .+-++++|+.|+|++|+|.......+.+++.|+.|+||+|+++.+..
T Consensus 359 ~~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~a 437 (1081)
T KOG0618|consen 359 AALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRA 437 (1081)
T ss_pred HHHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhh
Confidence 11111 13455566666666666665555556666666666666666654321
Q ss_pred --------CCCccCCCCcEEeccCCcceeeccC---CCcccceeEeecCCcccccccccCcc
Q 002121 354 --------MGNAVGPLLQLVDLQNNQISAITLG---SGIKNYTLILVGNPVCTATLANTNYC 404 (964)
Q Consensus 354 --------~~~~~l~~L~~L~L~~N~l~~i~~~---~~~~l~~l~l~~Np~c~~~l~~~~~~ 404 (964)
..+..++.|+.+||+.|+|+.+... ++.+++.|+|+||+.-.-...++..|
T Consensus 438 hsN~l~~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~l 499 (1081)
T KOG0618|consen 438 HSNQLLSFPELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKVL 499 (1081)
T ss_pred cCCceeechhhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHHh
Confidence 1677889999999999999987643 33668899999999644444444443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-20 Score=208.69 Aligned_cols=259 Identities=28% Similarity=0.418 Sum_probs=197.6
Q ss_pred CCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCC-CccceeEEEEeeCceEEEEEe
Q 002121 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHK-NLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~E~ 704 (964)
|...+.||.|+||.||++... ..+|+|.+...... ....+.+|+.+++.+.|+ +|+++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566788999999999999986 78999988765443 356799999999999988 799999999777778999999
Q ss_pred ccCCChhhhhcCCCC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSG-IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~ 782 (964)
+.++++.+++..... ..+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765421 25888999999999999999999988 99999999999999998 79999999998655433
Q ss_pred CCc----eeecccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccc
Q 002121 783 KGH----VSTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 783 ~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 853 (964)
... ......||..|+|||.+.. ..+....|+||+|++++++++|..|+..... ........+...... .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 234 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP--S 234 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--c
Confidence 211 2355679999999999987 5788999999999999999999999764432 112222221111100 0
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.......... ......+.+++..|+..+|..|.++.+....
T Consensus 235 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNP---ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCcccc---chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000000 1122456688999999999999999887754
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=191.41 Aligned_cols=261 Identities=19% Similarity=0.269 Sum_probs=196.3
Q ss_pred hcCCCccceeecCCcEEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCC-CCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH-KNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E 703 (964)
.+.|...++||+|+||.+|.|. ..+|+.||||+-...... .++..|..+.+.++| ..|..+..|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4679999999999999999999 678999999987654332 367789999999975 567778888888899999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecccceeecC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~~ 780 (964)
.. |-||++++.-++ ..++..+++..|-|+..-++|+|.++ +|||||||+|+|.. ....+.++|||+|+...+
T Consensus 92 LL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d 166 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD 166 (341)
T ss_pred cc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhcc
Confidence 87 569999887654 46999999999999999999999998 99999999999995 445789999999987654
Q ss_pred CCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccc
Q 002121 781 SSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 781 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 853 (964)
.... .......||.+|.+-....+...+.+.|+-|+|.+|.++.-|..||+.-.. -.+-+..+.+..
T Consensus 167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK------ 240 (341)
T KOG1163|consen 167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK------ 240 (341)
T ss_pred ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh------
Confidence 3221 223456799999988777777778899999999999999999999974221 112122111111
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
+...+.........++...+..|-..--++-|...-+-+.+.-+..
T Consensus 241 ----~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 241 ----MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred ----cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 1111111111222455667778888888888888777666655544
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=229.59 Aligned_cols=262 Identities=23% Similarity=0.257 Sum_probs=207.0
Q ss_pred cccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccc
Q 002121 89 ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDL 168 (964)
Q Consensus 89 ~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 168 (964)
.-..|+|+.| .+. .+|+.+.. +|+.|+|.+|+|+ .+|.. +++|++|+|++|+|+ .+|.. .++|+.|+|
T Consensus 202 ~~~~LdLs~~-~Lt-sLP~~l~~--~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGES-GLT-TLPDCLPA--HITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCC-CCC-cCCcchhc--CCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 3567999999 676 68887764 8999999999999 57753 589999999999999 55653 368999999
Q ss_pred cccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 002121 169 ADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248 (964)
Q Consensus 169 s~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 248 (964)
++|+++ .+|. .+++|+.|++++|+++ .+|. ..++|+.|++++|+|++ +|.. ..+|+.|+++
T Consensus 270 s~N~L~-~Lp~---------lp~~L~~L~Ls~N~Lt-~LP~----~p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls 330 (788)
T PRK15387 270 FSNPLT-HLPA---------LPSGLCKLWIFGNQLT-SLPV----LPPGLQELSVSDNQLAS-LPAL---PSELCKLWAY 330 (788)
T ss_pred cCCchh-hhhh---------chhhcCEEECcCCccc-cccc----cccccceeECCCCcccc-CCCC---cccccccccc
Confidence 999998 5652 2367889999999998 6665 34689999999999996 4542 3568899999
Q ss_pred cCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccccc
Q 002121 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRV 328 (964)
Q Consensus 249 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 328 (964)
+|+|+ .+|.. ..+|+.|+|++|+|+++++. ..+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|++ +
T Consensus 331 ~N~L~-~LP~l---p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~--~LP~l---~~~L~~LdLs~N~Lt~-L 397 (788)
T PRK15387 331 NNQLT-SLPTL---PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT--SLPAL---PSGLKELIVSGNRLTS-L 397 (788)
T ss_pred cCccc-ccccc---ccccceEecCCCccCCCCCC---Ccccceehhhccccc--cCccc---ccccceEEecCCcccC-C
Confidence 99999 46642 25899999999999987653 357889999999996 35543 3679999999999995 5
Q ss_pred ChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC--CCcccceeEeecCCccccccccc
Q 002121 329 PDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG--SGIKNYTLILVGNPVCTATLANT 401 (964)
Q Consensus 329 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~--~~~~l~~l~l~~Np~c~~~l~~~ 401 (964)
|.. .++|+.|+|++|+|+.+ |.. ...|+.|+|++|+|+.+|.. ....+..|+|++||++...+..+
T Consensus 398 P~l---~s~L~~LdLS~N~LssI-P~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 398 PVL---PSELKELMVSGNRLTSL-PML---PSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred CCc---ccCCCEEEccCCcCCCC-Ccc---hhhhhhhhhccCcccccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 543 36899999999999864 432 35689999999999999753 45568889999999876554433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=228.35 Aligned_cols=338 Identities=20% Similarity=0.268 Sum_probs=234.7
Q ss_pred ccCCCHHHHHHHHHHHHHcCCCC------CCCCCCCCCCCCC---------------ccEEecCCCeeEEEcCCCCcccc
Q 002121 21 SSATDSRDAAALQSLKDAWQNTP------PTWKNSDDPCGSW---------------EGVTCNNSRVTALGLSTMGLTGK 79 (964)
Q Consensus 21 ~~~~~~~~~~aL~~~k~~~~~~~------~~W~~~~~~C~~w---------------~gv~C~~~~v~~L~L~~~~l~g~ 79 (964)
+..+.+.+...+..+.+.+..++ ..|...+++|-.= ..|.|....||.+..-+......
T Consensus 57 ~~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~~~vt~l~~~g~~~~~~ 136 (754)
T PRK15370 57 PETASPEEIKSKFECLRMLAFPAYADNIQYSRGGADQYCILSENSQEILSIVFNTEGYTVEGGGKSVTYTRVTESEQASS 136 (754)
T ss_pred CCCCCHHHHHHHHHHHHHhcCCchhhccccccCCCCcccccCCcchhhheeeecCCceEEecCCCccccccccccccccc
Confidence 45567788999988888885544 4599999999311 14899998999888777433322
Q ss_pred ccCCcCCCCcccEEec----ccCCCCCCC----------CCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcc
Q 002121 80 LSGDIGGLTELRSLDL----SYNGGLTGS----------LSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145 (964)
Q Consensus 80 ~~~~l~~l~~L~~L~L----~~N~~l~~~----------~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 145 (964)
..+. -+.-.+... ..+ .-.+. +...+ ..+...|+|+++.++ .+|..+. ++|+.|+|+
T Consensus 137 ~~~~---~~~~~~~~~w~~w~~~-~~~~~~~~r~~a~~r~~~Cl--~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls 207 (754)
T PRK15370 137 ASGS---KDAVNYELIWSEWVKE-APAKEAANREEAVQRMRDCL--KNNKTELRLKILGLT-TIPACIP--EQITTLILD 207 (754)
T ss_pred CCCC---CChhhHHHHHHHHHhc-CCCCccccHHHHHHHHHhhc--ccCceEEEeCCCCcC-cCCcccc--cCCcEEEec
Confidence 1110 000000000 001 00000 01111 235678888888888 6777663 578999999
Q ss_pred cCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccC
Q 002121 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDG 225 (964)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~ 225 (964)
+|+|+ .+|..+. ++|++|+|++|+|+ .+|.. + ..+|+.|+|++|++. .+|..+. .+|+.|++++
T Consensus 208 ~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~------l--~~~L~~L~Ls~N~L~-~LP~~l~---s~L~~L~Ls~ 271 (754)
T PRK15370 208 NNELK-SLPENLQ--GNIKTLYANSNQLT-SIPAT------L--PDTIQEMELSINRIT-ELPERLP---SALQSLDLFH 271 (754)
T ss_pred CCCCC-cCChhhc--cCCCEEECCCCccc-cCChh------h--hccccEEECcCCccC-cCChhHh---CCCCEEECcC
Confidence 99998 5666554 58999999999988 66732 1 247889999999988 7777654 4788999999
Q ss_pred CcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCC
Q 002121 226 NQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAP 305 (964)
Q Consensus 226 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~ 305 (964)
|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|.++.++..+. ++|+.|++++|.++ .+|
T Consensus 272 N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt--~LP 341 (754)
T PRK15370 272 NKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALT--SLP 341 (754)
T ss_pred CccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCcccc--ccceeccccCCccc--cCC
Confidence 9998 4676554 58999999999998 4665543 478999999999997665443 68999999999996 355
Q ss_pred cccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC------C
Q 002121 306 LWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG------S 379 (964)
Q Consensus 306 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~------~ 379 (964)
..+. ++|+.|+|++|+|+ .+|..+ .++|+.|+|++|+|+..++ .+. ..|+.|++++|+|+.+|.. .
T Consensus 342 ~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~LP~-~l~--~sL~~LdLs~N~L~~LP~sl~~~~~~ 413 (754)
T PRK15370 342 ASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTNLPE-NLP--AALQIMQASRNNLVRLPESLPHFRGE 413 (754)
T ss_pred hhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCCCCH-hHH--HHHHHHhhccCCcccCchhHHHHhhc
Confidence 5443 68999999999998 466655 3689999999999986544 332 3689999999999988642 1
Q ss_pred CcccceeEeecCCccccccccc
Q 002121 380 GIKNYTLILVGNPVCTATLANT 401 (964)
Q Consensus 380 ~~~l~~l~l~~Np~c~~~l~~~ 401 (964)
...+..|+|.+||+....++.+
T Consensus 414 ~~~l~~L~L~~Npls~~tl~~L 435 (754)
T PRK15370 414 GPQPTRIIVEYNPFSERTIQNM 435 (754)
T ss_pred CCCccEEEeeCCCccHHHHHHH
Confidence 2345778999999765444443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-22 Score=234.09 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=187.4
Q ss_pred ccceeecCCcEEEEEEEe-cCCcEEEEEEecCC--Ccch----hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 631 ESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG--SMQG----GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~--~~~~----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
..+.+|.|++|.|+.+.. ...+..+.|.+... .... ...+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 457899999998887763 33444555543311 1111 1125668888888999999988888887777777799
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||++ +|...+.... .+...++..+..|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+....-+..
T Consensus 402 ~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred cccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 9999 9999987652 5788889999999999999999999 99999999999999999999999999987655444
Q ss_pred C--ceeecccccCcccCccccccCCCCC-chhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 G--HVSTQVKGTMGYLDPEYYMTQQLTE-KSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~--~~~~~~~gt~~y~aPE~~~~~~~~~-~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. ......+|+-.|+|||++....|++ ..||||.|+++..|.+|+.||.................+ .....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~-------~~~~~ 548 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQ-------RNIFE 548 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccc-------ccccc
Confidence 3 4556788999999999999999985 689999999999999999999633221111100000000 00011
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...........+...++.++++.+|.+|.|+++|++.
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 1111122233455689999999999999999999863
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-23 Score=240.15 Aligned_cols=298 Identities=26% Similarity=0.309 Sum_probs=211.3
Q ss_pred CeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcc-------------------------------
Q 002121 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQ------------------------------- 113 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~------------------------------- 113 (964)
.++.++|..+.+.+.++.++.++++ .|||++| .+.. -.+.++.
T Consensus 157 ~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N-~~~~---~dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~ 230 (1081)
T KOG0618|consen 157 SIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYN-EMEV---LDLSNLANLEVLHCERNQLSELEISGPSLTALYADHNP 230 (1081)
T ss_pred cchhhhhhhhhcccchhcchhhhhe--eeecccc-hhhh---hhhhhccchhhhhhhhcccceEEecCcchheeeeccCc
Confidence 3566667777777666666666666 6666666 3331 1222222
Q ss_pred -----------cchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccC
Q 002121 114 -----------KLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTI 182 (964)
Q Consensus 114 -----------~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~ 182 (964)
+|+++++++|+++ .+|.+++.+.+|+.|+..+|+|+ .+|..+..+++|+.|++.+|+++ .+|
T Consensus 231 l~~~~~~p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip---- 303 (1081)
T KOG0618|consen 231 LTTLDVHPVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIP---- 303 (1081)
T ss_pred ceeeccccccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCC----
Confidence 3444555555554 34455555555555555555554 44555555555555555555555 444
Q ss_pred CCCccccccCCCeeEccCCcccccccccccCCCcc-eeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCcccc
Q 002121 183 TSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMV-LIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLN 261 (964)
Q Consensus 183 ~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~-L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 261 (964)
+.+..++.|+.|+|..|+|. .+|+..|..... |..|..+.|.+....-..=..++.|+.|++.+|.|+...-..|.
T Consensus 304 --~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~ 380 (1081)
T KOG0618|consen 304 --PFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLV 380 (1081)
T ss_pred --Ccccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhc
Confidence 34556777788888888876 677766655544 67777777777643322223456789999999999988888899
Q ss_pred CCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCE
Q 002121 262 NLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQ 340 (964)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 340 (964)
++.+|+.|+|++|+|...+.. +.++..|+.|+||+|++ ..+|..+.+++.|+.|...+|+|. ..| .+..++.|+.
T Consensus 381 ~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL--~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~ 456 (1081)
T KOG0618|consen 381 NFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKL--TTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKV 456 (1081)
T ss_pred cccceeeeeecccccccCCHHHHhchHHhHHHhcccchh--hhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceE
Confidence 999999999999999987775 89999999999999999 677788999999999999999998 566 8999999999
Q ss_pred EEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcc
Q 002121 341 VKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK 382 (964)
Q Consensus 341 L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 382 (964)
+||+.|+|+...-......++|++|||++|....++...+..
T Consensus 457 lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~ 498 (1081)
T KOG0618|consen 457 LDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKV 498 (1081)
T ss_pred EecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHH
Confidence 999999998776655555699999999999987766554443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=192.23 Aligned_cols=139 Identities=18% Similarity=0.221 Sum_probs=109.8
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--h-------hHHH-----------------HHHHHHHHhcCCCCc
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--G-------GLEF-----------------KTEIELLSRVHHKNL 685 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~-------~~~~-----------------~~E~~~l~~l~H~nI 685 (964)
...||+|+||.||+|...+|+.||||+++..... . ...| ..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999878999999998754221 1 1122 349999999998887
Q ss_pred cceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHH-hhcCCCCeeccCCCCCcEEECCC
Q 002121 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL-HELANPPIIHRDVKSTNILLDEN 764 (964)
Q Consensus 686 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk~~NILl~~~ 764 (964)
.....+. ....++||||++++++....... ..+++.+...++.|++.+|+|+ |+.+ |+||||||+|||++ +
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-C
Confidence 5544332 23348999999998776543222 3588999999999999999999 6777 99999999999998 4
Q ss_pred CcEEEeecccceee
Q 002121 765 LTAKVADFGLSKLV 778 (964)
Q Consensus 765 ~~~kl~DFGla~~~ 778 (964)
+.++|+|||+|...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.5e-21 Score=195.87 Aligned_cols=171 Identities=13% Similarity=0.131 Sum_probs=135.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhH---------HHHHHHHHHHhcCCCCccceeEEEEee
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL---------EFKTEIELLSRVHHKNLVGLVGFCFEQ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~---------~~~~E~~~l~~l~H~nIv~l~~~~~~~ 695 (964)
..++|+..+.+|.|+||.||.+.. ++..+|||.+......... .+.+|+..+.++.|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 468999999999999999999766 5778999999754433322 268999999999999999999886643
Q ss_pred --------CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 696 --------GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 696 --------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
+..+|||||++|.+|.++.. ++. ....+++.++..+|+.+ ++|||+||+||+++.++ +
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 35789999999999988732 222 24568999999999988 99999999999999988 9
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHH
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELI 824 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ell 824 (964)
+|+|||..+....... . ..+.....+..++|+|+|||.+..+.
T Consensus 174 ~liDfg~~~~~~e~~a---~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKA---K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhh---H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999998865432110 0 11445556778999999999877654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=235.48 Aligned_cols=305 Identities=17% Similarity=0.173 Sum_probs=204.9
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
..++.|++.++.+. .+|..+ .+.+|+.|+|++| .+. .++..+..+++|+.|+|++|.....+|. +..+++|++|+
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s-~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~ 663 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGS-KLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLK 663 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCc-ccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEE
Confidence 46788888888775 667666 5688889999888 444 5677788888899999988765557774 77888899999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|.....+|..+.++++|+.|++++|...+.+|.. + ++++|+.|+|++|...+.+|. ...+|+.|++
T Consensus 664 L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~------i-~l~sL~~L~Lsgc~~L~~~p~----~~~nL~~L~L 732 (1153)
T PLN03210 664 LSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG------I-NLKSLYRLNLSGCSRLKSFPD----ISTNISWLDL 732 (1153)
T ss_pred ecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc------C-CCCCCCEEeCCCCCCcccccc----ccCCcCeeec
Confidence 9888766688888888889999999887555567732 2 678888888888866555553 2457888888
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCc-------cccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEcc
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALT-------GKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLS 295 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls 295 (964)
++|.++ .+|..+ .+++|+.|++.++... ...+..+...++|+.|+|++|...+..| .+.++++|+.|+|+
T Consensus 733 ~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls 810 (1153)
T PLN03210 733 DETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIE 810 (1153)
T ss_pred CCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECC
Confidence 888876 456544 4667777776653321 1122223334567777777775544444 46777777777777
Q ss_pred CCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccC-Cccee
Q 002121 296 NNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQN-NQISA 374 (964)
Q Consensus 296 ~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~ 374 (964)
+|... ..+|..+ ++++|+.|+|++|.....+|.. .++|+.|+|++|.++. +|..+..+++|+.|+|++ |+|..
T Consensus 811 ~C~~L-~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~~-iP~si~~l~~L~~L~L~~C~~L~~ 884 (1153)
T PLN03210 811 NCINL-ETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIEE-VPWWIEKFSNLSFLDMNGCNNLQR 884 (1153)
T ss_pred CCCCc-CeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCcc-ChHHHhcCCCCCEEECCCCCCcCc
Confidence 76432 3344433 5677777777776654444442 3567777777777763 455666777777777776 56666
Q ss_pred eccC--CCcccceeEeecCC
Q 002121 375 ITLG--SGIKNYTLILVGNP 392 (964)
Q Consensus 375 i~~~--~~~~l~~l~l~~Np 392 (964)
++.. ....+..+++.+++
T Consensus 885 l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 885 VSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCcccccccCCCeeecCCCc
Confidence 6542 23335555565544
|
syringae 6; Provisional |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.9e-21 Score=226.79 Aligned_cols=248 Identities=21% Similarity=0.265 Sum_probs=181.4
Q ss_pred CCCccceeecCCcEEEEEEEecCCcEEEEEEecCCC-cchhHHHHHHHHH--HHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGS-MQGGLEFKTEIEL--LSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+|...+.+|++.|=+|.+|+.++|. |+||++-+.. .-....|.++++- ...++|||.+++.-+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999999887 9999986544 2233445544443 4445899999998887777888999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee--cCC-
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV--SDS- 781 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~--~~~- 781 (964)
+.+ +|++.+..+. .+...+...||.|++.||..+|..+ |.|||||.+|||++.-.-+.|+||.--+.. +.+
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 977 9999998764 6888899999999999999999998 999999999999999999999999765432 211
Q ss_pred --CCCceeecccccCcccCccccccC-----------CCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccC
Q 002121 782 --SKGHVSTQVKGTMGYLDPEYYMTQ-----------QLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 782 --~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~ 847 (964)
+.......-..-..|+|||-+... ..+++-||||.||++.||++ |+++|.-. +.....-...
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~aYr~~~~ 252 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLAYRSGNA 252 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHhHhccCc
Confidence 122223333455689999987431 15678999999999999998 56666411 1111000001
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
......+.++-|. .+.+++..|++.||++|-++++.++.
T Consensus 253 ~~~e~~Le~Ied~-----------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQLLEKIEDV-----------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHHHHHhCcCc-----------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 1001111222222 34589999999999999999999876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=231.33 Aligned_cols=306 Identities=18% Similarity=0.176 Sum_probs=241.4
Q ss_pred CCeeEEEcCCC------CccccccCCcCCCC-cccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCC
Q 002121 64 SRVTALGLSTM------GLTGKLSGDIGGLT-ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNL 136 (964)
Q Consensus 64 ~~v~~L~L~~~------~l~g~~~~~l~~l~-~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 136 (964)
.++..|.+..+ .+...+|..+..++ +|+.|++.+|. ...+|..| ...+|+.|+|.+|++. .+|..+..+
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~--l~~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l 633 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYP--LRCMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSL 633 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCC--CCCCCCcC-CccCCcEEECcCcccc-ccccccccC
Confidence 46777777554 34456787787774 59999999883 46777777 5789999999999998 788889999
Q ss_pred CCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCc
Q 002121 137 AELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDM 216 (964)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~ 216 (964)
++|+.|+|++|.....+| .++.+++|++|+|++|.....+| ..+..+++|+.|++++|..-+.+|... .+.
T Consensus 634 ~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp------~si~~L~~L~~L~L~~c~~L~~Lp~~i--~l~ 704 (1153)
T PLN03210 634 TGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELP------SSIQYLNKLEDLDMSRCENLEILPTGI--NLK 704 (1153)
T ss_pred CCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccc------hhhhccCCCCEEeCCCCCCcCccCCcC--CCC
Confidence 999999999887555776 48889999999999987666788 457889999999999976555888765 578
Q ss_pred ceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccC-------CCC-CCCCCC
Q 002121 217 VLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGP-------FPD-LSQMNS 288 (964)
Q Consensus 217 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-------~~~-l~~l~~ 288 (964)
+|+.|++++|...+.+|.. ..+|+.|+|++|.++ .+|..+ .+++|++|++.++..... .+. ....++
T Consensus 705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s 779 (1153)
T PLN03210 705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS 779 (1153)
T ss_pred CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence 8999999999776666653 468999999999998 677665 588899998887543221 111 233578
Q ss_pred CCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEecc
Q 002121 289 LSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQ 368 (964)
Q Consensus 289 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 368 (964)
|+.|+|++|... ..+|..+.++++|+.|+|++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|+
T Consensus 780 L~~L~Ls~n~~l-~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls 854 (1153)
T PLN03210 780 LTRLFLSDIPSL-VELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS 854 (1153)
T ss_pred chheeCCCCCCc-cccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence 999999999876 6678889999999999999987666778766 7899999999998765554432 3679999999
Q ss_pred CCcceeecc--CCCcccceeEeecCC
Q 002121 369 NNQISAITL--GSGIKNYTLILVGNP 392 (964)
Q Consensus 369 ~N~l~~i~~--~~~~~l~~l~l~~Np 392 (964)
+|.++.+|. ..+..+..|+|.+++
T Consensus 855 ~n~i~~iP~si~~l~~L~~L~L~~C~ 880 (1153)
T PLN03210 855 RTGIEEVPWWIEKFSNLSFLDMNGCN 880 (1153)
T ss_pred CCCCccChHHHhcCCCCCEEECCCCC
Confidence 999999874 456678889998865
|
syringae 6; Provisional |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=223.67 Aligned_cols=210 Identities=25% Similarity=0.387 Sum_probs=131.2
Q ss_pred CccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCC
Q 002121 56 WEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN 135 (964)
Q Consensus 56 w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 135 (964)
|.-..|-..+.+.|++++++++ .+|..+. +.|+.|+|++| .+. .+|..+. .+|+.|+|++|+|+ .+|..+.
T Consensus 170 ~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N-~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~- 240 (754)
T PRK15370 170 QRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNN-ELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP- 240 (754)
T ss_pred HHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCC-CCC-cCChhhc--cCCCEEECCCCccc-cCChhhh-
Confidence 4445677778899999999998 4676553 57889999988 566 4565554 47888888888888 5676553
Q ss_pred CCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCC
Q 002121 136 LAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPD 215 (964)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~ 215 (964)
.+|+.|+|++|++. .+|..+. ++|+.|+|++|+|+ .+|.. + .++|+.|++++|+|+ .+|..+.
T Consensus 241 -~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~------l--~~sL~~L~Ls~N~Lt-~LP~~lp--- 303 (754)
T PRK15370 241 -DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPEN------L--PEELRYLSVYDNSIR-TLPAHLP--- 303 (754)
T ss_pred -ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccc------c--CCCCcEEECCCCccc-cCcccch---
Confidence 46888888888887 6666554 46888888888887 56632 1 136777777777776 4554322
Q ss_pred cceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEcc
Q 002121 216 MVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLS 295 (964)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls 295 (964)
.+|+.|++++|+++. +|..+. ++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+.++..+ .++|++|+|+
T Consensus 304 ~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~LP~~l--p~~L~~LdLs 375 (754)
T PRK15370 304 SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQITVLPETL--PPTITTLDVS 375 (754)
T ss_pred hhHHHHHhcCCcccc-CCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCCcCChhh--cCCcCEEECC
Confidence 345556666666653 333222 45555666666555 2444332 45555555555555433222 1345555555
Q ss_pred CCCC
Q 002121 296 NNSF 299 (964)
Q Consensus 296 ~N~l 299 (964)
+|+|
T Consensus 376 ~N~L 379 (754)
T PRK15370 376 RNAL 379 (754)
T ss_pred CCcC
Confidence 5555
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.8e-19 Score=184.69 Aligned_cols=139 Identities=17% Similarity=0.209 Sum_probs=112.1
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcch--------------------------hHHHHHHHHHHHhcCCCCc
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG--------------------------GLEFKTEIELLSRVHHKNL 685 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~H~nI 685 (964)
...||+|+||.||+|...+|+.||||+++...... ...++.|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999997789999999987542210 1124678999999999998
Q ss_pred cceeEEEEeeCceEEEEEeccCCChhhh-hcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECC
Q 002121 686 VGLVGFCFEQGEQMLVYEFMANGTLRES-LSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDE 763 (964)
Q Consensus 686 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~ 763 (964)
.....+... ..+|||||++++++... +.. ..++..+...++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655554433 35899999998865443 332 247788899999999999999999 88 99999999999999
Q ss_pred CCcEEEeecccceeec
Q 002121 764 NLTAKVADFGLSKLVS 779 (964)
Q Consensus 764 ~~~~kl~DFGla~~~~ 779 (964)
++.++|+|||+++...
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 8999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=178.67 Aligned_cols=184 Identities=14% Similarity=0.105 Sum_probs=140.0
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEEecCCCcch----hHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEec
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG----GLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+...|++|+||+||.+.. .+.+++.+.+....... ...+++|+++|+++. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 67888888777554421 225889999999995 5889999886 4579999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCC-CCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDV-KSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dl-k~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
.|.+|.+.+.. ....++.|++++|+++|+.+ |+|||| ||+|||++.++.++|+|||+|.........
T Consensus 81 ~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~ 148 (218)
T PRK12274 81 AGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW 148 (218)
T ss_pred cCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence 99999765421 11357789999999999998 999999 799999999999999999999865433210
Q ss_pred ----ce-------eecccccCcccCcccccc-CCCC-CchhHHHHHHHHHHHHhCCCCCC
Q 002121 785 ----HV-------STQVKGTMGYLDPEYYMT-QQLT-EKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 785 ----~~-------~~~~~gt~~y~aPE~~~~-~~~~-~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
.. ......++.|++|+...- ...+ .+.+.++-|..+|.++|++.+..
T Consensus 149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 00 112236778888875432 1233 57799999999999999998753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=214.74 Aligned_cols=256 Identities=21% Similarity=0.241 Sum_probs=190.5
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC---CCCccceeEEEEeeCc
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH---HKNLVGLVGFCFEQGE 697 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~ 697 (964)
+.+...+.|.+.+.||+|+||+||+|...+|+.||+|+-+.....+ |.-=.+++.||+ -+-|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4445566888899999999999999998889999999987765542 222234444554 2345566666667788
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-------CCCcEEEe
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-------ENLTAKVA 770 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-------~~~~~kl~ 770 (964)
-+||+||.+.|+|.+++... ..++|.-.+.++.|+++.+++||..+ ||||||||+|+||. +..-++|+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred ceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEE
Confidence 89999999999999999844 46999999999999999999999999 99999999999994 23468999
Q ss_pred ecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 850 (964)
|||.+..+..-.........++|-.+-.+|+..++.+++.+|.|.++.+++-||.|+.-- ..+..
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q------------~~~g~--- 908 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME------------VKNGS--- 908 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH------------hcCCc---
Confidence 999997765444445566788999999999999999999999999999999999987421 11111
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...++..++..... ..+-++...+|..|-..=|...++...++.++.+.
T Consensus 909 ----~~~~~~~~~Ry~~~--~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 909 ----SWMVKTNFPRYWKR--DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred ----ceeccccchhhhhH--HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 11112212211111 11235666677755555588888888888777543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.1e-19 Score=200.94 Aligned_cols=217 Identities=27% Similarity=0.455 Sum_probs=163.6
Q ss_pred HHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCC
Q 002121 677 LSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKS 756 (964)
Q Consensus 677 l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 756 (964)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...++|.-...++++|+.||+|+|... -..|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeecc
Confidence 45789999999999999999999999999999999999874 467999999999999999999999754 238999999
Q ss_pred CcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccC-------CCCCchhHHHHHHHHHHHHhCCCC
Q 002121 757 TNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-------QLTEKSDVYSFGVVMLELITAKQP 829 (964)
Q Consensus 757 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDv~S~Gvvl~elltg~~p 829 (964)
+|.++|....+||+|||+.................-..-|.|||.++.. ..+.++||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998776431111111222244569999998753 146789999999999999999999
Q ss_pred CCCCchhH--HHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 830 IEKGKYVV--REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 830 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
|+...... ..+...+... ....+.|.+.... +....+..++.+||..+|++||++++|-..++.+..
T Consensus 158 ~~~~~~~~~~~eii~~~~~~------~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKG------GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHhc------CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 97533221 1222222221 1122233333222 222367899999999999999999999887776654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.2e-20 Score=207.04 Aligned_cols=185 Identities=31% Similarity=0.373 Sum_probs=158.2
Q ss_pred eecCCcEEEEEEE----ecCCcEEEEEEecCCCcch--hHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEeccC
Q 002121 635 IGSGGYGKVYRGM----LSDGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 635 lG~G~fg~Vy~~~----~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+|+|+||.|+.++ .+.|..+|.|+.++..... ....+.|..++...+ ||.+|++...+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6999999999765 3457789999887654322 224567889999997 99999999999999999999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
|.|...+.... .++..........+|-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-+...
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99998887653 5777777888889999999999999 99999999999999999999999999987654322
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
.+||..|||||++. ....++|.||||++++||+||..||..
T Consensus 153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 27999999999998 567889999999999999999999965
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.4e-18 Score=175.99 Aligned_cols=137 Identities=19% Similarity=0.201 Sum_probs=107.1
Q ss_pred CCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-----CCCCccceeEEEEeeC---c-eE
Q 002121 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-----HHKNLVGLVGFCFEQG---E-QM 699 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~-~~ 699 (964)
++..+.||+|+||.||. .++....+||++........+.+.+|+++++++ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34457899999999996 433333479988765444556799999999999 5799999999998863 3 33
Q ss_pred EEEEe--ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHH-HHHhhcCCCCeeccCCCCCcEEECC----CCcEEEeec
Q 002121 700 LVYEF--MANGTLRESLSGRSGIHLDWKRRLRIALGSARGL-AYLHELANPPIIHRDVKSTNILLDE----NLTAKVADF 772 (964)
Q Consensus 700 lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~Dlk~~NILl~~----~~~~kl~DF 772 (964)
+|||| +++|+|.+++... .+++. ..++.+++.++ +|||+++ ||||||||+|||++. ++.++|+||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 78999 5689999999653 25554 35677888777 9999988 999999999999974 348999995
Q ss_pred ccc
Q 002121 773 GLS 775 (964)
Q Consensus 773 Gla 775 (964)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.9e-19 Score=185.55 Aligned_cols=198 Identities=22% Similarity=0.301 Sum_probs=136.9
Q ss_pred CCCCccceeEEEEe---------------------------eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHH
Q 002121 681 HHKNLVGLVGFCFE---------------------------QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALG 733 (964)
Q Consensus 681 ~H~nIv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 733 (964)
+|||||++.++|.+ +...|+||...+. +|.+++..+. .+...+.-++.|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC---CchHHHHHHHHH
Confidence 59999999987752 2346899998865 9999997653 555667778889
Q ss_pred HHHHHHHHhhcCCCCeeccCCCCCcEEE--CCCC--cEEEeecccceeecCC----CCCceeecccccCcccCccccccC
Q 002121 734 SARGLAYLHELANPPIIHRDVKSTNILL--DENL--TAKVADFGLSKLVSDS----SKGHVSTQVKGTMGYLDPEYYMTQ 805 (964)
Q Consensus 734 ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~--~~kl~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~ 805 (964)
+++|+.|||.++ |.|||+|++|||+ |+|+ ...|+|||++---... ....-.....|...-||||+....
T Consensus 350 lLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 999999999999 9999999999998 4444 5689999987432110 000011234578889999998643
Q ss_pred C-----CC-CchhHHHHHHHHHHHHhCCCCCCC-CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHH
Q 002121 806 Q-----LT-EKSDVYSFGVVMLELITAKQPIEK-GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELAL 878 (964)
Q Consensus 806 ~-----~~-~~sDv~S~Gvvl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~ 878 (964)
+ .+ .|+|.|+.|.+.||+++...||.. ++...+... ..+.. -..+.+.+. ..+.+++.
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~--Yqe~q--LPalp~~vp-----------p~~rqlV~ 491 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT--YQESQ--LPALPSRVP-----------PVARQLVF 491 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh--hhhhh--CCCCcccCC-----------hHHHHHHH
Confidence 2 22 589999999999999999999964 322221110 00000 011222222 33458999
Q ss_pred HhhhcCCCCCCCHHHHHHHHHH
Q 002121 879 QCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 879 ~cl~~dP~~RPs~~evl~~L~~ 900 (964)
..++.||.+|++..-....++-
T Consensus 492 ~lL~r~pskRvsp~iAANvl~L 513 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLNL 513 (598)
T ss_pred HHhcCCccccCCccHHHhHHHH
Confidence 9999999999987666555543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.1e-17 Score=177.70 Aligned_cols=229 Identities=18% Similarity=0.202 Sum_probs=146.7
Q ss_pred CccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcC----------CCCccceeEEEEe-
Q 002121 630 SESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVH----------HKNLVGLVGFCFE- 694 (964)
Q Consensus 630 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~----------H~nIv~l~~~~~~- 694 (964)
...+.||.|+|+.||.++.. +|+.+|||++..... ...+++++|.-....+. |-.++..++...-
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44678999999999999975 589999998764332 23456777765555532 2223333333221
Q ss_pred --------e---C-----ceEEEEEeccCCChhhhhcC---C--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 002121 695 --------Q---G-----EQMLVYEFMANGTLRESLSG---R--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753 (964)
Q Consensus 695 --------~---~-----~~~lV~E~~~~gsL~~~l~~---~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 753 (964)
. . ..+++|+-+. ++|.+.+.. . ....+....++.+..|+.+.+++||+.| +||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 1 1 2367888774 588877542 1 1234667778888899999999999999 99999
Q ss_pred CCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCcccccc--------CCCCCchhHHHHHHHHHHHHh
Q 002121 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT--------QQLTEKSDVYSFGVVMLELIT 825 (964)
Q Consensus 754 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~ellt 825 (964)
|||+|++++.+|.++|+||+....... .......+..|.|||.... -.++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 999999999999999999988765432 1111345678999997643 257889999999999999999
Q ss_pred CCCCCCCCchhHHHHHHHhccCcccccccccccCc-cchhhhHHHHHHHHHHHHHhhhcCCCCC
Q 002121 826 AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP-TIRNTVLLGFRRYLELALQCVEESATDR 888 (964)
Q Consensus 826 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-~l~~~~~~~~~~l~~li~~cl~~dP~~R 888 (964)
|+.||....... .+. .+..-. ...+.+..+|..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~--------------------~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEA--------------------DPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGS--------------------TSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccc--------------------cccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999996422110 000 111111 233556789999999999987
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-19 Score=203.17 Aligned_cols=135 Identities=23% Similarity=0.324 Sum_probs=66.7
Q ss_pred cceeEEEccCCcCcc----cCCcccCCCCCCcEEEcccCcCcc----ccCccccCCCCCCeeeccCccCccCCC-----C
Q 002121 216 MVLIHVLFDGNQLSG----NIPESLGYVQTLEVLRLDRNALTG----KVPTNLNNLTNVNELNLAHNDLKGPFP-----D 282 (964)
Q Consensus 216 ~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~ 282 (964)
++|++|++++|.+++ .++..+..+++|+.|+|++|.+++ .++..+..+++|++|+|++|.+++... .
T Consensus 137 ~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~ 216 (319)
T cd00116 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAET 216 (319)
T ss_pred CCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHH
Confidence 344555555555442 122334455566666666666652 223334445566666666666653221 2
Q ss_pred CCCCCCCCEEEccCCCCCCCCCCcccC----CCCCCcEEECCCCcccc----ccChhccCCCCCCEEEcCCccccc
Q 002121 283 LSQMNSLSYVDLSNNSFDPTEAPLWFS----TLPSLTTLICEFGSLQG----RVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~~~~~~~~~~----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
+..+++|++|++++|.++......... ..++|+.|++++|.++. .+...+..+++|+.|++++|.++.
T Consensus 217 ~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 217 LASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred hcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 445556666666666654211111111 12556666666666541 223344445566666666666653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.2e-17 Score=170.49 Aligned_cols=134 Identities=20% Similarity=0.334 Sum_probs=115.2
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
+.||+|++|.||+|.. .|..|++|+....... ....+.+|++++.+++|++|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999998 6788999986643321 123578899999999999999888888888889999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
+++++|.+++.... + ++..++.+++.+|+++|+.+ ++|||++|.|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 2 88899999999999999988 99999999999999 78999999998864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.8e-17 Score=171.19 Aligned_cols=143 Identities=17% Similarity=0.219 Sum_probs=111.3
Q ss_pred CCCccceeecCCcEEEEEEE--ecCCcEEEEEEecCCCcc------------------------hhHHHHHHHHHHHhcC
Q 002121 628 NFSESNEIGSGGYGKVYRGM--LSDGQVVAIKRAQQGSMQ------------------------GGLEFKTEIELLSRVH 681 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 681 (964)
.|.+.+.||+|+||.||+|. ..+|+.||+|+++..... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46777899999999999998 568999999998743210 0123578999999997
Q ss_pred CCC--ccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcE
Q 002121 682 HKN--LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNI 759 (964)
Q Consensus 682 H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NI 759 (964)
+.. +.+++++ ...++||||+++++|....... ..+...+...++.|++.+++|||+.+ .|+||||||+||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI 180 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI 180 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence 643 3344432 3458999999998887765332 24566667899999999999999865 399999999999
Q ss_pred EECCCCcEEEeecccceeec
Q 002121 760 LLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 760 Ll~~~~~~kl~DFGla~~~~ 779 (964)
+++ ++.++|+|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.6e-17 Score=166.20 Aligned_cols=145 Identities=21% Similarity=0.208 Sum_probs=114.2
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc----------------------hhHHHHHHHHHH
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ----------------------GGLEFKTEIELL 677 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 677 (964)
.++......|...+.||+|+||.||+|..++|+.||||++...... ....+..|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 4455554557788999999999999999888999999987643210 112367889999
Q ss_pred HhcCCCC--ccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 002121 678 SRVHHKN--LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVK 755 (964)
Q Consensus 678 ~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 755 (964)
.++.|++ +.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+|||||
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 9998874 444443 3456899999999999776431 235678899999999999988 9999999
Q ss_pred CCcEEECCCCcEEEeecccceeec
Q 002121 756 STNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 756 ~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|+||++++++.++|+|||++....
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCC
Confidence 999999999999999999996544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-19 Score=167.29 Aligned_cols=162 Identities=27% Similarity=0.476 Sum_probs=113.6
Q ss_pred CCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCC
Q 002121 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSP 214 (964)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~ 214 (964)
.+.+.+.|.||+|+++ .+|+.++.+.+|+.|++++|+++ .+| ..++.++.|+.|+++-|++.
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp------~~issl~klr~lnvgmnrl~---------- 92 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELP------TSISSLPKLRILNVGMNRLN---------- 92 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcC------hhhhhchhhhheecchhhhh----------
Confidence 4455555555666655 55555556666666666666665 445 23444555555555544443
Q ss_pred CcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCc-cccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEE
Q 002121 215 DMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALT-GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVD 293 (964)
Q Consensus 215 ~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~ 293 (964)
..|..|+.++.|+.|||..|.+. ..+|..|..++.|+.|+|++|.+.-.+++++++++|+.|.
T Consensus 93 ----------------~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~ 156 (264)
T KOG0617|consen 93 ----------------ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILS 156 (264)
T ss_pred ----------------cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEe
Confidence 56777888888888888888887 4678888889999999999999998888999999999999
Q ss_pred ccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhcc
Q 002121 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF 333 (964)
Q Consensus 294 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 333 (964)
+.+|.+ ...|..++.++.|++|++.+|+++ .+|..++
T Consensus 157 lrdndl--l~lpkeig~lt~lrelhiqgnrl~-vlppel~ 193 (264)
T KOG0617|consen 157 LRDNDL--LSLPKEIGDLTRLRELHIQGNRLT-VLPPELA 193 (264)
T ss_pred eccCch--hhCcHHHHHHHHHHHHhcccceee-ecChhhh
Confidence 999988 566777777777777777777776 4443333
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-19 Score=166.90 Aligned_cols=166 Identities=27% Similarity=0.476 Sum_probs=120.9
Q ss_pred CcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccc
Q 002121 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQ 162 (964)
Q Consensus 83 ~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 162 (964)
.+.++..++.|.||+| .+ ..+|+.+..|.+|+.|++.+|+|. .+|.+++.+++|+.|+++-|++. ..|..|+.++-
T Consensus 28 gLf~~s~ITrLtLSHN-Kl-~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~ 103 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHN-KL-TVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPA 103 (264)
T ss_pred cccchhhhhhhhcccC-ce-eecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCch
Confidence 3556677777777777 33 356667777777777777777777 77777777777777777777777 67777777777
Q ss_pred cccccccccccccc-cCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCC
Q 002121 163 LYWLDLADNQLTGS-IPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQT 241 (964)
Q Consensus 163 L~~L~Ls~N~l~g~-iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~ 241 (964)
|+.|||++|++... +| +.|..+ ..|+-|+|+.|.++ .+|..++++++
T Consensus 104 levldltynnl~e~~lp------gnff~m-------------------------~tlralyl~dndfe-~lp~dvg~lt~ 151 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLP------GNFFYM-------------------------TTLRALYLGDNDFE-ILPPDVGKLTN 151 (264)
T ss_pred hhhhhccccccccccCC------cchhHH-------------------------HHHHHHHhcCCCcc-cCChhhhhhcc
Confidence 77777777777521 22 233333 44444455555555 67777888999
Q ss_pred CcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCC
Q 002121 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQ 285 (964)
Q Consensus 242 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~ 285 (964)
|+.|.+..|.+- .+|..++.++.|++|.+.+|+++-.+|++++
T Consensus 152 lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlppel~~ 194 (264)
T KOG0617|consen 152 LQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPELAN 194 (264)
T ss_pred eeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecChhhhh
Confidence 999999998888 7888899999999999999999888886654
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-18 Score=187.92 Aligned_cols=175 Identities=26% Similarity=0.361 Sum_probs=130.3
Q ss_pred ceEEEEEeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 697 EQMLVYEFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
..|+.|++|.-.+|.+|+.++. ....+|.....++.|++.|++| ++ .+|||+||.||+...+..+||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999997543 5567899999999999999999 56 899999999999999999999999998
Q ss_pred eeecCCC----CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc
Q 002121 776 KLVSDSS----KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 776 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
....... .....+.-.||..||+||.+.+..|+.|+||||+|++|+|+++ +|.....-.......
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~-------- 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDI-------- 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhh--------
Confidence 7665443 1223456679999999999999999999999999999999997 332111111110000
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEV 894 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 894 (964)
-...+++.....++. =..++.+++.+.|.+||++.++
T Consensus 473 --r~g~ip~~~~~d~p~----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 473 --RDGIIPPEFLQDYPE----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred --hcCCCChHHhhcCcH----HHHHHHHhcCCCcccCchHHHH
Confidence 011122222222222 2368889999999999955444
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=165.25 Aligned_cols=130 Identities=23% Similarity=0.341 Sum_probs=108.8
Q ss_pred eeecCCcEEEEEEEecCCcEEEEEEecCCCcc--------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.||+|+||.||+|.+ +|..|++|+....... ...++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 5788999986543211 1245778999999999998777666677777889999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
++++|.+++.... . .++.+++.+|++||+.+ ++|||++|.||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875432 1 78999999999999988 99999999999999 88999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=190.00 Aligned_cols=143 Identities=20% Similarity=0.292 Sum_probs=115.1
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEe-cCC-Cc------chhHHHHHHHHHHHhcCCCCccceeEE
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRA-QQG-SM------QGGLEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~-~~~-~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
.........|...+.||+|+||+||+|.+... .+++|+. ... .. ....++.+|++++++++|++++....+
T Consensus 326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~ 404 (535)
T PRK09605 326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIY 404 (535)
T ss_pred ccccccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEE
Confidence 33334445566789999999999999997544 3444432 211 11 112468899999999999999998888
Q ss_pred EEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 692 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
+.+....++||||+++++|.+++. ....++.+++++|+|||+.+ |+||||||+|||+ +++.++|+|
T Consensus 405 ~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liD 470 (535)
T PRK09605 405 DVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLID 470 (535)
T ss_pred EEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEe
Confidence 888788899999999999999875 35678999999999999988 9999999999999 678999999
Q ss_pred ccccee
Q 002121 772 FGLSKL 777 (964)
Q Consensus 772 FGla~~ 777 (964)
||+++.
T Consensus 471 FGla~~ 476 (535)
T PRK09605 471 FGLGKY 476 (535)
T ss_pred Cccccc
Confidence 999875
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.69 E-value=6.9e-19 Score=196.38 Aligned_cols=277 Identities=22% Similarity=0.229 Sum_probs=182.1
Q ss_pred EEcCCCCcc-ccccCCcCCCCcccEEecccCCCCCC----CCCCCCCCcccchhhccccccccC------cCCcccCCCC
Q 002121 69 LGLSTMGLT-GKLSGDIGGLTELRSLDLSYNGGLTG----SLSPRIGDLQKLNILILAGCGFTG------NIPDEIGNLA 137 (964)
Q Consensus 69 L~L~~~~l~-g~~~~~l~~l~~L~~L~L~~N~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~------~~p~~~~~l~ 137 (964)
|+|..+.++ +.....+..++.|+.|+|+++ .+.. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~-~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGN-TLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCC-CCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 556666665 234444556666777777776 4432 244455566667777777776652 2345566777
Q ss_pred CccEEEcccCcccCcCCCcCCCccc---cccccccccccccccCcccCCCCccccc-cCCCeeEccCCccccccccc---
Q 002121 138 ELSFLALNSNNFSGRIPPSLGKLSQ---LYWLDLADNQLTGSIPVSTITSPGLDQL-KNAKHFHFNKNKLSGTISEQ--- 210 (964)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~g~iP~~~~~~~~l~~l-~~L~~L~L~~N~l~g~l~~~--- 210 (964)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++.-...+ ...+..+ ++|+.|++++|.+++.....
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l--~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLL--AKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHH--HHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 8888888888887655555555555 8888888887763111000 0223455 77888888888887433222
Q ss_pred ccCCCcceeEEEccCCcCccc----CCcccCCCCCCcEEEcccCcCccc----cCccccCCCCCCeeeccCccCccCCC-
Q 002121 211 LFSPDMVLIHVLFDGNQLSGN----IPESLGYVQTLEVLRLDRNALTGK----VPTNLNNLTNVNELNLAHNDLKGPFP- 281 (964)
Q Consensus 211 ~f~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~- 281 (964)
.+..+..|++|++++|.+++. ++..+..+++|+.|+|++|.+++. +...+..+++|++|++++|.+++...
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 245556788888888888742 334456667999999999998733 44567778899999999999886221
Q ss_pred C-----CCCCCCCCEEEccCCCCCC---CCCCcccCCCCCCcEEECCCCccccc----cChhccCC-CCCCEEEcCCccc
Q 002121 282 D-----LSQMNSLSYVDLSNNSFDP---TEAPLWFSTLPSLTTLICEFGSLQGR----VPDKLFSY-SQIQQVKLRNNAF 348 (964)
Q Consensus 282 ~-----l~~l~~L~~L~Ls~N~l~~---~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l 348 (964)
. ....+.|++|++++|.++. ......+..+++|++|++++|.+... ....+... +.|+.|++.+|.+
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 1 1135789999999999851 12234566678999999999999965 44445445 6777777777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.7e-16 Score=182.57 Aligned_cols=207 Identities=26% Similarity=0.355 Sum_probs=139.3
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
..+|..++.|..|+||.||..+++ ..+.+|+|+-++.-. .++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li-----lRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI-----LRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccchh-----hhc---cccccCCccee------------------
Confidence 458888999999999999999875 467788854332110 011 22222233333
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC-
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK- 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~- 783 (964)
|+=...++.-+..+.+ ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++..-....
T Consensus 136 ---gDc~tllk~~g~lPvd----------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ---GDCATLLKNIGPLPVD----------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ---chhhhhcccCCCCcch----------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 3444444443322222 267899999988 99999999999999999999999999875321100
Q ss_pred ------------CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcc
Q 002121 784 ------------GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDE 849 (964)
Q Consensus 784 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~ 849 (964)
.....+++||+.|+|||++..+.|...+|.|++|+++||.+-|+.||+... .+...+. .....
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi---sd~i~ 276 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI---SDDIE 276 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh---hhhcc
Confidence 011235689999999999999999999999999999999999999997542 1222221 11110
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP 889 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP 889 (964)
+.|. |..+ ..+..+++.+.++.+|..|-
T Consensus 277 ----wpE~-dea~-------p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 277 ----WPEE-DEAL-------PPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ----cccc-CcCC-------CHHHHHHHHHHHHhChHhhc
Confidence 1111 2121 14455788899999999994
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.63 E-value=5.3e-16 Score=186.47 Aligned_cols=149 Identities=36% Similarity=0.639 Sum_probs=112.0
Q ss_pred ccCCCHHHHHHHHHHHHHcCCCC-CCCCCCCCCCC----CCccEEecC------CCeeEEEcCCCCccccccCCcCCCCc
Q 002121 21 SSATDSRDAAALQSLKDAWQNTP-PTWKNSDDPCG----SWEGVTCNN------SRVTALGLSTMGLTGKLSGDIGGLTE 89 (964)
Q Consensus 21 ~~~~~~~~~~aL~~~k~~~~~~~-~~W~~~~~~C~----~w~gv~C~~------~~v~~L~L~~~~l~g~~~~~l~~l~~ 89 (964)
...+.+.|..||+++|.++.... .+|. .++|+ .|.||.|+. .+|+.|+|++|+++|.+|..++.|++
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~ 443 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLRFGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRH 443 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCcccCCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCC
Confidence 34567889999999999997543 4895 35663 799999952 14788888888888888888888888
Q ss_pred ccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCc-cccccccc
Q 002121 90 LRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKL-SQLYWLDL 168 (964)
Q Consensus 90 L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L 168 (964)
|+.|+|++| .+.|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|..+..+ .++..+++
T Consensus 444 L~~L~Ls~N-~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 444 LQSINLSGN-SIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCEEECCCC-cccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 888888888 6777777777777777777777777777777777777777777777777777777766543 24445555
Q ss_pred cccc
Q 002121 169 ADNQ 172 (964)
Q Consensus 169 s~N~ 172 (964)
.+|.
T Consensus 523 ~~N~ 526 (623)
T PLN03150 523 TDNA 526 (623)
T ss_pred cCCc
Confidence 5554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.6e-15 Score=151.85 Aligned_cols=136 Identities=21% Similarity=0.259 Sum_probs=100.0
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcch--hHH----------------------HHHHHHHHHhcCCCC--c
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG--GLE----------------------FKTEIELLSRVHHKN--L 685 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--I 685 (964)
.+.||+|+||+||+|...+|+.||||++....... ... ...|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999998889999999887532211 111 135666677765443 4
Q ss_pred cceeEEEEeeCceEEEEEeccCCChhhh-hcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECC
Q 002121 686 VGLVGFCFEQGEQMLVYEFMANGTLRES-LSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDE 763 (964)
Q Consensus 686 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~ 763 (964)
.+.+++ ...++||||++++.+... +.... .. .+...++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 346899999999654321 21111 11 5678899999999999998 77 99999999999999
Q ss_pred CCcEEEeecccceeec
Q 002121 764 NLTAKVADFGLSKLVS 779 (964)
Q Consensus 764 ~~~~kl~DFGla~~~~ 779 (964)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=6e-15 Score=144.77 Aligned_cols=135 Identities=21% Similarity=0.228 Sum_probs=115.3
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCC--CCccceeEEEEeeCceEEEEEeccCC
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH--KNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35779999999999999854 7899999865443 4578999999999987 58999999888888899999999987
Q ss_pred ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 709 TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 709 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.+..+ +......++.+++++++++|.....+++|||++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4566778899999999999986545699999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=2e-14 Score=152.25 Aligned_cols=134 Identities=19% Similarity=0.203 Sum_probs=106.0
Q ss_pred ceee-cCCcEEEEEEEecCCcEEEEEEecCCC-------------cchhHHHHHHHHHHHhcCCCCc--cceeEEEEeeC
Q 002121 633 NEIG-SGGYGKVYRGMLSDGQVVAIKRAQQGS-------------MQGGLEFKTEIELLSRVHHKNL--VGLVGFCFEQG 696 (964)
Q Consensus 633 ~~lG-~G~fg~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~ 696 (964)
..|| .|+.|+||++... +..+|||++.... ......+.+|++++.+++|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5788 8999999999885 7789999875321 1123467889999999998885 67777755432
Q ss_pred c----eEEEEEeccC-CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 697 E----QMLVYEFMAN-GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 697 ~----~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
. .++||||+++ .+|.+++... .++.. .+.+++.+|++||+.+ |+||||||.|||++.++.++|+|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 2 2599999997 6999888643 24433 3568999999999998 99999999999999999999999
Q ss_pred ccccee
Q 002121 772 FGLSKL 777 (964)
Q Consensus 772 FGla~~ 777 (964)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.53 E-value=8.4e-16 Score=181.92 Aligned_cols=254 Identities=21% Similarity=0.258 Sum_probs=186.2
Q ss_pred CCCccceeecCCcEEEEEEEec--CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS--DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.|...+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556677999999999877753 34567777665443 222234556788877776 999999999999999999999
Q ss_pred EeccCCChhhhh-cCCCCCccchHHHHHHHHHHHHHHHHHh-hcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeec
Q 002121 703 EFMANGTLRESL-SGRSGIHLDWKRRLRIALGSARGLAYLH-ELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~ 779 (964)
||..+|++.+-+ +... ...+....-.+..|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|....
T Consensus 101 ~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred CcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999999988 4432 24556667788999999999999 777 99999999999999999 99999999998877
Q ss_pred C-CCCCceeecccc-cCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 780 D-SSKGHVSTQVKG-TMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 780 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
. .+........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++............+....
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~-------- 248 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG-------- 248 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc--------
Confidence 6 444455556678 9999999998874 4457899999999999999999998743221111111110000
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+. .-.....++..+++..+|..|.+.+++..
T Consensus 249 ~~~~~~~~---~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFTQLPWN---SISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccCccc---cCChhhhhcccccccCCchhccccccccc
Confidence 00001111 11123446777888899999999988753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.7e-13 Score=155.94 Aligned_cols=141 Identities=22% Similarity=0.242 Sum_probs=102.1
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcch----------------------------------------hHHHH
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG----------------------------------------GLEFK 671 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~----------------------------------------~~~~~ 671 (964)
.+.||+|++|.||+|++++|+.||||+.+...... +..|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999986532110 01255
Q ss_pred HHHHHHHhcC----CCCccceeEEE-EeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHH-HHHHHhhcC
Q 002121 672 TEIELLSRVH----HKNLVGLVGFC-FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR-GLAYLHELA 745 (964)
Q Consensus 672 ~E~~~l~~l~----H~nIv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 745 (964)
+|++.+.+++ |.+-+.+-.++ ......+|||||++|++|.++...... .. .+..++..++. .+..+|..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 5666666653 32223322233 224567999999999999887643211 12 34567777766 478889887
Q ss_pred CCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 746 ~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
++|+|+||.||+++++++++++|||++..++
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.36 E-value=6e-13 Score=137.81 Aligned_cols=201 Identities=21% Similarity=0.322 Sum_probs=140.0
Q ss_pred HHHHHhcCCCCccceeEEEEeeC-----ceEEEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCC
Q 002121 674 IELLSRVHHKNLVGLVGFCFEQG-----EQMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELAN 746 (964)
Q Consensus 674 ~~~l~~l~H~nIv~l~~~~~~~~-----~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 746 (964)
..-|-++.|.|||+++.|+.+.. +..+++|||.-|++..+|+.-. +..+......+|+.||..||.|||+. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 44556677999999999997643 5789999999999999997532 44577778889999999999999986 5
Q ss_pred CCeeccCCCCCcEEECCCCcEEEeecccceeecC--CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHH
Q 002121 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD--SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELI 824 (964)
Q Consensus 747 ~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ell 824 (964)
|+|+|+++..+-|++..+|-+|++----...... .........-.+-++|.|||+-.....+-++|||+||...+||-
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 9999999999999999999888863221111000 00000111224678999999988888889999999999999998
Q ss_pred hCCCCCCCCch--hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 825 TAKQPIEKGKY--VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 825 tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
.+..--.++.. ..+..... ..-.+...+ -...+..|++..|..||+|.+++
T Consensus 277 ilEiq~tnseS~~~~ee~ia~----------~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIAN----------VIIGLENGL----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred HheeccCCCcceeehhhhhhh----------heeeccCcc----------ccCcCcccccCCCCCCcchhhhh
Confidence 87643222111 11000000 000000011 12567899999999999999874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.33 E-value=8.2e-14 Score=153.63 Aligned_cols=174 Identities=31% Similarity=0.463 Sum_probs=101.2
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
|..-...||+.|++. ++|..+..+..|+.|.|++|.+. .+|..++++..|++|||+.|+++ .+|. .+..|
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~------~lC~l- 143 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPD------GLCDL- 143 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCCh------hhhcC-
Confidence 444455666666766 66766666667777777777776 66777777777777777777776 4441 12111
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
-|+.|-+++|+++ .+|+.++.+.+|..||.+.|.+. .+|..++++.+|+.|.+
T Consensus 144 pLkvli~sNNkl~--------------------------~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~v 196 (722)
T KOG0532|consen 144 PLKVLIVSNNKLT--------------------------SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNV 196 (722)
T ss_pred cceeEEEecCccc--------------------------cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHH
Confidence 2444444444444 44445555555555566666555 55555566666666666
Q ss_pred cCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccc
Q 002121 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 272 s~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
..|.+..+++++. .-.|..||+|.|++ ..+|..|.+|..|++|-|.+|.|+
T Consensus 197 rRn~l~~lp~El~-~LpLi~lDfScNki--s~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 197 RRNHLEDLPEELC-SLPLIRLDFSCNKI--SYLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhhCCHHHh-CCceeeeecccCce--eecchhhhhhhhheeeeeccCCCC
Confidence 6666655555555 23355566666665 344555555555555555555555
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.7e-12 Score=125.70 Aligned_cols=131 Identities=18% Similarity=0.136 Sum_probs=98.9
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccc-eeEEEEeeCceEEEEEeccCCCh
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG-LVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
.+.++.|.++.||++... |+.|++|....... ....+..|+++++.+.+.++++ ++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999975 77899998765432 2235788999999997666654 44432 3446899999999887
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA--NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.+.- .....++.+++++|+.||+.+ ...++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6430 111345678999999999876 23469999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.5e-13 Score=151.63 Aligned_cols=197 Identities=28% Similarity=0.406 Sum_probs=140.5
Q ss_pred CCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccc
Q 002121 85 GGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLY 164 (964)
Q Consensus 85 ~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 164 (964)
..|+.-...||+.|+ ...+|..+..+..|+.|.|..|.|. .+|..+.++..|++|||+.|+++ .+|..++.|+ |+
T Consensus 72 ~~ltdt~~aDlsrNR--~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lk 146 (722)
T KOG0532|consen 72 YDLTDTVFADLSRNR--FSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LK 146 (722)
T ss_pred ccccchhhhhccccc--cccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ce
Confidence 445556677777773 3466777777777777777777777 77777777777777777777777 6677777764 77
Q ss_pred cccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcE
Q 002121 165 WLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEV 244 (964)
Q Consensus 165 ~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~ 244 (964)
.|-+++|+++ .+| ..++.+..|..|+.+.|.+. .+|..+ ..+.+|+.|.+..|++. .+|..+. .-.|..
T Consensus 147 vli~sNNkl~-~lp------~~ig~~~tl~~ld~s~nei~-slpsql-~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~ 215 (722)
T KOG0532|consen 147 VLIVSNNKLT-SLP------EEIGLLPTLAHLDVSKNEIQ-SLPSQL-GYLTSLRDLNVRRNHLE-DLPEELC-SLPLIR 215 (722)
T ss_pred eEEEecCccc-cCC------cccccchhHHHhhhhhhhhh-hchHHh-hhHHHHHHHHHhhhhhh-hCCHHHh-CCceee
Confidence 7777777777 666 34556677777777777777 666554 34556777777777777 4555555 345788
Q ss_pred EEcccCcCccccCccccCCCCCCeeeccCccCccCCCCC---CCCCCCCEEEccCCC
Q 002121 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL---SQMNSLSYVDLSNNS 298 (964)
Q Consensus 245 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l---~~l~~L~~L~Ls~N~ 298 (964)
||+|.|+++ .+|-.|.+|+.|++|-|.+|.|+..+..+ +...-.++|+..-++
T Consensus 216 lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 216 LDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred eecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHHhccceeeeeeecchhcc
Confidence 888888888 88888999999999999999888766653 333335666666553
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.5e-12 Score=147.96 Aligned_cols=197 Identities=30% Similarity=0.447 Sum_probs=96.5
Q ss_pred hhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcc-ccccccccccccccccCcccCCCCccccccCCCe
Q 002121 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLS-QLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195 (964)
Q Consensus 117 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~ 195 (964)
.|++..|.+. .....+..++.++.|++.+|.++ .++.....+. +|+.|++++|++. .+| ..+..+++|+.
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~------~~~~~l~~L~~ 167 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP------SPLRNLPNLKN 167 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhh------hhhhccccccc
Confidence 4666666654 22333455566777777777777 5555565553 7777777777776 333 23556666666
Q ss_pred eEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCcc
Q 002121 196 FHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHND 275 (964)
Q Consensus 196 L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 275 (964)
|++++|+++ .+|. ..+.+++|+.|++++|+++ .+|........|++|.+++|.
T Consensus 168 L~l~~N~l~-~l~~-------------------------~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~ 220 (394)
T COG4886 168 LDLSFNDLS-DLPK-------------------------LLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS 220 (394)
T ss_pred cccCCchhh-hhhh-------------------------hhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence 666666665 3322 2223344444444444444 333333333334444444443
Q ss_pred CccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccC
Q 002121 276 LKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD 353 (964)
Q Consensus 276 l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 353 (964)
+...+..+..+.++..|.+.+|++. ..+..+..+++|+.|++++|+++.... +..+.+|+.|++++|.+....+
T Consensus 221 ~~~~~~~~~~~~~l~~l~l~~n~~~--~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 221 IIELLSSLSNLKNLSGLELSNNKLE--DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred ceecchhhhhcccccccccCCceee--eccchhccccccceecccccccccccc--ccccCccCEEeccCccccccch
Confidence 3333333444444444444444442 223334444444444444444443322 4444445555555554444333
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.7e-12 Score=147.74 Aligned_cols=200 Identities=31% Similarity=0.428 Sum_probs=126.8
Q ss_pred EEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCC-CccEEEcccCcccCcCCCcCCCccccccccccc
Q 002121 92 SLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLA-ELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170 (964)
Q Consensus 92 ~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 170 (964)
.|+++.| .+. .....+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..+.++++|+.|++++
T Consensus 97 ~l~~~~~-~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLN-RLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeecccc-ccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 5677666 221 22334555677888888888888 7777777774 8888888888888 6667788888888888888
Q ss_pred cccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 002121 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250 (964)
Q Consensus 171 N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 250 (964)
|+++ .+|. ....+++|+.|++++|+++ .+|. ....+..|+.|.+++|
T Consensus 173 N~l~-~l~~------~~~~~~~L~~L~ls~N~i~-~l~~-------------------------~~~~~~~L~~l~~~~N 219 (394)
T COG4886 173 NDLS-DLPK------LLSNLSNLNNLDLSGNKIS-DLPP-------------------------EIELLSALEELDLSNN 219 (394)
T ss_pred chhh-hhhh------hhhhhhhhhheeccCCccc-cCch-------------------------hhhhhhhhhhhhhcCC
Confidence 8888 5552 1226677777777777776 4433 2233344555555555
Q ss_pred cCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccCh
Q 002121 251 ALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPD 330 (964)
Q Consensus 251 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 330 (964)
.+. .++..+.++.++..|.+++|++...+..+..++.|++|++++|.++ .++. +..+.+|+.|++++|.+....|.
T Consensus 220 ~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i~--~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 220 SII-ELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS--SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cce-ecchhhhhcccccccccCCceeeeccchhccccccceecccccccc--cccc-ccccCccCEEeccCccccccchh
Confidence 433 3445555555555555566655554444555566666666666663 2222 56666666666666666655554
Q ss_pred hc
Q 002121 331 KL 332 (964)
Q Consensus 331 ~~ 332 (964)
..
T Consensus 296 ~~ 297 (394)
T COG4886 296 IA 297 (394)
T ss_pred hh
Confidence 43
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.6e-12 Score=143.17 Aligned_cols=247 Identities=23% Similarity=0.212 Sum_probs=178.3
Q ss_pred CCCccceeec--CCcEEEEEEEe---cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceE
Q 002121 628 NFSESNEIGS--GGYGKVYRGML---SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 628 ~~~~~~~lG~--G~fg~Vy~~~~---~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 699 (964)
.|.....+|+ |.+|.||.+.. .++..+|+|+-+.... .....=.+|+....+++ |+|.|+.+..+++.+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455678999 99999999986 3688999998543322 33334456777777774 999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHH----HHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeeccc
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR----GLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGL 774 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGl 774 (964)
+-+|++. .+|.++-+... ..++....+.+..+..+ ||.++|... ++|-|+||.||+...+ ...+++|||+
T Consensus 195 iqtE~~~-~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeecccc-chhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 9999986 68888877643 23555556666666666 999999987 9999999999999999 8999999999
Q ss_pred ceeecCCCCCce---eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc
Q 002121 775 SKLVSDSSKGHV---STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 775 a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
...+.+...... .....|...|++||... +.++.++|+|++|.++.|..++-.....+.+. .|..
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-~W~~---------- 337 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS-SWSQ---------- 337 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC-Cccc----------
Confidence 998876543222 22335788899999864 56789999999999999999987665433110 0100
Q ss_pred cccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 YGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.... ++.. ......++...+.++++.+|..|++.+++..
T Consensus 338 --~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 338 --LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11111 1111 0011123445888999999999999988753
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.4e-12 Score=146.60 Aligned_cols=143 Identities=17% Similarity=0.222 Sum_probs=95.6
Q ss_pred cCCCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCcc---------------------------------h-h----
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQ---------------------------------G-G---- 667 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~---------------------------------~-~---- 667 (964)
..|+. +.||+|++|.||+|++++ |+.||||+.+..... + .
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999887 999999998754210 0 0
Q ss_pred --HHHHHHHHHHHhcC----CCCccceeEEEEe-eCceEEEEEeccCCChhhh--hcCCCC--CccchHHHHHHHHHHHH
Q 002121 668 --LEFKTEIELLSRVH----HKNLVGLVGFCFE-QGEQMLVYEFMANGTLRES--LSGRSG--IHLDWKRRLRIALGSAR 736 (964)
Q Consensus 668 --~~~~~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lV~E~~~~gsL~~~--l~~~~~--~~l~~~~~~~i~~~ia~ 736 (964)
-+|.+|+.-+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.+. +...+. ..+.......++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~----- 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFF----- 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHH-----
Confidence 12445555555553 4444443343333 4567899999999999874 322210 012222222222
Q ss_pred HHHHHhhcCCCCeeccCCCCCcEEECCCC----cEEEeecccceeecC
Q 002121 737 GLAYLHELANPPIIHRDVKSTNILLDENL----TAKVADFGLSKLVSD 780 (964)
Q Consensus 737 gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGla~~~~~ 780 (964)
..++..| ++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 274 --~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 --TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred --HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 3334556 99999999999999988 999999999987754
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.2e-10 Score=115.91 Aligned_cols=136 Identities=17% Similarity=0.139 Sum_probs=99.2
Q ss_pred ceeecCCcEEEEEEEecC-------CcEEEEEEecCCCc----------------------chhHHHH----HHHHHHHh
Q 002121 633 NEIGSGGYGKVYRGMLSD-------GQVVAIKRAQQGSM----------------------QGGLEFK----TEIELLSR 679 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~-------g~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 679 (964)
..||.|.-+.||.|...+ +..+|||+.+.... .....++ +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47999997642110 0012233 89999999
Q ss_pred cCC--CCccceeEEEEeeCceEEEEEeccCCChhh-hhcCCCCCccchHHHHHHHHHHHHHHHHH-hhcCCCCeeccCCC
Q 002121 680 VHH--KNLVGLVGFCFEQGEQMLVYEFMANGTLRE-SLSGRSGIHLDWKRRLRIALGSARGLAYL-HELANPPIIHRDVK 755 (964)
Q Consensus 680 l~H--~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~Dlk 755 (964)
+.. -++.+++++ ...+|||||+.++.+.. .+.. ..++..+...+..+++.+|.+| |..+ ||||||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 964 456666654 56789999998754432 2222 1344456677889999999999 7777 9999999
Q ss_pred CCcEEECCCCcEEEeecccceeec
Q 002121 756 STNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 756 ~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+.|||++ ++.++|+|||.+....
T Consensus 153 ~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE-CCcEEEEECCCceeCC
Confidence 9999997 4689999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3.4e-12 Score=130.32 Aligned_cols=132 Identities=18% Similarity=0.276 Sum_probs=66.1
Q ss_pred cCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeee
Q 002121 191 KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELN 270 (964)
Q Consensus 191 ~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 270 (964)
..|+.|+|++|.|+ .+.+. ....+.++.|+++.|+|.. +. .+..+++|+.||||+|.++ .+..+-..+.|++.|.
T Consensus 284 q~LtelDLS~N~I~-~iDES-vKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDES-VKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred hhhhhccccccchh-hhhhh-hhhccceeEEeccccceee-eh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 34455555555554 22222 1223344444444444442 11 2455555555666655555 4444444455555555
Q ss_pred ccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccc-cChhccCCCCCCEEEcCCcccc
Q 002121 271 LAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGR-VPDKLFSYSQIQQVKLRNNAFN 349 (964)
Q Consensus 271 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~ 349 (964)
|++|.|... ..+.++-+|.. ||+++|+|... --..++++|-|+.|.|.+|.+.
T Consensus 359 La~N~iE~L-SGL~KLYSLvn-------------------------LDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 359 LAQNKIETL-SGLRKLYSLVN-------------------------LDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhhHhhh-hhhHhhhhhee-------------------------ccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 555555422 12334444444 44445544432 1235667777777777777777
Q ss_pred cccC
Q 002121 350 NTLD 353 (964)
Q Consensus 350 ~~~~ 353 (964)
+...
T Consensus 413 ~~vd 416 (490)
T KOG1259|consen 413 GSVD 416 (490)
T ss_pred ccch
Confidence 6655
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.18 E-value=7.9e-11 Score=141.93 Aligned_cols=93 Identities=23% Similarity=0.426 Sum_probs=82.3
Q ss_pred CCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEc
Q 002121 265 NVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKL 343 (964)
Q Consensus 265 ~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 343 (964)
.++.|+|++|.++|.+|. +..+++|+.|+|++|.+. ..+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~-g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR-GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCccc-CcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 378899999999987764 888999999999999997 567777999999999999999999999999999999999999
Q ss_pred CCcccccccCCCCcc
Q 002121 344 RNNAFNNTLDMGNAV 358 (964)
Q Consensus 344 ~~N~l~~~~~~~~~~ 358 (964)
++|++++.+|..+..
T Consensus 498 s~N~l~g~iP~~l~~ 512 (623)
T PLN03150 498 NGNSLSGRVPAALGG 512 (623)
T ss_pred cCCcccccCChHHhh
Confidence 999999988876654
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.7e-12 Score=129.33 Aligned_cols=134 Identities=20% Similarity=0.250 Sum_probs=82.9
Q ss_pred cCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCc
Q 002121 236 LGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLT 315 (964)
Q Consensus 236 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~ 315 (964)
+.-.+.|+.||||+|.|+ .+.+...-++.++.|++|+|.|+.+.. +..+++|+.||||+|.++ ....|-..+.+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls--~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLA--ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhH--hhhhhHhhhcCEe
Confidence 344466777788888777 666667777777777777777775443 677777777777777773 3444555666667
Q ss_pred EEECCCCccccccChhccCCCCCCEEEcCCcccccccC-CCCccCCCCcEEeccCCcceee
Q 002121 316 TLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD-MGNAVGPLLQLVDLQNNQISAI 375 (964)
Q Consensus 316 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~i 375 (964)
.|.|+.|.|... ..+.++-+|..||+++|+|..... ..+..+|-|+.|.|.+|+|..+
T Consensus 356 tL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 356 TLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred eeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 777777666522 234445555566666666544322 3444555555555555555443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=3.7e-10 Score=128.80 Aligned_cols=166 Identities=18% Similarity=0.200 Sum_probs=125.9
Q ss_pred ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHH
Q 002121 648 LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR 727 (964)
Q Consensus 648 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~ 727 (964)
..++.+|.|.+.+..........++-++.|+.+|||||++++..+++.+..|||+|.+. -|..++... .....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l-----~~~~v 106 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL-----GKEEV 106 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh-----HHHHH
Confidence 45788899988876655333456778899999999999999999999999999999985 566667643 34566
Q ss_pred HHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCC
Q 002121 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807 (964)
Q Consensus 728 ~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 807 (964)
...+.||+.||.|||+.++ ++|++|.-+-|++++.|+.||++|.++........ ......--..|..|+.+....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc-
Confidence 7788999999999997553 99999999999999999999999998865432211 001111122456666543222
Q ss_pred CCchhHHHHHHHHHHHHhC
Q 002121 808 TEKSDVYSFGVVMLELITA 826 (964)
Q Consensus 808 ~~~sDv~S~Gvvl~elltg 826 (964)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.8e-10 Score=119.70 Aligned_cols=142 Identities=21% Similarity=0.342 Sum_probs=112.8
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCC--CccceeEEEEeeC---ceEEEEEecc
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHK--NLVGLVGFCFEQG---EQMLVYEFMA 706 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~~~---~~~lV~E~~~ 706 (964)
+.|+.|..+.||++...+|+.+++|....... .....+..|+++++.+++. ++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998765432 1345789999999999764 4577787776543 6689999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC-----------------------------------------
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA----------------------------------------- 745 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 745 (964)
++++.+.+.. ..++..++..++.+++++|++||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9988876642 24777888889999999999999521
Q ss_pred ------------CCCeeccCCCCCcEEECC--CCcEEEeeccccee
Q 002121 746 ------------NPPIIHRDVKSTNILLDE--NLTAKVADFGLSKL 777 (964)
Q Consensus 746 ------------~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~ 777 (964)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=6.4e-12 Score=135.16 Aligned_cols=216 Identities=20% Similarity=0.203 Sum_probs=90.9
Q ss_pred CCCCccEEEcccCcccCcCC--CcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccccccccccc
Q 002121 135 NLAELSFLALNSNNFSGRIP--PSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLF 212 (964)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f 212 (964)
++++|+...|.+..+. ..+ .....+++++.|||++|-+..--|.. .-...|++|+.|+|+.|++.....+..-
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~----~i~eqLp~Le~LNls~Nrl~~~~~s~~~ 193 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVL----KIAEQLPSLENLNLSSNRLSNFISSNTT 193 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHH----HHHHhcccchhcccccccccCCccccch
Confidence 4555666666665555 222 23445666666666666655222211 1234556666666666666522222222
Q ss_pred CCCcceeEEEccCCcCccc-CCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCC--CCCCCCCCC
Q 002121 213 SPDMVLIHVLFDGNQLSGN-IPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPF--PDLSQMNSL 289 (964)
Q Consensus 213 ~~~~~L~~L~l~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--~~l~~l~~L 289 (964)
..++.|+.|.|+.|.|+-. +-..+..+++|+.|+|..|..-+.-.....-+..|++|||++|++-... +....++.|
T Consensus 194 ~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L 273 (505)
T KOG3207|consen 194 LLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL 273 (505)
T ss_pred hhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence 2233333444444433311 1111223344444444444211122222223334444444444443332 223344444
Q ss_pred CEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccC-CCCccCCCCcEEecc
Q 002121 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD-MGNAVGPLLQLVDLQ 368 (964)
Q Consensus 290 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~ 368 (964)
+.|+++.+.+.....|+. ..-.....+++|++|+++.|++..... ..+..+++|+.|.+.
T Consensus 274 ~~Lnls~tgi~si~~~d~-------------------~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~ 334 (505)
T KOG3207|consen 274 NQLNLSSTGIASIAEPDV-------------------ESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRIT 334 (505)
T ss_pred hhhhccccCcchhcCCCc-------------------cchhhhcccccceeeecccCccccccccchhhccchhhhhhcc
Confidence 444444444432222222 000012334555555555555532211 233444555555555
Q ss_pred CCccee
Q 002121 369 NNQISA 374 (964)
Q Consensus 369 ~N~l~~ 374 (964)
.|.|+.
T Consensus 335 ~n~ln~ 340 (505)
T KOG3207|consen 335 LNYLNK 340 (505)
T ss_pred cccccc
Confidence 665554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.9e-11 Score=135.81 Aligned_cols=257 Identities=20% Similarity=0.201 Sum_probs=180.9
Q ss_pred cccccHHH-HHHhhcCCCccceeecCCcEEEEEEEec--CCcEEEEEEecCCCcchhHH--HHHHHHHHHhc-CCCCccc
Q 002121 614 ARWFSYDE-LKKCSNNFSESNEIGSGGYGKVYRGMLS--DGQVVAIKRAQQGSMQGGLE--FKTEIELLSRV-HHKNLVG 687 (964)
Q Consensus 614 ~~~~~~~e-l~~~~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~ 687 (964)
..+|.-++ ....+.+|.++..||.|.|+.||+...+ ++..+++|...........+ -..|+-+...+ .|.+++.
T Consensus 251 ~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 251 ANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred hheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCC
Confidence 34444445 4455678999999999999999988743 57889999876544332222 23566666666 4999999
Q ss_pred eeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-Cc
Q 002121 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LT 766 (964)
Q Consensus 688 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~ 766 (964)
.+..+......|+=-|||+++++...... ...++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.
T Consensus 331 ~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 331 KNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFF 405 (524)
T ss_pred CCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhh
Confidence 88888888888899999999988766522 235788889999999999999999877 9999999999999886 88
Q ss_pred EEEeecccceeecCCCCCceeecccccCccc--CccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYL--DPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~ 844 (964)
.+++|||++..+.-. .......-+++ +++......+-.+.|+||||.-+.|.+++..--..+.. |..
T Consensus 406 ~~~~~~~~~t~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---~~~--- 474 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---SLT--- 474 (524)
T ss_pred hhcccccccccccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---cee---
Confidence 899999998642211 11122333455 44555567788999999999999999998743322211 100
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
+..-.-+... . ....+..+...++..++..||.+.+.....+
T Consensus 475 ---------i~~~~~p~~~---~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 ---------IRSGDTPNLP---G-LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred ---------eecccccCCC---c-hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 0000001111 1 1144557788889999999999988765433
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.8e-12 Score=135.95 Aligned_cols=199 Identities=23% Similarity=0.259 Sum_probs=102.8
Q ss_pred CCcCCCCcccEEecccCCCCCC----CCCCCCCCcccchhhccccccccC----cCCcc-------cCCCCCccEEEccc
Q 002121 82 GDIGGLTELRSLDLSYNGGLTG----SLSPRIGDLQKLNILILAGCGFTG----NIPDE-------IGNLAELSFLALNS 146 (964)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~----~~p~~-------~~~l~~L~~L~Ls~ 146 (964)
+.+..+..++.|+|++| .+.. .+-..+.+.++|+..++++ -++| .+|.. +...++|++||||+
T Consensus 24 ~~~~~~~s~~~l~lsgn-t~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGN-TFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHhcccCceEEEeccCC-chhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 45677888899999998 4543 2344566677788887774 2333 24443 33456788888888
Q ss_pred CcccCcCCCc----CCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEE
Q 002121 147 NNFSGRIPPS----LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL 222 (964)
Q Consensus 147 N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~ 222 (964)
|.|...-+.. +..++.|++|.|.+|.+. ..-. ..++ ..|..|. .|+. ....+.|+.+.
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag-----~~l~--~al~~l~--~~kk--------~~~~~~Lrv~i 163 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAG-----GRLG--RALFELA--VNKK--------AASKPKLRVFI 163 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHH-----HHHH--HHHHHHH--HHhc--------cCCCcceEEEE
Confidence 8777444433 334566777777777665 1100 0000 0111111 1111 11233455555
Q ss_pred ccCCcCcccC----CcccCCCCCCcEEEcccCcCc--c--ccCccccCCCCCCeeeccCccCccCCC-----CCCCCCCC
Q 002121 223 FDGNQLSGNI----PESLGYVQTLEVLRLDRNALT--G--KVPTNLNNLTNVNELNLAHNDLKGPFP-----DLSQMNSL 289 (964)
Q Consensus 223 l~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~--~--~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L 289 (964)
..+|++.... ...|...+.|+.+.++.|.|. | .+...|..+++|+.|||.+|.++.... .+..+++|
T Consensus 164 ~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L 243 (382)
T KOG1909|consen 164 CGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHL 243 (382)
T ss_pred eeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchh
Confidence 5555555321 223444456666666666654 1 223345555556666666665553221 24444455
Q ss_pred CEEEccCCCCC
Q 002121 290 SYVDLSNNSFD 300 (964)
Q Consensus 290 ~~L~Ls~N~l~ 300 (964)
+.|++++|.+.
T Consensus 244 ~El~l~dcll~ 254 (382)
T KOG1909|consen 244 RELNLGDCLLE 254 (382)
T ss_pred eeecccccccc
Confidence 55555555554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.4e-09 Score=105.96 Aligned_cols=131 Identities=19% Similarity=0.319 Sum_probs=102.2
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEE-ecCCC-cc------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKR-AQQGS-MQ------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~-~~~~~-~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
..+++|+-+.+|.+.+. |..+++|. +.+.- .. ...+-.+|++++.+++--.|...+=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999874 44566663 32211 11 123467899999999877777777777788889999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
++|-.|.+.+... +..++..+-.-+.-||..+ |||+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888654 2456667777788899988 99999999999998775 99999999874
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-11 Score=132.36 Aligned_cols=184 Identities=23% Similarity=0.252 Sum_probs=137.6
Q ss_pred CCcccchhhccccccccCcCC--cccCCCCCccEEEcccCcccCcC--CCcCCCccccccccccccccccccCcccCCCC
Q 002121 110 GDLQKLNILILAGCGFTGNIP--DEIGNLAELSFLALNSNNFSGRI--PPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185 (964)
Q Consensus 110 ~~l~~L~~L~L~~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~ 185 (964)
+++.+|+...|.++.+. ..+ .....+++++.||||+|-|.... -.-...|++|+.|+|+.|++.-... . .
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~--s---~ 191 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS--S---N 191 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc--c---c
Confidence 46788999999998887 434 36778999999999999998422 2335678999999999999973222 1 1
Q ss_pred ccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccC--ccccCC
Q 002121 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVP--TNLNNL 263 (964)
Q Consensus 186 ~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l 263 (964)
.-..++.|+.|.|+.|.|+-.--..+....++|+.|+|..|...+.-......+..|+.|||++|++- ..+ ...+.+
T Consensus 192 ~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l 270 (505)
T KOG3207|consen 192 TTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTL 270 (505)
T ss_pred chhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccc
Confidence 12367889999999999974333444667889999999999654455555677889999999999987 333 567789
Q ss_pred CCCCeeeccCccCccCC-CC------CCCCCCCCEEEccCCCCC
Q 002121 264 TNVNELNLAHNDLKGPF-PD------LSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 264 ~~L~~L~Ls~N~l~~~~-~~------l~~l~~L~~L~Ls~N~l~ 300 (964)
+.|+.|+++.+.+..+- |+ ...+++|++|+++.|++.
T Consensus 271 ~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 271 PGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred cchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 99999999999988742 22 245677777777777774
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.1e-12 Score=133.37 Aligned_cols=218 Identities=24% Similarity=0.277 Sum_probs=146.4
Q ss_pred CCeeEEEcCCCCccc----cccCCcCCCCcccEEecccCCCCCCC----CCCC-------CCCcccchhhccccccccCc
Q 002121 64 SRVTALGLSTMGLTG----KLSGDIGGLTELRSLDLSYNGGLTGS----LSPR-------IGDLQKLNILILAGCGFTGN 128 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g----~~~~~l~~l~~L~~L~L~~N~~l~~~----~p~~-------l~~l~~L~~L~L~~n~l~~~ 128 (964)
..++.|+|++|.+.- .+.+.+.+.++|+..+++.- ++|. +|+. +...++|++|+||.|-|...
T Consensus 30 ~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~--ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 30 DSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM--FTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred CceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh--hcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 578999999998853 45567888999999999864 5554 3433 34456899999999999855
Q ss_pred CCcc----cCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccc
Q 002121 129 IPDE----IGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS 204 (964)
Q Consensus 129 ~p~~----~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~ 204 (964)
.+.. +.+...|+.|.|.+|-+.-.--..++. -|..|. .|+.. ..-+.|+++...+|++.
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk~-------------~~~~~Lrv~i~~rNrle 170 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKKA-------------ASKPKLRVFICGRNRLE 170 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhcc-------------CCCcceEEEEeeccccc
Confidence 4444 456789999999999987211111211 133322 22221 13345666666666664
Q ss_pred c---cccccccCCCcceeEEEccCCcCcc----cCCcccCCCCCCcEEEcccCcCcc----ccCccccCCCCCCeeeccC
Q 002121 205 G---TISEQLFSPDMVLIHVLFDGNQLSG----NIPESLGYVQTLEVLRLDRNALTG----KVPTNLNNLTNVNELNLAH 273 (964)
Q Consensus 205 g---~l~~~~f~~~~~L~~L~l~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~ 273 (964)
. ..-...|...+.|+.+.++.|.|.. .+...|..+++|+.|||..|-|+. .+...++.+++|++|++++
T Consensus 171 n~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~d 250 (382)
T KOG1909|consen 171 NGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGD 250 (382)
T ss_pred cccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccc
Confidence 1 1112336666777777777777652 233567889999999999999982 3566788899999999999
Q ss_pred ccCccCCCC-----C-CCCCCCCEEEccCCCCC
Q 002121 274 NDLKGPFPD-----L-SQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 274 N~l~~~~~~-----l-~~l~~L~~L~Ls~N~l~ 300 (964)
+.+...... + ...++|++|.|.+|.++
T Consensus 251 cll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt 283 (382)
T KOG1909|consen 251 CLLENEGAIAFVDALKESAPSLEVLELAGNEIT 283 (382)
T ss_pred cccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence 999764431 1 23556666666666664
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=9.1e-11 Score=116.38 Aligned_cols=106 Identities=24% Similarity=0.331 Sum_probs=23.4
Q ss_pred CCCCcEEEcccCcCccccCcccc-CCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCccc-CCCCCCcE
Q 002121 239 VQTLEVLRLDRNALTGKVPTNLN-NLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWF-STLPSLTT 316 (964)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~ 316 (964)
..+++.|+|++|+|+ .+. .++ .+.+|+.|+|++|.|+.+ +.+..++.|+.|++++|.|+ . +...+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~-~Ie-~L~~~l~~L~~L~Ls~N~I~~l-~~l~~L~~L~~L~L~~N~I~-~-i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIS-TIE-NLGATLDKLEVLDLSNNQITKL-EGLPGLPRLKTLDLSNNRIS-S-ISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---TT----TT--EEE--SS----S--CHHHHHH-TT--E
T ss_pred ccccccccccccccc-ccc-chhhhhcCCCEEECCCCCCccc-cCccChhhhhhcccCCCCCC-c-cccchHHhCCcCCE
Confidence 334555555555555 222 232 345555555555555543 23444555555555555553 1 11112 23455555
Q ss_pred EECCCCcccccc-ChhccCCCCCCEEEcCCcccc
Q 002121 317 LICEFGSLQGRV-PDKLFSYSQIQQVKLRNNAFN 349 (964)
Q Consensus 317 L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 349 (964)
|+|++|+|.... -..+..+++|+.|+|.+|++.
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 555555554321 123344445555555555444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.4e-11 Score=140.25 Aligned_cols=130 Identities=28% Similarity=0.287 Sum_probs=74.3
Q ss_pred CCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccc
Q 002121 110 GDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQ 189 (964)
Q Consensus 110 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~ 189 (964)
..+..++.+.+..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+.. ..+..
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i--------~~l~~ 138 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKL--------EGLST 138 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccc--------cchhh
Confidence 45566677777777776 33444667777777777777777 3333366677777777777777722 23555
Q ss_pred ccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCC-cccCCCCCCcEEEcccCcCc
Q 002121 190 LKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLDRNALT 253 (964)
Q Consensus 190 l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 253 (964)
++.|+.|++++|.|. .+.. |..+..|+.+++++|++...-+ . ...+.+|+.+++.+|.+.
T Consensus 139 l~~L~~L~l~~N~i~-~~~~--~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 139 LTLLKELNLSGNLIS-DISG--LESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred ccchhhheeccCcch-hccC--CccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 666777777777765 2221 2223444444444444443222 1 234444444555555444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-09 Score=103.35 Aligned_cols=143 Identities=22% Similarity=0.258 Sum_probs=108.0
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEE-ecCCC-c------chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKR-AQQGS-M------QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~-~~~~~-~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
....|-+|+-+.|+++.+ .|+...||. +.+.- . -...+.++|++.|.+++--.|.-..=++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 457889999999999999 477777773 32211 1 12346788999999998767776666777777888999
Q ss_pred EeccC-CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cEEEeeccccee
Q 002121 703 EFMAN-GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~ 777 (964)
||+++ -++.+++...-..+..-.....++.+|-+.+.-||..+ ||||||.++||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 47777775443333333344788899999999999988 99999999999996554 458999999864
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.9e-11 Score=139.55 Aligned_cols=219 Identities=27% Similarity=0.368 Sum_probs=154.9
Q ss_pred CCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccc
Q 002121 85 GGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLY 164 (964)
Q Consensus 85 ~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 164 (964)
..+..++.++|..| .+. .+-..+..+.+|+.|++.+|+|. .+...+..+++|++|+|++|.|+... .+..++.|+
T Consensus 69 ~~l~~l~~l~l~~n-~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQN-LIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchh-hhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchh
Confidence 35677777788887 333 34456788889999999999998 44444788899999999999998553 477778899
Q ss_pred cccccccccccccCcccCCCCccccccCCCeeEccCCcccccccc-cccCCCcceeEEEccCCcCcccCCcccCCCCCCc
Q 002121 165 WLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE-QLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLE 243 (964)
Q Consensus 165 ~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~-~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~ 243 (964)
.|++++|.++ .+ ..+..+++|+.+++++|++. .+.. . ...+..++.+++.+|.+... ..+..+..+.
T Consensus 144 ~L~l~~N~i~-~~-------~~~~~l~~L~~l~l~~n~i~-~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~ 211 (414)
T KOG0531|consen 144 ELNLSGNLIS-DI-------SGLESLKSLKLLDLSYNRIV-DIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLV 211 (414)
T ss_pred hheeccCcch-hc-------cCCccchhhhcccCCcchhh-hhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHH
Confidence 9999999988 32 35666889999999999987 4443 2 35667788899999988732 3345556666
Q ss_pred EEEcccCcCccccCccccCCC--CCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCC
Q 002121 244 VLRLDRNALTGKVPTNLNNLT--NVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF 321 (964)
Q Consensus 244 ~L~Ls~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~ 321 (964)
.+++..|.++..-+ +..+. .|+.+++++|.+......+..+..+..|++.+|++.... .+...+.+..+.++.
T Consensus 212 ~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~~~~~---~~~~~~~~~~~~~~~ 286 (414)
T KOG0531|consen 212 LLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRISNLE---GLERLPKLSELWLND 286 (414)
T ss_pred HhhcccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhccccccc---cccccchHHHhccCc
Confidence 77888888883322 12222 378888888888866556677777888888888875221 134445556666666
Q ss_pred Cccc
Q 002121 322 GSLQ 325 (964)
Q Consensus 322 N~l~ 325 (964)
|.+.
T Consensus 287 ~~~~ 290 (414)
T KOG0531|consen 287 NKLA 290 (414)
T ss_pred chhc
Confidence 6654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.7e-10 Score=114.41 Aligned_cols=103 Identities=24% Similarity=0.313 Sum_probs=41.1
Q ss_pred CCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCC-CCCCCCCEEEccCCCCCCCCCCcccCCCCCCcE
Q 002121 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL-SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTT 316 (964)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 316 (964)
.+.+|+.|+|++|.|+ .+. .+..+++|++|+|++|+|+.+.+.+ ..+++|++|+|++|+|.....-..+..+++|+.
T Consensus 40 ~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 40 TLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp T-TT--EEE-TTS--S---T-T----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 3566666666666666 232 3555666666666666666554333 246667777777777654444455667777777
Q ss_pred EECCCCcccccc---ChhccCCCCCCEEE
Q 002121 317 LICEFGSLQGRV---PDKLFSYSQIQQVK 342 (964)
Q Consensus 317 L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 342 (964)
|+|.+|.+.... ...+..+|+|+.||
T Consensus 118 L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 118 LSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred eeccCCcccchhhHHHHHHHHcChhheeC
Confidence 888777776431 12445677777766
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=3.1e-10 Score=134.41 Aligned_cols=250 Identities=19% Similarity=0.208 Sum_probs=165.9
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
..+.|.+.+.+-+|.++.++.+.-. .|...+.|+..... ....+....+-.++-..+||-++....-+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456666778889999999987632 34344444332211 1111223334344444456777766655555677899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|++|..+++|...++... ..+.......+..+..+++|||... +.|||++|.|.+...++..+++|||+......
T Consensus 882 ~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccccc
Confidence 999999999999998764 3444444455566778899999876 89999999999999999999999984432210
Q ss_pred C-----------------------------CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q 002121 781 S-----------------------------SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831 (964)
Q Consensus 781 ~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~ 831 (964)
- +.........||+.|.|||...+......+|.|++|++++|.++|.+||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 00011234569999999999999999999999999999999999999996
Q ss_pred CCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002121 832 KGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMS 892 (964)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 892 (964)
..... +.++.+... +..+..-.........+++.+.+..+|.+|-.|.
T Consensus 1037 a~tpq-~~f~ni~~~------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQ-QIFENILNR------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchh-hhhhccccC------------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 43211 111111111 1111111222223345788888899999997766
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.6e-08 Score=108.33 Aligned_cols=141 Identities=18% Similarity=0.138 Sum_probs=103.3
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcch-----------hHHHHHHHHHHHhcCCCCc--cceeEEEEe-----
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG-----------GLEFKTEIELLSRVHHKNL--VGLVGFCFE----- 694 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nI--v~l~~~~~~----- 694 (964)
+.+-+-....|++..+ +|+.|.||+........ ...+.+|.+.+.++...+| .+++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 3344444455777777 57899999875433211 1147899999999865444 455666654
Q ss_pred eCceEEEEEeccCC-ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-------CCc
Q 002121 695 QGEQMLVYEFMANG-TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-------NLT 766 (964)
Q Consensus 695 ~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------~~~ 766 (964)
...-+||||++++- +|.+++......+.+...+..++.+++..++-||..| |+|+|++++|||++. ++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 23468999999986 8998875322224556677899999999999999999 999999999999975 578
Q ss_pred EEEeeccccee
Q 002121 767 AKVADFGLSKL 777 (964)
Q Consensus 767 ~kl~DFGla~~ 777 (964)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.8e-08 Score=101.71 Aligned_cols=125 Identities=22% Similarity=0.281 Sum_probs=84.0
Q ss_pred EEEEEEecCCcEEEEEEecCCCc---------------------c-----hhHHHHHHHHHHHhcCCC--CccceeEEEE
Q 002121 642 KVYRGMLSDGQVVAIKRAQQGSM---------------------Q-----GGLEFKTEIELLSRVHHK--NLVGLVGFCF 693 (964)
Q Consensus 642 ~Vy~~~~~~g~~vavK~~~~~~~---------------------~-----~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 693 (964)
.||.|...+|..+|||..+.... . .....++|.+.|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 49999999999999998653210 0 012367899999999866 45566544
Q ss_pred eeCceEEEEEecc--CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHH-HhhcCCCCeeccCCCCCcEEECCCCcEEEe
Q 002121 694 EQGEQMLVYEFMA--NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY-LHELANPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 694 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
...+|||||++ +..+..+... .++......++.+++..+.. +|..+ |||||+.+.||+++++ .+.|+
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE-
T ss_pred --eCCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEE
Confidence 35579999998 5555444332 12345566777888886555 46777 9999999999999988 99999
Q ss_pred ecccceee
Q 002121 771 DFGLSKLV 778 (964)
Q Consensus 771 DFGla~~~ 778 (964)
|||.+...
T Consensus 149 Df~qav~~ 156 (188)
T PF01163_consen 149 DFGQAVDS 156 (188)
T ss_dssp -GTTEEET
T ss_pred ecCcceec
Confidence 99988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.3e-07 Score=104.76 Aligned_cols=166 Identities=16% Similarity=0.259 Sum_probs=127.8
Q ss_pred EEEEEEE-ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe----eCceEEEEEeccC-CChhhhh
Q 002121 641 GKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE----QGEQMLVYEFMAN-GTLRESL 714 (964)
Q Consensus 641 g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~l 714 (964)
.+.||+. ..+|..|++|+++............-+++++++.|.|+|++.+++.. +...++||+|.|+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 5889998 45899999999954433322223456889999999999999998873 4467999999986 6787754
Q ss_pred cCC-------------CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 715 SGR-------------SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 715 ~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
... .+...++...|.++.|++.||.++|+.| ..-+-|.+.+||++.+.+++|+--|....+..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 321 1334678999999999999999999998 888999999999999999999988877665443
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCC
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQ 828 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~ 828 (964)
.. |.+.. -.+-|.=.||.+++.|.||..
T Consensus 447 ~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 447 PT----------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC----------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 11111 235688899999999999954
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.7e-09 Score=133.11 Aligned_cols=282 Identities=23% Similarity=0.262 Sum_probs=148.3
Q ss_pred CeeEEEcCCCC--ccccccC-CcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccE
Q 002121 65 RVTALGLSTMG--LTGKLSG-DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSF 141 (964)
Q Consensus 65 ~v~~L~L~~~~--l~g~~~~-~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 141 (964)
.+++|-+..|. +. .++. .|..++.|+.|||++| .-.+.+|..+++|.+|++|+|+++.++ .+|..+++|+.|.+
T Consensus 546 ~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~-~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGN-SSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY 622 (889)
T ss_pred ccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCC-CccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence 57777777775 33 3443 3667888888888887 566788888888888888888888888 78888888888888
Q ss_pred EEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCccee--
Q 002121 142 LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLI-- 219 (964)
Q Consensus 142 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~-- 219 (964)
||+..+.-...+|..+..|++|++|.+..-... ........+..+.+|+.|........ +-.. +..+..|.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~----~~~~~l~el~~Le~L~~ls~~~~s~~--~~e~-l~~~~~L~~~ 695 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALS----NDKLLLKELENLEHLENLSITISSVL--LLED-LLGMTRLRSL 695 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccc----cchhhHHhhhcccchhhheeecchhH--hHhh-hhhhHHHHHH
Confidence 888887766566666777888888887654421 11111123334444444444222210 0000 01111111
Q ss_pred --EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCC
Q 002121 220 --HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297 (964)
Q Consensus 220 --~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 297 (964)
.+.+.++... ..+..+..+.+|+.|.+.++.+.......+.....+. .++++..+...++
T Consensus 696 ~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~-----------------~f~~l~~~~~~~~ 757 (889)
T KOG4658|consen 696 LQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLL-----------------CFPNLSKVSILNC 757 (889)
T ss_pred hHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhh-----------------hHHHHHHHHhhcc
Confidence 1111111111 2222334444444444444444321111111111110 0111111111111
Q ss_pred CCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc-cCCCCccCCCCcEEeccCCcceeec
Q 002121 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT-LDMGNAVGPLLQLVDLQNNQISAIT 376 (964)
Q Consensus 298 ~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~i~ 376 (964)
. ....+.+....++|+.|.+..+.....+......+..++.+.+..+.+.+. .-.....++++..+.+..=.|..+.
T Consensus 758 ~--~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~~l~~~~ 835 (889)
T KOG4658|consen 758 H--MLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFLKLEELI 835 (889)
T ss_pred c--cccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCccchhhee
Confidence 1 133344444557777777777766656665566666666666666666665 3445555555555554444444433
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.78 E-value=2.6e-07 Score=99.81 Aligned_cols=260 Identities=18% Similarity=0.188 Sum_probs=156.7
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEE----E---eeCceEEEE
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC----F---EQGEQMLVY 702 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~----~---~~~~~~lV~ 702 (964)
..+.||+|+-+.+|-.- +-...+.|+++........ +.++.|... .||-+-.=+.+= . ......+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 34779999999999532 1122356777655443322 233444444 466433211111 1 122356788
Q ss_pred EeccCCC-hhhhhc---C-CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 703 EFMANGT-LRESLS---G-RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~gs-L~~~l~---~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
..+++.- ...++. . ++-...+|.-.++++..+|.+.+-||++| .+-+|+.++|+|+.+++.+.|.|=.--..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8776642 222221 1 12345899999999999999999999999 88899999999999999999998654333
Q ss_pred ecCCCCCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhC-CCCCCCCc--------hhHHHHHHH
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITA-KQPIEKGK--------YVVREVRTA 843 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg-~~p~~~~~--------~~~~~~~~~ 843 (964)
. ..+......+|...|.+||.-. +..-+...|-|.+||++++++.| ++||..-. ...+.....
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~ 243 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGR 243 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcce
Confidence 2 2233445567999999999754 33456789999999999999987 89986210 000110000
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcC--CCCCCCHHHHHHHHHHHHHh
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEES--ATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~~~~~ 904 (964)
+....+.. .....+...-...--...+..+..+|+... +.-||+++..+..|..+.++
T Consensus 244 f~ya~~~~---~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 244 FAYASDQR---RGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeechhcc---CCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 00000000 000000000001111234557788898754 56799999998877766544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.3e-07 Score=97.82 Aligned_cols=133 Identities=22% Similarity=0.241 Sum_probs=95.5
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEEecCCCc----------------------chhHHHHHHHHHHHhcCCC--Ccc
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM----------------------QGGLEFKTEIELLSRVHHK--NLV 686 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~H~--nIv 686 (964)
+...||.|.-+.||.|..+.|.++|||.-+.... ..+...++|.++|.++.-. .+.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 3478999999999999999999999995432111 1123467899999999754 677
Q ss_pred ceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc
Q 002121 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 687 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
+.+++ +...+||||+++--|...-- +....-.++..|.+-+.-.-..| |||+|+.+-||+++++|.
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred Ccccc----ccceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 77653 67789999999866654321 12222333344444343333556 999999999999999999
Q ss_pred EEEeeccccee
Q 002121 767 AKVADFGLSKL 777 (964)
Q Consensus 767 ~kl~DFGla~~ 777 (964)
+.++||--+..
T Consensus 241 ~~vIDwPQ~v~ 251 (304)
T COG0478 241 IVVIDWPQAVP 251 (304)
T ss_pred EEEEeCccccc
Confidence 99999976643
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.8e-08 Score=82.24 Aligned_cols=61 Identities=25% Similarity=0.336 Sum_probs=41.3
Q ss_pred CCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcc
Q 002121 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQI 372 (964)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (964)
|+|+.|+|++|+|+...+..|.++++|++|+|++|+++...+..|..+++|+.|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666666666666666666677777777777777666666777777777777777664
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.1e-10 Score=127.64 Aligned_cols=177 Identities=25% Similarity=0.252 Sum_probs=127.3
Q ss_pred CCcceeEEEccCCcCcccCCcccCCC-CCCcEEEcccCcCc---cccC---ccccC---CCCCCeeeccCccCccCCCCC
Q 002121 214 PDMVLIHVLFDGNQLSGNIPESLGYV-QTLEVLRLDRNALT---GKVP---TNLNN---LTNVNELNLAHNDLKGPFPDL 283 (964)
Q Consensus 214 ~~~~L~~L~l~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~---~~~p---~~~~~---l~~L~~L~Ls~N~l~~~~~~l 283 (964)
+...|++|.|.++.|.. ...+..+ .+|+.|.. +|.+. ..+. ..+++ +..|...+.+.|.|+-.-..+
T Consensus 107 pF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~~Wn~L~~a~fsyN~L~~mD~SL 183 (1096)
T KOG1859|consen 107 PFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSPVWNKLATASFSYNRLVLMDESL 183 (1096)
T ss_pred cccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccchhhhhHhhhhcchhhHHhHHHHH
Confidence 45678999999888874 1112222 24555533 33332 1111 11111 457888999999999887788
Q ss_pred CCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCc
Q 002121 284 SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQ 363 (964)
Q Consensus 284 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 363 (964)
.-++.|+.|+|++|+++.. +.+..+++|++|||++|.+..+.--...++. |+.|+|+||.++.. ..+.++.+|+
T Consensus 184 qll~ale~LnLshNk~~~v---~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie~LksL~ 257 (1096)
T KOG1859|consen 184 QLLPALESLNLSHNKFTKV---DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIENLKSLY 257 (1096)
T ss_pred HHHHHhhhhccchhhhhhh---HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHHhhhhhh
Confidence 8899999999999999622 2688999999999999999854433444444 99999999999765 4577899999
Q ss_pred EEeccCCcceeecc----CCCcccceeEeecCCccccccc
Q 002121 364 LVDLQNNQISAITL----GSGIKNYTLILVGNPVCTATLA 399 (964)
Q Consensus 364 ~L~L~~N~l~~i~~----~~~~~l~~l~l~~Np~c~~~l~ 399 (964)
.|||+.|-|..... .....+..|+|.|||+|+....
T Consensus 258 ~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p~h 297 (1096)
T KOG1859|consen 258 GLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAPWH 297 (1096)
T ss_pred ccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCHHH
Confidence 99999999998753 3444578899999998876654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.4e-08 Score=80.58 Aligned_cols=60 Identities=33% Similarity=0.480 Sum_probs=32.8
Q ss_pred ceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccC
Q 002121 217 VLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDL 276 (964)
Q Consensus 217 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 276 (964)
+|++|++++|+|+...+..|..+++|++|++++|.++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 344455555555544445555555555555555555555555555555555555555543
|
... |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.59 E-value=1.1e-06 Score=89.29 Aligned_cols=138 Identities=16% Similarity=0.111 Sum_probs=105.1
Q ss_pred eecCCcEEEEEEEecCCcEEEEEEecCCC------cchhHHHHHHHHHHHhcCCCC--ccceeEEEE-ee----CceEEE
Q 002121 635 IGSGGYGKVYRGMLSDGQVVAIKRAQQGS------MQGGLEFKTEIELLSRVHHKN--LVGLVGFCF-EQ----GEQMLV 701 (964)
Q Consensus 635 lG~G~fg~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~-~~----~~~~lV 701 (964)
-|+||.+-|++..+. |+.+-+|+-...- +-.+..|.+|...|.++...+ +.+++ ++. .. ..-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 367899999998874 5578999765211 235568999999999996433 44555 333 21 235799
Q ss_pred EEeccC-CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc--EEEeeccccee
Q 002121 702 YEFMAN-GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT--AKVADFGLSKL 777 (964)
Q Consensus 702 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~~ 777 (964)
+|-+++ -+|.+++....-.+.+...+..+..+++..++-||..+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998764 58999886644335677888999999999999999998 999999999999986666 99999986653
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.5e-08 Score=122.86 Aligned_cols=253 Identities=20% Similarity=0.265 Sum_probs=130.2
Q ss_pred cccEEecccCCC-CCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccc
Q 002121 89 ELRSLDLSYNGG-LTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLD 167 (964)
Q Consensus 89 ~L~~L~L~~N~~-l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (964)
.|++|-+..|.. +.......|..++.|+.|||++|.=-+.+|..++.|-+|++|+|+++.++ .+|..+.+|..|.+||
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 456666655521 22222223555666666666655544456666666666666666666666 5566666666666666
Q ss_pred ccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEc
Q 002121 168 LADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247 (964)
Q Consensus 168 Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 247 (964)
+..+.-...+| .....|.+|++|.+..-.. ..+...-..+.++.+|+.|..
T Consensus 625 l~~~~~l~~~~------~i~~~L~~Lr~L~l~~s~~-----------------------~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 625 LEVTGRLESIP------GILLELQSLRVLRLPRSAL-----------------------SNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred ccccccccccc------chhhhcccccEEEeecccc-----------------------ccchhhHHhhhcccchhhhee
Confidence 66555432222 2233355555555543321 111122223344555555555
Q ss_pred ccCcCccccCccccCCCCCC----eeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCC------CCCcEE
Q 002121 248 DRNALTGKVPTNLNNLTNVN----ELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL------PSLTTL 317 (964)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l------~~L~~L 317 (964)
..... .+-..+..+++|. .+.+.++........+..+.+|+.|.+.++.+. .....++... +++..+
T Consensus 676 ~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~~~~~~~~~l~~L~~L~i~~~~~~-e~~~~~~~~~~~~~~f~~l~~~ 752 (889)
T KOG4658|consen 676 TISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKRTLISSLGSLGNLEELSILDCGIS-EIVIEWEESLIVLLCFPNLSKV 752 (889)
T ss_pred ecchh--HhHhhhhhhHHHHHHhHhhhhcccccceeecccccccCcceEEEEcCCCc-hhhcccccccchhhhHHHHHHH
Confidence 33322 1112223333333 333334455555666788888888888888875 2222222111 122221
Q ss_pred ECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceee
Q 002121 318 ICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAI 375 (964)
Q Consensus 318 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i 375 (964)
...++... ..+....-.++|+.|.+..++....+......+..+..+-+..+.+..+
T Consensus 753 ~~~~~~~~-r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l 809 (889)
T KOG4658|consen 753 SILNCHML-RDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGL 809 (889)
T ss_pred Hhhccccc-cccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccc
Confidence 11111111 1222223468899999998888777777777777777666666666554
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.56 E-value=4.5e-10 Score=127.32 Aligned_cols=87 Identities=29% Similarity=0.266 Sum_probs=44.3
Q ss_pred cCCCCCCcEEEcccCcCccccCcc-ccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCC
Q 002121 236 LGYVQTLEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSL 314 (964)
Q Consensus 236 ~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 314 (964)
+..+++|++|||+.|.|+ .+|.. -.++ .|..|.|++|.++.. -++.+|.+|+.||+++|-|.+-..-..+..|..|
T Consensus 205 Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lrnN~l~tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L 281 (1096)
T KOG1859|consen 205 LRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLRNNALTTL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSL 281 (1096)
T ss_pred HHhcccccccccccchhc-cccccchhhh-hheeeeecccHHHhh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHH
Confidence 444555555555555555 33322 1222 255555555555532 2345555666666666665533333344455566
Q ss_pred cEEECCCCccc
Q 002121 315 TTLICEFGSLQ 325 (964)
Q Consensus 315 ~~L~Ls~N~l~ 325 (964)
+.|+|.+|.+-
T Consensus 282 ~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 282 IVLWLEGNPLC 292 (1096)
T ss_pred HHHhhcCCccc
Confidence 66666666654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.1e-07 Score=92.60 Aligned_cols=106 Identities=25% Similarity=0.286 Sum_probs=86.0
Q ss_pred HHHHHHHHHHHhcCCCC--ccceeEEEEeeC----ceEEEEEeccCC-ChhhhhcCCCCCccchHHHHHHHHHHHHHHHH
Q 002121 668 LEFKTEIELLSRVHHKN--LVGLVGFCFEQG----EQMLVYEFMANG-TLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740 (964)
Q Consensus 668 ~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~y 740 (964)
....+|...+.++.... ..+.+++.+... ..+||||++++- +|.+++.... ..+...+..++.++++.++-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 46788999988886443 557777776532 348999999874 8999887633 25566788999999999999
Q ss_pred HhhcCCCCeeccCCCCCcEEECCCC---cEEEeecccceee
Q 002121 741 LHELANPPIIHRDVKSTNILLDENL---TAKVADFGLSKLV 778 (964)
Q Consensus 741 LH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~~ 778 (964)
||+.+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 134 lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 99999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4e-08 Score=112.89 Aligned_cols=151 Identities=20% Similarity=0.317 Sum_probs=98.3
Q ss_pred HHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce-------eecccccCcccCcccccc
Q 002121 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV-------STQVKGTMGYLDPEYYMT 804 (964)
Q Consensus 732 ~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 804 (964)
.+++.|+.|+|.. ..+||++|.|++|.++..+..||+.|+.+........... ..-......|.|||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999974 4599999999999999999999999998765433111110 011124567999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcC
Q 002121 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEES 884 (964)
Q Consensus 805 ~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~d 884 (964)
...+.++|+||+||++|-+..|..+.......................... ..+ ..++.+=+.+.+..+
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s----~~~-------p~el~~~l~k~l~~~ 252 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS----NNL-------PSELRESLKKLLNGD 252 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc----ccC-------cHHHHHHHHHHhcCC
Confidence 888999999999999999995555543221111111111111110000011 111 245567778899999
Q ss_pred CCCCCCHHHHH
Q 002121 885 ATDRPTMSEVV 895 (964)
Q Consensus 885 P~~RPs~~evl 895 (964)
+..||++.++.
T Consensus 253 ~~~rp~~~~l~ 263 (700)
T KOG2137|consen 253 SAVRPTLDLLL 263 (700)
T ss_pred cccCcchhhhh
Confidence 99999887764
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.8e-08 Score=103.63 Aligned_cols=187 Identities=26% Similarity=0.304 Sum_probs=98.8
Q ss_pred cccchhhccccccccC--cCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccc
Q 002121 112 LQKLNILILAGCGFTG--NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQ 189 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~ 189 (964)
.+.++.|||.+|.|+. .+-.-+.+|+.|++|+|+.|++...|-..-..+.+|+.|-|.+..+. +.-....+..
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~-----w~~~~s~l~~ 144 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLS-----WTQSTSSLDD 144 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCC-----hhhhhhhhhc
Confidence 4667778888887762 24444667888888888888887443222134557777777766654 1111134566
Q ss_pred ccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCc--ccCCCCCCcEEEcccCcCccccCccccCCCCCC
Q 002121 190 LKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE--SLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVN 267 (964)
Q Consensus 190 l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 267 (964)
+|.++.|+++.|.+. .+++..|-++...|. .+..++++..+.++-|++... ++++.
T Consensus 145 lP~vtelHmS~N~~r---------------q~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~-------Fpnv~ 202 (418)
T KOG2982|consen 145 LPKVTELHMSDNSLR---------------QLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRI-------FPNVN 202 (418)
T ss_pred chhhhhhhhccchhh---------------hhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhh-------cccch
Confidence 777777777777543 223333333321111 112223333333333343322 23455
Q ss_pred eeeccCccCccCCCC--CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccc
Q 002121 268 ELNLAHNDLKGPFPD--LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 268 ~L~Ls~N~l~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
.+.+..|.|...... ...++.+..|+|+.|+|..-..-+.+.++++|..|.+++|.|.
T Consensus 203 sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 203 SVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred heeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 555555655544332 4445555556666666643333444555555666655555554
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.2e-06 Score=101.64 Aligned_cols=141 Identities=22% Similarity=0.289 Sum_probs=95.5
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcc---------------------h-------------------hHHHHH
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ---------------------G-------------------GLEFKT 672 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~---------------------~-------------------~~~~~~ 672 (964)
+.|+.++-|.||+|++++|+.||||+.+..-.. . +-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 678999999999999999999999986542110 0 012455
Q ss_pred HHHHHHhcC-----CCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHH-HHHHhhcCC
Q 002121 673 EIELLSRVH-----HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG-LAYLHELAN 746 (964)
Q Consensus 673 E~~~l~~l~-----H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~yLH~~~~ 746 (964)
|+.-+.+++ .+++.-..=|++-.+...|+|||++|-.+.+...-.. ...+ +..++..++++ +..+=..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHHhcC-
Confidence 666666653 3333322223333567899999999988887742221 2244 33344444333 33333345
Q ss_pred CCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 747 ~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
++|.|..|.||+++.+|++.+.|||+...+++
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.37 E-value=4.2e-06 Score=87.92 Aligned_cols=138 Identities=17% Similarity=0.222 Sum_probs=86.5
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc--cceeEEEEeeCceEEEEEeccCCC-
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL--VGLVGFCFEQGEQMLVYEFMANGT- 709 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~~~~lV~E~~~~gs- 709 (964)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999983 25567889876533 23457899999999975444 577888777777889999999863
Q ss_pred hhhh---------------------hcCCCCCccchHHHHH-H---HH-------HH-HHHHHHHhhc-CCCCeeccCCC
Q 002121 710 LRES---------------------LSGRSGIHLDWKRRLR-I---AL-------GS-ARGLAYLHEL-ANPPIIHRDVK 755 (964)
Q Consensus 710 L~~~---------------------l~~~~~~~l~~~~~~~-i---~~-------~i-a~gL~yLH~~-~~~~ivH~Dlk 755 (964)
+.+. +|...........+.. + +. .+ ....++|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 2111 1221100111000000 0 00 00 0112222211 23457899999
Q ss_pred CCcEEECCCCcEEEeecccce
Q 002121 756 STNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 756 ~~NILl~~~~~~kl~DFGla~ 776 (964)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 964 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-57 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-57 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-30 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-27 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-27 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-27 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-27 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-27 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-25 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-24 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-23 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-23 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-23 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-23 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-23 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-23 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-23 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 6e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-23 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-23 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-23 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-23 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-22 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-22 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-22 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-22 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-22 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-22 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-22 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-22 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-22 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-22 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-22 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-22 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-22 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-22 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-22 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-22 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-22 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-21 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-21 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-21 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-21 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-21 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-21 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-21 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-21 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-21 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-21 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-21 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-21 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-21 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-21 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-21 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-21 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-21 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-21 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-21 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-21 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-21 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-21 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-21 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-20 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-20 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-20 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-20 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-19 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-19 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-18 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-18 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-18 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-18 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-18 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-18 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-18 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-18 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-18 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-18 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-18 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-18 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-18 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 8e-18 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-17 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-17 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-17 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-17 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-17 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 6e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-16 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 8e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 9e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-15 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-15 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-15 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 7e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-14 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-14 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 6e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 8e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 8e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 9e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-13 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-13 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-13 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-13 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-13 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-13 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-13 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-13 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-12 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 4e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 5e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 7e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 8e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 8e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-11 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-11 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-11 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-11 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 7e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-10 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 7e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 9e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-09 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-09 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 8e-09 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 6e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 7e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 8e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 8e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-06 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-06 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-06 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-06 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 6e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-06 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 478 bits (1233), Expect = e-163
Identities = 127/323 (39%), Positives = 191/323 (59%), Gaps = 16/323 (4%)
Query: 589 IGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGML 648
+G A+ + + S + +L++ +NNF IG G +GKVY+G+L
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 649 SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANG 708
DG VA+KR S QG EF+TEIE LS H +LV L+GFC E+ E +L+Y++M NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 709 TLRESLSGRSG--IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766
L+ L G + + W++RL I +G+ARGL YLH IIHRDVKS NILLDEN
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFV 177
Query: 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITA 826
K+ DFG+SK ++ + H+ST VKGT+GY+DPEY++ +LTEKSDVYSFGVV+ E++ A
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 827 KQPIEKGK-----YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV-LLGFRRYLELALQC 880
+ I + + + N L +++DP + + + R++ + A++C
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQ-----LEQIVDPNLADKIRPESLRKFGDTAVKC 292
Query: 881 VEESATDRPTMSEVVKAIETLLQ 903
+ S+ DRP+M +V+ +E L+
Sbjct: 293 LALSSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 408 bits (1051), Expect = e-135
Identities = 128/300 (42%), Positives = 188/300 (62%), Gaps = 17/300 (5%)
Query: 611 LKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGG-LE 669
L + FS EL+ S+NFS N +G GG+GKVY+G L+DG +VA+KR ++ QGG L+
Sbjct: 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ 73
Query: 670 FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG--IHLDWKRR 727
F+TE+E++S H+NL+ L GFC E++LVY +MANG++ L R LDW +R
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
RIALGSARGLAYLH+ +P IIHRDVK+ NILLDE A V DFGL+KL+ HV+
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY-KDTHVT 192
Query: 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPI-------EKGKYVVREV 840
T V+GT+G++ PEY T + +EK+DV+ +GV++LELIT ++ + ++ V
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 841 RTAMNRDDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
+ + L ++D ++ + +++AL C + S +RP MSEVV+ +E
Sbjct: 253 KGLLKEKK-----LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-129
Identities = 97/302 (32%), Positives = 166/302 (54%), Gaps = 23/302 (7%)
Query: 615 RWFSYDELKKCSNNFSE------SNEIGSGGYGKVYRGMLSDGQVVAIKR----AQQGSM 664
FS+ ELK +NNF E N++G GG+G VY+G + + VA+K+ +
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 665 QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG-IHLD 723
+ +F EI+++++ H+NLV L+GF + + LVY +M NG+L + LS G L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLS 131
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783
W R +IA G+A G+ +LHE IHRD+KS NILLDE TAK++DFGL++ ++
Sbjct: 132 WHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK---YVVREV 840
+++++ GT Y+ PE + ++T KSD+YSFGVV+LE+IT +++ + ++
Sbjct: 189 TVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247
Query: 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900
+ + + + +D + + +A QC+ E RP + +V + ++
Sbjct: 248 EEIEDEEK----TIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 901 LL 902
+
Sbjct: 304 MT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 3e-95
Identities = 74/314 (23%), Positives = 125/314 (39%), Gaps = 28/314 (8%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIEL 676
+ L S G +G V++ L + VA+K Q + + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 677 LSRVHHKNLVGLVGFCFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL 732
L + H+N++ +G + L+ F G+L + L + W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELCHIAE 128
Query: 733 GSARGLAYLHE-------LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785
ARGLAYLHE P I HRD+KS N+LL NLTA +ADFGL+
Sbjct: 129 TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAG 188
Query: 786 VSTQVKGTMGYLDPEY-----YMTQQLTEKSDVYSFGVVMLELITAKQPIEK--GKYVV- 837
+ GT Y+ PE + + D+Y+ G+V+ EL + + +Y++
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248
Query: 838 --REVRTAMNRDDEEHYGLTEMMDPTIRNTVL--LGFRRYLELALQCVEESATDRPTMSE 893
E+ + +D + + + P +R+ G E +C + A R +
Sbjct: 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGC 308
Query: 894 VVKAIETLLQNDGM 907
V + I + + +
Sbjct: 309 VGERITQMQRLTNI 322
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 251 bits (643), Expect = 5e-76
Identities = 79/338 (23%), Positives = 131/338 (38%), Gaps = 45/338 (13%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIE- 675
+ E +N IG G YG VY+G L D + VA+K + Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 676 -LLSRVHHKNLVGLVGFCFE-----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR 729
+ + H N+ + + E +LV E+ NG+L + LS + DW R
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCR 115
Query: 730 IALGSARGLAYLHE------LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS- 782
+A RGLAYLH P I HRD+ S N+L+ + T ++DFGLS ++ +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 783 -----KGHVSTQVKGTMGYLDPEYYM-------TQQLTEKSDVYSFGVVMLELITAKQPI 830
+ + + GT+ Y+ PE + ++ D+Y+ G++ E+ +
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 831 EKGKYVVREVRTAMNRDDEEHYGLTEMMD--------PTIRNTVL---LGFRRYLELALQ 879
G+ V E + A + H +M P L R E
Sbjct: 236 FPGE-SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294
Query: 880 CVEESATDRPTMSEVVKAIETLLQNDGMNTNSTSASSS 917
C ++ A R T + + L+ N + + +
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 3e-75
Identities = 86/311 (27%), Positives = 139/311 (44%), Gaps = 33/311 (10%)
Query: 599 APSGKDSGGAPQLKGARW-FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIK 657
P+ ++ + G + +L +IG+G +G V+R G VA+K
Sbjct: 15 IPTTENLYFQGAMDGDDMDIPWCDLN-------IKEKIGAGSFGTVHRAEW-HGSDVAVK 66
Query: 658 RAQQGSMQGGL--EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESL- 714
+ EF E+ ++ R+ H N+V +G + +V E+++ G+L L
Sbjct: 67 ILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH 126
Query: 715 SGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774
+ LD +RRL +A A+G+ YLH NPPI+HR++KS N+L+D+ T KV DFGL
Sbjct: 127 KSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
Query: 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE--K 832
S+L + + S GT ++ PE + EKSDVYSFGV++ EL T +QP
Sbjct: 186 SRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 243
Query: 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMS 892
VV V R I + + C RP+ +
Sbjct: 244 PAQVVAAVGFKCKR-------------LEIPRNLNPQVA---AIIEGCWTNEPWKRPSFA 287
Query: 893 EVVKAIETLLQ 903
++ + L++
Sbjct: 288 TIMDLLRPLIK 298
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-73
Identities = 73/279 (26%), Positives = 125/279 (44%), Gaps = 25/279 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+G G +G V + + VAIK+ + S + F E+ LSRV+H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIV 64
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
L G C LV E+ G+L L + + L ++G+AYLH +
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 746 NPPIIHRDVKSTNILLDENLT-AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
+IHRD+K N+LL T K+ DFG + + T KG+ ++ PE +
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEG 177
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864
+EK DV+S+G+++ E+IT ++P ++ + A++ G P +
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN------GTR----PPLIK 227
Query: 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ L +C + + RP+M E+VK + L++
Sbjct: 228 NLPKPIE---SLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (616), Expect = 2e-72
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 18/286 (6%)
Query: 24 TDSRDAAALQSLKDAWQNTP--PTWKNSDDPC-GSWEGVTCNN----SRVTALGLSTMGL 76
+ +D AL +K N +W + D C +W GV C+ RV L LS + L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 77 TG--KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIG 134
+ + L L L + L G + P I L +L+ L + +G IPD +
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK 194
+ L L + N SG +PPS+ L L + N+++G+IP S + L
Sbjct: 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFT----- 177
Query: 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG 254
++N+L+G I + + L V N L G+ G + + + L +N+L
Sbjct: 178 SMTISRNRLTGKIPPTFAN--LNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
Query: 255 KVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSF 299
+ + N+N L+L +N + G P L+Q+ L +++S N+
Sbjct: 236 DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 2e-18
Identities = 31/116 (26%), Positives = 46/116 (39%), Gaps = 3/116 (2%)
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAG 122
N + + LS L G S G + + L+ N L L ++G + LN L L
Sbjct: 196 NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNS-LAFDL-GKVGLSKNLNGLDLRN 253
Query: 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
G +P + L L L ++ NN G IP G L + A+N+ P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 30/157 (19%), Positives = 66/157 (42%), Gaps = 8/157 (5%)
Query: 223 FDGNQLSGNIPESLGYVQTLEVLRLDRNALTG--KVPTNLNNLTNVNELNLAH-NDLKGP 279
G + ++ + L L L +P++L NL +N L + N+L GP
Sbjct: 33 CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGP 92
Query: 280 FPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQI 338
P ++++ L Y+ +++ + P + S + +L TL + +L G +P + S +
Sbjct: 93 IPPAIAKLTQLHYLYITHTNVS-GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 339 QQVKLRNNAFNNTL--DMGNAVGPLLQLVDLQNNQIS 373
+ N + + G+ L + + N+++
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSK-LFTSMTISRNRLT 187
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 8e-71
Identities = 86/290 (29%), Positives = 132/290 (45%), Gaps = 36/290 (12%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL-------EFKTEIELLS 678
N +IG GG+G V++G + D VVAIK G +G EF+ E+ ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
++H N+V L G +V EF+ G L L ++ + W +LR+ L A G+
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGI 135
Query: 739 AYLHELANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
Y+ NPPI+HRD++S NI L + AKVADFGLS+ S G + G
Sbjct: 136 EYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLL-----GN 189
Query: 794 MGYLDPEYYMTQQL--TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851
++ PE ++ TEK+D YSF +++ ++T + P ++ Y + +
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI-----RE 244
Query: 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901
GL PTI R + C RP S +VK + L
Sbjct: 245 EGLR----PTIPEDCPPRLR---NVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-69
Identities = 80/283 (28%), Positives = 125/283 (44%), Gaps = 38/283 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL----EFKTEIELLSRVHHKNLVGL 688
IG GG+GKVYR G VA+K A+ + + E +L + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
G C ++ LV EF G L LSG+ + + A+ ARG+ YLH+ A P
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 749 IIHRDVKSTNILLDE--------NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
IIHRD+KS+NIL+ + N K+ DFGL++ ++K G ++ PE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPE 184
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMM 858
++ SDV+S+GV++ EL+T + P G V V
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA------------ 232
Query: 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901
I +T F +L C RP+ + ++ + T+
Sbjct: 233 -LPIPSTCPEPFA---KLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 8e-67
Identities = 57/288 (19%), Positives = 112/288 (38%), Gaps = 37/288 (12%)
Query: 628 NFSE---SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHH 682
+F + ++ G++++G G + +K + +F E L H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 683 KNLVGLVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
N++ ++G C L+ +M G+L L + +D + ++ AL ARG+A+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
LH L P I + S ++++DE++TA+++ + S ++ PE
Sbjct: 127 LHTL-EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPE 178
Query: 801 YYMTQQL---TEKSDVYSFGVVMLELITAKQPIE--KGKYVVREVRTAMNRDDEEHYGLT 855
+ +D++SF V++ EL+T + P + +V R
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR--------- 229
Query: 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
PTI + +L C+ E RP +V +E +
Sbjct: 230 ----PTIPPGISPHVS---KLMKICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-66
Identities = 100/371 (26%), Positives = 159/371 (42%), Gaps = 26/371 (7%)
Query: 14 SFHIQLISSATDSRDAAALQSLKDAWQNTP--PTWKNSDDPCGSWEGVTCNNSRVTALGL 71
SF S + L S KD + P W ++ +PC +++GVTC + +VT++ L
Sbjct: 1 SFQASPSQSLYR--EIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCRDDKVTSIDL 57
Query: 72 STMGLT---GKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN 128
S+ L +S + LT L SL LS + + GS+ L L L+ +G
Sbjct: 58 SSKPLNVGFSAVSSSLLSLTGLESLFLSNS-HINGSV-SGFKCSASLTSLDLSRNSLSGP 115
Query: 129 IPD--EIGNLAELSFLALNSNNFSGRIP-PSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
+ +G+ + L FL ++SN KL+ L LDL+ N ++G+ V + S
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
G +L KH + NK+SG + L + N S IP LG L+ L
Sbjct: 176 GCGEL---KHLAISGNKISGDVDVSRCVN---LEFLDVSSNNFSTGIP-FLGDCSALQHL 228
Query: 246 RLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAP 305
+ N L+G ++ T + LN++ N GP P + SL Y+ L+ N F
Sbjct: 229 DISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAENKFTGEIPD 287
Query: 306 LWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTL---DMGNAVGPLL 362
+LT L G VP S S ++ + L +N F+ L + L
Sbjct: 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKM--RGL 345
Query: 363 QLVDLQNNQIS 373
+++DL N+ S
Sbjct: 346 KVLDLSFNEFS 356
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-58
Identities = 83/345 (24%), Positives = 147/345 (42%), Gaps = 30/345 (8%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDI---GGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNI 117
+ + L LS ++G G EL+ L +S N ++G + + L
Sbjct: 148 LKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNK-ISGDVD--VSRCVNLEF 204
Query: 118 LILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSI 177
L ++ F+ IP +G+ + L L ++ N SG ++ ++L L+++ NQ G I
Sbjct: 205 LDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 178 PVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLG 237
P LK+ ++ +NK +G I + L L + GN G +P G
Sbjct: 264 PPL--------PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 238 YVQTLEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPD-LSQM-NSLSYVDL 294
LE L L N +G++P + L + + L+L+ N+ G P+ L+ + SL +DL
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 295 SNNSFD---PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351
S+N+F L + +L L + G++P L + S++ + L N + T
Sbjct: 376 SSNNFSGPILPN--LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGT 433
Query: 352 L--DMGNAVGPLLQLVDLQNNQISAI---TLGSGIKNYTLILVGN 391
+ +G+ L+ + L N + L TLIL N
Sbjct: 434 IPSSLGS--LSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFN 476
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 6e-49
Identities = 79/318 (24%), Positives = 144/318 (45%), Gaps = 20/318 (6%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+ + L L G TGK+ + +EL SL LS+N L+G++ +G L KL L L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY-LSGTIPSSLGSLSKLRDLKL 449
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
G IP E+ + L L L+ N+ +G IP L + L W+ L++N+LTG IP
Sbjct: 450 WLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP-- 507
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ 240
+ +L+N + N SG I +L LI + + N +G IP ++
Sbjct: 508 ----KWIGRLENLAILKLSNNSFSGNIPAELGDCRS-LIWLDLNTNLFNGTIPAAMFKQS 562
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHND--LKGPFP-DLSQMNSLSYVDLSNN 297
+ N + GK + N E + A N +G L+++++ + ++++
Sbjct: 563 GK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSR 618
Query: 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTL--DMG 355
+ F S+ L + L G +P ++ S + + L +N + ++ ++G
Sbjct: 619 VYGGHT-SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVG 677
Query: 356 NAVGPLLQLVDLQNNQIS 373
+ G L ++DL +N++
Sbjct: 678 DLRG--LNILDLSSNKLD 693
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-44
Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 17/243 (6%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
N + + + LS LTG++ IG L L L LS N +G++ +GD + L L L
Sbjct: 487 SNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS-FSGNIPAELGDCRSLIWLDL 545
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN--QLTGSIP 178
F G IP + + +N +G+ + A N + G
Sbjct: 546 NTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601
Query: 179 VSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL-FDGNQLSGNIPESLG 237
L++L + G S + + L N LSG IP+ +G
Sbjct: 602 EQ------LNRLSTRNPCNITSRVYGGHTSPTFDN--NGSMMFLDMSYNMLSGYIPKEIG 653
Query: 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSN 296
+ L +L L N ++G +P + +L +N L+L+ N L G P +S + L+ +DLSN
Sbjct: 654 SMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 297 NSF 299
N+
Sbjct: 714 NNL 716
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-26
Identities = 38/147 (25%), Positives = 60/147 (40%), Gaps = 7/147 (4%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+ + + G S + L+ +++ G SP + + L +
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV-YGGHTSPTFDNNGSMMFLDM 639
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
+ +G IP EIG++ L L L N+ SG IP +G L L LDL+ N+L G IP +
Sbjct: 640 SYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA 699
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTI 207
+ L + N LSG I
Sbjct: 700 ------MSALTMLTEIDLSNNNLSGPI 720
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-66
Identities = 69/312 (22%), Positives = 118/312 (37%), Gaps = 55/312 (17%)
Query: 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTE 673
R F +L +G G +G+ + G+V+ +K + + F E
Sbjct: 5 RIFRPSDLIHG-------EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKE 57
Query: 674 IELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALG 733
++++ + H N++ +G ++ + E++ GTLR + W +R+ A
Sbjct: 58 VKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKD 116
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS----------- 782
A G+AYLH + IIHRD+ S N L+ EN VADFGL++L+ D
Sbjct: 117 IASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 783 -KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841
V G ++ PE + EK DV+SFG+V+ E+I
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------------ 221
Query: 842 TAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRY---------LELALQCVEESATDRPTMS 892
V RY + ++C + RP+
Sbjct: 222 ----------DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFV 271
Query: 893 EVVKAIETLLQN 904
++ +ETL +
Sbjct: 272 KLEHWLETLRMH 283
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-64
Identities = 77/276 (27%), Positives = 129/276 (46%), Gaps = 22/276 (7%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGLVG 690
IGSG +G VY+G G V A+K + FK E+ +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
+ + +V ++ +L L + K+ + IA +ARG+ YLH II
Sbjct: 88 YS-TAPQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL--- 807
HRD+KS NI L E+ T K+ DFGL+ S S H Q+ G++ ++ PE Q
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 808 TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867
+ +SDVY+FG+V+ EL+T + P ++ + R G +R+
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIEMVGR------GSLSPDLSKVRSNCP 255
Query: 868 LGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ L +C+++ +RP+ ++ IE L +
Sbjct: 256 KRMK---RLMAECLKKKRDERPSFPRILAEIEELAR 288
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-62
Identities = 61/293 (20%), Positives = 109/293 (37%), Gaps = 47/293 (16%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGLVG 690
IG G +G+VY G G+V AI+ FK E+ + H+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
C ++ TL + I LD + +IA +G+ YLH I+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGIL 152
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSD---SSKGHVSTQVKGTMGYLDPEYYMTQQL 807
H+D+KS N+ D + DFGL + + G + +L PE
Sbjct: 153 HKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSP 211
Query: 808 ---------TEKSDVYSFGVVMLELITAKQPIEKGKY------VVREVRTAMNRDDEEHY 852
++ SDV++ G + EL + P + + ++ +++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG---- 267
Query: 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
M I ++ L C +RPT ++++ +E L + +
Sbjct: 268 -----MGKEIS-----------DILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 7e-62
Identities = 70/298 (23%), Positives = 118/298 (39%), Gaps = 40/298 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIEL--LSRVHHKNLVGLVG 690
+G G YG+V+RG G+ VA+K + + E EL + H+N++G +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 691 FC----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA- 745
+ L+ + G+L + L + LD LRI L A GLA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 746 ----NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK--GHVSTQVKGTMGYLDP 799
P I HRD+KS NIL+ +N +AD GL+ + S S+ + GT Y+ P
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 800 E------YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853
E ++ D+++FG+V+ E+ +V + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG----IVEDYKPPFYDVVPNDPS 242
Query: 854 LTEMMD--------PTIRNTVLL--GFRRYLELALQCVEESATDRPTMSEVVKAIETL 901
+M P I N +L +C ++ + R T + K + +
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-61
Identities = 72/301 (23%), Positives = 122/301 (40%), Gaps = 40/301 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+IG G YG+V+ G G+ VA+K + + +TEI + H+N++G +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASW---FRETEIYQTVLMRHENILGFIA 98
Query: 691 FC----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA- 745
+ L+ ++ NG+L + L + LD K L++A S GL +LH
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 746 ----NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH--VSTQVKGTMGYLDP 799
P I HRD+KS NIL+ +N T +AD GL+ + GT Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 800 E------YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853
E Q +D+YSFG+++ E+ +V E + +
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG----IVEEYQLPYHDLVPSDPS 271
Query: 854 LTEMMD--------PTIRNTVLL--GFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+M + P+ N R+ +L +C + R T V K + + +
Sbjct: 272 YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331
Query: 904 N 904
+
Sbjct: 332 S 332
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-58
Identities = 68/300 (22%), Positives = 129/300 (43%), Gaps = 32/300 (10%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
IG G +G+V+RG G+ VA+K +++ + EI + H+N++G +
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENILGFIA 103
Query: 691 FCFEQGEQ----MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE--- 743
+ LV ++ +G+L + L+ + + + +++AL +A GLA+LH
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 744 --LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--KGHVSTQVKGTMGYLDP 799
P I HRD+KS NIL+ +N T +AD GL+ ++ GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 800 E------YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK-YVV---REVRTAMNRDDE 849
E + +++D+Y+ G+V E+ + Y + V + + ++
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 850 EHYGLTEMMDPTIRNTVLL--GFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907
+ + P I N R ++ +C + R T + K + L Q +G+
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-50
Identities = 65/397 (16%), Positives = 120/397 (30%), Gaps = 46/397 (11%)
Query: 17 IQLISSATDSRDAAALQSLKDA-----WQNTPPT------WKNSDDPC--GSWEGVTCNN 63
I+L +A +D AL+ + DA W W + + G+ GV+ N+
Sbjct: 20 IKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNS 79
Query: 64 -SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYN---GGLTGSLSPRIGDLQKLNILI 119
RVT L L G +G++ IG LTEL L L + I
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 120 LAGCGFTGNIPDEIGNLA--ELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSI 177
+ D +L +NS+ I S + + N +T +
Sbjct: 140 KMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-FV 198
Query: 178 PVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLG 237
+ +L + F+ + + + + Q
Sbjct: 199 S------KAVMRLTKLRQFYMGNSPFVAENICEA------WENENSEYAQQYKTEDLKWD 246
Query: 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGP---------FPDLSQMNS 288
++ L + + K+PT L L + +N+A N D
Sbjct: 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
Query: 289 LSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348
+ + + N+ + L L C + L+G S ++ + L N
Sbjct: 307 IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQI 365
Query: 349 NNTLDMGNAVGPL--LQLVDLQNNQISAITLGSGIKN 383
N G ++ + +N++ I K+
Sbjct: 366 TEIPA--NFCGFTEQVENLSFAHNKLKYIPNIFDAKS 400
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 1e-40
Identities = 58/348 (16%), Positives = 119/348 (34%), Gaps = 31/348 (8%)
Query: 48 NSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSP 107
NSD S + + + T +G + +T +S + LT+LR + +
Sbjct: 167 NSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP-FVAENIC 224
Query: 108 RIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLD 167
+ + + NL +L+ + + + ++P L L ++ ++
Sbjct: 225 EAWENENSEYAQQ-----YKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279
Query: 168 LADNQLTG--SIPVSTITSPGLDQLKNAKHFHFNKNKL-SGTISEQLFSPDMVLIHVLF- 223
+A N+ + + + + N L + + L M + +L
Sbjct: 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK--MKKLGMLEC 337
Query: 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLKG--PF 280
NQL G + G L L L N +T +P N V L+ AHN LK
Sbjct: 338 LYNQLEG-KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNI 395
Query: 281 PDLSQMNSLSYVDLSNNSF------DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFS 334
D ++ +S +D S N + +++++ + + +
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 335 YSQIQQVKLRNNAF-----NNTLDMGNAVGPL--LQLVDLQNNQISAI 375
S + + L N N+ D L +DL+ N+++ +
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKL 503
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-39
Identities = 59/348 (16%), Positives = 118/348 (33%), Gaps = 37/348 (10%)
Query: 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN 128
+ + + D +++ + + YN T + + ++KL +L G
Sbjct: 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG- 344
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
G+ +L+ L L N + IP + G Q+ L A N+L IP
Sbjct: 345 KLPAFGSEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIP----NIFDA 398
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMV------LIHVLFDGNQLSGNIPESLGYVQT 241
+ F+ N++ + D + + NQ+S E
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458
Query: 242 LEVLRLDRNALTG-------KVPTNLNNLTNVNELNLAHNDLKGPFPDL--SQMNSLSYV 292
L + L N LT N N + ++L N L D + + L +
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGI 518
Query: 293 DLSNNSFDPTEAPLWFSTLPSLTTLICEFG------SLQGRVPDKLFSYSQIQQVKLRNN 346
DLS NSF ++ P +L P+ + + Q+++ +N
Sbjct: 519 DLSYNSF--SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSN 576
Query: 347 AFNNTLDMGNAVGPLLQLVDLQNNQISAI---TLGSGIKNYTLILVGN 391
++ + P + ++D+++N +I + I+ +L +
Sbjct: 577 DI-RKVN--EKITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-20
Identities = 24/162 (14%), Positives = 43/162 (26%), Gaps = 19/162 (11%)
Query: 75 GLTGKLSGDIGGLTELRSLDLSYNGGLTG-SLSPRIGDLQKLNILILAGCGFTGNIPDEI 133
+ + L S+DL +N LT S R L L + L+ F+ P +
Sbjct: 475 NSLKDENENFKNTYLLTSIDLRFNK-LTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQP 532
Query: 134 GNLAELSFLALN------SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
N + L + N P + L L + N + +
Sbjct: 533 LNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI------ 585
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS 229
N N + P + + ++
Sbjct: 586 --TPNISVLDIKDNPNISIDLSYVC-PYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 5e-05
Identities = 8/80 (10%), Positives = 20/80 (25%), Gaps = 4/80 (5%)
Query: 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN 128
+ I L L + N + ++ +I +++L +
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSN-DIR-KVNEKI--TPNISVLDIKDNPNISI 602
Query: 129 IPDEIGNLAELSFLALNSNN 148
+ E L +
Sbjct: 603 DLSYVCPYIEAGMYMLFYDK 622
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-47
Identities = 70/287 (24%), Positives = 117/287 (40%), Gaps = 48/287 (16%)
Query: 634 EIGSGGYGKVYRGMLSDGQV-VAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGF 691
+IG G +G+V+ G L VA+K ++ +F E +L + H N+V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
C ++ +V E + G L G L K L++ +A G+ YL IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIH 236
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSD----SSKGHVSTQVKGTMGYLDPEYYMTQQL 807
RD+ + N L+ E K++DFG+S+ +D +S G VK T PE +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA----PEALNYGRY 292
Query: 808 TEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
+ +SDV+SFG+++ E + P Y + + R V
Sbjct: 293 SSESDVWSFGILLWETFSLGASP----------------------YP--NLSNQQTREFV 328
Query: 867 LLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
G R L QC RP+ S + + ++++ +
Sbjct: 329 EKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-46
Identities = 65/293 (22%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 633 NEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++G G +G V + G+VVA+K+ Q + + +F+ EIE+L + H N+V
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 688 LVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
G C+ G + L+ E++ G+LR+ L +D + L+ +G+ YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPE 800
IHRD+ + NIL++ K+ DFGL+K++ + + + PE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA----PE 187
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
+ + SDV+SFGVV+ EL T + + + G +M+
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QG--QMIVF 239
Query: 861 TIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ + R + +C + RP+ ++ ++ + N
Sbjct: 240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-45
Identities = 64/293 (21%), Positives = 122/293 (41%), Gaps = 37/293 (12%)
Query: 633 NEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++G G +G V + G+VVA+K+ Q + + +F+ EIE+L + H N+V
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 688 LVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
G C+ G + L+ E++ G+LR+ L +D + L+ +G+ YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPE 800
IHRD+ + NIL++ K+ DFGL+K++ + + + + PE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA----PE 218
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
+ + SDV+SFGVV+ EL T + + + G +M+
Sbjct: 219 SLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK------QG--QMIVF 270
Query: 861 TIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ + R + +C + RP+ ++ ++ +
Sbjct: 271 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 1e-44
Identities = 73/294 (24%), Positives = 122/294 (41%), Gaps = 40/294 (13%)
Query: 633 NEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
+++G G +G V + G +VA+K+ Q +F+ EI++L +H +V
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 688 LVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
G + G Q LV E++ +G LR+ L LD R L + +G+ YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR 147
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPE 800
+HRD+ + NIL++ K+ADFGL+KL+ +V + + PE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA----PE 200
Query: 801 YYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
+ +SDV+SFGVV+ EL T + M + + L+ +++
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFTYCDKS-----CSPSAEFLRMMGCERDVPALSRLLE 255
Query: 860 PTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ G R EL C S DRP+ S + ++ L
Sbjct: 256 -LLEE----GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 39/293 (13%)
Query: 633 NEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLV 686
++G G +GKV + G+ VA+K + S + + K EIE+L ++H+N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 687 GLVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
G C E G L+ EF+ +G+L+E L ++ K++L+ A+ +G+ YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYLGSR 145
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDP 799
+HRD+ + N+L++ K+ DFGL+K + + + V P
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA----P 198
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
E M + SDV+SFGV + EL+T + +G +M
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT------YCD-SDSSPMALFLKMIGPTHG--QMTV 249
Query: 860 PTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ NT+ G R +L +C E ++R + +++ E LL+
Sbjct: 250 TRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK 302
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-44
Identities = 73/287 (25%), Positives = 126/287 (43%), Gaps = 46/287 (16%)
Query: 633 NEIGSGGYGKVYRGMLSDGQV-VAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF 691
+++G G YG+VY G+ + VA+K ++ +M+ EF E ++ + H NLV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
C + ++ EFM G L + L + + L +A + + YL + IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIH 341
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDS---SKGHVSTQVKGTMGYLDPEYYMTQQLT 808
R++ + N L+ EN KVADFGLS+L++ + +K T PE + +
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA----PESLAYNKFS 397
Query: 809 EKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVL 867
KSDV++FGV++ E+ T P + + +
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPYPG------------------------IDLSQVYELLE 433
Query: 868 LGFRRYL---------ELALQCVEESATDRPTMSEVVKAIETLLQND 905
+R EL C + + +DRP+ +E+ +A ET+ Q
Sbjct: 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 480
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 9e-44
Identities = 77/286 (26%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
++G G +G+V+ G + VAIK + G+M F E +++ ++ H+ LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
E+ +V E+M+ G+L + L G +G +L + + +A A G+AY+ + +HR
Sbjct: 249 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDS---SKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
D+++ NIL+ ENL KVADFGL++L+ D+ ++ +K T PE + + T
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 360
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868
KSDV+SFG+++ EL T + P M++ + + V
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPG------------------------MVNREVLDQVER 396
Query: 869 GFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
G+R +L QC + +RPT + +E +
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-43
Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 54/288 (18%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
IG G +G V G G VA+K + + F E +++++ H NLV L+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVI 255
Query: 693 FEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
E+ +V E+MA G+L + L R L L+ +L + YL +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ--VKGTMGYLDPEYYMTQQLTE 809
RD+ + N+L+ E+ AKV+DFGL+K S + + VK T PE ++ +
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKLPVKWTA----PEALREKKFST 365
Query: 810 KSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT---EMMDPTIRNTV 866
KSDV+SFG+++ E+ + +G + + V
Sbjct: 366 KSDVWSFGILLWEIYS--------------------------FGRVPYPRIPLKDVVPRV 399
Query: 867 LLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
G++ ++ C A RPT ++ + +E + ++
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-43
Identities = 79/306 (25%), Positives = 130/306 (42%), Gaps = 39/306 (12%)
Query: 608 APQLKGARWFSYD--ELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ 665
AP G Y E+ + + E+G+G +G V G VAIK ++GSM
Sbjct: 8 APSTAG---LGYGSWEIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS 62
Query: 666 GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWK 725
EF E +++ + H+ LV L G C +Q ++ E+MANG L L +
Sbjct: 63 ED-EFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQ 120
Query: 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS---S 782
+ L + + YL E +HRD+ + N L+++ KV+DFGLS+ V D S
Sbjct: 121 QLLEMCKDVCEAMEYL-ESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177
Query: 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVR 841
V+ + PE M + + KSD+++FGV+M E+ + K P E ++ E
Sbjct: 178 SVGSKFPVRWSP----PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE--RFTNSETA 231
Query: 842 TAMNRDDEEHYGLTEMMD--PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
+ + L + Y + C E A +RPT ++ I
Sbjct: 232 EHIAQG----LRLYRPHLASEKV----------Y-TIMYSCWHEKADERPTFKILLSNIL 276
Query: 900 TLLQND 905
++ +
Sbjct: 277 DVMDEE 282
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 1e-42
Identities = 85/278 (30%), Positives = 132/278 (47%), Gaps = 32/278 (11%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
EIGSG +G V+ G + VAIK ++G+M +F E E++ ++ H LV L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
EQ LV EFM +G L + L + G + L + L G+AYL E A +IHR
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAETLLGMCLDVCEGMAYL-EEAC--VIHR 128
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDSS-KGHVSTQ--VKGTMGYLDPEYYMTQQLTE 809
D+ + N L+ EN KV+DFG+++ V D T+ VK PE + + +
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS----PEVFSFSRYSS 184
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD--PTIRNTV 866
KSDV+SFGV+M E+ + K P E EV ++ + L + +
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYE--NRSNSEVVEDISTG----FRLYKPRLASTHV---- 234
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
Y ++ C E DRP S +++ + + ++
Sbjct: 235 ------Y-QIMNHCWRERPEDRPAFSRLLRQLAEIAES 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-42
Identities = 78/286 (27%), Positives = 136/286 (47%), Gaps = 46/286 (16%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
++G G +G+V+ G + VAIK + G+M F E +++ ++ H+ LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
E+ +V E+M+ G+L + L G +G +L + + +A A G+AY+ + +HR
Sbjct: 332 SEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDS---SKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
D+++ NIL+ ENL KVADFGL++L+ D+ ++ +K T PE + + T
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA----PEAALYGRFTI 443
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868
KSDV+SFG+++ EL T + P Y M++ + + V
Sbjct: 444 KSDVWSFGILLTELTTKGRVP-----Y-------------------PGMVNREVLDQVER 479
Query: 869 GFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
G+R +L QC + +RPT + +E +
Sbjct: 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 2e-42
Identities = 80/280 (28%), Positives = 134/280 (47%), Gaps = 32/280 (11%)
Query: 633 NEIGSGGYGKVYRGMLSDGQV-VAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF 691
+++G G YG+VY G+ + VA+K ++ +M+ EF E ++ + H NLV L+G
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 77
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
C + ++ EFM G L + L + + L +A + + YL E N IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKN--FIH 134
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSS-KGHVSTQ--VKGTMGYLDPEYYMTQQLT 808
RD+ + N L+ EN KVADFGLS+L++ + H + +K T PE + +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNKFS 190
Query: 809 EKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD--PTIRNT 865
KSDV++FGV++ E+ T P + +V + +D Y + +
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKD----YRMERPEGCPEKV--- 241
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
Y EL C + + +DRP+ +E+ +A ET+ Q
Sbjct: 242 -------Y-ELMRACWQWNPSDRPSFAEIHQAFETMFQES 273
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 71/294 (24%), Positives = 120/294 (40%), Gaps = 41/294 (13%)
Query: 633 NEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLV 686
++G G +GKV G++VA+K + + +K EI++L ++H++++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 687 GLVGFCFEQGEQ--MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
G C + G LV E++ G+LR+ L S + + L A G+AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ 153
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDP 799
IHRD+ + N+LLD + K+ DFGL+K V + + + + V P
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA----P 206
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
E + SDV+SFGV + EL+T + M
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT------HCDSSQSPPTKFLELIGIAQGQ---MTV 257
Query: 860 PTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ + G R L C E A+ RPT ++ ++T+ +
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 42/298 (14%)
Query: 633 NEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVG 687
IGSG G+V G L VAIK + G + +F +E ++ + H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L G M+V E+M NG+L L G + + + G G+ YL +L
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLSDLG-- 171
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYY 802
+HRD+ + N+L+D NL KV+DFGLS+++ D +T ++ T PE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEAI 226
Query: 803 MTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD 859
+ + SDV+SFGVVM E++ ++P + V+ V EE Y L M
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV--------EEGYRLPAPMG 278
Query: 860 --PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNSTSAS 915
+ + +L L C + RP S++V ++ L+++ + + S
Sbjct: 279 CPHAL----------H-QLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATVS 325
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-42
Identities = 73/279 (26%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
IG G +G V G G VA+K + + F E +++++ H NLV L+G
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 693 FEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
E+ +V E+MA G+L + L R L L+ +L + YL E N +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FVH 140
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ--VKGTMGYLDPEYYMTQQLTE 809
RD+ + N+L+ E+ AKV+DFGL+K S + + VK T PE ++ +
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT---GKLPVKWTA----PEALREKKFST 193
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD--PTIRNTV 866
KSDV+SFG+++ E+ + + P + +++V + + Y + P +
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYP--RIPLKDVVPRVEKG----YKMDAPDGCPPAV---- 243
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
Y E+ C A RP+ ++ + +E + ++
Sbjct: 244 ------Y-EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 80/282 (28%), Positives = 131/282 (46%), Gaps = 40/282 (14%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
E+GSG +G V G VA+K ++GSM EF E + + ++ H LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
++ +V E+++NG L L L+ + L + G+A+L E IHRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFL-ESHQ--FIHRD 129
Query: 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYYMTQQLT 808
+ + N L+D +L KV+DFG+++ V D +VS+ VK + PE + + +
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVKWSA----PEVFHYFKYS 183
Query: 809 EKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD--PTIR 863
KSDV++FG++M E+ + K P + VV +V + + L TI
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV--------SQGHRLYRPHLASDTI- 234
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
Y ++ C E RPT +++ +IE L + D
Sbjct: 235 ---------Y-QIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 9e-42
Identities = 65/223 (29%), Positives = 98/223 (43%), Gaps = 28/223 (12%)
Query: 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQ-QGSMQGGLE-FK 671
R+ +D IG G + VY+G+ VA Q + + + FK
Sbjct: 26 RFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFK 73
Query: 672 TEIELLSRVHHKNLVGLVGFCFEQGEQM----LVYEFMANGTLRESLSGRSGIHLDWKRR 727
E E+L + H N+V + LV E M +GTL+ L + + K
Sbjct: 74 EEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVL 131
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHV 786
+GL +LH PPIIHRD+K NI + + K+ D GL+ L S
Sbjct: 132 RSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---- 186
Query: 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ V GT ++ PE Y ++ E DVY+FG+ MLE+ T++ P
Sbjct: 187 AKAVIGTPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 46/285 (16%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
+G+G +G+V+ G + VA+K +QGSM F E L+ ++ H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVV 77
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
++ ++ E+M NG+L + L SGI L + L +A A G+A++ E N IHR
Sbjct: 78 TQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERN--YIHR 133
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDS---SKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
D+++ NIL+ + L+ K+ADFGL++L+ D+ ++ +K T PE T
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA----PEAINYGTFTI 189
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868
KSDV+SFG+++ E++T + P Y M +P + +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP----------------------YP--GMTNPEVIQNLER 225
Query: 869 GFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
G+R +L C +E DRPT + +E
Sbjct: 226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-41
Identities = 70/282 (24%), Positives = 128/282 (45%), Gaps = 38/282 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
++G+G +G+V+ + VA+K + GSM F E ++ + H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
++ ++ EFMA G+L + L G + + + A G+A++ E N IHR
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN--YIHR 308
Query: 753 DVKSTNILLDENLTAKVADFGLSKLVSDS---SKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
D+++ NIL+ +L K+ADFGL++++ D+ ++ +K T PE T
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA----PEAINFGSFTI 364
Query: 810 KSDVYSFGVVMLELIT-AKQPIEKGKY---VVREVRTAMNRDDEEHYGLTEMMD--PTIR 863
KSDV+SFG++++E++T + P Y EV A+ R Y + + +
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP-----YPGMSNPEVIRALERG----YRMPRPENCPEEL- 414
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
Y + ++C + +RPT + ++
Sbjct: 415 ---------Y-NIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-41
Identities = 78/303 (25%), Positives = 144/303 (47%), Gaps = 42/303 (13%)
Query: 633 NEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVG 687
+G+G +G+V G L VAIK + G + +F E ++ + H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L G + M+V E+M NG+L L + + + G A G+ YL ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLSDMG-- 167
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYY 802
+HRD+ + NIL++ NL KV+DFGL +++ D + +T+ ++ T PE
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEAI 222
Query: 803 MTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD 859
++ T SDV+S+G+V+ E+++ ++P + V++ V +E Y L MD
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV--------DEGYRLPPPMD 274
Query: 860 --PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNSTSASSS 917
+ Y +L L C ++ +RP ++V ++ L++N G TSA++
Sbjct: 275 CPAAL----------Y-QLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAAR 323
Query: 918 ATD 920
++
Sbjct: 324 PSN 326
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-41
Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 43/287 (14%)
Query: 634 EIGSGGYGKVYRGMLSDGQV-----VAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVG 687
IG+G +G+VY+GML VAIK + G + ++F E ++ + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
L G + M++ E+M NG L + L + G + + + G A G+ YL +
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLANMN-- 167
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYY 802
+HRD+ + NIL++ NL KV+DFGLS+++ D + +T ++ T PE
Sbjct: 168 -YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PEAI 222
Query: 803 MTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD 859
++ T SDV+SFG+VM E++T ++P V++ + + + L MD
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI--------NDGFRLPTPMD 274
Query: 860 --PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
I Y +L +QC ++ RP +++V ++ L++
Sbjct: 275 CPSAI----------Y-QLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 71/309 (22%)
Query: 633 NEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
E+G G +GKV+ D +VA+K + ++ +F+ E ELL+ + H+++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIAL 732
G C + ++V+E+M +G L + L L + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
A G+ YL +HRD+ + N L+ NL K+ DFG+S+ V + G
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST-----DYYRVG 192
Query: 793 TMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846
L PE M ++ T +SDV+SFGV++ E+ T KQP
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP----------------- 235
Query: 847 DDEEHYGLT--EMMDPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVV 895
+ L+ E+++ + G ++ L C + R + E+
Sbjct: 236 ----WFQLSNTEVIE-----CITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIY 286
Query: 896 KAIETLLQN 904
K + L +
Sbjct: 287 KILHALGKA 295
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 78/295 (26%), Positives = 120/295 (40%), Gaps = 56/295 (18%)
Query: 633 NEIGSGGYGKVYRGMLSDG----QVVAIKRAQQG-SMQGGLEFKTEIELLSRVHHKNLVG 687
IG G +G VY G L D A+K + + +F TE ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 688 LVGFCFEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L+G C ++V +M +G LR + + + K + L A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKYLASKK- 148
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL-----DPEY 801
+HRD+ + N +LDE T KVADFGL++ + D + T L E
Sbjct: 149 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE---YYSVHNKTGAKLPVKWMALES 203
Query: 802 YMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLT--EMM 858
TQ+ T KSDV+SFGV++ EL+T P Y + ++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP-----Y----------------PDVNTFDIT 242
Query: 859 DPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+L G R E+ L+C A RP+ SE+V I +
Sbjct: 243 -----VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-40
Identities = 67/310 (21%), Positives = 127/310 (40%), Gaps = 42/310 (13%)
Query: 606 GGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDG-----QVVAIKRAQ 660
G AP R E KK +GSG +G VY+G+ VAIK +
Sbjct: 1 GEAPNQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 661 QGSMQGGL-EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG 719
+ + E E +++ V + ++ L+G C L+ + M G L + +
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 720 IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
++ + L + A+G+ YL + ++HRD+ + N+L+ K+ DFGL+KL+
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYV 836
K + + K + ++ E + + T +SDV+S+GV + EL+T +P + +
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI 228
Query: 837 VREVRTAMNRDDEEHYGLTEMMD--PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEV 894
+ E+ L + + Y + +C A RP E+
Sbjct: 229 SSIL--------EKGERLPQPPICTIDV----------Y-MIMRKCWMIDADSRPKFREL 269
Query: 895 VKAIETLLQN 904
+ + ++
Sbjct: 270 IIEFSKMARD 279
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 60/303 (19%), Positives = 114/303 (37%), Gaps = 55/303 (18%)
Query: 634 EIGSGGYGKVYRGMLSDGQV--------VAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL 685
+G G + K+++G+ + V +K + F ++S++ HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
V G C E +LV EF+ G+L L ++ I++ WK L +A A + +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFL-EE 131
Query: 745 ANPPIIHRDVKSTNILLD--------ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
+IH +V + NILL K++D G+S V +
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER--IPWVP-- 185
Query: 797 LDPE---YYMTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEE 850
PE + L +D +SFG + E+ + +P+ + ++ E+
Sbjct: 186 --PECIENP--KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY--------ED 233
Query: 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTN 910
+ L + L C++ RP+ +++ + +L D +
Sbjct: 234 RHQLPAPKAAEL----------A-NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282
Query: 911 STS 913
S
Sbjct: 283 SHH 285
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-40
Identities = 79/306 (25%), Positives = 120/306 (39%), Gaps = 70/306 (22%)
Query: 633 NEIGSGGYGKVYRGMLSDG----QVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+G G +G V G L VA+K + S + EF +E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 687 GLVGFCFEQGEQ-----MLVYEFMANGTL----RESLSGRSGIHLDWKRRLRIALGSARG 737
L+G C E Q M++ FM G L S H+ + L+ + A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+ YL +N +HRD+ + N +L +++T VADFGLSK + +G + +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSG-----DYYRQGRIAKM 211
Query: 798 -----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851
E + T KSDV++FGV M E+ T P Y
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP-----Y---------------- 250
Query: 852 YGLT--EMMDPTIRNTVLLGFRRYLE-----------LALQCVEESATDRPTMSEVVKAI 898
G+ EM D +L G R L+ + C DRPT S + +
Sbjct: 251 PGVQNHEMYD-----YLLHGHR--LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQL 303
Query: 899 ETLLQN 904
E LL++
Sbjct: 304 EKLLES 309
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-40
Identities = 78/295 (26%), Positives = 120/295 (40%), Gaps = 56/295 (18%)
Query: 633 NEIGSGGYGKVYRGMLSDG----QVVAIKRAQQG-SMQGGLEFKTEIELLSRVHHKNLVG 687
IG G +G VY G L D A+K + + +F TE ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 688 LVGFCFEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L+G C ++V +M +G LR + + + K + L A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKK- 212
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL-----DPEY 801
+HRD+ + N +LDE T KVADFGL++ + D V T L E
Sbjct: 213 --FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKWMALES 267
Query: 802 YMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLT--EMM 858
TQ+ T KSDV+SFGV++ EL+T P Y + ++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP-----Y----------------PDVNTFDIT 306
Query: 859 DPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+L G R E+ L+C A RP+ SE+V I +
Sbjct: 307 -----VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 44/286 (15%)
Query: 634 EIGSGGYGKVYRGMLSDGQV---VAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGL 688
E+GSG +G V +G +V VA+K + + L E E ++ ++ + +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+G C + MLV E G L + L + H+ K + + + G+ YL E +N
Sbjct: 84 IGICEAES-WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYL-EESN-- 137
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYYM 803
+HRD+ + N+LL AK++DFGLSK + + + VK PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PECIN 193
Query: 804 TQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD- 859
+ + KSDV+SFGV+M E + ++P KG V + E+ +
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--------EKGERMGCPAGC 245
Query: 860 -PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ Y +L C +RP + V + +
Sbjct: 246 PREM----------Y-DLMNLCWTYDVENRPGFAAVELRLRNYYYD 280
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 69/306 (22%), Positives = 125/306 (40%), Gaps = 68/306 (22%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNL 685
E+G G +G VY G+ VAIK + + +EF E ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS--------GIHLDWKRRLRIALGSARG 737
V L+G + +++ E M G L+ L + +++A A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+AYL+ +HRD+ + N ++ E+ T K+ DFG+++ + ++ KG G L
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET-----DYYRKGGKGLL 202
Query: 798 -----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851
PE T SDV+SFGVV+ E+ T A+QP +
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---------------------Y 241
Query: 852 YGLT--EMMDPTIRNTVLLGFR----------RYLELALQCVEESATDRPTMSEVVKAIE 899
GL+ +++ V+ G + EL C + + RP+ E++ +I+
Sbjct: 242 QGLSNEQVLR-----FVMEGGLLDKPDNCPDMLF-ELMRMCWQYNPKMRPSFLEIISSIK 295
Query: 900 TLLQND 905
++
Sbjct: 296 EEMEPG 301
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 72/308 (23%), Positives = 121/308 (39%), Gaps = 70/308 (22%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
E+G G +GKV+ + +VA+K ++ S +F+ E ELL+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR-------------LRIALG 733
G C E ++V+E+M +G L L L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
A G+ YL L +HRD+ + N L+ + L K+ DFG+S+ + + G
Sbjct: 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST-----DYYRVGG 218
Query: 794 MGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRD 847
L PE + ++ T +SDV+SFGVV+ E+ T KQP
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP------------------ 260
Query: 848 DEEHYGLT--EMMDPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVK 896
Y L+ E +D + G + C + R ++ +V
Sbjct: 261 ---WYQLSNTEAID-----CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312
Query: 897 AIETLLQN 904
++ L Q
Sbjct: 313 RLQALAQA 320
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-39
Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 67/305 (21%)
Query: 633 NEIGSGGYGKVYRGMLSDG----QVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+G G +G V L VA+K +A + EF E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 687 GLVGFCFEQGEQ------MLVYEFMANGT----LRESLSGRSGIHLDWKRRLRIALGSAR 736
LVG + M++ FM +G L S G + +L + +R + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
G+ YL ++ IHRD+ + N +L E++T VADFGLS+ + +G
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG-----DYYRQGCASK 200
Query: 797 L-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEE 850
L E T SDV++FGV M E++T + P Y
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP-----Y--------------- 240
Query: 851 HYGLT--EMMDPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIE 899
G+ E+ N ++ G R +L QC RP+ + + +E
Sbjct: 241 -AGIENAEIY-----NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELE 294
Query: 900 TLLQN 904
+L +
Sbjct: 295 NILGH 299
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-39
Identities = 75/299 (25%), Positives = 118/299 (39%), Gaps = 52/299 (17%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLSDG----QVVAIKRAQQG-SMQGGLEFKTEIELLSRV 680
IG G +G VY G D AIK + MQ F E L+ +
Sbjct: 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL 79
Query: 681 HHKNLVGLVGFCF-EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+H N++ L+G +G ++ +M +G L + + + K + L ARG+
Sbjct: 80 NHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR-NPTVKDLISFGLQVARGME 138
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL-- 797
YL E +HRD+ + N +LDE+ T KVADFGL++ + D + + L
Sbjct: 139 YLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE---YYSVQQHRHARLPV 192
Query: 798 ---DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYG 853
E T + T KSDV+SFGV++ EL+T P Y
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP----------------------YR 230
Query: 854 LTEMMDPTIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ + + + G R ++ QC E RPT +V +E ++
Sbjct: 231 --HIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 81/311 (26%), Positives = 135/311 (43%), Gaps = 77/311 (24%)
Query: 633 NEIGSGGYGKVYRGMLSDG---QVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKNLVG 687
+ IG G +G+V + + AIKR ++ + + +F E+E+L ++ HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESL--------------SGRSGIHLDWKRRLRIALG 733
L+G C +G L E+ +G L + L + + L ++ L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
ARG+ YL + IHRD+ + NIL+ EN AK+ADFGLS+ VK T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEVYVKKT 199
Query: 794 MGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRD 847
MG L E T SDV+S+GV++ E+++ P Y
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-----Y------------ 242
Query: 848 DEEHYGLT--EMMDPTIRNTVLLGFRRYLE-----------LALQCVEESATDRPTMSEV 894
G+T E+ + + G+R LE L QC E +RP+ +++
Sbjct: 243 ----CGMTCAELYE-----KLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 291
Query: 895 VKAIETLLQND 905
+ ++ +L+
Sbjct: 292 LVSLNRMLEER 302
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 71/301 (23%), Positives = 117/301 (38%), Gaps = 58/301 (19%)
Query: 634 EIGSGGYGKVYRGML--SDGQV-VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGLV 689
E+G G +G V +G+ Q+ VAIK +QG+ + E E +++ ++ + +V L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 690 GFCFEQGEQ-MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
G C Q E MLV E G L + L G+ + + + G+ YL E N
Sbjct: 77 GVC--QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL-EEKN-- 130
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYYM 803
+HRD+ + N+LL AK++DFGLSK + + + +K PE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 186
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT---EMMDP 860
++ + +SDV+S+GV M E ++ YG +M P
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALS--------------------------YGQKPYKKMKGP 220
Query: 861 TIRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNS 911
+ + G R L C DRP V + + +
Sbjct: 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 280
Query: 912 T 912
Sbjct: 281 H 281
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 61/233 (26%), Positives = 110/233 (47%), Gaps = 29/233 (12%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL 685
+F E IGSGG+G+V++ DG+ IKR + + + + E++ L+++ H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNI 66
Query: 686 VGLVGFCFEQGEQM-----------------LVYEFMANGTLRESLSGRSGIHLDWKRRL 728
V G C++ + + EF GTL + + R G LD L
Sbjct: 67 VHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
+ +G+ Y+H +I+RD+K +NI L + K+ DFGL + + K T
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK---RT 179
Query: 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841
+ KGT+ Y+ PE +Q ++ D+Y+ G+++ EL+ + ++R
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLR 232
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 9e-39
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 68/305 (22%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNL 685
+G G +G+VY G +S VA+K + Q L+F E ++S+ +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESL-----SGRSGIHLDWKRRLRIALGSARGLAY 740
V +G + + ++ E MA G L+ L L L +A A G Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 741 LHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L E IHRD+ + N LL AK+ DFG+++ + + S KG L
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----SYYRKGGCAML 207
Query: 798 -----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851
PE +M T K+D +SFGV++ E+ + P +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---------------------Y 246
Query: 852 YGLT--EMMDPTIRNTVLLGFR----------RYLELALQCVEESATDRPTMSEVVKAIE 899
+ E+++ V G R Y + QC + DRP + +++ IE
Sbjct: 247 PSKSNQEVLE-----FVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRPNFAIILERIE 300
Query: 900 TLLQN 904
Q+
Sbjct: 301 YCTQD 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-39
Identities = 73/364 (20%), Positives = 136/364 (37%), Gaps = 74/364 (20%)
Query: 577 YAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARW-FSYDELKKCSNNFSESNEI 635
Y +QK + + + + + + + D P + +W F + L+ +
Sbjct: 4 YKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNE--KWEFPRNNLQF-------GKTL 54
Query: 636 GSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKNLVG 687
G+G +GKV VA+K + + +E++++S + H+N+V
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESL------------SGRSGIHLDWKRRLRIALGSA 735
L+G C G +++ E+ G L L + + L + A
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
+G+A+L A+ IHRDV + N+LL AK+ DFGL++ + + S +
Sbjct: 175 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND-----SNYIVKGNA 226
Query: 796 YL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP---IEKGKYVVREVRTA--M 844
L PE T +SDV+S+G+++ E+ + P I + V+ M
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286
Query: 845 NRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901
+ + Y +M C T RPT ++ ++
Sbjct: 287 AQPAFAPKNIY---SIM-------------------QACWALEPTHRPTFQQICSFLQEQ 324
Query: 902 LQND 905
Q D
Sbjct: 325 AQED 328
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 1e-38
Identities = 68/372 (18%), Positives = 130/372 (34%), Gaps = 81/372 (21%)
Query: 577 YAIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARW-FSYDELKKCSNNFSESNEI 635
+ +++ R E + + + S +W F + L+ +
Sbjct: 1 HKYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEF-------GKVL 53
Query: 636 GSGGYGKVYRGMLSDG------QVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKNLVG 687
GSG +GKV VA+K ++ + +E+++++++ H+N+V
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESL---------------------SGRSGIHLDWKR 726
L+G C G L++E+ G L L L ++
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
L A A+G+ +L +HRD+ + N+L+ K+ DFGL++ +
Sbjct: 174 LLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD----- 225
Query: 787 STQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP---IEKGKYVV 837
S V L PE T KSDV+S+G+++ E+ + P I
Sbjct: 226 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 838 REVRTA--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMS 892
+ ++ M++ EE Y +M C + RP+
Sbjct: 286 KLIQNGFKMDQPFYATEEIY---IIM-------------------QSCWAFDSRKRPSFP 323
Query: 893 EVVKAIETLLQN 904
+ + L +
Sbjct: 324 NLTSFLGCQLAD 335
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-38
Identities = 74/310 (23%), Positives = 126/310 (40%), Gaps = 67/310 (21%)
Query: 633 NEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKN 684
+G G +G+V + + VA+K ++G+ +E+++L + HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 685 LVGLVGFCFEQGE-QMLVYEFMANGTLRESLSGRSGI--------------HLDWKRRLR 729
+V L+G C + G M++ EF G L L + L + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
+ A+G+ +L A+ IHRD+ + NILL E K+ DFGL++ +
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----PDY 204
Query: 790 VKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP---IEKGKYVVREV 840
V+ L PE + T +SDV+SFGV++ E+ + P ++ + R +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 841 RTA--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895
+ M D E Y + M L C + RPT SE+V
Sbjct: 265 KEGTRMRAPDYTTPEMY---QTM-------------------LDCWHGEPSQRPTFSELV 302
Query: 896 KAIETLLQND 905
+ + LLQ +
Sbjct: 303 EHLGNLLQAN 312
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 69/287 (24%), Positives = 124/287 (43%), Gaps = 45/287 (15%)
Query: 634 EIGSGGYGKVYRGMLSDGQV----VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGL 688
+G G +G+VY G+ ++ + VA+K ++ +F +E ++ + H ++V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+G E+ ++ E G L L L + +L + +AYL E N
Sbjct: 79 IGIIEEE-PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYL-ESIN-- 133
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSD-----SSKGHVSTQVKGTMGYLDPEYYM 803
+HRD+ NIL+ K+ DFGLS+ + D +S + +K PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMS----PESIN 187
Query: 804 TQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD- 859
++ T SDV+ F V M E+++ KQP + K V+ + E+ L +
Sbjct: 188 FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--------EKGDRLPKPDLC 239
Query: 860 -PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
P + Y L +C + +DRP +E+V ++ + Q +
Sbjct: 240 PPVL----------Y-TLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-38
Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 45/287 (15%)
Query: 634 EIGSGGYGKVYRGMLSDG----QVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGL 688
IG G +G V++G+ VAIK + + +F E + + H ++V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+G E ++ E G LR L R LD + A + LAYL
Sbjct: 82 IGVITEN-PVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALAYLESKR--- 136
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSD-----SSKGHVSTQVKGTMGYLDPEYYM 803
+HRD+ + N+L+ N K+ DFGLS+ + D +SKG + +K PE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP--IKWMA----PESIN 190
Query: 804 TQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD- 859
++ T SDV+ FGV M E++ +P + K V+ + E L +
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPMPPNC 242
Query: 860 -PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
PT+ Y L +C + RP +E+ + T+L+ +
Sbjct: 243 PPTL----------Y-SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 75/314 (23%), Positives = 129/314 (41%), Gaps = 77/314 (24%)
Query: 633 NEIGSGGYGKVYRGMLSD--------GQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HH 682
+G G +G+V VA+K + + + L + +E+E++ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRL 728
KN++ L+G C + G ++ E+ + G LRE L R + +K +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
ARG+ YL A+ IHRD+ + N+L+ EN K+ADFGL++ +++
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-----DY 212
Query: 789 QVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKY------- 835
K T G L PE + T +SDV+SFGV+M E+ T P Y
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-----YPGIPVEE 267
Query: 836 VVREVRTA--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT 890
+ + ++ M++ E Y MM C + RPT
Sbjct: 268 LFKLLKEGHRMDKPANCTNELY---MMM-------------------RDCWHAVPSQRPT 305
Query: 891 MSEVVKAIETLLQN 904
++V+ ++ +L
Sbjct: 306 FKQLVEDLDRILTL 319
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-38
Identities = 73/313 (23%), Positives = 126/313 (40%), Gaps = 75/313 (23%)
Query: 633 NEIGSGGYGKVYRGMLSD--------GQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HH 682
+G G +G+V VA+K + + + L + +E+E++ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESL--------------SGRSGIHLDWKRRL 728
KN++ L+G C + G ++ E+ + G LRE L + + +K +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
ARG+ YL A+ IHRD+ + N+L+ EN K+ADFGL++ +++
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI-----DY 258
Query: 789 QVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRT 842
K T G L PE + T +SDV+SFGV+M E+ T P Y
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP-----Y------- 306
Query: 843 AMNRDDEEHYGLT--EMMDPTIRNTVLLGFR---------RYLELALQCVEESATDRPTM 891
G+ E+ + G R + C + RPT
Sbjct: 307 ---------PGIPVEELFK-----LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTF 352
Query: 892 SEVVKAIETLLQN 904
++V+ ++ +L
Sbjct: 353 KQLVEDLDRILTL 365
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 74/320 (23%), Positives = 128/320 (40%), Gaps = 82/320 (25%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNL 685
+G G +GKV + VA+K ++ + L + +E +L +V+H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESL----------------------SGRSGIHLD 723
+ L G C + G +L+ E+ G+LR L L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783
+ A ++G+ Y LA ++HRD+ + NIL+ E K++DFGLS+ V +
Sbjct: 149 MGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEE-- 203
Query: 784 GHVSTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKY-- 835
+ VK + G + E T +SDV+SFGV++ E++T P Y
Sbjct: 204 ---DSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP-----YPG 255
Query: 836 -----VVREVRTA--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESA 885
+ ++T M R D EE Y +M LQC ++
Sbjct: 256 IPPERLFNLLKTGHRMERPDNCSEEMY---RLM-------------------LQCWKQEP 293
Query: 886 TDRPTMSEVVKAIETLLQND 905
RP +++ K +E ++
Sbjct: 294 DKRPVFADISKDLEKMMVKR 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 68/305 (22%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQG-SMQGGLEFKTEIELLSRVHHKNL 685
+G G +G+VY G +S VA+K + S Q L+F E ++S+ +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESL-----SGRSGIHLDWKRRLRIALGSARGLAY 740
V +G + + ++ E MA G L+ L L L +A A G Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 741 LHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L E IHRD+ + N LL AK+ DFG+++ + + KG L
Sbjct: 197 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA-----GYYRKGGCAML 248
Query: 798 -----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEH 851
PE +M T K+D +SFGV++ E+ + P +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---------------------Y 287
Query: 852 YGLT--EMMDPTIRNTVLLGFR----------RYLELALQCVEESATDRPTMSEVVKAIE 899
+ E+++ V G R Y + QC + DRP + +++ IE
Sbjct: 288 PSKSNQEVLE-----FVTSGGRMDPPKNCPGPVY-RIMTQCWQHQPEDRPNFAIILERIE 341
Query: 900 TLLQN 904
Q+
Sbjct: 342 YCTQD 346
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 68/310 (21%), Positives = 118/310 (38%), Gaps = 68/310 (21%)
Query: 633 NEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKN 684
+G+G +GKV VA+K + + +E+++LS + +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESL----------------SGRSGIHLDWKRRL 728
+V L+G C G +++ E+ G L L + LD + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
+ A+G+A+L A+ IHRD+ + NILL K+ DFGL++ + + S
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND-----SN 200
Query: 789 QVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP---IEKGKYVVRE 839
V L PE T +SDV+S+G+ + EL + P + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 840 VRTA--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEV 894
++ M + E Y ++M C + RPT ++
Sbjct: 261 IKEGFRMLSPEHAPAEMY---DIM-------------------KTCWDADPLKRPTFKQI 298
Query: 895 VKAIETLLQN 904
V+ IE +
Sbjct: 299 VQLIEKQISE 308
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-37
Identities = 74/314 (23%), Positives = 128/314 (40%), Gaps = 77/314 (24%)
Query: 633 NEIGSGGYGKVYRGML--------SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HH 682
+G G +G+V + VA+K + + + L + +E+E++ + H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESL--------------SGRSGIHLDWKRRL 728
KN++ L+G C + G ++ E+ + G LRE L S L K +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
A ARG+ YL A+ IHRD+ + N+L+ E+ K+ADFGL++ +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI-----DY 246
Query: 789 QVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKY------- 835
K T G L PE + T +SDV+SFGV++ E+ T P Y
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-----YPGVPVEE 301
Query: 836 VVREVRTA--MNRDD---EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT 890
+ + ++ M++ E Y MM C + RPT
Sbjct: 302 LFKLLKEGHRMDKPSNCTNELY---MMM-------------------RDCWHAVPSQRPT 339
Query: 891 MSEVVKAIETLLQN 904
++V+ ++ ++
Sbjct: 340 FKQLVEDLDRIVAL 353
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 68/318 (21%), Positives = 126/318 (39%), Gaps = 58/318 (18%)
Query: 606 GGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDG-----QVVAIKRAQ 660
G AP R E KK +GSG +G VY+G+ VAIK +
Sbjct: 1 GEAPNQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR 53
Query: 661 QGSMQGGL-EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG 719
+ + E E +++ V + ++ L+G C L+ + M G L + +
Sbjct: 54 EATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD 112
Query: 720 IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
++ + L + A+G+ YL + ++HRD+ + N+L+ K+ DFGL+KL+
Sbjct: 113 -NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839
K + + K + ++ E + + T +SDV+S+GV + EL+T
Sbjct: 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT-------------- 214
Query: 840 VRTAMNRDDEEHYGLT---EMMDPTIRNTVLLGFR----------RYLELALQCVEESAT 886
+G + I + + G R Y + ++C A
Sbjct: 215 ------------FGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-MIMVKCWMIDAD 261
Query: 887 DRPTMSEVVKAIETLLQN 904
RP E++ + ++
Sbjct: 262 SRPKFRELIIEFSKMARD 279
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-37
Identities = 61/284 (21%), Positives = 118/284 (41%), Gaps = 37/284 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQ-----VVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNL 685
+GSG +G V++G+ V IK + G + + + H ++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSF-QAVTDHMLAIGSLDHAHI 77
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
V L+G C LV +++ G+L + + G L + L + A+G+ YL E
Sbjct: 78 VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRG-ALGPQLLLNWGVQIAKGMYYLEEHG 135
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
++HR++ + N+LL +VADFG++ L+ K + ++ K + ++ E
Sbjct: 136 ---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192
Query: 806 QLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD--P 860
+ T +SDV+S+GV + EL+T +P + V + E+ L +
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--------EKGERLAQPQICTI 244
Query: 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ Y + ++C RPT E+ + ++
Sbjct: 245 DV----------Y-MVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 20/221 (9%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN 684
+ ++ ++G GG+ V L DG A+KR Q E + E ++ +H N
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPN 87
Query: 685 LVGLVGFCFEQGEQM----LVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGL 738
++ LV +C + L+ F GTL + G L + L + LG RGL
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV-------K 791
+H HRD+K TNILL + + D G +G +
Sbjct: 148 EAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQR 204
Query: 792 GTMGYLDPE---YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
T+ Y PE + E++DV+S G V+ ++ + P
Sbjct: 205 CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 5e-37
Identities = 68/289 (23%), Positives = 110/289 (38%), Gaps = 44/289 (15%)
Query: 634 EIGSGGYGKVYRGML----SDGQVVAIKRAQQGSMQGGL---EFKTEIELLSRVHHKNLV 686
++G G +G V RG VA+K + + +F E+ + + H+NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L G +V E G+L + L G H R A+ A G+ YL E
Sbjct: 85 RLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMGYL-ESKR 141
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEY 801
IHRD+ + N+LL K+ DFGL + + + +V + PE
Sbjct: 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----PES 195
Query: 802 YMTQQLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMM 858
T+ + SD + FGV + E+ T ++P G ++ ++ D+E L
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI-------DKEGERLPRPE 248
Query: 859 D--PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
D I Y + +QC DRPT + + D
Sbjct: 249 DCPQDI----------Y-NVMVQCWAHKPEDRPTFVALRDFLLEAQPTD 286
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 65/308 (21%), Positives = 118/308 (38%), Gaps = 76/308 (24%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNL 685
E+G +GKVY+G L Q VAIK + + EF+ E L +R+ H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIA 731
V L+G + +++ + ++G L E L RS L+ + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
A G+ YL ++H+D+ + N+L+ + L K++D GL + V +
Sbjct: 135 AQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAA-----DYYKL 186
Query: 792 GTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMN 845
L PE M + + SD++S+GVV+ E+ + QP Y
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP-----Y---------- 231
Query: 846 RDDEEHYGLT--EMMDPTIRNTVLLGFRRYLE-----------LALQCVEESATDRPTMS 892
G + ++++ + L L ++C E + RP
Sbjct: 232 ------CGYSNQDVVE-----MIRNRQV--LPCPDDCPAWVYALMIECWNEFPSRRPRFK 278
Query: 893 EVVKAIET 900
++ +
Sbjct: 279 DIHSRLRA 286
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-37
Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 20/224 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG--LEFKTEIELLSRVHHK 683
+ +IG G +GK DG+ IK M E + E+ +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
N+V E G +V ++ G L + ++ + G+ + L + L ++H+
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
I+HRD+KS NI L ++ T ++ DFG+++++ +S ++ GT YL PE
Sbjct: 144 RK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGTPYYLSPEICE 198
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
+ KSD+++ G V+ EL T K I G +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF 242
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-37
Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 11/236 (4%)
Query: 600 PSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR 658
G PQ + + D NF +IG G + +VYR L DG VA+K+
Sbjct: 5 SQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKK 64
Query: 659 ---AQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLS 715
+ + EI+LL +++H N++ E E +V E G L +
Sbjct: 65 VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 716 --GRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773
+ + + + + L ++H ++HRD+K N+ + K+ D G
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLG 181
Query: 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
L + S S + V GT Y+ PE KSD++S G ++ E+ + P
Sbjct: 182 LGRFFS-SKTTAAHSLV-GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-37
Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 39/284 (13%)
Query: 634 EIGSGGYGKVYRGMLSDG----QVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGL 688
IG G +G V++G+ VAIK + + +F E + + H ++V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+G E ++ E G LR L R LD + A + LAYL
Sbjct: 457 IGVITEN-PVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLESKR--- 511
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDS---SKGHVSTQVKGTMGYLDPEYYMTQ 805
+HRD+ + N+L+ N K+ DFGLS+ + DS +K PE +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA----PESINFR 567
Query: 806 QLTEKSDVYSFGVVMLELIT-AKQPIE--KGKYVVREVRTAMNRDDEEHYGLTEMMD-PT 861
+ T SDV+ FGV M E++ +P + K V+ + E L + P
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------ENGERLPMPPNCP- 618
Query: 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
L +C + RP +E+ + T+L+ +
Sbjct: 619 ---------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-36
Identities = 70/302 (23%), Positives = 118/302 (39%), Gaps = 56/302 (18%)
Query: 634 EIGSGGYGKVYRGML--SDGQV-VAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNLVGLV 689
E+G G +G V +G+ Q+ VAIK +QG+ + E E +++ ++ + +V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 690 GFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749
G C + MLV E G L + L G+ + + + G+ YL E N
Sbjct: 403 GVCQAE-ALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL-EEKN--F 457
Query: 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ-----VKGTMGYLDPEYYMT 804
+HR++ + N+LL AK++DFGLSK + + + +K PE
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECINF 513
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT---EMMDPT 861
++ + +SDV+S+GV M E ++ YG +M P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALS--------------------------YGQKPYKKMKGPE 547
Query: 862 IRNTVLLGFR---------RYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTNST 912
+ + G R L C DRP V + + +
Sbjct: 548 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGG 607
Query: 913 SA 914
SA
Sbjct: 608 SA 609
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-36
Identities = 57/327 (17%), Positives = 113/327 (34%), Gaps = 36/327 (11%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146
T + L+L++N L + +L L + + P+ L L L L
Sbjct: 24 PTNITVLNLTHNQ-LRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82
Query: 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP------------------VSTITSPGLD 188
N S + + L L L N + +S+
Sbjct: 83 NELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQV 142
Query: 189 QLKNAKHFHFNKNKLSGTISEQL-FSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247
QL+N + + NK+ SE+L + L + NQ+ P + L L L
Sbjct: 143 QLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFL 202
Query: 248 DRNALTGKVPTNL---NNLTNVNELNLAHNDLKGPFPDL---SQMNSLSYVDLSNNSFDP 301
+ L + L T++ L+L+++ L + +L+ +DLS N+ +
Sbjct: 203 NNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLN- 261
Query: 302 TEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG-- 359
F+ LP L E+ ++Q L ++ + L+ + ++ + +
Sbjct: 262 VVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKID 321
Query: 360 -------PLLQLVDLQNNQISAITLGS 379
L+ +++++N I I
Sbjct: 322 DFSFQWLKCLEHLNMEDNDIPGIKSNM 348
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-34
Identities = 69/347 (19%), Positives = 136/347 (39%), Gaps = 23/347 (6%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIG---GLTELRSLDLSYNGGLTGSLSPRIGDLQ--KLN 116
R+ L L+ + L L+ + T +R+L LS + L+ + + L+ L
Sbjct: 193 AIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ-LSTTSNTTFLGLKWTNLT 251
Query: 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGS 176
+L L+ D L +L + L NN SL L + +L+L + S
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311
Query: 177 IPVSTITSPG---LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIP 233
I ++++ LK +H + N + G I +F+ + L ++ + S
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPG-IKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 234 ESLGYVQ----TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD--LSQMN 287
+ +V L +L L +N ++ + L ++ L+L N++ +
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430
Query: 288 SLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG--RVPDKLFSYSQIQQVKLRN 345
++ + LS N + F+ +PSL L+ +L+ P + + L N
Sbjct: 431 NIFEIYLSYNKYL-QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 346 NAFNNTLDMGNAVGPL--LQLVDLQNNQISAITLGSGIKNYTLILVG 390
N N D + + L L+++DLQ+N ++ + + L G
Sbjct: 490 NNIANIND--DMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKG 534
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-33
Identities = 61/322 (18%), Positives = 106/322 (32%), Gaps = 26/322 (8%)
Query: 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAG--CGFT 126
+S L L L L++ N + G S L L L L+
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDND-IPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 127 GNIPDEIGNLAE--LSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS 184
+ +LA L L L N S + L L LDL N++ +
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
Query: 185 PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG--NIPESLGYVQTL 242
L+N + + NK ++ F+ L ++ L + P ++ L
Sbjct: 429 -----LENIFEIYLSYNKYLQ-LTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNL 482
Query: 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK---------GPFPDLSQMNSLSYVD 293
+L L N + L L + L+L HN+L GP L ++ L ++
Sbjct: 483 TILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILN 542
Query: 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD 353
L +N FD F L L + +L + ++ + L+ N +++
Sbjct: 543 LESNGFD-EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLI-TSVE 600
Query: 354 MGNAVGPL--LQLVDLQNNQIS 373
L +D++ N
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-33
Identities = 53/290 (18%), Positives = 96/290 (33%), Gaps = 30/290 (10%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPR-IGDLQKLNILI 119
+S + L L+ ++ S L L LDL N + L+ + L+ + +
Sbjct: 378 LAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLN-EIGQELTGQEWRGLENIFEIY 436
Query: 120 LAGCGFTGNIPDEIGNLAELSFLALNSNNFSG--RIPPSLGKLSQLYWLDLADNQLTGSI 177
L+ + + + L L L P L L LDL++N +
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN 496
Query: 178 PVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL-------FDGNQLSG 230
L+ L+ + N L+ + + L + N
Sbjct: 497 DDM------LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL--SQMNS 288
E + L+++ L N L + NN ++ LNL N + + +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 289 LSYVDLSNNSFDPT-EAPLWFS--------TLPSLTT-LICEF-GSLQGR 327
L+ +D+ N FD T E+ WF +P L++ +C G
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGF 660
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-30
Identities = 54/300 (18%), Positives = 95/300 (31%), Gaps = 44/300 (14%)
Query: 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSN 147
D S+ LT + + + +L L ++L+ L + N
Sbjct: 4 VSHEVADCSHLK-LT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 148 NFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTI 207
S P KL L L+L N+L+ + N
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKT------FAFCTN--------------- 98
Query: 208 SEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVN 267
L + N + + L L L N L+ L N+
Sbjct: 99 ----------LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQ 148
Query: 268 ELNLAHNDLKG-PFPDLSQMN--SLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSL 324
EL L++N ++ +L SL ++LS+N +P F + L L L
Sbjct: 149 ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK-EFSPGCFHAIGRLFGLFLNNVQL 207
Query: 325 QGRVPDKLFSY---SQIQQVKLRNNAFNNTLD--MGNAVGPLLQLVDLQNNQISAITLGS 379
+ +KL + I+ + L N+ + T + L ++DL N ++ + S
Sbjct: 208 GPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-18
Identities = 36/189 (19%), Positives = 56/189 (29%), Gaps = 15/189 (7%)
Query: 58 GVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYN-------GGLTGSLSPRIG 110
+T L LS + + GL +L LDL +N G +
Sbjct: 474 SPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLK 533
Query: 111 DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170
L L+IL L GF + +L EL + L NN + L L+L
Sbjct: 534 GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQK 593
Query: 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMV---LIHVLFDGNQ 227
N +T + P L N T + + + ++ +
Sbjct: 594 NLITSVEK--KVFGPAFRNL---TELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSH 648
Query: 228 LSGNIPESL 236
N P
Sbjct: 649 YLCNTPPHY 657
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 50/270 (18%), Positives = 84/270 (31%), Gaps = 20/270 (7%)
Query: 71 LSTMGLTGKLSGDIGGLTELRSLDLSYNG-GLTGSLSPRIGDLQKLNILILAGCGFTGNI 129
L+ G + L L LDLS NG G S L L L+ G +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-M 388
Query: 130 PDEIGNLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
L +L L +N S L L +LD++ + +
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI------FN 442
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
L + + N +F+ L + QL P + + +L+VL +
Sbjct: 443 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL--SQMNSLSYVDLSNNSFDPTEAPL 306
N L ++ L+ + N + +SL++++L+ N F T
Sbjct: 503 HNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQ 562
Query: 307 WF--------STLPSLTTLICEF-GSLQGR 327
F L + + C QG
Sbjct: 563 SFLQWIKDQRQLLVEVERMECATPSDKQGM 592
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-35
Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 21/298 (7%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
+ V++ L ++ + D + L+L + ++ L++L
Sbjct: 280 CLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK-FGQFPTLKLKSLKRLTFT--- 333
Query: 122 GCGFTGNIPDEIGNLAELSFLAL--NSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPV 179
G +L L FL L N +F G S + L +LDL+ N +
Sbjct: 334 --SNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM--- 388
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
S L+ +H F + L +F LI++ +
Sbjct: 389 ----SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 240 QTLEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNN 297
+LEVL++ N+ + L N+ L+L+ L+ P + ++SL +++S+N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504
Query: 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFS-YSQIQQVKLRNNAFNNTLDM 354
+F + + L SL L + +L S + + L N F T +
Sbjct: 505 NFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 561
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-33
Identities = 60/355 (16%), Positives = 102/355 (28%), Gaps = 34/355 (9%)
Query: 51 DPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIG 110
+PC +T + K+ ++ ++LDLS+N L S
Sbjct: 1 EPC------VEVVPNITYQ-CMELNFY-KIPDNL--PFSTKNLDLSFNP-LRHLGSYSFF 49
Query: 111 DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170
+L +L L+ C +L+ LS L L N + LS L L +
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG 230
L + LK K + N + + FS L H+ N++
Sbjct: 110 TNLASLENFP------IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 231 NIPESLGYVQTLEV----LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD--LS 284
L + + + L L N + P + +++L L +N +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
Query: 285 QMNSLSYVDLSNNSF--DPTEAPLWFSTLPSLTTLICEFGSLQ------GRVPDKLFSYS 336
+ L L F + S L L L E L + D +
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 337 QIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGN 391
+ L + D Q ++L N + L N
Sbjct: 283 NVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSN 335
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-32
Identities = 56/335 (16%), Positives = 112/335 (33%), Gaps = 26/335 (7%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
S + L L + IG L L+ L++++N + L +L L L L+
Sbjct: 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 122 GCGFTGNIPDEIGNLAELSFLALN---SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
++ L ++ L L+ S N I P K +L+ L L +N + ++
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM 217
Query: 179 VSTITS-PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS------GN 231
+ I GL+ + N+ L L L ++ + +L+ +
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG----LCNLTIEEFRLAYLDYYLDD 273
Query: 232 IPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLS 290
I + + + L + + + L L + P L + L+
Sbjct: 274 IIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331
Query: 291 YVDLSNNSFDPTEAPLWFSTLPSLTTLICEF--GSLQGRVPDKLFSYSQIQQVKLRNNAF 348
+ + LPSL L S +G F + ++ + L N
Sbjct: 332 FTSNKGGN------AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 349 NNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKN 383
T+ L+ +D Q++ + ++ S +
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 419
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-30
Identities = 63/334 (18%), Positives = 101/334 (30%), Gaps = 53/334 (15%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+ S ++ L L+ + G GL+ L+ L L + IG L+ L L +
Sbjct: 73 QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN-LASLENFPIGHLKTLKELNV 131
Query: 121 AGCGFTG-NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQL----YWLDLADNQLTG 175
A +P+ NL L L L+SN L L Q+ LDL+ N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191
Query: 176 SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVL------IHVLFDGNQLS 229
P G + N S + + L + + L
Sbjct: 192 IQP-------GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244
Query: 230 GNIPESLGYVQTLEVLRLDRNAL---TGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQM 286
+L + L + L + N LTNV+ +L ++ D S
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV-KDFSYN 303
Query: 287 NSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNN 346
+++L N F L +L LT +N
Sbjct: 304 FGWQHLELVNCKFGQFP-TLKLKSLKRLT---------------------------FTSN 335
Query: 347 AFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSG 380
N + P L+ +DL N +S S
Sbjct: 336 KGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQ 367
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 48/310 (15%), Positives = 89/310 (28%), Gaps = 28/310 (9%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN------IPDEIGNL 136
L L L N + I L L + L F + L
Sbjct: 195 GAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 137 AELSF--LALNSNNFS-GRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA 193
L+ L ++ I L+ + L + S
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--------YNFGW 306
Query: 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALT 253
+H K F + G S + +LE L L RN L+
Sbjct: 307 QHLELVNCKFGQ------FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLS 360
Query: 254 --GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL 311
G + T++ L+L+ N + + + L ++D +++ F +L
Sbjct: 361 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 420
Query: 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL--LQLVDLQN 369
+L L + S ++ +K+ N+F + L L +DL
Sbjct: 421 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELRNLTFLDLSQ 479
Query: 370 NQISAITLGS 379
Q+ ++ +
Sbjct: 480 CQLEQLSPTA 489
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 64/330 (19%), Positives = 105/330 (31%), Gaps = 34/330 (10%)
Query: 62 NNSRVTALGLSTMGLTGKLSGD-IGGLTELRSLDLSYN-----GGLTGSLSPRIGDLQKL 115
R+ L L + + I GL L L G L + L L
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 116 NILILAGC---GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQ 172
I + +I D L +S +L S L+L + +
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCK 315
Query: 173 LTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS--G 230
+LK+ K F NK SE L + N LS G
Sbjct: 316 FGQFPT---------LKLKSLKRLTFTSNKGGNAFSEVDLPS---LEFLDLSRNGLSFKG 363
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG--PFPDLSQMNS 288
+S +L+ L L N + + +N L + L+ H++LK F + +
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 289 LSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY-SQIQQVKLRNNA 347
L Y+D+S+ F+ L SL L S Q +F+ + + L
Sbjct: 423 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 481
Query: 348 FNNTLDMGNAVGPL--LQLVDLQNNQISAI 375
A L LQ++++ +N ++
Sbjct: 482 LEQLSP--TAFNSLSSLQVLNMSHNNFFSL 509
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 36/181 (19%), Positives = 61/181 (33%), Gaps = 8/181 (4%)
Query: 58 GVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLN 116
V + + L +S +G GL+ L L ++ N + P I +L+ L
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS-FQENFLPDIFTELRNLT 473
Query: 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGS 176
L L+ C P +L+ L L ++ NNF L+ L LD + N + S
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 533
Query: 177 IPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF-DGNQLSGNIPES 235
L + +N + T Q F + L + ++ P
Sbjct: 534 KK--QELQHFPSSL---AFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 588
Query: 236 L 236
Sbjct: 589 K 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 21/127 (16%), Positives = 37/127 (29%), Gaps = 28/127 (22%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
+T L LS L L+ L+ L++S+N + L L +L +
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNN-FFSLDTFPYKCLNSLQVLDYS 526
Query: 122 GCGFTGNIPDEIGNLAE-LSFLALNSNNFSG--------------------------RIP 154
+ E+ + L+FL L N+F+ P
Sbjct: 527 LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
Query: 155 PSLGKLS 161
+
Sbjct: 587 SDKQGMP 593
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 72/320 (22%), Positives = 123/320 (38%), Gaps = 84/320 (26%)
Query: 633 NEIGSGGYGKVYRGMLSDG------QVVAIKRAQQGSMQGGL-EFKTEIELLSRVHHKNL 685
+IG G +G+V++ +VA+K ++ + +F+ E L++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR------------------ 727
V L+G C L++E+MA G L E L S +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 728 ----LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783
L IA A G+AYL E +HRD+ + N L+ EN+ K+ADFGLS+ + +
Sbjct: 173 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA-- 227
Query: 784 GHVSTQVKGTMGYL-----DPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVV 837
+ PE + T +SDV+++GVV+ E+ + QP Y
Sbjct: 228 ---DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-----Y-- 277
Query: 838 REVRTAMNRDDEEHYGLT--EMMDPTIRNTVLLGFRRYLE-----------LALQCVEES 884
YG+ E++ V G L L C +
Sbjct: 278 --------------YGMAHEEVIY-----YVRDGNI--LACPENCPLELYNLMRLCWSKL 316
Query: 885 ATDRPTMSEVVKAIETLLQN 904
DRP+ + + ++ + +
Sbjct: 317 PADRPSFCSIHRILQRMCER 336
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 5e-36
Identities = 60/340 (17%), Positives = 113/340 (33%), Gaps = 40/340 (11%)
Query: 78 GKLSGDIGGLTELRSLDLSYNGGLTG-SLSPRIGDLQKLNILILAGCGFTGNIPDEIGNL 136
+L+ D +++ + YN L S + + KL +L + G
Sbjct: 538 TRLADDEDTGPKIQIFYMGYNN-LEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTN 594
Query: 137 AELSFLALNSNNFSGRIPPSLGK-LSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195
+L+ L L+ N IP Q+ L + N+L IP +
Sbjct: 595 VKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIP----NIFNAKSVYVMGS 648
Query: 196 FHFNKNKLSGTISEQLFSPDMV----LIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNA 251
F+ NK+ S D V N++ E + + L N
Sbjct: 649 VDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNL 708
Query: 252 LT-------GKVPTNLNNLTNVNELNLAHNDLKGPFPD---LSQMNSLSYVDLSNNSFDP 301
+T N N + ++L N L D + + LS +D+S N F
Sbjct: 709 MTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCF-- 765
Query: 302 TEAPLWFSTLPSLTTL------ICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMG 355
+ P L E + + P + + + Q+++ +N +D
Sbjct: 766 SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVD-- 822
Query: 356 NAVGPLLQLVDLQNNQISAITLGS---GIKNYTLILVGNP 392
+ P L ++D+ +N +I + S I+ +L+ +
Sbjct: 823 EKLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-34
Identities = 62/331 (18%), Positives = 120/331 (36%), Gaps = 29/331 (8%)
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAG 122
+ + T +G T +T +S I LT+L+ + + + T + +
Sbjct: 424 SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSP-FTY-DNIAVD----WEDANSDY 476
Query: 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS-- 180
N NL +L+ + L + ++P L L +L L++A N+ + +
Sbjct: 477 AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKAD 536
Query: 181 -TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
T + D + F+ N L + + L + N++ E+ G
Sbjct: 537 WTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTN 594
Query: 240 QTLEVLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLKG--PFPDLSQMNSLSYVDLSN 296
L L+LD N + +P + V L +HN LK + + + VD S
Sbjct: 595 VKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSY 653
Query: 297 NSF----DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY-SQIQQVKLRNNAF--- 348
N + + +T+ + +Q P +LF+ S I + L NN
Sbjct: 654 NKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK-FPTELFATGSPISTIILSNNLMTSI 712
Query: 349 --NNTLDMGNAVGPL--LQLVDLQNNQISAI 375
N+ L +DL+ N+++++
Sbjct: 713 PENSLKPKDGNYKNTYLLTTIDLRFNKLTSL 743
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 9e-32
Identities = 51/337 (15%), Positives = 114/337 (33%), Gaps = 35/337 (10%)
Query: 61 CNNSRVTALGLSTMGLTG-KLSGDIGGLTELRSLDLSYNGGLTGSLS--PRIGDLQKLNI 117
++ + L S + + +L LD +N + G KL
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN-----KVRHLEAFGTNVKLTD 599
Query: 118 LILAGCGFTGNIPDEIGNLA-ELSFLALNSNNFSGRIPP--SLGKLSQLYWLDLADNQLT 174
L L IP++ ++ L + N IP + + + +D + N++
Sbjct: 600 LKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 175 GSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS----- 229
S + S + NA + N++ +E LF+ + ++ N ++
Sbjct: 658 -SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTE-LFATGSPISTIILSNNLMTSIPEN 715
Query: 230 --GNIPESLGYVQTLEVLRLDRNALTGKVPTNL--NNLTNVNELNLAHNDLKGPFPDLSQ 285
+ L + L N LT + + L ++ +++++N
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFSSFPTQPLN 774
Query: 286 MNSLSYVDLSNNSFDP-----TEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQ 340
+ L + + + P +T PSL L ++ V +KL Q+
Sbjct: 775 SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLT--PQLYI 831
Query: 341 VKLRNNAFNNTLDMGNAVGPL-LQLVDLQNNQISAIT 376
+ + +N N ++D+ + + + L ++ I
Sbjct: 832 LDIADNP-NISIDVTSVCPYIEAGMYVLLYDKTQDIR 867
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-28
Identities = 48/296 (16%), Positives = 103/296 (34%), Gaps = 24/296 (8%)
Query: 92 SLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSG 151
+ +L G G G + L+ LAG G G +PD IG L EL L+ +++ +
Sbjct: 305 NKELDMWGDQPGVDLDNNGRVTGLS---LAGFGAKGRVPDAIGQLTELKVLSFGTHSETV 361
Query: 152 RIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQL 211
+ + +++ + L + N+N I +
Sbjct: 362 SGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDS 421
Query: 212 FSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271
+ + N+++ I +++ + L+++ + T N + + N
Sbjct: 422 RI-SLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTY-----DNIAVDWEDANS 474
Query: 272 AHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL---------ICEF 321
+ S + L+ V+L N T+ P + LP L +L +
Sbjct: 475 DYAKQYENEELSWSNLKDLTDVELYNCPNM-TQLPDFLYDLPELQSLNIACNRGISAAQL 533
Query: 322 GSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL--LQLVDLQNNQISAI 375
+ R+ D + +IQ + N ++ + L L+D +N++ +
Sbjct: 534 KADWTRLADDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVRHL 588
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 6e-36
Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 23/230 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG--LEFKTEIELLSRVHHK 683
++ IG+G YG+ + SDG+++ K GSM +E+ LL + H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 684 NLVGLVGFCFEQGEQML--VYEFMANGTLRESLS--GRSGIHLDWKRRLRIALGSARGLA 739
N+V ++ L V E+ G L ++ + +LD + LR+ L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 740 YLHE--LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
H ++HRD+K N+ LD K+ DFGL+++++ T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN-HDTSFAKTFV-GTPYYM 183
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE EKSD++S G ++ EL P I +GK+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF 233
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 18/220 (8%)
Query: 618 SYDELKKCS---NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM--QGGLEFK 671
YD + S +F + +G G YG+V++ DG++ A+KR+ +
Sbjct: 45 GYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL 104
Query: 672 TEIELLSRV-HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR 729
E+ +V H V L +E+G + L E +L++ G L +
Sbjct: 105 AEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTEL-CGPSLQQHCE-AWGASLPEAQVWG 161
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
+ LA+LH ++H DVK NI L K+ DFGL + + G V
Sbjct: 162 YLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--- 215
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+G Y+ PE + +DV+S G+ +LE+ +
Sbjct: 216 QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVG 690
+G GG VY VAIK + L+ F+ E+ S++ H+N+V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
E LV E++ TL E + L + G+ + H++ I+
Sbjct: 79 VDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IV 133
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
HRD+K NIL+D N T K+ DFG++K +S++S + V GT+ Y PE + E
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDEC 192
Query: 811 SDVYSFGVVMLELITAKQP 829
+D+YS G+V+ E++ + P
Sbjct: 193 TDIYSIGIVLYEMLVGEPP 211
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 51/225 (22%), Positives = 88/225 (39%), Gaps = 28/225 (12%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKN 684
+F +G GG+G V+ D AIKR + + + E E++ L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 685 LVGLVGFCFEQGEQM------------LVYEFMANGTLRESLSGRSGIH-LDWKRRLRIA 731
+V E+ + + L++ ++GR I + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--------- 782
L A + +LH ++HRD+K +NI + KV DFGL +
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 783 -KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITA 826
T GT Y+ PE + K D++S G+++ EL+
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP 226
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 22/208 (10%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVG 690
+G GG +V+ L D + VA+K RA F+ E + + ++H +V +
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV-- 77
Query: 691 FCFEQGEQM--------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
++ GE +V E++ TLR+ + + KR + + + + L + H
Sbjct: 78 --YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH 133
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST-QVKGTMGYLDPEY 801
+ IIHRDVK NI++ KV DFG+++ ++DS T V GT YL PE
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ +SDVYS G V+ E++T + P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 28/209 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
+G G YG VY G LS+ +AIK + + EI L + HKN+V +G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRI----ALGSARGLAYLHELANPPI 749
E G + E + G+L L + G D ++ + L GL YLH+ I
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL---EGLKYLHDNQ---I 143
Query: 750 IHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM----- 803
+HRD+K N+L++ + K++DFG SK ++ + + GT+ YM
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTL------QYMAPEII 195
Query: 804 ---TQQLTEKSDVYSFGVVMLELITAKQP 829
+ + +D++S G ++E+ T K P
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 48/221 (21%), Positives = 90/221 (40%), Gaps = 28/221 (12%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKR-----AQQGSMQGGLEFKTEIELLSRVH 681
+S +IGSGG KV++ + Q+ AIK A ++ ++ EI L+++
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQ 84
Query: 682 HKNL--VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+ + L + +V E N L L + I ++ + +
Sbjct: 85 QHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVH 141
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
+H+ I+H D+K N L+ + K+ DFG++ + + V GT+ Y+ P
Sbjct: 142 TIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
Query: 800 E-----------YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
E +++ KSDV+S G ++ + K P
Sbjct: 198 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 57/235 (24%), Positives = 103/235 (43%), Gaps = 44/235 (18%)
Query: 624 KCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH 682
+ +++F E +G G +G+V + D + AIK+ + + +E+ LL+ ++H
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNH 61
Query: 683 KNLVGLVGFCFEQGEQM-------------LVYEFMANGTLRESLSGRSGIHLDWKRRLR 729
+ +V E+ + + E+ NGTL + + ++ R
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH-SENLNQQRDEYWR 120
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS-------- 781
+ L+Y+H IIHRD+K NI +DE+ K+ DFGL+K V S
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 782 -----SKGHVSTQVKGTMGYLDPE------YYMTQQLTEKSDVYSFGVVMLELIT 825
S ++++ + GT Y+ E +Y EK D+YS G++ E+I
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHY-----NEKIDMYSLGIIFFEMIY 226
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 58/232 (25%), Positives = 90/232 (38%), Gaps = 32/232 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC 692
+ GG+ VY + G+ A+KR + E+ + ++ H N+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 693 FEQGEQM-------LVYEFMANGTLRESL-SGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
E+ L+ + G L E L S L L+I + R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK----------GTM 794
PPIIHRD+K N+LL T K+ DFG + +S S Q + T
Sbjct: 156 -KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 795 GYLDPE---YYMTQQLTEKSDVYSFGVVMLELITAKQP--------IEKGKY 835
Y PE Y + EK D+++ G ++ L + P I GKY
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGKY 266
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 15/214 (7%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSR 679
E ++ + + +G G +G+V+R G A+K+ + + E+ +
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAG 106
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+ +V L G E + E + G+L + + + L R L + GL
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLE 164
Query: 740 YLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLSKLVSDSSKGHVSTQ---VKGTMG 795
YLH I+H DVK+ N+LL + A + DFG + + G + GT
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
++ PE M + K D++S +ML ++ P
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 47/215 (21%), Positives = 88/215 (40%), Gaps = 28/215 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKR-----AQQGSMQGGLEFKTEIELLSRVHHKNL-- 685
+IGSGG KV++ + Q+ AIK A ++ ++ EI L+++ +
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 71
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
+ L + +V E N L L + I ++ + + +H+
Sbjct: 72 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG 128
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE----- 800
I+H D+K N L+ + K+ DFG++ + + V GT+ Y+ PE
Sbjct: 129 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 801 ------YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+++ KSDV+S G ++ + K P
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 67/344 (19%), Positives = 115/344 (33%), Gaps = 22/344 (6%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTE--LRSLDLSYNGGLTGSLSPRIGDLQKLNIL 118
+ M GL E + S++L + S L L
Sbjct: 225 STIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHY-FFNISSNTFHCFSGLQEL 283
Query: 119 ILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
L + +P + L+ L L L++N F S L L + N +
Sbjct: 284 DLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELG 342
Query: 179 VSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF-DGNQLSGNIPESLG 237
L+ L+N + + + + + L ++ + L N+ E+
Sbjct: 343 TGC-----LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFK 397
Query: 238 YVQTLEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLS 295
LE+L L L K + NL + LNL+H+ L + +L +++L
Sbjct: 398 ECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQ 457
Query: 296 NNSF--DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY-SQIQQVKLRNNAFNNTL 352
N F + TL L L+ F L + F+ + V L +N +
Sbjct: 458 GNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRL-TSS 515
Query: 353 DMGNAVGPLLQLV-DLQNNQISAI---TLGSGIKNYTLILVGNP 392
A+ L + +L +N IS I L + T+ L NP
Sbjct: 516 S-IEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQNP 558
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-28
Identities = 60/379 (15%), Positives = 113/379 (29%), Gaps = 61/379 (16%)
Query: 53 CGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDL 112
S + T +GL ++ G + L+ S+N L + L
Sbjct: 2 TSSDQKCIEKEVNKTYN-CENLGLN-EIPGTL--PNSTECLEFSFNV-LPTIQNTTFSRL 56
Query: 113 QKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQ 172
L L L C D + L L L +N +L L L
Sbjct: 57 INLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTG 116
Query: 173 LTGSIPV------------------STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSP 214
++ + S+I P + K F N + +S++ S
Sbjct: 117 ISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSS 175
Query: 215 DMVLIHVLFD--GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL--NNLTNVNELN 270
++ + GN ++G I + L + L + + ++
Sbjct: 176 LQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 271 LAHNDLK----GPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG 326
D + F L +M+ + ++L + F + F L L L
Sbjct: 235 FEDMDDEDISPAVFEGLCEMS-VESINLQKHYFF-NISSNTFHCFSGLQELDLTATHLS- 291
Query: 327 RVPDKLFSYSQIQQVKLRNN--------AFNN-----TLDM-GN---------AVGPL-- 361
+P L S ++++ L N + +N L + GN + L
Sbjct: 292 ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351
Query: 362 LQLVDLQNNQISAITLGSG 380
L+ +DL ++ I +
Sbjct: 352 LRELDLSHDDIETSDCCNL 370
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-14
Identities = 40/268 (14%), Positives = 71/268 (26%), Gaps = 60/268 (22%)
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
+ + IP +L + L+ + N L TI + +L N + ++
Sbjct: 19 CENLGLN-EIPGTL--PNSTECLEFSFNVLP------TIQNTTFSRLINLTFLDLTRCQI 69
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL 263
I E F L ++ N L +L + L+ L + ++ L+N
Sbjct: 70 Y-WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQ 128
Query: 264 TNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322
+ L L N + P L +D NN+ + S+L T L
Sbjct: 129 KTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAI-HYLSKEDMSSLQQATNLS---- 183
Query: 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAI--TLGSG 380
++L N I+ I
Sbjct: 184 ------------------------------------------LNLNGNDIAGIEPGAFDS 201
Query: 381 IKNYTLILVGNPVCTATLANTNYCQLQQ 408
+L G +Q
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQS 229
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-12
Identities = 35/185 (18%), Positives = 61/185 (32%), Gaps = 12/185 (6%)
Query: 215 DMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHN 274
V + L+ IP +L + E L N L T + L N+ L+L
Sbjct: 11 KEVNKTYNCENLGLN-EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC 67
Query: 275 DLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF 333
+ D + L + L+ N A S +L L + +
Sbjct: 68 QIYWIHEDTFQSQHRLDTLVLTANPLI-FMAETALSGPKALKHLFFIQTGISS-IDFIPL 125
Query: 334 SY-SQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS-----GIKNYTLI 387
++ + L +N ++ L+++D QNN I ++ N +L
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 388 LVGNP 392
L GN
Sbjct: 186 LNGND 190
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 48/203 (23%), Positives = 78/203 (38%), Gaps = 18/203 (8%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVG 690
+G GG G VY ++VA+K S + E R+ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI-- 99
Query: 691 FCFEQGE----QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+ GE + + L L + L R + I L H
Sbjct: 100 --HDFGEIDGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG- 154
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
HRDVK NIL+ + A + DFG++ +D + V GT+ Y+ PE +
Sbjct: 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211
Query: 807 LTEKSDVYSFGVVMLELITAKQP 829
T ++D+Y+ V+ E +T P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 7e-32
Identities = 46/215 (21%), Positives = 87/215 (40%), Gaps = 28/215 (13%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIKR-----AQQGSMQGGLEFKTEIELLSRVHHKNL-- 685
+IGSGG KV++ + Q+ AIK A ++ ++ EI L+++ +
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS---YRNEIAYLNKLQQHSDKI 118
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
+ L + +V E N L L + I ++ + + +H+
Sbjct: 119 IRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQHG 175
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE----- 800
I+H D+K N L+ + K+ DFG++ + + V G + Y+ PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 801 ------YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+++ KSDV+S G ++ + K P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-31
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLV 686
+F + +G G G + + D + VA+KR E++LL H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF---ADREVQLLRESDEHPNVI 81
Query: 687 GLVGFCFEQGEQM--LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
FC E+ Q + E A TL+E + + HL + + + GLA+LH L
Sbjct: 82 RY--FCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLG-LEPITLLQQTTSGLAHLHSL 137
Query: 745 ANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSK-LVSDSSKGHVSTQVKGTMGYLD 798
I+HRD+K NIL+ + A ++DFGL K L + V GT G++
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 799 PEYY---MTQQLTEKSDVYSFGVVMLELITAKQP 829
PE + T D++S G V +I+
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-30
Identities = 45/207 (21%), Positives = 77/207 (37%), Gaps = 31/207 (14%)
Query: 635 IGSGGYGKVYRG--MLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGF 691
I GG G +Y +G+ V +K E + L+ V H ++V +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI--- 144
Query: 692 CFEQGEQM---------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
F E +V E++ +L+ S + L + L L+YLH
Sbjct: 145 -FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPALSYLH 199
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+ +++ D+K NI+L E K+ D G ++ + GT G+ PE
Sbjct: 200 SI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG------YLYGTPGFQAPEIV 249
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
T T +D+Y+ G + L
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 71/334 (21%), Positives = 126/334 (37%), Gaps = 36/334 (10%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123
+T L ++ + + G I LT L L+L+ N +T +SP + +L KL L +
Sbjct: 44 ESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGN-QIT-DISP-LSNLVKLTNLYIGTN 98
Query: 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTIT 183
T + NL L L LN +N S L L+++Y L+L N +
Sbjct: 99 KIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDL------ 148
Query: 184 SPGLDQLKNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTL 242
L + + ++K+ L L + + NQ+ L + +L
Sbjct: 149 -SPLSNMTGLNYLTVTESKVKDVTPIANLTD----LYSLSLNYNQIED--ISPLASLTSL 201
Query: 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302
N +T T + N+T +N L + +N + L+ ++ L+++++ N
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD-LSPLANLSQLTWLEIGTNQISDI 258
Query: 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL- 361
A L L L + L + SQ+ + L NN N DM +G L
Sbjct: 259 NA---VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGN-EDM-EVIGGLT 311
Query: 362 -LQLVDLQNNQISAITLGSGIKN-YTLILVGNPV 393
L + L N I+ I + + + +
Sbjct: 312 NLTTLFLSQNHITDIRPLASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 9e-30
Identities = 48/291 (16%), Positives = 104/291 (35%), Gaps = 29/291 (9%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
+ L +L +L + N +T +S + +L L L L + + NL ++ L
Sbjct: 84 LSNLVKLTNLYIGTNK-IT-DISA-LQNLTNLRELYLNEDNISD--ISPLANLTKMYSLN 138
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
L +N+ L ++ L +L + ++++ P + L + N N++
Sbjct: 139 LGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--------IANLTDLYSLSLNYNQI 189
Query: 204 SGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
L S L + NQ++ P + + L L++ N +T + L N
Sbjct: 190 EDISPLASLTS----LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLAN 241
Query: 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322
L+ + L + N + + + L +++ +N + L L +L
Sbjct: 242 LSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISDISV---LNNLSQLNSLFLNNN 297
Query: 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373
L + + + + + L N + + + + D N I
Sbjct: 298 QLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASL--SKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-21
Identities = 48/261 (18%), Positives = 98/261 (37%), Gaps = 27/261 (10%)
Query: 133 IGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKN 192
+LAE L + + + +L + L +A ++ SI G++ L N
Sbjct: 18 DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-------GIEYLTN 67
Query: 193 AKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNA 251
++ + N N+++ L L ++ N+++ +L + L L L+ +
Sbjct: 68 LEYLNLNGNQITDISPLSNLVK----LTNLYIGTNKIT--DISALQNLTNLRELYLNEDN 121
Query: 252 LTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL 311
++ + L NLT + LNL N LS M L+Y+ ++ + + L
Sbjct: 122 ISD--ISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANL 176
Query: 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371
L +L Q L S + + N + + N L + + NN+
Sbjct: 177 TDLYSL--SLNYNQIEDISPLASLTSLHYFTAYVNQITDITPVANM--TRLNSLKIGNNK 232
Query: 372 ISAITLGSGIKN-YTLILVGN 391
I+ ++ + + L + N
Sbjct: 233 ITDLSPLANLSQLTWLEIGTN 253
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 8e-15
Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 15/144 (10%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
N +R+ +L + +T LS + L++L L++ N ++ ++ + DL KL +L +
Sbjct: 218 ANMTRLNSLKIGNNKIT-DLSP-LANLSQLTWLEIGTNQ-IS-DINA-VKDLTKLKMLNV 272
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
+ + NL++L+ L LN+N +G L+ L L L+ N +T P
Sbjct: 273 GSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP-- 328
Query: 181 TITSPGLDQLKNAKHFHFNKNKLS 204
L L F +
Sbjct: 329 ------LASLSKMDSADFANQVIK 346
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 71/329 (21%), Positives = 125/329 (37%), Gaps = 34/329 (10%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
L +T +S L ++ +L G S+ + L L + +
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDG-VEYLNNLTQINFSNNQL 80
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
T P + NL +L + +N+N + L L+ L L L +NQ+T P
Sbjct: 81 TDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITDIDP------- 129
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
L L N + N +S + + + L GNQ++ P L + TLE L
Sbjct: 130 -LKNLTNLNRLELSSNTISDISALS----GLTSLQQLSFGNQVTDLKP--LANLTTLERL 182
Query: 246 RLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAP 305
+ N ++ + L LTN+ L +N + L + +L + L+ N
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLKDIGT- 238
Query: 306 LWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLV 365
++L +LT L + L +++ ++KL N +N + L +
Sbjct: 239 --LASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQISNISPLAGL--TALTNL 292
Query: 366 DLQNNQISAITLGSGIKN-YTLILVGNPV 393
+L NQ+ I+ S +KN L L N +
Sbjct: 293 ELNENQLEDISPISNLKNLTYLTLYFNNI 321
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-29
Identities = 77/345 (22%), Positives = 141/345 (40%), Gaps = 40/345 (11%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123
+VT L +G+ + G + L L ++ S N LT ++P + +L KL +++
Sbjct: 46 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN-QLT-DITP-LKNLTKLVDILMNNN 100
Query: 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTIT 183
P + NL L+ L L +N + L L+ L L+L+ N ++ +S +T
Sbjct: 101 QIADITP--LANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALSGLT 156
Query: 184 S-------------PGLDQLKNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLS 229
S L L + + NK+S +L + L ++ NQ+S
Sbjct: 157 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTN----LESLIATNNQIS 212
Query: 230 GNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSL 289
P LG + L+ L L+ N L L +LTN+ +L+LA+N + LS + L
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAPLSGLTKL 267
Query: 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349
+ + L N + L +LT L L+ + + + + L N +
Sbjct: 268 TELKLGANQISNISP---LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNIS 322
Query: 350 NTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKN-YTLILVGNPV 393
+ + + LQ + NN++S ++ + + N L N +
Sbjct: 323 DISPVSSL--TKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQI 365
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-28
Identities = 73/329 (22%), Positives = 124/329 (37%), Gaps = 36/329 (10%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
+ LT L L+LS N ++ +S + L L L G T P + NL L L
Sbjct: 130 LKNLTNLNRLELSSNT-IS-DISA-LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
++SN S L KL+ L L +NQ++ P L L N N N+L
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--------LGILTNLDELSLNGNQL 233
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL 263
I + L + NQ+S P L + L L+L N ++ + L L
Sbjct: 234 KD-IGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN--ISPLAGL 286
Query: 264 TNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGS 323
T + L L N L+ +S + +L+Y+ L N+ S+L L L
Sbjct: 287 TALTNLELNENQLED-ISPISNLKNLTYLTLYFNNISDISP---VSSLTKLQRLFFYNNK 342
Query: 324 LQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSG--- 380
+ L + + I + +N ++ + N + + L + + +
Sbjct: 343 VSD--VSSLANLTNINWLSAGHNQISDLTPLANL--TRITQLGLNDQAWTNAPVNYKANV 398
Query: 381 -IKNYTLILVGNPVCTATLAN-TNYCQLQ 407
I N + G + AT+++ +Y +
Sbjct: 399 SIPNTVKNVTGALIAPATISDGGSYTEPD 427
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 6e-28
Identities = 67/305 (21%), Positives = 119/305 (39%), Gaps = 55/305 (18%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
+ LT L LD+S N ++ +S + L L LI + P +G L L L+
Sbjct: 173 LANLTTLERLDISSNK-VS-DISV-LAKLTNLESLIATNNQISDITP--LGILTNLDELS 227
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS--------------PGLDQ 189
LN N +L L+ L LDLA+NQ++ P+S +T L
Sbjct: 228 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAG 285
Query: 190 LKNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
L + N+N+L L + L ++ N +S P + + L+ L
Sbjct: 286 LTALTNLELNENQLEDISPISNLKN----LTYLTLYFNNISDISP--VSSLTKLQRLFFY 339
Query: 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWF 308
N ++ ++L NLTN+N L+ HN + L+ + ++ + L++ ++ T AP+ +
Sbjct: 340 NNKVSD--VSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQAW--TNAPVNY 394
Query: 309 STLPSLTTL-------------ICEFGSLQ---------GRVPDKLFSYSQIQQVKLRNN 346
S+ I + GS + +++SQ +
Sbjct: 395 KANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTT 454
Query: 347 AFNNT 351
F+ T
Sbjct: 455 TFSGT 459
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-21
Identities = 51/287 (17%), Positives = 92/287 (32%), Gaps = 52/287 (18%)
Query: 90 LRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNF 149
L S ++ + + + L + +L T + +L +++ L +
Sbjct: 3 LGSATITQDTPIN-QIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI 58
Query: 150 SGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE 209
+ L+ L ++ ++NQLT P L L N N+++
Sbjct: 59 K--SIDGVEYLNNLTQINFSNNQLTDITP--------LKNLTKLVDILMNNNQIAD---- 104
Query: 210 QLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNEL 269
L + L L L N +T L NLTN+N L
Sbjct: 105 -----------------------ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRL 139
Query: 270 NLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVP 329
L+ N + LS + SL + N D + L +L L +
Sbjct: 140 ELSSNTISDI-SALSGLTSLQQLSFGNQVTDLKP----LANLTTLERLDISSNKVSD--I 192
Query: 330 DKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAIT 376
L + ++ + NN ++ +G L + L NQ+ I
Sbjct: 193 SVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDIG 237
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-18
Identities = 42/241 (17%), Positives = 83/241 (34%), Gaps = 26/241 (10%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+ + +T L L+ ++ + GLT+L L L N ++ ++SP + L L L L
Sbjct: 240 ASLTNLTDLDLANNQISN--LAPLSGLTKLTELKLGANQ-IS-NISP-LAGLTALTNLEL 294
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
P I NL L++L L NN S P + L++L L +N+++
Sbjct: 295 NENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV---- 346
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
L L N N++S L + + + +
Sbjct: 347 ----SSLANLTNINWLSAGHNQISDLTPLANLTR----ITQLGLNDQAWTNAPVNYK--- 395
Query: 240 QTLEVLRLDRNALTGKV-PTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNS 298
+ + +N + P +++ + E ++ N + + +
Sbjct: 396 ANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTT 455
Query: 299 F 299
F
Sbjct: 456 F 456
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 47/246 (19%), Positives = 96/246 (39%), Gaps = 46/246 (18%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG--LEFKTEIELLSRV-H 681
+ F E +IGSG +G V++ + DG + AIKR+++ E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 682 HKNLVGLVGFCFEQGEQMLVY-EFMANGTLRESLS--GRSGIHLDWKRRLRIALGSARGL 738
H ++V + + + ML+ E+ G+L +++S R + + L RGL
Sbjct: 70 HSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 739 AYLHELANPPIIHRDVKSTNILLDEN-------------------LTAKVADFGLSKLVS 779
Y+H ++ ++H D+K +NI + + K+ D G +S
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQP--------- 829
+ G +L E K+D+++ + ++ A+
Sbjct: 186 SP-----QVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
Query: 830 IEKGKY 835
I +G+
Sbjct: 240 IRQGRL 245
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 56/348 (16%), Positives = 112/348 (32%), Gaps = 33/348 (9%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTG-SLSPRIGDLQKLNILIL 120
+ + L L S IG L L+ L++++N + L +L L + L
Sbjct: 102 GLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHN-FIHSCKLPAYFSNLTNLVHVDL 160
Query: 121 AGCGFTGNIPDEIGNLAELSFLALN---SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSI 177
+ +++ L E + L+ S N I + +L+ L L N + +I
Sbjct: 161 SYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 178 PVSTITS-PGLDQLKNAKHFHFNKNKLSGTISEQLFS--PDMVLIHVLFDGNQLSGNIPE 234
+ + + GL + ++ L + D+ + +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLE-IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIV 279
Query: 235 SLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVD 293
+ + + L ++ ++ L++ LK P DL L +
Sbjct: 280 KFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLP---FLKSLT 334
Query: 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG----RVPDKLFSYSQIQQVKLRNNAFN 349
L+ N LPSL+ L L +S ++ + +FN
Sbjct: 335 LTMNKGS---ISFKKVALPSLSYL-----DLSRNALSFSGCCSYSDLGTNSLRHLDLSFN 386
Query: 350 NTLDMGNAVGPL--LQLVDLQNNQISAITLGSGIKN----YTLILVGN 391
+ M L LQ +D Q++ + +T S + L +
Sbjct: 387 GAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYT 434
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-29
Identities = 59/342 (17%), Positives = 107/342 (31%), Gaps = 31/342 (9%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
+ LS L S +EL+ LDLS + L L+ LIL G
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCE-IETIEDKAWHGLHHLSNLILTGNPI 92
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
P L L L + +G+L L L++A N + S +
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH-SCKLPAY--- 148
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN----IPESLGYVQT 241
L N H + N + I+ V + +S N I +
Sbjct: 149 -FSNLTNLVHVDLSYNYIQT-ITVNDLQFLRENPQVNLSLD-MSLNPIDFIQDQAFQGIK 205
Query: 242 LEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKG-------PFPDLSQMNSLSYVD 293
L L L N + + L NL ++ L + K + + ++ +
Sbjct: 206 LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE 265
Query: 294 LSNNSFDPTEAPLW-FSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN-- 350
+ + F L +++ + S++ + + + + Q + +
Sbjct: 266 FRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFP 323
Query: 351 TLDMGNAVGPLLQLVDLQNNQISAITLGSGIKN-YTLILVGN 391
TLD+ L+ + L N+ S + + L L N
Sbjct: 324 TLDLPF-----LKSLTLTMNKGSISFKKVALPSLSYLDLSRN 360
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-28
Identities = 48/313 (15%), Positives = 102/313 (32%), Gaps = 27/313 (8%)
Query: 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNI------PDE 132
+ +L L L N + + + +L L++ L F P
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 133 IGNLAELSF--LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL 190
+ L +++ L N L+ + + LA + + +
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK--------YLEDVPKH 306
Query: 191 KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250
+ + +L + L L + N+ S I + +L L L RN
Sbjct: 307 FKWQSLSIIRCQLKQFPTLDLPF----LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRN 360
Query: 251 ALTGKVPTNLNNL--TNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWF 308
AL+ + ++L ++ L+L+ N + + L ++D +++ F
Sbjct: 361 ALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAF 420
Query: 309 STLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL--LQLVD 366
+L L L + + + + + +K+ N+F + N L +D
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTL-SNVFANTTNLTFLD 479
Query: 367 LQNNQISAITLGS 379
L Q+ I+ G
Sbjct: 480 LSKCQLEQISWGV 492
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-28
Identities = 47/262 (17%), Positives = 81/262 (30%), Gaps = 19/262 (7%)
Query: 78 GKLSGDIGGLTELRSLDLSYNG-GLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNL 136
G +S L L LDLS N +G S L L L+ G + L
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL 398
Query: 137 AELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195
EL L + S L +L +LD++ L +
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI------FLGLTSLNT 452
Query: 196 FHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK 255
N +F+ L + QL + L++L + N L
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512
Query: 256 VPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFS----- 309
++ N L +++ L+ + N ++ SL++ +L+NNS F
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQWVKE 572
Query: 310 ---TLPSLTTLICEF-GSLQGR 327
L ++ + C +
Sbjct: 573 QKQFLVNVEQMTCATPVEMNTS 594
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-27
Identities = 60/338 (17%), Positives = 105/338 (31%), Gaps = 49/338 (14%)
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLS--PRIGDLQKLNILIL 120
+ + L+ L + ++ L+ S+ + K L +
Sbjct: 260 DVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV-----SIKYLEDVPKHFKWQSLSI 314
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
C ++ L L+ L N S I L L +LDL+ N L+
Sbjct: 315 IRCQLKQFPTLDLPFLKSLT---LTMNKGS--ISFKKVALPSLSYLDLSRNALS-FSGCC 368
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPES-LGYV 239
+ + G + L+ H + N I F L H+ F + L S +
Sbjct: 369 SYSDLGTNSLR---HLDLSFNGA--IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSL 423
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD--LSQMNSLSYVDLSNN 297
+ L L + LT++N L +A N K + +L+++DLS
Sbjct: 424 EKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKC 483
Query: 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNA 357
+ + F TL L L S++ + L ++ +N
Sbjct: 484 QLE-QISWGVFDTLHRLQLLN--------------MSHNNLLF--LDSSHYNQL------ 520
Query: 358 VGPLLQLVDLQNNQISAI--TLGSGIKN-YTLILVGNP 392
L +D N+I L K+ L N
Sbjct: 521 --YSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNS 556
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-17
Identities = 46/268 (17%), Positives = 95/268 (35%), Gaps = 22/268 (8%)
Query: 127 GNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186
G++ I + +++ S ++P + S +DL+ N L + S
Sbjct: 2 GSLNPCIEVVPNITYQ-CMDQKLS-KVPDDIP--SSTKNIDLSFNPLK------ILKSYS 51
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL-FDGNQLSGNIPESLGYVQTLEVL 245
+ ++ ++ I ++ + + + L GN + P S + +LE L
Sbjct: 52 FSNFSELQWLDLSRCEIET-IEDKAWH-GLHHLSNLILTGNPIQSFSPGSFSGLTSLENL 109
Query: 246 RLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPD-LSQMNSLSYVDLSNNSF---D 300
L + L + +LN+AHN + P S + +L +VDLS N
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTIT 169
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP 360
+ +L + + D+ F ++ ++ LR N FN++ M +
Sbjct: 170 VNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGN-FNSSNIMKTCLQN 227
Query: 361 L--LQLVDLQNNQISAITLGSGIKNYTL 386
L L + L + + +
Sbjct: 228 LAGLHVHRLILGEFKDERNLEIFEPSIM 255
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-17
Identities = 29/144 (20%), Positives = 50/144 (34%), Gaps = 6/144 (4%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+ ++ L +S G GLT L +L ++ N +LS + L L L
Sbjct: 421 LSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDL 480
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
+ C L L L ++ NN +L L LD + N++ S +
Sbjct: 481 SKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
Query: 181 TITSPGLDQLKNAKHFHFNKNKLS 204
K+ F+ N ++
Sbjct: 541 ------QHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 3e-06
Identities = 23/121 (19%), Positives = 35/121 (28%), Gaps = 25/121 (20%)
Query: 54 GSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQ 113
+ V N + +T L LS L G L L+ L++S+N
Sbjct: 463 NTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN--------------- 507
Query: 114 KLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQL 173
L L L LS L + N L + +L +N +
Sbjct: 508 NLLFL----------DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557
Query: 174 T 174
Sbjct: 558 A 558
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 4e-29
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 16/271 (5%)
Query: 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEF-KTEIELLSRVHHK 683
++F + +E+G+G G V++ G V+A K E+++L +
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSP 91
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
+VG G + GE + E M G+L + L I + +++ +GL YL E
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLRE 149
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS-SKGHVSTQVKGTMGYLDPEYY 802
I+HRDVK +NIL++ K+ DFG+S + DS + V GT Y+ PE
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERL 202
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPI----EKGKYVVREVRTAMNRDDEEHYGLTEMM 858
+ +SD++S G+ ++E+ + PI K ++ + + + T
Sbjct: 203 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262
Query: 859 DPTIRNTVLLGFRRYLELALQCVEESATDRP 889
EL V E P
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLP 293
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 53/214 (24%), Positives = 83/214 (38%), Gaps = 25/214 (11%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGF 691
+G G V+RG G + AIK S ++ E E+L +++HKN+V L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 692 CFEQGEQMLVY---EFMANGTLRESLSGR-SGIHLDWKRRLRIALGSARGLAYLHELANP 747
E+ EF G+L L + L L + G+ +L E
Sbjct: 76 -EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132
Query: 748 PIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY- 802
I+HR++K NI+ D K+ DFG ++ + D + GT YL P+ Y
Sbjct: 133 -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMYE 188
Query: 803 -------MTQQLTEKSDVYSFGVVMLELITAKQP 829
++ D++S GV T P
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-29
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 47/229 (20%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G GG+ K + +V A K + + + EI + + H+++VG
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRSLAHQHVVGF 106
Query: 689 VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--------GLA 739
G FE + + +V E +L E KRR + AR G
Sbjct: 107 HG-FFEDNDFVFVVLELCRRRSLLELH----------KRRKALTEPEARYYLRQIVLGCQ 155
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQVKGTMGYLD 798
YLH +IHRD+K N+ L+E+L K+ DFGL+ V D + V GT Y+
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 209
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE + + + DV+S G +M L+ K P I+K +Y
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 258
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G G +G VY ++A+K + ++ ++ L + E+E+ S + H N++ L
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL--RREVEIQSHLRHPNILRL 74
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
G+ + L+ E+ GT+ L + D +R A L+Y H
Sbjct: 75 YGYFHDATRVYLILEYAPLGTVYRELQ-KLS-KFDEQRTATYITELANALSYCHSKR--- 129
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
+IHRD+K N+LL K+ADFG S S + + GT+ YL PE +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLC-GTLDYLPPEMIEGRMHD 185
Query: 809 EKSDVYSFGVVMLELITAKQP------------IEKGKY 835
EK D++S GV+ E + K P I + ++
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF 224
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-29
Identities = 63/337 (18%), Positives = 116/337 (34%), Gaps = 43/337 (12%)
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILA 121
+ L L + + L L+L+ N ++ ++ P +L L L L
Sbjct: 31 PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI-VS-AVEPGAFNNLFNLRTLGLR 88
Query: 122 GCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPV 179
IP + L+ L+ L ++ N + L L L++ DN L I
Sbjct: 89 SNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISH 145
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
+ GL+ L+ K L+ +I + S LI + ++ S +
Sbjct: 146 RAFS--GLNSLE---QLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNS 298
L+VL + + N N+ L++ H +L P+ + + L +++LS N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNP 259
Query: 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAV 358
T L L + Q+ + AF
Sbjct: 260 IS-TIEGSMLHELLRLQEIQ--------------LVGGQLA--VVEPYAFRGL------- 295
Query: 359 GPLLQLVDLQNNQISAITLG--SGIKN-YTLILVGNP 392
L+++++ NQ++ + + N TLIL NP
Sbjct: 296 -NYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNP 331
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 41/220 (18%), Positives = 69/220 (31%), Gaps = 43/220 (19%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLA 143
GL L L L LT S+ L L +L L I D L L L
Sbjct: 150 GLNSLEQLTLEKCN-LT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLE 206
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
++ + + P+ L L + LT ++P + L + + + N +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA-----VRHLVYLRFLNLSYNPI 260
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL 263
S TI + + L+ ++L L P L
Sbjct: 261 S-TIEGSMLHE------------------------LLRLQEIQLVGGQLAVVEPYAFRGL 295
Query: 264 TNVNELNLAHNDL----KGPFPDLSQMNSLSYVDLSNNSF 299
+ LN++ N L + F + +L + L +N
Sbjct: 296 NYLRVLNVSGNQLTTLEESVFHSVG---NLETLILDSNPL 332
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 6e-29
Identities = 61/229 (26%), Positives = 95/229 (41%), Gaps = 47/229 (20%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G GG+ K + +V A K + + + EI + + H+++VG
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE--KMSMEISIHRSLAHQHVVGF 80
Query: 689 VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--------GLA 739
G FE + + +V E +L E KRR + AR G
Sbjct: 81 HG-FFEDNDFVFVVLELCRRRSLLELH----------KRRKALTEPEARYYLRQIVLGCQ 129
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQVKGTMGYLD 798
YLH +IHRD+K N+ L+E+L K+ DFGL+ V D + V GT Y+
Sbjct: 130 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIA 183
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE + + + DV+S G +M L+ K P I+K +Y
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 56/221 (25%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G G + VYR + G VAIK + M + + E+++ ++ H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRV--QNEVKIHCQLKHPSILEL 76
Query: 689 VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
FE + LV E NG + L R G+ YLH
Sbjct: 77 YN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVK-PFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
I+HRD+ +N+LL N+ K+ADFGL+ +L K + GT Y+ PE
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPEIATRSA 188
Query: 807 LTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
+SDV+S G + L+ + P + Y
Sbjct: 189 HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 9e-29
Identities = 37/352 (10%), Positives = 80/352 (22%), Gaps = 53/352 (15%)
Query: 583 KRAERAIGLSKPFASWAPSGKDSGGAPQL--KGARWFSYDELKKCSNNFSESNEIGSGGY 640
KR E IG + A P+ + + A L + + G
Sbjct: 16 KREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDR 75
Query: 641 GKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC---- 692
V+ + + A+K + S +R+ ++
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 693 ----------------------FEQGEQMLVYEFMA--NGTLRESLS--GRSGIHLDWKR 726
+ +L+ + L +L
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILA 195
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
+ R A L ++H N+ + + + D V G
Sbjct: 196 LHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKV-----GTR 247
Query: 787 STQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM 844
+ Y E+ T T + + G+ + + P ++
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307
Query: 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ L + + V L + + R E ++
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFV-------KTLIGRFLNFDRRRRLLPLEAME 352
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 53/337 (15%), Positives = 100/337 (29%), Gaps = 50/337 (14%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
N +R ++ L L+ ++ LDLS N + +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN---------PLSQIS-------- 50
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVST 181
++ +L L L+SN L LS L LDL +N + +
Sbjct: 51 --------AADLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL--- 96
Query: 182 ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQT 241
+ + H N +S +S ++ N+++ G
Sbjct: 97 -------VGPSIETLHAANNNIS-RVSCSRGQG---KKNIYLANNKITMLRDLDEGCRSR 145
Query: 242 LEVLRLDRNALTG-KVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD 300
++ L L N + + + LNL +N + L +DLS+N
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKL- 203
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP 360
F + +T + L + L ++ LR N F + + +
Sbjct: 204 -AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSK 260
Query: 361 LLQLVDLQNNQISAIT--LGSGIKNYTLILVGNPVCT 395
++ + + +T TL G C
Sbjct: 261 NQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-28
Identities = 60/254 (23%), Positives = 96/254 (37%), Gaps = 50/254 (19%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-H 681
+ N +G G G V G+ VA+KR EI+LL+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDD 67
Query: 682 HKNLVGLVGFCFEQGEQM--LVYEFMANGTL-----RESLSGRSGIHLDWKRRLRIALGS 734
H N++ +C E ++ + E N L +++S + + +
Sbjct: 68 HPNVIRY--YCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLD-------------ENLTAKVADFGLSKLVSD- 780
A G+A+LH L IIHRD+K NIL+ ENL ++DFGL K +
Sbjct: 125 ASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 781 -SSKGHVSTQVKGTMGYLDPE-------YYMTQQLTEKSDVYSFGVVMLELITAKQP--- 829
SS GT G+ PE ++LT D++S G V +++ +
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 830 --------IEKGKY 835
I +G +
Sbjct: 242 DKYSRESNIIRGIF 255
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 46/260 (17%), Positives = 82/260 (31%), Gaps = 28/260 (10%)
Query: 590 GLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS 649
GLSKP +S+ + + P +K E + S + +G G + +VY
Sbjct: 33 GLSKPVSSYPNTFEWQCKLPAIKPKT-----EFQLGSKLVYVHHLLGEGAFAQVYEATQG 87
Query: 650 D------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703
D Q +K + + +E L + Q +LV E
Sbjct: 88 DLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGE 147
Query: 704 FMANGTLRE---SLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNIL 760
+ GTL + + A+ + +H+ IIH D+K N +
Sbjct: 148 LYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFI 204
Query: 761 L-----------DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTE 809
L D + + D G S + KG + T T G+ E +
Sbjct: 205 LGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNY 264
Query: 810 KSDVYSFGVVMLELITAKQP 829
+ D + + ++
Sbjct: 265 QIDYFGVAATVYCMLFGTYM 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-28
Identities = 69/249 (27%), Positives = 114/249 (45%), Gaps = 24/249 (9%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGF 691
+G+GG+G V R + G+ VAIK+ +Q E + EI+++ +++H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE- 79
Query: 692 CFEQGEQM-------LVYEFMANGTLRESLSGR---SGIHLDWKRRLRIALGSARGLAYL 741
+ +++ L E+ G LR+ L+ G+ R L + SA L YL
Sbjct: 80 VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYL 137
Query: 742 HELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
HE IIHRD+K NI+L + L K+ D G +K + G + T+ GT+ YL
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTEFVGTLQYLA 191
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
PE ++ T D +SFG + E IT +P V+ + +E ++
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251
Query: 859 DPTIRNTVL 867
++VL
Sbjct: 252 GAVKFSSVL 260
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-28
Identities = 60/303 (19%), Positives = 101/303 (33%), Gaps = 44/303 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLVGFC 692
+G G V+RG G + AIK S ++ E E+L +++HKN+V L
Sbjct: 17 LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI- 75
Query: 693 FEQGEQMLVY---EFMANGTLRESLSGR-SGIHLDWKRRLRIALGSARGLAYLHELANPP 748
E+ EF G+L L + L L + G+ +L E
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--- 132
Query: 749 IIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY-- 802
I+HR++K NI+ D K+ DFG ++ + D + GT YL P+ Y
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLYGTEEYLHPDMYER 189
Query: 803 ------MTQQLTEKSDVYSFGVVMLELITAKQP----------------IEKGKYVVREV 840
++ D++S GV T P I GK
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS 249
Query: 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900
+ + + ++ + + L L+ +E +
Sbjct: 250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE---KCWGFDQFFAETSD 306
Query: 901 LLQ 903
+L
Sbjct: 307 ILH 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 64/226 (28%), Positives = 100/226 (44%), Gaps = 35/226 (15%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR----AQQGSMQGGLEFKTEIELLSRV 680
+++ IGSG V + VAIKR Q SM E EI+ +S+
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD---ELLKEIQAMSQC 70
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR---IAL---G 733
HH N+V F +++ LV + ++ G++ + + L IA
Sbjct: 71 HHPNIVSYYT-SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK-- 791
GL YLH+ IHRDVK+ NILL E+ + ++ADFG+S ++ + K
Sbjct: 130 VLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 792 -GTMGYLDPEYYM----TQQLT---EKSDVYSFGVVMLELITAKQP 829
GT P +M +Q+ K+D++SFG+ +EL T P
Sbjct: 187 VGT-----P-CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 52/268 (19%), Positives = 91/268 (33%), Gaps = 32/268 (11%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
AL L ++ L + L+ L+ + + G L L + L L L
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG-LM-ELPDTMQQFAGLETLTL 134
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGK---------LSQLYWLDLADN 171
A +P I +L L L++ + +P L L L L L
Sbjct: 135 ARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWT 193
Query: 172 QLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG---TISEQLFSPDMVLIHVLFDGNQL 228
+ S+P S + L+N K + LS I L L + G
Sbjct: 194 GIR-SLPAS------IANLQNLKSLKIRNSPLSALGPAIH-HLPK----LEELDLRGCTA 241
Query: 229 SGNIPESLGYVQTLEVLRL-DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQM 286
N P G L+ L L D + L +P +++ LT + +L+L P ++Q+
Sbjct: 242 LRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
Query: 287 NSLSYVDLSNNSFDPTEAPLWFSTLPSL 314
+ + + + + + P+
Sbjct: 301 PANCIILVPPHLQAQLDQHRPVA-RPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 32/226 (14%), Positives = 57/226 (25%), Gaps = 27/226 (11%)
Query: 103 GSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQ 162
GS L G D + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 163 LYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL 222
L +T L +Q F + + +
Sbjct: 58 PQIETRTGRALK-----ATADLLEDATQPGRVALELRSVPLP-QFPDQAF--RLSHLQHM 109
Query: 223 F-DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP 281
D L +P+++ LE L L RN L +P ++ +L + EL++ P
Sbjct: 110 TIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELP 167
Query: 282 D----------LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
+ + +L + L P + L +L +L
Sbjct: 168 EPLASTDASGEHQGLVNLQSLRLEWTGI--RSLPASIANLQNLKSL 211
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-28
Identities = 51/318 (16%), Positives = 98/318 (30%), Gaps = 24/318 (7%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
N +R ++ L L+ ++ LDLS N L+ + + KL +L L+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN-PLSQISAADLAPFTKLELLNLS 66
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVST 181
D + +L+ L L LN+N L + L A+N ++ + S
Sbjct: 67 SNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR 118
Query: 182 ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG-NIPESLGYVQ 240
+ + NK++ + + + ++ N++ N E
Sbjct: 119 GQG--KKNI------YLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD 300
TLE L L N + V + + L+L+ N L P+ ++++ L NN
Sbjct: 170 TLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKL- 226
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP 360
+L FS +Q + +
Sbjct: 227 -VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ-RVQTVAKQTVKKLTGQNEEECT 284
Query: 361 LLQLVDLQNNQISAITLG 378
+ L +
Sbjct: 285 VPTLGHYGAYCCEDLPAP 302
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 52/334 (15%), Positives = 101/334 (30%), Gaps = 54/334 (16%)
Query: 76 LTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN 135
L+ + D+ T+L L+LS N L + + L L L L N E+
Sbjct: 46 LSQISAADLAPFTKLELLNLSSNV-LYET--LDLESLSTLRTLDLNN-----NYVQELLV 97
Query: 136 LAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195
+ L +NN S R+ S + LA+N++T + ++
Sbjct: 98 GPSIETLHAANNNIS-RVSCSR--GQGKKNIYLANNKIT------MLRDLDEGCRSRVQY 148
Query: 196 FHFNKNKLSGTISEQLFSPDMVLIHVLF-DGNQLSGNIPESLGYVQTLEVLRLDRNALTG 254
N++ T++ + + L N + ++ + L+ L L N L
Sbjct: 149 LDLKLNEID-TVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA- 204
Query: 255 KVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSL 314
+ + V ++L +N L L +L + DL N F +FS +
Sbjct: 205 FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 315 TTLICE-FGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT---------------------- 351
T+ + L G+ ++ + +
Sbjct: 265 QTVAKQTVKKLTGQNEEEC---TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQ 321
Query: 352 ------LDMGNAVGPLLQLVDLQNNQISAITLGS 379
L+ + +D Q +
Sbjct: 322 GSETERLECERENQARQREIDALKEQYRTVIDQV 355
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 40/325 (12%), Positives = 96/325 (29%), Gaps = 48/325 (14%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142
D+ L+ LR+LDL+ N + + + L A + + +
Sbjct: 75 DLESLSTLRTLDLNNN-----YVQ-ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNI 125
Query: 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
L +N + G S++ +LDL N++ ++ + + + +H + N
Sbjct: 126 YLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVNFAELAA----SSDTLEHLNLQYNF 180
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
+ + Q+ L + N+L+ + + + L N L + L
Sbjct: 181 IY-DVKGQVVFAK--LKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 263 LTNVNELNLAHNDLKG------------------------PFPDLSQMNSLSYVDLSNNS 298
N+ +L N + + +
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYC 295
Query: 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKL----FSYSQIQQVKLRNNAFNNTLDM 354
+ AP + L +L S QG ++L + ++ +++ + +D
Sbjct: 296 CEDLPAP-FADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQ 354
Query: 355 GNAVGPLLQLVDLQNNQISAITLGS 379
++ + +
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNG 379
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-25
Identities = 41/302 (13%), Positives = 96/302 (31%), Gaps = 29/302 (9%)
Query: 104 SLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQL 163
++ + + I + + + + L L+ N S L ++L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 164 YWLDLADNQLTGSIPVSTITS-----------PGLDQLKNAKHFHFNKNKLSGTISEQLF 212
L+L+ N L ++ + ++++ L + + H N +S +S
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 213 SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG-KVPTNLNNLTNVNELNL 271
++ N+++ G ++ L L N + + + LNL
Sbjct: 120 QG---KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG----R 327
+N + L +DLS+N F + +T + SL+
Sbjct: 177 QYNFIYD-VKGQVVFAKLKTLDLSSNKL--AFMGPEFQSAAGVTWI-----SLRNNKLVL 228
Query: 328 VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLI 387
+ L ++ LR N F + + + ++ + + +T + +
Sbjct: 229 IEKALRFSQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 388 LV 389
L
Sbjct: 288 LG 289
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 2e-14
Identities = 33/234 (14%), Positives = 62/234 (26%), Gaps = 26/234 (11%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146
+L++LDLS N L + P + + L I + L L
Sbjct: 190 FAKLKTLDLSSNK-LA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 147 NNFSGRIPPSL-GKLSQLYWLDLADNQL----------------TGSIPVSTITSPGLDQ 189
N F K ++ + + G+ + +P D+
Sbjct: 247 NGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306
Query: 190 LKNAKHFHFNKNKLSGTISEQL---FSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246
L K G+ +E+L + Q I + Q L
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366
Query: 247 LDRNALTGKVPTNLNNLTNVNELNLAHN---DLKGPFPDLSQMNSLSYVDLSNN 297
+ AL +V ++ +L+ + S + L +
Sbjct: 367 QKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 33/161 (20%), Positives = 58/161 (36%), Gaps = 33/161 (20%)
Query: 232 IPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLS 290
I E ++ ++ ++L + + + NV EL+L+ N L DL+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 291 YVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350
++LS+N L +L S ++ + L NN
Sbjct: 62 LLNLSSNVL---------YETLDLESL------------------STLRTLDLNNNYVQ- 93
Query: 351 TLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGN 391
L VGP ++ + NN IS ++ G + L N
Sbjct: 94 ELL----VGPSIETLHAANNNISRVSCSRGQGKKNIYLANN 130
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 58/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNLV 686
F++ +IG G +G+V++G+ +VVAIK + +E + EI +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
G + + ++ ++ E++ G+ + L LD + I +GL YLH
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEK 139
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
IHRD+K+ N+LL E+ K+ADFG++ +L K + T V GT ++ PE
Sbjct: 140 ---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN--TFV-GTPFWMAPEVIKQ 193
Query: 805 QQLTEKSDVYSFGVVMLELITAKQP 829
K+D++S G+ +EL + P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 47/243 (19%), Positives = 90/243 (37%), Gaps = 53/243 (21%)
Query: 635 IGSGGYGKVYRGMLSDGQVVAIK-------------------RAQQGSMQGGLEFKTEIE 675
+ G + K+ D + A+K + S K E++
Sbjct: 39 LNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF--KNELQ 95
Query: 676 LLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSA 735
+++ + ++ + G E ++YE+M N ++ + LD I +
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVI 153
Query: 736 R--------GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
+ +Y+H N I HRDVK +NIL+D+N K++DFG S+ + D +
Sbjct: 154 KCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVD---KKIK 208
Query: 788 TQVKGTMGYLDPEYYMTQQLT--EKSDVYSFGVVMLELITAKQP-------------IEK 832
GT ++ PE++ + K D++S G+ + + P I
Sbjct: 209 GSR-GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 833 GKY 835
Sbjct: 268 KNI 270
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/215 (25%), Positives = 100/215 (46%), Gaps = 28/215 (13%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
+ E+G G +GKVY+ G + A K + S + ++ EIE+L+ H +V
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 688 LVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR------IALGSARGLAY 740
L+G + ++ ++ EF G + I L+ R L + L +
Sbjct: 81 LLG-AYYHDGKLWIMIEFCPGGAVDA-------IMLELDRGLTEPQIQVVCRQMLEALNF 132
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDP 799
LH IIHRD+K+ N+L+ ++ADFG+S K + K + + GT ++ P
Sbjct: 133 LHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD--SFI-GTPYWMAP 186
Query: 800 EYYMTQQLTE-----KSDVYSFGVVMLELITAKQP 829
E M + + + K+D++S G+ ++E+ + P
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
++ +IG G G VY M ++ GQ VAI++ EI ++ + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 688 LVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+ + G+++ +V E++A G+L + ++ +D + + + L +LH
Sbjct: 82 YLD-SYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ- 136
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
+IHRD+KS NILL + + K+ DFG ++ + SK T V GT ++ PE +
Sbjct: 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEVVTRK 191
Query: 806 QLTEKSDVYSFGVVMLELITAKQP 829
K D++S G++ +E+I + P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 58/206 (28%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKNL 685
F ++G G YG VY+ + GQ+VAIK Q ++ L+ EI ++ + ++
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIK---QVPVESDLQEIIKEISIMQQCDSPHV 86
Query: 686 VGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
V G + + + +V E+ G++ + + R+ L I + +GL YLH +
Sbjct: 87 VKYYG-SYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFM 144
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
IHRD+K+ NILL+ AK+ADFG++ +L +K + T + GT ++ PE
Sbjct: 145 R---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRN--TVI-GTPFWMAPEVIQ 198
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQP 829
+D++S G+ +E+ K P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 29/219 (13%)
Query: 635 IGSGGYGKVYRG-MLSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G G +G VY + ++A+K + ++ ++ L + EIE+ S + H N++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL--RREIEIQSHLRHPNILRM 79
Query: 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+ ++ L+ EF G L + L + G D +R A L Y HE
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQ-KHG-RFDEQRSATFMEELADALHYCHERK--- 134
Query: 749 IIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT 808
+IHRD+K N+L+ K+ADFG S S + GT+ YL PE +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWSVHA-PSLRRRTMC---GTLDYLPPEMIEGKTHD 190
Query: 809 EKSDVYSFGVVMLELITAKQP------------IEKGKY 835
EK D++ GV+ E + P I
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDL 229
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-27
Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 25/221 (11%)
Query: 626 SNNFSESNEIGSG--GYGKVYRGM-LSDGQVVAIKRA--QQGSMQGGLEFKTEIELLSRV 680
+ IG G V G+ V ++R + S + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSAR 736
+H N+V F ++ +V FMA G+ ++ + ++ L IA G +
Sbjct: 84 NHPNIVPYRA-TFIADNELWVVTSFMAYGSAKDLICTHFMDGMN---ELAIAYILQGVLK 139
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVK---- 791
L Y+H + +HR VK+++IL+ + ++ + ++S + V
Sbjct: 140 ALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 792 GTMGYLDPEYYMTQQL---TEKSDVYSFGVVMLELITAKQP 829
+ +L PE + Q L KSD+YS G+ EL P
Sbjct: 197 KVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 54/330 (16%), Positives = 118/330 (35%), Gaps = 42/330 (12%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
+ + + + + ++ L+L+ + + + L +
Sbjct: 45 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL-QIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 123 CGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWLDLADNQLTGSIPVS 180
+P + N+ L+ L L N+ S +P + +L L +++N L I
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 159
Query: 181 T----------------ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFD 224
T +T L + + H + + N LS + + + +
Sbjct: 160 TFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLS------TLAIPIAVEELDAS 213
Query: 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDL 283
N ++ + + L +L+L N LT L N + E++L++N+L+ +
Sbjct: 214 HNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPF 268
Query: 284 SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKL 343
+M L + +SNN L+ +P+L L L V + +++ + L
Sbjct: 269 VKMQRLERLYISNNRL--VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYL 325
Query: 344 RNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373
+N+ TL + L+ + L +N
Sbjct: 326 DHNSI-VTLKLSTH--HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 54/331 (16%), Positives = 98/331 (29%), Gaps = 49/331 (14%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLAL 144
L + + + + L + +++ +L L I + L +
Sbjct: 44 LNNQKIVTFKNS-TMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYM 100
Query: 145 NSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
N +PP + L L L N L+ S+P + N L
Sbjct: 101 GFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGI-----FHNTPKLTTLSMSNNNL 153
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQ----------------LSGNIPESLGYVQTLEVLRL 247
I + F L ++ N+ +S N+ +L +E L
Sbjct: 154 E-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDA 212
Query: 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD--PTEAP 305
N++ V + + L L HN+L L L VDLS N +
Sbjct: 213 SHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHP- 267
Query: 306 LWFSTLPSLTTLICEFGSLQG----RVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL 361
F + L L + + ++ + L +N ++
Sbjct: 268 --FVKMQRLERL-----YISNNRLVALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDR 319
Query: 362 LQLVDLQNNQISAITLGSGIKNYTLILVGNP 392
L+ + L +N I + L + L L N
Sbjct: 320 LENLYLDHNSIVTLKLSTHHTLKNLTLSHND 350
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 52/256 (20%), Positives = 86/256 (33%), Gaps = 25/256 (9%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
N ++T L +S L T L++L LS N LT + + L ++
Sbjct: 139 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR-LT-HVDL--SLIPSLFHANVS 194
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVST 181
N+ + + L + N+ + + + +L L L N LT
Sbjct: 195 Y-----NLLSTLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT------- 239
Query: 182 ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQT 241
+ L + N+L I F L + N+L + + T
Sbjct: 240 -DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPT 296
Query: 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDP 301
L+VL L N L V N + L L HN + LS ++L + LS+N +D
Sbjct: 297 LKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLTLSHNDWDC 353
Query: 302 TEAPLWFSTLPSLTTL 317
F +
Sbjct: 354 NSLRALFRNVARPAVD 369
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 46/248 (18%), Positives = 92/248 (37%), Gaps = 26/248 (10%)
Query: 135 NLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA 193
L + ++ ++P + L Q+ L+L D Q+ I
Sbjct: 43 TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYA-----FAYAHTI 95
Query: 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL-GYVQTLEVLRLDRNAL 252
+ + N + + +F +L ++ + N LS ++P + L L + N L
Sbjct: 96 QKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNL 153
Query: 253 TGKVPTN-LNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL 311
++ + T++ L L+ N L LS + SL + ++S N +
Sbjct: 154 E-RIEDDTFQATTSLQNLQLSSNRLTH-VD-LSLIPSLFHANVSYNLLST------LAIP 204
Query: 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371
++ L S+ V + ++ +KL++N +T + N P L VDL N+
Sbjct: 205 IAVEELDASHNSIN-VVRGPVN--VELTILKLQHNNLTDTAWLLNY--PGLVEVDLSYNE 259
Query: 372 ISAITLGS 379
+ I
Sbjct: 260 LEKIMYHP 267
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-26
Identities = 35/240 (14%), Positives = 67/240 (27%), Gaps = 54/240 (22%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSR----------- 679
+G G+ + ++ + K E+ L
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 680 -----------VHHKNLVGLVGFCFEQGEQMLVYEFMA-------NGTLRESLSGRSGIH 721
V ++ ++ + ++ F T E L S H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 722 --LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
L RL++ L R LA LH ++H ++ +I+LD+ + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 780 DSSKGHVSTQVKGTMGYLDPEY----------YMTQQLTEKSDVYSFGVVMLELITAKQP 829
S G+ PE + +T D ++ G+ + + A P
Sbjct: 263 A------SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 51/203 (25%), Positives = 90/203 (44%), Gaps = 11/203 (5%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG 687
+IG G G V G+ VA+K Q E+ ++ H N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+ E ++ EF+ G L + +S L+ ++ + + LAYLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQG-- 161
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+KS +ILL + K++DFG ++ D K + V GT ++ PE
Sbjct: 162 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISRSL 217
Query: 807 LTEKSDVYSFGVVMLELITAKQP 829
+ D++S G++++E++ + P
Sbjct: 218 YATEVDIWSLGIMVIEMVDGEPP 240
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 53/216 (24%), Positives = 95/216 (43%), Gaps = 17/216 (7%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR-AQQGSMQGGLEFKTEIE-LLSRVHH 682
+++ E+G G YG V + + GQ++A+KR + Q +++ + V
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDC 65
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGT---LRESLSGRSGIHLDWKRRLRIALGSARGLA 739
V G F +G+ + E M ++ + I D + IA+ + L
Sbjct: 66 PFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGK--IAVSIVKALE 123
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
+LH + +IHRDVK +N+L++ K+ DFG+S + D G Y+ P
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK--DIDA-GCKPYMAP 178
Query: 800 E----YYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
E + + KSD++S G+ M+EL + P +
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 57/221 (25%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIE-----LLSR 679
+ + + EIG G YG V + + GQ++A+KR + + + ++ ++
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR---STVDEKEQKQLLMDLDVVMRS 77
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRL------RIALG 733
+V G F +G+ + E M+ ++ + +I L
Sbjct: 78 SDCPYIVQFYGALFREGDCWICMELMSTS----FDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS-KLVSDSSKGHVSTQVKG 792
+ + L +L E IIHRD+K +NILLD + K+ DFG+S +LV +K T+ G
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAG 187
Query: 793 TMGYLDPE----YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
Y+ PE Q +SDV+S G+ + EL T + P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 55/338 (16%), Positives = 108/338 (31%), Gaps = 41/338 (12%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
+ + + + + ++ L+L+ + + + L +
Sbjct: 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL-QIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 123 CGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWLDLADNQLTGSIPVS 180
+P + N+ L+ L L N+ S +P + +L L +++N L I
Sbjct: 109 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDD 165
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ 240
T + ++ + N+L+ + L L H N LS +L
Sbjct: 166 T-----FQATTSLQNLQLSSNRLT-HVDLSLIPS---LFHANVSYNLLS-----TLAIPI 211
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD 300
+E L N++ V + + L L HN+L L L VDLS N +
Sbjct: 212 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE 267
Query: 301 --PTEAPLWFSTLPSLTTLICEFGSLQG----RVPDKLFSYSQIQQVKLRNNAFNNTLDM 354
F + L L + + ++ + L +N ++
Sbjct: 268 KIMYHP---FVKMQRLERL-----YISNNRLVALNLYGQPIPTLKVLDLSHNHL-LHVER 318
Query: 355 GNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP 392
L+ + L +N I + L + L L N
Sbjct: 319 NQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHND 356
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 47/274 (17%), Positives = 93/274 (33%), Gaps = 42/274 (15%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
I + + ++ L+ + ++ + +P + LD
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL-----LD 72
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
+ + + N ++ I F+ + + N + P V L VL L+
Sbjct: 73 SFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131
Query: 249 RNALTGKVPTNL-NNLTNVNELNLAHNDL----KGPFPDLSQMNSLSYVDLSNNSFDPTE 303
RN L+ +P + +N + L++++N+L F + SL + LS+N T
Sbjct: 132 RNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT---SLQNLQLSSNRL--TH 185
Query: 304 APLWFSTLPSLTTL------ICEFGSLQG------------RVPDKLFSYSQIQQVKLRN 345
S +PSL + V + ++ +KL++
Sbjct: 186 VD--LSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVN--VELTILKLQH 241
Query: 346 NAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379
N +T + N P L VDL N++ I
Sbjct: 242 NNLTDTAWLLNY--PGLVEVDLSYNELEKIMYHP 273
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-16
Identities = 49/308 (15%), Positives = 101/308 (32%), Gaps = 34/308 (11%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142
D+ + L ++SYN LS + + L + + + EL+ L
Sbjct: 187 DLSLIPSLFHANVSYN-----LLS-TLAIPIAVEELDASHNSIN-VVRGPV--NVELTIL 237
Query: 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
L NN + L L +DL+ N+L I +++ + + + N+
Sbjct: 238 KLQHNNLTD--TAWLLNYPGLVEVDLSYNELE-KIMYHP-----FVKMQRLERLYISNNR 289
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
L ++ P L + N L ++ + LE L LD N++ + +
Sbjct: 290 LV-ALNL-YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHT 346
Query: 263 LTNVN--ELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLP-------- 312
L N+ + N L+ F ++++ ++ D E L
Sbjct: 347 LKNLTLSHNDWDCNSLRALFRNVAR-PAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLL 405
Query: 313 ---SLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQN 369
+LT+++ + QGR S L + + + +
Sbjct: 406 QYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEV 465
Query: 370 NQISAITL 377
Q++ +
Sbjct: 466 QQLTNEQI 473
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 53/319 (16%), Positives = 108/319 (33%), Gaps = 53/319 (16%)
Query: 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTG----------- 127
++ + + +++ + P G+ +++ + L C
Sbjct: 25 EMPVEAENVKSKTEYYNAWS-EWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83
Query: 128 -NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVST----- 181
++P+ +L L + N+ + +P L L + L+ P+
Sbjct: 84 SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVS 139
Query: 182 ---ITS-PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLG 237
+ P L K + N L + + S L + NQL +PE L
Sbjct: 140 NNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPPS----LEFIAAGNNQLE-ELPE-LQ 192
Query: 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297
+ L + D N+L K+P +L + +N L+ P+L + L+ + NN
Sbjct: 193 NLPFLTAIYADNNSLK-KLPDLPLSLE---SIVAGNNILEEL-PELQNLPFLTTIYADNN 247
Query: 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN-TLDMGN 356
P PSL L L +P+ + + + N F+ + N
Sbjct: 248 LL--KTLPDL---PPSLEALNVRDNYLT-DLPELP---QSLTFLDVSENIFSGLSELPPN 298
Query: 357 AVGPLLQLVDLQNNQISAI 375
L ++ +N+I ++
Sbjct: 299 -----LYYLNASSNEIRSL 312
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 62/351 (17%), Positives = 113/351 (32%), Gaps = 75/351 (21%)
Query: 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYN--GGLTGSLS------------PRIGDL 112
+L S LT +L L L + + L L P + +
Sbjct: 94 ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNS 152
Query: 113 QKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQ 172
L I+ + +PD +L ++ +N P L L L + +N
Sbjct: 153 SFLKIIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE--ELPELQNLPFLTAIYADNNS 206
Query: 173 LTGSIPVS------------TITS-PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLI 219
L +P + P L L + + N L T+ + S L
Sbjct: 207 LK-KLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLK-TLPDLPPS----LE 260
Query: 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGP 279
+ N L+ ++PE + L+V + L+ N+ LN + N+++
Sbjct: 261 ALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIRSL 312
Query: 280 FPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQ 339
+ L ++SNN E P + P L LI F L VP+ ++
Sbjct: 313 CDLPPSLEEL---NVSNNKL--IELP---ALPPRLERLIASFNHLA-EVPELP---QNLK 360
Query: 340 QVKLRNNAFNN---------TLDMGNAVGPL------LQLVDLQNNQISAI 375
Q+ + N L M + + + L+ + ++ N +
Sbjct: 361 QLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREF 411
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 53/302 (17%), Positives = 109/302 (36%), Gaps = 49/302 (16%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142
++ L L ++ N SL L ++ E+ NL L+ +
Sbjct: 190 ELQNLPFLTAIYADNN-----SLKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTI 242
Query: 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA--------- 193
++N +P L L ++ DN LT +P + LD +N
Sbjct: 243 YADNNLLK-TLPDLPPSLEAL---NVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297
Query: 194 --KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNA 251
+ + + N++ ++ + S L + N+L +P LE L N
Sbjct: 298 NLYYLNASSNEIR-SLCDLPPS----LEELNVSNNKLI-ELPALPP---RLERLIASFNH 348
Query: 252 LTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL 311
L +VP NL +L++ +N L+ FPD+ S+ + ++++ E P
Sbjct: 349 LA-EVPELPQNLK---QLHVEYNPLRE-FPDI--PESVEDLRMNSHL---AEVP---ELP 395
Query: 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371
+L L E L+ PD ++ +++ + + + + L+ +++
Sbjct: 396 QNLKQLHVETNPLR-EFPDIP---ESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHH 451
Query: 372 IS 373
Sbjct: 452 HH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 56/305 (18%), Positives = 107/305 (35%), Gaps = 50/305 (16%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
T L+ + LT + +++ A + N P G E++
Sbjct: 7 NVSNTFLQEPLRHSSN-LT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64
Query: 144 LN------------SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191
L +N +P L L + N LT +P LK
Sbjct: 65 LRDCLDRQAHELELNNLGLSSLPELPPHLES---LVASCNSLT-ELP------ELPQSLK 114
Query: 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNA 251
+ + N LS L ++ NQL +PE L L+++ +D N+
Sbjct: 115 SLLVDNNNLKALSDLPPL--------LEYLGVSNNQLE-KLPE-LQNSSFLKIIDVDNNS 164
Query: 252 LTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL 311
L K+P +L + +N L+ P+L + L+ + NNS + P
Sbjct: 165 LK-KLPDLPPSLE---FIAAGNNQLEE-LPELQNLPFLTAIYADNNSL--KKLP---DLP 214
Query: 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371
SL +++ G+ +L + + + NN D+ P L+ +++++N
Sbjct: 215 LSLESIVA--GNNILEELPELQNLPFLTTIYADNNLLKTLPDL----PPSLEALNVRDNY 268
Query: 372 ISAIT 376
++ +
Sbjct: 269 LTDLP 273
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 31/236 (13%)
Query: 622 LKKCSNNFSE----SNEIGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGG--LEFKTEI 674
+ + SE ++GSG YG+V AIK ++ S+ + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 675 ELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS 734
+L + H N++ L F ++ LV E G L + + R + I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQV 145
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
G+ YLH+ I+HRD+K N+LL +++ K+ DFGLS + + +
Sbjct: 146 LSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERL 199
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
GT Y+ PE + ++ EK DV+S GV++ L+ P +EKGKY
Sbjct: 200 GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY 254
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 55/215 (25%), Positives = 88/215 (40%), Gaps = 21/215 (9%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIE-----LLSR 679
N+ E+GSG G+V++ G V+A+K+ + G E I +L
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKS 80
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+V G + + E M + + I + + + + L
Sbjct: 81 HDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALY 138
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
YL E +IHRDVK +NILLDE K+ DFG+S + D G Y+ P
Sbjct: 139 YLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSA-GCAAYMAP 193
Query: 800 EYYMTQQLTE-----KSDVYSFGVVMLELITAKQP 829
E T+ ++DV+S G+ ++EL T + P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 32/237 (13%)
Query: 622 LKKCSNNFSE----SNEIGSGGYGKVYRG-MLSDGQVVAIK---RAQQGSMQGGLEFKTE 673
++ + FS+ +G G +G+V GQ A+K + Q E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 674 IELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALG 733
++LL ++ H N++ L F ++G LV E G L + + R RI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQ 134
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQV 790
G+ Y+H+ I+HRD+K N+LL ++ ++ DFGLS
Sbjct: 135 VLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDK 188
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
GT Y+ PE + EK DV+S GV++ L++ P +EKGKY
Sbjct: 189 IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKY 244
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 26/234 (11%)
Query: 599 APSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK 657
P G Q+ F + K S+N+ E+G G + V R + + G A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 658 RAQQGSMQGGLE--FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL----- 710
+ + E + ++ H N+V L E+ LV++ + G L
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 711 -RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLT 766
RE S H ++ L +AY H I+HR++K N+LL +
Sbjct: 121 AREFYSEADASHC-----IQQILE---SIAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVM 820
K+ADFGL+ V+D GT GYL PE ++ D+++ GV++
Sbjct: 170 VKLADFGLAIEVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 45/245 (18%), Positives = 89/245 (36%), Gaps = 31/245 (12%)
Query: 663 SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH- 721
S +I + KN VG + + + + L++ ++ R +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 722 LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
+ L I + A + +LH ++HRD+K +NI + KV DFGL +
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 782 S----------KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE 831
T GT Y+ PE + K D++S G+++ EL+ +
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS--- 274
Query: 832 KGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTM 891
T M R +T++ + + + + + S T+RP
Sbjct: 275 ----------TQMERVRI----ITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEA 320
Query: 892 SEVVK 896
+++++
Sbjct: 321 TDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 18/81 (22%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKN 684
+F +G GG+G V+ D AIKR + + + E E++ L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 685 LVGLVGFCFEQGEQMLVYEFM 705
+V E + E
Sbjct: 66 IVRYFNAWLETPPEKWQEEMD 86
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 65/227 (28%), Positives = 99/227 (43%), Gaps = 45/227 (19%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRV-HHKN 684
F +G+G YG+VY+G + GQ+ AIK + G E K EI +L + HH+N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIK---VMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 685 LVGLVGFCFEQGEQM-------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
+ G F + LV EF G++ + + G L + I RG
Sbjct: 83 IATYYG-AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L++LH+ +IHRD+K N+LL EN K+ DFG VS Q+ T+G
Sbjct: 142 LSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG------------VSAQLDRTVGRR 186
Query: 798 D----------PEYYMTQQLTE-----KSDVYSFGVVMLELITAKQP 829
+ PE + + KSD++S G+ +E+ P
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-25
Identities = 31/241 (12%), Positives = 64/241 (26%), Gaps = 55/241 (22%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK----------------------------RAQQGSMQ 665
+G G+ + Q +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 666 GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM-ANGTLRESLS-----GRSG 719
L F +L+ K ++ + + + + L+ +
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 720 IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779
L RL++ L R LA LH ++H ++ +I+LD+ + F
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254
Query: 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQL-----------TEKSDVYSFGVVMLELITAKQ 828
+ + G+ PE + T D ++ G+V+ + A
Sbjct: 255 ---RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 829 P 829
P
Sbjct: 312 P 312
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-24
Identities = 70/356 (19%), Positives = 117/356 (32%), Gaps = 38/356 (10%)
Query: 61 CNNSRVTALGLSTMGLTGKL--SGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNIL 118
+ L L GL+ + G L L LDLS N + L P G L L +
Sbjct: 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSI 153
Query: 119 ILAGCGFTGNIPDEIGNLA--ELSFLALNSNNFSGRIPPSLGKLSQ------LYWLDLAD 170
+ E+ L LSF +L +N+ R+ GK L LD++
Sbjct: 154 DFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG 213
Query: 171 NQLTGSIP------VSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSP--DMVLIHVL 222
N T I +S + L + F + + + F+ + H+
Sbjct: 214 NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLARSSVRHLD 272
Query: 223 FDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFP 281
+ ++ L+VL L N + L N+ LNL++N L
Sbjct: 273 LSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332
Query: 282 DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQV 341
+ + ++Y+DL N F L L TL L+ + I +
Sbjct: 333 NFYGLPKVAYIDLQKNHI-AIIQDQTFKFLEKLQTL-----DLRDNALTTIHFIPSIPDI 386
Query: 342 KLRNNAFNN--TLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYT----LILVGN 391
L N +++ L+ L N++ + + + LIL N
Sbjct: 387 FLSGNKLVTLPKINLT------ANLIHLSENRLENLDILYFLLRVPHLQILILNQN 436
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-23
Identities = 69/345 (20%), Positives = 117/345 (33%), Gaps = 40/345 (11%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
+ L LS + + L +L+ L+L ++ +L L IL L
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ-YTPLTIDKEAFRNLPNLRILDLGS 82
Query: 123 CGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPPS--LGKLSQLYWLDLADNQLTGSIPV 179
+ + L L L L S + L L LDL+ NQ+
Sbjct: 83 SKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR----- 136
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSP--DMVLIHVLFDGNQLSGNIPESLG 237
S P +L + K F+ N++ + E P L N L + G
Sbjct: 137 SLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWG 195
Query: 238 YVQ------TLEVLRLDRNALTGKVPTNLNN------------LTNVNELNLAHNDLKGP 279
LE+L + N T + N +N ++ +++K P
Sbjct: 196 KCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 280 FPDL---SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY- 335
+ +S+ ++DLS+ + F TL L L + + ++ D+ F
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGL 313
Query: 336 SQIQQVKLRNNAFNNTLDMGNAVG-PLLQLVDLQNNQISAITLGS 379
+Q + L N L N G P + +DLQ N I+ I +
Sbjct: 314 DNLQVLNLSYNLL-GELYSSNFYGLPKVAYIDLQKNHIAIIQDQT 357
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 6e-22
Identities = 76/399 (19%), Positives = 129/399 (32%), Gaps = 38/399 (9%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGL--TELRSLDLSYNGGLTGSLSPRI-GDLQKLNIL 118
+ G + GL + +R LDLS+ + SL+ R+ L+ L +L
Sbjct: 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF-VF-SLNSRVFETLKDLKVL 295
Query: 119 ILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
LA + L L L L+ N + L ++ ++DL N +
Sbjct: 296 NLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA---- 351
Query: 179 VSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGY 238
I L+ + N L+ + I +F LSGN +L
Sbjct: 352 --IIQDQTFKFLEKLQTLDLRDNALT-------TIHFIPSIPDIF----LSGNKLVTLPK 398
Query: 239 VQ-TLEVLRLDRNALTG-KVPTNLNNLTNVNELNLAHNDLKGPFPD--LSQMNSLSYVDL 294
+ T ++ L N L + L + ++ L L N D S+ SL + L
Sbjct: 399 INLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFL 458
Query: 295 SNNSFDPTEA----PLWFSTLPSLTTLICEFGSLQGRVPDKLFS-YSQIQQVKLRNNAFN 349
N F L L L L +P +FS + ++ + L +N
Sbjct: 459 GENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT 517
Query: 350 NTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCT---ATLANTNYCQ 405
L N + L+++D+ NQ+ A + L + N +C +T N
Sbjct: 518 -VLS-HNDLPANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHT 575
Query: 406 LQQPTTKAYSTSLANCGGKSCPPEQKLSPQSCECAYPYE 444
S LS + C+ +
Sbjct: 576 NVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLK 614
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 9e-21
Identities = 57/367 (15%), Positives = 111/367 (30%), Gaps = 72/367 (19%)
Query: 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQ-----KLNILILAGCGFTGNIPDEI 133
L G L L+S+D S N + + +L+ L+ LA + +
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQ-IF-LVCE--HELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 134 GNLAE------LSFLALNSNNFSGRIP------------PSLGKLSQLYWLDLADNQLTG 175
G L L ++ N ++ I SL + + +
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK- 253
Query: 176 SIPVST---------------------ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSP 214
+T + S + LK+ K + NK++ I+++ F
Sbjct: 254 DPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYG 312
Query: 215 DMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHN 274
L + N L + + + + L +N + L + L+L N
Sbjct: 313 LDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDN 372
Query: 275 DLKGPFP-------DLSQMN---------SLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318
L LS + + + LS N + + + +P L LI
Sbjct: 373 ALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILI 432
Query: 319 CEFGSLQGRVPDKLFSY-SQIQQVKLRNNAFNNTLDMGNAVGPL-----LQLVDLQNNQI 372
D+ S ++Q+ L N + LQ++ L +N +
Sbjct: 433 LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492
Query: 373 SAITLGS 379
+++ G
Sbjct: 493 NSLPPGV 499
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-20
Identities = 61/322 (18%), Positives = 107/322 (33%), Gaps = 38/322 (11%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLA 143
L L LS+N + +++ L++L +L L I E NL L L
Sbjct: 22 VLNTTERLLLSFNY-IR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79
Query: 144 LNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
L S+ + P L L+ L L L+ ++ + LK +KN+
Sbjct: 80 LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAV----LKDGYFRNLKALTRLDLSKNQ 134
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ--TLEVLRLDRNALTGKVPTNL 260
+ F L + F NQ+ L +Q TL L N+L +V +
Sbjct: 135 IRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDW 194
Query: 261 NNLTNV------NELNLAHNDL-------------KGPFPDLSQMNSLSYVDLSNNSF-D 300
N L+++ N K L + + ++ D
Sbjct: 195 GKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD 254
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFS-YSQIQQVKLRNNAFNNTLDMGNAVG 359
P + S+ L G + + ++F ++ + L N N D A
Sbjct: 255 PDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIAD--EAFY 311
Query: 360 PL--LQLVDLQNNQISAITLGS 379
L LQ+++L N + + +
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSN 333
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 48/270 (17%), Positives = 87/270 (32%), Gaps = 38/270 (14%)
Query: 133 IGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKN 192
G +A F L +P L + L L+ N + T+T+ L+
Sbjct: 5 DGRIAFYRFCNLTQ------VPQVL---NTTERLLLSFNYIR------TVTASSFPFLEQ 49
Query: 193 AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNAL 252
+ TI ++ F L + +++ P++ + L LRL L
Sbjct: 50 LQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGL 109
Query: 253 TGKV--PTNLNNLTNVNELNLAHNDLK--GPFPDLSQMNSLSYVDLSNNSF-DPTEAPLW 307
+ V NL + L+L+ N ++ P ++NSL +D S+N E L
Sbjct: 110 SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169
Query: 308 FSTLPSLTTLICEFGSLQGRVPD------KLFSYSQIQQVKLRNN--------AFNNTLD 353
+L+ SL RV F ++ + + N F+N +
Sbjct: 170 PLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAIS 229
Query: 354 MGNAV----GPLLQLVDLQNNQISAITLGS 379
A + + I +
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 56/208 (26%), Positives = 86/208 (41%), Gaps = 36/208 (17%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK--------RAQQGSMQGGLEFKTEIELLSRVHHKN 684
+GSG G+V + VAI+ L +TEIE+L +++H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGL 738
++ + F F+ + +V E M G L + L K L +
Sbjct: 202 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCKLYFYQMLL---AV 252
Query: 739 AYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
YLHE IIHRD+K N+LL +E+ K+ DFG SK++ + + + GT
Sbjct: 253 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPT 306
Query: 796 YLDPE---YYMTQQLTEKSDVYSFGVVM 820
YL PE T D +S GV++
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 33/201 (16%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLV 689
+GSG + +V+ G++ A+K ++ + EI +L ++ H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDS---SLENEIAVLKKIKHENIVTLE 72
Query: 690 GFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
+E LV + ++ G L R + + + ++ L + YLH
Sbjct: 73 DI-YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS---AVKYLH 123
Query: 743 ELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
E I+HRD+K N+L +EN + DFGLSK+ + G +ST GT GY+ P
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN---GIMSTAC-GTPGYVAP 176
Query: 800 EYYMTQQLTEKSDVYSFGVVM 820
E + ++ D +S GV+
Sbjct: 177 EVLAQKPYSKAVDCWSIGVIT 197
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 55/330 (16%), Positives = 114/330 (34%), Gaps = 21/330 (6%)
Query: 80 LSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAEL 139
++ LT L++L + + L LN L + + ++ ++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 140 SFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFN 199
L L+ + + + LS + +L+L D L +K
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 200 KNKLSGTISEQLFSPDMVLIHVLFDGNQLSG---------NIPESLGYVQT--LEVLRLD 248
S +L + L V FD L+G ++ LG V+T + L +
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNN--SFDPTEAP 305
+ L + T + L V + + ++ + P + SL ++DLS N + +
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 306 LWFSTLPSLTTLICEFGSLQ--GRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL-- 361
PSL TL+ L+ + + L + + + + N F+ M ++
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHP---MPDSCQWPEK 411
Query: 362 LQLVDLQNNQISAITLGSGIKNYTLILVGN 391
++ ++L + I + L + N
Sbjct: 412 MRFLNLSSTGIRVVKTCIPQTLEVLDVSNN 441
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-22
Identities = 54/341 (15%), Positives = 114/341 (33%), Gaps = 33/341 (9%)
Query: 60 TCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPR-IGDLQKLNIL 118
+ + + T + + ++SLDLS+N +T + + L +L
Sbjct: 1 SLSCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNK-IT-YIGHGDLRACANLQVL 55
Query: 119 ILAGCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGS 176
IL I + +L L L L+ N+ S + S G LS L +L+L N +
Sbjct: 56 ILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQ-T 112
Query: 177 IPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL 236
+ V+++ L N + + I F+ L + L +SL
Sbjct: 113 LGVTSL----FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168
Query: 237 GYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYV 292
++ + L L + + + L++V L L +L P P + + +
Sbjct: 169 KSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228
Query: 293 DLSNNSFDP------TEAPLWFSTLPSLTTLIC---EFGSLQGRVPDKLFSYSQIQQVKL 343
+ + + L + C G D + +++ V +
Sbjct: 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTI 288
Query: 344 RNNAFNN---TLDMGNAVGPL--LQLVDLQNNQISAITLGS 379
R D+ L ++ + ++N+++ +
Sbjct: 289 RRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSF 329
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 5e-20
Identities = 55/380 (14%), Positives = 122/380 (32%), Gaps = 59/380 (15%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGD-LQKLNILIL 120
+ + L + + L S + + ++ L L + + L D L + L L
Sbjct: 146 GLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE--SAFLLEIFADILSSVRYLEL 203
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSN----------NFSGRIPPSLGKLSQLYWLDLAD 170
+ S + + N ++ + +LS++ + D
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263
Query: 171 NQLT--GSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQ- 227
N L ++ G + + H + L ++S + + + ++
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF-YDLSTVYSLLEKVKRITVENSKV 322
Query: 228 ------------------LSGNI--------PESLGYVQTLEVLRLDRNALT--GKVPTN 259
LS N+ G +L+ L L +N L K
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 260 LNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLIC 319
L L N+ L+++ N + +++LS+ + +L L
Sbjct: 383 LLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI----RVVKTCIPQTLEVLDV 438
Query: 320 EFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG- 378
+L L ++Q++ + N TL ++ P+L ++ + NQ+ ++ G
Sbjct: 439 SNNNLD-SFSLFL---PRLQELYISRNKL-KTLP-DASLFPVLLVMKISRNQLKSVPDGI 492
Query: 379 -SGIKN-YTLILVGNP-VCT 395
+ + + L NP C+
Sbjct: 493 FDRLTSLQKIWLHTNPWDCS 512
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 38/218 (17%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKR---AQQGSMQGGLEFKTEIELLSRVHHKN 684
FS+ EIG G +G VY + + +VVAIK+ + + S + + E+ L ++ H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 685 LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL---GSARGLAY 740
+ G C+ + LV E+ + + IA G+ +GLAY
Sbjct: 116 TIQYRG-CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-----IAAVTHGALQGLAY 169
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK------GTM 794
LH +IHRDVK+ NILL E K+ DFG ++ + GT
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFG------------SASIMAPANSFVGTP 214
Query: 795 GYLDPEYYMTQQLTE---KSDVYSFGVVMLELITAKQP 829
++ PE + + K DV+S G+ +EL K P
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-24
Identities = 62/348 (17%), Positives = 110/348 (31%), Gaps = 43/348 (12%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
L LS L S EL+ LDLS + L L+ LIL G
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
L+ L L N + +G L L L++A N + S +
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY--- 144
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSP----DMVLIHVLFDGNQLSGNIPESLGYVQT 241
L N +H + NK+ +I ++ + + N ++ I
Sbjct: 145 -FSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIR 201
Query: 242 LEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLK----------GPFPDLSQMNSLS 290
L L L N + V + L + L + + L + +
Sbjct: 202 LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT-IE 260
Query: 291 YVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF------------SYSQI 338
L+ + + F+ L ++++ +++ RV D + + Q
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQF 319
Query: 339 QQVKLRN-----NAFNNTLDMGNAVG-PLLQLVDLQNNQISAITLGSG 380
+KL++ N + + V P L+ +DL N +S S
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQ 367
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-23
Identities = 50/219 (22%), Positives = 79/219 (36%), Gaps = 14/219 (6%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFT--GNIPDEIGNLAELSFLA 143
L L+ L + N G + DL L L L+ G + G L +L
Sbjct: 323 KLKSLKRLTFTSN---KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
L+ N + + L QL LD + L S L+N + +
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV-----FLSLRNLIYLDISHTHT 433
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNI-PESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
+F+ L + GN N P+ ++ L L L + L PT N+
Sbjct: 434 R-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492
Query: 263 LTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFD 300
L+++ LN+A N LK ++ SL + L N +D
Sbjct: 493 LSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-22
Identities = 57/374 (15%), Positives = 108/374 (28%), Gaps = 60/374 (16%)
Query: 57 EGVTCNNSRVTALGLSTMGLT-GKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKL 115
+ + L ++ + KL LT L LDLS N + + L ++
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK-IQSIYCTDLRVLHQM 175
Query: 116 NI----LILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLAD 170
+ L L+ I L L L +N S + + L+ L L
Sbjct: 176 PLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVL 234
Query: 171 NQLTGSIPVSTITSPGLDQLKN--AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQ- 227
+ + L+ L N + F LF+ +
Sbjct: 235 GEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI 294
Query: 228 -------------------------------------LSGNIPESLG---YVQTLEVLRL 247
+ N + + +LE L L
Sbjct: 295 ERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDL 354
Query: 248 DRNALT--GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAP 305
RN L+ G + T++ L+L+ N + + + L ++D +++
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 306 LWFSTLPSLTTLI---CEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG-PL 361
F +L +L L + + L S ++ +K+ N+F
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGL---SSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 362 LQLVDLQNNQISAI 375
L +DL Q+ +
Sbjct: 472 LTFLDLSQCQLEQL 485
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 64/358 (17%), Positives = 102/358 (28%), Gaps = 55/358 (15%)
Query: 51 DPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIG 110
+PC +T + K+ ++ ++LDLS+N L S
Sbjct: 1 EPC------VEVVPNITYQ-CMELNFY-KIPDNLP--FSTKNLDLSFNP-LRHLGSYSFF 49
Query: 111 DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170
+L +L L+ C +L+ LS L L N + LS L L +
Sbjct: 50 SFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109
Query: 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG 230
L S+ + LK K + N + S
Sbjct: 110 TNLA-SLENFP-----IGHLKTLKELNVAHNLIQ------------------------SF 139
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTN----VNELNLAHNDLKGPFPDLSQM 286
+PE + LE L L N + T+L L L+L+ N + P +
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199
Query: 287 NSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYS------QIQQ 340
L + L NN L L G + + F S +
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 341 VKLRNNAFNNTLDMGNAV---GPLLQLVDLQNNQISAITLGSGIKN-YTLILVGNPVC 394
+ R + LD + + L + I + S L LV
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-19
Identities = 42/201 (20%), Positives = 66/201 (32%), Gaps = 11/201 (5%)
Query: 86 GLTELRSLDLSYNG-GLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLAL 144
L L LDLS NG G S L L L+ G + L +L L
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 145 NSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
+N S L L +LD++ + L + + N
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGI-----FNGLSSLEVLKMAGNSF 457
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN-LNN 262
+F+ L + QL P + + +L+VL + N L VP +
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDR 516
Query: 263 LTNVNELNLAHNDLKGPFPDL 283
LT++ ++ L N P +
Sbjct: 517 LTSLQKIWLHTNPWDCSCPRI 537
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 55/292 (18%), Positives = 97/292 (33%), Gaps = 64/292 (21%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145
LT + S L Q L ++ F L L L
Sbjct: 280 CLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTL------KLKSLKRLTFT 333
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG 205
SN S L L +LDL+ N L+ + + G LK
Sbjct: 334 SNKGGN--AFSEVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLK-------------- 376
Query: 206 TISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN-LNNLT 264
++ N + + + ++ LE L + L + +L
Sbjct: 377 --------------YLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421
Query: 265 NVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGS 323
N+ L+++H + F + ++SL + ++ NSF P F+ L +LT L
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLD----- 476
Query: 324 LQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAI 375
S Q++Q L AFN+ LQ++++ +NQ+ ++
Sbjct: 477 ---------LSQCQLEQ--LSPTAFNSL--------SSLQVLNMASNQLKSV 509
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 29/124 (23%), Positives = 47/124 (37%), Gaps = 4/124 (3%)
Query: 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKL 115
V + + L +S +G GL+ L L ++ N + P I +L+ L
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS-FQENFLPDIFTELRNL 472
Query: 116 NILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLT 174
L L+ C P +L+ L L + SN +P +L+ L + L N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 531
Query: 175 GSIP 178
S P
Sbjct: 532 CSCP 535
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 53/211 (25%), Positives = 91/211 (43%), Gaps = 39/211 (18%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV-HH 682
+G G V R + + A+K + + + E+++L +V H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 683 KNLVGLVGFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSA 735
N++ L +E LV++ M G L + +LS + + ++ +R L
Sbjct: 84 PNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETRKIMRALLE-- 135
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
+ LH+L I+HRD+K NILLD+++ K+ DFG S + G +V GT
Sbjct: 136 -VICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLREVCGTPS 188
Query: 796 YLDPE------YYMTQQLTEKSDVYSFGVVM 820
YL PE ++ D++S GV+M
Sbjct: 189 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 36/208 (17%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK--------RAQQGSMQGGLEFKTEIELLSRVHHKN 684
+GSG G+V + VAIK L +TEIE+L +++H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGL 738
++ + F F+ + +V E M G L + L K L +
Sbjct: 77 IIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCKLYFYQMLL---AV 127
Query: 739 AYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
YLHE IIHRD+K N+LL +E+ K+ DFG SK++ + + + GT
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE---TSLMRTLCGTPT 181
Query: 796 YLDPE---YYMTQQLTEKSDVYSFGVVM 820
YL PE T D +S GV++
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-24
Identities = 70/247 (28%), Positives = 100/247 (40%), Gaps = 42/247 (17%)
Query: 622 LKKCSNNFSE----SNEIGSGGYGKVYRG-MLSDGQVVAIK------------RAQQGSM 664
++K E ++GSG YG+V + AIK ++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 665 QGGLE-FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD 723
+ E EI LL + H N++ L ++ LV EF G L E + R D
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFD 144
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSD 780
I G+ YLH+ I+HRD+K NILL + L K+ DFGLS S
Sbjct: 145 ECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP----------- 829
+ GT Y+ PE + ++ EK DV+S GV+M L+ P
Sbjct: 202 ---DYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK 257
Query: 830 -IEKGKY 835
+EKGKY
Sbjct: 258 KVEKGKY 264
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 66/320 (20%), Positives = 117/320 (36%), Gaps = 55/320 (17%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
L L +T GD L L +L L N ++ +SP L KL L L+
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-IS-KISPGAFAPLVKLERLYLSK 109
Query: 123 CGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGS-IPV 179
+P+++ L EL ++ N + ++ L+Q+ ++L N L S I
Sbjct: 110 NQLK-ELPEKMPKTLQELR---VHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 164
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLGY 238
+K + ++ TI + L L + DGN+++ + SL
Sbjct: 165 GA-----FQGMKKLSYIRIADTNIT-TIPQGLPPS---LTELHLDGNKIT-KVDAASLKG 214
Query: 239 VQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN- 297
+ L L L N+++ +L N ++ EL+L +N L L+ + V L NN
Sbjct: 215 LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 274
Query: 298 -------SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350
F P P + + S + + SL + +Q +++ + F
Sbjct: 275 ISAIGSNDFCP---PGYNTKKASYSGV-----SL---------FSNPVQYWEIQPSTFRC 317
Query: 351 TLDMGNAVGPLLQLVDLQNN 370
+ V L N
Sbjct: 318 V--------YVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 58/302 (19%), Positives = 99/302 (32%), Gaps = 47/302 (15%)
Query: 88 TELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLALN 145
+ LDL N +T + +L+ L+ LIL + I L +L L L+
Sbjct: 52 PDTALLDLQNNK-IT-EIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLS 108
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL-S 204
N +P + L L + +N++T + S + L N L S
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSV-----FNGLNQMIVVELGTNPLKS 159
Query: 205 GTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN-LNNL 263
I F L ++ ++ IP+ L +L L LD N +T KV L L
Sbjct: 160 SGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGL 215
Query: 264 TNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLIC 319
N+ +L L+ N + G + + L L+NN + P + + +
Sbjct: 216 NNLAKLGLSFNSISAVDNGSLANTPHLREL---HLNNNKL--VKVPGGLADHKYIQVVY- 269
Query: 320 EFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379
+ I + +N F V L +N + +
Sbjct: 270 -------------LHNNNIS--AIGSNDFCPPGYNTKK--ASYSGVSLFSNPVQYWEIQP 312
Query: 380 GI 381
Sbjct: 313 ST 314
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 57/209 (27%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRV 680
+ F ++GSG +G V+ S G IK + Q +E + EIE+L +
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIH-----LDWKRRLRIALGS 734
H N++ + FE M +V E G L E + ++ +
Sbjct: 78 DHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN- 135
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
LAY H ++H+D+K NIL + K+ DFGL++L ST
Sbjct: 136 --ALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAA 187
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVM 820
GT Y+ PE + +T K D++S GVVM
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 27/231 (11%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGG--LEFKTEIELLSR 679
+ ++ +G G +G+V + Q A+K + S + E+ELL +
Sbjct: 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKK 77
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+ H N++ L + +V E G L + + R RI G+
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGIT 135
Query: 740 YLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
Y+H+ I+HRD+K NILL +++ K+ DFGLS GT Y
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYY 189
Query: 797 LDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
+ PE + EK DV+S GV++ L++ P +E GKY
Sbjct: 190 IAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKY 239
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 58/282 (20%), Positives = 91/282 (32%), Gaps = 65/282 (23%)
Query: 616 WFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLE 669
+F L + + IG G YG V + + AIK + +Q + +
Sbjct: 15 YFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER 74
Query: 670 FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLR 729
KTE+ L+ ++HH N+ L ++ LV E G L + L+
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 730 IALGSAR--------------------------------------GLAYLHELANPPIIH 751
+ L YLH I H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICH 191
Query: 752 RDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVS--TQVKGTMGYLDPE--YYMTQ 805
RD+K N L +++ K+ DFGLSK + G T GT ++ PE +
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251
Query: 806 QLTEKSDVYSFGVVMLELITAKQP------------IEKGKY 835
K D +S GV++ L+ P + K
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 55/211 (26%), Positives = 91/211 (43%), Gaps = 30/211 (14%)
Query: 626 SNNFSE----SNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLS 678
S FS+ E+G G + V R + + G A K ++ S + + + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIAL 732
++ H N+V L E+ LV++ + G L RE S H ++ L
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQQIL 115
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQ 789
+AY H I+HR++K N+LL + K+ADFGL+ V+D
Sbjct: 116 E---SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHG 166
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVM 820
GT GYL PE ++ D+++ GV++
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK-------RAQQGSMQGGLE-FKTEIELLSRVH-HK 683
IG G V R + + G A+K R ++ E + E +L +V H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 684 NLVGLVGFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSAR 736
+++ L+ +E M LV++ M G L + +LS + + + +R L
Sbjct: 161 HIITLIDS-YESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETRSIMRSLLE--- 211
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
+++LH I+HRD+K NILLD+N+ +++DFG S + G ++ GT GY
Sbjct: 212 AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCGTPGY 265
Query: 797 LDPE------YYMTQQLTEKSDVYSFGVVM 820
L PE ++ D+++ GV++
Sbjct: 266 LAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGL--EFKTEIELLSRVHHKNLV 686
E+GSG + V + S G A K R + S +G E + E+ +L +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLA 739
L +E + L+ E ++ G L +ESLS ++ L G+
Sbjct: 79 TLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVN 129
Query: 740 YLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
YLH I H D+K NI+L K+ DFGL+ + D G + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPE 183
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVM 820
++ PE + L ++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 74/330 (22%), Positives = 124/330 (37%), Gaps = 41/330 (12%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
+ +T+L +T ++G I LT L L + N +T +L + L L
Sbjct: 40 QLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSN-NIT-TLD--LSQNTNLTYLACD 93
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVST 181
T N+ + L +L++L ++N + + S + L +L+ A N LT I VS
Sbjct: 94 SNKLT-NLD--VTPLTKLTYLNCDTNKLTK-LDVS--QNPLLTYLNCARNTLT-EIDVS- 145
Query: 182 ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQT 241
+ NK I++ +P L + N+++ + + +
Sbjct: 146 -------HNTQLTELDCHLNKK---ITKLDVTPQTQLTTLDCSFNKIT-ELD--VSQNKL 192
Query: 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDP 301
L L D N +T +LN + L+ + N L D++ + L+Y D S N
Sbjct: 193 LNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTE--IDVTPLTQLTYFDCSVNPLT- 246
Query: 302 TEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL 361
L STL LTTL C L +Q+ + LD+ +
Sbjct: 247 ---ELDVSTLSKLTTLHCIQTDLLEIDLTHN---TQLIYFQAEGCRKIKELDVTHN--TQ 298
Query: 362 LQLVDLQNNQISAITLGSGIKNYTLILVGN 391
L L+D Q I+ + L K L L
Sbjct: 299 LYLLDCQAAGITELDLSQNPKLVYLYLNNT 328
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-20
Identities = 57/310 (18%), Positives = 103/310 (33%), Gaps = 40/310 (12%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142
D+ LT+L L+ N LT L + L L A T I + + +L+ L
Sbjct: 101 DVTPLTKLTYLNCDTNK-LT-KLD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTEL 153
Query: 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
+ N + +QL LD + N++T + VS Q K + + N
Sbjct: 154 DCHLNKKIT--KLDVTPQTQLTTLDCSFNKIT-ELDVS--------QNKLLNRLNCDTNN 202
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
++ + + ++ L + N+L+ I + + L N LT +++
Sbjct: 203 IT-KLD---LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVST 252
Query: 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322
L+ + L+ DL DL+ L Y L + L L C+
Sbjct: 253 LSKLTTLHCIQTDLLEI--DLTHNTQLIYFQAEGCRKIKE---LDVTHNTQLYLLDCQAA 307
Query: 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK 382
+ L ++ + L N LD+ + L+ + N I + I
Sbjct: 308 GIT---ELDLSQNPKLVYLYLNNTELT-ELDVSHN--TKLKSLSCVNAHIQDFSSVGKIP 361
Query: 383 N-YTLILVGN 391
Sbjct: 362 ALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 56/312 (17%), Positives = 109/312 (34%), Gaps = 41/312 (13%)
Query: 93 LDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGR 152
+ ++ T ++S L L L T ++ I L L+ L SNN +
Sbjct: 24 VAAAFEMQATDTIS--EEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNITT- 78
Query: 153 IPPSLGKLSQLYWLDLADNQLTGSIPVST-------------ITSPGLDQLKNAKHFHFN 199
+ L + + L +L N+LT ++ V+ +T + Q + +
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT-NLDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCA 135
Query: 200 KNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN 259
+N L+ I S + L + N+ + + L L N +T +
Sbjct: 136 RNTLT-EID---VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LD 186
Query: 260 LNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLIC 319
++ +N LN N++ DL+Q L+++D S+N TE + L LT C
Sbjct: 187 VSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKL--TEID--VTPLTQLTYFDC 240
Query: 320 EFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379
L + S++ + +D+ + L+ +I + +
Sbjct: 241 SVNPLT-ELDVSTL--SKLTTLHCIQTDL-LEIDLTHNTQ-LIYFQAEGCRKIKELDVTH 295
Query: 380 GIKNYTLILVGN 391
+ Y L
Sbjct: 296 NTQLYLLDCQAA 307
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 56/268 (20%), Positives = 94/268 (35%), Gaps = 34/268 (12%)
Query: 125 FTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITS 184
F PD+ N A A S +L+ L LD ++ +T
Sbjct: 11 FNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT--------DM 57
Query: 185 PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEV 244
G+++L N ++ T+ S + L ++ D N+L+ N+ + + L
Sbjct: 58 TGIEKLTGLTKLICTSNNIT-TLD---LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTY 110
Query: 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304
L D N LT + LT LN A N L D+S L+ +D N
Sbjct: 111 LNCDTNKLTKLDVSQNPLLT---YLNCARNTLT--EIDVSHNTQLTELDCHLNKK---IT 162
Query: 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQL 364
L + LTTL C F + + + ++ N LD+ L
Sbjct: 163 KLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI-TKLDLNQN--IQLTF 216
Query: 365 VDLQNNQISAITLGSGIKNYTLILVGNP 392
+D +N+++ I + + NP
Sbjct: 217 LDCSSNKLTEIDVTPLTQLTYFDCSVNP 244
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 37/236 (15%), Positives = 71/236 (30%), Gaps = 32/236 (13%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142
D+ LT+L D S N LT L + L KL L I + + +L +
Sbjct: 228 DVTPLTQLTYFDCSVNP-LT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYF 280
Query: 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
+ + +QLY LD +T + +S Q + + N +
Sbjct: 281 QAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDLS--------QNPKLVYLYLNNTE 329
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262
L+ + S + L + + + +G + L L N
Sbjct: 330 LT-ELD---VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTN 383
Query: 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318
+ ++ D G N ++ +D + + L + +
Sbjct: 384 NSLTIAVSPDLLDQFG--------NPMNIEPGDGGVYDQATNTITWENLSTDNPAV 431
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 14/159 (8%), Positives = 46/159 (28%), Gaps = 32/159 (20%)
Query: 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDP 301
+ + L + L+ ++ + + ++ L+ + ++N+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSNNI-- 76
Query: 302 TEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPL 361
T S +LT L C +++ + +
Sbjct: 77 TTLD--LSQNTNLTYLAC--------------DSNKLTNLDVTPL-------------TK 107
Query: 362 LQLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLAN 400
L ++ N+++ + + L N + +++
Sbjct: 108 LTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEIDVSH 146
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 33/205 (16%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGL--EFKTEIELLSRVHHKNLV 686
E+GSG + V + G+ A K R S +G E + E+ +L + H N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLA 739
L FE + L+ E ++ G L +ESL+ L+ L G+
Sbjct: 72 TLHDI-FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVH 122
Query: 740 YLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
YLH I H D+K NI+L N K+ DFG++ + G+ + GT
Sbjct: 123 YLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---GNEFKNIFGTPE 176
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVM 820
++ PE + L ++D++S GV+
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGL--EFKTEIELLSRVHHKNLV 686
E+GSG + V + S G A K R + S +G E + E+ +L +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLA 739
L +E + L+ E ++ G L +ESLS ++ L G+
Sbjct: 79 TLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVN 129
Query: 740 YLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
YLH I H D+K NI+L K+ DFGL+ + D G + GT
Sbjct: 130 YLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFKNIFGTPE 183
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVM 820
++ PE + L ++D++S GV+
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-23
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 45/232 (19%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLE-FKTEIELLSRVHHKNLVGLV 689
+G G YGKV + A+K + + + G K EI+LL R+ HKN++ LV
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 690 GFCFEQGEQM--LVYEFMANGT--LRESLSGRSGIHLDWKRRLRIALGSAR--------G 737
+ + +Q +V E+ G + +S+ ++R + A G
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVP---------EKRFPVC--QAHGYFCQLIDG 121
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
L YLH I+H+D+K N+LL T K++ G+++ + + +G+ +
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 798 DPEYYMTQQLTE--KSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE K D++S GV + + T P I KG Y
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 6e-23
Identities = 63/387 (16%), Positives = 118/387 (30%), Gaps = 71/387 (18%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146
L++ +G LT +L + + L++ T ++P L L ++
Sbjct: 39 NNGNAVLNVGESG-LT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSG 90
Query: 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT 206
N + +P L +L L N+L+ +
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLP-------------ALPSGLCKLWIFGNQLT-S 135
Query: 207 ISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNV 266
+ L + NQL+ ++P L L N LT +P + L
Sbjct: 136 LPVLPPG----LQELSVSDNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQ-- 184
Query: 267 NELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG 326
EL+++ N L P L + L + NN T P + L LI L
Sbjct: 185 -ELSVSDNQLAS-LPTL--PSELYKLWAYNNRL--TSLP---ALPSGLKELIVSGNRLT- 234
Query: 327 RVPDKLFSYSQIQQVKLRNNAFNNTLD--MGNAVGPLLQLVDLQNNQISAI--TLGSGIK 382
+P S+++++ + N +L L + + NQ++ + +L
Sbjct: 235 SLPVLP---SELKELMVSGNRL-TSLPMLPSG-----LLSLSVYRNQLTRLPESLIHLSS 285
Query: 383 NYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGK--SCPPEQKLSPQSCECA 440
T+ L GNP+ + ++ TS G +P+
Sbjct: 286 ETTVNLEGNPL--SERTLQALREI---------TSAPGYSGPIIRFDMAGASAPRETRA- 333
Query: 441 YPYEGTMYFRGPSFRELSNVTVFHSLE 467
+ E + +H
Sbjct: 334 LHLAAADWLVPAREGEPAPADRWHMFG 360
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 97.3 bits (242), Expect = 6e-21
Identities = 59/254 (23%), Positives = 92/254 (36%), Gaps = 45/254 (17%)
Query: 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFT 126
L +S LT L GL EL L L KL + G T
Sbjct: 84 RTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT-----HLPALPSGLCKLW---IFGNQLT 134
Query: 127 GNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186
++P L ELS S+N +P +L +L+ +NQLT S+P+
Sbjct: 135 -SLPVLPPGLQELSV----SDNQLASLPALPSELCKLW---AYNNQLT-SLPML------ 179
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246
L + + N+L+ ++ L + N+L+ ++P L+ L
Sbjct: 180 PSGL---QELSVSDNQLA-SLPTLPSE----LYKLWAYNNRLT-SLPALPS---GLKELI 227
Query: 247 LDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPL 306
+ N LT +P + L L ++ N L P L + L + + N T P
Sbjct: 228 VSGNRLTS-LPVLPSELKE---LMVSGNRLTS-LPML--PSGLLSLSVYRNQL--TRLPE 278
Query: 307 WFSTLPSLTTLICE 320
L S TT+ E
Sbjct: 279 SLIHLSSETTVNLE 292
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 40/191 (20%), Positives = 67/191 (35%), Gaps = 34/191 (17%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146
+ L+ L +S N LT SL +L++L ++G T ++P L LS +
Sbjct: 220 PSGLKELIVSGNR-LT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLLSLS---VYR 270
Query: 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT 206
N + R+P SL LS ++L N L+ T L ++ +A +
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLS------ERTLQALREITSAPGY---------- 313
Query: 207 ISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNV 266
S + DM + L + L + E DR N
Sbjct: 314 -SGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADR-------WHMFGQEDNA 365
Query: 267 NELNLAHNDLK 277
+ +L + L
Sbjct: 366 DAFSLFLDRLS 376
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 62/301 (20%), Positives = 101/301 (33%), Gaps = 48/301 (15%)
Query: 88 TELRSLDLSYNGGLTGSLSPR-IGDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLALN 145
+ LDL N ++ L LQ L L+L + I ++ L +L L ++
Sbjct: 54 PDTTLLDLQNND-IS-ELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYIS 110
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL-S 204
N+ IPP+L S L L + DN++ +P L+N N L +
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGV-----FSGLRNMNCIEMGGNPLEN 161
Query: 205 GTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN-LNNL 263
F + L ++ +L+ IP+ L +TL L LD N + + L
Sbjct: 162 SGFEPGAFD-GLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRY 216
Query: 264 TNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLIC 319
+ + L L HN ++ G L + L L NN + P L L +
Sbjct: 217 SKLYRLGLGHNQIRMIENGSLSFLPTLREL---HLDNNKL--SRVPAGLPDLKLLQVVY- 270
Query: 320 EFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379
+ I K+ N F + L NN + +
Sbjct: 271 -------------LHTNNIT--KVGVNDFCPVGFGVKR--AYYNGISLFNNPVPYWEVQP 313
Query: 380 G 380
Sbjct: 314 A 314
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 57/321 (17%), Positives = 101/321 (31%), Gaps = 56/321 (17%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
T L L ++ D GL L +L L N ++ + + L+KL L ++
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK-IS-KIHEKAFSPLRKLQKLYISK 111
Query: 123 CGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLT-GSIPV 179
IP + +L EL ++ N ++P L + +++ N L
Sbjct: 112 NHLV-EIPPNLPSSLVELR---IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLGY 238
L+ L ++ KL+ I + L L + D N++ I L
Sbjct: 167 GAFDGLKLNYL------RISEAKLT-GIPKDLPET---LNELHLDHNKIQ-AIELEDLLR 215
Query: 239 VQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN- 297
L L L N + +L+ L + EL+L +N L L + L V L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNN 275
Query: 298 -------SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350
F P + + SL + + +++ F
Sbjct: 276 ITKVGVNDFCPVGFGV---KRAYYNGI-----SLFN---------NPVPYWEVQPATFRC 318
Query: 351 TLDMGNAVGPLLQLVDLQNNQ 371
+ N +
Sbjct: 319 V--------TDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 7e-19
Identities = 59/284 (20%), Positives = 100/284 (35%), Gaps = 54/284 (19%)
Query: 130 PDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
D+ L L L L +N S +I + L +L L ++ N L IP + L
Sbjct: 71 KDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLV 126
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL-SGNIPESLGYVQTLEVLRL 247
+L + N++ + + +FS + + GN L + L LR+
Sbjct: 127 EL------RIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRI 179
Query: 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNSFDPTE-AP 305
LT +P +L +NEL+L HN ++ DL + + L + L +N
Sbjct: 180 SEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQ--IRMIEN 234
Query: 306 LWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLV 365
S LP+L L L +++ +V + LLQ+V
Sbjct: 235 GSLSFLPTLREL-----HL---------DNNKLSRVP---AGLPDL--------KLLQVV 269
Query: 366 DLQNNQISAITLGS---------GIKNYTLILVGNPVCTATLAN 400
L N I+ + + + L NPV +
Sbjct: 270 YLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 7e-23
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 27/199 (13%)
Query: 634 EIGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGGLE--FKTEIELLSRVHHKNLVGLVG 690
+G G +G+V + Q A+K + S + E+ELL ++ H N++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 691 FCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+ +V E G L R+ S D R ++ G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAARIIKQVFS---GITYMHKH 140
Query: 745 ANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
I+HRD+K NILL +++ K+ DFGLS GT Y+ PE
Sbjct: 141 N---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGTAYYIAPE- 193
Query: 802 YMTQQLTEKSDVYSFGVVM 820
+ EK DV+S GV++
Sbjct: 194 VLRGTYDEKCDVWSAGVIL 212
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRVH 681
IG G +GKV + ++ A+K R + ++ E++++ +
Sbjct: 23 IGKGSFGKV---CIVQKNDTKKMYAMKYMNKQKCVERNEVRNV------FKELQIMQGLE 73
Query: 682 HKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIA-LGSARGLA 739
H LV L + F+ E M +V + + G LR L ++ + +L I L A L
Sbjct: 74 HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ-QNVHFKEETVKLFICELVMA--LD 129
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
YL IIHRD+K NILLDE+ + DF ++ ++ T + GT Y+ P
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAP 183
Query: 800 EYYMTQQLTE--KS-DVYSFGVVMLELITAKQP 829
E + +++ + D +S GV EL+ ++P
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
E+G G + V R + + GQ A ++ S + + + E + + H N+V L
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 691 FCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
E+G L+++ + G L RE S H ++ L + + H++
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-----IQQILE---AVLHCHQM 129
Query: 745 ANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
++HR++K N+LL + K+ADFGL+ V GT GYL PE
Sbjct: 130 G---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE--QQAWFGFAGTPGYLSPEV 184
Query: 802 YMTQQLTEKSDVYSFGVVM 820
+ D+++ GV++
Sbjct: 185 LRKDPYGKPVDLWACGVIL 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 33/205 (16%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGL--EFKTEIELLSRVHHKNLV 686
E+GSG + V + S G A K R + S +G + + E+ +L + H N++
Sbjct: 18 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLA 739
L +E + L+ E +A G L +ESL+ L+ L G+
Sbjct: 78 TLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GVY 128
Query: 740 YLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
YLH L I H D+K NI+L K+ DFGL+ + G+ + GT
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFKNIFGTPE 182
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVM 820
++ PE + L ++D++S GV+
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 60/228 (26%), Positives = 107/228 (46%), Gaps = 37/228 (16%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRV 680
+ + + ++G G YG VY+ S G++VA+KR + + G+ EI LL +
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKR---RLRIALGSA-- 735
HH N+V L+ + LV+EFM D K+ + L +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFM---------------EKDLKKVLDENKTGLQDSQI 121
Query: 736 --------RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
RG+A+ H+ I+HRD+K N+L++ + K+ADFGL++ + +
Sbjct: 122 KIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYT 177
Query: 788 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+V T+ Y P+ M +++ + D++S G + E+IT +P+ G
Sbjct: 178 HEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT-GKPLFPGV 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 51/201 (25%), Positives = 81/201 (40%), Gaps = 22/201 (10%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGLE-FKTEIELLSRVHHKNLVG 687
IG G + V R + GQ A+K S E K E + + H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHL-----DWKRRLRIALGSARGLAYLH 742
L+ G +V+EFM L + R+ +R L L Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE---ALRYCH 147
Query: 743 ELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
+ IIHRDVK +LL + + K+ FG++ + +S G V+ GT ++ P
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES--GLVAGGRVGTPHFMAP 202
Query: 800 EYYMTQQLTEKSDVYSFGVVM 820
E + + DV+ GV++
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 57/275 (20%), Positives = 103/275 (37%), Gaps = 25/275 (9%)
Query: 88 TELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLALN 145
++SLDLS N +T +S L L+L G I ++ +L L L L+
Sbjct: 52 EAVKSLDLSNNR-IT-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLS 108
Query: 146 SNNFSGRIPPSL-GKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS 204
N S + S LS L +L+L N ++ +++ L +
Sbjct: 109 YNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSL----FSHLTKLQILRVGNMDTF 162
Query: 205 GTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLT 264
I + F+ L + D + L P+SL +Q + L L + ++ +
Sbjct: 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTS 222
Query: 265 NVNELNLAHNDL---------KGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLT 315
+V L L DL G L + + V +++ S + + + L
Sbjct: 223 SVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL--FQVMKLLNQISGLL 280
Query: 316 TLICEFGSLQGRVPDKLF-SYSQIQQVKLRNNAFN 349
L L+ VPD +F + +Q++ L N ++
Sbjct: 281 ELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 3e-18
Identities = 50/231 (21%), Positives = 85/231 (36%), Gaps = 30/231 (12%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI--GNLAELSFL 142
L L LDLSYN L+ +LS L L L L G + + + +L +L L
Sbjct: 98 SLGSLEHLDLSYN-YLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQIL 154
Query: 143 ALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKN 201
+ + + +I L+ L L++ + L S + L ++N H +
Sbjct: 155 RVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKS-----LKSIQNVSHLILHMK 208
Query: 202 KLSGTISEQLFSPDMVLIHVLFDGNQLSGN--------IPESLGYVQTLEVLRLDRNALT 253
+ + E + + L SL T +++ +L
Sbjct: 209 QHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 254 GKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
+V LN ++ + EL + N LK G F L+ SL + L N +D
Sbjct: 268 -QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLT---SLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 31/174 (17%), Positives = 58/174 (33%), Gaps = 34/174 (19%)
Query: 224 DGNQLSGNIPESL--GYVQTLEVLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLK--- 277
N+++ I S V L+ L L N + + + ++L ++ L+L++N L
Sbjct: 60 SNNRIT-YISNSDLQRCVN-LQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLS 116
Query: 278 -GPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF--- 333
F LS SL++++L N + FS L L L ++ K F
Sbjct: 117 SSWFKPLS---SLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 334 --------SYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379
S +Q + + + + L Q +
Sbjct: 174 TFLEELEIDASDLQ--SYEPKSLKSI--------QNVSHLILHMKQHILLLEIF 217
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 18/144 (12%), Positives = 45/144 (31%), Gaps = 14/144 (9%)
Query: 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYN-------GGLTGSLSPRIGDLQKLNILI 119
L + L + + + L L + + S +L+ ++
Sbjct: 177 EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT 236
Query: 120 LAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPV 179
+ + + + + + ++ L ++S L L+ + NQL S+P
Sbjct: 237 FHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPD 294
Query: 180 STITSPGLDQLKNAKHFHFNKNKL 203
D+L + + + N
Sbjct: 295 GI-----FDRLTSLQKIWLHTNPW 313
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 3e-22
Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 34/236 (14%)
Query: 599 APSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAI- 656
+ + + G L W S+ F +E+G G VYR + A+
Sbjct: 25 SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK 84
Query: 657 ---KRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL--- 710
K + + +TEI +L R+ H N++ L E LV E + G L
Sbjct: 85 VLKKTVDKKIV------RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDR 138
Query: 711 ---RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DEN 764
+ S R ++ L +AYLHE I+HRD+K N+L +
Sbjct: 139 IVEKGYYSERDAADA-----VKQILE---AVAYLHENG---IVHRDLKPENLLYATPAPD 187
Query: 765 LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVM 820
K+ADFGLSK+V + V GT GY PE + D++S G++
Sbjct: 188 APLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-22
Identities = 51/282 (18%), Positives = 90/282 (31%), Gaps = 30/282 (10%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGD-LQKLNILILAG 122
S T L L + L G LT+L L LS NG + L L L+
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS--LGKLSQLYWLDLADNQLTGSIPVS 180
G + L +L L +N ++ L L +LD++
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF-DGNQLSGNIPE-SLGY 238
+ L + + N +F+ ++ + L QL + +
Sbjct: 145 I-----FNGLSSLEVLKMAGNSFQENFLPDIFT-ELRNLTFLDLSQCQLE-QLSPTAFNS 197
Query: 239 VQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDL----KGPFPDLSQMNSLSYVDL 294
+ +L+VL + N L ++ L+ + N + K +SL++++L
Sbjct: 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP--SSLAFLNL 255
Query: 295 SNNSFDPTEAPLWFS--------TLPSLTTLICEF-GSLQGR 327
+ N F T F L + + C QG
Sbjct: 256 TQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 297
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 57/278 (20%), Positives = 96/278 (34%), Gaps = 47/278 (16%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
+P I + + L L SN +P KL+QL L L+ N L+ S
Sbjct: 22 VPTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS----FKGCCSQSD 74
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL-GYVQTLEVLR 246
+ K+ + N + T+S F L H+ F + L S+ ++ L L
Sbjct: 75 FGTTSLKYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLD 132
Query: 247 LDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD--LSQMNSLSYVDLSNNSFD--PT 302
+ N L+++ L +A N + F +++ +L+++DLS +
Sbjct: 133 ISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 192
Query: 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLL 362
A F++L SL L S++ L + L
Sbjct: 193 TA---FNSLSSLQVL--------------NMSHNNFFS--LDTFPYKCL--------NSL 225
Query: 363 QLVDLQNNQISAI---TLGSGIKN-YTLILVGNP-VCT 395
Q++D N I L + L L N CT
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 263
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 3e-22
Identities = 55/225 (24%), Positives = 93/225 (41%), Gaps = 37/225 (16%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHK 683
+ + +IG G YG V++ ++VA+KR + G+ EI LL + HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKR---RLRIALGSA----- 735
N+V L + LV+EF D K+ L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC---------------DQDLKKYFDSCNGDLDPEIVKSF 106
Query: 736 -----RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
+GL + H ++HRD+K N+L++ N K+A+FGL++ + S +V
Sbjct: 107 LFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEV 162
Query: 791 KGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
T+ Y P+ + + D++S G + EL A +P+ G
Sbjct: 163 V-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 48/198 (24%), Positives = 86/198 (43%), Gaps = 21/198 (10%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLV 689
E+G G + V + + S GQ A K + ++ E EI +L ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHL---DWKRRLRIALGSARGLAYLHELA 745
+E ++ L+ E+ A G + + D R ++ L G+ YLH+
Sbjct: 96 EV-YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE---GVYYLHQNN 151
Query: 746 NPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
I+H D+K NILL K+ DFG+S+ + + + + + GT YL PE
Sbjct: 152 ---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE--LREIM-GTPEYLAPEIL 205
Query: 803 MTQQLTEKSDVYSFGVVM 820
+T +D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 48/197 (24%), Positives = 78/197 (39%), Gaps = 25/197 (12%)
Query: 634 EIGSGGYGKVYRG-MLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
IG G +G+V A K+ + ++ FK EIE++ + H N++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 693 FEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+ + LV E G L + D R ++ L +AY H+L
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAARIMKDVLS---AVAYCHKLN- 126
Query: 747 PPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
+ HRD+K N L + K+ DFGL+ G + GT Y+ P+ +
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQ-VL 180
Query: 804 TQQLTEKSDVYSFGVVM 820
+ D +S GV+M
Sbjct: 181 EGLYGPECDEWSAGVMM 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 50/198 (25%), Positives = 90/198 (45%), Gaps = 26/198 (13%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
E+GSG +G V+R + + G+V K K EI +++++HH L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA- 116
Query: 693 FEQGEQM-LVYEFMANGTL-------RESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
FE +M L+ EF++ G L +S I+ +R A GL ++HE
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH 168
Query: 745 ANPPIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+ I+H D+K NI+ + + K+ DFGL+ ++ + T + PE
Sbjct: 169 S---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAEFAAPEIV 222
Query: 803 MTQQLTEKSDVYSFGVVM 820
+ + +D+++ GV+
Sbjct: 223 DREPVGFYTDMWAIGVLG 240
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 4e-22
Identities = 71/353 (20%), Positives = 122/353 (34%), Gaps = 105/353 (29%)
Query: 633 NEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSRV-HHKN 684
+G G +G+V + + VA+K ++G+ +E+++L + HH N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 685 LVGLVGFCFEQGEQ-MLVYEFMANGTLRESL---------------------SGRSGIHL 722
+V L+G C + G M++ EF G L L I +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 723 DWKRRLRIALGS----------ARGLAYLHELANPPIIHRDVKSTNILL----------- 761
D KRRL S + L+ + E P +++D + L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 762 -------------------DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD---- 798
E K+ DFGL++ + V+ L
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD-----PDYVRKGDARLPLKWM 262
Query: 799 -PEYYMTQQLTEKSDVYSFGVVMLELIT-AKQP---IEKGKYVVREVRTA--MNRDDEEH 851
PE + T +SDV+SFGV++ E+ + P ++ + R ++ M D
Sbjct: 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTT 322
Query: 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ + M L C + RPT SE+V+ + LLQ
Sbjct: 323 PEMYQTM-------------------LDCWHGEPSQRPTFSELVEHLGNLLQA 356
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 7e-22
Identities = 61/268 (22%), Positives = 103/268 (38%), Gaps = 47/268 (17%)
Query: 599 APSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK 657
P G L + E + + + +GSGG+G VY G+ +SD VAIK
Sbjct: 15 VPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIK 74
Query: 658 R------AQQGSMQGGLEFKTEIELLSRVHHK--NLVGLVGFCFEQGEQMLVYEF----- 704
+ G + G E+ LL +V ++ L+ + +L+ E
Sbjct: 75 HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQ 134
Query: 705 ------MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758
G L+E L+ R + A + + H ++HRD+K N
Sbjct: 135 DLFDFITERGALQEELA----------RSFFWQVLEA--VRHCHNCG---VLHRDIKDEN 179
Query: 759 ILLDEN-LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSF 816
IL+D N K+ DFG L+ D + GT Y PE+ + + V+S
Sbjct: 180 ILIDLNRGELKLIDFGSGALLKD---TVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSL 235
Query: 817 GVVMLELITAKQP------IEKGKYVVR 838
G+++ +++ P I +G+ R
Sbjct: 236 GILLYDMVCGDIPFEHDEEIIRGQVFFR 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 7e-22
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+G G YG+V + + VA+K + + K EI + ++H+N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI--KKEICINKMLNHENVVKFYG 72
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
E Q L E+ + G L + + G+ +R L + + YLH + I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHGIG---IT 127
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV-STQVKGTMGYLDPEYYMTQQLT- 808
HRD+K N+LLDE K++DFGL+ + +++ + + GT+ Y+ PE ++
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847
E DV+S G+V+ ++ + P ++ +E +
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-22
Identities = 62/225 (27%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT-EIELLSRVHHKNL 685
+++++ IG+G +G VY+ L D G++VAIK+ Q FK E++++ ++ H N+
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNI 109
Query: 686 VGLVGFCFEQGEQM------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS----- 734
V L F + GE+ LV +++ E++ + + + +
Sbjct: 110 VRLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRV--ARHYSRAKQTLPVIYVKLYM 162
Query: 735 ---ARGLAYLHELANPPIIHRDVKSTNILLDENLTA-KVADFGLSKLVSDSSKGHVSTQV 790
R LAY+H I HRD+K N+LLD + K+ DFG +K + +G +
Sbjct: 163 YQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL---VRGEPNVSY 216
Query: 791 KGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ Y PE T DV+S G V+ EL+ QPI G
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL-GQPIFPGD 260
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 1e-21
Identities = 51/255 (20%), Positives = 95/255 (37%), Gaps = 30/255 (11%)
Query: 581 QKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSE----SNEIG 636
+K+R + + + + + ++ ++ + E+G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 637 SGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 695
+G +G V+R + G A K + EI+ +S + H LV L FE
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA-FED 225
Query: 696 GEQM-LVYEFMANGTL-------RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+M ++YEFM+ G L +S + +R GL ++HE
Sbjct: 226 DNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQVCK---GLCHMHENN-- 275
Query: 748 PIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
+H D+K NI+ + K+ DFGL+ + GT + PE +
Sbjct: 276 -YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGK 331
Query: 806 QLTEKSDVYSFGVVM 820
+ +D++S GV+
Sbjct: 332 PVGYYTDMWSVGVLS 346
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-21
Identities = 60/226 (26%), Positives = 98/226 (43%), Gaps = 36/226 (15%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKT-EIELLSRVHHKN 684
++ IG+G +G V++ L + VAIK+ Q FK E++++ V H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPN 93
Query: 685 LVGLVGFCFEQGEQM------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS---- 734
+V L F + G++ LV E++ E++ K + + +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP-----ETVYRA--SRHYAKLKQTMPMLLIKLY 146
Query: 735 ----ARGLAYLHELANPPIIHRDVKSTNILLDENLTA-KVADFGLSKLVSDSSKGHVSTQ 789
R LAY+H + I HRD+K N+LLD K+ DFG +K++ G +
Sbjct: 147 MYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL---IAGEPNVS 200
Query: 790 VKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ Y PE T D++S G VM EL+ QP+ G+
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ-GQPLFPGE 245
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-21
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 26/204 (12%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
S++ +G G +G+V++ + G +A K + M+ E K EI +++++ H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTL-------RESLSGRSGIHLDWKRRLRIALGSARGL 738
L FE + LV E++ G L +L+ I ++ G+
Sbjct: 150 QLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILF-----MKQICE---GI 200
Query: 739 AYLHELANPPIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
++H++ I+H D+K NIL + K+ DFGL++ GT +
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVNFGTPEF 254
Query: 797 LDPEYYMTQQLTEKSDVYSFGVVM 820
L PE ++ +D++S GV+
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 41/209 (19%), Positives = 88/209 (42%), Gaps = 27/209 (12%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK----RAQQGSMQGGLEFKTEIELL 677
K+ + + ++G G +G V+R + S + K + + K EI +L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-----VKKEISIL 55
Query: 678 SRVHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHL---DWKRRLRIALG 733
+ H+N++ L FE E++ +++EF++ + E ++ L + +
Sbjct: 56 NIARHRNILHLHES-FESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCE 113
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
L +LH I H D++ NI+ + T K+ +FG ++ + G +
Sbjct: 114 ---ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLF 164
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVM 820
Y PE + ++ +D++S G ++
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 2e-21
Identities = 50/237 (21%), Positives = 102/237 (43%), Gaps = 20/237 (8%)
Query: 609 PQLKGARWFSYDELKKCSN--NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQ 665
Q +G S ++ + ++G G YG+VY+ + + VAIKR + +
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73
Query: 666 GGLEFKT--EIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLD 723
G+ E+ LL + H+N++ L L++E+ N L++ + + +
Sbjct: 74 EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMR 132
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA-----KVADFGLSKLV 778
+ L G+ + H +HRD+K N+LL + + K+ DFGL++
Sbjct: 133 VIKSFLYQL--INGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
Query: 779 SDSSKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ + ++ T+ Y PE + ++ + D++S + E++ K P+ G
Sbjct: 188 GIPIRQF-THEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPLFPGD 241
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.1 bits (235), Expect = 3e-21
Identities = 52/212 (24%), Positives = 100/212 (47%), Gaps = 13/212 (6%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHKN 684
+ +IG G YG VY+ + G+ A+K+ + G+ T EI +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHLDWKRRLRIALGSARGLAYLHE 743
+V L + +LV+E + L++ L G+ + + L G+AY H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL--LNGIAYCHD 118
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
++HRD+K N+L++ K+ADFGL++ + + ++ T+ Y P+ M
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIV-TLWYRAPDVLM 173
Query: 804 -TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+++ + D++S G + E++ P+ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGV 204
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 3e-21
Identities = 63/271 (23%), Positives = 94/271 (34%), Gaps = 45/271 (16%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
+PD I L L+ N I S L L L L+ N + TI
Sbjct: 58 VPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHI------RTIEIGAF 108
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL-GYVQTLEVLR 246
+ L N N+L+ TI F L + N + +IP + +L L
Sbjct: 109 NGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLD 166
Query: 247 LDR-NALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304
L L+ + L+N+ LNLA +L+ P+L+ + L +DLS N
Sbjct: 167 LGELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIR- 223
Query: 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQL 364
P F L L L SQIQ + NAF+N L
Sbjct: 224 PGSFQGLMHLQKL--------------WMIQSQIQVI--ERNAFDNL--------QSLVE 259
Query: 365 VDLQNNQISAI---TLGSGIKNYTLILVGNP 392
++L +N ++ + + L NP
Sbjct: 260 INLAHNNLTLLPHDLFTPLHHLERIHLHHNP 290
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 64/272 (23%), Positives = 101/272 (37%), Gaps = 53/272 (19%)
Query: 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSN 147
T R L+L N I I+ F +L L L L+ N
Sbjct: 64 TNTRLLNLHEN-----------------QIQIIKVNSFK--------HLRHLEILQLSRN 98
Query: 148 NFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT 206
+ I + L+ L L+L DN+LT +IP L +L K N + +
Sbjct: 99 HIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV--YLSKL---KELWLRNNPIE-S 150
Query: 207 ISEQLFSPDMVLIH-VLFDGNQLSGNIPE-SLGYVQTLEVLRLDRNALTGKVPTNLNNLT 264
I F+ L L + +LS I E + + L L L L ++P L L
Sbjct: 151 IPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLI 207
Query: 265 NVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD--PTEAPLWFSTLPSLTTLI 318
++EL+L+ N L G F L L + + + A F L SL +
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLM---HLQKLWMIQSQIQVIERNA---FDNLQSLVEIN 261
Query: 319 CEFGSLQGRVPDKLFSY-SQIQQVKLRNNAFN 349
+L +P LF+ ++++ L +N +N
Sbjct: 262 LAHNNLT-LLPHDLFTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 57/258 (22%), Positives = 96/258 (37%), Gaps = 29/258 (11%)
Query: 59 VTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSP 107
V C + L L + L L L LS N + ++
Sbjct: 48 VICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-HIR-TIEI 105
Query: 108 RI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPPSL-GKLSQLY 164
L LN L L T IP+ L++L L L +N IP ++ L
Sbjct: 106 GAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163
Query: 165 WLDLAD-NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223
LDL + +L+ I + L N ++ + L +P + L +
Sbjct: 164 RLDLGELKRLS-YISEGA-----FEGLSNLRYLNLAMCNLR---EIPNLTPLIKLDELDL 214
Query: 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPD 282
GN LS P S + L+ L + ++ + +NL ++ E+NLAHN+L P
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDL 274
Query: 283 LSQMNSLSYVDLSNNSFD 300
+ ++ L + L +N ++
Sbjct: 275 FTPLHHLERIHLHHNPWN 292
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 56/235 (23%), Positives = 90/235 (38%), Gaps = 49/235 (20%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKR------AQQGSMQGGLEFKTEIELLSRVH----H 682
+G GG+G V+ G L+D VAIK + + E+ LL +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 683 KNLVGLVGFCFEQGEQMLVYEF-----------MANGTLRESLSGRSGIHLDWKRRLRIA 731
++ L+ + Q MLV E G L E S R
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS----------RCFFGQ 147
Query: 732 LGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQV 790
+ +A + + H ++HRD+K NIL+D AK+ DFG L+ D +
Sbjct: 148 VVAA--IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFD 199
Query: 791 KGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQP------IEKGKYVVR 838
GT Y PE+ Q + V+S G+++ +++ P I + +
Sbjct: 200 -GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFP 253
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 4e-21
Identities = 59/250 (23%), Positives = 110/250 (44%), Gaps = 34/250 (13%)
Query: 593 KPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSD-G 651
PFA + S + + +W + N F + +G GG+G+V + G
Sbjct: 156 APFADYLDSIYFN------RFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATG 209
Query: 652 QVVAIKRAQQGS--MQGGLEF-KTEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMAN 707
++ A K+ ++ + G E ++L +V+ + +V L + +E + + LV M
Sbjct: 210 KMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNG 268
Query: 708 GTLRESLSGRSGIHLDWKRRLRIALGSAR--------GLAYLHELANPPIIHRDVKSTNI 759
G L+ H+ + A GL LH I++RD+K NI
Sbjct: 269 GDLK--------FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENI 317
Query: 760 LLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVV 819
LLD++ +++D GL+ V + + +V GT+GY+ PE ++ T D ++ G +
Sbjct: 318 LLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCL 374
Query: 820 MLELITAKQP 829
+ E+I + P
Sbjct: 375 LYEMIAGQSP 384
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 55/219 (25%), Positives = 101/219 (46%), Gaps = 14/219 (6%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+G G YG+V + + VA+K + + K EI + ++H+N+V G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI--KKEICINKMLNHENVVKFYG 72
Query: 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPII 750
E Q L E+ + G L + + G+ +R L + + YLH + I
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAG--VVYLHGIG---IT 127
Query: 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV-STQVKGTMGYLDPEYYMTQQLT- 808
HRD+K N+LLDE K++DFGL+ + +++ + + GT+ Y+ PE ++
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 809 EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847
E DV+S G+V+ ++ + P ++ +E +
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 14/224 (6%)
Query: 612 KGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF 670
G + + + + +G G YG V + G++VAIK+ + ++
Sbjct: 10 SGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK 69
Query: 671 KT--EIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESL-SGRSGIHLDWKRR 727
EI+LL ++ H+NLV L+ C ++ LV+EF+ + T+ + L +G+ ++
Sbjct: 70 IAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQK 128
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
+ G+ + H IIHRD+K NIL+ ++ K+ DFG ++ + ++ G V
Sbjct: 129 YLFQI--INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVY 181
Query: 788 TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPI 830
T Y PE + + + DV++ G ++ E+ +P+
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPL 224
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 8e-21
Identities = 54/226 (23%), Positives = 86/226 (38%), Gaps = 37/226 (16%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--------RAQQGSMQGGLEFKTEIELLSRVHHKNL 685
+GSG +G V+ + + V +K + EI +LSRV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 686 VGLVGFCFEQGEQMLVYEFMANGT-LRESLSGRSGIHLDWKRRLRIALGS------ARGL 738
+ ++ QG LV E +G L +D RL L S +
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFA--------FIDRHPRLDEPLASYIFRQLVSAV 143
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
YL IIHRD+K NI++ E+ T K+ DFG + + + GT+ Y
Sbjct: 144 GYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCA 197
Query: 799 PEYYMTQQLT-EKSDVYSFGVVMLELITAKQP------IEKGKYVV 837
PE M + +++S GV + L+ + P +
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHP 243
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 8e-21
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT--EIELLSRVHHK 683
+ + +IG G YG V++ GQ+VAIK+ + ++ EI +L ++ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
NLV L+ + LV+E+ + T+ L R + I + + + + H+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELD-RYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE--- 800
IHRDVK NIL+ ++ K+ DFG ++L++ S + +V T Y PE
Sbjct: 121 HN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-DDEV-ATRWYRSPELLV 175
Query: 801 ---YYMTQQLTEKSDVYSFGVVMLELITAKQPI 830
Y DV++ G V EL++ P+
Sbjct: 176 GDTQYGPP-----VDVWAIGCVFAELLS-GVPL 202
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 25/202 (12%), Positives = 57/202 (28%), Gaps = 44/202 (21%)
Query: 634 EIGSGGYGKVYRGMLSD---GQVVAIK--RAQQGSMQGGLE-FKTEIELLSRVHHKNLVG 687
G + ++ + D + VA+ Q L+ + LSR+ +
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
++ + ++V E++ G+L+E +R A H
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
+ + + + + +A TM +P+
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYP-------------------ATMPDANPQ------- 182
Query: 808 TEKSDVYSFGVVMLELITAKQP 829
D+ G + L+ + P
Sbjct: 183 ---DDIRGIGASLYALLVNRWP 201
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 58/273 (21%), Positives = 92/273 (33%), Gaps = 49/273 (17%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
+P I + +L L NN I + L L L L N + I V
Sbjct: 69 VPQGI--PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIR-QIEVGA-----F 119
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF-DGNQLSGNIPE-SLGYVQTLEVL 245
+ L + N L+ I F + + L+ N + +IP + V +L L
Sbjct: 120 NGLASLNTLELFDNWLT-VIPSGAFE-YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176
Query: 246 RLDR-NALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD--PT 302
L L L N+ LNL ++K P+L+ + L +++S N F
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIRP 235
Query: 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLL 362
+ F L SL L SQ+ + NAF+ L
Sbjct: 236 GS---FHGLSSLKKL--------------WVMNSQVSLI--ERNAFDGL--------ASL 268
Query: 363 QLVDLQNNQISAI---TLGSGIKNYTLILVGNP 392
++L +N +S++ L L NP
Sbjct: 269 VELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 59/277 (21%), Positives = 97/277 (35%), Gaps = 26/277 (9%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
S L L + + L L L L N + + L LN L L
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS-IR-QIEVGAFNGLASLNTLELFD 132
Query: 123 CGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLAD-NQLTGSIPV 179
T IP L++L L L +N IP + ++ L LDL + +L I
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLE-YISE 189
Query: 180 STITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
+ L N K+ + + +P + L + GN P S +
Sbjct: 190 GA-----FEGLFNLKYLNLGMCNIK---DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGL 241
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNS 298
+L+ L + + ++ + L ++ ELNLAHN+L P + + L + L +N
Sbjct: 242 SSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNP 301
Query: 299 F--DPTEAPLW-----FSTLPSLTTLICEF-GSLQGR 327
+ D L + S C ++GR
Sbjct: 302 WNCDCDILWLAWWLREYIPTNSTCCGRCHAPMHMRGR 338
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 41/227 (18%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRG-MLSDGQVVAIK---------RAQQGSMQGGLEFKT 672
KK +F +G G + V L+ + AIK + +
Sbjct: 26 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYV------TR 79
Query: 673 EIELLSRVHHKNLVGLVGFCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLRI 730
E +++SR+ H V L F F Q ++ L + NG E L ++ ++
Sbjct: 80 ERDVMSRLDHPFFVKLY-FTF-QDDEKLYFGLSYAKNG---ELLK-----YI--RKIGSF 127
Query: 731 ALGSAR--------GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782
R L YLH IIHRD+K NILL+E++ ++ DFG +K++S S
Sbjct: 128 DETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184
Query: 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
K + GT Y+ PE + + SD+++ G ++ +L+ P
Sbjct: 185 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-20
Identities = 62/240 (25%), Positives = 112/240 (46%), Gaps = 28/240 (11%)
Query: 614 ARWFSYDELKKCS--NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF 670
A+ + E C + + + +IG G +G+V++ GQ VA+K+ + + G
Sbjct: 2 AKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI 61
Query: 671 KT--EIELLSRVHHKNLVGLVGFCFEQGEQM--------LVYEFMAN---GTLRESLSGR 717
EI++L + H+N+V L+ C + LV++F + G L L
Sbjct: 62 TALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKF 121
Query: 718 SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777
+ + KR +++ L GL Y+H I+HRD+K+ N+L+ + K+ADFGL++
Sbjct: 122 TLSEI--KRVMQMLL---NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA 173
Query: 778 VSDSSKGHVS--TQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
S + + T T+ Y PE + + D++ G +M E+ T + PI +G
Sbjct: 174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGN 232
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 64/229 (27%), Positives = 88/229 (38%), Gaps = 48/229 (20%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLE--FKT---------EIELLSRVHH 682
I SG YG V G+ S+G VAIKR G EI LL+ HH
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 683 KNLVGLVG-FCFEQGEQM----LVYEFMA---NGTLRESLSGRSGIH--------LDWKR 726
N++GL F + M LV E M + + S H L
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHIL---- 144
Query: 727 RLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786
GL LHE A ++HRD+ NILL +N + DF L++ + +
Sbjct: 145 ---------LGLHVLHE-AG--VVHRDLHPGNILLADNNDITICDFNLAREDTADAN--- 189
Query: 787 STQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
T Y PE M + T+ D++S G VM E+ K + +G
Sbjct: 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGS 237
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 6e-20
Identities = 57/250 (22%), Positives = 107/250 (42%), Gaps = 31/250 (12%)
Query: 593 KPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSD-G 651
PF + S + +W + + F + +G GG+G+V+ + G
Sbjct: 157 APFQEFLDSLYFL------RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATG 210
Query: 652 QVVAIKRAQQGS--MQGGLEF-KTEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMAN 707
++ A K+ + + G + E ++L++VH + +V L + FE + LV M
Sbjct: 211 KLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNG 269
Query: 708 GTLRESLSGRSGIHLDWKRRLRIALGSAR--------GLAYLHELANPPIIHRDVKSTNI 759
G +R I+ + A GL +LH+ II+RD+K N+
Sbjct: 270 GDIR------YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENV 320
Query: 760 LLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVV 819
LLD++ +++D GL+ + GT G++ PE + ++ D ++ GV
Sbjct: 321 LLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVT 378
Query: 820 MLELITAKQP 829
+ E+I A+ P
Sbjct: 379 LYEMIAARGP 388
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 1e-19
Identities = 61/226 (26%), Positives = 96/226 (42%), Gaps = 22/226 (9%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEF--KT---EIEL 676
++ + EIG G YG VY+ G VA+K + + GG + E+ L
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 677 L---SRVHHKNLVGL----VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRL 728
L H N+V L ++ ++ LV+E + LR L L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
+ RGL +LH I+HRD+K NIL+ T K+ADFGL+++ S T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LT 177
Query: 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
V T+ Y PE + D++S G + E+ ++P+ G
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGN 222
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 55/233 (23%), Positives = 94/233 (40%), Gaps = 37/233 (15%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT----EIELL 677
+K + F G G +G V G G VAIK+ Q F+ ++ L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQIMQDL 73
Query: 678 SRVHHKNLVGLVGFCFEQGEQ-------MLVYEFMANGTLRESLSGRSGIHLDWKRRLRI 730
+ +HH N+V L + + GE+ +V E++ ++L + +
Sbjct: 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPP 128
Query: 731 ALGS------ARGLAYLHEL-ANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSS 782
L R + LH N + HRD+K N+L++ + T K+ DFG +K + S
Sbjct: 129 ILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL---S 183
Query: 783 KGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ + Y PE Q T D++S G + E++ +PI +G
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGD 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 23/196 (11%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC 692
+G G GKV GQ A+K + + + E++ + ++V ++
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALK-----LLYDSPKARQEVDHHWQASGGPHIVCILDV- 90
Query: 693 FEQGEQM-----LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
+E ++ E M G L + R + I + +LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN-- 148
Query: 748 PIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
I HRDVK N+L +++ K+ DFG +K + + T T Y+ PE
Sbjct: 149 -IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ---NALQTPC-YTPYYVAPEVLGP 203
Query: 805 QQLTEKSDVYSFGVVM 820
++ + D++S GV+M
Sbjct: 204 EKYDKSCDMWSLGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 58/255 (22%), Positives = 91/255 (35%), Gaps = 68/255 (26%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK------------------------RAQQGSMQGGL 668
EIG G YG V +D A+K G
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 669 EFKT--EIELLSRVHHKNLVGL--VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDW 724
+ EI +L ++ H N+V L V + +V+E + G + E +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--------- 130
Query: 725 KRRLRIALGSAR--------GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776
+ L AR G+ YLH IIHRD+K +N+L+ E+ K+ADFG+S
Sbjct: 131 LKPLSEDQ--ARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT---EKSDVYSFGVVMLELITAKQP---- 829
S +S V GT ++ PE + + DV++ GV + + + P
Sbjct: 186 EFKGSD-ALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243
Query: 830 --------IEKGKYV 836
I+
Sbjct: 244 RIMCLHSKIKSQALE 258
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-19
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 41/234 (17%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR---AQQGSMQGGLEFKT--EI 674
++K + + + + +G G + VY+ + Q+VAIK+ + + G+ EI
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 675 ELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKR---RLRIA 731
+LL + H N++GL+ + LV++FM D + +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM---------------ETDLEVIIKDNSLV 108
Query: 732 LGSA----------RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781
L + +GL YLH+ I+HRD+K N+LLDEN K+ADFGL+K
Sbjct: 109 LTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 165
Query: 782 SKGHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
++ + + QV T Y PE + D+++ G ++ EL+ + P G
Sbjct: 166 NRAY-THQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGD 216
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 61/362 (16%), Positives = 106/362 (29%), Gaps = 75/362 (20%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGD-LQKLNILILAGCG 124
V + LS + L +L+ L + + L L IL L
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQ-TPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 125 FTGNIPDEI-GNLAELSFLALNSNNF-SGRIPP-SLGKLSQLYWLDLADNQLTGSIPVST 181
F + LA L L L N + L+ L L L DN + I ++
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPAS 148
Query: 182 ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFS--PDMVLIHVLFDGNQLSGNIPESLGYV 239
++ NK+ +I E+ + L
Sbjct: 149 F----FLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITL----------- 192
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLS 295
++ L + N T++ L+L+ N K F D + + LS
Sbjct: 193 -----QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 296 NNSF-----------DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF----------- 333
N+ DP + T + + +F
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTL 306
Query: 334 SYSQIQQVKLRNNAFNN-----TLDM-GNAVGPL----------LQLVDLQNNQISAITL 377
+ ++I K+ +NAF L++ N +G + L+++DL N I A+
Sbjct: 307 AQNEIN--KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGD 364
Query: 378 GS 379
S
Sbjct: 365 QS 366
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-17
Identities = 56/343 (16%), Positives = 108/343 (31%), Gaps = 66/343 (19%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLA 143
GL L L L+ LS L L +L+L P N+ L
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160
Query: 144 LNSNNFSGRIPP----SLGKLSQLYWLDLADNQLT--GSIPVSTITSPGLDQLKNAKHFH 197
L N I + L L+ L + + +
Sbjct: 161 LTFNKVK-SICEEDLLNFQGK-HFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLD 218
Query: 198 FNKNKLSGTISEQLFS-------PDMVLIHVLFDGNQLSGNIPESLG-------YVQTLE 243
+ N +++++ F ++L + G+ + ++
Sbjct: 219 LSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVK 278
Query: 244 VLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNS 298
L ++ + + ++ ++ T++ +L LA N++ F L+ + L +LS N
Sbjct: 279 TCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKL---NLSQNF 334
Query: 299 FD--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGN 356
+ F L L L L SY+ I+ L + +F
Sbjct: 335 LGSIDSRM---FENLDKLEVL-----DL---------SYNHIRA--LGDQSFLGL----- 370
Query: 357 AVGPLLQLVDLQNNQISAITLG--SGIKN-YTLILVGNP-VCT 395
P L+ + L NQ+ ++ G + + + L NP C+
Sbjct: 371 ---PNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-14
Identities = 37/268 (13%), Positives = 87/268 (32%), Gaps = 36/268 (13%)
Query: 137 AELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195
A ++++ L+ N+ + + S +L L +L + I +T L +
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNT-----FRGLSSLII 83
Query: 196 FHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL-SGNIPE-SLGYVQTLEVLRLDRNALT 253
+ N+ + F+ L + L + + +LE+L L N +
Sbjct: 84 LKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 254 GKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLS---------QMNSLSYVDLSNNSF 299
P + N+ + L+L N +K + +L ++ +
Sbjct: 143 KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGW 202
Query: 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359
+ P +++ +L F + + ++IQ + L N+ +
Sbjct: 203 EKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFK 262
Query: 360 PL------------LQLVDLQNNQISAI 375
++ DL ++I A+
Sbjct: 263 DPDNFTFKGLEASGVKTCDLSKSKIFAL 290
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-13
Identities = 49/239 (20%), Positives = 89/239 (37%), Gaps = 30/239 (12%)
Query: 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN 128
++ L + G+ T + +LDLS NG S++ R D + N
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNG-FKESMAKRFFDAIAGTKIQSLILS---N 248
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
+ + +F ++ F G + S + DL+ +++ ++ S
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGL------EASGVKTCDLSKSKIF-ALLKSV-----FS 296
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL--GYVQTLEVLR 246
+ + +N+++ I + F L+ + N L +I + + LEVL
Sbjct: 297 HFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDK-LEVLD 353
Query: 247 LDRNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
L N + + L N+ EL L N LK G F L+ SL + L N +D
Sbjct: 354 LSYNHIRA-LGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLT---SLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 34/142 (23%), Positives = 51/142 (35%), Gaps = 13/142 (9%)
Query: 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGD-LQKLNILILA 121
S V LS + L T+L L L+ N + + L L L L+
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNE-IN-KIDDNAFWGLTHLLKLNLS 331
Query: 122 GCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPV 179
+I + NL +L L L+ N+ + S L L L L NQL S+P
Sbjct: 332 QNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD 388
Query: 180 STITSPGLDQLKNAKHFHFNKN 201
D+L + + + N
Sbjct: 389 GI-----FDRLTSLQKIWLHTN 405
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 49/216 (22%), Positives = 84/216 (38%), Gaps = 33/216 (15%)
Query: 621 ELKKCSNNFSE----SNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIE 675
+L + S F++ +IG G Y R + + A+K + EIE
Sbjct: 12 QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIE 67
Query: 676 LLSR-VHHKNLVGLVGFCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRL 728
+L R H N++ L + +V E M G L ++ S R + L
Sbjct: 68 ILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EASAVL 122
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTA-KVADFGLSKLVSDSSKG 784
+ YLH ++HRD+K +NIL N + ++ DFG +K + +
Sbjct: 123 FTITK---TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA--EN 174
Query: 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVM 820
+ T ++ PE Q D++S GV++
Sbjct: 175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 38/226 (16%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
IG G + KV + G+ VAIK + S+Q + E+ ++ ++H N+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILNHPNIVKL 79
Query: 689 VGFCFE--QGEQM--LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
FE + E+ L+ E+ + G + + L + R + SA + Y H+
Sbjct: 80 ----FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCHQK 133
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
I+HRD+K+ N+LLD ++ K+ADFG S + G + G Y PE +
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFC-GAPPYAAPELFQG 187
Query: 805 QQLT-EKSDVYSFGVVMLELITAKQP------------IEKGKYVV 837
++ + DV+S GV++ L++ P + +GKY +
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRI 233
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-19
Identities = 52/248 (20%), Positives = 91/248 (36%), Gaps = 20/248 (8%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIG-----GLTELRSLDLSYNGGLTGSLSPRIGDLQKLN 116
++ V +S + L G+L L L + + S +N
Sbjct: 245 WHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDV-FGFPQSYIYEIFSNMN 303
Query: 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGS 176
I G ++ L ++N + + + G L++L L L NQL
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-E 362
Query: 177 IPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL 236
+ + Q+K+ + ++N +S + S L+ + N L+ I L
Sbjct: 363 LS---KIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 237 GYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYV 292
++VL L N + +P + L + ELN+A N LK G F L+ SL +
Sbjct: 420 P--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLT---SLQKI 473
Query: 293 DLSNNSFD 300
L N +D
Sbjct: 474 WLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-16
Identities = 56/294 (19%), Positives = 106/294 (36%), Gaps = 23/294 (7%)
Query: 116 NILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKL---SQLYWLDLADNQ 172
+L C + +I ++ +LS L LN+ + + +L + +++ +++ +
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
Query: 173 LTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL-FDGNQLSGN 231
L G + G LK + ++ +++ F +
Sbjct: 259 LQGQLDFRDFDYSGT-SLKALSIHQVVSDVFG-FPQSYIYE-IFSNMNIKNFTVSGTRMV 315
Query: 232 IPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK------GPFPDLSQ 285
+ L N LT V N +LT + L L N LK +Q
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMT---TQ 372
Query: 286 MNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRN 345
M SL +D+S NS E S SL +L L + L +I+ + L +
Sbjct: 373 MKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHS 430
Query: 346 NAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS--GIKNYTLI-LVGNP-VCT 395
N ++ LQ +++ +NQ+ ++ G + + I L NP C+
Sbjct: 431 NKI-KSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 483
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 1e-14
Identities = 63/337 (18%), Positives = 117/337 (34%), Gaps = 37/337 (10%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAG 122
+ T L +S ++ + DI L++LR L +S+N + L + Q+L L L+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHN-RIQ-YLDISVFKFNQELEYLDLSH 78
Query: 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS--LGKLSQLYWLDLADNQLTGSIPVS 180
I L L L+ N F +P G +SQL +L L+ L V
Sbjct: 79 NKLV-KIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE-KSSVL 133
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLGYV 239
I + ++ + E L + +H++F N+ I + S+ V
Sbjct: 134 PIAHLNISKV----LLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTV 189
Query: 240 QTLEVLRLDRNALTGKVPTNLNNL----TNVNELNLAHNDLKGPFPDLSQM------NSL 289
LE+ + K L+ L TN NL N+++ + ++ ++
Sbjct: 190 ANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTV 249
Query: 290 SYVDLSNNSFDP----TEAPLWFSTLPSLTTL---ICEFGSLQGRVPDKLFSYSQIQQVK 342
Y +SN + ++L +L+ FG Q + + S +
Sbjct: 250 WYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF---SNMNIKN 306
Query: 343 LRNNAFNNTLDMGNAVGPL-LQLVDLQNNQISAITLG 378
+ + M +D NN ++
Sbjct: 307 FTVSG-TRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 37/175 (21%), Positives = 64/175 (36%), Gaps = 16/175 (9%)
Query: 58 GVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIG---DLQK 114
S L S LT + + G LTEL +L L N L LS ++
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMN-QLK-ELSKIAEMTTQMKS 375
Query: 115 LNILILAGCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQL 173
L L ++ + + L L ++SN + I L ++ LDL N++
Sbjct: 376 LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKI 433
Query: 174 TGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228
SIP + +L+ + + N+L ++ + +F L + N
Sbjct: 434 K-SIP------KQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 22/142 (15%), Positives = 49/142 (34%), Gaps = 32/142 (22%)
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSF 299
+L + +N ++ +++ +L+ + L ++HN ++ L Y+DLS+N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359
+ +L L L NAF+ L + G
Sbjct: 82 --VKIS--CHPTVNLKHL------------------------DLSFNAFD-ALPICKEFG 112
Query: 360 PL--LQLVDLQNNQISAITLGS 379
+ L+ + L + ++
Sbjct: 113 NMSQLKFLGLSTTHLEKSSVLP 134
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-19
Identities = 59/227 (25%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 620 DELKKCSNNFSESNEIGSGGYGKVYRG--MLSDGQVVAIKRAQQGSMQGGLEFKT--EIE 675
D L + + EIG G YGKV++ + + G+ VA+KR + + + G+ T E+
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 676 LL---SRVHHKNLVGL----VGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRR 727
+L H N+V L ++ ++ LV+E + + L L + +
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETI 122
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
+ RGL +LH ++HRD+K NIL+ + K+ADFGL+++ S
Sbjct: 123 KDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---L 176
Query: 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
T V T+ Y PE + D++S G + E+ ++P+ +G
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGS 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 44/201 (21%), Positives = 81/201 (40%), Gaps = 33/201 (16%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRV-HHKNLVGL 688
+G G + + + Q A+K + + + Q EI L H N+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ------KEITALKLCEGHPNIVKL 71
Query: 689 VGFCFEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
+Q LV E + G L ++ S ++ +R + ++++H
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-----MRKLVS---AVSHMH 123
Query: 743 ELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
++ ++HRD+K N+L ++NL K+ DFG ++L T+ Y P
Sbjct: 124 DVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFTLHYAAP 178
Query: 800 EYYMTQQLTEKSDVYSFGVVM 820
E E D++S GV++
Sbjct: 179 ELLNQNGYDESCDLWSLGVIL 199
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 57/232 (24%), Positives = 98/232 (42%), Gaps = 53/232 (22%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G G +GKV G G VA+K + + + G + K EI+ L H +++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKI--KREIQNLKLFRHPHIIKL 76
Query: 689 VGFCFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR-------- 736
++ + +V E+++ G L + ++ R+ AR
Sbjct: 77 ----YQVISTPTDFFMVMEYVSGGELFD--------YICKHGRVEEM--EARRLFQQILS 122
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
+ Y H ++HRD+K N+LLD ++ AK+ADFGLS ++SD S G+ Y
Sbjct: 123 AVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNY 176
Query: 797 LDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE + + D++S GV++ L+ P I G +
Sbjct: 177 AAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVF 228
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 6e-19
Identities = 33/198 (16%), Positives = 72/198 (36%), Gaps = 29/198 (14%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
NIPD L ++ + + +++ L ++ LA+ +T +T G+
Sbjct: 16 NIPDS--TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT------DLT--GI 62
Query: 188 DQLKNAKHFHFNKNKLSGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
+ N K N + + L + L + G ++ + +L + +L +L
Sbjct: 63 EYAHNIKDLTINNIHAT-NYNPISGLSN----LERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 246 RLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN---SFDPT 302
+ +A + T +N L VN ++L++N L + L +++ + +
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHDYRG- 176
Query: 303 EAPLWFSTLPSLTTLICE 320
P L L
Sbjct: 177 -----IEDFPKLNQLYAF 189
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 4e-14
Identities = 27/139 (19%), Positives = 54/139 (38%), Gaps = 12/139 (8%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
+T + L+ + +T L+G I ++ L ++ T + +P I L L L + G
Sbjct: 46 LTYITLANINVT-DLTG-IEYAHNIKDLTINNIH-AT-NYNP-ISGLSNLERLRIMGKDV 100
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
T + + L L+ L ++ + I + L ++ +DL+ N I
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-------M 153
Query: 186 GLDQLKNAKHFHFNKNKLS 204
L L K + + +
Sbjct: 154 PLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-13
Identities = 28/191 (14%), Positives = 57/191 (29%), Gaps = 39/191 (20%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
+ L + L+ +T L+ I + L + T N + I L+ L L
Sbjct: 40 EAQMNSLTYITLANIN-VT-DLTG-IEYAHNIKDLTINNIHAT-NY-NPISGLSNLERLR 94
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
+ + + P+L L+ L LD++ + SI ++ L + N
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSIL------TKINTLPKVNSIDLSYNGA 148
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL 263
I L + L+ L + + + + +
Sbjct: 149 ITDIM--------------------------PLKTLPELKSLNIQFDGVHD--YRGIEDF 180
Query: 264 TNVNELNLAHN 274
+N+L
Sbjct: 181 PKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 4/114 (3%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
S + L + +T ++ GLT L LD+S++ S+ +I L K+N + L+
Sbjct: 86 GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHS-AHDDSILTKINTLPKVNSIDLS 144
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTG 175
G +I + L EL L + + + +L L + G
Sbjct: 145 YNGAITDI-MPLKTLPELKSLNIQFDGVHD-YRG-IEDFPKLNQLYAFSQTIGG 195
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 6e-19
Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 24/210 (11%)
Query: 635 IGSGGYGKVY--RGMLSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLV 689
IG G + +V + M GQV A+K + M E F+ E ++L + + L
Sbjct: 69 IGRGAFSEVAVVK-MKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKR-RLRIA-LGSARGLAYLHELAN 746
F F+ + LV E+ G L LS + G + + R +A + A + +H L
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMARFYLAEIVMA--IDSVHRLG- 182
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+HRD+K NILLD ++ADFG + V GT YL PE
Sbjct: 183 --YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVG 239
Query: 807 LTEKSDVY-------SFGVVMLELITAKQP 829
+ Y + GV E+ + P
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 60/218 (27%), Positives = 107/218 (49%), Gaps = 18/218 (8%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQG----GLEFKTEIELLSRV 680
S+ F + ++G+G Y VY+G+ + G VA+K + S +G + EI L+ +
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKEL 60
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMAN---GTLRESLSGRSGIHLDWKRRLRIALGSARG 737
H+N+V L + + LV+EFM N + G + L+ +G
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
LA+ HE I+HRD+K N+L+++ K+ DFGL++ S++V T+ Y
Sbjct: 121 LAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN-TFSSEVV-TLWYR 175
Query: 798 DPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
P+ M ++ + D++S G ++ E+IT +P+ G
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMIT-GKPLFPGT 212
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 7e-19
Identities = 43/249 (17%), Positives = 83/249 (33%), Gaps = 17/249 (6%)
Query: 62 NNSRVTALGLSTMGLTGKLSGD---IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNI- 117
+ + L + + ++ + G++ L+ L L +TG+ P + + ++
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLE-VTGTAPPPLLEATGPDLN 124
Query: 118 -LILAGCGFTG--NIPDEIGNLAELSFLALN-SNNFSGRIP-PSLGKLSQLYWLDLADNQ 172
L L + E+ + L+ + S + L LDL+DN
Sbjct: 125 ILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP 184
Query: 173 LTGSIPVSTITSPG-LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN 231
G + + P L+ + SG S + L + N L
Sbjct: 185 ELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQ-LQGLDLSHNSLRDA 243
Query: 232 IPESL-GYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLS 290
+ L L L L +VP L ++ L+L++N L P ++ +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLDR-NPSPDELPQVG 299
Query: 291 YVDLSNNSF 299
+ L N F
Sbjct: 300 NLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 7e-16
Identities = 43/276 (15%), Positives = 78/276 (28%), Gaps = 46/276 (16%)
Query: 132 EIGNLAELSFLALNSNNFSGRIPPSLGKL---SQLYWLDLADNQLTGSIPVSTITSPGLD 188
+I L L + + RI ++ S L L L + ++TG+ P
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP----LLEA 118
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL---FDGNQLSGNIPESLGYVQTLEVL 245
+ + + + + + E + L L
Sbjct: 119 TGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178
Query: 246 RLDRNALTGKVP----TNLNNLTNVNELNLAHNDLKGPFPDLSQ----MNSLSYVDLSNN 297
L N G+ + L L + ++ P S L +DLS+N
Sbjct: 179 DLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNA 357
S L +L +L S++ ++QV
Sbjct: 239 SLRDAAGAPSCDWPSQLNSL-----NL---------SFTGLKQVP-------------KG 271
Query: 358 VGPLLQLVDLQNNQISAITLGSGIKN-YTLILVGNP 392
+ L ++DL N++ + L L GNP
Sbjct: 272 LPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLKGNP 307
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 43/227 (18%), Positives = 67/227 (29%), Gaps = 17/227 (7%)
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLT--ELRSLDLSYNGGLT-GSLSPRIGDLQKLNI- 117
S + L L + +TG + T +L L+L T + + K +
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 118 -LILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS----LGKLSQLYWLDLADNQ 172
L +A +++ LS L L+ N G K L L L +
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 173 LTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNI 232
+ S + S + + N L L + L +
Sbjct: 213 MET---PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-V 268
Query: 233 PESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGP 279
P+ L L VL L N L P+ L V L+L N
Sbjct: 269 PKGLP--AKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 26/168 (15%), Positives = 59/168 (35%), Gaps = 18/168 (10%)
Query: 227 QLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN--------LNNLTNVNELNLAHNDLKG 278
+ + + ++ L L R + + + ++ + EL L + ++ G
Sbjct: 50 KRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG 109
Query: 279 PFPD---LSQMNSLSYVDLSNNS---FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKL 332
P + L+ ++L N S D A L P L L +++
Sbjct: 110 TAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQV 169
Query: 333 FSYSQIQQVKLRNNAFNNTLDMGNAVG----PLLQLVDLQNNQISAIT 376
+ + + L +N + +A+ P LQ++ L+N + +
Sbjct: 170 RVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPS 217
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 635 IGSGGYGKVY--RGMLSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLV 689
IG G +G+V + + + +V A+K + M E F+ E ++L K + L
Sbjct: 82 IGRGAFGEVAVVK-LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIA-LGSARGLAYLHELANP 747
+ F+ + LV ++ G L LS + R +A + A + +H+L
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIA--IDSVHQLH-- 195
Query: 748 PIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL 807
+HRD+K NIL+D N ++ADFG + + S V GT Y+ PE +
Sbjct: 196 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEG 253
Query: 808 TEKS-----DVYSFGVVMLELITAKQP 829
+ D +S GV M E++ + P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-19
Identities = 54/250 (21%), Positives = 85/250 (34%), Gaps = 31/250 (12%)
Query: 581 QKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGY 640
P P G K A Y + +G G
Sbjct: 25 TPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQ---------VLGLGIN 75
Query: 641 GKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQ 698
GKV + + A+K +Q + + E+EL R ++V +V +E
Sbjct: 76 GKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV-YENLYA 129
Query: 699 M-----LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753
+V E + G L + R + I + YLH + I HRD
Sbjct: 130 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRD 186
Query: 754 VKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
VK N+L N K+ DFG +K + + T T Y+ PE ++ +
Sbjct: 187 VKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKS 243
Query: 811 SDVYSFGVVM 820
D++S GV+M
Sbjct: 244 CDMWSLGVIM 253
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 51/231 (22%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFK-----T---EIELL 677
+ + +++G G Y VY+G +VA+K + LE + T E+ LL
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54
Query: 678 SRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKR---RLRIALGS 734
+ H N+V L + LV+E++ D K+ +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLTLVFEYL---------------DKDLKQYLDDCGNIINM 99
Query: 735 A----------RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784
RGLAY H ++HRD+K N+L++E K+ADFGL++ S +K
Sbjct: 100 HNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT 156
Query: 785 HVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ +V T+ Y P+ + + + + D++ G + E+ T +P+ G
Sbjct: 157 Y-DNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPLFPGS 204
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 34/208 (16%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC 692
+G G + +V + L Q A+K ++ E+E+L + H+N++ L+ F
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 693 FEQGEQMLVYEFMANGTL------RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
E+ LV+E M G++ R + + ++ L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EASVVVQDVAS---ALDFLHNKG- 131
Query: 747 PPIIHRDVKSTNILL---DENLTAKVADFGLSKLV------SDSSKGHVSTQVKGTMGYL 797
I HRD+K NIL ++ K+ DF L + S S + T G+ Y+
Sbjct: 132 --IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYM 188
Query: 798 DPEYYMTQQLTEKS-----DVYSFGVVM 820
PE D++S GV++
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 1e-18
Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 58/237 (24%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EI 674
+ +GSG YG V + G+ VAIK+ + F++ E+
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYREL 74
Query: 675 ELLSRVHHKNLVGL--VGFCFEQGEQM----LVYEFMANGTLRESLSGRSGIHLDWKRRL 728
LL + H+N++GL V LV FM T D ++ +
Sbjct: 75 LLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM--QT-------------DLQKIM 119
Query: 729 RIALGSA----------RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778
+ +GL Y+H A ++HRD+K N+ ++E+ K+ DFGL++
Sbjct: 120 GLKFSEEKIQYLVYQMLKGLKYIHS-AG--VVHRDLKPGNLAVNEDCELKILDFGLARHA 176
Query: 779 SDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
G+V T+ Y PE ++ + D++S G +M E++T K + KGK
Sbjct: 177 DAEMTGYVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGK 227
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 56/232 (24%), Positives = 98/232 (42%), Gaps = 54/232 (23%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK-----RAQQGSMQGGLEFKTEIELLSRVHHKNLVGL 688
+G G +GKV Q VA+K ++ M + + EI L + H +++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRV--EREISYLKLLRHPHIIKL 74
Query: 689 VGFCFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR-------- 736
++ + ++V E+ A G L + ++ K+R+ R
Sbjct: 75 ----YDVITTPTDIVMVIEY-AGGELFD--------YIVEKKRMTEDE--GRRFFQQIIC 119
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
+ Y H I+HRD+K N+LLD+NL K+ADFGLS +++D + S G+ Y
Sbjct: 120 AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNY 173
Query: 797 LDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE + + DV+S G+V+ ++ + P + Y
Sbjct: 174 AAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 3e-18
Identities = 40/234 (17%), Positives = 82/234 (35%), Gaps = 36/234 (15%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146
+ + L L+ L+ SL + ++ +L + ++P+ +L L
Sbjct: 58 INQFSELQLNRL-NLS-SLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACD 109
Query: 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT 206
N S +P L LD+ +NQLT +P + ++ + + N+L+
Sbjct: 110 NRLS-TLPELPASLKH---LDVDNNQLT-MLP---------ELPALLEYINADNNQLT-M 154
Query: 207 ISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG--KVPTNLNNLT 264
+ E S L + NQL+ +PE +LE L + N L VP ++
Sbjct: 155 LPELPTS----LEVLSVRNNQLTF-LPELPE---SLEALDVSTNLLESLPAVPVRNHHSE 206
Query: 265 NVN-ELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
N + ++ ++ + L +N + + +
Sbjct: 207 ETEIFFRCRENRITHIPENILSLDPTCTIILEDNPL--SSRIRESLSQQTAQPD 258
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 3e-18
Identities = 49/317 (15%), Positives = 98/317 (30%), Gaps = 60/317 (18%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
NN+ + ++G + + L + + + + L L
Sbjct: 7 INNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQL 66
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
+ ++PD + +++ L + N +P L +LD DN+L+ ++P
Sbjct: 67 NRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELPASLE---YLDACDNRLS-TLP-- 116
Query: 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ 240
+ + KH + N+L+ +PE
Sbjct: 117 -------ELPASLKHLDVDNNQLT--------------------------MLPELPA--- 140
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD 300
LE + D N LT +P +L L++ +N L P+L SL +D+S N
Sbjct: 141 LLEYINADNNQLT-MLPELPTSLE---VLSVRNNQLTF-LPEL--PESLEALDVSTNLL- 192
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQG----RVPDKLFSYSQIQQVKLRNNAFNNTLDMGN 356
P F + +P+ + S + L +N ++ +
Sbjct: 193 -ESLPAVPVRNHHSEETEIFF-RCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 357 AVGPLLQLVDLQNNQIS 373
+ S
Sbjct: 251 SQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 3e-17
Identities = 42/291 (14%), Positives = 99/291 (34%), Gaps = 52/291 (17%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
C ++ + L L+ + L+ L ++ ++ L+++ N L SL L+ L+
Sbjct: 56 CLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNA-LI-SLPELPASLEYLD---A 107
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLY---------------- 164
+ +P+ +L L +++N + +P L +
Sbjct: 108 CDNRLS-TLPELPASLKHLD---VDNNQLT-MLPELPALLEYINADNNQLTMLPELPTSL 162
Query: 165 -WLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE---QLFSPDMVLIH 220
L + +NQLT +P + ++ + + N L ++ + + I
Sbjct: 163 EVLSVRNNQLT-FLP---------ELPESLEALDVSTNLLE-SLPAVPVRNHHSEETEIF 211
Query: 221 VLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPF 280
N+++ +IPE++ + + L+ N L+ ++ +L+ T + +
Sbjct: 212 FRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSD 270
Query: 281 PDLSQMNSLSYVDLSNNSFDPTEAP----LW--FSTLPSLTTLICEFGSLQ 325
+ + D F + +W F T L
Sbjct: 271 GQQNTL-HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLS 320
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 37/227 (16%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT-------EIEL 676
+ IGSG G V + + VAIK+ + + +T E+ L
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKK-----LSRPFQNQTHAKRAYRELVL 77
Query: 677 LSRVHHKNLVGL--VGFCFEQGEQM----LVYEFMA---NGTLRESLSGRSGIHLDWKRR 727
+ V+HKN++GL V + E+ +V E M ++ L + +
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH---ERMSY--- 131
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
+ G+ +LH A IIHRD+K +NI++ + T K+ DFGL++ S +
Sbjct: 132 --LLYQMLCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMM 183
Query: 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
T T Y PE + E D++S G +M E+I + G
Sbjct: 184 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFPGT 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 45/234 (19%), Positives = 104/234 (44%), Gaps = 27/234 (11%)
Query: 612 KGARWFSYDELK---KCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG 667
+ ++ Y+ +++ ++G G Y +V+ + +++ + V +K + +
Sbjct: 18 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-- 75
Query: 668 LEFKTEIELLSRV-HHKNLVGL--VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDW 724
+ K EI++L + N++ L + LV+E + N ++ + +
Sbjct: 76 -KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDI-- 132
Query: 725 KRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSK 783
+ + L + L Y H I+HRDVK N+++D E+ ++ D+GL++ +
Sbjct: 133 RFYMYEIL---KALDYCHS-MG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186
Query: 784 --GHVSTQVKGTMGYLDPEYYMTQQLTEKS-DVYSFGVVMLELITAKQPIEKGK 834
V+++ + PE + Q+ + S D++S G ++ +I K+P G
Sbjct: 187 YNVRVASRY-----FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 3e-18
Identities = 55/249 (22%), Positives = 102/249 (40%), Gaps = 30/249 (12%)
Query: 620 DELKKCSNNFS-ESNEIGSGGYGKVYRGM---LSDGQVVAIKRAQQGSMQGGLEFKT--E 673
E ++ + F E ++G G YG VY+ D + A+K+ + G+ E
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT----GISMSACRE 68
Query: 674 IELLSRVHHKNLVGLVGFCFEQGEQ--MLVYEFMAN------GTLRESLSGRSGIHLDWK 725
I LL + H N++ L ++ L++++ + R S + + + L
Sbjct: 69 IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRG 128
Query: 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA----KVADFGLSKLVSDS 781
+ G+ YLH ++HRD+K NIL+ K+AD G ++L +
Sbjct: 129 MVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
Query: 782 SKG--HVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR 838
K + V T Y PE + + T+ D+++ G + EL+T +PI +
Sbjct: 186 LKPLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPIFHCRQEDI 243
Query: 839 EVRTAMNRD 847
+ + D
Sbjct: 244 KTSNPYHHD 252
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-18
Identities = 59/220 (26%), Positives = 97/220 (44%), Gaps = 35/220 (15%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQG---SMQGGLEFKTEIELLSRVHH 682
N+FS IG GG+G+VY +D G++ A+K + QG E +LS V
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 683 KN---LVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR-- 736
+ +V + + F +++ + + M G L HL + + R
Sbjct: 249 GDCPFIVCMS-YAFHTPDKLSFILDLMNGGDLH--------YHL--SQHGVFSEADMRFY 297
Query: 737 ------GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
GL ++H +++RD+K NILLDE+ +++D GL+ D SK V
Sbjct: 298 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASV 351
Query: 791 KGTMGYLDPEYYMTQQLTEKS-DVYSFGVVMLELITAKQP 829
GT GY+ PE + S D +S G ++ +L+ P
Sbjct: 352 -GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 4e-18
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 41/229 (17%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EI 674
+ IGSG G V + VAIK+ + F+ E+
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYREL 112
Query: 675 ELLSRVHHKNLVGL--VGFCFEQGEQM----LVYEFMA---NGTLRESLSGRSGIHLDWK 725
L+ V+HKN++ L V + E+ LV E M ++ L +
Sbjct: 113 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERM 166
Query: 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785
L + G+ +LH A IIHRD+K +NI++ + T K+ DFGL++ S
Sbjct: 167 SYLLYQM--LCGIKHLHS-AG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---F 218
Query: 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ T T Y PE + E D++S G +M E++ K + G+
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-ILFPGR 266
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 1e-17
Identities = 47/254 (18%), Positives = 94/254 (37%), Gaps = 59/254 (23%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT---EIELLSRVH 681
S +S +G+G +G V + G+ A+K+ Q + + E++++ +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-------DPRYKNRELDIMKVLD 58
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHL------------------- 722
H N++ LV + + G++ + + +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 723 ----DWKRRLRIALGSA----------------RGLAYLHELANPPIIHRDVKSTNILLD 762
+ L+ + S R + ++H I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LG--ICHRDIKPQNLLVN 175
Query: 763 -ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVM 820
++ T K+ DFG +K + S + Y PE + + T D++S G V
Sbjct: 176 SKDNTLKLCDFGSAKKL---IPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232
Query: 821 LELITAKQPIEKGK 834
ELI +P+ G+
Sbjct: 233 GELIL-GKPLFSGE 245
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 49/230 (21%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
+G G +GKV G G VA+K R + S+ + + EI+ L H +++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81
Query: 691 FCFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--------GL 738
++ + +V E+++ G L + ++ RL +R G+
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFD--------YICKNGRLDEKE--SRRLFQQILSGV 129
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
Y H ++HRD+K N+LLD ++ AK+ADFGLS ++SD S G+ Y
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAA 183
Query: 799 PEYYMTQQLT-EKSDVYSFGVVMLELITAKQP------------IEKGKY 835
PE + + D++S GV++ L+ P I G +
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 3e-17
Identities = 44/190 (23%), Positives = 80/190 (42%), Gaps = 26/190 (13%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT-------EIELLSRVHHKNL 685
IG G YG VY + + VAIK+ + E EI +L+R+ +
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKK-----VNRMFEDLIDCKRILREITILNRLKSDYI 87
Query: 686 VGLVG-FCFEQGEQM----LVYEFMANGT-LRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+ L + + +V E + L++ ++ I L + I G
Sbjct: 88 IRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF--KTPIFLTEEHIKTILYNLLLGEN 143
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
++HE + IIHRD+K N LL+++ + KV DFGL++ ++ ++ ++
Sbjct: 144 FIHE-SG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 800 EYYMTQQLTE 809
+ +QLT
Sbjct: 201 NKNLKKQLTS 210
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 48/243 (19%), Positives = 98/243 (40%), Gaps = 28/243 (11%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
L + +L G+T ++ + L L L L T ++ + NL +++ L
Sbjct: 37 QADLDGITTLSAFGT-GVT-TIEG-VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITELE 91
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
L+ N + + L + LDL Q+T L L N + + + N++
Sbjct: 92 LSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT--------DVTPLAGLSNLQVLYLDLNQI 141
Query: 204 SGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLN 261
+ IS L + L ++ Q+S ++ L + L L+ D N ++ + L
Sbjct: 142 T-NISPLAGLTN----LQYLSIGNAQVS-DL-TPLANLSKLTTLKADDNKISD--ISPLA 192
Query: 262 NLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF 321
+L N+ E++L +N + L+ ++L V L+N + + + + L +
Sbjct: 193 SLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKGPS 250
Query: 322 GSL 324
G+
Sbjct: 251 GAP 253
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 54/284 (19%), Positives = 96/284 (33%), Gaps = 55/284 (19%)
Query: 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN 171
L + T + +L ++ L+ + I + L+ L L+L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDN 73
Query: 172 QLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN 231
Q+T + L L + N L N
Sbjct: 74 QIT-DL-------APLKNLTKITELELSGNPLK--------------------------N 99
Query: 232 IPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSY 291
+ ++ +Q+++ L L +T T L L+N+ L L N + L+ + +L Y
Sbjct: 100 V-SAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITN-ISPLAGLTNLQY 155
Query: 292 VDLSNN---SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348
+ + N P + L LTTL + + P L S + +V L+NN
Sbjct: 156 LSIGNAQVSDLTP------LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQI 207
Query: 349 NNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP 392
++ + N L +V L N I+ + +V P
Sbjct: 208 SDVSPLANT--SNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGP 249
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 27/214 (12%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
+ LT++ L+LS N L ++S I LQ + L L T P + L+ L L
Sbjct: 81 LKNLTKITELELSGNP-LK-NVSA-IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLY 135
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
L+ N + I P L L+ L +L + + Q++ L L + NK+
Sbjct: 136 LDLNQIT-NISP-LAGLTNLQYLSIGNAQVS--------DLTPLANLSKLTTLKADDNKI 185
Query: 204 SGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLN 261
S IS L + LI V NQ+S ++ L L ++ L +T + N
Sbjct: 186 S-DISPLASLPN----LIEVHLKNNQIS-DV-SPLANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 262 NLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLS 295
NL N+ P + ++ +Y +
Sbjct: 239 NLV---VPNVVKGPSGAPIAPATISDNGTYASPN 269
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 45/222 (20%), Positives = 87/222 (39%), Gaps = 18/222 (8%)
Query: 173 LTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNI 232
+T ++ I L NA K+ ++ T+++ + + G ++ I
Sbjct: 3 ITQPTAINVIF--PDPALANAIKIAAGKSNVTDTVTQADLD---GITTLSAFGTGVT-TI 56
Query: 233 PESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYV 292
E + Y+ L L L N +T L NLT + EL L+ N LK ++ + S+ +
Sbjct: 57 -EGVQYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLKNVSA-IAGLQSIKTL 112
Query: 293 DLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTL 352
DL++ + L +L L Q L + +Q + + N ++
Sbjct: 113 DLTSTQITDVTP---LAGLSNLQVLYL--DLNQITNISPLAGLTNLQYLSIGNAQVSDLT 167
Query: 353 DMGNAVGPLLQLVDLQNNQISAITLGSGIKN-YTLILVGNPV 393
+ N L + +N+IS I+ + + N + L N +
Sbjct: 168 PLANL--SKLTTLKADDNKISDISPLASLPNLIEVHLKNNQI 207
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 37/227 (16%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EI 674
+ + +GSG YG V + G VAIK+ + F++ E+
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYREL 75
Query: 675 ELLSRVHHKNLVGL--VGFCFEQGEQM----LVYEFMANGTLRESLSGRSGIHLDWKRRL 728
LL + H+N++GL V E + LV FM L + + L R
Sbjct: 76 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQ 131
Query: 729 RIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVST 788
+ +GL Y+H A IIHRD+K N+ ++E+ K+ DFGL++ G+V T
Sbjct: 132 FLVYQMLKGLRYIHA-AG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVT 188
Query: 789 QVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ Y PE + + T+ D++S G +M E+IT K + KG
Sbjct: 189 RW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGS 229
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 55/219 (25%), Positives = 84/219 (38%), Gaps = 50/219 (22%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRVH 681
+G G +GKV +L + G+ A+K + + TE +L
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHT------LTENRVLQNSR 206
Query: 682 HKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR----------I 730
H L L + F+ +++ V E+ G L HL +R I
Sbjct: 207 HPFLTALK-YSFQTHDRLCFVMEYANGGELF--------FHLSRERVFSEDRARFYGAEI 257
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
L YLH N +++RD+K N++LD++ K+ DFGL K G
Sbjct: 258 VSA----LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE--GIKDGATMKTF 309
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT YL PE D + GVVM E++ + P
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 7e-17
Identities = 55/219 (25%), Positives = 84/219 (38%), Gaps = 51/219 (23%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRVH 681
+G G +GKV +L + G+ A+K + + TE +L
Sbjct: 13 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHT------VTESRVLQNTR 63
Query: 682 HKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR----------I 730
H L L + F+ +++ V E+ G L HL +R I
Sbjct: 64 HPFLTALK-YAFQTHDRLCFVMEYANGGELF--------FHLSRERVFTEERARFYGAEI 114
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
L YLH +++RD+K N++LD++ K+ DFGL K S G
Sbjct: 115 VSA----LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTF 165
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT YL PE D + GVVM E++ + P
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-17
Identities = 57/266 (21%), Positives = 89/266 (33%), Gaps = 50/266 (18%)
Query: 60 TCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILI 119
C N GL + I + + L N RI +
Sbjct: 7 VCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGN---------RISHVP------ 48
Query: 120 LAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIP 178
L+ L L+SN + RI + L+ L LDL+DN S+
Sbjct: 49 ----------AASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 179 VSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLG 237
+T GL +L H ++ L + LF L ++ N L +P+ +
Sbjct: 98 PATFH--GLGRL---HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVD 293
+ L L L N ++ L +++ L L N + F DL L +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG---RLMTLY 207
Query: 294 LSNNSFD--PTEAPLWFSTLPSLTTL 317
L N+ PTEA + L +L L
Sbjct: 208 LFANNLSALPTEA---LAPLRALQYL 230
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 55/275 (20%), Positives = 80/275 (29%), Gaps = 75/275 (27%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
+P I A + L+ N S +P S L L L N L I +
Sbjct: 26 VPVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLA------RIDAAAF 76
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247
L + + N ++ F + L L L
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHG------------------------LGRLHTLHL 112
Query: 248 DRNALTGKVPTN-LNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD-- 300
DR L ++ L + L L N L+ F DL L+++ L N
Sbjct: 113 DRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN---LTHLFLHGNRISSV 168
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP 360
P A F L SL L L +++ V +AF +
Sbjct: 169 PERA---FRGLHSLDRL-----LLHQ---------NRVAHVH--PHAFRDL--------G 201
Query: 361 LLQLVDLQNNQISAI---TLGSGIKNYTLILVGNP 392
L + L N +SA+ L L L NP
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 7e-12
Identities = 35/146 (23%), Positives = 55/146 (37%), Gaps = 14/146 (9%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLA 143
GL L +L L G L L P + L L L L +PD+ +L L+ L
Sbjct: 103 GLGRLHTLHLDRCG-LQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLF 159
Query: 144 LNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
L+ N S +P + L L L L N++ + L +L + N
Sbjct: 160 LHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFR--DLGRL---MTLYLFANN 212
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQL 228
LS + + +P L ++ + N
Sbjct: 213 LS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-16
Identities = 63/238 (26%), Positives = 102/238 (42%), Gaps = 55/238 (23%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EI 674
++ + IG G YG V + VAIK+ F+ EI
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREI 76
Query: 675 ELLSRVHHKNLVGLVG-FCFEQGEQM----LVYEFMANGT-LRESLSGR--SGIH----- 721
++L R H+N++G+ EQM +V + M T L + L + S H
Sbjct: 77 KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQHLSNDHICYFL 134
Query: 722 ---LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778
L RGL Y+H AN ++HRD+K +N+LL+ K+ DFGL+++
Sbjct: 135 YQIL-------------RGLKYIHS-AN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
Query: 779 S-DSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
D T+ T Y PE + + T+ D++S G ++ E+++ + PI GK
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGK 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 1e-16
Identities = 48/241 (19%), Positives = 86/241 (35%), Gaps = 25/241 (10%)
Query: 111 DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170
+ L T + L + + N+++ + + L + L L
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL-FDGNQLS 229
N+LT I L LKN ++NK+ +S D+ + L + N +S
Sbjct: 75 NKLT-DIK-------PLTNLKNLGWLFLDENKIK-DLSSL---KDLKKLKSLSLEHNGIS 122
Query: 230 GNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSL 289
+I L ++ LE L L N +T T L+ LT ++ L+L N + L+ + L
Sbjct: 123 -DI-NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKL 177
Query: 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349
+ LS N A + L +L L + + + VK + +
Sbjct: 178 QNLYLSKNHISDLRA---LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
Query: 350 N 350
Sbjct: 235 T 235
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 49/267 (18%), Positives = 88/267 (32%), Gaps = 76/267 (28%)
Query: 130 PDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQ 189
PD+ AE L + + + +L+ + + ++ + S+ G+
Sbjct: 16 PDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-------GIQY 63
Query: 190 LKNAKHFHFNKNKLSGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247
L N N NKL+ I L + L + D N++ ++ SL ++ L+ L L
Sbjct: 64 LPNVTKLFLNGNKLT-DIKPLTNLKN----LGWLFLDENKIK-DL-SSLKDLKKLKSLSL 116
Query: 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLW 307
+ N ++ L +L + L L +N + LS++ L + L +N
Sbjct: 117 EHNGIS--DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQI-------- 165
Query: 308 FSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDL 367
S + L L LQ + L
Sbjct: 166 -SDIVPLAGL------------------------------------------TKLQNLYL 182
Query: 368 QNNQISAITLGSGIKN-YTLILVGNPV 393
N IS + +G+KN L L
Sbjct: 183 SKNHISDLRALAGLKNLDVLELFSQEC 209
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 44/226 (19%), Positives = 80/226 (35%), Gaps = 44/226 (19%)
Query: 173 LTGSIPVST-ITS-PGLDQLKNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLS 229
+ +I VST I D + K ++ ++ +L S + ++ + + +
Sbjct: 1 MGETITVSTPIKQIFPDDAFAETIKDNLKKKSVTDAVTQNELNS----IDQIIANNSDIK 56
Query: 230 GNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSL 289
++ + + Y+ + L L+ N LT L NL N+ L L N +K L + L
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLT--DIKPLTNLKNLGWLFLDENKIKD-LSSLKDLKKL 111
Query: 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK-LRNNAF 348
+ L +N LP L +L ++I + L
Sbjct: 112 KSLSLEHNGISDING---LVHLPQLESLYL--------------GNNKITDITVLSRL-- 152
Query: 349 NNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYT-LILVGNPV 393
L + L++NQIS I +G+ L L N +
Sbjct: 153 -----------TKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 187
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 50/265 (18%), Positives = 93/265 (35%), Gaps = 58/265 (21%)
Query: 578 AIRQKKRAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELK-KCSNNFSESNEIG 636
+ + G + G+ K + + + + IG
Sbjct: 3 SHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIG 62
Query: 637 SGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EIELLSRVHHKNLV 686
+G YG V + +VVAIK+ F+ EI +L+R++H ++V
Sbjct: 63 TGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDHVV 115
Query: 687 GLVG-FCFEQGEQM----LVYEFMANGTLRESLSGRSGIHLDWKRRLR--IALGSA---- 735
++ + E+ +V E D+K+ R + L
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIA---------------DSDFKKLFRTPVYLTELHIKT 160
Query: 736 ------RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
G+ Y+H A I+HRD+K N L++++ + KV DFGL++ V G+
Sbjct: 161 LLYNLLVGVKYVHS-AG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLP 217
Query: 790 VKGT-----MGYLDPEYYMTQQLTE 809
+ + + +QLT
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTG 242
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 35/213 (16%)
Query: 635 IGSGGYGKVY--RGMLSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHHKNLVGLV 689
IG G +G+V R S +V A+K + M + F E ++++ + +V L
Sbjct: 77 IGRGAFGEVQLVR-HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 690 GFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--------GLAY 740
+ F+ + +V E+M G L ++ + AR L
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVLALDA 183
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
+H + IHRDVK N+LLD++ K+ADFG ++ T V GT Y+ PE
Sbjct: 184 IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239
Query: 801 YYMTQQLTEK----SDVYSFGVVMLELITAKQP 829
+Q D +S GV + E++ P
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 45/217 (20%)
Query: 635 IGSGGYGKVY----RGMLSDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRVH 681
+G G +GKV+ Q+ A+K R + + K E ++L V+
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR-------VRTKMERDILVEVN 84
Query: 682 HKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR---- 736
H +V L + F+ ++ L+ +F+ G L L + + +
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDL--------FTRL--SKEVMFTEEDVKFYLA 133
Query: 737 ----GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
L +LH L II+RD+K NILLDE K+ DFGLSK + G
Sbjct: 134 ELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKE--SIDHEKKAYSFCG 188
Query: 793 TMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
T+ Y+ PE + T+ +D +SFGV+M E++T P
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 43/230 (18%)
Query: 625 CSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT---------EI 674
+ + +GSG YG V + G VA+K+ F++ E+
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKK-------LSRPFQSIIHAKRTYREL 79
Query: 675 ELLSRVHHKNLVGLV-----GFCFEQGEQM-LVYEFMANGT-LRESLSGR--SGIHLDWK 725
LL + H+N++GL+ E+ + LV M G L + + + H+ +
Sbjct: 80 RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQF- 136
Query: 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785
+ RGL Y+H A+ IIHRD+K +N+ ++E+ K+ DFGL++ +D G+
Sbjct: 137 ----LIYQILRGLKYIHS-AD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY 189
Query: 786 VSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
V+T+ Y PE + + D++S G +M EL+T + + G
Sbjct: 190 VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPGT 233
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 56/201 (27%), Positives = 82/201 (40%), Gaps = 30/201 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG 690
IGSG +G ++VA+K R + EI + H N+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN----VQREIINHRSLRHPNIVRF-- 81
Query: 691 FCFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
E ++ E+ + G L E + D R L S ++Y H +
Sbjct: 82 --KEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG--VSYCHSMQ- 136
Query: 747 PPIIHRDVKSTNILLDENLTA--KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
I HRD+K N LLD + K+ DFG SK S+ + V GT Y+ PE +
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPEVLLR 191
Query: 805 QQLT-EKSDVYSFGV---VML 821
Q+ + +DV+S GV VML
Sbjct: 192 QEYDGKIADVWSCGVTLYVML 212
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 5e-16
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 49/220 (22%)
Query: 635 IGSGGYGKVY----RGMLSDGQVVAIK----------RAQQGSMQGGLEFKTEIELLSRV 680
+G GGYGKV+ + G++ A+K K E +L V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT------KAERNILEEV 78
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR---------- 729
H +V L+ + F+ G ++ L+ E+++ G L + L+ +
Sbjct: 79 KHPFIVDLI-YAFQTGGKLYLILEYLSGGELF--------MQLEREGIFMEDTACFYLAE 129
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
I++ L +LH+ II+RD+K NI+L+ K+ DFGL K G V+
Sbjct: 130 ISMA----LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHT 180
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT+ Y+ PE M D +S G +M +++T P
Sbjct: 181 FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 6e-16
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 62/236 (26%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EIELLSRVHHK 683
+G G YG V G++VAIK+ + F EI++L H+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHE 69
Query: 684 NLVGLVG-FCFEQGEQM----LVYEFMANGT-LRESLSGR--SGIH--------LDWKRR 727
N++ + + E ++ E M T L +S + S H L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIYQTL----- 122
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
R + LH +N +IHRD+K +N+L++ N KV DFGL++++ +S+ +
Sbjct: 123 --------RAVKVLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 788 TQVKG--------TMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ T Y PE +T + + DV+S G ++ EL + PI G+
Sbjct: 172 PTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGR 226
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 53/256 (20%), Positives = 90/256 (35%), Gaps = 28/256 (10%)
Query: 59 VTCNNSRVTA-----------LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSP 107
C S+VT L L G G +L +++S N L +
Sbjct: 14 FLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE-VIEA 72
Query: 108 RI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLY 164
+ +L KL+ + + I E NL L +L +++ +P Q
Sbjct: 73 DVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKV 131
Query: 165 WLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFD 224
LD+ DN +I ++ GL + NKN + I F+ + L D
Sbjct: 132 LLDIQDNINIHTIERNSFV--GL--SFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186
Query: 225 GNQLSGNIPE-SLGYVQTLEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPD 282
N L +P +L + R + +P+ L NL + + +LK P
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKK-LPT 241
Query: 283 LSQMNSLSYVDLSNNS 298
L ++ +L L+ S
Sbjct: 242 LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 33/250 (13%), Positives = 73/250 (29%), Gaps = 25/250 (10%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITS-PG 186
IP ++ L I + L ++++ N + I ++ P
Sbjct: 24 IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLGYVQTLEVL 245
L ++ N L I+ + F L ++L + ++P+ + +L
Sbjct: 81 LHEI-----RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 246 RLDRNALTGKVPTN-LNNLT-NVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNSFD-- 300
+ N + N L+ L L N ++ + NN+ +
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEEL 193
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP 360
P + F L + +P +++++ R+ L +
Sbjct: 194 PNDV---FHGASGPVILDISRTRIH-SLPSYGLEN--LKKLRARSTYNLKKLPTLEKL-V 246
Query: 361 LLQLVDLQNN 370
L L
Sbjct: 247 ALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 38/214 (17%)
Query: 166 LDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDG 225
++++T IP S + +NA F KL I + FS L +
Sbjct: 14 FLCQESKVT-EIP-SDL-------PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQ 63
Query: 226 NQLSGNIPES-LGYVQTLEVLRLDR-NALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL 283
N + I + L +R+++ N L P NL N+ L +++ +K PD+
Sbjct: 64 NDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDV 122
Query: 284 S--QMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQV 341
+D+ +N T F L + ++ + + IQ++
Sbjct: 123 HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW-------------LNKNGIQEI 169
Query: 342 KLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAI 375
N+AFN T L +L NN + +
Sbjct: 170 --HNSAFNGT--------QLDELNLSDNNNLEEL 193
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 57/239 (23%), Positives = 104/239 (43%), Gaps = 50/239 (20%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKT---------EIE 675
+ + + +G GG G V+ + +D + VAIK+ + EI+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKK---------IVLTDPQSVKHALREIK 60
Query: 676 LLSRVHHKNLVGLV----------GFCFEQGEQM----LVYEFMANGT-LRESLSGRSGI 720
++ R+ H N+V + ++ +V E+M T L L G
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVL--EQGP 116
Query: 721 HLDWKRRLRI--ALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKL 777
L+ RL + L RGL Y+H AN ++HRD+K N+ ++ E+L K+ DFGL+++
Sbjct: 117 LLEEHARLFMYQLL---RGLKYIHS-AN--VLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 778 V-SDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
+ S ++ T Y P ++ T+ D+++ G + E++T K + G
Sbjct: 171 MDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGA 228
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 51/250 (20%), Positives = 81/250 (32%), Gaps = 42/250 (16%)
Query: 51 DPC---GSWEGVTCNNSRVTA-----------LGLSTMGLTGKLSGDIGGLTELRSLDLS 96
+PC C L LS L S EL+ LDLS
Sbjct: 1 EPCVEVVPNITYQCMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 97 YNGGLTGSLSPRIGD-LQKLNILILAGCGFTGN----IPDEI-GNLAELSFLALNSNNFS 150
+ ++ L L+ LIL TGN + L+ L L N +
Sbjct: 61 RC-EIQ-TIEDGAYQSLSHLSTLIL-----TGNPIQSLALGAFSGLSSLQKLVAVETNLA 113
Query: 151 GRIPPSL-GKLSQLYWLDLADNQLTGSIPVSTITSPGL-DQLKNAKHFHFNKNKLSGTIS 208
+ G L L L++A N + + P L N +H + NK+ +I
Sbjct: 114 -SLENFPIGHLKTLKELNVAHNLIQ------SFKLPEYFSNLTNLEHLDLSSNKIQ-SIY 165
Query: 209 EQLFSP----DMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLT 264
++ + + N ++ I L+ L LD N L + LT
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT 224
Query: 265 NVNELNLAHN 274
++ ++ L N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 50/230 (21%), Positives = 90/230 (39%), Gaps = 29/230 (12%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
IPD + L L+ N + S +L LDL+ ++ +I
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA-----Y 72
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL-GYVQTLEVLR 246
L + N + +++ FS L ++ L+ ++ G+++TL+ L
Sbjct: 73 QSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELN 130
Query: 247 LDRNALTGKVPTN--LNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYV-DLSNNSF 299
+ N + +NLTN+ L+L+ N ++ L QM L+ DLS N
Sbjct: 131 VAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 300 D--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY-SQIQQVKLRNN 346
+ A F + L L + L+ VPD +F + +Q++ L N
Sbjct: 190 NFIQPGA---FKEI-RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 37/164 (22%), Positives = 63/164 (38%), Gaps = 37/164 (22%)
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQM 286
N+P S + L L N L + + + L+L+ +++ G + LS +
Sbjct: 25 NLPFST------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 287 NSLSYVDLSNN--SFDPTEAPLWFSTLPSLTTLI---CEFGSLQGRVPDKLFS------- 334
++L L+ N A FS L SL L+ SL+ L +
Sbjct: 79 STL---ILTGNPIQSLALGA---FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVA 132
Query: 335 YSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG 378
++ IQ KL F+N L+ +DL +N+I +I
Sbjct: 133 HNLIQSFKL-PEYFSNL--------TNLEHLDLSSNKIQSIYCT 167
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 41/238 (17%), Positives = 71/238 (29%), Gaps = 27/238 (11%)
Query: 53 CGSWEGVTCNNSRVTA----------LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLT 102
C E + L L L S L + + +S + L
Sbjct: 10 CHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 103 GSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLALNSNNFSGRIPP--SLG 158
L +L K+ + + I + L L FL + + P +
Sbjct: 70 -QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 159 KLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVL 218
+ L++ DN SIPV+ GL N + ++ F+ L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQ--GLCNET--LTLKLYNNGFT-SVQGYAFN-GTKL 181
Query: 219 IHVLFDGNQLSGNIPESL--GYVQTLEVLRLDRNALT---GKVPTNLNNLTNVNELNL 271
V + N+ I + G +L + + ++T K +L L N L
Sbjct: 182 DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 34/193 (17%), Positives = 71/193 (36%), Gaps = 13/193 (6%)
Query: 192 NAKHFHFNKNKLSGTISEQLFS--PDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDR 249
+ + + L TI FS P++ I+ + L S + + + +
Sbjct: 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIY-VSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 250 NALTGKVPTN-LNNLTNVNELNLAHNDLKGPFPDLS---QMNSLSYVDLSNNSFDPTEAP 305
+ + L L + L + + LK FPDL+ + +++++N + +
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 306 LWFSTLPSLT-TLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMG--NAVGPLL 362
F L + T TL V F+ +++ V L N + +D V
Sbjct: 149 NAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 363 QLVDLQNNQISAI 375
L+D+ ++A+
Sbjct: 208 SLLDVSQTSVTAL 220
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 47/234 (20%), Positives = 86/234 (36%), Gaps = 28/234 (11%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145
E +L +L ++ +I ++ I L ++ L LN
Sbjct: 22 AFAETIKDNLKKKS--VTDAVT-QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLN 76
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG 205
N + I P L L L WL L +N++ ++ L LK K N +S
Sbjct: 77 GNKLT-DIKP-LANLKNLGWLFLDENKVK------DLS--SLKDLKKLKSLSLEHNGIS- 125
Query: 206 TIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL 263
I+ L L + N+++ +I L + L+ L L+ N ++ + L L
Sbjct: 126 DINGLVHLPQ----LESLYLGNNKIT-DI-TVLSRLTKLDTLSLEDNQIS-DIV-PLAGL 177
Query: 264 TNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
T + L L+ N + L+ + +L ++L + + S L T+
Sbjct: 178 TKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTV 229
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 43/256 (16%), Positives = 88/256 (34%), Gaps = 33/256 (12%)
Query: 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK 194
AE L + + + +L+ + + ++ + S+ G+ L N
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-------QGIQYLPNVT 71
Query: 195 HFHFNKNKLSGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNAL 252
N NKL+ I L + L + D N++ ++ SL ++ L+ L L+ N +
Sbjct: 72 KLFLNGNKLT-DIKPLANLKN----LGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGI 124
Query: 253 TGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN---SFDPTEAPLWFS 309
+ L +L + L L +N + LS++ L + L +N P +
Sbjct: 125 S--DINGLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISDIVP------LA 175
Query: 310 TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQN 369
L L L + L + ++L + N + + V +
Sbjct: 176 GLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
Query: 370 NQISAITLGSGIKNYT 385
+ + S +Y
Sbjct: 234 GSLVTPEIISDDGDYE 249
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 50/216 (23%), Positives = 85/216 (39%), Gaps = 26/216 (12%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
+ + + + + G I L + L L+ N LT + P + +L+ L L L
Sbjct: 48 IDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNK-LT-DIKP-LANLKNLGWLFLDENKV 102
Query: 126 TGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
++ + +L +L L+L N S I L L QL L L +N++T IT
Sbjct: 103 K-DL-SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT------DIT-- 150
Query: 186 GLDQLKNAKHFHFNKNKLSGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLE 243
L +L N++S I L L ++ N +S ++ +L ++ L+
Sbjct: 151 VLSRLTKLDTLSLEDNQIS-DIVPLAGLTK----LQNLYLSKNHIS-DL-RALAGLKNLD 203
Query: 244 VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGP 279
VL L K + +NL N + L P
Sbjct: 204 VLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 30/176 (17%), Positives = 69/176 (39%), Gaps = 35/176 (19%)
Query: 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN---S 298
L + ++T N L +++++ ++D+K + + +++ + L+ N
Sbjct: 26 TIKDNLKKKSVTD--AVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTD 82
Query: 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN-------- 350
P + L +L L + ++ L +++ + L +N ++
Sbjct: 83 IKP------LANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 351 ---TLDMGN----AVGPL-----LQLVDLQNNQISAITLGSGIKN-YTLILVGNPV 393
+L +GN + L L + L++NQIS I +G+ L L N +
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 9e-15
Identities = 61/222 (27%), Positives = 87/222 (39%), Gaps = 56/222 (25%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTE--IELLSR 679
IG G +GKV +L ++ A+K + ++ + +E + LL
Sbjct: 46 IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHI------MSERNV-LLKN 95
Query: 680 VHHKNLVGLVGFCFEQGEQML--VYEFMANGTLRESLSGRSGIHLDWKRRLR-------- 729
V H LVGL F F Q L V +++ G L HL +R
Sbjct: 96 VKHPFLVGLH-FSF-QTADKLYFVLDYINGGELF--------YHLQRERCFLEPRARFYA 145
Query: 730 --IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
IA L YLH L I++RD+K NILLD + DFGL K + +
Sbjct: 146 AEIASA----LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKE--NIEHNSTT 196
Query: 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ GT YL PE Q D + G V+ E++ P
Sbjct: 197 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 1e-14
Identities = 57/240 (23%), Positives = 99/240 (41%), Gaps = 53/240 (22%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV- 680
IG G Y KV +L ++ A+K + +TE + +
Sbjct: 17 IGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWV------QTEKHVFEQAS 67
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--- 736
+H LVGL CF+ ++ V E++ G L H+ +R+ ++ AR
Sbjct: 68 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLM--------FHM--QRQRKLPEEHARFYS 116
Query: 737 -----GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
L YLHE II+RD+K N+LLD K+ D+G+ K G ++
Sbjct: 117 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFC 171
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851
GT Y+ PE + D ++ GV+M E++ + P + + +++ E++
Sbjct: 172 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP-----FDIVGSSDNPDQNTEDY 226
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 53/240 (22%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV- 680
IG G Y KV +L ++ A++ + +TE + +
Sbjct: 60 IGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWV------QTEKHVFEQAS 110
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR--- 736
+H LVGL CF+ ++ V E++ G L H+ +R+ ++ AR
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLM--------FHM--QRQRKLPEEHARFYS 159
Query: 737 -----GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVK 791
L YLHE II+RD+K N+LLD K+ D+G+ K G ++
Sbjct: 160 AEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFC 214
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851
GT Y+ PE + D ++ GV+M E++ + P + + +++ E++
Sbjct: 215 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP-----FDIVGSSDNPDQNTEDY 269
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 3e-14
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 52/220 (23%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV- 680
+G G +GKV ML ++ A+K E +L+
Sbjct: 28 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECT------MVEKRVLALPG 78
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR---------- 729
L L CF+ +++ V E++ G L H+ R +
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--------YHIQQVGRFKEPHAVFYAAE 129
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
IA+G L +L II+RD+K N++LD K+ADFG+ K + G +
Sbjct: 130 IAIG----LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKT 180
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT Y+ PE Q + D ++FGV++ E++ + P
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 57/220 (25%), Positives = 84/220 (38%), Gaps = 52/220 (23%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV- 680
+G G +GKV ML G + A+K TE +LS
Sbjct: 31 LGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECT------MTEKRILSLAR 81
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR---------- 729
+H L L CF+ +++ V EF+ G L H+ RR
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLM--------FHIQKSRRFDEARARFYAAE 132
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
I L +LH+ II+RD+K N+LLD K+ADFG+ K G +
Sbjct: 133 IISA----LMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTAT 183
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT Y+ PE D ++ GV++ E++ P
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 4e-14
Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 52/220 (23%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV- 680
+G G +GKV ML ++ A+K E +L+
Sbjct: 349 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECT------MVEKRVLALPG 399
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR---------- 729
L L CF+ +++ V E++ G L H+ R +
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLM--------YHIQQVGRFKEPHAVFYAAE 450
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
IA+G L +L II+RD+K N++LD K+ADFG+ K + G +
Sbjct: 451 IAIG----LFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKT 501
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT Y+ PE Q + D ++FGV++ E++ + P
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 4e-14
Identities = 56/220 (25%), Positives = 85/220 (38%), Gaps = 52/220 (23%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRV- 680
+G G +GKV L Q AIK E +LS
Sbjct: 25 LGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECT------MVEKRVLSLAW 75
Query: 681 HHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR---------- 729
H L + F+ E + V E++ G L H+ +
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLM--------YHIQSCHKFDLSRATFYAAE 126
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQ 789
I LG L +LH I++RD+K NILLD++ K+ADFG+ K + +
Sbjct: 127 IILG----LQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE--NMLGDAKTNT 177
Query: 790 VKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT Y+ PE + Q+ D +SFGV++ E++ + P
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 6e-14
Identities = 58/366 (15%), Positives = 121/366 (33%), Gaps = 46/366 (12%)
Query: 44 PTWKNSDDPCGSWEGVTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRS 92
+ V +N R AL LS ++ DI L+ELR
Sbjct: 21 IVGSMTPFSNELESMVDYSNRNLTHVPKDLPPRTKALSLSQNSISELRMPDISFLSELRV 80
Query: 93 LDLSYNGGLTGSLSPRIGD-LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSG 151
L LS+N + SL + Q L L ++ NI +A L L L+ N+F
Sbjct: 81 LRLSHN-RIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD- 134
Query: 152 RIPPS--LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE 209
+P G L++L +L L+ + + + + L + + G +E
Sbjct: 135 VLPVCKEFGNLTKLTFLGLSAAKFR-QLDLLPVAHLHLSCI----LLDLVSYHIKGGETE 189
Query: 210 QLFSPDMVLIHVLFDGNQLSGNIPE-SLGYVQTLEVLRLDRNALTGKVPTNL--NNLTNV 266
L P+ ++H++F N L S+ + L++ + N +
Sbjct: 190 SLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249
Query: 267 NELNLAHNDLKGPFPDLSQM------NSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICE 320
LN+ ++ + ++ + Y+++ N + + + +
Sbjct: 250 TLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT----ERIDREEFTYSETALK 305
Query: 321 FGSLQGRVPDKLFS-----YSQIQQVKLRNNAFNNT--LDMGNAVGPL-LQLVDLQNNQI 372
++ YS ++ ++ + ++T + M P ++ N
Sbjct: 306 SLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF 365
Query: 373 SAITLG 378
+
Sbjct: 366 TDSVFQ 371
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 4e-13
Identities = 50/316 (15%), Positives = 94/316 (29%), Gaps = 16/316 (5%)
Query: 90 LRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNF 149
L + L + + + + L+ +
Sbjct: 203 FHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT 262
Query: 150 SGRIPP--SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTI 207
+ +L++ + +T I T LK+ H
Sbjct: 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSET-ALKSLMIEHVKNQVFL-FS 320
Query: 208 SEQLFSPDMVLIHVL-FDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNV 266
E L+S +++ + + L +N T V + L +
Sbjct: 321 KEALYS-VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 267 NELNLAHNDLK---GPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGS 323
L L N LK M+SL +D+S NS + + S+ L
Sbjct: 380 QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNM 439
Query: 324 LQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS--GI 381
L G V L +++ + L NN ++ LQ +++ +NQ+ ++ G +
Sbjct: 440 LTGSVFRCLP--PKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRL 496
Query: 382 KNYTLI-LVGNP-VCT 395
+ I L NP CT
Sbjct: 497 TSLQYIWLHDNPWDCT 512
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 37/318 (11%), Positives = 85/318 (26%), Gaps = 68/318 (21%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
+P ++ L+L+ N+ S + + LS+L L L+ N++ S+
Sbjct: 46 VPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHV-----F 96
Query: 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247
++ ++ + N+L NI + +L L L
Sbjct: 97 LFNQDLEYLDVSHNRLQ--------------------------NIS--CCPMASLRHLDL 128
Query: 248 DRNALTG-KVPTNLNNLTNVNELNLAHNDLK-GPFPDLSQMN------------------ 287
N V NLT + L L+ + ++ ++
Sbjct: 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGET 188
Query: 288 --------SLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQ-- 337
++ ++ NS + + + L L + + S
Sbjct: 189 ESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRG 248
Query: 338 IQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVCTAT 397
+ + T + ++ I +T+ I + +
Sbjct: 249 PTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308
Query: 398 LANTNYCQLQQPTTKAYS 415
+ + YS
Sbjct: 309 IEHVKNQVFLFSKEALYS 326
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 39/157 (24%), Positives = 63/157 (40%), Gaps = 23/157 (14%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGF 691
+G G GKV + + A+K +Q + + E+EL R ++V +V
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALK-----MLQDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 692 CFEQGEQM-----LVYEFMANGTLRESLSGRSGIHLDWK--RRLRIALGSARGLAYLHEL 744
+E +V E + G L + R + + ++G A + YLH +
Sbjct: 80 -YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA--IQYLHSI 136
Query: 745 ANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLV 778
I HRDVK N+L N K+ DFG +K
Sbjct: 137 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 170
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 8e-14
Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 50/237 (21%)
Query: 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGML----SDGQVVAIK---------RAQQ 661
+W + + + F +G+G +G+V ML G A+K Q
Sbjct: 29 KWETPSQNTAQLDQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQI 85
Query: 662 GSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGI 720
E +L V+ LV L F F+ + +V E++A G +
Sbjct: 86 EHT------LNEKRILQAVNFPFLVKLE-FSFKDNSNLYMVMEYVAGGEMFS-------- 130
Query: 721 HLDWKRRLRIALGSAR--------GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772
HL +R R + AR YLH L +I+RD+K N+L+D+ +V DF
Sbjct: 131 HL--RRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDF 185
Query: 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
G +K V + T + GT L PE +++ + D ++ GV++ E+ P
Sbjct: 186 GFAKRVKGRTW----T-LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 37/214 (17%), Positives = 78/214 (36%), Gaps = 46/214 (21%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143
GL +L + DL L+ +
Sbjct: 15 DPGLANAVKQNLGKQ---------SVTDLVSQK------------------ELSGVQNFN 47
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
+++N + + + L L L+ NQ++ ++ L L + N+N+L
Sbjct: 48 GDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS------DLS--PLKDLTKLEELSVNRNRL 97
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNL 263
++ P L + D N+L +SL +++ LE+L + N L L L
Sbjct: 98 K-NLN---GIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK--SIVMLGFL 149
Query: 264 TNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297
+ + L+L N++ L+++ ++++DL+
Sbjct: 150 SKLEVLDLHGNEITN-TGGLTRLKKVNWIDLTGQ 182
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 36/190 (18%), Positives = 68/190 (35%), Gaps = 32/190 (16%)
Query: 133 IGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKN 192
LA L + + + +LS + + ++ + S+ G+ N
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SLA-------GMQFFTN 64
Query: 193 AKHFHFNKNKLSGTIS--EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250
K H + N++S +S + L L + + N+L L L LD N
Sbjct: 65 LKELHLSHNQIS-DLSPLKDLTK----LEELSVNRNRLKNLNGIPS---ACLSRLFLDNN 116
Query: 251 ALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN---SFDPTEAPLW 307
L +L +L N+ L++ +N LK L ++ L +DL N +
Sbjct: 117 ELRD--TDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEITNTGG------ 167
Query: 308 FSTLPSLTTL 317
+ L + +
Sbjct: 168 LTRLKKVNWI 177
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 8e-08
Identities = 39/217 (17%), Positives = 78/217 (35%), Gaps = 41/217 (18%)
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL-FDGNQLSGNIPESLGYVQTLEV 244
L NA + K ++ + Q ++ + D + + ++ + + L+
Sbjct: 14 PDPGLANAVKQNLGKQSVT-DLVSQ---KELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKE 67
Query: 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304
L L N ++ + L +LT + EL++ N LK + LS + L NN T++
Sbjct: 68 LHLSHNQIS--DLSPLKDLTKLEELSVNRNRLKN-LNGIPSAC-LSRLFLDNNELRDTDS 123
Query: 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQL 364
L +L L +RNN + + +G L++
Sbjct: 124 ---LIHLKNLEILS------------------------IRNNKLKSIVMLGFL--SKLEV 154
Query: 365 VDLQNNQISAITLGSGIKNYT-LILVGNPVCTATLAN 400
+DL N+I+ + +K + L G +
Sbjct: 155 LDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEPVKY 191
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 7e-06
Identities = 30/124 (24%), Positives = 49/124 (39%), Gaps = 22/124 (17%)
Query: 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN-IPD--EIGNLAELS 140
+ LT+L L ++ N R+ +L + L+ N + D + +L L
Sbjct: 81 LKDLTKLEELSVNRN---------RLKNLNGIPSACLSRLFLDNNELRDTDSLIHLKNLE 131
Query: 141 FLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNK 200
L++ +N I LG LS+L LDL N++T + GL +LK
Sbjct: 132 ILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEIT-NT-------GGLTRLKKVNWIDLTG 181
Query: 201 NKLS 204
K
Sbjct: 182 QKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 16/135 (11%), Positives = 37/135 (27%), Gaps = 32/135 (23%)
Query: 258 TNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
L N + NL + +++ + + N++ +L L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTD-LVSQKELSGVQNFNGDNSNIQSLAG---MQFFTNLKEL 68
Query: 318 ICEFGSLQGRVPDKLFSYSQIQQVK-LRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAIT 376
S++QI + L++ L+ + + N++ +
Sbjct: 69 H--------------LSHNQISDLSPLKDL-------------TKLEELSVNRNRLKNLN 101
Query: 377 LGSGIKNYTLILVGN 391
L L N
Sbjct: 102 GIPSACLSRLFLDNN 116
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 45/225 (20%), Positives = 76/225 (33%), Gaps = 51/225 (22%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
+P ++ + + L L+ N +L ++L L+L +LT + V
Sbjct: 25 LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-------G 74
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
L + N+L ++P + L VL +
Sbjct: 75 TLPVLGTLDLSHNQLQ--------------------------SLPLLGQTLPALTVLDVS 108
Query: 249 RNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD--P 301
N LT +P L + EL L N+LK G + L + L+NN+ P
Sbjct: 109 FNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK---LEKLSLANNNLTELP 164
Query: 302 TEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNN 346
+ L +L TL+ + SL +P F + L N
Sbjct: 165 AGL---LNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 54/235 (22%), Positives = 77/235 (32%), Gaps = 61/235 (25%)
Query: 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFT 126
T L LS L + T L L+L +L KL +
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRA------------ELTKLQVD-------- 73
Query: 127 GNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186
G L L L L+ N +P L L LD++ N+LT S+P+
Sbjct: 74 -------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGA----- 119
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246
L L + + N+L T+ L +P LE L
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTP-------------TPK-----------LEKLS 154
Query: 247 LDRNALTGKVPTNL-NNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD 300
L N LT ++P L N L N++ L L N L + L + L N +
Sbjct: 155 LANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 36/147 (24%), Positives = 55/147 (37%), Gaps = 21/147 (14%)
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFD 300
+L L N L L T + +LNL +L + L +DLS+N
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVDGTLPVLGTLDLSHNQL- 89
Query: 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF-SYSQIQQVKLRNN--------AFNNT 351
PL TLP+LT L F L +P ++Q++ L+ N T
Sbjct: 90 -QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 352 LDMGNAVGPLLQLVDLQNNQISAITLG 378
P L+ + L NN ++ + G
Sbjct: 148 --------PKLEKLSLANNNLTELPAG 166
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 2e-13
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 635 IGSGGYGKVY----RGMLSDGQVVAIKRAQQGSMQGGLEF----KTEIELLSRV-HHKNL 685
+G+G YGKV+ G++ A+K ++ ++ + +TE ++L + L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 686 VGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR-------- 736
V L + F+ ++ L+ +++ G L HL +R R +
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELF--------THL--SQRERFTEHEVQIYVGEIVL 170
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
L +LH+L II+RD+K NILLD N + DFGLSK GT+ Y
Sbjct: 171 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226
Query: 797 LDPE--YYMTQQLTEKSDVYSFGVVMLELITAKQP 829
+ P+ + D +S GV+M EL+T P
Sbjct: 227 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.6 bits (174), Expect = 3e-13
Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 54/219 (24%)
Query: 635 IGSGGYGKVYRGML----SDGQVVAIK---------RAQQGSMQGGLEFKTEIELLSRVH 681
+G+G +G+V L +G+ A+K Q E +LS V
Sbjct: 14 LGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT------NDERLMLSIVT 64
Query: 682 HKNLVGLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLR----------I 730
H ++ + F+ +Q+ ++ +++ G L L +R +
Sbjct: 65 HPFIIRMW-GTFQDAQQIFMIMDYIEGGELF--------SLLRKSQRFPNPVAKFYAAEV 115
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
L L YLH II+RD+K NILLD+N K+ DFG +K V D + T +
Sbjct: 116 CLA----LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----T-L 163
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT Y+ PE T+ + D +SFG+++ E++ P
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 6e-13
Identities = 54/244 (22%), Positives = 98/244 (40%), Gaps = 70/244 (28%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKT---------EIELLSRVH-HK 683
+G G YG V++ + G+VVA+K+ F+ EI +L+ + H+
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIMILTELSGHE 69
Query: 684 NLVGLVG-FCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRI-ALGSA----- 735
N+V L+ + + LV+++M E+ D +R L
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYM------ET---------DLHAVIRANILEPVHKQYV 114
Query: 736 -----RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
+ + YLH ++HRD+K +NILL+ KVADFGLS+ + + + +
Sbjct: 115 VYQLIKVIKYLHS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPL 171
Query: 791 KGTMGYLDPEY---YMT-----------------QQLTEKSDVYSFGVVMLELITAKQPI 830
+ + +T + T+ D++S G ++ E++ K PI
Sbjct: 172 SINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PI 230
Query: 831 EKGK 834
G
Sbjct: 231 FPGS 234
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 69.5 bits (169), Expect = 1e-12
Identities = 35/206 (16%), Positives = 55/206 (26%), Gaps = 53/206 (25%)
Query: 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIK--------RAQQGSMQGGLEFKTEIELL 677
+ +IG G +G+V++ + D VAIK + E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 678 SRVH---------HKNLVGLVGFCFEQGE------------------------------Q 698
+ + +GL QG
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTN 758
+V EF G E + + I LA HRD+ N
Sbjct: 138 FIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192
Query: 759 ILLDENLTAKVADFGLSKLVSDSSKG 784
+LL + K+ K + S G
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCG 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 59/201 (29%), Positives = 85/201 (42%), Gaps = 35/201 (17%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPG 186
NIP A+ L L SN S +P +L++L L L DN+L ++P
Sbjct: 34 NIP------ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGI----- 80
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQ---LSGNIPESLGYVQTLE 243
+LKN + NKL + +F + L + D NQ L + +SL L
Sbjct: 81 FKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT---KLT 136
Query: 244 VLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNS 298
L L N L +P + + LT++ EL L +N LK G F L++ L + L NN
Sbjct: 137 YLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE---LKTLKLDNNQ 192
Query: 299 FD--PTEAPLWFSTLPSLTTL 317
P A F +L L L
Sbjct: 193 LKRVPEGA---FDSLEKLKML 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 1e-10
Identities = 50/211 (23%), Positives = 79/211 (37%), Gaps = 38/211 (18%)
Query: 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGF 125
L L + L+ S LT+LR L L+ N L +L I +L+ L L +
Sbjct: 40 KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNK-LQ-TLPAGIFKELKNLETLWVTDNKL 97
Query: 126 TGNIPDEI-GNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWLDLADNQLTGSIPVSTIT 183
+P + L L+ L L+ N +PP + L++L +L L N+L S+P
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV-- 152
Query: 184 SPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLE 243
D+L + K N+L + FD + L+
Sbjct: 153 ---FDKLTSLKELRLYNNQLK------------RVPEGAFDK-------------LTELK 184
Query: 244 VLRLDRNALTGKVPTNLNNLTNVNELNLAHN 274
L+LD N L ++L + L L N
Sbjct: 185 TLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 35/155 (22%), Positives = 56/155 (36%), Gaps = 34/155 (21%)
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSN 296
+ L L N L+ + LT + L L N L+ G F +L L + +++
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN---LETLWVTD 94
Query: 297 NSFD--PTEAPLWFSTLPSLTTLIC---EFGSLQGRVPDKLFSYSQIQQVKLRNN----- 346
N P F L +L L + SL RV D L +++ + L N
Sbjct: 95 NKLQALPIGV---FDQLVNLAELRLDRNQLKSLPPRVFDSL---TKLTYLSLGYNELQSL 148
Query: 347 ---AFNNTLDMGNAVGPLLQLVDLQNNQISAITLG 378
F+ L+ + L NNQ+ + G
Sbjct: 149 PKGVFDKL--------TSLKELRLYNNQLKRVPEG 175
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 41/184 (22%), Positives = 74/184 (40%), Gaps = 28/184 (15%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPP--SLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
++P + + L L+ NN S R+ + +L+ L+ L L+ N L I
Sbjct: 36 SLP------SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEA---- 83
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLGYVQTLEV 244
+ N ++ + N L T+ E LFS L +L N + + + + L+
Sbjct: 84 -FVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK 140
Query: 245 LRLDRNALTGKVP----TNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSN 296
L L +N ++ + P + N L + L+L+ N LK L + + L N
Sbjct: 141 LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAW-VKNGLYLHN 198
Query: 297 NSFD 300
N +
Sbjct: 199 NPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 40/199 (20%), Positives = 72/199 (36%), Gaps = 19/199 (9%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRI-GDLQKLNILILAGCGFTGNIPDEI-GNLAELSFLA 143
LT L SL LS+N L +S + L L L+ + + + +L L L
Sbjct: 62 RLTNLHSLLLSHN-HLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLL 118
Query: 144 LNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNK 202
L +N+ + + ++QL L L+ NQ++ PV I ++L + NK
Sbjct: 119 LYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK--DGNKLPKLMLLDLSSNK 174
Query: 203 LSGTISEQLFS--PDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDR-----NALTGK 255
L + P V + N L + + + +L L
Sbjct: 175 LK-KLPLTDLQKLPAWVKNGLYLHNNPLECD-CKLYQLFSHWQYRQLSSVMDFQEDLYCM 232
Query: 256 VPTNLNNLTNVNELNLAHN 274
L+N+ +++ N +
Sbjct: 233 HSKKLHNIFSLDFFNCSEY 251
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 41/184 (22%), Positives = 67/184 (36%), Gaps = 41/184 (22%)
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTN--LNNLTNVNELNLAHNDLK----GPFPDLS 284
++P +L L N L+ ++ LTN++ L L+HN L F +
Sbjct: 36 SLPSYT------ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 285 QMNSLSYVDLSNNSFD--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY-SQIQQV 341
+ L DLS+N FS L +L L+ + V F +Q+Q++
Sbjct: 89 NLRYL---DLSSNHLHTLDEFL---FSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKL 141
Query: 342 KLRNN--------AFNNTLDMGNAVGPLLQLVDLQNNQISAITLG-----SGIKNYTLIL 388
L N + + P L L+DL +N++ + L L L
Sbjct: 142 YLSQNQISRFPVELIKDGNKL-----PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196
Query: 389 VGNP 392
NP
Sbjct: 197 HNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 33/128 (25%)
Query: 256 VPTNLNNLTNVNELNLAHNDLK--GPFPDLSQMNSLSYVDLSNNSFD--PTEAPLWFSTL 311
VP +L + L+L+HN+L +++ +L + LS+N + +EA F +
Sbjct: 33 VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEA---FVPV 87
Query: 312 PSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371
P+L L L S + + L F++ L+++ L NN
Sbjct: 88 PNLRYL-------------DL-SSNHLHT--LDEFLFSDL--------QALEVLLLYNNH 123
Query: 372 ISAITLGS 379
I + +
Sbjct: 124 IVVVDRNA 131
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 6e-11
Identities = 50/251 (19%), Positives = 100/251 (39%), Gaps = 48/251 (19%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVH---------- 681
+G G + V+ + + VA+K R + + + EI+LL RV+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED---EIKLLQRVNDADNTKEDSM 83
Query: 682 -HKNLVGLVG---FCFEQGEQM-LVYEFMANGTLRESL--SGRSGIHLDWKRRLRIALGS 734
+++ L+ G + +V+E + L + GI L + ++ I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ--ISKQL 140
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDE------NLTAKVADFGLSKLVSDSSKGHVST 788
GL Y+H IIH D+K N+L++ + K+AD G + + + T
Sbjct: 141 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 198
Query: 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD 848
+ Y PE + +D++S ++ ELIT G ++ D
Sbjct: 199 RE-----YRSPEVLLGAPWGCGADIWSTACLIFELIT-------GDFLFEPDEGHSYTKD 246
Query: 849 EEHYGLTEMMD 859
++H + ++++
Sbjct: 247 DDH--IAQIIE 255
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.4 bits (156), Expect = 1e-10
Identities = 39/174 (22%), Positives = 64/174 (36%), Gaps = 9/174 (5%)
Query: 2 DELRLLIFIALFSFHIQLISSATDSRDAAALQSLKDAWQNTPPTWKNSDDPCGSWEGVTC 61
++ LL I L L+ + + L+++ D + S +
Sbjct: 381 NKWCLLTIILLMRALDPLLYEKETLQYFSTLKAV-DPMRAAYLDDLRSKF-LLENSVLKM 438
Query: 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA 121
+ V L L+ LT L + L + LDLS+N L +L P + L+ L +L +
Sbjct: 439 EYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHN-RLR-ALPPALAALRCLEVLQAS 494
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSG-RIPPSLGKLSQLYWLDLADNQLT 174
N+ + NL L L L +N L +L L+L N L
Sbjct: 495 DNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 3e-10
Identities = 49/250 (19%), Positives = 77/250 (30%), Gaps = 47/250 (18%)
Query: 130 PDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQ 189
+ +L L S S + L +L L+ + +I + LD
Sbjct: 342 CRDSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTI---ILLMRALDP 397
Query: 190 LKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDR 249
L K + L + D + L + VL L
Sbjct: 398 LLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLL-------ENSVLKMEYADVRVLHLAH 450
Query: 250 NALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN---SFDPTEAPL 306
LT V +L L V L+L+HN L+ P L+ + L + S+N + D
Sbjct: 451 KDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG----- 503
Query: 307 WFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG-PLLQLV 365
+ LP L L+ L NN + + V P L L+
Sbjct: 504 -VANLPRLQELL------------------------LCNNRLQQSAAIQPLVSCPRLVLL 538
Query: 366 DLQNNQISAI 375
+LQ N +
Sbjct: 539 NLQGNSLCQE 548
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 2e-10
Identities = 47/285 (16%), Positives = 94/285 (32%), Gaps = 66/285 (23%)
Query: 619 YDELKKCSNNFSESNEI---GSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIE 675
Y +L++ + + G G GK VA+ +Q ++FK
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGK---------TWVALDVCLSYKVQCKMDFK---- 183
Query: 676 LLSRVHHKNLVGLVGFCFEQGE-----QMLVYEFMANGTLRESLSGRSGIHLDW-KRRLR 729
+ N + C Q L+Y+ N T R S + + + LR
Sbjct: 184 ----IFWLN----LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR 235
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV----ADFGLSKLVSDSSKGH 785
L S Y + L ++ +V++ NL+ K+ ++ +S ++ H
Sbjct: 236 RLLKSKP---YENCL----LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTH 288
Query: 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE--KG-----KYVVR 838
+S +M E + L K L+ P E +
Sbjct: 289 IS-LDHHSMTLTPDE---VKSLLLKY---------LDCRPQDLPREVLTTNPRRLSIIAE 335
Query: 839 EVRTAMNRDDE-EHYG---LTEMMDPTIRNTVLLGFRR-YLELAL 878
+R + D +H LT +++ ++ +R+ + L++
Sbjct: 336 SIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-09
Identities = 66/425 (15%), Positives = 117/425 (27%), Gaps = 125/425 (29%)
Query: 31 ALQSLKDAWQNTPPTWKNSDDPCGSWEGVTCNNSRVT-ALGLSTMGLTGKLSGD--IGGL 87
L L + W + C +T +VT L +T T +S D L
Sbjct: 246 CLLVLLNVQ--NAKAWNAFNLSCKIL--LTTRFKQVTDFLSAAT---TTHISLDHHSMTL 298
Query: 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEI--GNLAELSFLALN 145
T L L L R DL P E+ N LS +A +
Sbjct: 299 TPDEVKSL-----LLKYLDCRPQDL-----------------PREVLTTNPRRLSIIAES 336
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA---KHFHFNKNK 202
+ W + ++LT I S L+ L+ A K F +
Sbjct: 337 IRDGLATWD---------NWKHVNCDKLTTIIESS------LNVLEPAEYRKMFD----R 377
Query: 203 LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL---------RLDRNALT 253
LS +F P +IP L ++ + N L
Sbjct: 378 LS------VFPPSA--------------HIPT-----ILLSLIWFDVIKSDVMVVVNKLH 412
Query: 254 GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSL---SYVDL----SNNSFDPTEAPL 306
+ + + +LK + ++ Y S++ P
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY 472
Query: 307 WFSTLP------SLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP 360
++S + + F + ++Q K+R+++ NA G
Sbjct: 473 FYSHIGHHLKNIEHPERMTLF-------RMVFLDFRFLEQ-KIRHDSTA-----WNASGS 519
Query: 361 LLQ-LVDLQNNQISAITLGSGIKNYTLILVGN--PVCTATLANTNYC---Q--LQQPTTK 412
+L L L+ + I + + + P L + Y + L
Sbjct: 520 ILNTLQQLKFYK-PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEA 578
Query: 413 AYSTS 417
+ +
Sbjct: 579 IFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 69/511 (13%), Positives = 138/511 (27%), Gaps = 172/511 (33%)
Query: 112 LQKL----NILI--LAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYW 165
L +L N+LI + G G T ++ S ++ +++W
Sbjct: 144 LLELRPAKNVLIDGVLGSGKT-----------WVALDVCLSYKVQCKMD------FKIFW 186
Query: 166 LDLADNQLTGSIP---------VSTITSPGLDQLKNAKH-FHFNKNKLSGTISEQLFSPD 215
L+L + ++ + + D N K H + +L + + + +
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY-EN 245
Query: 216 MVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK----VPTNLNNLTN-VNELN 270
+L+ L + VQ + NA + T +T+ ++
Sbjct: 246 CLLV--LLN--------------VQNAKAW----NAFNLSCKILLTTRFKQVTDFLSAAT 285
Query: 271 LAHNDLKGPFPDLSQMNSLS----YVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG 326
H L L+ S Y+D P E +T P ++I E
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL-PREVL---TTNPRRLSIIAE------ 335
Query: 327 RVPDKLFSYSQIQQVKLRNNAFNNTLDMG-NAVGPLLQ---LVDL----QNNQISAITLG 378
+ D L ++ + V + ++ N + P L + I I L
Sbjct: 336 SIRDGLATWDNWKHVN--CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS 393
Query: 379 ---SGIKNYTLILVGNPVCTATLANTN-----------YCQLQQPTTK----------AY 414
+ +++V N + +L Y +L+ Y
Sbjct: 394 LIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHY 453
Query: 415 STSLANCGGKSCPP------------------------------------EQKLSPQSCE 438
+ PP EQK+ S
Sbjct: 454 NIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTA 513
Query: 439 CAYP------------YEGTMYFRGPSFRELSNVTVFHSLEMSLWVKLGLTPGSVFLQNP 486
Y+ + P + L N + L + +
Sbjct: 514 WNASGSILNTLQQLKFYKPYICDNDPKYERLVN-AILDFLP---------KIEENLICSK 563
Query: 487 FFNIDDYLQIQVALFPSGEKSFNRSE--VQK 515
+ ++ +++AL E F + VQ+
Sbjct: 564 YTDL-----LRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 2e-05
Identities = 86/636 (13%), Positives = 176/636 (27%), Gaps = 196/636 (30%)
Query: 328 VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDL---QNNQISAITLGSGI-KN 383
V D + + L ++ + +AV L+L + ++ + + N
Sbjct: 38 VQDMP------KSI-LSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN 90
Query: 384 YTLILVGNPVCTAT----------------LANTN-------------YCQLQQPTTKAY 414
Y ++ +P+ T L N N Y +L+Q +
Sbjct: 91 YKFLM--SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELR 148
Query: 415 STS-LANCG----GKSCPPEQKLSPQSCECAYPYEGTMYFRGPSFRELSNVTVFHSLEMS 469
+ G GK+ ++ C +Y + M F+ +F
Sbjct: 149 PAKNVLIDGVLGSGKTW-----VALDVCL-SYKVQCKMDFK-----------IF------ 185
Query: 470 LWVKLGL--TPGSVF--LQNPFFNIDDYLQIQVALFPSG----------------EKSFN 509
W+ L +P +V LQ + ID + + K +
Sbjct: 186 -WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 510 RS-----EVQ--KI--GFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNS--ISPGVAA 558
VQ K F LS + + F+++ + +S ++P
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVK 304
Query: 559 GI---------------ACGGAVLVLGLVGLGLYAIRQ-KKRAERAIGLSKPFASWAPSG 602
+ L ++ +IR + W
Sbjct: 305 SLLLKYLDCRPQDLPREVLTTNPRRLSIIAE---SIRDGLATWDN----------WKHVN 351
Query: 603 KDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYR--GMLSDGQVVAIKRAQ 660
D +L S + L E E Y K++ + I
Sbjct: 352 CD-----KLTTIIESSLNVL--------EPAE-----YRKMFDRLSVFPPS--AHIPTIL 391
Query: 661 QGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGI 720
+ + + +++++H +LV +Q ++ + L+ L +
Sbjct: 392 LSLIWFDVIKSDVMVVVNKLHKYSLV------EKQPKESTISIPSIYLELKVKLENEYAL 445
Query: 721 HLDWKRRLRIALGSARG------------------LAYLHELANPPIIHRDVKSTNILLD 762
H R + + + + H L N R + LD
Sbjct: 446 H----RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-H-LKNIEHPERMTLFRMVFLD 499
Query: 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLE 822
F K+ DS+ + S + T+ ++Y + + Y V +
Sbjct: 500 FR-------FLEQKIRHDSTAWNASGSILNTL--QQLKFY-KPYICDNDPKYERLVNAIL 549
Query: 823 --LITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856
L ++ + KY +R A+ +DE +
Sbjct: 550 DFLPKIEENLICSKY-TDLLRIALMAEDEAIFEEAH 584
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 40/180 (22%), Positives = 65/180 (36%), Gaps = 49/180 (27%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPPS--LGKLSQLYWLDLADNQLTGSIPVSTITSP 185
+IP + L LN+N F+ + + KL QL ++ ++N++T I
Sbjct: 29 HIP------QYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGA---- 76
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
+ N+L + M F G L L+ L
Sbjct: 77 -FEGASGVNEILLTSNRL------ENVQHKM------FKG--LES-----------LKTL 110
Query: 246 RLDRNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
L N +T V + L++V L+L N + G F L SLS ++L N F+
Sbjct: 111 MLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH---SLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 35/166 (21%), Positives = 61/166 (36%), Gaps = 33/166 (19%)
Query: 55 SWEGVTCNNSRVTA-----------LGLSTMGLTG-KLSGDIGGLTELRSLDLSYNGGLT 102
V C+N ++ L L+ T + +G L +LR ++ S N +T
Sbjct: 12 EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNN-KIT 70
Query: 103 GSLSPRIGD-LQKLNILILAGCGFTGN----IPDEI-GNLAELSFLALNSNNFSGRIPP- 155
+ + +N ++L T N + ++ L L L L SN + +
Sbjct: 71 -DIEEGAFEGASGVNEILL-----TSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGND 123
Query: 156 SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKN 201
S LS + L L DNQ+T ++ D L + + N
Sbjct: 124 SFIGLSSVRLLSLYDNQIT-TVAPGA-----FDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 38/172 (22%), Positives = 68/172 (39%), Gaps = 46/172 (26%)
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPT-NLNNLTNVNELNLAHNDLK----GPFPDLSQ 285
+IP Q LRL+ N T T L + ++N ++N + G F S
Sbjct: 29 HIP------QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82
Query: 286 MNSLSYVDLSNNSFD--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKL 343
+N + L++N + + F L SL TL L ++I +
Sbjct: 83 VNEI---LLTSNRLENVQHKM---FKGLESLKTL-----ML---------RSNRITC--V 120
Query: 344 RNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG--SGIKNYTLI-LVGNP 392
N++F L ++L+ L +NQI+ + G + + + + L+ NP
Sbjct: 121 GNDSFIG-L-------SSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP 164
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 26/119 (21%), Positives = 39/119 (32%), Gaps = 22/119 (18%)
Query: 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNN 297
L + N +T + VNE+ L N L+ F L L + L +N
Sbjct: 59 LRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLES---LKTLMLRSN 115
Query: 298 --SFDPTEAPLWFSTLPSLTTLICEFGSLQG----RVPDKLFSY-SQIQQVKLRNNAFN 349
+ ++ F L S+ L SL V F + + L N FN
Sbjct: 116 RITCVGNDS---FIGLSSVRLL-----SLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 20/166 (12%)
Query: 142 LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKN 201
L L S + + L++L WL+L NQL ++ D L N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGV-----FDDLTELGTLGLANN 93
Query: 202 KLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL--GYVQTLEVLRLDRNALTGKVPTN 259
+L+ ++ +F L + GNQL +P + + L+ LRL+ N L +P
Sbjct: 94 QLA-SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTK-LKELRLNTNQLQ-SIPAG 149
Query: 260 L-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
+ LTN+ L+L+ N L+ G F L L + L N FD
Sbjct: 150 AFDKLTNLQTLSLSTNQLQSVPHGAFDRLG---KLQTITLFGNQFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 53/198 (26%), Positives = 79/198 (39%), Gaps = 34/198 (17%)
Query: 53 CGSWEGVTCNNS---------RVTA-----------LGLSTMGLTGKLSGDIGGLTELRS 92
C + G TCN + + L L + GL GLT+L
Sbjct: 4 CETVTGCTCNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTW 63
Query: 93 LDLSYNGGLTGSLSPRIGD-LQKLNILILAGCGFTGNIPDEI-GNLAELSFLALNSNNFS 150
L+L YN L +LS + D L +L L LA ++P + +L +L L L N
Sbjct: 64 LNLDYN-QLQ-TLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK 120
Query: 151 GRIPPSL-GKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE 209
+P + +L++L L L NQL SIP D+L N + + N+L ++
Sbjct: 121 -SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGA-----FDKLTNLQTLSLSTNQLQ-SVPH 172
Query: 210 QLFSPDMVLIHVLFDGNQ 227
F L + GNQ
Sbjct: 173 GAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-04
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 29/166 (17%)
Query: 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNS 298
E L L L LT + LNL +N L+ G F DL++ L + L+NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGLANNQ 94
Query: 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF-SYSQIQQVKLRNN--------AFN 349
+ F L L L L+ +P +F +++++++L N AF+
Sbjct: 95 LASLPLGV-FDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD 152
Query: 350 NTLDMGNAVGPLLQLVDLQNNQISAITLGS--GIKNYTLI-LVGNP 392
+ LQ + L NQ+ ++ G+ + I L GN
Sbjct: 153 KLTN--------LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 2e-09
Identities = 53/214 (24%), Positives = 87/214 (40%), Gaps = 47/214 (21%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHK------NL 685
IG G +G+V + Q VA+K R ++ + EI +L + + N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA---EEIRILEHLRKQDKDNTMNV 161
Query: 686 VGLVGF-------C--FEQGEQML---VYEFMANGTLRESLSGRSGIHLDWKRRLRIALG 733
+ ++ C FE +L +YE + + G L R+ A
Sbjct: 162 IHMLENFTFRNHICMTFE----LLSMNLYELIKKNKFQ-------GFSLPLVRK--FAHS 208
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILLDENLTA--KVADFGLSKLVSDSSKGHVSTQVK 791
+ L LH+ IIH D+K NILL + + KV DFG S V T ++
Sbjct: 209 ILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ----RVYTYIQ 261
Query: 792 GTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
+ Y PE + + D++S G ++ EL+T
Sbjct: 262 -SRFYRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 23/163 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC- 692
IGSG +G +Y G ++ G+ VAIK + L E ++ K + G VG
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIY-----KMMQGGVGIPT 69
Query: 693 -----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
E ++V E + G E L K L +A + Y+H
Sbjct: 70 IRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN-- 125
Query: 748 PIIHRDVKSTNILLDENLTAK---VADFGLSKLVSDSSKG-HV 786
IHRDVK N L+ + DFGL+K D+ H+
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI 167
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 31/162 (19%), Positives = 60/162 (37%), Gaps = 36/162 (22%)
Query: 142 LALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNK 200
+ L N IPP + +L +DL++NQ++ + L++
Sbjct: 37 IRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA-----FQGLRSLNSLVLYG 89
Query: 201 NKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL 260
NK+ + F+G L L++L L+ N + + +
Sbjct: 90 NKI------TELPKSL------FEG--LFS-----------LQLLLLNANKIN-CLRVDA 123
Query: 261 -NNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNSFD 300
+L N+N L+L N L+ S + ++ + L+ N F
Sbjct: 124 FQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 13/139 (9%)
Query: 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGD-LQKLNILILAGCG 124
+T + L + G +LR +DLS N ++ L+P L+ LN L+L G
Sbjct: 34 ITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN-QIS-ELAPDAFQGLRSLNSLVLYGNK 91
Query: 125 FTGNIPDEI-GNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTI 182
T +P + L L L LN+N + + + L L L L DN+L +I T
Sbjct: 92 IT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT- 147
Query: 183 TSPGLDQLKNAKHFHFNKN 201
L+ + H +N
Sbjct: 148 ----FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 40/171 (23%), Positives = 64/171 (37%), Gaps = 45/171 (26%)
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQM 286
N+PE T+ +RL++N + P + + ++L++N + F L +
Sbjct: 29 NLPE------TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSL 82
Query: 287 NSLSYVDLSNNSFD--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLR 344
NSL L N P F L SL L L + ++I LR
Sbjct: 83 NSL---VLYGNKITELPKSL---FEGLFSLQLL--------------LLNANKINC--LR 120
Query: 345 NNAFNNTLDMGNAVGPLLQLVDLQNNQISAI---TLGSGIKNYTLILVGNP 392
+AF + L L L+ L +N++ I T T+ L NP
Sbjct: 121 VDAFQD-L-------HNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNP 163
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 40/162 (24%), Positives = 58/162 (35%), Gaps = 24/162 (14%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC- 692
IG G +G ++ G L + Q VAIK + S L E K L G G
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTY-----KLLAGCTGIPN 70
Query: 693 -----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
E +LV + + G E L G K A + +HE +
Sbjct: 71 VYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS-- 126
Query: 748 PIIHRDVKSTNILLDENLTAK-----VADFGLSKLVSDSSKG 784
+++RD+K N L+ + V DFG+ K D
Sbjct: 127 -LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 27/205 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRV------HHKNL 685
IG G +G+V + + + VAIK + ++ + E+ LL + +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ---IEVRLLELMNKHDTEMKYYI 118
Query: 686 VGLVGFCFEQGEQMLVYEFMA-NGTLRESL--SGRSGIHLDWKRRLRIALGSARGLAYLH 742
V L + LV+E ++ N L + L + G+ L+ R+ A L +L
Sbjct: 119 VHLKRHFMFRNHLCLVFEMLSYN--LYDLLRNTNFRGVSLNLTRK--FAQQMCTALLFLA 174
Query: 743 ELANPPIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPE 800
IIH D+K NILL + K+ DFG S + + ++ + Y PE
Sbjct: 175 T-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ----RIYQYIQ-SRFYRSPE 228
Query: 801 YYMTQQLTEKSDVYSFGVVMLELIT 825
+ D++S G +++E+ T
Sbjct: 229 VLLGMPYDLAIDMWSLGCILVEMHT 253
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 46/178 (25%), Positives = 63/178 (35%), Gaps = 47/178 (26%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
IP L L+ N + P L L L L NQL ++P G+
Sbjct: 37 GIP------TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALP------VGV 83
Query: 188 -DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246
D L N+L+ P V FD L L+ L
Sbjct: 84 FDSLTQLTVLDLGTNQLTVL-------PSAV-----FD----------RLV---HLKELF 118
Query: 247 LDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
+ N LT ++P + LT++ L L N LK G F LS SL++ L N +D
Sbjct: 119 MCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLS---SLTHAYLFGNPWD 172
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 9e-07
Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 45/157 (28%)
Query: 59 VTCNNSRVTA-----------LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSP 107
V C + R + L L +T G L L+ L L N
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ-------- 75
Query: 108 RIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWL 166
L L G + D L +L+ L L +N + +P ++ +L L L
Sbjct: 76 ----LGALP----VG------VFDS---LTQLTVLDLGTNQLT-VLPSAVFDRLVHLKEL 117
Query: 167 DLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
+ N+LT +P G+++L + H ++N+L
Sbjct: 118 FMCCNKLT-ELP------RGIERLTHLTHLALDQNQL 147
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 7e-08
Identities = 59/308 (19%), Positives = 100/308 (32%), Gaps = 109/308 (35%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHH-------KN 684
+G G + V+ + + VA+K ++ + + L+ EI LL V + +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRNSDPNDPNRE 101
Query: 685 LVGLVGFCFE----QGEQM-LVYEFMANGTLRESL------SGRSGIHLDWKRRLRIALG 733
+V + F+ G + +V+E + L S G+ L ++ I
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-----GHHLLKWIIKSNYQGLPLPCVKK--IIQQ 154
Query: 734 SARGLAYLHELANPPIIHRDVKSTNILL-------------------------------- 761
+GL YLH IIH D+K NILL
Sbjct: 155 VLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVST 212
Query: 762 -----------------DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
E L K+AD G + V + T+ Y E +
Sbjct: 213 APATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIG 267
Query: 805 QQLTEKSDVYSFGVVMLELITAK---QPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861
+D++S + EL T +P +Y DE+H + +++
Sbjct: 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT----------RDEDH--IALIIE-- 313
Query: 862 IRNTVLLG 869
LLG
Sbjct: 314 -----LLG 316
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 58/287 (20%), Positives = 90/287 (31%), Gaps = 45/287 (15%)
Query: 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIG----GLTELRSLDLSYNG-GLTG--SLSPRI 109
EG+ R+ L L L+ + + + L +S N G L +
Sbjct: 135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGL 194
Query: 110 GDLQ-KLNILILAGCGFTGNIPDEIGNLAE-------LSFLALNSNNFSGR-----IPPS 156
D +L L L CG T D +L L LAL SN P
Sbjct: 195 KDSPCQLEALKLESCGVT---SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGL 251
Query: 157 LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT----ISEQLF 212
L S+L L + + +T + + L ++ K N+L + E L
Sbjct: 252 LHPSSRLRTLWIWECGIT-AKGCGDLCR-VLRAKESLKELSLAGNELGDEGARLLCETLL 309
Query: 213 SPDMVLIHVLFDGNQLSG----NIPESLGYVQTLEVLRLDRNALTGKVPTNL-----NNL 263
P L + + + L + L L++ N L L
Sbjct: 310 EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369
Query: 264 TNVNELNLAHNDL--KGPFPDLSQM----NSLSYVDLSNNSFDPTEA 304
+ + L LA D+ L+ +SL +DLSNN
Sbjct: 370 SVLRVLWLADCDVSDSS-CSSLAATLLANHSLRELDLSNNCLGDAGI 415
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 52/339 (15%), Positives = 98/339 (28%), Gaps = 80/339 (23%)
Query: 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSN 147
+++SLD+ + + LQ+ ++ L CG T +++ AL N
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT---EARCKDISS----ALRVN 55
Query: 148 NFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTI 207
L L+L N+L +
Sbjct: 56 -------------PALAELNLRSNELGDV---------------GVHC-----------V 76
Query: 208 SEQLFSPDMVLIHVLFDGNQLS----GNIPESLGYVQTLEVLRLDRNALTGKVPTNL--- 260
+ L +P + + L+ G + +L + TL+ L L N L L
Sbjct: 77 LQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEG 136
Query: 261 --NNLTNVNELNLAHNDLKGP-----FPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLP- 312
+ + +L L + L L + +SNN + + L
Sbjct: 137 LLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKD 196
Query: 313 ---SLTTLI---CEFGSLQGRV-PDKLFSYSQIQQVKLRNNAFNNT-----LDMGNAVGP 360
L L C S R + S + ++++ L +N +
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256
Query: 361 LLQLVDLQNNQIS---AITLGSGIKNYT----LILVGNP 392
L+ + + I+ L ++ L L GN
Sbjct: 257 RLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE 295
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 34/179 (18%), Positives = 63/179 (35%), Gaps = 37/179 (20%)
Query: 635 IGSGGYGKVYRGM---------LSDGQVVAIKR-AQQGSMQGGLEF------KTEIELLS 678
G +Y Q ++K A+ G + F ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 679 RVHHKNLVG---LVGFCFEQGEQMLVYEFMANGTLRESL------SGRSGIHLDWKRRLR 729
+++ L+ +GF Q + Y F+ +L SL S + + + L+
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKHVLSE--RSVLQ 163
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV--ADFGLSKLVSDSSKGHV 786
+A L +LHE +H +V + NI +D ++V A +G + S HV
Sbjct: 164 VACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHV 218
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 43/164 (26%), Positives = 63/164 (38%), Gaps = 28/164 (17%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHK 683
NF +IG G +G++ G L + VAIK + + Q LE++ +K
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---------YK 59
Query: 684 NLVGLVGFC------FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
L G +V E + G E L K L IA+
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISR 117
Query: 738 LAYLHELANPPIIHRDVKSTNILL--DENLTAKVA---DFGLSK 776
+ Y+H +I+RDVK N L+ N T +V DF L+K
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 41/160 (25%), Positives = 65/160 (40%), Gaps = 22/160 (13%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC- 692
IGSG +G++Y G + + VAIK + L + E ++ + L G G
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIY-----RILQGGTGIPN 67
Query: 693 -----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANP 747
E +LV + + G E L L K L +A + ++H +
Sbjct: 68 VRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-- 123
Query: 748 PIIHRDVKSTNILLDENLTAK---VADFGLSKLVSDSSKG 784
+HRD+K N L+ A + DFGL+K D+S
Sbjct: 124 -FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 34/173 (19%), Positives = 61/173 (35%), Gaps = 25/173 (14%)
Query: 635 IGSGGYGKVYRGM------LSDGQVVAIKRAQQGSMQGGLEFK--------TEIELLSRV 680
IG GG+G +Y + +K + E K +I+ R
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 681 HHKNLVGL--VGFCFEQGEQMLVYEFMAN---GTLRESLSGRSGIHLDWKRRLRIALGSA 735
+G+ + Y FM G+ + + + K L+++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRIL 162
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKV--ADFGLSKLVSDSSKGHV 786
L Y+HE +H D+K++N+LL+ +V D+GL+ H
Sbjct: 163 DILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP-EGVHK 211
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 26/155 (16%), Positives = 47/155 (30%), Gaps = 33/155 (21%)
Query: 244 VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTE 303
+++L + N EL+L + + ++ +D S+N +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD 58
Query: 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQ 363
F L L TL+ + NN + + P L
Sbjct: 59 G---FPLLRRLKTLL------------------------VNNNRICRIGEGLDQALPDLT 91
Query: 364 LVDLQNNQISAIT----LGSGIKNYTLILVGNPVC 394
+ L NN + + L S L ++ NPV
Sbjct: 92 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 7e-07
Identities = 19/114 (16%), Positives = 38/114 (33%), Gaps = 10/114 (8%)
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD--LSQMNSLSYVDLSNN 297
+ + AL +L N+ EL + + L + L + + +
Sbjct: 9 GSSGLRCTRDGALD--SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 298 SFD--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349
+A F P L+ L F +L+ + K +Q++ L N +
Sbjct: 67 GLRFVAPDA---FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 14/102 (13%), Positives = 32/102 (31%), Gaps = 9/102 (8%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186
+ + L+ L + + + L L +L L + + L +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA----- 75
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228
+ + N L ++S + + L ++ GN L
Sbjct: 76 FHFTPRLSRLNLSFNALE-SLSWKTVQG-LSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 2e-04
Identities = 18/84 (21%), Positives = 32/84 (38%), Gaps = 1/84 (1%)
Query: 218 LIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDL 276
L + + Q ++ L + L L + ++ L P + ++ LNL+ N L
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92
Query: 277 KGPFPDLSQMNSLSYVDLSNNSFD 300
+ Q SL + LS N
Sbjct: 93 ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 45/179 (25%), Positives = 75/179 (41%), Gaps = 48/179 (26%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187
IP A+ ++L L +N+ +L+ L L L N+L S+P G+
Sbjct: 25 GIP------AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLP------NGV 71
Query: 188 -DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246
++L + + + + N+L L + +FD L Q L+ L
Sbjct: 72 FNKLTSLTYLNLSTNQLQ------------SLPNGVFD----------KL--TQ-LKELA 106
Query: 247 LDRNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
L+ N L +P + + LT + +L L N LK G F L+ SL Y+ L +N +D
Sbjct: 107 LNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT---SLQYIWLHDNPWD 161
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 9e-05
Identities = 40/158 (25%), Positives = 57/158 (36%), Gaps = 46/158 (29%)
Query: 59 VTCNNSRVTA-----------LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSP 107
V C + T+ L L T L +G LT L L L N L SL
Sbjct: 12 VECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN-KLQ-SLPN 69
Query: 108 RIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWL 166
+ + L L++L L++N +P + KL+QL L
Sbjct: 70 GVFN-----------------------KLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKEL 105
Query: 167 DLADNQLTGSIPVSTITSPGL-DQLKNAKHFHFNKNKL 203
L NQL S+P G+ D+L K +N+L
Sbjct: 106 ALNTNQLQ-SLP------DGVFDKLTQLKDLRLYQNQL 136
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 57/355 (16%), Positives = 104/355 (29%), Gaps = 85/355 (23%)
Query: 63 NSRVTALGLSTMGLTGK----LSGDIGGLTELRSLDLSYNG-GLTG--SLSPRIGDLQKL 115
+ L +T + + + ++ + LS N G LS I + L
Sbjct: 3 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 62
Query: 116 NILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTG 175
I + FTG + DEI L L +L K +L+ + L+DN G
Sbjct: 63 EIAEFSDI-FTGRVKDEI--PEALRLLL-----------QALLKCPKLHTVRLSDNAF-G 107
Query: 176 SIPVSTITSPGLDQLKNAKHFHFNKNKLS----GTISEQLFSPDMVLIHVLFDGNQLSGN 231
+ L + +H + + N L I+ L
Sbjct: 108 PTAQEPL-IDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL----------------A 150
Query: 232 IPESLGYVQTLEVLRLDRNALT-------GKVPTNLNNLTNVNELNLAHNDL--KGPFPD 282
+ + L + RN L K + ++ + + N + +G
Sbjct: 151 VNKKAKNAPPLRSIICGRNRLENGSMKEWAKT---FQSHRLLHTVKMVQNGIRPEGIEHL 207
Query: 283 LSQ----MNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI------CEFGS--------- 323
L + L +DL +N+F + L S L C +
Sbjct: 208 LLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDA 267
Query: 324 LQGRVPDKLFSYSQIQQVKLRNNAFNNT--LDMGNAV---GPLLQLVDLQNNQIS 373
+Q ++L+ N + + P L ++L N+ S
Sbjct: 268 F------SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 25/123 (20%), Positives = 53/123 (43%), Gaps = 18/123 (14%)
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQM-NSL 289
+ +L ++ + L L N + K+ ++L+ + N+ L+L N +K +L + ++L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIKK-IENLDAVADTL 95
Query: 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTL------ICEFGSLQGRVPDKLFSYSQIQQVKL 343
+ +S N L +L L I +G + DKL + +++ + L
Sbjct: 96 EELWISYNQIASLSG---IEKLVNLRVLYMSNNKITNWGEI-----DKLAALDKLEDLLL 147
Query: 344 RNN 346
N
Sbjct: 148 AGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 29/164 (17%), Positives = 53/164 (32%), Gaps = 22/164 (13%)
Query: 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNG-----GLTGSLSPRIGD 111
+ V + L + K+ + L + L LS N L+G
Sbjct: 18 KSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISSLSG-------- 68
Query: 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN 171
++ L IL L I + L L ++ N + + + KL L L +++N
Sbjct: 69 MENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNN 125
Query: 172 QLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPD 215
++T + L L + N L E + +
Sbjct: 126 KITNWGEIDK-----LAALDKLEDLLLAGNPLYNDYKENNATSE 164
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 55/244 (22%), Positives = 85/244 (34%), Gaps = 73/244 (29%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123
+ + + + + L +R L L N L ++ L
Sbjct: 41 NSIDQIIANNSDIKSVQGIQY--LPNVRYLALGGN------------KLHDISAL----- 81
Query: 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWLDLADNQLTGSIPVSTI 182
L L++L L N +P + KL+ L L L +NQL S+P
Sbjct: 82 ----------KELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLP---- 125
Query: 183 TSPGL-DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQT 241
G+ D+L N + + N+L L +FD L
Sbjct: 126 --DGVFDKLTNLTYLNLAHNQLQ------------SLPKGVFD----------KL--TN- 158
Query: 242 LEVLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSN 296
L L L N L +P + + LT + +L L N LK G F L+ SL Y+ L +
Sbjct: 159 LTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLT---SLQYIWLHD 214
Query: 297 NSFD 300
N +D
Sbjct: 215 NPWD 218
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 48/246 (19%), Positives = 85/246 (34%), Gaps = 69/246 (28%)
Query: 142 LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKN 201
L + + + +L+ + + ++ + + G+ L N ++ N
Sbjct: 24 ANLKKKSVTD--AVTQNELNSIDQIIANNSDIK--------SVQGIQYLPNVRYLALGGN 73
Query: 202 KLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL- 260
KL I + L L L N L +P +
Sbjct: 74 KLHD-------------ISA-LKE-------------LTNLTYLILTGNQLQ-SLPNGVF 105
Query: 261 NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTT 316
+ LTN+ EL L N L+ G F L+ + L +L++N + F L +LT
Sbjct: 106 DKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL---NLAHNQLQSLPKGV-FDKLTNLTE 161
Query: 317 LICE---FGSLQGRVPDKLFSYSQIQQVKLRNN--------AFNNTLDMGNAVGPLLQLV 365
L SL V DKL +Q++ ++L N F+ + + LQ +
Sbjct: 162 LDLSYNQLQSLPEGVFDKL---TQLKDLRLYQNQLKSVPDGVFDR---LTS-----LQYI 210
Query: 366 DLQNNQ 371
L +N
Sbjct: 211 WLHDNP 216
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 36/172 (20%), Positives = 58/172 (33%), Gaps = 29/172 (16%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVA---IKRAQQGSMQGGLEFK--------TEIELLSRVHH 682
IGSGG+G +Y + + A +K Q + E K I+
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 683 KNLVGL--VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRR------LRIALGS 734
+ +G+ + Y FM L L L++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQK----ISGQNGTFKKSTVLQLGIRM 160
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV--ADFGLSKLVSDSSKG 784
L Y+HE +H D+K+ N+LL +V AD+GLS +
Sbjct: 161 LDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 51/236 (21%), Positives = 91/236 (38%), Gaps = 69/236 (29%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRV-----HHKNLV 686
+G G +G+V + + + A+K R + + K E ++L ++ ++ N+V
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA---KIEADILKKIQNDDINNNNIV 99
Query: 687 GLVGF-------C--FEQGEQML---VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS 734
G C FE L +YE + + +G H++ + +
Sbjct: 100 KYHGKFMYYDHMCLIFE----PLGPSLYEIITR-------NNYNGFHIEDIKL--YCIEI 146
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTA-------------------------KV 769
+ L YL +++ + H D+K NILLD+ K+
Sbjct: 147 LKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
DFG + SD + + + T Y PE + SD++SFG V+ EL T
Sbjct: 204 IDFGCATFKSD----YHGSIIN-TRQYRAPEVILNLGWDVSSDMWSFGCVLAELYT 254
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 29/164 (17%), Positives = 51/164 (31%), Gaps = 65/164 (39%)
Query: 142 LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL-DQLKNAKHFHFNK 200
L L+ N F+ +P L L +DL++N+++ ++ + +
Sbjct: 36 LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLS------NQSFSNMTQLLTLILSY 87
Query: 201 NKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL 260
N+L P FDG
Sbjct: 88 NRLRCI-------PPRT-----FDG----------------------------------- 100
Query: 261 NNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSNNSFD 300
L ++ L+L ND+ G F DLS +LS++ + N
Sbjct: 101 --LKSLRLLSLHGNDISVVPEGAFNDLS---ALSHLAIGANPLY 139
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 4e-05
Identities = 49/229 (21%), Positives = 89/229 (38%), Gaps = 59/229 (25%)
Query: 635 IGSGGYGKVYRG--MLSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHK------N 684
+G G +GKV + G+ VA+K + + ++EI++L ++
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA---RSEIQVLEHLNTTDPNSTFR 78
Query: 685 LVGLVGFCFE-QGEQMLVYEFM-ANGTLRESL--SGRSGIHLDWKRRLRIALGSARGLAY 740
V ++ FE G +V+E + + + + +G LD R+ +A + + +
Sbjct: 79 CVQMLE-WFEHHGHICIVFELLGLS--TYDFIKENGFLPFRLDHIRK--MAYQICKSVNF 133
Query: 741 LHELANPPIIHRDVKSTNILLDENLTA-------------------KVADFGLSKLVSDS 781
LH + H D+K NIL ++ KV DFG + +
Sbjct: 134 LHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE- 189
Query: 782 SKGHVSTQVKGTMGYLDPE-----YYMTQQLTEKSDVYSFGVVMLELIT 825
H ST V T Y PE + ++ DV+S G +++E
Sbjct: 190 ---HHSTLVS-TRHYRAPEVILALGW-----SQPCDVWSIGCILIEYYL 229
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 42/281 (14%), Positives = 87/281 (30%), Gaps = 56/281 (19%)
Query: 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIGGL-----TELRSLDLSYNG-------GLTGS 104
+ + VT+L LS L K S ++ + + SL+LS N L +
Sbjct: 44 QAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKT 103
Query: 105 LSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLY 164
L+ + L+ L F+ + A ++ + +
Sbjct: 104 LAAIPFTITVLD---LGWNDFS---SKSSSEFKQ----AFSNLP------------ASIT 141
Query: 165 WLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT----ISEQLFSPDMVLIH 220
L+L N L G + N + N L+ +++ L S +
Sbjct: 142 SLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTS 200
Query: 221 VLFDGNQLSGN----IPESLGYVQ-TLEVLRLDRNALTGK----VPTNLNNLTNVNELNL 271
+ N L + + + L L N L G + ++L ++ + L
Sbjct: 201 LDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260
Query: 272 AHNDLKGPFPD--------LSQMNSLSYVDLSNNSFDPTEA 304
++ +K + + + VD + P+ +
Sbjct: 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 51/271 (18%), Positives = 86/271 (31%), Gaps = 49/271 (18%)
Query: 90 LRSLDLSYNG-------GLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAE---- 138
+ SLDLS N L + + + LN L+G L +
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLN---LSGNSLG---FKNSDELVQILAA 77
Query: 139 ----LSFLALNSNNFSGRIPPSLGKL-----SQLYWLDLADNQLTGSIPVSTITSPGLDQ 189
++ L L+ N S + L K + LDL N S S +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF-SSKSSSEFKQAFSNL 136
Query: 190 LKNAKHFHFNKNKLSGT----ISEQLFSPDMVLIHVLFDGNQLSGN----IPESLGYV-Q 240
+ + N L + + L + + + GN L+ + + L +
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPA 196
Query: 241 TLEVLRLDRNALTGKVPTNL-----NNLTNVNELNLAHNDLKGP-FPDLSQM----NSLS 290
++ L L N L K L + +V LNL N L GP +L + L
Sbjct: 197 SVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQ 256
Query: 291 YVDLSNNSFD---PTEAPLWFSTLPSLTTLI 318
V L + + + P++ +I
Sbjct: 257 TVYLDYDIVKNMSKEQCKALGAAFPNIQKII 287
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 48/235 (20%), Positives = 75/235 (31%), Gaps = 71/235 (30%)
Query: 635 IGSGGYGKVYRGM--LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSR----------- 679
+G G +GKV + VA+K R + + EI +L +
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA---RLEINVLKKIKEKDKENKFL 83
Query: 680 -VH------HKNLVGLVGFCFEQGEQML---VYEFMANGTLRESLSGRSGIHLDWKRRLR 729
V + + FE +L +EF+ L R
Sbjct: 84 CVLMSDWFNFHGHMCIA---FE----LLGKNTFEFLKEN-------NFQPYPLPHVRH-- 127
Query: 730 IALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA-------------------KVA 770
+A L +LHE + H D+K NIL + +VA
Sbjct: 128 MAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVA 184
Query: 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT 825
DFG + + H +T V T Y PE + + DV+S G ++ E
Sbjct: 185 DFGSATFDHE----HHTTIVA-TRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 5e-05
Identities = 31/214 (14%), Positives = 69/214 (32%), Gaps = 45/214 (21%)
Query: 78 GKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIG--- 134
LS + + L +L + L+ P L L + G ++ ++I
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKP----RPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 135 --NLAELSFLALNSNNFSGRIPP-------SLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
NL +L L + ++ S + L WL + D + + + S
Sbjct: 218 LPNLEKLV-LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESD 276
Query: 186 GLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVL 245
L QL + + L+ + L + + ++ L+ +
Sbjct: 277 ILPQL---ETMDISAGVLTDEGARLLL---------------------DHVDKIKHLKFI 312
Query: 246 RLDRNALTG----KVPTNLNNLTNVNELNLAHND 275
+ N L+ ++ +L +V++ +D
Sbjct: 313 NMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDDD 346
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 26/156 (16%), Positives = 48/156 (30%), Gaps = 47/156 (30%)
Query: 240 QTLEVLRLDRNALT-GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNS 298
++ L LD + GK+ + + L+ + L +L ++N L ++LS+N
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNR 75
Query: 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAV 358
+ P+LT L L N + +
Sbjct: 76 VS-GGLEVLAEKCPNLTHLN------------------------LSGNKIKDLST----I 106
Query: 359 GPLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVC 394
PL +L +L+ +L L V
Sbjct: 107 EPLKKLENLK----------------SLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 28/120 (23%), Positives = 50/120 (41%), Gaps = 12/120 (10%)
Query: 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK 194
++ EL L + +N G++ + +L +L + LT SI L +L K
Sbjct: 18 DVKELV-LDNSRSN-EGKLEGLTDEFEELEFLSTINVGLT-SIA-------NLPKLNKLK 67
Query: 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG-NIPESLGYVQTLEVLRLDRNALT 253
+ N++S E L L H+ GN++ + E L ++ L+ L L +T
Sbjct: 68 KLELSDNRVS-GGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 22/90 (24%), Positives = 38/90 (42%), Gaps = 6/90 (6%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFT--GNIPDEIGNLAELSFLAL 144
++++ L L + G L + ++L L G T N+P L +L L L
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP----KLNKLKKLEL 71
Query: 145 NSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174
+ N SG + K L L+L+ N++
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 11/121 (9%)
Query: 135 NLAELSFLAL-NSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA 193
A + L L N + G+I + L +L L + L S+ L +L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-------NLPKLPKL 73
Query: 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG-NIPESLGYVQTLEVLRLDRNAL 252
K ++N++ + L L H+ GN+L + E L ++ L+ L L +
Sbjct: 74 KKLELSENRIF-GGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEV 132
Query: 253 T 253
T
Sbjct: 133 T 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 28/156 (17%), Positives = 45/156 (28%), Gaps = 47/156 (30%)
Query: 240 QTLEVLRLDRNALT-GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNS 298
+ L LD GK+ N+ L+L + L +L ++ L ++LS N
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENR 82
Query: 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAV 358
+ LP+LT L L N + +
Sbjct: 83 IF-GGLDMLAEKLPNLTHLN------------------------LSGNKLKDIST----L 113
Query: 359 GPLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVC 394
PL +L L+ +L L V
Sbjct: 114 EPLKKLECLK----------------SLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 27/111 (24%), Positives = 43/111 (38%), Gaps = 8/111 (7%)
Query: 68 ALGLSTMGLTGKLSGDIGGLT--ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF 125
+ G S M + ++ ++ T +R L L G + + L L L G
Sbjct: 2 SSGSSGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL 61
Query: 126 T--GNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174
N+P L +L L L+ N G + KL L L+L+ N+L
Sbjct: 62 ISVSNLP----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 28/113 (24%), Positives = 48/113 (42%), Gaps = 14/113 (12%)
Query: 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK----GPFPDLSQMNSLSYVDLSN 296
+ L L+ N L + LT + +L+L+ N ++ G F L++ L+ + L
Sbjct: 29 SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTK---LTILYLHE 85
Query: 297 NSFD--PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF-SYSQIQQVKLRNN 346
N P F L L L + L+ VPD +F + +Q++ L N
Sbjct: 86 NKLQSLPNGV---FDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 32/158 (20%), Positives = 49/158 (31%), Gaps = 49/158 (31%)
Query: 59 VTCNNSRVTA-----------LGLSTMGLTGKLS--GDIGGLTELRSLDLSYNGGLTGSL 105
V C + L L+ L ++S G G L L L+L N LT +
Sbjct: 13 VDCTGRGLKEIPRDIPLHTTELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQ-LT-GI 69
Query: 106 SPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSL-GKLSQLY 164
P + + + L L N I + L QL
Sbjct: 70 EPNAFE-----------------------GASHIQELQLGENKIK-EISNKMFLGLHQLK 105
Query: 165 WLDLADNQLTGSIPVSTITSPG-LDQLKNAKHFHFNKN 201
L+L DNQ++ + PG + L + + N
Sbjct: 106 TLNLYDNQIS-CVM------PGSFEHLNSLTSLNLASN 136
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 964 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.98 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.98 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.98 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.97 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.96 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.9 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.88 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.86 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.83 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.82 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.8 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.77 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.77 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.74 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.71 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.7 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.69 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.68 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.68 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.67 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.63 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.61 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.57 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.56 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.55 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.54 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.46 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.45 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.36 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.35 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.33 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.27 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.18 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.17 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.16 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.13 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.01 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.0 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.86 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.71 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.68 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.65 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.64 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.64 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.31 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.22 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.2 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.19 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.01 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.87 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.64 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.61 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.35 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.35 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.3 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.28 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.21 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.88 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.81 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.22 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.21 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.19 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 95.16 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 93.47 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 93.42 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 92.69 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.47 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 87.07 | |
| 4d8k_A | 175 | Tyrosine-protein kinase LCK; protein kinases, SH2 | 80.1 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=466.40 Aligned_cols=260 Identities=26% Similarity=0.438 Sum_probs=207.8
Q ss_pred cCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|...++||+|+||+||+|+++ +++.||||+++.......++|.+|+++|++++|||||+++|+|.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45667789999999999999864 478999999987766667789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC-------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 701 VYEFMANGTLRESLSGRS-------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
|||||++|+|.++++... ..+++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997642 236999999999999999999999987 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||+|+...........+...||+.|||||++.+..++.++|||||||++|||+| |+.||..... .+.+......
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-~~~~~~i~~g 276 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TEAIDCITQG 276 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-HHHHHHHHHT
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcC
Confidence 9999999997755444444556789999999999999999999999999999999999 8999975432 2222222211
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
... ..++. ....+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 277 ~~~---~~p~~-----------~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 277 REL---ERPRA-----------CPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp CCC---CCCTT-----------CCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCC---CCccc-----------ccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 110 01111 124567899999999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=463.00 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=214.9
Q ss_pred cCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|...+.||+|+||+||+|++. +|+.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999864 478899999987766667789999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC-----------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 701 VYEFMANGTLRESLSGRS-----------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
|||||++|+|.++|+..+ ...++|.+++.|+.|||+||+|||+++ ||||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997532 346999999999999999999999988 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
+|||+|+...............||+.|||||++.++.|+.++|||||||++|||+| |+.||.... ..+.+........
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~-~~~~~~~i~~~~~ 248 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-NNEVIECITQGRV 248 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-HHHHHHHHHHTCC
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHHHcCCC
Confidence 99999987654433333344579999999999999999999999999999999999 899996533 2222222221111
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
. ..++ . ....+.+++.+||+.||++||||+||++.|+.+.+..
T Consensus 249 ~---~~p~----~-------~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 249 L---QRPR----T-------CPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp C---CCCT----T-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred C---CCCc----c-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 0 0111 1 1245678999999999999999999999999987644
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-53 Score=461.48 Aligned_cols=256 Identities=24% Similarity=0.375 Sum_probs=209.5
Q ss_pred CCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
+++..++||+|+||+||+|++. +++.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4556789999999999999863 467899999975433 335689999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc
Q 002121 701 VYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
|||||++|+|.++|+.+. ...++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996542 235899999999999999999999988 999999999999999999
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhc
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 845 (964)
+||+|||+|+.....+.....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||.... ..+.+.. +.
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-~~~~~~~-i~ 261 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDVVEM-IR 261 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-HHHHHHH-HH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-HHHHHHH-HH
Confidence 99999999997755444344456789999999999999999999999999999999999 899996433 2222222 22
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.... . ..+. .....+.+++.+||+.||++||||+||++.|+.+
T Consensus 262 ~~~~-----~-----~~p~---~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 262 NRQV-----L-----PCPD---DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp TTCC-----C-----CCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred cCCC-----C-----CCcc---cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2110 0 0111 1224567899999999999999999999998853
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=455.58 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=204.1
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...++||+|+||+||+|++++ .||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4577888999999999999999753 699999875433 334679999999999999999999999864 57899999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||++|+|.++++... ..++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+.......
T Consensus 112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999997653 46999999999999999999999987 99999999999999999999999999987654443
Q ss_pred CceeecccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.......+||+.|||||++.. +.|+.++|||||||++|||+||+.||....... .+...+.... ..|
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-~~~~~~~~~~---------~~p 257 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-QIIFMVGRGY---------ASP 257 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-HHHHHHHTTC---------CCC
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-HHHHHHhcCC---------CCC
Confidence 344556789999999999863 468999999999999999999999997543322 2222222211 111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.+..........+.+++.+||+.||++||||.||++.|+.+.
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~ 299 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 111111122245678999999999999999999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=450.86 Aligned_cols=250 Identities=24% Similarity=0.404 Sum_probs=204.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|.+.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999996 4799999999976533 334579999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||++|+|.+++...++..+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 999999999998666667899999999999999999999988 9999999999999999999999999998764321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
...+..+||+.|||||++.+..|+.++||||+||++|||+||+.||... ...+.+.......... . ...+
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~~---~----~~~~- 249 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG-SMKNLVLKIISGSFPP---V----SLHY- 249 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-SHHHHHHHHHHTCCCC---C----CTTS-
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-CHHHHHHHHHcCCCCC---C----CccC-
Confidence 2234567999999999999999999999999999999999999999653 3333333333322110 1 1111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+||+.||++|||++|+++
T Consensus 250 ------s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 250 ------SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 134668999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=446.23 Aligned_cols=249 Identities=22% Similarity=0.359 Sum_probs=208.8
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
..|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999964 79999999997665555667899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++... .+++.++..++.||+.||+|||+++ ||||||||+||||+.++.+||+|||+|+.+.... .
T Consensus 154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 225 (346)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--C
Confidence 999999999753 4999999999999999999999998 9999999999999999999999999999875432 2
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.+........ +.+..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~-----------~~~~~- 292 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-PLKAMKMIRDNLP-----------PRLKN- 292 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSSC-----------CCCSC-
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHcCCC-----------CCCCc-
Confidence 2345789999999999999999999999999999999999999996543 2333332222111 00000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||+.||++|||++|+++
T Consensus 293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011144668999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=444.36 Aligned_cols=267 Identities=26% Similarity=0.387 Sum_probs=204.6
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC----ceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG----EQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 702 (964)
++|...++||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++|+|.+++ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 3567788999999999999998 589999999865322 1223345666677899999999999998765 479999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC-----CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA-----NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
|||++|+|.++++.. .++|.++.+++.|+|+||+|||+++ .++||||||||+||||++++++||+|||+|+.
T Consensus 81 Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred cCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999864 4999999999999999999999862 34699999999999999999999999999998
Q ss_pred ecCCCCC--ceeecccccCcccCccccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCc-------------hh
Q 002121 778 VSDSSKG--HVSTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVVMLELITAKQPIEKGK-------------YV 836 (964)
Q Consensus 778 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~elltg~~p~~~~~-------------~~ 836 (964)
....... ......+||+.|||||++.+. .++.++|||||||++|||+||++|+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 7654321 122345799999999998754 46789999999999999999987764211 11
Q ss_pred HHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCC
Q 002121 837 VREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907 (964)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 907 (964)
.+.+..... .+.++|.++.. .......+.+++.+||+.||++||||.||++.|+++.++++.
T Consensus 238 ~~~~~~~~~---------~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 238 VEEMRKVVC---------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHHT---------TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred HHHHHHHHh---------cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 222222221 12233333322 234456788999999999999999999999999999877654
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=450.15 Aligned_cols=272 Identities=24% Similarity=0.412 Sum_probs=221.2
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEecC------CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCC-CCccce
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHH-KNLVGL 688 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H-~nIv~l 688 (964)
+..++++...++|+..+.||+|+||+||+|++.. ++.||||+++..... ..++|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3456677778899999999999999999998642 368999999865443 34579999999999965 899999
Q ss_pred eEEEEee-CceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 002121 689 VGFCFEQ-GEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753 (964)
Q Consensus 689 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 753 (964)
+|+|.+. +..++|||||++|+|.++|+... ...++|.+++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999765 56899999999999999997532 235899999999999999999999988 99999
Q ss_pred CCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 002121 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEK 832 (964)
Q Consensus 754 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~ 832 (964)
|||+|||+++++.+||+|||+|+.+.............||+.|||||++.++.|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999998765544445556789999999999999999999999999999999998 8999965
Q ss_pred CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
..... .+...+..... ...++. ...++.+++.+||+.||++||||.||++.|+.+++..
T Consensus 291 ~~~~~-~~~~~i~~g~~--~~~p~~-----------~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 291 VKIDE-EFCRRLKEGTR--MRAPDY-----------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp CCCSH-HHHHHHHHTCC--CCCCTT-----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred CCHHH-HHHHHHHcCCC--CCCCcc-----------CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 33222 22222222110 001111 1245678999999999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=432.61 Aligned_cols=246 Identities=27% Similarity=0.433 Sum_probs=198.8
Q ss_pred CccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEe----eCceEEEE
Q 002121 630 SESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE----QGEQMLVY 702 (964)
Q Consensus 630 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lV~ 702 (964)
...++||+|+||+||+|+.. +++.||||++.... ....+.|.+|+++|++++|||||++++++.+ ++..||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 45678999999999999964 68999999987543 2334579999999999999999999999976 34579999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccceeecCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~ 781 (964)
|||++|+|.++++... .+++..+..++.||+.||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999997643 6899999999999999999999875 56999999999999984 79999999999986432
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......+||+.|||||++. +.|+.++|||||||++|||+||+.||.................. .+.
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~----------~~~ 250 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------PAS 250 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------CGG
T ss_pred ---CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC----------CCC
Confidence 2234568999999999886 46999999999999999999999999765444443333322211 011
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.... ...+.+++.+||+.||++|||++|+++
T Consensus 251 ~~~~~---~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 251 FDKVA---IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGCC---CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111 134668999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=442.42 Aligned_cols=258 Identities=21% Similarity=0.271 Sum_probs=207.3
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.+.|...++||+|+||+||+|+. .+|+.||||+++.... ..+|+++|++++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34677788999999999999996 4699999999975432 24799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeecCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~~~ 783 (964)
|++|+|.++++..+ .+++.++..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus 132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999997653 6999999999999999999999988 99999999999999988 699999999998754322
Q ss_pred Cc---eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GH---VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +.+......... .. .+.+
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~i~~~~~~----~~-~~~~ 280 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-PLCLKIASEPPP----IR-EIPP 280 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-CCHHHHHHSCCG----GG-GSCT
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHHcCCCC----ch-hcCc
Confidence 11 223457999999999999999999999999999999999999999642211 111111111110 00 0111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
.+ ...+.+++.+||+.||++|||+.|+++.|...++..+
T Consensus 281 ~~-------s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 281 SC-------APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp TS-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred cC-------CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 11 2456689999999999999999999999999887654
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=438.87 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=209.9
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999995 479999999987432 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||++|+|.+++...+ .+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999997643 6999999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
........+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+.+......... ..+.+.
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-~~~~~~~~i~~~~~~----~p~~~s--- 258 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-NEGLIFAKIIKLEYD----FPEKFF--- 258 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC----CCTTCC---
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCC----CCcccC---
Confidence 444455678999999999999999999999999999999999999999643 333333333322211 221111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+++.+||+.||++|||++|+..
T Consensus 259 --------~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 259 --------PKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp --------HHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred --------HHHHHHHHHHccCCHhHCcChHHHcC
Confidence 34568999999999999999999753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=447.70 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=209.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+++|++++|||||++++++.+++..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56899999999999999999964 69999999998766666678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++... .+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+.+.... .
T Consensus 231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~ 302 (423)
T 4fie_A 231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--P 302 (423)
T ss_dssp TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--C
T ss_pred CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--c
Confidence 999999999754 4899999999999999999999998 9999999999999999999999999999875432 2
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... ..+.+..+...... .+..
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-~~~~~~~i~~~~~~-----------~~~~- 369 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-PLKAMKMIRDNLPP-----------RLKN- 369 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-HHHHHHHHHHSCCC-----------CCSC-
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHcCCCC-----------CCcc-
Confidence 2345789999999999999999999999999999999999999996543 23333322222110 0000
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||+.||++|||+.|+++
T Consensus 370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001134668999999999999999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=421.35 Aligned_cols=245 Identities=24% Similarity=0.385 Sum_probs=191.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999995 4799999999875432 23457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||| +|+|.+++..++ .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence 999 689999987654 6999999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.....+||+.|||||++.+..+ +.++||||+||++|||+||+.||... ............... ..+.++
T Consensus 167 ---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-~~~~~~~~i~~~~~~----~p~~~s-- 236 (275)
T 3hyh_A 167 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-SIPVLFKNISNGVYT----LPKFLS-- 236 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC----CCTTSC--
T ss_pred ---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHcCCCC----CCCCCC--
Confidence 2345679999999999998776 58999999999999999999999643 333333333222211 222121
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+++.+||+.||++|||++|+++
T Consensus 237 ---------~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 237 ---------PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ---------HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---------HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 34568999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=427.83 Aligned_cols=242 Identities=26% Similarity=0.356 Sum_probs=194.4
Q ss_pred cCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|++.+.||+|+||+||+|+.. .++.||||+++.... ....++.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46899999999999999999852 478999999875432 233468899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|||||++|+|.+++...+ .+++.++..++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999997643 6999999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||... +..+.+......... ..+.++
T Consensus 179 ~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-~~~~~~~~i~~~~~~----~p~~~s- 250 (304)
T 3ubd_A 179 HE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-DRKETMTMILKAKLG----MPQFLS- 250 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC----CCTTSC-
T ss_pred CC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-CHHHHHHHHHcCCCC----CCCcCC-
Confidence 32 2234567999999999999999999999999999999999999999643 333333333322211 111121
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
..+.+++.+||+.||++|||+
T Consensus 251 ----------~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 251 ----------PEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----------HHHHHHHHHHTCSSGGGSTTC
T ss_pred ----------HHHHHHHHHHcccCHHHCCCC
Confidence 345689999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=419.42 Aligned_cols=250 Identities=23% Similarity=0.391 Sum_probs=189.8
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCc-------
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE------- 697 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------- 697 (964)
++|+..+.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 46888999999999999999964 7999999998754433 34578999999999999999999999986553
Q ss_pred -----eEEEEEeccCCChhhhhcCCCC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 698 -----QMLVYEFMANGTLRESLSGRSG-IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 698 -----~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
.|+|||||++|+|.+++..... ...++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 6899999999999999987642 23566778899999999999999988 99999999999999999999999
Q ss_pred cccceeecCCCCC----------ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002121 772 FGLSKLVSDSSKG----------HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841 (964)
Q Consensus 772 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~ 841 (964)
||+|+........ ...+..+||+.|||||++.+..|+.++|||||||++|||++ ||.........+.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~ 238 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT 238 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence 9999876543211 11234579999999999999999999999999999999997 7754322222222
Q ss_pred HHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 842 TAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ..+ ..........+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~----------~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 239 DVRNLK----------FPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHTTC----------CCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhcCC----------CCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 211110 111 11122234567999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=407.86 Aligned_cols=212 Identities=22% Similarity=0.382 Sum_probs=178.4
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE 694 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 694 (964)
+++....+.|++.+.||+|+||+||+|+.+ .++.||||++.... ...++.+|+++|+++ +|||||++++++.+
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~ 91 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRK 91 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEE
Confidence 344456788999999999999999999853 46899999987543 235688999999998 69999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeecc
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFG 773 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFG 773 (964)
.+..|+|||||++|+|.+++. .+++.++..++.|++.||+|||+++ ||||||||+|||++.+ +.+||+|||
T Consensus 92 ~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 92 NDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp TTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 999999999999999999984 3889999999999999999999998 9999999999999876 799999999
Q ss_pred cceeecCCCC--------------------------CceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhC
Q 002121 774 LSKLVSDSSK--------------------------GHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITA 826 (964)
Q Consensus 774 la~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg 826 (964)
+|+...+... ....+..+||+.|||||++.+. .|+.++||||+||++|||+||
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9986543211 0112345799999999999775 589999999999999999999
Q ss_pred CCCCCCCchhHHHHH
Q 002121 827 KQPIEKGKYVVREVR 841 (964)
Q Consensus 827 ~~p~~~~~~~~~~~~ 841 (964)
+.||..+.+..+.+.
T Consensus 244 ~~Pf~~~~~~~~~l~ 258 (361)
T 4f9c_A 244 RYPFYKASDDLTALA 258 (361)
T ss_dssp CSSSSCCSSHHHHHH
T ss_pred CCCCCCCCCHHHHHH
Confidence 999986665544443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=413.01 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=201.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEe------eCc
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFE------QGE 697 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 697 (964)
++|.+.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 5799999999999999999996 4799999999975433 234568899999999999999999999864 357
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|||||||+ |+|.+++...+ .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999996 68999997653 6999999999999999999999998 99999999999999999999999999987
Q ss_pred ecCCC--CCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 778 VSDSS--KGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 778 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
+.... ........+||+.|||||++.+. .++.++||||+||++|||++|++||.... ..+.+..++..........
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-~~~~l~~I~~~~g~p~~~~ 286 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-YVHQLQLIMMVLGTPSPAV 286 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-HHHHHHHHHHHHCCCCGGG
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-HHHHHHHHHHhcCCCChHH
Confidence 64322 12234457899999999998764 56999999999999999999999996433 3333332221111000000
Q ss_pred ccc------------cCc----cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEM------------MDP----TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~------------~d~----~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... +.+ .+..........+.+++.+||..||++|||++|+++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 287 IQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp TC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 000 000001111245678999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=399.27 Aligned_cols=282 Identities=44% Similarity=0.758 Sum_probs=234.7
Q ss_pred cccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee
Q 002121 616 WFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 695 (964)
Q Consensus 616 ~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 695 (964)
.+++.++..++++|+..+.||+|+||+||+|+.++|+.||||++........+.+.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 45566777889999999999999999999999888999999998876666667899999999999999999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
+..++||||+++|+|.+++.... ...++|.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg 184 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG 184 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence 99999999999999999997654 235899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc-----hhHHHHHHHhccCc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK-----YVVREVRTAMNRDD 848 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~-----~~~~~~~~~~~~~~ 848 (964)
+++...............||+.|+|||++.++.++.++|||||||++|||++|+.||.... ....+.........
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence 9987654333333445569999999999999999999999999999999999999986321 22333332222221
Q ss_pred ccccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 849 EEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+.+.+++.+... .......+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 265 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~ 317 (321)
T 2qkw_B 265 -----LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317 (321)
T ss_dssp -----CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -----HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence 334444444332 3455677889999999999999999999999999988644
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=425.01 Aligned_cols=398 Identities=23% Similarity=0.363 Sum_probs=275.4
Q ss_pred CCCCCCCchhHhhHHHHHHHHhCcccc-eEEeecccccCCcceeEEEeec-----------------CCCcceeecccee
Q 002121 453 SFRELSNVTVFHSLEMSLWVKLGLTPG-SVFLQNPFFNIDDYLQIQVALF-----------------PSGEKSFNRSEVQ 514 (964)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 514 (964)
+|++++-+++... +.+||.......+ .+|+|++|+.+.+.++.+.|++ +.|+|++|.|+..
T Consensus 26 ~~~~gd~~~v~~~-~~~W~~~~~~~~g~~G~~P~~yv~~~~~le~~~W~~g~i~r~~ae~~L~~~~~~~G~FLvR~s~~~ 104 (454)
T 1qcf_A 26 SFQKGDQMVVLEE-SGEWWKARSLATRKEGYIPSNYVARVDSLETEEWFFKGISRKDAERQLLAPGNMLGSFMIRDSETT 104 (454)
T ss_dssp CBCTTCEEEEEEC-CTTEEEEEETTTCCEEEEEGGGEEETTCGGGSTTEETTCCHHHHHHHHHSTTCCTTCEEEEECSSS
T ss_pred cccCCCEEEEEec-CCCCeEEEECCCCceEEecchhcccccccccccccccccchhhhhhhhhcCCCCCceEEEEECcCC
Confidence 4677777777766 4679988765444 6899999999988888889987 4589999999988
Q ss_pred eeeeEeecceeCCCcccCC-cccccCCcccccCCCCCCCCcceeehhHHHHHHHHHHHHHHHHHHhhhhhhhhhhcCCCC
Q 002121 515 KIGFELSNQTYKPPKEFGP-YYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIGLSK 593 (964)
Q Consensus 515 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~r~~~~~~~~~ 593 (964)
...+.++.....+...... .|.+.. ...++--......... + .-+.-.+. +....-......
T Consensus 105 ~g~y~lsv~~~~~~~~~~v~H~~I~~-----~~~g~~~i~~~~~F~s-l---------~eLv~~y~--~~~~~l~~~~~~ 167 (454)
T 1qcf_A 105 KGSYSLSVRDYDPRQGDTVKHYKIRT-----LDNGGFYISPRSTFST-L---------QELVDHYK--KGNDGLCQKLSV 167 (454)
T ss_dssp TTSEEEEEEEEETTTEEEEEEEEEEE-----CTTSCEESSSSSCBSS-H---------HHHHHHHT--SSCTTSSSCCCS
T ss_pred CCeEEEEEEecccCCCCceEEEEEEE-----cCCCcEEEeCccccCC-H---------HHHHHHHH--hccCCccccccc
Confidence 8888877665321110000 111100 0000000000000000 0 00001111 000000000000
Q ss_pred CCCcCCCCCCCCCCCCCCCCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHH
Q 002121 594 PFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTE 673 (964)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E 673 (964)
+.... .+ ...+..++++...++|...+.||+|+||+||+|.++++..||||+++... ...++|.+|
T Consensus 168 ~~~~~---------~~----~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E 233 (454)
T 1qcf_A 168 PCMSS---------KP----QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAE 233 (454)
T ss_dssp BCCCC---------CC----CCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHH
T ss_pred ccccc---------Cc----cccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHH
Confidence 00000 00 01122233445567888999999999999999999888999999998654 345689999
Q ss_pred HHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 002121 674 IELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753 (964)
Q Consensus 674 ~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 753 (964)
+++|++++|||||++++++. .+..++|||||++|+|.++++...+..+++.+++.++.||+.||+|||+.+ |+|||
T Consensus 234 ~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrD 309 (454)
T 1qcf_A 234 ANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRD 309 (454)
T ss_dssp HHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSS
T ss_pred HHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCC
Confidence 99999999999999999986 667899999999999999998654446889999999999999999999988 99999
Q ss_pred CCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 002121 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEK 832 (964)
Q Consensus 754 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~ 832 (964)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||++..+.++.++|||||||++|||+| |+.||..
T Consensus 310 lkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 310 LRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp CSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987543211 11223446789999999998999999999999999999999 9999964
Q ss_pred CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
... .+.... +..... .. ... .....+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 389 ~~~-~~~~~~-i~~~~~----~~--~~~-------~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 389 MSN-PEVIRA-LERGYR----MP--RPE-------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp CCH-HHHHHH-HHHTCC----CC--CCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCH-HHHHHH-HHcCCC----CC--CCC-------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 322 222222 111110 00 000 11245678999999999999999999999998765
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=421.89 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=210.2
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|.+.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+++|++++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999996 47999999999876666667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC--CcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN--LTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 782 (964)
|++|+|.+++.... ..+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 99999999997543 36999999999999999999999998 9999999999999854 89999999999987543
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... ..+.+......... ++...
T Consensus 311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-~~~~~~~i~~~~~~--------~~~~~ 379 (573)
T 3uto_A 311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-DDETLRNVKSCDWN--------MDDSA 379 (573)
T ss_dssp --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHTTCCC--------CCSGG
T ss_pred --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-HHHHHHHHHhCCCC--------CCccc
Confidence 23345679999999999999999999999999999999999999996433 33333333322211 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.... ...+.+++.+||+.||++|||+.|+++
T Consensus 380 ~~~~---s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 380 FSGI---SEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GTTS---CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCC---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111 134568999999999999999999876
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=422.45 Aligned_cols=392 Identities=26% Similarity=0.421 Sum_probs=272.2
Q ss_pred CCCCCCCchhHhhHHHHHHHHhCccc-ceEEeecccccCCcceeEEEeec-----------------CCCcceeecccee
Q 002121 453 SFRELSNVTVFHSLEMSLWVKLGLTP-GSVFLQNPFFNIDDYLQIQVALF-----------------PSGEKSFNRSEVQ 514 (964)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 514 (964)
+|++++-+.+....+.+||....... ..+|+|++|+.+.+.++.+.|++ +.|+|++|.|+..
T Consensus 20 ~~~~gd~~~v~~~~~~~ww~~~~~~~g~~G~~P~~yv~~~~~le~~~w~~g~~~r~~ae~~L~~~~~~~G~FLvR~s~~~ 99 (452)
T 1fmk_A 20 SFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETT 99 (452)
T ss_dssp CBCTTCEEEESCCCSSSEEEEEETTTCCEEEEEGGGEEETTSGGGSTTEEETCCHHHHHHHHTCTTSCTTEEEEEECSSS
T ss_pred CccCCCEEEEeccCCCCceEEEEcCCCcccccCcccccccccccccccccCCccHHHHHHHhccCCCCCceEEEEeCCCC
Confidence 47788888888777888998776643 46999999999999888888988 3599999999987
Q ss_pred eeeeEeecceeCCC-----------cccCCcccccCCcccccCCCCCCCCcceeehhHHHHHHHHHHHHHHHHHHhhhhh
Q 002121 515 KIGFELSNQTYKPP-----------KEFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKK 583 (964)
Q Consensus 515 ~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (964)
...+.+|....... ......++......+. .+. -++-+. + +.
T Consensus 100 ~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~~~~~~~F~--------------Sl~-----------~Li~~y-~-~~ 152 (452)
T 1fmk_A 100 KGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFN--------------SLQ-----------QLVAYY-S-KH 152 (452)
T ss_dssp TTCEEEEEEEEETTTEEEEEEEEEEECTTSCEESSTTSEES--------------SHH-----------HHHHHH-T-TC
T ss_pred CCceEEEEEeeccCCCCcEEEEEEEEcCCCCEEEecCcccC--------------CHH-----------HHHHHh-h-hc
Confidence 77777776542110 0001111111110000 010 001111 1 10
Q ss_pred hhhhhcCCCCCCCcCCCCCCCCCCCCCCCCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCC
Q 002121 584 RAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGS 663 (964)
Q Consensus 584 r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~ 663 (964)
. .+.........+.. .+. ...+..++++...++|...+.||+|+||.||+|.+.++..||||+++...
T Consensus 153 ~----~~l~~~l~~~~~~~-----~~~---~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~ 220 (452)
T 1fmk_A 153 A----DGLCHRLTTVCPTS-----KPQ---TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220 (452)
T ss_dssp C----TTSSSCCCEECCCC-----CCC---CSSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS
T ss_pred c----ccchhhcccccccc-----ccc---cCCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC
Confidence 0 01100000000000 000 01112223344556788899999999999999999888889999998654
Q ss_pred cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh
Q 002121 664 MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743 (964)
Q Consensus 664 ~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 743 (964)
. ..++|.+|+++|++++||||+++++++.+ +..++||||+++|+|.+++....+..+++.+++.++.|++.||+|||+
T Consensus 221 ~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 298 (452)
T 1fmk_A 221 M-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298 (452)
T ss_dssp S-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred C-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3 34679999999999999999999999876 778999999999999999975433468999999999999999999999
Q ss_pred cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHH
Q 002121 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLEL 823 (964)
Q Consensus 744 ~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 823 (964)
.+ |+||||||+|||+++++.+||+|||+++....... .......+|+.|+|||++..+.++.++|||||||++|||
T Consensus 299 ~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el 374 (452)
T 1fmk_A 299 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374 (452)
T ss_dssp TT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHH
Confidence 88 99999999999999999999999999987653321 222344578899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 824 IT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 824 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
+| |+.||..... .+.... +..... . ...+. ....+.+++.+||+.||++|||++++++.|+.+.
T Consensus 375 ~t~g~~P~~~~~~-~~~~~~-i~~~~~----~--~~~~~-------~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 375 TTKGRVPYPGMVN-REVLDQ-VERGYR----M--PCPPE-------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp HTTTCCSSTTCCH-HHHHHH-HHTTCC----C--CCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred HhCCCCCCCCCCH-HHHHHH-HHcCCC----C--CCCCC-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99 8999864322 222222 211110 0 00111 1245678999999999999999999999999876
Q ss_pred Hh
Q 002121 903 QN 904 (964)
Q Consensus 903 ~~ 904 (964)
..
T Consensus 440 ~~ 441 (452)
T 1fmk_A 440 TS 441 (452)
T ss_dssp SC
T ss_pred cc
Confidence 43
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=393.51 Aligned_cols=282 Identities=45% Similarity=0.783 Sum_probs=232.9
Q ss_pred CcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEE
Q 002121 613 GARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 613 ~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
....|+++++..+.++|+..+.||+|+||+||+|...+|+.||||++...... ....+.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 35678999999999999999999999999999999888999999998764432 23478999999999999999999999
Q ss_pred EEeeCceEEEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 692 CFEQGEQMLVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 692 ~~~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
+.+.+..++||||+++|+|.+++.... ...++|..+..++.|++.||+|||+.+.++|+||||||+|||++.++.+||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl 175 (326)
T 3uim_A 96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV 175 (326)
T ss_dssp ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence 999999999999999999999998654 345999999999999999999999983334999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCC-------CCchhHHHHHH
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIE-------KGKYVVREVRT 842 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~-------~~~~~~~~~~~ 842 (964)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+ ......+++..
T Consensus 176 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 176 GDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp CCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred ccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999987654332 33445669999999999998899999999999999999999999995 12223344333
Q ss_pred HhccCcccccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 843 AMNRDDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
...... .....+..+... .......+.+++.+||+.||++|||+.||++.|+.
T Consensus 255 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 255 LLKEKK-----LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TTSSCC-----STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred Hhhchh-----hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 322222 334444443322 45556788999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=423.65 Aligned_cols=393 Identities=24% Similarity=0.318 Sum_probs=275.0
Q ss_pred CCCCCCCchhHhhH-HHHHHHHhCcccceEEeecccccCCcceeEEEeec---------------CCCcceeeccceeee
Q 002121 453 SFRELSNVTVFHSL-EMSLWVKLGLTPGSVFLQNPFFNIDDYLQIQVALF---------------PSGEKSFNRSEVQKI 516 (964)
Q Consensus 453 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~ 516 (964)
+|++++.++++... +.+||.... .-.++|+|++|+.+...+..+.|++ +.|+|++|.|+....
T Consensus 61 s~~~gd~~~v~~~~~~~~w~~~~~-~~~~G~~P~~yv~~~~~le~~~wyhg~i~r~~ae~ll~~~~~G~fLvR~s~~~~~ 139 (495)
T 1opk_A 61 SITKGEKLRVLGYNHNGEWCEAQT-KNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPG 139 (495)
T ss_dssp CBCTTCEEEEEEECTTSSEEEEEC-SSCEEEEEGGGEEESSSGGGSTTEEEECCHHHHHHHGGGCCTTEEEEEECSSSTT
T ss_pred CccCCCEEEEeecCCCCCceeeee-cCCcceeccccccccccccchhhhccCCCHHHHHHHhhCCCCceEEEEeCCCCCC
Confidence 47888888888755 667886653 3557999999999999999999988 579999999998777
Q ss_pred eeEeeccee------CCCcccCCcccccCCcccccCCCCCCCCcceeehhHHHHHHHHHHHHHHHHHHhhhhhhhhhhcC
Q 002121 517 GFELSNQTY------KPPKEFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIG 590 (964)
Q Consensus 517 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~r~~~~~~ 590 (964)
.+.+|.... +........++......+. .+. -+ +-... .. ..+
T Consensus 140 ~~~lsv~~~~~v~h~~I~~~~~g~~~~~~~~~F~--------------sl~--------eL---v~~~~----~~--~~g 188 (495)
T 1opk_A 140 QRSISLRYEGRVYHYRINTASDGKLYVSSESRFN--------------TLA--------EL---VHHHS----TV--ADG 188 (495)
T ss_dssp CEEEEEEETTEEEEEECEECTTSCEESSTTSCBS--------------SHH--------HH---HHHHT----TC--CTT
T ss_pred ceEEEEeeCCeEEEEEEEecCCCceEeccCccch--------------hHH--------HH---hhhhc----cc--ccc
Confidence 777765541 1111011111111110000 000 00 00000 00 000
Q ss_pred CCCCCCcCCCCCCCCCCCCCCCCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecC-CcEEEEEEecCCCcchhHH
Q 002121 591 LSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLE 669 (964)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~ 669 (964)
.........+.. ..+.... ....+++++....+|...+.||+|+||.||+|++.. ++.||||+++.... ..++
T Consensus 189 ~~~~l~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~ 262 (495)
T 1opk_A 189 LITTLHYPAPKR----NKPTIYG-VSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEE 262 (495)
T ss_dssp SSSCCCEECCCC----SCCCCSS-SCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHH
T ss_pred cchhcccccccc----ccccccc-cCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHH
Confidence 000000000000 0000000 000122233345678889999999999999999764 88999999976443 3568
Q ss_pred HHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002121 670 FKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749 (964)
Q Consensus 670 ~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 749 (964)
|.+|+++|++++|||||+++++|.+.+..++|||||++|+|.+++.......+++..++.++.||+.||+|||+.+ |
T Consensus 263 ~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---i 339 (495)
T 1opk_A 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339 (495)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 9999999999999999999999999999999999999999999998655567999999999999999999999988 9
Q ss_pred eccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCC
Q 002121 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQ 828 (964)
Q Consensus 750 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~ 828 (964)
+||||||+|||++.++.+||+|||+++...... ........+|+.|+|||++..+.++.++|||||||++|||+| |+.
T Consensus 340 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~ 418 (495)
T 1opk_A 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 418 (495)
T ss_dssp ECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCC
Confidence 999999999999999999999999998764322 122233456789999999999999999999999999999999 899
Q ss_pred CCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 829 PIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 829 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
||...... + +...+..... .... ......+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 419 p~~~~~~~-~-~~~~~~~~~~----------~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 419 PYPGIDLS-Q-VYELLEKDYR----------MERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp SSTTCCGG-G-HHHHHHTTCC----------CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCHH-H-HHHHHHcCCC----------CCCC---CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 98643211 1 1111111110 0000 011245678999999999999999999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=416.35 Aligned_cols=247 Identities=24% Similarity=0.330 Sum_probs=198.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHH---HHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEF---KTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++.... .....+ +.++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 367999999999999999999964 699999999864321 112223 3446677788999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
|||||||+||+|.+++...+ .+++.++..++.||+.||+|||+++ ||||||||+||||+.+|.+||+|||+|+..
T Consensus 268 ylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999997653 6899999999999999999999988 999999999999999999999999999977
Q ss_pred cCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~ 855 (964)
.... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.... ............... ..
T Consensus 343 ~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~----~p 414 (689)
T 3v5w_A 343 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE----LP 414 (689)
T ss_dssp SSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC----CC
T ss_pred CCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC----CC
Confidence 5432 234689999999999975 579999999999999999999999996422 222222222222111 11
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
..+. ..+.+++.+||+.||++|++ ++||.+
T Consensus 415 ~~~S-----------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSFS-----------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTSC-----------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccCC-----------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1111 34568999999999999998 677754
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=426.27 Aligned_cols=366 Identities=22% Similarity=0.276 Sum_probs=311.1
Q ss_pred CCCHHHHHHHHHHHHHcCCCC-----------CCCCCCCCCCCCC---ccEEecC-CCeeEEEcCCCCccccccCCcCCC
Q 002121 23 ATDSRDAAALQSLKDAWQNTP-----------PTWKNSDDPCGSW---EGVTCNN-SRVTALGLSTMGLTGKLSGDIGGL 87 (964)
Q Consensus 23 ~~~~~~~~aL~~~k~~~~~~~-----------~~W~~~~~~C~~w---~gv~C~~-~~v~~L~L~~~~l~g~~~~~l~~l 87 (964)
+....|+.||.+|+.++..+. .+|..+.++| .| .||.|+. ++|+.|+|++++++|.+|++|++|
T Consensus 26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L 104 (636)
T 4eco_A 26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQL 104 (636)
T ss_dssp CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGC
T ss_pred hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcC
Confidence 344679999999999975332 3798776766 89 9999975 699999999999999999999999
Q ss_pred CcccEEecccCC--------------------------------------------------------------------
Q 002121 88 TELRSLDLSYNG-------------------------------------------------------------------- 99 (964)
Q Consensus 88 ~~L~~L~L~~N~-------------------------------------------------------------------- 99 (964)
++|++|+|++|.
T Consensus 105 ~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~ 184 (636)
T 4eco_A 105 TELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK 184 (636)
T ss_dssp TTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCC
T ss_pred ccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchh
Confidence 999999999982
Q ss_pred ---------CCCCCCCCCCCCcccchhhccccccccCc-----------------CCcccC--CCCCccEEEcccCcccC
Q 002121 100 ---------GLTGSLSPRIGDLQKLNILILAGCGFTGN-----------------IPDEIG--NLAELSFLALNSNNFSG 151 (964)
Q Consensus 100 ---------~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-----------------~p~~~~--~l~~L~~L~Ls~N~l~~ 151 (964)
.+.| +|..|+++++|++|+|++|.|++. +|..++ ++++|++|+|++|++.+
T Consensus 185 ~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~ 263 (636)
T 4eco_A 185 DTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLT 263 (636)
T ss_dssp TTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCS
T ss_pred hhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCc
Confidence 2334 788899999999999999999986 999999 99999999999999999
Q ss_pred cCCCcCCCccccccccccccc-ccc-ccCcccCCCCccccccCCCeeEccCCcccccccc-cccCCCcceeEEEccCCcC
Q 002121 152 RIPPSLGKLSQLYWLDLADNQ-LTG-SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE-QLFSPDMVLIHVLFDGNQL 228 (964)
Q Consensus 152 ~~p~~~~~l~~L~~L~Ls~N~-l~g-~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~-~~f~~~~~L~~L~l~~N~l 228 (964)
.+|..|+++++|++|+|++|+ ++| .+|..+.....+..+++|++|++++|+++ .+|. ..+..+++|++|++++|++
T Consensus 264 ~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l 342 (636)
T 4eco_A 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQL 342 (636)
T ss_dssp SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCC
T ss_pred cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcC
Confidence 999999999999999999998 998 88843221112233499999999999999 8887 4678889999999999999
Q ss_pred cccCCcccCCCCCCcEEEcccCcCccccCccccCCCC-CCeeeccCccCccCCCCCCCCC--CCCEEEccCCCCCCCCCC
Q 002121 229 SGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTN-VNELNLAHNDLKGPFPDLSQMN--SLSYVDLSNNSFDPTEAP 305 (964)
Q Consensus 229 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~l~~l~--~L~~L~Ls~N~l~~~~~~ 305 (964)
+|.+| .++.+++|+.|+|++|+++ .+|..|.++++ |++|+|++|.++.++..+..+. +|++|++++|.++ ...|
T Consensus 343 ~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp~~~~~~~l~~L~~L~Ls~N~l~-~~~p 419 (636)
T 4eco_A 343 EGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIG-SVDG 419 (636)
T ss_dssp EEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCCSCCCTTCSSCEEEEECCSSCTT-TTTT
T ss_pred ccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCcccchhhhhcccCccCEEECcCCcCC-Ccch
Confidence 99999 8999999999999999999 88999999999 9999999999997666666554 8999999999998 6667
Q ss_pred cccC-------CCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCC-------CCcEEeccCCc
Q 002121 306 LWFS-------TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP-------LLQLVDLQNNQ 371 (964)
Q Consensus 306 ~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-------~L~~L~L~~N~ 371 (964)
..+. .+++|+.|+|++|+++...+..+..+++|+.|+|++|+++...+..+.... +|+.|+|++|+
T Consensus 420 ~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~ 499 (636)
T 4eco_A 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNK 499 (636)
T ss_dssp CSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSC
T ss_pred hhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCc
Confidence 7777 788999999999999965555667799999999999999965555555443 89999999999
Q ss_pred ceeeccC----CCcccceeEeecCCcc
Q 002121 372 ISAITLG----SGIKNYTLILVGNPVC 394 (964)
Q Consensus 372 l~~i~~~----~~~~l~~l~l~~Np~c 394 (964)
++.++.. ....++.|+|++|.+.
T Consensus 500 l~~lp~~~~~~~l~~L~~L~Ls~N~l~ 526 (636)
T 4eco_A 500 LTKLSDDFRATTLPYLVGIDLSYNSFS 526 (636)
T ss_dssp CCBCCGGGSTTTCTTCCEEECCSSCCS
T ss_pred CCccChhhhhccCCCcCEEECCCCCCC
Confidence 9988754 3456888999999864
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=435.93 Aligned_cols=362 Identities=29% Similarity=0.382 Sum_probs=256.1
Q ss_pred hhccCCCHHHHHHHHHHHHHcCCC--CCCCCCCCCCCCCCccEEecCCCeeEEEcCCCCcccc---ccCCcCCCCcccEE
Q 002121 19 LISSATDSRDAAALQSLKDAWQNT--PPTWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGK---LSGDIGGLTELRSL 93 (964)
Q Consensus 19 ~~~~~~~~~~~~aL~~~k~~~~~~--~~~W~~~~~~C~~w~gv~C~~~~v~~L~L~~~~l~g~---~~~~l~~l~~L~~L 93 (964)
++++++.++|++||++||+++.+. .++|..++||| +|.||+|+.++|+.|+|+++++.|. +|+++.+|++|+.+
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~l 82 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESL 82 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEETTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCEE
T ss_pred CccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEECCCcEEEEECCCCCcCCccCccChhHhccCccccc
Confidence 344555688999999999999743 27898666666 9999999989999999999999998 88888888888888
Q ss_pred ecccCCCCCCCCCCCCCCcccchhhccccccccCcCCc--ccCCCCCccEEEcccCcccCcCCCcC-CCccccccccccc
Q 002121 94 DLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPD--EIGNLAELSFLALNSNNFSGRIPPSL-GKLSQLYWLDLAD 170 (964)
Q Consensus 94 ~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~ 170 (964)
+++.| .+. .+|..|+++++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .++++|++|+|++
T Consensus 83 ~~~~~-~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~ 160 (768)
T 3rgz_A 83 FLSNS-HIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSA 160 (768)
T ss_dssp ECTTS-CEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCS
T ss_pred CCcCC-CcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCC
Confidence 88887 332 3567888888888888888888888887 88888888888888888887777765 7788888888888
Q ss_pred cccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 002121 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250 (964)
Q Consensus 171 N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 250 (964)
|++++..|... ..+..+++|++|++++|.+++.++. ..+++|++|++++|++++.+|. ++++++|++|+|++|
T Consensus 161 n~l~~~~~~~~---~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n 233 (768)
T 3rgz_A 161 NSISGANVVGW---VLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGN 233 (768)
T ss_dssp SCCEEETHHHH---HHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSS
T ss_pred CccCCcCChhh---hhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCC
Confidence 88886665210 0145667777777777777655543 5566677777777777766665 677777777777777
Q ss_pred cCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCC-CCCcEEECCCCccccccC
Q 002121 251 ALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL-PSLTTLICEFGSLQGRVP 329 (964)
Q Consensus 251 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p 329 (964)
.+++.+|..|.++++|++|+|++|.+++..|.. .+++|++|+|++|.++ ..+|..+..+ ++|++|+|++|++++.+|
T Consensus 234 ~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-~l~~L~~L~L~~n~l~-~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p 311 (768)
T 3rgz_A 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPPL-PLKSLQYLSLAENKFT-GEIPDFLSGACDTLTGLDLSGNHFYGAVP 311 (768)
T ss_dssp CCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC-CCTTCCEEECCSSEEE-ESCCCCSCTTCTTCSEEECCSSEEEECCC
T ss_pred cCCCcccHHHhcCCCCCEEECCCCcccCccCcc-ccCCCCEEECcCCccC-CccCHHHHhhcCcCCEEECcCCcCCCccc
Confidence 777777777777777777777777777666554 6666666666666665 3344444443 666666666666666666
Q ss_pred hhccCCCCCCEEEcCCcccccccCCC-CccCCCCcEEeccCCccee-eccC--CCc-ccceeEeecCC
Q 002121 330 DKLFSYSQIQQVKLRNNAFNNTLDMG-NAVGPLLQLVDLQNNQISA-ITLG--SGI-KNYTLILVGNP 392 (964)
Q Consensus 330 ~~~~~l~~L~~L~L~~N~l~~~~~~~-~~~l~~L~~L~L~~N~l~~-i~~~--~~~-~l~~l~l~~Np 392 (964)
..|..+++|++|+|++|++++.+|.. +..+++|+.|+|++|+++. ++.. ... .++.|+|.+|.
T Consensus 312 ~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~ 379 (768)
T 3rgz_A 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSE
T ss_pred hHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCC
Confidence 66666666666666666666555544 6666666666666666663 2221 111 45556666655
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=429.63 Aligned_cols=363 Identities=24% Similarity=0.356 Sum_probs=244.7
Q ss_pred cCCCHHHHHHHHHHHHHcCCCCCCCCCCC-----CCC-CCC------------ccEEec-CCCeeEEEcCCCCccccccC
Q 002121 22 SATDSRDAAALQSLKDAWQNTPPTWKNSD-----DPC-GSW------------EGVTCN-NSRVTALGLSTMGLTGKLSG 82 (964)
Q Consensus 22 ~~~~~~~~~aL~~~k~~~~~~~~~W~~~~-----~~C-~~w------------~gv~C~-~~~v~~L~L~~~~l~g~~~~ 82 (964)
+++..+|+.||++||+++.+. +|+.++ +|| |+| .||.|+ .++|+.|+|++++++|.+|+
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~ 341 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD 341 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECG
T ss_pred cccchHHHHHHHHHHHHcCCC--CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCch
Confidence 445568999999999999544 897665 562 599 999998 48999999999999999999
Q ss_pred CcCCCCcccEEec-ccCCCCCCC---------------------------------------------------------
Q 002121 83 DIGGLTELRSLDL-SYNGGLTGS--------------------------------------------------------- 104 (964)
Q Consensus 83 ~l~~l~~L~~L~L-~~N~~l~~~--------------------------------------------------------- 104 (964)
+|++|++|++|+| ++| .+.|.
T Consensus 342 ~l~~L~~L~~LdLss~N-~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~ 420 (876)
T 4ecn_A 342 AIGQLTELKVLSFGTHS-ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420 (876)
T ss_dssp GGGGCTTCCEEESCCTT-HHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCC
T ss_pred HHhccccceEeeecccc-cccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccc
Confidence 9999999999999 666 44333
Q ss_pred -------------------CCCCCCCcccchhhccccccccC-----------------cCCcccC--CCCCccEEEccc
Q 002121 105 -------------------LSPRIGDLQKLNILILAGCGFTG-----------------NIPDEIG--NLAELSFLALNS 146 (964)
Q Consensus 105 -------------------~p~~l~~l~~L~~L~L~~n~l~~-----------------~~p~~~~--~l~~L~~L~Ls~ 146 (964)
+|..|+++++|++|+|++|.|++ .+|..++ ++++|++|+|++
T Consensus 421 ~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~ 500 (876)
T 4ecn_A 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500 (876)
T ss_dssp CCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEES
T ss_pred cccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcC
Confidence 78889999999999999999998 3999988 999999999999
Q ss_pred CcccCcCCCcCCCccccccccccccc-ccc-ccCcccCCC------------------------C--ccccccCCCeeEc
Q 002121 147 NNFSGRIPPSLGKLSQLYWLDLADNQ-LTG-SIPVSTITS------------------------P--GLDQLKNAKHFHF 198 (964)
Q Consensus 147 N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~g-~iP~~~~~~------------------------~--~l~~l~~L~~L~L 198 (964)
|++.+.+|..|+++++|++|+|++|+ ++| .+|..+... . .+..+++|+.|+|
T Consensus 501 N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~ip~~~~l~~L~~L~~L~L 580 (876)
T 4ecn_A 501 CPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580 (876)
T ss_dssp CTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCBCCCHHHHTTCTTCCEEEC
T ss_pred CCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCCccCChhhhhcCCCCCEEEC
Confidence 99999999999999999999999998 988 677432111 1 3455556666666
Q ss_pred cCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCC-CcEEEcccCcCccccCccccCCCC--CCeeeccCcc
Q 002121 199 NKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQT-LEVLRLDRNALTGKVPTNLNNLTN--VNELNLAHND 275 (964)
Q Consensus 199 ~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~ 275 (964)
++|+++ .+| .|..+++|+.|+|++|+++ .+|..+..+++ |+.|+|++|.|+ .+|..+..++. |+.|+|++|+
T Consensus 581 s~N~l~-~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~ 655 (876)
T 4ecn_A 581 VHNKVR-HLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNK 655 (876)
T ss_dssp TTSCCC-BCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSC
T ss_pred CCCCcc-cch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCc
Confidence 666665 555 4555666666666666666 56655666666 666666666655 44444433321 3333333333
Q ss_pred CccCCCCC------------------------------CCCCCCCEEEccCCCCCC------------------------
Q 002121 276 LKGPFPDL------------------------------SQMNSLSYVDLSNNSFDP------------------------ 301 (964)
Q Consensus 276 l~~~~~~l------------------------------~~l~~L~~L~Ls~N~l~~------------------------ 301 (964)
+++.+|.+ ..+++|+.|+|++|+++.
T Consensus 656 l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~L 735 (876)
T 4ecn_A 656 IGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735 (876)
T ss_dssp TTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEEC
T ss_pred CCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEEC
Confidence 33322110 123344444444444430
Q ss_pred -----CCCCcccC--CCCCCcEEECCCCccccccChhccCCCCCCEEEcCC------cccccccCCCCccCCCCcEEecc
Q 002121 302 -----TEAPLWFS--TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRN------NAFNNTLDMGNAVGPLLQLVDLQ 368 (964)
Q Consensus 302 -----~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~------N~l~~~~~~~~~~l~~L~~L~L~ 368 (964)
..+|..+. .+++|+.|+|++|+|++ +|..+..+++|+.|+|++ |++.+.+|..+..+++|+.|+|+
T Consensus 736 s~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls 814 (876)
T 4ecn_A 736 RFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIG 814 (876)
T ss_dssp CSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECC
T ss_pred CCCCCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECC
Confidence 12333343 55555555555555554 455555555555555544 55555555556666666666666
Q ss_pred CCcceeeccCCCcccceeEeecCCc
Q 002121 369 NNQISAITLGSGIKNYTLILVGNPV 393 (964)
Q Consensus 369 ~N~l~~i~~~~~~~l~~l~l~~Np~ 393 (964)
+|+|..||......+..|+|++||+
T Consensus 815 ~N~L~~Ip~~l~~~L~~LdLs~N~l 839 (876)
T 4ecn_A 815 SNDIRKVDEKLTPQLYILDIADNPN 839 (876)
T ss_dssp SSCCCBCCSCCCSSSCEEECCSCTT
T ss_pred CCCCCccCHhhcCCCCEEECCCCCC
Confidence 6666555554444555566666653
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=410.34 Aligned_cols=395 Identities=20% Similarity=0.277 Sum_probs=268.7
Q ss_pred CCCCCCCchhHhh-HHHHHHHHhCcccceEEeecccccCCcc------eeEEEeec---------------CCCcceeec
Q 002121 453 SFRELSNVTVFHS-LEMSLWVKLGLTPGSVFLQNPFFNIDDY------LQIQVALF---------------PSGEKSFNR 510 (964)
Q Consensus 453 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---------------~~~~~~~~~ 510 (964)
+|++++-+++... .+.+||......-.++++|++|+++.+. ++.+.|++ +.|+|++|.
T Consensus 29 ~~~~gd~i~v~~~~~~~~ww~~~~~~g~~G~~P~~yv~~~~~~~~~~~~~~~~wyhg~i~r~~ae~~L~~~~~G~FlvR~ 108 (450)
T 1k9a_A 29 PFCKGDVLTIVAVTKDPNWYKAKNKVGREGIIPANYVQKREGVKAGTKLSLMPWFHGKITREQAERLLYPPETGLFLVRE 108 (450)
T ss_dssp CBCTTCEEEEEEECSSTTEEEEECTTCCEEEEEGGGEEECCCCCCCTTEESCTTBCTTCCHHHHHHHTCSCCTTEEEEEE
T ss_pred CCCCCCEEEEeeccCCCCceEEEECCCceeeechhccccccccccccccccccccccCcCHHHhhhhhccCCCceEEEEe
Confidence 4778888888776 5678998776544469999999988655 57778887 459999999
Q ss_pred cceeeeeeEeecceeCCCcccCCcccccCCcccccCCCCCCCCcceeehhHHHHHHHHHHHHHHHHHHhhhhhhhhhhcC
Q 002121 511 SEVQKIGFELSNQTYKPPKEFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKKRAERAIG 590 (964)
Q Consensus 511 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~r~~~~~~ 590 (964)
|+.....+.++...-....++. +......+... ......... -+.-+... . ..+
T Consensus 109 S~~~~g~~~Lsv~~~~~v~H~~---I~~~~~~~~i~-------~~~~F~sl~----------eLv~~y~~--~----~~~ 162 (450)
T 1k9a_A 109 STNYPGDYTLCVSCEGKVEHYR---IMYHASKLSID-------EEVYFENLM----------QLVEHYTT--D----ADG 162 (450)
T ss_dssp CSSSTTSEEEEEECSSSEEEEE---EEEETTEEESS-------SSSCBSSHH----------HHHHHHHH--C----CTT
T ss_pred cCCCCCceEEEEEeCCeeeEEE---EEecCCceEec-------cccccccHH----------HHHhhhcc--c----ccc
Confidence 9887666666653211000000 00000000000 000000000 00111110 0 001
Q ss_pred CCCCCCcCCCCCCCCCCCCCCCCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHH
Q 002121 591 LSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEF 670 (964)
Q Consensus 591 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~ 670 (964)
....... +... . . + ......+..++++...++|...+.||+|+||.||+|.+. |+.||||+++... ..+.|
T Consensus 163 ~~~~l~~--~~~~-~-~-~-~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~ 233 (450)
T 1k9a_A 163 LCTRLIK--PKVM-E-G-T-VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAF 233 (450)
T ss_dssp SSSCCCE--ECCC-T-T-C-EEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHH
T ss_pred hhhhccc--cccc-c-C-c-ccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHH
Confidence 0000000 0000 0 0 0 000000111222334567888999999999999999985 7899999998654 34679
Q ss_pred HHHHHHHHhcCCCCccceeEEEEeeC-ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002121 671 KTEIELLSRVHHKNLVGLVGFCFEQG-EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749 (964)
Q Consensus 671 ~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 749 (964)
.+|+++|++++|||||++++++.+.+ ..++|||||++|+|.+++.......+++..++.++.||++||+|||+.+ |
T Consensus 234 ~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i 310 (450)
T 1k9a_A 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310 (450)
T ss_dssp HHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred HHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 99999999999999999999987765 7899999999999999998665445799999999999999999999988 9
Q ss_pred eccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCC
Q 002121 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQ 828 (964)
Q Consensus 750 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~ 828 (964)
+||||||+|||+++++.+||+|||+++..... .....+++.|+|||++.+..++.++|||||||++|||+| |+.
T Consensus 311 vHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~ 385 (450)
T 1k9a_A 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385 (450)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999999864322 122357899999999999999999999999999999999 999
Q ss_pred CCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 829 PIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 829 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
||..... .+.... +..... ..... .....+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 386 P~~~~~~-~~~~~~-i~~~~~----------~~~p~---~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 386 PYPRIPL-KDVVPR-VEKGYK----------MDAPD---GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp SSTTSCT-TTHHHH-HHTTCC----------CCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCCCH-HHHHHH-HHcCCC----------CCCCC---cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 9964321 111111 111110 00011 11245678999999999999999999999999987653
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=377.73 Aligned_cols=280 Identities=34% Similarity=0.613 Sum_probs=229.7
Q ss_pred cccccHHHHHHhhcCCCcc------ceeecCCcEEEEEEEecCCcEEEEEEecCCC----cchhHHHHHHHHHHHhcCCC
Q 002121 614 ARWFSYDELKKCSNNFSES------NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGS----MQGGLEFKTEIELLSRVHHK 683 (964)
Q Consensus 614 ~~~~~~~el~~~~~~~~~~------~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~ 683 (964)
...|+++++..++++|... +.||+|+||+||+|.. +++.||||++.... ......+.+|++++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 4568999999999999988 8999999999999997 58899999987532 22345789999999999999
Q ss_pred CccceeEEEEeeCceEEEEEeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC
Q 002121 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD 762 (964)
Q Consensus 684 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~ 762 (964)
||+++++++.+.+..++||||+++|+|.+++.... ...++|..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~ 167 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLD 167 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEC
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEc
Confidence 99999999999999999999999999999987532 346999999999999999999999988 99999999999999
Q ss_pred CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch---hHHH
Q 002121 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY---VVRE 839 (964)
Q Consensus 763 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~---~~~~ 839 (964)
+++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|||++|+.||..... ....
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 246 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence 999999999999987654433333445679999999998764 589999999999999999999999974321 1222
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
........ ..+.+.+++.+..........+.+++.+||+.||++||++.|+++.|+++.
T Consensus 247 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 247 KEEIEDEE----KTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HHHHHTTS----CCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred HHHhhhhh----hhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 22211111 113344444444444556677889999999999999999999999999874
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=425.97 Aligned_cols=391 Identities=26% Similarity=0.421 Sum_probs=276.6
Q ss_pred CCCCCCCchhHhhHHHHHHHHhCcccc-eEEeecccccCCcceeEEEeec-----------------CCCcceeecccee
Q 002121 453 SFRELSNVTVFHSLEMSLWVKLGLTPG-SVFLQNPFFNIDDYLQIQVALF-----------------PSGEKSFNRSEVQ 514 (964)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 514 (964)
+|++++-++++...+.+||.......+ ++|+|.+|++..+.++.+.|++ +.|.|++|.|+..
T Consensus 103 ~~~~gd~i~v~~~~~~~ww~~~~~~~g~~G~~P~~yv~~~~~l~~~~wy~g~i~r~~ae~~L~~~~~~~G~FLvR~S~~~ 182 (535)
T 2h8h_A 103 SFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETT 182 (535)
T ss_dssp CBCTTCEEEEEECSSSSEEEEEETTTCCEEEEEGGGEEETTSGGGSTTBCCSCCHHHHHHHHTCTTCCTTEEEEEECSSS
T ss_pred CcCCCCEEEEEEecCCCceEEEECCCCcceEecchhhcccccccccceeccccCHHHHHHHhccCCCCCCeEEEEecCCC
Confidence 478888888888878899988766444 6999999999999998899988 3499999999987
Q ss_pred eeeeEeecceeC-----------CCcccCCcccccCCcccccCCCCCCCCcceeehhHHHHHHHHHHHHHHHHHHhhhhh
Q 002121 515 KIGFELSNQTYK-----------PPKEFGPYYFIASPYAFQVPQGGNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQKK 583 (964)
Q Consensus 515 ~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (964)
...+.++..... ........+++.....+ ..+. -++-++.. .
T Consensus 183 ~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~~i~~~~~F--------------~SL~-----------eLv~~y~~--~ 235 (535)
T 2h8h_A 183 KGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQF--------------NSLQ-----------QLVAYYSK--H 235 (535)
T ss_dssp TTCEEEEEEEEETTTEEEEEEEEEBC-CCSCEEEETTEEE--------------SSHH-----------HHHHHHHH--C
T ss_pred CCcEEEEEEeeccCCCCceEEEEEEEcCCCcEEeeccccc--------------cChH-----------Hhheeecc--c
Confidence 777777765421 11000011111110000 0000 01111111 0
Q ss_pred hhhhhcCCCCCCCcCCCCCCCCCCCCCCCCcccccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCC
Q 002121 584 RAERAIGLSKPFASWAPSGKDSGGAPQLKGARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGS 663 (964)
Q Consensus 584 r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~ 663 (964)
. .+.........+.. .+. ...+..++++...++|...+.||+|+||.||+|.+.++..||||+++...
T Consensus 236 ~----~~~~~~l~~~~~~~-----~~~---~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~ 303 (535)
T 2h8h_A 236 A----DGLCHRLTTVCPTS-----KPQ---TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 303 (535)
T ss_dssp C----TTSSSCCCEECCCC-----CCC---CSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS
T ss_pred c----Cccccccccccccc-----ccc---ccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC
Confidence 0 01000000000000 000 01122233344566788899999999999999999888889999998654
Q ss_pred cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh
Q 002121 664 MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743 (964)
Q Consensus 664 ~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~ 743 (964)
. ..++|.+|+++|++++|||||++++++.+ +..++|||||++|+|.+++....+..+++.+++.++.||++||+|||+
T Consensus 304 ~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 381 (535)
T 2h8h_A 304 M-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381 (535)
T ss_dssp S-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred C-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3 34679999999999999999999999876 778999999999999999975433468999999999999999999999
Q ss_pred cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHH
Q 002121 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLEL 823 (964)
Q Consensus 744 ~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el 823 (964)
.+ ||||||||+|||+++++.+||+|||+++...... ........++..|+|||++..+.++.++|||||||++|||
T Consensus 382 ~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el 457 (535)
T 2h8h_A 382 MN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 457 (535)
T ss_dssp TT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred CC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 88 9999999999999999999999999998654211 1112234577899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 824 IT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 824 lt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
++ |+.||..... .+.+.. +..... . ..... ....+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 458 ~t~g~~P~~~~~~-~~~~~~-i~~~~~----~--~~~~~-------~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 458 TTKGRVPYPGMVN-REVLDQ-VERGYR----M--PCPPE-------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp TTTTCCSSTTCCH-HHHHHH-HHTTCC----C--CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HhCCCCCCCCCCH-HHHHHH-HHcCCC----C--CCCCC-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 99 8999864322 222222 211110 0 00111 1245678999999999999999999999998765
Q ss_pred H
Q 002121 903 Q 903 (964)
Q Consensus 903 ~ 903 (964)
.
T Consensus 523 ~ 523 (535)
T 2h8h_A 523 T 523 (535)
T ss_dssp C
T ss_pred h
Confidence 3
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-42 Score=379.31 Aligned_cols=270 Identities=29% Similarity=0.473 Sum_probs=206.4
Q ss_pred cHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEee
Q 002121 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 695 (964)
Q Consensus 618 ~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 695 (964)
+.+++....++|++.+.||+|+||+||+|+. +|+.||||++...... ...++.+|++++++++||||+++++++.+.
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 3344445567899999999999999999987 5889999998765433 335788999999999999999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999999998654 224899999999999999999999875 5699999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........... ...
T Consensus 186 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-~~~~~~~~~~~~--~~~ 260 (309)
T 3p86_A 186 SRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-QVVAAVGFKCKR--LEI 260 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-HHHHHHHHSCCC--CCC
T ss_pred Cccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHhcCCC--CCC
Confidence 98654321 2233457999999999999999999999999999999999999999754322 122111111110 001
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...+ ...+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 261 ~~~~-----------~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 261 PRNL-----------NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp CTTS-----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred CccC-----------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 1111 134678999999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=372.74 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=208.5
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|+..+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45799999999999999999995 57899999998766555567789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 9999999999764 4899999999999999999999988 99999999999999999999999999987654332
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. ....+
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-------~~~~~---- 239 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-------ELQNP---- 239 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-------CCSCG----
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-------CCCCc----
Confidence 234467999999999999999999999999999999999999999754433222221111111 00000
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+||+.||++|||+.|+++
T Consensus 240 --~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 --EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111244668999999999999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=375.01 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=215.9
Q ss_pred ccccHHHHHHhhcC----------CCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCC
Q 002121 615 RWFSYDELKKCSNN----------FSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHK 683 (964)
Q Consensus 615 ~~~~~~el~~~~~~----------~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~ 683 (964)
..+++++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45889999988875 667789999999999999975 7999999999876666667899999999999999
Q ss_pred CccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC
Q 002121 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE 763 (964)
Q Consensus 684 nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~ 763 (964)
||+++++++...+..++||||+++|+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTL 176 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECT
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECC
Confidence 9999999999999999999999999999998753 5999999999999999999999988 999999999999999
Q ss_pred CCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002121 764 NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843 (964)
Q Consensus 764 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 843 (964)
++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.....
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-~~~~~~~ 253 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-VQAMKRL 253 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHH
T ss_pred CCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHH
Confidence 99999999999987654322 23345799999999999999999999999999999999999999975432 2222222
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..... +.+.. .......+.+++.+||+.||++|||+.|+++
T Consensus 254 ~~~~~-----------~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 254 RDSPP-----------PKLKN-SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHSSC-----------CCCTT-GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCC-----------CCcCc-cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 21111 00000 0011244668999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=380.44 Aligned_cols=263 Identities=26% Similarity=0.367 Sum_probs=209.7
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCc----eEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE----QMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----~~lV 701 (964)
.++|+..+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++|||||++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 467889999999999999999985 7999999986532 233456679999999999999999999988654 6999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc----------CCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL----------ANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
|||+++|+|.++++.. .++|.++..++.|+++||+|||+. + |+||||||+|||++.++.+||+|
T Consensus 101 ~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECC
T ss_pred EecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEcc
Confidence 9999999999999764 499999999999999999999987 6 99999999999999999999999
Q ss_pred cccceeecCCCCCceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCch-----------
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKY----------- 835 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~----------- 835 (964)
||+++...............||+.|+|||++.+ ..++.++|||||||++|||+||+.||.....
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 999988765443333444679999999999876 3566789999999999999999999863211
Q ss_pred ---hHHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 836 ---VVREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 836 ---~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
....+....... ...+.+... .......+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus 255 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 255 QHPSLEDMQEVVVHK---------KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp SSCCHHHHHHHHTTS---------CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCchhhhhhhhhcc---------cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 011111111111 111111111 2233456889999999999999999999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=384.99 Aligned_cols=261 Identities=25% Similarity=0.428 Sum_probs=211.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEee
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ 695 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 695 (964)
.++|...+.||+|+||+||+|+.. ++..||||+++.... ....++.+|+++++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999852 356899999976533 2345789999999999 899999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997543 135899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~-~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV-EELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-GGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-HHHH
Confidence 9999999999999987654433333344567889999999999999999999999999999999 9999864321 1111
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
........ +.... .....+.+++.+||+.||++||++.|+++.|+.+++.
T Consensus 316 ~~~~~~~~-----------~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 316 KLLKEGHR-----------MDKPA---NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HHHHTTCC-----------CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCC-----------CCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11111110 00010 1124567899999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=371.59 Aligned_cols=262 Identities=24% Similarity=0.415 Sum_probs=210.2
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|...+.||+|+||+||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56788899999999999999964 68999999987766666678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.... ..++|.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 90 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 90 KGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp TTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999998643 46999999999999999999999988 9999999999999999999999999998764332211
Q ss_pred ------------eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 786 ------------VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 786 ------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
......||+.|+|||++.+..++.++|||||||++|||++|..|+....... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~----------~~~~~~ 235 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT----------MDFGLN 235 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC----------TTSSBC
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH----------HHHhhh
Confidence 1114579999999999999999999999999999999999999875321000 000000
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.....+... .......+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 236 ~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 236 VRGFLDRYC---PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHHHHTC---CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhccccccC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000000000 0011134668999999999999999999999999887653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=375.10 Aligned_cols=262 Identities=27% Similarity=0.438 Sum_probs=210.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|.+.+.||+|+||+||+|... .+..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 357888899999999999999974 345699999986533 344679999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999997653 36999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCC-CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 781 SSK-GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 781 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +.......... . ..
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~~~~-----~--~~ 275 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-DVISSVEEGYR-----L--PA 275 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHHHHHHTTCC-----C--CC
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-HHHHHHHcCCC-----C--CC
Confidence 322 122333456889999999998999999999999999999999 99999643321 22222111111 0 00
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
... ....+.+++.+||+.||++||++.|+++.|+.+++...
T Consensus 276 ~~~-------~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 276 PMG-------CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp CTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred CCC-------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111 12456789999999999999999999999999986653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=385.24 Aligned_cols=272 Identities=25% Similarity=0.417 Sum_probs=219.5
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccce
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGL 688 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l 688 (964)
+...++....++|...+.||+|+||.||+|++ .+++.||||+++..... ..+.+.+|++++.++ +|||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 55667777889999999999999999999984 24679999999865433 345799999999999 79999999
Q ss_pred eEEEEeeCc-eEEEEEeccCCChhhhhcCCCC------------------------------------------------
Q 002121 689 VGFCFEQGE-QMLVYEFMANGTLRESLSGRSG------------------------------------------------ 719 (964)
Q Consensus 689 ~~~~~~~~~-~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------ 719 (964)
++++.+.+. .++||||+++|+|.++++....
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 8999999999999999976532
Q ss_pred ----------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 720 ----------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 720 ----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12899999999999999999999988 99999999999999999999999999987655444
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
........||+.|+|||++.+..++.++|||||||++|||+| |+.||................... ......
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 321 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---RAPDYT---- 321 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---CCCTTC----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---CCCCCC----
Confidence 444555678999999999999999999999999999999998 999996543222222221111110 011111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...+.+++.+||+.||++|||+.|+++.|+.+++..
T Consensus 322 -------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 322 -------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp -------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 134678999999999999999999999999988653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=370.32 Aligned_cols=263 Identities=25% Similarity=0.388 Sum_probs=207.2
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|+..+.||+|+||.||+|+. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 45789999999999999999995 4689999999865432 2235789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 164 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164 (294)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred EeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence 99999999999997643 6899999999999999999999988 999999999999999999999999999865433
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||................... ......+.
T Consensus 165 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 239 (294)
T 4eqm_A 165 SL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPN----VTTDVRKD 239 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCC----HHHHSCTT
T ss_pred cc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCC----cchhcccC
Confidence 21 22334569999999999999999999999999999999999999997554333222222111110 00001111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRP-TMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 905 (964)
....+.+++.+|++.||++|| +++++.+.|+.++...
T Consensus 240 -------~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~ 277 (294)
T 4eqm_A 240 -------IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHEN 277 (294)
T ss_dssp -------SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred -------CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence 124567899999999999998 8999998888765433
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=375.83 Aligned_cols=248 Identities=22% Similarity=0.343 Sum_probs=205.4
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
..++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999996 5799999999875432 3345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++...+ .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp ECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred EECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999997643 5899999999999999999999988 999999999999999999999999999866433
Q ss_pred CCCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. ......||+.|+|||++.+..+. .++||||+||++|||++|+.||.... ..+........... .+..+
T Consensus 168 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-~~~~~~~i~~~~~~----~p~~~-- 237 (328)
T 3fe3_A 168 G---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVLRGKYR----IPFYM-- 237 (328)
T ss_dssp C---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTS--
T ss_pred C---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC----CCCCC--
Confidence 2 23456799999999999887765 79999999999999999999996533 22222222222111 11111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+||+.||.+|||++|+++
T Consensus 238 ---------s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 238 ---------STDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ---------CHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ---------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 134568999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=384.86 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=211.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..++|...+.||+|+||.||+|... +|+.||||+++..... ...+|.+|++++++++|||||++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3567888999999999999999975 7899999998754332 3356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 192 e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~ 267 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267 (377)
T ss_dssp ECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred EcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence 9999999999997542 45899999999999999999999988 9999999999999999999999999998654321
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.........+++.|+|||++..+.++.++|||||||++|||+| |+.||..... ..+...+...... ...+.
T Consensus 268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~--~~~~~---- 339 (377)
T 3cbl_A 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGGRL--PCPEL---- 339 (377)
T ss_dssp EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTCCC--CCCTT----
T ss_pred eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC--CCCCC----
Confidence 1111112235778999999998899999999999999999999 9999864332 1222222211100 01111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
....+.+++.+||+.||++|||+.++++.|+.+.++.
T Consensus 340 -------~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~~ 376 (377)
T 3cbl_A 340 -------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRH 376 (377)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhhc
Confidence 1145678999999999999999999999999987653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=362.78 Aligned_cols=257 Identities=32% Similarity=0.523 Sum_probs=211.4
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|...+.||+|+||+||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 57888899999999999999998899999999986543 34579999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ..
T Consensus 89 ~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 163 (269)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HS
T ss_pred CCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccc-cc
Confidence 999999997653 46899999999999999999999988 99999999999999999999999999986543211 12
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....+|+.|+|||++....++.++||||+|+++|||++ |+.||..... .+.......... ...+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~~~~~~~~~~~~--------~~~~~~--- 231 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFR--------LYKPRL--- 231 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCC--------CCCCTT---
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-HHHHHHHhcCcc--------CCCCCc---
Confidence 223457788999999998999999999999999999999 8999865332 222222211111 001110
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
....+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 232 ---~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 232 ---ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ---CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 114467899999999999999999999999998753
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=380.02 Aligned_cols=262 Identities=27% Similarity=0.481 Sum_probs=200.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|+..+.||+|+||.||+|+.. ++..||||+++.... ...++|.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 357889999999999999999864 577899999976433 344579999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.++++... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 124 v~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999998653 46999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 781 SSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 781 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+.. ..+..... .. .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~~~~-~~i~~~~~----~~--~ 271 (373)
T 2qol_A 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QDVI-KAVDEGYR----LP--P 271 (373)
T ss_dssp --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-HHHH-HHHHTTEE----CC--C
T ss_pred CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHH-HHHHcCCC----CC--C
Confidence 3221 11222346788999999999999999999999999999998 9999964332 1111 11211110 00 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
. ......+.+++.+||+.||++||++.||++.|+.+++..+
T Consensus 272 ~-------~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 272 P-------MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp C-------TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred C-------ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 0 0112456789999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=378.27 Aligned_cols=263 Identities=24% Similarity=0.423 Sum_probs=214.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccceeEEEEee
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ 695 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 695 (964)
.++|...+.||+|+||+||+|+.. .+..||||+++..... ...++.+|+++++++ +|||||++++++.+.
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 467888999999999999999852 2357999999765433 346789999999999 899999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEE
Confidence 99999999999999999997643 235899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~-~~~~~ 303 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VEELF 303 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-HHHHH
Confidence 9999999999999987654433333445568899999999999999999999999999999999 999986432 22222
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
. .+....... .. .. ....+.+++.+||+.||++||++.||++.|+.++....
T Consensus 304 ~-~~~~~~~~~--~~----~~-------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 304 K-LLKEGHRMD--KP----SN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp H-HHHTTCCCC--CC----SS-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred H-HHHcCCCCC--CC----cc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 2 222111000 01 11 12456789999999999999999999999999987664
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=374.27 Aligned_cols=269 Identities=24% Similarity=0.409 Sum_probs=206.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee--Cce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 698 (964)
.++|+..+.||+|+||+||+|++ .+|+.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 35788899999999999999984 36889999999876666667899999999999999999999999654 568
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999997653 35899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccc---c-
Q 002121 779 SDSSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY---G- 853 (964)
Q Consensus 779 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~- 853 (964)
...... .......+|..|+|||++.+..++.++||||||+++|||+||..|+....... ............ .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 241 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF---MRMIGNDKQGQMIVFHL 241 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH---HHHHCTTCCTHHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH---HhhhcCccccchhHHHH
Confidence 543221 22233457888999999999999999999999999999999999985322110 000100000000 0
Q ss_pred ---cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 854 ---LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 854 ---~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
......... .......+.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 242 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPR---PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCC---CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCC---CcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000000000 111224577899999999999999999999999998764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=362.16 Aligned_cols=258 Identities=28% Similarity=0.446 Sum_probs=211.8
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|+..+.||+|+||.||+|..+++..||||+++..... ..++.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 4678889999999999999999988889999999765433 457899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 86 ~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-V 160 (268)
T ss_dssp TTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-E
T ss_pred CCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh-h
Confidence 9999999997542 35899999999999999999999988 99999999999999999999999999987654322 2
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......+|+.|+|||++.+..++.++||||||+++|||++ |+.||...... ............ ..+..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~~~~~~~~~~--------~~~~~-- 229 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-EVVLKVSQGHRL--------YRPHL-- 229 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTCCC--------CCCTT--
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-HHHHHHHcCCCC--------CCCCc--
Confidence 2334456778999999998889999999999999999999 99999644322 222222111110 01111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
....+.+++.+||+.||++|||+.|+++.|+.+.++
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 230 ----ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ----SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ----ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 113567899999999999999999999999887544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=373.17 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=206.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
..+.|...+.||+|+||+||+|+.. +|+.||+|+++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 3467899999999999999999965 6899999998764332 24578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC----cEEEeecc
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL----TAKVADFG 773 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFG 773 (964)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999997643 6999999999999999999999988 99999999999998877 79999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+.+.........
T Consensus 165 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-~~~~~~~i~~~~~~---- 236 (361)
T 2yab_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANITAVSYD---- 236 (361)
T ss_dssp SCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHTTCCC----
T ss_pred CceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhcCCC----
Confidence 998765432 2234579999999999999899999999999999999999999996432 22222222221110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+++..... ....+.+++.+||..||++|||+.|+++
T Consensus 237 ----~~~~~~~~---~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 ----FDEEFFSQ---TSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----CCHHHHTT---SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----CCchhccC---CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111111 1234668999999999999999999874
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=371.92 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=204.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||+||+|+.. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 367899999999999999999965 789999999865433 234568999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 86 YCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999997653 6899999999999999999999988 99999999999999999999999999987654332
Q ss_pred CceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
........||+.|+|||++.+..+ +.++|||||||++|||++|+.||................... ..+ .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~-~ 231 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------LNP-W 231 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--------STT-G
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--------CCc-c
Confidence 233345679999999999987765 789999999999999999999997544332222222211110 000 0
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 232 ----KKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----ccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111244568999999999999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=370.50 Aligned_cols=247 Identities=23% Similarity=0.282 Sum_probs=203.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57888999999999999999965 68999999987532 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999997543 5899999999999999999999988 9999999999999999999999999998643222
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ....+
T Consensus 160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~----~p~~~---- 228 (337)
T 1o6l_A 160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-ERLFELILMEEIR----FPRTL---- 228 (337)
T ss_dssp --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC----CCTTS----
T ss_pred --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC----CCCCC----
Confidence 223456799999999999999999999999999999999999999965332 2222222221110 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||++|| +++|+++
T Consensus 229 -------s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 229 -------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 13456899999999999999 8999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=364.06 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=202.6
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHh--cCCCCccceeEEEEee----CceE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSR--VHHKNLVGLVGFCFEQ----GEQM 699 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 699 (964)
.++|+..+.||+|+||+||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46899999999999999999998 6899999998643 33456677777776 7999999999997653 4579
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHh--------hcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH--------ELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
+||||+++|+|.++++.. .+++..++.++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 83 lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999653 5999999999999999999999 666 99999999999999999999999
Q ss_pred cccceeecCCCCCc--eeecccccCcccCccccccC------CCCCchhHHHHHHHHHHHHhC----------CCCCCCC
Q 002121 772 FGLSKLVSDSSKGH--VSTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVVMLELITA----------KQPIEKG 833 (964)
Q Consensus 772 FGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~elltg----------~~p~~~~ 833 (964)
||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+|| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99998765443211 12234799999999999876 455799999999999999999 7887532
Q ss_pred ---chhHHHHHHHhccCcccccccccccCccchh--hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 834 ---KYVVREVRTAMNRDDEEHYGLTEMMDPTIRN--TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 834 ---~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
......+........ ..+.+.. ........+.+++.+||+.||++|||+.||++.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQ---------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SCSSCCHHHHHHHHTTSC---------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccC---------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 122222322222111 1111111 1223446788999999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=365.68 Aligned_cols=260 Identities=27% Similarity=0.423 Sum_probs=210.5
Q ss_pred hhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
..++|...+.||+|+||+||+|...++..||||+++..... ..++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 35678889999999999999999988889999999865433 46799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-Y 175 (283)
T ss_dssp CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-H
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc-c
Confidence 99999999997632 35999999999999999999999988 9999999999999999999999999998654321 1
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.......+|+.|+|||++....++.++||||||+++|||+| |+.||...... +............ .....
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~~~~~~~~~~~~~---~~~~~----- 246 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETAEHIAQGLRLY---RPHLA----- 246 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTCCCC---CCTTC-----
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-HHHHHHhcccCCC---CCCcC-----
Confidence 11223456788999999998899999999999999999998 99999754322 2222221111100 01111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...+.+++.+||+.||++||++.|+++.|++++.++
T Consensus 247 ------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 247 ------SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp ------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 145678999999999999999999999999998765
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=368.57 Aligned_cols=252 Identities=18% Similarity=0.273 Sum_probs=207.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|...+.||+|+||+||+|... +|+.||+|++.... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 468899999999999999999965 68899999987543 3445688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC--CCcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE--NLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~~ 782 (964)
+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 99999999997643 46899999999999999999999988 999999999999987 789999999999877543
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+......... .+...
T Consensus 158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~--------~~~~~ 226 (321)
T 1tki_A 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENIMNAEYT--------FDEEA 226 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC--------CCHHH
T ss_pred --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-HHHHHHHHcCCCC--------CChhh
Confidence 233456799999999999988899999999999999999999999965332 2222222222111 01111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
. ......+.+++.+||+.||++|||+.|+++.
T Consensus 227 ~---~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 227 F---KEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h---ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 1112456789999999999999999999873
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=375.69 Aligned_cols=266 Identities=26% Similarity=0.404 Sum_probs=213.8
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEE
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCF 693 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 693 (964)
++....++|...+.||+|+||.||+|+.. +++.||||+++.... .....+.+|++++++++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 44455789999999999999999999974 348999999986543 23457899999999999999999999999
Q ss_pred eeCceEEEEEeccCCChhhhhcCCC----------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeec
Q 002121 694 EQGEQMLVYEFMANGTLRESLSGRS----------------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751 (964)
Q Consensus 694 ~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 751 (964)
+.+..++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999997542 146899999999999999999999988 999
Q ss_pred cCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCC
Q 002121 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPI 830 (964)
Q Consensus 752 ~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~ 830 (964)
|||||+|||+++++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999987644332223344568999999999998899999999999999999999 99999
Q ss_pred CCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 831 EKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
..... .+.......... . ..... ....+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 278 ~~~~~-~~~~~~~~~~~~------~-~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 278 YGMAH-EEVIYYVRDGNI------L-ACPEN-------CPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTSCH-HHHHHHHHTTCC------C-CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CCCCh-HHHHHHHhCCCc------C-CCCCC-------CCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 64332 222222211111 0 00111 114567899999999999999999999999987643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=371.55 Aligned_cols=269 Identities=24% Similarity=0.364 Sum_probs=196.7
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEecC-C---cEEEEEEecCC--CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLSD-G---QVVAIKRAQQG--SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG 696 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 696 (964)
....++|...+.||+|+||+||+|+... + ..||||+++.. .....+++.+|++++++++||||+++++++...+
T Consensus 19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR 98 (323)
T ss_dssp BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence 3445689999999999999999999653 3 27999998764 2334567999999999999999999999998766
Q ss_pred ce------EEEEEeccCCChhhhhcCCC----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc
Q 002121 697 EQ------MLVYEFMANGTLRESLSGRS----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT 766 (964)
Q Consensus 697 ~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~ 766 (964)
.. ++||||+++|+|.+++.... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence 55 99999999999999985422 235899999999999999999999988 999999999999999999
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhc
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~ 845 (964)
+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||...... +.......
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-EIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-HHHHHHhc
Confidence 99999999987654433333344567889999999999999999999999999999999 89998643321 11121111
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCCC
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNT 909 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 909 (964)
.... ...+. ....+.+++.+||+.||++|||+.|+++.|+++++......
T Consensus 255 ~~~~-------~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~ 304 (323)
T 3qup_A 255 GNRL-------KQPPE-------CMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304 (323)
T ss_dssp TCCC-------CCCTT-------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred CCCC-------CCCCc-------cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence 1110 00111 12456799999999999999999999999999998765443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=366.52 Aligned_cols=264 Identities=24% Similarity=0.405 Sum_probs=215.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEeeC
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG 696 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 696 (964)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 356788999999999999999985 3467999999986543 3346789999999999 9999999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCCC----------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 002121 697 EQMLVYEFMANGTLRESLSGRSG----------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNIL 760 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 760 (964)
..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999976432 24899999999999999999999988 999999999999
Q ss_pred ECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHH
Q 002121 761 LDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVRE 839 (964)
Q Consensus 761 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~ 839 (964)
++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.||.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 257 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence 99999999999999987765544333445567889999999999999999999999999999999 99998653322221
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
. ........ ....... ...+.+++.+||+.||++||++.|+++.|++++++.
T Consensus 258 ~-~~~~~~~~------~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 258 Y-KMIKEGFR------MLSPEHA-------PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H-HHHHHTCC------CCCCTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H-HHhccCCC------CCCcccC-------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 11111110 0001111 145678999999999999999999999999998764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=367.10 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=213.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
..++|...+.||+|+||.||+|.. .+++.||||+++.... ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356788899999999999999985 2458899999975433 334578999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCC----------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCC
Q 002121 698 QMLVYEFMANGTLRESLSGRSG----------------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVK 755 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk 755 (964)
.++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999975432 34899999999999999999999988 9999999
Q ss_pred CCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCc
Q 002121 756 STNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGK 834 (964)
Q Consensus 756 ~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~ 834 (964)
|+||++++++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987754433223334567889999999998899999999999999999999 999996432
Q ss_pred hhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 835 YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.. . +...+..... ...... ....+.+++.+||+.||++||++.|+++.|++++.+.
T Consensus 258 ~~-~-~~~~~~~~~~------~~~~~~-------~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 258 PE-R-LFNLLKTGHR------MERPDN-------CSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp GG-G-HHHHHHTTCC------CCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HH-H-HHHHhhcCCc------CCCCcc-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 21 1 1111111110 000111 1245678999999999999999999999999988653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=378.84 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=210.5
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|...+.||+|+||+||+|++. +++.||||+++... .....++.+|+.++++++|||||++++++.+.+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 357888999999999999999953 46789999997543 33445788999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCC-----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cEEEe
Q 002121 699 MLVYEFMANGTLRESLSGRS-----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TAKVA 770 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~ 770 (964)
++||||+++|+|.+++.... ...+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997532 235899999999999999999999988 99999999999999555 59999
Q ss_pred ecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||..... .+...........
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-~~~~~~i~~~~~~ 305 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRM 305 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCC
Confidence 9999986543322233344568999999999999999999999999999999998 9999965332 2222222211110
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
. . ... ....+.+++.+||+.||++||++.||++.|+.+.+..
T Consensus 306 ~---~----~~~-------~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 306 D---P----PKN-------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp C---C----CTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred C---C----Ccc-------CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 0 0 011 1134678999999999999999999999999887654
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=369.68 Aligned_cols=291 Identities=26% Similarity=0.464 Sum_probs=214.6
Q ss_pred CCCHHHHHHHHHHHHHcCCCC--CCCCCCCCCC-CCCccEEecC----CCeeEEEcCCCCccc--cccCCcCCCCcccEE
Q 002121 23 ATDSRDAAALQSLKDAWQNTP--PTWKNSDDPC-GSWEGVTCNN----SRVTALGLSTMGLTG--KLSGDIGGLTELRSL 93 (964)
Q Consensus 23 ~~~~~~~~aL~~~k~~~~~~~--~~W~~~~~~C-~~w~gv~C~~----~~v~~L~L~~~~l~g--~~~~~l~~l~~L~~L 93 (964)
.|+++|++||++||+++.+.. .+|..+++|| |.|.||.|+. ++|+.|+|++++++| .+|..|+++++|++|
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L 81 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCee
Confidence 588999999999999996533 6898777777 2399999985 789999999999999 899999999999999
Q ss_pred eccc-CCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccc
Q 002121 94 DLSY-NGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQ 172 (964)
Q Consensus 94 ~L~~-N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 172 (964)
+|++ | .+.+.+|..|+++++|++|+|++|.+++.+|..|.++++|++|+|++|.+++.+|..|.++++|++|+|++|+
T Consensus 82 ~L~~~n-~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 160 (313)
T 1ogq_A 82 YIGGIN-NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNR 160 (313)
T ss_dssp EEEEET-TEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSC
T ss_pred eCCCCC-cccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCc
Confidence 9995 7 7888888888888888888888888888888888888888888888888888888888888888888888888
Q ss_pred cccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcC
Q 002121 173 LTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNAL 252 (964)
Q Consensus 173 l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 252 (964)
++|.+|. .+..++ ..|++|++++|++++.+|..+..++ |+.|+|++|.+
T Consensus 161 l~~~~p~------~l~~l~------------------------~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l 209 (313)
T 1ogq_A 161 ISGAIPD------SYGSFS------------------------KLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209 (313)
T ss_dssp CEEECCG------GGGCCC------------------------TTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEE
T ss_pred ccCcCCH------HHhhhh------------------------hcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcc
Confidence 8766662 233333 2344445555555556666666665 88888888888
Q ss_pred ccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhc
Q 002121 253 TGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKL 332 (964)
Q Consensus 253 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 332 (964)
++.+|..|..+++|+.|+|++|.+++.++.+..+++|++|+|++|++ ++.+|..|
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l-------------------------~~~~p~~l 264 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI-------------------------YGTLPQGL 264 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCC-------------------------EECCCGGG
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcc-------------------------cCcCChHH
Confidence 77777777777777777777777776655554445555555554444 44555555
Q ss_pred cCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCc
Q 002121 333 FSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371 (964)
Q Consensus 333 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (964)
..+++|+.|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 265 ~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 265 TQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp GGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred hcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 55555555555555555555543 555666666666665
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=365.95 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=204.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.+.|...+.||+|+||.||+|... +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 356888999999999999999965 6899999998754322 346799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC----cEEEeeccc
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL----TAKVADFGL 774 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGl 774 (964)
++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 9999999999999999754 36999999999999999999999988 99999999999999887 899999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
++....... .....||+.|+|||++....++.++|||||||++|||++|+.||..... .+.+.........
T Consensus 165 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~~~~~~~~----- 235 (326)
T 2y0a_A 165 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANVSAVNYE----- 235 (326)
T ss_dssp CEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHTCCC-----
T ss_pred CeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-HHHHHHHHhcCCC-----
Confidence 987653322 2345699999999999989999999999999999999999999964332 2222221111110
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ......+.+++.+||+.||++|||+.|+++
T Consensus 236 ---~~~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 236 ---FEDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ---CCHHHH---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---cCcccc---ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 011111 111244668999999999999999999986
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=371.04 Aligned_cols=266 Identities=21% Similarity=0.350 Sum_probs=212.2
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEe
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE 694 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 694 (964)
+...++|...+.||+|+||.||+|.. .+++.||||+++... ......+.+|+++++++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 33457889999999999999999996 245689999997543 23446799999999999 89999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCCCC---------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSG---------------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 753 (964)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 9999999999999999999976542 23799999999999999999999988 99999
Q ss_pred CCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 002121 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEK 832 (964)
Q Consensus 754 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~ 832 (964)
|||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999987765544344455668899999999999999999999999999999998 9999965
Q ss_pred CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...... +...+..... ...... ....+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 278 ~~~~~~-~~~~~~~~~~------~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 278 IPVDAN-FYKLIQNGFK------MDQPFY-------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCCSHH-HHHHHHTTCC------CCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CCcHHH-HHHHHhcCCC------CCCCCC-------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 432222 1122211110 000111 1245678999999999999999999999999886543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=364.54 Aligned_cols=255 Identities=22% Similarity=0.361 Sum_probs=205.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CC-------cEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DG-------QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
.++|...+.||+|+||+||+|+.. ++ ..||+|++........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357888999999999999999854 33 4799999976665666789999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc--------EEE
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT--------AKV 769 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--------~kl 769 (964)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999997653 34899999999999999999999988 999999999999998887 999
Q ss_pred eecccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
+|||+++.... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..................
T Consensus 163 ~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~ 236 (289)
T 4fvq_A 163 SDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236 (289)
T ss_dssp CCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC
T ss_pred ccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCC
Confidence 99999865422 123468999999999987 77899999999999999999966555443333222222111111
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
.....+ ..+.+++.+||+.||++|||+.|+++.|++++...+
T Consensus 237 -----~~~~~~-----------~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 237 -----LPAPKA-----------AELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp -----CCCCSS-----------CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred -----CCCCCC-----------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 111111 234589999999999999999999999998876554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=367.90 Aligned_cols=265 Identities=17% Similarity=0.237 Sum_probs=213.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+|+++++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35788999999999999999995 5789999999875432 24688999999999 99999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc-----EEEeecccceee
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT-----AKVADFGLSKLV 778 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGla~~~ 778 (964)
|+ +|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999864 246999999999999999999999988 999999999999999887 999999999876
Q ss_pred cCCCCCc-----eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--chhHHHHHHHhccCcccc
Q 002121 779 SDSSKGH-----VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 779 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~ 851 (964)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+.+.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~-- 238 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA-- 238 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH--
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc--
Confidence 5433211 123567999999999999999999999999999999999999999742 2222222221111000
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCC
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMN 908 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 908 (964)
.... ........+.+++.+||+.||.+||++.++.+.|+.+.++.+..
T Consensus 239 ------~~~~---~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 239 ------TPIE---VLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp ------SCHH---HHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred ------CCHH---HHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 0000 00001126779999999999999999999999999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=368.84 Aligned_cols=259 Identities=24% Similarity=0.442 Sum_probs=201.3
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
.++|+..+.||+|+||+||+|+.. +|+ +||+|.+.... .....++.+|+.++++++||||++++++|.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence 356888999999999999999953 444 46888876433 23456799999999999999999999999875 478
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999997653 46899999999999999999999988 9999999999999999999999999998776
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
............||+.|+|||++.+..++.++|||||||++|||+| |+.||....... +...+..... . ..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~~~----~--~~ 240 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER----L--PQ 240 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC----C--CC
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHcCCC----C--CC
Confidence 5444333445567889999999999999999999999999999999 999996432211 1111111110 0 00
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
.+. ....+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 241 ~~~-------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 241 PPI-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp CTT-------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred Ccc-------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 011 124567899999999999999999999999988753
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=361.93 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=203.5
Q ss_pred hhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..++|+..+.||+|+||+||+|+..+|+.||||++...... ....+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999999988999999998754322 2357889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++ +|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 173 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV 173 (311)
T ss_dssp ECCSE-EHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred cCCCC-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence 99985 8888887643 45899999999999999999999988 9999999999999999999999999998764332
Q ss_pred CCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcccccc-cc---
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEHYG-LT--- 855 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~-~~--- 855 (964)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.... .....+............. ..
T Consensus 174 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 174 --RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred --ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22334568999999999876 568999999999999999999999996322 2222332222221111000 00
Q ss_pred -------cccCcc-chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 -------EMMDPT-IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 -------~~~d~~-l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ..........++.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000 00011112245779999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=356.43 Aligned_cols=253 Identities=29% Similarity=0.489 Sum_probs=196.2
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc----hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ----GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|+..+.||+|+||.||+|... |+.||||+++..... ..+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357888999999999999999985 899999998754322 235789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC--------CCcEEEeecc
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE--------NLTAKVADFG 773 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--------~~~~kl~DFG 773 (964)
|||+++|+|.+++... .+++..+..++.|+++||+|||+.+..+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999643 5899999999999999999999987566999999999999986 7789999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||............ .....
T Consensus 162 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~----- 231 (271)
T 3dtc_A 162 LAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-AMNKL----- 231 (271)
T ss_dssp C-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH-HTSCC-----
T ss_pred ccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh-hcCCC-----
Confidence 998654332 22356999999999999999999999999999999999999999754432222111 11111
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
....... ....+.+++.+||+.||++|||+.|+++.|++
T Consensus 232 -~~~~~~~-------~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 232 -ALPIPST-------CPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp -CCCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred -CCCCCcc-------cCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 0001111 11456789999999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-40 Score=372.52 Aligned_cols=252 Identities=20% Similarity=0.336 Sum_probs=207.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|...+.||+|+||+||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999964 6899999999876555566799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC--CCcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE--NLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~~ 782 (964)
+++|+|.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++......
T Consensus 130 ~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 205 (387)
T 1kob_A 130 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 205 (387)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence 99999999997543 46899999999999999999999988 999999999999974 5789999999998765432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+......... .++..
T Consensus 206 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-~~~~~~i~~~~~~--------~~~~~ 273 (387)
T 1kob_A 206 ---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-LETLQNVKRCDWE--------FDEDA 273 (387)
T ss_dssp ---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHHCCCC--------CCSST
T ss_pred ---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC--------CCccc
Confidence 23345799999999999999999999999999999999999999975432 2222222222111 01111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ....+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~~---~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 274 FSS---VSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTT---SCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccc---CCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 111 1145668999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=361.94 Aligned_cols=260 Identities=29% Similarity=0.500 Sum_probs=196.0
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||+||+|+.. ..||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467899999999999999999874 3599999875443 2345789999999999999999999965 4567899999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999997543 46999999999999999999999988 99999999999999999999999999986654333
Q ss_pred CceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
........||+.|+|||++. ...++.++||||||+++|||++|+.||............ ..... ..+
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~---------~~~ 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-VGRGS---------LSP 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHH-HHHTS---------CCC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHH-hcccc---------cCc
Confidence 33344567999999999986 567889999999999999999999999754433222222 21111 011
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.+..........+.+++.+||+.||++||++.|+++.|+++.
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111111112245779999999999999999999999999864
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=366.69 Aligned_cols=258 Identities=23% Similarity=0.399 Sum_probs=204.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
++|...+.||+|+||+||+|+.. +|+ +||+|++.... ......+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57888899999999999999964 454 38888876433 233356789999999999999999999986 567899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999998653 46899999999999999999999988 99999999999999999999999999998765
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........||+.|+|||++.++.++.++|||||||++|||+| |+.||....... +...+..... ........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~--~~~~~~~~ 243 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEKGER--LAQPQICT 243 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHTTCB--CCCCTTBC
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCC--CCCCCcCc
Confidence 544344455678899999999999999999999999999999999 999997433211 1111111110 00111122
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
..+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 244 -----------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 244 -----------IDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp -----------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred -----------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 2345899999999999999999999999988643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=365.30 Aligned_cols=272 Identities=25% Similarity=0.417 Sum_probs=219.6
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccce
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGL 688 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l 688 (964)
+...++....++|...+.||+|+||+||+|.. .+++.||||+++..... ....+.+|+++++++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 45566667778999999999999999999984 34689999999765433 345789999999999 79999999
Q ss_pred eEEEEeeC-ceEEEEEeccCCChhhhhcCCCC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccC
Q 002121 689 VGFCFEQG-EQMLVYEFMANGTLRESLSGRSG--------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRD 753 (964)
Q Consensus 689 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~D 753 (964)
++++.+.+ ..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998754 48999999999999999986542 12899999999999999999999988 99999
Q ss_pred CCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCC
Q 002121 754 VKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEK 832 (964)
Q Consensus 754 lk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~ 832 (964)
|||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999987655443334445668999999999999999999999999999999998 9999965
Q ss_pred CchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 833 GKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
................. ...... ...+.+++.+||+.||++||++.|+++.|+.+++..
T Consensus 254 ~~~~~~~~~~~~~~~~~---~~~~~~-----------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRM---RAPDYT-----------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHHHHHHHHHTCCC---CCCTTC-----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccC---CCCCCC-----------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 43222222221111110 011111 134678999999999999999999999999998754
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=357.29 Aligned_cols=264 Identities=17% Similarity=0.229 Sum_probs=212.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...+.||+|+||+||+|+. .+|+.||||++..... ...+.+|+++++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45789999999999999999995 5789999999865432 34688999999999 79999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc-----EEEeecccceee
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT-----AKVADFGLSKLV 778 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DFGla~~~ 778 (964)
|+ +|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++..
T Consensus 87 ~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence 99 999999998643 35999999999999999999999988 999999999999987776 999999999877
Q ss_pred cCCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcccc
Q 002121 779 SDSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEH 851 (964)
Q Consensus 779 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~ 851 (964)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~-- 239 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-- 239 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH--
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC--
Confidence 543221 12345679999999999999999999999999999999999999997532 111111111111000
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
.............+.+++.+||+.||++||++++|++.|+++.++.+
T Consensus 240 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 240 --------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp --------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 00000011112457799999999999999999999999999987764
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=372.07 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=205.2
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
...++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++|||||++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34568999999999999999999964 689999999976443 234568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cEEEeeccccee
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TAKVADFGLSKL 777 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~ 777 (964)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.
T Consensus 106 v~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp EECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999997653 6899999999999999999999988 99999999999998654 599999999987
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+........... .
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-~~~~~~i~~~~~~----~--- 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-HRLYAQIKAGAYD----Y--- 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC----C---
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCCC----C---
Confidence 65432 22346799999999999998999999999999999999999999965432 2222222211110 0
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+. .. .....+.+++.+||+.||++||++.|+++
T Consensus 250 ~~~~-~~---~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPE-WD---TVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTG-GG---GSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Cccc-cc---CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0001 11 11244668999999999999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=369.55 Aligned_cols=251 Identities=25% Similarity=0.325 Sum_probs=191.1
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
..++|...+.||+|+||+||+|+.. +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4568999999999999999999975 58899999997543 33568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccceeecC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~~~~~ 780 (964)
|+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999997653 5899999999999999999999988 999999999999975 89999999999987643
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||................... . ..+
T Consensus 204 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~----~---~~~ 273 (349)
T 2w4o_A 204 Q---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY----F---ISP 273 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC----C---CTT
T ss_pred c---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc----c---CCc
Confidence 2 12334579999999999999899999999999999999999999997544333233333222111 0 000
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... .....+.+++.+||+.||++|||+.|+++
T Consensus 274 -~~~---~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 -WWD---EVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp -TTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -hhh---hCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 11245678999999999999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=365.95 Aligned_cols=251 Identities=20% Similarity=0.341 Sum_probs=198.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE------ 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------ 697 (964)
.++|+..+.||+|+||.||+|+.. +|+.||||+++.... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457888999999999999999975 799999999875433 345679999999999999999999999876432
Q ss_pred ---------------------------------------------------eEEEEEeccCCChhhhhcCCCC-CccchH
Q 002121 698 ---------------------------------------------------QMLVYEFMANGTLRESLSGRSG-IHLDWK 725 (964)
Q Consensus 698 ---------------------------------------------------~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 725 (964)
.++|||||++|+|.+++..... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 7999999999999999987542 345677
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC----------ceeecccccCc
Q 002121 726 RRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG----------HVSTQVKGTMG 795 (964)
Q Consensus 726 ~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~ 795 (964)
.++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 78999999999999999988 999999999999999999999999999877543211 12234569999
Q ss_pred ccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHH
Q 002121 796 YLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLE 875 (964)
Q Consensus 796 y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~ 875 (964)
|+|||++.+..++.++|||||||++|||++|..|+...... ..... .. ............+.+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~---~~~~~-~~-------------~~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRI---ITDVR-NL-------------KFPLLFTQKYPQEHM 304 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHH---HHHHH-TT-------------CCCHHHHHHCHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHH---HHHhh-cc-------------CCCcccccCChhHHH
Confidence 99999999999999999999999999999998775321111 11111 00 111111222345678
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 002121 876 LALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 876 li~~cl~~dP~~RPs~~evl~ 896 (964)
++.+||+.||++||++.|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999985
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=382.47 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=210.9
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEE
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFC 692 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 692 (964)
+.+.+++...++|+..+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|+.++.+++||||++++++|
T Consensus 64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 143 (437)
T 4aw2_A 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF 143 (437)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345667777899999999999999999999975 578999999865321 1223488999999999999999999999
Q ss_pred EeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 693 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
.+.+..++|||||++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ||||||||+|||++.++.+||+||
T Consensus 144 ~~~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 144 QDDNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999998642 36999999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
|+|+....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||.... ..+.....+...
T Consensus 220 Gla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~ 297 (437)
T 4aw2_A 220 GSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKIMNHK 297 (437)
T ss_dssp TTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHH
T ss_pred hhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-hhHHHHhhhhcc
Confidence 99987654322 2334467999999999987 5678999999999999999999999997533 223333332211
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVK 896 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 896 (964)
.. ....... ..+ ...+.+++.+|+..+|++ ||+++|+++
T Consensus 298 ~~--~~~p~~~-~~~-------s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 ER--FQFPTQV-TDV-------SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HH--CCCCSSC-CCS-------CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cc--ccCCccc-ccC-------CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 00 0011110 001 134568999999888888 999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=372.27 Aligned_cols=274 Identities=16% Similarity=0.200 Sum_probs=207.8
Q ss_pred hhcCCCccceeecCCcEEEEEEEecC------CcEEEEEEecCCCcchh-----------HHHHHHHHHHHhcCCCCccc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQGG-----------LEFKTEIELLSRVHHKNLVG 687 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~ 687 (964)
..++|.+.+.||+|+||+||+|.... ++.||||++........ ..+..|+..+++++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35689999999999999999999754 47899999875432111 12345666777888999999
Q ss_pred eeEEEEee----CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-
Q 002121 688 LVGFCFEQ----GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD- 762 (964)
Q Consensus 688 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~- 762 (964)
+++++... ...++||||+ +|+|.+++.... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 99999875 4589999999 999999997642 46999999999999999999999988 99999999999999
Q ss_pred -CCCcEEEeecccceeecCCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh
Q 002121 763 -ENLTAKVADFGLSKLVSDSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV 836 (964)
Q Consensus 763 -~~~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~ 836 (964)
.++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~ 267 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD 267 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence 8999999999999876533211 1113345999999999999999999999999999999999999999743222
Q ss_pred HHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCC
Q 002121 837 VREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMN 908 (964)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 908 (964)
...+......... .+.+.+++.+.. ......+.+++.+||+.+|++||++.++++.|+.+++..+..
T Consensus 268 ~~~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 268 PKYVRDSKIRYRE---NIASLMDKCFPA--ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHHHHHHHHHHH---CHHHHHHHHSCT--TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhhh---hHHHHHHHhccc--ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 2221111100000 011111111100 111245778999999999999999999999999999876543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=361.09 Aligned_cols=269 Identities=21% Similarity=0.276 Sum_probs=210.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeC--ceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--EQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 702 (964)
++|.+.+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 57888999999999999999975 589999999875432 33456889999999999999999999998765 679999
Q ss_pred EeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----CCCCcEEEeeccccee
Q 002121 703 EFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla~~ 777 (964)
||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 9999999999998654 234899999999999999999999988 9999999999999 8888999999999987
Q ss_pred ecCCCCCceeecccccCcccCccccc--------cCCCCCchhHHHHHHHHHHHHhCCCCCCC---CchhHHHHHHHhcc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYM--------TQQLTEKSDVYSFGVVMLELITAKQPIEK---GKYVVREVRTAMNR 846 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDv~S~Gvvl~elltg~~p~~~---~~~~~~~~~~~~~~ 846 (964)
...... .....||+.|+|||++. +..++.++|||||||++|||++|+.||.. .....+.+......
T Consensus 166 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 166 LEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred cCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 654322 23456999999999986 57789999999999999999999999962 22233333333332
Q ss_pred Ccccccc-cccccCc------cch---hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 847 DDEEHYG-LTEMMDP------TIR---NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 847 ~~~~~~~-~~~~~d~------~l~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
.+..... ....... .+. .........+.+++.+||+.||++|||++|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2211100 0000000 000 11233445678999999999999999999999877654
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=371.74 Aligned_cols=248 Identities=23% Similarity=0.298 Sum_probs=199.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|+..+.||+|+||+||+|+.. +|+.||||+++... ......+.+|.++++++ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999964 68999999987532 22334678899999998 69999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999997643 5899999999999999999999988 99999999999999999999999999985432
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+........... ....+.
T Consensus 177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~~- 248 (353)
T 3txo_A 177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAILNDEVV----YPTWLH- 248 (353)
T ss_dssp -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTSC-
T ss_pred CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC----CCCCCC-
Confidence 21 23345679999999999998899999999999999999999999996433 22333333322211 111111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTM------SEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 896 (964)
..+.+++.+||+.||++||++ .|+++
T Consensus 249 ----------~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 249 ----------EDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----------HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----------HHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 345689999999999999998 66654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=355.25 Aligned_cols=253 Identities=21% Similarity=0.347 Sum_probs=205.7
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lV~ 702 (964)
++|...+.||+|+||+||+|+.+ |+.||||+++.... ...+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 57888999999999999999985 88999999986543 3345799999999999999999999999876 7789999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-- 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--
Confidence 9999999999998876557999999999999999999999865 5699999999999999999999999998754222
Q ss_pred CCceeecccccCcccCccccccCCCCC---chhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTE---KSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
....||+.|+|||++.+..++. ++|||||||++|||++|+.||........ ......... .
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~~~~----------~ 229 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-GMKVALEGL----------R 229 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-HHHHHHSCC----------C
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-HHHHHhcCC----------C
Confidence 2245899999999998765544 89999999999999999999975433222 122211111 0
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
+.+... ....+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 230 ~~~~~~---~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 230 PTIPPG---ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCCCC---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111111 1145678999999999999999999999999874
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=379.93 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=208.3
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
..+++...++|...+.||+|+||+||+|+.. +|+.||+|+++... ......+.+|+++++.++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4556667789999999999999999999965 68999999986422 1223458899999999999999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
.+..++|||||++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 99999999999999999999754 4889999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ----LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 850 (964)
|+....... ......+||+.|+|||++.... ++.++|||||||++|||++|+.||.... .......++......
T Consensus 215 a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 215 CMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSL 292 (410)
T ss_dssp CEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTHHHHC
T ss_pred eEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-hhhHHHHHHhccccc
Confidence 987654321 2234567999999999997655 7899999999999999999999996433 233333332211100
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATD--RPTMSEVVK 896 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 896 (964)
. ... ...+ ...+.+++.+||+.+|++ ||+++||++
T Consensus 293 ~--~p~--~~~~-------s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 293 T--FPD--DNDI-------SKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp C--CCT--TCCC-------CHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred c--CCC--cccc-------cHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 0 000 0011 144568999999999988 999999976
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=357.25 Aligned_cols=262 Identities=28% Similarity=0.455 Sum_probs=212.9
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+...++|+..+.||+|+||.||+|...+++.||||+++.... ..+.+.+|++++++++||||+++++++. .+..++||
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 86 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIIT 86 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEE
Confidence 334567889999999999999999988888999999976443 3467999999999999999999999986 45689999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++....+..+++.+++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 9999999999997654346899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. .......+|+.|+|||++.++.++.++||||||+++|||++ |+.||..... .+.......... ......
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~-------~~~~~~ 234 (279)
T 1qpc_A 164 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYR-------MVRPDN 234 (279)
T ss_dssp E-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCC-------CCCCTT
T ss_pred c-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-HHHHHHHhcccC-------CCCccc
Confidence 1 22233457889999999998889999999999999999999 8999864332 222222211110 000111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
....+.+++.+|++.||++||++.++++.|+.+....
T Consensus 235 -------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 235 -------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -------ccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1145678999999999999999999999999998664
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=359.64 Aligned_cols=260 Identities=26% Similarity=0.396 Sum_probs=198.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
..++|...+.||+|+||.||+|.... +..||+|+++.... ...+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34678889999999999999998642 45799999876433 33457899999999999999999999984 56789
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999997543 46899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... .......+|+.|+|||++....++.++||||||+++|||++ |+.||...... +........... ..
T Consensus 168 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-~~~~~i~~~~~~-------~~ 238 (281)
T 1mp8_A 168 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIGRIENGERL-------PM 238 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHHHHHTTCCC-------CC
T ss_pred cccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-HHHHHHHcCCCC-------CC
Confidence 4322 22233457889999999998899999999999999999997 99999643221 111111111110 01
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.+.. ...+.+++.+||+.||++||++.|+++.|+.++++.
T Consensus 239 ~~~~-------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 239 PPNC-------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCC-------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 245668999999999999999999999999988654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=377.54 Aligned_cols=253 Identities=21% Similarity=0.309 Sum_probs=204.4
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
..++|...+.||+|+||+||+|.. .+|+.||+|++...... ....+.+|++++++++|||||++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 456799999999999999999985 47899999998765432 345689999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecccceee
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLV 778 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~ 778 (964)
||||++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999987653 5899999999999999999999988 99999999999998 5688999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... .+........... . .
T Consensus 164 ~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-~~~~~~i~~~~~~----~---~ 233 (444)
T 3soa_A 164 EGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-HRLYQQIKAGAYD----F---P 233 (444)
T ss_dssp CTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCC----C---C
T ss_pred cCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-HHHHHHHHhCCCC----C---C
Confidence 5432 223446799999999999998999999999999999999999999965332 2222222221111 0 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+... .....+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 234 SPEWD----TVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccc----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11110 11144668999999999999999999986
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=358.46 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=203.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|+||+||+|+.. +|+.||||++...... ....+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47888999999999999999964 6899999998754332 23578899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++ ++.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV- 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence 9986 5655554432 36999999999999999999999988 9999999999999999999999999998764332
Q ss_pred CceeecccccCcccCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc-cccccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY-GLTEMM 858 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~ 858 (964)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..|+..+....+.+..... ....... ...+..
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence 2234457899999999997765 799999999999999999999997665554444443322 1111000 000000
Q ss_pred C----------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 859 D----------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 859 d----------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+ ..+..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0000011122345679999999999999999999975
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=355.77 Aligned_cols=253 Identities=31% Similarity=0.521 Sum_probs=201.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchh-------HHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGG-------LEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
.++|...+.||+|+||+||+|+. .+++.||||++........ ..+.+|++++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 35788899999999999999996 4789999999865433211 57899999999999999999999986543
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc-----EEEeec
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT-----AKVADF 772 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-----~kl~DF 772 (964)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++|+||||||+|||++.++. +||+||
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred -eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 79999999999999887653 46999999999999999999999865 56999999999999988876 999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccc--cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHH-HHHHHhccCcc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM--TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR-EVRTAMNRDDE 849 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~ 849 (964)
|+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ..........
T Consensus 174 g~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 247 (287)
T 4f0f_A 174 GLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL- 247 (287)
T ss_dssp TTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC-
T ss_pred Cccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC-
Confidence 99975432 234467999999999984 45678999999999999999999999974332221 1221111111
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
...+.... ...+.+++.+||+.||++||++.|+++.|++
T Consensus 248 -----~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 248 -----RPTIPEDC-------PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp -----CCCCCTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -----CCCCCccc-------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 01111111 1456799999999999999999999998875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=360.75 Aligned_cols=262 Identities=27% Similarity=0.430 Sum_probs=215.4
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
...++|...+.||+|+||+||+|... +++.||+|++.... ...+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34678889999999999999999975 48899999997543 34567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 9999999999998766567999999999999999999999998 9999999999999999999999999998765332
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
........+|+.|+|||++.+..++.++||||||+++|||++ |..||...... .... .+..... ......
T Consensus 166 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~-~~~~-~~~~~~~------~~~~~~ 236 (288)
T 3kfa_A 166 -YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYE-LLEKDYR------MERPEG 236 (288)
T ss_dssp -SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHH-HHHTTCC------CCCCTT
T ss_pred -cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH-HHhccCC------CCCCCC
Confidence 233344567889999999998999999999999999999999 99998643211 1111 1111110 000111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
....+.+++.+|++.||++||++.|+++.|+.+.++.
T Consensus 237 -------~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 237 -------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------CCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 1145678999999999999999999999999987653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=356.96 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=196.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--------------------------hhHHHHHHHHHHH
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--------------------------GGLEFKTEIELLS 678 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 678 (964)
.++|...+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 36788999999999999999996 46899999998654321 1246889999999
Q ss_pred hcCCCCccceeEEEEe--eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCC
Q 002121 679 RVHHKNLVGLVGFCFE--QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKS 756 (964)
Q Consensus 679 ~l~H~nIv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 756 (964)
+++||||+++++++.+ .+..++||||+++|+|.+++.. ..+++.++..++.|+++||+|||+.+ |+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 9999999999999987 5678999999999999987654 35999999999999999999999988 99999999
Q ss_pred CcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCCC
Q 002121 757 TNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVVMLELITAKQPIEKG 833 (964)
Q Consensus 757 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvvl~elltg~~p~~~~ 833 (964)
+|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 99999999999999999998765432 2234467999999999997654 478899999999999999999999754
Q ss_pred chhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 834 KYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 834 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. ............. ... .+.+ ...+.+++.+||+.||++||++.|+++
T Consensus 244 ~~-~~~~~~~~~~~~~----~~~--~~~~-------~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RI-MCLHSKIKSQALE----FPD--QPDI-------AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SH-HHHHHHHHHCCCC----CCS--SSCC-------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cH-HHHHHHHhcccCC----CCC--cccc-------CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 32 2222221111110 000 0111 145678999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=365.72 Aligned_cols=259 Identities=26% Similarity=0.430 Sum_probs=205.0
Q ss_pred cCCCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEee--Cce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 698 (964)
+.|+..+.||+|+||.||+|++ .+|+.||||+++.... .....+.+|++++++++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4578889999999999999984 3688999999875432 3346789999999999999999999999876 668
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999996443 35899999999999999999999988 999999999999999999999999999877
Q ss_pred cCCCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh-------------HHHHHHHh
Q 002121 779 SDSSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-------------VREVRTAM 844 (964)
Q Consensus 779 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-------------~~~~~~~~ 844 (964)
...... .......||..|+|||++.+..++.++||||+|+++|||++|+.|+...... ...+....
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH
Confidence 544321 1233456888999999999999999999999999999999999986432111 11111111
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
.... ..... ......+.+++.+||+.||++|||+.|+++.|+.++
T Consensus 257 ~~~~----------~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 257 KEGK----------RLPCP---PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HTTC----------CCCCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hccC----------CCCCC---CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1110 00000 111245779999999999999999999999999876
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.04 Aligned_cols=263 Identities=21% Similarity=0.323 Sum_probs=200.2
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|...+.||+|+||+||+|+..+|+.||+|++...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 468889999999999999999988999999998754332 235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc--
Confidence 985 9999987643 36899999999999999999999988 9999999999999999999999999998654321
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccc-ccc--ccc
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHY-GLT--EMM 858 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~-~~~--~~~ 858 (964)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..+............ ... ...
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccc
Confidence 12234568999999999875 458999999999999999999999997543221 111111111110000 000 001
Q ss_pred Cccc--------hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 859 DPTI--------RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 859 d~~l--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
++.. ..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1100 0001112245679999999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=364.04 Aligned_cols=262 Identities=25% Similarity=0.437 Sum_probs=211.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec--------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEee
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ 695 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 695 (964)
.++|...+.||+|+||.||+|... +++.||||+++.... .....+.+|+++++++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467888999999999999999863 467899999976533 3345789999999999 899999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCCC--------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSG--------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+..++||||+++|+|.+++..... ..+++.+++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999986531 24899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.... ..+..
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~~~~~ 269 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF 269 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHH
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-HHHHH
Confidence 9999999999999987754433223334567889999999998889999999999999999999 999986432 22222
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
......... ..... ....+.+++.+||+.||++||++.|+++.|+.+++..
T Consensus 270 ~~~~~~~~~-------~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 270 KLLKEGHRM-------DKPAN-------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp HHHHHTCCC-------CCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-------CCCcc-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 221111110 00111 1245678999999999999999999999999998654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=361.52 Aligned_cols=244 Identities=23% Similarity=0.356 Sum_probs=203.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|+..+.||+|+||+||+|+.. +|+.||+|+++... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999964 78999999987532 123456789999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999997643 6899999999999999999999988 999999999999999999999999999876432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ....+
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~----~p~~~---- 226 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-MKTYEKILNAELR----FPPFF---- 226 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHCCCC----CCTTS----
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC----CCCCC----
Confidence 2345799999999999999999999999999999999999999965432 2333333322111 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+|++.||++|| +++|+++
T Consensus 227 -------~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 -------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 13466899999999999999 8888874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=371.36 Aligned_cols=246 Identities=22% Similarity=0.298 Sum_probs=198.3
Q ss_pred cceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccCCCh
Q 002121 632 SNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
.+.||+|+||.||+|.. .+|+.||+|+++.......+++.+|++++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999996 46899999999876666667899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE--CCCCcEEEeecccceeecCCCCCceee
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVST 788 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl--~~~~~~kl~DFGla~~~~~~~~~~~~~ 788 (964)
.+++.... ..+++.++..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~ 246 (373)
T 2x4f_A 174 FDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LK 246 (373)
T ss_dssp HHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CC
T ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cc
Confidence 99886542 46899999999999999999999988 9999999999999 6778999999999987654322 23
Q ss_pred cccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHH
Q 002121 789 QVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLL 868 (964)
Q Consensus 789 ~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 868 (964)
...||+.|+|||++....++.++|||||||++|||++|+.||..... .+.+......... . ..... ..
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-~~~~~~i~~~~~~----~----~~~~~---~~ 314 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND-AETLNNILACRWD----L----EDEEF---QD 314 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHHTCCC----S----CSGGG---TT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhccCC----C----Chhhh---cc
Confidence 34699999999999988999999999999999999999999975432 2233333222211 0 00000 01
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 869 GFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 869 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.+++.+||+.||++||++.|+++
T Consensus 315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1245678999999999999999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.08 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=203.5
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-----cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-----MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
.+.|...+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 457889999999999999999964 68999999986321 123467999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc---EEEeeccc
Q 002121 700 LVYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT---AKVADFGL 774 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGl 774 (964)
+|||||++|+|.+++.... +..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 9999999999998875432 345899999999999999999999988 999999999999987655 99999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...........
T Consensus 180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~~~~~----- 250 (351)
T 3c0i_A 180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIKGKYK----- 250 (351)
T ss_dssp CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHHTCCC-----
T ss_pred eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHcCCCC-----
Confidence 98765432 223445799999999999999999999999999999999999999975432 112222111110
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.++.... .....+.+++.+||+.||++||++.|+++
T Consensus 251 ---~~~~~~~---~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 ---MNPRQWS---HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp ---CCHHHHT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCccccc---cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111111 11245678999999999999999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=371.34 Aligned_cols=245 Identities=21% Similarity=0.294 Sum_probs=197.7
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|+..+.||+|+||+||+|+.. +++.||||+++.... .....+.+|..++.++ +|||||++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357889999999999999999965 688999999875432 2234588999999887 89999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999997643 6899999999999999999999988 99999999999999999999999999986332
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc-------hhHHHHHHHhccCcccccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK-------YVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~ 853 (964)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ...+.+...+..... .
T Consensus 206 ~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~---~ 280 (396)
T 4dc2_A 206 PG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI---R 280 (396)
T ss_dssp TT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC---C
T ss_pred CC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc---C
Confidence 22 23345679999999999999999999999999999999999999995211 111112111111110 0
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
....+ ...+.+++.+||+.||++||++
T Consensus 281 ~p~~~-----------s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 281 IPRSL-----------SVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCTTS-----------CHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCcC-----------CHHHHHHHHHHhcCCHhHcCCC
Confidence 11111 1345689999999999999996
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=362.04 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=197.7
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCce---
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ--- 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~--- 698 (964)
.++|+..+.||+|+||.||+|+. .+|+.||||+++..... ....+.+|++++++++||||+++++++...+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 46789999999999999999995 57899999999764332 234688999999999999999999999876544
Q ss_pred -EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 699 -MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 699 -~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
++||||+++|+|.++++... .+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 99999999999999997543 6899999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 778 VSDSSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 778 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-~~~~~~~~~~~~------- 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV-SVAYQHVREDPI------- 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHCCCC-------
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHhcCCCC-------
Confidence 6543221 2223456999999999999999999999999999999999999999754332 222222221110
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH-HHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV-KAIETLL 902 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~~~ 902 (964)
.+.. ........+.+++.+||+.||++||++.+++ +.+....
T Consensus 238 --~~~~--~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 238 --PPSA--RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp --CHHH--HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred --Cccc--ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0000 0011124567899999999999999776655 4444443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=353.27 Aligned_cols=258 Identities=31% Similarity=0.484 Sum_probs=211.1
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|...+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 3578888999999999999999988899999999865433 467999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 9999999997643 36899999999999999999999988 9999999999999999999999999998653221 11
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
......+|+.|+|||++....++.++||||||+++|||++ |+.||..... .+........... .....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~i~~~~~~-------~~~~~--- 229 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFRL-------YKPRL--- 229 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCCC-------CCCTT---
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-HHHHHHHhcCCcC-------CCCcc---
Confidence 1223457789999999998899999999999999999999 8999865332 2222222111110 00111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
....+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 230 ----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 230 ----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 114567899999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=362.95 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=193.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|+..++||+|+||+||+|+.. +|+.||||++...... ...++..|+..+.++ +||||++++++|.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 357999999999999999999975 7999999998654332 233455666666665 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+ +|+|.+++.... ..++|.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 136 ~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp EECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred Eecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 9999 679999887543 46999999999999999999999988 999999999999999999999999999876443
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. ......||+.|+|||++.+ .++.++|||||||++|||++|..|+...... .... .. ...+.
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----~~~~-~~---------~~~~~ 272 (311)
T 3p1a_A 211 G---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----QQLR-QG---------YLPPE 272 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----HHHT-TT---------CCCHH
T ss_pred C---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----HHHh-cc---------CCCcc
Confidence 2 2334569999999998875 7899999999999999999998776543221 1111 11 11111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 273 ~~~---~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 273 FTA---GLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHT---TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc---CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 11245678999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=366.31 Aligned_cols=252 Identities=21% Similarity=0.347 Sum_probs=199.1
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCC--CCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHH--KNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lV 701 (964)
.++|++.+.||+|+||.||+|...+++.||||++...... ....+.+|++++++++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568889999999999999999888999999998754332 33578999999999976 9999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|| +.+|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 88 ~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EC-CCSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred Ee-CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 99 56889999998653 6899999999999999999999988 99999999999997 678999999999876544
Q ss_pred CCCceeecccccCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMT-----------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 850 (964)
..........||+.|+|||++.. ..++.++|||||||++|||++|+.||.........+..........
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 240 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc
Confidence 33333445679999999999864 6789999999999999999999999976444444444333222110
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...... ...+.+++.+||+.||++|||+.|+++.
T Consensus 241 --~~~~~~-----------~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 241 --EFPDIP-----------EKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --CCCCCS-----------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --CCcccC-----------CHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 011111 1346689999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=356.58 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=199.0
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|+..+.||+|+||+||+|+.. ++.||||++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46778899999999999999985 789999998643 34467999999999999999999999886 45899999999
Q ss_pred CCChhhhhcCCCC-CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc-EEEeecccceeecCCCCC
Q 002121 707 NGTLRESLSGRSG-IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT-AKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 707 ~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~-~kl~DFGla~~~~~~~~~ 784 (964)
+|+|.+++..... ..+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||+++.....
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999986542 24788999999999999999999943334999999999999998886 799999999765432
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh-HHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-VREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ +...
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 226 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-----------PPLI 226 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC-----------CCCB
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC-----------CCcc
Confidence 22346999999999999999999999999999999999999999743221 111111111111 0011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.. ....+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 227 ~~---~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 227 KN---LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp TT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cc---cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 1134668999999999999999999999999987654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=367.82 Aligned_cols=249 Identities=22% Similarity=0.318 Sum_probs=203.1
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCce
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 698 (964)
...++|...+.||+|+||+||+|+.+ +|+.||||+++... ......+..|.+++.++ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999975 68999999987532 22345678899999987 899999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999997543 5899999999999999999999988 999999999999999999999999999864
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... ....+
T Consensus 169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~ 241 (345)
T 1xjd_A 169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPF----YPRWL 241 (345)
T ss_dssp CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTS
T ss_pred ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHhCCCC----CCccc
Confidence 3222 22345679999999999999999999999999999999999999996433 22222222222111 11111
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMS-EVV 895 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 895 (964)
+ ..+.+++.+||+.||++||++. |+.
T Consensus 242 s-----------~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 242 E-----------KEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp C-----------HHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred C-----------HHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 3456899999999999999997 664
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=370.36 Aligned_cols=210 Identities=24% Similarity=0.339 Sum_probs=185.0
Q ss_pred cccccHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-----CCCccc
Q 002121 614 ARWFSYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-----HKNLVG 687 (964)
Q Consensus 614 ~~~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~ 687 (964)
...+++.+.....++|.+.+.||+|+||+||+|+. .+|+.||||+++.. ......+..|++++++++ |||||+
T Consensus 22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 44566777777789999999999999999999996 47899999998743 233456788999999996 999999
Q ss_pred eeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC----
Q 002121 688 LVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---- 763 (964)
Q Consensus 688 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---- 763 (964)
+++++...+..++||||+ +++|.+++.......+++.++..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 999999999999999999 899999998766556999999999999999999999988 999999999999976
Q ss_pred ---------------------CCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHH
Q 002121 764 ---------------------NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLE 822 (964)
Q Consensus 764 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~e 822 (964)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 8899999999998754322 34568999999999999999999999999999999
Q ss_pred HHhCCCCCCCC
Q 002121 823 LITAKQPIEKG 833 (964)
Q Consensus 823 lltg~~p~~~~ 833 (964)
|++|+.||...
T Consensus 252 ll~g~~pf~~~ 262 (360)
T 3llt_A 252 LYTGSLLFRTH 262 (360)
T ss_dssp HHHSSCSCCCS
T ss_pred HHHCCCCCCCC
Confidence 99999999743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=361.69 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=194.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe----cCCcEEEEEEecCCCc----chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM----QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
.++|...+.||+|+||.||+|+. .+|+.||+|+++.... .....+.+|++++++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35788899999999999999996 4789999999976432 233467899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999997543 5889999999999999999999988 99999999999999999999999999976
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+......... ...
T Consensus 171 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-~~~~~~i~~~~~~----~p~- 242 (327)
T 3a62_A 171 SIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-KKTIDKILKCKLN----LPP- 242 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHTCCC----CCT-
T ss_pred cccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhCCCC----CCC-
Confidence 43221 223446799999999999999999999999999999999999999975432 2222222222110 111
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
.+ ...+.+++.+||+.||++|| ++.|+++
T Consensus 243 ---~~-------~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 243 ---YL-------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp ---TS-------CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred ---CC-------CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 14466899999999999999 6777764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=358.15 Aligned_cols=270 Identities=26% Similarity=0.410 Sum_probs=206.7
Q ss_pred HHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc--CCCCccceeEEEEee----
Q 002121 622 LKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV--HHKNLVGLVGFCFEQ---- 695 (964)
Q Consensus 622 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~l~~~~~~~---- 695 (964)
-....++|+..+.||+|+||.||+|+.. |+.||||++... ....+..|.+++... +||||+++++++.+.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445678999999999999999999985 899999998643 233455666666655 899999999999887
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC-----CCCeeccCCCCCcEEECCCCcEEEe
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA-----NPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
...++||||+++|+|.++++.. .+++.+++.++.|++.||+|||+.+ .++|+||||||+|||++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 6789999999999999999754 5999999999999999999999871 1239999999999999999999999
Q ss_pred ecccceeecCCCCCc--eeecccccCcccCccccccCCCCCc------hhHHHHHHHHHHHHhC----------CCCCCC
Q 002121 771 DFGLSKLVSDSSKGH--VSTQVKGTMGYLDPEYYMTQQLTEK------SDVYSFGVVMLELITA----------KQPIEK 832 (964)
Q Consensus 771 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------sDv~S~Gvvl~elltg----------~~p~~~ 832 (964)
|||+++......... ......||+.|+|||++.+...+.+ +|||||||++|||+|| +.||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 999998764432211 1124579999999999987766654 9999999999999999 566642
Q ss_pred C---chhHHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCC
Q 002121 833 G---KYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907 (964)
Q Consensus 833 ~---~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 907 (964)
. ............... ..+..... .......+.+++.+||+.||++|||+.|+++.|+.+.+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 265 LVPSDPSYEDMREIVCIKK---------LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TSCSSCCHHHHHHHHTTSC---------CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hcCCCCchhhhHHHHhhhc---------cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 1 112222222221111 11111111 224456788999999999999999999999999999876643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=364.21 Aligned_cols=261 Identities=24% Similarity=0.286 Sum_probs=203.6
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC-----CcchhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG-----SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
++....++|...+.||+|+||+||+|.. .+++.||+|++... .....+.+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 3456678899999999999999999996 46889999998643 23445679999999999999999999999999
Q ss_pred eCceEEEEEeccCCChhhhhcCC--------------------------------------CCCccchHHHHHHHHHHHH
Q 002121 695 QGEQMLVYEFMANGTLRESLSGR--------------------------------------SGIHLDWKRRLRIALGSAR 736 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia~ 736 (964)
.+..++||||+++|+|.+++... ....+++..+..++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999998521 0123577888999999999
Q ss_pred HHHHHhhcCCCCeeccCCCCCcEEECCCC--cEEEeecccceeecCCCCC--ceeecccccCcccCcccccc--CCCCCc
Q 002121 737 GLAYLHELANPPIIHRDVKSTNILLDENL--TAKVADFGLSKLVSDSSKG--HVSTQVKGTMGYLDPEYYMT--QQLTEK 810 (964)
Q Consensus 737 gL~yLH~~~~~~ivH~Dlk~~NILl~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~ 810 (964)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++........ .......||+.|+|||++.. ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999988 99999999999998776 8999999999876432221 12345679999999999875 678999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 002121 811 SDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT 890 (964)
Q Consensus 811 sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs 890 (964)
+|||||||++|||++|+.||...... +............ ..+.. ......+.+++.+||+.||++||+
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~li~~~l~~~p~~Rps 324 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA-DTISQVLNKKLCF-------ENPNY----NVLSPLARDLLSNLLNRNVDERFD 324 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCCT-------TSGGG----GGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH-HHHHHHHhccccc-------CCccc----ccCCHHHHHHHHHHcCCChhHCCC
Confidence 99999999999999999999654332 2223322222110 01111 011245678999999999999999
Q ss_pred HHHHHH
Q 002121 891 MSEVVK 896 (964)
Q Consensus 891 ~~evl~ 896 (964)
+.|+++
T Consensus 325 ~~~~l~ 330 (345)
T 3hko_A 325 AMRALQ 330 (345)
T ss_dssp HHHHHH
T ss_pred HHHHhc
Confidence 999986
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=376.60 Aligned_cols=263 Identities=21% Similarity=0.245 Sum_probs=208.5
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEE
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFC 692 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 692 (964)
+.+.+++...++|+..+.||+|+||+||+|+.+ +|+.||||+++.... .....+.+|++++.+++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 455666777889999999999999999999974 799999999875321 2234588999999999999999999999
Q ss_pred EeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 693 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
.+.+..|+||||+++|+|.+++...+ ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+||
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 99999999999999999999997532 36899999999999999999999988 999999999999999999999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccc-------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-------TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN 845 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~ 845 (964)
|+++....... ......+||+.|+|||++. .+.++.++|||||||++|||++|+.||..... .+.+.....
T Consensus 207 Gla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-~~~~~~i~~ 284 (412)
T 2vd5_A 207 GSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST-AETYGKIVH 284 (412)
T ss_dssp TTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHT
T ss_pred hhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Confidence 99987654322 2233467999999999987 35789999999999999999999999965432 222222221
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHH
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDR---PTMSEVVK 896 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~ 896 (964)
.... ..... .+..+ ...+.+++.+||. +|++| |+++|+++
T Consensus 285 ~~~~--~~~p~-~~~~~-------s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKEH--LSLPL-VDEGV-------PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHH--CCCC-----CC-------CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cccC--cCCCc-cccCC-------CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1100 00000 00111 1446689999999 99998 58988864
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=366.82 Aligned_cols=257 Identities=16% Similarity=0.193 Sum_probs=210.3
Q ss_pred HHhhcCCCccceeecCCcEEEEEEE------ecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC---CCCccceeEEEE
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGM------LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH---HKNLVGLVGFCF 693 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~ 693 (964)
....++|.+.+.||+|+||+||+|. ..+++.||||+++... ..++..|++++++++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3445789999999999999999994 4568899999997543 346788888888886 999999999999
Q ss_pred eeCceEEEEEeccCCChhhhhcCC---CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-------
Q 002121 694 EQGEQMLVYEFMANGTLRESLSGR---SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE------- 763 (964)
Q Consensus 694 ~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~------- 763 (964)
..+..++|||||++|+|.+++... ....++|.+++.++.||++||+|||+.+ ||||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 999999999999999999999642 2346999999999999999999999988 999999999999998
Q ss_pred ----CCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002121 764 ----NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839 (964)
Q Consensus 764 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~ 839 (964)
++.+||+|||+|+...............||++|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--- 291 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG--- 291 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence 8999999999998765444445556678999999999999999999999999999999999999998532210
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHHHHHHhC
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDR-PTMSEVVKAIETLLQND 905 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~~~~~~ 905 (964)
.......+... . ....+.+++..|++.+|.+| |+++++.+.|+.++...
T Consensus 292 -----------~~~~~~~~~~~-~-----~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 292 -----------ECKPEGLFRRL-P-----HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----------EEEECSCCTTC-S-----SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----------ceeechhcccc-C-----cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 00011111111 1 12345688999999999998 78899999999988764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=357.30 Aligned_cols=265 Identities=25% Similarity=0.336 Sum_probs=202.4
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-----chhHHHHHHHHHHHhcC---CCCccceeEEEEee
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-----QGGLEFKTEIELLSRVH---HKNLVGLVGFCFEQ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~ 695 (964)
..++|+..+.||+|+||+||+|+. .+|+.||||++..... .....+.+|++++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 357899999999999999999995 5789999999864221 12346778888887775 99999999999875
Q ss_pred C-----ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEe
Q 002121 696 G-----EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVA 770 (964)
Q Consensus 696 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~ 770 (964)
. ..++||||++ |+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 4799999997 59999998776556999999999999999999999988 9999999999999999999999
Q ss_pred ecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDD 848 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~ 848 (964)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+........
T Consensus 163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999998654332 2345679999999999999999999999999999999999999996443221 22222221111
Q ss_pred ccccc----cc-----cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EEHYG----LT-----EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~~~~----~~-----~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..... .. ......+..........+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11000 00 00000011111122356779999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=367.12 Aligned_cols=268 Identities=25% Similarity=0.401 Sum_probs=214.3
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCcccee
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLV 689 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~ 689 (964)
+..++++...++|...+.||+|+||.||+|+.. +++.||||++..... ....++.+|++++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444556667789999999999999999999854 368899999975433 3345689999999999999999999
Q ss_pred EEEEeeCceEEEEEeccCCChhhhhcCCC--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 690 GFCFEQGEQMLVYEFMANGTLRESLSGRS--------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 690 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+++.+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999986532 135789999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
+.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~ 250 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-EQVL 250 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-HHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-HHHH
Confidence 9999999999999986644322222233457889999999999999999999999999999999 8888864332 2222
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
........ .. .... ....+.+++.+||+.||++||++.|+++.|+..+
T Consensus 251 ~~~~~~~~------~~-~~~~-------~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 251 RFVMEGGL------LD-KPDN-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHTTCC------CC-CCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHcCCc------CC-CCCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 22221111 00 0111 1244678999999999999999999999988764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=369.52 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=208.7
Q ss_pred cCCCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 699 (964)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++.. .+..+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5788899999999999999984 3688999999987766666779999999999999999999999874 45689
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred EEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 9999999999999997533 35899999999999999999999988 9999999999999999999999999998775
Q ss_pred CCCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH-------------HHHHHHhc
Q 002121 780 DSSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV-------------REVRTAMN 845 (964)
Q Consensus 780 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~-------------~~~~~~~~ 845 (964)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence 433211 2233458888999999998889999999999999999999999986422110 01111111
Q ss_pred cCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 846 RDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 846 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
... .... .......+.+++.+||+.||++|||+.|+++.|+.+....
T Consensus 259 ~~~----------~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 259 EGQ----------RLPA---PPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp TTC----------CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred ccc----------CCCC---CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 100 0000 1112245779999999999999999999999999886544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=357.93 Aligned_cols=264 Identities=22% Similarity=0.352 Sum_probs=200.9
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45789999999999999999996 578999999987533 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 702 YEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|||+++|+|.+++... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999998642 2346899999999999999999999988 9999999999999999999999999998664
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.............+.... ......
T Consensus 188 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~ 260 (310)
T 2wqm_A 188 SKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-----YPPLPS 260 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-----SCCCCT
T ss_pred CCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-----CCCCcc
Confidence 322 1223456899999999999999999999999999999999999999644322222222221111 110000
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
.. ....+.+++.+||+.||++||++.|+++.|+++.....
T Consensus 261 ~~-------~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 261 DH-------YSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp TT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred cc-------cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 11456789999999999999999999999999886654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=351.79 Aligned_cols=263 Identities=25% Similarity=0.382 Sum_probs=210.3
Q ss_pred cCCCccc-eeecCCcEEEEEEEec---CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESN-EIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|.+.+ .||+|+||.||+|... +++.||||+++.... ...+++.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555555 8999999999999853 578899999986533 3456789999999999999999999999 56679999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhCC-ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999999997543 46999999999999999999999988 999999999999999999999999999877543
Q ss_pred CCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 782 SKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 782 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+.......... ....
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~i~~~~~-------~~~~ 235 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAFIEQGKR-------MECP 235 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHHHHHTTCC-------CCCC
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-HHHHHHHhcCCc-------CCCC
Confidence 2211 1223456899999999988889999999999999999999 9999964332 122222111111 0011
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCCC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNT 909 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 909 (964)
+.. ...+.+++.+||+.||++||++.|+++.|+.+......+.
T Consensus 236 ~~~-------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 236 PEC-------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp TTC-------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred CCc-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 111 2456789999999999999999999999999987765443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=364.41 Aligned_cols=258 Identities=26% Similarity=0.412 Sum_probs=206.9
Q ss_pred CCccceeecCCcEEEEEEEec-----CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEee--CceEE
Q 002121 629 FSESNEIGSGGYGKVYRGMLS-----DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ--GEQML 700 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~-----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 700 (964)
|+..+.||+|+||+||++.+. +|+.||||+++.... .....+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 478899999999999998753 688999999986543 3345789999999999999999999999884 56799
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++... .+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 113 v~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 99999999999999765 3899999999999999999999988 99999999999999999999999999988754
Q ss_pred CCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH-------------HHHHHHhcc
Q 002121 781 SSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV-------------REVRTAMNR 846 (964)
Q Consensus 781 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~-------------~~~~~~~~~ 846 (964)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+......
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence 3321 12234568889999999998899999999999999999999999986432111 011111111
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.. .... .......+.+++.+||+.||++|||+.|+++.|+.+.++.
T Consensus 267 ~~----------~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 267 GE----------RLPR---PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp TC----------CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cc----------CCCC---CccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 10 0000 0111245779999999999999999999999999987654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=366.92 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=200.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|.+.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36788999999999999999996 578999999986432 12234789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+ +|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 689999886543 5899999999999999999999998 999999999999999999999999999865443
Q ss_pred CCCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .......... .
T Consensus 162 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----~~~~~i~~~~--------~ 225 (336)
T 3h4j_B 162 N---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----NLFKKVNSCV--------Y 225 (336)
T ss_dssp B---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----TCBCCCCSSC--------C
T ss_pred c---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----HHHHHHHcCC--------C
Confidence 2 2234579999999999988776 68999999999999999999999642210 0000000000 0
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.++. .....+.+++.+||+.||.+|||++|+++.
T Consensus 226 ~~p~---~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 226 VMPD---FLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCCT---TSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CCcc---cCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111 112446689999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=356.35 Aligned_cols=250 Identities=26% Similarity=0.475 Sum_probs=206.4
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe---------
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--------- 694 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 694 (964)
..++|+..+.||+|+||.||+|... +|+.||+|+++... ..+.+|++++++++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3457889999999999999999975 79999999987543 357899999999999999999999865
Q ss_pred -------eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 695 -------QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 695 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
....++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence 445799999999999999997654457999999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
||+|||+++....... .....||+.|+|||++.+..++.++||||||+++|||++|..|+........ . ....
T Consensus 162 kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~-~~~~ 234 (284)
T 2a19_B 162 KIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFT---D-LRDG 234 (284)
T ss_dssp EECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHH---H-HHTT
T ss_pred EECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHH---H-hhcc
Confidence 9999999987654322 2345699999999999999999999999999999999999988743221111 1 1111
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
. ....++ ..+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 235 ~-----~~~~~~-----------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 235 I-----ISDIFD-----------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp C-----CCTTSC-----------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred c-----ccccCC-----------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1 111111 3456899999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=363.53 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=203.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999965 68999999986432 123456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999997643 5899999999999999999999988 999999999999999999999999999876432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... ....+
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~---- 261 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKIVSGKVR----FPSHF---- 261 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTC----
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-HHHHHHHHHcCCCC----CCCCC----
Confidence 234579999999999999999999999999999999999999997543 22333332222111 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
...+.+++.+||+.||++||+ ++|+++
T Consensus 262 -------~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 -------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 134668999999999999998 788764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=364.49 Aligned_cols=267 Identities=24% Similarity=0.383 Sum_probs=214.1
Q ss_pred HHHhhcCCCccceeecCCcEEEEEEEecC-C-----cEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEE
Q 002121 622 LKKCSNNFSESNEIGSGGYGKVYRGMLSD-G-----QVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCF 693 (964)
Q Consensus 622 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 693 (964)
++...++|...+.||+|+||.||+|.... + ..||+|+++.... .....+.+|+++++++ +||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 41 WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp GBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 34456789999999999999999999642 2 4899999976543 3345789999999999 8999999999999
Q ss_pred eeCceEEEEEeccCCChhhhhcCCC------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 694 EQGEQMLVYEFMANGTLRESLSGRS------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 694 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL 197 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence 9999999999999999999986432 235799999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |..||........ +
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-~ 276 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-F 276 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-H
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-H
Confidence 9999999999999987655443333445567889999999999999999999999999999999 8899864332211 1
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
......... ...... ....+.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus 277 ~~~~~~~~~------~~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 YKLVKDGYQ------MAQPAF-------APKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHTCC------CCCCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHhcCCC------CCCCCC-------CCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 111111110 000000 1145678999999999999999999999999887643
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=368.70 Aligned_cols=251 Identities=21% Similarity=0.346 Sum_probs=199.5
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcC--CCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVH--HKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|.+.+.||+|+||+||+|...+|+.||||++..... .....+.+|++++++++ |||||++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45889999999999999999988899999999875433 33467899999999996 599999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
| +.+|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 67889999998654 6889999999999999999999988 99999999999996 5899999999998765433
Q ss_pred CCceeecccccCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT-----------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH 851 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 851 (964)
.........||+.|+|||++.. ..++.++|||||||++|||++|+.||.........+..........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~- 287 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI- 287 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCC-
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccC-
Confidence 3223345679999999999864 4688999999999999999999999975444334444333222110
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...... ...+.+++.+||+.||++||++.|+++.
T Consensus 288 -~~~~~~-----------~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 288 -EFPDIP-----------EKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp -CCCCCS-----------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCCccc-----------hHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 011111 1346689999999999999999999864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=367.68 Aligned_cols=268 Identities=16% Similarity=0.204 Sum_probs=208.9
Q ss_pred cCCCccceeecCCcEEEEEEEecC---------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccc----------
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD---------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVG---------- 687 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~---------- 687 (964)
++|...+.||+|+||.||+|+... ++.||||++... ..+.+|++++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 578899999999999999999753 789999998754 36889999999999999988
Q ss_pred -----eeEEEEe-eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 688 -----LVGFCFE-QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 688 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+++++.. .+..++||||+ +|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~ 192 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFV 192 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEE
Confidence 6777776 67789999999 999999998654457999999999999999999999988 9999999999999
Q ss_pred CCCC--cEEEeecccceeecCCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Q 002121 762 DENL--TAKVADFGLSKLVSDSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834 (964)
Q Consensus 762 ~~~~--~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~ 834 (964)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998 9999999999876432211 11234579999999999999899999999999999999999999997543
Q ss_pred hhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCC
Q 002121 835 YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMN 908 (964)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~ 908 (964)
.....+.......... .....+.... .......+.+++.+||+.||++||++.|+++.|+.++++.+..
T Consensus 273 ~~~~~~~~~~~~~~~~---~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 273 PNTEDIMKQKQKFVDK---PGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TCHHHHHHHHHHHHHS---CCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred cCHHHHHHHHHhccCC---hhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 1122221111100000 0111110000 0001145678999999999999999999999999999887543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=376.15 Aligned_cols=360 Identities=19% Similarity=0.191 Sum_probs=299.4
Q ss_pred CCcc--EEecC----------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCC-CCCCCCcccchhhccc
Q 002121 55 SWEG--VTCNN----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSL-SPRIGDLQKLNILILA 121 (964)
Q Consensus 55 ~w~g--v~C~~----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~-p~~l~~l~~L~~L~L~ 121 (964)
.|.+ |.|+. .+++.|+|++|.+++..|..|+++++|++|+|++| .+.+.+ +..|.++++|++|+|+
T Consensus 9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n-~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQ-TPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCC-STTCEECTTTTTTCTTCCEEECT
T ss_pred EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCC-cccceECcccccccccCCEEeCC
Confidence 5555 88874 46899999999999988999999999999999999 677665 5679999999999999
Q ss_pred cccccCcCCcccCCCCCccEEEcccCcccCcCCCc--CCCccccccccccccccccccCcccCCCCccccccCCCeeEcc
Q 002121 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS--LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFN 199 (964)
Q Consensus 122 ~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~ 199 (964)
+|.+++..|..|+++++|++|+|++|++++.+|.. |.++++|++|+|++|++++..|.. .+..+++|++|+++
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-----~~~~l~~L~~L~L~ 162 (455)
T 3v47_A 88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS-----FFLNMRRFHVLDLT 162 (455)
T ss_dssp TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG-----GGGGCTTCCEEECT
T ss_pred CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc-----ccCCCCcccEEeCC
Confidence 99999888999999999999999999999855544 999999999999999999665621 37889999999999
Q ss_pred CCcccccccccccC-CCcceeEEEccCCcCcccCCccc--------CCCCCCcEEEcccCcCccccCccccC--------
Q 002121 200 KNKLSGTISEQLFS-PDMVLIHVLFDGNQLSGNIPESL--------GYVQTLEVLRLDRNALTGKVPTNLNN-------- 262 (964)
Q Consensus 200 ~N~l~g~l~~~~f~-~~~~L~~L~l~~N~l~~~~p~~~--------~~l~~L~~L~Ls~N~l~~~~p~~~~~-------- 262 (964)
+|++++..+..+.. ....|+.|++++|.+.+..+..+ ..+++|+.|++++|++++..|..+..
T Consensus 163 ~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~ 242 (455)
T 3v47_A 163 FNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242 (455)
T ss_dssp TCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEE
T ss_pred CCcccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhcccccccee
Confidence 99999666654422 12578888888888876555432 35577888888888777655544322
Q ss_pred -------------------------------CCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCC
Q 002121 263 -------------------------------LTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFST 310 (964)
Q Consensus 263 -------------------------------l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 310 (964)
.++|+.|+|++|.+++.++. +..+++|++|+|++|.++ ...+..|.+
T Consensus 243 ~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~ 321 (455)
T 3v47_A 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWG 321 (455)
T ss_dssp EEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTT
T ss_pred eEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccc-ccChhHhcC
Confidence 26899999999999998775 899999999999999998 677888999
Q ss_pred CCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC---CcccceeE
Q 002121 311 LPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS---GIKNYTLI 387 (964)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~---~~~l~~l~ 387 (964)
+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|+|+.++... ...++.|+
T Consensus 322 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 401 (455)
T 3v47_A 322 LTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIW 401 (455)
T ss_dssp CTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE
T ss_pred cccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEE
Confidence 999999999999999999999999999999999999999999999999999999999999999998643 45588999
Q ss_pred eecCC-ccccc-ccccCccccCCCCCcccccccccCCCC
Q 002121 388 LVGNP-VCTAT-LANTNYCQLQQPTTKAYSTSLANCGGK 424 (964)
Q Consensus 388 l~~Np-~c~~~-l~~~~~~~~~~~~~~~~~~~~~~c~~~ 424 (964)
|.+|| .|+|. +.++..|...... .......|.++
T Consensus 402 l~~N~l~~~~~~~~~l~~~l~~~~~---~~~~~~~c~~~ 437 (455)
T 3v47_A 402 LHTNPWDCSCPRIDYLSRWLNKNSQ---KEQGSAKCSGS 437 (455)
T ss_dssp CCSSCBCCCTTTTHHHHHHHHHTTT---TEESCCBBTTT
T ss_pred ccCCCcccCCCcchHHHHHHHhCcc---ceeeeeeecCC
Confidence 99999 89997 6677777433222 12233456654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=366.23 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=201.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||.||+|+.. +|+.||+|++.... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57888999999999999999964 68999999986432 223456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999998653 6899999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCceeecccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC--chhHHHHHHHhccCcccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ......+......... ...
T Consensus 170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~p~- 241 (384)
T 4fr4_A 170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT----YPS- 241 (384)
T ss_dssp ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC----CCT-
T ss_pred ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC----CCC-
Confidence 2345679999999999864 45899999999999999999999999632 2222222221111110 111
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPT-MSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 896 (964)
.+ ...+.+++.+||+.||++||+ ++++.+
T Consensus 242 ---~~-------s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 ---AW-------SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ---TS-------CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ---cC-------CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 11 145678999999999999998 666653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=356.59 Aligned_cols=251 Identities=21% Similarity=0.308 Sum_probs=205.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|...+.||+|+||.||+|+.. +|+.||||+++..... ..+++.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 457888999999999999999965 6899999998754322 246799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC----cEEEeeccc
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL----TAKVADFGL 774 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGl 774 (964)
++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 99999999999999997643 6899999999999999999999988 99999999999999888 799999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+..........
T Consensus 166 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~------ 235 (321)
T 2a2a_A 166 AHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-QETLANITSVSY------ 235 (321)
T ss_dssp CEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-HHHHHHHHTTCC------
T ss_pred ceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhccc------
Confidence 987654322 2345699999999999999999999999999999999999999964332 222222221111
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..++.... .....+.+++.+||+.||++|||+.|+++
T Consensus 236 --~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 --DFDEEFFS---HTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp --CCCHHHHT---TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred --ccChhhhc---ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 01111111 11245678999999999999999999975
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=356.91 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=200.3
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|+.. +++.||||++...... ....+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999964 6899999998754322 235788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999997543 5899999999999999999999988 999999999999999999999999999876443
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+...+...... .....+.
T Consensus 188 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~----~~~~~~~ 260 (309)
T 2h34_A 188 KL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIPR----PSTVRPG 260 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCCC----GGGTSTT
T ss_pred cc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCCC----ccccCCC
Confidence 21 2223456999999999999999999999999999999999999999754322 222222221110 0011111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRP-TMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~~~~ 905 (964)
+ ...+.+++.+||+.||++|| +++++++.|+..+...
T Consensus 261 ~-------~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 261 I-------PVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp C-------CTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred C-------CHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 1 13466899999999999999 9999999998875443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=362.01 Aligned_cols=244 Identities=21% Similarity=0.306 Sum_probs=197.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|...+.||+|+||+||+|+.. +|+.||+|+++.... .....+.+|+.++.++ +|||||++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999965 689999999975432 2234578999999988 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999997543 5899999999999999999999988 999999999999999999999999999864322
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc-------hhHHHHHHHhccCccccccc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK-------YVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~-------~~~~~~~~~~~~~~~~~~~~ 854 (964)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....+...+.... ...
T Consensus 164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---~~~ 238 (345)
T 3a8x_A 164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---IRI 238 (345)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC---CCC
T ss_pred C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC---CCC
Confidence 2 22345679999999999999999999999999999999999999996311 11111211111111 001
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
.. .+ ...+.+++.+||+.||++||++
T Consensus 239 p~----~~-------s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 239 PR----SL-------SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp CT----TS-------CHHHHHHHHHHTCSSTTTSTTC
T ss_pred CC----CC-------CHHHHHHHHHHhcCCHhHCCCC
Confidence 11 11 1346689999999999999996
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=349.36 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=204.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|...+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 457889999999999999999965 5789999999876556667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceeecCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~~~ 781 (964)
+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 88 CTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162 (277)
T ss_dssp CCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence 99999999887543 5899999999999999999999988 9999999999999 88899999999999876543
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. ......||+.|+|||++.+ .++.++||||||+++|||++|+.||...... +........... . ...
T Consensus 163 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~----~----~~~ 229 (277)
T 3f3z_A 163 K---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-EVMLKIREGTFT----F----PEK 229 (277)
T ss_dssp S---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC----C----CHH
T ss_pred c---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC----C----Cch
Confidence 2 2234569999999998865 4899999999999999999999999754322 222222111110 0 000
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .......+.+++.+||+.||++||++.|+++
T Consensus 230 ~---~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 230 D---WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp H---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred h---hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0011245678999999999999999999985
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=369.95 Aligned_cols=204 Identities=20% Similarity=0.288 Sum_probs=177.3
Q ss_pred hcCCCccceeecC--CcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSG--GYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G--~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|++.+.||+| +||+||+|+.. +|+.||||+++.... .....+.+|++++++++|||||++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578889999999 99999999975 799999999875432 234568899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|||||++|+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 999999999999998765456999999999999999999999988 99999999999999999999999999875432
Q ss_pred CCC-----CceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 002121 781 SSK-----GHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEK 832 (964)
Q Consensus 781 ~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~ 832 (964)
... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 211 111223468999999999987 6799999999999999999999999964
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=358.04 Aligned_cols=267 Identities=26% Similarity=0.373 Sum_probs=199.9
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
++....++|...+.||+|+||.||+|... .++.||||+++.... ...+.+.+|++++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33344568888999999999999999854 345899999875433 234568999999999999999999999987
Q ss_pred eC-----ceEEEEEeccCCChhhhhcCC----CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC
Q 002121 695 QG-----EQMLVYEFMANGTLRESLSGR----SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL 765 (964)
Q Consensus 695 ~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~ 765 (964)
.+ ..++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 55 349999999999999998432 2346999999999999999999999988 99999999999999999
Q ss_pred cEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHh
Q 002121 766 TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAM 844 (964)
Q Consensus 766 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~ 844 (964)
.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||...... .......
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~~~~~ 263 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-EMYDYLL 263 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-GHHHHHH
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHH
Confidence 999999999987654433233344567889999999999999999999999999999999 88888643321 1111111
Q ss_pred ccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 845 NRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 845 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
..... ... . .....+.+++.+||+.||++||++.|+++.|+.+++.-
T Consensus 264 ~~~~~---~~~----~-------~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 HGHRL---KQP----E-------DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp TTCCC---CCB----T-------TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCCC---CCC----c-------cccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11110 000 1 11245678999999999999999999999999988653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=363.37 Aligned_cols=248 Identities=21% Similarity=0.261 Sum_probs=202.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|...+.||+|+||+||+|+.. +|+.||||+++... ......+..|.+++..+ +||||+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 468999999999999999999975 58899999987532 22345678999999988 79999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 99 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999997543 5899999999999999999999988 99999999999999999999999999986432
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... ....+
T Consensus 174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~-- 244 (353)
T 2i0e_A 174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSIMEHNVA----YPKSM-- 244 (353)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTS--
T ss_pred CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-HHHHHHHHHhCCCC----CCCCC--
Confidence 22 22345679999999999999999999999999999999999999996432 22333333322211 11111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
...+.+++.+||+.||++||+ ++|+++
T Consensus 245 ---------s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 245 ---------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---------CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 134668999999999999996 466654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=360.14 Aligned_cols=258 Identities=24% Similarity=0.436 Sum_probs=198.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
.++|+..+.||+|+||+||+|+.. +++ +||+|.+.... .....++.+|+.++++++||||+++++++.+. ..+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SEE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cce
Confidence 357889999999999999999953 454 35778776433 33456799999999999999999999999865 488
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 9999999999999997653 36899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
............||+.|+|||++.+..++.++|||||||++|||++ |+.||....... +...+..... . ..
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~~~~----~--~~ 240 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGER----L--PQ 240 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHTTCC----C--CC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCCC----C--CC
Confidence 4433333344567889999999999999999999999999999999 999996432211 1111111110 0 00
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
.+. ....+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 241 ~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 241 PPI-------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred Ccc-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 11346789999999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=353.86 Aligned_cols=260 Identities=29% Similarity=0.430 Sum_probs=203.2
Q ss_pred cCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEe-eCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFE-QGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~l 700 (964)
.+|...+.||+|+||+||+|...+ +..||+|++..... ...+.+.+|++++++++||||+++++++.+ ++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 467788999999999999998642 23689999876443 334578999999999999999999999754 567899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 46899999999999999999999988 99999999999999999999999999986643
Q ss_pred CCC--CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCC-CCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 781 SSK--GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAK-QPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 781 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
... ........||+.|+|||.+.+..++.++||||||+++|||++|. +||.. ....+........... .
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~-------~ 252 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-VNTFDITVYLLQGRRL-------L 252 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT-SCTTTHHHHHHTTCCC-------C
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCcc-CCHHHHHHHHhcCCCC-------C
Confidence 221 11233456788999999999999999999999999999999954 45542 2222222222111110 0
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
..... ...+.+++.+||+.||++||++.|+++.|++++...
T Consensus 253 ~~~~~-------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 253 QPEYC-------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp CCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCccC-------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00111 135678999999999999999999999999998754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=351.55 Aligned_cols=260 Identities=27% Similarity=0.359 Sum_probs=205.8
Q ss_pred CCCccceeecCCcEEEEEEEec-CC---cEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCce-EEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DG---QVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ-MLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lV 701 (964)
.|...+.||+|+||+||+|... ++ ..||+|++..... ...+.+.+|++++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4555689999999999999853 33 3799999876443 3346789999999999999999999999876655 999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+.+|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 46899999999999999999999988 999999999999999999999999999865332
Q ss_pred C--CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 782 S--KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 782 ~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
. .........+|+.|+|||.+.+..++.++||||||+++|||++|..|+.......+............ ...
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 251 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP---QPE--- 251 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCC---CCT---
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCC---CCc---
Confidence 1 11122345688999999999999999999999999999999997666543333222222211111100 000
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
. ....+.+++.+||+.||++|||+.|+++.|+++++..
T Consensus 252 -~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 252 -Y-------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp -T-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -c-------chHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 1 1145678999999999999999999999999998765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=357.45 Aligned_cols=265 Identities=23% Similarity=0.370 Sum_probs=190.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||+||+|... +|+.||||+++.... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 357888999999999999999964 689999999875433 234578899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCC----CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 704 FMANGTLRESLSGRS----GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|++ |+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886431 235899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCcccccc-cc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYG-LT 855 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~-~~ 855 (964)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+............. ..
T Consensus 160 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 3321 2234568999999999876 46899999999999999999999999754322 12222222111110000 00
Q ss_pred c--ccCc--------cchhh-----hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 E--MMDP--------TIRNT-----VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~--~~d~--------~l~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ...+ .+... .......+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000 00000 0011245779999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=358.35 Aligned_cols=268 Identities=27% Similarity=0.415 Sum_probs=199.9
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHH--HHhcCCCCccceeEEEEee-----Cce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIEL--LSRVHHKNLVGLVGFCFEQ-----GEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~~-----~~~ 698 (964)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++... ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 35788899999999999999987 68999999986432 2344445554 4458999999999876542 256
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC------CCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA------NPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
++||||+++|+|.+++.... .++..+..++.|+++||+|||+.. .++|+||||||+|||++.++.+||+||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 89999999999999997653 689999999999999999999881 113999999999999999999999999
Q ss_pred ccceeecCCCC------CceeecccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchh---
Q 002121 773 GLSKLVSDSSK------GHVSTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--- 836 (964)
Q Consensus 773 Gla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--- 836 (964)
|+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+..+...
T Consensus 165 G~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~ 244 (336)
T 3g2f_A 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244 (336)
T ss_dssp TTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCC
T ss_pred cceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHH
Confidence 99987653221 112234569999999999876 45678999999999999999998877533211
Q ss_pred -------------HHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 837 -------------VREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 837 -------------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
............ ....+.... .........+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 245 QMAFQTEVGNHPTFEDMQVLVSREK-----QRPKFPEAW-KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCTTHHHHCSSCCHHHHHHHHTTSC-----CCCCCCTTC-CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhhhcccCCCchHHHHHhhhcccc-----cCCCCCccc-ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 111111111111 000011111 1122344568899999999999999999999999999997
Q ss_pred hCC
Q 002121 904 NDG 906 (964)
Q Consensus 904 ~~~ 906 (964)
...
T Consensus 319 ~~~ 321 (336)
T 3g2f_A 319 IWE 321 (336)
T ss_dssp CCC
T ss_pred HHH
Confidence 654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=356.42 Aligned_cols=267 Identities=26% Similarity=0.421 Sum_probs=211.9
Q ss_pred HHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHh--cCCCCccceeEEEEeeC---
Q 002121 622 LKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSR--VHHKNLVGLVGFCFEQG--- 696 (964)
Q Consensus 622 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~--- 696 (964)
-....++|...+.||+|+||.||+|+. +|+.||||++... ....+.+|++++.. ++||||+++++++...+
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344567899999999999999999998 5899999998643 34567889999988 78999999999998876
Q ss_pred -ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHh--------hcCCCCeeccCCCCCcEEECCCCcE
Q 002121 697 -EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH--------ELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 697 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
..++||||+++|+|.+++... .+++.+++.++.|++.||+||| +.+ |+||||||+|||++.++.+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCE
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCE
Confidence 789999999999999999754 5899999999999999999999 666 9999999999999999999
Q ss_pred EEeecccceeecCCCCCc--eeecccccCcccCccccccC------CCCCchhHHHHHHHHHHHHhC----------CCC
Q 002121 768 KVADFGLSKLVSDSSKGH--VSTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVVMLELITA----------KQP 829 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~elltg----------~~p 829 (964)
||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+|| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 999999998775543211 12345799999999998765 234789999999999999999 678
Q ss_pred CCCCc---hhHHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 830 IEKGK---YVVREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 830 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
|.... .....+........ ..+.+... .......+.+++.+||+.||++||++.||++.|+.+.++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQK---------LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSC---------CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccCcCcccHHHHHHHHHHHH---------hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 75321 11222222221111 11222211 234456788999999999999999999999999999887
Q ss_pred CCC
Q 002121 905 DGM 907 (964)
Q Consensus 905 ~~~ 907 (964)
.+.
T Consensus 338 ~~~ 340 (342)
T 1b6c_B 338 EGI 340 (342)
T ss_dssp TC-
T ss_pred hcC
Confidence 653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=350.37 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=203.3
Q ss_pred hcCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|...+.||+|+||+||+|+... +..||||+++.... ...+.+.+|++++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998643 34699999876533 345679999999999999999999999864 56789
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999997543 35899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCch--hHHHHHHHhccCcccccccccc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKY--VVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
... .......+|+.|+|||++....++.++||||||+++|||++ |+.||..... ....+.. .... .....
T Consensus 166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~---~~~~~ 238 (281)
T 3cc6_A 166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRL---PKPDL 238 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCC---CCCTT
T ss_pred ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCC---CCCCC
Confidence 322 22234457889999999998899999999999999999998 9999963322 2221111 1100 01111
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
....+.+++.+||+.||++||++.|+++.|+.+.+.
T Consensus 239 -----------~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 239 -----------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp -----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----------CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 114467899999999999999999999999988754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=348.32 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=204.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357888999999999999999975 78999999986433 2334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999999764 36899999999999999999999988 99999999999999999999999999987643322
Q ss_pred CceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
........||+.|+|||++.+..+ +.++||||||+++|||++|+.||................... .. ..
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~-~~ 231 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--------LN-PW 231 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--------ST-TG
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--------cC-ch
Confidence 222344579999999999987665 689999999999999999999997543322222222111110 00 00
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
......+.+++.+||+.||++|||+.|+++
T Consensus 232 ----~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 232 ----KKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----hhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011244668999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=351.94 Aligned_cols=260 Identities=25% Similarity=0.382 Sum_probs=205.5
Q ss_pred hhcCCCccc-eeecCCcEEEEEEEe---cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 625 CSNNFSESN-EIGSGGYGKVYRGML---SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 625 ~~~~~~~~~-~lG~G~fg~Vy~~~~---~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
..++|...+ .||+|+||+||+|.+ ..++.||||+++..... ..+++.+|++++++++||||+++++++ +.+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 999999999999964 34689999998764322 246799999999999999999999999 66788
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... .+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999997643 5899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 779 SDSSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 779 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+ +...+..... .
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~-~~~~~~~~~~-----~- 239 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SE-VTAMLEKGER-----M- 239 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH-HHHHHHTTCC-----C-
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-HH-HHHHHHcCCC-----C-
Confidence 5433211 1223346789999999988889999999999999999999 9999975332 11 2222211110 0
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
..... ....+.+++.+||+.||++||++.|+++.|+.+..+.
T Consensus 240 ~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 GCPAG-------CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CCCTT-------CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCC-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 01111 1245678999999999999999999999999998654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=366.73 Aligned_cols=249 Identities=22% Similarity=0.294 Sum_probs=190.4
Q ss_pred cCCCcc-ceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe----eCceE
Q 002121 627 NNFSES-NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE----QGEQM 699 (964)
Q Consensus 627 ~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~~ 699 (964)
++|... +.||+|+||+||+|... +|+.||||+++.. ..+.+|++++.++ +||||+++++++.. .+..+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999964 6899999998632 3677899987554 89999999999876 56789
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccce
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLSK 776 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~ 776 (964)
+|||||++|+|.+++.......+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999998765567999999999999999999999988 999999999999997 7899999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH---HHHHHHhccCcccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV---REVRTAMNRDDEEHYG 853 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~---~~~~~~~~~~~~~~~~ 853 (964)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~---- 285 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE---- 285 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCC----
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCccc----
Confidence 764322 2345678999999999999999999999999999999999999996432110 001111111000
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.. .+.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 286 ~~---~~~~----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 286 FP---NPEW----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CC---TTTT----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC---Cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000 0112456789999999999999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=378.42 Aligned_cols=248 Identities=22% Similarity=0.275 Sum_probs=194.8
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC---CcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG---SMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|+..+.||+|+||.||+|.. .+|+.||||+++.. .......+.+|++++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46789999999999999999995 46899999998753 223334678899999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|||+++|+|.+++.... .+++.++..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997543 68999999999999999999998 77 99999999999999999999999999985432
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ............. ....++
T Consensus 302 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~i~~~~~~----~p~~~~- 373 (446)
T 4ejn_A 302 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-EKLFELILMEEIR----FPRTLG- 373 (446)
T ss_dssp -------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC----CCTTSC-
T ss_pred CC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-HHHHHHHHhCCCC----CCccCC-
Confidence 21 223456799999999999999999999999999999999999999965432 2222222221111 111111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
..+.+++.+||+.||++|| +++|+++
T Consensus 374 ----------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 374 ----------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ----------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 3466899999999999999 9999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=366.24 Aligned_cols=263 Identities=18% Similarity=0.230 Sum_probs=197.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCcc-----------hhHHHHHHHHHHHhcCCCCccceeE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSMQ-----------GGLEFKTEIELLSRVHHKNLVGLVG 690 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~H~nIv~l~~ 690 (964)
.++|...+.||+|+||+||+|... ++..||||+....... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999975 5789999998765322 1123667889999999999999999
Q ss_pred EEEe----eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-
Q 002121 691 FCFE----QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL- 765 (964)
Q Consensus 691 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~- 765 (964)
++.+ ....++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 9988 67889999999 999999998654 7999999999999999999999988 99999999999998887
Q ss_pred -cEEEeecccceeecCCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002121 766 -TAKVADFGLSKLVSDSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839 (964)
Q Consensus 766 -~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~ 839 (964)
.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus 190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~ 269 (345)
T 2v62_A 190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA 269 (345)
T ss_dssp TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence 9999999999876432211 1113457999999999999999999999999999999999999999532111111
Q ss_pred HHHHhccCcccccccccccCccchhhh--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTV--LLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
....... ....+...+.... ......+.+++.+||+.||++||++.+|++.|+..
T Consensus 270 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 270 VQTAKTN-------LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHH-------HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHh-------hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111000 0000111111000 01224677999999999999999999999988753
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=365.87 Aligned_cols=259 Identities=30% Similarity=0.467 Sum_probs=194.9
Q ss_pred CCCccceeecCCcEEEEEEEec--CC--cEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEe-eCceEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS--DG--QVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFE-QGEQMLV 701 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV 701 (964)
.|...+.||+|+||+||+|... ++ ..||||.++.... ...+++.+|+.++++++||||+++++++.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4566789999999999999863 22 4689999875433 345679999999999999999999999765 4578999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997643 46899999999999999999999988 999999999999999999999999999866433
Q ss_pred CCC--ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 782 SKG--HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 782 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
... .......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...... +.......... ..
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~-~~~~~~~~~~~--------~~ 316 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-DITVYLLQGRR--------LL 316 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS-CHHHHHHTTCC--------CC
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH-HHHHHHHcCCC--------CC
Confidence 211 12234567889999999999999999999999999999999 66676532211 11111111111 00
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.+. .....+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 317 ~p~------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 317 QPE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp CCT------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 010 11145678999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=372.94 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=204.7
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 357888999999999999999965 799999999865321 2235788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++...+ .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999997643 6899999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||.... .............. ....++
T Consensus 170 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~s- 240 (476)
T 2y94_A 170 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKICDGIFY----TPQYLN- 240 (476)
T ss_dssp C---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-SHHHHHHHHTTCCC----CCTTCC-
T ss_pred c---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-HHHHHHHHhcCCcC----CCccCC-
Confidence 2 2234579999999999988765 689999999999999999999997433 22233332222110 111111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+++.+||+.||++|||+.|+++
T Consensus 241 ----------~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 241 ----------PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ----------HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ----------HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 34568999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=351.06 Aligned_cols=263 Identities=21% Similarity=0.294 Sum_probs=205.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEE-eeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF-EQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~ 702 (964)
..++|...+.||+|+||+||+|+. .+|+.||||++...... .++.+|++++++++|++++..++++. +.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999995 57899999987654322 36889999999999988887777764 556779999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceeec
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~ 779 (964)
||+ +|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++...
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 159 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence 999 999999997433 35999999999999999999999988 9999999999999 789999999999998775
Q ss_pred CCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch-----hHHHHHHHhccCcc
Q 002121 780 DSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY-----VVREVRTAMNRDDE 849 (964)
Q Consensus 780 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-----~~~~~~~~~~~~~~ 849 (964)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+........
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 238 (296)
T 4hgt_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP- 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-
T ss_pred CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch-
Confidence 44321 122345799999999999999999999999999999999999999964211 1111111000000
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCC
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 907 (964)
...........+.+++.+||+.||++||++.|+++.|+.+.++.+.
T Consensus 239 ------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 239 ------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp ------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 0000001124577999999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.16 Aligned_cols=252 Identities=23% Similarity=0.330 Sum_probs=204.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++|+..+.||+|+||.||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 568999999999999999999964 689999999875432 23456889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc---EEEeecccceeec
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT---AKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGla~~~~ 779 (964)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999887543 5899999999999999999999988 999999999999986655 9999999998765
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .. .
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~----~~---~ 228 (284)
T 3kk8_A 160 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-RLYAQIKAGAYD----YP---S 228 (284)
T ss_dssp SSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHTCCC----CC---T
T ss_pred cCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-HHHHHHHhcccc----CC---c
Confidence 432 223456999999999999999999999999999999999999999654322 222222111110 00 0
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 229 ~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 229 PEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhh----cccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 0111446689999999999999999999873
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=355.61 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=202.3
Q ss_pred cCCCccceeecCCcEEEEEEEecC-----CcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSD-----GQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~-----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.+|...+.||+|+||+||+|.... +..||||+++.... .....+.+|++++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 466778999999999999998642 24699999976433 334578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999997543 46899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 781 SSKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 781 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... .......+|+.|+|||++....++.++|||||||++|||++ |+.||..... .+.... +..... .. .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~~~~~~-~~~~~~----~~--~ 271 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKA-INDGFR----LP--T 271 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHH-HHTTCC----CC--C
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-HHHHHH-HHCCCc----CC--C
Confidence 3221 12223446889999999998999999999999999999999 9999964332 122222 111110 00 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
... ....+.+++.+||+.||++||++.|+++.|+++++..
T Consensus 272 ~~~-------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 272 PMD-------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp CTT-------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ccc-------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 011 1245678999999999999999999999999988644
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=347.76 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=208.5
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEE-eeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF-EQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lV~E 703 (964)
.++|...+.||+|+||.||+|+. .+|+.||||++...... .++.+|++++++++|++++..+.++. +.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 56899999999999999999996 57999999998754432 46899999999999998887777664 4566799999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceeecC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~~ 780 (964)
|+ +|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....
T Consensus 86 ~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred ec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99 899999997433 36999999999999999999999988 9999999999999 4889999999999987654
Q ss_pred CCCCc-----eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch-----hHHHHHHHhccCccc
Q 002121 781 SSKGH-----VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY-----VVREVRTAMNRDDEE 850 (964)
Q Consensus 781 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~ 850 (964)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+........
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 238 (296)
T 3uzp_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-- 238 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC--
T ss_pred cccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc--
Confidence 43211 12345799999999999999999999999999999999999999964211 1111111000000
Q ss_pred ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCC
Q 002121 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907 (964)
Q Consensus 851 ~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 907 (964)
...........+.+++.+||+.||++||++.|+++.|+.+.+..+.
T Consensus 239 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 239 -----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp -----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred -----------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0000011124577999999999999999999999999999987754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=379.46 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+++|++++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467889999999999999999964 79999999986532 22345688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.......+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999998765556999999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccccccccC
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+...+...... ....+
T Consensus 340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~---~p~~~- 412 (576)
T 2acx_A 340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE---YSERF- 412 (576)
T ss_dssp C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC---CCTTS-
T ss_pred c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc---CCccC-
Confidence 2 23445799999999999998999999999999999999999999975321 122222222111100 11111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||++|| +++|+++
T Consensus 413 ----------s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 413 ----------SPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----------CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 14466899999999999999 7788864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-39 Score=367.83 Aligned_cols=273 Identities=22% Similarity=0.273 Sum_probs=213.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeC--ceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--EQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lV~ 702 (964)
++|...+.||+|+||+||+|+.. +|+.||||+++.... .....+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 57888999999999999999975 589999999975432 33456889999999999999999999998765 679999
Q ss_pred EeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----CCCCcEEEeeccccee
Q 002121 703 EFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL----DENLTAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~DFGla~~ 777 (964)
||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 9999999999997653 234899999999999999999999988 9999999999999 7888899999999987
Q ss_pred ecCCCCCceeecccccCcccCcccccc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCC---chhHHHHHHHhcc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMT--------QQLTEKSDVYSFGVVMLELITAKQPIEKG---KYVVREVRTAMNR 846 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~elltg~~p~~~~---~~~~~~~~~~~~~ 846 (964)
..... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||... ....+.+......
T Consensus 166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 166 LEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 65432 2234569999999999864 56788999999999999999999999621 2223333333333
Q ss_pred Cccccc-ccccccCc------cc---hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 847 DDEEHY-GLTEMMDP------TI---RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 847 ~~~~~~-~~~~~~d~------~l---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.+.... ........ .+ ..........+.+++.+||+.||++||++.|+++.++.++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 221110 00000000 00 0112334466789999999999999999999999999988653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=361.11 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=194.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|...+.||+|+||+||+|+.. +|+.||||++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 457889999999999999999965 789999999975433 235788999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc--EEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT--AKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~~~~~~~ 782 (964)
+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 98 ASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp CCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred CCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999987543 5899999999999999999999988 999999999999987765 999999999754322
Q ss_pred CCceeecccccCcccCccccccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCc---hhHHHHHHHhccCccccccccccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEK-SDVYSFGVVMLELITAKQPIEKGK---YVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDv~S~Gvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.... .....+......... ...
T Consensus 172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~-- 243 (361)
T 3uc3_A 172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS----IPD-- 243 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC----CCT--
T ss_pred --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC----CCC--
Confidence 12234569999999999988877655 899999999999999999997432 222222222221110 110
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+..+ ...+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~-------s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 244 DIRI-------SPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TSCC-------CHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCC-------CHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 0011 1456689999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=372.94 Aligned_cols=259 Identities=24% Similarity=0.318 Sum_probs=195.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee------C
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------G 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 696 (964)
.++|+..+.||+|+||+||+|.. .+|+.||||++.... .....++.+|+.++++++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999985 468999999997542 23345788999999999999999999999754 3
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++|||||++ +|.+.+.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 56999999986 57666643 3899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccc---
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEE--- 850 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~--- 850 (964)
..... ...+...||+.|+|||++.+..++.++||||+||++|||++|+.||....... .+..++. ....+
T Consensus 213 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 213 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp ----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHT
T ss_pred ecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHH
Confidence 76432 22345679999999999999999999999999999999999999997544322 2222211 10000
Q ss_pred -----------------ccccccccCccc----hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 -----------------HYGLTEMMDPTI----RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 -----------------~~~~~~~~d~~l----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+...+ ..........+.+++.+||+.||++|||++|+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000111000 0001112456789999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=384.20 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=203.1
Q ss_pred CCCccc-eeecCCcEEEEEEEec---CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESN-EIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++...+ .||+|+||.||+|.+. ++..||||+++.... ...+++.+|+++|++++|||||+++++|.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999864 466899999986533 345689999999999999999999999976 6799999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||++|+|.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 415 E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~ 490 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490 (613)
T ss_dssp ECCTTCBHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred EeCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence 9999999999997643 46999999999999999999999988 9999999999999999999999999998764332
Q ss_pred CC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 783 KG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 783 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. .......+|+.|+|||++..+.++.++|||||||++|||+| |+.||..... .+.... +..... . ...+
T Consensus 491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~~~~~~-i~~~~~----~--~~p~ 562 (613)
T 2ozo_A 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMAF-IEQGKR----M--ECPP 562 (613)
T ss_dssp -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS-HHHHHH-HHTTCC----C--CCCT
T ss_pred ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHH-HHcCCC----C--CCCC
Confidence 21 11223346789999999999999999999999999999998 9999964332 122221 211110 0 0011
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
. ....+.+++.+||+.||++||++.+|++.|+.+.....
T Consensus 563 ~-------~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 563 E-------CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp T-------CCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred c-------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 1 12456789999999999999999999999999887654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=354.51 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=195.8
Q ss_pred cCCCcc-ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSES-NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
+.|.+. +.||+|+||+||+|.. .+|+.||||++..........+.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 467664 7899999999999995 47899999999876655567899999999995 79999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc---EEEeecccceeecC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT---AKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGla~~~~~ 780 (964)
|+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 92 KMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred cCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999999997643 5899999999999999999999988 999999999999998776 99999999976542
Q ss_pred CCC-----CceeecccccCcccCcccccc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCchh-------------H
Q 002121 781 SSK-----GHVSTQVKGTMGYLDPEYYMT-----QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-------------V 837 (964)
Q Consensus 781 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-------------~ 837 (964)
... ........||+.|+|||++.. ..++.++|||||||++|||++|+.||...... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 211 111223469999999999875 56889999999999999999999999643210 0
Q ss_pred HHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+...+..... .. .... .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~i~~~~~---~~----~~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKY---EF----PDKD---WAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCC---CC----CHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCc---cc----Cchh---cccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111111111100 00 0000 0011245679999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=361.46 Aligned_cols=246 Identities=28% Similarity=0.433 Sum_probs=199.8
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+.|...+.||+|+||+||+|+. .+|+.||||++...... ...++.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4588889999999999999995 57899999998754332 2346889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||++ |+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-
Confidence 9997 68888875432 46899999999999999999999988 999999999999999999999999999865432
Q ss_pred CCceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 783 KGHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
....||+.|+|||++. .+.++.++|||||||++|||++|+.||...... ..+........ .....
T Consensus 208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~-~~~~~~~~~~~------~~~~~ 275 (348)
T 1u5q_A 208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNES------PALQS 275 (348)
T ss_dssp -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCC------CCCCC
T ss_pred -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHhcCC------CCCCC
Confidence 2356999999999984 567899999999999999999999999754432 22222222111 00011
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
... ...+.+++.+||+.||++|||+.|+++.
T Consensus 276 ~~~-------~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 276 GHW-------SEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TTS-------CHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC-------CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111 1346689999999999999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=370.07 Aligned_cols=253 Identities=24% Similarity=0.368 Sum_probs=191.6
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--------chhHHHHHHHHHHHhcCCCCccceeEEEEe
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--------QGGLEFKTEIELLSRVHHKNLVGLVGFCFE 694 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 694 (964)
...++|...+.||+|+||+||+|... +++.||||++..... .....+.+|+++|++++|||||++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999964 689999999864321 12235889999999999999999999975
Q ss_pred eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC---CcEEEee
Q 002121 695 QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN---LTAKVAD 771 (964)
Q Consensus 695 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~D 771 (964)
.+..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.+ +.+||+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEee
Confidence 456899999999999999987653 6899999999999999999999988 9999999999999654 4599999
Q ss_pred cccceeecCCCCCceeecccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCc
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDD 848 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~ 848 (964)
||+++..... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||..................
T Consensus 286 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~ 362 (419)
T 3i6u_A 286 FGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY 362 (419)
T ss_dssp SSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred cccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence 9999876432 22345679999999999853 67788999999999999999999999643221111111111110
Q ss_pred ccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 EEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ..+... ......+.+++.+||+.||++||+++|+++
T Consensus 363 ~--------~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 363 N--------FIPEVW---AEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C--------CCHHHH---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C--------CCchhh---cccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0 011111 112245678999999999999999999875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=351.14 Aligned_cols=263 Identities=24% Similarity=0.324 Sum_probs=198.7
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|...+.||+|+||+||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999975 5899999998654433 24568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 999999999887543 5899999999999999999999988 9999999999999999999999999998765332
Q ss_pred CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHH--HHHHHhccCccc---------c
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR--EVRTAMNRDDEE---------H 851 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~---------~ 851 (964)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||........ .+.......... .
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (311)
T 4agu_A 157 -DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY 235 (311)
T ss_dssp ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred -cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence 22334568999999999875 6789999999999999999999999975433221 111111110000 0
Q ss_pred cccccccCcc----chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 YGLTEMMDPT----IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ~~~~~~~d~~----l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......++. +..........+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000000 00001122345779999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=349.72 Aligned_cols=253 Identities=26% Similarity=0.433 Sum_probs=202.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||+||+|... +++.||||++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467889999999999999999864 578999999864321 2235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999987543 5899999999999999999999988 999999999999999999999999998654332
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +........... ..+.+
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~----~~~~~--- 230 (279)
T 3fdn_A 163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-ETYKRISRVEFT----FPDFV--- 230 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCCC----CCTTS---
T ss_pred ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH-HHHHHHHhCCCC----CCCcC---
Confidence 223457999999999999999999999999999999999999999754322 222211111110 11111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...+.+++.+||+.||++||++.|+++. .+++..
T Consensus 231 --------~~~~~~li~~~l~~~p~~Rps~~e~l~h--~~~~~~ 264 (279)
T 3fdn_A 231 --------TEGARDLISRLLKHNPSQRPMLREVLEH--PWITAN 264 (279)
T ss_dssp --------CHHHHHHHHHHCCSSGGGSCCHHHHHHC--HHHHHH
T ss_pred --------CHHHHHHHHHHhccChhhCCCHHHHhhC--ccccCC
Confidence 1345689999999999999999999974 444433
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=362.34 Aligned_cols=262 Identities=24% Similarity=0.419 Sum_probs=209.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-----cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC--ce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-----SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG--EQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~ 698 (964)
.++|...+.||+|+||.||+|++ .+|+.||||++..........+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35678889999999999999984 368899999998766666678999999999999999999999987644 78
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999997653 35899999999999999999999988 999999999999999999999999999877
Q ss_pred cCCCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--------------HHHHHH
Q 002121 779 SDSSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--------------REVRTA 843 (964)
Q Consensus 779 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--------------~~~~~~ 843 (964)
....... ......++..|+|||++.+..++.++||||||+++|||+||..|+....... ..+...
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence 5433211 1223457788999999998889999999999999999999999985321110 011111
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
+.... ..... ......+.+++.+||+.||++||++.|+++.|+++.++
T Consensus 276 ~~~~~----------~~~~~---~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 276 LKNNG----------RLPRP---DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHTTC----------CCCCC---TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCC----------CCCCC---CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11100 00000 11124577899999999999999999999999988754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=357.84 Aligned_cols=262 Identities=25% Similarity=0.387 Sum_probs=206.0
Q ss_pred hcCCCccceeecCCcEEEEEEEe------cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|...+.||+|+||.||+|+. .+++.||||++.... .....++.+|+.++++++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46889999999999999999984 257799999997543 23445789999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCC-----CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEe
Q 002121 699 MLVYEFMANGTLRESLSGRSG-----IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVA 770 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~ 770 (964)
++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999976431 35899999999999999999999988 999999999999984 4569999
Q ss_pred ecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcc
Q 002121 771 DFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 771 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
|||+++...............||+.|+|||++.+..++.++||||||+++|||+| |+.||..... .+...........
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~ 264 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-QEVLEFVTSGGRM 264 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCC
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-HHHHHHHhcCCCC
Confidence 9999986544333233344568999999999998999999999999999999998 8999864332 1222221111110
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.. ... ....+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 265 ---~~----~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 265 ---DP----PKN-------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp ---CC----CTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred ---CC----CCC-------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 00 111 1145678999999999999999999999999887644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=349.87 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=182.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999996 5789999999864321 2235789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999998653 46899999999999999999999988 999999999999999999999999999876432
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ........ . +..
T Consensus 166 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~---------~---~~~ 230 (278)
T 3cok_A 166 HE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKVVL---------A---DYE 230 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------CCS---------S---CCC
T ss_pred CC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHHhh---------c---ccC
Confidence 21 123356899999999999888999999999999999999999999643211 11111000 0 001
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.... ....+.+++.+||+.||++||++.|+++
T Consensus 231 ~~~~---~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 231 MPSF---LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CCTT---SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Cccc---cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1111 1145668999999999999999999875
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=345.10 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=204.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
++|...+.||+|+||.||+|+.. +|+.||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 56888999999999999999975 6899999998754321 3467999999999999999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC----cEEEeecccc
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL----TAKVADFGLS 775 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGla 775 (964)
+||||+++++|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 999999999999999753 36899999999999999999999988 99999999999998877 8999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (964)
+...... ......||+.|+|||++....++.++||||||+++|||++|+.||..... .+..........
T Consensus 160 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~------- 228 (283)
T 3bhy_A 160 HKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-QETLTNISAVNY------- 228 (283)
T ss_dssp EECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-HHHHHHHHTTCC-------
T ss_pred eeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-HHHHHHhHhccc-------
Confidence 8764432 22345699999999999989999999999999999999999999975432 222222111111
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH--HHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK--AIETLL 902 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~--~L~~~~ 902 (964)
..+.... ......+.+++.+||+.||++||++.|+++ .++.+.
T Consensus 229 -~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 -DFDEEYF---SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp -CCCHHHH---TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred -CCcchhc---ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0111111 111245678999999999999999999987 455544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=367.15 Aligned_cols=263 Identities=22% Similarity=0.365 Sum_probs=192.1
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcC-CCCccceeEEEEeeC--c
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQG--E 697 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~ 697 (964)
...++|...+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999995 478999999986542 233456789999999997 999999999997644 6
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++|||||+ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999998 5999998753 5899999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCC-------------------CCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH
Q 002121 778 VSDSS-------------------KGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837 (964)
Q Consensus 778 ~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~ 837 (964)
..... .....+...||+.|+|||++.+ ..++.++||||+||++|||++|++||..... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-~ 237 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-M 237 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-H
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH-H
Confidence 54311 1122344679999999999876 6789999999999999999999999965433 2
Q ss_pred HHHHHHh---ccCcccccccccccCc----------------------cchhh---------hHHHHHHHHHHHHHhhhc
Q 002121 838 REVRTAM---NRDDEEHYGLTEMMDP----------------------TIRNT---------VLLGFRRYLELALQCVEE 883 (964)
Q Consensus 838 ~~~~~~~---~~~~~~~~~~~~~~d~----------------------~l~~~---------~~~~~~~l~~li~~cl~~ 883 (964)
+.+...+ ....... +.....+ ..... .......+.+++.+||+.
T Consensus 238 ~~~~~i~~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~ 315 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNED--VESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQF 315 (388)
T ss_dssp HHHHHHHHHHCCCCHHH--HHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhcCCCCHHH--HHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhcc
Confidence 2222221 1111000 0000000 00000 001124577999999999
Q ss_pred CCCCCCCHHHHHH
Q 002121 884 SATDRPTMSEVVK 896 (964)
Q Consensus 884 dP~~RPs~~evl~ 896 (964)
||++|||++|+++
T Consensus 316 dP~~R~t~~e~l~ 328 (388)
T 3oz6_A 316 NPNKRISANDALK 328 (388)
T ss_dssp SGGGSCCHHHHTT
T ss_pred CcccCCCHHHHhC
Confidence 9999999999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=359.46 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=201.8
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--------hhHHHHHHHHHHHhcCCCCccceeEEEEee
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 695 (964)
..++|...+.||+|+||+||+|+. .+|+.||||+++..... ....+.+|++++++++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 356899999999999999999995 57899999998765321 223578899999999999999999999999
Q ss_pred CceEEEEEeccCC-ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccc
Q 002121 696 GEQMLVYEFMANG-TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774 (964)
Q Consensus 696 ~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGl 774 (964)
+..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGS 176 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeeccc
Confidence 9999999999777 9999998654 5999999999999999999999988 99999999999999999999999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....
T Consensus 177 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------~~~~~----- 241 (335)
T 3dls_A 177 AAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------VEAAI----- 241 (335)
T ss_dssp CEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------TTTCC-----
T ss_pred ceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------Hhhcc-----
Confidence 987654322 234569999999999988776 78999999999999999999999642110 00000
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+.. ....+.+++.+||+.||++|||+.|+++.
T Consensus 242 ----~~~~~------~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 ----HPPYL------VSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----CCSSC------CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----CCCcc------cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 11456789999999999999999999863
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=350.25 Aligned_cols=254 Identities=26% Similarity=0.427 Sum_probs=200.1
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee-CceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-GEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~E~ 704 (964)
.++|+..+.||+|+||+||+|... |+.||||+++... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467888999999999999999884 8899999987543 345789999999999999999999997654 578999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999997654334889999999999999999999988 9999999999999999999999999998654321
Q ss_pred ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
....+++.|+|||++.+..++.++||||||+++|||+| |+.||..... .+.... +.... .....
T Consensus 172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~~-~~~~~----------~~~~~ 236 (278)
T 1byg_A 172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVPR-VEKGY----------KMDAP 236 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHHH-HTTTC----------CCCCC
T ss_pred ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH-HhcCC----------CCCCc
Confidence 22357899999999998999999999999999999998 9999864321 111111 11111 00011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
. .....+.+++.+||+.||++||++.|+++.|+.+...+
T Consensus 237 ~---~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 237 D---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred c---cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 1 11245678999999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=364.98 Aligned_cols=247 Identities=26% Similarity=0.332 Sum_probs=193.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHH-HHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIEL-LSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|...+.||+|+||+||+|+.. +++.||||+++.... .....+.+|..+ ++.++|||||++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357889999999999999999965 588999999875432 223356677776 577899999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 117 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred EEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999999997643 5889999999999999999999988 99999999999999999999999999986432
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... ..+........... . .+
T Consensus 192 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-~~~~~~~i~~~~~~----~----~~ 260 (373)
T 2r5t_A 192 HN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNILNKPLQ----L----KP 260 (373)
T ss_dssp CC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-HHHHHHHHHHSCCC----C----CS
T ss_pred CC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHhcccC----C----CC
Confidence 22 22345679999999999999999999999999999999999999996533 23333333322111 1 11
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
.+. ..+.+++.+||+.||++||++.+.+
T Consensus 261 ~~~-------~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 261 NIT-------NSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp SSC-------HHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred CCC-------HHHHHHHHHHcccCHHhCCCCCCCH
Confidence 111 3456899999999999999986433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.49 Aligned_cols=257 Identities=20% Similarity=0.277 Sum_probs=203.2
Q ss_pred HHHhhcCCCcc-ceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcC-CCCccceeEEEEeeC
Q 002121 622 LKKCSNNFSES-NEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQG 696 (964)
Q Consensus 622 l~~~~~~~~~~-~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~ 696 (964)
.+...+.|.+. +.||+|+||+||+|+.. +|+.||||+++.... ....++.+|+.++.+++ ||||+++++++.+.+
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 34445667776 88999999999999965 689999999875332 33567899999999995 699999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecc
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFG 773 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFG 773 (964)
..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999999997665567999999999999999999999988 999999999999998 7899999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 853 (964)
+++...... ......||+.|+|||++....++.++|||||||++|||++|+.||........ ..........
T Consensus 180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~~~---- 251 (327)
T 3lm5_A 180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET-YLNISQVNVD---- 251 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC----
T ss_pred cccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-HHHHHhcccc----
Confidence 998765332 22345799999999999999999999999999999999999999975433222 1111111110
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .... ......+.+++.+||+.||++|||++|+++
T Consensus 252 ~~----~~~~---~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 252 YS----EETF---SSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp CC----TTTT---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cC----chhh---cccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00 0000 111244668999999999999999999975
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.10 Aligned_cols=259 Identities=28% Similarity=0.448 Sum_probs=205.9
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcE--EEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQV--VAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|...+.||+|+||.||+|+.. +|.. ||+|+++... ......+.+|+++++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57888999999999999999964 5664 4999887533 23445789999999999 899999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 702 YEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
|||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 246899999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||+++...... ......+++.|+|||++....++.++|||||||++|||+| |+.||..... .+.... +..
T Consensus 182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-~~~~~~-~~~ 256 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYEK-LPQ 256 (327)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHH-GGG
T ss_pred EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-HHHHHH-hhc
Confidence 999999997432211 1223457889999999988889999999999999999998 9999965332 222222 211
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
... . ..... ....+.+++.+||+.||++||++.|+++.|+.++++..
T Consensus 257 ~~~----~--~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 257 GYR----L--EKPLN-------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp TCC----C--CCCTT-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred CCC----C--CCCCC-------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 110 0 00111 11456789999999999999999999999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=356.18 Aligned_cols=244 Identities=20% Similarity=0.304 Sum_probs=179.1
Q ss_pred cceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEeccCCC
Q 002121 632 SNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
.+.||+|+||+||+|... +|+.||||++... ....+.+|+.+++++. ||||+++++++.+.+..++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999974 6899999998643 3457889999999997 9999999999999999999999999999
Q ss_pred hhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cEEEeecccceeecCCCCCce
Q 002121 710 LRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 710 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~kl~DFGla~~~~~~~~~~~ 786 (964)
|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 93 L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~ 165 (325)
T 3kn6_A 93 LFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QP 165 (325)
T ss_dssp HHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--Cc
Confidence 999998653 6999999999999999999999988 99999999999997765 89999999998764432 22
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch------hHHHHHHHhccCcccccccccccCc
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY------VVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+........... ...
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~--------~~~ 237 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS--------FEG 237 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC--------CCS
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC--------CCc
Confidence 3445689999999999999999999999999999999999999964321 11222222111110 010
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .......+.+++.+||+.||++|||++|+++
T Consensus 238 ~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 238 EA---WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HH---HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cc---ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 11 1112245678999999999999999999874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=358.17 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=200.4
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..++|...+.||+|+||+||+|... +|+.||||+++.... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 3567899999999999999999965 689999999976432 345788899888 7999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC----CcEEEeecccceee
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN----LTAKVADFGLSKLV 778 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~~ 778 (964)
||+++|+|.+++.... .+++.++..++.||+.||+|||+.+ |+||||||+|||+.++ +.+||+|||+++..
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999997653 6899999999999999999999988 9999999999998443 35999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--chhHHHHHHHhccCccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG--KYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||... ....+........... ..
T Consensus 171 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~----~~- 243 (342)
T 2qr7_A 171 RAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS----LS- 243 (342)
T ss_dssp BCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC----CC-
T ss_pred cCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc----cC-
Confidence 54322 233457899999999998888999999999999999999999999743 2222222222211110 10
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...... ....+.+++.+||+.||++||++.|+++.
T Consensus 244 ---~~~~~~---~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 244 ---GGYWNS---VSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---STTTTT---SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cccccc---CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111 11446689999999999999999999863
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=363.23 Aligned_cols=266 Identities=24% Similarity=0.337 Sum_probs=193.4
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEe-------
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFE------- 694 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~------- 694 (964)
....+|...+.||+|+||.||+|+. .+|+.||||++..........+.+|+.++.++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 3345789999999999999999996 478999999987665555667899999999996 9999999999953
Q ss_pred -eCceEEEEEeccCCChhhhhcCC-CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeec
Q 002121 695 -QGEQMLVYEFMANGTLRESLSGR-SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADF 772 (964)
Q Consensus 695 -~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DF 772 (964)
....++||||++ |+|.+++... ....+++.+++.++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 334799999996 7999988642 2346999999999999999999999865 46999999999999999999999999
Q ss_pred ccceeecCCCCCc----------eeecccccCcccCcccc---ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002121 773 GLSKLVSDSSKGH----------VSTQVKGTMGYLDPEYY---MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839 (964)
Q Consensus 773 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~ 839 (964)
|+++......... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||...... ..
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-RI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-Hh
Confidence 9998765432211 11134589999999998 5667889999999999999999999999643221 11
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCCCC
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNT 909 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~~~ 909 (964)
........ ...... ..+.+++.+||+.||++||++.|+++.|+.+........
T Consensus 262 ~~~~~~~~------~~~~~~-----------~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~ 314 (337)
T 3ll6_A 262 VNGKYSIP------PHDTQY-----------TVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314 (337)
T ss_dssp ----CCCC------TTCCSS-----------GGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCT
T ss_pred hcCcccCC------cccccc-----------hHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCC
Confidence 10000000 000011 225589999999999999999999999999987765443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=347.80 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=196.5
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 357888999999999999999964 689999999875432 345678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceee
Q 002121 704 FMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLV 778 (964)
Q Consensus 704 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~ 778 (964)
|+++|+|.+++... .+..+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999999988543 1346899999999999999999999988 9999999999999 55688999999999865
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... ......||+.|+|||++. +.++.++||||||+++|||++|+.||...... +........... ....
T Consensus 178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~----~~~~- 247 (285)
T 3is5_A 178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-EVQQKATYKEPN----YAVE- 247 (285)
T ss_dssp ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHCCCC----CCC--
T ss_pred CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-HHHhhhccCCcc----cccc-
Confidence 4332 234456999999999875 56899999999999999999999999753321 111111111110 0000
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ....+.+++.+||+.||++||++.|+++
T Consensus 248 ~~~-------~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 248 CRP-------LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp -CC-------CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cCc-------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 1145668999999999999999999975
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=396.06 Aligned_cols=350 Identities=27% Similarity=0.403 Sum_probs=254.7
Q ss_pred CCeeEEEcCCCCccccccCC-cCCCCcccEEecccCCCCCCCCCCCCCCcc-cchhhccccccccCcCCcccCC--CCCc
Q 002121 64 SRVTALGLSTMGLTGKLSGD-IGGLTELRSLDLSYNGGLTGSLSPRIGDLQ-KLNILILAGCGFTGNIPDEIGN--LAEL 139 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~-l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~--l~~L 139 (964)
.+++.|+|++|.++|.+|.. +..+++|++|+|++| .+.+.+|..+.++. +|++|+|++|.+++.+|..+.. +++|
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n-~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L 396 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN-EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSS-EEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCC
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCC-ccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCc
Confidence 57888999999998888876 888999999999988 78888888888887 8888888888888777777766 7778
Q ss_pred cEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCccee
Q 002121 140 SFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLI 219 (964)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~ 219 (964)
++|+|++|.+++.+|..|.++++|++|+|++|+++|.+| ..+..+++|+.|++++|++++.+|.. |..+++|+
T Consensus 397 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p------~~l~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~ 469 (768)
T 3rgz_A 397 QELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIP------SSLGSLSKLRDLKLWLNMLEGEIPQE-LMYVKTLE 469 (768)
T ss_dssp CEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCC------GGGGGCTTCCEEECCSSCCCSCCCGG-GGGCTTCC
T ss_pred cEEECCCCccccccCHHHhcCCCCCEEECcCCcccCccc------HHHhcCCCCCEEECCCCcccCcCCHH-HcCCCCce
Confidence 888888888887788888888888888888888877777 44667777777777777777666654 44566777
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNS 298 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~ 298 (964)
+|++++|++++.+|..+..+++|++|+|++|++++.+|.+|+++++|++|+|++|++++.+|. +..+++|++|+|++|+
T Consensus 470 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 549 (768)
T 3rgz_A 470 TLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549 (768)
T ss_dssp EEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSE
T ss_pred EEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCc
Confidence 777777777777777777777777777777777777777777777777777777777765553 7777777777777777
Q ss_pred CCCCCCC---------------------------------------------------------------------cccC
Q 002121 299 FDPTEAP---------------------------------------------------------------------LWFS 309 (964)
Q Consensus 299 l~~~~~~---------------------------------------------------------------------~~~~ 309 (964)
+++..+. ..+.
T Consensus 550 l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~ 629 (768)
T 3rgz_A 550 FNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFD 629 (768)
T ss_dssp EESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCS
T ss_pred cCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhh
Confidence 7532221 1233
Q ss_pred CCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC---CCccccee
Q 002121 310 TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG---SGIKNYTL 386 (964)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~---~~~~l~~l 386 (964)
.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|++++.+|..+..+++|+.|||++|++++..+. ....+..|
T Consensus 630 ~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L 709 (768)
T 3rgz_A 630 NNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEI 709 (768)
T ss_dssp SSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEE
T ss_pred ccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEE
Confidence 456677777777777777777777777777777777777777777777777777777777777754332 33446677
Q ss_pred EeecCCcccccccccCccccCCCCCcccccccccCCCC
Q 002121 387 ILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGK 424 (964)
Q Consensus 387 ~l~~Np~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~ 424 (964)
+|++|++... ++... ..+......+..+...||.|
T Consensus 710 ~ls~N~l~g~-iP~~~--~~~~~~~~~~~gN~~Lcg~~ 744 (768)
T 3rgz_A 710 DLSNNNLSGP-IPEMG--QFETFPPAKFLNNPGLCGYP 744 (768)
T ss_dssp ECCSSEEEEE-CCSSS--SGGGSCGGGGCSCTEEESTT
T ss_pred ECcCCccccc-CCCch--hhccCCHHHhcCCchhcCCC
Confidence 7777775321 22111 11222333455566677765
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.76 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=205.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999975 58899999986542 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999887543 6899999999999999999999988 999999999999999999999999999876533
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +.......... .....++
T Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~----~~~~~~~-- 239 (294)
T 2rku_A 169 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY----SIPKHIN-- 239 (294)
T ss_dssp TC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCC----CCCTTSC--
T ss_pred cc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHhhccC----CCccccC--
Confidence 22 223456999999999999888999999999999999999999999754322 22222221111 0111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+.+++.+||+.||++||++.|+++.
T Consensus 240 ---------~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 240 ---------PVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---------HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 346689999999999999999999873
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=349.93 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=201.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|...+.||+|+||.||+|+.. +|+.||+|+++.........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 457888999999999999999964 7899999999865544556789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceeecCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~~~ 781 (964)
+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 162 (304)
T 2jam_A 88 VSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG 162 (304)
T ss_dssp CCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred CCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence 99999999986543 5899999999999999999999988 9999999999999 78899999999999764322
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ............. .. ..
T Consensus 163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~i~~~~~~----~~----~~ 229 (304)
T 2jam_A 163 ----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIKEGYYE----FE----SP 229 (304)
T ss_dssp ----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-HHHHHHHHHCCCC----CC----TT
T ss_pred ----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHcCCCC----CC----cc
Confidence 12345699999999999999999999999999999999999999965432 2222222111110 00 01
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... .....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~---~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 230 FWD---DISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTT---TSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccc---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 11145678999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=357.20 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=195.8
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch-hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG-GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|...+.||+|+||+||+|+.. +|+.||||++....... ...+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 47888999999999999999975 78999999987543322 22456799999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 154 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--
Confidence 98 59999887653 46899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccccccccC--
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYGLTEMMD-- 859 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d-- 859 (964)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ....+........... ......
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~ 232 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEET--WPGILSNE 232 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT--STTGGGCH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHh--chhhhcch
Confidence 22334568999999999876 5689999999999999999999999965432 1222222222111110 111000
Q ss_pred ------------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 ------------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ------------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+..........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000011112245679999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=354.79 Aligned_cols=266 Identities=25% Similarity=0.349 Sum_probs=198.7
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-----hhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-----GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
...++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34578999999999999999999964 6899999998753221 12468899999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+++ +|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999986 8998887643 46899999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcccc--
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEH-- 851 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~-- 851 (964)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|.+||..... .+.+...+. ......
T Consensus 162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSS
T ss_pred ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhhh
Confidence 64332 22334578999999999875 4588999999999999999999999865433 222222221 111000
Q ss_pred --cccccccCc------cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 852 --YGLTEMMDP------TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 852 --~~~~~~~d~------~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
....+.+.. .+..........+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000010000 0000011122567899999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=356.52 Aligned_cols=258 Identities=25% Similarity=0.395 Sum_probs=203.1
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe----eCceE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE----QGEQM 699 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 699 (964)
..++|...+.||+|+||.||+|.. .+|+.||||++..........+.+|++++++++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999996 5789999999876655566789999999999999999999999973 34789
Q ss_pred EEEEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 700 LVYEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
+||||+++|+|.+++... .+..+++.+++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999988752 2346999999999999999999999988 99999999999999999999999999876
Q ss_pred ecCCCCCc-------eeecccccCcccCccccccCC---CCCchhHHHHHHHHHHHHhCCCCCCC----CchhHHHHHHH
Q 002121 778 VSDSSKGH-------VSTQVKGTMGYLDPEYYMTQQ---LTEKSDVYSFGVVMLELITAKQPIEK----GKYVVREVRTA 843 (964)
Q Consensus 778 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~sDv~S~Gvvl~elltg~~p~~~----~~~~~~~~~~~ 843 (964)
........ ......||+.|+|||++.... ++.++||||||+++|||++|+.||.. ........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~--- 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV--- 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH---
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh---
Confidence 43211100 012345799999999987543 78999999999999999999999852 11111111
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
..... ... .+ .....+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 261 -~~~~~----~~~--~~-------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 261 -QNQLS----IPQ--SP-------RHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp -HCC------CCC--CT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred -hccCC----CCc--cc-------cCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 11000 000 01 11245678999999999999999999999998763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=355.63 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=205.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 457888999999999999999965 57899999986542 23345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999987543 6899999999999999999999988 999999999999999999999999999876533
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... +.......... .....++
T Consensus 195 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~----~~~~~~~-- 265 (335)
T 2owb_A 195 GE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK-ETYLRIKKNEY----SIPKHIN-- 265 (335)
T ss_dssp TC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHHTCC----CCCTTSC--
T ss_pred cc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH-HHHHHHhcCCC----CCCccCC--
Confidence 22 223456999999999999888999999999999999999999999754322 22222211111 0111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..+.+++.+||+.||++||++.|+++.
T Consensus 266 ---------~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 266 ---------PVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---------HHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---------HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 345689999999999999999999863
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=380.13 Aligned_cols=197 Identities=14% Similarity=0.064 Sum_probs=149.5
Q ss_pred CcccCCCCCCcEEEcccCcCccccC-ccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCC
Q 002121 233 PESLGYVQTLEVLRLDRNALTGKVP-TNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFST 310 (964)
Q Consensus 233 p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 310 (964)
|..+..+++|+.|++++|++++..| ..|.++++|++|+|++|.+++..+. +..+++|++|++++|.+++...|..+..
T Consensus 392 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 471 (606)
T 3vq2_A 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471 (606)
T ss_dssp CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc
Confidence 3455566666666666666665555 5677777777777777777776554 7778888888888888864356888899
Q ss_pred CCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC--CCc-ccceeE
Q 002121 311 LPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG--SGI-KNYTLI 387 (964)
Q Consensus 311 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~--~~~-~l~~l~ 387 (964)
+++|+.|+|++|++++..|..|..+++|+.|+|++|++++..|..+..+++|+.|+|++|+|+.+|.. ... .++.|+
T Consensus 472 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~ 551 (606)
T 3vq2_A 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFN 551 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEE
T ss_pred CCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999865 333 378899
Q ss_pred eecCC-cccccccccCccccCCCCCcccccccccCCCCCCCCCC
Q 002121 388 LVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQ 430 (964)
Q Consensus 388 l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~ 430 (964)
+.+|| .|+|.+.+...|.... ...+.......|..|....++
T Consensus 552 l~~N~~~c~c~~~~~~~~l~~~-~~~~~~~~~~~C~~p~~~~~~ 594 (606)
T 3vq2_A 552 LTNNSVACICEHQKFLQWVKEQ-KQFLVNVEQMTCATPVEMNTS 594 (606)
T ss_dssp CCSCCCCCSSTTHHHHTTTTTS-SSSBSSGGGCCCC--------
T ss_pred ccCCCcccCCccHHHHHHHHcC-cccccCCccceeCCChHhCCC
Confidence 99999 8999999888884333 333334556678777544443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=346.12 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=200.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC----cchhHHHHHHHHHHHhcCCCCccceeEEEE--eeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS----MQGGLEFKTEIELLSRVHHKNLVGLVGFCF--EQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 698 (964)
.++|...+.||+|+||.||+|.. .+++.||+|+++... ......+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 46899999999999999999996 468999999987532 233467999999999999999999999984 45688
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++| |.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999876 777776655567999999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
.............||+.|+|||++.+.. ++.++||||||+++|||++|+.||.... ..+.......... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~i~~~~~----~~~~ 234 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSY----AIPG 234 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCC----CCCS
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-HHHHHHHHhcCCC----CCCC
Confidence 5433333444567999999999987643 4789999999999999999999997533 2222222211111 0111
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.. ...+.+++.+||+.||++||++.|+++.
T Consensus 235 ----~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 235 ----DC-------GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----SS-------CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----cc-------CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1346689999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=382.97 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=198.7
Q ss_pred ceeecCCcEEEEEEEec---CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
+.||+|+||+||+|.+. .++.||||+++.... ...+++.+|+++|++++|||||++++++. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 57999999999999753 467899999976433 23467999999999999999999999996 4568999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC-Cce
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK-GHV 786 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~-~~~ 786 (964)
|+|.+++.... .+++.+++.++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+++....... ...
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997543 6899999999999999999999988 99999999999999999999999999987654322 122
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....+|+.|+|||++....++.++|||||||++|||++ |+.||..... . .+...+...... ... ..
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-~-~~~~~i~~~~~~--~~p----~~---- 596 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-S-EVTAMLEKGERM--GCP----AG---- 596 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-H-HHHHHHHTTCCC--CCC----TT----
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-H-HHHHHHHcCCCC--CCC----CC----
Confidence 334457889999999999999999999999999999998 9999964332 1 122222221100 011 11
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
....+.+++.+||+.||++||++.+|++.|+.+..+
T Consensus 597 ---~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 597 ---CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp ---CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ---CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 124567899999999999999999999999988754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=357.67 Aligned_cols=263 Identities=19% Similarity=0.337 Sum_probs=207.8
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcch-----------------hHHHHHHHHHHHhcCCCCccce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG-----------------GLEFKTEIELLSRVHHKNLVGL 688 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~H~nIv~l 688 (964)
.++|...+.||+|+||.||+|.. +|+.||||++....... ...+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999999 89999999986432211 1679999999999999999999
Q ss_pred eEEEEeeCceEEEEEeccCCChhhh------hcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEE
Q 002121 689 VGFCFEQGEQMLVYEFMANGTLRES------LSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILL 761 (964)
Q Consensus 689 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl 761 (964)
++++.+.+..++||||+++|+|.++ +.......+++..+..++.|++.||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999999 665435679999999999999999999998 77 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccC-CCCC-chhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTE-KSDVYSFGVVMLELITAKQPIEKGKYVVRE 839 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDv~S~Gvvl~elltg~~p~~~~~~~~~~ 839 (964)
+.++.+||+|||+++..... ......||+.|+|||++.+. .++. ++||||||+++|||++|+.||.......+.
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 99999999999999876432 23446799999999999877 6666 999999999999999999999765443333
Q ss_pred HHHHhccCcccccccccccCccchh----hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRN----TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....................+.... ........+.+++.+||+.||++||++.|+++
T Consensus 262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3333322211110000000000000 00112245779999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=356.18 Aligned_cols=258 Identities=22% Similarity=0.351 Sum_probs=206.9
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--------hhHHHHHHHHHHHhc-CCCCccce
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--------GGLEFKTEIELLSRV-HHKNLVGL 688 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l-~H~nIv~l 688 (964)
+.......++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|+++++++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3445556678999999999999999999975 7999999998754321 134578999999999 79999999
Q ss_pred eEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEE
Q 002121 689 VGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAK 768 (964)
Q Consensus 689 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 768 (964)
++++...+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999999754 36899999999999999999999988 99999999999999999999
Q ss_pred EeecccceeecCCCCCceeecccccCcccCcccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH
Q 002121 769 VADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842 (964)
Q Consensus 769 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~ 842 (964)
|+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .....
T Consensus 241 l~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~-~~~~~ 316 (365)
T 2y7j_A 241 LSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI-LMLRM 316 (365)
T ss_dssp ECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHH
T ss_pred EEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH-HHHHH
Confidence 999999987754322 234679999999999863 35889999999999999999999999654322 22222
Q ss_pred HhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 843 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....... ...... ......+.+++.+||+.||++||++.|+++
T Consensus 317 i~~~~~~--------~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQ--------FSSPEW---DDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCC--------CCHHHH---SSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCC--------CCCccc---ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2111110 000000 011244678999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=344.67 Aligned_cols=252 Identities=24% Similarity=0.361 Sum_probs=198.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|.....||+|+||.||+|.. .+++.||||++..........+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455567999999999999995 568899999998766555678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccceeecCCCC
Q 002121 706 ANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 706 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla~~~~~~~~ 783 (964)
++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 9999999997653 345778999999999999999999988 999999999999987 8999999999998764322
Q ss_pred CceeecccccCcccCccccccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQ--LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
.......||+.|+|||++..+. ++.++||||||+++|||++|+.||................. ..+.
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----------~~~~ 246 (295)
T 2clq_A 178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK----------VHPE 246 (295)
T ss_dssp ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC----------CCCC
T ss_pred -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc----------cccc
Confidence 1223456899999999987643 78999999999999999999999964322221111110000 0011
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+... ....+.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~---~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 247 IPES---MSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCTT---SCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc---CCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 1145668999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.91 Aligned_cols=248 Identities=27% Similarity=0.426 Sum_probs=199.6
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee----CceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ----GEQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~~~~l 700 (964)
.|...+.||+|+||+||+|.. .++..||+|++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 466778999999999999996 468899999987543 23345789999999999999999999998763 45899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEEEeecccceeec
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVS 779 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~ 779 (964)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||||+|||++ +++.+||+|||++....
T Consensus 107 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 99999999999999754 35899999999999999999999865 4699999999999997 88999999999997543
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.. ......||+.|+|||++. +.++.++||||+||++|||++|+.||...................
T Consensus 184 ~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------- 248 (290)
T 1t4h_A 184 AS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---------- 248 (290)
T ss_dssp TT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----------
T ss_pred cc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----------
Confidence 32 223456999999999876 568999999999999999999999997655444444333222110
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ....+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~---~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 ASFDKV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCC---CCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 011111 1135678999999999999999999985
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=358.10 Aligned_cols=272 Identities=25% Similarity=0.321 Sum_probs=201.9
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcch-----------hHHHHHHHHHHHhcCCCCc
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQG-----------GLEFKTEIELLSRVHHKNL 685 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nI 685 (964)
....++....++|...+.||+|+||.||+|...+|+.||||++....... .+.+.+|++++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 45678889999999999999999999999998889999999986432211 2578999999999999999
Q ss_pred cceeEEEEee-----CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 002121 686 VGLVGFCFEQ-----GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNIL 760 (964)
Q Consensus 686 v~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 760 (964)
+++++++... ...++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 166 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL 166 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence 9999999653 35799999998 68888887543 46999999999999999999999988 999999999999
Q ss_pred ECCCCcEEEeecccceeecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--
Q 002121 761 LDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV-- 837 (964)
Q Consensus 761 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~-- 837 (964)
++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 243 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL 243 (362)
T ss_dssp ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999999854432 22334578999999999876 678999999999999999999999997543211
Q ss_pred HHHHHHhccCcccc--------------cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 838 REVRTAMNRDDEEH--------------YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 838 ~~~~~~~~~~~~~~--------------~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+........... .....................+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111000 000000000111111122345779999999999999999999985
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=392.48 Aligned_cols=119 Identities=23% Similarity=0.157 Sum_probs=70.2
Q ss_pred CCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCC-CCCCCCcccchhhccccccccCcCCccc
Q 002121 55 SWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSL-SPRIGDLQKLNILILAGCGFTGNIPDEI 133 (964)
Q Consensus 55 ~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~~ 133 (964)
+|..|.+...+++.|+|++|.+++..+..|.++++|++|+|++| ...+.+ |..|+++++|++|+|++|.|++..|..|
T Consensus 15 ~L~~vP~lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n-~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~ 93 (844)
T 3j0a_A 15 NLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ-YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAF 93 (844)
T ss_dssp CSSCCCSSCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTT-CCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSS
T ss_pred CCCCCCCCCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCC-CCccccCHHHhcCCCCCCEEECCCCcCcccCHhHc
Confidence 56666664467778888888777766666666666666666666 333333 4555556666666666665555555555
Q ss_pred CCCCCccEEEcccCcccCcCCCc--CCCccccccccccccccc
Q 002121 134 GNLAELSFLALNSNNFSGRIPPS--LGKLSQLYWLDLADNQLT 174 (964)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~ 174 (964)
.++++|++|+|++|.+++.+|.. |.++++|++|+|++|.++
T Consensus 94 ~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~ 136 (844)
T 3j0a_A 94 QGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIR 136 (844)
T ss_dssp CSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCC
T ss_pred cCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCccc
Confidence 55555555555555555444333 555555555555555554
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=345.42 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=205.3
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.+.|...+.||+|+||.||+|+. .+|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 35688899999999999999985 4689999999875543 345679999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++++|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence 99999999999753 5899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......... ..+....
T Consensus 175 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-------~~~~~~~- 243 (303)
T 3a7i_A 175 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-VLFLIPKNNP-------PTLEGNY- 243 (303)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC-------CCCCSSC-
T ss_pred --ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-HHHHhhcCCC-------CCCcccc-
Confidence 2234568999999999999999999999999999999999999997543221 1111111110 0111111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...+.+++.+||+.||++||++.|+++.
T Consensus 244 ------~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 244 ------SKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ------CHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ------CHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1346689999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=345.33 Aligned_cols=246 Identities=24% Similarity=0.391 Sum_probs=203.1
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57888999999999999999965 67899999986432 122357899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999997643 5899999999999999999999988 9999999999999999999999999997654321
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ............ .. +.+
T Consensus 169 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~----~~----~~~ 235 (284)
T 2vgo_A 169 ----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-ETHRRIVNVDLK----FP----PFL 235 (284)
T ss_dssp ----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHHHTTCCC----CC----TTS
T ss_pred ----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-HHHHHHhccccC----CC----CcC
Confidence 23456899999999999999999999999999999999999999754322 222222211110 11 111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...+.+++.+|++.||++||++.|+++.
T Consensus 236 -------~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 236 -------SDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -------CHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -------CHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 1345689999999999999999999863
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=372.67 Aligned_cols=246 Identities=21% Similarity=0.348 Sum_probs=201.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||+||+|+.. +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 357888899999999999999975 699999999865322 2235688999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 702 YEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
|||+++|+|.+++.... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 99999999999987643 346999999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc---hhHHHHHHHhccCccccccccc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK---YVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............... ...
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~----~p~ 414 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT----YPD 414 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC----CCT
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC----CCc
Confidence 4322 2234579999999999999999999999999999999999999997432 112222222211110 111
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTM 891 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 891 (964)
.+ ...+.+++.+||+.||++||++
T Consensus 415 ~~-----------s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 415 KF-----------SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp TS-----------CHHHHHHHHHHSCSSGGGSCCC
T ss_pred cc-----------CHHHHHHHHHhccCCHhHCCCC
Confidence 11 1345689999999999999976
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=346.55 Aligned_cols=244 Identities=20% Similarity=0.345 Sum_probs=198.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||+||+|+.. +|+.||||+++... .....++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999975 79999999987543 23445788999999999 999999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC----------------
Q 002121 702 YEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---------------- 763 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---------------- 763 (964)
|||+++|+|.+++.... ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 99999999999997542 245899999999999999999999988 999999999999984
Q ss_pred ---CCcEEEeecccceeecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH
Q 002121 764 ---NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839 (964)
Q Consensus 764 ---~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~ 839 (964)
...+||+|||+++...... ...||+.|+|||++.+. .++.++|||||||++|||++|.+++........
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~- 239 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE- 239 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH-
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH-
Confidence 4489999999998765432 23589999999999765 566899999999999999999987754432211
Q ss_pred HHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+ ..... . .+...+ ...+.+++.+||+.||++||++.|+++
T Consensus 240 ~---~~~~~------~-~~~~~~-------~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 240 I---RQGRL------P-RIPQVL-------SQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp H---HTTCC------C-CCSSCC-------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H---HcCCC------C-CCCccc-------CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 11110 0 011111 145668999999999999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=354.48 Aligned_cols=264 Identities=19% Similarity=0.319 Sum_probs=194.5
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
...++|...+.||+|+||+||+|+. .+|+.||||+++...... ...+.+|++++++++||||+++++++.+.+..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 3456899999999999999999995 478999999987543322 3467899999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE-----CCCCcEEEeecccc
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL-----DENLTAKVADFGLS 775 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl-----~~~~~~kl~DFGla 775 (964)
||||++ |+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+ ++++.+||+|||++
T Consensus 111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 999998 49999997654 5899999999999999999999988 9999999999999 45566999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEH 851 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~ 851 (964)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+..... ......
T Consensus 185 ~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 185 RAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-QLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTT
T ss_pred cccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-HHHHHHHHhCCCchhh
Confidence 8764322 223345689999999999874 58999999999999999999999997544322 2222211 111000
Q ss_pred c-----------ccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 Y-----------GLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ~-----------~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .........+... .......+.+++.+||+.||++|||++|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0 0000000111110 0012245779999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=341.56 Aligned_cols=248 Identities=23% Similarity=0.369 Sum_probs=195.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||.||+|... +|+.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 467889999999999999999975 78999999986432 12345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999997543 5899999999999999999999998 999999999999999999999999999876433
Q ss_pred CCCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
. ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..... ............ ...+.+
T Consensus 165 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~----~~~~~~-- 234 (276)
T 2h6d_A 165 E---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-PTLFKKIRGGVF----YIPEYL-- 234 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCC----CCCTTS--
T ss_pred c---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-HHHHHHhhcCcc----cCchhc--
Confidence 2 2234568999999999987765 5899999999999999999999965332 122222111111 011111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
...+.+++.+||+.||++||++.|+++.
T Consensus 235 ---------~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 235 ---------NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---------CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1346689999999999999999999873
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=359.05 Aligned_cols=251 Identities=24% Similarity=0.323 Sum_probs=200.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe----cCCcEEEEEEecCCCc----chhHHHHHHHHHHHhc-CCCCccceeEEEEeeC
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM----QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQG 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 696 (964)
.++|...+.||+|+||+||+|+. .+|+.||||+++.... .....+.+|+++++++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35788999999999999999997 3689999999875321 2334678899999999 6999999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+++|+|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999997643 5899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCc---hhHHHHHHHhccCcccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPIEKGK---YVVREVRTAMNRDDEEH 851 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~ 851 (964)
....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ...............
T Consensus 208 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-- 284 (355)
T 1vzo_A 208 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP-- 284 (355)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC--
T ss_pred ecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC--
Confidence 7543221 22334679999999999985 457899999999999999999999996321 222222222211110
Q ss_pred cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002121 852 YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVKA 897 (964)
Q Consensus 852 ~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 897 (964)
.. +.+ ...+.+++.+||+.||++|| ++.|+++.
T Consensus 285 --~~----~~~-------~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 285 --YP----QEM-------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --CC----TTS-------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --CC----ccc-------CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 111 13456899999999999999 89998753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=365.68 Aligned_cols=264 Identities=20% Similarity=0.299 Sum_probs=207.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCC-CccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHK-NLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|.+.++||+|+||.||+|+. .+|+.||||++...... .++.+|+++++.++|+ +|..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 46899999999999999999996 57899999988754332 3688999999999874 55566666667778899999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceeecC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~~~ 780 (964)
|+ +++|.+++.... ..+++.+++.|+.||+.||+|||+.+ ||||||||+|||+ +.++.+||+|||+++....
T Consensus 84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99 999999997543 36999999999999999999999988 9999999999999 6889999999999998765
Q ss_pred CCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccc
Q 002121 781 SSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 781 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 853 (964)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ..+.+........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (483)
T 3sv0_A 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (483)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH-----
T ss_pred CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc-----
Confidence 4321 112356799999999999999999999999999999999999999974221 1222211111100
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
...+..........+.+++.+||+.+|++||++.+|++.|+.++...+
T Consensus 234 -----~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~ 281 (483)
T 3sv0_A 234 -----ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281 (483)
T ss_dssp -----HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred -----cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence 000000001112467799999999999999999999999999987554
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=368.88 Aligned_cols=195 Identities=27% Similarity=0.424 Sum_probs=154.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee-----Cc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 697 (964)
.++|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+++.+|+++|++++|||||++++++... +.
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 467999999999999999999954 789999999875432 2345788999999999999999999999543 56
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+||||+. |+|.+++... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeccc-cchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 899999985 6999999764 36999999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCC-------------------------ceeecccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHhC
Q 002121 778 VSDSSKG-------------------------HVSTQVKGTMGYLDPEYY-MTQQLTEKSDVYSFGVVMLELITA 826 (964)
Q Consensus 778 ~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~elltg 826 (964)
....... ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 6432211 123456789999999986 456799999999999999999993
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=353.38 Aligned_cols=264 Identities=23% Similarity=0.366 Sum_probs=200.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357888999999999999999975 5899999998654433 2345789999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999998876543 5899999999999999999999988 9999999999999999999999999998664332
Q ss_pred CCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh--cc-----------Cc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM--NR-----------DD 848 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~--~~-----------~~ 848 (964)
.......||+.|+|||++.+. .++.++|||||||++|||++|+.||.............. .. ..
T Consensus 179 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (331)
T 4aaa_A 179 --EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred --cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence 223345699999999999765 789999999999999999999999975443222111110 00 00
Q ss_pred c-cccccccccCcc-chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 849 E-EHYGLTEMMDPT-IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 849 ~-~~~~~~~~~d~~-l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ......+..... ...........+.+++.+||+.||++|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000011111100 00111122356789999999999999999999976
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=352.41 Aligned_cols=260 Identities=25% Similarity=0.424 Sum_probs=201.4
Q ss_pred ccHHHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe
Q 002121 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE 694 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 694 (964)
+++.++....++|...+.||+|+||.||+|+. .+|+.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 44445566778999999999999999999996 478999999987543 3346789999999999 79999999999987
Q ss_pred ------eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEE
Q 002121 695 ------QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAK 768 (964)
Q Consensus 695 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~k 768 (964)
.+..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~k 169 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVK 169 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEE
Confidence 457899999999999999998655457899999999999999999999988 99999999999999999999
Q ss_pred EeecccceeecCCCCCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH
Q 002121 769 VADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843 (964)
Q Consensus 769 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~ 843 (964)
|+|||++....... .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... .....
T Consensus 170 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 246 (326)
T 2x7f_A 170 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-ALFLI 246 (326)
T ss_dssp ECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHH
T ss_pred EeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-HHHHh
Confidence 99999998654321 1223456899999999986 5678999999999999999999999996543322 11111
Q ss_pred hccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 844 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..... .......+ ...+.+++.+||+.||++||++.|+++
T Consensus 247 ~~~~~------~~~~~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 247 PRNPA------PRLKSKKW-------SKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HHSCC------CCCSCSCS-------CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hcCcc------ccCCcccc-------CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111 11111111 145678999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=369.86 Aligned_cols=250 Identities=24% Similarity=0.354 Sum_probs=198.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.+.|...+.||+|+||+||+|+.. +++.||||++.... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457889999999999999999965 68999999987543 233567899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccceeec
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~~~~ 779 (964)
|||++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 116 e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 116 ECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999999886543 5899999999999999999999988 999999999999976 4559999999998765
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... ......||+.|+|||++. +.++.++||||+||++|||++|+.||..... .+.+......... ...
T Consensus 191 ~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~~i~~~~~~-------~~~ 258 (494)
T 3lij_A 191 NQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-QEILRKVEKGKYT-------FDS 258 (494)
T ss_dssp TTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC-------CCS
T ss_pred CCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCC-------CCc
Confidence 432 234457999999999876 5699999999999999999999999964332 2222222221110 001
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.+. .....+.+++.+||+.||++|||+.|+++
T Consensus 259 ~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 259 PEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 1111 11134668999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=356.34 Aligned_cols=258 Identities=26% Similarity=0.372 Sum_probs=195.7
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeC------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------ 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 696 (964)
.++|...+.||+|+||.||+|.. .+|+.||||++...... ..+++.+|++++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46899999999999999999996 47999999998654322 3456889999999999999999999997653
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+ +++|.+++... .+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 459999999 78999999763 5899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY 852 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~ 852 (964)
..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... +.+...+. ....+..
T Consensus 177 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 177 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence 76432 234568999999999877 67999999999999999999999999754332 22222211 1110000
Q ss_pred -------------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -------------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -------------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+.......+..........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000011111111122345779999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=356.61 Aligned_cols=199 Identities=28% Similarity=0.474 Sum_probs=175.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...+.||+|+||+||+|... +|+.||+|++..... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 357888999999999999999975 689999999876533 334578999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999997643 589999999999999999999985 7 999999999999999999999999999765322
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG 833 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~ 833 (964)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 123456999999999999999999999999999999999999999753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=356.30 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=193.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeC------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------ 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 696 (964)
.++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999954 689999999875432 23456889999999999999999999997654
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+++ +|.+++.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 175 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 175 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred ceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccc
Confidence 67999999975 78888863 4899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccc-----
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEH----- 851 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 851 (964)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+...+.......
T Consensus 176 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~ 251 (371)
T 2xrw_A 176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK 251 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHT
T ss_pred ccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence 65432 12334579999999999999999999999999999999999999997544322 2222222111000
Q ss_pred ------------------cccccccC----ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 ------------------YGLTEMMD----PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 ------------------~~~~~~~d----~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.+. +............+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 0000011222456789999999999999999999986
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=370.59 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=204.5
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|...+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++|||||++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 457888999999999999999965 78999999986543 23456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE---CCCCcEEEeecccceee
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLV 778 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---~~~~~~kl~DFGla~~~ 778 (964)
|||+.+|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 105 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp ECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999999997654 6899999999999999999999988 9999999999999 56789999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
.... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.... ..+.+.......... -
T Consensus 180 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~-------~ 247 (484)
T 3nyv_A 180 EASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-EYDILKKVEKGKYTF-------E 247 (484)
T ss_dssp CCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCCC-------C
T ss_pred cccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-HHHHHHHHHcCCCCC-------C
Confidence 5432 2344579999999999865 68999999999999999999999996533 222222222221110 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.+.. ......+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 248 LPQW----KKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp SGGG----GGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Cccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0111 1112456689999999999999999999863
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=344.44 Aligned_cols=251 Identities=23% Similarity=0.383 Sum_probs=188.9
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++|+..+.||+|+||+||+|+. .+|+.||||+++...... ...+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 46788999999999999999996 578999999997643322 223455566688889999999999999999999999
Q ss_pred EeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 703 EFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
||++ |+|.+++... .+..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9998 5888777531 234699999999999999999999997 7 9999999999999999999999999998764
Q ss_pred CCCCCceeecccccCcccCcccc----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYY----MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (964)
... ......||+.|+|||++ ....++.++|||||||++|||++|+.||.........+..........
T Consensus 162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----- 233 (290)
T 3fme_A 162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ----- 233 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC-----
T ss_pred ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC-----
Confidence 432 22334699999999996 456789999999999999999999999975444444444333322210
Q ss_pred cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...... ...+.+++.+||+.||++|||+.|+++
T Consensus 234 -~~~~~~-------~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 234 -LPADKF-------SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -CCTTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -cccccC-------CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 001111 145678999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=350.88 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=195.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--------chhHHHHHHHHHHHhcCCCCccceeEEEEee
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--------QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ 695 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 695 (964)
..++|...+.||+|+||.||+|... +|+.||||++..... .....+.+|++++++++||||+++++++..+
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3467899999999999999999964 689999999875321 1223588999999999999999999998655
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc---EEEeec
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT---AKVADF 772 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DF 772 (964)
..++||||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++. +||+||
T Consensus 88 -~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 88 -DYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -SEEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -ceEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 4899999999999999987643 6899999999999999999999988 999999999999987664 999999
Q ss_pred ccceeecCCCCCceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCch---hHHHHHHHhcc
Q 002121 773 GLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELITAKQPIEKGKY---VVREVRTAMNR 846 (964)
Q Consensus 773 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~---~~~~~~~~~~~ 846 (964)
|+++..... .......||+.|+|||++. ...++.++|||||||++|||++|+.||..... ....+.. .
T Consensus 162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~ 235 (322)
T 2ycf_A 162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---G 235 (322)
T ss_dssp TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---T
T ss_pred ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---C
Confidence 999876432 2233456999999999974 56788999999999999999999999964322 1221111 1
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. ...+... ......+.+++.+||+.||++||++.|+++
T Consensus 236 ~~--------~~~~~~~---~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 236 KY--------NFIPEVW---AEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp CC--------CCCHHHH---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cc--------ccCchhh---hhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00 0011111 111245679999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=369.40 Aligned_cols=252 Identities=27% Similarity=0.338 Sum_probs=201.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-------------chhHHHHHHHHHHHhcCCCCccceeE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-------------QGGLEFKTEIELLSRVHHKNLVGLVG 690 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~ 690 (964)
..++|...+.||+|+||+||+|... +++.||||++..... ...+.+.+|++++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 4578999999999999999999964 688999999875432 22457889999999999999999999
Q ss_pred EEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC---cE
Q 002121 691 FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL---TA 767 (964)
Q Consensus 691 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~---~~ 767 (964)
++.+.+..++|||||++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~ 188 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNI 188 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccE
Confidence 9999999999999999999999887543 5899999999999999999999988 99999999999998776 69
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|||++|+.||.... ..+.+.......
T Consensus 189 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~ 263 (504)
T 3q5i_A 189 KIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN-DQDIIKKVEKGK 263 (504)
T ss_dssp EECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCC
T ss_pred EEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCC
Confidence 999999998765432 234457999999999986 568999999999999999999999996433 222222222211
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.. .+..... .....+.+++.+||+.||.+|||+.|+++.
T Consensus 264 ~~--------~~~~~~~---~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 264 YY--------FDFNDWK---NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CC--------CCHHHHT---TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CC--------CCccccC---CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 10 0101001 112456789999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=366.74 Aligned_cols=241 Identities=15% Similarity=0.147 Sum_probs=189.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCC---CcchhHHHHHHH---HHHHhcCCCCcccee-------EE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQG---SMQGGLEFKTEI---ELLSRVHHKNLVGLV-------GF 691 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~ 691 (964)
.++|...+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788889999999999999995 57999999998743 233456789999 555566899999998 66
Q ss_pred EEeeC-----------------ceEEEEEeccCCChhhhhcCCC-----CCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002121 692 CFEQG-----------------EQMLVYEFMANGTLRESLSGRS-----GIHLDWKRRLRIALGSARGLAYLHELANPPI 749 (964)
Q Consensus 692 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 749 (964)
+.+.+ ..++||||+ +|+|.+++.... ...++|..++.|+.||+.||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 689999997532 234567899999999999999999988 9
Q ss_pred eccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccC-----------CCCCchhHHHHHH
Q 002121 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-----------QLTEKSDVYSFGV 818 (964)
Q Consensus 750 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDv~S~Gv 818 (964)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999986322 2344567 999999999877 8999999999999
Q ss_pred HHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 819 VMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 819 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
++|||++|+.||....... . ...... .. ......+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~---------~------~~~~~~-~~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALG---------G------SEWIFR-SC----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------C---------C------SGGGGS-SC----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCccccccc---------c------hhhhhh-hc----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999995321100 0 000000 00 011145678999999999999999999985
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=368.72 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=201.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++|.+.+.||+|+||+||+|... +|+.||||++.... ......+.+|++++++++|||||++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 457899999999999999999964 78999999986432 233467899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecccceeec
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVS 779 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~ 779 (964)
||+++|+|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999886543 6899999999999999999999988 99999999999995 56689999999998654
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.... ..+.+.......... -.
T Consensus 176 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~i~~~~~~~-------~~ 243 (486)
T 3mwu_A 176 QNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILKRVETGKYAF-------DL 243 (486)
T ss_dssp CC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHTCCCS-------CS
T ss_pred CCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCCC-------CC
Confidence 332 2334579999999999875 58999999999999999999999996433 222222222211100 00
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
+.+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 244 PQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp GGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred cccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111 112446689999999999999999999873
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-38 Score=362.13 Aligned_cols=199 Identities=27% Similarity=0.395 Sum_probs=167.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee-----Cc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 697 (964)
.++|...+.||+|+||.||+|+.. +|+.||||+++.... ...+++.+|+++|++++||||+++++++... +.
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 568999999999999999999964 688999999976432 2345788999999999999999999999776 56
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+||||++ |+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 899999997 5999999764 36999999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCC--------------------ceeecccccCcccCcccc-ccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 002121 778 VSDSSKG--------------------HVSTQVKGTMGYLDPEYY-MTQQLTEKSDVYSFGVVMLELITAKQPI 830 (964)
Q Consensus 778 ~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDv~S~Gvvl~elltg~~p~ 830 (964)
....... ...+...||++|+|||++ ....++.++||||+||++|||++|..|+
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 6543211 123556799999999986 5567999999999999999999854443
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=343.27 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=200.5
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~l 700 (964)
.++|+..+.||+|+||.||+|... +|+.||+|++..... ...+.+.+|++++++++||||+++++++.+ .+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357888999999999999999964 789999999975433 334578999999999999999999998865 567899
Q ss_pred EEEeccCCChhhhhcCCC--CCccchHHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 701 VYEFMANGTLRESLSGRS--GIHLDWKRRLRIALGSARGLAYLHELA--NPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999987532 345899999999999999999999876 2459999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .+.......... .
T Consensus 165 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~i~~~~~------~- 234 (279)
T 2w5a_A 165 ILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIREGKF------R- 234 (279)
T ss_dssp HC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCC------C-
T ss_pred eecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-HHHHHHHhhccc------c-
Confidence 654321 122345689999999999988999999999999999999999999975432 111111111111 0
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAI 898 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 898 (964)
.+... ....+.+++.+||+.||++||++.|+++.+
T Consensus 235 ~~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 235 RIPYR-------YSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp CCCTT-------SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cCCcc-------cCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 01111 124567899999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.56 Aligned_cols=265 Identities=22% Similarity=0.354 Sum_probs=200.7
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEe--------e
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFE--------Q 695 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 695 (964)
++|...+.||+|+||+||+|+. .+|+.||||++...... ....+.+|++++++++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788999999999999999997 57899999998654332 24568899999999999999999999987 3
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
+..++||||+++ +|.+.+.... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 468999999985 7877776543 35899999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCC--CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCccc
Q 002121 776 KLVSDSSK--GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEE 850 (964)
Q Consensus 776 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~ 850 (964)
+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+..........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 251 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 251 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 87653221 122344578999999999876 56899999999999999999999999754322 22222222211111
Q ss_pred ccc-c-----cc---ccC---ccchhhhH--HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HYG-L-----TE---MMD---PTIRNTVL--LGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~~-~-----~~---~~d---~~l~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... . .+ ... ..+..... .....+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 000 0 00 000 00000000 01234779999999999999999999986
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=348.67 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=203.4
Q ss_pred HhhcCCCccceeecCCcEEEEEEEe--cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhc---CCCCccceeEEEE---
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGML--SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRV---HHKNLVGLVGFCF--- 693 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~--- 693 (964)
.+.++|...+.||+|+||.||+|+. .+|+.||||+++.... .....+.+|+++++++ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3567899999999999999999997 4688999999864322 2234577888888777 8999999999997
Q ss_pred --eeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 694 --EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 694 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
.....++||||++ |+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999998765556999999999999999999999988 99999999999999999999999
Q ss_pred cccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCcc
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDE 849 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~ 849 (964)
||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.........
T Consensus 164 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (326)
T 1blx_A 164 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 240 (326)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred CcccccccCC---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCc
Confidence 9999865432 12234568999999999999999999999999999999999999997544322 112111111111
Q ss_pred cccc---------cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 EHYG---------LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 ~~~~---------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+. ........+..........+.+++.+||+.||++||++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 0000000111111112245678999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=348.34 Aligned_cols=263 Identities=27% Similarity=0.378 Sum_probs=186.3
Q ss_pred hhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..++|...+.||+|+||.||+|.. .+|+.||||++.... .....++.+|++++++++||||+++++++...+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 356899999999999999999995 478999999886543 233457889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcC------CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 703 EFMANGTLRESLSG------RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 703 E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
||+++|+|.+++.. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999863 12346899999999999999999999988 9999999999999999999999999997
Q ss_pred eecCCCC---CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccc
Q 002121 777 LVSDSSK---GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 777 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 852 (964)
....... ........||+.|+|||++.. ..++.++||||||+++|||++|+.||............ ........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~- 247 (303)
T 2vwi_A 170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-LQNDPPSL- 247 (303)
T ss_dssp HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-HTSSCCCT-
T ss_pred eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-hccCCCcc-
Confidence 6543221 112234569999999999875 56899999999999999999999999754332222211 11111000
Q ss_pred ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....++.... .....+.+++.+||+.||++||++.|+++
T Consensus 248 -~~~~~~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 248 -ETGVQDKEMLK---KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp -TC-----CCCC---CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -ccccccchhhh---hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00001111111 11245678999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=349.74 Aligned_cols=262 Identities=20% Similarity=0.336 Sum_probs=202.3
Q ss_pred cccHHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcC--CCCccceeEE
Q 002121 616 WFSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVH--HKNLVGLVGF 691 (964)
Q Consensus 616 ~~~~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--H~nIv~l~~~ 691 (964)
.+.++.+....++|...+.||+|+||.||+|...+|+.||||++..... .....+.+|++++++++ |+||++++++
T Consensus 17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 96 (313)
T 3cek_A 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 96 (313)
T ss_dssp ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence 3444455556678999999999999999999988899999999875433 33467899999999997 5999999999
Q ss_pred EEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 692 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
+.+.+..++||| +.+++|.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||+++ +.+||+|
T Consensus 97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~D 169 (313)
T 3cek_A 97 EITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLID 169 (313)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECC
T ss_pred eecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEee
Confidence 999999999999 66889999997653 6899999999999999999999988 999999999999964 8999999
Q ss_pred cccceeecCCCCCceeecccccCcccCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHH
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT-----------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREV 840 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~ 840 (964)
||+++...............||+.|+|||++.. ..++.++|||||||++|||++|+.||.........+
T Consensus 170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (313)
T 3cek_A 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL 249 (313)
T ss_dssp CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH
T ss_pred ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHH
Confidence 999987654333223344569999999999865 468889999999999999999999997654444444
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
.......... ...... ...+.+++.+||+.||++||++.|+++.
T Consensus 250 ~~~~~~~~~~--~~~~~~-----------~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 250 HAIIDPNHEI--EFPDIP-----------EKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp HHHHCTTSCC--CCCCCS-----------CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhccccc--CCcccc-----------hHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 3333222110 011111 1356689999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=346.43 Aligned_cols=252 Identities=22% Similarity=0.378 Sum_probs=198.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 467889999999999999999975 5899999999876666667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-- 171 (302)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc--
Confidence 99999999886532 35899999999999999999999988 9999999999999999999999999976432110
Q ss_pred ceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 785 HVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
.......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ............ ....
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~------~~~~ 244 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSDPP------TLLT 244 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCC------CCSS
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-HHHHHHhccCCc------ccCC
Confidence 1122346899999999983 567899999999999999999999999754322 222222211110 0000
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+ ......+.+++.+||+.||++|||+.|+++
T Consensus 245 ~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 245 P------SKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp G------GGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred c------cccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0 011245678999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=348.24 Aligned_cols=254 Identities=19% Similarity=0.296 Sum_probs=200.5
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEe--eCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFE--QGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lV 701 (964)
.++|+..+.||+|+||+||+|+. .+|+.||||+++... ...+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 35788999999999999999985 578999999987432 457899999999997 9999999999987 5678999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeecC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVSD 780 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~ 780 (964)
|||+++++|.+++. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 99999999999985 3788999999999999999999988 99999999999999776 899999999987654
Q ss_pred CCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc---------
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE--------- 850 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------- 850 (964)
... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..+....+.+..........
T Consensus 184 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 260 (330)
T 3nsz_A 184 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 260 (330)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred CCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence 322 234568999999999876 6789999999999999999999999965544333322211100000
Q ss_pred ----------------ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 ----------------HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ----------------~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+...... .......+.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 261 NIELDPRFNDILGRHSRKRWERFVHSEN---QHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp TCCCCTHHHHHHCCCCCCCGGGGCCTTT---GGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccccccchhhhhhhccccchhhhccccc---cccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000000 0112356779999999999999999999985
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-38 Score=361.24 Aligned_cols=198 Identities=22% Similarity=0.264 Sum_probs=173.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhc------CCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRV------HHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 698 (964)
..+|.+.+.||+|+||+||+|... +++.||||+++... ....++.+|+++++.+ .|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457899999999999999999864 58999999997532 2335678899998887 467999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc--EEEeecccce
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT--AKVADFGLSK 776 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~ 776 (964)
++||||+. |+|.+++.......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 69999998766556999999999999999999999998 999999999999999987 9999999997
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKG 833 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~ 833 (964)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 251 ~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 251 YEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp ETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 65432 22357899999999999999999999999999999999999999644
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=342.73 Aligned_cols=251 Identities=26% Similarity=0.412 Sum_probs=199.9
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
..++|...+.||+|+||.||+|... +|+.||||++.... ...++.+|++++++++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 3567899999999999999999975 58999999987643 33578999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+++|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence 99999999998632 236899999999999999999999988 99999999999999999999999999987654321
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ........ .. ...+.
T Consensus 181 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~-----~~~~~-- 249 (314)
T 3com_A 181 --KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI-FMIPTNPP-PT-----FRKPE-- 249 (314)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-HHHHHSCC-CC-----CSSGG--
T ss_pred --ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH-HHHhcCCC-cc-----cCCcc--
Confidence 223456899999999999989999999999999999999999999754432221 11111111 00 00011
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.....+.+++.+||+.||++||++.|+++
T Consensus 250 ----~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 ----LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 11245678999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=355.37 Aligned_cols=263 Identities=22% Similarity=0.309 Sum_probs=195.4
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEee------
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------ 695 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 695 (964)
....++|...+.||+|+||+||+|+. .+|+.||||++..... ...+|++++++++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567899999999999999999995 5799999999865432 234799999999999999999998543
Q ss_pred --------------------------------CceEEEEEeccCCChhhhhcC--CCCCccchHHHHHHHHHHHHHHHHH
Q 002121 696 --------------------------------GEQMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAYL 741 (964)
Q Consensus 696 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yL 741 (964)
...++||||++ |+|.+.+.. ..+..+++..+..++.|+++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 23789999998 588777653 1234699999999999999999999
Q ss_pred hhcCCCCeeccCCCCCcEEEC-CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHH
Q 002121 742 HELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVV 819 (964)
Q Consensus 742 H~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvv 819 (964)
|+.+ |+||||||+|||++ .++.+||+|||+|+....... .....||+.|+|||++.+. .++.++||||+||+
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 9988 99999999999997 689999999999987654322 2345689999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCchhHHH--HHHHhccCccc----------ccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCC
Q 002121 820 MLELITAKQPIEKGKYVVRE--VRTAMNRDDEE----------HYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESAT 886 (964)
Q Consensus 820 l~elltg~~p~~~~~~~~~~--~~~~~~~~~~~----------~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~ 886 (964)
+|||++|+.||......... +.........+ ...........+... .......+.+++.+||+.||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 99999999999754332211 11111111000 000111111111110 111224577999999999999
Q ss_pred CCCCHHHHHH
Q 002121 887 DRPTMSEVVK 896 (964)
Q Consensus 887 ~RPs~~evl~ 896 (964)
+|||+.|+++
T Consensus 312 ~R~t~~e~l~ 321 (383)
T 3eb0_A 312 LRINPYEAMA 321 (383)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999984
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=340.80 Aligned_cols=252 Identities=25% Similarity=0.320 Sum_probs=203.2
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---------chhHHHHHHHHHHHhcC-CCCccceeEEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---------QGGLEFKTEIELLSRVH-HKNLVGLVGFCF 693 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 693 (964)
..++|...+.||+|+||.||+|... +|+.||||+++.... ...+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999974 689999999875431 12346789999999996 999999999999
Q ss_pred eeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 694 EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 694 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
+.+..++||||+++|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 999999999999999999999754 36899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYM------TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...........
T Consensus 170 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~ 245 (298)
T 1phk_A 170 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGN 245 (298)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTC
T ss_pred chhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-HHHHHHHhcCC
Confidence 998765432 223456899999999985 45688999999999999999999999965432 22222222211
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. . ..+.. ......+.+++.+||+.||++||++.|+++
T Consensus 246 ~~----~---~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 246 YQ----F---GSPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CC----C---CTTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cc----c---Ccccc----cccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 11 0 00110 111245679999999999999999999975
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=344.47 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=197.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec--CCc--EEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS--DGQ--VVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.++|+..+.||+|+||+||+|++. +++ .||||+++... ....+.+.+|++++++++||||+++++++.+.+ .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 357888999999999999999853 333 68999887542 233467899999999999999999999998654 8
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++|+|.+++.... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 89999999999999997542 35899999999999999999999988 999999999999999999999999999877
Q ss_pred cCCCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 779 SDSSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 779 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... .+.+......... ..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~~~~~~~~~~----~~- 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-SQILHKIDKEGER----LP- 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTSCCC----CC-
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-HHHHHHHHccCCC----CC-
Confidence 5433211 2234457889999999998889999999999999999999 9999964332 2222222211110 00
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
.... ....+.+++.+||+.||++||++.++++.|+++..
T Consensus 246 -~~~~-------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 246 -RPED-------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -CCTT-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -CCcC-------cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0011 12456789999999999999999999999988754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=342.10 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=192.9
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe----------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE---------- 694 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 694 (964)
.++|+..+.||+|+||.||+|+. .+|+.||||++... ......+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 46788999999999999999996 47899999998642 2334578899999999999999999999865
Q ss_pred ---eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 695 ---QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 695 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
.+..++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d 159 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD 159 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence 456799999999999999997543 46788999999999999999999988 99999999999999999999999
Q ss_pred cccceeecCCCC------------CceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHH
Q 002121 772 FGLSKLVSDSSK------------GHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVR 838 (964)
Q Consensus 772 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~ 838 (964)
||+++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||..+.....
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~ 236 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence 999986542210 1122345689999999998754 78999999999999999998 5544333223
Q ss_pred HHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 839 EVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
........... . .+.+.. .....+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~----~----~~~~~~---~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 237 ILKKLRSVSIE----F----PPDFDD---NKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHSTTCC----C----CTTCCT---TTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhccccccc----c----Cccccc---cchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 22222211110 1 111111 11244668999999999999999999985
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=380.14 Aligned_cols=249 Identities=20% Similarity=0.254 Sum_probs=204.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 699 (964)
..++|...+.||+|+||+||+|+.. +|+.||||+++... ......+..|.+++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999964 68899999987532 22345678899999988 7999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+||||+++|+|.+++...+ .+++.++..++.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+|+...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998643 5899999999999999999999988 9999999999999999999999999998643
Q ss_pred CCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||... ...+.+..++..... ....+
T Consensus 494 ~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~----~p~~~- 565 (674)
T 3pfq_A 494 WDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE-DEDELFQSIMEHNVA----YPKSM- 565 (674)
T ss_dssp CTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHSSCCC----CCTTS-
T ss_pred cCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC-CHHHHHHHHHhCCCC----CCccC-
Confidence 322 2234567999999999999999999999999999999999999999653 333333333332221 11111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTM-----SEVVK 896 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 896 (964)
...+.+++.+||+.||++||++ +||++
T Consensus 566 ----------s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 566 ----------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ----------CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ----------CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1346689999999999999997 56543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-38 Score=354.49 Aligned_cols=265 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEee-----Cc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 697 (964)
..++|+..+.||+|+||.||+|... +++.||||++...... ....+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 4568999999999999999999964 6889999999754332 335788999999999999999999999765 36
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||++ |+|.+++... .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 899999998 5999998754 4899999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCC-ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccc
Q 002121 778 VSDSSKG-HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 778 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 853 (964)
....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ....+.............
T Consensus 178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (364)
T 3qyz_A 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257 (364)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 6533211 11234579999999998764 4589999999999999999999999964332 222222222111110000
Q ss_pred -------------cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 854 -------------LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 854 -------------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....-...+..........+.+++.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000001112245779999999999999999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-38 Score=354.91 Aligned_cols=258 Identities=24% Similarity=0.369 Sum_probs=183.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee------C
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------G 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 696 (964)
.++|...+.||+|+||.||+|.. .+|+.||||++..... .....+.+|++++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 47899999999999999999995 5789999999875432 2345788999999999999999999999754 5
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..++||||+ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 679999999 68999988753 5999999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDEEHY 852 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~ 852 (964)
..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .+.+... .........
T Consensus 181 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 181 HTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-IDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCSCCHHHH
T ss_pred ccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHHHhCCCCHHHH
Confidence 65432 234579999999999876 6789999999999999999999999965433 2222222 111110000
Q ss_pred -------------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -------------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -------------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+...-...+..........+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 00000000011111112245679999999999999999999985
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=358.63 Aligned_cols=252 Identities=11% Similarity=0.017 Sum_probs=180.4
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHHHHHHHHhc--CCCCcccee-------EEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKTEIELLSRV--HHKNLVGLV-------GFCF 693 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~H~nIv~l~-------~~~~ 693 (964)
.+|...+.||+|+||+||+|+.. +|+.||||++..... .....+++|+++++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 45888899999999999999964 789999999987553 2234677886555555 699988755 4544
Q ss_pred ee-----------------CceEEEEEeccCCChhhhhcCCCCCccchHHH------HHHHHHHHHHHHHHhhcCCCCee
Q 002121 694 EQ-----------------GEQMLVYEFMANGTLRESLSGRSGIHLDWKRR------LRIALGSARGLAYLHELANPPII 750 (964)
Q Consensus 694 ~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~iv 750 (964)
.. ...++|||||+ |+|.+++.... ..+.+..+ ..++.||++||+|||+.+ |+
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 33 23799999999 89999997642 23566666 788899999999999988 99
Q ss_pred ccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCC
Q 002121 751 HRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQ 828 (964)
Q Consensus 751 H~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~ 828 (964)
||||||+|||++.++.+||+|||+|+.... ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999986532 1224567799999999987 679999999999999999999999
Q ss_pred CCCCCchhHHHHHHHhccCcccccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 829 PIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 829 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
||......... ..... ............. .......+.+++.+||+.||++|||+.|+++
T Consensus 292 Pf~~~~~~~~~---~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKG---SWKRP-----SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTT---CCCBC-----CTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCccccc---chhhh-----hhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99643211000 00000 0000000000000 0112245678999999999999999999975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=375.29 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=206.8
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEec----CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLS----DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~----~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
....++|...+.||+|+||+||+|.+. .+..||||+++.... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 344567888999999999999999964 246799999876433 33467899999999999999999999985 467
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred eEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCee
Confidence 899999999999999997543 46899999999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
...... .......+|+.|+|||++....++.++|||||||++|||++ |..||..... .+.+......... ..
T Consensus 541 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~~~~i~~~~~~---~~-- 613 (656)
T 2j0j_A 541 MEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERL---PM-- 613 (656)
T ss_dssp CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHHTCCC---CC--
T ss_pred cCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHcCCCC---CC--
Confidence 644322 22234457889999999998899999999999999999997 9999864332 2222222111110 01
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.+.. ...+.+++.+||+.||++||++.|+++.|+.++++.
T Consensus 614 --~~~~-------~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 614 --PPNC-------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp --CTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --Cccc-------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1111 145678999999999999999999999999988654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.99 Aligned_cols=263 Identities=22% Similarity=0.321 Sum_probs=195.0
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEE-----------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF----------- 693 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~----------- 693 (964)
.++|...+.||+|+||.||+|... +|+.||||++........+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 467889999999999999999975 58999999998766556678999999999999999999999873
Q ss_pred ---eeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEEE
Q 002121 694 ---EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKV 769 (964)
Q Consensus 694 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl 769 (964)
+.+..++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++ +++.+||
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 3467899999998 6999999753 5899999999999999999999988 99999999999997 5779999
Q ss_pred eecccceeecCCCC-CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 770 ADFGLSKLVSDSSK-GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 770 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
+|||+++....... ........+|..|+|||.+.. ..++.++|||||||++|||++|+.||...... +.+.......
T Consensus 163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~~~~~~ 241 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL-EQMQLILESI 241 (320)
T ss_dssp CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHS
T ss_pred ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhc
Confidence 99999987643211 112234567999999998865 67899999999999999999999999754432 2222222111
Q ss_pred cccc----cccccccC-----------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 848 DEEH----YGLTEMMD-----------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 848 ~~~~----~~~~~~~d-----------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.... ......+. ..+..........+.+++.+||+.||++||+++|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1000 00000000 0000001112356789999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=343.83 Aligned_cols=261 Identities=20% Similarity=0.320 Sum_probs=203.3
Q ss_pred hcCCCccceeecCCcEEEEEEEe--cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCC------ccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML--SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN------LVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 697 (964)
.++|.+.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|++++++++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45889999999999999999986 368899999987532 33457889999999997664 9999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC--------------
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-------------- 763 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-------------- 763 (964)
.++||||+ +++|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999998766567899999999999999999999988 999999999999987
Q ss_pred -----CCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--
Q 002121 764 -----NLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-- 836 (964)
Q Consensus 764 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-- 836 (964)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999875432 23356899999999999999999999999999999999999999744321
Q ss_pred HHHHHHHhccCcccc--------c------cccc----------ccCc--cchhhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 002121 837 VREVRTAMNRDDEEH--------Y------GLTE----------MMDP--TIRNTVLLGFRRYLELALQCVEESATDRPT 890 (964)
Q Consensus 837 ~~~~~~~~~~~~~~~--------~------~~~~----------~~d~--~l~~~~~~~~~~l~~li~~cl~~dP~~RPs 890 (964)
...+.......+... + .... ...+ ............+.+++.+||+.||++|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 122222111111000 0 0000 0000 000001223466889999999999999999
Q ss_pred HHHHHH
Q 002121 891 MSEVVK 896 (964)
Q Consensus 891 ~~evl~ 896 (964)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=355.38 Aligned_cols=261 Identities=21% Similarity=0.220 Sum_probs=199.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC--------CCCccceeEEEE---
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH--------HKNLVGLVGFCF--- 693 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 693 (964)
.++|.+.+.||+|+||+||+|+. .+|+.||||+++.. ......+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 46899999999999999999985 46889999999743 233457889999999996 788999999998
Q ss_pred -eeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCC------
Q 002121 694 -EQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENL------ 765 (964)
Q Consensus 694 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~------ 765 (964)
+....++||||+ +|+|.+++.......+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 56777766554445699999999999999999999997 7 99999999999999775
Q ss_pred -------------------------------------------cEEEeecccceeecCCCCCceeecccccCcccCcccc
Q 002121 766 -------------------------------------------TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802 (964)
Q Consensus 766 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~ 802 (964)
.+||+|||+++..... .....||+.|+|||++
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence 8999999999876432 2335689999999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch-----hH---HHHHHHhccCcccc----------c----ccccccC-
Q 002121 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY-----VV---REVRTAMNRDDEEH----------Y----GLTEMMD- 859 (964)
Q Consensus 803 ~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-----~~---~~~~~~~~~~~~~~----------~----~~~~~~d- 859 (964)
.+..++.++|||||||++|||++|+.||..... .. ..+.......+... + ......+
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 999999999999999999999999999963221 11 11111111111000 0 0000000
Q ss_pred --ccc-------hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 860 --PTI-------RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 860 --~~l-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+ ..........+.+++.+||+.||++|||++|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0012334467889999999999999999999985
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=357.49 Aligned_cols=323 Identities=20% Similarity=0.180 Sum_probs=274.1
Q ss_pred EEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCc
Q 002121 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNN 148 (964)
Q Consensus 69 L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 148 (964)
++.++++++ .+|..+. ++|+.|+|++| .+.+..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus 16 v~c~~~~l~-~ip~~~~--~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~ 91 (477)
T 2id5_A 16 VLCHRKRFV-AVPEGIP--TETRLLDLGKN-RIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91 (477)
T ss_dssp EECCSCCCS-SCCSCCC--TTCSEEECCSS-CCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEeCCCCcC-cCCCCCC--CCCcEEECCCC-ccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCc
Confidence 344444554 4555443 57899999999 7888888899999999999999999998888899999999999999999
Q ss_pred ccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcC
Q 002121 149 FSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228 (964)
Q Consensus 149 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l 228 (964)
++...+..|.++++|++|+|++|++++..| ..+..+++|+.|++++|.++ .++...|..+++|++|++++|++
T Consensus 92 l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~------~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 92 LKLIPLGVFTGLSNLTKLDISENKIVILLD------YMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp CCSCCTTSSTTCTTCCEEECTTSCCCEECT------TTTTTCTTCCEEEECCTTCC-EECTTSSTTCTTCCEEEEESCCC
T ss_pred CCccCcccccCCCCCCEEECCCCccccCCh------hHccccccCCEEECCCCccc-eeChhhccCCCCCCEEECCCCcC
Confidence 997666678899999999999999986555 45788899999999999998 55566788889999999999999
Q ss_pred cccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcc
Q 002121 229 SGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLW 307 (964)
Q Consensus 229 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~ 307 (964)
++..+..+..+++|+.|+|++|.+++..+..|..+++|++|+|++|.+.+..+ ......+|++|+|++|.++ ...+..
T Consensus 165 ~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~ 243 (477)
T 2id5_A 165 TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243 (477)
T ss_dssp SSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCC-SCCHHH
T ss_pred cccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCccc-ccCHHH
Confidence 98777789999999999999999998888899999999999999987766444 4556669999999999996 555567
Q ss_pred cCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC---Ccccc
Q 002121 308 FSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS---GIKNY 384 (964)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~---~~~l~ 384 (964)
|..+++|+.|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|+.++... ...++
T Consensus 244 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 323 (477)
T 2id5_A 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323 (477)
T ss_dssp HTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCC
T ss_pred hcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccC
Confidence 899999999999999999999999999999999999999999999999999999999999999999988653 34578
Q ss_pred eeEeecCC-cccccccccCc
Q 002121 385 TLILVGNP-VCTATLANTNY 403 (964)
Q Consensus 385 ~l~l~~Np-~c~~~l~~~~~ 403 (964)
.|+|.+|| .|+|.+.+...
T Consensus 324 ~L~l~~N~l~c~c~~~~~~~ 343 (477)
T 2id5_A 324 TLILDSNPLACDCRLLWVFR 343 (477)
T ss_dssp EEECCSSCEECSGGGHHHHT
T ss_pred EEEccCCCccCccchHhHHh
Confidence 89999999 89999865433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=349.04 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=196.8
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCce----
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ---- 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 698 (964)
.++|...+.||+|+||+||+|... +|+.||||++...... ....+.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 568999999999999999999964 6899999999764332 245788999999999999999999999877654
Q ss_pred --EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 699 --MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 699 --~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
++||||++ |+|.+++.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred eEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 99999998 689888743 4899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY 852 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~ 852 (964)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+..... .......
T Consensus 193 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 193 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred ccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCcHHHH
Confidence 65432 234568999999999887 68899999999999999999999999754322 22222211 1110000
Q ss_pred -c------------cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -G------------LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -~------------~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ........+..........+.+++.+||+.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0 0000000011111112356789999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=354.95 Aligned_cols=258 Identities=24% Similarity=0.346 Sum_probs=192.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC------ceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------EQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~ 699 (964)
.+|...+.||+|+||.||+|+.. +|+.||||++.... ..+.+|+++|++++|||||++++++...+ ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 36888899999999999999975 68999999986532 22357999999999999999999986532 367
Q ss_pred EEEEeccCCChhhhhcC--CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-CcEEEeecccce
Q 002121 700 LVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-LTAKVADFGLSK 776 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-~~~kl~DFGla~ 776 (964)
+||||+++ +|.+.+.. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 66665542 12346999999999999999999999988 9999999999999965 678999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCcc---
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDE--- 849 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~--- 849 (964)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...... +.+...+. ....
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 7654322 2345789999999998764 7899999999999999999999999754322 22222111 1100
Q ss_pred -------cccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 -------EHYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 -------~~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.........+... .......+.+++.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 0000111100001000 0111246779999999999999999999985
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=348.22 Aligned_cols=264 Identities=23% Similarity=0.355 Sum_probs=201.5
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
++....++|...+.||+|+||.||+|.... .||+|+++.... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 344446788999999999999999999853 499999875432 2334678999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|||+++..
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~ 179 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSIS 179 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred EEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence 99999999999999997643 46899999999999999999999988 99999999999998 679999999998765
Q ss_pred cCCC---CCceeecccccCcccCcccccc---------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc
Q 002121 779 SDSS---KGHVSTQVKGTMGYLDPEYYMT---------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 779 ~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 846 (964)
.... .........||+.|+|||++.. ..++.++||||||+++|||++|+.||...... .........
T Consensus 180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~ 258 (319)
T 2y4i_B 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE-AIIWQMGTG 258 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH-HHHHHHHTT
T ss_pred ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhccC
Confidence 3211 1112233468999999999864 45788999999999999999999999754322 112221111
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
.. ......... ..+.+++.+||+.||++||++.|+++.|+.+.++.
T Consensus 259 ~~------~~~~~~~~~-------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 259 MK------PNLSQIGMG-------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp CC------CCCCCSSCC-------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred CC------CCCCcCCCC-------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 000111111 23568999999999999999999999999876554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=352.73 Aligned_cols=259 Identities=23% Similarity=0.332 Sum_probs=193.2
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCc------eEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE------QML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------~~l 700 (964)
.+|...+.||+|+||+||+|+...+..||+|++..... ...+|++++++++||||+++++++...+. .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999987777799998764322 22479999999999999999999977654 789
Q ss_pred EEEeccCCChhhhhcC-CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEEEeecccceee
Q 002121 701 VYEFMANGTLRESLSG-RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLV 778 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~ 778 (964)
||||++++.+....+. .....+++..+..++.|+++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987544433321 11346899999999999999999999988 99999999999999 8999999999999876
Q ss_pred cCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccc----
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEE---- 850 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~---- 850 (964)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...... +.+...+. .....
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 193 IAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI-DQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp CTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHHHh
Confidence 44322 2345689999999998764 5899999999999999999999999754322 22211111 11000
Q ss_pred ------ccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 ------HYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ------~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...........+... .......+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 000111000011100 0112246789999999999999999999985
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=370.98 Aligned_cols=366 Identities=19% Similarity=0.183 Sum_probs=282.1
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccC-----cCCc----ccC
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTG-----NIPD----EIG 134 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~-----~~p~----~~~ 134 (964)
.+++.|+|++|.+++..+..++.+++|++|+|++| .+.+..|..|..+++|++|+|++|...+ .+|. .|.
T Consensus 248 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~ 326 (680)
T 1ziw_A 248 TNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN-NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSC-CBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTT
T ss_pred CCCCEEECCCCCcCccCcccccCcccccEeeCCCC-ccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcc
Confidence 35888888888888777777888888888888888 6777777777777777777777665443 2332 677
Q ss_pred CCCCccEEEcccCcccCcCCCcCCCccccccccccccccccc-cCcc---------------------cCCCCccccccC
Q 002121 135 NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGS-IPVS---------------------TITSPGLDQLKN 192 (964)
Q Consensus 135 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-iP~~---------------------~~~~~~l~~l~~ 192 (964)
.+++|++|+|++|++++..+..|.++++|++|+|++|.+++. +|.. .+....+..+++
T Consensus 327 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~ 406 (680)
T 1ziw_A 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406 (680)
T ss_dssp TCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTT
T ss_pred cCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCC
Confidence 788888888888888887777788888888887777654321 1100 011245677889
Q ss_pred CCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCc--cccCccccCCCCCCeee
Q 002121 193 AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALT--GKVPTNLNNLTNVNELN 270 (964)
Q Consensus 193 L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ 270 (964)
|+.|++++|++++.+|...|..+.+|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..|.++++|+.|+
T Consensus 407 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~ 486 (680)
T 1ziw_A 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486 (680)
T ss_dssp CCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEE
T ss_pred CCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEE
Confidence 9999999999988888888889999999999999999888889999999999999999987 67899999999999999
Q ss_pred ccCccCccCCCC-CCCCCCCCEEEccCCCCCCC-------CCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEE
Q 002121 271 LAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPT-------EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 271 Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~-------~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (964)
|++|+|+++++. +.++++|++|+|++|++++. .....|.++++|+.|+|++|+++...+..|.++++|+.|+
T Consensus 487 Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 566 (680)
T 1ziw_A 487 LSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIID 566 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeE
Confidence 999999998886 89999999999999999732 1223488999999999999999977667899999999999
Q ss_pred cCCcccccccCCCCccCCCCcEEeccCCcceeeccC----CCcccceeEeecCC-cccccc-cccCccccCCCCCccccc
Q 002121 343 LRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG----SGIKNYTLILVGNP-VCTATL-ANTNYCQLQQPTTKAYST 416 (964)
Q Consensus 343 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~----~~~~l~~l~l~~Np-~c~~~l-~~~~~~~~~~~~~~~~~~ 416 (964)
|++|++++.++..|..+++|+.|+|++|+|+.++.. ....+..|+|.+|| .|+|.. .+...|............
T Consensus 567 Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~~~~~~~~~~~~~ 646 (680)
T 1ziw_A 567 LGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELS 646 (680)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCCCSSEECCSSCC--------
T ss_pred CCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCccHHHHHHHHHhcCccccccc
Confidence 999999999999999999999999999999999865 34568899999999 899996 888888433222222223
Q ss_pred ccccCCCCCCCCCC
Q 002121 417 SLANCGGKSCPPEQ 430 (964)
Q Consensus 417 ~~~~c~~~~~~~~~ 430 (964)
....|..|+-..++
T Consensus 647 ~~~~C~~p~~~~g~ 660 (680)
T 1ziw_A 647 SHYLCNTPPHYHGF 660 (680)
T ss_dssp --------------
T ss_pred CCcEECCchHHCCC
Confidence 45678888655555
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=348.24 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=190.3
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCc-
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE- 697 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~- 697 (964)
.+.....++|.+.+.||+|+||+||+|+.. +|+.||||++..... ....+.+|++.++.++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999974 689999998865432 23456788899999999999999999987554
Q ss_pred ------eEEEEEeccCCChhhhhcC--CCCCccchHHHHHHHHHHHHHHHHHh--hcCCCCeeccCCCCCcEEECC-CCc
Q 002121 698 ------QMLVYEFMANGTLRESLSG--RSGIHLDWKRRLRIALGSARGLAYLH--ELANPPIIHRDVKSTNILLDE-NLT 766 (964)
Q Consensus 698 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~ivH~Dlk~~NILl~~-~~~ 766 (964)
.++||||+++ +|.+.+.. .....+++..+..++.|++.||+||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999986 55443331 12346889999999999999999999 777 999999999999996 899
Q ss_pred EEEeecccceeecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHH
Q 002121 767 AKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTA 843 (964)
Q Consensus 767 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~ 843 (964)
+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ..+...
T Consensus 171 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 99999999987654322 2345689999999998654 48999999999999999999999997543221 111111
Q ss_pred hccCcccc----------cccccccCccch----hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 844 MNRDDEEH----------YGLTEMMDPTIR----NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 844 ~~~~~~~~----------~~~~~~~d~~l~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
........ ..........+. .........+.+++.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111000 000000000000 001113456789999999999999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=346.85 Aligned_cols=263 Identities=22% Similarity=0.337 Sum_probs=199.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEee-----Cce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 698 (964)
.++|...+.||+|+||.||+|+.. +|+.||||++..... .....+.+|++++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 468899999999999999999965 689999999975433 2345688999999999999999999998764 678
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999997 5999998753 5899999999999999999999988 999999999999999999999999999876
Q ss_pred cCCCCCc--------eeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH--HHHHhccC
Q 002121 779 SDSSKGH--------VSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE--VRTAMNRD 847 (964)
Q Consensus 779 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~ 847 (964)
....... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......... +.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 5322111 1223468999999998764 67899999999999999999999999754432111 11111111
Q ss_pred cccccccccc---------------cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 848 DEEHYGLTEM---------------MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 848 ~~~~~~~~~~---------------~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ...... ....+..........+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 243 HSD-NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CST-TTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred chh-ccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 100 000000 000011111122345779999999999999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=342.67 Aligned_cols=251 Identities=20% Similarity=0.283 Sum_probs=173.6
Q ss_pred hcCCCccc-eeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe----eCceE
Q 002121 626 SNNFSESN-EIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE----QGEQM 699 (964)
Q Consensus 626 ~~~~~~~~-~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 699 (964)
.++|.+.+ .||+|+||+||+|... +|+.||||++.... ....+....++.++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 56788854 6999999999999975 68999999986531 122233344666799999999999987 45589
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccce
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLSK 776 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla~ 776 (964)
+||||+++|+|.+++.......+++.+++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998776567999999999999999999999988 999999999999976 4559999999998
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHYGL 854 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~ 854 (964)
...... .....||+.|+|||++....++.++|||||||++|||++|+.||....... ......+.... ...
T Consensus 180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~ 252 (336)
T 3fhr_A 180 ETTQNA----LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---YGF 252 (336)
T ss_dssp EC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CC
T ss_pred eccccc----cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---ccc
Confidence 754322 234568999999999988889999999999999999999999996432111 00010000000 000
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
. .+. .......+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~---~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 253 P---NPE----WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp C---TTT----STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C---chh----hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 000 01112456789999999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=334.15 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=201.0
Q ss_pred hhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++++++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 4568999999999999999999975 78999999986533 23456789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC---CcEEEeecccceee
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN---LTAKVADFGLSKLV 778 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~---~~~kl~DFGla~~~ 778 (964)
|||+++++|.+++.... .+++.++..++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||+++..
T Consensus 100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~ 174 (287)
T 2wei_A 100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (287)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence 99999999999886543 5899999999999999999999988 9999999999999754 47999999999865
Q ss_pred cCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
..... .....||+.|+|||++.+ .++.++||||||+++|||++|+.||..... .+........... .
T Consensus 175 ~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~--------~ 241 (287)
T 2wei_A 175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-YDILKRVETGKYA--------F 241 (287)
T ss_dssp CCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHCCCC--------C
T ss_pred cCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCCCC--------C
Confidence 43321 233458999999998865 589999999999999999999999965332 2222222211110 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+.... ......+.+++.+||+.||++|||+.|+++
T Consensus 242 ~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 DLPQW---RTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CSGGG---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cchhh---hhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000 011245678999999999999999999987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=351.64 Aligned_cols=263 Identities=21% Similarity=0.331 Sum_probs=182.2
Q ss_pred CCCc-cceeecCCcEEEEEEEec---CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceEEE
Q 002121 628 NFSE-SNEIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQMLV 701 (964)
Q Consensus 628 ~~~~-~~~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 701 (964)
.|.. .++||+|+||+||+|+.. +++.||||++..... ...+.+|+++|++++|||||++++++.. ....++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3444 457999999999999965 578999999975433 2468899999999999999999999965 5678999
Q ss_pred EEeccCCChhhhhcCC-------CCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----CCCCcEEEe
Q 002121 702 YEFMANGTLRESLSGR-------SGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL----DENLTAKVA 770 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl----~~~~~~kl~ 770 (964)
|||+++ +|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+
T Consensus 99 ~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999974 888877522 1235899999999999999999999988 9999999999999 778999999
Q ss_pred ecccceeecCCCC-CceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch-----------hH
Q 002121 771 DFGLSKLVSDSSK-GHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY-----------VV 837 (964)
Q Consensus 771 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-----------~~ 837 (964)
|||+|+....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ..
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999987653221 122344679999999999987 4589999999999999999999999963321 11
Q ss_pred HHHHHHhccCcccccccccccCc-----------cchhh-hH--------HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 838 REVRTAMNRDDEEHYGLTEMMDP-----------TIRNT-VL--------LGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~d~-----------~l~~~-~~--------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+...+.............+.. ..... .. .....+.+++.+||+.||++|||++|+++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 22222222111110000000000 00000 00 00235678999999999999999999986
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=347.87 Aligned_cols=261 Identities=19% Similarity=0.249 Sum_probs=199.5
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-----------CCCccceeEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-----------HKNLVGLVGFCF 693 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~ 693 (964)
.++|...+.||+|+||+||+|+. .+|+.||||++.... .....+.+|++++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35788999999999999999996 578999999987432 33456889999999886 899999999998
Q ss_pred eeC----ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEEC------
Q 002121 694 EQG----EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLD------ 762 (964)
Q Consensus 694 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~------ 762 (964)
..+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+. + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 765 789999999 88999999876555699999999999999999999997 7 99999999999994
Q ss_pred CCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch-------
Q 002121 763 ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY------- 835 (964)
Q Consensus 763 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~------- 835 (964)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4558999999999876432 2334689999999999999999999999999999999999999973321
Q ss_pred -hHHHHHHHhccCcccc-------------ccccccc-Ccc---c-------hhhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 002121 836 -VVREVRTAMNRDDEEH-------------YGLTEMM-DPT---I-------RNTVLLGFRRYLELALQCVEESATDRPT 890 (964)
Q Consensus 836 -~~~~~~~~~~~~~~~~-------------~~~~~~~-d~~---l-------~~~~~~~~~~l~~li~~cl~~dP~~RPs 890 (964)
....+.......+... ......+ ... + ..........+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 1111111111111000 0000000 000 0 0012344567889999999999999999
Q ss_pred HHHHHH
Q 002121 891 MSEVVK 896 (964)
Q Consensus 891 ~~evl~ 896 (964)
++|+++
T Consensus 328 ~~ell~ 333 (373)
T 1q8y_A 328 AGGLVN 333 (373)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=342.80 Aligned_cols=254 Identities=25% Similarity=0.402 Sum_probs=177.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHH-HHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIE-LLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++|...+.||+|+||.||+|... +|+.||||+++.... ....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 367888899999999999999974 789999999976533 23345556665 777789999999999999999999999
Q ss_pred EeccCCChhhhhcC---CCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 703 EFMANGTLRESLSG---RSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 703 E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
||+++ +|.+++.. .....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99985 88777652 1234689999999999999999999997 7 999999999999999999999999999876
Q ss_pred cCCCCCceeecccccCcccCcccc----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYY----MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
.... ......||+.|+|||++ .+..++.++|||||||++|||++|+.||.......+.+........
T Consensus 177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------ 247 (327)
T 3aln_A 177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP------ 247 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC------
T ss_pred cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC------
Confidence 4332 22334699999999998 4567899999999999999999999999753322222111111100
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .+.... .......+.+++.+||+.||++||++.|+++
T Consensus 248 ~-~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 248 P-QLSNSE---EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp C-CCCCCS---SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred C-CCCCcc---cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 0 000000 0011245779999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=345.09 Aligned_cols=203 Identities=23% Similarity=0.295 Sum_probs=173.1
Q ss_pred HhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CC-----CccceeEEEEeeC
Q 002121 624 KCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HK-----NLVGLVGFCFEQG 696 (964)
Q Consensus 624 ~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~ 696 (964)
...++|...+.||+|+||+||+|+.. +|+.||||+++... ....++..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 34678999999999999999999964 68899999997432 23456788999999885 55 4999999999999
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC--CCCcEEEeeccc
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD--ENLTAKVADFGL 774 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGl 774 (964)
..++||||++ |+|.+++.......+++..+..++.|++.||+|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 5999999876545699999999999999999999953 13499999999999994 578899999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~ 834 (964)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 208 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 208 SCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9876432 234568999999999999999999999999999999999999997543
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-36 Score=367.00 Aligned_cols=362 Identities=22% Similarity=0.198 Sum_probs=282.3
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
..++.|||++|+|++..+.+|.++++|++|||++| .+.+..+..|.++++|++|+|++|+|++..+..|.++++|++|+
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N-~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~ 130 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC-EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 130 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTC-CCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCC-cCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence 36899999999999888889999999999999999 79888888999999999999999999977777899999999999
Q ss_pred cccCcccCcCCCcCCCcccccccccccccccc-ccCcccCCCCccccccCCCeeEccCCcccccccccc-----------
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTG-SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQL----------- 211 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~----------- 211 (964)
|++|+|++..+..|+++++|++|+|++|++++ .+| ..+..+++|++|+|++|++++..+..+
T Consensus 131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~ 204 (635)
T 4g8a_A 131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP------EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNL 204 (635)
T ss_dssp CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCC------GGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCC
T ss_pred CCCCcCCCCChhhhhcCcccCeeccccCccccCCCc------hhhccchhhhhhcccCccccccccccccchhhhhhhhh
Confidence 99999998777889999999999999999974 234 457788999999999998864322211
Q ss_pred ----------------c---------------------------------------------------------------
Q 002121 212 ----------------F--------------------------------------------------------------- 212 (964)
Q Consensus 212 ----------------f--------------------------------------------------------------- 212 (964)
+
T Consensus 205 ~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~ 284 (635)
T 4g8a_A 205 SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 284 (635)
T ss_dssp EEECTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEE
T ss_pred hhhcccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhh
Confidence 0
Q ss_pred ----------------------------------------CCCcceeEEEccCCcCcccCCcc-----------------
Q 002121 213 ----------------------------------------SPDMVLIHVLFDGNQLSGNIPES----------------- 235 (964)
Q Consensus 213 ----------------------------------------~~~~~L~~L~l~~N~l~~~~p~~----------------- 235 (964)
.....|+.|++.+|++.+..+..
T Consensus 285 ~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~ 364 (635)
T 4g8a_A 285 EFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA 364 (635)
T ss_dssp EEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCB
T ss_pred hhhhhhhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCC
Confidence 00011223333333332211111
Q ss_pred --cCCCCCCcEEEcccCcCcc-------------------------------------------------c-cCccccCC
Q 002121 236 --LGYVQTLEVLRLDRNALTG-------------------------------------------------K-VPTNLNNL 263 (964)
Q Consensus 236 --~~~l~~L~~L~Ls~N~l~~-------------------------------------------------~-~p~~~~~l 263 (964)
...+++|+.|++++|.+.. . .+..|.++
T Consensus 365 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l 444 (635)
T 4g8a_A 365 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSL 444 (635)
T ss_dssp CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTC
T ss_pred cccccccccccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccc
Confidence 1234556666666665531 1 11234555
Q ss_pred CCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEE
Q 002121 264 TNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 264 ~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (964)
++|+.++++.|.+.+..+. +..+++|+.|+|++|.+.....|..|..+++|++|+|++|+|++..|..|.++++|++|+
T Consensus 445 ~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~ 524 (635)
T 4g8a_A 445 RNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 524 (635)
T ss_dssp TTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEE
T ss_pred cccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEE
Confidence 6666666677777766654 677888999999998865466788899999999999999999999999999999999999
Q ss_pred cCCcccccccCCCCccCCCCcEEeccCCcceeeccCCC----cccceeEeecCC-cccccccccCccccCCCCCcccccc
Q 002121 343 LRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSG----IKNYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTS 417 (964)
Q Consensus 343 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~----~~l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~ 417 (964)
|++|+|++..+..|..+++|+.|+|++|+|+.+++..+ ..++.|+|.+|| .|||.+.++..|...... .+....
T Consensus 525 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~wl~~~~~-~~~~~~ 603 (635)
T 4g8a_A 525 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQ-LLVEVE 603 (635)
T ss_dssp CTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHHHHHHTTT-TBSCGG
T ss_pred CCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHHHHHhCCC-ccCCCC
Confidence 99999999999999999999999999999999987643 347889999999 899999999999543333 233345
Q ss_pred cccCCCCCCCCCCCCC
Q 002121 418 LANCGGKSCPPEQKLS 433 (964)
Q Consensus 418 ~~~c~~~~~~~~~~~~ 433 (964)
...|.+|+-..|+...
T Consensus 604 ~~~C~~P~~~~g~~l~ 619 (635)
T 4g8a_A 604 RMECATPSDKQGMPVL 619 (635)
T ss_dssp GCBBCSSTTTTTCBGG
T ss_pred CceeCCchHHCCCEee
Confidence 6789999888877443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=342.10 Aligned_cols=257 Identities=22% Similarity=0.361 Sum_probs=195.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCc-----
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE----- 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 697 (964)
.++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.++++++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467888999999999999999964 6899999999764332 24568899999999999999999999987654
Q ss_pred -eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 698 -QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 698 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
.++||||++ |+|.+++.. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999998 589888753 4899999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY 852 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~ 852 (964)
..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+..... .......
T Consensus 175 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~ 248 (353)
T 3coi_A 175 HADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV 248 (353)
T ss_dssp C-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHH
T ss_pred CCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence 65422 234568999999999876 67899999999999999999999999754422 22222111 1100000
Q ss_pred -------------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -------------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -------------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+.....+.+..........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000111111122356779999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=336.29 Aligned_cols=251 Identities=22% Similarity=0.357 Sum_probs=182.1
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcch--hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQG--GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
.++|...+.||+|+||.||+|... +|+.||||++....... ...+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467888999999999999999975 78999999997654322 223455566788889999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||+ ++.+..+.... ...+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 44555554322 34689999999999999999999985 7 999999999999999999999999999765433
Q ss_pred CCCceeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||.......+.+.......... ...
T Consensus 179 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~ 252 (318)
T 2dyl_A 179 K---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPL---LPG 252 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCC---CCS
T ss_pred c---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCC---CCc
Confidence 2 223456999999999984 45788999999999999999999999976444444444333322210 000
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+ ...+.+++.+||+.||.+||++.|+++
T Consensus 253 --~~~~-------~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 --HMGF-------SGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --SSCC-------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cCCC-------CHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0011 144668999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=339.22 Aligned_cols=245 Identities=23% Similarity=0.397 Sum_probs=191.4
Q ss_pred HHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc------hhHHHHHHHHHHHhc----CCCCcccee
Q 002121 621 ELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRV----HHKNLVGLV 689 (964)
Q Consensus 621 el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~ 689 (964)
+.....++|...+.||+|+||.||+|.. .+|+.||||+++..... ....+.+|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3345567899999999999999999985 57899999998754332 223466899999999 899999999
Q ss_pred EEEEeeCceEEEEEe-ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcE
Q 002121 690 GFCFEQGEQMLVYEF-MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTA 767 (964)
Q Consensus 690 ~~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~ 767 (964)
+++.+.+..++|||| +.+++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence 999999999999999 78999999997643 5899999999999999999999998 99999999999999 89999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhcc
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLT-EKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNR 846 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~ 846 (964)
||+|||+++...... .....||..|+|||++.+..+. .++||||||+++|||++|+.||...... ...
T Consensus 180 kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~ 248 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI-------LEA 248 (312)
T ss_dssp EECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHT
T ss_pred EEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH-------hhh
Confidence 999999998765432 2345699999999998876664 5899999999999999999999653211 111
Q ss_pred CcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 847 DDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 847 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .... .+ ...+.+++.+||+.||++||++.|+++
T Consensus 249 ~~----~~~~----~~-------~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 249 EL----HFPA----HV-------SPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp CC----CCCT----TS-------CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cc----CCcc----cC-------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 10 0111 11 134668999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=343.21 Aligned_cols=246 Identities=24% Similarity=0.420 Sum_probs=199.4
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc------hhHHHHHHHHHHHhcC--CCCccceeE
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRVH--HKNLVGLVG 690 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~ 690 (964)
.+.....++|...+.||+|+||.||+|+. .+|+.||||+++..... ....+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34455567899999999999999999985 57899999998754322 2245778999999996 599999999
Q ss_pred EEEeeCceEEEEEeccC-CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEE
Q 002121 691 FCFEQGEQMLVYEFMAN-GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAK 768 (964)
Q Consensus 691 ~~~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~k 768 (964)
++.+.+..++||||+.+ ++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+|
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 99999999999999986 89999987643 6899999999999999999999988 99999999999999 789999
Q ss_pred EeecccceeecCCCCCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 769 VADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 769 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
|+|||+++...... .....||+.|+|||++....+ +.++|||||||++|||++|+.||...... ....
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------~~~~ 259 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------IRGQ 259 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-------HHCC
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-------hccc
Confidence 99999998765432 234569999999999987665 68899999999999999999999653211 1111
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .....+. ..+.+++.+||+.||++||++.|+++
T Consensus 260 ~--------~~~~~~~-------~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 260 V--------FFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp C--------CCSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred c--------cccccCC-------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0111111 35668999999999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=352.48 Aligned_cols=251 Identities=24% Similarity=0.282 Sum_probs=185.6
Q ss_pred CCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEecc
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
.|...+.||+|+||+||.+...+|+.||||++... ....+.+|+++++++ +|||||++++++.+.+..++|||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34456889999999998776668999999998643 234678999999987 89999999999999999999999996
Q ss_pred CCChhhhhcCCCCCc-----cchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC-------------CcEE
Q 002121 707 NGTLRESLSGRSGIH-----LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN-------------LTAK 768 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~-------------~~~k 768 (964)
|+|.+++....... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 69999998654211 234456889999999999999988 9999999999999654 4899
Q ss_pred EeecccceeecCCCCC--ceeecccccCcccCcccccc-------CCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHH
Q 002121 769 VADFGLSKLVSDSSKG--HVSTQVKGTMGYLDPEYYMT-------QQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVR 838 (964)
Q Consensus 769 l~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~ 838 (964)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+| |+.||........
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~ 248 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence 9999999987543221 11234579999999999865 678999999999999999999 9999964332221
Q ss_pred HHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 839 EVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+.. .... .... +.+ ........+.+++.+||+.||++||++.|+++
T Consensus 249 ~i~~---~~~~----~~~~--~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 NIIR---GIFS----LDEM--KCL--HDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHH---TCCC----CCCC--TTC--CCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhc---CCCC----cccc--ccc--ccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1111 1110 1000 000 01223356779999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=340.06 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=200.9
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CC-cEEEEEEecCCCcchhHHHHHHHHHHHhcCCCC------ccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DG-QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN------LVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 697 (964)
.++|.+.+.||+|+||+||+|... ++ +.||||+++.. ......+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999964 34 78999999753 233457889999999998766 8999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE----------------
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL---------------- 761 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl---------------- 761 (964)
.++||||+ +|+|.+++.......+++.++..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 667777776655457999999999999999999999988 9999999999999
Q ss_pred ---CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--
Q 002121 762 ---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV-- 836 (964)
Q Consensus 762 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~-- 836 (964)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 247 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH 247 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 56889999999999875432 23356999999999999999999999999999999999999999754322
Q ss_pred HHHHHHHhccCcccc--------c--ccccccCcc----------------chhhhHHHHHHHHHHHHHhhhcCCCCCCC
Q 002121 837 VREVRTAMNRDDEEH--------Y--GLTEMMDPT----------------IRNTVLLGFRRYLELALQCVEESATDRPT 890 (964)
Q Consensus 837 ~~~~~~~~~~~~~~~--------~--~~~~~~d~~----------------l~~~~~~~~~~l~~li~~cl~~dP~~RPs 890 (964)
...+.......+... + ......+.. ...........+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 327 (355)
T 2eu9_A 248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT 327 (355)
T ss_dssp HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence 122222221111000 0 000000000 00001122346789999999999999999
Q ss_pred HHHHHH
Q 002121 891 MSEVVK 896 (964)
Q Consensus 891 ~~evl~ 896 (964)
+.|+++
T Consensus 328 ~~e~l~ 333 (355)
T 2eu9_A 328 LAEALL 333 (355)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999974
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-36 Score=353.13 Aligned_cols=334 Identities=16% Similarity=0.148 Sum_probs=298.3
Q ss_pred CCccEEecC-----------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccc
Q 002121 55 SWEGVTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123 (964)
Q Consensus 55 ~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n 123 (964)
.|..|.|.. ..++.|+|++|++++..+..|.++++|++|+|++| .+.+..|..|.++++|++|+|++|
T Consensus 12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNEN-IVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTS-CCCEECTTTTTTCTTCCEEECCSS
T ss_pred CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCC-ccCEeChhhhhCCccCCEEECCCC
Confidence 578899974 36889999999999988999999999999999999 799999999999999999999999
Q ss_pred cccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcc
Q 002121 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203 (964)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l 203 (964)
++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..| ..+..+++|+.|+|++|++
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l 164 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH------RAFSGLNSLEQLTLEKCNL 164 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECT------TSSTTCTTCCEEEEESCCC
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeCh------hhccCCCCCCEEECCCCcC
Confidence 9996666778999999999999999999999999999999999999999995555 4688899999999999999
Q ss_pred cccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-C
Q 002121 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-D 282 (964)
Q Consensus 204 ~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~ 282 (964)
+ .++...|..+++|+.|++++|++++..+..|..+++|+.|++++|.+.+.+|..+....+|++|+|++|+|++.++ .
T Consensus 165 ~-~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~ 243 (477)
T 2id5_A 165 T-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLA 243 (477)
T ss_dssp S-SCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHH
T ss_pred c-ccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHH
Confidence 8 7888889999999999999999999999999999999999999999988888888888899999999999998775 4
Q ss_pred CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCC
Q 002121 283 LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLL 362 (964)
Q Consensus 283 l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 362 (964)
+..+++|++|+|++|+++ ...+..|..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|
T Consensus 244 ~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 322 (477)
T 2id5_A 244 VRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322 (477)
T ss_dssp HTTCTTCCEEECCSSCCC-EECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGC
T ss_pred hcCccccCeeECCCCcCC-ccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCccc
Confidence 889999999999999998 6777789999999999999999999999999999999999999999999999999999999
Q ss_pred cEEeccCCcceeeccCCCc--ccceeEeecCC-ccccc
Q 002121 363 QLVDLQNNQISAITLGSGI--KNYTLILVGNP-VCTAT 397 (964)
Q Consensus 363 ~~L~L~~N~l~~i~~~~~~--~l~~l~l~~Np-~c~~~ 397 (964)
+.|+|++|+|++-....+. ....+.+.+|. .|.+.
T Consensus 323 ~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 323 ETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred CEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence 9999999999974322111 12234455555 55543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=350.55 Aligned_cols=250 Identities=25% Similarity=0.351 Sum_probs=187.8
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
..+|...+.||+|+||+||.....+|+.||||++...... .+.+|+++++++ +|||||++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4568888999999999966555567999999998754332 467899999999 799999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-----CCcEEEeecccceeec
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSKLVS 779 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGla~~~~ 779 (964)
|+ |+|.+++.... ....+.+++.++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+|+...
T Consensus 100 ~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 97 59999998654 34556677899999999999999988 999999999999943 3468899999998765
Q ss_pred CCCC-CceeecccccCcccCccccc---cCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 780 DSSK-GHVSTQVKGTMGYLDPEYYM---TQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 780 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
.... ........||+.|+|||++. ...++.++|||||||++|||++ |..||..... ........... .
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--~~~~~~~~~~~-----~ 247 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--RQANILLGACS-----L 247 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--HHHHHHTTCCC-----C
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--HHHHHHhccCC-----c
Confidence 3321 12234567999999999997 4567889999999999999999 8888854322 11111111111 0
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+ .......+.+++.+||+.||++||++.||++
T Consensus 248 -~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 -DCLHP-----EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp -TTSCT-----TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -cccCc-----cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01111 1112234668999999999999999999973
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=363.85 Aligned_cols=318 Identities=20% Similarity=0.258 Sum_probs=287.3
Q ss_pred cCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCC-CCC-CCCCCCCCc------ccchhhccccccccCcCCc--
Q 002121 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGG-LTG-SLSPRIGDL------QKLNILILAGCGFTGNIPD-- 131 (964)
Q Consensus 62 ~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~-l~~-~~p~~l~~l------~~L~~L~L~~n~l~~~~p~-- 131 (964)
...+++.|+|++|.+.|.+|..|+++++|++|+|++| . +.| .+|..++++ ++|++|+|++|+++ .+|.
T Consensus 247 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n-~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~ 324 (636)
T 4eco_A 247 NLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN-RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVET 324 (636)
T ss_dssp GCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC-TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHH
T ss_pred ccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC-CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchh
Confidence 3468999999999999999999999999999999999 6 888 899999887 99999999999999 8999
Q ss_pred ccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccC-CCeeEccCCccccccccc
Q 002121 132 EIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKN-AKHFHFNKNKLSGTISEQ 210 (964)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~-L~~L~L~~N~l~g~l~~~ 210 (964)
.|+++++|++|+|++|+++|.+| .|.++++|++|+|++|+++ .+| ..+..+++ |++|++++|+++ .+|..
T Consensus 325 ~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp------~~l~~l~~~L~~L~Ls~N~l~-~lp~~ 395 (636)
T 4eco_A 325 SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIP------ANFCGFTEQVENLSFAHNKLK-YIPNI 395 (636)
T ss_dssp HHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECC------TTSEEECTTCCEEECCSSCCS-SCCSC
T ss_pred hhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-ccc------HhhhhhcccCcEEEccCCcCc-ccchh
Confidence 99999999999999999999999 9999999999999999999 788 45889999 999999999999 88875
Q ss_pred ccCC-CcceeEEEccCCcCcccCCcccC-------CCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC
Q 002121 211 LFSP-DMVLIHVLFDGNQLSGNIPESLG-------YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD 282 (964)
Q Consensus 211 ~f~~-~~~L~~L~l~~N~l~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 282 (964)
+... +.+|+.|++++|++++.+|..+. .+++|+.|+|++|++++..+..+..+++|++|+|++|+|+.+++.
T Consensus 396 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~ 475 (636)
T 4eco_A 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKN 475 (636)
T ss_dssp CCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSS
T ss_pred hhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHH
Confidence 4332 34899999999999999999998 888999999999999955445567799999999999999976665
Q ss_pred CCC--------CCCCCEEEccCCCCCCCCCCcccC--CCCCCcEEECCCCccccccChhccCCCCCCEEEc------CCc
Q 002121 283 LSQ--------MNSLSYVDLSNNSFDPTEAPLWFS--TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKL------RNN 346 (964)
Q Consensus 283 l~~--------l~~L~~L~Ls~N~l~~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------~~N 346 (964)
... +++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+| ++|
T Consensus 476 ~~~~~~~~~~~l~~L~~L~Ls~N~l~--~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N 552 (636)
T 4eco_A 476 SLKDENENFKNTYLLTSIDLRFNKLT--KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN 552 (636)
T ss_dssp SSEETTEECTTGGGCCEEECCSSCCC--BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCC
T ss_pred HhccccccccccCCccEEECcCCcCC--ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccC
Confidence 322 239999999999996 5666676 99999999999999998 8999999999999999 568
Q ss_pred ccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCCc
Q 002121 347 AFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNPV 393 (964)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np~ 393 (964)
++.+.+|..+..+++|+.|+|++|+++.+|......++.|+|++||+
T Consensus 553 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ip~~~~~~L~~L~Ls~N~l 599 (636)
T 4eco_A 553 RTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNISVLDIKDNPN 599 (636)
T ss_dssp BCCCCCCTTGGGCSSCCEEECCSSCCCBCCSCCCTTCCEEECCSCTT
T ss_pred cccccChHHHhcCCCCCEEECCCCcCCccCHhHhCcCCEEECcCCCC
Confidence 89999999999999999999999999999987667799999999995
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=359.42 Aligned_cols=357 Identities=18% Similarity=0.208 Sum_probs=229.5
Q ss_pred CCCccEEecC-------------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhcc
Q 002121 54 GSWEGVTCNN-------------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120 (964)
Q Consensus 54 ~~w~gv~C~~-------------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L 120 (964)
|.|.|+ |+. .+++.|+|++|++++..|..|..+++|++|+|++| .+.+..|..|+++++|++|+|
T Consensus 4 C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 4 CDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS-RINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp ECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTS-CCCEECTTTTTTCTTCCEEEC
T ss_pred CCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCC-CcCccChhhccccccCCEEEC
Confidence 389998 863 37999999999999988899999999999999999 788888889999999999999
Q ss_pred ccccccCcCCcccCCCCCccEEEcccCcccC-cCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEcc
Q 002121 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSG-RIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFN 199 (964)
Q Consensus 121 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~ 199 (964)
++|.+++..|..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++.+.+|.. .+..+++|++|+++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~-----~~~~l~~L~~L~L~ 156 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI-----DFAGLTSLNELEIK 156 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT-----TTTTCCEEEEEEEE
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHh-----hhhcccccCeeecc
Confidence 9999997777779999999999999999986 34667777777777777777754455421 22333333333333
Q ss_pred CCcccccccccc-----------------------cCCCcceeEEEccCCcCcc--------------------------
Q 002121 200 KNKLSGTISEQL-----------------------FSPDMVLIHVLFDGNQLSG-------------------------- 230 (964)
Q Consensus 200 ~N~l~g~l~~~~-----------------------f~~~~~L~~L~l~~N~l~~-------------------------- 230 (964)
+|++++.+|..+ +..+++|++|++++|++++
T Consensus 157 ~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 236 (549)
T 2z81_A 157 ALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLT 236 (549)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEE
T ss_pred CCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccc
Confidence 333332222111 0112222222222222222
Q ss_pred --------------------------------------------------------------------------------
Q 002121 231 -------------------------------------------------------------------------------- 230 (964)
Q Consensus 231 -------------------------------------------------------------------------------- 230 (964)
T Consensus 237 ~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~ 316 (549)
T 2z81_A 237 DESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316 (549)
T ss_dssp HHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEE
T ss_pred hhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEE
Confidence
Q ss_pred -------cCCccc-CCCCCCcEEEcccCcCccccCc---cccCCCCCCeeeccCccCccCCC---CCCCCCCCCEEEccC
Q 002121 231 -------NIPESL-GYVQTLEVLRLDRNALTGKVPT---NLNNLTNVNELNLAHNDLKGPFP---DLSQMNSLSYVDLSN 296 (964)
Q Consensus 231 -------~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~~---~l~~l~~L~~L~Ls~ 296 (964)
.+|..+ ..+++|++|+|++|++++.+|. .+..+++|++|+|++|++++.++ .+..+++|++|+|++
T Consensus 317 l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~ 396 (549)
T 2z81_A 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396 (549)
T ss_dssp EESSCCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTT
T ss_pred eccCccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCC
Confidence 122222 2355566666666666554432 24555555555555555554432 144555555555555
Q ss_pred CCCCCCCCCcccCCCCCCcEEECCCCccccccCh-----------------hccCCCCCCEEEcCCcccccccCCCCccC
Q 002121 297 NSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPD-----------------KLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359 (964)
Q Consensus 297 N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~-----------------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 359 (964)
|+++ .+|..+..+++|++|+|++|++++.... .+..+++|++|+|++|+++.+ |. ...+
T Consensus 397 N~l~--~lp~~~~~~~~L~~L~Ls~N~l~~l~~~~~~~L~~L~Ls~N~l~~~~~~l~~L~~L~Ls~N~l~~i-p~-~~~l 472 (549)
T 2z81_A 397 NTFH--PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTL-PD-ASLF 472 (549)
T ss_dssp CCCC--CCCSCCCCCTTCCEEECTTSCCSCCCTTSCTTCSEEECCSSCCSCCCCCCTTCCEEECCSSCCSSC-CC-GGGC
T ss_pred CCCc--cCChhhcccccccEEECCCCCcccccchhcCCceEEECCCCChhhhcccCChhcEEECCCCccCcC-CC-cccC
Confidence 5553 3444445555555555555554421110 123788999999999999854 43 4678
Q ss_pred CCCcEEeccCCcceeeccC---CCcccceeEeecCC-ccccc-ccccCccccCCCCCcccccccccCCCC
Q 002121 360 PLLQLVDLQNNQISAITLG---SGIKNYTLILVGNP-VCTAT-LANTNYCQLQQPTTKAYSTSLANCGGK 424 (964)
Q Consensus 360 ~~L~~L~L~~N~l~~i~~~---~~~~l~~l~l~~Np-~c~~~-l~~~~~~~~~~~~~~~~~~~~~~c~~~ 424 (964)
++|+.|+|++|+++.++.. ....++.|+|.+|| .|+|. +.....|..++... ......|.+|
T Consensus 473 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~l~~~l~~~~~~---~~~~~~C~~~ 539 (549)
T 2z81_A 473 PVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQK---EQGSAKCSGS 539 (549)
T ss_dssp TTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHHHHHHHHHHHHCTTT---EESCCBBTTT
T ss_pred ccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCccHHHHHHHHHhcccc---cCCCCeECCC
Confidence 9999999999999998765 34557889999999 89998 56666674332221 2345567665
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=362.03 Aligned_cols=332 Identities=19% Similarity=0.174 Sum_probs=222.6
Q ss_pred ccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccc
Q 002121 90 LRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLA 169 (964)
Q Consensus 90 L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 169 (964)
|+.|+|++| .+.+..+..|+.+++|++|+|++|.++ .+|..+..+++|++|+|++|.+++..|..+.++++|++|+++
T Consensus 256 L~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 256 VESINLQKH-YFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEEEECTTC-CCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred eeEEEeecC-ccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 333344443 333333444555555555555555555 455555555555555555555555545555555555555555
Q ss_pred ccccccccCcccCCCCccccccCCCeeEccCCccccccc-ccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 002121 170 DNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248 (964)
Q Consensus 170 ~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~-~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 248 (964)
+|.+.+.+|. ..+..+++|++|++++|++++... ...+..+++|++|++++|++++..|..|..+++|+.|+++
T Consensus 334 ~n~~~~~~~~-----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 408 (606)
T 3t6q_A 334 GNTKRLELGT-----GCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLA 408 (606)
T ss_dssp SCSSCCBCCS-----STTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECT
T ss_pred CCCcccccch-----hhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECC
Confidence 5555544442 235566677777777777663321 3345666777777777777777777777777777777777
Q ss_pred cCcCccccCc-cccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCC--CCCcccCCCCCCcEEECCCCcc
Q 002121 249 RNALTGKVPT-NLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPT--EAPLWFSTLPSLTTLICEFGSL 324 (964)
Q Consensus 249 ~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~--~~~~~~~~l~~L~~L~Ls~N~l 324 (964)
+|++++..+. .|.++++|++|+|++|.+++.++. +..+++|++|++++|++++. ..+..+..+++|+.|+|++|++
T Consensus 409 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l 488 (606)
T 3t6q_A 409 FTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDL 488 (606)
T ss_dssp TCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCC
T ss_pred CCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCcc
Confidence 7777765544 377777777777777777776654 67778888888888887632 2335677888888888888888
Q ss_pred ccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC---CcccceeEeecCC-cccccccc
Q 002121 325 QGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS---GIKNYTLILVGNP-VCTATLAN 400 (964)
Q Consensus 325 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~---~~~l~~l~l~~Np-~c~~~l~~ 400 (964)
++..|..|..+++|+.|+|++|++++..+..+..++.| .|+|++|+++.++... ...++.|++.+|| .|+|...+
T Consensus 489 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~ 567 (606)
T 3t6q_A 489 SSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIY 567 (606)
T ss_dssp CEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHH
T ss_pred CccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHH
Confidence 88888888888888888888888888888888888888 8888888888876543 3457889999999 89999988
Q ss_pred cCccccCCCCCcccccccccCCCCCCCCCC
Q 002121 401 TNYCQLQQPTTKAYSTSLANCGGKSCPPEQ 430 (964)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~ 430 (964)
...|..++.. .+.......|..|+...++
T Consensus 568 ~~~w~~~~~~-~~~~~~~~~C~~p~~~~g~ 596 (606)
T 3t6q_A 568 FLEWYKENMQ-KLEDTEDTLCENPPLLRGV 596 (606)
T ss_dssp HHHHHHHCGG-GEECGGGCBEEESGGGTTC
T ss_pred HHHHHHhCcc-cccCCCCCeeCCchHhCCC
Confidence 8888543322 2334455667776544444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=352.93 Aligned_cols=326 Identities=22% Similarity=0.191 Sum_probs=270.4
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|.+++..+..|..+++|++|+|++| .+.+..|..|.++++|++|+|++|.|+ .+|.. .+++|++|+
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 127 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHN-RIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD 127 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSC-CCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCC-CCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence 57899999999999888889999999999999999 799888999999999999999999999 67776 899999999
Q ss_pred cccCcccC-cCCCcCCCccccccccccccccccccCcccCCCCccccccCC--CeeEccCCcc--cccccccccC-----
Q 002121 144 LNSNNFSG-RIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA--KHFHFNKNKL--SGTISEQLFS----- 213 (964)
Q Consensus 144 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L--~~L~L~~N~l--~g~l~~~~f~----- 213 (964)
|++|++++ .+|..|+++++|++|+|++|++++ ..+..+++| +.|++++|++ ++..|..+..
T Consensus 128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~---------~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~ 198 (562)
T 3a79_B 128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ---------LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTV 198 (562)
T ss_dssp CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCT---------TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEE
T ss_pred CCCCCccccCchHhhcccCcccEEecCCCcccc---------CchhhhhhceeeEEEeecccccccccCcccccccCcce
Confidence 99999996 346899999999999999999873 123344444 7777777766 4333322211
Q ss_pred --------------------C-------------------------------------------------------Ccce
Q 002121 214 --------------------P-------------------------------------------------------DMVL 218 (964)
Q Consensus 214 --------------------~-------------------------------------------------------~~~L 218 (964)
. ..+|
T Consensus 199 l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L 278 (562)
T 3a79_B 199 LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV 278 (562)
T ss_dssp EEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSE
T ss_pred EEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccc
Confidence 0 1156
Q ss_pred eEEEccCCcCcccCCccc-----------------------------------------------------CCCCCCcEE
Q 002121 219 IHVLFDGNQLSGNIPESL-----------------------------------------------------GYVQTLEVL 245 (964)
Q Consensus 219 ~~L~l~~N~l~~~~p~~~-----------------------------------------------------~~l~~L~~L 245 (964)
++|++++|+++|.+|..+ ..+++|++|
T Consensus 279 ~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~l~~L~~L 358 (562)
T 3a79_B 279 EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFL 358 (562)
T ss_dssp EEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEE
T ss_pred cEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCcccccCccCCCCceEE
Confidence 677777777777666654 678899999
Q ss_pred EcccCcCccccCccccCCCCCCeeeccCccCccCCC---CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCC
Q 002121 246 RLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP---DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322 (964)
Q Consensus 246 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~---~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 322 (964)
++++|.+++.+|..|.++++|++|+|++|++++..+ .+..+++|++|++++|++++...+..+..+++|+.|+|++|
T Consensus 359 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n 438 (562)
T 3a79_B 359 NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSN 438 (562)
T ss_dssp ECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSS
T ss_pred ECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCC
Confidence 999999999899999999999999999999998653 48999999999999999984466667999999999999999
Q ss_pred ccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC---CCcccceeEeecCC-cccccc
Q 002121 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG---SGIKNYTLILVGNP-VCTATL 398 (964)
Q Consensus 323 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~---~~~~l~~l~l~~Np-~c~~~l 398 (964)
++++..|..+. ++|+.|+|++|+++. +|..+..+++|+.|+|++|+|+.++.. ....++.|+|.+|| .|+|.+
T Consensus 439 ~l~~~~~~~l~--~~L~~L~L~~N~l~~-ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 439 MLTGSVFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp CCCGGGGSSCC--TTCSEEECCSSCCCC-CCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCCcchhhhhc--CcCCEEECCCCcCcc-cChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 99988877664 799999999999995 455555999999999999999999865 44557889999999 899998
Q ss_pred ccc-Cccc
Q 002121 399 ANT-NYCQ 405 (964)
Q Consensus 399 ~~~-~~~~ 405 (964)
... ..|.
T Consensus 516 ~~~~~~~~ 523 (562)
T 3a79_B 516 IRYLSEWI 523 (562)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 876 4463
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=357.86 Aligned_cols=350 Identities=23% Similarity=0.214 Sum_probs=246.9
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|.+++..|..|..+++|++|+|++| .+.+..|..|+++++|++|+|++|+|+ .+|.. .+++|++|+
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~ 96 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHN-RIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD 96 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSS-CCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCC-ccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence 45666666666666655556666666666666666 566665666666666666666666666 45544 566666666
Q ss_pred cccCcccC-cCCCcCCCccccccccccccccc-------------------------cccCcccCCCC------------
Q 002121 144 LNSNNFSG-RIPPSLGKLSQLYWLDLADNQLT-------------------------GSIPVSTITSP------------ 185 (964)
Q Consensus 144 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~-------------------------g~iP~~~~~~~------------ 185 (964)
|++|++++ .+|..|+++++|++|+|++|+++ +.+|..+....
T Consensus 97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~ 176 (520)
T 2z7x_B 97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176 (520)
T ss_dssp CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSS
T ss_pred ccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCc
Confidence 66666665 34566666666666666666554 33332221100
Q ss_pred --------c------------------------------ccc---------------------------ccCCCeeEccC
Q 002121 186 --------G------------------------------LDQ---------------------------LKNAKHFHFNK 200 (964)
Q Consensus 186 --------~------------------------------l~~---------------------------l~~L~~L~L~~ 200 (964)
. +.. .++|++|++++
T Consensus 177 ~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~ 256 (520)
T 2z7x_B 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256 (520)
T ss_dssp CCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEE
T ss_pred chhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeec
Confidence 0 000 12566666666
Q ss_pred Cccccccccccc----CCCcceeEEEccCCcCcccCC-cc-------------------------cCCCCCCcEEEcccC
Q 002121 201 NKLSGTISEQLF----SPDMVLIHVLFDGNQLSGNIP-ES-------------------------LGYVQTLEVLRLDRN 250 (964)
Q Consensus 201 N~l~g~l~~~~f----~~~~~L~~L~l~~N~l~~~~p-~~-------------------------~~~l~~L~~L~Ls~N 250 (964)
|+++|.+|..+| ..+..|+.+++++|.+ .+| .. +..+++|++|++++|
T Consensus 257 n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n 334 (520)
T 2z7x_B 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334 (520)
T ss_dssp EEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSS
T ss_pred ccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECC
Confidence 666666666654 4455555555555554 222 00 167889999999999
Q ss_pred cCccccCccccCCCCCCeeeccCccCccCC---CCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccc
Q 002121 251 ALTGKVPTNLNNLTNVNELNLAHNDLKGPF---PDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGR 327 (964)
Q Consensus 251 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~---~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (964)
++++.+|..+.++++|++|+|++|++++.. ..+..+++|++|+|++|.+++......+..+++|+.|+|++|++++.
T Consensus 335 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~ 414 (520)
T 2z7x_B 335 LLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDT 414 (520)
T ss_dssp CCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGG
T ss_pred ccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcc
Confidence 999889999999999999999999999733 24889999999999999997434445688999999999999999988
Q ss_pred cChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC---CCcccceeEeecCC-ccccccccc-C
Q 002121 328 VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG---SGIKNYTLILVGNP-VCTATLANT-N 402 (964)
Q Consensus 328 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~---~~~~l~~l~l~~Np-~c~~~l~~~-~ 402 (964)
.|..+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+.++.. ....++.|+|.+|| .|+|.+.+. .
T Consensus 415 ~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~ 491 (520)
T 2z7x_B 415 IFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLS 491 (520)
T ss_dssp GGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCHHHHHHHH
T ss_pred hhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCCcccCCchHHHH
Confidence 887765 79999999999999 5666666999999999999999999865 34457889999999 899999888 7
Q ss_pred ccccCCCCCcccccccccCCCCC
Q 002121 403 YCQLQQPTTKAYSTSLANCGGKS 425 (964)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~c~~~~ 425 (964)
.|..+.... ......|.+|.
T Consensus 492 ~~~~~~~~~---~~~~~~C~~p~ 511 (520)
T 2z7x_B 492 RWLNKNSQK---EQGSAKCSGSG 511 (520)
T ss_dssp HHHHHTTTT---EESCCBBTTTC
T ss_pred HHHHhcccc---CCCCCCcCCcc
Confidence 784433321 33556788773
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=361.91 Aligned_cols=272 Identities=24% Similarity=0.338 Sum_probs=205.8
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEe------eCce
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE------QGEQ 698 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~ 698 (964)
++|.+.+.||+|+||.||+|.. .+|+.||||+++... ......+.+|++++++++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6799999999999999999996 468999999987643 3335678999999999999999999998765 6678
Q ss_pred EEEEEeccCCChhhhhcCCC-CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCc---EEEeeccc
Q 002121 699 MLVYEFMANGTLRESLSGRS-GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLT---AKVADFGL 774 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~---~kl~DFGl 774 (964)
++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998643 336899999999999999999999988 999999999999997765 99999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccc----
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE---- 850 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 850 (964)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........|...........
T Consensus 171 a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 171 AKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred cccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 98765432 22446799999999999999999999999999999999999999976544333221111100000
Q ss_pred -----ccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHH-----HHHHHHHHHHhC
Q 002121 851 -----HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSE-----VVKAIETLLQND 905 (964)
Q Consensus 851 -----~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~~~~~~ 905 (964)
........ +............+.+++.+||+.||++|||+.| ..+.++.++...
T Consensus 248 ~~l~g~~~~~~~l-p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k 311 (676)
T 3qa8_A 248 DDLTGAVKFSSVL-PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311 (676)
T ss_dssp CCCSSSCCCCSSS-CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred hhhcccccccccc-CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence 00000000 0000112223466789999999999999999988 567777777544
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=338.23 Aligned_cols=339 Identities=17% Similarity=0.130 Sum_probs=282.8
Q ss_pred CCCCCCCCCCCCCccEEe---cC------------------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCC
Q 002121 44 PTWKNSDDPCGSWEGVTC---NN------------------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLT 102 (964)
Q Consensus 44 ~~W~~~~~~C~~w~gv~C---~~------------------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~ 102 (964)
++|....+||+.|.+..| +. ..++.|+++++.++..-+..+..+++|++|+|++| .+.
T Consensus 4 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n-~i~ 82 (390)
T 3o6n_A 4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL-QIE 82 (390)
T ss_dssp ---CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTS-CCC
T ss_pred CCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchhhCChhHhcccccCcEEECCCC-ccc
Confidence 578877788866555544 31 46788999999988544344789999999999999 788
Q ss_pred CCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccC
Q 002121 103 GSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTI 182 (964)
Q Consensus 103 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~ 182 (964)
+..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|++|+|++|++++..|
T Consensus 83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~---- 158 (390)
T 3o6n_A 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED---- 158 (390)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT----
T ss_pred ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccCh----
Confidence 8888899999999999999999998888889999999999999999995555567999999999999999985444
Q ss_pred CCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccC
Q 002121 183 TSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262 (964)
Q Consensus 183 ~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 262 (964)
..+..+++|++|++++|++++ ++ +..+++|+.|++++|.+++ +....+|+.|++++|.++.. |..+
T Consensus 159 --~~~~~l~~L~~L~l~~n~l~~-~~---~~~l~~L~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~-~~~~-- 224 (390)
T 3o6n_A 159 --DTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVV-RGPV-- 224 (390)
T ss_dssp --TTTSSCTTCCEEECCSSCCSB-CC---GGGCTTCSEEECCSSCCSE-----EECCSSCSEEECCSSCCCEE-ECCC--
T ss_pred --hhccCCCCCCEEECCCCcCCc-cc---cccccccceeecccccccc-----cCCCCcceEEECCCCeeeec-cccc--
Confidence 457889999999999999984 33 4556889999999999985 34457899999999999954 4433
Q ss_pred CCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEE
Q 002121 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (964)
.++|+.|+|++|.+++. +.+..+++|++|+|++|.++ ...|..|..+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus 225 ~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 301 (390)
T ss_dssp CSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC-EEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred cccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCC-CcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence 57999999999999976 56899999999999999997 6678889999999999999999996 466678899999999
Q ss_pred cCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCccc
Q 002121 343 LRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYCQ 405 (964)
Q Consensus 343 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~ 405 (964)
|++|+++.. +..+..+++|+.|+|++|+++.++......++.|++.+|| .|+|.......|.
T Consensus 302 L~~n~l~~~-~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~ 364 (390)
T 3o6n_A 302 LSHNHLLHV-ERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNVA 364 (390)
T ss_dssp CCSSCCCCC-GGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHHHHHTTTCC
T ss_pred CCCCcceec-CccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccchhHHHHHHHHH
Confidence 999999854 5567889999999999999999998888889999999999 7888776666653
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=364.28 Aligned_cols=240 Identities=22% Similarity=0.346 Sum_probs=193.7
Q ss_pred hcCCCccceeecCCcEEEEEEEec--CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc-----
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS--DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE----- 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~--~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 697 (964)
.++|.+.+.||+|+||+||+|... +|+.||||++..... .....+.+|++++++++|||||++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 589999999875432 334578899999999999999999999998776
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+||||+++++|.+++.. .++|.+++.++.||++||+|||+.+ ||||||||+|||++.+ .+||+|||+++.
T Consensus 159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 5899999999999999999999988 9999999999999986 999999999987
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
.... ....||++|+|||++.++. +.++|||||||++|||++|..|+.... ...
T Consensus 231 ~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~--------------------~~~ 283 (681)
T 2pzi_A 231 INSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY--------------------VDG 283 (681)
T ss_dssp TTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE--------------------CSS
T ss_pred cccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc--------------------ccc
Confidence 6432 3356999999999987654 899999999999999999998875310 000
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPT-MSEVVKAIETLL 902 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L~~~~ 902 (964)
+... .........+.+++.+||+.||++||+ ++++.+.+..++
T Consensus 284 ~~~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 LPED--DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CCTT--CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccc--ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000 011112245778999999999999995 666667676654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=355.91 Aligned_cols=338 Identities=17% Similarity=0.133 Sum_probs=290.0
Q ss_pred CCCCCCCCCCCC---CccEEecC------------------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCC
Q 002121 44 PTWKNSDDPCGS---WEGVTCNN------------------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLT 102 (964)
Q Consensus 44 ~~W~~~~~~C~~---w~gv~C~~------------------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~ 102 (964)
++|..+.+||.. |.++.|+. .+++.++++++.++...+..+..+++|++|+|++| .+.
T Consensus 10 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n-~l~ 88 (597)
T 3oja_B 10 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL-QIE 88 (597)
T ss_dssp -CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTS-CCC
T ss_pred cCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCC-CCC
Confidence 678877777743 66665541 35688999999998655555789999999999999 799
Q ss_pred CCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccC
Q 002121 103 GSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTI 182 (964)
Q Consensus 103 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~ 182 (964)
+..|..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|++|+|++|.+++..|
T Consensus 89 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~---- 164 (597)
T 3oja_B 89 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIED---- 164 (597)
T ss_dssp EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCT----
T ss_pred CCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCCh----
Confidence 8888899999999999999999998888889999999999999999996666678999999999999999996555
Q ss_pred CCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccC
Q 002121 183 TSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNN 262 (964)
Q Consensus 183 ~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 262 (964)
..+..+++|+.|+|++|.+++ ++ +..+++|+.|++++|.+++ +....+|+.|++++|.++...+ .+
T Consensus 165 --~~~~~l~~L~~L~L~~N~l~~-~~---~~~l~~L~~L~l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~-~~-- 230 (597)
T 3oja_B 165 --DTFQATTSLQNLQLSSNRLTH-VD---LSLIPSLFHANVSYNLLST-----LAIPIAVEELDASHNSINVVRG-PV-- 230 (597)
T ss_dssp --TTTTTCTTCCEEECTTSCCSB-CC---GGGCTTCSEEECCSSCCSE-----EECCTTCSEEECCSSCCCEEEC-SC--
T ss_pred --hhhhcCCcCcEEECcCCCCCC-cC---hhhhhhhhhhhcccCcccc-----ccCCchhheeeccCCccccccc-cc--
Confidence 457889999999999999984 44 4456789999999999985 3455789999999999994433 33
Q ss_pred CCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEE
Q 002121 263 LTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 263 l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (964)
.++|+.|+|++|.+++. +.+..+++|+.|+|++|.++ ...|..|..+++|+.|+|++|++++ +|..+..+++|+.|+
T Consensus 231 ~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 231 NVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 307 (597)
T ss_dssp CSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC-EEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred CCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccC-CCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence 36899999999999985 66899999999999999998 6678889999999999999999997 467778899999999
Q ss_pred cCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCcc
Q 002121 343 LRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYC 404 (964)
Q Consensus 343 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~ 404 (964)
|++|+++. +|..+..+++|+.|+|++|+|+.++......+..|+|.+|| .|+|.......+
T Consensus 308 Ls~N~l~~-i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~~~~~~~~~~ 369 (597)
T 3oja_B 308 LSHNHLLH-VERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLRALFRNV 369 (597)
T ss_dssp CCSSCCCC-CGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHHHHHTTTC
T ss_pred CCCCCCCc-cCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCChhHHHHHHHH
Confidence 99999995 56677899999999999999999998888889999999999 788866555544
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-35 Score=349.64 Aligned_cols=205 Identities=20% Similarity=0.197 Sum_probs=162.6
Q ss_pred CcceeEEEccCCcCcccC--CcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC--CCCCCCCCC
Q 002121 215 DMVLIHVLFDGNQLSGNI--PESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP--DLSQMNSLS 290 (964)
Q Consensus 215 ~~~L~~L~l~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~ 290 (964)
+++|++|++++|++++.. +..+..+++|++|++++|.+++..+ .+.++++|++|++++|.+++.++ .+..+++|+
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 424 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 424 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCC
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCC
Confidence 345566666666665443 4556667777777777777774444 48888899999999999888766 488999999
Q ss_pred EEEccCCCCCCCCCCcccCCCCCCcEEECCCCccc-cccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccC
Q 002121 291 YVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ-GRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQN 369 (964)
Q Consensus 291 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 369 (964)
+|++++|.+. ...+..+.++++|+.|+|++|++. +.+|..+..+++|+.|+|++|++++..+..+..+++|+.|+|++
T Consensus 425 ~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 503 (570)
T 2z63_A 425 YLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503 (570)
T ss_dssp EEECTTSCCE-ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEeCcCCccc-ccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCC
Confidence 9999999997 667888999999999999999998 68999999999999999999999999999999999999999999
Q ss_pred CcceeeccCC---CcccceeEeecCC-cccccccccC-ccccCCCCCcccccccccCCCC
Q 002121 370 NQISAITLGS---GIKNYTLILVGNP-VCTATLANTN-YCQLQQPTTKAYSTSLANCGGK 424 (964)
Q Consensus 370 N~l~~i~~~~---~~~l~~l~l~~Np-~c~~~l~~~~-~~~~~~~~~~~~~~~~~~c~~~ 424 (964)
|+++.++... ...++.|++.+|| .|+|...... .|...... .+ .....|.+|
T Consensus 504 n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~wl~~~~~-~~--~~~~~C~~~ 560 (570)
T 2z63_A 504 NQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQ-KE--QGSAKCSGS 560 (570)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTHHHHHHHHHTGG-GE--ESCCBBTTT
T ss_pred CcCCCCCHHHhhcccCCcEEEecCCcccCCCcchHHHHHHHHhccc-cC--CCchhhCCC
Confidence 9999997653 3457889999999 8999876654 67333222 11 122277766
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-35 Score=317.65 Aligned_cols=234 Identities=10% Similarity=0.050 Sum_probs=182.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.++++++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 357899999999999999999975 5899999999865432 235789999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||+++++|.+++... ....++.+++.|++.||+|||+.+ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred EEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence 9999999999999642 344568899999999999999988 9999999999999999999998543
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
|++| ++.++|||||||++|||+||+.||........ +.... ....... +.
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~-----~~~~~---~~~~~~~-~~ 224 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSG-----LAPAE---RDTAGQP-IE 224 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCC-----SEECC---BCTTSCB-CC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchh-----hHHHH---HHhccCC-CC
Confidence 3332 68899999999999999999999964321000 00000 0000000 00
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
...........+.+++.+||+.||++| |+.|+++.|+++....
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 001111122457799999999999999 9999999999987544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=347.02 Aligned_cols=310 Identities=19% Similarity=0.193 Sum_probs=204.1
Q ss_pred CccEEecC-----------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhcccccc
Q 002121 56 WEGVTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCG 124 (964)
Q Consensus 56 w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~ 124 (964)
+..+.|.. ..++.|+|++|.+++..|..|+++++|++|+|++| .+.+..|..|+++++|++|+|++|.
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~Ls~n~ 92 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRC-QIYWIHEDTFQSQHRLDTLVLTANP 92 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTC-CCCEECTTTTTTCTTCCEEECTTCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCC-ccceeChhhccCccccCeeeCCCCc
Confidence 55688863 47899999999999988999999999999999999 7999899999999999999999999
Q ss_pred ccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccc-cCcccCCCCccccccCCCeeEccCCcc
Q 002121 125 FTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGS-IPVSTITSPGLDQLKNAKHFHFNKNKL 203 (964)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~~~~l~~l~~L~~L~L~~N~l 203 (964)
+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++. +| .+..+++|++|++++|++
T Consensus 93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~-------~~~~l~~L~~L~L~~n~l 165 (606)
T 3t6q_A 93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLP-------KGFPTEKLKVLDFQNNAI 165 (606)
T ss_dssp CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCC-------TTCCCTTCCEEECCSSCC
T ss_pred ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcc-------cccCCcccCEEEcccCcc
Confidence 9988899999999999999999999987788899999999999999999852 23 333467777777777777
Q ss_pred cccccccccCCCccee--EEEccCCcCcccCC------------------------------------------------
Q 002121 204 SGTISEQLFSPDMVLI--HVLFDGNQLSGNIP------------------------------------------------ 233 (964)
Q Consensus 204 ~g~l~~~~f~~~~~L~--~L~l~~N~l~~~~p------------------------------------------------ 233 (964)
+ .++...|..+.+|+ .|++++|++++..|
T Consensus 166 ~-~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~ 244 (606)
T 3t6q_A 166 H-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244 (606)
T ss_dssp C-EECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCC
T ss_pred c-ccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccC
Confidence 6 33333344444444 45555555554444
Q ss_pred ---------------------------cccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCC
Q 002121 234 ---------------------------ESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQ 285 (964)
Q Consensus 234 ---------------------------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~ 285 (964)
..|..+++|+.|++++|.++ .+|..+.++++|++|+|++|.+++.++ .+..
T Consensus 245 ~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~ 323 (606)
T 3t6q_A 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASN 323 (606)
T ss_dssp GGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGG
T ss_pred hhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhc
Confidence 34444444555555555444 444444444455555555554444433 2444
Q ss_pred CCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccccc--ChhccCCCCCCEEEcCCcccccccCCCCccCCCCc
Q 002121 286 MNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRV--PDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQ 363 (964)
Q Consensus 286 l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 363 (964)
+++|++|++++|.+.+...+..+..+++|++|+|++|++++.. +..+..+++|+.|+|++|++.+..+..+..+++|+
T Consensus 324 l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 403 (606)
T 3t6q_A 324 FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLE 403 (606)
T ss_dssp CTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCS
T ss_pred cCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCC
Confidence 4444444444444443333334444555555555555554443 44444555555555555555544444455555555
Q ss_pred EEeccCCcceee
Q 002121 364 LVDLQNNQISAI 375 (964)
Q Consensus 364 ~L~L~~N~l~~i 375 (964)
.|+|++|+++.+
T Consensus 404 ~L~l~~n~l~~~ 415 (606)
T 3t6q_A 404 LLDLAFTRLKVK 415 (606)
T ss_dssp EEECTTCCEECC
T ss_pred eEECCCCcCCCc
Confidence 555555555443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=336.93 Aligned_cols=305 Identities=17% Similarity=0.229 Sum_probs=255.5
Q ss_pred CCCeeEEEcCCCCcccccc-CCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcc--cCCCCCc
Q 002121 63 NSRVTALGLSTMGLTGKLS-GDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDE--IGNLAEL 139 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~-~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L 139 (964)
..+++.|+|++|.+.+.++ ..|..+++|++|+|++| .+.+..|..|+++++|++|+|++|.+++.+|.. |..+++|
T Consensus 53 l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L 131 (455)
T 3v47_A 53 LQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN-QFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131 (455)
T ss_dssp CTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTC-TTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTC
T ss_pred CccccEEECcCCcccceECcccccccccCCEEeCCCC-ccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccC
Confidence 3689999999999987775 57999999999999999 798888999999999999999999999866555 9999999
Q ss_pred cEEEcccCcccCcCCCc-CCCccccccccccccccccccCcccCCCCccccc--cCCCeeEccCCcccccccccc-----
Q 002121 140 SFLALNSNNFSGRIPPS-LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL--KNAKHFHFNKNKLSGTISEQL----- 211 (964)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l--~~L~~L~L~~N~l~g~l~~~~----- 211 (964)
++|+|++|++++..|.. |.++++|++|+|++|++++..|.. +..+ .+|+.|++++|.+.+ ++...
T Consensus 132 ~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~------l~~l~~~~L~~L~l~~n~l~~-~~~~~~~~~~ 204 (455)
T 3v47_A 132 EMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEED------LLNFQGKHFTLLRLSSITLQD-MNEYWLGWEK 204 (455)
T ss_dssp CEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTT------SGGGTTCEEEEEECTTCBCTT-CSTTCTTHHH
T ss_pred CEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhh------hhccccccccccccccCcccc-cchhhccccc
Confidence 99999999999887876 899999999999999999766632 3333 455555555555552 22111
Q ss_pred ---cCCCcceeEEEccCCcCcccCCccc-------------------------------------C--CCCCCcEEEccc
Q 002121 212 ---FSPDMVLIHVLFDGNQLSGNIPESL-------------------------------------G--YVQTLEVLRLDR 249 (964)
Q Consensus 212 ---f~~~~~L~~L~l~~N~l~~~~p~~~-------------------------------------~--~l~~L~~L~Ls~ 249 (964)
+...++|++|++++|++++..|..+ . ..++|+.|++++
T Consensus 205 ~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~ 284 (455)
T 3v47_A 205 CGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSK 284 (455)
T ss_dssp HCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCS
T ss_pred cccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecC
Confidence 1123455555555555554333322 1 126899999999
Q ss_pred CcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccccc
Q 002121 250 NALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRV 328 (964)
Q Consensus 250 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 328 (964)
|.+++.+|..|..+++|++|+|++|++++.++ .+..+++|++|+|++|.++ ...+..|..+++|++|+|++|++++..
T Consensus 285 n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 363 (455)
T 3v47_A 285 SKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRALG 363 (455)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECGGGGTTCTTCCEEECCSSCCCEEC
T ss_pred ccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccC-CcChhHhcCcccCCEEECCCCcccccC
Confidence 99999999999999999999999999999877 5899999999999999997 677888999999999999999999999
Q ss_pred ChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeec
Q 002121 329 PDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAIT 376 (964)
Q Consensus 329 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 376 (964)
|..|..+++|++|+|++|++++..+..+..+++|+.|+|++|+|++-.
T Consensus 364 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 411 (455)
T 3v47_A 364 DQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 411 (455)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred hhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCC
Confidence 999999999999999999999998888999999999999999999743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=317.85 Aligned_cols=230 Identities=22% Similarity=0.287 Sum_probs=179.4
Q ss_pred hcCCCcc-ceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHH-HhcCCCCccceeEEEEe----eCce
Q 002121 626 SNNFSES-NEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELL-SRVHHKNLVGLVGFCFE----QGEQ 698 (964)
Q Consensus 626 ~~~~~~~-~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~ 698 (964)
.++|... +.||+|+||.||+|.. .+|+.||+|+++. ...+.+|++++ +..+||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3466666 7799999999999996 5789999999864 24678899988 55589999999999987 6788
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccc
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLS 775 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla 775 (964)
++||||+++|+|.+++.......+++.++..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 99999999999999998766567999999999999999999999988 999999999999998 789999999998
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT 855 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (964)
+... +..++.++|||||||++|||++|+.||........ ...... ..
T Consensus 168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----~~~~~~----~~ 214 (299)
T 3m2w_A 168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGMKT----RI 214 (299)
T ss_dssp EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------CCSCC----SS
T ss_pred cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----hHHHHH----HH
Confidence 7542 13467899999999999999999999964321100 000000 00
Q ss_pred cccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......... .......+.+++.+||+.||++|||+.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000000000 1112356779999999999999999999986
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-35 Score=335.36 Aligned_cols=240 Identities=15% Similarity=0.136 Sum_probs=179.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCC-CCccc---------eeE-
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHH-KNLVG---------LVG- 690 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H-~nIv~---------l~~- 690 (964)
..+|...+.||+|+||+||+|+. .+|+.||||++...... ..+.+++|+.+++.++| +|... ...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 44577788999999999999995 57999999998843322 24679999999999987 32211 111
Q ss_pred -----------EEEe-----eCceEEEEEeccCCChhhhhc-----CCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002121 691 -----------FCFE-----QGEQMLVYEFMANGTLRESLS-----GRSGIHLDWKRRLRIALGSARGLAYLHELANPPI 749 (964)
Q Consensus 691 -----------~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 749 (964)
++.. ....+++|+++ +|+|.+++. ...+..++|..++.++.|+++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 1111 12356777755 679999884 233456899999999999999999999988 9
Q ss_pred eccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCcccc----------ccCCCCCchhHHHHHHH
Q 002121 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY----------MTQQLTEKSDVYSFGVV 819 (964)
Q Consensus 750 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDv~S~Gvv 819 (964)
|||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999999865322 344567 999999999 55568899999999999
Q ss_pred HHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002121 820 MLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 820 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 895 (964)
+|||++|+.||....... . ....+... . .....+.+++.+||+.||++||++.|++
T Consensus 307 l~elltg~~Pf~~~~~~~---------~------~~~~~~~~-~----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALG---------G------SEWIFRSC-K----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HHHHHHSSCCCCTTGGGS---------C------SGGGGSSC-C----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HHHHHHCCCCCCCcchhh---------h------HHHHHhhc-c----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999999996432100 0 00001100 0 0114577899999999999999987774
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=327.58 Aligned_cols=242 Identities=18% Similarity=0.195 Sum_probs=184.3
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc--------chhHHHHHHHHHHHhcC---------CCCccce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM--------QGGLEFKTEIELLSRVH---------HKNLVGL 688 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------H~nIv~l 688 (964)
.++|...+.||+|+||+||+|+. +|+.||||+++.... ...+.+.+|++++++++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35677889999999999999998 689999999875432 22367899999999986 7777777
Q ss_pred eEEEE-----------------e-------------eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHH
Q 002121 689 VGFCF-----------------E-------------QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738 (964)
Q Consensus 689 ~~~~~-----------------~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 738 (964)
.+++. + .+..++|||||++|++.+.+.. ..+++.++..++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77643 1 5789999999999987777654 3589999999999999999
Q ss_pred HHHh-hcCCCCeeccCCCCCcEEECCCC--------------------cEEEeecccceeecCCCCCceeecccccCccc
Q 002121 739 AYLH-ELANPPIIHRDVKSTNILLDENL--------------------TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797 (964)
Q Consensus 739 ~yLH-~~~~~~ivH~Dlk~~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~ 797 (964)
+||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+
T Consensus 175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~ 244 (336)
T 2vuw_A 175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTT
T ss_pred HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeeccc
Confidence 9999 888 99999999999999887 9999999999976532 246999999
Q ss_pred CccccccCCCCCchhHHHHHHH-HHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHH
Q 002121 798 DPEYYMTQQLTEKSDVYSFGVV-MLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLEL 876 (964)
Q Consensus 798 aPE~~~~~~~~~~sDv~S~Gvv-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l 876 (964)
|||++.+.. +.++||||+|++ .+++++|..||.................. .... ............+.++
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMT-----FKTK---CNTPAMKQIKRKIQEF 315 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCC-----CSSC---CCSHHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhc-----cCcc---cchhhhhhcCHHHHHH
Confidence 999998665 899999998777 78899999998432111111111111111 0000 0111122344667899
Q ss_pred HHHhhhcCCCCCCCHHHHH
Q 002121 877 ALQCVEESATDRPTMSEVV 895 (964)
Q Consensus 877 i~~cl~~dP~~RPs~~evl 895 (964)
+.+||+.| |++|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 888887
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=346.08 Aligned_cols=318 Identities=19% Similarity=0.272 Sum_probs=255.0
Q ss_pred cCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCC-CCC-CCCCCCCCcc-------cchhhccccccccCcCCc-
Q 002121 62 NNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGG-LTG-SLSPRIGDLQ-------KLNILILAGCGFTGNIPD- 131 (964)
Q Consensus 62 ~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~-l~~-~~p~~l~~l~-------~L~~L~L~~n~l~~~~p~- 131 (964)
...+++.|+|++|++.|.+|..|+++++|++|+|++| . +.| .+|..++++. +|++|+|++|+++ .+|.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N-~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~ 566 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN-RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPAS 566 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC-TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC-CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCCh
Confidence 3467899999999999999999999999999999999 5 888 7888777766 8999999999999 8888
Q ss_pred -ccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccC-CCeeEccCCcccccccc
Q 002121 132 -EIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKN-AKHFHFNKNKLSGTISE 209 (964)
Q Consensus 132 -~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~-L~~L~L~~N~l~g~l~~ 209 (964)
.|+++++|+.|+|++|+++ .+| .|+++++|++|+|++|+++ .+| ..+..+++ |+.|+|++|+++ .+|.
T Consensus 567 ~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp------~~l~~l~~~L~~L~Ls~N~L~-~lp~ 636 (876)
T 4ecn_A 567 ASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIP------EDFCAFTDQVEGLGFSHNKLK-YIPN 636 (876)
T ss_dssp HHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCC------TTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred hhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cch------HHHhhccccCCEEECcCCCCC-cCch
Confidence 8999999999999999998 777 8888899999999999988 777 34667777 777777777776 5664
Q ss_pred cccC------------------------------CCcceeEEEccCCcCcccCCcc-cCCCCCCcEEEcccCcCccccCc
Q 002121 210 QLFS------------------------------PDMVLIHVLFDGNQLSGNIPES-LGYVQTLEVLRLDRNALTGKVPT 258 (964)
Q Consensus 210 ~~f~------------------------------~~~~L~~L~l~~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~p~ 258 (964)
.+.. ...+|+.|++++|+|+ .+|.. +..+++|+.|+|++|+|+ .+|.
T Consensus 637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~ 714 (876)
T 4ecn_A 637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPE 714 (876)
T ss_dssp CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCT
T ss_pred hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccCh
Confidence 3211 1124555555555555 33333 346788899999999888 5665
Q ss_pred cccC--------CCCCCeeeccCccCccCCCCCC--CCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCC------C
Q 002121 259 NLNN--------LTNVNELNLAHNDLKGPFPDLS--QMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF------G 322 (964)
Q Consensus 259 ~~~~--------l~~L~~L~Ls~N~l~~~~~~l~--~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~------N 322 (964)
.+.. +++|+.|+|++|+|+.++..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++ |
T Consensus 715 ~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~--lp~~l~~L~~L~~L~Ls~N~~ls~N 792 (876)
T 4ecn_A 715 NSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS--FPTQPLNSSQLKAFGIRHQRDAEGN 792 (876)
T ss_dssp TSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS--CCCGGGGCTTCCEEECCCCBCTTCC
T ss_pred HHhccccccccccCCccEEECCCCCCccchHHhhhccCCCcCEEEeCCCCCCc--cchhhhcCCCCCEEECCCCCCcccc
Confidence 4433 2389999999999997766666 99999999999999974 688899999999999976 8
Q ss_pred ccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcc---cceeEeecCC---cccc
Q 002121 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK---NYTLILVGNP---VCTA 396 (964)
Q Consensus 323 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~---l~~l~l~~Np---~c~~ 396 (964)
++.+.+|..|..+++|+.|+|++|++ +.+|..+. ++|+.|+|++|+|..++...+.. ...+.|.+|+ ++.|
T Consensus 793 ~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC 869 (876)
T 4ecn_A 793 RILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGC 869 (876)
T ss_dssp BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESC
T ss_pred cccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCC
Confidence 89999999999999999999999999 66676655 69999999999999998765543 4567788887 3455
Q ss_pred cc
Q 002121 397 TL 398 (964)
Q Consensus 397 ~l 398 (964)
..
T Consensus 870 ~~ 871 (876)
T 4ecn_A 870 DA 871 (876)
T ss_dssp GG
T ss_pred CC
Confidence 43
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=338.08 Aligned_cols=310 Identities=20% Similarity=0.188 Sum_probs=238.1
Q ss_pred CCccEEecC-----------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccc
Q 002121 55 SWEGVTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123 (964)
Q Consensus 55 ~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n 123 (964)
.+..|.|+. .+++.|+|++|++++..+..|.++++|++|+|++| .+.+..|..|+++++|++|+|++|
T Consensus 5 ~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~L~~n 83 (680)
T 1ziw_A 5 SHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN-TISKLEPELCQKLPMLKVLNLQHN 83 (680)
T ss_dssp BSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSS-CCCCCCTTHHHHCTTCCEEECCSS
T ss_pred ECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCC-ccCccCHHHHhcccCcCEEECCCC
Confidence 556677752 47999999999999888888999999999999999 799999999999999999999999
Q ss_pred cccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcc
Q 002121 124 GFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203 (964)
Q Consensus 124 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l 203 (964)
.+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..| ..+..+++|++|++++|++
T Consensus 84 ~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~------~~~~~l~~L~~L~L~~n~l 157 (680)
T 1ziw_A 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKL------GTQVQLENLQELLLSNNKI 157 (680)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCC------CSSSCCTTCCEEECCSSCC
T ss_pred ccCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCc------hhhcccccCCEEEccCCcc
Confidence 9996555679999999999999999998778899999999999999999996655 4577899999999999999
Q ss_pred cccccccc-cCCCcceeEEEccCCcCcccCCcccCCC---------------------------CCCcEEEcccCcCccc
Q 002121 204 SGTISEQL-FSPDMVLIHVLFDGNQLSGNIPESLGYV---------------------------QTLEVLRLDRNALTGK 255 (964)
Q Consensus 204 ~g~l~~~~-f~~~~~L~~L~l~~N~l~~~~p~~~~~l---------------------------~~L~~L~Ls~N~l~~~ 255 (964)
++..+..+ +....+|++|++++|++++..|..+..+ ++|+.|++++|.+++.
T Consensus 158 ~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~ 237 (680)
T 1ziw_A 158 QALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTT 237 (680)
T ss_dssp CCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEE
T ss_pred cccCHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCccccc
Confidence 85444332 2345789999999999998888776654 4456666777777766
Q ss_pred cCccccCCCC--CCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccc-----c
Q 002121 256 VPTNLNNLTN--VNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG-----R 327 (964)
Q Consensus 256 ~p~~~~~l~~--L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-----~ 327 (964)
.|..|.+++. |+.|+|++|.+++.++. +..+++|++|++++|.++ ...+..|.++++|+.|+|++|...+ .
T Consensus 238 ~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~ 316 (680)
T 1ziw_A 238 SNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ-HLFSHSLHGLFNVRYLNLKRSFTKQSISLAS 316 (680)
T ss_dssp CTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBS-EECTTTTTTCTTCCEEECTTCBCCC------
T ss_pred ChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccC-ccChhhhcCCCCccEEeccchhhhccccccc
Confidence 6777766654 77777777777776653 667777777777777776 4555566666777777766654432 1
Q ss_pred cC----hhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcc
Q 002121 328 VP----DKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQI 372 (964)
Q Consensus 328 ~p----~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (964)
+| ..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|.+
T Consensus 317 lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~ 365 (680)
T 1ziw_A 317 LPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT 365 (680)
T ss_dssp CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBS
T ss_pred ccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCch
Confidence 22 2556666677777777776666666666666666666666653
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-32 Score=329.95 Aligned_cols=163 Identities=19% Similarity=0.150 Sum_probs=148.7
Q ss_pred ccCCCcceeEEEccCCcCcccCC-cccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCcc--CCCCCCCCC
Q 002121 211 LFSPDMVLIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG--PFPDLSQMN 287 (964)
Q Consensus 211 ~f~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~l~~l~ 287 (964)
.|..+++|+.|++++|++++..| ..+..+++|+.|++++|.+++..|..|.++++|++|+|++|.+++ .+..+..++
T Consensus 394 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~ 473 (606)
T 3vq2_A 394 NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTT 473 (606)
T ss_dssp CCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCT
T ss_pred hccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCC
Confidence 45667889999999999998888 689999999999999999999999999999999999999999998 344589999
Q ss_pred CCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCC-CCcEEe
Q 002121 288 SLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP-LLQLVD 366 (964)
Q Consensus 288 ~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~ 366 (964)
+|++|+|++|+++ ...|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++|+++.. |..+..++ +|+.|+
T Consensus 474 ~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-p~~~~~l~~~L~~l~ 551 (606)
T 3vq2_A 474 NLTFLDLSKCQLE-QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETS-KGILQHFPKSLAFFN 551 (606)
T ss_dssp TCCEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCE-ESCGGGSCTTCCEEE
T ss_pred CCCEEECCCCcCC-ccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCccc-CHhHhhhcccCcEEE
Confidence 9999999999998 67788899999999999999999999999999999999999999999954 44588887 599999
Q ss_pred ccCCcceee
Q 002121 367 LQNNQISAI 375 (964)
Q Consensus 367 L~~N~l~~i 375 (964)
|++|+|.+-
T Consensus 552 l~~N~~~c~ 560 (606)
T 3vq2_A 552 LTNNSVACI 560 (606)
T ss_dssp CCSCCCCCS
T ss_pred ccCCCcccC
Confidence 999999973
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-32 Score=326.98 Aligned_cols=308 Identities=19% Similarity=0.189 Sum_probs=237.8
Q ss_pred eEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEccc
Q 002121 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146 (964)
Q Consensus 67 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 146 (964)
+.|++++|+++ .+|..+. ++|++|+|++| .+.+..|..|.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~ 78 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQN-YISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSH 78 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSS-CCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCC-cccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCC
Confidence 57999999999 6888776 89999999999 78888888999999999999999999988899999999999999999
Q ss_pred CcccCcCCCcCCCcccccccccccccccc-ccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcce--eEEEc
Q 002121 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTG-SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVL--IHVLF 223 (964)
Q Consensus 147 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L--~~L~l 223 (964)
|+|+ .+|.. .+++|++|+|++|++++ .+| ..+..+++|++|++++|++++ ..|..+.+| ++|++
T Consensus 79 N~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p------~~~~~l~~L~~L~L~~n~l~~----~~~~~l~~L~L~~L~l 145 (520)
T 2z7x_B 79 NKLV-KISCH--PTVNLKHLDLSFNAFDALPIC------KEFGNMSQLKFLGLSTTHLEK----SSVLPIAHLNISKVLL 145 (520)
T ss_dssp SCCC-EEECC--CCCCCSEEECCSSCCSSCCCC------GGGGGCTTCCEEEEEESSCCG----GGGGGGTTSCEEEEEE
T ss_pred Ccee-ecCcc--ccCCccEEeccCCccccccch------hhhccCCcceEEEecCcccch----hhccccccceeeEEEe
Confidence 9999 56666 89999999999999985 455 468889999999999999874 234555566 88888
Q ss_pred cCCcC--cccCCcccCCCC-------------------------------------------------------------
Q 002121 224 DGNQL--SGNIPESLGYVQ------------------------------------------------------------- 240 (964)
Q Consensus 224 ~~N~l--~~~~p~~~~~l~------------------------------------------------------------- 240 (964)
++|++ .+..|..+..+.
T Consensus 146 ~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L 225 (520)
T 2z7x_B 146 VLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225 (520)
T ss_dssp EECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEE
T ss_pred ecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhc
Confidence 88888 666666665533
Q ss_pred ----------------------CCcEEEcccCcCccccCccc-----cCCCCCCeeeccCccCccCCC------------
Q 002121 241 ----------------------TLEVLRLDRNALTGKVPTNL-----NNLTNVNELNLAHNDLKGPFP------------ 281 (964)
Q Consensus 241 ----------------------~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~~------------ 281 (964)
+|+.|++++|.++|.+|..+ .++++|+.+++++|.+ ..+.
T Consensus 226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~~~~~~~~~L 304 (520)
T 2z7x_B 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYIYEIFSNMNI 304 (520)
T ss_dssp EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHHHHHHHTCCC
T ss_pred cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhhhcccccCce
Confidence 67777777777777777776 5555555555555554 1110
Q ss_pred --------------CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccc--ccChhccCCCCCCEEEcCC
Q 002121 282 --------------DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG--RVPDKLFSYSQIQQVKLRN 345 (964)
Q Consensus 282 --------------~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~ 345 (964)
....+++|++|++++|+++ ...|..+..+++|++|+|++|++++ .+|..+..+++|+.|+|++
T Consensus 305 ~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~ 383 (520)
T 2z7x_B 305 KNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQ 383 (520)
T ss_dssp SEEEEESSCCCCCCCCSSCCCCCEEECCSSCCC-TTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCS
T ss_pred eEEEcCCCccccccchhhCCcccEEEeECCccC-hhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCC
Confidence 0156778888888888886 4566677888888888888888876 4567778888888888888
Q ss_pred ccccc-ccCCCCccCCCCcEEeccCCcceeeccCCC-cccceeEeecCCc
Q 002121 346 NAFNN-TLDMGNAVGPLLQLVDLQNNQISAITLGSG-IKNYTLILVGNPV 393 (964)
Q Consensus 346 N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~-~~l~~l~l~~Np~ 393 (964)
|++++ .....+..+++|+.|+|++|+++....... ..++.|+|++|.+
T Consensus 384 N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~L~~L~Ls~N~l 433 (520)
T 2z7x_B 384 NSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKI 433 (520)
T ss_dssp SCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCCTTCCEEECCSSCC
T ss_pred CcCCcccccchhccCccCCEEECcCCCCCcchhhhhcccCCEEECCCCcc
Confidence 88877 444457777778888888887765433332 4577777777764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-32 Score=323.24 Aligned_cols=309 Identities=20% Similarity=0.213 Sum_probs=243.5
Q ss_pred eeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcc
Q 002121 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145 (964)
Q Consensus 66 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 145 (964)
.+.++++++++++ +|..+. ++|++|+|++| .+.+..+..|.++++|++|+|++|+|++..|+.|.++++|++|+|+
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N-~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 108 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQN-SISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSS-CCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCC-CccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECC
Confidence 3889999999995 887665 89999999999 7998888999999999999999999998889999999999999999
Q ss_pred cCcccCcCCCcCCCcccccccccccccccc-ccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcce--eEEE
Q 002121 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTG-SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVL--IHVL 222 (964)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L--~~L~ 222 (964)
+|+|+ .+|.. .+++|++|+|++|++++ .+| ..+..+++|++|++++|++++. .|..+.+| ++|+
T Consensus 109 ~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p------~~~~~l~~L~~L~L~~n~l~~~----~~~~l~~L~L~~L~ 175 (562)
T 3a79_B 109 HNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVC------KEFGNLTKLTFLGLSAAKFRQL----DLLPVAHLHLSCIL 175 (562)
T ss_dssp TSCCC-EECSC--CCTTCSEEECCSSCCSBCCCC------GGGGGCTTCCEEEEECSBCCTT----TTGGGTTSCEEEEE
T ss_pred CCcCC-ccCcc--ccccCCEEECCCCCccccCch------HhhcccCcccEEecCCCccccC----chhhhhhceeeEEE
Confidence 99999 66766 89999999999999984 233 4688999999999999999842 24444455 9999
Q ss_pred ccCCcC--cccCCcccCCCC------------------------------------------------------------
Q 002121 223 FDGNQL--SGNIPESLGYVQ------------------------------------------------------------ 240 (964)
Q Consensus 223 l~~N~l--~~~~p~~~~~l~------------------------------------------------------------ 240 (964)
+++|++ ++..|..+..+.
T Consensus 176 L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~ 255 (562)
T 3a79_B 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255 (562)
T ss_dssp EEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEE
T ss_pred eecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEE
Confidence 999999 777777766544
Q ss_pred ---------------------CCcEEEcccCcCccccCccc---------------------------------------
Q 002121 241 ---------------------TLEVLRLDRNALTGKVPTNL--------------------------------------- 260 (964)
Q Consensus 241 ---------------------~L~~L~Ls~N~l~~~~p~~~--------------------------------------- 260 (964)
+|++|++++|.++|.+|..+
T Consensus 256 L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~ 335 (562)
T 3a79_B 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335 (562)
T ss_dssp EEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSE
T ss_pred ecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceE
Confidence 77888888888888887765
Q ss_pred --------------cCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCC-CCCcccCCCCCCcEEECCCCcc
Q 002121 261 --------------NNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPT-EAPLWFSTLPSLTTLICEFGSL 324 (964)
Q Consensus 261 --------------~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~~l~~L~~L~Ls~N~l 324 (964)
..+++|++|+|++|++++..+ .+.++++|++|+|++|++++. ..|..+..+++|+.|+|++|++
T Consensus 336 L~l~~n~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l 415 (562)
T 3a79_B 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSL 415 (562)
T ss_dssp EEEESSCCCCCCCCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCC
T ss_pred EEccCCCcccccCccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcC
Confidence 566777777777777777444 477777788888888777521 1235577777788888888887
Q ss_pred ccccCh-hccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC--CcccceeEeecCCc
Q 002121 325 QGRVPD-KLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS--GIKNYTLILVGNPV 393 (964)
Q Consensus 325 ~~~~p~-~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~--~~~l~~l~l~~Np~ 393 (964)
++.+|. .+..+++|+.|+|++|++++..+..+. ++|+.|+|++|+|+.++... ...++.|+|.+|.+
T Consensus 416 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~~ip~~~~~l~~L~~L~L~~N~l 485 (562)
T 3a79_B 416 NSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQL 485 (562)
T ss_dssp BSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCCCCCTTTTSSCCCSEEECCSSCC
T ss_pred CCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCcccChhhcCCCCCCEEECCCCCC
Confidence 774443 467777788888888877766655443 67888888888888776543 34467778888774
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.98 E-value=9.8e-33 Score=307.40 Aligned_cols=274 Identities=18% Similarity=0.231 Sum_probs=143.6
Q ss_pred ccCCCHHHHHHHHHHHHHcCCCC----CCC----CCCCCCCCCCccEEecC----------CCeeEEEcCCCCccccccC
Q 002121 21 SSATDSRDAAALQSLKDAWQNTP----PTW----KNSDDPCGSWEGVTCNN----------SRVTALGLSTMGLTGKLSG 82 (964)
Q Consensus 21 ~~~~~~~~~~aL~~~k~~~~~~~----~~W----~~~~~~C~~w~gv~C~~----------~~v~~L~L~~~~l~g~~~~ 82 (964)
++....+|+.||++||.++..++ .+| ....++| .|.|+.|.. .+|+.|+|++|+++ .+|+
T Consensus 21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~ 98 (328)
T 4fcg_A 21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD 98 (328)
T ss_dssp --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred ccccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence 34455678999999999996665 456 3344555 899999952 56777777777766 5666
Q ss_pred CcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccc
Q 002121 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQ 162 (964)
Q Consensus 83 ~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 162 (964)
.++.+++|++|+|++| .+. .+|..++++++|++|+|++|.++ .+|..|+++++|++|+|++|++.+.+|..+...
T Consensus 99 ~l~~l~~L~~L~L~~n-~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~-- 173 (328)
T 4fcg_A 99 QAFRLSHLQHMTIDAA-GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST-- 173 (328)
T ss_dssp CGGGGTTCSEEEEESS-CCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEE--
T ss_pred hhhhCCCCCEEECCCC-Ccc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhc--
Confidence 6666666666666666 444 55555555555555555555555 455555555555555555555554554443320
Q ss_pred cccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCC
Q 002121 163 LYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTL 242 (964)
Q Consensus 163 L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L 242 (964)
.+. ..+..+++|++|+|++|+++ .+|..++.+++|
T Consensus 174 ---------~~~----------~~~~~l~~L~~L~L~~n~l~--------------------------~lp~~l~~l~~L 208 (328)
T 4fcg_A 174 ---------DAS----------GEHQGLVNLQSLRLEWTGIR--------------------------SLPASIANLQNL 208 (328)
T ss_dssp ---------C-C----------CCEEESTTCCEEEEEEECCC--------------------------CCCGGGGGCTTC
T ss_pred ---------cch----------hhhccCCCCCEEECcCCCcC--------------------------cchHhhcCCCCC
Confidence 000 11223333333333333332 333444445555
Q ss_pred cEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCC
Q 002121 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF 321 (964)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~ 321 (964)
+.|+|++|.++ .+|..|..+++|++|+|++|.+.+..|. +..+++|++|+|++|++. ..+|..+.++++|+.|+|++
T Consensus 209 ~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~ 286 (328)
T 4fcg_A 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNL-LTLPLDIHRLTQLEKLDLRG 286 (328)
T ss_dssp CEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTC-CBCCTTGGGCTTCCEEECTT
T ss_pred CEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCch-hhcchhhhcCCCCCEEeCCC
Confidence 55555555555 2333444555555555555444443332 444444444444444443 33333444444444444444
Q ss_pred CccccccChhccCCCCCCEEEcCCccc
Q 002121 322 GSLQGRVPDKLFSYSQIQQVKLRNNAF 348 (964)
Q Consensus 322 N~l~~~~p~~~~~l~~L~~L~L~~N~l 348 (964)
|++.+.+|..+..+++|+.+++..|.+
T Consensus 287 n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 287 CVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp CTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred CCchhhccHHHhhccCceEEeCCHHHH
Confidence 444444555454444444444444433
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1e-31 Score=337.32 Aligned_cols=316 Identities=21% Similarity=0.200 Sum_probs=236.0
Q ss_pred eEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcC-CcccCCCCCccEEEcc
Q 002121 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNI-PDEIGNLAELSFLALN 145 (964)
Q Consensus 67 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls 145 (964)
...+.++++++ .+|. ..++|++|||++| .+.+..|..|.++++|++|+|++|.+.+.+ |..|.++++|++|+|+
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N-~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls 81 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFN-YIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESC-CCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCC-cCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECC
Confidence 34566778887 4565 4688999999999 799999999999999999999999776666 7889999999999999
Q ss_pred cCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccC
Q 002121 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDG 225 (964)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~ 225 (964)
+|.+++..|..|.++++|++|+|++|.+++.+|.. ..+..+++|++|+|++|.+++..+...|..+++|++|++++
T Consensus 82 ~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~----~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~ 157 (844)
T 3j0a_A 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD----GYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157 (844)
T ss_dssp TCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTT----CCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEES
T ss_pred CCcCcccCHhHccCCcccCEeeCcCCCCCcccccC----ccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCC
Confidence 99999999999999999999999999999766632 34889999999999999999776767889999999999999
Q ss_pred CcCcccCCcccCCC--CCCcEEEcccCcCccccCccccCCCC------CCeeeccCccCccCCCC---------------
Q 002121 226 NQLSGNIPESLGYV--QTLEVLRLDRNALTGKVPTNLNNLTN------VNELNLAHNDLKGPFPD--------------- 282 (964)
Q Consensus 226 N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~~~--------------- 282 (964)
|++++..+..+..+ ++|+.|+|++|.+++..|..+..+++ |+.|+|++|.+++..+.
T Consensus 158 N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~ 237 (844)
T 3j0a_A 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLI 237 (844)
T ss_dssp SCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEE
T ss_pred CcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCccccccee
Confidence 99998888887766 67777777777777766666655554 66667666655543221
Q ss_pred ----------------------CCC--CCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCC
Q 002121 283 ----------------------LSQ--MNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQI 338 (964)
Q Consensus 283 ----------------------l~~--l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 338 (964)
+.+ .++|+.|+|++|.+. ...+..|..+++|+.|+|++|++.+..|..|.++++|
T Consensus 238 l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 316 (844)
T 3j0a_A 238 LAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316 (844)
T ss_dssp CCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCC-EECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSC
T ss_pred cccccccccccccccCCCChhhhhccccCCccEEECCCCccc-ccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCC
Confidence 111 145666666666665 4445556666666666666666666666666666666
Q ss_pred CEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC---CcccceeEeecCC
Q 002121 339 QQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS---GIKNYTLILVGNP 392 (964)
Q Consensus 339 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~---~~~l~~l~l~~Np 392 (964)
+.|+|++|++++..+..+..+++|+.|+|++|+++.++... ...++.|+|.+|.
T Consensus 317 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 373 (844)
T 3j0a_A 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNA 373 (844)
T ss_dssp CEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCC
T ss_pred CEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCC
Confidence 66666666666666666666666666666666666655432 2335555666655
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.5e-32 Score=326.72 Aligned_cols=320 Identities=19% Similarity=0.177 Sum_probs=247.5
Q ss_pred EEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCC
Q 002121 59 VTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAE 138 (964)
Q Consensus 59 v~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 138 (964)
..|....+ .+.++++++ .+|..+. ++|++|+|++| .+.+..|..|.++++|++|+|++|++++..|..|.++++
T Consensus 2 ~~C~~~~~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 2 LSCDASGV--CDGRSRSFT-SIPSGLT--AAMKSLDLSFN-KITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp CEECTTSE--EECTTSCCS-SCCSCCC--TTCCEEECCSS-CCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred ccCCCCce--EECCCCccc-cccccCC--CCccEEECcCC-ccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 35766555 799999998 6777664 79999999999 799888999999999999999999999888899999999
Q ss_pred ccEEEcccCcccCcCCCcCCCcccccccccccccccc-ccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcc
Q 002121 139 LSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTG-SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMV 217 (964)
Q Consensus 139 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~ 217 (964)
|++|+|++|++++..|..|+++++|++|+|++|++++ .+| ..+..+++|++|++++|++.+.+|...|..+++
T Consensus 76 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~------~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~ 149 (549)
T 2z81_A 76 LEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT------SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS 149 (549)
T ss_dssp CCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSS------CSCTTCTTCCEEEEEESSSCCEECTTTTTTCCE
T ss_pred CCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchh------hhhhccCCccEEECCCCccccccCHhhhhcccc
Confidence 9999999999998877789999999999999999984 233 467899999999999999777899888999999
Q ss_pred eeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCcc-ccCCCCCCeeeccCccCccCC----CCCCC-------
Q 002121 218 LIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN-LNNLTNVNELNLAHNDLKGPF----PDLSQ------- 285 (964)
Q Consensus 218 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~----~~l~~------- 285 (964)
|++|++++|++++..|..++.+++|+.|++++|.+. .+|.. +..+++|++|+|++|++++.. +....
T Consensus 150 L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L 228 (549)
T 2z81_A 150 LNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228 (549)
T ss_dssp EEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBST-THHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred cCeeeccCCcccccChhhhhccccCceEecccCccc-ccchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence 999999999999999999988877777777777766 33333 345666777777776666531 00000
Q ss_pred --------------------------------------------------------------------------------
Q 002121 286 -------------------------------------------------------------------------------- 285 (964)
Q Consensus 286 -------------------------------------------------------------------------------- 285 (964)
T Consensus 229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~ 308 (549)
T 2z81_A 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308 (549)
T ss_dssp EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHH
T ss_pred eccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhh
Confidence
Q ss_pred CCCCCEEEccCCCCCCCCCCccc-CCCCCCcEEECCCCccccccCh---hccCCCCCCEEEcCCcccccccC--CCCccC
Q 002121 286 MNSLSYVDLSNNSFDPTEAPLWF-STLPSLTTLICEFGSLQGRVPD---KLFSYSQIQQVKLRNNAFNNTLD--MGNAVG 359 (964)
Q Consensus 286 l~~L~~L~Ls~N~l~~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~~--~~~~~l 359 (964)
+.+|+.|++++|.++ .+|..+ ..+++|+.|+|++|++.+.+|. .+..+++|+.|+|++|++++..+ ..+..+
T Consensus 309 ~~~L~~L~l~~n~l~--~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 309 LEKVKRITVENSKVF--LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp STTCCEEEEESSCCC--CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred cccceEEEeccCccc--cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 124555555566553 334333 5678888888888888776643 36677788888888888776543 446777
Q ss_pred CCCcEEeccCCcceeeccC--CCcccceeEeecCCc
Q 002121 360 PLLQLVDLQNNQISAITLG--SGIKNYTLILVGNPV 393 (964)
Q Consensus 360 ~~L~~L~L~~N~l~~i~~~--~~~~l~~l~l~~Np~ 393 (964)
++|+.|+|++|+++.+|.. ....++.|+|.+|.+
T Consensus 387 ~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l 422 (549)
T 2z81_A 387 KNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGI 422 (549)
T ss_dssp TTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCC
T ss_pred CCCCEEECCCCCCccCChhhcccccccEEECCCCCc
Confidence 7788888888888777643 334567777777774
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=305.63 Aligned_cols=306 Identities=18% Similarity=0.200 Sum_probs=262.0
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|.+++..+..|..+++|++|+|++| .+.+..|..|+++++|++|+|++|.++...+..|.++++|++|+
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 147 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN-AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 147 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSS-CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCC-CCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence 68999999999999888889999999999999999 79988888999999999999999999954444579999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|.+++..|..|.++++|++|+|++|++++ ++ +..+++|+.|++++|.+++ + .....|++|++
T Consensus 148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-~~--------~~~l~~L~~L~l~~n~l~~-~-----~~~~~L~~L~l 212 (390)
T 3o6n_A 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--------LSLIPSLFHANVSYNLLST-L-----AIPIAVEELDA 212 (390)
T ss_dssp CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSB-CC--------GGGCTTCSEEECCSSCCSE-E-----ECCSSCSEEEC
T ss_pred CCCCccCccChhhccCCCCCCEEECCCCcCCc-cc--------cccccccceeecccccccc-c-----CCCCcceEEEC
Confidence 99999998888899999999999999999983 23 5678999999999999973 2 23467999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
++|+++.... ...++|+.|++++|.+++. ..+.++++|++|+|++|.+++..+ .+..+++|++|+|++|+++
T Consensus 213 ~~n~l~~~~~---~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-- 285 (390)
T 3o6n_A 213 SHNSINVVRG---PVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-- 285 (390)
T ss_dssp CSSCCCEEEC---CCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCC--
T ss_pred CCCeeeeccc---cccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCc--
Confidence 9999996533 2358999999999999964 679999999999999999999866 4899999999999999995
Q ss_pred CCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcc
Q 002121 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK 382 (964)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 382 (964)
..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+++... +..+++|+.|+|++|+|++-....+..
T Consensus 286 ~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~---~~~~~~L~~L~l~~N~~~~~~~~~~~~ 361 (390)
T 3o6n_A 286 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSLRALFR 361 (390)
T ss_dssp EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHHHHHTT
T ss_pred ccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC---chhhccCCEEEcCCCCccchhHHHHHH
Confidence 45666788999999999999998 56777889999999999999998763 778899999999999999865433322
Q ss_pred -cceeEeecCC-cccc
Q 002121 383 -NYTLILVGNP-VCTA 396 (964)
Q Consensus 383 -l~~l~l~~Np-~c~~ 396 (964)
.....+.+++ .|.+
T Consensus 362 ~~~~~~~~~~~~~c~~ 377 (390)
T 3o6n_A 362 NVARPAVDDADQHCKI 377 (390)
T ss_dssp TCCTTTBCCCCSCCCT
T ss_pred HHHhhcccccCceecc
Confidence 3334455665 5543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=324.10 Aligned_cols=184 Identities=20% Similarity=0.160 Sum_probs=159.1
Q ss_pred cCCCeeEccCCccccccc-ccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccC-ccccCCCCCCe
Q 002121 191 KNAKHFHFNKNKLSGTIS-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVP-TNLNNLTNVNE 268 (964)
Q Consensus 191 ~~L~~L~L~~N~l~g~l~-~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~ 268 (964)
++|+.|++++|++++... ...+..+++|++|++++|++++..+. +..+++|+.|++++|.+++..| ..|.++++|++
T Consensus 347 ~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~ 425 (570)
T 2z63_A 347 PSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425 (570)
T ss_dssp TTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCE
T ss_pred CCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCE
Confidence 344445555555442210 23355678999999999999976555 9999999999999999997766 57899999999
Q ss_pred eeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcc
Q 002121 269 LNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNA 347 (964)
Q Consensus 269 L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 347 (964)
|+|++|.+++..+. +.++++|++|+|++|.++....|..+..+++|+.|+|++|++++..|..|..+++|+.|+|++|+
T Consensus 426 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 505 (570)
T 2z63_A 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQ 505 (570)
T ss_dssp EECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCc
Confidence 99999999997775 89999999999999999644678889999999999999999999999999999999999999999
Q ss_pred cccccCCCCccCCCCcEEeccCCcceee
Q 002121 348 FNNTLDMGNAVGPLLQLVDLQNNQISAI 375 (964)
Q Consensus 348 l~~~~~~~~~~l~~L~~L~L~~N~l~~i 375 (964)
+++.++..+..+++|+.|+|++|++++-
T Consensus 506 l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 506 LKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 9999999999999999999999999974
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-31 Score=294.26 Aligned_cols=288 Identities=20% Similarity=0.248 Sum_probs=229.2
Q ss_pred eeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcc
Q 002121 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145 (964)
Q Consensus 66 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 145 (964)
++.+++++++++ .+|..+. +.|++|+|++| .+.+..+..|+++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 33 l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n-~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNN-KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSS-CCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CeEEEecCCCcc-ccCccCC--CCCeEEECCCC-cCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 345556666665 4555543 57888999888 6887777788889999999999999887778888889999999999
Q ss_pred cCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccc-cccccccCCCcceeEEEcc
Q 002121 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG-TISEQLFSPDMVLIHVLFD 224 (964)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g-~l~~~~f~~~~~L~~L~l~ 224 (964)
+|+++ .+|..+. ++|++|++++|++++..+ ..+..+++|+.|++++|.++. .+....|..+++|++|+++
T Consensus 109 ~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~ 179 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KTLQELRVHENEITKVRK------SVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179 (330)
T ss_dssp SSCCS-BCCSSCC--TTCCEEECCSSCCCBBCH------HHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECC
T ss_pred CCcCC-ccChhhc--ccccEEECCCCcccccCH------hHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECC
Confidence 99888 5666654 688899999998884333 346778889999999998863 2445667788889999999
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCC
Q 002121 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
+|+++. +|..+. ++|+.|++++|++++..|..|.++++|++|+|++|.+++.++ .+..+++|++|+|++|+++ .
T Consensus 180 ~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~--~ 254 (330)
T 1xku_A 180 DTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV--K 254 (330)
T ss_dssp SSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS--S
T ss_pred CCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc--c
Confidence 999884 555443 789999999999998888889999999999999999988877 4888899999999999994 6
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccC------CCCCCEEEcCCccccc--ccCCCCccCCCCcEEeccCCc
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFS------YSQIQQVKLRNNAFNN--TLDMGNAVGPLLQLVDLQNNQ 371 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~ 371 (964)
+|..+..+++|++|+|++|+|++..+..|.. .+.|+.|+|++|++.. ..+..|..+..|+.++|++|+
T Consensus 255 lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 255 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred CChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 6777889999999999999999887777754 3788999999999864 566788889999999999985
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=296.83 Aligned_cols=301 Identities=23% Similarity=0.277 Sum_probs=258.0
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+++++++.. ++ .+..+++|++|+|++| .+.+..+ +..+++|++|+|++|.++. +| .+..+++|++|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n-~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~ 116 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGN-QITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELY 116 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSS-CCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCC-ccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEE
Confidence 689999999999974 44 4899999999999999 6776544 9999999999999999984 44 699999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|.+++. +. +.++++|++|++++|.....++ .+..+++|++|++++|.+.+. +. +..+++|++|++
T Consensus 117 l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~~~-------~~~~l~~L~~L~l~~~~~~~~-~~--~~~l~~L~~L~l 184 (347)
T 4fmz_A 117 LNEDNISDI-SP-LANLTKMYSLNLGANHNLSDLS-------PLSNMTGLNYLTVTESKVKDV-TP--IANLTDLYSLSL 184 (347)
T ss_dssp CTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCCCG-------GGTTCTTCCEEECCSSCCCCC-GG--GGGCTTCSEEEC
T ss_pred CcCCcccCc-hh-hccCCceeEEECCCCCCccccc-------chhhCCCCcEEEecCCCcCCc-hh--hccCCCCCEEEc
Confidence 999999954 33 8899999999999997654443 478899999999999999843 33 778889999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
++|++++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|.+++.++ +..+++|++|++++|.++.
T Consensus 185 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~-- 257 (347)
T 4fmz_A 185 NYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISD-- 257 (347)
T ss_dssp TTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC--
T ss_pred cCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-hhcCCCCCEEECCCCccCC--
Confidence 9999986544 8889999999999999996554 8899999999999999998776 8899999999999999963
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeecc-CCCcc
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITL-GSGIK 382 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~-~~~~~ 382 (964)
. ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|+++.++. .....
T Consensus 258 ~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~l~~ 334 (347)
T 4fmz_A 258 I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSK 334 (347)
T ss_dssp C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGGGGGCTT
T ss_pred C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccChhhhhc
Confidence 2 4688999999999999999875 468899999999999999999998889999999999999999999865 55666
Q ss_pred cceeEeecCCc
Q 002121 383 NYTLILVGNPV 393 (964)
Q Consensus 383 l~~l~l~~Np~ 393 (964)
+..|++.+|++
T Consensus 335 L~~L~l~~N~i 345 (347)
T 4fmz_A 335 MDSADFANQVI 345 (347)
T ss_dssp CSEESSSCC--
T ss_pred cceeehhhhcc
Confidence 88999999984
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=299.83 Aligned_cols=252 Identities=30% Similarity=0.494 Sum_probs=155.6
Q ss_pred cccEEecccCCCCCC--CCCCCCCCcccchhhcccc-ccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccc
Q 002121 89 ELRSLDLSYNGGLTG--SLSPRIGDLQKLNILILAG-CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYW 165 (964)
Q Consensus 89 ~L~~L~L~~N~~l~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 165 (964)
+++.|+|++| .+.+ .+|..|+++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 51 ~l~~L~L~~~-~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 51 RVNNLDLSGL-NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CEEEEEEECC-CCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred eEEEEECCCC-CccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 4555555555 4555 4555555555555555553 5555555555555555555555555555555555555555555
Q ss_pred ccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCC-CCcE
Q 002121 166 LDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ-TLEV 244 (964)
Q Consensus 166 L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~-~L~~ 244 (964)
|+|++|++++.+| ..+..++ +|++|++++|++++.+|..+..++ +|+.
T Consensus 130 L~Ls~N~l~~~~p------~~~~~l~-------------------------~L~~L~L~~N~l~~~~p~~l~~l~~~L~~ 178 (313)
T 1ogq_A 130 LDFSYNALSGTLP------PSISSLP-------------------------NLVGITFDGNRISGAIPDSYGSFSKLFTS 178 (313)
T ss_dssp EECCSSEEESCCC------GGGGGCT-------------------------TCCEEECCSSCCEEECCGGGGCCCTTCCE
T ss_pred EeCCCCccCCcCC------hHHhcCC-------------------------CCCeEECcCCcccCcCCHHHhhhhhcCcE
Confidence 5555555443333 1122222 233333333333334444445554 5555
Q ss_pred EEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcc
Q 002121 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSL 324 (964)
Q Consensus 245 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 324 (964)
|+|++|++++.+|..|..++ |++|+|++|.++ ...+..|..+++|+.|+|++|++
T Consensus 179 L~L~~N~l~~~~~~~~~~l~------------------------L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l 233 (313)
T 1ogq_A 179 MTISRNRLTGKIPPTFANLN------------------------LAFVDLSRNMLE-GDASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp EECCSSEEEEECCGGGGGCC------------------------CSEEECCSSEEE-ECCGGGCCTTSCCSEEECCSSEE
T ss_pred EECcCCeeeccCChHHhCCc------------------------ccEEECcCCccc-CcCCHHHhcCCCCCEEECCCCce
Confidence 55555555555555555443 555555555554 34556677778888888888888
Q ss_pred ccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee-eccC-CCcccceeEeecCC-cccccc
Q 002121 325 QGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA-ITLG-SGIKNYTLILVGNP-VCTATL 398 (964)
Q Consensus 325 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-i~~~-~~~~l~~l~l~~Np-~c~~~l 398 (964)
++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|+|++|++++ +|.. ....+..+++.+|| .|...+
T Consensus 234 ~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~ 309 (313)
T 1ogq_A 234 AFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309 (313)
T ss_dssp CCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred eeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCC
Confidence 777666 8889999999999999999999999999999999999999995 4433 34457789999999 887543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=296.49 Aligned_cols=287 Identities=22% Similarity=0.276 Sum_probs=240.4
Q ss_pred eeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcc
Q 002121 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145 (964)
Q Consensus 66 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls 145 (964)
++.+++++++++ .+|..+. ++|++|+|++| .+.+..|..|.++++|++|+|++|.+++..|..|.++++|++|+|+
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNN-DISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSS-CCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCC-cCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 455666777776 5666663 68999999999 7888778899999999999999999998888999999999999999
Q ss_pred cCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccc-cccccccCCCcceeEEEcc
Q 002121 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG-TISEQLFSPDMVLIHVLFD 224 (964)
Q Consensus 146 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g-~l~~~~f~~~~~L~~L~l~ 224 (964)
+|+++ .+|..+. ++|++|++++|+++ .+|. ..+..+++|+.|++++|.++. .+....|..+ +|++|+++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~-~~~~-----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~ 180 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPK-----GVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRIS 180 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCC-CCCS-----GGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCC
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccC-ccCH-----hHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECc
Confidence 99999 6666665 78999999999998 3441 357889999999999999963 2445556666 89999999
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCC
Q 002121 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
+|++++ +|..+. ++|+.|+|++|.+++..+..|.++++|+.|+|++|++++.++. +..+++|++|+|++|+++ .
T Consensus 181 ~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--~ 255 (332)
T 2ft3_A 181 EAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS--R 255 (332)
T ss_dssp SSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC--B
T ss_pred CCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe--e
Confidence 999996 565544 7899999999999988889999999999999999999998874 889999999999999995 6
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCC------CCCCEEEcCCcccc--cccCCCCccCCCCcEEeccCCc
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSY------SQIQQVKLRNNAFN--NTLDMGNAVGPLLQLVDLQNNQ 371 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~L~~N~l~--~~~~~~~~~l~~L~~L~L~~N~ 371 (964)
+|..+..+++|+.|+|++|+|++..+..|..+ +.|+.|+|++|++. ...+..|..++.|+.|+|++|+
T Consensus 256 lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 256 VPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred cChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 77779999999999999999998888877653 67999999999998 6778889999999999999985
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=319.93 Aligned_cols=287 Identities=19% Similarity=0.215 Sum_probs=256.2
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|.+++..+..|+.+++|++|+|++| .+.+..|..|+++++|++|+|++|.|++..+..|+++++|++|+
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~ 153 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN-AIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS 153 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSS-CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCC-cCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence 58999999999999988889999999999999999 79998888999999999999999999966566679999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|.+++..|..|.++++|++|+|++|.+++ +| +..+++|+.|++++|.+++ +....+|+.|++
T Consensus 154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~--------~~~l~~L~~L~l~~n~l~~------l~~~~~L~~L~l 218 (597)
T 3oja_B 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VD--------LSLIPSLFHANVSYNLLST------LAIPIAVEELDA 218 (597)
T ss_dssp CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSB-CC--------GGGCTTCSEEECCSSCCSE------EECCTTCSEEEC
T ss_pred eeCCcCCCCChhhhhcCCcCcEEECcCCCCCC-cC--------hhhhhhhhhhhcccCcccc------ccCCchhheeec
Confidence 99999999889999999999999999999984 33 5678999999999999984 234467999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
++|.++...+.. .++|+.|+|++|.+++ +..+..+++|+.|+|++|.|++.+| .+..+++|++|+|++|.++
T Consensus 219 s~n~l~~~~~~~---~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-- 291 (597)
T 3oja_B 219 SHNSINVVRGPV---NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-- 291 (597)
T ss_dssp CSSCCCEEECSC---CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCC--
T ss_pred cCCccccccccc---CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCC--
Confidence 999998654432 3689999999999996 4789999999999999999999876 4899999999999999996
Q ss_pred CCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeecc
Q 002121 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITL 377 (964)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 377 (964)
.+|..+..+++|+.|+|++|.+. .+|..+..+++|+.|+|++|++++.. +..++.|+.|+|++|+|++-..
T Consensus 292 ~l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~L~~L~l~~N~~~~~~~ 362 (597)
T 3oja_B 292 ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTHHTLKNLTLSHNDWDCNSL 362 (597)
T ss_dssp EEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTTCCCSEEECCSSCEEHHHH
T ss_pred CCCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhcCCCCEEEeeCCCCCChhH
Confidence 35777788999999999999999 67788899999999999999998763 6778999999999999997653
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=290.64 Aligned_cols=279 Identities=21% Similarity=0.230 Sum_probs=184.6
Q ss_pred CCCccEEecC-----------CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhcccc
Q 002121 54 GSWEGVTCNN-----------SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAG 122 (964)
Q Consensus 54 ~~w~gv~C~~-----------~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~ 122 (964)
|.|+.+.|+. ..++.|+|++|++++..+..|+++++|++|+|++| .+.+..|..|+++++|++|+|++
T Consensus 31 c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n-~l~~~~~~~~~~l~~L~~L~Ls~ 109 (330)
T 1xku_A 31 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN-KISKISPGAFAPLVKLERLYLSK 109 (330)
T ss_dssp EETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS-CCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCC-cCCeeCHHHhcCCCCCCEEECCC
Confidence 4677777752 24666777777777666666777777777777777 56666677777777777777777
Q ss_pred ccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccccccccc--ccCcccCCCCccccccCCCeeEccC
Q 002121 123 CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTG--SIPVSTITSPGLDQLKNAKHFHFNK 200 (964)
Q Consensus 123 n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~iP~~~~~~~~l~~l~~L~~L~L~~ 200 (964)
|.++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|+++. ..| ..+..+++|++|++++
T Consensus 110 n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 110 NQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN------GAFQGMKKLSYIRIAD 180 (330)
T ss_dssp SCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT------TGGGGCTTCCEEECCS
T ss_pred CcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcCh------hhccCCCCcCEEECCC
Confidence 7776 5555544 567777777777776655667777777777777777652 222 3566677777777777
Q ss_pred CcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCC
Q 002121 201 NKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPF 280 (964)
Q Consensus 201 N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 280 (964)
|+++ .+|..++ ++|++|++++|++++..|..+..+++|+.|+|++|.+++..+..|..+++|++|+|++|+++.++
T Consensus 181 n~l~-~l~~~~~---~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp 256 (330)
T 1xku_A 181 TNIT-TIPQGLP---PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 256 (330)
T ss_dssp SCCC-SCCSSCC---TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCC
T ss_pred Cccc-cCCcccc---ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCccCC
Confidence 7776 4555544 56777777777777666677777777777777777777666666777777777777777777666
Q ss_pred CCCCCCCCCCEEEccCCCCCCCCCCcccCC------CCCCcEEECCCCcccc--ccChhccCCCCCCEEEcCCcc
Q 002121 281 PDLSQMNSLSYVDLSNNSFDPTEAPLWFST------LPSLTTLICEFGSLQG--RVPDKLFSYSQIQQVKLRNNA 347 (964)
Q Consensus 281 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~------l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~ 347 (964)
..+..+++|++|++++|+++ ...+..|.. .+.|+.|++++|.+.. ..|..|..+.+|+.|+|++|+
T Consensus 257 ~~l~~l~~L~~L~l~~N~i~-~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 257 GGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTTTTCSSCCEEECCSSCCC-CCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred hhhccCCCcCEEECCCCcCC-ccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 66677777777777777776 444444432 3566777777777653 455667777777777777764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-31 Score=293.44 Aligned_cols=265 Identities=25% Similarity=0.315 Sum_probs=150.7
Q ss_pred cccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccc
Q 002121 89 ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDL 168 (964)
Q Consensus 89 ~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 168 (964)
+|+.+++++| .+. .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 34 ~l~~l~~~~~-~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 109 (332)
T 2ft3_A 34 HLRVVQCSDL-GLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYI 109 (332)
T ss_dssp ETTEEECCSS-CCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEEC
T ss_pred cCCEEECCCC-Ccc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEEC
Confidence 4556666655 333 4444442 45666666666666544555666666666666666666555556666666666666
Q ss_pred cccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCc--ccCCcccCCCCCCcEEE
Q 002121 169 ADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS--GNIPESLGYVQTLEVLR 246 (964)
Q Consensus 169 s~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~ 246 (964)
++|+++ .+|.. +. ++|++|++++|+++ .++...|..+++|++|++++|+++ +..+..+..+ +|+.|+
T Consensus 110 ~~n~l~-~l~~~------~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~ 178 (332)
T 2ft3_A 110 SKNHLV-EIPPN------LP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLR 178 (332)
T ss_dssp CSSCCC-SCCSS------CC--TTCCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCB
T ss_pred CCCcCC-ccCcc------cc--ccCCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEE
Confidence 666665 44422 11 45666666666665 455555555666666666666664 2455555555 666666
Q ss_pred cccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccc
Q 002121 247 LDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 247 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
+++|++++ +|..+. ++|++|+|++|.+++.++ .+..+++|++|+|++|+++ ...+..+..+++|+.|+|++|+++
T Consensus 179 l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~ 254 (332)
T 2ft3_A 179 ISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254 (332)
T ss_dssp CCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCC-CCCTTGGGGCTTCCEEECCSSCCC
T ss_pred CcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCC-cCChhHhhCCCCCCEEECCCCcCe
Confidence 66666663 444333 456666666666665553 3555666666666666665 344445566666666666666665
Q ss_pred cccChhccCCCCCCEEEcCCcccccccCCCCccC------CCCcEEeccCCcce
Q 002121 326 GRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG------PLLQLVDLQNNQIS 373 (964)
Q Consensus 326 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l------~~L~~L~L~~N~l~ 373 (964)
.+|..+..+++|+.|+|++|++++..+..|... +.|+.|++++|++.
T Consensus 255 -~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 255 -RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp -BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred -ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccc
Confidence 455556666666666666666665555554432 34566666666655
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-30 Score=301.96 Aligned_cols=298 Identities=19% Similarity=0.223 Sum_probs=253.1
Q ss_pred CCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEE
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 142 (964)
-.+++.|+|++|++++. | .++.+++|++|+|++| .+.+. | ++.+++|++|+|++|.|++. | ++++++|++|
T Consensus 41 l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n-~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L 111 (457)
T 3bz5_A 41 LATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSN-NITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYL 111 (457)
T ss_dssp HTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSS-CCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEE
T ss_pred cCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCC-cCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEE
Confidence 36899999999999975 4 7999999999999999 68774 3 89999999999999999964 4 8999999999
Q ss_pred EcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEE
Q 002121 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL 222 (964)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~ 222 (964)
+|++|++++ +| ++++++|++|++++|++++ +| +..+++|++|++++|+..+.++ +..+++|++|+
T Consensus 112 ~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--------l~~l~~L~~L~l~~n~~~~~~~---~~~l~~L~~L~ 176 (457)
T 3bz5_A 112 NCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--------VSHNTQLTELDCHLNKKITKLD---VTPQTQLTTLD 176 (457)
T ss_dssp ECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--------CTTCTTCCEEECTTCSCCCCCC---CTTCTTCCEEE
T ss_pred ECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--------cccCCcCCEEECCCCCcccccc---cccCCcCCEEE
Confidence 999999996 44 8999999999999999995 33 6788999999999997666663 67789999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCC
Q 002121 223 FDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 223 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
+++|++++ +| ++.+++|+.|++++|.+++. .+..+++|++|+|++|++++++ +..+++|++|++++|++++
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip--~~~l~~L~~L~l~~N~l~~- 247 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEID--VTPLTQLTYFDCSVNPLTE- 247 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCC--CTTCTTCSEEECCSSCCSC-
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccC--ccccCCCCEEEeeCCcCCC-
Confidence 99999997 44 88999999999999999965 4889999999999999999954 8899999999999999984
Q ss_pred CCCcccCCCC-------CCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCC--------CCccCCCCcEEec
Q 002121 303 EAPLWFSTLP-------SLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDM--------GNAVGPLLQLVDL 367 (964)
Q Consensus 303 ~~~~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~--------~~~~l~~L~~L~L 367 (964)
..+..+..+. +|+.|++++|.+.+.+| +..+++|+.|+|++|++.+.+|. .+..+++|+.|+|
T Consensus 248 ~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L 325 (457)
T 3bz5_A 248 LDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYL 325 (457)
T ss_dssp CCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEEC
T ss_pred cCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEEC
Confidence 3444444444 55666777777666666 56789999999999987665553 3667788999999
Q ss_pred cCCcceeeccCCCcccceeEeecCCccc
Q 002121 368 QNNQISAITLGSGIKNYTLILVGNPVCT 395 (964)
Q Consensus 368 ~~N~l~~i~~~~~~~l~~l~l~~Np~c~ 395 (964)
++|+|+.++......++.|++.+|.+-+
T Consensus 326 ~~N~l~~l~l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 326 NNTELTELDVSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp TTCCCSCCCCTTCTTCSEEECCSSCCCB
T ss_pred CCCcccccccccCCcCcEEECCCCCCCC
Confidence 9999999988888889999999998643
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=304.17 Aligned_cols=296 Identities=26% Similarity=0.313 Sum_probs=154.1
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|.+++..+ +..+++|++|+|++| .+.+..+ ++++++|++|+|++|.+++. +. +.++++|++|+
T Consensus 68 ~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n-~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~L~ 140 (466)
T 1o6v_A 68 NNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN-QIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNRLE 140 (466)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS-CCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSEEE
T ss_pred cCCCEEECCCCccCCchh--hhccccCCEEECCCC-ccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCEEE
Confidence 456666666666665433 666666666666666 4554443 66666666666666666633 22 66666666666
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|.+++. + .+.++++|++|+++ |.+.+ ...+..+++|+.|++++|.+++ ++ .+..+++|++|++
T Consensus 141 l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~--------~~~~~~l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l 206 (466)
T 1o6v_A 141 LSSNTISDI-S-ALSGLTSLQQLSFG-NQVTD--------LKPLANLTTLERLDISSNKVSD-IS--VLAKLTNLESLIA 206 (466)
T ss_dssp EEEEEECCC-G-GGTTCTTCSEEEEE-ESCCC--------CGGGTTCTTCCEEECCSSCCCC-CG--GGGGCTTCSEEEC
T ss_pred CCCCccCCC-h-hhccCCcccEeecC-CcccC--------chhhccCCCCCEEECcCCcCCC-Ch--hhccCCCCCEEEe
Confidence 666666532 2 23333333333332 11111 1124455556666666665552 22 2444555555555
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
++|++++..| ++.+++|+.|++++|.+++. ..+..+++|+.|+|++|.+++..+ +..+++|++|++++|.++ .
T Consensus 207 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~-~- 279 (466)
T 1o6v_A 207 TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQIS-N- 279 (466)
T ss_dssp CSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCC-C-
T ss_pred cCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccC-c-
Confidence 5555554433 44455555555555555532 234555555555555555555443 555555555555555553 1
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeec-cCCCcc
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAIT-LGSGIK 382 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~-~~~~~~ 382 (964)
.+. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|++++|+++.++ ......
T Consensus 280 ~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~ 354 (466)
T 1o6v_A 280 ISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTN 354 (466)
T ss_dssp CGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTT
T ss_pred ccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCC
Confidence 121 4555555555555555554433 4455555555555555555443 445555555555555555543 122333
Q ss_pred cceeEeecCC
Q 002121 383 NYTLILVGNP 392 (964)
Q Consensus 383 l~~l~l~~Np 392 (964)
++.|++.+|+
T Consensus 355 L~~L~l~~n~ 364 (466)
T 1o6v_A 355 INWLSAGHNQ 364 (466)
T ss_dssp CCEEECCSSC
T ss_pred CCEEeCCCCc
Confidence 4455555555
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-30 Score=300.50 Aligned_cols=299 Identities=26% Similarity=0.359 Sum_probs=259.3
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|++.+++++. +| .+..+++|++|+|++| .+.+..+ +.++++|++|+|++|.+++..| ++++++|++|+
T Consensus 46 ~~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n-~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~ 118 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNN-QLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLT 118 (466)
T ss_dssp HTCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSS-CCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred ccccEEecCCCCCcc-Cc-chhhhcCCCEEECCCC-ccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEE
Confidence 579999999999985 55 4889999999999999 6776655 9999999999999999996554 99999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|++|.+++..+ +.++++|++|++++|++++ +| .+..+++|+.|+++ |.+.+. +. +..+++|++|++
T Consensus 119 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~-------~~~~l~~L~~L~l~-~~~~~~-~~--~~~l~~L~~L~l 184 (466)
T 1o6v_A 119 LFNNQITDIDP--LKNLTNLNRLELSSNTISD-IS-------ALSGLTSLQQLSFG-NQVTDL-KP--LANLTTLERLDI 184 (466)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CG-------GGTTCTTCSEEEEE-ESCCCC-GG--GTTCTTCCEEEC
T ss_pred CCCCCCCCChH--HcCCCCCCEEECCCCccCC-Ch-------hhccCCcccEeecC-CcccCc-hh--hccCCCCCEEEC
Confidence 99999996543 9999999999999999983 33 47889999999997 555533 22 788899999999
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
++|++++. ..+..+++|+.|++++|.+++..| +..+++|++|+|++|.+++. +.+..+++|++|++++|.++ ..
T Consensus 185 ~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~-~~ 258 (466)
T 1o6v_A 185 SSNKVSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-GTLASLTNLTDLDLANNQIS-NL 258 (466)
T ss_dssp CSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCC-CC
T ss_pred cCCcCCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc-hhhhcCCCCCEEECCCCccc-cc
Confidence 99999864 348899999999999999997666 78899999999999999975 56889999999999999997 33
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeecc-CCCcc
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITL-GSGIK 382 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~-~~~~~ 382 (964)
.+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|+++.++. .....
T Consensus 259 ~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~ 332 (466)
T 1o6v_A 259 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTK 332 (466)
T ss_dssp GG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTT
T ss_pred hh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCcc
Confidence 33 8999999999999999998765 8899999999999999998766 8899999999999999998864 45566
Q ss_pred cceeEeecCCccc
Q 002121 383 NYTLILVGNPVCT 395 (964)
Q Consensus 383 l~~l~l~~Np~c~ 395 (964)
++.|++.+|++.+
T Consensus 333 L~~L~l~~n~l~~ 345 (466)
T 1o6v_A 333 LQRLFFYNNKVSD 345 (466)
T ss_dssp CCEEECCSSCCCC
T ss_pred CCEeECCCCccCC
Confidence 8999999998543
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=288.71 Aligned_cols=283 Identities=18% Similarity=0.273 Sum_probs=247.4
Q ss_pred CCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEE
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 142 (964)
..+++.|++++|.+++..+ +..+++|++|+|++| .+... +.+..+++|++|+|++|.+++ ++. +..+++|++|
T Consensus 65 ~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n-~i~~~--~~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~~L 137 (347)
T 4fmz_A 65 LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTN-KITDI--SALQNLTNLRELYLNEDNISD-ISP-LANLTKMYSL 137 (347)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS-CCCCC--GGGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCCEE
T ss_pred cCCccEEEccCCccccchh--hhcCCcCCEEEccCC-cccCc--hHHcCCCcCCEEECcCCcccC-chh-hccCCceeEE
Confidence 4689999999999986544 999999999999999 67653 479999999999999999995 444 8999999999
Q ss_pred EcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEE
Q 002121 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL 222 (964)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~ 222 (964)
++++|.....+ ..+..+++|++|++++|.+.+ ++ .+..+++|+.|++++|.+. .++. +..+.+|+.|+
T Consensus 138 ~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~-~~-------~~~~l~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~ 205 (347)
T 4fmz_A 138 NLGANHNLSDL-SPLSNMTGLNYLTVTESKVKD-VT-------PIANLTDLYSLSLNYNQIE-DISP--LASLTSLHYFT 205 (347)
T ss_dssp ECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCC-CG-------GGGGCTTCSEEECTTSCCC-CCGG--GGGCTTCCEEE
T ss_pred ECCCCCCcccc-cchhhCCCCcEEEecCCCcCC-ch-------hhccCCCCCEEEccCCccc-cccc--ccCCCccceee
Confidence 99999776444 459999999999999999983 22 2788999999999999998 4444 77889999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCC
Q 002121 223 FDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 223 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
+++|++++..+ +..+++|+.|++++|.+++..+ +..+++|++|+|++|.+++. +.+..+++|++|++++|.++.
T Consensus 206 l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~l~~n~l~~- 279 (347)
T 4fmz_A 206 AYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI-NAVKDLTKLKMLNVGSNQISD- 279 (347)
T ss_dssp CCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCCC-
T ss_pred cccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC-hhHhcCCCcCEEEccCCccCC-
Confidence 99999997655 8899999999999999995544 99999999999999999986 568899999999999999963
Q ss_pred CCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
. ..+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+ +..+++|+.|++++|+|+.
T Consensus 280 -~-~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~~ 347 (347)
T 4fmz_A 280 -I-SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIKK 347 (347)
T ss_dssp -C-GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC----
T ss_pred -C-hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhcccC
Confidence 3 458999999999999999999999999999999999999999998877 8899999999999999863
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=294.60 Aligned_cols=288 Identities=20% Similarity=0.200 Sum_probs=209.8
Q ss_pred CCCCCCCCCCCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhcccccc
Q 002121 45 TWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCG 124 (964)
Q Consensus 45 ~W~~~~~~C~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~ 124 (964)
.|.....+| .|.|+ | ++++++++ .+|..+. ++|++|+|++| .+.+..+..|.++++|++|+|++|+
T Consensus 22 ~~~~~~~~C-~~~~~-c--------~~~~~~l~-~iP~~~~--~~L~~L~l~~n-~i~~~~~~~~~~l~~L~~L~L~~n~ 87 (353)
T 2z80_A 22 SSNQASLSC-DRNGI-C--------KGSSGSLN-SIPSGLT--EAVKSLDLSNN-RITYISNSDLQRCVNLQALVLTSNG 87 (353)
T ss_dssp -----CCEE-CTTSE-E--------ECCSTTCS-SCCTTCC--TTCCEEECTTS-CCCEECTTTTTTCTTCCEEECTTSC
T ss_pred CCCccCCCC-CCCeE-e--------eCCCCCcc-ccccccc--ccCcEEECCCC-cCcccCHHHhccCCCCCEEECCCCc
Confidence 343334445 89887 6 45677777 5676655 58999999999 7887777789999999999999999
Q ss_pred ccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccc
Q 002121 125 FTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS 204 (964)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~ 204 (964)
+++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|+++ .+|.. ..+..+++|++|++++|+..
T Consensus 88 l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~----~~~~~l~~L~~L~l~~n~~~ 162 (353)
T 2z80_A 88 INTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGET----SLFSHLTKLQILRVGNMDTF 162 (353)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSS----CSCTTCTTCCEEEEEESSSC
T ss_pred cCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCch----hhhccCCCCcEEECCCCccc
Confidence 99877888999999999999999999655555889999999999999998 45521 35678888999999888533
Q ss_pred ccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-C
Q 002121 205 GTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-L 283 (964)
Q Consensus 205 g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l 283 (964)
+.++...|..+++|++|++++|++++..|..+..+++|+.|++++|.++...+..+..+++|+.|+|++|.+++..+. +
T Consensus 163 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l 242 (353)
T 2z80_A 163 TKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSEL 242 (353)
T ss_dssp CEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC--
T ss_pred cccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCcccccccccc
Confidence 366666777778888888888888877788888888888888888887743333445577788888888877765432 1
Q ss_pred CCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccc----ccChhccCCCCCCEEEcCCcccccccCCCCccC
Q 002121 284 SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG----RVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359 (964)
Q Consensus 284 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 359 (964)
.. ....+.++.++|++|.+.+ .+|..+..+++|+.|+|++|+++...+..+..+
T Consensus 243 ~~----------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l 300 (353)
T 2z80_A 243 ST----------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRL 300 (353)
T ss_dssp --------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred cc----------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcC
Confidence 10 1123344455555555544 367778888888888888888886555556777
Q ss_pred CCCcEEeccCCcce
Q 002121 360 PLLQLVDLQNNQIS 373 (964)
Q Consensus 360 ~~L~~L~L~~N~l~ 373 (964)
++|+.|+|++|+++
T Consensus 301 ~~L~~L~L~~N~~~ 314 (353)
T 2z80_A 301 TSLQKIWLHTNPWD 314 (353)
T ss_dssp TTCCEEECCSSCBC
T ss_pred CCCCEEEeeCCCcc
Confidence 77887777777664
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=295.97 Aligned_cols=262 Identities=19% Similarity=0.181 Sum_probs=135.2
Q ss_pred CccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcc
Q 002121 138 ELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMV 217 (964)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~ 217 (964)
+|++|+|++|+|++..|..|.++++|++|+|++|++++..| ..|..+++|++|+|++|+++ .++...|..+++
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~------~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~ 148 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEV------GAFNGLASLNTLELFDNWLT-VIPSGAFEYLSK 148 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECT------TTTTTCTTCCEEECCSSCCS-BCCTTTSSSCTT
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcCh------hhccCcccCCEEECCCCcCC-ccChhhhcccCC
Confidence 44444444444444444444444444444444444442222 22333344444444444433 333333444444
Q ss_pred eeEEEccCCcCcccCCcccCCCCCCcEEEccc-CcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccC
Q 002121 218 LIHVLFDGNQLSGNIPESLGYVQTLEVLRLDR-NALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSN 296 (964)
Q Consensus 218 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~ 296 (964)
|++|+|++|+|+...+..|..+++|+.|+|++ |.++...+..|.++++|++|+|++|++++. |.+..+++|++|+|++
T Consensus 149 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~ 227 (452)
T 3zyi_A 149 LRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSG 227 (452)
T ss_dssp CCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTT
T ss_pred CCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-ccccccccccEEECcC
Confidence 44444455555444444556666666666665 334433334566666666666666666544 3455555555555555
Q ss_pred CCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeec
Q 002121 297 NSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAIT 376 (964)
Q Consensus 297 N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 376 (964)
|.++ ...+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+..+..+++|+
T Consensus 228 N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~------------- 293 (452)
T 3zyi_A 228 NHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV------------- 293 (452)
T ss_dssp SCCS-EECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC-------------
T ss_pred CcCc-ccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC-------------
Confidence 5554 34444455555555555555555555555555555555555555555544444444444444
Q ss_pred cCCCcccceeEeecCC-cccccccccCccccCCCCCcccccccccCCCCCCCCCCC
Q 002121 377 LGSGIKNYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQK 431 (964)
Q Consensus 377 ~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~ 431 (964)
.|+|.+|| .|+|.+.++..|..+... ...+....|.+|.-..++.
T Consensus 294 --------~L~L~~Np~~CdC~~~~l~~~l~~~~~--~~~~~~~~C~~P~~l~g~~ 339 (452)
T 3zyi_A 294 --------ELHLHHNPWNCDCDILWLAWWLREYIP--TNSTCCGRCHAPMHMRGRY 339 (452)
T ss_dssp --------EEECCSSCEECSTTTHHHHHHHHHHC-----CCSSCBEEESTTTTTCB
T ss_pred --------EEEccCCCcCCCCCchHHHHHHHHhCc--cCCccCcEeCCchHhccch
Confidence 45566666 699999988888533221 1223346788887666663
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-29 Score=291.98 Aligned_cols=280 Identities=20% Similarity=0.187 Sum_probs=148.7
Q ss_pred cEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccc
Q 002121 91 RSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170 (964)
Q Consensus 91 ~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 170 (964)
+.++.+++ .+. .+|..+. .+|+.|+|++|+|++..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 46 ~~v~c~~~-~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 46 SKVICVRK-NLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp CEEECCSC-CCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CEEEeCCC-CcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 45666655 232 3444443 3455555555555544455555555555555555555544445555555555555555
Q ss_pred cccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEccc-
Q 002121 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDR- 249 (964)
Q Consensus 171 N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~- 249 (964)
|+++ .++...|..+++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus 122 n~l~-------------------------------~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~ 170 (440)
T 3zyj_A 122 NRLT-------------------------------TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGEL 170 (440)
T ss_dssp SCCS-------------------------------SCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCC
T ss_pred CcCC-------------------------------eeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCC
Confidence 5554 33333333444444444444444444444555666666666665
Q ss_pred CcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccC
Q 002121 250 NALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVP 329 (964)
Q Consensus 250 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 329 (964)
|.++...+..|.++++|++|+|++|+|+.+ |.+..+++|++|+|++|+++ ...+..|.++++|+.|+|++|+|++..+
T Consensus 171 ~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 248 (440)
T 3zyj_A 171 KRLSYISEGAFEGLSNLRYLNLAMCNLREI-PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIER 248 (440)
T ss_dssp TTCCEECTTTTTTCSSCCEEECTTSCCSSC-CCCTTCSSCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred CCcceeCcchhhcccccCeecCCCCcCccc-cccCCCcccCEEECCCCccC-ccChhhhccCccCCEEECCCCceeEECh
Confidence 333333333556666666666666666533 23455555555555555554 3334445555555555555555555555
Q ss_pred hhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCccccCC
Q 002121 330 DKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYCQLQQ 408 (964)
Q Consensus 330 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~~~~ 408 (964)
..|.++++|+.|+|++|+++...+..+..+++| +.|+|.+|| .|||.+.++..|....
T Consensus 249 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L---------------------~~L~L~~Np~~CdC~l~~l~~~~~~~ 307 (440)
T 3zyj_A 249 NAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL---------------------ERIHLHHNPWNCNCDILWLSWWIKDM 307 (440)
T ss_dssp TSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC---------------------CEEECCSSCEECSSTTHHHHHHHHTT
T ss_pred hhhcCCCCCCEEECCCCCCCccChhHhccccCC---------------------CEEEcCCCCccCCCCchHHHHHHHhc
Confidence 555555555555555555554444444444444 455566666 6999999998885443
Q ss_pred CCCcccccccccCCCCCCCCCC
Q 002121 409 PTTKAYSTSLANCGGKSCPPEQ 430 (964)
Q Consensus 409 ~~~~~~~~~~~~c~~~~~~~~~ 430 (964)
.. ........|..|+-..++
T Consensus 308 ~~--~~~~~~~~C~~P~~l~g~ 327 (440)
T 3zyj_A 308 AP--SNTACCARCNTPPNLKGR 327 (440)
T ss_dssp SC--SSCSCCCBEEESTTTTTC
T ss_pred cc--cCCccccCCCChhHhcCc
Confidence 22 122334567777666555
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=302.58 Aligned_cols=308 Identities=17% Similarity=0.175 Sum_probs=247.4
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.|+|++|+|++..+.+|.+|++|++|+|++| .+.+..+..|.++++|++|+|++|+|++..+..|+++++|++|+
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N-~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~ 154 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN-PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELN 154 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTC-CCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCC-cCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeec
Confidence 57899999999999888889999999999999999 78887778899999999999999999977777899999999999
Q ss_pred cccCcccC-cCCCcCCCccccccccccccccccccCcccCC---------------------------------------
Q 002121 144 LNSNNFSG-RIPPSLGKLSQLYWLDLADNQLTGSIPVSTIT--------------------------------------- 183 (964)
Q Consensus 144 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~--------------------------------------- 183 (964)
|++|.+++ .+|..++++++|++|+|++|++++..|.....
T Consensus 155 Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 155 VAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred cccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 99999986 45788999999999999999987543321000
Q ss_pred --------------------------------------------------------------------------------
Q 002121 184 -------------------------------------------------------------------------------- 183 (964)
Q Consensus 184 -------------------------------------------------------------------------------- 183 (964)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred ------CCccccccCCCeeEccCCcccccccccc-------------------cCCCcceeEEEccCCcC----------
Q 002121 184 ------SPGLDQLKNAKHFHFNKNKLSGTISEQL-------------------FSPDMVLIHVLFDGNQL---------- 228 (964)
Q Consensus 184 ------~~~l~~l~~L~~L~L~~N~l~g~l~~~~-------------------f~~~~~L~~L~l~~N~l---------- 228 (964)
...+.....|+.|++.+|.+.+ ++... +..+++|+.|++++|.+
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~-~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~ 393 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSD 393 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEESS-CCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHH
T ss_pred ccccccccccccchhhhhhhcccccccC-cCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccch
Confidence 0000111123444444444331 11000 01233444444444443
Q ss_pred ---------------------------------------cccC-CcccCCCCCCcEEEcccCcCccccCccccCCCCCCe
Q 002121 229 ---------------------------------------SGNI-PESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNE 268 (964)
Q Consensus 229 ---------------------------------------~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (964)
.... +..+..+.+++.++++.|.+++..+..+..++.|+.
T Consensus 394 ~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~ 473 (635)
T 4g8a_A 394 FGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 473 (635)
T ss_dssp HSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCE
T ss_pred hhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhh
Confidence 3222 234677888999999999999999999999999999
Q ss_pred eeccCccCcc-CCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCc
Q 002121 269 LNLAHNDLKG-PFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNN 346 (964)
Q Consensus 269 L~Ls~N~l~~-~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 346 (964)
|+|++|.+.. ..| .+..+++|++|+|++|+|+ ...|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus 474 L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~-~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N 552 (635)
T 4g8a_A 474 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 552 (635)
T ss_dssp EECTTCEEGGGEECSCCTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTS
T ss_pred hhhhhcccccccCchhhhhccccCEEECCCCccC-CcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCC
Confidence 9999998544 444 4899999999999999998 777889999999999999999999999999999999999999999
Q ss_pred ccccccCCCCccC-CCCcEEeccCCccee
Q 002121 347 AFNNTLDMGNAVG-PLLQLVDLQNNQISA 374 (964)
Q Consensus 347 ~l~~~~~~~~~~l-~~L~~L~L~~N~l~~ 374 (964)
+|++..+..+..+ ++|+.|+|++|+|++
T Consensus 553 ~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 553 HIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp CCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred cCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 9999999999988 579999999999997
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-29 Score=287.60 Aligned_cols=289 Identities=17% Similarity=0.135 Sum_probs=240.6
Q ss_pred CCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEE
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 142 (964)
..+++.|+|++|++++. | ++.+++|++|+|++| .+.+. + ++++++|++|+|++|.+++ +| ++.+++|++|
T Consensus 63 l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N-~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L 132 (457)
T 3bz5_A 63 LTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSN-KLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLTYL 132 (457)
T ss_dssp CTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSS-CCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCCEE
T ss_pred cCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCC-CCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCCEE
Confidence 46899999999999985 3 999999999999999 68774 3 9999999999999999996 55 8999999999
Q ss_pred EcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEE
Q 002121 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVL 222 (964)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~ 222 (964)
+|++|++++. + ++++++|++|++++|+..+.++ +..+++|+.|++++|++++ +| +..+++|+.|+
T Consensus 133 ~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~--------~~~l~~L~~L~ls~n~l~~-l~---l~~l~~L~~L~ 197 (457)
T 3bz5_A 133 NCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD--------VTPQTQLTTLDCSFNKITE-LD---VSQNKLLNRLN 197 (457)
T ss_dssp ECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC--------CTTCTTCCEEECCSSCCCC-CC---CTTCTTCCEEE
T ss_pred ECCCCcccee-c--cccCCcCCEEECCCCCcccccc--------cccCCcCCEEECCCCccce-ec---cccCCCCCEEE
Confidence 9999999974 3 8899999999999997665553 6788999999999999995 65 77889999999
Q ss_pred ccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCC
Q 002121 223 FDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 223 l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
+++|++++. .++.+++|+.|++++|++++ +| +..+++|+.|+|++|++++.++ ..+++|+.|++++|.+...
T Consensus 198 l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~--~~l~~L~~L~l~~n~L~~L 269 (457)
T 3bz5_A 198 CDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDV--STLSKLTTLHCIQTDLLEI 269 (457)
T ss_dssp CCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCC--TTCTTCCEEECTTCCCSCC
T ss_pred CcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCH--HHCCCCCEEeccCCCCCEE
Confidence 999999975 38899999999999999997 66 8999999999999999999764 4455555554444444311
Q ss_pred C-------CCcccCCCCCCcEEECCCCccccccCh--------hccCCCCCCEEEcCCcccccccCCCCccCCCCcEEec
Q 002121 303 E-------APLWFSTLPSLTTLICEFGSLQGRVPD--------KLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDL 367 (964)
Q Consensus 303 ~-------~~~~~~~l~~L~~L~Ls~N~l~~~~p~--------~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 367 (964)
. ....+..+++|+.|+|++|...+.+|. .+.++++|+.|+|++|++++. .+..+++|+.|++
T Consensus 270 ~l~~n~~~~~~~~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l---~l~~l~~L~~L~l 346 (457)
T 3bz5_A 270 DLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL---DVSHNTKLKSLSC 346 (457)
T ss_dssp CCTTCTTCCEEECTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC---CCTTCTTCSEEEC
T ss_pred ECCCCccCCcccccccccCCEEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc---ccccCCcCcEEEC
Confidence 1 111256789999999999998777664 356678999999999999995 3889999999999
Q ss_pred cCCcceeeccCCCcccceeEeecCC
Q 002121 368 QNNQISAITLGSGIKNYTLILVGNP 392 (964)
Q Consensus 368 ~~N~l~~i~~~~~~~l~~l~l~~Np 392 (964)
++|+|++++ .+..|.+.+|.
T Consensus 347 ~~N~l~~l~-----~L~~L~l~~n~ 366 (457)
T 3bz5_A 347 VNAHIQDFS-----SVGKIPALNNN 366 (457)
T ss_dssp CSSCCCBCT-----TGGGSSGGGTS
T ss_pred CCCCCCCcc-----ccccccccCCc
Confidence 999999864 34455566665
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.8e-29 Score=289.85 Aligned_cols=294 Identities=20% Similarity=0.256 Sum_probs=153.1
Q ss_pred CCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccc-------------hhhccccccccCcC
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKL-------------NILILAGCGFTGNI 129 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L-------------~~L~L~~n~l~~~~ 129 (964)
..+++.|++++|++ |.+|.+|+++++|++|+|++| .+.|.+|..++++.+| ++|++++|.+++ +
T Consensus 10 ~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n-~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 10 NTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWS-EWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp -------------------------CCHHHHHHHHH-HHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred cccchhhhcccCch-hhCChhHhcccchhhhhccCC-cccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 35677888888888 788888888888888888888 6788888888877664 666666666663 3
Q ss_pred CcccCCCCCccEEEcccCcccCcCCCcCC----------------Cc-cccccccccccccccccCcccCCCCccccccC
Q 002121 130 PDEIGNLAELSFLALNSNNFSGRIPPSLG----------------KL-SQLYWLDLADNQLTGSIPVSTITSPGLDQLKN 192 (964)
Q Consensus 130 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----------------~l-~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~ 192 (964)
|.. .++|++|+|++|.+++ +|..+. .+ ++|++|++++|++++ +| .+..+++
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-------~~~~l~~ 154 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-------ELQNSSF 154 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-------CCTTCTT
T ss_pred CCC---cCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-------ccCCCCC
Confidence 331 1344444444444443 232211 11 456666666666663 44 3667777
Q ss_pred CCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeecc
Q 002121 193 AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLA 272 (964)
Q Consensus 193 L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 272 (964)
|++|++++|++++ +|.. ..+|++|++++|++++ +| .++.+++|+.|++++|++++ +|... ++|++|+++
T Consensus 155 L~~L~l~~N~l~~-lp~~----~~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~ 223 (454)
T 1jl5_A 155 LKIIDVDNNSLKK-LPDL----PPSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAG 223 (454)
T ss_dssp CCEEECCSSCCSC-CCCC----CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECC
T ss_pred CCEEECCCCcCcc-cCCC----cccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECc
Confidence 7777777777773 5543 2467777777777775 44 46777777777777777764 33322 356666666
Q ss_pred CccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc-
Q 002121 273 HNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT- 351 (964)
Q Consensus 273 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~- 351 (964)
+|.++.+ |.+..+++|++|++++|++++ +|. .+++|+.|++++|++++ +|.. +++|+.|+|++|++++.
T Consensus 224 ~n~l~~l-p~~~~l~~L~~L~l~~N~l~~--l~~---~~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l~ 293 (454)
T 1jl5_A 224 NNILEEL-PELQNLPFLTTIYADNNLLKT--LPD---LPPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLS 293 (454)
T ss_dssp SSCCSSC-CCCTTCTTCCEEECCSSCCSS--CCS---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEES
T ss_pred CCcCCcc-cccCCCCCCCEEECCCCcCCc--ccc---cccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCccc
Confidence 6666633 346666666666666666642 222 12445555555555543 2221 13444444444444331
Q ss_pred -cCCC-------------CccC-CCCcEEeccCCcceeeccCCCcccceeEeecCCc
Q 002121 352 -LDMG-------------NAVG-PLLQLVDLQNNQISAITLGSGIKNYTLILVGNPV 393 (964)
Q Consensus 352 -~~~~-------------~~~l-~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np~ 393 (964)
.+.. +..+ ++|+.|+|++|+++.++.. ...++.|++.+|.+
T Consensus 294 ~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~lp~~-~~~L~~L~L~~N~l 349 (454)
T 1jl5_A 294 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL-PPRLERLIASFNHL 349 (454)
T ss_dssp CCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCCCC-CTTCCEEECCSSCC
T ss_pred CcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccccccc-CCcCCEEECCCCcc
Confidence 1111 1112 3677777777777765543 34566777777764
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=279.44 Aligned_cols=249 Identities=21% Similarity=0.274 Sum_probs=131.7
Q ss_pred CCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCc--CCc
Q 002121 54 GSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN--IPD 131 (964)
Q Consensus 54 ~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~p~ 131 (964)
|.|.+|.|+..+++ .+|..+. ++|++|+|++| .+....+..|.++++|++|+|++|.++.. .|.
T Consensus 7 C~~~~l~c~~~~l~-----------~ip~~~~--~~l~~L~L~~n-~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 72 (306)
T 2z66_A 7 CSGTEIRCNSKGLT-----------SVPTGIP--SSATRLELESN-KLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQ 72 (306)
T ss_dssp EETTEEECCSSCCS-----------SCCSCCC--TTCCEEECCSS-CCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEH
T ss_pred eCCCEEEcCCCCcc-----------cCCCCCC--CCCCEEECCCC-ccCccCHhHhhccccCCEEECCCCccCcccCccc
Confidence 68888888654433 3343332 57888888888 56644444467777777777777777622 355
Q ss_pred ccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccc
Q 002121 132 EIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQL 211 (964)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~ 211 (964)
.+..+++|++|+|++|.++ .+|..+.++++|++|+|++|++++ +| +...
T Consensus 73 ~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~-~~-----------------------------~~~~ 121 (306)
T 2z66_A 73 SDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ-MS-----------------------------EFSV 121 (306)
T ss_dssp HHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEES-ST-----------------------------TTTT
T ss_pred ccccccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccc-cc-----------------------------cchh
Confidence 5666677777777777766 345556666666666666666652 11 1122
Q ss_pred cCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCcc-ccCccccCCCCCCeeeccCccCccCCCC-CCCCCCC
Q 002121 212 FSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG-KVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSL 289 (964)
Q Consensus 212 f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L 289 (964)
|..+++|++|++++|++++..+..+..+++|+.|+|++|.+++ .+|..|..+++|++|+|++|.+++.++. +..+++|
T Consensus 122 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 201 (306)
T 2z66_A 122 FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 201 (306)
T ss_dssp TTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred hhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCC
Confidence 2333334444444444444444555555555555555555554 3455555555555555555555554332 4444444
Q ss_pred CEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCC-CCCEEEcCCccc
Q 002121 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYS-QIQQVKLRNNAF 348 (964)
Q Consensus 290 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l 348 (964)
++|+|++|+++ ...+..+..+++|+.|+|++|++++..|..+..++ +|+.|+|++|++
T Consensus 202 ~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~ 260 (306)
T 2z66_A 202 QVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260 (306)
T ss_dssp CEEECTTSCCS-BCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCE
T ss_pred CEEECCCCccC-ccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCe
Confidence 44444444443 22233344444444444444444444444444432 344444444443
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=276.21 Aligned_cols=280 Identities=19% Similarity=0.179 Sum_probs=189.8
Q ss_pred hhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccccccccc--ccCcccCCCCccccccCC
Q 002121 116 NILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTG--SIPVSTITSPGLDQLKNA 193 (964)
Q Consensus 116 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g--~iP~~~~~~~~l~~l~~L 193 (964)
+.++++++.++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|+++. .+| ..+..+++|
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~------~~~~~~~~L 80 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCS------QSDFGTTSL 80 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEE------HHHHSCSCC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcc------ccccccccc
Confidence 35566666666 5565443 577777888777774444456777778888888777762 122 234456777
Q ss_pred CeeEccCCcccccccccccCCCcceeEEEccCCcCcccCC-cccCCCCCCcEEEcccCcCccccCccccCCCCCCeeecc
Q 002121 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLA 272 (964)
Q Consensus 194 ~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 272 (964)
++|++++|.++ .+|.. |..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..|.++++|++|+|+
T Consensus 81 ~~L~Ls~n~i~-~l~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 158 (306)
T 2z66_A 81 KYLDLSFNGVI-TMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMA 158 (306)
T ss_dssp CEEECCSCSEE-EEEEE-EETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECT
T ss_pred CEEECCCCccc-cChhh-cCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECC
Confidence 77777777776 45544 5556777777777777776554 567788888888888888887777788888888888888
Q ss_pred CccCcc--CCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccc
Q 002121 273 HNDLKG--PFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 273 ~N~l~~--~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
+|.+++ .+..+..+++|++|+|++|.++ ...+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++
T Consensus 159 ~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 237 (306)
T 2z66_A 159 GNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT 237 (306)
T ss_dssp TCEEGGGEECSCCTTCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCB
T ss_pred CCccccccchhHHhhCcCCCEEECCCCCcC-CcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcc
Confidence 888876 3445777778888888888776 5556677777777777777777777777677777777777777777777
Q ss_pred ccCCCCccCC-CCcEEeccCCcceeeccCCCcccceeEeecCCcccccccccCccccCCCCCcccccccccCCCCCCCC
Q 002121 351 TLDMGNAVGP-LLQLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPP 428 (964)
Q Consensus 351 ~~~~~~~~l~-~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~ 428 (964)
..+..+..++ +|+.|+|++|+| .|+|.+.....|...... .........|..|+-..
T Consensus 238 ~~~~~~~~~~~~L~~L~L~~N~~--------------------~~~c~~~~~~~~l~~~~~-~~~~~~~~~C~~p~~~~ 295 (306)
T 2z66_A 238 SKKQELQHFPSSLAFLNLTQNDF--------------------ACTCEHQSFLQWIKDQRQ-LLVEVERMECATPSDKQ 295 (306)
T ss_dssp CSSSSCCCCCTTCCEEECTTCCE--------------------ECSGGGHHHHHHHHHTGG-GBSCGGGCBEEESGGGT
T ss_pred cCHHHHHhhhccCCEEEccCCCe--------------------ecccChHHHHHHHHhhhh-hhccccccccCCchhhC
Confidence 7777666664 566666665555 467776666566322221 12223445566554333
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=266.87 Aligned_cols=264 Identities=19% Similarity=0.221 Sum_probs=189.1
Q ss_pred ccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCC
Q 002121 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNL 136 (964)
Q Consensus 57 ~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 136 (964)
.+..|.....+.++.++++++ .+|..+ .++|++|+|++| .+.+..+..|..+++|++|+|++|.+++..|..|..+
T Consensus 4 ~~C~C~~~~~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n-~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 79 (285)
T 1ozn_A 4 GACVCYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGN-RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGL 79 (285)
T ss_dssp TTCEEECSSSCEEECCSSCCS-SCCTTC--CTTCSEEECTTS-CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTC
T ss_pred CCceECCCCCeEEEcCcCCcc-cCCcCC--CCCceEEEeeCC-cCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCc
Confidence 355677666678889998887 456544 578999999999 7888777889999999999999999998778899999
Q ss_pred CCccEEEcccCc-ccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCC
Q 002121 137 AELSFLALNSNN-FSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPD 215 (964)
Q Consensus 137 ~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~ 215 (964)
++|++|+|++|. ++...|..|.++++|++|+|++|++++..| ..+..+++|++|++++|+++ .++...|..+
T Consensus 80 ~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l 152 (285)
T 1ozn_A 80 ALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP------GLFRGLAALQYLYLQDNALQ-ALPDDTFRDL 152 (285)
T ss_dssp TTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCT------TTTTTCTTCCEEECCSSCCC-CCCTTTTTTC
T ss_pred cCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECH------hHhhCCcCCCEEECCCCccc-ccCHhHhccC
Confidence 999999999997 876668889999999999999999985444 45677788888888888877 5555566666
Q ss_pred cceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEc
Q 002121 216 MVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDL 294 (964)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~L 294 (964)
++|++|++++|++++..+..+..+++|+.|+|++|.+++..|..|.++++|+.|+|++|++++.++. +..+++|++|+|
T Consensus 153 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l 232 (285)
T 1ozn_A 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRL 232 (285)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEec
Confidence 6777777777777665555666677777777777777666666666666777777777766665543 566666666666
Q ss_pred cCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhcc
Q 002121 295 SNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF 333 (964)
Q Consensus 295 s~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 333 (964)
++|++.+.....++ ...++.+..+.+.+.+..|..+.
T Consensus 233 ~~N~~~c~~~~~~~--~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 233 NDNPWVCDCRARPL--WAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CSSCEECSGGGHHH--HHHHHHCCSEECCCBEEESGGGT
T ss_pred cCCCccCCCCcHHH--HHHHHhcccccCccccCCchHhC
Confidence 66666432221111 12233334445555555555443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-27 Score=274.81 Aligned_cols=244 Identities=21% Similarity=0.219 Sum_probs=171.4
Q ss_pred EEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccC
Q 002121 68 ALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSN 147 (964)
Q Consensus 68 ~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N 147 (964)
.++..+.+++ .+|..+. +.|+.|+|++| .+.+..+..|.++++|++|+|++|.|++..+..|.++++|++|+|++|
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n-~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHEN-QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSC-CCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCC-cCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 4455555665 5666554 68999999999 799888899999999999999999999888889999999999999999
Q ss_pred cccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCc
Q 002121 148 NFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQ 227 (964)
Q Consensus 148 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~ 227 (964)
+|+...+..|.++++|++|+|++|+++ .+|. ..+..+++|+.|+|++|+..+.++...|..+.+|++|++++|+
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~-----~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~ 196 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPS-----YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCN 196 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCC-EECT-----TTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSC
T ss_pred cCCeeCHhHhhccccCceeeCCCCccc-ccCH-----HHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCc
Confidence 999777778999999999999999998 3442 4577888888888888655556666666666667777777766
Q ss_pred CcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCc
Q 002121 228 LSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPL 306 (964)
Q Consensus 228 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~ 306 (964)
++. +| .+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+. +.++++|++|+|++|+++ ...+.
T Consensus 197 l~~-~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~ 273 (440)
T 3zyj_A 197 LRE-IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273 (440)
T ss_dssp CSS-CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCC-CCCTT
T ss_pred Ccc-cc-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCC-ccChh
Confidence 663 33 255666666666666666655566666666666666666666655443 444444444444444444 33333
Q ss_pred ccCCCCCCcEEECCCCcc
Q 002121 307 WFSTLPSLTTLICEFGSL 324 (964)
Q Consensus 307 ~~~~l~~L~~L~Ls~N~l 324 (964)
.|..+++|+.|+|++|.+
T Consensus 274 ~~~~l~~L~~L~L~~Np~ 291 (440)
T 3zyj_A 274 LFTPLHHLERIHLHHNPW 291 (440)
T ss_dssp TTSSCTTCCEEECCSSCE
T ss_pred HhccccCCCEEEcCCCCc
Confidence 334444444444444433
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-28 Score=268.36 Aligned_cols=238 Identities=20% Similarity=0.259 Sum_probs=200.5
Q ss_pred CCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccc
Q 002121 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWL 166 (964)
Q Consensus 87 l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 166 (964)
.+.++.|+|++| .+. .+|+.++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..|+++++|++|
T Consensus 80 ~~~l~~L~L~~n-~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 80 QPGRVALELRSV-PLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp STTCCEEEEESS-CCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred ccceeEEEccCC-Cch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 467788888887 555 67777777888888888888877 77777777888888888888877 667777777777777
Q ss_pred cccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEE
Q 002121 167 DLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246 (964)
Q Consensus 167 ~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 246 (964)
+|++|++.+.+|.. +.. + ..+..+..+++|++|+
T Consensus 156 ~L~~n~~~~~~p~~------~~~------------------------------------~----~~~~~~~~l~~L~~L~ 189 (328)
T 4fcg_A 156 SIRACPELTELPEP------LAS------------------------------------T----DASGEHQGLVNLQSLR 189 (328)
T ss_dssp EEEEETTCCCCCSC------SEE------------------------------------E----C-CCCEEESTTCCEEE
T ss_pred ECCCCCCccccChh------Hhh------------------------------------c----cchhhhccCCCCCEEE
Confidence 77777776666622 100 0 1233467789999999
Q ss_pred cccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccc
Q 002121 247 LDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG 326 (964)
Q Consensus 247 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (964)
|++|+|+ .+|..|.++++|++|+|++|.+++.++.+..+++|++|+|++|.+. ...|..+..+++|+.|+|++|++.+
T Consensus 190 L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~Ls~n~~~-~~~p~~~~~l~~L~~L~L~~n~~~~ 267 (328)
T 4fcg_A 190 LEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTAL-RNYPPIFGGRAPLKRLILKDCSNLL 267 (328)
T ss_dssp EEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEECTTCTTC-CBCCCCTTCCCCCCEEECTTCTTCC
T ss_pred CcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEECcCCcch-hhhHHHhcCCCCCCEEECCCCCchh
Confidence 9999999 8899999999999999999999998888999999999999999998 6778889999999999999999999
Q ss_pred ccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeec
Q 002121 327 RVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAIT 376 (964)
Q Consensus 327 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~ 376 (964)
.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.+++..|.+..++
T Consensus 268 ~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l~ 317 (328)
T 4fcg_A 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317 (328)
T ss_dssp BCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC--
T ss_pred hcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHHh
Confidence 99999999999999999999999999999999999999999999887754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=299.79 Aligned_cols=185 Identities=18% Similarity=0.124 Sum_probs=130.9
Q ss_pred eeecCCcEEEEEEE-ecCCcEEEEEEecCCCc----------chhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM----------QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 634 ~lG~G~fg~Vy~~~-~~~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
..+.|++|.+..++ .-.|+.+|||++..... ...++|.+|+++|+++ .|+||+++++++++++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666655 33589999999875321 1234699999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
|||++||+|.++|...+ +++.. +|+.||+.||+|+|+++ ||||||||+|||++++|++||+|||+|+.....
T Consensus 321 MEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp EECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred EecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 99999999999998754 45543 58899999999999999 999999999999999999999999999876543
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCC
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p 829 (964)
. ......+||++|||||++.+ .+..++|+||+|++++++.++..+
T Consensus 393 ~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 22345679999999999864 567889999999998887665443
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=284.46 Aligned_cols=281 Identities=24% Similarity=0.269 Sum_probs=233.1
Q ss_pred CCCCCCCCCCCCccE--------EecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccch
Q 002121 45 TWKNSDDPCGSWEGV--------TCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLN 116 (964)
Q Consensus 45 ~W~~~~~~C~~w~gv--------~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~ 116 (964)
.|....++| .|+|. .|....++.|++++++++ .+|..+. ++|++|+|++| .+. .+|. .+++|+
T Consensus 14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N-~l~-~lp~---~l~~L~ 84 (622)
T 3g06_A 14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDN-NLT-SLPA---LPPELR 84 (622)
T ss_dssp HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSC-CCS-CCCC---CCTTCC
T ss_pred HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCC-CCC-CCCC---cCCCCC
Confidence 465444554 88663 444568999999999999 7888776 89999999999 676 4565 578999
Q ss_pred hhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCee
Q 002121 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHF 196 (964)
Q Consensus 117 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L 196 (964)
+|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|+.|+|++|+++ .+|. .+++|++|
T Consensus 85 ~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~---------~l~~L~~L 146 (622)
T 3g06_A 85 TLEVSGNQLT-SLPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLT-SLPV---------LPPGLQEL 146 (622)
T ss_dssp EEEECSCCCS-CCCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCS-CCCC---------CCTTCCEE
T ss_pred EEEcCCCcCC-cCCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCC-cCCC---------CCCCCCEE
Confidence 9999999999 5776 78999999999999995 555 5689999999999999 4662 24899999
Q ss_pred EccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccC
Q 002121 197 HFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDL 276 (964)
Q Consensus 197 ~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 276 (964)
+|++|+++ .+|. ...+|+.|++++|+|++ +| ..+++|+.|+|++|.|++ +|.. +++|+.|++++|.|
T Consensus 147 ~Ls~N~l~-~l~~----~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l 213 (622)
T 3g06_A 147 SVSDNQLA-SLPA----LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRL 213 (622)
T ss_dssp ECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred ECcCCcCC-CcCC----ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCcc
Confidence 99999998 4554 34689999999999996 55 557899999999999994 5543 47899999999999
Q ss_pred ccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCC
Q 002121 277 KGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGN 356 (964)
Q Consensus 277 ~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 356 (964)
+.++.. +++|++|+|++|.|++ +| ..+++|+.|+|++|+|+. +|. .+++|+.|+|++|+|+ .+|..+
T Consensus 214 ~~l~~~---~~~L~~L~Ls~N~L~~--lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l 280 (622)
T 3g06_A 214 TSLPAL---PSGLKELIVSGNRLTS--LP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESL 280 (622)
T ss_dssp SSCCCC---CTTCCEEECCSSCCSC--CC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGG
T ss_pred cccCCC---CCCCCEEEccCCccCc--CC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHH
Confidence 977653 4789999999999963 44 567899999999999995 454 6789999999999999 557789
Q ss_pred ccCCCCcEEeccCCcceeeccC
Q 002121 357 AVGPLLQLVDLQNNQISAITLG 378 (964)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~i~~~ 378 (964)
..+++|+.|+|++|+|++..+.
T Consensus 281 ~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 281 IHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp GGSCTTCEEECCSCCCCHHHHH
T ss_pred hhccccCEEEecCCCCCCcCHH
Confidence 9999999999999999986544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-27 Score=273.29 Aligned_cols=244 Identities=20% Similarity=0.211 Sum_probs=176.0
Q ss_pred EEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCc
Q 002121 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNN 148 (964)
Q Consensus 69 L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 148 (964)
++..+.+++ .+|..+. ++|++|+|++| .+.+..+..|.++++|++|+|++|.|++..|..|.++++|++|+|++|+
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n-~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~ 134 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMEN-NIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSS-CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCC-cCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCc
Confidence 334444554 4555443 68899999999 7888888999999999999999999998888899999999999999999
Q ss_pred ccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcC
Q 002121 149 FSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228 (964)
Q Consensus 149 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l 228 (964)
|++..+..|.++++|++|+|++|+++ .+|. ..+..+++|+.|++++|+..+.++...|..+.+|++|++++|++
T Consensus 135 l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~-----~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l 208 (452)
T 3zyi_A 135 LTVIPSGAFEYLSKLRELWLRNNPIE-SIPS-----YAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI 208 (452)
T ss_dssp CSBCCTTTSSSCTTCCEEECCSCCCC-EECT-----TTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCC
T ss_pred CCccChhhhcccCCCCEEECCCCCcc-eeCH-----hHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcc
Confidence 99777777999999999999999998 4442 35778888888888886555577777777777777777777777
Q ss_pred cccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcc
Q 002121 229 SGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLW 307 (964)
Q Consensus 229 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~ 307 (964)
++. | .+..+++|+.|+|++|.|++..|..|.++++|+.|+|++|++++..+. +..+++|++|+|++|+|+ ...+..
T Consensus 209 ~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~ 285 (452)
T 3zyi_A 209 KDM-P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285 (452)
T ss_dssp SSC-C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCS-CCCTTS
T ss_pred ccc-c-cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCC-ccChHH
Confidence 743 3 366677777777777777766677777777777777777777665543 555555555555555554 333334
Q ss_pred cCCCCCCcEEECCCCccc
Q 002121 308 FSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~ 325 (964)
|..+++|+.|+|++|.+.
T Consensus 286 ~~~l~~L~~L~L~~Np~~ 303 (452)
T 3zyi_A 286 FTPLRYLVELHLHHNPWN 303 (452)
T ss_dssp STTCTTCCEEECCSSCEE
T ss_pred hccccCCCEEEccCCCcC
Confidence 444444444444444433
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=276.97 Aligned_cols=249 Identities=20% Similarity=0.230 Sum_probs=146.6
Q ss_pred cCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccc-cCcCCcccC-------CCCCccEEEcccCcccCcCCC
Q 002121 84 IGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGF-TGNIPDEIG-------NLAELSFLALNSNNFSGRIPP 155 (964)
Q Consensus 84 l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l-~~~~p~~~~-------~l~~L~~L~Ls~N~l~~~~p~ 155 (964)
++..++|+.|+|++| .+ .+|..+... |+.|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|.
T Consensus 39 ~~~~~~L~~l~l~~n-~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVD-TE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEECTTHHHHCC-TT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EccCCCceeEeeccc-cc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 456677888888888 56 667666554 88888888888 445776665 788888888888888888888
Q ss_pred cC--CCccccccccccccccccccCcccCCCCccccc-----cCCCeeEccCCcccccccccccCCCcceeEEEccCCcC
Q 002121 156 SL--GKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL-----KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228 (964)
Q Consensus 156 ~~--~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l-----~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l 228 (964)
.+ ..+++|++|+|++|++++. | ..+..+ ++|++|+|++|+++
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~------~~~~~l~~~~~~~L~~L~L~~N~l~------------------------ 162 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-D------AWLAELQQWLKPGLKVLSIAQAHSL------------------------ 162 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-S------SHHHHHHTTCCTTCCEEEEESCSCC------------------------
T ss_pred HHHHhcCCCccEEEccCCCCcch-h------HHHHHHHHhhcCCCcEEEeeCCCCc------------------------
Confidence 76 7888888888888888854 5 334444 56666666666655
Q ss_pred cccCCcccCCCCCCcEEEcccCcCccc--cCccc--cCCCCCCeeeccCccCccCCC---C-CCCCCCCCEEEccCCCCC
Q 002121 229 SGNIPESLGYVQTLEVLRLDRNALTGK--VPTNL--NNLTNVNELNLAHNDLKGPFP---D-LSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 229 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~~~~---~-l~~l~~L~~L~Ls~N~l~ 300 (964)
+..|..|+.+++|++|+|++|++.+. .+..+ .++++|++|+|++|+|++... . +..+++|++|+|++|+++
T Consensus 163 -~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 241 (312)
T 1wwl_A 163 -NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLR 241 (312)
T ss_dssp -CCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCC
T ss_pred -cchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCC
Confidence 33334444444444444444444432 12222 444444445554444442211 1 233444555555555554
Q ss_pred CCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 301 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
+......+..+++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 242 ~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 242 DAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 2221233444555555555555555 4444443 5566666666666555 22 5566666666666666654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.9e-27 Score=272.95 Aligned_cols=272 Identities=21% Similarity=0.229 Sum_probs=195.0
Q ss_pred CCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCc-------------cEEEcccCc
Q 002121 82 GDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAEL-------------SFLALNSNN 148 (964)
Q Consensus 82 ~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-------------~~L~Ls~N~ 148 (964)
+.-...++|++|++++| .+ |.+|++++++++|++|++++|.++|.+|..++++++| ++|++++|.
T Consensus 5 p~~~~~~~L~~L~l~~n-~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~ 82 (454)
T 1jl5_A 5 PRNVSNTFLQEPLRHSS-NL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLG 82 (454)
T ss_dssp -------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSC
T ss_pred ccccccccchhhhcccC-ch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCc
Confidence 33445789999999999 67 8999999999999999999999999999999999875 999999999
Q ss_pred ccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcC
Q 002121 149 FSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQL 228 (964)
Q Consensus 149 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l 228 (964)
+++ +|.. .++|++|++++|++++ +|. .+++|++|++++|++++ ++.. .++|++|++++|++
T Consensus 83 l~~-lp~~---~~~L~~L~l~~n~l~~-lp~---------~~~~L~~L~l~~n~l~~-l~~~----~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 83 LSS-LPEL---PPHLESLVASCNSLTE-LPE---------LPQSLKSLLVDNNNLKA-LSDL----PPLLEYLGVSNNQL 143 (454)
T ss_dssp CSC-CCSC---CTTCSEEECCSSCCSS-CCC---------CCTTCCEEECCSSCCSC-CCSC----CTTCCEEECCSSCC
T ss_pred ccc-CCCC---cCCCCEEEccCCcCCc-ccc---------ccCCCcEEECCCCccCc-ccCC----CCCCCEEECcCCCC
Confidence 995 4542 3789999999999995 772 23788999999999883 4432 26899999999999
Q ss_pred cccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCccc
Q 002121 229 SGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWF 308 (964)
Q Consensus 229 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 308 (964)
++ +| .++.+++|++|++++|++++ +|..+ ++|++|+|++|++++. |.+.++++|++|++++|.+++ +|..
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~l-~~~~~l~~L~~L~l~~N~l~~--l~~~- 213 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLKK--LPDL- 213 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCSS--CCCC-
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCcC-ccccCCCCCCEEECCCCcCCc--CCCC-
Confidence 86 66 58889999999999999985 66543 5889999999999885 478889999999999999863 3332
Q ss_pred CCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEe
Q 002121 309 STLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLIL 388 (964)
Q Consensus 309 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l 388 (964)
.++|+.|++++|+++ .+| .+..+++|+.|++++|++++... .+++|+.|++++|+++.++.. ...++.|++
T Consensus 214 --~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~----~~~~L~~L~l~~N~l~~l~~~-~~~L~~L~l 284 (454)
T 1jl5_A 214 --PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPD----LPPSLEALNVRDNYLTDLPEL-PQSLTFLDV 284 (454)
T ss_dssp --CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCS----CCTTCCEEECCSSCCSCCCCC-CTTCCEEEC
T ss_pred --cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcccc----cccccCEEECCCCcccccCcc-cCcCCEEEC
Confidence 258889999999888 566 48888899999999998886432 247788888888888887643 355778888
Q ss_pred ecCCc
Q 002121 389 VGNPV 393 (964)
Q Consensus 389 ~~Np~ 393 (964)
++|.+
T Consensus 285 s~N~l 289 (454)
T 1jl5_A 285 SENIF 289 (454)
T ss_dssp CSSCC
T ss_pred cCCcc
Confidence 88874
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.5e-29 Score=274.27 Aligned_cols=264 Identities=18% Similarity=0.215 Sum_probs=188.0
Q ss_pred CCCCCCCCCCCCCcc--EEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCC-CCCCCCCCC-------Ccc
Q 002121 44 PTWKNSDDPCGSWEG--VTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGL-TGSLSPRIG-------DLQ 113 (964)
Q Consensus 44 ~~W~~~~~~C~~w~g--v~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l-~~~~p~~l~-------~l~ 113 (964)
.+|.....|+ .+.. +.|...+++.|++++|.+ .+|..+... |+.|+|++| .+ .+.+|..+. +++
T Consensus 22 ~~~~~~~~c~-~~~~~~~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n-~l~~~~~~~~~~~~~~~~~~l~ 95 (312)
T 1wwl_A 22 PDWSSAFNCL-GAADVELYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRL-TVRAARIPSRILFGALRVLGIS 95 (312)
T ss_dssp CCGGGGGGSS-SCSEEEEEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEE-EEEEEECBHHHHHHHHHHHTTS
T ss_pred cchHHHhhhh-ccccEEEEccCCCceeEeeccccc--ccHHHHHHH--Hhhcccccc-cccCCCcCHHHHHHHHHhcCcC
Confidence 5676444443 4544 567777899999999999 777766655 999999999 66 556776666 789
Q ss_pred cchhhccccccccCcCCccc--CCCCCccEEEcccCcccCcCCCcCCCc-----cccccccccccccccccCcccCCCCc
Q 002121 114 KLNILILAGCGFTGNIPDEI--GNLAELSFLALNSNNFSGRIPPSLGKL-----SQLYWLDLADNQLTGSIPVSTITSPG 186 (964)
Q Consensus 114 ~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~g~iP~~~~~~~~ 186 (964)
+|++|+|++|.+++.+|..+ ..+++|++|+|++|++++. |..+..+ ++|++|+|++|++++..| ..
T Consensus 96 ~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~------~~ 168 (312)
T 1wwl_A 96 GLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSC------EQ 168 (312)
T ss_dssp CCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCT------TT
T ss_pred CccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchH------HH
Confidence 99999999999999999987 8999999999999999977 8888888 899999999999996554 45
Q ss_pred cccccCCCeeEccCCcccccc--c-ccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCcc---ccCccc
Q 002121 187 LDQLKNAKHFHFNKNKLSGTI--S-EQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG---KVPTNL 260 (964)
Q Consensus 187 l~~l~~L~~L~L~~N~l~g~l--~-~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~p~~~ 260 (964)
+..+++|++|+|++|++.+.+ + ...| ..+++|++|+|++|+|++ .....+
T Consensus 169 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~------------------------~~l~~L~~L~L~~N~l~~~~~~~~~~~ 224 (312)
T 1wwl_A 169 VRVFPALSTLDLSDNPELGERGLISALCP------------------------LKFPTLQVLALRNAGMETPSGVCSALA 224 (312)
T ss_dssp CCCCSSCCEEECCSCTTCHHHHHHHHSCT------------------------TSCTTCCEEECTTSCCCCHHHHHHHHH
T ss_pred hccCCCCCEEECCCCCcCcchHHHHHHHh------------------------ccCCCCCEEECCCCcCcchHHHHHHHH
Confidence 778889999999999876542 1 1112 444555555555555551 111233
Q ss_pred cCCCCCCeeeccCccCccCCC--CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCC
Q 002121 261 NNLTNVNELNLAHNDLKGPFP--DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQI 338 (964)
Q Consensus 261 ~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 338 (964)
.++++|++|+|++|++++.++ .+..+++|++|+|++|.|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|
T Consensus 225 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~--~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L 298 (312)
T 1wwl_A 225 AARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK--QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQV 298 (312)
T ss_dssp HTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS--SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEE
T ss_pred hcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC--hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCC
Confidence 455566666666666665442 3455566666666666664 3344343 6677777777777655 44 6677777
Q ss_pred CEEEcCCccccc
Q 002121 339 QQVKLRNNAFNN 350 (964)
Q Consensus 339 ~~L~L~~N~l~~ 350 (964)
++|+|++|++++
T Consensus 299 ~~L~L~~N~l~~ 310 (312)
T 1wwl_A 299 GNLSLKGNPFLD 310 (312)
T ss_dssp EEEECTTCTTTC
T ss_pred CEEeccCCCCCC
Confidence 777777777764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.5e-28 Score=270.64 Aligned_cols=261 Identities=19% Similarity=0.165 Sum_probs=170.3
Q ss_pred EEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccccc
Q 002121 92 SLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN 171 (964)
Q Consensus 92 ~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 171 (964)
.++++.+ .+...+...+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+ |..+++|++|+|++|
T Consensus 14 i~~ls~~-~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n 90 (317)
T 3o53_A 14 IEKVTDS-SLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNN 90 (317)
T ss_dssp EESCCTT-THHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSS
T ss_pred Eeecccc-chhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCC
Confidence 3444444 3333333333444555666666666665555566666666666666666664443 666666666666666
Q ss_pred ccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCc
Q 002121 172 QLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNA 251 (964)
Q Consensus 172 ~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 251 (964)
++++ +| ..++|+.|++++|++++..+ . .+++|++|++++|++++..+..+..+++|++|+|++|.
T Consensus 91 ~l~~-l~----------~~~~L~~L~l~~n~l~~~~~-~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 155 (317)
T 3o53_A 91 YVQE-LL----------VGPSIETLHAANNNISRVSC-S---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155 (317)
T ss_dssp EEEE-EE----------ECTTCCEEECCSSCCSEEEE-C---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSC
T ss_pred cccc-cc----------CCCCcCEEECCCCccCCcCc-c---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCC
Confidence 6652 22 23566666666666663322 2 23557777777777777667677777778888888888
Q ss_pred CccccCcccc-CCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccCh
Q 002121 252 LTGKVPTNLN-NLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPD 330 (964)
Q Consensus 252 l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 330 (964)
+++..+..+. .+++|++|+|++|.|++.+ ....+++|++|+|++|+++ .++..+..+++|+.|+|++|+|+ .+|.
T Consensus 156 l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~-~~~~l~~L~~L~Ls~N~l~--~l~~~~~~l~~L~~L~L~~N~l~-~l~~ 231 (317)
T 3o53_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKLKTLDLSSNKLA--FMGPEFQSAAGVTWISLRNNKLV-LIEK 231 (317)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEEE-CCCCCTTCCEEECCSSCCC--EECGGGGGGTTCSEEECTTSCCC-EECT
T ss_pred CCcccHHHHhhccCcCCEEECCCCcCcccc-cccccccCCEEECCCCcCC--cchhhhcccCcccEEECcCCccc-chhh
Confidence 8766666653 6777888888888877763 3345777888888888885 33444777888888888888887 4566
Q ss_pred hccCCCCCCEEEcCCcccc-cccCCCCccCCCCcEEecc-CCccee
Q 002121 331 KLFSYSQIQQVKLRNNAFN-NTLDMGNAVGPLLQLVDLQ-NNQISA 374 (964)
Q Consensus 331 ~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~-~N~l~~ 374 (964)
.+..+++|+.|+|++|++. +..+..+..++.|+.|+++ .+.++.
T Consensus 232 ~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~ 277 (317)
T 3o53_A 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTG 277 (317)
T ss_dssp TCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHS
T ss_pred HhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccC
Confidence 7778888888888888887 6666677777788888887 334444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-28 Score=272.30 Aligned_cols=237 Identities=18% Similarity=0.155 Sum_probs=130.3
Q ss_pred chhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCC
Q 002121 115 LNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK 194 (964)
Q Consensus 115 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~ 194 (964)
++.++++.+.+...++..+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..| +..+++|+
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--------~~~l~~L~ 83 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--------LESLSTLR 83 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--------ETTCTTCC
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--------hhhcCCCC
Confidence 4444555555543333444455566666666666665555556666666666666666653222 44556666
Q ss_pred eeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCc
Q 002121 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHN 274 (964)
Q Consensus 195 ~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 274 (964)
+|++++|+++ .++ ..++|++|++++|++++..+.. +++|+.|++++|++++..+..|..+++|++|+|++|
T Consensus 84 ~L~Ls~n~l~-~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 154 (317)
T 3o53_A 84 TLDLNNNYVQ-ELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154 (317)
T ss_dssp EEECCSSEEE-EEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTS
T ss_pred EEECcCCccc-ccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCC
Confidence 6666666655 222 1245666666666665544332 355666666666666555555666666666666666
Q ss_pred cCccCCCC-C-CCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccccc
Q 002121 275 DLKGPFPD-L-SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTL 352 (964)
Q Consensus 275 ~l~~~~~~-l-~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 352 (964)
.+++..+. + ..+++|++|+|++|.++.. +. ...+++|++|+|++|++++..+ .+..+++|+.|+|++|+++. +
T Consensus 155 ~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~--~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~-l 229 (317)
T 3o53_A 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDV--KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-I 229 (317)
T ss_dssp CCCEEEGGGGGGGTTTCCEEECTTSCCCEE--EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-E
T ss_pred CCCcccHHHHhhccCcCCEEECCCCcCccc--cc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc-h
Confidence 66654433 2 3455666666666666411 21 2235666666666666654333 35556666666666666653 3
Q ss_pred CCCCccCCCCcEEeccCCcce
Q 002121 353 DMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 353 ~~~~~~l~~L~~L~L~~N~l~ 373 (964)
|..+..+++|+.|+|++|+++
T Consensus 230 ~~~~~~l~~L~~L~l~~N~~~ 250 (317)
T 3o53_A 230 EKALRFSQNLEHFDLRGNGFH 250 (317)
T ss_dssp CTTCCCCTTCCEEECTTCCCB
T ss_pred hhHhhcCCCCCEEEccCCCcc
Confidence 444555666666666666665
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=253.63 Aligned_cols=222 Identities=21% Similarity=0.190 Sum_probs=109.3
Q ss_pred hhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCee
Q 002121 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHF 196 (964)
Q Consensus 117 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L 196 (964)
.++++++.++ .+|..+ .++|++|+|++|.+++..+..|.++++|++|+|++|++++..| ..+..+++|++|
T Consensus 15 ~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L 85 (285)
T 1ozn_A 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA------AAFTGLALLEQL 85 (285)
T ss_dssp EEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT------TTTTTCTTCCEE
T ss_pred EEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCH------hhcCCccCCCEE
Confidence 3444444444 334322 2345555555555554444445555555555555555543222 233444444444
Q ss_pred EccCCc-ccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCcc
Q 002121 197 HFNKNK-LSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHND 275 (964)
Q Consensus 197 ~L~~N~-l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 275 (964)
++++|+ ++ .++...|..+++|++|++++|++++..|..+..+++|++|+|++|++++..+..|.++++|++|+|++|+
T Consensus 86 ~l~~n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~ 164 (285)
T 1ozn_A 86 DLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNR 164 (285)
T ss_dssp ECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred eCCCCCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCc
Confidence 444443 22 3333333444444444444444444445555555555555555555554444445555555555555555
Q ss_pred CccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccc
Q 002121 276 LKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349 (964)
Q Consensus 276 l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 349 (964)
+++.++. +..+++|++|+|++|.++ ...|..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++.
T Consensus 165 l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~ 238 (285)
T 1ozn_A 165 ISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (285)
T ss_dssp CCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccCHHHhcCccccCEEECCCCccc-ccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCcc
Confidence 5554443 455555555555555554 333444555555555555555555444444555555555555555544
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-26 Score=261.72 Aligned_cols=296 Identities=20% Similarity=0.188 Sum_probs=182.3
Q ss_pred ccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccc
Q 002121 90 LRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLA 169 (964)
Q Consensus 90 L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 169 (964)
....++++| .+. .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 33 ~~~c~~~~~-~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (353)
T 2z80_A 33 NGICKGSSG-SLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLS 108 (353)
T ss_dssp TSEEECCST-TCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECC
T ss_pred CeEeeCCCC-Ccc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECC
Confidence 334555554 222 3333333 245555555555553333345555555555555555554444445555555555555
Q ss_pred ccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCC-cccCCCCCCcEEEcc
Q 002121 170 DNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLD 248 (964)
Q Consensus 170 ~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls 248 (964)
+|+++ .++...|..+++|++|++++|++++..+ ..+..+++|++|+++
T Consensus 109 ~n~l~-------------------------------~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~ 157 (353)
T 2z80_A 109 YNYLS-------------------------------NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVG 157 (353)
T ss_dssp SSCCS-------------------------------SCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEE
T ss_pred CCcCC-------------------------------cCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECC
Confidence 55554 3444444555555555555555553332 356666677777777
Q ss_pred cC-cCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccc
Q 002121 249 RN-ALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG 326 (964)
Q Consensus 249 ~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (964)
+| .+++..+..|.++++|++|+|++|.+++..+ .+..+++|++|++++|.++ ......+..+++|+.|+|++|++++
T Consensus 158 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~-~~~~~~~~~~~~L~~L~L~~n~l~~ 236 (353)
T 2z80_A 158 NMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDT 236 (353)
T ss_dssp ESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCST-THHHHHHHHTTTEEEEEEESCBCTT
T ss_pred CCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccc-cchhhhhhhcccccEEECCCCcccc
Confidence 66 3555555666667777777777777766644 3666777777777777764 3333344557777777777777776
Q ss_pred ccChhcc---CCCCCCEEEcCCcccccc----cCCCCccCCCCcEEeccCCcceeeccC---CCcccceeEeecCC-ccc
Q 002121 327 RVPDKLF---SYSQIQQVKLRNNAFNNT----LDMGNAVGPLLQLVDLQNNQISAITLG---SGIKNYTLILVGNP-VCT 395 (964)
Q Consensus 327 ~~p~~~~---~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~i~~~---~~~~l~~l~l~~Np-~c~ 395 (964)
..+..+. ....++.++|++|.+++. +|..+..+++|+.|+|++|+++.++.. ....++.|+|.+|| .|+
T Consensus 237 ~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~ 316 (353)
T 2z80_A 237 FHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 316 (353)
T ss_dssp CCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCc
Confidence 6555443 467789999999998873 556678899999999999999999864 34558899999999 899
Q ss_pred cc-ccccCccccCCCCCcccccccccCCCC
Q 002121 396 AT-LANTNYCQLQQPTTKAYSTSLANCGGK 424 (964)
Q Consensus 396 ~~-l~~~~~~~~~~~~~~~~~~~~~~c~~~ 424 (964)
|. +.++..|....... + .....|.+|
T Consensus 317 ~~~l~~l~~~~~~~~~~-~--~~~~~C~~p 343 (353)
T 2z80_A 317 CPRIDYLSRWLNKNSQK-E--QGSAKCSGS 343 (353)
T ss_dssp HHHHHHHHHHHHHTTTT-E--ESCCBBTTT
T ss_pred CCCcHHHHHHHHhcccc-C--CCCcccCCC
Confidence 96 77778884333221 1 234567665
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-27 Score=276.67 Aligned_cols=219 Identities=19% Similarity=0.181 Sum_probs=140.4
Q ss_pred CCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccc
Q 002121 110 GDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQ 189 (964)
Q Consensus 110 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~ 189 (964)
..+++|++|+|++|.|++..|..|..+++|++|+|++|.+++.+| |..+++|++|+|++|.+++ +| .
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~----------~ 97 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----------V 97 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EE----------E
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CC----------C
Confidence 344567777777777776666777777777777777777776554 7777777777777777763 22 2
Q ss_pred ccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCcccc-CCCCCCe
Q 002121 190 LKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLN-NLTNVNE 268 (964)
Q Consensus 190 l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~ 268 (964)
.++|+.|++++|.+++..+. .+++|+.|++++|+|++..|..++.+++|+.|+|++|.|++.+|..|. .+++|+.
T Consensus 98 ~~~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~ 173 (487)
T 3oja_A 98 GPSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173 (487)
T ss_dssp CTTCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCE
T ss_pred CCCcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccE
Confidence 36777777777777643332 235677777777777777777777777777777777777777777665 6777777
Q ss_pred eeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccc
Q 002121 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348 (964)
Q Consensus 269 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 348 (964)
|+|++|.|++.++ ...+++|++|+|++|.++ . +|..+..+++|+.|+|++|.|++ +|..+..+++|+.|+|++|++
T Consensus 174 L~Ls~N~l~~~~~-~~~l~~L~~L~Ls~N~l~-~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l 249 (487)
T 3oja_A 174 LNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLA-F-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGF 249 (487)
T ss_dssp EECTTSCCCEEEC-CCCCTTCCEEECCSSCCC-E-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCB
T ss_pred EecCCCccccccc-cccCCCCCEEECCCCCCC-C-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCC
Confidence 7777777776633 334666666666666664 2 22235555555555555555553 344444555555555555554
Q ss_pred c
Q 002121 349 N 349 (964)
Q Consensus 349 ~ 349 (964)
.
T Consensus 250 ~ 250 (487)
T 3oja_A 250 H 250 (487)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-29 Score=292.98 Aligned_cols=328 Identities=19% Similarity=0.168 Sum_probs=207.1
Q ss_pred CCeeEEEcCCCCccc----cccCCcCCCCcccEEecccCCCCCCCCCCCCC-Ccc----cchhhccccccccC----cCC
Q 002121 64 SRVTALGLSTMGLTG----KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIG-DLQ----KLNILILAGCGFTG----NIP 130 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g----~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~-~l~----~L~~L~L~~n~l~~----~~p 130 (964)
.+++.|+|++|++++ .++..+..+++|++|+|++| .+.+..+..+. .+. +|++|+|++|.++. .+|
T Consensus 28 ~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n-~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~ 106 (461)
T 1z7x_W 28 QQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN-ELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 106 (461)
T ss_dssp TTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTC-CCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCC-cCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHH
Confidence 467777777777764 34556667777777777777 45543332222 233 57777777777773 456
Q ss_pred cccCCCCCccEEEcccCcccCcCCCcCC-----CccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccc
Q 002121 131 DEIGNLAELSFLALNSNNFSGRIPPSLG-----KLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG 205 (964)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g 205 (964)
..+..+++|++|+|++|.++...+..+. .+++|++|+|++|++++..+..+ ...+..+++|++|++++|.++.
T Consensus 107 ~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l--~~~l~~~~~L~~L~L~~n~i~~ 184 (461)
T 1z7x_W 107 STLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL--ASVLRAKPDFKELTVSNNDINE 184 (461)
T ss_dssp HHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH--HHHHHHCTTCCEEECCSSBCHH
T ss_pred HHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH--HHHHhhCCCCCEEECcCCCcch
Confidence 7777777777777777777643333222 24567777777777764221000 0235556777888888887764
Q ss_pred ccccccc----CCCcceeEEEccCCcCccc----CCcccCCCCCCcEEEcccCcCcccc-----CccccCCCCCCeeecc
Q 002121 206 TISEQLF----SPDMVLIHVLFDGNQLSGN----IPESLGYVQTLEVLRLDRNALTGKV-----PTNLNNLTNVNELNLA 272 (964)
Q Consensus 206 ~l~~~~f----~~~~~L~~L~l~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls 272 (964)
..+..+. ...++|++|++++|++++. ++..+..+++|+.|+|++|.+++.. +..+..+++|++|+|+
T Consensus 185 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~ 264 (461)
T 1z7x_W 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264 (461)
T ss_dssp HHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred HHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECc
Confidence 3332222 2344777888888877753 4666667777888888888776432 3333457778888888
Q ss_pred CccCccC-----CCCCCCCCCCCEEEccCCCCCCCCCCcccC-----CCCCCcEEECCCCccccc----cChhccCCCCC
Q 002121 273 HNDLKGP-----FPDLSQMNSLSYVDLSNNSFDPTEAPLWFS-----TLPSLTTLICEFGSLQGR----VPDKLFSYSQI 338 (964)
Q Consensus 273 ~N~l~~~-----~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L 338 (964)
+|.++.. +..+..+++|++|+|++|.++ ...+..+. ..++|+.|+|++|.+++. ++..+..+++|
T Consensus 265 ~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~-~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L 343 (461)
T 1z7x_W 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELG-DEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 343 (461)
T ss_dssp TSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCH-HHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSC
T ss_pred CCCCCHHHHHHHHHHHhhCCCcceEECCCCCCc-hHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCc
Confidence 8877763 333556777888888888774 22121222 235788888888887765 45566677888
Q ss_pred CEEEcCCcccccccCCCCcc-----CCCCcEEeccCCccee-----ec--cCCCcccceeEeecCCccc
Q 002121 339 QQVKLRNNAFNNTLDMGNAV-----GPLLQLVDLQNNQISA-----IT--LGSGIKNYTLILVGNPVCT 395 (964)
Q Consensus 339 ~~L~L~~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~-----i~--~~~~~~l~~l~l~~Np~c~ 395 (964)
+.|+|++|++++..+..+.. .++|+.|+|++|+++. ++ ......++.|+|.+|++.+
T Consensus 344 ~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~ 412 (461)
T 1z7x_W 344 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 412 (461)
T ss_dssp CEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred cEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence 88888888777655443332 5678888888888773 33 1234557778888887543
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-25 Score=241.12 Aligned_cols=214 Identities=20% Similarity=0.145 Sum_probs=175.6
Q ss_pred cccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCC
Q 002121 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNV 266 (964)
Q Consensus 187 l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 266 (964)
+..+++++.+++++|.++ .+|..++ ..++.|++++|+|++..+..|..+++|+.|+|++|.|++..+. ..+++|
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 455666666666666666 5665543 4677888888888877788888888899999999988854332 788889
Q ss_pred CeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCc
Q 002121 267 NELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNN 346 (964)
Q Consensus 267 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 346 (964)
++|+|++|+|+.++..+..+++|++|+|++|+++ ...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 80 ~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCCcCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 9999999999877777888899999999999997 666678899999999999999999888888889999999999999
Q ss_pred ccccccCCCCccCCCCcEEeccCCcceeeccCCC--cccceeEeecCC-cccccccccCccccC
Q 002121 347 AFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSG--IKNYTLILVGNP-VCTATLANTNYCQLQ 407 (964)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~--~~l~~l~l~~Np-~c~~~l~~~~~~~~~ 407 (964)
+|+...+..+..+++|+.|+|++|+|+.++...+ ..+..++|.+|| .|+|.+.++..|..+
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np~~C~c~~~~l~~wl~~ 222 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQD 222 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHHHH
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCCccCcCccHHHHHHHHh
Confidence 9998888888899999999999999998886543 347889999999 899999888888543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-26 Score=270.68 Aligned_cols=253 Identities=18% Similarity=0.150 Sum_probs=211.5
Q ss_pred EcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcc
Q 002121 70 GLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNF 149 (964)
Q Consensus 70 ~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 149 (964)
++....+...+......+++|++|+|++| .+.+..|..|+.+++|++|+|++|.+++..| |..+++|++|+|++|.|
T Consensus 16 ~~~~~~l~~~l~~l~~~~~~L~~L~Ls~n-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l 92 (487)
T 3oja_A 16 KVTDSSLKQALASLRQSAWNVKELDLSGN-PLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV 92 (487)
T ss_dssp SCCTTTHHHHHHTTSTTGGGCCEEECCSS-CCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEE
T ss_pred cCchhhhHHHHHHhcccCCCccEEEeeCC-cCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcC
Confidence 44444454444445556668999999999 7888888899999999999999999987665 89999999999999999
Q ss_pred cCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCc
Q 002121 150 SGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS 229 (964)
Q Consensus 150 ~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~ 229 (964)
++..+ .++|++|+|++|.+++..+ ..+++|+.|+|++|.+++. +...|..+++|+.|+|++|+|+
T Consensus 93 ~~l~~-----~~~L~~L~L~~N~l~~~~~---------~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~ 157 (487)
T 3oja_A 93 QELLV-----GPSIETLHAANNNISRVSC---------SRGQGKKNIYLANNKITML-RDLDEGCRSRVQYLDLKLNEID 157 (487)
T ss_dssp EEEEE-----CTTCCEEECCSSCCCCEEE---------CCCSSCEEEECCSSCCCSG-GGBCGGGGSSEEEEECTTSCCC
T ss_pred CCCCC-----CCCcCEEECcCCcCCCCCc---------cccCCCCEEECCCCCCCCC-CchhhcCCCCCCEEECCCCCCC
Confidence 85432 3789999999999985443 2357899999999999854 4445677889999999999999
Q ss_pred ccCCcccC-CCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCccc
Q 002121 230 GNIPESLG-YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWF 308 (964)
Q Consensus 230 ~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 308 (964)
+.+|..+. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|.|++.++.+..+++|+.|+|++|.++ .+|..+
T Consensus 158 ~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~--~lp~~l 233 (487)
T 3oja_A 158 TVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV--LIEKAL 233 (487)
T ss_dssp EEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCC--EECTTC
T ss_pred CcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCCcCc--ccchhh
Confidence 98888886 79999999999999996633 44699999999999999999999999999999999999996 367779
Q ss_pred CCCCCCcEEECCCCccc-cccChhccCCCCCCEEEcC
Q 002121 309 STLPSLTTLICEFGSLQ-GRVPDKLFSYSQIQQVKLR 344 (964)
Q Consensus 309 ~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~ 344 (964)
..+++|+.|+|++|.+. +.+|..+..++.|+.|+++
T Consensus 234 ~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp CCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred ccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 99999999999999998 6778888888888877775
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.4e-24 Score=257.98 Aligned_cols=259 Identities=22% Similarity=0.249 Sum_probs=216.7
Q ss_pred CcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccc
Q 002121 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLD 167 (964)
Q Consensus 88 ~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (964)
..++.|++++| .+. .+|..+. ++|++|+|++|.|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+
T Consensus 40 ~~l~~L~ls~n-~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~ 107 (622)
T 3g06_A 40 NGNAVLNVGES-GLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELS 107 (622)
T ss_dssp HCCCEEECCSS-CCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEE
T ss_pred CCCcEEEecCC-CcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEE
Confidence 45899999999 566 7787776 79999999999999 6776 5799999999999999 5665 678999999
Q ss_pred ccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEc
Q 002121 168 LADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247 (964)
Q Consensus 168 Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 247 (964)
|++|+++ .+|. .+++|+.|++++|+++ .+|.. .++|++|++++|+|++ +|. .+.+|+.|++
T Consensus 108 Ls~N~l~-~l~~---------~l~~L~~L~L~~N~l~-~lp~~----l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L 168 (622)
T 3g06_A 108 IFSNPLT-HLPA---------LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLAS-LPA---LPSELCKLWA 168 (622)
T ss_dssp ECSCCCC-CCCC---------CCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSC-CCC---CCTTCCEEEC
T ss_pred CcCCcCC-CCCC---------CCCCcCEEECCCCCCC-cCCCC----CCCCCEEECcCCcCCC-cCC---ccCCCCEEEC
Confidence 9999998 4552 5689999999999998 57654 4889999999999996 443 3578999999
Q ss_pred ccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccc
Q 002121 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGR 327 (964)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (964)
++|.|++ +| ..+++|+.|+|++|.|++++.. +++|+.|++++|.++ .+|. .+++|+.|+|++|+|++
T Consensus 169 ~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~--~l~~---~~~~L~~L~Ls~N~L~~- 235 (622)
T 3g06_A 169 YNNQLTS-LP---MLPSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT--SLPA---LPSGLKELIVSGNRLTS- 235 (622)
T ss_dssp CSSCCSC-CC---CCCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS--SCCC---CCTTCCEEECCSSCCSC-
T ss_pred CCCCCCC-Cc---ccCCCCcEEECCCCCCCCCCCc---cchhhEEECcCCccc--ccCC---CCCCCCEEEccCCccCc-
Confidence 9999994 66 5578999999999999986653 478999999999996 3443 35899999999999997
Q ss_pred cChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeecc--CCCcccceeEeecCCccccc
Q 002121 328 VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITL--GSGIKNYTLILVGNPVCTAT 397 (964)
Q Consensus 328 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~--~~~~~l~~l~l~~Np~c~~~ 397 (964)
+| ..+++|+.|+|++|+|+.... .+++|+.|+|++|+|+.+|. .....+..|+|.+|++....
T Consensus 236 lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~~~ 300 (622)
T 3g06_A 236 LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERT 300 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCHHH
T ss_pred CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCCcC
Confidence 45 567899999999999996544 67889999999999999874 34556888999999965433
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=237.43 Aligned_cols=215 Identities=23% Similarity=0.289 Sum_probs=158.8
Q ss_pred CCCCCCccEEecC-CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcC
Q 002121 51 DPCGSWEGVTCNN-SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNI 129 (964)
Q Consensus 51 ~~C~~w~gv~C~~-~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 129 (964)
+.| .|.|+.|.- ..++.+++++++++ .+|..+. ++|++|+|++| .+.+..+..|.++++|++|+|++|.++...
T Consensus 3 ~~C-~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~ 77 (270)
T 2o6q_A 3 ALC-KKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSN-KLSSLPSKAFHRLTKLRLLYLNDNKLQTLP 77 (270)
T ss_dssp CCB-GGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSS-CCSCCCTTSSSSCTTCCEEECCSSCCSCCC
T ss_pred ccC-CCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCC-CCCeeCHHHhcCCCCCCEEECCCCccCeeC
Confidence 555 899999864 56789999999998 4676554 67888899888 677766667888888888888888887555
Q ss_pred CcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccc
Q 002121 130 PDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE 209 (964)
Q Consensus 130 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~ 209 (964)
+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++ ++.
T Consensus 78 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~-------------------------------~~~ 126 (270)
T 2o6q_A 78 AGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-------------------------------LPP 126 (270)
T ss_dssp TTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC-------------------------------CCT
T ss_pred hhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe-------------------------------eCH
Confidence 5556778888888888888886666667777777777777777763 222
Q ss_pred cccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCC
Q 002121 210 QLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNS 288 (964)
Q Consensus 210 ~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~ 288 (964)
..|..+++|++|++++|+|++..+..|..+++|+.|+|++|++++..+..|.++++|++|+|++|+|++.++. +..+++
T Consensus 127 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 206 (270)
T 2o6q_A 127 RVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206 (270)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred HHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccC
Confidence 3334444455555555555555555577778888888888888866666788888888888888888877765 777888
Q ss_pred CCEEEccCCCCCC
Q 002121 289 LSYVDLSNNSFDP 301 (964)
Q Consensus 289 L~~L~Ls~N~l~~ 301 (964)
|+.|+|++|++.+
T Consensus 207 L~~L~l~~N~~~c 219 (270)
T 2o6q_A 207 LKMLQLQENPWDC 219 (270)
T ss_dssp CCEEECCSSCBCC
T ss_pred CCEEEecCCCeeC
Confidence 8888888888863
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-26 Score=270.51 Aligned_cols=184 Identities=16% Similarity=0.206 Sum_probs=146.6
Q ss_pred ccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--------hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 631 ESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--------GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 631 ~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
..+.||+|+||+||+|.. .++.+|+|+....... ..+++.+|++++++++||||+++..++...+..++||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 357899999999999955 5788999986543221 1235899999999999999997777777888899999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+++|+|.+++.. +..++.|+++||+|||+++ |+||||||+|||+++ .+||+|||+++......
T Consensus 419 E~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 419 SYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp ECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred ECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 99999999999975 5689999999999999988 999999999999999 99999999999875422
Q ss_pred CCc-----eeecccccCcccCcccccc--CCCCCchhHHHHHHHHHHHHhCCCCC
Q 002121 783 KGH-----VSTQVKGTMGYLDPEYYMT--QQLTEKSDVYSFGVVMLELITAKQPI 830 (964)
Q Consensus 783 ~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~sDv~S~Gvvl~elltg~~p~ 830 (964)
... ......||+.|||||++.. ..|+..+|+|+...-..+-+.++.+|
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 111 1235679999999999976 56788899999998888888777665
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.92 E-value=3.4e-28 Score=284.26 Aligned_cols=329 Identities=18% Similarity=0.139 Sum_probs=257.2
Q ss_pred CCeeEEEcCCCCccccccCC-cCCCCcccEEecccCCCCCC----CCCCCCCCcccchhhccccccccCcCCcccC-CCC
Q 002121 64 SRVTALGLSTMGLTGKLSGD-IGGLTELRSLDLSYNGGLTG----SLSPRIGDLQKLNILILAGCGFTGNIPDEIG-NLA 137 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~-l~~l~~L~~L~L~~N~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~ 137 (964)
.+++.|+|++++++...... +..+++|++|+|++| .+.+ .++..+..+++|++|+|++|.+++..+..+. .++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~-~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~ 81 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC-GLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 81 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESS-CCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCC-CCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence 36899999999998654443 788999999999999 5664 4566778889999999999999865444433 355
Q ss_pred ----CccEEEcccCcccC----cCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccc
Q 002121 138 ----ELSFLALNSNNFSG----RIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISE 209 (964)
Q Consensus 138 ----~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~ 209 (964)
+|++|+|++|+++. .++..+.++++|++|+|++|.+++..+..+. .......++|++|++++|++++....
T Consensus 82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~-~~l~~~~~~L~~L~L~~n~l~~~~~~ 160 (461)
T 1z7x_W 82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC-EGLLDPQCRLEKLQLEYCSLSAASCE 160 (461)
T ss_dssp STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHH-HHHTSTTCCCCEEECTTSCCBGGGHH
T ss_pred hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHH-HHHhcCCCcceEEECCCCCCCHHHHH
Confidence 79999999999994 5688899999999999999999854332110 00122356899999999999854322
Q ss_pred ---cccCCCcceeEEEccCCcCcccCCcccC-----CCCCCcEEEcccCcCccc----cCccccCCCCCCeeeccCccCc
Q 002121 210 ---QLFSPDMVLIHVLFDGNQLSGNIPESLG-----YVQTLEVLRLDRNALTGK----VPTNLNNLTNVNELNLAHNDLK 277 (964)
Q Consensus 210 ---~~f~~~~~L~~L~l~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 277 (964)
..+..+++|++|++++|.++...+..+. ..++|+.|+|++|.+++. ++..+..+++|++|+|++|.++
T Consensus 161 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~ 240 (461)
T 1z7x_W 161 PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 240 (461)
T ss_dssp HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCH
T ss_pred HHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCC
Confidence 2345578999999999999876555543 367999999999999963 6788889999999999999998
Q ss_pred cCC-----CC-CCCCCCCCEEEccCCCCCCCC---CCcccCCCCCCcEEECCCCccccccChhccC-----CCCCCEEEc
Q 002121 278 GPF-----PD-LSQMNSLSYVDLSNNSFDPTE---APLWFSTLPSLTTLICEFGSLQGRVPDKLFS-----YSQIQQVKL 343 (964)
Q Consensus 278 ~~~-----~~-l~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~L 343 (964)
+.. +. +..+++|++|++++|.++... ++..+..+++|+.|+|++|.+.+..+..+.. .++|+.|+|
T Consensus 241 ~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L 320 (461)
T 1z7x_W 241 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWV 320 (461)
T ss_dssp HHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEEC
T ss_pred hHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEc
Confidence 642 22 446899999999999996221 4666778999999999999998776655543 379999999
Q ss_pred CCcccccc----cCCCCccCCCCcEEeccCCcceeeccC--------CCcccceeEeecCCcc
Q 002121 344 RNNAFNNT----LDMGNAVGPLLQLVDLQNNQISAITLG--------SGIKNYTLILVGNPVC 394 (964)
Q Consensus 344 ~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~i~~~--------~~~~l~~l~l~~Np~c 394 (964)
++|.+++. ++..+..+++|+.|+|++|+++..... ....++.|+|.+|.+.
T Consensus 321 ~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp TTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred CCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 99999876 345566779999999999999876432 1346889999999864
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-24 Score=232.64 Aligned_cols=197 Identities=17% Similarity=0.190 Sum_probs=135.0
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCC
Q 002121 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
+|++++..+..|..+++|++|+|++|.+++..+..|.++++|++|++++|.+++..+ .+..+++|++|++++|.++...
T Consensus 61 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 140 (276)
T 2z62_A 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140 (276)
T ss_dssp TCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCC
T ss_pred CCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceec
Confidence 333333344456666677777777777776666677777777777777777777665 3777777777777777776444
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCCCCCC----EEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQ----QVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 379 (964)
.|..+..+++|+.|+|++|++++..+..+..+++|+ .|+|++|++++..+..+... +|+.|+|++|+++.++...
T Consensus 141 l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~ 219 (276)
T 2z62_A 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGI 219 (276)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSC-CEEEEECCSSCCSCCCTTT
T ss_pred CchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCC-cccEEECCCCceeecCHhH
Confidence 577788888888888888888877777777666666 78888888887766655544 7888888888888887543
Q ss_pred ---CcccceeEeecCC-ccccc-ccccCccccCCCCCcccccccccCCCCC
Q 002121 380 ---GIKNYTLILVGNP-VCTAT-LANTNYCQLQQPTTKAYSTSLANCGGKS 425 (964)
Q Consensus 380 ---~~~l~~l~l~~Np-~c~~~-l~~~~~~~~~~~~~~~~~~~~~~c~~~~ 425 (964)
...++.|+|.+|| .|+|. +.++..|...... .......|..+.
T Consensus 220 ~~~l~~L~~L~l~~N~~~c~c~~l~~l~~~~~~~~~---~~~~~~~C~~~~ 267 (276)
T 2z62_A 220 FDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLNKNSQ---KEQGSAKCSGSG 267 (276)
T ss_dssp TTTCCSCCEEECCSSCBCCCTTTTHHHHHHHHHTGG---GBCSCCBBTTTC
T ss_pred hcccccccEEEccCCcccccCCchHHHHHHHHhccc---ccCCCceeeCCC
Confidence 3456778888888 78985 6666677432221 122334676653
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-24 Score=230.66 Aligned_cols=208 Identities=21% Similarity=0.246 Sum_probs=128.8
Q ss_pred CCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeecc
Q 002121 193 AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLA 272 (964)
Q Consensus 193 L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 272 (964)
++.+++++|+++ .+|..+. .++++|++++|++++..+..|..+++|++|+|++|.++...+..|.++++|++|+|+
T Consensus 18 ~~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 18 KNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCEEEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 344444444444 3443322 345556666666665555566666666666666666664444555666666666666
Q ss_pred CccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 273 HNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 273 ~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
+|.+++.++. +..+++|++|+|++|.++ ...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 6666665554 466666666666666665 44555566666677777777766666656666667777777777777666
Q ss_pred cCCCCccCCCCcEEeccCCcceeeccCC---CcccceeEeecCC-ccccc-ccccCccc
Q 002121 352 LDMGNAVGPLLQLVDLQNNQISAITLGS---GIKNYTLILVGNP-VCTAT-LANTNYCQ 405 (964)
Q Consensus 352 ~~~~~~~l~~L~~L~L~~N~l~~i~~~~---~~~l~~l~l~~Np-~c~~~-l~~~~~~~ 405 (964)
.+..|..+++|+.|+|++|+++.++... ...+..|+|.+|| .|+|. +.++..|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~~~l 231 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCNGIIYMAKWL 231 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSSSSHHHHHHH
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCccHHHHHHHH
Confidence 6666666777777777777777666432 2345667777778 68886 44555563
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.5e-24 Score=232.34 Aligned_cols=212 Identities=23% Similarity=0.250 Sum_probs=134.3
Q ss_pred cccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCC
Q 002121 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLG 158 (964)
Q Consensus 79 ~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 158 (964)
.+|..+. ++|++|+|++| .+.+..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|.
T Consensus 21 ~ip~~l~--~~l~~L~ls~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFN-PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97 (276)
T ss_dssp SCCSSSC--TTCCEEECTTC-CCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred ccCCCCC--CCccEEECCCC-cccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhc
Confidence 3444443 46788888888 67766666777777788888887777766666777777777777777777766667777
Q ss_pred CccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcc-cCCcccC
Q 002121 159 KLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG-NIPESLG 237 (964)
Q Consensus 159 ~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~-~~p~~~~ 237 (964)
++++|++|++++|++++..+ ..+..+++|++|++++| ++++ .+|..+.
T Consensus 98 ~l~~L~~L~l~~n~l~~~~~------~~~~~l~~L~~L~l~~n-------------------------~l~~~~l~~~~~ 146 (276)
T 2z62_A 98 GLSSLQKLVAVETNLASLEN------FPIGHLKTLKELNVAHN-------------------------LIQSFKLPEYFS 146 (276)
T ss_dssp TCTTCCEEECTTSCCCCSTT------CCCTTCTTCCEEECCSS-------------------------CCCCCCCCGGGG
T ss_pred CCccccEEECCCCCccccCc------hhcccCCCCCEEECcCC-------------------------ccceecCchhhc
Confidence 77777777777777763221 12344444444444444 4443 2466677
Q ss_pred CCCCCcEEEcccCcCccccCccccCCCCCC----eeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCC
Q 002121 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVN----ELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPS 313 (964)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~ 313 (964)
.+++|+.|+|++|++++..+..|..+++|+ .|+|++|.+++.++......+|++|+|++|+++ ...+..|..+++
T Consensus 147 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~-~~~~~~~~~l~~ 225 (276)
T 2z62_A 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTS 225 (276)
T ss_dssp GCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCS-CCCTTTTTTCCS
T ss_pred cCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCCCcccEEECCCCcee-ecCHhHhccccc
Confidence 777777777777777766666666666666 666777777666655444445555666555554 333333444555
Q ss_pred CcEEECCCCccc
Q 002121 314 LTTLICEFGSLQ 325 (964)
Q Consensus 314 L~~L~Ls~N~l~ 325 (964)
|+.|+|++|.+.
T Consensus 226 L~~L~l~~N~~~ 237 (276)
T 2z62_A 226 LQKIWLHTNPWD 237 (276)
T ss_dssp CCEEECCSSCBC
T ss_pred ccEEEccCCccc
Confidence 555555555444
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6e-24 Score=234.64 Aligned_cols=227 Identities=17% Similarity=0.165 Sum_probs=130.0
Q ss_pred cchhhccccccccCc----CCcccCCCCCccEEEcccCcccCcCCCcC--CCccccccccccccccccccCcccCCCCcc
Q 002121 114 KLNILILAGCGFTGN----IPDEIGNLAELSFLALNSNNFSGRIPPSL--GKLSQLYWLDLADNQLTGSIPVSTITSPGL 187 (964)
Q Consensus 114 ~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l 187 (964)
.++.|.+.++.++.. ++. +..+++|++|+|++|.+++..|..+ .++++|++|+|++|++++..|.. ....+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~-~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~--~~~~~ 141 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALR-VLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWL--AELQQ 141 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHH-HHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSH--HHHHT
T ss_pred ceeEEEEeCCcCCHHHHHHHHH-hcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhh--HHHHh
Confidence 355566666655421 111 2235679999999999998888888 88899999999999988544410 00112
Q ss_pred ccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccc--c--CccccCC
Q 002121 188 DQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK--V--PTNLNNL 263 (964)
Q Consensus 188 ~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~--p~~~~~l 263 (964)
..+++|++|+|++|++ ++..+..|+.+++|++|+|++|++.+. + +..+..+
T Consensus 142 ~~~~~L~~L~Ls~n~l-------------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l 196 (310)
T 4glp_A 142 WLKPGLKVLSIAQAHS-------------------------PAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKF 196 (310)
T ss_dssp TBCSCCCEEEEECCSS-------------------------CCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSS
T ss_pred hhccCCCEEEeeCCCc-------------------------chhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcC
Confidence 2345555555555555 444445555555555555555555431 1 1223455
Q ss_pred CCCCeeeccCccCccCCCC----CCCCCCCCEEEccCCCCCCCCCCcccCCC---CCCcEEECCCCccccccChhccCCC
Q 002121 264 TNVNELNLAHNDLKGPFPD----LSQMNSLSYVDLSNNSFDPTEAPLWFSTL---PSLTTLICEFGSLQGRVPDKLFSYS 336 (964)
Q Consensus 264 ~~L~~L~Ls~N~l~~~~~~----l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~ 336 (964)
++|++|+|++|+++..... +..+++|++|+|++|.++ ...|..+..+ ++|++|+|++|+|+ .+|..+. +
T Consensus 197 ~~L~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~-~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~ 272 (310)
T 4glp_A 197 PAIQNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLR-ATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--A 272 (310)
T ss_dssp CCCCSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCC-CCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--S
T ss_pred CCCCEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCC-ccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--C
Confidence 5566666666655433221 244555666666666654 3323333333 46666666666666 4454443 5
Q ss_pred CCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 337 QIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
+|+.|+|++|++++... +..+++|+.|+|++|+|+.
T Consensus 273 ~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 273 KLRVLDLSSNRLNRAPQ--PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCEECCSCCCCSCCC--TTSCCCCSCEECSSTTTSC
T ss_pred CCCEEECCCCcCCCCch--hhhCCCccEEECcCCCCCC
Confidence 66666666666665422 4566667777777776653
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=225.79 Aligned_cols=224 Identities=19% Similarity=0.230 Sum_probs=127.3
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
+.++..+++..+.+.... .+..+++|+.|++++|.++. + ..+..+++|++|+|++|++++ ++ .+..++
T Consensus 18 ~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~-~~l~~l~~L~~L~l~~n~l~~-~~-------~l~~l~ 85 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-V-QGIQYLPNVRYLALGGNKLHD-IS-------ALKELT 85 (272)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECTTSCCCC-CG-------GGTTCT
T ss_pred HHHHHHHHhcCccccccc--ccccccceeeeeeCCCCccc-c-cccccCCCCcEEECCCCCCCC-ch-------hhcCCC
Confidence 456666777777766432 35567778888888887773 3 347777778888888877763 22 455666
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
+|++|++++|.++ .++...|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|
T Consensus 86 ~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 164 (272)
T 3rfs_A 86 NLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL 164 (272)
T ss_dssp TCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC
Confidence 6666666666665 444444555555555555555555555555555555555555555555444445555555555555
Q ss_pred cCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccc
Q 002121 272 AHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 272 s~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
++|++++.++. +..+++|++|+|++|+++ ...+..+..+++|+.|+|++|.+.+. +++|+.|+++.|.+++
T Consensus 165 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g 236 (272)
T 3rfs_A 165 SYNQLQSLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSG 236 (272)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGG
T ss_pred CCCCcCccCHHHhcCCccCCEEECCCCcCC-ccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCC
Confidence 55555554443 345555555555555554 33334445555555555555544422 2344444555555554
Q ss_pred ccCCCC
Q 002121 351 TLDMGN 356 (964)
Q Consensus 351 ~~~~~~ 356 (964)
.+|..+
T Consensus 237 ~ip~~~ 242 (272)
T 3rfs_A 237 VVRNSA 242 (272)
T ss_dssp GBBCTT
T ss_pred cccCcc
Confidence 444433
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-24 Score=229.09 Aligned_cols=227 Identities=24% Similarity=0.308 Sum_probs=164.1
Q ss_pred cccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccc
Q 002121 89 ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDL 168 (964)
Q Consensus 89 ~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 168 (964)
++..+++..+ .+... ..+..+.+|+.|++++|.++ .++ .+..+++|++|+|++|.+++. ..+.++++|++|+|
T Consensus 20 ~l~~l~l~~~-~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 20 ETIKANLKKK-SVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHTCS-CTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred HHHHHHhcCc-ccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence 3444455444 23322 23445566666666666665 222 356666666666666666642 35666666666666
Q ss_pred cccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcc
Q 002121 169 ADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248 (964)
Q Consensus 169 s~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls 248 (964)
++|++++..| ..+..+++|++|++++|+++ .++...|..+++|++|++++|++++..+..+..+++|+.|+|+
T Consensus 93 ~~n~l~~~~~------~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 165 (272)
T 3rfs_A 93 TGNQLQSLPN------GVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLS 165 (272)
T ss_dssp TTSCCCCCCT------TTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCccCccCh------hHhcCCcCCCEEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECC
Confidence 6666663222 23556666666666666666 5555667777778888888888887777778899999999999
Q ss_pred cCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccc
Q 002121 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGR 327 (964)
Q Consensus 249 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 327 (964)
+|++++..+..|.++++|++|+|++|++++.++. +..+++|++|+|++|++. +.+++|+.|++..|.+.|.
T Consensus 166 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~--------~~~~~l~~l~~~~n~~~g~ 237 (272)
T 3rfs_A 166 YNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD--------CTCPGIRYLSEWINKHSGV 237 (272)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC--------CCTTTTHHHHHHHHHTGGG
T ss_pred CCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcc--------ccCcHHHHHHHHHHhCCCc
Confidence 9999988888889999999999999999998876 788999999999999985 3467899999999999999
Q ss_pred cChhccCCCC
Q 002121 328 VPDKLFSYSQ 337 (964)
Q Consensus 328 ~p~~~~~l~~ 337 (964)
+|..++.+..
T Consensus 238 ip~~~~~~~~ 247 (272)
T 3rfs_A 238 VRNSAGSVAP 247 (272)
T ss_dssp BBCTTSCBCG
T ss_pred ccCcccccCC
Confidence 9998877653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-22 Score=219.93 Aligned_cols=134 Identities=22% Similarity=0.235 Sum_probs=79.2
Q ss_pred CCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcE
Q 002121 238 YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTT 316 (964)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 316 (964)
.+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++.++. +.++++|++|+|++|+++ ...+..|..+++|+.
T Consensus 75 ~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~ 152 (290)
T 1p9a_G 75 TLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEK 152 (290)
T ss_dssp CCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCE
T ss_pred CCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCC-ccChhhcccccCCCE
Confidence 4445555555555555 4455555555555555555555555443 555555555555555554 444445566666666
Q ss_pred EECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 317 LICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 317 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
|+|++|+|++..+..|..+++|+.|+|++|+++ .+|..+..++.|+.|+|++|+|.+
T Consensus 153 L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 153 LSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp EECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred EECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 666666666555555666666777777777666 334455555677777777777765
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=231.79 Aligned_cols=200 Identities=18% Similarity=0.147 Sum_probs=102.1
Q ss_pred cchhhccccccccCcCCccc--CCCCCccEEEcccCcccCcCC----CcCCCccccccccccccccccccCcccCCCCcc
Q 002121 114 KLNILILAGCGFTGNIPDEI--GNLAELSFLALNSNNFSGRIP----PSLGKLSQLYWLDLADNQLTGSIPVSTITSPGL 187 (964)
Q Consensus 114 ~L~~L~L~~n~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l 187 (964)
+|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..| ..+
T Consensus 92 ~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~------~~~ 165 (310)
T 4glp_A 92 RLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSC------EQV 165 (310)
T ss_dssp CCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCT------TSC
T ss_pred ceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhH------HHh
Confidence 35555555555554444444 445555555555555544332 123344455555555555543222 234
Q ss_pred ccccCCCeeEccCCccccc--cc-ccccCCCcceeEEEccCCcCcccCCc----ccCCCCCCcEEEcccCcCccccCccc
Q 002121 188 DQLKNAKHFHFNKNKLSGT--IS-EQLFSPDMVLIHVLFDGNQLSGNIPE----SLGYVQTLEVLRLDRNALTGKVPTNL 260 (964)
Q Consensus 188 ~~l~~L~~L~L~~N~l~g~--l~-~~~f~~~~~L~~L~l~~N~l~~~~p~----~~~~l~~L~~L~Ls~N~l~~~~p~~~ 260 (964)
..+++|++|+|++|++.+. ++ ...+..+++|++|++++|+++. ++. .++.+++|++|+|++|+|++..|..+
T Consensus 166 ~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~ 244 (310)
T 4glp_A 166 RAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSA 244 (310)
T ss_dssp CCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCC
T ss_pred ccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhH
Confidence 4445555555555554321 11 1222344455555555555542 111 23455666666666666665555555
Q ss_pred cCC---CCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccc
Q 002121 261 NNL---TNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 261 ~~l---~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
..+ ++|++|+|++|+|+.++..+. ++|++|+|++|++++. |. +..+++|+.|+|++|+++
T Consensus 245 ~~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~--~~-~~~l~~L~~L~L~~N~l~ 307 (310)
T 4glp_A 245 PRCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA--PQ-PDELPEVDNLTLDGNPFL 307 (310)
T ss_dssp SSCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC--CC-TTSCCCCSCEECSSTTTS
T ss_pred HhccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC--ch-hhhCCCccEEECcCCCCC
Confidence 554 466666666666665544442 5666666666666522 22 456667777777777665
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9e-23 Score=217.94 Aligned_cols=188 Identities=26% Similarity=0.333 Sum_probs=111.3
Q ss_pred CCCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcc
Q 002121 53 CGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDE 132 (964)
Q Consensus 53 C~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 132 (964)
|+.|.|+.|.. ..+.+++++++++ .+|..+. +.|+.|+|++| .+.+..+..|.++++|++|+|++|.|++..|..
T Consensus 4 Cp~~~gC~C~~-~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n-~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 78 (251)
T 3m19_A 4 CETVTGCTCNE-GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQST-GLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78 (251)
T ss_dssp CHHHHSSEEEG-GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTS-CCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTT
T ss_pred CCCCCceEcCC-CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCC-CcCccCHhHhcCcccCCEEECCCCcCCccCHhH
Confidence 55899999953 3456888888887 5555554 46777777777 566666666666666666666666666555555
Q ss_pred cCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccccccccccc
Q 002121 133 IGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLF 212 (964)
Q Consensus 133 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f 212 (964)
|..+++|++|+|++|+|++..+..|.++++|++|+|++|+++
T Consensus 79 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-------------------------------------- 120 (251)
T 3m19_A 79 FDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-------------------------------------- 120 (251)
T ss_dssp TTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC--------------------------------------
T ss_pred hccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCC--------------------------------------
Confidence 666666666666666666554455555555555555555554
Q ss_pred CCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCE
Q 002121 213 SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSY 291 (964)
Q Consensus 213 ~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~ 291 (964)
+..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+|++.++. +..+++|++
T Consensus 121 -----------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 183 (251)
T 3m19_A 121 -----------------SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQT 183 (251)
T ss_dssp -----------------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCE
T ss_pred -----------------CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCE
Confidence 12222334445555555555555544444555555555555555555555542 555566666
Q ss_pred EEccCCCCC
Q 002121 292 VDLSNNSFD 300 (964)
Q Consensus 292 L~Ls~N~l~ 300 (964)
|+|++|+++
T Consensus 184 L~l~~N~~~ 192 (251)
T 3m19_A 184 ITLFGNQFD 192 (251)
T ss_dssp EECCSCCBC
T ss_pred EEeeCCcee
Confidence 666666664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.3e-23 Score=223.90 Aligned_cols=153 Identities=13% Similarity=0.068 Sum_probs=124.1
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCc------------------chhHHHHHHHHHHHhc
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSM------------------QGGLEFKTEIELLSRV 680 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l 680 (964)
...+......|...+.||+|+||.||+|...+|+.||||+++.... .....+.+|+++++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 3444555667777899999999999999997799999999864322 1245688999999999
Q ss_pred CCCCccceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEE
Q 002121 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNIL 760 (964)
Q Consensus 681 ~H~nIv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NIL 760 (964)
+ | +++.+++. .+..++||||+++|+|.+ +.. .+...++.|++.||+|||+.+ |+||||||+|||
T Consensus 162 ~--~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL 225 (282)
T 1zar_A 162 Q--G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL 225 (282)
T ss_dssp T--T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred c--C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence 9 5 77777654 456799999999999998 432 224579999999999999988 999999999999
Q ss_pred ECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccc
Q 002121 761 LDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803 (964)
Q Consensus 761 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 803 (964)
++ ++.+||+|||+|+. +..|+|||++.
T Consensus 226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~ 252 (282)
T 1zar_A 226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILE 252 (282)
T ss_dssp EE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred EE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence 99 99999999999873 34578899874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=215.36 Aligned_cols=203 Identities=14% Similarity=0.170 Sum_probs=138.4
Q ss_pred cccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhcccccc-ccCcCCcccCCCCCccEEEccc-CcccCcCCCc
Q 002121 79 KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCG-FTGNIPDEIGNLAELSFLALNS-NNFSGRIPPS 156 (964)
Q Consensus 79 ~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~ 156 (964)
.+|. +. ++|++|+|++| .+.+..+..|.++++|++|+|++|. ++...+..|.++++|++|+|++ |++++..+..
T Consensus 25 ~ip~-~~--~~l~~L~l~~n-~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~ 100 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIET-HLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDA 100 (239)
T ss_dssp SCCC-CC--TTCCEEEEESC-CCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTS
T ss_pred ccCC-CC--CcccEEEEeCC-cceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHH
Confidence 4555 33 37889999998 6887777788889999999999996 8766666888899999999998 8898777778
Q ss_pred CCCccccccccccccccccccCcccCCCCccccccCCC---eeEccCC-cccccccccccCCCccee-EEEccCCcCccc
Q 002121 157 LGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAK---HFHFNKN-KLSGTISEQLFSPDMVLI-HVLFDGNQLSGN 231 (964)
Q Consensus 157 ~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~---~L~L~~N-~l~g~l~~~~f~~~~~L~-~L~l~~N~l~~~ 231 (964)
|.++++|++|+|++|++++ +|. +..+++|+ .|++++| +++ .++...|..+.+|+ +|++++|+++..
T Consensus 101 f~~l~~L~~L~l~~n~l~~-lp~-------~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~~i 171 (239)
T 2xwt_C 101 LKELPLLKFLGIFNTGLKM-FPD-------LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFTSV 171 (239)
T ss_dssp EECCTTCCEEEEEEECCCS-CCC-------CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCCEE
T ss_pred hCCCCCCCEEeCCCCCCcc-ccc-------cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCccc
Confidence 8888899999999998884 551 45555555 7777777 666 55555566666666 666666666633
Q ss_pred CCcccCCCCCCcEEEcccCc-CccccCccccCC-CCCCeeeccCccCccCCCCCCCCCCCCEEEccCC
Q 002121 232 IPESLGYVQTLEVLRLDRNA-LTGKVPTNLNNL-TNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297 (964)
Q Consensus 232 ~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 297 (964)
.+..+.. ++|+.|+|++|+ +++..+..|.++ ++|+.|+|++|+|+++++. .+++|+.|+++++
T Consensus 172 ~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 172 QGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT--TCTTCSEEECTTC
T ss_pred CHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh--HhccCceeeccCc
Confidence 3333333 566666666663 664445556666 6666666666666554443 3445555555543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.1e-22 Score=211.47 Aligned_cols=178 Identities=19% Similarity=0.179 Sum_probs=133.3
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
..+.++++++.++ .+|..+. ..++.|+|++|++++..+..|..+++|++|+|++|.|++..+..|.++++|++|+|
T Consensus 15 ~~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 90 (251)
T 3m19_A 15 GKKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL 90 (251)
T ss_dssp GGTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEEC
Confidence 3445566666665 5554433 45677777777777777777788888888888888888777777888888888888
Q ss_pred cCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccc
Q 002121 272 AHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 272 s~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
++|+|++.++. +..+++|++|+|++|.++ ...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++
T Consensus 91 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 169 (251)
T 3m19_A 91 ANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQS 169 (251)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred CCCcccccChhHhcccCCCCEEEcCCCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCc
Confidence 88888877665 677788888888888886 5556667778888888888888887777778888888888888888887
Q ss_pred ccCCCCccCCCCcEEeccCCccee
Q 002121 351 TLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 351 ~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
..+..+..+++|+.|+|++|+|++
T Consensus 170 ~~~~~~~~l~~L~~L~l~~N~~~c 193 (251)
T 3m19_A 170 VPHGAFDRLGKLQTITLFGNQFDC 193 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSCCBCT
T ss_pred cCHHHHhCCCCCCEEEeeCCceeC
Confidence 777777777888887777777764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.6e-25 Score=245.13 Aligned_cols=269 Identities=15% Similarity=0.153 Sum_probs=171.2
Q ss_pred CCCCCCccEEecCCCeeEEEcCCCCccccccCCcCCC--CcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCc
Q 002121 51 DPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGL--TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGN 128 (964)
Q Consensus 51 ~~C~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l--~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 128 (964)
..|..|.++.|+...++.++++++.+. +..+..+ +.|+.|+|++| .+.+..+. +..+++|++|+|++|.+++.
T Consensus 34 ~vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n-~l~~~~~~-~~~~~~L~~L~L~~~~l~~~ 108 (336)
T 2ast_B 34 GVCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRS-FMDQPLAE-HFSPFRVQHMDLSNSVIEVS 108 (336)
T ss_dssp SSCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTC-EECSCCCS-CCCCBCCCEEECTTCEECHH
T ss_pred HHHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCc-cccccchh-hccCCCCCEEEccCCCcCHH
Confidence 446579999888777899999999887 3456666 88999999998 67766554 66789999999999998865
Q ss_pred -CCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccccc-ccccc-cCcccCCCCccccccCCCeeEccCC-ccc
Q 002121 129 -IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN-QLTGS-IPVSTITSPGLDQLKNAKHFHFNKN-KLS 204 (964)
Q Consensus 129 -~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~g~-iP~~~~~~~~l~~l~~L~~L~L~~N-~l~ 204 (964)
+|..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. +| ..+..+++|++|++++| .++
T Consensus 109 ~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~------~~~~~~~~L~~L~l~~~~~l~ 182 (336)
T 2ast_B 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ------TLLSSCSRLDELNLSWCFDFT 182 (336)
T ss_dssp HHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH------HHHHHCTTCCEEECCCCTTCC
T ss_pred HHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHH------HHHhcCCCCCEEcCCCCCCcC
Confidence 7888888999999999999988777888888899999999998 67642 44 23566778888888877 776
Q ss_pred ccccccccCCCc-ceeEEEccCC--cCc-ccCCcccCCCCCCcEEEcccCc-CccccCccccCCCCCCeeeccCccCccC
Q 002121 205 GTISEQLFSPDM-VLIHVLFDGN--QLS-GNIPESLGYVQTLEVLRLDRNA-LTGKVPTNLNNLTNVNELNLAHNDLKGP 279 (964)
Q Consensus 205 g~l~~~~f~~~~-~L~~L~l~~N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 279 (964)
+.-....+..++ +|++|++++| .++ +.++..+..+++|+.|+|++|. +++..+..+.++
T Consensus 183 ~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l---------------- 246 (336)
T 2ast_B 183 EKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQL---------------- 246 (336)
T ss_dssp HHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGC----------------
T ss_pred hHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCC----------------
Confidence 331122233344 5555555555 233 2333344444555555555554 443444444444
Q ss_pred CCCCCCCCCCCEEEccCCC-CCCCCCCcccCCCCCCcEEECCCCccccccChhccCC-CCCCEEEcCCcccccccCCCCc
Q 002121 280 FPDLSQMNSLSYVDLSNNS-FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY-SQIQQVKLRNNAFNNTLDMGNA 357 (964)
Q Consensus 280 ~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~~~~~~ 357 (964)
++|++|++++|. +. ......+..+++|+.|+|++| +... .+..+ ..|+.|++++|++++..|..+.
T Consensus 247 -------~~L~~L~l~~~~~~~-~~~~~~l~~~~~L~~L~l~~~-i~~~---~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 247 -------NYLQHLSLSRCYDII-PETLLELGEIPTLKTLQVFGI-VPDG---TLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp -------TTCCEEECTTCTTCC-GGGGGGGGGCTTCCEEECTTS-SCTT---CHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred -------CCCCEeeCCCCCCCC-HHHHHHHhcCCCCCEEeccCc-cCHH---HHHHHHhhCcceEEecccCccccCCccc
Confidence 555555555543 11 111123455666666666666 2221 22222 2244555667777766665554
Q ss_pred c
Q 002121 358 V 358 (964)
Q Consensus 358 ~ 358 (964)
.
T Consensus 315 ~ 315 (336)
T 2ast_B 315 N 315 (336)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.88 E-value=7e-23 Score=242.35 Aligned_cols=210 Identities=22% Similarity=0.348 Sum_probs=118.5
Q ss_pred CCCCCCCCCC----CCccE-EecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhc
Q 002121 45 TWKNSDDPCG----SWEGV-TCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILI 119 (964)
Q Consensus 45 ~W~~~~~~C~----~w~gv-~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~ 119 (964)
+|..+.++|. .|.|+ .|...+++.|+|++|++++ +|..+. ++|++|+|++| .+. .+| ..+++|++|+
T Consensus 35 ~W~~~~~~~~~~~~~~~~l~~C~~~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N-~l~-~ip---~~l~~L~~L~ 106 (571)
T 3cvr_A 35 KWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQN-ALI-SLP---ELPASLEYLD 106 (571)
T ss_dssp HHHTTCCTTCCHHHHHHHHHHHHHTTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSS-CCS-CCC---CCCTTCCEEE
T ss_pred HHhccCCccccccchhhhccccccCCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCC-CCc-ccc---cccCCCCEEE
Confidence 4655666773 49999 7887889999999999986 776653 67888888877 455 344 3345555555
Q ss_pred cccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEcc
Q 002121 120 LAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFN 199 (964)
Q Consensus 120 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~ 199 (964)
|++|+|++ +|. +.. +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|
T Consensus 107 Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp--------------------- 156 (571)
T 3cvr_A 107 ACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LP--------------------- 156 (571)
T ss_dssp CCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---------------------
T ss_pred ccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CC---------------------
Confidence 55555553 444 333 45555555555553 333 33444444444444441 22
Q ss_pred CCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccC
Q 002121 200 KNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGP 279 (964)
Q Consensus 200 ~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 279 (964)
. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|+|+.+
T Consensus 157 ----------------------------------~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~l 195 (571)
T 3cvr_A 157 ----------------------------------E---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESL 195 (571)
T ss_dssp ----------------------------------C---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSC
T ss_pred ----------------------------------C---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCch
Confidence 1 22344444444444442 333 33 4444444445544433
Q ss_pred CCCCCC-----CCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCC
Q 002121 280 FPDLSQ-----MNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYS 336 (964)
Q Consensus 280 ~~~l~~-----l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 336 (964)
+. +.. ...|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus 196 p~-~~~~L~~~~~~L~~L~Ls~N~l~--~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 196 PA-VPVRNHHSEETEIFFRCRENRIT--HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp CC-CC--------CCEEEECCSSCCC--CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred hh-HHHhhhcccccceEEecCCCcce--ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 33 222 122377777777774 3555556677777777777777777777766543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.1e-22 Score=210.40 Aligned_cols=197 Identities=16% Similarity=0.092 Sum_probs=130.3
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCc-CcccCCcccCCCCCCcEEEccc-CcCccccCccccCCCCCCee
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQ-LSGNIPESLGYVQTLEVLRLDR-NALTGKVPTNLNNLTNVNEL 269 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~-l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L 269 (964)
+|++|++++|+++ .++...|..+++|++|++++|+ +++..+..|..+++|++|+|++ |++++..+..|.++++|++|
T Consensus 32 ~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 32 STQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred cccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 4555555555554 4444455555666666666664 5555555666777777777776 77775555667777777777
Q ss_pred eccCccCccCCCCCCCCCCCC---EEEccCC-CCCCCCCCcccCCCCCCc-EEECCCCccccccChhccCCCCCCEEEcC
Q 002121 270 NLAHNDLKGPFPDLSQMNSLS---YVDLSNN-SFDPTEAPLWFSTLPSLT-TLICEFGSLQGRVPDKLFSYSQIQQVKLR 344 (964)
Q Consensus 270 ~Ls~N~l~~~~~~l~~l~~L~---~L~Ls~N-~l~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 344 (964)
+|++|.+++++. +..+++|+ +|++++| .++ ...+..|.++++|+ .|+|++|+++...+..|.. ++|+.|+|+
T Consensus 111 ~l~~n~l~~lp~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~ 187 (239)
T 2xwt_C 111 GIFNTGLKMFPD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLN 187 (239)
T ss_dssp EEEEECCCSCCC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECT
T ss_pred eCCCCCCccccc-cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcC
Confidence 777777776443 66666666 7777777 665 44555677777777 7777777777444444444 677777777
Q ss_pred Ccc-cccccCCCCccC-CCCcEEeccCCcceeeccCCCcccceeEeecCC
Q 002121 345 NNA-FNNTLDMGNAVG-PLLQLVDLQNNQISAITLGSGIKNYTLILVGNP 392 (964)
Q Consensus 345 ~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np 392 (964)
+|+ ++...+..|..+ ++|+.|+|++|+|+.++...+..+..|.+.+++
T Consensus 188 ~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTW 237 (239)
T ss_dssp TCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEECTTC-
T ss_pred CCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeeccCcc
Confidence 774 777777777777 777777777777777777666667777776654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=2.5e-24 Score=243.16 Aligned_cols=105 Identities=23% Similarity=0.181 Sum_probs=58.8
Q ss_pred EEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCC----CCCCCcc-cchhhccccccccCcCCcccCCC-----CC
Q 002121 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLS----PRIGDLQ-KLNILILAGCGFTGNIPDEIGNL-----AE 138 (964)
Q Consensus 69 L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~~~~l-----~~ 138 (964)
.+|+.++++|.+|..+...++|++|||++| .+.+..+ ..|..++ +|++|+|++|.|++..+..+..+ ++
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n-~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLN-NLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTS-CGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCC-CCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 456666666666665555555666666666 4554444 4445555 56666666666655545444443 55
Q ss_pred ccEEEcccCcccCcCCCcCCCc-----cccccccccccccc
Q 002121 139 LSFLALNSNNFSGRIPPSLGKL-----SQLYWLDLADNQLT 174 (964)
Q Consensus 139 L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~ 174 (964)
|++|+|++|.+++..+..+... ++|++|+|++|+++
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 122 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS 122 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGG
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCC
Confidence 6666666666554444433222 45555555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=6e-22 Score=218.27 Aligned_cols=217 Identities=24% Similarity=0.342 Sum_probs=135.8
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
+.++..+.+..+.++..++ +..+++|++|++++|.++. +| .+..+++|++|+|++|++++ +| .+..++
T Consensus 18 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~-~~-------~~~~l~ 85 (308)
T 1h6u_A 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITD-LA-------PLKNLT 85 (308)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-------GGTTCC
T ss_pred HHHHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCC-Ch-------hHccCC
Confidence 4455566666666664332 4567778888888887773 44 57777777777777777762 22 155566
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
+|++|+|++|++++ ++ .+..+++|+.|+|++|++++. +. +..+++|++|+|
T Consensus 86 ~L~~L~L~~n~l~~-~~--------------------------~~~~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l 136 (308)
T 1h6u_A 86 KITELELSGNPLKN-VS--------------------------AIAGLQSIKTLDLTSTQITDV-TP-LAGLSNLQVLYL 136 (308)
T ss_dssp SCCEEECCSCCCSC-CG--------------------------GGTTCTTCCEEECTTSCCCCC-GG-GTTCTTCCEEEC
T ss_pred CCCEEEccCCcCCC-ch--------------------------hhcCCCCCCEEECCCCCCCCc-hh-hcCCCCCCEEEC
Confidence 66666666666552 21 345555666666666666532 22 556666666666
Q ss_pred cCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 272 s~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
++|.+++.++ +..+++|++|+|++|.++ . .+. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++.
T Consensus 137 ~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~ 210 (308)
T 1h6u_A 137 DLNQITNISP-LAGLTNLQYLSIGNAQVS-D-LTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDV 210 (308)
T ss_dssp CSSCCCCCGG-GGGCTTCCEEECCSSCCC-C-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCcCcc-ccCCCCccEEEccCCcCC-C-Chh-hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcc
Confidence 6666655444 556666666666666664 2 222 6666677777777777665443 66777777777777777766
Q ss_pred cCCCCccCCCCcEEeccCCcceeecc
Q 002121 352 LDMGNAVGPLLQLVDLQNNQISAITL 377 (964)
Q Consensus 352 ~~~~~~~l~~L~~L~L~~N~l~~i~~ 377 (964)
.+ +..+++|+.|+|++|+++..+.
T Consensus 211 ~~--l~~l~~L~~L~l~~N~i~~~~~ 234 (308)
T 1h6u_A 211 SP--LANTSNLFIVTLTNQTITNQPV 234 (308)
T ss_dssp GG--GTTCTTCCEEEEEEEEEECCCE
T ss_pred cc--ccCCCCCCEEEccCCeeecCCe
Confidence 53 6677777777777777776554
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=9.4e-24 Score=238.41 Aligned_cols=259 Identities=17% Similarity=0.163 Sum_probs=203.3
Q ss_pred EEecccCCCCCCCCCCCCCCcccchhhccccccccCcCC----cccCCCC-CccEEEcccCcccCcCCCcCCCc-----c
Q 002121 92 SLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIP----DEIGNLA-ELSFLALNSNNFSGRIPPSLGKL-----S 161 (964)
Q Consensus 92 ~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~ 161 (964)
+++|++| .+.+.+|..+....+|++|+|++|.|++..+ ..|.+++ +|++|+|++|.+++..+..|..+ +
T Consensus 2 ~~~ls~n-~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 2 NYKLTLH-PGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80 (362)
T ss_dssp EEECCCC-TTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred ccccccc-cchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence 4688899 7999998888888889999999999997666 7788898 89999999999998878777776 8
Q ss_pred ccccccccccccccccCcccCCCCccccc-cCCCeeEccCCcccccccccc---cCC-CcceeEEEccCCcCcccCC---
Q 002121 162 QLYWLDLADNQLTGSIPVSTITSPGLDQL-KNAKHFHFNKNKLSGTISEQL---FSP-DMVLIHVLFDGNQLSGNIP--- 233 (964)
Q Consensus 162 ~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l-~~L~~L~L~~N~l~g~l~~~~---f~~-~~~L~~L~l~~N~l~~~~p--- 233 (964)
+|++|+|++|++++..+..+. ..+..+ ++|++|+|++|++++..+..+ +.. ..+|++|++++|+|++..+
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~--~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l 158 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELV--KTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDEL 158 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHH--HHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHH
T ss_pred CccEEECcCCcCChHHHHHHH--HHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHH
Confidence 999999999999855442110 123444 899999999999985444333 333 4689999999999996443
Q ss_pred -cccCCCC-CCcEEEcccCcCccccCcccc----CC-CCCCeeeccCccCccCC-----CCCCC-CCCCCEEEccCCCCC
Q 002121 234 -ESLGYVQ-TLEVLRLDRNALTGKVPTNLN----NL-TNVNELNLAHNDLKGPF-----PDLSQ-MNSLSYVDLSNNSFD 300 (964)
Q Consensus 234 -~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~~-----~~l~~-l~~L~~L~Ls~N~l~ 300 (964)
..+..++ +|+.|+|++|+|++..+..+. .+ ++|++|+|++|.|++.. ..+.. .++|++|+|++|.++
T Consensus 159 ~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~ 238 (362)
T 3goz_A 159 IQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238 (362)
T ss_dssp HHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCC
T ss_pred HHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCC
Confidence 4445555 999999999999977765444 44 69999999999999832 23444 469999999999997
Q ss_pred CCCC---CcccCCCCCCcEEECCCCcccccc-------ChhccCCCCCCEEEcCCcccccccC
Q 002121 301 PTEA---PLWFSTLPSLTTLICEFGSLQGRV-------PDKLFSYSQIQQVKLRNNAFNNTLD 353 (964)
Q Consensus 301 ~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~-------p~~~~~l~~L~~L~L~~N~l~~~~~ 353 (964)
.... ...+..+++|+.|+|++|.+.+.. +..+..+++|+.|+|++|++....+
T Consensus 239 ~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp CCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3222 345678899999999999955443 3467788999999999999987644
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.86 E-value=1.4e-21 Score=215.32 Aligned_cols=196 Identities=25% Similarity=0.401 Sum_probs=123.8
Q ss_pred CCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccc
Q 002121 109 IGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188 (964)
Q Consensus 109 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~ 188 (964)
+..+++|++|++++|.++ .+| .+..+++|++|+|++|.+++..+ +.++++|++|+|++|++++ +| .+.
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~-~~-------~~~ 104 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-------AIA 104 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-------GGT
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCC-ch-------hhc
Confidence 456777777777777777 445 57777888888888888875433 7778888888888888773 22 466
Q ss_pred cccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCe
Q 002121 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNE 268 (964)
Q Consensus 189 ~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (964)
.+++|++|++++|++++ ++. +..+++|+.|+|++|.+++..+ +..+++|++
T Consensus 105 ~l~~L~~L~l~~n~l~~-~~~--------------------------l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~ 155 (308)
T 1h6u_A 105 GLQSIKTLDLTSTQITD-VTP--------------------------LAGLSNLQVLYLDLNQITNISP--LAGLTNLQY 155 (308)
T ss_dssp TCTTCCEEECTTSCCCC-CGG--------------------------GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCE
T ss_pred CCCCCCEEECCCCCCCC-chh--------------------------hcCCCCCCEEECCCCccCcCcc--ccCCCCccE
Confidence 67777777777777662 221 4444555555555555553322 555555555
Q ss_pred eeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccc
Q 002121 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348 (964)
Q Consensus 269 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 348 (964)
|+|++|.+++..+ +..+++|++|++++|.++ . .+. +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++
T Consensus 156 L~l~~n~l~~~~~-l~~l~~L~~L~l~~n~l~-~-~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 156 LSIGNAQVSDLTP-LANLSKLTTLKADDNKIS-D-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229 (308)
T ss_dssp EECCSSCCCCCGG-GTTCTTCCEEECCSSCCC-C-CGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEE
T ss_pred EEccCCcCCCChh-hcCCCCCCEEECCCCccC-c-Chh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCee
Confidence 5555555555444 555566666666666664 2 222 5666677777777777765543 67777777777777777
Q ss_pred ccc
Q 002121 349 NNT 351 (964)
Q Consensus 349 ~~~ 351 (964)
++.
T Consensus 230 ~~~ 232 (308)
T 1h6u_A 230 TNQ 232 (308)
T ss_dssp ECC
T ss_pred ecC
Confidence 653
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=9.5e-24 Score=240.64 Aligned_cols=67 Identities=25% Similarity=0.269 Sum_probs=28.7
Q ss_pred cCCCCCCcEEECCCCccccc----cChhccC--CCCCCEEEcCCccccc----ccCCCC-ccCCCCcEEeccCCccee
Q 002121 308 FSTLPSLTTLICEFGSLQGR----VPDKLFS--YSQIQQVKLRNNAFNN----TLDMGN-AVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 308 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~--l~~L~~L~L~~N~l~~----~~~~~~-~~l~~L~~L~L~~N~l~~ 374 (964)
+..+++|+.|+|++|+|++. ++..+.. +++|+.|+|++|++++ .++..+ ..+++|+.|+|++|+++.
T Consensus 240 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~ 317 (386)
T 2ca6_A 240 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 317 (386)
T ss_dssp GGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCc
Confidence 33444444444444444433 2333322 4444444444444444 233222 334455555555555443
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.2e-23 Score=239.64 Aligned_cols=243 Identities=16% Similarity=0.210 Sum_probs=154.6
Q ss_pred CCCCCCCCcccchhhccccccccCc----CCcccCCCCCccEEEcccC---cccCcCCCcC-------CCcccccccccc
Q 002121 104 SLSPRIGDLQKLNILILAGCGFTGN----IPDEIGNLAELSFLALNSN---NFSGRIPPSL-------GKLSQLYWLDLA 169 (964)
Q Consensus 104 ~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N---~l~~~~p~~~-------~~l~~L~~L~Ls 169 (964)
.++..+..+++|++|+|++|.|++. ++..+..+++|++|+|++| ++++.+|..+ .++++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 4455566677788888888877755 3334667778888888775 4444555444 567777778888
Q ss_pred cccccc----ccCcccCCCCccccccCCCeeEccCCccccccccccc---CCC---------cceeEEEccCCcCc-ccC
Q 002121 170 DNQLTG----SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLF---SPD---------MVLIHVLFDGNQLS-GNI 232 (964)
Q Consensus 170 ~N~l~g----~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f---~~~---------~~L~~L~l~~N~l~-~~~ 232 (964)
+|.+++ .+| ..+..+++|++|+|++|.+++..+..+. ..+ ++|++|++++|+++ +.+
T Consensus 103 ~n~l~~~~~~~l~------~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~ 176 (386)
T 2ca6_A 103 DNAFGPTAQEPLI------DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM 176 (386)
T ss_dssp SCCCCTTTHHHHH------HHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGH
T ss_pred CCcCCHHHHHHHH------HHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHH
Confidence 777774 244 3456677777777777777533222221 112 56777777777776 333
Q ss_pred C---cccCCCCCCcEEEcccCcCc--c---ccCccccCCCCCCeeeccCccCc----c-CCCCCCCCCCCCEEEccCCCC
Q 002121 233 P---ESLGYVQTLEVLRLDRNALT--G---KVPTNLNNLTNVNELNLAHNDLK----G-PFPDLSQMNSLSYVDLSNNSF 299 (964)
Q Consensus 233 p---~~~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~-~~~~l~~l~~L~~L~Ls~N~l 299 (964)
+ ..+..+++|+.|+|++|+|+ | .++..+..+++|+.|+|++|.|+ + ++..+..+++|++|+|++|.+
T Consensus 177 ~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i 256 (386)
T 2ca6_A 177 KEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLL 256 (386)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCC
T ss_pred HHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCC
Confidence 3 35556677777777777776 2 34446677777777777777774 2 223366677777777777777
Q ss_pred CCC---CCCccc--CCCCCCcEEECCCCcccc----ccChhc-cCCCCCCEEEcCCccccccc
Q 002121 300 DPT---EAPLWF--STLPSLTTLICEFGSLQG----RVPDKL-FSYSQIQQVKLRNNAFNNTL 352 (964)
Q Consensus 300 ~~~---~~~~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~~ 352 (964)
+.. .++..+ ..+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..
T Consensus 257 ~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 257 SARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp CHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred chhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 521 023344 336777777777777776 366665 45677777777777776554
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=7.4e-21 Score=213.58 Aligned_cols=248 Identities=12% Similarity=0.038 Sum_probs=117.3
Q ss_pred hhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCe
Q 002121 116 NILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195 (964)
Q Consensus 116 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~ 195 (964)
++++.++++++ .+|..+ .++|++|+|++|+|+...+.+|.++++|++|+|++|++.+.+|. ..|.++++|.+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~-----~~f~~L~~l~~ 83 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA-----DVFSNLPKLHE 83 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT-----TSBCSCTTCCE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh-----hHhhcchhhhh
Confidence 34566666666 566555 24677777777777744445667777777777777766544442 23444444443
Q ss_pred -eEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEccc-CcCccccCccccCCC-CCCeeecc
Q 002121 196 -FHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDR-NALTGKVPTNLNNLT-NVNELNLA 272 (964)
Q Consensus 196 -L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~-~L~~L~Ls 272 (964)
+.++.|+++ .++...|..+++|++|++++|+|++..+..+....++..|++.+ |.++...+..|..+. .|+.|+|+
T Consensus 84 ~l~~~~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~ 162 (350)
T 4ay9_X 84 IRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLN 162 (350)
T ss_dssp EEEEEETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECC
T ss_pred hhcccCCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccc
Confidence 333344444 33333444444444444444444433333333333444444432 333333333333332 24444444
Q ss_pred CccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCC-CccccccChhccCCCCCCEEEcCCcccccc
Q 002121 273 HNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF-GSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 273 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
+|+|+.+++..... .+|+.|++++ |.++.+.+..|.++++|++|+|++|+|+.+
T Consensus 163 ~N~i~~i~~~~f~~-------------------------~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~l 217 (350)
T 4ay9_X 163 KNGIQEIHNSAFNG-------------------------TQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 217 (350)
T ss_dssp SSCCCEECTTSSTT-------------------------EEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCC
T ss_pred cccccCCChhhccc-------------------------cchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCcc
Confidence 44444443333333 3444444442 333333333445555555555555555544
Q ss_pred cCCCCccCCCCcEEeccCCcceeecc-CCCcccceeEeecCCccccccc
Q 002121 352 LDMGNAVGPLLQLVDLQNNQISAITL-GSGIKNYTLILVGNPVCTATLA 399 (964)
Q Consensus 352 ~~~~~~~l~~L~~L~L~~N~l~~i~~-~~~~~l~~l~l~~Np~c~~~l~ 399 (964)
++..+..+++|+.+++ ++++.+|. ..+..+..+++..+..|+|...
T Consensus 218 p~~~~~~L~~L~~l~~--~~l~~lP~l~~l~~L~~l~l~~~~~c~~~~~ 264 (350)
T 4ay9_X 218 PSYGLENLKKLRARST--YNLKKLPTLEKLVALMEASLTYPSHCCAFAN 264 (350)
T ss_dssp CSSSCTTCCEEECTTC--TTCCCCCCTTTCCSCCEEECSCHHHHHHHHH
T ss_pred ChhhhccchHhhhccC--CCcCcCCCchhCcChhhCcCCCCccccchhh
Confidence 4444433333333222 33444442 3344455566654446765443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=6.2e-23 Score=229.10 Aligned_cols=250 Identities=16% Similarity=0.168 Sum_probs=161.0
Q ss_pred chhhccccccccCcCCcccCCC--CCccEEEcccCcccCcCCCcCCCccccccccccccccccc-cCcccCCCCcccccc
Q 002121 115 LNILILAGCGFTGNIPDEIGNL--AELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGS-IPVSTITSPGLDQLK 191 (964)
Q Consensus 115 L~~L~L~~n~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~-iP~~~~~~~~l~~l~ 191 (964)
++.|++++|.+. |..+..+ ++|+.|++++|.+.+..+. +.++++|++|+|++|.+++. +| ..+..++
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~------~~~~~~~ 118 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLH------GILSQCS 118 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHH------HHHTTBC
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHH------HHHhhCC
Confidence 334444444443 2333444 4555555555555544333 33455555555555555433 33 2244455
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCC-cCcc-cCCcccCCCCCCcEEEcccC-cCccc-cCccccCCC-CC
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGN-QLSG-NIPESLGYVQTLEVLRLDRN-ALTGK-VPTNLNNLT-NV 266 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N-~l~~-~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L 266 (964)
+|++|+|++|.+++..+.. +..+++|++|++++| .+++ .++..+..+++|+.|++++| .+++. ++..+..++ +|
T Consensus 119 ~L~~L~L~~~~l~~~~~~~-l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L 197 (336)
T 2ast_B 119 KLQNLSLEGLRLSDPIVNT-LAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI 197 (336)
T ss_dssp CCSEEECTTCBCCHHHHHH-HTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred CCCEEeCcCcccCHHHHHH-HhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC
Confidence 5555555555555444332 333566666666666 4554 25556777888888888888 88854 577788888 89
Q ss_pred CeeeccCc--cCc--cCCCCCCCCCCCCEEEccCCC-CCCCCCCcccCCCCCCcEEECCCCc-cccccChhccCCCCCCE
Q 002121 267 NELNLAHN--DLK--GPFPDLSQMNSLSYVDLSNNS-FDPTEAPLWFSTLPSLTTLICEFGS-LQGRVPDKLFSYSQIQQ 340 (964)
Q Consensus 267 ~~L~Ls~N--~l~--~~~~~l~~l~~L~~L~Ls~N~-l~~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~ 340 (964)
++|+|++| .++ +.+..+..+++|++|++++|. ++ ...+..+..+++|+.|+|++|. +.......+..+++|+.
T Consensus 198 ~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~-~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~ 276 (336)
T 2ast_B 198 TQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK-NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKT 276 (336)
T ss_dssp CEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCC-GGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred CEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCC-HHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCE
Confidence 99999988 444 233346678899999999998 55 4556678999999999999995 44333346889999999
Q ss_pred EEcCCcccccccCCCCccC-CCCcEEeccCCcceeeccCCC
Q 002121 341 VKLRNNAFNNTLDMGNAVG-PLLQLVDLQNNQISAITLGSG 380 (964)
Q Consensus 341 L~L~~N~l~~~~~~~~~~l-~~L~~L~L~~N~l~~i~~~~~ 380 (964)
|+|++| ++ ...+..+ ..|+.|++++|+++.+.....
T Consensus 277 L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~ 313 (336)
T 2ast_B 277 LQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTI 313 (336)
T ss_dssp EECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSC
T ss_pred EeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcc
Confidence 999999 33 3344444 347888899999998765543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.84 E-value=3.8e-21 Score=215.96 Aligned_cols=218 Identities=13% Similarity=0.105 Sum_probs=139.8
Q ss_pred cEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCccee
Q 002121 140 SFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLI 219 (964)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~ 219 (964)
++++.++|+++ .+|..+. ++|++|+|++|+|+ .||. ..|.++++|++|+|++|++.+.+|..+
T Consensus 12 ~~v~C~~~~Lt-~iP~~l~--~~l~~L~Ls~N~i~-~i~~-----~~f~~l~~L~~L~Ls~N~i~~~i~~~~-------- 74 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQK-----GAFSGFGDLEKIEISQNDVLEVIEADV-------- 74 (350)
T ss_dssp TEEEEESTTCC-SCCTTCC--TTCSEEEEESCCCS-EECT-----TSSTTCTTCCEEEEECCTTCCEECTTS--------
T ss_pred CEEEecCCCCC-ccCcCcC--CCCCEEEccCCcCC-CcCH-----HHHcCCCCCCEEECcCCCCCCccChhH--------
Confidence 34556666666 4554442 35566666666665 3331 234455555555555555443444444
Q ss_pred EEEccCCcCcccCCcccCCCCCCc-EEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccC-
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLE-VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSN- 296 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~- 296 (964)
|.++++|. .+.++.|+|+...|..|.++++|++|++++|+|+..++. +....++..|++.+
T Consensus 75 ----------------f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~ 138 (350)
T 4ay9_X 75 ----------------FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 138 (350)
T ss_dssp ----------------BCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESC
T ss_pred ----------------hhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccc
Confidence 44555543 244455566655555666666666666666666655443 44455566666654
Q ss_pred CCCCCCCCCcccCCCC-CCcEEECCCCccccccChhccCCCCCCEEEcCC-cccccccCCCCccCCCCcEEeccCCccee
Q 002121 297 NSFDPTEAPLWFSTLP-SLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRN-NAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 297 N~l~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
|.+. ...+..|..+. .++.|+|++|+|+.+.+..| ...+|+.|++++ |.++.+.+..|..+++|+.|||++|+|+.
T Consensus 139 ~~i~-~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f-~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~ 216 (350)
T 4ay9_X 139 INIH-TIERNSFVGLSFESVILWLNKNGIQEIHNSAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 216 (350)
T ss_dssp TTCC-EECTTSSTTSBSSCEEEECCSSCCCEECTTSS-TTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCC
T ss_pred cccc-cccccchhhcchhhhhhccccccccCCChhhc-cccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCc
Confidence 4453 44445566664 58889999999986555444 567899999985 77887777889999999999999999999
Q ss_pred eccCCCcccceeEeecCC
Q 002121 375 ITLGSGIKNYTLILVGNP 392 (964)
Q Consensus 375 i~~~~~~~l~~l~l~~Np 392 (964)
+|...+..+..|.+.+++
T Consensus 217 lp~~~~~~L~~L~~l~~~ 234 (350)
T 4ay9_X 217 LPSYGLENLKKLRARSTY 234 (350)
T ss_dssp CCSSSCTTCCEEECTTCT
T ss_pred cChhhhccchHhhhccCC
Confidence 999888888888877765
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=6e-21 Score=197.54 Aligned_cols=183 Identities=22% Similarity=0.251 Sum_probs=130.4
Q ss_pred CCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCccc
Q 002121 54 GSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEI 133 (964)
Q Consensus 54 ~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~ 133 (964)
|.|.+|.|+...++ .+|..+ .++|++|+|++| .+.+..+..|..+++|++|+|++|++++..+..|
T Consensus 7 C~~~~v~c~~~~l~-----------~~p~~~--~~~l~~L~l~~n-~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 72 (208)
T 2o6s_A 7 CSGTTVECYSQGRT-----------SVPTGI--PAQTTYLDLETN-SLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVF 72 (208)
T ss_dssp EETTEEECCSSCCS-----------SCCSCC--CTTCSEEECCSS-CCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTT
T ss_pred ECCCEEEecCCCcc-----------CCCCCC--CCCCcEEEcCCC-ccCcCChhhhcccccCcEEECCCCccCccChhhc
Confidence 68999998754433 233333 457889999998 6877767778888889999999888886666667
Q ss_pred CCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccC
Q 002121 134 GNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFS 213 (964)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~ 213 (964)
..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+ ..+..+++|++|++++|+++ .++...|.
T Consensus 73 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~------~~~~~l~~L~~L~l~~N~l~-~~~~~~~~ 145 (208)
T 2o6s_A 73 NKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPD------GVFDKLTQLKDLRLYQNQLK-SVPDGVFD 145 (208)
T ss_dssp TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT------TTTTTCTTCCEEECCSSCCS-CCCTTTTT
T ss_pred CCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCH------hHhccCCcCCEEECCCCccc-eeCHHHhc
Confidence 888889999999888886666678888888888888888873222 34566777777777777776 45555566
Q ss_pred CCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCC
Q 002121 214 PDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLT 264 (964)
Q Consensus 214 ~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 264 (964)
.+++|++|++++|.+.+ .+++|++|+++.|+++|.+|..++.++
T Consensus 146 ~l~~L~~L~l~~N~~~~-------~~~~l~~L~~~~n~~~g~ip~~~~~l~ 189 (208)
T 2o6s_A 146 RLTSLQYIWLHDNPWDC-------TCPGIRYLSEWINKHSGVVRNSAGSVA 189 (208)
T ss_dssp TCTTCCEEECCSCCBCC-------CTTTTHHHHHHHHHCTTTBBCTTSSBC
T ss_pred cCCCccEEEecCCCeec-------CCCCHHHHHHHHHhCCceeeccCcccc
Confidence 66666666666665552 344566666666666666666665544
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.83 E-value=7.5e-21 Score=214.46 Aligned_cols=202 Identities=25% Similarity=0.264 Sum_probs=131.5
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCcccc-CCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLN-NLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNN 297 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N 297 (964)
.+++++|+|+ .+|..+. ..++.|+|++|+|++..+..|. ++++|++|+|++|+|+++++. +..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 3445555554 2443332 3466666666666655555565 666666666666666666653 666677777777777
Q ss_pred CCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCC---ccCCCCcEEeccCCccee
Q 002121 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGN---AVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 298 ~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~---~~l~~L~~L~L~~N~l~~ 374 (964)
+|+ ...+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..+ ..+++|+.|+|++|+|+.
T Consensus 99 ~l~-~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 99 HLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp CCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred cCC-cCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 765 4555567777777777777777777777778888888888888888877666555 567888888888888888
Q ss_pred eccCCCcc-----cceeEeecCC-ccccccccc-CccccCCCCCcccccccccCCCCC
Q 002121 375 ITLGSGIK-----NYTLILVGNP-VCTATLANT-NYCQLQQPTTKAYSTSLANCGGKS 425 (964)
Q Consensus 375 i~~~~~~~-----l~~l~l~~Np-~c~~~l~~~-~~~~~~~~~~~~~~~~~~~c~~~~ 425 (964)
++...+.. +..|+|.+|| .|+|.+... ..|................|..|.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~~~~~~~~~~~~~~~~~~~~~~C~~p~ 235 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSK 235 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECCHHHHHHHHHHHHTTCHHHHTTGGGCEEESSS
T ss_pred cCHHHhhhccHhhcceEEecCCCccCCcCcHHHHHHHHHhcCCchhccCcCCEeCCCh
Confidence 77543222 3668999999 899998763 556433322111122345666654
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.82 E-value=1.1e-22 Score=245.51 Aligned_cols=319 Identities=10% Similarity=0.014 Sum_probs=190.8
Q ss_pred eeEEEcCCCC-ccc-cccCCcCCCCcccEEecccCCCCCCC----CCCCCCCcccchhhcccccccc----CcCCcccCC
Q 002121 66 VTALGLSTMG-LTG-KLSGDIGGLTELRSLDLSYNGGLTGS----LSPRIGDLQKLNILILAGCGFT----GNIPDEIGN 135 (964)
Q Consensus 66 v~~L~L~~~~-l~g-~~~~~l~~l~~L~~L~L~~N~~l~~~----~p~~l~~l~~L~~L~L~~n~l~----~~~p~~~~~ 135 (964)
++.|+|+++. ++. .++..+..+++|++|+|++| .+.+. ++..+..+++|++|+|++|.++ +.++..+.+
T Consensus 140 L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~-~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 140 LETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEES-SFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp CCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTC-EEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred CcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccc-cccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 6666666654 111 12222235566666666666 34333 2223344556666666666655 223333445
Q ss_pred CCCccEEEcccCcccCcCCCcCCCccccccccc---------------------------cccccccccCcccCCCCccc
Q 002121 136 LAELSFLALNSNNFSGRIPPSLGKLSQLYWLDL---------------------------ADNQLTGSIPVSTITSPGLD 188 (964)
Q Consensus 136 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L---------------------------s~N~l~g~iP~~~~~~~~l~ 188 (964)
+++|++|+|++|.+.+ +|..+.++++|++|++ +++... .+| ..+.
T Consensus 219 ~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~------~~~~ 290 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMP------ILFP 290 (592)
T ss_dssp CTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGG------GGGG
T ss_pred CCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHH------HHHh
Confidence 5666666666665553 3344444444444444 443221 233 2345
Q ss_pred cccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcc-----------cCcCccc-c
Q 002121 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD-----------RNALTGK-V 256 (964)
Q Consensus 189 ~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls-----------~N~l~~~-~ 256 (964)
.+++|++|+|++|.+++.....++..+++|++|+++++-..+.++..+..+++|+.|+|+ .|.+++. +
T Consensus 291 ~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~ 370 (592)
T 3ogk_B 291 FAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGL 370 (592)
T ss_dssp GGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHH
T ss_pred hcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHH
Confidence 677888888888877655444556677788888887333233334444567788888888 3566643 2
Q ss_pred CccccCCCCCCeeeccCccCccCCCC-CC-CCCCCCEEEcc----CCCCCCC----CCCcccCCCCCCcEEECCCCc--c
Q 002121 257 PTNLNNLTNVNELNLAHNDLKGPFPD-LS-QMNSLSYVDLS----NNSFDPT----EAPLWFSTLPSLTTLICEFGS--L 324 (964)
Q Consensus 257 p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~-~l~~L~~L~Ls----~N~l~~~----~~~~~~~~l~~L~~L~Ls~N~--l 324 (964)
+..+..+++|++|+|+.|.+++.... +. .+++|+.|+++ .|.+++. .++..+.++++|+.|+|++|. +
T Consensus 371 ~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l 450 (592)
T 3ogk_B 371 IALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGL 450 (592)
T ss_dssp HHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGC
T ss_pred HHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCc
Confidence 33345578888888888887764332 33 37788888886 6677522 123336678888888887543 6
Q ss_pred ccccChhcc-CCCCCCEEEcCCccccccc-CCCCccCCCCcEEeccCCcceeecc----CCCcccceeEeecCCc
Q 002121 325 QGRVPDKLF-SYSQIQQVKLRNNAFNNTL-DMGNAVGPLLQLVDLQNNQISAITL----GSGIKNYTLILVGNPV 393 (964)
Q Consensus 325 ~~~~p~~~~-~l~~L~~L~L~~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~i~~----~~~~~l~~l~l~~Np~ 393 (964)
++..+..+. .+++|+.|+|++|++++.. +..+..+++|+.|+|++|+++.... .....++.|+|++|++
T Consensus 451 ~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i 525 (592)
T 3ogk_B 451 TDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA 525 (592)
T ss_dssp CHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred cHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence 666555554 3788999999988887633 3344677889999999998764322 2345678888888874
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.81 E-value=3.3e-22 Score=241.13 Aligned_cols=304 Identities=13% Similarity=0.066 Sum_probs=220.5
Q ss_pred CCeeEEEcCCCCcccc----ccCCcCCCCcccEEecccCCCCC----CCCCCCCCCcccchhhccccccccCcCCcccCC
Q 002121 64 SRVTALGLSTMGLTGK----LSGDIGGLTELRSLDLSYNGGLT----GSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN 135 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~----~~~~l~~l~~L~~L~L~~N~~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 135 (964)
.+++.|+|++|.+++. ++..+..+++|++|+|++| .+. +.++..+.++++|++|+|++|.+.+ +|..+..
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n-~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~ 241 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMT-EFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKA 241 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTC-CCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHH
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeecc-CCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhh
Confidence 5788888888877654 3344566778888888877 555 2334445567778888888877763 4445555
Q ss_pred CCCccEEEcc---------------------------cCcccCcCCCcCCCccccccccccccccccccCcccCCCCccc
Q 002121 136 LAELSFLALN---------------------------SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188 (964)
Q Consensus 136 l~~L~~L~Ls---------------------------~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~ 188 (964)
+++|+.|+++ ++.. +.+|..+..+++|++|+|++|.+++.... ..+.
T Consensus 242 ~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~-----~~~~ 315 (592)
T 3ogk_B 242 AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKLDLLYALLETEDHC-----TLIQ 315 (592)
T ss_dssp CTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEEEETTCCCCHHHHH-----HHHT
T ss_pred hhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEEecCCCcCCHHHHH-----HHHH
Confidence 5555555554 4322 24566777889999999999998744321 1256
Q ss_pred cccCCCeeEccCCcccccccccccCCCcceeEEEcc-----------CCcCcccCC-cccCCCCCCcEEEcccCcCcccc
Q 002121 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFD-----------GNQLSGNIP-ESLGYVQTLEVLRLDRNALTGKV 256 (964)
Q Consensus 189 ~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~-----------~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~ 256 (964)
.+++|+.|+++ |.+.......++..+++|++|+++ .|.+++... ..+..+++|+.|+++.|.+++..
T Consensus 316 ~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~ 394 (592)
T 3ogk_B 316 KCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNES 394 (592)
T ss_dssp TCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHH
T ss_pred hCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHH
Confidence 88999999999 555544444555667889999999 367765422 22456899999999999999887
Q ss_pred CccccC-CCCCCeeecc----CccCccCCCC------CCCCCCCCEEEccCCC--CCCCCCCcccCCCCCCcEEECCCCc
Q 002121 257 PTNLNN-LTNVNELNLA----HNDLKGPFPD------LSQMNSLSYVDLSNNS--FDPTEAPLWFSTLPSLTTLICEFGS 323 (964)
Q Consensus 257 p~~~~~-l~~L~~L~Ls----~N~l~~~~~~------l~~l~~L~~L~Ls~N~--l~~~~~~~~~~~l~~L~~L~Ls~N~ 323 (964)
+..+.. +++|+.|+|+ .|.+++.+.+ +.++++|++|+|++|. ++..........+++|+.|+|++|+
T Consensus 395 ~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~ 474 (592)
T 3ogk_B 395 LESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVG 474 (592)
T ss_dssp HHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCC
T ss_pred HHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCC
Confidence 777776 9999999996 7788875432 5678999999998544 6533333333458999999999999
Q ss_pred cccc-cChhccCCCCCCEEEcCCcccccccC-CCCccCCCCcEEeccCCcceeec
Q 002121 324 LQGR-VPDKLFSYSQIQQVKLRNNAFNNTLD-MGNAVGPLLQLVDLQNNQISAIT 376 (964)
Q Consensus 324 l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~i~ 376 (964)
+++. ++..+.++++|++|+|++|++++... .....+++|+.|+|++|+++...
T Consensus 475 l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~ 529 (592)
T 3ogk_B 475 ESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTG 529 (592)
T ss_dssp SSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTC
T ss_pred CCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHH
Confidence 9874 45566889999999999999876533 33457899999999999988654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=189.64 Aligned_cols=161 Identities=19% Similarity=0.264 Sum_probs=104.7
Q ss_pred EEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCC
Q 002121 221 VLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSF 299 (964)
Q Consensus 221 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l 299 (964)
+++++|+++ .+|..+. ++|+.|+|++|.|++..+..|.++++|++|+|++|+|+++.+ .+.++++|++|+|++|.|
T Consensus 16 v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l 92 (220)
T 2v9t_B 16 VDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKI 92 (220)
T ss_dssp EECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCC
T ss_pred EEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcC
Confidence 444444444 3343332 456666666666665555566666666666666666666544 366666666666666666
Q ss_pred CCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCC
Q 002121 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGS 379 (964)
Q Consensus 300 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~ 379 (964)
+ ...+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|
T Consensus 93 ~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~------- 164 (220)
T 2v9t_B 93 T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF------- 164 (220)
T ss_dssp C-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCE-------
T ss_pred C-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCc-------
Confidence 5 44455566777777777777777777777777777777777777777777766677777666666555544
Q ss_pred CcccceeEeecCCcccccccccCccc
Q 002121 380 GIKNYTLILVGNPVCTATLANTNYCQ 405 (964)
Q Consensus 380 ~~~l~~l~l~~Np~c~~~l~~~~~~~ 405 (964)
.|+|.+.++..|.
T Consensus 165 -------------~c~c~l~~l~~~l 177 (220)
T 2v9t_B 165 -------------ICDCHLKWLADYL 177 (220)
T ss_dssp -------------ECSGGGHHHHHHH
T ss_pred -------------CCCCccHHHHHHH
Confidence 5889888877773
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=7.9e-20 Score=189.10 Aligned_cols=179 Identities=24% Similarity=0.296 Sum_probs=110.6
Q ss_pred hhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCee
Q 002121 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHF 196 (964)
Q Consensus 117 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L 196 (964)
.++++++.++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 11 ~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~---------------------- 65 (208)
T 2o6s_A 11 TVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ---------------------- 65 (208)
T ss_dssp EEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC----------------------
T ss_pred EEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC----------------------
Confidence 3444555554 344333 235666666666666544445556666666666666555
Q ss_pred EccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccC
Q 002121 197 HFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDL 276 (964)
Q Consensus 197 ~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 276 (964)
.++...|..+++|++|++++|+|++..+..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++
T Consensus 66 ---------~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l 136 (208)
T 2o6s_A 66 ---------SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQL 136 (208)
T ss_dssp ---------CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred ---------ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCcc
Confidence 22223333344444444444444444445566777777777777777766666677777777777777777
Q ss_pred ccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCC
Q 002121 277 KGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQ 337 (964)
Q Consensus 277 ~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 337 (964)
++.++. +..+++|++|+|++|++. ..+++|++|+++.|+++|.+|..++.++.
T Consensus 137 ~~~~~~~~~~l~~L~~L~l~~N~~~--------~~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 137 KSVPDGVFDRLTSLQYIWLHDNPWD--------CTCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp SCCCTTTTTTCTTCCEEECCSCCBC--------CCTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ceeCHHHhccCCCccEEEecCCCee--------cCCCCHHHHHHHHHhCCceeeccCccccC
Confidence 776665 667777777777777764 34567777777777777777777666554
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.80 E-value=1.2e-20 Score=231.28 Aligned_cols=271 Identities=17% Similarity=0.176 Sum_probs=114.0
Q ss_pred CHHHHHHHHHHHHHcC----CCCCCCCCCCCCCCCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCC
Q 002121 25 DSRDAAALQSLKDAWQ----NTPPTWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGG 100 (964)
Q Consensus 25 ~~~~~~aL~~~k~~~~----~~~~~W~~~~~~C~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~ 100 (964)
...++.+|+++..+.. .....|.....+++.|.++.++.++++.|+|.++++.. ++. ..|+.++|+.|
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~-- 201 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDE-ANQ-----ALLQHKKLSQY-- 201 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecCCccceEEeeCCCCCc-chh-----hHhhcCccCcc--
Confidence 3456889999887652 22356765556666899999999999999999999886 232 33566777776
Q ss_pred CCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcc
Q 002121 101 LTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180 (964)
Q Consensus 101 l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~ 180 (964)
++..++++.|.+. ..|+.+..+++|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|
T Consensus 202 -------------~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp-- 263 (727)
T 4b8c_D 202 -------------SIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELP-- 263 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCC--
T ss_pred -------------cccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccC--
Confidence 2344556666666 66777777777888888888777 66666677777888888888777 666
Q ss_pred cCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccc
Q 002121 181 TITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNL 260 (964)
Q Consensus 181 ~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 260 (964)
..+..+++|++|+|++|+|+ .+|.. |..+.+|++|+|++|.|+ .+|..|+.+++|+.|+|++|.|++.+|..+
T Consensus 264 ----~~~~~l~~L~~L~Ls~N~l~-~lp~~-~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~ 336 (727)
T 4b8c_D 264 ----AEIKNLSNLRVLDLSHNRLT-SLPAE-LGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKIL 336 (727)
T ss_dssp ----GGGGGGTTCCEEECTTSCCS-SCCSS-GGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHH
T ss_pred ----hhhhCCCCCCEEeCcCCcCC-ccChh-hcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHH
Confidence 34667777777777777777 66654 455667777777777776 667778888888888888888888888777
Q ss_pred cCCCC-CCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCC
Q 002121 261 NNLTN-VNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQ 339 (964)
Q Consensus 261 ~~l~~-L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 339 (964)
..+.. +..|+|++|.+++.+| ..|..|+++.|... ....+.|.+..+..+..+..+.
T Consensus 337 ~~~~~~~~~l~l~~N~l~~~~p-----~~l~~l~l~~n~~~-----------------~~~~~~l~~~~~~~~~~l~~~~ 394 (727)
T 4b8c_D 337 TEKSVTGLIFYLRDNRPEIPLP-----HERRFIEINTDGEP-----------------QREYDSLQQSTEHLATDLAKRT 394 (727)
T ss_dssp HHHHHHHHHHHHHHCCCCCCCC-----CC---------------------------------------------------
T ss_pred hhcchhhhHHhhccCcccCcCc-----cccceeEeeccccc-----------------ccccCCccccccchhhcccccc
Confidence 65432 2346788888887665 34566666666210 0011233344444555666667
Q ss_pred EEEcCCccccc
Q 002121 340 QVKLRNNAFNN 350 (964)
Q Consensus 340 ~L~L~~N~l~~ 350 (964)
...+++|-+.+
T Consensus 395 ~~~ls~Nil~~ 405 (727)
T 4b8c_D 395 FTVLSYNTLCQ 405 (727)
T ss_dssp -------CCCG
T ss_pred eeeeecccccc
Confidence 77777777654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.6e-19 Score=211.79 Aligned_cols=187 Identities=27% Similarity=0.380 Sum_probs=136.5
Q ss_pred CccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcc
Q 002121 138 ELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMV 217 (964)
Q Consensus 138 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~ 217 (964)
+|+.|+|++|.|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. + .. +
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---------~~l~~L~~L~Ls~N~l~~-ip~-l-~~--~ 121 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---------ELPASLEYLDACDNRLST-LPE-L-PA--S 121 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---------CCCTTCCEEECCSSCCSC-CCC-C-CT--T
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---------cccCCCCEEEccCCCCCC-cch-h-hc--C
Confidence 67777777777764 555443 56777777777776 454 124667777777777764 665 2 22 7
Q ss_pred eeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCC
Q 002121 218 LIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297 (964)
Q Consensus 218 L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N 297 (964)
|++|++++|+|++ +|. .+++|+.|+|++|.|++ +|. .+++|++|+|++|+|++++. +. ++|++|+|++|
T Consensus 122 L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~-l~--~~L~~L~Ls~N 190 (571)
T 3cvr_A 122 LKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE-LP--ESLEALDVSTN 190 (571)
T ss_dssp CCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC-CC--TTCCEEECCSS
T ss_pred CCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch-hh--CCCCEEECcCC
Confidence 7888888888886 555 57889999999999985 665 57889999999999998666 55 88999999999
Q ss_pred CCCCCCCCcccCCCCCC-------cEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccC
Q 002121 298 SFDPTEAPLWFSTLPSL-------TTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG 359 (964)
Q Consensus 298 ~l~~~~~~~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 359 (964)
+|+ .+|. |.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|++++.+|..+..+
T Consensus 191 ~L~--~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 191 LLE--SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp CCS--SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred CCC--chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 995 4444 443 66 88888888888 467777778888888888888888777666554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=195.98 Aligned_cols=177 Identities=21% Similarity=0.303 Sum_probs=129.0
Q ss_pred cccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCC
Q 002121 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNV 266 (964)
Q Consensus 187 l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 266 (964)
+..+++|+.|++++|.+. .++. +..+++|++|++++|++++..+ +..+++|++|+|++|.+++ ++ .+..+++|
T Consensus 42 ~~~l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L 114 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKL 114 (291)
T ss_dssp HHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTC
T ss_pred hhhcCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCC
Confidence 345566666666666665 3332 4455666667777777765444 7777888888888888874 33 37778888
Q ss_pred CeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCc
Q 002121 267 NELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNN 346 (964)
Q Consensus 267 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 346 (964)
++|+|++|++++. +.+..+++|++|++++|++++ . ..+..+++|+.|+|++|++++..+ +..+++|+.|+|++|
T Consensus 115 ~~L~L~~n~i~~~-~~l~~l~~L~~L~l~~n~l~~--~-~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 115 KSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITD--I-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188 (291)
T ss_dssp CEEECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC--C-GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCCC-hhhcCCCCCCEEEccCCcCCc--c-hhhccCCCCCEEEccCCccccchh--hcCCCccCEEECCCC
Confidence 8888888888775 557778888888888888863 2 467888888888888888887665 888888888888888
Q ss_pred ccccccCCCCccCCCCcEEeccCCcceeeccC
Q 002121 347 AFNNTLDMGNAVGPLLQLVDLQNNQISAITLG 378 (964)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 378 (964)
++++.. .+..+++|+.|+|++|+++..+..
T Consensus 189 ~i~~l~--~l~~l~~L~~L~l~~n~i~~~~~~ 218 (291)
T 1h6t_A 189 HISDLR--ALAGLKNLDVLELFSQECLNKPIN 218 (291)
T ss_dssp CCCBCG--GGTTCTTCSEEEEEEEEEECCCEE
T ss_pred cCCCCh--hhccCCCCCEEECcCCcccCCccc
Confidence 888753 377888888888888888876543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=3.4e-19 Score=185.98 Aligned_cols=162 Identities=20% Similarity=0.224 Sum_probs=118.6
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccC-ccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVP-TNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNN 297 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N 297 (964)
.+++++|.++. +|..+. ..++.|+|++|+|++..+ ..|.++++|++|+|++|+|+++++ .+.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 45555555553 454443 445777777777776544 456777778888888887777766 4777777888888888
Q ss_pred CCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeecc
Q 002121 298 SFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITL 377 (964)
Q Consensus 298 ~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 377 (964)
.++ ...+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|++++..+..|..+++|+.|+|++|+|
T Consensus 92 ~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l----- 165 (220)
T 2v70_A 92 RLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF----- 165 (220)
T ss_dssp CCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE-----
T ss_pred ccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC-----
Confidence 876 55666788888888888888888888888888888888888888888888788888887777777666655
Q ss_pred CCCcccceeEeecCCcccccccccCccc
Q 002121 378 GSGIKNYTLILVGNPVCTATLANTNYCQ 405 (964)
Q Consensus 378 ~~~~~l~~l~l~~Np~c~~~l~~~~~~~ 405 (964)
.|+|.+.++..|.
T Consensus 166 ---------------~c~c~l~~l~~~~ 178 (220)
T 2v70_A 166 ---------------NCNCYLAWLGEWL 178 (220)
T ss_dssp ---------------ECSGGGHHHHHHH
T ss_pred ---------------cCCCchHHHHHHH
Confidence 4778877776664
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.6e-19 Score=189.14 Aligned_cols=136 Identities=19% Similarity=0.172 Sum_probs=108.0
Q ss_pred CCccceeecCCcEEEEEEEe-cCCcE--EEEEEecCCCcc------------------------hhHHHHHHHHHHHhcC
Q 002121 629 FSESNEIGSGGYGKVYRGML-SDGQV--VAIKRAQQGSMQ------------------------GGLEFKTEIELLSRVH 681 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 681 (964)
|...+.||+|+||.||+|.. .+|+. ||||+++..... ....+.+|+++|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 78999 999987543211 0125789999999999
Q ss_pred CCCc--cceeEEEEeeCceEEEEEeccC-C----ChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHh-hcCCCCeeccC
Q 002121 682 HKNL--VGLVGFCFEQGEQMLVYEFMAN-G----TLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH-ELANPPIIHRD 753 (964)
Q Consensus 682 H~nI--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~D 753 (964)
|+++ ..++++ +..+|||||+.+ | +|.++... .++.++..++.|++.||+||| +.+ |+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE---LVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCC
Confidence 8865 333332 467899999952 4 66665432 345678899999999999999 887 99999
Q ss_pred CCCCcEEECCCCcEEEeecccceee
Q 002121 754 VKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 754 lk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
|||+|||+++ .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999764
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.9e-21 Score=229.72 Aligned_cols=121 Identities=24% Similarity=0.323 Sum_probs=63.1
Q ss_pred CcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCC
Q 002121 242 LEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF 321 (964)
Q Consensus 242 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~ 321 (964)
|+.|+|++|.|++ +|. |.++++|+.|+|++|.|+.++..+..+++|++|+|++|.|++ +| .+..+++|+.|+|++
T Consensus 443 L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~--lp-~l~~l~~L~~L~Ls~ 517 (567)
T 1dce_A 443 VRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN--VD-GVANLPRLQELLLCN 517 (567)
T ss_dssp CSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC--CG-GGTTCSSCCEEECCS
T ss_pred ceEEEecCCCCCC-CcC-ccccccCcEeecCcccccccchhhhcCCCCCEEECCCCCCCC--Cc-ccCCCCCCcEEECCC
Confidence 4445555555542 333 444555555555555555443344555555555555555532 33 455555555566666
Q ss_pred Ccccccc-ChhccCCCCCCEEEcCCcccccccCCC---CccCCCCcEEec
Q 002121 322 GSLQGRV-PDKLFSYSQIQQVKLRNNAFNNTLDMG---NAVGPLLQLVDL 367 (964)
Q Consensus 322 N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~l~~L~~L~L 367 (964)
|+|++.. |..|..+++|+.|+|++|++++.++.. +..+++|+.|+|
T Consensus 518 N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 518 NRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 6555554 566666666666666666666554422 223566666653
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=5.5e-19 Score=211.34 Aligned_cols=195 Identities=21% Similarity=0.292 Sum_probs=97.3
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
+..+..+.|..+.+...++ +..|++|+.|+|++|.+.. ++ .|..+++|+.|+|++|++++..| +..++
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--------l~~l~ 87 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--------LTNLK 87 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--------GGGCT
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--------hccCC
Confidence 4445555666655553332 3455666666666666653 22 35556666666666666652211 44555
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
+|+.|+|++|.+++ ++ .+..+++|+.|+|++|.|++ + ..+..+++|+.|+|
T Consensus 88 ~L~~L~Ls~N~l~~-l~--------------------------~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~L 138 (605)
T 1m9s_A 88 NLGWLFLDENKIKD-LS--------------------------SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 138 (605)
T ss_dssp TCCEEECCSSCCCC-CT--------------------------TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEEC
T ss_pred CCCEEECcCCCCCC-Ch--------------------------hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEEC
Confidence 55555555555441 11 23444445555555555442 1 23444455555555
Q ss_pred cCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 272 s~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
++|.|+++ +.+..+++|+.|+|++|.|+ ...| +..+++|+.|+|++|+|.+. ..+..+++|+.|+|++|++.+.
T Consensus 139 s~N~l~~l-~~l~~l~~L~~L~Ls~N~l~-~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 139 GNNKITDI-TVLSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CSSCCCCC-GGGGSCTTCSEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CCCccCCc-hhhcccCCCCEEECcCCcCC-Cchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 55555443 33444555555555555553 2222 45555555555555555543 2355555555555555555544
Q ss_pred cC
Q 002121 352 LD 353 (964)
Q Consensus 352 ~~ 353 (964)
..
T Consensus 213 p~ 214 (605)
T 1m9s_A 213 PI 214 (605)
T ss_dssp CC
T ss_pred cc
Confidence 33
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-22 Score=240.71 Aligned_cols=328 Identities=11% Similarity=0.035 Sum_probs=198.0
Q ss_pred CCCeeEEEcCCCCccccccCCcC-CCCcccEEecccCCCCCCC-CCCCCCCcccchhhccccccccCcCCcccC----CC
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIG-GLTELRSLDLSYNGGLTGS-LSPRIGDLQKLNILILAGCGFTGNIPDEIG----NL 136 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~-~l~~L~~L~L~~N~~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~----~l 136 (964)
..+++.|+|+++.+++..+..+. .+++|++|+|++|..+... ++..+.++++|++|+|++|.+++..+..+. .+
T Consensus 104 ~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~ 183 (594)
T 2p1m_B 104 YTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTY 183 (594)
T ss_dssp CTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTC
T ss_pred CCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcC
Confidence 35788899999888877666665 6888999999887433332 333445788899999998888765444443 56
Q ss_pred CCccEEEcccCc--ccCc-CCCcCCCcccccccccccc-ccccccCccc-------------------------------
Q 002121 137 AELSFLALNSNN--FSGR-IPPSLGKLSQLYWLDLADN-QLTGSIPVST------------------------------- 181 (964)
Q Consensus 137 ~~L~~L~Ls~N~--l~~~-~p~~~~~l~~L~~L~Ls~N-~l~g~iP~~~------------------------------- 181 (964)
++|++|+|++|. ++.. ++..+.++++|++|+|++| .+.+ +|...
T Consensus 184 ~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 184 TSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred CcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 688888888886 2210 1111234578888888877 2221 22100
Q ss_pred -------------CCC----CccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCccc-CCcccCCCCCCc
Q 002121 182 -------------ITS----PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN-IPESLGYVQTLE 243 (964)
Q Consensus 182 -------------~~~----~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~-~p~~~~~l~~L~ 243 (964)
... ..+..+++|++|++++|.+++.....++..+++|++|++++| ++.. ++.....+++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 000 001134566666666666554333344455566666666665 3321 122222356666
Q ss_pred EEEcc---------cCcCccccCcccc-CCCCCCeeeccCccCccCCCC-C-CCCCCCCEEEcc--C----CCCCCC---
Q 002121 244 VLRLD---------RNALTGKVPTNLN-NLTNVNELNLAHNDLKGPFPD-L-SQMNSLSYVDLS--N----NSFDPT--- 302 (964)
Q Consensus 244 ~L~Ls---------~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~~~-l-~~l~~L~~L~Ls--~----N~l~~~--- 302 (964)
.|+|+ .|.+++.....+. ++++|+.|.++.|.+++.... + ..+++|+.|+|+ + |.++..
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~ 421 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLD 421 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTH
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchh
Confidence 66662 3444433222222 366777777766766653322 2 246788888888 3 455311
Q ss_pred -CCCcccCCCCCCcEEECCCCccccccChhccC-CCCCCEEEcCCcccccccCCCC-ccCCCCcEEeccCCcceeeccC-
Q 002121 303 -EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFS-YSQIQQVKLRNNAFNNTLDMGN-AVGPLLQLVDLQNNQISAITLG- 378 (964)
Q Consensus 303 -~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~i~~~- 378 (964)
..+..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++.....+ ..+++|+.|+|++|+++.....
T Consensus 422 ~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~ 500 (594)
T 2p1m_B 422 IGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLA 500 (594)
T ss_dssp HHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHH
T ss_pred hHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHH
Confidence 1112256678888888876 666666666655 7888888888888876555444 5678888888888888654322
Q ss_pred ---CCcccceeEeecCCc
Q 002121 379 ---SGIKNYTLILVGNPV 393 (964)
Q Consensus 379 ---~~~~l~~l~l~~Np~ 393 (964)
....++.|++.+|+.
T Consensus 501 ~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 501 NASKLETMRSLWMSSCSV 518 (594)
T ss_dssp TGGGGGGSSEEEEESSCC
T ss_pred HHHhCCCCCEEeeeCCCC
Confidence 344577888888875
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.78 E-value=7.3e-19 Score=210.30 Aligned_cols=199 Identities=20% Similarity=0.282 Sum_probs=156.6
Q ss_pred cccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCC
Q 002121 161 SQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQ 240 (964)
Q Consensus 161 ~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~ 240 (964)
.++..+.+..+.+...++ +..|++|+.|++++|.+. .++. +..+++|+.|+|++|+|++..+ +..++
T Consensus 21 ~~l~~l~l~~~~i~~~~~--------~~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~ 87 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--------QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLK 87 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--------HHHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCT
T ss_pred HHHHHHhccCCCcccccc--------hhcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCC
Confidence 344455555555542222 345556666666666655 3432 4556667777777777776554 88999
Q ss_pred CCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECC
Q 002121 241 TLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICE 320 (964)
Q Consensus 241 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls 320 (964)
+|+.|+|++|.|++ +| .|..+++|+.|+|++|.|+++ +.+..+++|+.|+|++|.+++. ..+..+++|+.|+|+
T Consensus 88 ~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~l-~~l~~l~~L~~L~Ls~N~l~~l---~~l~~l~~L~~L~Ls 161 (605)
T 1m9s_A 88 NLGWLFLDENKIKD-LS-SLKDLKKLKSLSLEHNGISDI-NGLVHLPQLESLYLGNNKITDI---TVLSRLTKLDTLSLE 161 (605)
T ss_dssp TCCEEECCSSCCCC-CT-TSTTCTTCCEEECTTSCCCCC-GGGGGCTTCSEEECCSSCCCCC---GGGGSCTTCSEEECC
T ss_pred CCCEEECcCCCCCC-Ch-hhccCCCCCEEEecCCCCCCC-ccccCCCccCEEECCCCccCCc---hhhcccCCCCEEECc
Confidence 99999999999995 44 799999999999999999985 5689999999999999999732 568999999999999
Q ss_pred CCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcc
Q 002121 321 FGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK 382 (964)
Q Consensus 321 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~ 382 (964)
+|+|.+..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|+++..+......
T Consensus 162 ~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~~~~~~ 219 (605)
T 1m9s_A 162 DNQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSN 219 (605)
T ss_dssp SSCCCCCGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCCCCCSS
T ss_pred CCcCCCchh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCccccccc
Confidence 999998877 99999999999999999986 36889999999999999999877654433
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.6e-19 Score=198.51 Aligned_cols=175 Identities=18% Similarity=0.124 Sum_probs=120.5
Q ss_pred eeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccC-CCCCCcEEEcccCcCccccCccccCCCCCCeeeccC
Q 002121 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLG-YVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAH 273 (964)
Q Consensus 195 ~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 273 (964)
.+++++|.++ .+|..++ ..++.|+|++|+|++..+..+. .+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 22 ~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp EEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 4455555554 4444332 2356666666666666666665 677777777777777766666777777777777777
Q ss_pred ccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhc---cCCCCCCEEEcCCcccc
Q 002121 274 NDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKL---FSYSQIQQVKLRNNAFN 349 (964)
Q Consensus 274 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~~L~L~~N~l~ 349 (964)
|+|+++++. +..+++|++|+|++|+|+ ...+..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|+|+
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCccc-EECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 777776664 677777777777777776 5556667777777777777777776555555 56788888888888888
Q ss_pred cccCCCCccCCC--CcEEeccCCccee
Q 002121 350 NTLDMGNAVGPL--LQLVDLQNNQISA 374 (964)
Q Consensus 350 ~~~~~~~~~l~~--L~~L~L~~N~l~~ 374 (964)
...+..+..++. |+.|+|++|+|.+
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred ccCHHHhhhccHhhcceEEecCCCccC
Confidence 776666777766 4788888888875
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.77 E-value=4.3e-19 Score=193.62 Aligned_cols=193 Identities=21% Similarity=0.281 Sum_probs=105.0
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
+.++..+.+..+.+++..+ +..+++|+.|++++|.++.. + .+..+++|++|+|++|++++ ++ .+..++
T Consensus 23 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~-~~-------~l~~l~ 90 (291)
T 1h6t_A 23 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-------PLANLK 90 (291)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-------GGTTCT
T ss_pred HHHHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCC-Cc-------ccccCC
Confidence 3445555666666653322 34566677777777776633 2 36666667777777666662 22 144555
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
+|+.|++++|++++ ++ .+..+++|+.|+|++|++++. ..+..+++|+.|+|
T Consensus 91 ~L~~L~l~~n~l~~-~~--------------------------~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l 141 (291)
T 1h6t_A 91 NLGWLFLDENKVKD-LS--------------------------SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYL 141 (291)
T ss_dssp TCCEEECCSSCCCC-GG--------------------------GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEEC
T ss_pred CCCEEECCCCcCCC-Ch--------------------------hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEc
Confidence 55665555555541 21 134444555555555555432 23444555555555
Q ss_pred cCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 272 s~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
++|++++. +.+..+++|++|+|++|.++ ...+ +..+++|+.|+|++|++++. + .+..+++|+.|+|++|+++..
T Consensus 142 ~~n~l~~~-~~l~~l~~L~~L~L~~N~l~-~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 142 GNNKITDI-TVLSRLTKLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CSSCCCCC-GGGGGCTTCSEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred cCCcCCcc-hhhccCCCCCEEEccCCccc-cchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 55555544 34555555555555555554 2222 55566666666666666543 2 366667777777777766553
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.8e-18 Score=181.74 Aligned_cols=163 Identities=22% Similarity=0.253 Sum_probs=120.5
Q ss_pred CCCCCCCCCCCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhcccccc
Q 002121 45 TWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCG 124 (964)
Q Consensus 45 ~W~~~~~~C~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~ 124 (964)
-|......| +|++|.|+..+++ .+|..+. ++|++|+|++| .+.+..|..|..+++|++|+|++|+
T Consensus 11 ~~~~~~~~C-s~~~v~c~~~~l~-----------~ip~~~~--~~L~~L~Ls~n-~i~~~~~~~~~~l~~L~~L~L~~N~ 75 (229)
T 3e6j_A 11 AACPSQCSC-SGTTVDCRSKRHA-----------SVPAGIP--TNAQILYLHDN-QITKLEPGVFDSLINLKELYLGSNQ 75 (229)
T ss_dssp CCCCTTCEE-ETTEEECTTSCCS-----------SCCSCCC--TTCSEEECCSS-CCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred ccCCCCCEE-eCCEeEccCCCcC-----------ccCCCCC--CCCCEEEcCCC-ccCccCHHHhhCccCCcEEECCCCC
Confidence 444455666 8999999755433 4444433 78999999999 7888888889999999999999999
Q ss_pred ccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccc
Q 002121 125 FTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS 204 (964)
Q Consensus 125 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~ 204 (964)
|+...+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+| ..+..+++|+.|+|++|+|+
T Consensus 76 l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp------~~~~~l~~L~~L~L~~N~l~ 148 (229)
T 3e6j_A 76 LGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELP------RGIERLTHLTHLALDQNQLK 148 (229)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCC------TTGGGCTTCSEEECCSSCCC
T ss_pred CCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccC------cccccCCCCCEEECCCCcCC
Confidence 98555567788999999999999998777777888889999999999888 666 34566666666666666665
Q ss_pred ccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCcc
Q 002121 205 GTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTG 254 (964)
Q Consensus 205 g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 254 (964)
. ..+..|..+++|+.|+|++|.+.+
T Consensus 149 -~------------------------~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 149 -S------------------------IPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp -C------------------------CCTTTTTTCTTCCEEECTTSCBCT
T ss_pred -c------------------------cCHHHHhCCCCCCEEEeeCCCccC
Confidence 3 333445556666666666666653
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=9.3e-21 Score=225.37 Aligned_cols=205 Identities=17% Similarity=0.090 Sum_probs=156.6
Q ss_pred CCcccchhhccccccccCcCCcccCCCCCccEEEcccCc-------------ccCcCCCcCCCcccccccc-cccccccc
Q 002121 110 GDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNN-------------FSGRIPPSLGKLSQLYWLD-LADNQLTG 175 (964)
Q Consensus 110 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~g 175 (964)
..+++|+.|+|++|+++ .+|..++++++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 45667777777777776 677777777777777776664 4555666667777777776 5655543
Q ss_pred ccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccc
Q 002121 176 SIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGK 255 (964)
Q Consensus 176 ~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 255 (964)
.|+.+.+++|.++ .++. ..|+.|+|++|+|++ +|. ++.+++|+.|+|++|.|+ .
T Consensus 424 ----------------~L~~l~l~~n~i~-~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~ 477 (567)
T 1dce_A 424 ----------------DLRSKFLLENSVL-KMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-A 477 (567)
T ss_dssp ----------------HHHHHHHHHHHHH-HHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-C
T ss_pred ----------------hhhhhhhhccccc-ccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-c
Confidence 3344556666665 3332 247889999999986 565 888999999999999999 7
Q ss_pred cCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccCh---hc
Q 002121 256 VPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPD---KL 332 (964)
Q Consensus 256 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~---~~ 332 (964)
+|..|+++++|+.|+|++|+|++++ .+..+++|++|+|++|+|++...|..+..+++|+.|+|++|++++.+|. .+
T Consensus 478 lp~~~~~l~~L~~L~Ls~N~l~~lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~ 556 (567)
T 1dce_A 478 LPPALAALRCLEVLQASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLA 556 (567)
T ss_dssp CCGGGGGCTTCCEEECCSSCCCCCG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHH
T ss_pred cchhhhcCCCCCEEECCCCCCCCCc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHH
Confidence 8889999999999999999999854 8889999999999999997333388899999999999999999887653 23
Q ss_pred cCCCCCCEEEc
Q 002121 333 FSYSQIQQVKL 343 (964)
Q Consensus 333 ~~l~~L~~L~L 343 (964)
..+++|+.|+|
T Consensus 557 ~~lp~L~~L~l 567 (567)
T 1dce_A 557 EMLPSVSSILT 567 (567)
T ss_dssp HHCTTCSEEEC
T ss_pred HHCcccCccCC
Confidence 45888998875
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=5.8e-18 Score=176.62 Aligned_cols=152 Identities=19% Similarity=0.199 Sum_probs=128.7
Q ss_pred CeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccC
Q 002121 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAH 273 (964)
Q Consensus 194 ~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 273 (964)
+.+++++|.++ .+|..+. .+|+.|++++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 45566666665 5665443 5678888888888877777888899999999999999988888999999999999999
Q ss_pred ccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccc
Q 002121 274 NDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 274 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
|+|+.+++. +.++++|++|+|++|+|+ ...+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCC-EeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 999988776 688999999999999997 6677889999999999999999998888889999999999999999864
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-17 Score=174.85 Aligned_cols=149 Identities=19% Similarity=0.250 Sum_probs=98.9
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNS 298 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~ 298 (964)
.+++++++++ .+|..+. ++|+.|+|++|.|++..|..|.++++|++|+|++|+|+.+++. +..+++|++|+|++|+
T Consensus 23 ~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~ 99 (229)
T 3e6j_A 23 TVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQ 99 (229)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCc
Confidence 3444555544 3443332 6667777777777766666677777777777777777666554 5666777777777777
Q ss_pred CCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcce
Q 002121 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 299 l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
|+ ...+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+|++|+|+
T Consensus 100 l~-~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 100 LT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CC-CCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBC
T ss_pred CC-ccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCcc
Confidence 75 445555667777777777777777 56667777777777777777777776666777777777766666654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.1e-17 Score=174.60 Aligned_cols=152 Identities=18% Similarity=0.200 Sum_probs=104.3
Q ss_pred eeEccCCcccccccccccCCCcceeEEEccCCcCcccCC-cccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccC
Q 002121 195 HFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAH 273 (964)
Q Consensus 195 ~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 273 (964)
.+++++|.++ .+|..++ ..+++|+|++|+|++..+ ..|..+++|+.|+|++|+|++..+..|.++++|++|+|++
T Consensus 15 ~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp EEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred EeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 4444444444 3444332 234556666666665543 3466677777777777777766666777777777777777
Q ss_pred ccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 274 NDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 274 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
|+|++.++. +..+++|++|+|++|+|+ ...|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|++...
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCC-CBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCC-eECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 777766664 667777777777777776 55566777888888888888888888888888888888888888888754
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.73 E-value=3.8e-20 Score=223.16 Aligned_cols=302 Identities=15% Similarity=0.113 Sum_probs=199.5
Q ss_pred CCeeEEEcCCC-Ccccc-ccCCcCCCCcccEEecccCCCCCCCCCCCC----CCcccchhhcccccc--ccCc-CCcccC
Q 002121 64 SRVTALGLSTM-GLTGK-LSGDIGGLTELRSLDLSYNGGLTGSLSPRI----GDLQKLNILILAGCG--FTGN-IPDEIG 134 (964)
Q Consensus 64 ~~v~~L~L~~~-~l~g~-~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l----~~l~~L~~L~L~~n~--l~~~-~p~~~~ 134 (964)
.+++.|+|.+| .++.. ++..+..+++|++|+|++| .+.+..+..+ ..+++|++|+|++|. ++.. ++..+.
T Consensus 130 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~-~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~ 208 (594)
T 2p1m_B 130 KNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRES-DVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208 (594)
T ss_dssp TTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTC-EEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHH
T ss_pred CCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCC-ccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHH
Confidence 46777777776 44432 3333346677777777776 4444333222 244566666666665 2111 111123
Q ss_pred CCCCccEEEcccCc--------------------------------------------------ccC----cCCCcCCCc
Q 002121 135 NLAELSFLALNSNN--------------------------------------------------FSG----RIPPSLGKL 160 (964)
Q Consensus 135 ~l~~L~~L~Ls~N~--------------------------------------------------l~~----~~p~~~~~l 160 (964)
++++|++|+|++|. +.. .++..+..+
T Consensus 209 ~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~ 288 (594)
T 2p1m_B 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288 (594)
T ss_dssp HCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHH
T ss_pred hCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhh
Confidence 34566666666551 111 112222356
Q ss_pred cccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc---------cCCcCccc
Q 002121 161 SQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF---------DGNQLSGN 231 (964)
Q Consensus 161 ~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l---------~~N~l~~~ 231 (964)
++|++|+|++|.+++.... ..+..+++|+.|++++| ++......+...+++|++|++ ..|.+++.
T Consensus 289 ~~L~~L~L~~~~l~~~~l~-----~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~ 362 (594)
T 2p1m_B 289 SRLTTLNLSYATVQSYDLV-----KLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQ 362 (594)
T ss_dssp TTCCEEECTTCCCCHHHHH-----HHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHH
T ss_pred CCCCEEEccCCCCCHHHHH-----HHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHH
Confidence 8899999999987743221 12457899999999998 543333334445788999998 34566654
Q ss_pred CCcccC-CCCCCcEEEcccCcCccccCcccc-CCCCCCeeecc--C----ccCccCCCC------CCCCCCCCEEEccCC
Q 002121 232 IPESLG-YVQTLEVLRLDRNALTGKVPTNLN-NLTNVNELNLA--H----NDLKGPFPD------LSQMNSLSYVDLSNN 297 (964)
Q Consensus 232 ~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls--~----N~l~~~~~~------l~~l~~L~~L~Ls~N 297 (964)
....+. .+++|+.|.++.|.+++.....+. .+++|+.|+|+ + |.++..+.+ +..+++|++|+|++
T Consensus 363 ~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~- 441 (594)
T 2p1m_B 363 GLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG- 441 (594)
T ss_dssp HHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-
T ss_pred HHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-
Confidence 333333 489999999999999977666665 58999999999 4 666644321 56788999999987
Q ss_pred CCCCCCCCcccC-CCCCCcEEECCCCccccccChhc-cCCCCCCEEEcCCcccccccCC-CCccCCCCcEEeccCCccee
Q 002121 298 SFDPTEAPLWFS-TLPSLTTLICEFGSLQGRVPDKL-FSYSQIQQVKLRNNAFNNTLDM-GNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 298 ~l~~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~ 374 (964)
.++ ......+. .+++|+.|+|++|.+++..+..+ .++++|+.|+|++|++++.... ....+++|+.|+|++|+++.
T Consensus 442 ~l~-~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~ 520 (594)
T 2p1m_B 442 LLT-DKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSF 520 (594)
T ss_dssp SCC-HHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBH
T ss_pred ccc-HHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCH
Confidence 665 22233343 38999999999999987766666 6799999999999999765543 34568999999999999854
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.6e-17 Score=178.28 Aligned_cols=174 Identities=21% Similarity=0.282 Sum_probs=117.3
Q ss_pred CccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCC
Q 002121 159 KLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGY 238 (964)
Q Consensus 159 ~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~ 238 (964)
++.++..+++++|.++ .++ .+..+++|+.|++++|+++ . ++ .+..
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-------~~~~l~~L~~L~l~~n~i~-~-------------------------l~-~l~~ 61 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-------SQKELSGVQNFNGDNSNIQ-S-------------------------LA-GMQF 61 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-------CHHHHTTCSEEECTTSCCC-C-------------------------CT-TGGG
T ss_pred HHHHHHHHHhcCCCcc-ccc-------chhhcCcCcEEECcCCCcc-c-------------------------ch-HHhh
Confidence 4556666777777666 222 2455666666666666554 2 22 3556
Q ss_pred CCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEE
Q 002121 239 VQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318 (964)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 318 (964)
+++|+.|+|++|+|++..+ +.++++|++|+|++|++++.++ +.. ++|++|+|++|.+++ .+ .+..+++|+.|+
T Consensus 62 l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~l~~-~~~-~~L~~L~L~~N~l~~--~~-~l~~l~~L~~L~ 134 (263)
T 1xeu_A 62 FTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNG-IPS-ACLSRLFLDNNELRD--TD-SLIHLKNLEILS 134 (263)
T ss_dssp CTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSCCTT-CCC-SSCCEEECCSSCCSB--SG-GGTTCTTCCEEE
T ss_pred CCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCCcCc-ccc-CcccEEEccCCccCC--Ch-hhcCcccccEEE
Confidence 6667777777777764433 6677777777777777766443 223 777777777777752 22 477778888888
Q ss_pred CCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccC
Q 002121 319 CEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLG 378 (964)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~ 378 (964)
|++|+|++. + .+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+++..+..
T Consensus 135 Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~~ 190 (263)
T 1xeu_A 135 IRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPVK 190 (263)
T ss_dssp CTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCEE
T ss_pred CCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCccc
Confidence 888887765 2 577788888888888888776 6677888888888888888876543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-17 Score=179.72 Aligned_cols=168 Identities=20% Similarity=0.330 Sum_probs=95.6
Q ss_pred CcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccc
Q 002121 111 DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL 190 (964)
Q Consensus 111 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l 190 (964)
.+.++..+++++|.++ .++ .+..+++|++|++++|.++ .++ .+..+++|++|+|++|++++ +| .+..+
T Consensus 17 ~l~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~-------~l~~l 84 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LS-------PLKDL 84 (263)
T ss_dssp HHHHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CG-------GGTTC
T ss_pred HHHHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Ch-------hhccC
Confidence 5667777788888877 334 5777788888888888887 444 67777888888888888773 33 15666
Q ss_pred cCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeee
Q 002121 191 KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELN 270 (964)
Q Consensus 191 ~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 270 (964)
++|+.|+|++|+++ .++...+ .+|++|++++|+|++. ..+..+++|+.|+|++|+|++. + .+..+++|+.|+
T Consensus 85 ~~L~~L~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~ 156 (263)
T 1xeu_A 85 TKLEELSVNRNRLK-NLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLD 156 (263)
T ss_dssp SSCCEEECCSSCCS-CCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEE
T ss_pred CCCCEEECCCCccC-CcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEE
Confidence 77777777777766 2332111 4444455555544432 1344455555555555555432 2 344444444444
Q ss_pred ccCccCccCCCCCCCCCCCCEEEccCCCC
Q 002121 271 LAHNDLKGPFPDLSQMNSLSYVDLSNNSF 299 (964)
Q Consensus 271 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 299 (964)
|++|++++. +.+..+++|+.|++++|++
T Consensus 157 L~~N~i~~~-~~l~~l~~L~~L~l~~N~~ 184 (263)
T 1xeu_A 157 LHGNEITNT-GGLTRLKKVNWIDLTGQKC 184 (263)
T ss_dssp CTTSCCCBC-TTSTTCCCCCEEEEEEEEE
T ss_pred CCCCcCcch-HHhccCCCCCEEeCCCCcc
Confidence 444444443 3333344444444444433
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.70 E-value=8.4e-18 Score=186.93 Aligned_cols=280 Identities=13% Similarity=0.110 Sum_probs=133.7
Q ss_pred ccccCCcCC--CCcccEEecccCCCCCCCCCCCCCC-cccchhhcccccccc--CcCCcccCCCCCccEEEcccCcccCc
Q 002121 78 GKLSGDIGG--LTELRSLDLSYNGGLTGSLSPRIGD-LQKLNILILAGCGFT--GNIPDEIGNLAELSFLALNSNNFSGR 152 (964)
Q Consensus 78 g~~~~~l~~--l~~L~~L~L~~N~~l~~~~p~~l~~-l~~L~~L~L~~n~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~ 152 (964)
|.++..+.. +.+|+.|.++++ +...-...+.. +++|+.|+|++|+|. ...+. .++.++.+.+..|.|.
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~--i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I~-- 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK--LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFVP-- 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE--ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEEC--
T ss_pred CcHHhhccchhhCceeEEEEecc--ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---cccccccccccccccC--
Confidence 344444443 667788888765 22111112222 566777777777776 22222 2223455555555433
Q ss_pred CCCcCCC--------ccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEcc
Q 002121 153 IPPSLGK--------LSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFD 224 (964)
Q Consensus 153 ~p~~~~~--------l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~ 224 (964)
+.+|.+ +++|+.|+|.+ .++ .|+ ...|.++++|+.|++++|.+. .++..+|....++..+.+.
T Consensus 86 -~~aF~~~~~~~~~g~~~L~~l~L~~-~i~-~I~-----~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~ 156 (329)
T 3sb4_A 86 -AYAFSNVVNGVTKGKQTLEKVILSE-KIK-NIE-----DAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLG 156 (329)
T ss_dssp -TTTTEEEETTEEEECTTCCC-CBCT-TCC-EEC-----TTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTT
T ss_pred -HHHhcccccccccccCCCcEEECCc-ccc-chh-----HHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCc
Confidence 355666 77777777777 665 333 346777777777777777776 6777777777667666655
Q ss_pred CCc----CcccCCcccCCCCCCc-EEEcccCcCccccCccc----cCCCCCCeeeccCccCccCCCCC-CCCCCCCEEEc
Q 002121 225 GNQ----LSGNIPESLGYVQTLE-VLRLDRNALTGKVPTNL----NNLTNVNELNLAHNDLKGPFPDL-SQMNSLSYVDL 294 (964)
Q Consensus 225 ~N~----l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~----~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~L~L 294 (964)
.+. ........|.++..|+ .+.+.... .++..+ ....++..+.+.++-.......+ ..+++|+.|+|
T Consensus 157 ~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L 233 (329)
T 3sb4_A 157 SSDAYRFKNRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDI 233 (329)
T ss_dssp CTHHHHTSTTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEEC
T ss_pred chhhhhccccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEEC
Confidence 522 1222233344444444 33332211 111100 01222233333222110000000 11344444444
Q ss_pred cCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCC-EEEcCCcccccccCCCCccCCCCcEEeccCCcce
Q 002121 295 SNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQ-QVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 295 s~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
++|.++ .+....|.++++|+.|+|.+| ++.+.+.+|.++++|+ .|+|.+ .++.+.+.+|.++++|+.|+|++|+++
T Consensus 234 ~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~ 310 (329)
T 3sb4_A 234 SKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT 310 (329)
T ss_dssp TTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred CCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence 444443 333444444444444444444 4444444444444454 444444 444444444555555555555445554
Q ss_pred eeccCC
Q 002121 374 AITLGS 379 (964)
Q Consensus 374 ~i~~~~ 379 (964)
.|+...
T Consensus 311 ~I~~~a 316 (329)
T 3sb4_A 311 TLGDEL 316 (329)
T ss_dssp EECTTT
T ss_pred ccchhh
Confidence 444433
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.69 E-value=8e-17 Score=164.17 Aligned_cols=160 Identities=17% Similarity=0.226 Sum_probs=98.8
Q ss_pred cEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC--CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECC
Q 002121 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD--LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICE 320 (964)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~--l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls 320 (964)
+.|++++|.|+ .+|..+.. +|++|+|++|+|++.++. +..+++|++|+|++|.|+ ...|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCC-CcCHhHcCCcccCCEEECC
Confidence 45555555554 44443332 556666666666655543 555666666666666665 4455566677777777777
Q ss_pred CCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCCcccccccc
Q 002121 321 FGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLAN 400 (964)
Q Consensus 321 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np~c~~~l~~ 400 (964)
+|+|++..+..|.++++|++|+|++|++++..+..+..+++|+.|+|++|+|+ |+|.+..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--------------------c~c~l~~ 146 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN--------------------CNCHLAW 146 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC--------------------CSGGGHH
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCcc--------------------CcCcchH
Confidence 77777777777777777777777777777777777777777777776666654 6666665
Q ss_pred cCccccCCCCCcccccccccCCCCCCCCCC
Q 002121 401 TNYCQLQQPTTKAYSTSLANCGGKSCPPEQ 430 (964)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~ 430 (964)
+..|.... ........|+.|.-..+.
T Consensus 147 ~~~~l~~~----~~~~~~~~C~~P~~l~~~ 172 (192)
T 1w8a_A 147 FAEWLRKK----SLNGGAARCGAPSKVRDV 172 (192)
T ss_dssp HHHHHHHH----CCSGGGCBBCSSTTTTTS
T ss_pred HHHHHHHc----CCCCCCCCCCCChHHcCC
Confidence 55552221 112345567777655544
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.68 E-value=7.6e-17 Score=164.40 Aligned_cols=139 Identities=22% Similarity=0.280 Sum_probs=69.8
Q ss_pred CCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCC
Q 002121 266 VNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRN 345 (964)
Q Consensus 266 L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 345 (964)
|++|+|++|.|+.++..+..+++|++|+|++|.|+ ...+..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus 33 l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~~ 111 (193)
T 2wfh_A 33 VTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHG 111 (193)
T ss_dssp CCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCcCchhHHHhhcccCCCEEECCCCcCC-EeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECCC
Confidence 33444444433333323333334444444444443 33333445555555555555555555555555555555555555
Q ss_pred cccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCccccCCCCCcccccccccCCCC
Q 002121 346 NAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGK 424 (964)
Q Consensus 346 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~ 424 (964)
|+|+...+..|..+++|+.|+ |.+|| .|+|.+.++..|...... ......|.+|
T Consensus 112 N~l~~~~~~~~~~l~~L~~L~---------------------L~~N~~~C~c~l~~l~~~~~~~~~----~~~~~~C~~P 166 (193)
T 2wfh_A 112 NDISVVPEGAFNDLSALSHLA---------------------IGANPLYCDCNMQWLSDWVKSEYK----EPGIARCAGP 166 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEE---------------------CCSSCEECSGGGHHHHHHHHHSSC----CCSCCBEEES
T ss_pred CCCCeeChhhhhcCccccEEE---------------------eCCCCeecCCcCHHHHHHHHhccC----CCCCcCcCCc
Confidence 555555555555555555544 44555 599999988888433211 1223456555
Q ss_pred CCCCCC
Q 002121 425 SCPPEQ 430 (964)
Q Consensus 425 ~~~~~~ 430 (964)
+-..++
T Consensus 167 ~~l~g~ 172 (193)
T 2wfh_A 167 GEMADK 172 (193)
T ss_dssp GGGTTC
T ss_pred hHHCCC
Confidence 444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=5.3e-17 Score=166.28 Aligned_cols=153 Identities=15% Similarity=0.252 Sum_probs=80.3
Q ss_pred cCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccccccccccc
Q 002121 133 IGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLF 212 (964)
Q Consensus 133 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f 212 (964)
...+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+ +.+..+++|++|++++|++
T Consensus 40 ~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~~-------~~l~~l~~L~~L~l~~n~l--------- 100 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-NY-------NPISGLSNLERLRIMGKDV--------- 100 (197)
T ss_dssp HHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-CC-------GGGTTCTTCCEEEEECTTC---------
T ss_pred hhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-cc-------hhhhcCCCCCEEEeECCcc---------
Confidence 356677777777777777 444 5666777777777777554 11 1233344444444444433
Q ss_pred CCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCcc-CccCCCCCCCCCCCCE
Q 002121 213 SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHND-LKGPFPDLSQMNSLSY 291 (964)
Q Consensus 213 ~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~~~l~~l~~L~~ 291 (964)
++..+..++.+++|++|+|++|++++..|..|..+++|++|+|++|. ++.. +.+..+++|++
T Consensus 101 ----------------~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~~l~~l~~L~~ 163 (197)
T 4ezg_A 101 ----------------TSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKS 163 (197)
T ss_dssp ----------------BGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-GGGGGCSSCCE
T ss_pred ----------------CcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-HhhcCCCCCCE
Confidence 33344445556666666666666665555556666666666666665 3332 23444555555
Q ss_pred EEccCCCCCCCCCCcccCCCCCCcEEECCCCcc
Q 002121 292 VDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSL 324 (964)
Q Consensus 292 L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l 324 (964)
|++++|+++. .+ .+..+++|+.|++++|++
T Consensus 164 L~l~~n~i~~--~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 164 LNIQFDGVHD--YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp EECTTBCCCC--CT-TGGGCSSCCEEEECBC--
T ss_pred EECCCCCCcC--hH-HhccCCCCCEEEeeCccc
Confidence 5555555431 11 233444444444444443
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.68 E-value=1.2e-16 Score=163.74 Aligned_cols=131 Identities=18% Similarity=0.326 Sum_probs=71.3
Q ss_pred cCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCcc-CCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCC
Q 002121 236 LGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKG-PFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSL 314 (964)
Q Consensus 236 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L 314 (964)
+..+++|++|++++|.++ .+..+..+++|++|+|++|.+++ .+..+..+++|++|++++|.++ ...+..+..+++|
T Consensus 62 l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~-~~~~~~l~~l~~L 138 (197)
T 4ezg_A 62 IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHD-DSILTKINTLPKV 138 (197)
T ss_dssp GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCB-GGGHHHHTTCSSC
T ss_pred HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccC-cHhHHHHhhCCCC
Confidence 444555555555555444 12245555555555555555554 2333555555555555555554 3334455566666
Q ss_pred cEEECCCCc-cccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcce
Q 002121 315 TTLICEFGS-LQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 315 ~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
++|+|++|+ ++ .+| .+..+++|+.|+|++|++++.. .+..+++|+.|++++|++.
T Consensus 139 ~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~~~--~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 139 NSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHDYR--GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCCCT--TGGGCSSCCEEEECBC---
T ss_pred CEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcChH--HhccCCCCCEEEeeCcccC
Confidence 666666665 33 333 4666666666666666666533 5666666777776666654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.67 E-value=1.2e-17 Score=204.79 Aligned_cols=168 Identities=23% Similarity=0.290 Sum_probs=115.2
Q ss_pred eeEEEcCCCCccc---------cccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCC
Q 002121 66 VTALGLSTMGLTG---------KLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNL 136 (964)
Q Consensus 66 v~~L~L~~~~l~g---------~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 136 (964)
+..++|+.+.|.+ ..+..+..++.|+.|+|++| .+. .+|..+.++++|++|+|++|.|+ .+|..|++|
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n-~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l 269 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNL-QIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNL 269 (727)
T ss_dssp -----------------------------CCCCCCEEECTTS-CCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGG
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCC-CCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCC
Confidence 3445555554443 44677889999999999998 565 77878889999999999999999 889889999
Q ss_pred CCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCc
Q 002121 137 AELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDM 216 (964)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~ 216 (964)
++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+| ..|..+++|+.|+|++|+|++.+|..++....
T Consensus 270 ~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp------~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~ 341 (727)
T 4b8c_D 270 SNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLP------WEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV 341 (727)
T ss_dssp TTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCC------SSTTSCTTCCCEECTTSCCCSHHHHHHHHHHH
T ss_pred CCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccC------hhhhcCCCccEEeCCCCccCCCChHHHhhcch
Confidence 99999999999999 77899999999999999999987 777 34778889999999999998877766654433
Q ss_pred ceeEEEccCCcCcccCCcccCCCCCCcEEEcccC
Q 002121 217 VLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN 250 (964)
Q Consensus 217 ~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N 250 (964)
.+..|+|++|.+++.+|.. |+.|++++|
T Consensus 342 ~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 342 TGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp HHHHHHHHHCCCCCCCCCC---------------
T ss_pred hhhHHhhccCcccCcCccc------cceeEeecc
Confidence 4445677788887776653 455566665
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=5.3e-16 Score=172.35 Aligned_cols=138 Identities=16% Similarity=0.148 Sum_probs=101.8
Q ss_pred CCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--------------hhHH--------HHHHHHHHHhcCCCCc
Q 002121 628 NFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--------------GGLE--------FKTEIELLSRVHHKNL 685 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--------------~~~~--------~~~E~~~l~~l~H~nI 685 (964)
-|++.+.||+|+||.||+|...+|+.||||+++..... .... ...|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 48889999999999999999989999999987532110 0011 2346666777755544
Q ss_pred cceeEEEEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC
Q 002121 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL 765 (964)
Q Consensus 686 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~ 765 (964)
....-+ . ....+|||||+++++|.++... .....++.|++.+|.|||+.+ ||||||||.|||+++++
T Consensus 176 ~vp~p~-~-~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dg 242 (397)
T 4gyi_A 176 PVPEPI-A-QSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEK 242 (397)
T ss_dssp SCCCEE-E-EETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEE
T ss_pred CCCeee-e-ccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCC
Confidence 322211 1 2234799999999998766432 223567899999999999988 99999999999998877
Q ss_pred ----------cEEEeecccceee
Q 002121 766 ----------TAKVADFGLSKLV 778 (964)
Q Consensus 766 ----------~~kl~DFGla~~~ 778 (964)
.+.|+||+-+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 3899999987643
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.63 E-value=5.8e-16 Score=157.76 Aligned_cols=110 Identities=21% Similarity=0.259 Sum_probs=64.9
Q ss_pred CCcEEEcccCcCccccCc-cccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEE
Q 002121 241 TLEVLRLDRNALTGKVPT-NLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318 (964)
Q Consensus 241 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 318 (964)
+|+.|+|++|.|++..+. .|..+++|++|+|++|+|++..+ .+.++++|++|+|++|+|+ ...+..|.++++|+.|+
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 108 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC-EECSSSSTTCTTCCEEE
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCC-ccCHHHhcCCCCCCEEE
Confidence 455555555555533332 24555555555555555555443 2555555555555555554 44444566666677777
Q ss_pred CCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 319 CEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
|++|+|++..|..|..+++|+.|+|++|++.+.
T Consensus 109 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 777777777777777777777777777777654
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=6.8e-16 Score=171.48 Aligned_cols=284 Identities=13% Similarity=0.068 Sum_probs=173.0
Q ss_pred CeeEEEcCCCCccccccCCcCC-CCcccEEecccCCCCC--CCCCCCCCCcccchhhccccccccCcCCcccCC------
Q 002121 65 RVTALGLSTMGLTGKLSGDIGG-LTELRSLDLSYNGGLT--GSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN------ 135 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~-l~~L~~L~L~~N~~l~--~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~------ 135 (964)
+++.|.++++ +.+..-..+.. +++|+.|||++| .+. ......+ +.++.+.+..|.|. +..|.+
T Consensus 26 ~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n-~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~ 97 (329)
T 3sb4_A 26 SITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNA-EIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVT 97 (329)
T ss_dssp HCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEE-EECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEE
T ss_pred ceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcc-eeEEecCccccc---cccccccccccccC---HHHhcccccccc
Confidence 5667777643 22111112333 778899999988 555 2222222 22344444444332 234445
Q ss_pred --CCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcc---ccccccc
Q 002121 136 --LAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL---SGTISEQ 210 (964)
Q Consensus 136 --l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l---~g~l~~~ 210 (964)
+++|+.|+|.+ .++...+.+|.++++|+.|+|++|.++ .|+. ..|..+.++..+.+..+.. ...+...
T Consensus 98 ~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~-----~aF~~~~~l~~l~~~~~~~~~~~~~i~~~ 170 (329)
T 3sb4_A 98 KGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLP-----EALADSVTAIFIPLGSSDAYRFKNRWEHF 170 (329)
T ss_dssp EECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECT-----TSSCTTTCEEEECTTCTHHHHTSTTTTTS
T ss_pred cccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccch-----hhhcCCCceEEecCcchhhhhcccccccc
Confidence 77888888877 777566667777888888888877776 3432 3455555555555554322 0133444
Q ss_pred ccCCCccee-EEEccCCcC-cccCCcccCCCCCCcEEEcccCcCccccCccc-cCCCCCCeeeccCccCccCCCC-CCCC
Q 002121 211 LFSPDMVLI-HVLFDGNQL-SGNIPESLGYVQTLEVLRLDRNALTGKVPTNL-NNLTNVNELNLAHNDLKGPFPD-LSQM 286 (964)
Q Consensus 211 ~f~~~~~L~-~L~l~~N~l-~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~~~-l~~l 286 (964)
.|.....|+ .+.+....- ...+...--...++..+.+.++-.. .....+ ..+++|+.|+|++|+++.+++. |.++
T Consensus 171 ~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~ 249 (329)
T 3sb4_A 171 AFIEGEPLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQK 249 (329)
T ss_dssp CEEESCCCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTC
T ss_pred ccccccccceeEEecCCCcHHHHHhhcccCccccceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhhCC
Confidence 454444555 343332211 1001111113455666666655322 111122 2367788888888887777664 7778
Q ss_pred CCCCEEEccCCCCCCCCCCcccCCCCCCc-EEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEE
Q 002121 287 NSLSYVDLSNNSFDPTEAPLWFSTLPSLT-TLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLV 365 (964)
Q Consensus 287 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 365 (964)
.+|+.|+|.+| ++ .+.+..|.++++|+ .|+|.+ .++.+.+.+|.++++|+.|+|++|+++.+.+..|.++++|+.+
T Consensus 250 ~~L~~l~l~~n-i~-~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~l 326 (329)
T 3sb4_A 250 KYLLKIKLPHN-LK-TIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLI 326 (329)
T ss_dssp TTCCEEECCTT-CC-EECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEE
T ss_pred CCCCEEECCcc-cc-eehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhh
Confidence 88888888887 55 66777788888888 888887 7777778888888888888888888888888888888888888
Q ss_pred ec
Q 002121 366 DL 367 (964)
Q Consensus 366 ~L 367 (964)
+.
T Consensus 327 y~ 328 (329)
T 3sb4_A 327 YK 328 (329)
T ss_dssp EC
T ss_pred cc
Confidence 64
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=6.9e-16 Score=153.51 Aligned_cols=136 Identities=21% Similarity=0.180 Sum_probs=92.5
Q ss_pred CCCcEEEcccCcCc-cccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEE
Q 002121 240 QTLEVLRLDRNALT-GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318 (964)
Q Consensus 240 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 318 (964)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.|++. +.+..+++|++|+|++|.++ ..+|..+..+++|+.|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIF-GGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCC-SCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCc-hHHHHHHhhCCCCCEEe
Confidence 55666666666666 55666666666666666666666665 55666677777777777775 33566666677777777
Q ss_pred CCCCcccccc-ChhccCCCCCCEEEcCCcccccccC---CCCccCCCCcEEeccCCcceeecc
Q 002121 319 CEFGSLQGRV-PDKLFSYSQIQQVKLRNNAFNNTLD---MGNAVGPLLQLVDLQNNQISAITL 377 (964)
Q Consensus 319 Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~i~~ 377 (964)
|++|++++.. +..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++|.+..++.
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~ 164 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAPD 164 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCCS
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhccc
Confidence 7777776542 2667777777777777777776655 466777777777777777776653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.61 E-value=1.4e-14 Score=164.59 Aligned_cols=262 Identities=12% Similarity=0.079 Sum_probs=122.8
Q ss_pred CcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccc
Q 002121 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLD 167 (964)
Q Consensus 88 ~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (964)
..++.+.+..+ +...-...|.+. +|+.+.|..+ ++..-..+|.+ .+|+.+.|.+ .++...+.+|.++++|+.++
T Consensus 113 ~~l~~i~ip~~--i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 113 KGYNEIILPNS--VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp SSCSEEECCTT--CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred CCccEEEECCc--cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 44555555432 333334445443 4666665544 44333444544 3466666654 44434445566666666666
Q ss_pred ccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEc
Q 002121 168 LADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247 (964)
Q Consensus 168 Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 247 (964)
|++|+++ .+|.. .|. ..+|+.+.|.++ ++ .|+..+|..+.+|+.+.+..| ++..-..+|.+ .+|+.+.|
T Consensus 187 l~~n~l~-~I~~~-----aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l 255 (401)
T 4fdw_A 187 LSKTKIT-KLPAS-----TFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL 255 (401)
T ss_dssp CTTSCCS-EECTT-----TTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE
T ss_pred cCCCcce-Eechh-----hEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe
Confidence 6665555 33322 222 345555555533 44 555555555555555555543 44344444444 45555555
Q ss_pred ccCcCccccCccccCCCCCCeeeccCccCc-----cCCC-CCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCC
Q 002121 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLK-----GPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEF 321 (964)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~ 321 (964)
.|.++..-..+|.++++|+.+++.+|.+. .+.+ .|.++++|+.++|.+ .++ .+....|.++++|+.|.|..
T Consensus 256 -p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~-~I~~~aF~~c~~L~~l~lp~ 332 (401)
T 4fdw_A 256 -PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIR-ILGQGLLGGNRKVTQLTIPA 332 (401)
T ss_dssp -ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCC-EECTTTTTTCCSCCEEEECT
T ss_pred -CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceE-EEhhhhhcCCCCccEEEECc
Confidence 23344344455555555555555555443 1111 244444444444442 233 33334444444444444422
Q ss_pred CccccccChhccCCCCCCEEEcCCcccccccCCCCccCC-CCcEEeccCCc
Q 002121 322 GSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGP-LLQLVDLQNNQ 371 (964)
Q Consensus 322 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~ 371 (964)
| ++.+...+|.++ +|+.|++.+|.+.......|..++ .++.|++..|.
T Consensus 333 ~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 333 N-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp T-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred c-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 2 333344444444 444444444444444444444442 34444444433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.59 E-value=2.4e-15 Score=149.61 Aligned_cols=135 Identities=17% Similarity=0.160 Sum_probs=93.9
Q ss_pred cceeEEEccCCcCc-ccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEE
Q 002121 216 MVLIHVLFDGNQLS-GNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVD 293 (964)
Q Consensus 216 ~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~ 293 (964)
.+|++|++++|+++ +.+|..+..+++|+.|+|++|.+++. ..|..+++|++|+|++|++++.+|. +..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 34555566666655 55666666677777777777777744 6677777777777777777775554 44477777777
Q ss_pred ccCCCCCCCCCCcccCCCCCCcEEECCCCccccccC---hhccCCCCCCEEEcCCccccccc
Q 002121 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVP---DKLFSYSQIQQVKLRNNAFNNTL 352 (964)
Q Consensus 294 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~ 352 (964)
|++|.+++...+..+..+++|+.|+|++|.+++..+ ..+..+++|+.|++++|.+....
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~ 163 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP 163 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence 777777532233667788888888888888886665 57888888888888888876544
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.3e-15 Score=146.50 Aligned_cols=128 Identities=20% Similarity=0.216 Sum_probs=81.6
Q ss_pred CCCcEEEcccCcCc-cccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEE
Q 002121 240 QTLEVLRLDRNALT-GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318 (964)
Q Consensus 240 ~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 318 (964)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. +.+..+++|++|++++|.++ ..+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVS-GGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCC-SCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCccc-chHHHHhhhCCCCCEEE
Confidence 45556666666665 55555556666666666666666655 45666666666666666665 33555566667777777
Q ss_pred CCCCccccc-cChhccCCCCCCEEEcCCcccccccC---CCCccCCCCcEEeccC
Q 002121 319 CEFGSLQGR-VPDKLFSYSQIQQVKLRNNAFNNTLD---MGNAVGPLLQLVDLQN 369 (964)
Q Consensus 319 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~L~~ 369 (964)
|++|++++. .+..+..+++|+.|+|++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 777777653 34666777777777777777776655 4566777777777653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.57 E-value=4.1e-14 Score=160.87 Aligned_cols=262 Identities=10% Similarity=0.094 Sum_probs=213.9
Q ss_pred eEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEccc
Q 002121 67 TALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146 (964)
Q Consensus 67 ~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~ 146 (964)
+.+.+.+ +++.+-..+|.+. +|+.++|..| +...-...|.+ .+|+.+.|.+ .++..-+.+|.++++|+.++|++
T Consensus 116 ~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~--i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 116 NEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG--LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp SEEECCT-TCCEECTTTTTTC-CCSEEECCTT--CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred cEEEECC-ccCEehHhhcccC-CccEEEeCCC--ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 3344433 4554445577774 7999999876 56566667777 4799999986 77756678899999999999999
Q ss_pred CcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCC
Q 002121 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGN 226 (964)
Q Consensus 147 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N 226 (964)
|+++.....+|. .++|+.+.|.++ ++ .|+ ...|.++++|+.+++..| ++ .|+..+|.. .+|+.+.+ .|
T Consensus 190 n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~-----~~aF~~~~~L~~l~l~~~-l~-~I~~~aF~~-~~L~~i~l-p~ 257 (401)
T 4fdw_A 190 TKITKLPASTFV-YAGIEEVLLPVT-LK-EIG-----SQAFLKTSQLKTIEIPEN-VS-TIGQEAFRE-SGITTVKL-PN 257 (401)
T ss_dssp SCCSEECTTTTT-TCCCSEEECCTT-CC-EEC-----TTTTTTCTTCCCEECCTT-CC-EECTTTTTT-CCCSEEEE-ET
T ss_pred CcceEechhhEe-ecccCEEEeCCc-hh-eeh-----hhHhhCCCCCCEEecCCC-cc-Ccccccccc-CCccEEEe-CC
Confidence 999965555666 689999999855 65 333 467899999999999976 55 889999988 78999999 56
Q ss_pred cCcccCCcccCCCCCCcEEEcccCcCc-----cccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCC
Q 002121 227 QLSGNIPESLGYVQTLEVLRLDRNALT-----GKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 227 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~ 300 (964)
.++.....+|.++++|+.+++.+|.+. ...+.+|.+|++|+.++|. |.++.+... |.++++|+.|+|..| ++
T Consensus 258 ~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~ 335 (401)
T 4fdw_A 258 GVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VT 335 (401)
T ss_dssp TCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CC
T ss_pred CccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-cc
Confidence 688778899999999999999998876 4667899999999999999 457776664 999999999999766 65
Q ss_pred CCCCCcccCCCCCCcEEECCCCccccccChhccCCC-CCCEEEcCCccccc
Q 002121 301 PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYS-QIQQVKLRNNAFNN 350 (964)
Q Consensus 301 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~ 350 (964)
.+...+|.++ +|+.|++++|.+....+..|.+++ +++.|.+..|.+..
T Consensus 336 -~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 336 -QINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK 384 (401)
T ss_dssp -EECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred -EEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence 6778889999 999999999999988888999985 79999999887653
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.56 E-value=2e-14 Score=146.47 Aligned_cols=125 Identities=22% Similarity=0.271 Sum_probs=79.9
Q ss_pred EEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCC
Q 002121 221 VLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSF 299 (964)
Q Consensus 221 L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l 299 (964)
+++++|+++ .+|..+. ++|+.|+|++|.|+ .+|..|.++++|+.|+|++|.|+++++. |.++++|++|+|++|.|
T Consensus 15 l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 15 VRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 444444444 3343332 45666666666666 5556666666666666666666665553 66666666666666666
Q ss_pred CCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccc
Q 002121 300 DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 300 ~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 350 (964)
+ ...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 91 ~-~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 91 R-CIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp C-BCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred C-EeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 5 4555567777777777777777776666667777778888888877753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.55 E-value=4.4e-14 Score=141.68 Aligned_cols=129 Identities=20% Similarity=0.216 Sum_probs=67.1
Q ss_pred eEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCC
Q 002121 219 IHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNS 298 (964)
Q Consensus 219 ~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~ 298 (964)
+.+++++|+++. +|..+ .++|+.|++++|++++..+..|.++++|++|+|++|+|++.++
T Consensus 10 ~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~----------------- 69 (177)
T 2o6r_A 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPD----------------- 69 (177)
T ss_dssp TEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT-----------------
T ss_pred CEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeCh-----------------
Confidence 345555555552 33222 2445555555555554444444445555555555554444433
Q ss_pred CCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 299 FDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 299 l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++
T Consensus 70 -------~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 70 -------GVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp -------TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred -------hHccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 334455555555555555555555555555666666666666655555555556666666666665543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.54 E-value=4.1e-15 Score=144.72 Aligned_cols=128 Identities=17% Similarity=0.171 Sum_probs=99.7
Q ss_pred cceeEEEccCCcCc-ccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEE
Q 002121 216 MVLIHVLFDGNQLS-GNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVD 293 (964)
Q Consensus 216 ~~L~~L~l~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~ 293 (964)
.+|+.|++++|+++ +.+|..+..+++|+.|++++|.+++. ..+.++++|++|+|++|.+++.+|. +..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45667777777776 66777777888888888888888855 6778888888888888888875554 55588888888
Q ss_pred ccCCCCCCCCCCcccCCCCCCcEEECCCCccccccC---hhccCCCCCCEEEcCC
Q 002121 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVP---DKLFSYSQIQQVKLRN 345 (964)
Q Consensus 294 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~L~~ 345 (964)
+++|++++...+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 888888632234678889999999999999988776 6788899999998864
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.54 E-value=4.2e-14 Score=141.87 Aligned_cols=131 Identities=17% Similarity=0.221 Sum_probs=94.8
Q ss_pred CeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccC
Q 002121 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAH 273 (964)
Q Consensus 194 ~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 273 (964)
+.+++++|+++ .+|..++ .+|++|++++|++++..+..|..+++|++|+|++|.|++..+..|.++++|++|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 45566666665 5554433 4677888888888877777788889999999999999877777788888999999999
Q ss_pred ccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccC
Q 002121 274 NDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVP 329 (964)
Q Consensus 274 N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 329 (964)
|+|++.++. +..+++|++|+|++|.++ ...+..+..+++|+.|+|++|.+.+..|
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCccccCHHHhhCCcccCEEECcCCcce-EeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 888877765 567777777777777775 4444455666666666666666665443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=2.5e-14 Score=143.37 Aligned_cols=136 Identities=17% Similarity=0.167 Sum_probs=83.3
Q ss_pred cCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCc
Q 002121 236 LGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLT 315 (964)
Q Consensus 236 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~ 315 (964)
+..+.+|+.|++++|+++ .+|......++|++|+|++|.|++. +.+..+++|++|+|++|.++ ...+..|..+++|+
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLT 91 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCC
T ss_pred cCCcCCceEEEeeCCCCc-hhHHhhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCccc-ccCcchhhcCCCCC
Confidence 344556666666666666 3333222223666666666666655 45666666666666666665 33344456667777
Q ss_pred EEECCCCccccccCh--hccCCCCCCEEEcCCcccccccCC---CCccCCCCcEEeccCCcceee
Q 002121 316 TLICEFGSLQGRVPD--KLFSYSQIQQVKLRNNAFNNTLDM---GNAVGPLLQLVDLQNNQISAI 375 (964)
Q Consensus 316 ~L~Ls~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~i 375 (964)
.|+|++|+|.. +|. .+..+++|+.|+|++|+++..... .+..+++|+.||+++|.+...
T Consensus 92 ~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~Ld~~~n~~~~~ 155 (176)
T 1a9n_A 92 ELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDFQKVKLKER 155 (176)
T ss_dssp EEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETTEECCHHHH
T ss_pred EEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccceeCCCcCCHHHH
Confidence 77777777643 343 666777777777777777644322 366777788888877777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=8.2e-16 Score=157.49 Aligned_cols=133 Identities=21% Similarity=0.232 Sum_probs=67.0
Q ss_pred ccchhhccccccccCcCCc------ccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCc
Q 002121 113 QKLNILILAGCGFTGNIPD------EIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186 (964)
Q Consensus 113 ~~L~~L~L~~n~l~~~~p~------~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~ 186 (964)
..++.++++.+.++|.+|. .|..+++|++|+|++|.+++ +| .+.++++|++|+|++|+++ .+| ..
T Consensus 18 ~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~------~~ 88 (198)
T 1ds9_A 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIE------NL 88 (198)
T ss_dssp TCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCS------SH
T ss_pred ccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-ccc------ch
Confidence 3444555555555554444 55556666666666666653 44 5555566666666666655 344 22
Q ss_pred cccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCC-cccCCCCCCcEEEcccCcCccccC
Q 002121 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIP-ESLGYVQTLEVLRLDRNALTGKVP 257 (964)
Q Consensus 187 l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p 257 (964)
+..+++|+.|++++|++++ +| .+..+++|++|++++|++++..+ ..+..+++|+.|++++|.+++.+|
T Consensus 89 ~~~~~~L~~L~L~~N~l~~-l~--~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~ 157 (198)
T 1ds9_A 89 DAVADTLEELWISYNQIAS-LS--GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHHHHCSEEEEEEEECCC-HH--HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHH
T ss_pred hhcCCcCCEEECcCCcCCc-CC--ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccc
Confidence 3444555555555555542 22 12333344444444444443211 245555566666666666554443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.46 E-value=1.7e-13 Score=136.38 Aligned_cols=104 Identities=17% Similarity=0.119 Sum_probs=56.4
Q ss_pred CeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCc
Q 002121 267 NELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNN 346 (964)
Q Consensus 267 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 346 (964)
+.|++++|.|+.++..+. ++|++|+|++|.|+ ...+..|.++++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 12 ~~l~~s~n~l~~ip~~~~--~~l~~L~L~~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLASVPTGIP--TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCccCccCC--CCCcEEEcCCCcCC-ccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 344444444444333321 44445555555554 334444555555555555555555555555566666666666666
Q ss_pred ccccccCCCCccCCCCcEEeccCCcce
Q 002121 347 AFNNTLDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 347 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
+|++..+..|..+++|+.|+|++|+|+
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 666665555666666666666655554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.45 E-value=8.2e-14 Score=139.62 Aligned_cols=129 Identities=15% Similarity=0.154 Sum_probs=82.4
Q ss_pred cceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCC-CCCCCCCEEEc
Q 002121 216 MVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL-SQMNSLSYVDL 294 (964)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l-~~l~~L~~L~L 294 (964)
.+|++|++++|+++. +|......++|++|+|++|.|++. ..|..+++|++|+|++|.|++.++.+ ..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~~-i~~~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCch-hHHhhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 344444444444442 233222223677777777777643 56667777777777777777666553 66777777777
Q ss_pred cCCCCCCCCCCc--ccCCCCCCcEEECCCCccccccCh----hccCCCCCCEEEcCCccccc
Q 002121 295 SNNSFDPTEAPL--WFSTLPSLTTLICEFGSLQGRVPD----KLFSYSQIQQVKLRNNAFNN 350 (964)
Q Consensus 295 s~N~l~~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~~ 350 (964)
++|+++ ..|. .+..+++|+.|+|++|.+.. +|. .+..+++|+.|++++|.+..
T Consensus 96 ~~N~i~--~~~~~~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~~ 154 (176)
T 1a9n_A 96 TNNSLV--ELGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLKE 154 (176)
T ss_dssp CSCCCC--CGGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHHH
T ss_pred CCCcCC--cchhhHhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHHH
Confidence 777773 3333 67777788888888888774 344 37778888888888887654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.44 E-value=4.2e-16 Score=159.64 Aligned_cols=161 Identities=19% Similarity=0.218 Sum_probs=95.9
Q ss_pred cccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCC
Q 002121 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNV 266 (964)
Q Consensus 187 l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 266 (964)
+.....++.++++.|.++|.+|. ++ .+|..+..+++|++|+|++|.+++ +| .+.++++|
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~------------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L 72 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPP------------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENL 72 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTT------------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTC
T ss_pred HHhcccccCcchheeEeccccCc------------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCC
Confidence 34455666666666666654442 11 222356666666666666666664 45 66666666
Q ss_pred CeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccC-hhccCCCCCCEEEcCC
Q 002121 267 NELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVP-DKLFSYSQIQQVKLRN 345 (964)
Q Consensus 267 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~ 345 (964)
++|+|++|.|+.++..+..+++|++|+|++|++++ +| .+..+++|+.|+|++|++++..+ ..+..+++|+.|+|++
T Consensus 73 ~~L~l~~n~l~~l~~~~~~~~~L~~L~L~~N~l~~--l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~ 149 (198)
T 1ds9_A 73 RILSLGRNLIKKIENLDAVADTLEELWISYNQIAS--LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149 (198)
T ss_dssp CEEEEEEEEECSCSSHHHHHHHCSEEEEEEEECCC--HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECS
T ss_pred CEEECCCCCcccccchhhcCCcCCEEECcCCcCCc--CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecC
Confidence 66666666666544434445666666666666642 23 46666667777777777665433 4566677777777777
Q ss_pred cccccccCCC----------CccCCCCcEEeccCCcce
Q 002121 346 NAFNNTLDMG----------NAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 346 N~l~~~~~~~----------~~~l~~L~~L~L~~N~l~ 373 (964)
|++.+..+.. +..+++|+.|| +|.++
T Consensus 150 N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 150 NPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 7776655543 55666666665 45444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.9e-12 Score=128.00 Aligned_cols=87 Identities=20% Similarity=0.136 Sum_probs=46.6
Q ss_pred CCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEe
Q 002121 287 NSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVD 366 (964)
Q Consensus 287 ~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 366 (964)
++|++|+|++|+|+ ...|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 33 ~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCcc-ccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 33444444444443 33344455555555555555555554444455566666666666666655555566666666666
Q ss_pred ccCCccee
Q 002121 367 LQNNQISA 374 (964)
Q Consensus 367 L~~N~l~~ 374 (964)
|++|+|++
T Consensus 112 L~~N~~~c 119 (174)
T 2r9u_A 112 LYNNPWDC 119 (174)
T ss_dssp CCSSCBCT
T ss_pred eCCCCccc
Confidence 66665543
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.1e-12 Score=129.07 Aligned_cols=111 Identities=21% Similarity=0.243 Sum_probs=91.9
Q ss_pred ccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCC
Q 002121 57 EGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNL 136 (964)
Q Consensus 57 ~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 136 (964)
.+..|. .+.+++++++++ .+|..+. ++|++|+|++| .+.+..|..|.++++|++|+|++|+|++..+..|.++
T Consensus 8 ~~C~C~---~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l 80 (174)
T 2r9u_A 8 SQCSCD---QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNN-QITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKL 80 (174)
T ss_dssp TTSEEC---SSEEECCSSCCS-SCCSCCC--TTCSEEECCSS-CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTC
T ss_pred CCCEEC---CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCC-CccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCc
Confidence 455664 367899999985 6777664 88999999999 7888888889999999999999999986655667889
Q ss_pred CCccEEEcccCcccCcCCCcCCCccccccccccccccc
Q 002121 137 AELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174 (964)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 174 (964)
++|++|+|++|+|++..+..|.++++|++|+|++|.+.
T Consensus 81 ~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 81 TQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred chhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 99999999999999666666888899999999999887
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.35 E-value=3.4e-12 Score=126.97 Aligned_cols=86 Identities=22% Similarity=0.273 Sum_probs=46.1
Q ss_pred CCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEE
Q 002121 264 TNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 264 ~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 342 (964)
++|++|+|++|+|+++++. +.++++|++|+|++|+|+ ...+..|..+++|++|+|++|+|++..+..|..+++|+.|+
T Consensus 30 ~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 108 (170)
T 3g39_A 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIW 108 (170)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCCCCCEEECCCCccCEeCHHHhcCCCCCCEEE
Confidence 3444444444444444332 444444444444444444 33444455556666666666666655555566666666666
Q ss_pred cCCccccc
Q 002121 343 LRNNAFNN 350 (964)
Q Consensus 343 L~~N~l~~ 350 (964)
|++|++..
T Consensus 109 L~~N~~~c 116 (170)
T 3g39_A 109 LLNNPWDC 116 (170)
T ss_dssp CCSSCBCT
T ss_pred eCCCCCCC
Confidence 66666653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.33 E-value=8.6e-11 Score=133.67 Aligned_cols=302 Identities=10% Similarity=0.016 Sum_probs=151.4
Q ss_pred CeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEc
Q 002121 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLAL 144 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 144 (964)
.++.+.|.. +++.+-..+|.++++|+.++|..+ +...-...|.++.+|+.+.+..+ +......+|.+...++....
T Consensus 72 ~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~--l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~ 147 (394)
T 4fs7_A 72 KVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS--VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIP 147 (394)
T ss_dssp TEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT--CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECC
T ss_pred CceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC--ceEccchhhcccccchhhcccCc-eeeecceeeecccccccccC
Confidence 455555542 344333445555555555555433 23233344555555555544432 22122223333322222211
Q ss_pred ccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEcc
Q 002121 145 NSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFD 224 (964)
Q Consensus 145 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~ 224 (964)
... ......+|.++++|+.+.+.++.. .+ ....|.++.+|+.+.+..| ++ .++...|.....|+.+.+.
T Consensus 148 ~~~--~~i~~~aF~~c~~L~~i~l~~~~~--~I-----~~~~F~~c~~L~~i~l~~~-~~-~I~~~~F~~~~~L~~i~~~ 216 (394)
T 4fs7_A 148 EGV--TVIGDEAFATCESLEYVSLPDSME--TL-----HNGLFSGCGKLKSIKLPRN-LK-IIRDYCFAECILLENMEFP 216 (394)
T ss_dssp TTC--CEECTTTTTTCTTCCEEECCTTCC--EE-----CTTTTTTCTTCCBCCCCTT-CC-EECTTTTTTCTTCCBCCCC
T ss_pred ccc--cccchhhhcccCCCcEEecCCccc--ee-----ccccccCCCCceEEEcCCC-ce-EeCchhhccccccceeecC
Confidence 111 112234455566666666554322 12 2234555566666666554 33 5555556655556555554
Q ss_pred CCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCC
Q 002121 225 GNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304 (964)
Q Consensus 225 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~ 304 (964)
.+... +.+.+....+|+.+.+..+ ++..-...|.++.+|+.+.+..+...-....+..+..|+.+.+..+.+ .
T Consensus 217 ~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l~~~~~~~~~i----~ 289 (394)
T 4fs7_A 217 NSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGLKKVIYGSVIV----P 289 (394)
T ss_dssp TTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTCCEEEECSSEE----C
T ss_pred CCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeeccccccccccceeccCceee----c
Confidence 44322 2222333445555555432 232444556666666666666654443333456666666666555443 2
Q ss_pred CcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcc--
Q 002121 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK-- 382 (964)
Q Consensus 305 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~-- 382 (964)
...|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.++|..| ++.|....+..
T Consensus 290 ~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~ 366 (394)
T 4fs7_A 290 EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCI 366 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCT
T ss_pred cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCC
Confidence 334666666666666544 55555566666677777776543 66666666767777777777655 66665544432
Q ss_pred -cceeEeecC
Q 002121 383 -NYTLILVGN 391 (964)
Q Consensus 383 -l~~l~l~~N 391 (964)
++.+.|..|
T Consensus 367 ~L~~i~lp~~ 376 (394)
T 4fs7_A 367 NLKKVELPKR 376 (394)
T ss_dssp TCCEEEEEGG
T ss_pred CCCEEEECCC
Confidence 455555443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9.5e-12 Score=133.12 Aligned_cols=148 Identities=15% Similarity=0.141 Sum_probs=116.5
Q ss_pred HHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEE
Q 002121 622 LKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 622 l~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 700 (964)
+......|.....++.|+.+.||++... |+.+++|+...........+.+|+++++.+. |..+.++++++.+.+..|+
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567888888898999999999864 6899999987532223346899999999995 6778899999988888999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA----------------------------------- 745 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----------------------------------- 745 (964)
||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999999876421 1234578899999999999811
Q ss_pred ---------------------CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 746 ---------------------NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 746 ---------------------~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.+.++|+|++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766668999997753
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.27 E-value=9.1e-12 Score=139.15 Aligned_cols=130 Identities=18% Similarity=0.188 Sum_probs=67.0
Q ss_pred eccCc-cCccCCCCCCCCCCCCEEEccC-CCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcc
Q 002121 270 NLAHN-DLKGPFPDLSQMNSLSYVDLSN-NSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNA 347 (964)
Q Consensus 270 ~Ls~N-~l~~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 347 (964)
+++++ .|+.+++ +..+++|++|+|++ |.|+ ...+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+
T Consensus 14 ~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 91 (347)
T 2ifg_A 14 RCTRDGALDSLHH-LPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (347)
T ss_dssp ECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EcCCCCCCCccCC-CCCCCCeeEEEccCCCCCC-CcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCCc
Confidence 44444 4444333 44444444444443 4443 3333445555555555555555555555555556666666666665
Q ss_pred cccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCccccCCCCCcccccccccCCCCC
Q 002121 348 FNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGKS 425 (964)
Q Consensus 348 l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~ 425 (964)
|++.++..+..++ |+ .|+|.+|+ .|+|.+..+..|...... . .......|..|.
T Consensus 92 l~~~~~~~~~~~~-L~---------------------~l~l~~N~~~c~c~l~~~~~~~~~~~~-~-l~~~~~~C~~~~ 146 (347)
T 2ifg_A 92 LESLSWKTVQGLS-LQ---------------------ELVLSGNPLHCSCALRWLQRWEEEGLG-G-VPEQKLQCHGQG 146 (347)
T ss_dssp CSCCCSTTTCSCC-CC---------------------EEECCSSCCCCCGGGHHHHHHHHTTCS-S-CGGGCCCCSSSS
T ss_pred cceeCHHHcccCC-ce---------------------EEEeeCCCccCCCccHHHHHHHHhCcc-c-ccccCCCCCCCh
Confidence 5555444444433 44 44555555 578888877777433221 1 123445666554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=2.9e-11 Score=128.86 Aligned_cols=138 Identities=18% Similarity=0.167 Sum_probs=102.9
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc--cceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL--VGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~~~~~lV~E~ 704 (964)
.++......+.|..+.||++...+|+.+++|+.... ....+.+|+++++.+.+.++ .+++++..+.+..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344433333455669999998877888999997654 22468899999999975554 5688888877788999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA--------------------------------------- 745 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 745 (964)
++|.+|. ... . ....++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 97 VPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 9998884 221 1 12367788888888888643
Q ss_pred ----------------CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 746 ----------------NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 746 ----------------~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
...++|||++|.||+++++..+.|+|||.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998876678999998764
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.18 E-value=7.6e-10 Score=125.82 Aligned_cols=287 Identities=11% Similarity=0.070 Sum_probs=215.6
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.++|+.+ ++-.-..+|.+++.|+.+.+..+ +...-...|.+...+........ ......+|.++++|+.+.
T Consensus 94 ~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~--l~~i~~~aF~~~~~~~~~~~~~~--~~i~~~aF~~c~~L~~i~ 168 (394)
T 4fs7_A 94 SKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM--LKSIGVEAFKGCDFKEITIPEGV--TVIGDEAFATCESLEYVS 168 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT--CCEECTTTTTTCCCSEEECCTTC--CEECTTTTTTCTTCCEEE
T ss_pred CCCcEEEeCCC-ceEccchhhcccccchhhcccCc--eeeecceeeecccccccccCccc--cccchhhhcccCCCcEEe
Confidence 46888888754 66455568999999999888765 44444556766654444333332 223456799999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
|.++..+ .....|.++++|+.+++..| ++ .+ ....+..+..|+.+.+..+... +....| ....|+.+.+
T Consensus 169 l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~-~I-----~~~~F~~~~~L~~i~~~~~~~~--i~~~~~-~~~~l~~i~i 237 (394)
T 4fs7_A 169 LPDSMET-LHNGLFSGCGKLKSIKLPRN-LK-II-----RDYCFAECILLENMEFPNSLYY--LGDFAL-SKTGVKNIII 237 (394)
T ss_dssp CCTTCCE-ECTTTTTTCTTCCBCCCCTT-CC-EE-----CTTTTTTCTTCCBCCCCTTCCE--ECTTTT-TTCCCCEEEE
T ss_pred cCCccce-eccccccCCCCceEEEcCCC-ce-Ee-----CchhhccccccceeecCCCceE--eehhhc-ccCCCceEEE
Confidence 9876543 66778999999999999876 44 23 3356888889999888776542 333333 3467888888
Q ss_pred cCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCC
Q 002121 224 DGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTE 303 (964)
Q Consensus 224 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~ 303 (964)
..+ ++......|..+..|+.+.+..+..+ .....|.++..|+.+.+..+.+.. ..+..+.+|+.+.+.++ ++ .+
T Consensus 238 p~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~--~~F~~~~~L~~i~l~~~-i~-~I 311 (394)
T 4fs7_A 238 PDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPE--KTFYGCSSLTEVKLLDS-VK-FI 311 (394)
T ss_dssp CTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECT--TTTTTCTTCCEEEECTT-CC-EE
T ss_pred CCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecc--ccccccccccccccccc-cc-ee
Confidence 644 44455677888999999999988665 777889999999999887765321 24788999999999876 54 66
Q ss_pred CCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceee
Q 002121 304 APLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAI 375 (964)
Q Consensus 304 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i 375 (964)
...+|.++.+|+.++|..+ ++.+...+|.++.+|+.++|..| ++.+...+|.++.+|+.++|.+| ++.+
T Consensus 312 ~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~~~ 380 (394)
T 4fs7_A 312 GEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LEQY 380 (394)
T ss_dssp CTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GGGG
T ss_pred chhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CEEh
Confidence 6778999999999999754 87778889999999999999887 88888999999999999999755 4443
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.18 E-value=2e-11 Score=136.30 Aligned_cols=103 Identities=18% Similarity=0.179 Sum_probs=66.6
Q ss_pred eEccCC-cccccccccccCCCcceeEEEccC-CcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccC
Q 002121 196 FHFNKN-KLSGTISEQLFSPDMVLIHVLFDG-NQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAH 273 (964)
Q Consensus 196 L~L~~N-~l~g~l~~~~f~~~~~L~~L~l~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 273 (964)
++++++ +|+ .+|. +..+.+|++|+|++ |+|++..+..|.++++|+.|+|++|+|++..|..|.++++|++|+|++
T Consensus 13 v~~~~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 13 LRCTRDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp EECCSSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEcCCCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 445554 554 4554 44555566666664 666666666677777777777777777777777777777777777777
Q ss_pred ccCccCCCCCCCCCCCCEEEccCCCCCC
Q 002121 274 NDLKGPFPDLSQMNSLSYVDLSNNSFDP 301 (964)
Q Consensus 274 N~l~~~~~~l~~l~~L~~L~Ls~N~l~~ 301 (964)
|+|+++++.......|+.|+|++|+|.+
T Consensus 90 N~l~~~~~~~~~~~~L~~l~l~~N~~~c 117 (347)
T 2ifg_A 90 NALESLSWKTVQGLSLQELVLSGNPLHC 117 (347)
T ss_dssp SCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CccceeCHHHcccCCceEEEeeCCCccC
Confidence 7777766653332337777777777753
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.17 E-value=3.9e-13 Score=151.28 Aligned_cols=38 Identities=21% Similarity=0.158 Sum_probs=19.5
Q ss_pred CCccEEEcccCcccCcCCCcCCCc-----cccccccccccccc
Q 002121 137 AELSFLALNSNNFSGRIPPSLGKL-----SQLYWLDLADNQLT 174 (964)
Q Consensus 137 ~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~Ls~N~l~ 174 (964)
++|+.|+|++|.|+......+..+ ++|++|+|++|.++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~ 114 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLD 114 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCC
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCC
Confidence 456666776666653322222221 45555555555554
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.16 E-value=2.1e-09 Score=122.18 Aligned_cols=289 Identities=11% Similarity=0.087 Sum_probs=137.1
Q ss_pred eeEEEcCCCCccccccCCcCCCCcccEEecccCC--CCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 66 VTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNG--GLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 66 v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~--~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
++.+.+.. .++.+-..+|.++++|+.+.+..|. .+...-...|..+.+|+.+.+..+ ++......|..+.+|+.+.
T Consensus 66 L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~ 143 (394)
T 4gt6_A 66 LTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVT 143 (394)
T ss_dssp CCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEE
T ss_pred CEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhccccccc
Confidence 34444432 2333333445555555555554431 122222334445555555554432 2323334455555555555
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLF 223 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l 223 (964)
+..+. .......|.++.+|+.+.+.++ ++ .|. ...|.. ..|+.+.+..+-. .+....|.....+.....
T Consensus 144 lp~~~-~~I~~~~F~~c~~L~~i~~~~~-~~-~I~-----~~aF~~-~~l~~i~ip~~~~--~i~~~af~~c~~l~~~~~ 212 (394)
T 4gt6_A 144 IPEGV-TSVADGMFSYCYSLHTVTLPDS-VT-AIE-----ERAFTG-TALTQIHIPAKVT--RIGTNAFSECFALSTITS 212 (394)
T ss_dssp CCTTC-CEECTTTTTTCTTCCEEECCTT-CC-EEC-----TTTTTT-CCCSEEEECTTCC--EECTTTTTTCTTCCEEEE
T ss_pred cccee-eeecccceecccccccccccce-ee-Eec-----cccccc-cceeEEEECCccc--ccccchhhhccccceecc
Confidence 54332 2233444555555555555433 22 111 112221 3344444433321 233344444444444443
Q ss_pred cCCcCcccCCcc-------------cCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCC
Q 002121 224 DGNQLSGNIPES-------------LGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLS 290 (964)
Q Consensus 224 ~~N~l~~~~p~~-------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~ 290 (964)
..+......... +.....+..+.+. +.++..-..+|.++.+|+.+.+.++..+--...+.++.+|+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~I~~~aF~~c~~L~ 291 (394)
T 4gt6_A 213 DSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVSIGTGAFMNCPALQ 291 (394)
T ss_dssp CCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCEECTTTTTTCTTCC
T ss_pred cccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccceecCcccccccccc
Confidence 333222110000 0011122222222 12222334456666777777766554332222366667777
Q ss_pred EEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCC
Q 002121 291 YVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNN 370 (964)
Q Consensus 291 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 370 (964)
.+.+.. .++ .+....|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+++.+|
T Consensus 292 ~i~l~~-~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~ 367 (394)
T 4gt6_A 292 DIEFSS-RIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGS 367 (394)
T ss_dssp EEECCT-TCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSC
T ss_pred cccCCC-ccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCc
Confidence 777753 343 445556777777777777543 55555666777777777777544 66666667777777777777766
Q ss_pred cc
Q 002121 371 QI 372 (964)
Q Consensus 371 ~l 372 (964)
..
T Consensus 368 ~~ 369 (394)
T 4gt6_A 368 RS 369 (394)
T ss_dssp HH
T ss_pred ee
Confidence 54
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=5.6e-13 Score=149.97 Aligned_cols=140 Identities=20% Similarity=0.158 Sum_probs=68.7
Q ss_pred cCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCccc-----CCCCCCcEEEcccCcCcc----ccCcccc
Q 002121 191 KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESL-----GYVQTLEVLRLDRNALTG----KVPTNLN 261 (964)
Q Consensus 191 ~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~----~~p~~~~ 261 (964)
++|+.|+|++|.++..-...++..+.+|++|+|++|+|+......+ ...++|+.|+|++|.|+. .++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 3555555555555432222333334455555555555543332222 234566777777776653 2344445
Q ss_pred CCCCCCeeeccCccCccCC-----CCCCCCCCCCEEEccCCCCCCC---CCCcccCCCCCCcEEECCCCccccccCh
Q 002121 262 NLTNVNELNLAHNDLKGPF-----PDLSQMNSLSYVDLSNNSFDPT---EAPLWFSTLPSLTTLICEFGSLQGRVPD 330 (964)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~-----~~l~~l~~L~~L~Ls~N~l~~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 330 (964)
.+++|++|+|++|.|+... ..+..+++|++|+|++|.|+.. .+...+...++|++|+|++|.|+.....
T Consensus 181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~ 257 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQ 257 (372)
T ss_dssp TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHH
T ss_pred cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHH
Confidence 6667777777777766422 1234445556666666655410 1111222334455555555554443333
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.9e-08 Score=114.17 Aligned_cols=290 Identities=10% Similarity=0.081 Sum_probs=177.7
Q ss_pred CCcCCCC-cccEEecccCCCCCCCCCCCCCCcccchhhcccccc---ccCcCCcccCCCCCccEEEcccCcccCcCCCcC
Q 002121 82 GDIGGLT-ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCG---FTGNIPDEIGNLAELSFLALNSNNFSGRIPPSL 157 (964)
Q Consensus 82 ~~l~~l~-~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 157 (964)
.+|.+.. .|+.+.|-.+ +...-..+|.++.+|+.+.+..|. ++..-..+|.++.+|+.+.+..+ ++.....+|
T Consensus 57 ~aF~~~~~~L~sI~iP~s--vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF 133 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT--VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAF 133 (394)
T ss_dssp TTTTTCCSCCCEEEECTT--CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTT
T ss_pred hhccCCCCcCEEEEECCC--eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhh
Confidence 3455553 4666666543 444445566666666666666543 44333445666666666655443 332444556
Q ss_pred CCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccC
Q 002121 158 GKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLG 237 (964)
Q Consensus 158 ~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~ 237 (964)
.++.+|+.+.+..+. . .+ ....+..+.+|+.+.+..+ ++ .+...+|.. ..|+.+.+..+- +.....+|.
T Consensus 134 ~~c~~L~~i~lp~~~-~-~I-----~~~~F~~c~~L~~i~~~~~-~~-~I~~~aF~~-~~l~~i~ip~~~-~~i~~~af~ 202 (394)
T 4gt6_A 134 HHCEELDTVTIPEGV-T-SV-----ADGMFSYCYSLHTVTLPDS-VT-AIEERAFTG-TALTQIHIPAKV-TRIGTNAFS 202 (394)
T ss_dssp TTCTTCCEEECCTTC-C-EE-----CTTTTTTCTTCCEEECCTT-CC-EECTTTTTT-CCCSEEEECTTC-CEECTTTTT
T ss_pred hhhccccccccccee-e-ee-----cccceecccccccccccce-ee-Eeccccccc-cceeEEEECCcc-cccccchhh
Confidence 666666666665332 1 11 2234555666666666544 33 455555543 346666655432 224445556
Q ss_pred CCCCCcEEEcccCcCccccCccc--------------cCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCC
Q 002121 238 YVQTLEVLRLDRNALTGKVPTNL--------------NNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPT 302 (964)
Q Consensus 238 ~l~~L~~L~Ls~N~l~~~~p~~~--------------~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~ 302 (964)
.+.+|+......+... .+...+ .....+..+.+.+ .++.+.. .|.++..|+.+.+.++.. .
T Consensus 203 ~c~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip~-~v~~i~~~aF~~c~~L~~i~lp~~~~--~ 278 (394)
T 4gt6_A 203 ECFALSTITSDSESYP-AIDNVLYEKSANGDYALIRYPSQREDPAFKIPN-GVARIETHAFDSCAYLASVKMPDSVV--S 278 (394)
T ss_dssp TCTTCCEEEECCSSSC-BSSSCEEEECTTSCEEEEECCTTCCCSEEECCT-TEEEECTTTTTTCSSCCEEECCTTCC--E
T ss_pred hccccceecccccccc-cccceeecccccccccccccccccccceEEcCC-cceEcccceeeecccccEEecccccc--e
Confidence 6666666655544433 111111 1112222222221 1222222 388899999999987765 5
Q ss_pred CCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCc-
Q 002121 303 EAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGI- 381 (964)
Q Consensus 303 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~- 381 (964)
+....|.++++|+.+.+. +.++.+...+|.++.+|+.++|..+ ++.+...+|.++.+|+.+.|.++ ++.|....+.
T Consensus 279 I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~ 355 (394)
T 4gt6_A 279 IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSN 355 (394)
T ss_dssp ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTT
T ss_pred ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhC
Confidence 667789999999999996 5677788889999999999999865 88888899999999999999755 8888766554
Q ss_pred --ccceeEeecCC
Q 002121 382 --KNYTLILVGNP 392 (964)
Q Consensus 382 --~l~~l~l~~Np 392 (964)
.|+.+.+.+|.
T Consensus 356 C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 356 CTALNNIEYSGSR 368 (394)
T ss_dssp CTTCCEEEESSCH
T ss_pred CCCCCEEEECCce
Confidence 47788888876
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.00 E-value=9.5e-10 Score=123.33 Aligned_cols=142 Identities=15% Similarity=0.271 Sum_probs=107.6
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEec--CCC-cchhHHHHHHHHHHHhcC--CCCccceeEEEEee---CceEEEEE
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQ--QGS-MQGGLEFKTEIELLSRVH--HKNLVGLVGFCFEQ---GEQMLVYE 703 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lV~E 703 (964)
.+.++.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+. +..+.++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999998754 678888775 322 122346889999999997 45578899988766 45899999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA-------------------------------------- 745 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------- 745 (964)
|++|..+.+... ..++..++..++.++++.|+.||+..
T Consensus 122 ~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 122 FVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp CCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred ecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 999987754221 23677888999999999999999731
Q ss_pred -----------------CCCeeccCCCCCcEEECCCCc--EEEeecccceee
Q 002121 746 -----------------NPPIIHRDVKSTNILLDENLT--AKVADFGLSKLV 778 (964)
Q Consensus 746 -----------------~~~ivH~Dlk~~NILl~~~~~--~kl~DFGla~~~ 778 (964)
.+.++|||+++.|||++.++. +.|+||+.+..-
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246899999999999997753 689999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=7.4e-10 Score=121.14 Aligned_cols=187 Identities=19% Similarity=0.200 Sum_probs=122.7
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCC--ccceeEEEEeeC---ceEEEEEec
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKN--LVGLVGFCFEQG---EQMLVYEFM 705 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~n--Iv~l~~~~~~~~---~~~lV~E~~ 705 (964)
.+.++.|....||+.. ..+++|+.... .....+.+|+++|+.+. +.. +.+++......+ ..|+||||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999853 46889986532 33457899999999884 433 334444433333 348999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA---------------------------------------- 745 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 745 (964)
+|.+|.+... ..++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 99 KGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 9988875332 13667778888889999888888611
Q ss_pred ---------------CCCeeccCCCCCcEEECC--CCcEEEeecccceeecCCCCCcee------------ecccccCcc
Q 002121 746 ---------------NPPIIHRDVKSTNILLDE--NLTAKVADFGLSKLVSDSSKGHVS------------TQVKGTMGY 796 (964)
Q Consensus 746 ---------------~~~ivH~Dlk~~NILl~~--~~~~kl~DFGla~~~~~~~~~~~~------------~~~~gt~~y 796 (964)
.+.++|+|++|.||++++ +..+.|+||+.+..-+....-... ......+++
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence 245899999999999998 556799999998764321000000 000001111
Q ss_pred cC-ccccccCCCCCchhHHHHHHHHHHHHhCCCCC
Q 002121 797 LD-PEYYMTQQLTEKSDVYSFGVVMLELITAKQPI 830 (964)
Q Consensus 797 ~a-PE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~ 830 (964)
.. |+.... .....+.|++|+++|++.+|..++
T Consensus 255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 12 222111 122368999999999999998775
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.86 E-value=1.6e-07 Score=105.90 Aligned_cols=295 Identities=11% Similarity=0.093 Sum_probs=174.5
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
.+++.+.+.. +++.+-..+|.++++|+.++|..+ +...-..+|.+. +|+.+.+..+ ++..-..+|.. .+|+.++
T Consensus 46 ~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~--v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~ 119 (379)
T 4h09_A 46 DRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST--VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFE 119 (379)
T ss_dssp GGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT--CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEE
T ss_pred cCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc--ceEechhhhcCC-CCceEECCce-eeEeccceecc-CCccccc
Confidence 3566666653 455444556777777777777543 443444455554 4555555432 44222233433 4677777
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCccccccc-----------cccc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTIS-----------EQLF 212 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~-----------~~~f 212 (964)
+..+... .....|.+. +|+.+.+..+ ++ .+....+....+++.+.+..+....... ...|
T Consensus 120 lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~------~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (379)
T 4h09_A 120 FPGATTE-IGNYIFYNS-SVKRIVIPKS-VT------TIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESY 190 (379)
T ss_dssp CCTTCCE-ECTTTTTTC-CCCEEEECTT-CC------EECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEEC
T ss_pred CCCcccc-ccccccccc-eeeeeeccce-ee------ccccchhcccccccccccccccceeecccceecccccceeccc
Confidence 7654322 333344433 4444444332 11 1222345566666666655443321100 1112
Q ss_pred CCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCE
Q 002121 213 SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSY 291 (964)
Q Consensus 213 ~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~ 291 (964)
.....+..+.+..+ ........+....+|+.+.+..+ ++......|.++.+|+.+.+..+ ++.+.. .+.++.+|+.
T Consensus 191 ~~~~~~~~~~~~~~-~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~ 267 (379)
T 4h09_A 191 PAAKTGTEFTIPST-VKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKT 267 (379)
T ss_dssp CTTCCCSEEECCTT-CCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCE
T ss_pred cccccccccccccc-eeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcc
Confidence 23333444443332 22244455667777888877655 44355667888888888888765 554444 3777888888
Q ss_pred EEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCc
Q 002121 292 VDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQ 371 (964)
Q Consensus 292 L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 371 (964)
+.+..+ +. ......|.++++|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+...+|.++.+|+.+.|..+
T Consensus 268 i~l~~~-i~-~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~- 343 (379)
T 4h09_A 268 LNFYAK-VK-TVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS- 343 (379)
T ss_dssp EEECCC-CS-EECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-
T ss_pred cccccc-ce-eccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-
Confidence 888654 43 555667888888888888888888777788888888888888754 77777788888888888888655
Q ss_pred ceeeccCCC
Q 002121 372 ISAITLGSG 380 (964)
Q Consensus 372 l~~i~~~~~ 380 (964)
++.|....+
T Consensus 344 v~~I~~~aF 352 (379)
T 4h09_A 344 ITLIESGAF 352 (379)
T ss_dssp CCEECTTTT
T ss_pred cCEEchhHh
Confidence 666654443
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=2.6e-10 Score=127.22 Aligned_cols=82 Identities=15% Similarity=0.210 Sum_probs=44.4
Q ss_pred CcceeEEEccCCcCcccCCccc---CCCCCCcEEEcccCcCccc----cCccccCCCCCCeeeccCccCccCCCC-CCC-
Q 002121 215 DMVLIHVLFDGNQLSGNIPESL---GYVQTLEVLRLDRNALTGK----VPTNLNNLTNVNELNLAHNDLKGPFPD-LSQ- 285 (964)
Q Consensus 215 ~~~L~~L~l~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~- 285 (964)
+++|+.|.|.+|++.+..+..+ ..+++|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-. +..
T Consensus 251 ~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~a 330 (362)
T 2ra8_A 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330 (362)
T ss_dssp CTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHH
T ss_pred CCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHH
Confidence 4556666665555553322222 2356777777777777643 333334567777777777776542211 111
Q ss_pred CCCCCEEEccCCC
Q 002121 286 MNSLSYVDLSNNS 298 (964)
Q Consensus 286 l~~L~~L~Ls~N~ 298 (964)
+ ...+++++|+
T Consensus 331 l--g~~~~~~~~~ 341 (362)
T 2ra8_A 331 L--PMKIDVSDSQ 341 (362)
T ss_dssp C--CSEEECCSBC
T ss_pred c--CCEEEecCCc
Confidence 1 3456777766
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.71 E-value=7.4e-07 Score=100.38 Aligned_cols=284 Identities=12% Similarity=0.020 Sum_probs=191.6
Q ss_pred CcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccc
Q 002121 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQ 162 (964)
Q Consensus 83 ~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 162 (964)
.+....+|+.+.+..+ ++..-..+|.++.+|+.+.|..+ ++..-..+|.+. +|+.+.+..+ ++.....+|.+ .+
T Consensus 41 ~~~~~~~i~~v~ip~~--vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~ 114 (379)
T 4h09_A 41 WYKDRDRISEVRVNSG--ITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD 114 (379)
T ss_dssp TGGGGGGCSEEEECTT--EEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred ccccccCCEEEEeCCC--ccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence 4556677888888654 55555667888888888888654 664445567665 6777777544 44344445554 47
Q ss_pred cccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcc------------
Q 002121 163 LYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG------------ 230 (964)
Q Consensus 163 L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~------------ 230 (964)
|+.+.+..+-.. +. ...+... +|+.+.+..+ ++ .+....|.....+..+.+..+....
T Consensus 115 L~~i~lp~~~~~--i~-----~~~F~~~-~l~~~~~~~~-v~-~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 184 (379)
T 4h09_A 115 LDDFEFPGATTE--IG-----NYIFYNS-SVKRIVIPKS-VT-TIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNK 184 (379)
T ss_dssp CSEEECCTTCCE--EC-----TTTTTTC-CCCEEEECTT-CC-EECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTS
T ss_pred cccccCCCcccc--cc-----ccccccc-eeeeeeccce-ee-ccccchhcccccccccccccccceeecccceeccccc
Confidence 888887655321 22 1233332 4555555433 33 5666677777777777665544321
Q ss_pred cCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCC-CCCCCCCCCEEEccCCCCCCCCCCcccC
Q 002121 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP-DLSQMNSLSYVDLSNNSFDPTEAPLWFS 309 (964)
Q Consensus 231 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 309 (964)
.....+.....+..+.+..+.-. .....+..+.+|+.+.+..+ ++.+.. .+.++..|+.+.+..+ ++ .+....|.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~-~I~~~aF~ 260 (379)
T 4h09_A 185 TILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VT-SIGSFLLQ 260 (379)
T ss_dssp SEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CC-EECTTTTT
T ss_pred ceeccccccccccccccccceeE-Eeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-cc-EeCccccc
Confidence 11223444555666665544333 55667788889999988765 333333 4788899999999876 44 56677899
Q ss_pred CCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcc---ccee
Q 002121 310 TLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIK---NYTL 386 (964)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~---l~~l 386 (964)
++.+|+.+.+..+ ++......|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|.++ ++.|....+.. ++.+
T Consensus 261 ~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i 338 (379)
T 4h09_A 261 NCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTI 338 (379)
T ss_dssp TCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCC
T ss_pred eeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEE
Confidence 9999999999654 66677788999999999999999999999999999999999999765 88887665543 4455
Q ss_pred Ee
Q 002121 387 IL 388 (964)
Q Consensus 387 ~l 388 (964)
.+
T Consensus 339 ~i 340 (379)
T 4h09_A 339 SY 340 (379)
T ss_dssp CC
T ss_pred EE
Confidence 44
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.68 E-value=2.6e-09 Score=119.07 Aligned_cols=34 Identities=24% Similarity=0.315 Sum_probs=16.7
Q ss_pred CCCCcEEEcccCcCccccCcccc--CCCCCCeeecc
Q 002121 239 VQTLEVLRLDRNALTGKVPTNLN--NLTNVNELNLA 272 (964)
Q Consensus 239 l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls 272 (964)
+++|+.|+|..|.++......++ .+++|++|+|+
T Consensus 192 ~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~ 227 (362)
T 2ra8_A 192 RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227 (362)
T ss_dssp CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEE
T ss_pred CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEe
Confidence 45555555555555432222332 45555555553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.64 E-value=2.8e-10 Score=120.48 Aligned_cols=147 Identities=16% Similarity=0.165 Sum_probs=92.3
Q ss_pred CCCCCccEEecCC--CeeEEEcCC---CCccccccC-CcCCCCcccEEecccCCCCCCCCC-CCCCCcccchh--hcccc
Q 002121 52 PCGSWEGVTCNNS--RVTALGLST---MGLTGKLSG-DIGGLTELRSLDLSYNGGLTGSLS-PRIGDLQKLNI--LILAG 122 (964)
Q Consensus 52 ~C~~w~gv~C~~~--~v~~L~L~~---~~l~g~~~~-~l~~l~~L~~L~L~~N~~l~~~~p-~~l~~l~~L~~--L~L~~ 122 (964)
.| +|.|+.|... +|+.+...+ ..+.+.+.+ .+..++. .|...+| ...+.+. ..|...+.|+. ++++.
T Consensus 77 l~-~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn-~~~~~LdLs~l~~dp~L~~~~l~l~~ 152 (267)
T 3rw6_A 77 LK-AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYD-GSQQALDLKGLRSDPDLVAQNIDVVL 152 (267)
T ss_dssp HH-HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEE-TTTTEEECTTGGGCHHHHHTTCCCCT
T ss_pred HH-hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccc-hhccccCHHHcCCCcchhhcCccccC
Confidence 35 7999999754 777766655 334444432 2223332 3445555 3333333 23666677777 77788
Q ss_pred cccc---CcCCcccCCCCCccEEEcccCcccC--cCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeE
Q 002121 123 CGFT---GNIPDEIGNLAELSFLALNSNNFSG--RIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFH 197 (964)
Q Consensus 123 n~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~ 197 (964)
|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. . ....+..+ +|++|+
T Consensus 153 N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~-~----~l~~l~~l-~L~~L~ 226 (267)
T 3rw6_A 153 NRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE-R----ELDKIKGL-KLEELW 226 (267)
T ss_dssp TSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG-G----GGGGGTTS-CCSEEE
T ss_pred CHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc-h----hhhhcccC-CcceEE
Confidence 8543 2223233568899999999999997 4566777899999999999999842 1 01222333 777777
Q ss_pred ccCCccccccc
Q 002121 198 FNKNKLSGTIS 208 (964)
Q Consensus 198 L~~N~l~g~l~ 208 (964)
|++|.+.+.+|
T Consensus 227 L~~Npl~~~~~ 237 (267)
T 3rw6_A 227 LDGNSLCDTFR 237 (267)
T ss_dssp CTTSTTGGGCS
T ss_pred ccCCcCccccC
Confidence 77777765544
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.6e-06 Score=94.51 Aligned_cols=136 Identities=21% Similarity=0.224 Sum_probs=95.4
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCC---CccceeEEEE-eeCceEEEEEeccC
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHK---NLVGLVGFCF-EQGEQMLVYEFMAN 707 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lV~E~~~~ 707 (964)
.+.++.|....||+. |..++||+... ......+.+|+++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999987 56788888532 22345789999999999753 2556666664 34567899999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-------------------------------------------
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL------------------------------------------- 744 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 744 (964)
..+.+.... .++..++..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 98 QILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp EECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred eECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 888763211 134445555556666666655542
Q ss_pred --------------CCCCeeccCCCCCcEEECC---CCc-EEEeeccccee
Q 002121 745 --------------ANPPIIHRDVKSTNILLDE---NLT-AKVADFGLSKL 777 (964)
Q Consensus 745 --------------~~~~ivH~Dlk~~NILl~~---~~~-~kl~DFGla~~ 777 (964)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234699999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=1.6e-06 Score=92.51 Aligned_cols=136 Identities=18% Similarity=0.163 Sum_probs=98.7
Q ss_pred ceeecCCcE-EEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCceEEEEEeccCCC
Q 002121 633 NEIGSGGYG-KVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 633 ~~lG~G~fg-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
+.+..|..| .||+.... ++..++||+.... ....+.+|.++|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556665 69988754 4678999986532 3346889999999885 3336688999998899999999999988
Q ss_pred hhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC--------------------------------------------
Q 002121 710 LRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA-------------------------------------------- 745 (964)
Q Consensus 710 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-------------------------------------------- 745 (964)
+.+.... .......++.++++.|+-||+..
T Consensus 107 ~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8765432 12233456666677777777421
Q ss_pred -----------CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 746 -----------NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 746 -----------~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12378999999999999887778999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=1.5e-06 Score=97.02 Aligned_cols=80 Identities=8% Similarity=0.048 Sum_probs=57.3
Q ss_pred cee-ecCCcEEEEEEEec-------CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcC-C--CCccceeEEEEee---
Q 002121 633 NEI-GSGGYGKVYRGMLS-------DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVH-H--KNLVGLVGFCFEQ--- 695 (964)
Q Consensus 633 ~~l-G~G~fg~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~--- 695 (964)
+.| +.|....+|+.... +++.+++|+..... ......+.+|+++++.+. + -.+.++++++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78888999998764 26788999865432 111246789999999885 3 3466788887654
Q ss_pred CceEEEEEeccCCChhh
Q 002121 696 GEQMLVYEFMANGTLRE 712 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~ 712 (964)
+..++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.22 E-value=1.3e-07 Score=95.09 Aligned_cols=66 Identities=17% Similarity=0.190 Sum_probs=31.4
Q ss_pred ccCCCCCCcEEEcccC-cCcc----ccCccccCCCCCCeeeccCccCccCCC-----CCCCCCCCCEEEccCCCCC
Q 002121 235 SLGYVQTLEVLRLDRN-ALTG----KVPTNLNNLTNVNELNLAHNDLKGPFP-----DLSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 235 ~~~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~ 300 (964)
.+...++|+.|+|++| .|.. .+...+...++|++|+|++|.|..... .+...++|++|+|++|.|+
T Consensus 31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 3444555666666665 5542 233344445555555555555543111 1233344555555555553
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.20 E-value=6e-08 Score=102.61 Aligned_cols=43 Identities=28% Similarity=0.361 Sum_probs=27.4
Q ss_pred CCCCCCcEEEcccCcCcc--ccCccccCCCCCCeeeccCccCccC
Q 002121 237 GYVQTLEVLRLDRNALTG--KVPTNLNNLTNVNELNLAHNDLKGP 279 (964)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~ 279 (964)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++.
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~ 211 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE 211 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence 345667777777777765 3445556666666666666666654
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.19 E-value=1e-07 Score=95.73 Aligned_cols=120 Identities=13% Similarity=0.153 Sum_probs=91.9
Q ss_pred ccCccccCCCCCCeeeccCc-cCccCC-----CCCCCCCCCCEEEccCCCCCCC---CCCcccCCCCCCcEEECCCCccc
Q 002121 255 KVPTNLNNLTNVNELNLAHN-DLKGPF-----PDLSQMNSLSYVDLSNNSFDPT---EAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 255 ~~p~~~~~l~~L~~L~Ls~N-~l~~~~-----~~l~~l~~L~~L~Ls~N~l~~~---~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
.+...+...+.|++|+|++| .|.... ..+...++|++|+|++|.|+.. .+...+...++|++|+|++|.|.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 45566778899999999999 887532 2367788999999999999621 12334556688999999999998
Q ss_pred cc----cChhccCCCCCCEEEc--CCcccccccC----CCCccCCCCcEEeccCCccee
Q 002121 326 GR----VPDKLFSYSQIQQVKL--RNNAFNNTLD----MGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 326 ~~----~p~~~~~l~~L~~L~L--~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~ 374 (964)
.. +...+...+.|++|+| ++|.|..... ..+...+.|+.|+|++|.+..
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~ 165 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP 165 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence 65 4566777889999999 8899986533 344455889999999998864
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2.5e-05 Score=88.44 Aligned_cols=75 Identities=20% Similarity=0.131 Sum_probs=50.6
Q ss_pred cceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-------chhHHHHHHHHHHHhcCC--CCcc-ceeEEEEeeCceEE
Q 002121 632 SNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-------QGGLEFKTEIELLSRVHH--KNLV-GLVGFCFEQGEQML 700 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~nIv-~l~~~~~~~~~~~l 700 (964)
.+.||.|.++.||++... +++.++||....... ....++..|+++++.+.+ +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 468899998653211 123457889999988843 3444 45543 4456789
Q ss_pred EEEeccCC
Q 002121 701 VYEFMANG 708 (964)
Q Consensus 701 V~E~~~~g 708 (964)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=2.3e-05 Score=86.60 Aligned_cols=139 Identities=17% Similarity=0.213 Sum_probs=81.8
Q ss_pred ceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCC--CCccceeE------EEEeeCceEEEEEe
Q 002121 633 NEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH--KNLVGLVG------FCFEQGEQMLVYEF 704 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~------~~~~~~~~~lV~E~ 704 (964)
+.|+.|..+.||+....+| .+++|+.... ..++..|+++++.+.. -.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999988655 4899988752 2344556666666631 12333432 12345667999999
Q ss_pred ccCCChh--------------hhhcCC--C---C-------CccchHHHH------------------------------
Q 002121 705 MANGTLR--------------ESLSGR--S---G-------IHLDWKRRL------------------------------ 728 (964)
Q Consensus 705 ~~~gsL~--------------~~l~~~--~---~-------~~l~~~~~~------------------------------ 728 (964)
++|..+. ..+|.. . . ..-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 111210 0 0 001232210
Q ss_pred -HHHHHHHHHHHHHhh----------cCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 729 -RIALGSARGLAYLHE----------LANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 729 -~i~~~ia~gL~yLH~----------~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
.+...+..++++|+. .....++|||+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111223446677763 124569999999999999888899999999775
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.90 E-value=5.1e-05 Score=82.45 Aligned_cols=137 Identities=18% Similarity=0.199 Sum_probs=92.7
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC---CCCccceeEEEEeeCceEEEEEeccCC
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH---HKNLVGLVGFCFEQGEQMLVYEFMANG 708 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lV~E~~~~g 708 (964)
.+.|+.|....+|+... ++..++||+.... ....+..|++.|+.+. ...+.++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4678889987642 2456889999999884 356788999888778899999999987
Q ss_pred Chhh-----------hhcCCCC-C-------------------ccchHHHH-----HHHHH--------------HH-HH
Q 002121 709 TLRE-----------SLSGRSG-I-------------------HLDWKRRL-----RIALG--------------SA-RG 737 (964)
Q Consensus 709 sL~~-----------~l~~~~~-~-------------------~l~~~~~~-----~i~~~--------------ia-~g 737 (964)
.+.. .||.... . .-+|.+.. .-..+ +. ..
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 2232211 0 11454322 11111 11 11
Q ss_pred HHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 738 LAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 738 L~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
...|.. ...+.++|+|+.+.|++++.++ +.|.||+
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2356799999999999999887 8899974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.87 E-value=4.7e-05 Score=82.02 Aligned_cols=78 Identities=18% Similarity=0.218 Sum_probs=58.0
Q ss_pred CCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCC---CccceeEEEEeeCceEEEEEec
Q 002121 629 FSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHK---NLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 629 ~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
....+.+|.|..+.||+.+..+|+.|+||+...........|..|++.|+.+.-. -+.+++++ +..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEee
Confidence 3445789999999999999999999999987655444445688999999988522 23444443 3457999999
Q ss_pred cCCCh
Q 002121 706 ANGTL 710 (964)
Q Consensus 706 ~~gsL 710 (964)
+++..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87653
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.85 E-value=2.1e-05 Score=73.68 Aligned_cols=72 Identities=17% Similarity=0.127 Sum_probs=44.6
Q ss_pred CCCEEEcCCcccccccCCCCccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCccccCCCCCcccc
Q 002121 337 QIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYCQLQQPTTKAYS 415 (964)
Q Consensus 337 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~ 415 (964)
+|+.|+|++|+|+.+.+..|..+++|+ .|+|.+|| .|||.+.++..|........ .
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~---------------------~L~L~~NP~~CdC~l~~l~~wl~~~~~~~--~ 88 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALR---------------------TAHLGANPWRCDCRLVPLRAWLAGRPERA--P 88 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCC---------------------EEECCSSCCBCSGGGHHHHHHHHTSSCSG--G
T ss_pred CCCEEECCCCcCCccChhhhhhccccC---------------------EEEecCCCeeccCccHHHHHHHHhCcccc--c
Confidence 345555555555554444444444444 45566777 79999999999965443322 1
Q ss_pred cccccCCCCCCCCCCC
Q 002121 416 TSLANCGGKSCPPEQK 431 (964)
Q Consensus 416 ~~~~~c~~~~~~~~~~ 431 (964)
.....|.+|+-..++.
T Consensus 89 ~~~~~C~~P~~l~g~~ 104 (130)
T 3rfe_A 89 YRDLRCVAPPALRGRL 104 (130)
T ss_dssp GTTCBCCBSTTTTTCB
T ss_pred ccCcEeCcChHHcCCC
Confidence 3567899988777763
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00035 Score=76.26 Aligned_cols=159 Identities=14% Similarity=0.093 Sum_probs=93.8
Q ss_pred cccHHHHHHhhcCCCc-----cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc--cce
Q 002121 616 WFSYDELKKCSNNFSE-----SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL--VGL 688 (964)
Q Consensus 616 ~~~~~el~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI--v~l 688 (964)
.++.+++......|.. .+.|+.|....+|+....+| .+++|+..... ...++..|++++..+....+ .++
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~ 82 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP 82 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 3667777777777765 24566788899999988666 68899887531 22356778888888753222 333
Q ss_pred eEE------EEeeCceEEEEEeccCCChhh--------------hhcCC----CCC------ccchHHHHHH--------
Q 002121 689 VGF------CFEQGEQMLVYEFMANGTLRE--------------SLSGR----SGI------HLDWKRRLRI-------- 730 (964)
Q Consensus 689 ~~~------~~~~~~~~lV~E~~~~gsL~~--------------~l~~~----~~~------~l~~~~~~~i-------- 730 (964)
+.. ....+..++||||++|..+.. .+|.. ... ...|.....-
T Consensus 83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~ 162 (322)
T 2ppq_A 83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV 162 (322)
T ss_dssp CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence 321 122356789999999865421 11211 000 1134331111
Q ss_pred ----HHHHHHHHHHHhhc----CCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 731 ----ALGSARGLAYLHEL----ANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 731 ----~~~ia~gL~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
...+.+.++++++. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 11234456666532 234589999999999999876668999987753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00019 Score=81.78 Aligned_cols=77 Identities=14% Similarity=0.133 Sum_probs=48.2
Q ss_pred CCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccc--cCcccCccccccC---CCCCchhHHHHHHHH
Q 002121 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG--TMGYLDPEYYMTQ---QLTEKSDVYSFGVVM 820 (964)
Q Consensus 746 ~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~sDv~S~Gvvl 820 (964)
.+.++|||+++.|||++.++ ++|+||+.+..-+..-. ...... ...|++|+..... ......++......+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D---la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD---IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH---HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH---HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45599999999999999876 99999999875432100 000011 1346666655321 112345566778888
Q ss_pred HHHHhC
Q 002121 821 LELITA 826 (964)
Q Consensus 821 ~elltg 826 (964)
|+.+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0021 Score=70.16 Aligned_cols=157 Identities=11% Similarity=0.091 Sum_probs=91.7
Q ss_pred ccHHHHHHhhcCCCc-----cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCC--cccee
Q 002121 617 FSYDELKKCSNNFSE-----SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN--LVGLV 689 (964)
Q Consensus 617 ~~~~el~~~~~~~~~-----~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~ 689 (964)
++.+++..+...|.. ...++ |....||+....+|+.+++|+...... ....+..|..+++.+.... +.+++
T Consensus 11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~ 88 (328)
T 1zyl_A 11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV 88 (328)
T ss_dssp CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence 555666655544432 34566 888899998887788899999864322 2346778888888885322 34444
Q ss_pred EE-----EEeeCceEEEEEeccCCChhh--------------hhcC----CC---CCccchHHH----HHHH--------
Q 002121 690 GF-----CFEQGEQMLVYEFMANGTLRE--------------SLSG----RS---GIHLDWKRR----LRIA-------- 731 (964)
Q Consensus 690 ~~-----~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~~---~~~l~~~~~----~~i~-------- 731 (964)
.. ....+..++||||++|..+.. .+|. .. ....++... ..+.
T Consensus 89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 168 (328)
T 1zyl_A 89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS 168 (328)
T ss_dssp CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence 43 122445678999998754321 0111 00 011222211 0011
Q ss_pred -------HHHHHHHHHHhhc----CCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 732 -------LGSARGLAYLHEL----ANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 732 -------~~ia~gL~yLH~~----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
..+.+.++.+.+. ....++|||+++.|||++ + .+.|+||+.+..
T Consensus 169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1111223333221 234578999999999999 4 899999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.001 Score=71.86 Aligned_cols=138 Identities=14% Similarity=0.143 Sum_probs=77.9
Q ss_pred cceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCcc-ceeEEEEeeCceEEEEEec-cCCC
Q 002121 632 SNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV-GLVGFCFEQGEQMLVYEFM-ANGT 709 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~E~~-~~gs 709 (964)
.+.|+.|....+|+. +.+++|+....... .....+|+.+++.+....+. +++++ +.+.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 577999999999998 56888987653211 12346788888888544444 55543 344568999999 5544
Q ss_pred hhh------------------hhcCCCC---Cccc-hHHHHHHHHH--------------HHHHH----HHHhh-cCCCC
Q 002121 710 LRE------------------SLSGRSG---IHLD-WKRRLRIALG--------------SARGL----AYLHE-LANPP 748 (964)
Q Consensus 710 L~~------------------~l~~~~~---~~l~-~~~~~~i~~~--------------ia~gL----~yLH~-~~~~~ 748 (964)
+.. .+|.... ...+ +.+...+... +.+.+ +.+.. .....
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 421 1122110 0001 1111111000 11111 11111 12344
Q ss_pred eeccCCCCCcEEECCCCcEEEeecccceee
Q 002121 749 IIHRDVKSTNILLDENLTAKVADFGLSKLV 778 (964)
Q Consensus 749 ivH~Dlk~~NILl~~~~~~kl~DFGla~~~ 778 (964)
++|+|+.+.||+ ..++.+.++||..+..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 799999999999 56678899999987653
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.35 E-value=5.9e-05 Score=73.94 Aligned_cols=81 Identities=6% Similarity=-0.004 Sum_probs=40.7
Q ss_pred CCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCc-cccccChhccCC----CCCCEEEcCCcc-cccccCCCCccCCCC
Q 002121 289 LSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGS-LQGRVPDKLFSY----SQIQQVKLRNNA-FNNTLDMGNAVGPLL 362 (964)
Q Consensus 289 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~L~~N~-l~~~~~~~~~~l~~L 362 (964)
|+.|||+++.++ ...-..+.++++|+.|+|++|. |+..--..+..+ ++|+.|+|++|. +++..-..+..+++|
T Consensus 63 L~~LDLs~~~It-d~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 63 IQAIDATDSCIM-SIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp EEEEEEESCCCC-GGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred EeEEeCcCCCcc-HHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 444444444443 2222234455555555555553 444444444443 246666666653 555444445556666
Q ss_pred cEEeccCC
Q 002121 363 QLVDLQNN 370 (964)
Q Consensus 363 ~~L~L~~N 370 (964)
+.|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666665
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.30 E-value=3.3e-05 Score=75.78 Aligned_cols=83 Identities=14% Similarity=0.215 Sum_probs=40.9
Q ss_pred CeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCc----ccchhhcccccc-ccCcCCcccCCCCCc
Q 002121 65 RVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDL----QKLNILILAGCG-FTGNIPDEIGNLAEL 139 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l----~~L~~L~L~~n~-l~~~~p~~~~~l~~L 139 (964)
+++.|||+++.++..--..+..+++|++|+|+++..++..--..++.+ ++|++|+|++|. |+..--..+.++++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 566677766666554444456666666666666643443332233332 235555555542 443222233444444
Q ss_pred cEEEcccC
Q 002121 140 SFLALNSN 147 (964)
Q Consensus 140 ~~L~Ls~N 147 (964)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 44444443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00074 Score=74.14 Aligned_cols=141 Identities=13% Similarity=0.093 Sum_probs=75.0
Q ss_pred ceeecCCcEE-EEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCC--ccceeEEEEeeCceEEEEEeccCCC
Q 002121 633 NEIGSGGYGK-VYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN--LVGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 633 ~~lG~G~fg~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
+.|+.|+... +|+....+|+.+++|....... ..+..|+++++.+.... +.+++.+..+ .-++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 4565565554 6677664467788876543221 34567788888775323 4566665332 2378999997766
Q ss_pred hhhhhcC---------------------CCC---CccchHHHH-------H-------------HHHHHHHHHHHHh---
Q 002121 710 LRESLSG---------------------RSG---IHLDWKRRL-------R-------------IALGSARGLAYLH--- 742 (964)
Q Consensus 710 L~~~l~~---------------------~~~---~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 742 (964)
+.+++.. ... ..++..... . ....+...++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6543321 110 011110000 0 0011112222221
Q ss_pred hcCCCCeeccCCCCCcEEECCC----CcEEEeecccceee
Q 002121 743 ELANPPIIHRDVKSTNILLDEN----LTAKVADFGLSKLV 778 (964)
Q Consensus 743 ~~~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~~ 778 (964)
....+.++|||+.+.|||++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123568999999999999875 68999999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.21 E-value=0.00082 Score=76.53 Aligned_cols=73 Identities=15% Similarity=0.156 Sum_probs=51.1
Q ss_pred cceeecCCcEEEEEEEecC--------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc-cceeEEEEeeCceEEEE
Q 002121 632 SNEIGSGGYGKVYRGMLSD--------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL-VGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~ 702 (964)
.+.|+.|....||+....+ ++.+++|+..... ....+.+|..+++.+...++ .++++.+.+ .+||
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998753 5789999985421 11456689999998864444 566665532 3899
Q ss_pred EeccCCCh
Q 002121 703 EFMANGTL 710 (964)
Q Consensus 703 E~~~~gsL 710 (964)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0027 Score=70.68 Aligned_cols=140 Identities=17% Similarity=0.181 Sum_probs=83.8
Q ss_pred ceeecCCcEEEEEEEec--------CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc-cceeEEEEeeCceEEEEE
Q 002121 633 NEIGSGGYGKVYRGMLS--------DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL-VGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E 703 (964)
+.+..|-...+|+.... +++.+++|+.... ......+.+|.++++.+.-..+ .++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45666777889998875 2578999986432 2234567789999998853333 466666543 39999
Q ss_pred eccCCChhh-----------------hhcCCC---CCcc--chHHHHHHHHHHHH-------------------HHHHHh
Q 002121 704 FMANGTLRE-----------------SLSGRS---GIHL--DWKRRLRIALGSAR-------------------GLAYLH 742 (964)
Q Consensus 704 ~~~~gsL~~-----------------~l~~~~---~~~l--~~~~~~~i~~~ia~-------------------gL~yLH 742 (964)
|++|..|.. .||... +... -|.++.++..++.. .++.|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999765531 112211 1112 24455555443321 233332
Q ss_pred ----hc-CCCCeeccCCCCCcEEECCC----CcEEEeeccccee
Q 002121 743 ----EL-ANPPIIHRDVKSTNILLDEN----LTAKVADFGLSKL 777 (964)
Q Consensus 743 ----~~-~~~~ivH~Dlk~~NILl~~~----~~~kl~DFGla~~ 777 (964)
.. ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23457899999999999876 7899999998764
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00013 Score=72.88 Aligned_cols=18 Identities=17% Similarity=0.350 Sum_probs=8.0
Q ss_pred ccCCCCCCeeeccCccCc
Q 002121 260 LNNLTNVNELNLAHNDLK 277 (964)
Q Consensus 260 ~~~l~~L~~L~Ls~N~l~ 277 (964)
+..-+.|+.|+|++|.|.
T Consensus 66 L~~N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 66 ACNSKHIEKFSLANTAIS 83 (197)
T ss_dssp HTTCSCCCEEECTTSCCB
T ss_pred HhhCCCcCEEEccCCCCC
Confidence 333444444444444443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0019 Score=71.95 Aligned_cols=73 Identities=14% Similarity=0.124 Sum_probs=46.0
Q ss_pred ceeecCCcEEEEEEEecC---------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCcc-ceeEEEEeeCceEEEE
Q 002121 633 NEIGSGGYGKVYRGMLSD---------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV-GLVGFCFEQGEQMLVY 702 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ 702 (964)
+.++.|....+|+....+ ++.+++|+..... ........|.++++.+...+++ ++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 567778888999998754 2688999875432 1112346888999888644443 666543 237899
Q ss_pred EeccCCCh
Q 002121 703 EFMANGTL 710 (964)
Q Consensus 703 E~~~~gsL 710 (964)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.88 E-value=0.0046 Score=70.75 Aligned_cols=74 Identities=15% Similarity=0.039 Sum_probs=49.4
Q ss_pred cceeecCCcEEEEEEEecC-CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc-cceeEEEEeeCceEEEEEeccCCC
Q 002121 632 SNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL-VGLVGFCFEQGEQMLVYEFMANGT 709 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E~~~~gs 709 (964)
.+.|+.|-...+|+....+ +..+++|+..... .......+|..+++.+...++ .++++++. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3568888889999999865 5788999875432 111223689999999975555 46676662 2 35999998755
Q ss_pred h
Q 002121 710 L 710 (964)
Q Consensus 710 L 710 (964)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.00021 Score=71.30 Aligned_cols=116 Identities=16% Similarity=0.149 Sum_probs=75.3
Q ss_pred ccccCCCCCCeeeccCc-cCccC-----CCCCCCCCCCCEEEccCCCCC---CCCCCcccCCCCCCcEEECCCCccccc-
Q 002121 258 TNLNNLTNVNELNLAHN-DLKGP-----FPDLSQMNSLSYVDLSNNSFD---PTEAPLWFSTLPSLTTLICEFGSLQGR- 327 (964)
Q Consensus 258 ~~~~~l~~L~~L~Ls~N-~l~~~-----~~~l~~l~~L~~L~Ls~N~l~---~~~~~~~~~~l~~L~~L~Ls~N~l~~~- 327 (964)
..+.+-+.|++|+|++| .|... ...+...+.|+.|+|++|.|. ...+...+..-+.|+.|+|+.|.|...
T Consensus 35 ~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~G 114 (197)
T 1pgv_A 35 RLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPEL 114 (197)
T ss_dssp HHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHH
T ss_pred HHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHH
Confidence 34455567777777774 66432 123667788999999999996 222233344567899999999998865
Q ss_pred ---cChhccCCCCCCEEEcCCcc---cccc----cCCCCccCCCCcEEeccCCcce
Q 002121 328 ---VPDKLFSYSQIQQVKLRNNA---FNNT----LDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 328 ---~p~~~~~l~~L~~L~L~~N~---l~~~----~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
+.+.+..-+.|+.|+|++|. +... +...+..-+.|+.|+|+.|.+.
T Consensus 115 a~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 115 LARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 33455666778889988653 3322 2233445567888888776543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.0066 Score=66.71 Aligned_cols=66 Identities=11% Similarity=0.067 Sum_probs=43.8
Q ss_pred CCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCC---CCccceeEE------EEeeCceEEEEEeccCC
Q 002121 638 GGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH---KNLVGLVGF------CFEQGEQMLVYEFMANG 708 (964)
Q Consensus 638 G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~------~~~~~~~~lV~E~~~~g 708 (964)
|....||+....+| .+++|+...... ..|+++++.+.. |.+.+++.. ....+..++||||++|.
T Consensus 34 g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 34 DTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp CSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 33679999998777 899998765432 356666666632 224455432 23346779999999987
Q ss_pred Ch
Q 002121 709 TL 710 (964)
Q Consensus 709 sL 710 (964)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.21 E-value=0.006 Score=56.74 Aligned_cols=36 Identities=28% Similarity=0.416 Sum_probs=20.0
Q ss_pred CCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCC
Q 002121 265 NVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 265 ~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~ 300 (964)
+|++|+|++|+|+.+++. |..+++|+.|+|++|++.
T Consensus 32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 355555555555554443 455556666666666664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=95.82 E-value=0.078 Score=53.14 Aligned_cols=103 Identities=14% Similarity=0.099 Sum_probs=66.9
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCcee
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 787 (964)
-+|.+.|...+ .++++++++.++.|.+.+|.-+-....+ ..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence 37889887654 6899999999999999988766211111 1233456899999999988764 1111
Q ss_pred ecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCC
Q 002121 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829 (964)
Q Consensus 788 ~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p 829 (964)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0123467888763 3456788999999999998874444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.19 E-value=0.11 Score=58.58 Aligned_cols=139 Identities=15% Similarity=0.166 Sum_probs=84.9
Q ss_pred ceeecCCcEEEEEEEecC--------CcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCc-cceeEEEEeeCceEEEEE
Q 002121 633 NEIGSGGYGKVYRGMLSD--------GQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL-VGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lV~E 703 (964)
+.+..|-...+|+....+ ++.+++|+..... .......+|.++++.+.-.++ .++++.+ .-++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEEE
Confidence 567677788999998753 5789999865432 222245689999988853344 4555533 2378999
Q ss_pred eccCCChhh-----------------hhcCC-----------CCCccchHHHHHHHHHH-------------------HH
Q 002121 704 FMANGTLRE-----------------SLSGR-----------SGIHLDWKRRLRIALGS-------------------AR 736 (964)
Q Consensus 704 ~~~~gsL~~-----------------~l~~~-----------~~~~l~~~~~~~i~~~i-------------------a~ 736 (964)
|++|..|.. .+|.. ...+.-|.++.++..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 999866421 01110 11112244433333222 22
Q ss_pred HHHHHhh---------------------cCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 737 GLAYLHE---------------------LANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 737 gL~yLH~---------------------~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.+++|.+ .....++|+|+.+.||+ +.++.+.++||..|..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2333321 11245789999999999 8888999999998864
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=95.16 E-value=0.00057 Score=78.51 Aligned_cols=60 Identities=8% Similarity=0.005 Sum_probs=44.1
Q ss_pred hhHHHHHHHHhCcccc-eEEeecccccCCcceeEEEee-----c--------------CCCcceeeccceeeeeeEeecc
Q 002121 464 HSLEMSLWVKLGLTPG-SVFLQNPFFNIDDYLQIQVAL-----F--------------PSGEKSFNRSEVQKIGFELSNQ 523 (964)
Q Consensus 464 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-----~--------------~~~~~~~~~~~~~~~~~~~~~~ 523 (964)
.+.+++||-+..+.+. ++|||++|+.+.+ ++.+.|+ + +.|+|++|.|+.....+.+|..
T Consensus 13 ~~~~~~ww~~~~~~~~~~g~~P~~~v~~~~-~~~~~wy~~~w~hg~i~r~~ae~lL~~~~G~FLvR~S~~~~g~~~Lsv~ 91 (463)
T 3cxl_A 13 NLYFQGVWKSYLYQLQQEAPHPRRITCTCE-VENRPKYYGREFHGMISREAADQLLIVAEGSYLIRESQRQPGTYTLALR 91 (463)
T ss_dssp -----CCSCCHHHHHHHHSCCCEECCCCCC-CTTCCTTCCTTBCCSCCHHHHHHHHTTSTTEEEEEECSSSTTCEEEEEE
T ss_pred CCCCCCEEEEEecCcCccCCCCcCccCCcc-ccCCCCccccccccCCCHHHHHHHHcCCCCeEEEeccCCCCCCEEEEEE
Confidence 4456889987777765 5899999998764 6677888 3 5799999999988777887765
Q ss_pred e
Q 002121 524 T 524 (964)
Q Consensus 524 ~ 524 (964)
.
T Consensus 92 ~ 92 (463)
T 3cxl_A 92 F 92 (463)
T ss_dssp C
T ss_pred E
Confidence 4
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.47 E-value=0.049 Score=39.17 Aligned_cols=32 Identities=16% Similarity=0.044 Sum_probs=18.1
Q ss_pred CcceeehhHHHHHHHHHHHHHHHHHHhhhhhh
Q 002121 553 SPGVAAGIACGGAVLVLGLVGLGLYAIRQKKR 584 (964)
Q Consensus 553 ~~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~r 584 (964)
..+.|++.+++|+++++++++..++++|+|++
T Consensus 8 ~~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 8 RTPLIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp SSHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred CcceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 34456666666666665555555555555443
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=93.42 E-value=0.05 Score=38.00 Aligned_cols=33 Identities=15% Similarity=0.246 Sum_probs=23.0
Q ss_pred CCCCCcceeehhHHHHHHHHHHHHHHHHHHhhh
Q 002121 549 GNSISPGVAAGIACGGAVLVLGLVGLGLYAIRQ 581 (964)
Q Consensus 549 ~~~~~~~~i~~~~~~~~~~~~~l~~~~~~~~~~ 581 (964)
.++.+.+.|+|++++.++.++++++++++++|+
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 345567888999988877766666666665554
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.69 E-value=0.11 Score=37.46 Aligned_cols=30 Identities=17% Similarity=-0.017 Sum_probs=16.0
Q ss_pred cceeehhHHHHHHHHHHHHHHHHHHhhhhh
Q 002121 554 PGVAAGIACGGAVLVLGLVGLGLYAIRQKK 583 (964)
Q Consensus 554 ~~~i~~~~~~~~~~~~~l~~~~~~~~~~~~ 583 (964)
.+.|++.+++|+++++++++..++++|+|+
T Consensus 10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 10 IPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp SSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 344566666666655555554455554443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.47 E-value=1.1 Score=50.07 Aligned_cols=29 Identities=34% Similarity=0.487 Sum_probs=24.8
Q ss_pred eeccCCCCCcEEE------CCCCcEEEeeccccee
Q 002121 749 IIHRDVKSTNILL------DENLTAKVADFGLSKL 777 (964)
Q Consensus 749 ivH~Dlk~~NILl------~~~~~~kl~DFGla~~ 777 (964)
++|+|+.+.|||+ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 4699999999999 4567899999998764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=87.07 E-value=0.42 Score=34.33 Aligned_cols=9 Identities=11% Similarity=0.099 Sum_probs=5.2
Q ss_pred ceeehhHHH
Q 002121 555 GVAAGIACG 563 (964)
Q Consensus 555 ~~i~~~~~~ 563 (964)
..++++++|
T Consensus 12 ~~Ia~~vVG 20 (44)
T 2jwa_A 12 TSIISAVVG 20 (44)
T ss_dssp HHHHHHHHH
T ss_pred cchHHHHHH
Confidence 345666666
|
| >4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A* | Back alignment and structure |
|---|
Probab=80.10 E-value=0.09 Score=51.45 Aligned_cols=71 Identities=21% Similarity=0.305 Sum_probs=57.6
Q ss_pred CCCCCCCchhHhhHHHHHHHHhCcccc-eEEeecccccCCcceeEEEeec-----------------CCCcceeecccee
Q 002121 453 SFRELSNVTVFHSLEMSLWVKLGLTPG-SVFLQNPFFNIDDYLQIQVALF-----------------PSGEKSFNRSEVQ 514 (964)
Q Consensus 453 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~ 514 (964)
+|++++-+.++.. +.+||....+..+ ++|+|.+|+.+...+..+.|++ +.|+|++|.|+..
T Consensus 30 s~~~Gd~i~v~~~-~~~Ww~~~~~~~g~~G~vP~~yv~~~~~l~~~~w~~g~isr~~ae~lL~~~~~~~G~FLVR~S~~~ 108 (175)
T 4d8k_A 30 GFEKGEQLRILEQ-SGEWWKAQSLTTGQEGFIPFNFVAKANSLEPEPWFFKNLSRKDAERQLLAPGNTHGSFLIRESEST 108 (175)
T ss_dssp CBCTTCEEEEEEC-CSSEEEEEETTTCCEEEEEGGGEEETTCSTTCTTBCSSCCHHHHHHHHHSTTCCTTCEEEEECSSS
T ss_pred ccccCCEEEEEcc-CCCEEEEEECCCCceeeeccccccccccccccceecCcccHHHHHHHHhcCCCCCCEEEEEECCCC
Confidence 5778888888777 6789988876444 6999999999988888888987 4799999999887
Q ss_pred eeeeEeecce
Q 002121 515 KIGFELSNQT 524 (964)
Q Consensus 515 ~~~~~~~~~~ 524 (964)
...+.+|...
T Consensus 109 ~g~y~LSv~~ 118 (175)
T 4d8k_A 109 AGSFSLSVRD 118 (175)
T ss_dssp TTCEEEEEEE
T ss_pred CCeEEEEEEe
Confidence 7777777654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 964 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-74 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-67 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-65 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-60 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-47 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-46 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-43 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-42 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 9e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-32 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 7e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-15 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 2e-74
Identities = 73/281 (25%), Positives = 130/281 (46%), Gaps = 18/281 (6%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+ IGSG +G VY+G V + + Q FK E+ +L + H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
+G+ + +V ++ +L L + + + IA +A+G+ YLH
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH---A 122
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
IIHRD+KS NI L E+LT K+ DFGL+ + S S H Q+ G++ ++ PE Q
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 807 ---LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863
+ +SDVY+FG+V+ EL+T + P ++ + R + P +
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGR---------GYLSPDLS 232
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ L +C+++ +RP +++ +IE L ++
Sbjct: 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (588), Expect = 1e-69
Identities = 76/273 (27%), Positives = 124/273 (45%), Gaps = 20/273 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+G+G +G+V+ G + VA+K +QGSM F E L+ ++ H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLV 71
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L Q ++ E+M NG+L + L SGI L + L +A A G+A++ E
Sbjct: 72 RLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE--- 127
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
IHRD+++ NIL+ + L+ K+ADFGL++L+ D+ K + + PE
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGT 186
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
T KSDV+SFG+++ E++T + G + E L +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPG-----------MTNPEVIQNLERGYRMVRPDNC 235
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
+L C +E DRPT + +E
Sbjct: 236 PEELY---QLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 5e-68
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 26/281 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+ + EIGSG +G V+ G + VAIK ++G+ +F E E++ ++ H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L G C EQ LV+EFM +G L + + L + L G+AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSD-YLRTQRGLFAAETLLGMCLDVCEGMAYLEE--- 119
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+IHRD+ + N L+ EN KV+DFG+++ V D ST K + + PE + +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSR 178
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKY---VVREVRTAMNRDDEEHYGLTEMMDPTIR 863
+ KSDV+SFGV+M E+ + + + + VV ++ T
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAS---------- 228
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
++ C +E DRP S +++ + + ++
Sbjct: 229 -------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 224 bits (572), Expect = 4e-67
Identities = 72/306 (23%), Positives = 135/306 (44%), Gaps = 37/306 (12%)
Query: 617 FSYDELKKCSNNFSES---------NEIGSGGYGKVYRGML----SDGQVVAIKRAQQGS 663
F++++ + F++ IG+G +G+V G L VAIK + G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 664 MQGGL-EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHL 722
+ +F +E ++ + H N++ L G + M++ EFM NG+L L G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125
Query: 723 DWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782
+ + + G A G+ YL + +HRD+ + NIL++ NL KV+DFGLS+ + D +
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 783 KGHVSTQV---KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE 839
T K + + PE ++ T SDV+S+G+VM E+++ +
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY-------- 234
Query: 840 VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF-RRYLELALQCVEESATDRPTMSEVVKAI 898
D + + ++ R + +L L C ++ RP ++V +
Sbjct: 235 -------WDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 899 ETLLQN 904
+ +++N
Sbjct: 288 DKMIRN 293
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (570), Expect = 6e-67
Identities = 77/289 (26%), Positives = 136/289 (47%), Gaps = 22/289 (7%)
Query: 618 SYDELKKCSNNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGLEFKTEIEL 676
+YD+ + + + +++G G YG+VY G+ VA+K ++ +M+ EF E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 66
Query: 677 LSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR 736
+ + H NLV L+G C + ++ EFM G L + L + + L +A +
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
+ YL + IHRD+ + N L+ EN KVADFGLS+L++ + K + +
Sbjct: 127 AMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKW 182
Query: 797 LDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856
PE + + KSDV++FGV++ E+ T G + + E
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG---------------IDLSQVYE 227
Query: 857 MMDPTIRNTVLLGF-RRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+++ R G + EL C + + +DRP+ +E+ +A ET+ Q
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-65
Identities = 67/297 (22%), Positives = 125/297 (42%), Gaps = 28/297 (9%)
Query: 634 EIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCF 693
IG G +G+V+RG G+ VA+K + + EI + H+N++G +
Sbjct: 10 SIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 67
Query: 694 EQGEQ----MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-----L 744
+ LV ++ +G+L + L+ + + + +++AL +A GLA+LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK--GHVSTQVKGTMGYLDPEYY 802
P I HRD+KS NIL+ +N T +AD GL+ ++ GT Y+ PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 803 MTQ------QLTEKSDVYSFGVVMLELITAKQPI----EKGKYVVREVRTAMNRDDEEHY 852
+ +++D+Y+ G+V E+ + V + + ++
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 853 GLTEMMDPTIRNTVLL--GFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907
+ + P I N R ++ +C + R T + K + L Q +G+
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 6e-65
Identities = 78/288 (27%), Positives = 136/288 (47%), Gaps = 20/288 (6%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIEL 676
+ D + + ++G G +G+V+ G + VAIK + G+M F E ++
Sbjct: 7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQV 65
Query: 677 LSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR 736
+ ++ H+ LV L + +V E+M+ G+L + L G +G +L + + +A A
Sbjct: 66 MKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
G+AY+ +HRD+++ NIL+ ENL KVADFGL++L+ D ++ K + +
Sbjct: 125 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 180
Query: 797 LDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856
PE + + T KSDV+SFG+++ EL T + G REV + R G
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVER------GYRM 233
Query: 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
P ++ +L QC + +RPT + +E +
Sbjct: 234 PCPPECPESL-------HDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (553), Expect = 7e-65
Identities = 67/276 (24%), Positives = 115/276 (41%), Gaps = 26/276 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+ + E+G+G +G V G VAIK ++GSM EF E +++ + H+ LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLV 62
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
L G C +Q ++ E+MANG L L ++ L + + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLE---S 118
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
+HRD+ + N L+++ KV+DFGLS+ V D S K + + PE M +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSK 177
Query: 807 LTEKSDVYSFGVVMLELITAKQPIEKGKY---VVREVRTAMNRDDEEHYGLTEMMDPTIR 863
+ KSD+++FGV+M E+ + + + + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS---------- 227
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
+ + C E A +RPT ++ I
Sbjct: 228 -------EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-64
Identities = 66/280 (23%), Positives = 119/280 (42%), Gaps = 26/280 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
IG G +G V G G VA+K + + F E +++++ H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLV 63
Query: 687 GLVGFCFEQGEQM-LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
L+G E+ + +V E+MA G+L + L R L L+ +L + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-- 121
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
+HRD+ + N+L+ E+ AKV+DFGL+K S + K + + PE +
Sbjct: 122 -NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREK 175
Query: 806 QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
+ + KSDV+SFG+++ E+ + + + V + + P +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVY-- 230
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
E+ C A RP+ ++ + +E + ++
Sbjct: 231 ---------EVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 8e-64
Identities = 80/284 (28%), Positives = 127/284 (44%), Gaps = 28/284 (9%)
Query: 628 NFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHH 682
+F+E IG G +G VY G L D A+K + + G + F TE ++ H
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 683 KNLVGLVGFCFE-QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
N++ L+G C +G ++V +M +G LR + + K + L A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLR-NFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS--KGHVSTQVKGTMGYLDP 799
+ +HRD+ + N +LDE T KVADFGL++ + D H T K + ++
Sbjct: 147 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
E TQ+ T KSDV+SFGV++ EL+T P + ++
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--------RLLQ 255
Query: 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
P L E+ L+C A RP+ SE+V I +
Sbjct: 256 PEYCPDPL------YEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 215 bits (548), Expect = 9e-64
Identities = 70/306 (22%), Positives = 121/306 (39%), Gaps = 46/306 (15%)
Query: 627 NNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGL-EFKTEIELLSR 679
NN +IG G +G+V++ +VA+K ++ + +F+ E L++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG-------------------- 719
+ N+V L+G C L++E+MA G L E L S
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 720 --IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777
L +L IA A G+AYL E +HRD+ + N L+ EN+ K+ADFGLS+
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837
+ + + ++ PE + T +SDV+++GVV+ E+ + G
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM--- 246
Query: 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897
D E + N L C + DRP+ + +
Sbjct: 247 AHEEVIYYVRDGNILACPENCPLELYN-----------LMRLCWSKLPADRPSFCSIHRI 295
Query: 898 IETLLQ 903
++ + +
Sbjct: 296 LQRMCE 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-63
Identities = 69/286 (24%), Positives = 132/286 (46%), Gaps = 27/286 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQ-----VVAIKRAQQGSMQGGL-EFKTEIELLSRV 680
+ + IG+G +G+VY+GML VAIK + G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 681 HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
H N++ L G + M++ E+M NG + + + + G A G+ Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQVKGTMGYLDP 799
L N +HRD+ + NIL++ NL KV+DFGLS+++ D + ++ K + + P
Sbjct: 126 LA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 800 EYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859
E ++ T SDV+SFG+VM E++T + + ++ + + ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPY---------------WELSNHEVMKAIN 227
Query: 860 PTIRNTVLLGF-RRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
R + +L +QC ++ RP +++V ++ L++
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 7e-63
Identities = 63/306 (20%), Positives = 121/306 (39%), Gaps = 40/306 (13%)
Query: 621 ELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLS 678
ELK ++F + +E+G+G G V++ G V+A K E+++L
Sbjct: 2 ELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLH 59
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
+ +VG G + GE + E M G+L + L + + ++++ +GL
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
YL E I+HRDVK +NIL++ K+ DFG+S + DS ++ GT Y+
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
PE + +SD++S G+ ++E+ + PI E+ + +
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 859 DPTIRNTVLLGFRRY----------------------------LELALQCVEESATDRPT 890
P + R + +C+ ++ +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 891 MSEVVK 896
+ +++
Sbjct: 292 LKQLMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-62
Identities = 67/284 (23%), Positives = 116/284 (40%), Gaps = 25/284 (8%)
Query: 627 NNFSESN-EIGSGGYGKVYRGML---SDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVH 681
+N ++ E+G G +G V +G+ VAIK +QG+ + E E +++ ++
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
+ +V L+G C + MLV E G L + L G+ + + + G+ YL
Sbjct: 68 NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYL 125
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQVKGTMGYLDPE 800
+HRD+ + N+LL AK++DFGLSK + +D S + K + + PE
Sbjct: 126 E---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 801 YYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860
++ + +SDV+S+GV M E ++ Q K + E P
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECPP 239
Query: 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ L C DRP V + + +
Sbjct: 240 ELY-----------ALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 1e-61
Identities = 68/280 (24%), Positives = 114/280 (40%), Gaps = 26/280 (9%)
Query: 631 ESNEIGSGGYGKVYRGMLSD---GQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNL 685
E E+GSG +G V +G + VA+K + + L E E ++ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
V ++G C E MLV E G L + L H+ K + + + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 746 NPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQVKGTMGYLDPEYYMT 804
+HRD+ + N+LL AK++DFGLSK + +D + T K + + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864
+ + KSDV+SFGV+M E + Q +G + + E G +
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPAGCPREMY- 240
Query: 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+L C +RP + V + +
Sbjct: 241 ----------DLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 2e-61
Identities = 67/301 (22%), Positives = 119/301 (39%), Gaps = 40/301 (13%)
Query: 627 NNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGSMQGGLE-FKTEIELLSR 679
N S +G+G +GKV VA+K + + E +E+++LS
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 680 V-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSG----------------IHL 722
+ +H N+V L+G C G +++ E+ G L L + + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 723 DWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782
D + L + A+G+A+L IHRD+ + NILL K+ DFGL++ + + S
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842
V + + ++ PE T +SDV+S+G+ + EL + G V +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259
Query: 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
+ E + ++ C + RPT ++V+ IE +
Sbjct: 260 MIKEGFRMLSP--EHAPAEMY-----------DIMKTCWDADPLKRPTFKQIVQLIEKQI 306
Query: 903 Q 903
Sbjct: 307 S 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 2e-60
Identities = 74/305 (24%), Positives = 130/305 (42%), Gaps = 39/305 (12%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDG---QVVAIKRAQQGSMQGGL-EFKTEIELLSRV-H 681
N+ + IG G +G+V + + AIKR ++ + + +F E+E+L ++ H
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH--------------LDWKRR 727
H N++ L+G C +G L E+ +G L + L + L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 728 LRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS 787
L A ARG+ YL + IHRD+ + NIL+ EN AK+ADFGLS+ K
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---K 183
Query: 788 TQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847
T + + ++ E T SDV+S+GV++ E+++ G
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243
Query: 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907
E D + +L QC E +RP+ ++++ ++ +L+
Sbjct: 244 RLE---KPLNCDDEVY-----------DLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 908 NTNST 912
N+T
Sbjct: 290 YVNTT 294
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-60
Identities = 60/278 (21%), Positives = 110/278 (39%), Gaps = 26/278 (9%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKN 684
++ IG+G YG+ + SDG+++ K GSM +E+ LL + H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 685 LVGLVGFCFEQGEQML--VYEFMANGTLRESL--SGRSGIHLDWKRRLRIALGSARGLAY 740
+V ++ L V E+ G L + + +LD + LR+ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 741 LHEL--ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
H ++HRD+K N+ LD K+ DFGL+++++ + + GT Y+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMS 182
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
PE EKSD++S G ++ EL P + A + + +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS----QKELAGKIREGKFRRIPYRY 238
Query: 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ E+ + + RP++ E+++
Sbjct: 239 SDELN-----------EIITRMLNLKDYHRPSVEEILE 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-59
Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGG---LEFKTEIELLSRVHH 682
+F +G G +G VY ++A+K + ++ + + E+E+ S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
N++ L G+ + L+ E+ GT+ L S D +R A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCH 123
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+IHRD+K N+LL K+ADFG S S + + GT+ YL PE
Sbjct: 124 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMI 176
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
+ EK D++S GV+ E + K P E +E Y ++ T
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE-------------ANTYQETYKRISRVEFTF 223
Query: 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ V G R +L + ++ + + RP + EV++
Sbjct: 224 PDFVTEGAR---DLISRLLKHNPSQRPMLREVLE 254
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 8e-59
Identities = 60/282 (21%), Positives = 122/282 (43%), Gaps = 25/282 (8%)
Query: 629 FSESNEIGSGGYGKVYRGM-LSDGQVVAIKRA-----QQGSMQGGLEFKTEIELLSRVHH 682
F + +GSG +G VY+G+ + +G+ V I A + S + E E +++ V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
++ L+G C L+ + M G L + + + L + A+G+ YL
Sbjct: 71 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+ ++HRD+ + N+L+ K+ DFGL+KL+ K + + K + ++ E
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
+ + T +SDV+S+GV + EL+T G E+ + + + + + +
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDG-IPASEISSILEKGERLPQ--PPICTIDV 242
Query: 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904
+ ++C A RP E++ + ++
Sbjct: 243 Y-----------MIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-58
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 25/284 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQGGLE-FKTEIELLSRVH 681
IG G +G V++G+ VAIK + + E F E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
H ++V L+G + ++ E G LR S LD + A + LAYL
Sbjct: 67 HPHIVKLIGVI-TENPVWIIMELCTLGELR-SFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
+HRD+ + N+L+ N K+ DFGLS+ + DS+ + +++ K + ++ PE
Sbjct: 125 ES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPES 180
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861
++ T SDV+ FGV M E++ +G + N + + PT
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPT 237
Query: 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
+ L +C + RP +E+ + T+L+ +
Sbjct: 238 LY-----------SLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-58
Identities = 59/305 (19%), Positives = 112/305 (36%), Gaps = 45/305 (14%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD------GQVVAIKRAQQGSMQGGLE-FKTEIELLSR 679
N +GSG +GKV VA+K ++ + E +E++++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 680 V-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH----------------- 721
+ H+N+V L+G C G L++E+ G L L +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 722 ----LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777
L ++ L A A+G+ +L +HRD+ + N+L+ K+ DFGL++
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVV 837
+ S V + + ++ PE T KSDV+S+G+++ E+ + G V
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 838 REVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897
+ + I + C + RP+ +
Sbjct: 274 ANFYKLIQNGFKMDQ--PFYATEEIYI-----------IMQSCWAFDSRKRPSFPNLTSF 320
Query: 898 IETLL 902
+ L
Sbjct: 321 LGCQL 325
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 3e-58
Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 29/272 (10%)
Query: 633 NEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHKNLVGLV 689
EIG G + VY+G+ ++ VA Q + FK E E+L + H N+V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 690 GFCFEQGEQ----MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
+ +LV E M +GTL+ L + + K +GL +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLHTR- 131
Query: 746 NPPIIHRDVKSTNILL-DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
PPIIHRD+K NI + + K+ D GL+ L + + V GT ++ PE Y
Sbjct: 132 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEMY-E 186
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864
++ E DVY+FG+ MLE+ T++ P + + + R + + ++ P ++
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF--DKVAIPEVK- 243
Query: 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
E+ C+ ++ +R ++ +++
Sbjct: 244 ----------EIIEGCIRQNKDERYSIKDLLN 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 62/273 (22%), Positives = 117/273 (42%), Gaps = 21/273 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKN 684
++ +G G YG+V + + VA+K E K EI + ++H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V G E Q L E+ + G L + + I + R G+ YLH +
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
I HRD+K N+LLDE K++DFGL+ + +++ + ++ GT+ Y+ PE
Sbjct: 123 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 805 QQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863
++ E DV+S G+V+ ++ + P ++ +E + + + +D
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP--WKKIDSAPL 237
Query: 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
L + + E+ + R T+ ++ K
Sbjct: 238 A-----------LLHKILVENPSARITIPDIKK 259
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 6e-58
Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 35/287 (12%)
Query: 617 FSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG---LEFKT 672
F D+ +K FS+ EIG G +G VY + + +VVAIK+ Q +
Sbjct: 8 FFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64
Query: 673 EIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIAL 732
E+ L ++ H N + G + LV E+ + L +
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTH 122
Query: 733 GSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKG 792
G+ +GLAYLH +IHRDVK+ NILL E K+ DFG + +++ + G
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVG 173
Query: 793 TMGYLDPEYYMTQ---QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE 849
T ++ PE + Q K DV+S G+ +EL K P+
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN------------AMS 221
Query: 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
Y + + P +++ + C+++ DRPT ++K
Sbjct: 222 ALYHIAQNESPALQSGHWS--EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 1e-56
Identities = 59/270 (21%), Positives = 113/270 (41%), Gaps = 25/270 (9%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF 691
E+G G +GKVY+ + A K S + ++ EI++L+ H N+V L+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIH 751
+ + ++ EF A G + + L + + + L YLH+ IIH
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDN---KIIH 133
Query: 752 RDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL---- 807
RD+K+ NIL + K+ADFG+S + + GT ++ PE M +
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRP 191
Query: 808 -TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866
K+DV+S G+ ++E+ + P + + V + + + ++
Sbjct: 192 YDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAKSEPPTLAQPSRWSSNFKD-- 247
Query: 867 LLGFRRYLELALQCVEESATDRPTMSEVVK 896
+C+E++ R T S++++
Sbjct: 248 ---------FLKKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 65/281 (23%), Positives = 103/281 (36%), Gaps = 26/281 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGML----SDGQVVAIKR---AQQGSMQGGLEFKTEIELLSR 679
+ ++G G +G V RG VA+K + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+ H+NL+ L G +V E G+L + L G H R A+ A G+
Sbjct: 68 LDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAEGMG 125
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV-STQVKGTMGYLD 798
YL IHRD+ + N+LL K+ DFGL + + + +V K +
Sbjct: 126 YLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
PE T+ + SD + FGV + E+ T Q G + + + E E
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK--EGERLPRPEDC 240
Query: 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899
I N + +QC DRPT + +
Sbjct: 241 PQDIYN-----------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 3e-56
Identities = 67/300 (22%), Positives = 119/300 (39%), Gaps = 39/300 (13%)
Query: 627 NNFSESNEIGSGGYGKVYRGM------LSDGQVVAIKRAQQGSMQGGL-EFKTEIELLSR 679
+ +G G +G+V + + VA+K ++G+ +E+++L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 680 -VHHKNLVGLVGFCFEQGEQ-MLVYEFMANGTLRESLSGRSG--------------IHLD 723
HH N+V L+G C + G M++ EF G L L + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783
+ + + A+G+ +L IHRD+ + NILL E K+ DFGL++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA 843
+ + ++ PE + T +SDV+SFGV++ E+ + G + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 249
Query: 844 MNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903
+ + P + + L C + RPT SE+V+ + LLQ
Sbjct: 250 LKEGTRMR--APDYTTPEMY-----------QTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 56/272 (20%), Positives = 111/272 (40%), Gaps = 22/272 (8%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN 684
++ +IG G G VY M ++ GQ VAI++ EI ++ + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V + E +V E++A G+L + ++ +D + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN 135
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
+IHRD+KS NILL + + K+ DFG ++ + + GT ++ PE
Sbjct: 136 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTR 190
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864
+ K D++S G++ +E+I + P + + + E + R+
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATNGTPELQNPEKLSAIFRD 248
Query: 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+C++ R + E+++
Sbjct: 249 -----------FLNRCLDMDVEKRGSAKELLQ 269
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-55
Identities = 64/309 (20%), Positives = 127/309 (41%), Gaps = 38/309 (12%)
Query: 616 WFSYDELKK------CSNNFSESNEIGSGGYGKVYRGML------SDGQVVAIKRAQQGS 663
+FS ++ + S E+G G +G VY G+ VAIK + +
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 664 MQGGL-EFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIH- 721
EF E ++ + ++V L+G + +++ E M G L+ L
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 722 -------LDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGL 774
+ +++A A G+AYL+ +HRD+ + N ++ E+ T K+ DFG+
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834
++ + ++ + + ++ PE T SDV+SFGVV+ E+ T + +G
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239
Query: 835 YVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEV 894
+ +R +M+ + + EL C + + RP+ E+
Sbjct: 240 SNEQVLR--------------FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 285
Query: 895 VKAIETLLQ 903
+ +I+ ++
Sbjct: 286 ISSIKEEME 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 5e-53
Identities = 65/301 (21%), Positives = 122/301 (40%), Gaps = 41/301 (13%)
Query: 627 NNFSESNEIGSGGYGKVYRGML--------SDGQVVAIKRAQQGSMQGGL-EFKTEIELL 677
+ +G G +G+V + VA+K + + + L + +E+E++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 678 SRV-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESL--------------SGRSGIHL 722
+ HKN++ L+G C + G ++ E+ + G LRE L S L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 723 DWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782
K + A ARG+ YL IHRD+ + N+L+ E+ K+ADFGL++ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT 842
+T + + ++ PE + T +SDV+SFGV++ E+ T G V +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 843 AMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902
+ + + C + RPT ++V+ ++ ++
Sbjct: 250 LKEGHRMD---KPSNCTNELY-----------MMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
Query: 903 Q 903
Sbjct: 296 A 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-52
Identities = 62/283 (21%), Positives = 106/283 (37%), Gaps = 25/283 (8%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSM---QGGLEFKTEIELLS 678
KK +F +G G + V L+ + AIK ++ + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
R+ H V L + + + NG L + + D L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSAL 121
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
YLH IIHRD+K NILL+E++ ++ DFG +K++S SK + GT Y+
Sbjct: 122 EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
PE + + SD+++ G ++ +L+ P G + + + Y E
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-----IFQKIIKLEYDFPEKF 233
Query: 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901
P R+ L + + AT R E+
Sbjct: 234 FPKARD-----------LVEKLLVLDATKRLGCEEMEGYGPLK 265
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (462), Expect = 3e-51
Identities = 54/274 (19%), Positives = 107/274 (39%), Gaps = 24/274 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL 685
+++ E+G+G +G V+R + G A K + EI+ +S + H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
V L + E +++YEFM+ G L E ++ + + +GL ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMHEN- 143
Query: 746 NPPIIHRDVKSTNILL--DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
+H D+K NI+ + K+ DFGL+ + GT + PE
Sbjct: 144 --NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVAE 198
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863
+ + +D++S GV+ L++ P +D+E + D +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFG-------------GENDDETLRNVKSCDWNMD 245
Query: 864 NTVLLGFRRYL-ELALQCVEESATDRPTMSEVVK 896
++ G + + + R T+ + ++
Sbjct: 246 DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 179 bits (456), Expect = 1e-50
Identities = 52/267 (19%), Positives = 107/267 (40%), Gaps = 24/267 (8%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
E+GSG +G V+R + + G+V K K EI +++++HH L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
++ E +L+ EF++ G L + ++ + + + GL ++HE I+H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIA-AEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHL 151
Query: 753 DVKSTNILLD--ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
D+K NI+ + + + K+ DFGL+ ++ T + PE + +
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVGFY 208
Query: 811 SDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870
+D+++ GV+ L++ P DD E + D
Sbjct: 209 TDMWAIGVLGYVLLSGLSPFA-------------GEDDLETLQNVKRCDWEFDEDAFSSV 255
Query: 871 RRYL-ELALQCVEESATDRPTMSEVVK 896
+ +++ R T+ + ++
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (427), Expect = 5e-47
Identities = 56/283 (19%), Positives = 117/283 (41%), Gaps = 25/283 (8%)
Query: 619 YDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIEL 676
+ + + + + + +G+G + +V ++VAIK + +++G + EI +
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 677 LSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR 736
L ++ H N+V L G L+ + ++ G L + + + + R+
Sbjct: 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLD 118
Query: 737 GLAYLHELANPPIIHRDVKSTNILL---DENLTAKVADFGLSKLVSDSSKGHVSTQVKGT 793
+ YLH+ I+HRD+K N+L DE+ ++DFGLSK+ G V + GT
Sbjct: 119 AVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGT 172
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853
GY+ PE + ++ D +S GV+ L+ P + + + + E
Sbjct: 173 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYEFDSP 231
Query: 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ + + ++ +E+ R T + ++
Sbjct: 232 YWDDISDSAKD-----------FIRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 7e-47
Identities = 49/266 (18%), Positives = 105/266 (39%), Gaps = 23/266 (8%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFC 692
++G G +G V+R + S + K + L K EI +L+ H+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70
Query: 693 FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHR 752
E ++++EF++ + E ++ S L+ + + L +LH I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERIN-TSAFELNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 753 DVKSTNILLD--ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEK 810
D++ NI+ + T K+ +FG ++ + G + Y PE + ++
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 811 SDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGF 870
+D++S G ++ L++ P ++ + + Y E I
Sbjct: 184 TDMWSLGTLVYVLLSGINP-----FLAETNQQIIENIMNAEYTFDEEAFKEISIEA---- 234
Query: 871 RRYLELALQCVEESATDRPTMSEVVK 896
++ + + + R T SE ++
Sbjct: 235 ---MDFVDRLLVKERKSRMTASEALQ 257
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (421), Expect = 2e-46
Identities = 55/293 (18%), Positives = 105/293 (35%), Gaps = 23/293 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL 685
N + +IGSG +G +Y G ++ G+ VAIK + + E ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP--QLHIESKIYKMMQGGVG 64
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
+ + +C +G+ ++ + +L + + S K L +A + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR-KFSLKTVLLLADQMISRIEYIHSKN 123
Query: 746 NPPIIHRDVKSTNIL---LDENLTAKVADFGLSKLVSDSSKG-----HVSTQVKGTMGYL 797
IHRDVK N L + + DFGL+K D+ + + GT Y
Sbjct: 124 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857
++ + + + D+ S G V++ P + + T + +
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLP-----WQGLKAATKRQKYERISEKKMST 235
Query: 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTN 910
+ F YL C D+P S + + L G + +
Sbjct: 236 PIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 165 bits (418), Expect = 3e-46
Identities = 64/290 (22%), Positives = 122/290 (42%), Gaps = 27/290 (9%)
Query: 623 KKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG---LEFKTEIELLS 678
S+ + +G GG +V+ L + VA+K + + L F+ E + +
Sbjct: 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62
Query: 679 RVHHKNLVGLVGFCFEQGEQ----MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGS 734
++H +V + + +V E++ TLR+ + + + KR + + +
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADA 120
Query: 735 ARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS-SKGHVSTQVKGT 793
+ L + H+ IIHRDVK NI++ KV DFG+++ ++DS + + V GT
Sbjct: 121 CQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 794 MGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYG 853
YL PE + +SDVYS G V+ E++T + P G V + D
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSA 236
Query: 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP-TMSEVVKAIETLL 902
E + + + L+ + ++ +R T +E+ + +
Sbjct: 237 RHEGLSADLD-----------AVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 164 bits (415), Expect = 7e-46
Identities = 62/286 (21%), Positives = 110/286 (38%), Gaps = 37/286 (12%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIKR---------AQQGSMQGGLEFKTEIELL 677
N+ +G G V R + + A+K + + + E+++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 678 SRVH-HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSAR 736
+V H N++ L LV++ M G L + L + L K +I
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL--TEKVTLSEKETRKIMRALLE 121
Query: 737 GLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGY 796
+ LH+L I+HRD+K NILLD+++ K+ DFG S + K +V GT Y
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSY 175
Query: 797 LDPEYYMTQQL------TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEE 850
L PE ++ D++S GV+M L+ P + + +R M+ + +
Sbjct: 176 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLMLRMIMSGNYQF 234
Query: 851 HYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ T+++ L + + R T E +
Sbjct: 235 GSPEWDDYSDTVKD-----------LVSRFLVVQPQKRYTAEEALA 269
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 8e-46
Identities = 61/292 (20%), Positives = 110/292 (37%), Gaps = 28/292 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRG--MLSDGQVVAIKRAQQGSMQGG--LEFKTEIEL---LSR 679
+ EIG G YGKV++ + + G+ VA+KR + + + G L E+ + L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFM----ANGTLRESLSGRSGIHLDWKRRLRIALGSA 735
H N+V L C + + L L + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMG 795
RGL +LH ++HRD+K NIL+ + K+ADFGL+++ S T V T+
Sbjct: 127 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLW 180
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP------IEKGKYVVREVRTAMNRDDE 849
Y PE + D++S G + E+ K +++ ++ + D
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 850 EHYGLTEMMDPTIRNTVLLGFRRYL-----ELALQCVEESATDRPTMSEVVK 896
L + + F + +L L+C+ + R + +
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 2e-45
Identities = 59/275 (21%), Positives = 104/275 (37%), Gaps = 30/275 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSD-GQVVAIKRAQQGSMQGG------LEFKTEIELLSR 679
N+FS IG GG+G+VY +D G++ A+K + ++ L + + L+S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 680 VHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLA 739
+V + + + + M G L LS R + GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI--ILGLE 121
Query: 740 YLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDP 799
++H +++RD+K NILLDE+ +++D GL+ S GT GY+ P
Sbjct: 122 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMAP 174
Query: 800 EYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858
E +D +S G ++ +L+ P + K +D E +T M
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK----------TKDKHEIDRMTLTM 224
Query: 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSE 893
+ ++ R L ++ R
Sbjct: 225 AVELPDSFSPELR---SLLEGLLQRDVNRRLGCLG 256
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-44
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 21/285 (7%)
Query: 628 NFSESNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKN 684
NF + +IG G YG VY+ G+VVA+K R + EI LL ++H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V L+ + + LV+EF+ + L++ + + + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS- 120
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
++HRD+K N+L++ K+ADFGL++ + + +V
Sbjct: 121 --HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGC 177
Query: 805 QQLTEKSDVYSFGVVMLELITAKQPIEKGKYV---VREVRTAMNRDDEEHYGLTEMMD-- 859
+ + D++S G + E++T + + R RT D+ G+T M D
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237
Query: 860 PTIRNTVLLGFRRY--------LELALQCVEESATDRPTMSEVVK 896
P+ F + L Q + R + +
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 159 bits (403), Expect = 3e-44
Identities = 51/285 (17%), Positives = 107/285 (37%), Gaps = 21/285 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHKN 684
+ +IG G YG VY+ + G+ A+K R ++ EI +L + H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
+V L + +LV+E + + G L+ L G+AY H+
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHD- 118
Query: 745 ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMT 804
++HRD+K N+L++ K+ADFGL++ + + ++ +
Sbjct: 119 --RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGS 175
Query: 805 QQLTEKSDVYSFGVVMLELITAKQP------------IEKGKYVVREVRTAMNRDDEEHY 852
++ + D++S G + E++ I + + ++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 853 GLTEMMDPTIRNTVLLGF-RRYLELALQCVEESATDRPTMSEVVK 896
+ +P + L G ++L + ++ R T + ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (403), Expect = 4e-44
Identities = 46/295 (15%), Positives = 96/295 (32%), Gaps = 25/295 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNL 685
++ IG G +G ++ G L + Q VAIK + S + + E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP--QLRDEYRTYKLLAGCTG 62
Query: 686 VGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA 745
+ V + ++G ++ + G E L G K A + +HE
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK- 120
Query: 746 NPPIIHRDVKSTNILLDENLT-----AKVADFGLSKLVSDSSKG-----HVSTQVKGTMG 795
+++RD+K N L+ + V DFG+ K D + GT
Sbjct: 121 --SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 796 YLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLT 855
Y+ ++ ++ + + D+ + G V + + P + + T + +
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP-----WQGLKAATNKQKYERIGEKKQ 233
Query: 856 EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGMNTN 910
+ F +Y+ + P + +L+ +
Sbjct: 234 STPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLNTTED 285
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 6e-44
Identities = 63/283 (22%), Positives = 113/283 (39%), Gaps = 26/283 (9%)
Query: 633 NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-----FKTEIELLSRVHHKNLV 686
+ +G G + VY+ + Q+VAIK+ + G + EI+LL + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 687 GLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELAN 746
GL+ + LV++FM + + + L L + +GL YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 747 PPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQ 806
I+HRD+K N+LLDEN K+ADFGL+K ++ + T T Y PE +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFGAR 176
Query: 807 L-TEKSDVYSFGVVMLELITAKQP------------IEKGKYVVREVRTAMNRDDEEHYG 853
+ D+++ G ++ EL+ I + E + ++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
+ + L+L + R T ++ +K
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 1e-43
Identities = 49/207 (23%), Positives = 91/207 (43%), Gaps = 14/207 (6%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEFKTEIELLSRVHH 682
+F +G+G +G+V+ +G+ A+K + ++ E +LS V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
++ + G + + ++ +++ G L L + + L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----CLALE 118
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
L + II+RD+K NILLD+N K+ DFG +K V D + + GT Y+ PE
Sbjct: 119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVV 173
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
T+ + D +SFG+++ E++ P
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 62/276 (22%), Positives = 106/276 (38%), Gaps = 28/276 (10%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRV-H 681
+F +G G +GKV+ Q AIK ++ + + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 682 HKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYL 741
H L + + V E++ G L + +S D R A GL +L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFL 119
Query: 742 HELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEY 801
H I++RD+K NILLD++ K+ADFG+ K GT Y+ PE
Sbjct: 120 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEI 174
Query: 802 YMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861
+ Q+ D +SFGV++ E++ + P +D+EE + M +P
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFH-------------GQDEEELFHSIRMDNPF 221
Query: 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKA 897
+ + +L ++ R + ++
Sbjct: 222 YPRWLEKEAK---DLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 7e-43
Identities = 66/291 (22%), Positives = 118/291 (40%), Gaps = 31/291 (10%)
Query: 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV 686
+++++ IG+G +G VY+ L G++VAIK+ Q E++++ ++ H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIV 76
Query: 687 GLVGFCFEQGEQM------LVYEFMANGTLRESLS-GRSGIHLDWKRRLRIALGSARGLA 739
L F + GE+ LV +++ R + R+ L R LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 740 YLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
Y+H I HRD+K N+LLD + K+ DFG +K + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAP 191
Query: 799 PEYYMTQQLTEKSDVYSFGVVMLELITAKQP------IEKGKYVVREVRTAMNRD-DEEH 851
+ T DV+S G V+ EL+ + +++ +++ + T E +
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 852 YGLTEMMDPTIRNTVLLGFRRY------LELALQCVEESATDRPTMSEVVK 896
TE P I+ R + L + +E + T R T E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 61/274 (22%), Positives = 105/274 (38%), Gaps = 41/274 (14%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKR------AQQGSMQGGLEFKTEIELLSRVH--HKN 684
+GSGG+G VY G+ +SD VAIK + G + G E+ LL +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 685 LVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL 744
++ L+ + +L+ E G L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC 129
Query: 745 ANPPIIHRDVKSTNILLDEN-LTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
++HRD+K NIL+D N K+ DFG L+ D+ V T GT Y PE+
Sbjct: 130 ---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIR 182
Query: 804 TQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862
+ + V+S G+++ +++ P E + ++R + +
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR-----------GQVFFRQRVSSEC 231
Query: 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896
++ L C+ +DRPT E+
Sbjct: 232 QH-----------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 2e-42
Identities = 58/293 (19%), Positives = 119/293 (40%), Gaps = 29/293 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE-FKTEIELLSRVHHKN 684
++ + IG G YG V + VAIK+ Q + EI++L R H+N
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 685 LVGLVGFC----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAY 740
++G+ EQ + + + + L + L + HL RGL Y
Sbjct: 68 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKY 124
Query: 741 LHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLV-SDSSKGHVSTQVKGTMGYLDP 799
+H ++HRD+K +N+LL+ K+ DFGL+++ D T+ T Y P
Sbjct: 125 IHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 800 EYYMTQQL-TEKSDVYSFGVVMLELITAKQP------IEKGKYVVREVRTAMNRDDEEHY 852
E + + T+ D++S G ++ E+++ + +++ +++ + + D
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241
Query: 853 GLTEM-MDPTIRNTVLLGFRRY--------LELALQCVEESATDRPTMSEVVK 896
L ++ + + + R L+L + + + R + + +
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 2e-42
Identities = 56/271 (20%), Positives = 96/271 (35%), Gaps = 28/271 (10%)
Query: 635 IGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFC 692
+G G GKV + + A+K +Q + + E+EL R ++V +V
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKM-----LQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 693 ----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPP 748
+ ++V E + G L + R + I + YLH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--- 131
Query: 749 IIHRDVKSTNILLD---ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQ 805
I HRDVK N+L N K+ DFG +K + + T Y+ PE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLGPE 188
Query: 806 QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865
+ + D++S GV+M L+ P + + R Y +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFY-SNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247
Query: 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896
V L ++ T R T++E +
Sbjct: 248 V-------KMLIRNLLKTEPTQRMTITEFMN 271
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 6e-42
Identities = 60/293 (20%), Positives = 119/293 (40%), Gaps = 24/293 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHK 683
+ + + +IG G +G+V++ GQ VA+K+ + + G EI++L + H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 684 NLVGLVGFCFEQGEQM--------LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSA 735
N+V L+ C + LV++F + + L +R+ L
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 736 RGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVS--TQVKGT 793
L L+ + I+HRD+K+ N+L+ + K+ADFGL++ S + + T T
Sbjct: 127 --LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 794 MGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHY 852
+ Y PE + ++ D++ G +M E+ T + + +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI-----MQGNTEQHQLALISQLCG 239
Query: 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905
+T + P + N L ++ + V++ + I+ LL D
Sbjct: 240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 50/283 (17%), Positives = 108/283 (38%), Gaps = 33/283 (11%)
Query: 626 SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL------EFKTEIELLS 678
+ + E+GSG + V + S G A K ++ + + + E+ +L
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 679 RVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
+ H N++ L + + +L+ E +A G L + L+ + + + G+
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT--EFLKQILNGV 126
Query: 739 AYLHELANPPIIHRDVKSTNILLDEN----LTAKVADFGLSKLVSDSSKGHVSTQVKGTM 794
YLH I H D+K NI+L + K+ DFGL+ + ++ + GT
Sbjct: 127 YYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGTP 180
Query: 795 GYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854
++ PE + L ++D++S GV+ L++ P + +E
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-------------LGDTKQETLAN 227
Query: 855 TEMMDPTIRNTVLLGFRRYL-ELALQCVEESATDRPTMSEVVK 896
++ + + + + + R T+ + ++
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (378), Expect = 9e-41
Identities = 53/287 (18%), Positives = 103/287 (35%), Gaps = 23/287 (8%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL--EFKTEIELLSRVHHK 683
+ + +IG G YG V++ ++VA+KR + G+ EI LL + HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 684 NLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHE 743
N+V L + LV+EF + S + + + + L L
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQLLKGLGF 116
Query: 744 LANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYM 803
+ ++HRD+K N+L++ N K+A+FGL++ + S +V +
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYSAEVVTLWYRPPDVLFG 175
Query: 804 TQQLTEKSDVYSFGVVMLELITAKQPIEKGK------YVVREVRTAMNRDDEEHYGLTEM 857
+ + D++S G + EL A +P+ G + + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 858 MDPTIRNTVLLGFRRY--------LELALQCVEESATDRPTMSEVVK 896
P +L ++ + R + E ++
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 53/207 (25%), Positives = 78/207 (37%), Gaps = 11/207 (5%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLE---FKTEIELLSRVHH 682
N+F +G G +GKV + G+ A+K ++ + E TE +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 683 KNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLH 742
L L V E+ G L L +R L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIVSALEYLH 122
Query: 743 ELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYY 802
+++RD+K N++LD++ K+ DFGL K G GT YL PE
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVL 177
Query: 803 MTQQLTEKSDVYSFGVVMLELITAKQP 829
D + GVVM E++ + P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 140 bits (354), Expect = 5e-37
Identities = 47/219 (21%), Positives = 86/219 (39%), Gaps = 14/219 (6%)
Query: 615 RWFSYDELKKCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK---RAQQGSMQGGLEF 670
+W + + + F +G+G +G+V G A+K + + ++
Sbjct: 29 KWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHT 88
Query: 671 KTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRI 730
E +L V+ LV L + +V E++A G + L
Sbjct: 89 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFY 146
Query: 731 ALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQV 790
A YLH L +I+RD+K N+L+D+ +V DFG +K + +
Sbjct: 147 AAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTL 198
Query: 791 KGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
GT L PE +++ + D ++ GV++ E+ P
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (347), Expect = 3e-36
Identities = 70/309 (22%), Positives = 112/309 (36%), Gaps = 41/309 (13%)
Query: 617 FSYDELKKCSNNFSES----NEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGL--E 669
F E+ K + +GSG YG V + G VAIK+ +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 670 FKTEIELLSRVHHKNLVGLVGFCFEQG------EQMLVYEFMANGTLRESLSGRSGIHLD 723
E+ LL + H+N++GL+ + LV FM + + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LG 119
Query: 724 WKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783
R + +GL Y+H IIHRD+K N+ ++E+ K+ DFGL++
Sbjct: 120 EDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT 176
Query: 784 GHVSTQVKGTMGYLDPEYYM-TQQLTEKSDVYSFGVVMLELITAKQP------------I 830
G+V T Y PE + + T+ D++S G +M E+IT K I
Sbjct: 177 GYV-----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
Query: 831 EKGKYVVRE---VRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATD 887
K R + GL E+ + + + L + + A
Sbjct: 232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQ 291
Query: 888 RPTMSEVVK 896
R T E +
Sbjct: 292 RVTAGEALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 131 bits (330), Expect = 4e-34
Identities = 43/232 (18%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 612 KGARWFSYDELK---KCSNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGG 667
+ ++ Y+ +++ ++G G Y +V+ + +++ + V +K + +
Sbjct: 17 RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK-- 74
Query: 668 LEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQM--LVYEFMANGTLRESLSGRSGIHLDW 724
+ K EI++L + N++ L + + LV+E + N ++ L
Sbjct: 75 -KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTD 128
Query: 725 KRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSK 783
+ L Y H + I+HRDVK N+++D E+ ++ D+GL++ +
Sbjct: 129 YDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 784 GHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGK 834
+ + PE + Q+ D++S G ++ +I K+P G
Sbjct: 186 ---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 126 bits (315), Expect = 3e-32
Identities = 67/300 (22%), Positives = 108/300 (36%), Gaps = 25/300 (8%)
Query: 25 DSRDAAALQSLKDAWQNTP--PTWKNSDDPCG-SWEGVTCNNS----RVTALGLSTMGLT 77
+ +D AL +K N +W + D C +W GV C+ RV L LS + L
Sbjct: 4 NPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 78 GK--LSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN 135
+ + L L L + L G + P I L +L+ L + +G IPD +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 136 LAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKH 195
+ L L + N SG +PPS+ L L + N+++G+IP S + L
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 196 FHFNKNKLSGTISEQLFSPDM----------------VLIHVLFDGNQLSGNIPESLGYV 239
+ L D+ + +G
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 240 QTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSF 299
+ L L L N + G +P L L ++ LN++ N+L G P + +NN
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 16/59 (27%), Positives = 23/59 (38%), Gaps = 1/59 (1%)
Query: 120 LAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
L G +P + L L L ++ NN G IP G L + A+N+ P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 6e-32
Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 20/212 (9%)
Query: 627 NNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLEFKTEIELLSRVHHK 683
+ IGSG G V + VAIK + E+ L+ V+HK
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 684 NLVGLVGFCFEQG------EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
N++ L+ Q + LV E M + LD +R + G
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQMLCG 131
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+ +LH IIHRD+K +NI++ + T K+ DFGL++ S + T T Y
Sbjct: 132 IKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYR 185
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
PE + E D++S G +M E++ K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (308), Expect = 4e-31
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 627 NNFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM----QGGLEFKTEIELLS 678
NF +G+G YGKV+ G++ A+K ++ ++ + +TE ++L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 679 RV-HHKNLVGLVGFCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARG 737
+ LV L + + L+ +++ G L LS R + +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHE-----VQIYVGEI 138
Query: 738 LAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
+ L L II+RD+K NILLD N + DFGLSK + + + GT+ Y+
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-VADETERAYDFCGTIEYM 197
Query: 798 DPEYYMTQQ--LTEKSDVYSFGVVMLELITAKQP 829
P+ + D +S GV+M EL+T P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 5e-30
Identities = 64/307 (20%), Positives = 116/307 (37%), Gaps = 37/307 (12%)
Query: 617 FSYDELKKC----SNNFSESNEIGSGGYGKVYRGM-LSDGQVVAIK--RAQQGSMQGGLE 669
F EL K + + +GSG YG V G VA+K S+
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 670 FKTEIELLSRVHHKNLVGLVGFC-----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDW 724
E+ LL + H+N++GL+ E+ + + + L + + L
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTD 120
Query: 725 KRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784
+ RGL Y+H IIHRD+K +N+ ++E+ K+ DFGL++ D G
Sbjct: 121 DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 785 HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP------------IEK 832
+V+T + D++S G +M EL+T + I +
Sbjct: 178 YVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 833 GKYVV-REVRTAMNRDDEEHY--GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRP 889
E+ ++ + +Y LT+M N + ++L + + + R
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 890 TMSEVVK 896
T ++ +
Sbjct: 294 TAAQALA 300
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (275), Expect = 1e-26
Identities = 38/212 (17%), Positives = 75/212 (35%), Gaps = 19/212 (8%)
Query: 634 EIGSGGYGKVYRGM-LSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVG-- 690
++G G + V+ + + VA+K + + + EI+LL RV+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 691 ------------FCFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
G +++ + L + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 739 AYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYL 797
Y+H IIH D+K N+L++ + + ++ L + T T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 798 DPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829
PE + +D++S ++ ELIT
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFL 228
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.8 bits (235), Expect = 7e-23
Identities = 30/209 (14%), Positives = 61/209 (29%), Gaps = 42/209 (20%)
Query: 633 NEIGSGGYGKVYRGMLSDGQVVAIK----------RAQQGSMQGGLEFKTEIELLSRVHH 682
+G G V+ +K + ++ G L F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 683 KNLVGLVGFC----FEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGL 738
+ L L G + ++ E + L + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELY---------RVRVENPDEVLDMILEEV 116
Query: 739 AYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLD 798
A + I+H D+ N+L+ E + DF S V +G L+
Sbjct: 117 AKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQS----------VEVGEEGWREILE 162
Query: 799 PEY-----YMTQQLTEKSDVYSFGVVMLE 822
+ Y ++ + D+ S +L+
Sbjct: 163 RDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 92.0 bits (227), Expect = 3e-20
Identities = 44/197 (22%), Positives = 76/197 (38%), Gaps = 20/197 (10%)
Query: 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN 171
L L LI + P I L L+LN N +L L+ L LDLA+N
Sbjct: 196 LTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 172 QLTGSIPVSTITS-----------PGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIH 220
Q++ P+S +T + L + + S L +
Sbjct: 252 QISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTY 311
Query: 221 VLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPF 280
+ N +S P + + L+ L N ++ ++L NLTN+N L+ HN +
Sbjct: 312 LTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLT 367
Query: 281 PDLSQMNSLSYVDLSNN 297
P L+ + ++ + L++
Sbjct: 368 P-LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 70.8 bits (172), Expect = 2e-13
Identities = 71/357 (19%), Positives = 123/357 (34%), Gaps = 46/357 (12%)
Query: 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGC 123
+VT L +G+ + G + L L ++ S N LT + +L KL +++
Sbjct: 44 DQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQ-LTDI--TPLKNLTKLVDILMNNN 98
Query: 124 GFTGNIPDEIGNLAELS---------FLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174
P L + R+ S +S + L +
Sbjct: 99 QIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQ 158
Query: 175 GSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE 234
S L L + + NK+S + LI NQ+S P
Sbjct: 159 LSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIA---TNNQISDITPL 215
Query: 235 SLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDL 294
+ L+ L L+ N L L +LTN+ +L+LA+N + P LS + L+ + L
Sbjct: 216 G--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKL 270
Query: 295 SNNSFD-------------------PTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSY 335
N E S L +LT L F ++ P + S
Sbjct: 271 GANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSL 328
Query: 336 SQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKN-YTLILVGN 391
+++Q++ NN ++ + N + + +NQIS +T + + L L
Sbjct: 329 TKLQRLFFANNKVSDVSSLANL--TNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 69.3 bits (168), Expect = 7e-13
Identities = 44/214 (20%), Positives = 73/214 (34%), Gaps = 23/214 (10%)
Query: 134 GNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNA 193
L L L +N S P + + L L L NQL L L N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--------GTLASLTNL 243
Query: 194 KHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALT 253
N++S S L + NQ+S P + T + N
Sbjct: 244 TDLDLANNQISNLAP---LSGLTKLTELKLGANQISNISPLAGLTALTNL----ELNENQ 296
Query: 254 GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPS 313
+ + ++NL N+ L L N++ P +S + L + +NN + L +
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKV---SDVSSLANLTN 352
Query: 314 LTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNA 347
+ L + P L + ++I Q+ L + A
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 62.3 bits (150), Expect = 1e-10
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 9/124 (7%)
Query: 61 CNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
+++T L L ++ I L L +L I +L+ L L L
Sbjct: 260 SGLTKLTELKLGANQISN-----ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTL 314
Query: 121 AGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVS 180
+ P + +L +L L +N S SL L+ + WL NQ++ P++
Sbjct: 315 YFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPLA 370
Query: 181 TITS 184
+T
Sbjct: 371 NLTR 374
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 3e-05
Identities = 53/306 (17%), Positives = 102/306 (33%), Gaps = 24/306 (7%)
Query: 111 DLQKLNILILAGCGFTGNIP-DEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLA 169
L + +L T + ++ + L L + G + L+ L ++ +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 170 DNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFS--------PDMVLIHV 221
+NQLT P+ +T L + + + L+ + + D +
Sbjct: 75 NNQLTDITPLKNLTK--LVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 222 LFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP 281
+ +LS N + + L L+ L NLT + L+++ N +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 282 DLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQV 341
N S + +N D T + +L L L+ L S + + +
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL----TNLDELSLNGNQLKD--IGTLASLTNLTDL 246
Query: 342 KLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNPVCTATLANT 401
L NN +N + L + L NQIS I+ +G+ T + + +
Sbjct: 247 DLANNQISNLAPLSGL--TKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 402 NYCQLQ 407
N L
Sbjct: 305 NLKNLT 310
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.2 bits (191), Expect = 4e-16
Identities = 46/251 (18%), Positives = 94/251 (37%), Gaps = 14/251 (5%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
+P ++ + + L L +N + L L+ L L +N+++ P +
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA------FA 76
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
L + + +KN+L + E++ L + ++ ++ L + +E L +
Sbjct: 77 PLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTN 134
Query: 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWF 308
+G + ++ + +A ++ L SL+ + L N +
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVD-AASL 191
Query: 309 STLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQ 368
L +L L F S+ L + ++++ L NN G A +Q+V L
Sbjct: 192 KGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLH 250
Query: 369 NNQISAITLGS 379
NN ISAI
Sbjct: 251 NNNISAIGSND 261
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.6 bits (187), Expect = 1e-15
Identities = 49/271 (18%), Positives = 91/271 (33%), Gaps = 22/271 (8%)
Query: 115 LNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174
+L L T + NL L L L +N S P + L +L L L+ NQL
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 175 GSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQL-FSPDMVLIHVLFDGNQLSGNIP 233
+P + + ++N+++ M+++ + + + SG
Sbjct: 93 -ELPEKMPKTL--------QELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 234 ESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVD 293
+ ++ L +R+ +T +LT EL+L N + + +
Sbjct: 144 GAFQGMKKLSYIRIADTNITTIPQGLPPSLT---ELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD 353
+ + + P L L L +VP L + IQ V L NN + +
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI-SAIG 258
Query: 354 MGNAVGPL-------LQLVDLQNNQISAITL 377
+ P V L +N + +
Sbjct: 259 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEI 289
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 76.2 bits (186), Expect = 1e-15
Identities = 58/306 (18%), Positives = 99/306 (32%), Gaps = 56/306 (18%)
Query: 55 SWEGVTCNNSRVTA-----------LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTG 103
V C++ + L L +T GD L L +L L N ++
Sbjct: 11 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK-ISK 69
Query: 104 SLSPRIGDLQKLNILILAGCGFTGNIPDEIG------------------------NLAEL 139
L KL L L+ +P+++ N +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 140 SFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFN 199
L N SG + + +L ++ +AD +T +IP + H +
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--------PPSLTELHLD 179
Query: 200 KNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTN 259
NK++ + L + L + N +S SL L L L+ N L KVP
Sbjct: 180 GNKITKVDAASLKGLNN-LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237
Query: 260 LNNLTNVNELNLAHNDLKG-------PFPDLSQMNSLSYVDLSNNSFDPTE-APLWFSTL 311
L + + + L +N++ P ++ S S V L +N E P F +
Sbjct: 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297
Query: 312 PSLTTL 317
+
Sbjct: 298 YVRAAV 303
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 39/195 (20%), Positives = 64/195 (32%), Gaps = 16/195 (8%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
+P ++ + + L L+ N +L ++L L+L +LT T+ G
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 189 QLKNAKHFHFNKNKLS--------------GTISEQLFSPDMVLIHVLFDGNQLSGNIPE 234
L + + + ++ L + GN+L P
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142
Query: 235 SLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDL 294
L LE L L N LT LN L N++ L L N L + L + L
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFL 202
Query: 295 SNNSFDPTEAPLWFS 309
N + L+F
Sbjct: 203 HGNPWLCNCEILYFR 217
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.4 bits (142), Expect = 4e-10
Identities = 46/307 (14%), Positives = 80/307 (26%), Gaps = 65/307 (21%)
Query: 52 PCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGD 111
PC C N GL + I + + L N ++ +
Sbjct: 1 PCPG--ACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNR-ISHVPAASFRA 54
Query: 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLAD 170
+ L IL L LA L L L+ N + P + L +L+ L L
Sbjct: 55 CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114
Query: 171 NQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG 230
L + LF L ++ N L
Sbjct: 115 CGLQ-------------------------------ELGPGLFRGLAALQYLYLQDNALQA 143
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDL------- 283
++ + L L L N ++ L +++ L L N + P
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 284 ------------------SQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ 325
+ + +L Y+ L++N + L +
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL--WAWLQKFRGSSSEVP 261
Query: 326 GRVPDKL 332
+P +L
Sbjct: 262 CSLPQRL 268
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (133), Expect = 6e-09
Identities = 43/222 (19%), Positives = 72/222 (32%), Gaps = 10/222 (4%)
Query: 153 IPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLF 212
+P + SQ + L N+++ S +N + N L+ +
Sbjct: 26 VPVGIPAASQ--RIFLHGNRISHVPAAS------FRACRNLTILWLHSNVLARIDAAAFT 77
Query: 213 SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLA 272
++ L D QL P + + L L LDR L P L + L L
Sbjct: 78 GLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ 137
Query: 273 HNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDK 331
N L+ D + +L+++ L N F L SL L+ + P
Sbjct: 138 DNALQALPDDTFRDLGNLTHLFLHGNRISSVPER-AFRGLHSLDRLLLHQNRVAHVHPHA 196
Query: 332 LFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373
++ + L N + A LQ + L +N
Sbjct: 197 FRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 38/248 (15%), Positives = 80/248 (32%), Gaps = 9/248 (3%)
Query: 65 RVTALGLSTMGLTGKLSGDI----GGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILIL 120
R+ + G+ ++ +DLS + +L + KL L L
Sbjct: 19 RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78
Query: 121 AGCGFTGNIPDEIGNLAELSFL--ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
G + I + + + L L + S + L S+L L+L+
Sbjct: 79 EGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKH 138
Query: 179 VSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGY 238
V + + + + KN +S + ++ L D L + +
Sbjct: 139 VQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQ 198
Query: 239 VQTLEVLRLDR-NALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNN 297
+ L+ L L R + + L + + L + G L + +L ++ ++ +
Sbjct: 199 LNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE--ALPHLQINCS 256
Query: 298 SFDPTEAP 305
F P
Sbjct: 257 HFTTIARP 264
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 6e-07
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 1/97 (1%)
Query: 245 LRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEA 304
L L L V L + V + + P + + ++DLSN+ + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 63
Query: 305 PLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQV 341
S L L E L + + L S + ++
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.4 bits (98), Expect = 1e-04
Identities = 20/93 (21%), Positives = 36/93 (38%), Gaps = 4/93 (4%)
Query: 74 MGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEI 133
+ L + L L+ L LS + +G++ L L + G G +
Sbjct: 186 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK 245
Query: 134 GNLAELSFLALNSNNFSGRIPPSLG-KLSQLYW 165
L L +N ++F+ P++G K +Q W
Sbjct: 246 EALPHLQ---INCSHFTTIARPTIGNKKNQEIW 275
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 5e-08
Identities = 34/218 (15%), Positives = 64/218 (29%), Gaps = 15/218 (6%)
Query: 86 GLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALN 145
L + + +T +++ DL + L G G T I + L L L L
Sbjct: 17 ALANAIKIAAGKSN-VTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 146 SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG 205
N + P L + +I +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 206 TISEQLFSP-------DMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPT 258
+ + + + L + L L+ D N ++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 259 NLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSN 296
L +L N+ E++L +N + L+ ++L V L+N
Sbjct: 191 -LASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 41.2 bits (95), Expect = 3e-04
Identities = 32/213 (15%), Positives = 63/213 (29%), Gaps = 15/213 (7%)
Query: 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADN 171
L + T + +L ++ L+ + + L+ L L+L DN
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDN 73
Query: 172 QLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN 231
Q+T P+ +T +L + + +I + + G
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 232 IPESLGYVQTLEVLRL-------DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLS 284
+ L + + L T L NL+ + L N + L+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 285 QMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
+ +L V L NN + +L +
Sbjct: 193 SLPNLIEVHLKNNQISDVSP---LANTSNLFIV 222
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 31/123 (25%), Positives = 45/123 (36%), Gaps = 30/123 (24%)
Query: 244 VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSL-------------- 289
VL L LT V +L L V L+L+HN L+ P L+ + L
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 290 --------SYVDLSNNSFDPTEAPLWFSTLPSLTTL------ICEFGSLQGRVPDKLFSY 335
+ L NN + A + P L L +C+ +Q R+ + L S
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 336 SQI 338
S I
Sbjct: 120 SSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 23/115 (20%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 142 LALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKN 201
L L + + + L +L + LDL+ N+L P L L+ + + N
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALP-------PALAALRCLEVLQASDN 53
Query: 202 KLSGTISEQLFSPDMVLIHVLFDGNQL-SGNIPESLGYVQTLEVLRLDRNALTGK 255
L L+ N+L + L L +L L N+L +
Sbjct: 54 ALENVDGVANLPRLQELL---LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 28/109 (25%), Positives = 37/109 (33%), Gaps = 9/109 (8%)
Query: 69 LGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILA-GCGFTG 127
L L+ LT L + L + LDLS+N L L L L +
Sbjct: 3 LHLAHKDLT-VLCH-LEQLLLVTHLDLSHN-----RLRALPPALAALRCLEVLQASDNAL 55
Query: 128 NIPDEIGNLAELSFLALNSNNF-SGRIPPSLGKLSQLYWLDLADNQLTG 175
D + NL L L L +N L +L L+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.9 bits (103), Expect = 8e-06
Identities = 27/108 (25%), Positives = 47/108 (43%), Gaps = 6/108 (5%)
Query: 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRV 328
L+LAH DL L Q+ ++++DLS+N P + L L +
Sbjct: 3 LHLAHKDLTVL-CHLEQLLLVTHLDLSHNRL--RALPPALAALRCLEV--LQASDNALEN 57
Query: 329 PDKLFSYSQIQQVKLRNNAFNNTLDMGNAVG-PLLQLVDLQNNQISAI 375
D + + ++Q++ L NN + + V P L L++LQ N +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 17/93 (18%), Positives = 34/93 (36%), Gaps = 9/93 (9%)
Query: 89 ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTG----NIPDEIGNLAELSFLAL 144
+++SLD+ + + LQ+ ++ L CG T +I + L+ L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 145 NSNNFSGRIPPSLGKL-----SQLYWLDLADNQ 172
SN + + ++ L L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 15/101 (14%), Positives = 28/101 (27%), Gaps = 9/101 (8%)
Query: 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGN----IPESLGYVQTLEVLRL 247
+ ++ + + L P VL + +S + + +L +L L L
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 248 DRNALTGKVPTNL-----NNLTNVNELNLAHNDLKGPFPDL 283
N L L + +L L D
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 14/94 (14%), Positives = 27/94 (28%), Gaps = 5/94 (5%)
Query: 122 GCGFTGNIPDEIGNLAELSFLALNSNNFSGR----IPPSLGKLSQLYWLDLADNQLTGSI 177
G + L L L + S + +L L LDL++N L +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 178 PVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQL 211
+ + + S + ++L
Sbjct: 414 -ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 12/83 (14%), Positives = 24/83 (28%), Gaps = 6/83 (7%)
Query: 242 LEVLRLDRNALTGK-VPTNLNNLTNVNELNLAHNDLKGPFPD-----LSQMNSLSYVDLS 295
++ L + L+ L L + L L L +L+ ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 296 NNSFDPTEAPLWFSTLPSLTTLI 318
+N L + + I
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 18/102 (17%), Positives = 37/102 (36%), Gaps = 10/102 (9%)
Query: 46 WKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGK----LSGDIGGLTELRSLDLSYNGGL 101
+G+ S + L L+ ++ L+ + LR LDLS N L
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNN-CL 409
Query: 102 TGSLSPRIGDLQK-----LNILILAGCGFTGNIPDEIGNLAE 138
+ ++ + + L L+L ++ + D + L +
Sbjct: 410 GDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 14/94 (14%), Positives = 24/94 (25%), Gaps = 4/94 (4%)
Query: 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSG----NIPESLGYVQTLEVLRL 247
+ + +LS +L V D L+ +I +L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFP 281
N L + + L+
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.7 bits (109), Expect = 2e-06
Identities = 35/199 (17%), Positives = 59/199 (29%), Gaps = 24/199 (12%)
Query: 55 SWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQK 114
V C + + DI L L+ N S G L
Sbjct: 9 EGTTVDCTGRGLKEI-----------PRDIP--LHTTELLLNDNELGRISSDGLFGRLPH 55
Query: 115 LNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLT 174
L L L TG P+ + + L L N L QL L+L DNQ++
Sbjct: 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQIS 115
Query: 175 GSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE 234
+P S + L + + N + F+ + + +G P
Sbjct: 116 CVMPGS------FEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSL--NGGAARCGAPS 167
Query: 235 SLGYVQTLEVLRLDRNALT 253
+ + +++ L +
Sbjct: 168 KV---RDVQIKDLPHSEFK 183
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 27/178 (15%), Positives = 59/178 (33%), Gaps = 12/178 (6%)
Query: 128 NIPDEI--GNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSP 185
++ D + L + + N+++ + L + L L N+LT P++ + +
Sbjct: 35 SVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNL 92
Query: 186 GLDQL------KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV 239
G L + K K + + ++ + L N + +
Sbjct: 93 GWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVL 152
Query: 240 QTLEVLRLDRNALTG-KVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSN 296
L L L LT + L L+ N + L+ + +L ++L +
Sbjct: 153 SRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.8 bits (102), Expect = 3e-05
Identities = 30/209 (14%), Positives = 61/209 (29%), Gaps = 33/209 (15%)
Query: 129 IPDEIG------NLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTI 182
+P I AE L + + + + +L+ + + ++ +
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV------ 61
Query: 183 TSPGLDQLKNAKHFHFNKNKLSGTI------SEQLFSPDMVLIHVLFDGNQLSGNIPESL 236
G+ L N N NKL+ + D + L L SL
Sbjct: 62 --QGIQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119
Query: 237 GYVQTLEVLRLDRNALTGKVPTNLNNLTNV--------NELNLAHNDLKGPFPDLSQMNS 288
+ ++ L + N +T++ + ++ L+ +
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTK 179
Query: 289 LSYVDLSNNSFDPTEAPLWFSTLPSLTTL 317
L + LS N A + L +L L
Sbjct: 180 LQNLYLSKNHISDLRA---LAGLKNLDVL 205
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 20/128 (15%), Positives = 36/128 (28%), Gaps = 10/128 (7%)
Query: 37 DAWQNTPPTWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLS 96
D + P S E + S + + ++ L L++S
Sbjct: 233 DNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 292
Query: 97 YNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPS 156
N L L L++L + +P+ NL +L + N P
Sbjct: 293 NN-KLI-ELPALPPRLERLI---ASFNHLA-EVPELPQNLKQLH---VEYNPLRE-FPDI 342
Query: 157 LGKLSQLY 164
+ L
Sbjct: 343 PESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 18/105 (17%), Positives = 36/105 (34%), Gaps = 19/105 (18%)
Query: 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKL 203
N S I L L++++N+L +P + + N L
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---------ALPPRLERLIASFNHL 316
Query: 204 SGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
+ + E + L + + N L P+ ++E LR++
Sbjct: 317 A-EVPELPQN----LKQLHVEYNPLRE-FPDIPE---SVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.3 bits (87), Expect = 0.004
Identities = 16/103 (15%), Positives = 30/103 (29%), Gaps = 10/103 (9%)
Query: 39 WQNTPPTWKNSDDPCGSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYN 98
PP + + + L +S KL L L S+N
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSN----NKLIELPALPPRLERLIASFN 314
Query: 99 GGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSF 141
L + +L++L+ + PD ++ +L
Sbjct: 315 -HLA-EVPELPQNLKQLH---VEYNPLRE-FPDIPESVEDLRM 351
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 18/122 (14%), Positives = 37/122 (30%), Gaps = 3/122 (2%)
Query: 231 NIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLS 290
+ + LD L + +L LN + + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELL 68
Query: 291 YVDLSNNSF-DPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349
++LSNN + P+L L L+ +++++ L N+ +
Sbjct: 69 SLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
Query: 350 NT 351
+T
Sbjct: 129 DT 130
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 26/156 (16%), Positives = 55/156 (35%), Gaps = 15/156 (9%)
Query: 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNS 146
L EL+ + L + + L G ++ L
Sbjct: 1 LNELKPEQVE-------QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNR-R 50
Query: 147 NNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGT 206
++ + + + +L L+L++N+L +S+I + + N K + + N+L +
Sbjct: 51 SSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSI----VQKAPNLKILNLSGNELK-S 105
Query: 207 ISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTL 242
E + L + DGN LS + Y+ +
Sbjct: 106 ERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.0 bits (90), Expect = 8e-04
Identities = 16/98 (16%), Positives = 32/98 (32%), Gaps = 4/98 (4%)
Query: 83 DIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTG--NIPDEIGNLAELS 140
D+ L+ + + +L ++ +L L L+ ++ + L
Sbjct: 37 DLVAQNIDVVLNRRSS--MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 141 FLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIP 178
L L+ N K +L L L N L+ +
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 2e-04
Identities = 36/204 (17%), Positives = 66/204 (32%), Gaps = 31/204 (15%)
Query: 129 IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLD 188
D LAE L N + S L Q+ L + SI G++
Sbjct: 12 FTDT--ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SID-------GVE 59
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLD 248
L N +F+ N+L+ + + + ++ ++ + TL +
Sbjct: 60 YLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ-I 118
Query: 249 RNALTGKVPTNLNNLTNVNELNLAHNDLKGP---------------FPDLSQMNSLSYVD 293
+ K TNLN L + + L G L+ + +L +D
Sbjct: 119 TDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLD 178
Query: 294 LSNNSFDPTEAPLWFSTLPSLTTL 317
+S+N + L +L +L
Sbjct: 179 ISSNKVSDISV---LAKLTNLESL 199
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 4e-04
Identities = 15/91 (16%), Positives = 30/91 (32%), Gaps = 3/91 (3%)
Query: 260 LNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLIC 319
N EL+L + + ++ +D S+N + F L L TL+
Sbjct: 14 YTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD---GFPLLRRLKTLLV 70
Query: 320 EFGSLQGRVPDKLFSYSQIQQVKLRNNAFNN 350
+ + + ++ L NN+
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVE 101
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (83), Expect = 0.004
Identities = 19/142 (13%), Positives = 45/142 (31%), Gaps = 10/142 (7%)
Query: 128 NIPDEIGNLAELSFLALNSNNFSGRIPP-SLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186
+ + L+ L + + + L L +L L + + L P + +P
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP- 80
Query: 187 LDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNI-PESLGYVQTLEVL 245
+ + N L ++S + + ++ GN L + L + +
Sbjct: 81 -----RLSRLNLSFNALE-SLSWKTVQGLSLQ-ELVLSGNPLHCSCALRWLQRWEEEGLG 133
Query: 246 RLDRNALTGKVPTNLNNLTNVN 267
+ L L ++ N +
Sbjct: 134 GVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 37.9 bits (86), Expect = 0.004
Identities = 15/112 (13%), Positives = 30/112 (26%), Gaps = 11/112 (9%)
Query: 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYV------QTL 242
+LK L + L + + LS ++ L
Sbjct: 216 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL 275
Query: 243 EVLRLDRNALTGKVPTNL-----NNLTNVNELNLAHNDLKGPFPDLSQMNSL 289
+ LRL N + L + ++ L L N + ++ +
Sbjct: 276 QTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 964 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.68 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.58 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.53 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.45 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.43 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.42 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.4 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.37 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.35 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.25 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.24 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.49 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.58 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.37 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.32 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.89 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.65 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.57 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.3 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.25 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=440.14 Aligned_cols=262 Identities=28% Similarity=0.473 Sum_probs=205.4
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|...+.||+|+||+||+|+++ ..||||+++... ....++|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467889999999999999999874 369999987543 3345679999999999999999999998754 56899999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||++|+|.++++... ..++|.++..++.|||+||+|||+.+ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997653 36999999999999999999999988 99999999999999999999999999987765444
Q ss_pred CceeecccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
........||+.|||||++.. +.++.++|||||||++|||+||+.||........ +........ ..+
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~---------~~p 229 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGY---------LSP 229 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTS---------CCC
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH-HHHHHhcCC---------CCC
Confidence 344556789999999999864 4589999999999999999999999975433222 222222211 111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
.+..........+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11111111224567899999999999999999999999988753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=431.51 Aligned_cols=258 Identities=30% Similarity=0.485 Sum_probs=204.1
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|+..+.||+|+||+||+|++.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 4678889999999999999999889999999997643 345689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++.... ..++|..++.++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 84 ~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TS 158 (263)
T ss_dssp TCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred CCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc-ee
Confidence 999999987653 46899999999999999999999988 99999999999999999999999999987654332 22
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTV 866 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 866 (964)
.....||+.|+|||++.++.++.++|||||||++|||+|+..|+.......+.+......... ..|..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~--------~~p~~---- 226 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL--------YKPRL---- 226 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCC--------CCCTT----
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCC--------CCccc----
Confidence 334579999999999999999999999999999999999655554444433333332221110 01111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 867 LLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 867 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
...++.+++.+||+.||++||||+||++.|+++.+.
T Consensus 227 --~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 114567899999999999999999999999998753
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=435.59 Aligned_cols=259 Identities=28% Similarity=0.449 Sum_probs=214.2
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|+..+.||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|++.+ +..++|||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 467888899999999999999998889999999976443 34679999999999999999999998854 5679999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++....+..++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++.+||+|||+|+...... ..
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT 165 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence 9999999887665556999999999999999999999988 9999999999999999999999999999875432 23
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......||+.|||||++.++.++.++|||||||++|||+||..|+.......+.+........ +..+..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~-----------~~~p~~ 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-----------MVRPDN 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC-----------CCCCTT
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------CCCccc
Confidence 334567999999999999999999999999999999999977776554444433333322111 011111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
....+.+++.+||+.||++||||+||++.|+.+...
T Consensus 235 ---~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 235 ---CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---ChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 113567899999999999999999999999988753
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-50 Score=436.55 Aligned_cols=262 Identities=27% Similarity=0.423 Sum_probs=217.5
Q ss_pred HHhhcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 623 KKCSNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 623 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
+...++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|+++|++++|||||+++++|.+++..++|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 334567888999999999999999975 58899999987543 3456799999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||||++|+|.+++.......++|..+..++.|||+||+|||+.+ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999999998766668999999999999999999999988 999999999999999999999999999876543
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. ........||+.|+|||++.++.++.++|||||||++|||++|+.|+..+....+... .+..... +.
T Consensus 169 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~-~i~~~~~----------~~ 236 (287)
T d1opja_ 169 T-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYR----------ME 236 (287)
T ss_dssp S-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH-HHHTTCC----------CC
T ss_pred C-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHH-HHhcCCC----------CC
Confidence 2 2334456689999999999999999999999999999999998888765544433322 2222210 01
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
.... ....+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 237 ~~~~---~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 RPEG---CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCcc---chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1111 11456789999999999999999999999987654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=427.03 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=205.0
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+++.+|+++|++++|||||++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5788999999999999999996 4799999999875433 2345789999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
|++|+|.+++.... .+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+........
T Consensus 85 ~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999997643 6999999999999999999999988 999999999999999999999999999987544333
Q ss_pred ceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 HVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||................... .+. .
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~---------~~~-~ 229 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY---------LNP-W 229 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT---------STT-G
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC---------CCc-c
Confidence 33455789999999999988776 578999999999999999999997544333333222221110 000 0
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .....+.+++.+||+.||++|||++|+++
T Consensus 230 ~---~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 230 K---KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp G---GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c---cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 11134568999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.8e-49 Score=430.23 Aligned_cols=259 Identities=27% Similarity=0.474 Sum_probs=198.3
Q ss_pred CCCccceeecCCcEEEEEEEec-CC---cEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DG---QVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
+|+..+.||+|+||+||+|+++ +| ..||||++..... ...++|.+|+++|++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4555689999999999999964 33 3689998875433 34567999999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||++|+|.+++.... ..++|.++..++.|||+||+|||+.+ ||||||||+||||++++.+||+|||+|+......
T Consensus 107 Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp ECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999887653 36999999999999999999999988 9999999999999999999999999998765432
Q ss_pred CCc---eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCccccccccccc
Q 002121 783 KGH---VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMM 858 (964)
Q Consensus 783 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (964)
... ......||+.|||||++.++.++.++|||||||++|||+| |+.||..... .+.+.. +..... .
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-~~~~~~-i~~~~~----~---- 252 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINA-IEQDYR----L---- 252 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHH-HHTTCC----C----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-HHHHHH-HHcCCC----C----
Confidence 211 1223457999999999999999999999999999999998 8999864332 222222 221110 0
Q ss_pred CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 859 DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 859 d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
... ......+.+++.+||+.||++||||.||++.|++++++.
T Consensus 253 --~~~---~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 253 --PPP---MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp --CCC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --CCC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence 000 011245678999999999999999999999999988653
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=423.30 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=208.1
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4689999999999999999995 579999999987655555678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++... .+++.++..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+...... .
T Consensus 100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--S 171 (293)
T ss_dssp TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--C
T ss_pred CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc--c
Confidence 999999988754 5899999999999999999999988 9999999999999999999999999999875432 2
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......||+.|+|||++.++.++.++||||+||++|||+||+.||...... +.+......... .. .....
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~~~~~~~~~~------~~---~~~~~ 241 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-RALYLIATNGTP------EL---QNPEK 241 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHHCSC------CC---SSGGG
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH-HHHHHHHhCCCC------CC---CCccc
Confidence 234567999999999999999999999999999999999999999754332 222222222110 00 00111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.+++.+||+.||++|||++|+++
T Consensus 242 ---~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 242 ---LSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1144668999999999999999999875
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-49 Score=418.39 Aligned_cols=245 Identities=26% Similarity=0.430 Sum_probs=205.3
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+|+.+ +|+.||+|++.... ......+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999974 68999999986432 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||++|+|.+++.... .+++.++..++.||++||+|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999997543 6999999999999999999999988 999999999999999999999999999866432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......||+.|||||++.+..++.++|||||||++|||++|+.||.... ..+........... .++.++
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~s--- 228 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-YQETYKRISRVEFT----FPDFVT--- 228 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHTTCCC----CCTTSC---
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC-HHHHHHHHHcCCCC----CCccCC---
Confidence 2344679999999999999999999999999999999999999996433 22333322222111 111111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+.+++.+||+.||++|||++|+++
T Consensus 229 --------~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 229 --------EGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------HHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 34568999999999999999999986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-48 Score=419.96 Aligned_cols=260 Identities=27% Similarity=0.439 Sum_probs=204.1
Q ss_pred cCCCccceeecCCcEEEEEEEecCC-----cEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDG-----QVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
..|+..+.||+|+||+||+|.++.. ..||||+++..... ...+|.+|++++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577789999999999999997532 47999999754433 34578999999999999999999999999999999
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
|||||.+|++.+++.... ..++|.+++.++.|||.||+|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999876543 46999999999999999999999988 99999999999999999999999999987654
Q ss_pred CCC-CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSK-GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... ........||+.|||||++.++.++.++|||||||++|||++|..|+..+....+.+........
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----------- 231 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----------- 231 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCC-----------
Confidence 322 12234456899999999999999999999999999999999987776554444333333222111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
+.... .....+.+++.+||+.||++||||.||++.|+.+++.
T Consensus 232 ~~~~~---~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 232 LPTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp CCCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCch---hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 01111 1124567899999999999999999999999998864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=411.84 Aligned_cols=253 Identities=28% Similarity=0.460 Sum_probs=211.0
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEecc
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMA 706 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~ 706 (964)
++|+..++||+|+||+||+|++++++.||||+++.... ..++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 57888999999999999999998899999999986544 34689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCce
Q 002121 707 NGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHV 786 (964)
Q Consensus 707 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 786 (964)
+|+|.+++.... ..+++..+++++.|+|+||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 83 ~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TS 157 (258)
T ss_dssp TEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CC
T ss_pred CCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc-ee
Confidence 999999976553 46899999999999999999999988 99999999999999999999999999987654433 23
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....||+.|+|||++....++.++|||||||++|||+| |+.||.... ..+.... +..... ...|..
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~-~~~~~~~-i~~~~~-------~~~p~~--- 225 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT-NSETAEH-IAQGLR-------LYRPHL--- 225 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-HHHHHHH-HHTTCC-------CCCCTT---
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC-HHHHHHH-HHhCCC-------CCCccc---
Confidence 344679999999999999999999999999999999998 788986433 2222222 222110 001111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIET 900 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 900 (964)
....+.+++.+||+.||++|||++|+++.|.+
T Consensus 226 ---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ---ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ---ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11456799999999999999999999988753
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-49 Score=423.12 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=207.9
Q ss_pred hcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
.++|++.+.||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++|||||+++|+|.+ +..++|||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 35788999999999999999999888899999997544 345689999999999999999999999854 5689999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|..++.......++|.+++.++.|||.||+|||+.+ |+||||||+||||++++++||+|||+|+....... .
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T 169 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCc-e
Confidence 9999999987654456999999999999999999999988 99999999999999999999999999987654322 3
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
......||+.|+|||++..+.++.++|||||||++|||+||+.|+..+....+.+......... -.++.+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~-------~~~~~~--- 239 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM-------PCPPEC--- 239 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC-------CCCTTS---
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC-------CCCccc---
Confidence 3344679999999999999999999999999999999999887876655554444433222110 011111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
..++.+++.+||+.||++||+|++|+++|+.+..
T Consensus 240 ----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 240 ----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred ----CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 1456789999999999999999999998887653
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=419.17 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=193.1
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEe--eCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFE--QGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lV 701 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5789999999999999999996 47999999998765432 34568899999999999999999999865 4568999
Q ss_pred EEeccCCChhhhhcCC--CCCccchHHHHHHHHHHHHHHHHHhhcC--CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 702 YEFMANGTLRESLSGR--SGIHLDWKRRLRIALGSARGLAYLHELA--NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
||||++|+|.+++... .+..+++..++.++.|++.||+|||+.+ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998642 2346999999999999999999999865 24599999999999999999999999999987
Q ss_pred ecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||.... ..+.......... . .
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~-~~~~~~~i~~~~~------~-~ 233 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIREGKF------R-R 233 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHTCC------C-C
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC-HHHHHHHHHcCCC------C-C
Confidence 65432 22345679999999999999999999999999999999999999996432 2222222222111 0 0
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+...+ ...+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~-------s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRY-------SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTS-------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCccc-------CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111 135678999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=420.28 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=205.2
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+.|++.+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4688889999999999999996 468999999998766666678999999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.... ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+...... .
T Consensus 92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~--~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 165 (288)
T ss_dssp TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--H
T ss_pred CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc--c
Confidence 9999999876432 36999999999999999999999988 9999999999999999999999999998654321 1
Q ss_pred eeecccccCcccCccccc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 786 VSTQVKGTMGYLDPEYYM-----TQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
......||+.|+|||++. ...|+.++|||||||++|||+||+.||...... +.+......... ....
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~i~~~~~~------~~~~- 237 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLKIAKSEPP------TLAQ- 237 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHHHHHSCCC------CCSS-
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHHHHcCCCC------CCCc-
Confidence 223467999999999984 456899999999999999999999999654322 222222222110 0000
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.......+.+++.+||+.||++|||++|+++
T Consensus 238 -----~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 238 -----PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp -----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0111245678999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=414.88 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=207.0
Q ss_pred cCCCccc-eeecCCcEEEEEEEec---CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESN-EIGSGGYGKVYRGMLS---DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~-~lG~G~fg~Vy~~~~~---~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|...+ +||+|+||+||+|.++ ++..||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455556 4999999999999864 356899999976543 345679999999999999999999999864 578999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||||++|+|.+++...+ ..+++.++..++.|||+||+|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999986543 46999999999999999999999988 999999999999999999999999999987543
Q ss_pred CCC-ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 782 SKG-HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 782 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... .......||+.|+|||++..+.++.++|||||||++|||+| |+.||..... .+... .+..... .+ ..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~~-~i~~~~~-----~~-~p 234 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVMA-FIEQGKR-----ME-CP 234 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHHH-HHHTTCC-----CC-CC
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHHHH-HHHcCCC-----CC-CC
Confidence 321 12234568999999999999999999999999999999998 8999974332 22222 2222110 00 11
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
+.. ...+.+++.+||+.||++||||.+|++.|+.+...
T Consensus 235 ~~~-------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 235 PEC-------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTC-------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcC-------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111 14567899999999999999999999999887643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=411.48 Aligned_cols=246 Identities=28% Similarity=0.432 Sum_probs=197.9
Q ss_pred CccceeecCCcEEEEEEEec-CCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEee----CceEEEE
Q 002121 630 SESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ----GEQMLVY 702 (964)
Q Consensus 630 ~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~~~~lV~ 702 (964)
+..++||+|+||+||+|+.. +++.||+|++.... ....+.+.+|+++|++++|||||++++++.+. ...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 44568999999999999964 68899999987543 23345789999999999999999999999763 4579999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC-CCCcEEEeecccceeecCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD-ENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~-~~~~~kl~DFGla~~~~~~ 781 (964)
|||++|+|.+++.... .+++.++..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~ 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence 9999999999997643 6899999999999999999999865 5699999999999996 5789999999999864322
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
......||+.|||||++.+ .++.++|||||||++|||++|+.||.................. .+.
T Consensus 169 ----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~----------~~~ 233 (270)
T d1t4ha_ 169 ----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK----------PAS 233 (270)
T ss_dssp ----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC----------CGG
T ss_pred ----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC----------Ccc
Confidence 2345679999999998864 6999999999999999999999999755444433333322211 011
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+... ...++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~---~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 FDKV---AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGC---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcc---CCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 1111 1134668999999999999999999975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=412.35 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=199.1
Q ss_pred ceeecCCcEEEEEEEecC---CcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEeccC
Q 002121 633 NEIGSGGYGKVYRGMLSD---GQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFMAN 707 (964)
Q Consensus 633 ~~lG~G~fg~Vy~~~~~~---g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~~~ 707 (964)
++||+|+||+||+|.+++ ++.||||+++.... ...++|.+|+++|++++|||||+++|+|. .+..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 579999999999998643 46899999875432 23457999999999999999999999985 4567999999999
Q ss_pred CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC-ce
Q 002121 708 GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG-HV 786 (964)
Q Consensus 708 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~-~~ 786 (964)
|+|.++++... .++|.+++.++.|||.||+|||+.+ ||||||||+|||++.++.+||+|||+|+........ ..
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999997653 6999999999999999999999988 999999999999999999999999999977544322 22
Q ss_pred eecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchhh
Q 002121 787 STQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNT 865 (964)
Q Consensus 787 ~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 865 (964)
.....||+.|||||++.++.++.++|||||||++|||+| |+.||..... .+ +...+..... ...+ ...
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-~~-~~~~i~~~~~--~~~p----~~~--- 235 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-SE-VTAMLEKGER--MGCP----AGC--- 235 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH-HHHHHHTTCC--CCCC----TTC---
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-HH-HHHHHHcCCC--CCCC----ccc---
Confidence 334579999999999999999999999999999999998 8999964332 22 2222222110 0011 111
Q ss_pred hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 866 VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 866 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
...+.+++.+||+.||++||||+||++.|+.+..
T Consensus 236 ----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 ----PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 1456789999999999999999999999887653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=424.20 Aligned_cols=257 Identities=21% Similarity=0.368 Sum_probs=207.5
Q ss_pred hcCCCccceeecCCcEEEEEEEecC-C-----cEEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD-G-----QVVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~-g-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 697 (964)
.++|+..+.||+|+||+||+|++.. + ..||||++.... ......+.+|+.+|.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999999642 2 369999986543 33445789999999998 89999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCC---------------------CccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCC
Q 002121 698 QMLVYEFMANGTLRESLSGRSG---------------------IHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKS 756 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 756 (964)
.++|||||++|+|.++++.+.. ..++|..++.++.|||+||+|||+.+ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999976531 35899999999999999999999988 99999999
Q ss_pred CcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCch
Q 002121 757 TNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKY 835 (964)
Q Consensus 757 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~ 835 (964)
+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999998766554444556678999999999999999999999999999999998 8999964332
Q ss_pred hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002121 836 VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIE 899 (964)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 899 (964)
. +.+...+..... +..+.. ....+.+++.+||+.||++||||+||++.|.
T Consensus 273 ~-~~~~~~~~~~~~----------~~~p~~---~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 D-ANFYKLIQNGFK----------MDQPFY---ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp S-HHHHHHHHTTCC----------CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H-HHHHHHHhcCCC----------CCCCCc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 2 222222222211 011111 1145678999999999999999999999885
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=419.23 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=203.7
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4688999999999999999996 479999999986432 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||++|+|.+++...+ .+++.++..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999987653 6999999999999999999999988 9999999999999999999999999999876544
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.........||+.|||||++.+..++.++||||+||++|||+||+.||.... .............. ..+. +
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~~----~p~~----~ 233 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-EYLIFQKIIKLEYD----FPEK----F 233 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHTTCCC----CCTT----C
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC-HHHHHHHHHcCCCC----CCcc----C
Confidence 3344455679999999999999999999999999999999999999997543 22223333222211 1111 1
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+||+.||++|||++|+++
T Consensus 234 -------s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 -------FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp -------CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred -------CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 134568999999999999999999764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-48 Score=427.56 Aligned_cols=200 Identities=28% Similarity=0.468 Sum_probs=177.7
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.++|+..+.||+|+||+||+|+. .+|+.||+|+++.... ....++.+|+++|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 56899999999999999999996 4789999999875433 334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhc-CCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHEL-ANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||++|+|.+++...+ .+++..+..++.|+++||+|||+. + |+||||||+|||+++++++||+|||+|+...+..
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~ 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 159 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCc
Confidence 999999999997643 589999999999999999999974 7 9999999999999999999999999998764321
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK 834 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~ 834 (964)
....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 160 ----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 160 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp ----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred ----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997543
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9e-48 Score=420.60 Aligned_cols=267 Identities=25% Similarity=0.384 Sum_probs=214.9
Q ss_pred HHHHHHhhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEE
Q 002121 619 YDELKKCSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 619 ~~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
+.+++...++|++.+.||+|+||+||+|+++ +++.||||+++..... ..++|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455566788999999999999999999864 3578999999765433 34679999999999999999999999
Q ss_pred EEeeCceEEEEEeccCCChhhhhcCCC----------------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCe
Q 002121 692 CFEQGEQMLVYEFMANGTLRESLSGRS----------------------GIHLDWKRRLRIALGSARGLAYLHELANPPI 749 (964)
Q Consensus 692 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 749 (964)
|.+.+..++||||+++|+|.++++... ...++|.+++.|+.|+|.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999986432 234899999999999999999999988 9
Q ss_pred eccCCCCCcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCC
Q 002121 750 IHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQP 829 (964)
Q Consensus 750 vH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p 829 (964)
|||||||+|||+|.++.+||+|||+|+...........+...||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876544443444556799999999999999999999999999999999999654
Q ss_pred CCCCchhHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 830 IEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
+..+....+.+........ .+ .+..+ ..++.+++.+||+.||++||||.||+++|+++.
T Consensus 242 p~~~~~~~e~~~~v~~~~~------~~-~p~~~-------~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNI------LA-CPENC-------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCC------CC-CCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHcCCC------CC-CCccc-------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 3333333333333322211 00 11111 145678999999999999999999999998763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.6e-47 Score=421.18 Aligned_cols=252 Identities=21% Similarity=0.304 Sum_probs=210.0
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999996 47999999999876666667899999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC--CCCcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD--ENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGla~~~~~~~ 782 (964)
|++|+|.+++.... ..+++.++..++.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+......
T Consensus 105 ~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 105 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999996543 36999999999999999999999998 99999999999995 46889999999999875432
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
......||+.|||||++.+..++.++||||+||++|||++|+.||... ...+.+......... . +...
T Consensus 181 ---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~----~----~~~~ 248 (350)
T d1koaa2 181 ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-NDDETLRNVKSCDWN----M----DDSA 248 (350)
T ss_dssp ---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHTCCC----S----CCGG
T ss_pred ---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCCC----C----Cccc
Confidence 234567999999999999999999999999999999999999999643 333334433322221 1 1111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ....+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~---~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 249 FSG---ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp GGG---CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ccC---CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 1134668999999999999999999976
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-47 Score=416.88 Aligned_cols=251 Identities=22% Similarity=0.360 Sum_probs=190.6
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.+.|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 467999999999999999999964 689999999875443 234568899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecccceeecC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~~ 780 (964)
||++|+|.+++...+ .+++.++..++.||+.||+|||+.+ ||||||||+|||+. +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999997653 6999999999999999999999988 99999999999994 578999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
.. .....+||+.|||||++.++.++.++||||+||++|||++|+.||..... .+............ .....+
T Consensus 163 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-~~~~~~i~~~~~~~----~~~~~~ 234 (307)
T d1a06a_ 163 GS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-AKLFEQILKAEYEF----DSPYWD 234 (307)
T ss_dssp -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHTTCCCC----CTTTTT
T ss_pred CC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-HHHHHHHhccCCCC----CCcccc
Confidence 32 23446799999999999999999999999999999999999999965432 22222332222211 100111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+ ...+.+++.+||+.||++|||++|+++
T Consensus 235 ~~-------s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 235 DI-------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TS-------CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CC-------CHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 11 144668999999999999999999875
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.1e-46 Score=419.02 Aligned_cols=251 Identities=20% Similarity=0.345 Sum_probs=209.3
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++.........+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999996 479999999998766566677899999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC--CCCcEEEeecccceeecCCCC
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD--ENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~--~~~~~kl~DFGla~~~~~~~~ 783 (964)
++|+|.+++.... ..+++.++..|+.||+.||+|||+.+ ||||||||+|||++ .++.+||+|||+|+......
T Consensus 109 ~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~- 183 (352)
T d1koba_ 109 SGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 183 (352)
T ss_dssp CCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred CCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence 9999999876543 46999999999999999999999988 99999999999998 67899999999999875432
Q ss_pred CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+.+......... ......+.+
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~----~~~~~~~~~- 255 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-DLETLQNVKRCDWE----FDEDAFSSV- 255 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-HHHHHHHHHHCCCC----CCSSTTTTS-
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC----CCcccccCC-
Confidence 2345679999999999999999999999999999999999999996433 22333333222211 111111111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...+.+++.+||+.||++|||++|+++
T Consensus 256 ------s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 256 ------SPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ------CHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 144668999999999999999999975
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.6e-47 Score=412.61 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=201.1
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch---hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG---GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
.|+..+.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+++|++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 488899999999999999995 578999999987654332 3468899999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
||++|+|..++... ..+++.++..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC--
Confidence 99999998776544 36999999999999999999999988 999999999999999999999999999865432
Q ss_pred CceeecccccCcccCcccccc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMT---QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDP 860 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 860 (964)
....||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... +.+......... ...+.
T Consensus 169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~-~~~~~i~~~~~~------~~~~~ 237 (309)
T d1u5ra_ 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-SALYHIAQNESP------ALQSG 237 (309)
T ss_dssp ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-HHHHHHHHSCCC------CCSCT
T ss_pred ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHhCCCC------CCCCC
Confidence 23569999999999863 56899999999999999999999999754332 333332222110 11111
Q ss_pred cchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 861 TIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 861 ~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+ ...+.+++.+||+.||++|||++|+++
T Consensus 238 ~~-------s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 238 HW-------SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp TS-------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-------CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11 145668999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=405.89 Aligned_cols=252 Identities=27% Similarity=0.422 Sum_probs=198.4
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEe-eCceEEEEEec
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFE-QGEQMLVYEFM 705 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lV~E~~ 705 (964)
++|+..+.||+|+||.||+|+++ |+.||||+++... ..++|.+|++++++++|||||+++|+|.+ ++..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46777899999999999999984 7899999997543 34679999999999999999999999965 46689999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
++|+|.+++.......++|..+++|+.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 9999999997654456899999999999999999999987 999999999999999999999999999865432
Q ss_pred eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccCccchh
Q 002121 786 VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIRN 864 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 864 (964)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.|+... ...+.+........ +.+..
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~i~~~~~-----------~~~~~ 223 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYK-----------MDAPD 223 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHHHTTTCC-----------CCCCT
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCCC-----------CCCCc
Confidence 223468999999999999999999999999999999999 57666532 22222222211111 11111
Q ss_pred hhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 865 TVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 865 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
. ...++.+++.+||+.||++||||.|+++.|+++.+.
T Consensus 224 ~---~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 224 G---CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred c---CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 1 114566899999999999999999999999988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=407.20 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=206.0
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc------chhHHHHHHHHHHHhcCCCCccceeEEEEeeCce
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM------QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 698 (964)
.+.|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+++|++++|||||++++++.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36799999999999999999996 5799999999865332 2246799999999999999999999999999999
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC----cEEEeeccc
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL----TAKVADFGL 774 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~----~~kl~DFGl 774 (964)
++|||||++|+|.+++.... .+++.++..++.|++.||+|||+.+ ||||||||+|||++.++ .+||+|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999997643 6999999999999999999999988 99999999999998876 599999999
Q ss_pred ceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 775 SKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 775 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
|+...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ..+.+.........
T Consensus 164 a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-~~~~~~~i~~~~~~----- 234 (293)
T d1jksa_ 164 AHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-KQETLANVSAVNYE----- 234 (293)
T ss_dssp CEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHTTCCC-----
T ss_pred hhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-HHHHHHHHHhcCCC-----
Confidence 98875432 2334579999999999999999999999999999999999999996432 22333322222111
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
..+... ......+.+++.+||+.||++|||++|+++
T Consensus 235 ---~~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ---FEDEYF---SNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ---CCHHHH---TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CCchhc---CCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011111 111245668999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-47 Score=412.55 Aligned_cols=268 Identities=25% Similarity=0.413 Sum_probs=203.9
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEE
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGF 691 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~ 691 (964)
++++...++|+..++||+|+||+||+|++. +++.||||+++.... ...+++.+|+.++.++ +|+|||+++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344444578999999999999999999853 246899999875443 3345688888888887 68999999999
Q ss_pred EEee-CceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCC
Q 002121 692 CFEQ-GEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKS 756 (964)
Q Consensus 692 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~ 756 (964)
+.+. +..++|||||++|+|.++++... ...++|.++..++.|||+||+|||+++ ||||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 8765 46899999999999999996542 235899999999999999999999988 99999999
Q ss_pred CcEEECCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCC-CCCCCch
Q 002121 757 TNILLDENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQ-PIEKGKY 835 (964)
Q Consensus 757 ~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~-p~~~~~~ 835 (964)
+|||+++++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||.. ||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987665444444455679999999999999999999999999999999999754 6653322
Q ss_pred hHHHHHHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 836 VVREVRTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
.+.+...+..... +..... ....+.+++.+||+.||++||||+|+++.|+.+++.
T Consensus 243 -~~~~~~~~~~~~~----------~~~~~~---~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 -DEEFCRRLKEGTR----------MRAPDY---TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp -SHHHHHHHHHTCC----------CCCCTT---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHHhcCCC----------CCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 2223222222211 011111 113567899999999999999999999999998864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=410.11 Aligned_cols=257 Identities=23% Similarity=0.427 Sum_probs=201.6
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc----EEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ----VVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.+|+..+.||+|+||+||+|++. +|+ +||+|+++... ....++|.+|++++++++|||||+++|+|.+ +..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence 46899999999999999999964 444 68999887533 3445689999999999999999999999976 46788
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+.+|+|.+++.... ..++|..+++++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 999999999999887653 46999999999999999999999988 99999999999999999999999999998765
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
...........||+.|+|||++.++.++.++|||||||++|||+| |++||..... .+ +...+...... ...+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~-~~~~i~~~~~~--~~p~--- 236 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SE-ISSILEKGERL--PQPP--- 236 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GG-HHHHHHHTCCC--CCCT---
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-HH-HHHHHHcCCCC--CCCc---
Confidence 544444455679999999999999999999999999999999999 7888764221 11 11111111100 0111
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
. ....+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 237 -~-------~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 237 -I-------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp -T-------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -c-------cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1 11456789999999999999999999999988764
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=405.55 Aligned_cols=259 Identities=26% Similarity=0.402 Sum_probs=198.4
Q ss_pred hcCCCccceeecCCcEEEEEEEecC----CcEEEEEEecCCCcc-hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD----GQVVAIKRAQQGSMQ-GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 700 (964)
.++|...+.||+|+||+||+|++.. +..||||+++..... ..+.|.+|+++|++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4578889999999999999998642 457999998754433 3457999999999999999999999995 467899
Q ss_pred EEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecC
Q 002121 701 VYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSD 780 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~ 780 (964)
||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ ||||||||+||++++++.+||+|||+|+....
T Consensus 85 v~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccC
Confidence 999999999999876543 46899999999999999999999988 99999999999999999999999999987654
Q ss_pred CCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccccC
Q 002121 781 SSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMD 859 (964)
Q Consensus 781 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 859 (964)
... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||..... .+.+......... ..+
T Consensus 161 ~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-~~~~~~i~~~~~~-------~~~ 231 (273)
T d1mp8a_ 161 STY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRIENGERL-------PMP 231 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHHHTTCCC-------CCC
T ss_pred Ccc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCC-------CCC
Confidence 322 23445678999999999999999999999999999999998 7888864322 1122222211110 011
Q ss_pred ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 860 PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 860 ~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
+.+ ...+.+++.+||+.||++|||+.||++.|+.+++++
T Consensus 232 ~~~-------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 232 PNC-------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp TTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCC-------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 111 145678999999999999999999999999988664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=408.23 Aligned_cols=260 Identities=28% Similarity=0.426 Sum_probs=207.8
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCc--EEEEEEecCCC-cchhHHHHHHHHHHHhc-CCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQ--VVAIKRAQQGS-MQGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|+..++||+|+||+||+|+++ +|. .||||+++... ....++|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56778899999999999999975 444 57888876443 33456799999999999 799999999999999999999
Q ss_pred EEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcE
Q 002121 702 YEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTA 767 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~ 767 (964)
|||+++|+|.++++... ...++|.++..++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997542 356899999999999999999999988 9999999999999999999
Q ss_pred EEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccC
Q 002121 768 KVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRD 847 (964)
Q Consensus 768 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~ 847 (964)
||+|||+|+....... .....||..|+|||.+..+.++.++|||||||++|||++|..|+..+....+.+.......
T Consensus 167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~ 243 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 243 (309)
T ss_dssp EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence 9999999986543221 2345689999999999999999999999999999999998765444444444433332211
Q ss_pred cccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 848 DEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 848 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
. +..... ....+.+++.+||+.||++||||.||++.|++++++..
T Consensus 244 ~-----------~~~~~~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 244 R-----------LEKPLN---CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp C-----------CCCCTT---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred C-----------CCCCcc---CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 1 111111 11456789999999999999999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-46 Score=408.07 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=216.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCcc-hhHHHHHHHHHHHhc-CCCCccceeEEEEeeCc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSMQ-GGLEFKTEIELLSRV-HHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 697 (964)
.++|+..+.||+|+||.||+|++. +++.||||+++..... ...+|.+|+.+++++ +|||||+++++|.+.+.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 467888899999999999999852 4578999999865433 345789999999999 69999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC----------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 698 QMLVYEFMANGTLRESLSGRS----------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
.++|||||++|+|.++++... ...+++..+..++.|||+||+|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999987542 235899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR 841 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~ 841 (964)
+.++.+|++|||+++...........+...||+.|+|||++.++.++.++|||||||++|||+|++.|+..+......+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999987665555555667899999999999999999999999999999999996555544433333333
Q ss_pred HHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhC
Q 002121 842 TAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQND 905 (964)
Q Consensus 842 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~ 905 (964)
..+..... +..... ....+.+++.+||+.||++||||+||+++|++.+++.
T Consensus 259 ~~i~~~~~----------~~~~~~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 259 KMIKEGFR----------MLSPEH---APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp HHHHHTCC----------CCCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHhcCCC----------CCCccc---ccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 33322211 000111 1145679999999999999999999999999887653
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-46 Score=405.38 Aligned_cols=267 Identities=26% Similarity=0.388 Sum_probs=205.3
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC----ceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG----EQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lV~ 702 (964)
++|...+.||+|+||+||+|++ +|+.||||+++.... ....++.|+..+.+++|||||+++++|.+.+ ..++||
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~ 80 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence 4566778999999999999997 589999999864321 1122334555566789999999999998765 578999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC-----CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA-----NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
|||++|+|.++++.. .++|..+++++.|+|.||+|||+.+ .++||||||||+||||++++.+||+|||+++.
T Consensus 81 Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 81 DYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp ECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence 999999999999864 4999999999999999999999741 24599999999999999999999999999998
Q ss_pred ecCCCCC--ceeecccccCcccCccccccC------CCCCchhHHHHHHHHHHHHhCCCCCCCCc-------------hh
Q 002121 778 VSDSSKG--HVSTQVKGTMGYLDPEYYMTQ------QLTEKSDVYSFGVVMLELITAKQPIEKGK-------------YV 836 (964)
Q Consensus 778 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~sDv~S~Gvvl~elltg~~p~~~~~-------------~~ 836 (964)
....... .......||+.|+|||++... .++.++|||||||++|||+||..|+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence 7654321 123456799999999998654 36779999999999999999988764211 11
Q ss_pred HHHHHHHhccCcccccccccccCccchhh--hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCC
Q 002121 837 VREVRTAMNRDDEEHYGLTEMMDPTIRNT--VLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907 (964)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 907 (964)
.......... +.++|.+... .......+.+++.+||+.||++||||.||++.|+++.++++.
T Consensus 238 ~~~~~~~~~~---------~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~ 301 (303)
T d1vjya_ 238 VEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp HHHHHHHHTT---------SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHhc---------cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCC
Confidence 2222222211 1223333222 233456688999999999999999999999999999887764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-45 Score=398.20 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=204.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---hhHHHHHHHHHHHhcCCCCccceeEEEEeeCc----
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE---- 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~---- 697 (964)
.++|.+.+.||+|+||+||+|+. .+|+.||||+++..... ....+.+|++++++++|||||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 46799999999999999999995 57999999999764332 23468999999999999999999999987654
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.|+|||||++|+|.+++...+ .+++.++..++.||+.||+|||+.+ ||||||||+|||++.++..+++|||.++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhh
Confidence 789999999999999887653 6999999999999999999999988 99999999999999999999999999876
Q ss_pred ecCCCC-CceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccccc
Q 002121 778 VSDSSK-GHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTE 856 (964)
Q Consensus 778 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (964)
...... ........||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..+.....+...... ..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~~~~~~~~~----~~ 235 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-PVSVAYQHVREDPIP----PS 235 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-HHHHHHHHHHCCCCC----GG
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-HHHHHHHHHhcCCCC----Cc
Confidence 543322 223445679999999999999999999999999999999999999996543 333333333332211 11
Q ss_pred ccCccchhhhHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHH
Q 002121 857 MMDPTIRNTVLLGFRRYLELALQCVEESATDRP-TMSEVVKAIETLL 902 (964)
Q Consensus 857 ~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~~~ 902 (964)
...+.+. ..+.+++.+||+.||++|| |++|+.+.|.++.
T Consensus 236 ~~~~~~s-------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 236 ARHEGLS-------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp GTSSSCC-------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred hhccCCC-------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1111111 4566899999999999999 8999998888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=403.88 Aligned_cols=255 Identities=30% Similarity=0.469 Sum_probs=204.3
Q ss_pred cceeecCCcEEEEEEEecCC----cEEEEEEecCCC-cchhHHHHHHHHHHHhcCCCCccceeEEEEee-CceEEEEEec
Q 002121 632 SNEIGSGGYGKVYRGMLSDG----QVVAIKRAQQGS-MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-GEQMLVYEFM 705 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lV~E~~ 705 (964)
.++||+|+||+||+|++.++ ..||||+++... ....++|.+|+++|++++|||||+++|++.+. +..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46899999999999997432 368999997543 33456799999999999999999999998764 5789999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC-
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG- 784 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~- 784 (964)
++|+|.++++... ..+++..++.++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999988654 46789999999999999999999988 999999999999999999999999999876543221
Q ss_pred -ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccch
Q 002121 785 -HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTIR 863 (964)
Q Consensus 785 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 863 (964)
.......||+.|+|||++.++.++.++||||||+++|||+||+.||.......+........... ..+.
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~--------~~p~-- 257 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--------LQPE-- 257 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC--------CCCT--
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC--------CCcc--
Confidence 22234568999999999999999999999999999999999888887544433333332222110 0111
Q ss_pred hhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHh
Q 002121 864 NTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQN 904 (964)
Q Consensus 864 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~ 904 (964)
. ....+.+++.+||+.||++||+|.||++.|+.+.+.
T Consensus 258 -~---~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 258 -Y---CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp -T---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -c---CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1 114567899999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-45 Score=406.47 Aligned_cols=248 Identities=23% Similarity=0.284 Sum_probs=205.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
.++|.+.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 35789999999999999999996 579999999987532 22345788999999999999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||||++|+|.+++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++++|.+||+|||+|+.....
T Consensus 84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999998654 5888999999999999999999998 999999999999999999999999999875432
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|++||.... ..+........... ....+.
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-~~~~~~~i~~~~~~----~p~~~s-- 229 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILMEEIR----FPRTLS-- 229 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTSC--
T ss_pred C--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-HHHHHHHHhcCCCC----CCccCC--
Confidence 2 22345679999999999999999999999999999999999999997543 22223322222211 111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
..+.+++.+||+.||++||+ ++|+++
T Consensus 230 ---------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 230 ---------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---------HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 34568999999999999995 778765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.1e-45 Score=403.13 Aligned_cols=244 Identities=23% Similarity=0.366 Sum_probs=204.3
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688999999999999999996 469999999986432 223457899999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
|||++|+|..++.... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence 9999999999987654 5788889999999999999999988 999999999999999999999999999986543
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....||+.|||||++.+..++.++||||+||++|||+||+.||.... ..+........... ....++
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~-~~~~~~~i~~~~~~----~p~~~s--- 225 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKILNAELR----FPPFFN--- 225 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHCCCC----CCTTSC---
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC-HHHHHHHHHcCCCC----CCCCCC---
Confidence 234679999999999999999999999999999999999999996533 23333333322211 111111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
..+.+++.+||+.||.+|| |++|+++
T Consensus 226 --------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 --------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --------HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 3456899999999999996 8888875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=401.29 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=208.3
Q ss_pred hcCCCccceeecCCcEEEEEEEecC--------CcEEEEEEecCCCc-chhHHHHHHHHHHHhc-CCCCccceeEEEEee
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLSD--------GQVVAIKRAQQGSM-QGGLEFKTEIELLSRV-HHKNLVGLVGFCFEQ 695 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~~--------g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 695 (964)
.++|.+.+.||+|+||.||+|+... +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3577888999999999999998532 24799999976544 3346788999999998 899999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCC--------------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEE
Q 002121 696 GEQMLVYEFMANGTLRESLSGRS--------------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILL 761 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl 761 (964)
+..++|||||++|+|.+++..+. ...+++.+++.++.|||.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997553 235899999999999999999999988 9999999999999
Q ss_pred CCCCcEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHH
Q 002121 762 DENLTAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREV 840 (964)
Q Consensus 762 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~ 840 (964)
+.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |++||.... .. .+
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~-~~-~~ 246 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-VE-EL 246 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-HH-HH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-HH-HH
Confidence 9999999999999998766554444556779999999999999999999999999999999998 677775332 22 22
Q ss_pred HHHhccCcccccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002121 841 RTAMNRDDEEHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQ 903 (964)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~ 903 (964)
...+...... ... ... ...+.+++.+||+.||++||||.||++.|+++++
T Consensus 247 ~~~i~~~~~~--~~p----~~~-------~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 FKLLKEGHRM--DKP----SNC-------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHTTCCC--CCC----SSC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHcCCCC--CCC----ccc-------hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 2332222110 011 111 1456799999999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=397.56 Aligned_cols=256 Identities=23% Similarity=0.379 Sum_probs=196.0
Q ss_pred cCCCccceeecCCcEEEEEEEec--CC--cEEEEEEecCCCc---chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS--DG--QVVAIKRAQQGSM---QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~--~g--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
++|+..+.||+|+||+||+|++. ++ ..||||+++.... ...++|.+|+++|++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 46888999999999999999853 23 3789998875432 234579999999999999999999999965 5678
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+|||||++|++.+++..+. ..+++..++.++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887543 46999999999999999999999988 9999999999999999999999999999875
Q ss_pred CCCCCc-eeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHh-CCCCCCCCchhHHHHHHHhccCcccccccccc
Q 002121 780 DSSKGH-VSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELIT-AKQPIEKGKYVVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 780 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
...... ......||..|+|||++.+..++.++|||||||++|||+| |+.||.. ....+.+......... . +
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~-~~~~~~~~~i~~~~~~----~-~- 235 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG-LNGSQILHKIDKEGER----L-P- 235 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT-CCHHHHHHHHHTSCCC----C-C-
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC-cCHHHHHHHHHhCCCC----C-C-
Confidence 543322 2334568889999999999999999999999999999998 8999864 3333333333222211 0 0
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETL 901 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~ 901 (964)
..+.+ ...+.+++.+||+.||++||||.||.+.|++.
T Consensus 236 ~~~~~-------~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 236 RPEDC-------PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCTTC-------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccccc-------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 01111 13567899999999999999999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-46 Score=408.75 Aligned_cols=261 Identities=24% Similarity=0.389 Sum_probs=212.3
Q ss_pred hhcCCCccceeecCCcEEEEEEEec------CCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeCc
Q 002121 625 CSNNFSESNEIGSGGYGKVYRGMLS------DGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGE 697 (964)
Q Consensus 625 ~~~~~~~~~~lG~G~fg~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 697 (964)
..++|...+.||+|+||+||+|.+. +++.||||+++.... .....|.+|++++++++|||||+++++|..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 3467888899999999999999863 357899999975443 334568999999999999999999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCC--------CCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEE
Q 002121 698 QMLVYEFMANGTLRESLSGRS--------GIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKV 769 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl 769 (964)
.++|||||++|+|.++++..+ ...++|..+.+++.|+|+||+|||+.+ |+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999886432 234789999999999999999999987 999999999999999999999
Q ss_pred eecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc
Q 002121 770 ADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 770 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
+|||+|+...............||+.|+|||.+.++.++.++|||||||++|||+||+.|+..+....+.+.........
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~ 254 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 254 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCC
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999987755443333444568999999999999999999999999999999999965444444554544443322210
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLL 902 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~ 902 (964)
. ... . ....+.+++.+||+.+|++||||.||++.|++.+
T Consensus 255 ~---~p~----~-------~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 255 D---KPD----N-------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp C---CCT----T-------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred C---Ccc----c-------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 0 111 1 1145779999999999999999999999887653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4e-45 Score=393.19 Aligned_cols=250 Identities=25% Similarity=0.313 Sum_probs=204.1
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc---------hhHHHHHHHHHHHhcC-CCCccceeEEEEee
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ---------GGLEFKTEIELLSRVH-HKNLVGLVGFCFEQ 695 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 695 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5788999999999999999996 57899999998754321 1235789999999997 99999999999999
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
+..|+|||||++|+|.+++..+. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999997643 6999999999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCCceeecccccCcccCcccccc------CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMT------QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDE 849 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~ 849 (964)
+...... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||..... .............
T Consensus 158 ~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-~~~~~~i~~~~~~ 233 (277)
T d1phka_ 158 CQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-MLMLRMIMSGNYQ 233 (277)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHTCCC
T ss_pred eEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-HHHHHHHHhCCCC
Confidence 9875432 2345679999999999853 3578899999999999999999999975432 2222223322211
Q ss_pred cccccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 850 EHYGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 850 ~~~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. . .+.. .....++.+++.+||+.||++|||++||++
T Consensus 234 ~----~---~~~~----~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 234 F----G---SPEW----DDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C----C---TTTG----GGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C----C---Cccc----ccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 0000 111245678999999999999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-45 Score=402.23 Aligned_cols=250 Identities=22% Similarity=0.298 Sum_probs=199.1
Q ss_pred hcCCCccc-eeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhc-CCCCccceeEEEEe----eCce
Q 002121 626 SNNFSESN-EIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRV-HHKNLVGLVGFCFE----QGEQ 698 (964)
Q Consensus 626 ~~~~~~~~-~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~ 698 (964)
.++|.+.. .||+|+||+||+|+. .+|+.||||+++. ...+.+|++++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 35788765 599999999999996 5799999999864 24678899987665 89999999999876 4668
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC---CCcEEEeecccc
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE---NLTAKVADFGLS 775 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~---~~~~kl~DFGla 775 (964)
|+|||||++|+|.+++..+....+++.++..++.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 99999999999999998765567999999999999999999999988 999999999999985 567999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch--hHHHHHHHhccCcccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY--VVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~ 853 (964)
+....... .....||+.|||||++.+..|+.++|||||||++|||+||+.||..... ....+........
T Consensus 162 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~----- 233 (335)
T d2ozaa1 162 KETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----- 233 (335)
T ss_dssp EECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS-----
T ss_pred eeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC-----
Confidence 87654322 3446799999999999999999999999999999999999999964221 1111111111000
Q ss_pred cccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002121 854 LTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVKA 897 (964)
Q Consensus 854 ~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 897 (964)
..++.. .......+.+++.+||+.||++|||+.|+++.
T Consensus 234 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 234 ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ------SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 001111 11223557799999999999999999999863
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=398.61 Aligned_cols=251 Identities=18% Similarity=0.276 Sum_probs=206.2
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
.++|.+.+.||+|+||+||+|+.. +|+.||||+++.... ....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 467899999999999999999964 689999999976433 345688999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCC--CcEEEeecccceeecCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDEN--LTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~--~~~kl~DFGla~~~~~~~ 782 (964)
|++|+|.+++.... ..+++.++..++.||+.||+|||+.+ |+||||||+|||++.+ +.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp CCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 99999999997653 36899999999999999999999988 9999999999999854 58999999999876443
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.......||+.|+|||...+..++.++||||+||++|||++|+.||.... ..+.+......... ++...
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-~~~~~~~i~~~~~~--------~~~~~ 226 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-NQQIIENIMNAEYT--------FDEEA 226 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-HHHHHHHHHHTCCC--------CCHHH
T ss_pred --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhCCCC--------CChhh
Confidence 23344679999999999999999999999999999999999999996543 22233333222211 11111
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .....+.+++.+||+.||++|||++|+++
T Consensus 227 ~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 227 FK---EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cc---CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 11234678999999999999999999986
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-44 Score=402.47 Aligned_cols=244 Identities=20% Similarity=0.287 Sum_probs=204.4
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC---cchhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS---MQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~ 702 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4788999999999999999996 479999999986432 223356889999999999999999999999999999999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSS 782 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~ 782 (964)
||+.+|+|.+++...+ .+++.++..++.||+.||.|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence 9999999999997653 6899999999999999999999988 999999999999999999999999999986532
Q ss_pred CCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCccc
Q 002121 783 KGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPTI 862 (964)
Q Consensus 783 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 862 (964)
.....||+.|||||++.+..++.++|||||||++|||+||+.||... ............... ... .+
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-~~~~~~~~i~~~~~~----~p~----~~ 261 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKIVSGKVR----FPS----HF 261 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-SHHHHHHHHHHCCCC----CCT----TC
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-CHHHHHHHHhcCCCC----CCc----cC
Confidence 23457999999999999999999999999999999999999999643 333333333322211 111 11
Q ss_pred hhhhHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002121 863 RNTVLLGFRRYLELALQCVEESATDRP-----TMSEVVK 896 (964)
Q Consensus 863 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 896 (964)
...+.+++.+||+.||.+|+ |++|+++
T Consensus 262 -------s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 262 -------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -------CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 13466899999999999994 8999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.3e-44 Score=402.58 Aligned_cols=247 Identities=23% Similarity=0.321 Sum_probs=197.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc---chhHHHHH---HHHHHHhcCCCCccceeEEEEeeCceE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM---QGGLEFKT---EIELLSRVHHKNLVGLVGFCFEQGEQM 699 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~---E~~~l~~l~H~nIv~l~~~~~~~~~~~ 699 (964)
++|++.+.||+|+||+||+|+.. +|+.||||++..... .....+.+ |+++++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57899999999999999999964 699999999864221 11223444 467777788999999999999999999
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+|||||++|+|.+++.... .+++.++..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999997643 6889999999999999999999988 9999999999999999999999999999765
Q ss_pred CCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCch-hHHHHHHHhccCcccccccccc
Q 002121 780 DSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKY-VVREVRTAMNRDDEEHYGLTEM 857 (964)
Q Consensus 780 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 857 (964)
... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||..... ....+........ ....+.
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~ 231 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA---VELPDS 231 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCC---CCCCSS
T ss_pred CCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC---CCCCCC
Confidence 432 234579999999999975 5689999999999999999999999974322 1122221111111 111111
Q ss_pred cCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 858 MDPTIRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 858 ~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
++ ..+.+++.+||+.||++||| ++|+++
T Consensus 232 ~s-----------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 232 FS-----------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SC-----------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC-----------HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 34568999999999999999 677764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-45 Score=398.65 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=201.5
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCC---cchhHHHHHHHHHHH-hcCCCCccceeEEEEeeCceEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGS---MQGGLEFKTEIELLS-RVHHKNLVGLVGFCFEQGEQMLV 701 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lV 701 (964)
++|.+.+.||+|+||+||+|+.. +|+.||||+++... ....+.+..|+.++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999964 78999999986432 222345667777665 68999999999999999999999
Q ss_pred EEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCC
Q 002121 702 YEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 702 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~ 781 (964)
||||++|+|.+++.... .+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc
Confidence 99999999999997654 5888999999999999999999988 999999999999999999999999999866433
Q ss_pred CCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCcccccccccccCcc
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGLTEMMDPT 861 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 861 (964)
. ...+...||+.|+|||++.++.++.++||||+||++|||+||+.||.... ..+........... ....++
T Consensus 157 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~-~~~~~~~i~~~~~~----~p~~~s-- 227 (320)
T d1xjda_ 157 D--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIRMDNPF----YPRWLE-- 227 (320)
T ss_dssp T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-HHHHHHHHHHCCCC----CCTTSC--
T ss_pred c--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC-HHHHHHHHHcCCCC----CCccCC--
Confidence 2 23345679999999999999999999999999999999999999996433 22323222222111 111111
Q ss_pred chhhhHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 002121 862 IRNTVLLGFRRYLELALQCVEESATDRPTMS-EVVK 896 (964)
Q Consensus 862 l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 896 (964)
..+.+++.+||+.||++||++. |+++
T Consensus 228 ---------~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 228 ---------KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---------HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 3456899999999999999995 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=391.07 Aligned_cols=257 Identities=25% Similarity=0.345 Sum_probs=195.4
Q ss_pred cceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcch-----hHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEec
Q 002121 632 SNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQG-----GLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEFM 705 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~~ 705 (964)
+++||+|+||+||+|+. .+|+.||||+++...... ...+.+|+++|++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 57899999999999996 469999999986543221 246889999999999999999999999999999999999
Q ss_pred cCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCCc
Q 002121 706 ANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKGH 785 (964)
Q Consensus 706 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~~ 785 (964)
+++++..+.... ..+++.++..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp SEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred cchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence 998877766543 46899999999999999999999988 99999999999999999999999999987654322
Q ss_pred eeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCccccc----ccccc
Q 002121 786 VSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDEEHY----GLTEM 857 (964)
Q Consensus 786 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~----~~~~~ 857 (964)
......||+.|+|||++..+ .++.++||||+||++|||+||+.||..... .+.+... ......... .....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCChhhccchhccchh
Confidence 23345799999999998754 679999999999999999999999864332 2222222 211111100 00000
Q ss_pred c------CccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 M------DPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~------d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. ...+..........+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0 00011111112346789999999999999999999975
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-44 Score=390.14 Aligned_cols=263 Identities=22% Similarity=0.338 Sum_probs=200.2
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|+..+.||+|+||+||+|+. .+|+.||||+++.... ....++.+|+++|++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5789999999999999999996 5799999999965432 234678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
|+.+ ++.+++.......+++.++..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 9976 4444444333457999999999999999999999988 9999999999999999999999999998765432
Q ss_pred CceeecccccCcccCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh---ccCcccccc----cc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM---NRDDEEHYG----LT 855 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~~~~~~~----~~ 855 (964)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||...... +.+.... ....+.... ..
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMP 234 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhcccccccc
Confidence 2233457999999999877655 578999999999999999999999754322 2222211 111111000 00
Q ss_pred -------cccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 -------EMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 -------~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.................+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000111111112245778999999999999999999975
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=386.20 Aligned_cols=239 Identities=25% Similarity=0.431 Sum_probs=195.5
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc------hhHHHHHHHHHHHhcC--CCCccceeEEEEeeCc
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ------GGLEFKTEIELLSRVH--HKNLVGLVGFCFEQGE 697 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~ 697 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++..... ...++.+|+.+|++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5789999999999999999996 57999999998753221 1234678999999996 8999999999999999
Q ss_pred eEEEEEeccC-CChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-CCcEEEeecccc
Q 002121 698 QMLVYEFMAN-GTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-NLTAKVADFGLS 775 (964)
Q Consensus 698 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-~~~~kl~DFGla 775 (964)
.++||||+.+ +++.+++.... .+++.++..++.|+++||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 67888876543 6899999999999999999999988 999999999999985 579999999999
Q ss_pred eeecCCCCCceeecccccCcccCccccccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhccCccccccc
Q 002121 776 KLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQL-TEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 776 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (964)
+..... ..+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... + .....
T Consensus 159 ~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i---~~~~~------ 221 (273)
T d1xwsa_ 159 ALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----I---IRGQV------ 221 (273)
T ss_dssp EECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----H---HHCCC------
T ss_pred eecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----H---hhccc------
Confidence 875432 2345679999999999987765 5779999999999999999999965321 1 11111
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.+.+.+. ..+.+++.+||+.||++|||++|+++
T Consensus 222 --~~~~~~s-------~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 --FFRQRVS-------SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --CCSSCCC-------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCC-------HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0111121 34668999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-43 Score=382.23 Aligned_cols=262 Identities=20% Similarity=0.312 Sum_probs=200.1
Q ss_pred cCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|...++||+|+||+||+|+.++|+.||||+++..... ..+++.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 578899999999999999999999999999999764332 246799999999999999999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSKG 784 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~~ 784 (964)
+.++.+..+.... ..+++.++..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||.|.......
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-- 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-- 154 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc--
Confidence 9887777776544 36999999999999999999999988 9999999999999999999999999998765432
Q ss_pred ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHH---hccCccccc-ccccc--
Q 002121 785 HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTA---MNRDDEEHY-GLTEM-- 857 (964)
Q Consensus 785 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~-~~~~~-- 857 (964)
.......|++.|+|||.+.. ..++.++||||+||++|||++|+.||..... .+..... ......... ...+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~ 233 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNVTELPK 233 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCChhhccchhhhhh
Confidence 22334568999999999875 4578999999999999999999999964332 2222211 111110000 00000
Q ss_pred c-------Ccc-chhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 858 M-------DPT-IRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 858 ~-------d~~-l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
. .+. ...........+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 000 00001111245679999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=380.23 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=197.6
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cC-CcEEEEEEecCCCc--chhHHHHHHHHHHHhc---CCCCccceeEEEEe----
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SD-GQVVAIKRAQQGSM--QGGLEFKTEIELLSRV---HHKNLVGLVGFCFE---- 694 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~-g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 694 (964)
.++|++.+.||+|+||+||+|+. .+ ++.||||+++.... .....+.+|+++|+.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999996 34 67899999864322 2234567888887776 79999999999864
Q ss_pred -eCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecc
Q 002121 695 -QGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFG 773 (964)
Q Consensus 695 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFG 773 (964)
....++||||+++|.+....... ...+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 34679999999988776554433 346899999999999999999999988 9999999999999999999999999
Q ss_pred cceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHH---HhccCccc
Q 002121 774 LSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRT---AMNRDDEE 850 (964)
Q Consensus 774 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~---~~~~~~~~ 850 (964)
+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .+.+.. ........
T Consensus 162 ~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEE 237 (305)
T ss_dssp SCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCCGG
T ss_pred hhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-HHHHHHHHHhhCCCchh
Confidence 99865432 233456799999999999999999999999999999999999999975432 222222 21111111
Q ss_pred cccc---------ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HYGL---------TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~~~---------~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.... ..................+.+++.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 1000 000000111111111245678999999999999999999875
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-41 Score=367.28 Aligned_cols=263 Identities=17% Similarity=0.225 Sum_probs=209.0
Q ss_pred cCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCC-CCccceeEEEEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHH-KNLVGLVGFCFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lV~E~ 704 (964)
++|.+.+.||+|+||+||+|+.. +|+.||||++..... ...+++|+++++.++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 57899999999999999999964 689999998865432 2467899999999975 8999999999999999999999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECC-----CCcEEEeecccceeec
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDE-----NLTAKVADFGLSKLVS 779 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~-----~~~~kl~DFGla~~~~ 779 (964)
+ +|+|.+++.... ..+++.++..++.|++.||+|||+.+ ||||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 83 L-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred c-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 9 689999887543 46899999999999999999999988 999999999999974 5789999999999875
Q ss_pred CCCCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCccccc
Q 002121 780 DSSKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEHY 852 (964)
Q Consensus 780 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~ 852 (964)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||.... ............... .
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~--~ 235 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS--T 235 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH--S
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC--C
Confidence 43221 12334679999999999999999999999999999999999999996322 122222111111000 0
Q ss_pred ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCC
Q 002121 853 GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDG 906 (964)
Q Consensus 853 ~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~ 906 (964)
...+ +. ....+++.+++..|+..+|++||+++.+.+.|++++++.+
T Consensus 236 ~~~~-----l~---~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 236 PLRE-----LC---AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp CHHH-----HT---TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred ChHH-----hc---CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 0000 00 1112457789999999999999999999999999987765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-41 Score=370.83 Aligned_cols=264 Identities=20% Similarity=0.280 Sum_probs=200.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEE-EEeeCceEEEEEe
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGF-CFEQGEQMLVYEF 704 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~-~~~~~~~~lV~E~ 704 (964)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ..++..|++++++++|+|+|..++. ..+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4689999999999999999996 5689999999875433 2468899999999987776655544 5666788899999
Q ss_pred ccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEEC---CCCcEEEeecccceeecCC
Q 002121 705 MANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLD---ENLTAKVADFGLSKLVSDS 781 (964)
Q Consensus 705 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~---~~~~~kl~DFGla~~~~~~ 781 (964)
+. |+|...+.... ..+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+.....
T Consensus 85 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp CC-CBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred cC-Cchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 95 56666654432 46899999999999999999999988 99999999999986 4557999999999987644
Q ss_pred CCC-----ceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchh--HHHHHHHhccCccccccc
Q 002121 782 SKG-----HVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYV--VREVRTAMNRDDEEHYGL 854 (964)
Q Consensus 782 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 854 (964)
... .......||+.|||||++.+..++.++|||||||++|||+||+.||...... ...+........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~------ 233 (299)
T d1ckia_ 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM------ 233 (299)
T ss_dssp TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH------
T ss_pred ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC------
Confidence 321 1234567999999999999999999999999999999999999999642211 111111100000
Q ss_pred ccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHhCCC
Q 002121 855 TEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVKAIETLLQNDGM 907 (964)
Q Consensus 855 ~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~~~~~~~~ 907 (964)
.............++.+++.+||+.+|++||+++++.+.|+.+..+.+.
T Consensus 234 ----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 234 ----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp ----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred ----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 0000000111124567899999999999999999999999998776553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=371.29 Aligned_cols=265 Identities=21% Similarity=0.320 Sum_probs=195.6
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCC--cchhHHHHHHHHHHHhcCCCCccceeEEEEe--------e
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGS--MQGGLEFKTEIELLSRVHHKNLVGLVGFCFE--------Q 695 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 695 (964)
++|++.++||+|+||+||+|+. .+|+.||||++.... .....++.+|+++|++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6788999999999999999996 579999999986442 2334578899999999999999999999865 3
Q ss_pred CceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccc
Q 002121 696 GEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLS 775 (964)
Q Consensus 696 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla 775 (964)
+..++||||++++.+....... ..++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 4679999999987776555443 36888889999999999999999988 999999999999999999999999999
Q ss_pred eeecCCCCC--ceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccc
Q 002121 776 KLVSDSSKG--HVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEE 850 (964)
Q Consensus 776 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~ 850 (964)
+........ .......||+.|+|||++... .++.++||||+||++|||++|+.||....... ..+..........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 876533221 122335699999999998754 68999999999999999999999996433221 2222222211111
Q ss_pred cc-cc-----------ccccCccchhhh--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 HY-GL-----------TEMMDPTIRNTV--LLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ~~-~~-----------~~~~d~~l~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.. .. ............ ......+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 00 00 000000011000 011234678999999999999999999985
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-41 Score=366.60 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=207.3
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEeeCceEEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQGEQMLVYE 703 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lV~E 703 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ....++.+|+.+|++++|||||++++++.+.+..++|||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5789999999999999999996 5789999999865433 334678999999999999999999999999999999999
Q ss_pred eccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeecCCCC
Q 002121 704 FMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVSDSSK 783 (964)
Q Consensus 704 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~~~~~ 783 (964)
++.+++|..++...+ .+++..+..++.|+++||+|||+++ ||||||||+|||++.++.+||+|||.|+.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999999988887543 6889999999999999999999988 99999999999999999999999999998754332
Q ss_pred CceeecccccCcccCccccccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc---cCccccc----ccc
Q 002121 784 GHVSTQVKGTMGYLDPEYYMTQQ-LTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN---RDDEEHY----GLT 855 (964)
Q Consensus 784 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~~----~~~ 855 (964)
......+++.|+|||++.... ++.++||||+||++|||++|+.||..+....+.+..... ....... ...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
T d1unla_ 157 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234 (292)
T ss_dssp --CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred --cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence 233445788999999987654 689999999999999999999998766665555443322 1110000 000
Q ss_pred cccC-------ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 856 EMMD-------PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 856 ~~~d-------~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
+..+ .............+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 0001111112245678999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-41 Score=375.54 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=191.4
Q ss_pred CCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCccceeEEEEeeC------ceEE
Q 002121 628 NFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------EQML 700 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 700 (964)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++|||||++++++.... ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5777899999999999999964 699999999875432 2357999999999999999999986532 4689
Q ss_pred EEEeccCCChhhhhcC-CCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceee
Q 002121 701 VYEFMANGTLRESLSG-RSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLV 778 (964)
Q Consensus 701 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~ 778 (964)
|||||++|.+..+.+. .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987644443321 12346999999999999999999999988 99999999999999775 8999999999876
Q ss_pred cCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHh---ccCccc----
Q 002121 779 SDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAM---NRDDEE---- 850 (964)
Q Consensus 779 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~~~~---- 850 (964)
..... .....||+.|+|||.+.. ..++.++||||+||++|||++|+.||...... +.+.... .....+
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCHHHHHH
T ss_pred cCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH-HHHHHHHHHhCCChHHhhhh
Confidence 54322 234579999999998765 57899999999999999999999999754322 2221111 110000
Q ss_pred ------ccccccccCccchhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 851 ------HYGLTEMMDPTIRNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 851 ------~~~~~~~~d~~l~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
...........+... .......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000000 1112245678999999999999999999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-41 Score=375.63 Aligned_cols=259 Identities=25% Similarity=0.353 Sum_probs=193.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEeeC------
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQG------ 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 696 (964)
.++|++.+.||+|+||+||+|+. .+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999996 46999999999754332 3456889999999999999999999998654
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
+.++||||+ +++|..+.+.. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhccccccccccccccee
Confidence 469999999 55788777643 5999999999999999999999988 9999999999999999999999999998
Q ss_pred eecCCCCCceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHH--HHHHhccCcccc--
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVRE--VRTAMNRDDEEH-- 851 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~-- 851 (964)
..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||......... ............
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred ccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence 76543 234579999999999876 45689999999999999999999999754332211 111111100000
Q ss_pred -----------cccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 852 -----------YGLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 852 -----------~~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
....+.....+..........+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000000001111111111245678999999999999999999986
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-41 Score=375.21 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=196.1
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCc-chhHHHHHHHHHHHhcCCCCccceeEEEEeeC----ceE
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSM-QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQG----EQM 699 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~ 699 (964)
+.+|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45788999999999999999985 5799999999975443 33457889999999999999999999997653 235
Q ss_pred EEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccceeec
Q 002121 700 LVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKLVS 779 (964)
Q Consensus 700 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~~~ 779 (964)
+++||+.+|+|.+++... .+++..+..++.|++.||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 566778899999999754 5899999999999999999999988 9999999999999999999999999998764
Q ss_pred CCCCC-ceeecccccCcccCcccccc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHH--HHhccCccccc---
Q 002121 780 DSSKG-HVSTQVKGTMGYLDPEYYMT-QQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR--TAMNRDDEEHY--- 852 (964)
Q Consensus 780 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~--- 852 (964)
..... .......||+.|+|||++.. ..++.++||||+||++|||++|+.||........... ...........
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 240 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence 33221 12344679999999999854 5678999999999999999999999975432211111 11111100000
Q ss_pred ----------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 ----------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 ----------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.........+.........++.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000001111135679999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-40 Score=365.86 Aligned_cols=256 Identities=18% Similarity=0.302 Sum_probs=196.8
Q ss_pred cCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEee--CceEEEE
Q 002121 627 NNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQ--GEQMLVY 702 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lV~ 702 (964)
++|++.++||+|+||+||+|+. .+|+.||||+++... .+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999996 578999999987532 457899999999995 99999999999754 4689999
Q ss_pred EeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCC-cEEEeecccceeecCC
Q 002121 703 EFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENL-TAKVADFGLSKLVSDS 781 (964)
Q Consensus 703 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~-~~kl~DFGla~~~~~~ 781 (964)
|||++|+|..+.+ .+++.++..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+.....
T Consensus 112 e~~~~~~L~~~~~-----~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp ECCCSCBGGGTTT-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eecCCCcHHHHhc-----CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999987753 4899999999999999999999998 99999999999998655 6899999999877543
Q ss_pred CCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHHHHhc------------c-C
Q 002121 782 SKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVRTAMN------------R-D 847 (964)
Q Consensus 782 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~~~~~------------~-~ 847 (964)
.. .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..+....+....... . .
T Consensus 184 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 184 QE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp CC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred Cc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 22 3445789999999998765 5799999999999999999999999765443322111110 0 0
Q ss_pred cccccccccccC----ccc----hhh-hHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 848 DEEHYGLTEMMD----PTI----RNT-VLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 848 ~~~~~~~~~~~d----~~l----~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
............ ... ... ......++.+++.+||+.||++|||++|+++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000000 000 000 1111245678999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-40 Score=365.01 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=197.8
Q ss_pred cCCCccceeecCCcEEEEEEEe----cCCcEEEEEEecCCCc----chhHHHHHHHHHHHhcCC-CCccceeEEEEeeCc
Q 002121 627 NNFSESNEIGSGGYGKVYRGML----SDGQVVAIKRAQQGSM----QGGLEFKTEIELLSRVHH-KNLVGLVGFCFEQGE 697 (964)
Q Consensus 627 ~~~~~~~~lG~G~fg~Vy~~~~----~~g~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 697 (964)
++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|++++++++| |||+++++++.+.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999985 2488999999864321 234568899999999976 899999999999999
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+.+|+|.+++...+ .+.......++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhh
Confidence 999999999999999997654 4677888999999999999999988 99999999999999999999999999987
Q ss_pred ecCCCCCceeecccccCcccCccccccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCc--hhHHHHHHHhccCcccccc
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQ--QLTEKSDVYSFGVVMLELITAKQPIEKGK--YVVREVRTAMNRDDEEHYG 853 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDv~S~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~ 853 (964)
...... .......|++.|+|||.+... .++.++||||+||++|||+||+.||.... .....+........
T Consensus 179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----- 252 (322)
T d1vzoa_ 179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 252 (322)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC-----
T ss_pred hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC-----
Confidence 654322 223446799999999998754 46789999999999999999999996432 22222222111111
Q ss_pred cccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002121 854 LTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPT-----MSEVVK 896 (964)
Q Consensus 854 ~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 896 (964)
+.+.. ....++.+++.+||+.||++||| ++|+++
T Consensus 253 ------~~~~~---~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 ------PPYPQ---EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ------CCCCT---TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ------CCCcc---cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 00111 11245678999999999999995 778764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-40 Score=365.96 Aligned_cols=260 Identities=23% Similarity=0.305 Sum_probs=189.4
Q ss_pred hcCCCccceeecCCcEEEEEEEec-CCcEEEEEEecCCCc--chhHHHHHHHHHHHhcCCCCccceeEEEEee------C
Q 002121 626 SNNFSESNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQGSM--QGGLEFKTEIELLSRVHHKNLVGLVGFCFEQ------G 696 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 696 (964)
.++|++.++||+|+||+||+|+.. +|+.||||++..... ....++.+|+.++++++|||||++++++... +
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 367999999999999999999964 699999999976433 2334688999999999999999999999643 5
Q ss_pred ceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 697 EQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 697 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
..|+|||||.++.+ +.+.. .+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 96 ~~~iv~Ey~~~~l~-~~~~~----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVIQM----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEEHH-HHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eeEEEEeccchHHH-Hhhhc----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 78999999976544 44432 4889999999999999999999998 9999999999999999999999999988
Q ss_pred eecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCchhHHHHH--HHhc---------
Q 002121 777 LVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKYVVREVR--TAMN--------- 845 (964)
Q Consensus 777 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~~~~~--~~~~--------- 845 (964)
...... ..+...||+.|+|||++.+..+++++||||+||++|||++|+.||........... ....
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 765432 33456799999999999999999999999999999999999999964432221111 0000
Q ss_pred ----------cCc-ccccccccccC----ccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 846 ----------RDD-EEHYGLTEMMD----PTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 846 ----------~~~-~~~~~~~~~~d----~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
... ........... +............+.+++.+||+.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 000 00000000111 1111112233456789999999999999999999975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=7.7e-40 Score=360.18 Aligned_cols=291 Identities=26% Similarity=0.440 Sum_probs=208.0
Q ss_pred CCCHHHHHHHHHHHHHcCCCC--CCCCCCCCCC-CCCccEEecC----CCeeEEEcCCCCccc--cccCCcCCCCcccEE
Q 002121 23 ATDSRDAAALQSLKDAWQNTP--PTWKNSDDPC-GSWEGVTCNN----SRVTALGLSTMGLTG--KLSGDIGGLTELRSL 93 (964)
Q Consensus 23 ~~~~~~~~aL~~~k~~~~~~~--~~W~~~~~~C-~~w~gv~C~~----~~v~~L~L~~~~l~g--~~~~~l~~l~~L~~L 93 (964)
-|+++|++||++||+++.++. ++|..++||| +.|.||+|+. .||+.|+|++++++| .+|++|++|++|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L 81 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFL 81 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEE
T ss_pred CCCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCcccccc
Confidence 489999999999999998765 7998888988 3699999975 379999999999998 578899999999999
Q ss_pred ecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccccccc
Q 002121 94 DLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQL 173 (964)
Q Consensus 94 ~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 173 (964)
+|++++.+.|.+|+.|++|++|++|+|++|+|.+..|..+..+.+|+.+++++|.+.+.+|..+.++++|+++++++|.+
T Consensus 82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l 161 (313)
T d1ogqa_ 82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161 (313)
T ss_dssp EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence 99863267778888888888888888888888777777777777888888888877777777777777777777777777
Q ss_pred ccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCc
Q 002121 174 TGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALT 253 (964)
Q Consensus 174 ~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 253 (964)
+|.+|. .++.....++.+++++|++++..|..+..+..+ .+++++|.+.
T Consensus 162 ~~~ip~------------------------------~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 162 SGAIPD------------------------------SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp EEECCG------------------------------GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred cccccc------------------------------ccccccccccccccccccccccccccccccccc-cccccccccc
Confidence 766662 222222233455566666666666666666544 6888888888
Q ss_pred cccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhcc
Q 002121 254 GKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLF 333 (964)
Q Consensus 254 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 333 (964)
+.+|..+..+++|+.|++++|.+.+.++.+..+++|+.|+|++|+++ ..+|..|.++++|++|+|++|+|+|.+|. +.
T Consensus 211 ~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~-g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~ 288 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY-GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288 (313)
T ss_dssp ECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCE-ECCCGGGGGCTTCCEEECCSSEEEEECCC-ST
T ss_pred ccccccccccccccccccccccccccccccccccccccccCccCeec-ccCChHHhCCCCCCEEECcCCcccccCCC-cc
Confidence 88888888888888888888888777666666666666666666654 23444455555555555555555544442 23
Q ss_pred CCCCCCEEEcCCc
Q 002121 334 SYSQIQQVKLRNN 346 (964)
Q Consensus 334 ~l~~L~~L~L~~N 346 (964)
++++|+.+++++|
T Consensus 289 ~L~~L~~l~l~~N 301 (313)
T d1ogqa_ 289 NLQRFDVSAYANN 301 (313)
T ss_dssp TGGGSCGGGTCSS
T ss_pred cCCCCCHHHhCCC
Confidence 3444444444444
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-40 Score=365.39 Aligned_cols=260 Identities=22% Similarity=0.337 Sum_probs=195.4
Q ss_pred hcCCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcc--hhHHHHHHHHHHHhcCCCCccceeEEEEee-----Cc
Q 002121 626 SNNFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQ--GGLEFKTEIELLSRVHHKNLVGLVGFCFEQ-----GE 697 (964)
Q Consensus 626 ~~~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 697 (964)
.++|+..+.||+|+||+||+|+. .+|+.||||+++..... ..+++.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999995 57999999999764432 345688999999999999999999998643 34
Q ss_pred eEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 698 QMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 698 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.++||||+.+|+|.+++..+ .+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcc
Confidence 57778889999999999654 5999999999999999999999988 99999999999999999999999999976
Q ss_pred ecCCCCCceeecccccCcccCccccccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCchhH--HHHHHHhccCccccc--
Q 002121 778 VSDSSKGHVSTQVKGTMGYLDPEYYMTQ-QLTEKSDVYSFGVVMLELITAKQPIEKGKYVV--REVRTAMNRDDEEHY-- 852 (964)
Q Consensus 778 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDv~S~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~-- 852 (964)
... ......||+.|+|||...+. .++.++||||+||++|||++|+.||....... ..+............
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred cCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 532 22345699999999987665 56899999999999999999999997543221 111111111110000
Q ss_pred -----------ccccccCccchhhhHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002121 853 -----------GLTEMMDPTIRNTVLLGFRRYLELALQCVEESATDRPTMSEVVK 896 (964)
Q Consensus 853 -----------~~~~~~d~~l~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 896 (964)
.........+..........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 00000000111111112245678999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.8e-35 Score=327.27 Aligned_cols=260 Identities=18% Similarity=0.194 Sum_probs=188.6
Q ss_pred CCCccceeecCCcEEEEEEEe-cCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-----------CCCccceeEEEEee
Q 002121 628 NFSESNEIGSGGYGKVYRGML-SDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-----------HKNLVGLVGFCFEQ 695 (964)
Q Consensus 628 ~~~~~~~lG~G~fg~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~~ 695 (964)
+|++.++||+|+||+||+|+. .+|+.||||+++.... ....+.+|++++++++ |+|||++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 488999999999999999996 5799999999975432 2356788999998875 57899999998754
Q ss_pred --CceEEEEEeccCCCh-hhhhcCCCCCccchHHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCC------
Q 002121 696 --GEQMLVYEFMANGTL-RESLSGRSGIHLDWKRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENL------ 765 (964)
Q Consensus 696 --~~~~lV~E~~~~gsL-~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~------ 765 (964)
...++||+++..+.. ...........+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 456777777765543 333333334568899999999999999999997 66 99999999999998665
Q ss_pred cEEEeecccceeecCCCCCceeecccccCcccCccccccCCCCCchhHHHHHHHHHHHHhCCCCCCCCch-----hHHHH
Q 002121 766 TAKVADFGLSKLVSDSSKGHVSTQVKGTMGYLDPEYYMTQQLTEKSDVYSFGVVMLELITAKQPIEKGKY-----VVREV 840 (964)
Q Consensus 766 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDv~S~Gvvl~elltg~~p~~~~~~-----~~~~~ 840 (964)
.++++|||.++..... .....||+.|+|||++....++.++||||+||+++||++|+.||..... .....
T Consensus 170 ~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred eeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999865432 2345699999999999999999999999999999999999999863211 01111
Q ss_pred H---HHhccCccc-----------------ccccccccCccch-------hhhHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002121 841 R---TAMNRDDEE-----------------HYGLTEMMDPTIR-------NTVLLGFRRYLELALQCVEESATDRPTMSE 893 (964)
Q Consensus 841 ~---~~~~~~~~~-----------------~~~~~~~~d~~l~-------~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 893 (964)
. ..+...+.. ............. .........+.+++.+||+.||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1 111110000 0000000000000 012344567889999999999999999999
Q ss_pred HHH
Q 002121 894 VVK 896 (964)
Q Consensus 894 vl~ 896 (964)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 975
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=6.5e-29 Score=272.28 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=196.2
Q ss_pred CcccEEecccCCCCCC--CCCCCCCCcccchhhcccc-ccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccc
Q 002121 88 TELRSLDLSYNGGLTG--SLSPRIGDLQKLNILILAG-CGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLY 164 (964)
Q Consensus 88 ~~L~~L~L~~N~~l~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 164 (964)
.+++.|||++| .+.| .+|+.+++|++|++|+|++ |+++|.+|..|++|++|++|+|++|++.+..+..+.++++|+
T Consensus 50 ~~v~~L~L~~~-~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~ 128 (313)
T d1ogqa_ 50 YRVNNLDLSGL-NLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CCEEEEEEECC-CCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred EEEEEEECCCC-CCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhc
Confidence 35777888887 5666 4667777777777777765 677777777777777777777777777776666677777777
Q ss_pred cccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCC-c
Q 002121 165 WLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTL-E 243 (964)
Q Consensus 165 ~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L-~ 243 (964)
++++++|.+.+.+| ..+.. ++.++.+++++|.+++.+|..+..+..+ +
T Consensus 129 ~l~l~~N~~~~~~p------~~l~~-------------------------l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~ 177 (313)
T d1ogqa_ 129 TLDFSYNALSGTLP------PSISS-------------------------LPNLVGITFDGNRISGAIPDSYGSFSKLFT 177 (313)
T ss_dssp EEECCSSEEESCCC------GGGGG-------------------------CTTCCEEECCSSCCEEECCGGGGCCCTTCC
T ss_pred ccccccccccccCc------hhhcc-------------------------Ccccceeecccccccccccccccccccccc
Confidence 77777777665555 22333 4455556666666777899999888876 8
Q ss_pred EEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCC
Q 002121 244 VLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322 (964)
Q Consensus 244 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 322 (964)
.+++++|++++..|..+.++..+ .+++++|.+.+.++. +..+++|+.|++++|.+. . .+..+..+++|+.|+|++|
T Consensus 178 ~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~-~-~~~~~~~~~~L~~L~Ls~N 254 (313)
T d1ogqa_ 178 SMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA-F-DLGKVGLSKNLNGLDLRNN 254 (313)
T ss_dssp EEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEEC-C-BGGGCCCCTTCCEEECCSS
T ss_pred ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccc-c-cccccccccccccccCccC
Confidence 99999999999999998887655 799999999998775 778899999999999996 3 3446888999999999999
Q ss_pred ccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcc
Q 002121 323 SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQI 372 (964)
Q Consensus 323 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 372 (964)
+++|.+|..|.++++|++|+|++|+|+|.+| .+..+.+|+.+++++|+.
T Consensus 255 ~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~~ 303 (313)
T d1ogqa_ 255 RIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303 (313)
T ss_dssp CCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSSE
T ss_pred eecccCChHHhCCCCCCEEECcCCcccccCC-CcccCCCCCHHHhCCCcc
Confidence 9999999999999999999999999998887 457788888888888873
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=4.6e-25 Score=248.06 Aligned_cols=304 Identities=24% Similarity=0.321 Sum_probs=242.1
Q ss_pred CCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEE
Q 002121 64 SRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLA 143 (964)
Q Consensus 64 ~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 143 (964)
..++.|++++++|+. + +.+..|++|++|+|++| .+.+.. .++++++|++|+|++|.+.+. + .++.+++|+.|+
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N-~l~~l~--~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNN-QLTDIT--PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSS-CCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCC-cCCCCc--cccCCcccccccccccccccc-c-cccccccccccc
Confidence 579999999999985 3 46889999999999999 677654 399999999999999999954 3 389999999999
Q ss_pred cccCcccCcCCCcCCCccccccccccccccccccCc-----------------------------------ccCCCCccc
Q 002121 144 LNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPV-----------------------------------STITSPGLD 188 (964)
Q Consensus 144 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~-----------------------------------~~~~~~~l~ 188 (964)
+++|.+++..+ ......+..+....|.+....+. .......+.
T Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 99999986433 22333444444444443211000 011123466
Q ss_pred cccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCe
Q 002121 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNE 268 (964)
Q Consensus 189 ~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (964)
.+++++.+++++|.+++..| +....+|++|++++|+++.. ..+..+++|+.|++++|.+++..+ +..+++|+.
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~---~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~ 267 (384)
T d2omza2 195 KLTNLESLIATNNQISDITP---LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTE 267 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGG---GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSE
T ss_pred cccccceeeccCCccCCCCc---ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccccccCCE
Confidence 77899999999999985444 34567899999999999853 467889999999999999996543 888999999
Q ss_pred eeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccc
Q 002121 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348 (964)
Q Consensus 269 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 348 (964)
|++++|++++..+ +..++.++.+++++|.+++ ...+..+++++.|++++|++++..+ +..+++|++|+|++|++
T Consensus 268 L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~---~~~~~~~~~l~~L~ls~n~l~~l~~--l~~l~~L~~L~L~~n~l 341 (384)
T d2omza2 268 LKLGANQISNISP-LAGLTALTNLELNENQLED---ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341 (384)
T ss_dssp EECCSSCCCCCGG-GTTCTTCSEEECCSSCCSC---CGGGGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECCSSCC
T ss_pred eeccCcccCCCCc-ccccccccccccccccccc---ccccchhcccCeEECCCCCCCCCcc--cccCCCCCEEECCCCCC
Confidence 9999999987654 7888999999999999962 2348889999999999999997643 88899999999999999
Q ss_pred ccccCCCCccCCCCcEEeccCCcceeec-cCCCcccceeEeecC
Q 002121 349 NNTLDMGNAVGPLLQLVDLQNNQISAIT-LGSGIKNYTLILVGN 391 (964)
Q Consensus 349 ~~~~~~~~~~l~~L~~L~L~~N~l~~i~-~~~~~~l~~l~l~~N 391 (964)
++.. .+..+++|+.|+|++|+|+.++ .....+++.|+|++|
T Consensus 342 ~~l~--~l~~l~~L~~L~l~~N~l~~l~~l~~l~~L~~L~L~~N 383 (384)
T d2omza2 342 SDVS--SLANLTNINWLSAGHNQISDLTPLANLTRITQLGLNDQ 383 (384)
T ss_dssp CCCG--GGGGCTTCCEEECCSSCCCBCGGGTTCTTCSEEECCCE
T ss_pred CCCh--hHcCCCCCCEEECCCCcCCCChhhccCCCCCEeeCCCC
Confidence 8753 5889999999999999999986 456667899999987
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.93 E-value=4.9e-25 Score=240.11 Aligned_cols=282 Identities=20% Similarity=0.252 Sum_probs=209.3
Q ss_pred CCCccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCccc
Q 002121 54 GSWEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEI 133 (964)
Q Consensus 54 ~~w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~ 133 (964)
|.|.+|.|+. ++++ .+|..+. +.|++|+|++| .+....+..|.++++|++|++++|.+....|..|
T Consensus 10 c~~~~~~C~~----------~~L~-~lP~~l~--~~l~~L~Ls~N-~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCSD----------LGLE-KVPKDLP--PDTALLDLQNN-KITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECTT----------SCCC-SCCCSCC--TTCCEEECCSS-CCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ecCCEEEecC----------CCCC-ccCCCCC--CCCCEEECcCC-cCCCcChhHhhccccccccccccccccccchhhh
Confidence 5777888764 3444 4555553 57888888888 6776666678888888889998888887777888
Q ss_pred CCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccc-ccccccc
Q 002121 134 GNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSG-TISEQLF 212 (964)
Q Consensus 134 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g-~l~~~~f 212 (964)
.++++|++|+|++|+++ .+|..+. ..|..|++++|.+.+ ++. ..+.....+..+++..|.... ......|
T Consensus 76 ~~l~~L~~L~l~~n~l~-~l~~~~~--~~l~~L~~~~n~l~~-l~~-----~~~~~~~~~~~l~~~~n~~~~~~~~~~~~ 146 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITK-VRK-----SVFNGLNQMIVVELGTNPLKSSGIENGAF 146 (305)
T ss_dssp TTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCB-BCH-----HHHTTCTTCCEEECCSSCCCGGGBCTTGG
T ss_pred hCCCccCEecccCCccC-cCccchh--hhhhhhhccccchhh-hhh-----hhhhccccccccccccccccccCCCcccc
Confidence 88888999999888888 4555433 467888888888873 331 234556667777777776532 2334457
Q ss_pred CCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCE
Q 002121 213 SPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSY 291 (964)
Q Consensus 213 ~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~ 291 (964)
..+.+|+.+++++|+++. +|.. .+++|+.|++++|.+++..+..|.+++.++.|++++|.+++..+. +.++++|++
T Consensus 147 ~~l~~L~~l~l~~n~l~~-l~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~ 223 (305)
T d1xkua_ 147 QGMKKLSYIRIADTNITT-IPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 223 (305)
T ss_dssp GGCTTCCEEECCSSCCCS-CCSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCE
T ss_pred ccccccCccccccCCccc-cCcc--cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccccccccccccccee
Confidence 777888888888888874 4443 357888899999888888888888888899999999988887664 778888999
Q ss_pred EEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhc------cCCCCCCEEEcCCcccc--cccCCCCccCCCCc
Q 002121 292 VDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKL------FSYSQIQQVKLRNNAFN--NTLDMGNAVGPLLQ 363 (964)
Q Consensus 292 L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~L~~N~l~--~~~~~~~~~l~~L~ 363 (964)
|+|++|+|+ .+|..|..+++|++|+|++|+|+......| ..+++|+.|+|++|+++ ...|..|.-+....
T Consensus 224 L~L~~N~L~--~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~ 301 (305)
T d1xkua_ 224 LHLNNNKLV--KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301 (305)
T ss_dssp EECCSSCCS--SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGG
T ss_pred eeccccccc--ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCc
Confidence 999999885 456678889999999999999886644443 45788999999999876 34555555444333
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.5e-25 Score=234.70 Aligned_cols=210 Identities=21% Similarity=0.153 Sum_probs=168.0
Q ss_pred cccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCe
Q 002121 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNE 268 (964)
Q Consensus 189 ~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (964)
....+.+++.+++.|+ .+|..+. +++++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~ 81 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGT 81 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccc
Confidence 3444455566666666 5665543 45777777777777766677888888888888888888 343 3577888888
Q ss_pred eeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccc
Q 002121 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348 (964)
Q Consensus 269 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 348 (964)
|+|++|++++.++.+..+++|+.|++++|.+. ...+..+..+.+++.|++++|.++...+..+..+++|+.|++++|++
T Consensus 82 L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp EECCSSCCSSCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred cccccccccccccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 88888888888777888888888888888887 66677788888999999999999888888888889999999999999
Q ss_pred ccccCCCCccCCCCcEEeccCCcceeeccCCC--cccceeEeecCC-cccccccccCccc
Q 002121 349 NNTLDMGNAVGPLLQLVDLQNNQISAITLGSG--IKNYTLILVGNP-VCTATLANTNYCQ 405 (964)
Q Consensus 349 ~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~--~~l~~l~l~~Np-~c~~~l~~~~~~~ 405 (964)
++..+..|..+++|+.|+|++|+|+.||.+.+ ..++.|+|.||| .|||.+.++..|.
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~~CdC~~~~l~~wl 220 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWL 220 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCBCCSGGGHHHHHHH
T ss_pred cccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCCCCCcchHHHHHHH
Confidence 98888888899999999999999998876533 447889999999 8999999888884
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.92 E-value=2e-24 Score=235.24 Aligned_cols=265 Identities=24% Similarity=0.273 Sum_probs=150.0
Q ss_pred ccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccccc
Q 002121 90 LRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLA 169 (964)
Q Consensus 90 L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 169 (964)
++.+|=+++ .++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|..|.++++|++|+++
T Consensus 12 ~~~~~C~~~-~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 12 LRVVQCSDL-GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp TTEEECTTS-CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCC-CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 445565555 333 5565553 467777777777774444467777777777777777776667777777777777777
Q ss_pred ccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCc--ccCCcccCCCCCCcEEEc
Q 002121 170 DNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLS--GNIPESLGYVQTLEVLRL 247 (964)
Q Consensus 170 ~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~--~~~p~~~~~l~~L~~L~L 247 (964)
+|+++ .+|.. ....+..|++.+|.+. .++...|.....+..+.+..|... ...+..+..+++|+.+++
T Consensus 88 ~n~l~-~l~~~--------~~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l 157 (305)
T d1xkua_ 88 KNQLK-ELPEK--------MPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 157 (305)
T ss_dssp SSCCS-BCCSS--------CCTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CCccC-cCccc--------hhhhhhhhhccccchh-hhhhhhhhccccccccccccccccccCCCccccccccccCcccc
Confidence 77777 45521 2345666666666666 455555555555555665555332 233444555556666666
Q ss_pred ccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCcccc
Q 002121 248 DRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQG 326 (964)
Q Consensus 248 s~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 326 (964)
++|.++ .+|..+ +++|+.|++++|.+++..+. +.+++.+++|++++|.++ ...+.++.++++|++|+|++|+|+
T Consensus 158 ~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~-~~~~~~~~~l~~L~~L~L~~N~L~- 232 (305)
T d1xkua_ 158 ADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV- 232 (305)
T ss_dssp CSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCC-EECTTTGGGSTTCCEEECCSSCCS-
T ss_pred ccCCcc-ccCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccccccc-ccccccccccccceeeeccccccc-
Confidence 666555 333332 34555555555555554432 455555555555555554 334445555555555555555554
Q ss_pred ccChhccCCCCCCEEEcCCcccccccCCCC------ccCCCCcEEeccCCcce
Q 002121 327 RVPDKLFSYSQIQQVKLRNNAFNNTLDMGN------AVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 327 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~------~~l~~L~~L~L~~N~l~ 373 (964)
.+|..|..+++|++|+|++|+|+.+....| ..+.+|+.|+|++|+|+
T Consensus 233 ~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 234455555555555555555554433222 23344555555555544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=5.8e-25 Score=236.98 Aligned_cols=234 Identities=18% Similarity=0.170 Sum_probs=124.1
Q ss_pred CccEEecCCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCC
Q 002121 56 WEGVTCNNSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGN 135 (964)
Q Consensus 56 w~gv~C~~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~ 135 (964)
..+..|.+..-..++.++++++ .+|..+. +.+++|+|++| .+....+..|.++++|++|++++|++....+..+..
T Consensus 3 p~~C~C~~~~~~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N-~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~ 78 (284)
T d1ozna_ 3 PGACVCYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGN-RISHVPAASFRACRNLTILWLHSNVLARIDAAAFTG 78 (284)
T ss_dssp CTTCEEECSSSCEEECCSSCCS-SCCTTCC--TTCSEEECTTS-CCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTT
T ss_pred CCCCEEcCCCCeEEEcCCCCCC-ccCCCCC--CCCCEEECcCC-cCCCCCHHHhhccccccccccccccccccccccccc
Confidence 3456675544445567777776 5565443 45677777777 565554555666666666666666666555555555
Q ss_pred CCCccEEEcc-cCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCC
Q 002121 136 LAELSFLALN-SNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSP 214 (964)
Q Consensus 136 l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~ 214 (964)
+..++.++.. .|.++...+..|.++++|++|++++|.+. .++...+..
T Consensus 79 ~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~-------------------------------~~~~~~~~~ 127 (284)
T d1ozna_ 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-------------------------------ELGPGLFRG 127 (284)
T ss_dssp CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCC-------------------------------CCCTTTTTT
T ss_pred cccccccccccccccccccchhhcccccCCEEecCCcccc-------------------------------cccccccch
Confidence 5555555443 34444444555555555555555555544 222233333
Q ss_pred CcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEE
Q 002121 215 DMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVD 293 (964)
Q Consensus 215 ~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~ 293 (964)
..+|+.+++++|+|++..+..|..+++|+.|+|++|+|++..+.+|.++++|++|++++|++++..|. |.++++|++|+
T Consensus 128 ~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~ 207 (284)
T d1ozna_ 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207 (284)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred hcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhccccc
Confidence 44444444444444444444555555556666666655555555555555555555555555554432 44444444444
Q ss_pred ccCCCCCCCCCCcccCCCCCCcEEECCCCccc
Q 002121 294 LSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 294 Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
+++|++. ...+..|.++++|++|+|++|.+.
T Consensus 208 l~~N~i~-~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 208 LFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp CCSSCCS-CCCHHHHTTCTTCCEEECCSSCEE
T ss_pred ccccccc-cccccccccccccCEEEecCCCCC
Confidence 4444443 333344444444444444444444
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=3.3e-24 Score=231.04 Aligned_cols=233 Identities=21% Similarity=0.197 Sum_probs=135.6
Q ss_pred hccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeE
Q 002121 118 LILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFH 197 (964)
Q Consensus 118 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~ 197 (964)
+++++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|++.+..+ ..+..+..++.+.
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~------~~~~~~~~~~~l~ 86 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA------AAFTGLALLEQLD 86 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECT------TTTTTCTTCCEEE
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccc------ccccccccccccc
Confidence 455556666 5665543 456777777777775555667777777777777777762221 1222333333332
Q ss_pred ccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCc
Q 002121 198 FNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLK 277 (964)
Q Consensus 198 L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 277 (964)
.. ..|.++...+..|.++++|++|++++|.+....+..+..+++|+.+++++|.|+
T Consensus 87 ~~------------------------~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~ 142 (284)
T d1ozna_ 87 LS------------------------DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142 (284)
T ss_dssp CC------------------------SCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cc------------------------cccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhcccccc
Confidence 22 233444444555666666666666666666555555666666666666666666
Q ss_pred cCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCCCC
Q 002121 278 GPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGN 356 (964)
Q Consensus 278 ~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~ 356 (964)
++++. +..+++|+.|++++|.++ ...+..|.++++|+.|++++|++++..|..|.++++|++|++++|++.+..+..|
T Consensus 143 ~i~~~~f~~~~~L~~L~l~~N~l~-~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~ 221 (284)
T d1ozna_ 143 ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221 (284)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHH
T ss_pred ccChhHhccccchhhcccccCccc-ccchhhhccccccchhhhhhccccccChhHhhhhhhccccccccccccccccccc
Confidence 55443 455555555555555554 4444555556666666666666665556666666666666666666655555555
Q ss_pred ccCCCCcEEeccCCcceeeccCCCcccceeEeecCC-cccccccccCccc
Q 002121 357 AVGPLLQLVDLQNNQISAITLGSGIKNYTLILVGNP-VCTATLANTNYCQ 405 (964)
Q Consensus 357 ~~l~~L~~L~L~~N~l~~i~~~~~~~l~~l~l~~Np-~c~~~l~~~~~~~ 405 (964)
..+++|+.|+ |.||| .|+|.+.++..|.
T Consensus 222 ~~~~~L~~L~---------------------l~~N~l~C~C~~~~l~~~l 250 (284)
T d1ozna_ 222 APLRALQYLR---------------------LNDNPWVCDCRARPLWAWL 250 (284)
T ss_dssp TTCTTCCEEE---------------------CCSSCEECSGGGHHHHHHH
T ss_pred ccccccCEEE---------------------ecCCCCCCCccchHHHHHH
Confidence 5555555444 55555 6888887777663
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=1.9e-23 Score=234.69 Aligned_cols=278 Identities=24% Similarity=0.289 Sum_probs=227.1
Q ss_pred CCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEE
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 142 (964)
-.+++.|+|++|+|++.. .++++++|++|+|++| .+.+.. .++.+++|+.|++++|.+++..+ ......+..+
T Consensus 65 L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n-~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~ 137 (384)
T d2omza2 65 LNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNN-QIADIT--PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRL 137 (384)
T ss_dssp CTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSS-CCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred CCCCCEEeCcCCcCCCCc--cccCCccccccccccc-cccccc--ccccccccccccccccccccccc--cccccccccc
Confidence 468999999999999754 3999999999999999 677644 38999999999999999885433 2334455555
Q ss_pred EcccCcccC-----------------------------------------cCCCcCCCccccccccccccccccccCccc
Q 002121 143 ALNSNNFSG-----------------------------------------RIPPSLGKLSQLYWLDLADNQLTGSIPVST 181 (964)
Q Consensus 143 ~Ls~N~l~~-----------------------------------------~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~ 181 (964)
....|.+.. .....+..+++++.+++++|.+++..|
T Consensus 138 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--- 214 (384)
T d2omza2 138 ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--- 214 (384)
T ss_dssp EEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG---
T ss_pred ccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc---
Confidence 554444321 122446677899999999999985443
Q ss_pred CCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCcccc
Q 002121 182 ITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLN 261 (964)
Q Consensus 182 ~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 261 (964)
+..+++|+.|++++|+++ .++ .+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+.
T Consensus 215 -----~~~~~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~ 282 (384)
T d2omza2 215 -----LGILTNLDELSLNGNQLK-DIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLA 282 (384)
T ss_dssp -----GGGCTTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGT
T ss_pred -----ccccCCCCEEECCCCCCC-Ccc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--ccc
Confidence 456789999999999998 444 36677899999999999997554 788999999999999999544 378
Q ss_pred CCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEE
Q 002121 262 NLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQV 341 (964)
Q Consensus 262 ~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 341 (964)
+++.++.+.+++|.+++. +.+..++++++|++++|++++ . + .+..+++|+.|+|++|+|++. + .+.++++|++|
T Consensus 283 ~~~~l~~l~~~~n~l~~~-~~~~~~~~l~~L~ls~n~l~~-l-~-~l~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L 356 (384)
T d2omza2 283 GLTALTNLELNENQLEDI-SPISNLKNLTYLTLYFNNISD-I-S-PVSSLTKLQRLFFANNKVSDV-S-SLANLTNINWL 356 (384)
T ss_dssp TCTTCSEEECCSSCCSCC-GGGGGCTTCSEEECCSSCCSC-C-G-GGGGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEE
T ss_pred cccccccccccccccccc-cccchhcccCeEECCCCCCCC-C-c-ccccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEE
Confidence 899999999999999974 458889999999999999973 2 3 388999999999999999863 3 68999999999
Q ss_pred EcCCcccccccCCCCccCCCCcEEeccCC
Q 002121 342 KLRNNAFNNTLDMGNAVGPLLQLVDLQNN 370 (964)
Q Consensus 342 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 370 (964)
+|++|++++..+ +..+++|+.|+|++|
T Consensus 357 ~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCcCCCChh--hccCCCCCEeeCCCC
Confidence 999999998865 889999999999998
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.1e-22 Score=214.42 Aligned_cols=200 Identities=22% Similarity=0.204 Sum_probs=102.8
Q ss_pred ccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccC
Q 002121 113 QKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKN 192 (964)
Q Consensus 113 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~ 192 (964)
..+.++++++++|+ .+|..+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+ .+| .+..+++
T Consensus 10 ~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-------~~~~l~~ 78 (266)
T d1p9ag_ 10 ASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-------VDGTLPV 78 (266)
T ss_dssp TTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-------CCSCCTT
T ss_pred CCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-------ccccccc
Confidence 34444556666666 4555443 35666666666666544455666666666666666665 232 1122333
Q ss_pred CCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeecc
Q 002121 193 AKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLA 272 (964)
Q Consensus 193 L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 272 (964)
|+.|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+|++|+++
T Consensus 79 L~~L~Ls~N~l~--------------------------~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~ 132 (266)
T d1p9ag_ 79 LGTLDLSHNQLQ--------------------------SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLK 132 (266)
T ss_dssp CCEEECCSSCCS--------------------------SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECT
T ss_pred cccccccccccc--------------------------ccccccccccccccccccccccceeecccccccccccccccc
Confidence 333333333332 123334445555555555555554444444444444444444
Q ss_pred CccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccccccc
Q 002121 273 HNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTL 352 (964)
Q Consensus 273 ~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 352 (964)
+|.++.++ +..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+
T Consensus 133 ~n~l~~l~------------------------~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 133 GNELKTLP------------------------PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp TSCCCCCC------------------------TTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred ccccceec------------------------cccccccccchhcccccccccccCccccccccccceeecccCCCc-cc
Confidence 44444433 334444555555555555555555555555555555555555555 34
Q ss_pred CCCCccCCCCcEEeccCCccee
Q 002121 353 DMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 353 ~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
|..+..+++|+.|+|++|+|.+
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBCC
T ss_pred ChhHCCCCCCCEEEecCCCCCC
Confidence 4444455666666666666654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=9.1e-23 Score=205.76 Aligned_cols=163 Identities=15% Similarity=0.158 Sum_probs=121.0
Q ss_pred CccceeecCCcEEEEEEEecCCcEEEEEEecCCCcc------------------hhHHHHHHHHHHHhcCCCCccceeEE
Q 002121 630 SESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQ------------------GGLEFKTEIELLSRVHHKNLVGLVGF 691 (964)
Q Consensus 630 ~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~H~nIv~l~~~ 691 (964)
.+.++||+|+||+||+|+..+|+.||||+++..... .......|...+.++.|.++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 356899999999999999889999999987532110 01234578899999999999988765
Q ss_pred EEeeCceEEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcCCCCeeccCCCCCcEEECCCCcEEEee
Q 002121 692 CFEQGEQMLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELANPPIIHRDVKSTNILLDENLTAKVAD 771 (964)
Q Consensus 692 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~Dlk~~NILl~~~~~~kl~D 771 (964)
. ..++||||++++.+.+ +++.....++.|++++|+|||+.+ |+||||||+|||++++ .++|+|
T Consensus 83 ~----~~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred c----CCEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEE
Confidence 3 3479999998865543 344456789999999999999988 9999999999999965 589999
Q ss_pred cccceeecCCCCCceeecccccCcccCc------cccccCCCCCchhHHHHHHHH
Q 002121 772 FGLSKLVSDSSKGHVSTQVKGTMGYLDP------EYYMTQQLTEKSDVYSFGVVM 820 (964)
Q Consensus 772 FGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~sDv~S~Gvvl 820 (964)
||+|+....+... .|... |. ..+.|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~----------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR----------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH----------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH----------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 9999865432110 11111 11 135678899999975433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.78 E-value=5.3e-18 Score=187.04 Aligned_cols=276 Identities=23% Similarity=0.303 Sum_probs=159.4
Q ss_pred CCCeeEEEcCCCCccccccCCcCCCCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEE
Q 002121 63 NSRVTALGLSTMGLTGKLSGDIGGLTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFL 142 (964)
Q Consensus 63 ~~~v~~L~L~~~~l~g~~~~~l~~l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 142 (964)
..+++.|||++++++ .+|+. +++|++|+|++| .++ .+|..+ .+|+.|++++|+++ .++.. .+.|++|
T Consensus 37 ~~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N-~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L 103 (353)
T d1jl5a_ 37 DRQAHELELNNLGLS-SLPEL---PPHLESLVASCN-SLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYL 103 (353)
T ss_dssp HHTCSEEECTTSCCS-CCCSC---CTTCSEEECCSS-CCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEE
T ss_pred HcCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCC-CCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccc
Confidence 357889999999998 57754 578999999999 676 667654 56888899999988 44431 1469999
Q ss_pred EcccCcccCcCCCcCCCccccccccccccccccccCccc-------------CCCCccccccCCCeeEccCCcccccccc
Q 002121 143 ALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVST-------------ITSPGLDQLKNAKHFHFNKNKLSGTISE 209 (964)
Q Consensus 143 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~-------------~~~~~l~~l~~L~~L~L~~N~l~g~l~~ 209 (964)
+|++|.++ .+|. ++++++|++|++++|.+.. .|... .....+..++.++.|++++|.+. .++.
T Consensus 104 ~L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~-~~~~ 179 (353)
T d1jl5a_ 104 GVSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLK-KLPD 179 (353)
T ss_dssp ECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCS-SCCC
T ss_pred cccccccc-cccc-hhhhccceeeccccccccc-cccccccccchhhccccccccccccccccceeccccccccc-cccc
Confidence 99999999 5564 6889999999999999873 22110 11122344455555555555554 2211
Q ss_pred cccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCC
Q 002121 210 QLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSL 289 (964)
Q Consensus 210 ~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L 289 (964)
.......+.+.++.+. .++ .+..++.|+.+++++|... .++.. ..++..+.+.+|.+...... ...+
T Consensus 180 ----~~~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~~~l~~~~~~~~~~~~~~~~---~~~l 246 (353)
T d1jl5a_ 180 ----LPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDL---PPSLEALNVRDNYLTDLPEL---PQSL 246 (353)
T ss_dssp ----CCTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCS-SCCSC---CTTCCEEECCSSCCSCCCCC---CTTC
T ss_pred ----cccccccccccccccc-ccc-ccccccccccccccccccc-ccccc---cccccccccccccccccccc---cccc
Confidence 1122233444444433 222 2455666677777766655 23322 34455566666655543321 1223
Q ss_pred CEEEccCCCCCC---------------CCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccCC
Q 002121 290 SYVDLSNNSFDP---------------TEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDM 354 (964)
Q Consensus 290 ~~L~Ls~N~l~~---------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 354 (964)
..+++..|.+.+ .........+++|++|+|++|+|+ .+|. .+++|+.|+|++|+|+.+. .
T Consensus 247 ~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~~l~-~ 321 (353)
T d1jl5a_ 247 TFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAEVP-E 321 (353)
T ss_dssp CEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSCCC-C
T ss_pred cccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCCccc-c
Confidence 333333332210 001111233456666666666665 3342 2456666666666665432 1
Q ss_pred CCccCCCCcEEeccCCcceeec
Q 002121 355 GNAVGPLLQLVDLQNNQISAIT 376 (964)
Q Consensus 355 ~~~~l~~L~~L~L~~N~l~~i~ 376 (964)
.+++|+.|+|++|+|+.+|
T Consensus 322 ---~~~~L~~L~L~~N~L~~lp 340 (353)
T d1jl5a_ 322 ---LPQNLKQLHVEYNPLREFP 340 (353)
T ss_dssp ---CCTTCCEEECCSSCCSSCC
T ss_pred ---ccCCCCEEECcCCcCCCCC
Confidence 2345666666666666655
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=2.6e-18 Score=177.78 Aligned_cols=208 Identities=23% Similarity=0.263 Sum_probs=96.1
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
|.++..++++.+++++.+ .+..+.+|+.|++++|.|+. + ..+.++++|++|+|++|++++.. .+..++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~--------~l~~l~ 85 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLA--------PLKNLT 85 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCG--------GGTTCC
T ss_pred HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeeccc--------cccccc
Confidence 444445555555555432 34455666666666666663 3 24566666666666666665221 144555
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
+|+.+++++|.++ .++. +..+.+|+.+.+++|+..+.. .+...+.++.+.++.+.+.... .+.++++|++|++
T Consensus 86 ~l~~l~~~~n~~~-~i~~--l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l 158 (227)
T d1h6ua2 86 KITELELSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSI 158 (227)
T ss_dssp SCCEEECCSCCCS-CCGG--GTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEEC
T ss_pred ccccccccccccc-cccc--ccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccc
Confidence 5555555555544 2221 222333333333333333211 1333444444444444444211 2333444444444
Q ss_pred cCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccc
Q 002121 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 272 s~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
++|.+++.. .+.++++|+.|+|++|++++.. .+.++++|++|+|++|++++.
T Consensus 159 ~~n~~~~~~--------------------------~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt~i 210 (227)
T d1h6ua2 159 GNAQVSDLT--------------------------PLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQISDV 210 (227)
T ss_dssp CSSCCCCCG--------------------------GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCCBC
T ss_pred cccccccch--------------------------hhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCCCC
Confidence 444443222 1444444444444444444321 244455555555555555543
Q ss_pred cCCCCccCCCCcEEecc
Q 002121 352 LDMGNAVGPLLQLVDLQ 368 (964)
Q Consensus 352 ~~~~~~~l~~L~~L~L~ 368 (964)
.+ +..+++|+.|+|+
T Consensus 211 ~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 211 SP--LANTSNLFIVTLT 225 (227)
T ss_dssp GG--GTTCTTCCEEEEE
T ss_pred cc--cccCCCCCEEEee
Confidence 32 4455555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.2e-18 Score=180.44 Aligned_cols=208 Identities=20% Similarity=0.284 Sum_probs=137.1
Q ss_pred CCcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccc
Q 002121 87 LTELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWL 166 (964)
Q Consensus 87 l~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 166 (964)
|.++..++++.+ .+.+.+ .+..+.+|+.|++.+|+|+ .++ .+.++++|++|+|++|++++..| +.++++|+++
T Consensus 18 l~~~~~~~l~~~-~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 18 LANAIKIAAGKS-NVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHTTCS-STTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHhCCC-CcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 334444566655 444433 4556777777777777777 343 47777777888887777775433 7777777777
Q ss_pred cccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEE
Q 002121 167 DLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLR 246 (964)
Q Consensus 167 ~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~ 246 (964)
++++|.++ .++ .+..+++|+.+++++|...+.. .+.....+..+.++++.+.... .+..+++|+.|+
T Consensus 91 ~~~~n~~~-~i~-------~l~~l~~L~~l~l~~~~~~~~~---~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~ 157 (227)
T d1h6ua2 91 ELSGNPLK-NVS-------AIAGLQSIKTLDLTSTQITDVT---PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLS 157 (227)
T ss_dssp ECCSCCCS-CCG-------GGTTCTTCCEEECTTSCCCCCG---GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEE
T ss_pred cccccccc-ccc-------cccccccccccccccccccccc---hhccccchhhhhchhhhhchhh--hhcccccccccc
Confidence 77777776 332 4667777777888777765322 2455667777888888776433 367788899999
Q ss_pred cccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECC
Q 002121 247 LDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICE 320 (964)
Q Consensus 247 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls 320 (964)
+++|.+++.. .|.++++|+.|+|++|+++++. .+.++++|++|+|++|+++ . ++ .+.++++|+.|+|+
T Consensus 158 l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~-~l~~l~~L~~L~Ls~N~lt-~-i~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 158 IGNAQVSDLT--PLANLSKLTTLKADDNKISDIS-PLASLPNLIEVHLKNNQIS-D-VS-PLANTSNLFIVTLT 225 (227)
T ss_dssp CCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECTTSCCC-B-CG-GGTTCTTCCEEEEE
T ss_pred ccccccccch--hhcccccceecccCCCccCCCh-hhcCCCCCCEEECcCCcCC-C-Cc-ccccCCCCCEEEee
Confidence 9999887433 3778888888888888887643 3666666666666666664 2 22 14555555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=6.6e-18 Score=176.44 Aligned_cols=218 Identities=12% Similarity=0.079 Sum_probs=95.1
Q ss_pred hhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCee
Q 002121 117 ILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHF 196 (964)
Q Consensus 117 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L 196 (964)
.+++++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+|. ..|..+++++++
T Consensus 12 ~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~-----~~f~~l~~l~~l 83 (242)
T d1xwdc1 12 VFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA-----DVFSNLPKLHEI 83 (242)
T ss_dssp EEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECS-----SSEESCTTCCEE
T ss_pred EEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeec-----cccccccccccc
Confidence 3444444555 4444432 3555666666665544344555555666666655555433331 234444455544
Q ss_pred EccC-CcccccccccccCCCcceeEEEccCCcCcccCCc-ccCCCCCCcEEEcccCcCccccCccccCCC-CCCeeeccC
Q 002121 197 HFNK-NKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPE-SLGYVQTLEVLRLDRNALTGKVPTNLNNLT-NVNELNLAH 273 (964)
Q Consensus 197 ~L~~-N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~ 273 (964)
.+.. |.+. .++...|..+++|++|++++|++....+. .+..+..+..+..+++.+....+..|.+++ .++.|++++
T Consensus 84 ~~~~~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~ 162 (242)
T d1xwdc1 84 RIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 162 (242)
T ss_dssp EEECCTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred ccccccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccc
Confidence 4432 3333 33333334444444444444444322111 122233344444444444433334444432 444444444
Q ss_pred ccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccccccC
Q 002121 274 NDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFNNTLD 353 (964)
Q Consensus 274 N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 353 (964)
|+++.+.+......++..+ +++++|+|+...+..|.++++|++|+|++|+|+...+
T Consensus 163 n~l~~i~~~~~~~~~l~~~------------------------~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 163 NGIQEIHNCAFNGTQLDEL------------------------NLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp SCCCEECTTTTTTCCEEEE------------------------ECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred ccccccccccccchhhhcc------------------------ccccccccccccHHHhcCCCCCCEEECCCCcCCccCH
Confidence 4444443332222332222 2333444443333344445555555555555554444
Q ss_pred CCCccCCCCcEEec
Q 002121 354 MGNAVGPLLQLVDL 367 (964)
Q Consensus 354 ~~~~~l~~L~~L~L 367 (964)
..|..+++|+.|++
T Consensus 219 ~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 219 YGLENLKKLRARST 232 (242)
T ss_dssp SSCTTCCEEESSSE
T ss_pred HHHcCCcccccCcC
Confidence 44444444444444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.72 E-value=1.8e-16 Score=174.59 Aligned_cols=265 Identities=21% Similarity=0.216 Sum_probs=178.8
Q ss_pred CcccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCcccccccc
Q 002121 88 TELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLD 167 (964)
Q Consensus 88 ~~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 167 (964)
.+|++|||++| .++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.-. +.|++|+
T Consensus 38 ~~l~~LdLs~~-~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNL-GLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLG 104 (353)
T ss_dssp HTCSEEECTTS-CCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEE
T ss_pred cCCCEEEeCCC-CCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---ccccccc
Confidence 46889999999 565 57754 468999999999999 788754 57999999999998 444321 4699999
Q ss_pred ccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEc
Q 002121 168 LADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRL 247 (964)
Q Consensus 168 Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~L 247 (964)
+++|+++ .+| .+..+++|+.|++++|.+.. .+. ....+..+.+..+... ....+..++.++.|++
T Consensus 105 L~~n~l~-~lp-------~~~~l~~L~~L~l~~~~~~~-~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l 169 (353)
T d1jl5a_ 105 VSNNQLE-KLP-------ELQNSSFLKIIDVDNNSLKK-LPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYA 169 (353)
T ss_dssp CCSSCCS-SCC-------CCTTCTTCCEEECCSSCCSC-CCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEEC
T ss_pred ccccccc-ccc-------chhhhccceeeccccccccc-ccc----ccccccchhhcccccc--ccccccccccceeccc
Confidence 9999998 555 35678999999999999873 222 2344556666555544 2344566677777777
Q ss_pred ccCcCccc------------------cCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccC
Q 002121 248 DRNALTGK------------------VPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFS 309 (964)
Q Consensus 248 s~N~l~~~------------------~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~ 309 (964)
++|.+... ....+..++.|+.+++++|.....+. ...++..+.+.+|.+. ..+.
T Consensus 170 ~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~---~~~~l~~~~~~~~~~~--~~~~--- 241 (353)
T d1jl5a_ 170 DNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPD---LPPSLEALNVRDNYLT--DLPE--- 241 (353)
T ss_dssp CSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCS---CCTTCCEEECCSSCCS--CCCC---
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccc--cccc---
Confidence 77665521 11224556677777777776665432 2345667777777664 1111
Q ss_pred CCCCCcEEECCCCccccc----------------cChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEeccCCcce
Q 002121 310 TLPSLTTLICEFGSLQGR----------------VPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 310 ~l~~L~~L~Ls~N~l~~~----------------~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 373 (964)
....+..+++..|.+.+. ++.....+++|++|+|++|+|+.+. . .+++|+.|+|++|+|+
T Consensus 242 ~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~~lp-~---~~~~L~~L~L~~N~L~ 317 (353)
T d1jl5a_ 242 LPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELP-A---LPPRLERLIASFNHLA 317 (353)
T ss_dssp CCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCS
T ss_pred ccccccccccccccccccccccchhcccccccCccccccccCCCCCEEECCCCccCccc-c---ccCCCCEEECCCCcCC
Confidence 123344444444333221 1111233579999999999998643 2 4688999999999999
Q ss_pred eeccCCCcccceeEeecCCc
Q 002121 374 AITLGSGIKNYTLILVGNPV 393 (964)
Q Consensus 374 ~i~~~~~~~l~~l~l~~Np~ 393 (964)
.++.. ...++.|+|++|++
T Consensus 318 ~l~~~-~~~L~~L~L~~N~L 336 (353)
T d1jl5a_ 318 EVPEL-PQNLKQLHVEYNPL 336 (353)
T ss_dssp CCCCC-CTTCCEEECCSSCC
T ss_pred ccccc-cCCCCEEECcCCcC
Confidence 98743 34688999999985
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.1e-17 Score=174.67 Aligned_cols=213 Identities=14% Similarity=0.116 Sum_probs=136.9
Q ss_pred cEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCccee
Q 002121 140 SFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLI 219 (964)
Q Consensus 140 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~ 219 (964)
+.++.+++.++ .+|..+. +++++|+|++|+++ .+|. ..|.++++|++|++++|.+...++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~-~l~~-----~~f~~l~~L~~L~ls~n~~~~~i~~~--------- 72 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLR-VIQK-----GAFSGFGDLEKIEISQNDVLEVIEAD--------- 72 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCC-EECT-----TTTTTCTTCCEEEEESCTTCCEECSS---------
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCC-ccCh-----hHhhccchhhhhhhccccccceeecc---------
Confidence 45666666666 5555443 35666666666665 3331 23445555555555555544333333
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEccc-CcCccccCccccCCCCCCeeeccCccCccCCC--CCCCCCCCCEEEccC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDR-NALTGKVPTNLNNLTNVNELNLAHNDLKGPFP--DLSQMNSLSYVDLSN 296 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~l~~l~~L~~L~Ls~ 296 (964)
.|..+++++.|.+.. |.+....+..|.++++|++|++++|.++...+ .+..+..+..+..++
T Consensus 73 ---------------~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n 137 (242)
T d1xwdc1 73 ---------------VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN 137 (242)
T ss_dssp ---------------SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESC
T ss_pred ---------------ccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccccccccc
Confidence 455556666665543 45555555666666666666666666655433 134455566666666
Q ss_pred CCCCCCCCCcccCCCC-CCcEEECCCCccccccChhccCCCCCCE-EEcCCcccccccCCCCccCCCCcEEeccCCccee
Q 002121 297 NSFDPTEAPLWFSTLP-SLTTLICEFGSLQGRVPDKLFSYSQIQQ-VKLRNNAFNNTLDMGNAVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 297 N~l~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 374 (964)
+.+. ...+..|.+++ .+..|++++|+++...+..+. .++++. +++++|+++.+.+..|..+++|+.|+|++|+|+.
T Consensus 138 ~~l~-~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~-~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~ 215 (242)
T d1xwdc1 138 INIH-TIERNSFVGLSFESVILWLNKNGIQEIHNCAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215 (242)
T ss_dssp TTCC-EECTTSSTTSBSSCEEEECCSSCCCEECTTTTT-TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCC
T ss_pred cccc-cccccccccccccceeeeccccccccccccccc-chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCc
Confidence 6665 44455566654 788899999999866665554 455544 4678899998888889999999999999999999
Q ss_pred eccCCCcccceeE
Q 002121 375 ITLGSGIKNYTLI 387 (964)
Q Consensus 375 i~~~~~~~l~~l~ 387 (964)
++...+..+..|.
T Consensus 216 l~~~~~~~l~~L~ 228 (242)
T d1xwdc1 216 LPSYGLENLKKLR 228 (242)
T ss_dssp CCSSSCTTCCEEE
T ss_pred cCHHHHcCCcccc
Confidence 9887777766654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=3.5e-17 Score=166.85 Aligned_cols=165 Identities=22% Similarity=0.286 Sum_probs=101.3
Q ss_pred ccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCee
Q 002121 190 LKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNEL 269 (964)
Q Consensus 190 l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 269 (964)
+.+|+.|++++|.++ .++. +..+++|++|++++|+|++.. .++.+++|++|++++|+|++ +| .+.++++|+.|
T Consensus 45 L~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L 117 (210)
T d1h6ta2 45 LNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (210)
T ss_dssp HHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-ccccccccccc
Confidence 445555555555554 2221 233445555555555555432 24666777777777777763 33 46667777777
Q ss_pred eccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCcccc
Q 002121 270 NLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349 (964)
Q Consensus 270 ~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 349 (964)
++++|.+... +.+..+++|+.+++++|.++. +..+..+++|+.+++++|++++.. .+.++++|+.|+|++|+++
T Consensus 118 ~l~~~~~~~~-~~l~~l~~l~~l~~~~n~l~~---~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 118 SLEHNGISDI-NGLVHLPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp ECTTSCCCCC-GGGGGCTTCCEEECCSSCCCC---CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc-ccccccccccccccccccccc---cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCC
Confidence 7777766543 346666777777777777641 234566777777777777776543 2667777777777777776
Q ss_pred cccCCCCccCCCCcEEeccC
Q 002121 350 NTLDMGNAVGPLLQLVDLQN 369 (964)
Q Consensus 350 ~~~~~~~~~l~~L~~L~L~~ 369 (964)
+.. .+..+++|+.|+|++
T Consensus 192 ~l~--~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 DLR--ALAGLKNLDVLELFS 209 (210)
T ss_dssp BCG--GGTTCTTCSEEEEEE
T ss_pred CCh--hhcCCCCCCEEEccC
Confidence 542 467777777777754
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=6e-17 Score=163.66 Aligned_cols=161 Identities=20% Similarity=0.265 Sum_probs=74.3
Q ss_pred cccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCe
Q 002121 189 QLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNE 268 (964)
Q Consensus 189 ~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 268 (964)
.+.++++|++++|.++ .++. +..+++|++|++++|+|++..+ ++++++|+.|++++|.+. .++ .+.++++|+.
T Consensus 38 ~l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~ 110 (199)
T d2omxa2 38 DLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTG 110 (199)
T ss_dssp HHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSE
T ss_pred HhcCCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccc
Confidence 3455555555555554 2211 2223344444444444443221 445555555555555554 222 2445555555
Q ss_pred eeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCCccc
Q 002121 269 LNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRNNAF 348 (964)
Q Consensus 269 L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 348 (964)
|++++|.+.... .+..+++|+.|++++|++. .++ .+..+++|+.|++++|++++.. .+.++++|+.|+|++|++
T Consensus 111 L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~--~~~-~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i 184 (199)
T d2omxa2 111 LTLFNNQITDID-PLKNLTNLNRLELSSNTIS--DIS-ALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKV 184 (199)
T ss_dssp EECCSSCCCCCG-GGTTCTTCSEEECCSSCCC--CCG-GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCC
T ss_pred cccccccccccc-ccchhhhhHHhhhhhhhhc--ccc-cccccccccccccccccccCCc--cccCCCCCCEEECCCCCC
Confidence 555555544322 2444555555555555553 111 2445555555555555554332 244555555555555555
Q ss_pred ccccCCCCccCCCCcE
Q 002121 349 NNTLDMGNAVGPLLQL 364 (964)
Q Consensus 349 ~~~~~~~~~~l~~L~~ 364 (964)
++.. .+..+++|+.
T Consensus 185 ~~i~--~l~~L~~L~~ 198 (199)
T d2omxa2 185 SDIS--VLAKLTNLES 198 (199)
T ss_dssp CCCG--GGGGCTTCSE
T ss_pred CCCc--cccCCCCCCc
Confidence 4421 2444444443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=2.6e-17 Score=165.34 Aligned_cols=108 Identities=21% Similarity=0.269 Sum_probs=49.3
Q ss_pred CCcEEEcccCcCcccc-CccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEE
Q 002121 241 TLEVLRLDRNALTGKV-PTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLI 318 (964)
Q Consensus 241 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 318 (964)
++++|+|++|+|++.+ +..|.++++|++|+|++|.+.+.++. +..+++|++|+|++|+|+ ...+.+|.++++|++|+
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~-~l~~~~F~~l~~L~~L~ 108 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLN 108 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCC-EECSSSSTTCTTCCEEE
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecccccc-ccCHHHHhCCCcccccc
Confidence 4444444444444322 33344444444444444444444332 334444444444444443 33334444444444555
Q ss_pred CCCCccccccChhccCCCCCCEEEcCCcccc
Q 002121 319 CEFGSLQGRVPDKLFSYSQIQQVKLRNNAFN 349 (964)
Q Consensus 319 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 349 (964)
|++|+|++..+..|..+++|++|+|++|.+.
T Consensus 109 L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 109 LYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cCCccccccCHHHhcCCcccccccccccccc
Confidence 5555544444444445555555555555443
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.68 E-value=1.8e-17 Score=166.63 Aligned_cols=109 Identities=25% Similarity=0.397 Sum_probs=68.2
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
++++|+|++|+|++.++...|..+.+|++|++++|++.+..+..|..+++|+.|+|++|+|++..|.+|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 34444444444443444455555555666666666666666666666677777777777777666666777777777777
Q ss_pred cCccCccCCCC-CCCCCCCCEEEccCCCCC
Q 002121 272 AHNDLKGPFPD-LSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 272 s~N~l~~~~~~-l~~l~~L~~L~Ls~N~l~ 300 (964)
++|+|+++++. |..+++|++|+|++|++.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCccccccCHHHhcCCcccccccccccccc
Confidence 77777766654 566666666666666664
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=5.8e-17 Score=165.21 Aligned_cols=187 Identities=21% Similarity=0.287 Sum_probs=103.0
Q ss_pred cccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCcccccc
Q 002121 112 LQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQLK 191 (964)
Q Consensus 112 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~ 191 (964)
+.++....+..+.+++.++. ..+.+|++|++++|.++.. + .+..+++|++|+|++|++++ ++ .+..++
T Consensus 23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-------~~~~l~ 90 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-------PLANLK 90 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-------GGTTCT
T ss_pred HHHHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-------ccccCc
Confidence 34444556666666654442 3456677777777777632 2 36667777777777777663 22 234555
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeec
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNL 271 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 271 (964)
+|+.|++++|+++ .++ .+..+++|+.|++++|.+.. + ..+..+++|+.+++
T Consensus 91 ~L~~L~l~~n~i~-~l~--------------------------~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~ 141 (210)
T d1h6ta2 91 NLGWLFLDENKVK-DLS--------------------------SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYL 141 (210)
T ss_dssp TCCEEECCSSCCC-CGG--------------------------GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEEC
T ss_pred ccccccccccccc-ccc--------------------------cccccccccccccccccccc-c-cccccccccccccc
Confidence 5666666655554 222 24445555555555555441 1 23445555555555
Q ss_pred cCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEEEcCC
Q 002121 272 AHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQVKLRN 345 (964)
Q Consensus 272 s~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 345 (964)
++|.+++. +.+..+++|+++++++|+++ . ++ .+.++++|+.|+|++|+|+. ++ .+.++++|++|+|++
T Consensus 142 ~~n~l~~~-~~~~~l~~L~~l~l~~n~l~-~-i~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 142 GNNKITDI-TVLSRLTKLDTLSLEDNQIS-D-IV-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CSSCCCCC-GGGGGCTTCSEEECCSSCCC-C-CG-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred cccccccc-cccccccccccccccccccc-c-cc-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 55555432 22444555666666666654 1 22 25566666666666666654 23 466677777777653
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=8.3e-17 Score=162.60 Aligned_cols=184 Identities=23% Similarity=0.315 Sum_probs=98.5
Q ss_pred CcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCccccc
Q 002121 111 DLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPGLDQL 190 (964)
Q Consensus 111 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l 190 (964)
++.++..+.++.+.+++.++ ...+.+|++|++++|.++. + ..+..+++|++|+|++|++++ ++ .+..+
T Consensus 16 ~l~~~i~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l-~~l~~l~nL~~L~Ls~N~l~~-~~-------~l~~l 83 (199)
T d2omxa2 16 ALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-------PLKNL 83 (199)
T ss_dssp HHHHHHHHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-------GGTTC
T ss_pred HHHHHHHHHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-c-cccccCCCcCcCccccccccC-cc-------cccCC
Confidence 34455556666666665433 2456677777777777763 3 346666777777777777663 22 24556
Q ss_pred cCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeee
Q 002121 191 KNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELN 270 (964)
Q Consensus 191 ~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 270 (964)
++|++|++++|.+. .++ .+.++++|+.|++++|.+... ..+..+++|+.|+
T Consensus 84 ~~L~~L~l~~n~~~-~~~--------------------------~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~ 134 (199)
T d2omxa2 84 TKLVDILMNNNQIA-DIT--------------------------PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE 134 (199)
T ss_dssp TTCCEEECCSSCCC-CCG--------------------------GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred cccccccccccccc-ccc--------------------------ccccccccccccccccccccc--cccchhhhhHHhh
Confidence 66666666666554 222 134444455555554444421 1244455555555
Q ss_pred ccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCCccccccChhccCCCCCCEE
Q 002121 271 LAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRVPDKLFSYSQIQQV 341 (964)
Q Consensus 271 Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 341 (964)
+++|++... +.+..+++|+.|++++|+++. ++ .+.++++|+.|++++|++++. + .+.++++|+.|
T Consensus 135 l~~n~l~~~-~~l~~~~~L~~L~l~~n~l~~--l~-~l~~l~~L~~L~ls~N~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 135 LSSNTISDI-SALSGLTSLQQLNFSSNQVTD--LK-PLANLTTLERLDISSNKVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CCSSCCCCC-GGGTTCTTCSEEECCSSCCCC--CG-GGTTCTTCCEEECCSSCCCCC-G-GGGGCTTCSEE
T ss_pred hhhhhhccc-ccccccccccccccccccccC--Cc-cccCCCCCCEEECCCCCCCCC-c-cccCCCCCCcC
Confidence 555554432 234455555555555555531 11 255566666666666665542 2 35566666654
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=3.6e-18 Score=195.36 Aligned_cols=328 Identities=18% Similarity=0.153 Sum_probs=210.2
Q ss_pred CeeEEEcCCCCcccc-ccCCcCCCCcccEEecccCCCCCC----CCCCCCCCcccchhhccccccccCc----CCcccCC
Q 002121 65 RVTALGLSTMGLTGK-LSGDIGGLTELRSLDLSYNGGLTG----SLSPRIGDLQKLNILILAGCGFTGN----IPDEIGN 135 (964)
Q Consensus 65 ~v~~L~L~~~~l~g~-~~~~l~~l~~L~~L~L~~N~~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~ 135 (964)
+++.||++++++++. +..-+..+++|++|+|++| .++. .+...+..+++|++|+|++|.|+.. +...+..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~-~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~ 81 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDC-GLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 81 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESS-CCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCC-CCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence 577888888888763 2334556777888888888 5552 3344456777888888888887532 2223322
Q ss_pred -CCCccEEEcccCcccCc----CCCcCCCccccccccccccccccccC----ccc----------------CC-------
Q 002121 136 -LAELSFLALNSNNFSGR----IPPSLGKLSQLYWLDLADNQLTGSIP----VST----------------IT------- 183 (964)
Q Consensus 136 -l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~g~iP----~~~----------------~~------- 183 (964)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++..-. ... ..
T Consensus 82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (460)
T d1z7xw1 82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161 (460)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence 34688888888888642 34566777888888888887653100 000 00
Q ss_pred CCccccccCCCeeEccCCccc-----------------------------ccc---cccccCCCcceeEEEccCCcCcc-
Q 002121 184 SPGLDQLKNAKHFHFNKNKLS-----------------------------GTI---SEQLFSPDMVLIHVLFDGNQLSG- 230 (964)
Q Consensus 184 ~~~l~~l~~L~~L~L~~N~l~-----------------------------g~l---~~~~f~~~~~L~~L~l~~N~l~~- 230 (964)
...+.....++.++++++.+. ..- -...+.....++.+++.+|++..
T Consensus 162 ~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~ 241 (460)
T d1z7xw1 162 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241 (460)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhcccccc
Confidence 000112234444444444332 000 00112335678999999998753
Q ss_pred ----cCCcccCCCCCCcEEEcccCcCccc----cCccccCCCCCCeeeccCccCccCCCC------CCCCCCCCEEEccC
Q 002121 231 ----NIPESLGYVQTLEVLRLDRNALTGK----VPTNLNNLTNVNELNLAHNDLKGPFPD------LSQMNSLSYVDLSN 296 (964)
Q Consensus 231 ----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~------l~~l~~L~~L~Ls~ 296 (964)
..+........|+.|++++|.+... ....+...+.++.+++++|.++..... ......|+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~ 321 (460)
T d1z7xw1 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKS 321 (460)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTT
T ss_pred ccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccccccccccccc
Confidence 2334455678899999999998732 334556788999999999998752211 23456899999999
Q ss_pred CCCCCCCC---CcccCCCCCCcEEECCCCccccc----cChhcc-CCCCCCEEEcCCcccccc----cCCCCccCCCCcE
Q 002121 297 NSFDPTEA---PLWFSTLPSLTTLICEFGSLQGR----VPDKLF-SYSQIQQVKLRNNAFNNT----LDMGNAVGPLLQL 364 (964)
Q Consensus 297 N~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~ 364 (964)
|.++.... ...+...++|++|+|++|+|... ++..+. ..+.|++|+|++|+|+.. +...+..+++|++
T Consensus 322 ~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~ 401 (460)
T d1z7xw1 322 CSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE 401 (460)
T ss_dssp SCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCE
T ss_pred cchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCE
Confidence 99862211 12334567899999999999764 334443 467899999999999864 2344566789999
Q ss_pred EeccCCcceeec-------cC-CCcccceeEeecCCc
Q 002121 365 VDLQNNQISAIT-------LG-SGIKNYTLILVGNPV 393 (964)
Q Consensus 365 L~L~~N~l~~i~-------~~-~~~~l~~l~l~~Np~ 393 (964)
|+|++|+|+.-. .. ....++.|.+.+|.+
T Consensus 402 L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~ 438 (460)
T d1z7xw1 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYW 438 (460)
T ss_dssp EECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCC
T ss_pred EECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCC
Confidence 999999998522 11 223477888888874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.53 E-value=3.1e-17 Score=187.37 Aligned_cols=305 Identities=19% Similarity=0.202 Sum_probs=207.3
Q ss_pred CcccEEecccCCCCCCCC-CCCCCCcccchhhccccccccC----cCCcccCCCCCccEEEcccCcccCc----CCCcCC
Q 002121 88 TELRSLDLSYNGGLTGSL-SPRIGDLQKLNILILAGCGFTG----NIPDEIGNLAELSFLALNSNNFSGR----IPPSLG 158 (964)
Q Consensus 88 ~~L~~L~L~~N~~l~~~~-p~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~ 158 (964)
.+|+.|||++| ++++.. ..-+..+++|+.|+|++|+|+. .++..+..+++|++|||++|.|+.. +...+.
T Consensus 2 ~~l~~ld~~~~-~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~ 80 (460)
T d1z7xw1 2 LDIQSLDIQCE-ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQ 80 (460)
T ss_dssp EEEEEEEEESC-CCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred CCCCEEEeeCC-cCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHh
Confidence 36899999999 677632 3446678999999999999873 3456678899999999999998631 222333
Q ss_pred -CccccccccccccccccccCcccCCCCccccccCCCeeEccCCcccccc----cccc----------------------
Q 002121 159 -KLSQLYWLDLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTI----SEQL---------------------- 211 (964)
Q Consensus 159 -~l~~L~~L~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l----~~~~---------------------- 211 (964)
..++|++|+|++|+++..-- .. -...+..+++|++|++++|.++..- ...+
T Consensus 81 ~~~~~L~~L~L~~n~it~~~~-~~-l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~ 158 (460)
T d1z7xw1 81 TPSCKIQKLSLQNCCLTGAGC-GV-LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASC 158 (460)
T ss_dssp STTCCCCEEECTTSCCBGGGH-HH-HHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGH
T ss_pred cCCCCCCEEECCCCCcccccc-cc-ccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhh
Confidence 23589999999999973210 00 0134667899999999999975210 0000
Q ss_pred ------cCCCcceeEEEccCCcCc-----------------------------cc----CCcccCCCCCCcEEEcccCcC
Q 002121 212 ------FSPDMVLIHVLFDGNQLS-----------------------------GN----IPESLGYVQTLEVLRLDRNAL 252 (964)
Q Consensus 212 ------f~~~~~L~~L~l~~N~l~-----------------------------~~----~p~~~~~l~~L~~L~Ls~N~l 252 (964)
......++.+.++++.+. .. ....+.....++.+++++|.+
T Consensus 159 ~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~ 238 (460)
T d1z7xw1 159 EPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKL 238 (460)
T ss_dssp HHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccc
Confidence 011223444554443322 10 001233457899999999987
Q ss_pred cc-----ccCccccCCCCCCeeeccCccCccCCC-----CCCCCCCCCEEEccCCCCCCCCCCc----ccCCCCCCcEEE
Q 002121 253 TG-----KVPTNLNNLTNVNELNLAHNDLKGPFP-----DLSQMNSLSYVDLSNNSFDPTEAPL----WFSTLPSLTTLI 318 (964)
Q Consensus 253 ~~-----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~~~~~~~----~~~~l~~L~~L~ 318 (964)
.. .....+.....|+.|++++|.+..... .+...+.++.+++++|.++...... .......|+.++
T Consensus 239 ~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~ 318 (460)
T d1z7xw1 239 GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLW 318 (460)
T ss_dssp HHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEE
T ss_pred cccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccc
Confidence 52 344556667899999999999875432 2566788999999999985211110 122456899999
Q ss_pred CCCCccccccChh----ccCCCCCCEEEcCCcccccccCCC----C-ccCCCCcEEeccCCcceeecc-------CCCcc
Q 002121 319 CEFGSLQGRVPDK----LFSYSQIQQVKLRNNAFNNTLDMG----N-AVGPLLQLVDLQNNQISAITL-------GSGIK 382 (964)
Q Consensus 319 Ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~i~~-------~~~~~ 382 (964)
+++|.+....... +...++|++|+|++|++++..... + ...+.|+.|+|++|+|+.... .....
T Consensus 319 l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~ 398 (460)
T d1z7xw1 319 VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 398 (460)
T ss_dssp CTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCC
T ss_pred ccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCC
Confidence 9999998764443 445679999999999997643222 2 245679999999999986421 23356
Q ss_pred cceeEeecCCccc
Q 002121 383 NYTLILVGNPVCT 395 (964)
Q Consensus 383 l~~l~l~~Np~c~ 395 (964)
++.|+|++|++-+
T Consensus 399 L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 399 LRELDLSNNCLGD 411 (460)
T ss_dssp CCEEECCSSSCCH
T ss_pred CCEEECCCCcCCH
Confidence 8899999999644
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=2.1e-14 Score=139.15 Aligned_cols=127 Identities=17% Similarity=0.148 Sum_probs=65.9
Q ss_pred CCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcE
Q 002121 237 GYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTT 316 (964)
Q Consensus 237 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~ 316 (964)
.++.+|+.|+|++|+|+ .++..+..+++|+.|+|++|+|+.+ +.+..+++|++|++++|+++ ...+..+..+++|+.
T Consensus 15 ~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~L~~ 91 (162)
T d1a9na_ 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRIC-RIGEGLDQALPDLTE 91 (162)
T ss_dssp ECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCC-EECSCHHHHCTTCCE
T ss_pred cCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhccccccc-CCCcccccccccccc
Confidence 34445555555555555 3344445555555555555555543 33555555555555555554 333333445555555
Q ss_pred EECCCCccccccC-hhccCCCCCCEEEcCCcccccccC---CCCccCCCCcEEe
Q 002121 317 LICEFGSLQGRVP-DKLFSYSQIQQVKLRNNAFNNTLD---MGNAVGPLLQLVD 366 (964)
Q Consensus 317 L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~---~~~~~l~~L~~L~ 366 (964)
|+|++|+|+.... ..+..+++|+.|++++|+++.... ..+..+|+|+.||
T Consensus 92 L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 92 LILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 5555555553321 345555666666666666544321 2344555666554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=1.1e-13 Score=133.12 Aligned_cols=137 Identities=15% Similarity=0.163 Sum_probs=86.6
Q ss_pred CEEEccCCCCCCCCCCcccCCCCCCcEEECCCC-ccccccChhccCCCCCCEEEcCCcccccccCCCCccCCCCcEEecc
Q 002121 290 SYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG-SLQGRVPDKLFSYSQIQQVKLRNNAFNNTLDMGNAVGPLLQLVDLQ 368 (964)
Q Consensus 290 ~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~ 368 (964)
+.++++++.+ ...|..+..+++|++|++++| .|+.+.+..|.++++|+.|+|++|+|+.+.+..|..+++|+.|+|+
T Consensus 11 ~~l~c~~~~~--~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 11 SGLRCTRDGA--LDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SCEECCSSCC--CTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CeEEecCCCC--ccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 3445555544 233444555566666666544 3665556666666777777777777766666667777777777777
Q ss_pred CCcceeeccCCCc--ccceeEeecCC-cccccccccCccccCCCCCcccccccccCCCCCCCCCC
Q 002121 369 NNQISAITLGSGI--KNYTLILVGNP-VCTATLANTNYCQLQQPTTKAYSTSLANCGGKSCPPEQ 430 (964)
Q Consensus 369 ~N~l~~i~~~~~~--~l~~l~l~~Np-~c~~~l~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~ 430 (964)
+|+|+.++.+.+. .+..|+|.+|| .|+|.+.++..|.... ...+ ......|.+|....+.
T Consensus 89 ~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C~~~~l~~~~~~~-~~~~-~~~~~~C~~p~~l~~~ 151 (156)
T d2ifga3 89 FNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG-LGGV-PEQKLQCHGQGPLAHM 151 (156)
T ss_dssp SSCCSCCCSTTTCSCCCCEEECCSSCCCCCGGGHHHHHHHHTT-CSSC-GGGCCCCSSSSCSSCC
T ss_pred CCCCcccChhhhccccccccccCCCcccCCchHHHHHHHHHhc-cCcc-CcCCcEECcChHHCcC
Confidence 7777776655332 46678888889 8999999888884332 2222 2356788887654443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.45 E-value=1.1e-13 Score=127.56 Aligned_cols=102 Identities=22% Similarity=0.231 Sum_probs=59.6
Q ss_pred EEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCC
Q 002121 220 HVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSF 299 (964)
Q Consensus 220 ~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l 299 (964)
.|+|++|+|+ .++ .+..+++|++|++++|+|+ .+|..|..+++|+.|++++|.|++. +.+..+++|++|++++|++
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l-~~~~~l~~L~~L~l~~N~i 77 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRL 77 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccccc-CccccccccCeEECCCCcc
Confidence 3455555555 233 2566666677777777666 4555666666666666666666654 3456666666666666666
Q ss_pred CCCCCCcccCCCCCCcEEECCCCccc
Q 002121 300 DPTEAPLWFSTLPSLTTLICEFGSLQ 325 (964)
Q Consensus 300 ~~~~~~~~~~~l~~L~~L~Ls~N~l~ 325 (964)
+.......+..+++|+.|++++|++.
T Consensus 78 ~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 78 QQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CCCCCchhhcCCCCCCEEECCCCcCC
Confidence 42222334555555556666555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.43 E-value=1.2e-13 Score=127.22 Aligned_cols=104 Identities=27% Similarity=0.389 Sum_probs=74.5
Q ss_pred cEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCCCCCcEEECCCC
Q 002121 243 EVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTLPSLTTLICEFG 322 (964)
Q Consensus 243 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N 322 (964)
++|+|++|+|+ .++ .+.++++|++|+|++|+|+.+++.+..+++|++|++++|.|+ .++ .+..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~--~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE--NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCC--CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhccccccccccccc--ccC-ccccccccCeEECCCC
Confidence 46888888887 444 377788888888888888877666777888888888888875 233 3677777777777777
Q ss_pred cccccc-ChhccCCCCCCEEEcCCcccccc
Q 002121 323 SLQGRV-PDKLFSYSQIQQVKLRNNAFNNT 351 (964)
Q Consensus 323 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~ 351 (964)
+|+... ...+..+++|+.|+|++|+++..
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence 777543 24566777777777777776543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.42 E-value=9.8e-14 Score=134.36 Aligned_cols=124 Identities=15% Similarity=0.123 Sum_probs=84.3
Q ss_pred cceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCC-CCCCCCCCEEEc
Q 002121 216 MVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPD-LSQMNSLSYVDL 294 (964)
Q Consensus 216 ~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-l~~l~~L~~L~L 294 (964)
..+++|+|++|+|+. ++..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++.+++. +..+++|++|++
T Consensus 18 ~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L 94 (162)
T d1a9na_ 18 VRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 94 (162)
T ss_dssp TSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CcCcEEECCCCCCCc-cCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccccccee
Confidence 345555555555553 3555566777777777777777 333 467777788888888877777665 456777888888
Q ss_pred cCCCCCCCCCCcccCCCCCCcEEECCCCcccccc---ChhccCCCCCCEEE
Q 002121 295 SNNSFDPTEAPLWFSTLPSLTTLICEFGSLQGRV---PDKLFSYSQIQQVK 342 (964)
Q Consensus 295 s~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---p~~~~~l~~L~~L~ 342 (964)
++|+++....-..+..+++|+.|++++|.++... +..+..+++|++||
T Consensus 95 ~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 95 TNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred ccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 8888752222245778888888888888886443 23577788888887
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.41 E-value=9.4e-15 Score=155.92 Aligned_cols=179 Identities=16% Similarity=0.204 Sum_probs=89.2
Q ss_pred CCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccC-cCccc-cCccccCCCCCCee
Q 002121 192 NAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRN-ALTGK-VPTNLNNLTNVNEL 269 (964)
Q Consensus 192 ~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~~L~~L 269 (964)
+|++|+++++.++......++...++|++|++++|.+++..+..++.+++|+.|+++++ .++.. +...+.++++|++|
T Consensus 47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L 126 (284)
T d2astb2 47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL 126 (284)
T ss_dssp CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence 33344444333332222333444444555555555544444445555556666666553 44421 12223345566666
Q ss_pred eccCc-cCccCC--CCC-CCCCCCCEEEccCC--CCCCCCCCcccCCCCCCcEEECCCC-ccccccChhccCCCCCCEEE
Q 002121 270 NLAHN-DLKGPF--PDL-SQMNSLSYVDLSNN--SFDPTEAPLWFSTLPSLTTLICEFG-SLQGRVPDKLFSYSQIQQVK 342 (964)
Q Consensus 270 ~Ls~N-~l~~~~--~~l-~~l~~L~~L~Ls~N--~l~~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~ 342 (964)
+|+++ .++... ..+ ...++|+.|+++++ .++...+...+.++++|++|+|++| .+++.....+..+++|++|+
T Consensus 127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~ 206 (284)
T d2astb2 127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 206 (284)
T ss_dssp ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence 66653 232210 111 12345666666643 2322222233345666666666664 35555666666666677777
Q ss_pred cCCc-ccccccCCCCccCCCCcEEeccCC
Q 002121 343 LRNN-AFNNTLDMGNAVGPLLQLVDLQNN 370 (964)
Q Consensus 343 L~~N-~l~~~~~~~~~~l~~L~~L~L~~N 370 (964)
|+++ .+++.....+..+++|+.|+++++
T Consensus 207 L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 207 LSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 7663 465555555666666777776665
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.40 E-value=1.2e-14 Score=155.17 Aligned_cols=60 Identities=20% Similarity=0.210 Sum_probs=34.9
Q ss_pred CcccchhhccccccccCc-CCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccc
Q 002121 111 DLQKLNILILAGCGFTGN-IPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLAD 170 (964)
Q Consensus 111 ~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 170 (964)
...+|++|+|++|.++.. ++..+.++++|++|+|+++.++...+..++.+++|++|+|++
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 444666666666665533 333455566666666666666555555555666666666665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.37 E-value=8.5e-15 Score=161.00 Aligned_cols=15 Identities=20% Similarity=0.100 Sum_probs=7.9
Q ss_pred cCCCCcccEEecccC
Q 002121 84 IGGLTELRSLDLSYN 98 (964)
Q Consensus 84 l~~l~~L~~L~L~~N 98 (964)
+.+.+.|+.|+|++|
T Consensus 27 L~~~~~l~~L~Ls~n 41 (344)
T d2ca6a1 27 LLEDDSVKEIVLSGN 41 (344)
T ss_dssp HHHCSCCCEEECTTS
T ss_pred HhhCCCCCEEECcCC
Confidence 444555555555555
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.35 E-value=1.6e-14 Score=158.67 Aligned_cols=254 Identities=15% Similarity=0.179 Sum_probs=121.1
Q ss_pred CCCCCcccchhhccccccccCc----CCcccCCCCCccEEEcccCcccCc----------CCCcCCCccccccccccccc
Q 002121 107 PRIGDLQKLNILILAGCGFTGN----IPDEIGNLAELSFLALNSNNFSGR----------IPPSLGKLSQLYWLDLADNQ 172 (964)
Q Consensus 107 ~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----------~p~~~~~l~~L~~L~Ls~N~ 172 (964)
..+.....|+.|+|++|.|... +...+...++|+.|+++++.+... +...+..+++|+.|+|++|.
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~ 104 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA 104 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence 3455567788888888877532 334466677788888877654421 11223455677777777777
Q ss_pred cccccCcccCCCCccccccCCCeeEccCCcccccccccccCCCcceeEEEccCCcCcccCCcccCCCCCCcEEEcccCcC
Q 002121 173 LTGSIPVSTITSPGLDQLKNAKHFHFNKNKLSGTISEQLFSPDMVLIHVLFDGNQLSGNIPESLGYVQTLEVLRLDRNAL 252 (964)
Q Consensus 173 l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~g~l~~~~f~~~~~L~~L~l~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 252 (964)
++..-...+ ...+...++|++|++++|.+...-...+...+ ..+ .........+.|+.|++++|.+
T Consensus 105 i~~~~~~~l--~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l---~~~---------~~~~~~~~~~~L~~l~l~~n~i 170 (344)
T d2ca6a1 105 FGPTAQEPL--IDFLSKHTPLEHLYLHNNGLGPQAGAKIARAL---QEL---------AVNKKAKNAPPLRSIICGRNRL 170 (344)
T ss_dssp CCTTTHHHH--HHHHHHCTTCCEEECCSSCCHHHHHHHHHHHH---HHH---------HHHHHHHTCCCCCEEECCSSCC
T ss_pred cccccccch--hhhhcccccchheecccccccccccccccccc---ccc---------ccccccccCcccceeecccccc
Confidence 652110000 01234556677777777765411000000000 000 0000012234455555555554
Q ss_pred cc----ccCccccCCCCCCeeeccCccCccC------CCCCCCCCCCCEEEccCCCCCCC---CCCcccCCCCCCcEEEC
Q 002121 253 TG----KVPTNLNNLTNVNELNLAHNDLKGP------FPDLSQMNSLSYVDLSNNSFDPT---EAPLWFSTLPSLTTLIC 319 (964)
Q Consensus 253 ~~----~~p~~~~~l~~L~~L~Ls~N~l~~~------~~~l~~l~~L~~L~Ls~N~l~~~---~~~~~~~~l~~L~~L~L 319 (964)
+. .+...+..++.|++|+|++|.++.. ...+..+++|+.|+|++|.++.. .+...+..+++|++|+|
T Consensus 171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L 250 (344)
T d2ca6a1 171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250 (344)
T ss_dssp TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence 41 1222233445555555555555431 11244455555555555555311 11223445556666666
Q ss_pred CCCccccccChh----ccC--CCCCCEEEcCCcccccccC----CCC-ccCCCCcEEeccCCccee
Q 002121 320 EFGSLQGRVPDK----LFS--YSQIQQVKLRNNAFNNTLD----MGN-AVGPLLQLVDLQNNQISA 374 (964)
Q Consensus 320 s~N~l~~~~p~~----~~~--l~~L~~L~L~~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~ 374 (964)
++|.|.+..... +.. .+.|++|+|++|+|+.... ..+ ...+.|+.|+|++|++..
T Consensus 251 s~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp TTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hcCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 666655442222 222 2456666666666553221 111 134556666666666643
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.25 E-value=6.6e-14 Score=140.49 Aligned_cols=87 Identities=22% Similarity=0.323 Sum_probs=45.8
Q ss_pred CCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcCCCcCCCccccccccccccccccccCcccCCCCc
Q 002121 107 PRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRIPPSLGKLSQLYWLDLADNQLTGSIPVSTITSPG 186 (964)
Q Consensus 107 ~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~iP~~~~~~~~ 186 (964)
..+..|++|++|+|++|+|+ .++ .|..+++|++|+|++|.|+ .+|..+..+++|++|++++|+++ .++ .
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-------~ 110 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-------G 110 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-------H
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-------c
Confidence 34555555555555555555 333 3555566666666666655 34444444455666666666555 221 2
Q ss_pred cccccCCCeeEccCCccc
Q 002121 187 LDQLKNAKHFHFNKNKLS 204 (964)
Q Consensus 187 l~~l~~L~~L~L~~N~l~ 204 (964)
+..+++|+.|++++|+++
T Consensus 111 ~~~l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 111 IEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHHHSSEEEESEEECC
T ss_pred ccccccccccccccchhc
Confidence 444555555555555554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.24 E-value=7e-12 Score=120.21 Aligned_cols=88 Identities=20% Similarity=0.141 Sum_probs=58.4
Q ss_pred cceeEEEccCC-cCcccCCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEc
Q 002121 216 MVLIHVLFDGN-QLSGNIPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDL 294 (964)
Q Consensus 216 ~~L~~L~l~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L 294 (964)
.+|++|++++| .|+...+..|.++++|+.|+|++|+|+...+.+|.++++|++|+|++|+|+.+++......+|+.|+|
T Consensus 31 ~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L 110 (156)
T d2ifga3 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVL 110 (156)
T ss_dssp SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEEC
T ss_pred cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcccChhhhcccccccccc
Confidence 44455555433 35545555677777777777777777766677777777777777777777776666444456777777
Q ss_pred cCCCCCCCC
Q 002121 295 SNNSFDPTE 303 (964)
Q Consensus 295 s~N~l~~~~ 303 (964)
++|++....
T Consensus 111 ~~Np~~C~C 119 (156)
T d2ifga3 111 SGNPLHCSC 119 (156)
T ss_dssp CSSCCCCCG
T ss_pred CCCcccCCc
Confidence 777775433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.22 E-value=7.8e-14 Score=139.93 Aligned_cols=117 Identities=20% Similarity=0.227 Sum_probs=70.3
Q ss_pred CCcccCCCCCCcEEEcccCcCccccCccccCCCCCCeeeccCccCccCCCCCCCCCCCCEEEccCCCCCCCCCCcccCCC
Q 002121 232 IPESLGYVQTLEVLRLDRNALTGKVPTNLNNLTNVNELNLAHNDLKGPFPDLSQMNSLSYVDLSNNSFDPTEAPLWFSTL 311 (964)
Q Consensus 232 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~~l 311 (964)
++..+..+++|++|+|++|+|+ .++ .|.++++|+.|+|++|.|+.+++....+++|++|++++|+++ . + ..+..+
T Consensus 40 l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~-~-l-~~~~~l 114 (198)
T d1m9la_ 40 MDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-S-L-SGIEKL 114 (198)
T ss_dssp CHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECC-C-H-HHHHHH
T ss_pred hhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhccccccccccccccccccccccccccccc-c-c-cccccc
Confidence 3445666677777777777776 333 366677777777777776654432333445666666666664 1 2 235566
Q ss_pred CCCcEEECCCCccccccC-hhccCCCCCCEEEcCCcccccccC
Q 002121 312 PSLTTLICEFGSLQGRVP-DKLFSYSQIQQVKLRNNAFNNTLD 353 (964)
Q Consensus 312 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~ 353 (964)
++|+.|+|++|+|+.... ..+..+++|+.|+|++|++....+
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 666666666666654322 356666666666666666655443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.49 E-value=3.9e-07 Score=94.33 Aligned_cols=150 Identities=15% Similarity=0.161 Sum_probs=104.9
Q ss_pred HHHHHhhcCCCccceeecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcC-CCCccceeEEEEeeCce
Q 002121 620 DELKKCSNNFSESNEIGSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVH-HKNLVGLVGFCFEQGEQ 698 (964)
Q Consensus 620 ~el~~~~~~~~~~~~lG~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~ 698 (964)
.|+++.-..|+..+..+-++.+.||+... +++.++||+...........+.+|...+..+. +--+.+++++..+++..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 36666667777666544444578999875 46677888876544444456788999988874 33356788888888889
Q ss_pred EEEEEeccCCChhhhhcCCCCCccchHHHHHHHHHHHHHHHHHhhcC---------------------------------
Q 002121 699 MLVYEFMANGTLRESLSGRSGIHLDWKRRLRIALGSARGLAYLHELA--------------------------------- 745 (964)
Q Consensus 699 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 745 (964)
++|||++++.++.+..... .....++.++++.++.||+..
T Consensus 86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 9999999998886554321 112334555666666666421
Q ss_pred -----------------------CCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 746 -----------------------NPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 746 -----------------------~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12278999999999999877778999998753
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.26 E-value=3.1e-08 Score=94.89 Aligned_cols=104 Identities=20% Similarity=0.100 Sum_probs=56.8
Q ss_pred cccEEecccCCCCCCCCCCCCCCcccchhhccccccccCcCCcccCCCCCccEEEcccCcccCcC--CCcCCCccccccc
Q 002121 89 ELRSLDLSYNGGLTGSLSPRIGDLQKLNILILAGCGFTGNIPDEIGNLAELSFLALNSNNFSGRI--PPSLGKLSQLYWL 166 (964)
Q Consensus 89 ~L~~L~L~~N~~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L 166 (964)
+.+.|||+++. . .+.+..+..+..|.+.++.+. .++..+..+++|++|+|++|+|+..- +..+..+++|+.|
T Consensus 23 ~~~~Ldls~l~-~----~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 23 SQQALDLKGLR-S----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSCCBCCCCCS-S----CTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred hhCeeecccCC-C----CchhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCccccc
Confidence 34556666552 1 123444445555555555443 44444556777888888888877432 2345567777777
Q ss_pred cccccccccccCcccCCCCccccccCCCeeEccCCccc
Q 002121 167 DLADNQLTGSIPVSTITSPGLDQLKNAKHFHFNKNKLS 204 (964)
Q Consensus 167 ~Ls~N~l~g~iP~~~~~~~~l~~l~~L~~L~L~~N~l~ 204 (964)
+|++|+++ .++.- ......+|+.|++++|.+.
T Consensus 97 ~Ls~N~i~-~l~~l-----~~l~~~~L~~L~L~~Npl~ 128 (162)
T d1koha1 97 NLSGNELK-SEREL-----DKIKGLKLEELWLDGNSLS 128 (162)
T ss_dssp CCTTSCCC-CGGGH-----HHHTTCCCSSCCCTTSTTS
T ss_pred ccccCccc-cchhh-----hhhhccccceeecCCCCcC
Confidence 77777776 23210 1112234555555555554
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=2.7e-08 Score=95.27 Aligned_cols=46 Identities=22% Similarity=0.270 Sum_probs=22.7
Q ss_pred ccCccccCCCCCCeeeccCccCccCCC--C-CCCCCCCCEEEccCCCCC
Q 002121 255 KVPTNLNNLTNVNELNLAHNDLKGPFP--D-LSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 255 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~--~-l~~l~~L~~L~Ls~N~l~ 300 (964)
.++..+..+++|++|+|++|+|+.+.+ . +..+++|+.|+|++|.++
T Consensus 56 ~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~ 104 (162)
T d1koha1 56 TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK 104 (162)
T ss_dssp HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC
T ss_pred hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccc
Confidence 334444455666666666666654432 1 333444445555555443
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=3.4e-06 Score=86.52 Aligned_cols=131 Identities=18% Similarity=0.179 Sum_probs=87.4
Q ss_pred eeecCCc-EEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCC--ccceeEEEEeeCceEEEEEeccCCCh
Q 002121 634 EIGSGGY-GKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKN--LVGLVGFCFEQGEQMLVYEFMANGTL 710 (964)
Q Consensus 634 ~lG~G~f-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lV~E~~~~gsL 710 (964)
.+..|.. +.||+...++|..+++|....... ..+..|++.++.+.... +.+++++..+++..++||||+++-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4455554 689999988888899998664432 35778888888875433 55778888888889999999988665
Q ss_pred hhhhcCCCCCccchHHHHHHHHHHHHHHHHHh------------------------------------------------
Q 002121 711 RESLSGRSGIHLDWKRRLRIALGSARGLAYLH------------------------------------------------ 742 (964)
Q Consensus 711 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~yLH------------------------------------------------ 742 (964)
.+... . ....+.++++.|+-||
T Consensus 94 ~~~~~-------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 94 LSSHL-------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TTSCC-------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccccc-------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 43110 0 0111122222222222
Q ss_pred ---hc----CCCCeeccCCCCCcEEECCCCcEEEeeccccee
Q 002121 743 ---EL----ANPPIIHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 743 ---~~----~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
.. ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 21 122379999999999999887778999987753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.58 E-value=0.00017 Score=78.60 Aligned_cols=76 Identities=20% Similarity=0.109 Sum_probs=49.4
Q ss_pred cceeecCCcEEEEEEEec-CCcEEEEEEecCC------C-cchhHHHHHHHHHHHhcC-C--CCccceeEEEEeeCceEE
Q 002121 632 SNEIGSGGYGKVYRGMLS-DGQVVAIKRAQQG------S-MQGGLEFKTEIELLSRVH-H--KNLVGLVGFCFEQGEQML 700 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~-~g~~vavK~~~~~------~-~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~l 700 (964)
.+.||.|....||+.... +|+.|+||..... . .....+...|.+.|+.+. + ..+.+++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 357899999999999865 4678999975421 1 112234567888887763 3 234455544 4566789
Q ss_pred EEEeccCCC
Q 002121 701 VYEFMANGT 709 (964)
Q Consensus 701 V~E~~~~gs 709 (964)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.37 E-value=1.7e-05 Score=75.65 Aligned_cols=16 Identities=19% Similarity=0.345 Sum_probs=6.8
Q ss_pred CCCCCcEEEcccCcCc
Q 002121 238 YVQTLEVLRLDRNALT 253 (964)
Q Consensus 238 ~l~~L~~L~Ls~N~l~ 253 (964)
..++|+.|+|++|.+.
T Consensus 42 ~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 42 NSKHIEKFSLANTAIS 57 (167)
T ss_dssp TCSCCCEEECTTSCCB
T ss_pred hCCccceeeccccccc
Confidence 3344444444444443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.32 E-value=2.2e-05 Score=74.71 Aligned_cols=64 Identities=11% Similarity=0.157 Sum_probs=35.1
Q ss_pred CCCCCCcEEEcccC-cCcc----ccCccccCCCCCCeeeccCccCccCCC-----CCCCCCCCCEEEccCCCCC
Q 002121 237 GYVQTLEVLRLDRN-ALTG----KVPTNLNNLTNVNELNLAHNDLKGPFP-----DLSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 237 ~~l~~L~~L~Ls~N-~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~ 300 (964)
.+.++|+.|+|+++ .++. .+-..+...+.|++|+|++|.++.... .+...+.|++|+|++|.++
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~ 85 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 85 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcc
Confidence 34567777777763 4542 133345566667777777776653211 1334455555555555554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.89 E-value=0.0018 Score=68.21 Aligned_cols=134 Identities=12% Similarity=0.090 Sum_probs=78.9
Q ss_pred EEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCcc--cee-----EEEEeeCceEEEEEeccCCChhh-
Q 002121 641 GKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV--GLV-----GFCFEQGEQMLVYEFMANGTLRE- 712 (964)
Q Consensus 641 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~-----~~~~~~~~~~lV~E~~~~gsL~~- 712 (964)
-.||++..++|+.|++|+.+.... ..+++..|.+.+..|....+. ..+ ......+..+.|+++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~-s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC-CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 589999999999999999875433 345788899998888533321 111 12234556788999997644310
Q ss_pred ----h---------hc----CCC---CCccch-------------------HHHHHHHHHHHHHHHHHhh----cCCCCe
Q 002121 713 ----S---------LS----GRS---GIHLDW-------------------KRRLRIALGSARGLAYLHE----LANPPI 749 (964)
Q Consensus 713 ----~---------l~----~~~---~~~l~~-------------------~~~~~i~~~ia~gL~yLH~----~~~~~i 749 (964)
+ +| ... ....++ ..+..+...+.+.++.+.. .....+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 0 01 000 011111 1111222222333333332 223458
Q ss_pred eccCCCCCcEEECCCCcEEEeeccccee
Q 002121 750 IHRDVKSTNILLDENLTAKVADFGLSKL 777 (964)
Q Consensus 750 vH~Dlk~~NILl~~~~~~kl~DFGla~~ 777 (964)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 46899997764
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.65 E-value=9.9e-05 Score=69.91 Aligned_cols=63 Identities=17% Similarity=0.218 Sum_probs=27.8
Q ss_pred CCCCCcEEEccc-CcCcc----ccCccccCCCCCCeeeccCccCccCCC-----CCCCCCCCCEEEccCCCCC
Q 002121 238 YVQTLEVLRLDR-NALTG----KVPTNLNNLTNVNELNLAHNDLKGPFP-----DLSQMNSLSYVDLSNNSFD 300 (964)
Q Consensus 238 ~l~~L~~L~Ls~-N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~~-----~l~~l~~L~~L~Ls~N~l~ 300 (964)
+.++|+.|+|++ +.++. .+-..+...++|++|+|++|.++.... .+...++|+.|++++|.++
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~ 87 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 87 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhcccccc
Confidence 334555555554 33431 122333444555555555555443211 1333445555555555553
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.57 E-value=0.0056 Score=63.81 Aligned_cols=157 Identities=13% Similarity=0.070 Sum_probs=87.8
Q ss_pred ccHHHHHHhhcCCCcccee-----ecCCcEEEEEEEecCCcEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCcc--cee
Q 002121 617 FSYDELKKCSNNFSESNEI-----GSGGYGKVYRGMLSDGQVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV--GLV 689 (964)
Q Consensus 617 ~~~~el~~~~~~~~~~~~l-----G~G~fg~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv--~l~ 689 (964)
++.+|++....+|...+.. ..|---+.|+....+|+ +++|++.... ...++..|++++..+.+.++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 6788999999999875543 35555788999887665 8999886532 224566778888887543321 111
Q ss_pred E------EEEeeCceEEEEEeccCCChhh--------------hhcC----CC-----CCcc----------------ch
Q 002121 690 G------FCFEQGEQMLVYEFMANGTLRE--------------SLSG----RS-----GIHL----------------DW 724 (964)
Q Consensus 690 ~------~~~~~~~~~lV~E~~~~gsL~~--------------~l~~----~~-----~~~l----------------~~ 724 (964)
. +....+..+.++.++.+..... .++. .. .... ..
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122345566777776543311 0000 00 0000 01
Q ss_pred HHHHHHHHHHHHHHHHHhh-cCCCCeeccCCCCCcEEECCCCcEEEeecccce
Q 002121 725 KRRLRIALGSARGLAYLHE-LANPPIIHRDVKSTNILLDENLTAKVADFGLSK 776 (964)
Q Consensus 725 ~~~~~i~~~ia~gL~yLH~-~~~~~ivH~Dlk~~NILl~~~~~~kl~DFGla~ 776 (964)
......+..+...+.-.+. .-..++||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222222222232221 123459999999999999998877899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.30 E-value=0.0055 Score=66.19 Aligned_cols=73 Identities=15% Similarity=0.145 Sum_probs=49.9
Q ss_pred cceeecCCcEEEEEEEecCC--------cEEEEEEecCCCcchhHHHHHHHHHHHhcCCCCcc-ceeEEEEeeCceEEEE
Q 002121 632 SNEIGSGGYGKVYRGMLSDG--------QVVAIKRAQQGSMQGGLEFKTEIELLSRVHHKNLV-GLVGFCFEQGEQMLVY 702 (964)
Q Consensus 632 ~~~lG~G~fg~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lV~ 702 (964)
.+.|+-|-.=.+|++...++ +.|.+++... ........+|..+++.+.-.+++ ++++++.+ .+||
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35677788889999987543 4677776653 22234567899999988534554 77777642 6899
Q ss_pred EeccCCCh
Q 002121 703 EFMANGTL 710 (964)
Q Consensus 703 E~~~~gsL 710 (964)
||+++-.+
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987544
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.25 E-value=0.0002 Score=67.65 Aligned_cols=116 Identities=14% Similarity=0.141 Sum_probs=75.0
Q ss_pred ccccCCCCCCeeeccC-ccCccCC-----CCCCCCCCCCEEEccCCCCCCCC---CCcccCCCCCCcEEECCCCccccc-
Q 002121 258 TNLNNLTNVNELNLAH-NDLKGPF-----PDLSQMNSLSYVDLSNNSFDPTE---APLWFSTLPSLTTLICEFGSLQGR- 327 (964)
Q Consensus 258 ~~~~~l~~L~~L~Ls~-N~l~~~~-----~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~~l~~L~~L~Ls~N~l~~~- 327 (964)
....+.++|++|+|++ |.++... ..+...++|++|+|++|.++... +...+...+.|+.|++++|.+...
T Consensus 11 ~~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g 90 (166)
T d1io0a_ 11 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSG 90 (166)
T ss_dssp HHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHH
T ss_pred HHHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchh
Confidence 3445678899999987 4565422 12567888999999999886211 122345667888888888888654
Q ss_pred ---cChhccCCCCCCEEEc--CCccccccc----CCCCccCCCCcEEeccCCcce
Q 002121 328 ---VPDKLFSYSQIQQVKL--RNNAFNNTL----DMGNAVGPLLQLVDLQNNQIS 373 (964)
Q Consensus 328 ---~p~~~~~l~~L~~L~L--~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~ 373 (964)
+...+...++|+.++| ++|.+.... ...+...+.|+.|+++.|...
T Consensus 91 ~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 91 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 3355666778887555 456665422 233445677777777766543
|